Citrus Sinensis ID: 005678
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 683 | 2.2.26 [Sep-21-2011] | |||||||
| Q39238 | 688 | Serine/threonine-protein | yes | no | 0.992 | 0.985 | 0.711 | 0.0 | |
| Q08CW1 | 697 | Serine/threonine-protein | yes | no | 0.695 | 0.681 | 0.476 | 1e-120 | |
| O55047 | 718 | Serine/threonine-protein | yes | no | 0.707 | 0.672 | 0.470 | 1e-119 | |
| Q1ECX4 | 697 | Serine/threonine-protein | yes | no | 0.816 | 0.800 | 0.431 | 1e-119 | |
| Q9UKI8 | 766 | Serine/threonine-protein | no | no | 0.740 | 0.660 | 0.454 | 1e-119 | |
| Q8C0V0 | 766 | Serine/threonine-protein | no | no | 0.740 | 0.660 | 0.454 | 1e-119 | |
| Q86UE8 | 772 | Serine/threonine-protein | yes | no | 0.710 | 0.628 | 0.457 | 1e-117 | |
| Q90ZY6 | 756 | Serine/threonine-protein | no | no | 0.708 | 0.640 | 0.457 | 1e-116 | |
| P34314 | 965 | Serine/threonine-protein | yes | no | 0.648 | 0.459 | 0.424 | 1e-109 | |
| P50528 | 683 | Serine/threonine-protein | yes | no | 0.366 | 0.366 | 0.339 | 2e-30 |
| >sp|Q39238|TSL_ARATH Serine/threonine-protein kinase TOUSLED OS=Arabidopsis thaliana GN=TOUSLED PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 986 bits (2550), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/693 (71%), Positives = 574/693 (82%), Gaps = 15/693 (2%)
Query: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKPPAAQQQQHQHQQH----ATWAALS 56
MSDDM++HFSSNSSNQSD SLP KIAKLEAR+ GK P++ + Q QQ + W++ S
Sbjct: 1 MSDDMVLHFSSNSSNQSDHSLPDKIAKLEARLTGKTPSSAKPPQQQQQQQQQVSLWSSAS 60
Query: 57 STSRSVAAAEDLAQESSSSDSDDDIGGEFLIQANTQKRQKVKEDDNSTVFDRVE---VVA 113
+ + V + E+S SDSDD+ G+FLI+ANT+KRQKV+E +N +V D VE
Sbjct: 61 AAVKVVTSTPPGLSETSISDSDDENTGDFLIRANTKKRQKVQESNNFSVVDHVEPQEAAY 120
Query: 114 DGRQNTTETLEAKASDVNRKKHGRGRGNSGSGRGRGSRAN-EQARSQISSSTVSPSNGQL 172
DGR+N E+ DV++KK GRGR +S +GRGRGS+ N + +SQ + VS ++ QL
Sbjct: 121 DGRKNDAES--KTGLDVSKKKQGRGRASS-TGRGRGSKTNNDVTKSQFVVAPVSAAS-QL 176
Query: 173 ESSHHKDNKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKE 232
++S KD +P Q CS +E++ SL K+A LEE+LRKSRQ++ +Y +L LE E
Sbjct: 177 DASDQKDFRPDGQLRNGECSLQDEDLKSLRAKIAMLEEELRKSRQDSSEYHHLVRNLENE 236
Query: 233 LKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISET 292
+KD+K+ EQQ K + TK+ISDLLISVSK ERQEAR K+R ES+RLG+VGV+R GT+I+ET
Sbjct: 237 VKDLKDQEQQGKQKTTKVISDLLISVSKTERQEARTKVRNESLRLGSVGVLRTGTIIAET 296
Query: 293 WEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQ-PDKGDGVDVESGVQEEDLVIQDEI 351
WEDGQ LKDLNA LRQLLETKEA+ERQRK LKKRQ DK DG D ESG QEED +I DE+
Sbjct: 297 WEDGQMLKDLNAQLRQLLETKEAIERQRKLLKKRQNGDKNDGTDTESGAQEED-IIPDEV 355
Query: 352 YKSRLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLL 411
YKSRL SIKREEEA+LRERERY LEKG L+REMKRIRDEDGSRFN+F +LN RYALLNLL
Sbjct: 356 YKSRLTSIKREEEAVLRERERYTLEKGLLMREMKRIRDEDGSRFNHFPVLNSRYALLNLL 415
Query: 412 GKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVR 471
GKGGFSEVYKAYDLV+HRYVACKLHGLNAQWSE+KKQSYIRHA RE IHK+LVHHHIVR
Sbjct: 416 GKGGFSEVYKAYDLVDHRYVACKLHGLNAQWSEEKKQSYIRHANRECEIHKSLVHHHIVR 475
Query: 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKI 531
LWD F ID +TFCTVLEYCSGKDLDAVLKAT LPE+EARIIIVQI QGL+YLNK++QKI
Sbjct: 476 LWDKFHIDMHTFCTVLEYCSGKDLDAVLKATSNLPEKEARIIIVQIVQGLVYLNKKSQKI 535
Query: 532 IHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK 591
IHYDLKPGNVLFDEFGVAKVTDFGLSKIVED+VGSQGMELTSQGAGTYWYLPPECFEL+K
Sbjct: 536 IHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDNVGSQGMELTSQGAGTYWYLPPECFELNK 595
Query: 592 TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP-SRPAVSNE 650
TP+ISSKVDVWS G+LFYQMLFG+RPFGHDQ+QERILREDTIIKA+KVEFP +RPA+SNE
Sbjct: 596 TPMISSKVDVWSVGVLFYQMLFGKRPFGHDQSQERILREDTIIKAKKVEFPVTRPAISNE 655
Query: 651 AKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
AKDLIRRCLTYNQ +RPDVLT+AQDPYL YSKK
Sbjct: 656 AKDLIRRCLTYNQEDRPDVLTMAQDPYLAYSKK 688
|
Required for correct initiation of floral organ primordia and for proper development of organ primordia. Phosphorylates in vitro ASF1B/SGA1, the C-terminal part of TKI1 and histone H3. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q08CW1|TLK2_XENTR Serine/threonine-protein kinase tousled-like 2 OS=Xenopus tropicalis GN=tlk2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 431 bits (1109), Expect = e-120, Method: Compositional matrix adjust.
Identities = 240/504 (47%), Positives = 323/504 (64%), Gaps = 29/504 (5%)
Query: 204 KVAALEE----DLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIIS---DLLI 256
K++ALE DL K D + L +++ + K+ ++ K R + ++ LLI
Sbjct: 163 KISALENSKSSDLEKKEGRIDDLLRVNCDLRRQMDEQKKMLEKYKERLNRCVTMSKKLLI 222
Query: 257 SVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAV 316
SK E+ R K Q+ +RLG+ +R G +E W DG A ++L ++ +E +
Sbjct: 223 EKSKQEKMACRDKSMQDRLRLGHFTTVRHGASFTEQWTDGYAFQNLIKQQERINTQREEI 282
Query: 317 ERQRKSLKKRQP-----------DKGDGVDVESGVQEEDLVI-----QDEIYKSRLASIK 360
ERQRK L KR+P ++ + +G + E L + Q+EI+K RL +K
Sbjct: 283 ERQRKMLAKRKPPAMGQTPPANNEQKQRKNKTNGAENEALTLAEYHEQEEIFKLRLGHLK 342
Query: 361 REEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVY 420
+EE I E ER E + IRE+KRI +ED S+F + LN RY LL+LLG+GGFSEVY
Sbjct: 343 KEEAEIQAELERLERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVY 402
Query: 421 KAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480
KA+DL E RYVA K+H LN W ++KK++Y +HA REY IHK L H IV+L+D F +D
Sbjct: 403 KAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 462
Query: 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGN 540
++FCTVLEYC G DLD LK ++ E+EAR II+QI L YLN+ IIHYDLKPGN
Sbjct: 463 DSFCTVLEYCEGNDLDFYLKQHKLMTEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGN 522
Query: 541 VLF---DEFGVAKVTDFGLSKIVEDDVGSQ--GMELTSQGAGTYWYLPPECFELSK-TPL 594
+L G K+TDFGLSKI++DD + GMELTSQGAGTYWYLPPECF + K P
Sbjct: 523 ILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPK 582
Query: 595 ISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDL 654
IS+KVDVWS G++FYQ L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+FP +P V+ EAK
Sbjct: 583 ISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAF 642
Query: 655 IRRCLTYNQAERPDVLTLAQDPYL 678
IRRCL Y + +R DV LA DPYL
Sbjct: 643 IRRCLAYRKEDRIDVQQLACDPYL 666
|
Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O55047|TLK2_MOUSE Serine/threonine-protein kinase tousled-like 2 OS=Mus musculus GN=Tlk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 431 bits (1107), Expect = e-119, Method: Compositional matrix adjust.
Identities = 242/514 (47%), Positives = 331/514 (64%), Gaps = 31/514 (6%)
Query: 188 IDNCSSLEEEVTS-LHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPR 246
I+ S+LE S L +K +++ LR + +L Q++++ K +++Y++++ R
Sbjct: 182 IEKISALENSKNSDLEKKEGRIDDLLRAN-------CDLRRQIDEQQKMLEKYKERLN-R 233
Query: 247 RTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHL 306
+ LLI SK E+ R K Q+ +RLG+ +R G +E W DG A ++L
Sbjct: 234 CVTMSKKLLIEKSKQEKMACRDKSMQDRLRLGHFTTVRHGASFTEQWTDGYAFQNLIKQQ 293
Query: 307 RQLLETKEAVERQRKSLKKRQP-----------DKGDGVDVESGVQEEDLVI-----QDE 350
++ +E +ERQRK L KR+P ++ +G + E L + Q+E
Sbjct: 294 ERINSQREEIERQRKMLAKRKPPAMGQAPPATNEQKQRKSKTNGAENETLTLAEYHEQEE 353
Query: 351 IYKSRLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNL 410
I+K RL +K+EE I E ER E + IRE+KRI +ED S+F + LN RY LL+L
Sbjct: 354 IFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHL 413
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
LG+GGFSEVYKA+DL E RYVA K+H LN W ++KK++Y +HA REY IHK L H IV
Sbjct: 414 LGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIV 473
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQK 530
+L+D F +D ++FCTVLEYC G DLD LK ++ E+EAR II+QI L YLN+
Sbjct: 474 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPP 533
Query: 531 IIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQ--GMELTSQGAGTYWYLPPE 585
IIHYDLKPGN+L G K+TDFGLSKI++DD + GMELTSQGAGTYWYLPPE
Sbjct: 534 IIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPE 593
Query: 586 CFELSK-TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
CF + K P IS+KVDVWS G++FYQ L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+FP +
Sbjct: 594 CFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK 653
Query: 645 PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
P V+ EAK IRRCL Y + +R DV LA DPYL
Sbjct: 654 PVVTPEAKAFIRRCLAYRKEDRIDVQQLACDPYL 687
|
Testis-specific isoforms may play a role in spermatogenesis. Highly expressed in embryos throughout development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1ECX4|TLK2_DANRE Serine/threonine-protein kinase tousled-like 2 OS=Danio rerio GN=tlk2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 430 bits (1106), Expect = e-119, Method: Compositional matrix adjust.
Identities = 266/616 (43%), Positives = 360/616 (58%), Gaps = 58/616 (9%)
Query: 121 ETLEAKASDV-NRKKHGRGRGNSGSGRGRGSRANEQARSQISSST-VSPSNG-----QLE 173
ET E K++D RK+ G + G G GRG + ++ S T SP+ G +
Sbjct: 51 ETPEKKSNDQRTRKRKGDPFDSQGKGGGRGHKISDYFEFAGGSGTGTSPARGIPPVARSS 110
Query: 174 SSHHKDNKPK--EQFLIDNCSSLEEE------------VTSLHR---------KVAALEE 210
H N P +Q + SS+ + + + HR K+AALE
Sbjct: 111 PQHSLSNPPAAVQQGSPSSISSVNTDHSHTSTSHKPASIHTQHRASQSELTMEKLAALES 170
Query: 211 ----DLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIIS---DLLISVSKAER 263
DL K D + L +++ + ++ + K R K ++ LLI SK E+
Sbjct: 171 SKSSDLEKKEGRIDDLLRVNCDLRRQIDEQQKMLEWCKERLNKCVTMSKKLLIEKSKQEK 230
Query: 264 QEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAVERQRKSL 323
R K Q+ +RLG+ +R G +E W DG A ++L ++ +E +ERQRK L
Sbjct: 231 IACREKSMQDRLRLGHFTTVRHGASFTEQWTDGYAFQNLVKQQERVNGQREEIERQRKLL 290
Query: 324 KKRQPDKGDGVDV-----------ESGVQEEDLVI-----QDEIYKSRLASIKREEEAIL 367
K++P +G + E L + Q+EI+K RL +K+EE I
Sbjct: 291 IKKKPPSASQTPPPNLEPNKRKSKSNGAENEMLSLAEYHEQEEIFKLRLGHLKKEEAEIQ 350
Query: 368 RERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVE 427
E ER E + IRE+KRI +ED S+F + LN RY LL+LLG+GGFSEVYKA+DL E
Sbjct: 351 VELERLERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTE 410
Query: 428 HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487
RYVA K+H LN W ++KK++Y +HA REY IHK L H IV+L+D F +D ++FCTVL
Sbjct: 411 QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 470
Query: 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---D 544
EYC G DLD LK ++ E+EAR II+Q+ L YLN+ IIHYDLKPGN+L
Sbjct: 471 EYCEGNDLDFYLKQHKLMSEKEARSIIMQVVNALKYLNEIRPPIIHYDLKPGNILLVNGT 530
Query: 545 EFGVAKVTDFGLSKIVEDD-VGSQGMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVW 602
G K+TDFGLSKI++DD G GMELTSQGAGTYWYLPPECF + K P IS+KVDVW
Sbjct: 531 ACGEIKITDFGLSKIMDDDNYGVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVW 590
Query: 603 SAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYN 662
S G++FYQ L+G++PFGH+Q+Q+ IL+E+TI+KA +V+FP +P VS EAK IRRCL Y
Sbjct: 591 SVGVIFYQCLYGKKPFGHNQSQQDILQENTILKATEVQFPPKPGVSPEAKAFIRRCLVYR 650
Query: 663 QAERPDVLTLAQDPYL 678
+ +R DV LA DPYL
Sbjct: 651 KEDRIDVHQLASDPYL 666
|
Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UKI8|TLK1_HUMAN Serine/threonine-protein kinase tousled-like 1 OS=Homo sapiens GN=TLK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 428 bits (1100), Expect = e-119, Method: Compositional matrix adjust.
Identities = 252/554 (45%), Positives = 337/554 (60%), Gaps = 48/554 (8%)
Query: 166 SPSNGQLESSHHKDNKPKE-QFLIDNCSSLEEEVTSLHRKVAALE----EDLRKSRQNAV 220
SPS L H +PK+ F I ++ ++T L K+AALE +DL K
Sbjct: 188 SPSPTALAFGDHPIVQPKQLSFKI-----IQTDLTML--KLAALESNKIQDLEKKEGRID 240
Query: 221 DYQNLCHQLEKELKDVKEYEQQMKPRRTKIIS---DLLISVSKAERQEARLKIRQESVRL 277
D L +++ + ++ ++ K R K IS LLI S E+ +R K Q+ +RL
Sbjct: 241 DLLRANCDLRRQIDEQQKLLEKYKERLNKCISMSKKLLIEKSTQEKLSSREKSMQDRLRL 300
Query: 278 GNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVE 337
G+ +R G +E W DG A ++L + + +E +ERQRK L KR+P +
Sbjct: 301 GHFTTVRHGASFTEQWTDGFAFQNLVKQQEWVNQQREDIERQRKLLAKRKPPTANNSQAP 360
Query: 338 S--------------GVQEEDLVI--------------QDEIYKSRLASIKREEEAILRE 369
S G + + V Q+EI+K RL +K+EE I E
Sbjct: 361 STNSEPKQRKNKAVNGAENDPFVRPNLPQLLTLAEYHEQEEIFKLRLGHLKKEEAEIQAE 420
Query: 370 RERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHR 429
ER E + IRE+KRI +ED S+F + LN RY LL+LLG+GGFSEVYKA+DL E R
Sbjct: 421 LERLERVRNLHIRELKRINNEDNSQFKDHPTLNERYLLLHLLGRGGFSEVYKAFDLYEQR 480
Query: 430 YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEY 489
Y A K+H LN W ++KK++Y +HA REY IHK L H IV+L+D F +D +TFCTVLEY
Sbjct: 481 YAAVKIHQLNKSWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDTFCTVLEY 540
Query: 490 CSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEF 546
C G DLD LK ++ E+EAR I++QI L YLN+ IIHYDLKPGN+L
Sbjct: 541 CEGNDLDFYLKQHKLMSEKEARSIVMQIVNALRYLNEIKPPIIHYDLKPGNILLVDGTAC 600
Query: 547 GVAKVTDFGLSKIVEDD-VGSQGMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVWSA 604
G K+TDFGLSKI++DD G GM+LTSQGAGTYWYLPPECF + K P IS+KVDVWS
Sbjct: 601 GEIKITDFGLSKIMDDDSYGVDGMDLTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 660
Query: 605 GILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQA 664
G++F+Q L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+FP +P VS+EAK IRRCL Y +
Sbjct: 661 GVIFFQCLYGRKPFGHNQSQQDILQENTILKATEVQFPVKPVVSSEAKAFIRRCLAYRKE 720
Query: 665 ERPDVLTLAQDPYL 678
+R DV LA DPYL
Sbjct: 721 DRFDVHQLANDPYL 734
|
Rapidly and transiently inhibited by phosphorylation following the generation of DNA double-stranded breaks during S-phase. This is cell cycle checkpoint and ATM-pathway dependent and appears to regulate processes involved in chromatin assembly. Isoform 3 phosphorylates and enhances the stability of the t-SNARE SNAP23, augmenting its assembly with syntaxin. Isoform 3 protects the cells from the ionizing radiation by faciliting the repair of DSBs. In vitro, phosphorylates histone H3 at 'Ser-10'. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8C0V0|TLK1_MOUSE Serine/threonine-protein kinase tousled-like 1 OS=Mus musculus GN=Tlk1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 428 bits (1100), Expect = e-119, Method: Compositional matrix adjust.
Identities = 252/554 (45%), Positives = 336/554 (60%), Gaps = 48/554 (8%)
Query: 166 SPSNGQLESSHHKDNKPKE-QFLIDNCSSLEEEVTSLHRKVAALE----EDLRKSRQNAV 220
SPS L H +PK+ F I + ++T L K+AALE +DL K
Sbjct: 188 SPSPTALAFGDHPVVQPKQLSFKI-----TQTDLTML--KLAALESTKNQDLEKKEGRID 240
Query: 221 DYQNLCHQLEKELKDVKEYEQQMKPRRTKIIS---DLLISVSKAERQEARLKIRQESVRL 277
D L +++ D ++ ++ K R K IS LLI S E+ +R K Q+ +RL
Sbjct: 241 DLLRANCDLRRQIDDQQKLLEKYKERLNKCISMSKKLLIEKSTQEKLSSREKSMQDRLRL 300
Query: 278 GNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVE 337
G+ +R G +E W DG A ++L + + +E +ERQRK L KR+P +
Sbjct: 301 GHFTTVRHGASFTEQWTDGFAFQNLVKQQEWVNQQREDIERQRKLLGKRKPPTANNSQAP 360
Query: 338 S--------------GVQEEDLVI--------------QDEIYKSRLASIKREEEAILRE 369
+ G + + V Q+EI+K RL +K+EE I E
Sbjct: 361 ATNSEAKQRKTKAVNGAENDPFVRPNLPQLLTLAEYHEQEEIFKLRLGHLKKEEAEIQAE 420
Query: 370 RERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHR 429
ER E + IRE+KRI +ED S+F + LN RY LL+LLG+GGFSEVYKA+DL E R
Sbjct: 421 LERLERVRNLHIRELKRINNEDNSQFKDHPTLNERYLLLHLLGRGGFSEVYKAFDLYEQR 480
Query: 430 YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEY 489
Y A K+H LN W ++KK++Y +HA REY IHK L H IV+L+D F +D +TFCTVLEY
Sbjct: 481 YAAVKIHQLNKSWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDTFCTVLEY 540
Query: 490 CSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEF 546
C G DLD LK ++ E+EAR I++QI L YLN+ IIHYDLKPGN+L
Sbjct: 541 CEGNDLDFYLKQHKLMSEKEARSIVMQIVNALRYLNEIKPPIIHYDLKPGNILLVDGTAC 600
Query: 547 GVAKVTDFGLSKIVEDD-VGSQGMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVWSA 604
G K+TDFGLSKI++DD G GM+LTSQGAGTYWYLPPECF + K P IS+KVDVWS
Sbjct: 601 GEIKITDFGLSKIMDDDSYGVDGMDLTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 660
Query: 605 GILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQA 664
G++F+Q L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+FP +P VS+EAK IRRCL Y +
Sbjct: 661 GVIFFQCLYGRKPFGHNQSQQDILQENTILKATEVQFPVKPVVSSEAKAFIRRCLAYRKE 720
Query: 665 ERPDVLTLAQDPYL 678
+R DV LA DPYL
Sbjct: 721 DRFDVHQLANDPYL 734
|
Rapidly and transiently inhibited by phosphorylation following the generation of DNA double-stranded breaks during S-phase. This is cell cycle checkpoint and ATM-pathway dependent and appears to regulate processes involved in chromatin assembly (By similarity). Isoform 3 protects the cells from the ionizing radiation by faciliting the repair of DSBs. In vitro, phosphorylates histone H3 at 'Ser-10'. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q86UE8|TLK2_HUMAN Serine/threonine-protein kinase tousled-like 2 OS=Homo sapiens GN=TLK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 246/538 (45%), Positives = 333/538 (61%), Gaps = 53/538 (9%)
Query: 186 FLIDNCSSLEEEVTS-LHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMK 244
I+ S+LE S L +K +++ LR + +L Q++++ K +++Y++++
Sbjct: 212 LTIEKISALENSKNSDLEKKEGRIDDLLRAN-------CDLRRQIDEQQKMLEKYKERLN 264
Query: 245 PRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKDLNA 304
R + LLI SK E+ R K Q+ +RLG+ +R G +E W DG A ++L
Sbjct: 265 -RCVTMSKKLLIEKSKQEKMACRDKSMQDRLRLGHFTTVRHGASFTEQWTDGYAFQNLIK 323
Query: 305 HLRQLLETKEAVERQRKSLKKRQP-----------------DKGDGVDVE---SGVQE-E 343
++ +E +ERQRK L KR+P K +G + E SG E +
Sbjct: 324 QQERINSQREEIERQRKMLAKRKPPAMGQAPPATNEQKQRKSKTNGAENETPSSGNTELK 383
Query: 344 DLVI-----------------QDEIYKSRLASIKREEEAILRERERYELEKGRLIREMKR 386
D Q+EI+K RL +K+EE I E ER E + IRE+KR
Sbjct: 384 DTAPALGAHSLLRLTLAEYHEQEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKR 443
Query: 387 IRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK 446
I +ED S+F + LN RY LL+LLG+GGFSEVYKA+DL E RYVA K+H LN W ++K
Sbjct: 444 IHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEK 503
Query: 447 KQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLP 506
K++Y +HA REY IHK L H IV+L+D F +D ++FCTVLEYC G DLD LK ++
Sbjct: 504 KENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMS 563
Query: 507 EREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDD 563
E+EAR II+QI L YLN+ IIHYDLKPGN+L G K+TDFGLSKI++DD
Sbjct: 564 EKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD 623
Query: 564 VGSQ--GMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVWSAGILFYQMLFGRRPFGH 620
+ GMELTSQGAGTYWYLPPECF + K P IS+KVDVWS G++FYQ L+GR+PFGH
Sbjct: 624 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 683
Query: 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+Q+Q+ IL+E+TI+KA +V+FP +P V+ EAK IRRCL Y + +R DV LA DPYL
Sbjct: 684 NQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQQLACDPYL 741
|
Serine/threonine-protein kinase involved in the process of chromatin assembly and probably also DNA replication, transcription, repair, and chromosome segregation. Phosphorylates the chromatin assembly factors ASF1A AND ASF1B. Phosphorylation of ASF1A prevents its proteasome-mediated degradation, thereby enhancing chromatin assembly. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q90ZY6|TLK1B_DANRE Serine/threonine-protein kinase tousled-like 1-B OS=Danio rerio GN=tlk1b PE=2 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1077), Expect = e-116, Method: Compositional matrix adjust.
Identities = 240/525 (45%), Positives = 324/525 (61%), Gaps = 41/525 (7%)
Query: 193 SLEEEVTSLHRKVAALEE----DLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRT 248
S++ ++T L K+AALE DL K D L +++ + ++ ++ K R
Sbjct: 206 SVQTDLTLL--KLAALESNKNLDLEKKEGRIDDLLRANCDLRRQIDEQQKLLERFKERLN 263
Query: 249 KIIS---DLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKDLNAH 305
K + LLI S E+Q R K Q+ +RLG+ +R G SE W DG A ++L
Sbjct: 264 KCTTMSKKLLIEKSTQEKQSCREKSMQDRLRLGHFTTVRHGASYSEQWTDGYAFQNLVKQ 323
Query: 306 LRQLLETKEAVERQRKSL-------------------KKRQPDKGDGVDVESGVQEEDLV 346
+ + +E +ERQRK L K+R+ +G D + ++
Sbjct: 324 QEWINQQREEIERQRKLLAKRKPSSTPSSQSPTPNESKQRKTKAVNGADNDPFLKPSLPT 383
Query: 347 I--------QDEIYKSRLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNF 398
+ Q+EI+K RL +K+EE I E ER E + IRE+KRI +ED S+F +
Sbjct: 384 LLTVAEYHEQEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRINNEDSSQFKDH 443
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
LN RY LL+LLG+GGFSEVYKA+DL E RY A K+H LN W E+KK++Y +HA REY
Sbjct: 444 PTLNERYLLLHLLGRGGFSEVYKAFDLFEQRYAAVKIHQLNKNWREEKKENYHKHACREY 503
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIF 518
IHK L H IV+L+D F +D +TFCTVLE+C G DLD LK ++ E+EAR I++QI
Sbjct: 504 RIHKQLDHPRIVKLYDYFSLDTDTFCTVLEFCEGNDLDFYLKQHKLMSEKEARSIVMQIV 563
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDD-VGSQGMELTSQ 574
L YLN+ IIHYDLKPGN+L G K+TDFGLSKI++DD G GM+LTSQ
Sbjct: 564 NALRYLNEIKPSIIHYDLKPGNILLVDGTACGEIKITDFGLSKIMDDDSYGVDGMDLTSQ 623
Query: 575 GAGTYWYLPPECFELSK-TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633
GAGTYWYLPPECF + K P IS+KVDVWS G++F+Q L+GR+PFGH+Q+Q+ IL+E+TI
Sbjct: 624 GAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFFQCLYGRKPFGHNQSQQDILQENTI 683
Query: 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+KA +V+FP++P SNEAK IRRCL Y + +R DV L D YL
Sbjct: 684 LKATEVQFPAKPVASNEAKAFIRRCLAYRKEDRSDVHQLGSDSYL 728
|
Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P34314|TLK1_CAEEL Serine/threonine-protein kinase tousled-like 1 OS=Caenorhabditis elegans GN=tlk-1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 396 bits (1017), Expect = e-109, Method: Compositional matrix adjust.
Identities = 205/483 (42%), Positives = 293/483 (60%), Gaps = 40/483 (8%)
Query: 231 KELKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVIS 290
+EL E++ + I LLI ++ ER+ R K +S R+G R G
Sbjct: 443 EELNSKNSLERRKNEASKETIKRLLIDKNQIERKALRDKTAADSPRIGCFKTTRTGDSFR 502
Query: 291 ETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQP----------------DKGDGV 334
+ W DG A +++ Q+ + + LKKR+P + +G+
Sbjct: 503 DQWVDGWAFAEMDKKTEQINAERNEIASASALLKKRKPLGIGKEPKRPQAVNSQNDSNGM 562
Query: 335 DVESG------------------VQEEDLVIQDEIYKSRLASIKREEEAILRERERYELE 376
+ +Q ++ + DEIYK R +++EE + E+ER E E
Sbjct: 563 QPSTSSNTNGDDAIFRRPEEPKEIQYQEYIELDEIYKLRREHLRKEETDLSMEKERLEKE 622
Query: 377 KGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLH 436
K +RE+KR +E S+FN+ ++L+ RY +LNLLGKGGFSEV+KA+D+ E+RYVACK+H
Sbjct: 623 KQHHVRELKRASNESASQFNDHRLLHKRYLMLNLLGKGGFSEVWKAFDIEENRYVACKIH 682
Query: 437 GLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLD 496
+N W E+KK +Y++HA+RE +IHK+L H IV+ +D ID ++FCTVLEY G DLD
Sbjct: 683 HVNKDWKEEKKANYVKHAMREKDIHKSLDHCRIVKQYDLLTIDNHSFCTVLEYVPGNDLD 742
Query: 497 AVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---FGVAKVTD 553
LK + E+EAR II+Q+ L+YLN+++ IIHYDLKP N+L + G K+TD
Sbjct: 743 FYLKQNRSISEKEARSIIMQVVSALVYLNEKSTPIIHYDLKPANILLESGNTSGAIKITD 802
Query: 554 FGLSKIV--EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM 611
FGLSKI+ E D G+ELTSQ AGTYWYLPPE F + P I+ KVDVWS G++FYQ
Sbjct: 803 FGLSKIMEGESDDHDLGIELTSQFAGTYWYLPPETF-IVPPPKITCKVDVWSIGVIFYQC 861
Query: 612 LFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLT 671
++G++PFG+D TQ++IL +TII AR+V FPS+P VS+ A+D IRRCL Y + +R DV
Sbjct: 862 IYGKKPFGNDLTQQKILEYNTIINAREVSFPSKPQVSSAAQDFIRRCLQYRKEDRADVFE 921
Query: 672 LAQ 674
LA+
Sbjct: 922 LAK 924
|
Essential for appropriate transcription during embryonic development. May act during transcription elongation to activate the RNA polymerase II large subunit (ama-1) by phosphorylating the Ser-2 residues of the C-terminal domain 7-residue repeats. Does not phosphorylate histone H3. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P50528|PLO1_SCHPO Serine/threonine-protein kinase plo1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=plo1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (338), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 91/268 (33%), Positives = 141/268 (52%), Gaps = 18/268 (6%)
Query: 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
N Y + +G+GGF+ ++ D + Y A + + Q + K + + E +H
Sbjct: 38 NIFYTRYDCIGEGGFARCFRVKDNYGNIYAAKVIAKRSLQNDKTKLKLF-----GEIKVH 92
Query: 462 KTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
+++ H +IV D FE N + +LE C K L +L+ L E E R +++QI L
Sbjct: 93 QSMSHPNIVGFIDCFEDSTNIYL-ILELCEHKSLMELLRKRKQLTEPEVRYLMMQILGAL 151
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
Y++K+ ++IH DLK GN++ DE K+ DFGL+ ++ DD E GT Y
Sbjct: 152 KYMHKK--RVIHRDLKLGNIMLDESNNVKIGDFGLAALLMDD-----EERKMTICGTPNY 204
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
+ PE SK S +VD+WSAG++ Y +L G+ PF D+ + I R+ IKA F
Sbjct: 205 IAPEILFNSKEGH-SFEVDLWSAGVVMYALLIGKPPF-QDKEVKTIYRK---IKANSYSF 259
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDV 669
PS +S EAKDLI LT++ + RP +
Sbjct: 260 PSNVDISAEAKDLISSLLTHDPSIRPSI 287
|
Required to form a bipolar spindle, the actin ring and septum. Functions upstream of the whole septum formation pathway, including actin ring formation (regulated by late septation genes) and septal material deposition (regulated by early septation genes). Behaves as a "septum-promoting factor", and could also be involved in inducing other late events of cell division. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 683 | ||||||
| 225436077 | 679 | PREDICTED: serine/threonine-protein kina | 0.992 | 0.998 | 0.837 | 0.0 | |
| 224102943 | 676 | predicted protein [Populus trichocarpa] | 0.985 | 0.995 | 0.816 | 0.0 | |
| 449439168 | 683 | PREDICTED: serine/threonine-protein kina | 0.988 | 0.988 | 0.797 | 0.0 | |
| 449525144 | 683 | PREDICTED: serine/threonine-protein kina | 0.988 | 0.988 | 0.794 | 0.0 | |
| 224132210 | 673 | predicted protein [Populus trichocarpa] | 0.969 | 0.983 | 0.786 | 0.0 | |
| 356499255 | 680 | PREDICTED: serine/threonine-protein kina | 0.989 | 0.994 | 0.804 | 0.0 | |
| 350539429 | 672 | tousled-like protein [Solanum lycopersic | 0.975 | 0.991 | 0.770 | 0.0 | |
| 356553689 | 679 | PREDICTED: serine/threonine-protein kina | 0.989 | 0.995 | 0.809 | 0.0 | |
| 357493449 | 670 | Tousled-like kinase [Medicago truncatula | 0.979 | 0.998 | 0.793 | 0.0 | |
| 255573267 | 688 | Serine/threonine-protein kinase plo1, pu | 0.978 | 0.970 | 0.755 | 0.0 |
| >gi|225436077|ref|XP_002276975.1| PREDICTED: serine/threonine-protein kinase TOUSLED [Vitis vinifera] gi|296084006|emb|CBI24394.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1132 bits (2928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 573/684 (83%), Positives = 620/684 (90%), Gaps = 6/684 (0%)
Query: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKPPAAQQQQHQHQQHATWAALSSTSR 60
MSDDM+IHFSSNSSN SDQSLPTKIAKLEARMVG+ P+A ATW++ S +S+
Sbjct: 1 MSDDMIIHFSSNSSNHSDQSLPTKIAKLEARMVGRDPSAVPATSTAP--ATWSSASVSSK 58
Query: 61 SVAAAEDLAQESSSSDSDDDIGGEFLIQANTQKRQKVKEDDNSTVFDRVEVVADGRQNTT 120
V A E+LA+ +SSDSDDD GG+FLIQANTQKRQK++EDD STVF+ VE VADGRQ
Sbjct: 59 FVPA-ENLAELGTSSDSDDDNGGDFLIQANTQKRQKLQEDD-STVFEHVEAVADGRQKIV 116
Query: 121 ETLEAKAS-DVNRKKHGRGRGNSGSGRGRGSRANEQARSQISSSTVSPSNGQLESSHHKD 179
ET+E KA DVNRKK GRGRG++GSGRGRGSRA++Q R+ IS ST+SPSNGQLE S HKD
Sbjct: 117 ETMETKAGFDVNRKKQGRGRGHAGSGRGRGSRASDQTRAHISPSTISPSNGQLEISCHKD 176
Query: 180 NKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEY 239
N+ KEQF D+ SSLE+ V SL K+ ALEEDL+KSRQ + YQ LCHQLEKELKD+K++
Sbjct: 177 NRSKEQFGNDDRSSLED-VASLRAKITALEEDLQKSRQESSHYQQLCHQLEKELKDLKDH 235
Query: 240 EQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQAL 299
EQQMKP+R KI+SDLLISVSKAERQEAR+K+RQ+S+RLGNVGVIRAGTVISETWEDGQ L
Sbjct: 236 EQQMKPKRMKIMSDLLISVSKAERQEARMKVRQDSLRLGNVGVIRAGTVISETWEDGQTL 295
Query: 300 KDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLASI 359
KDLNAHLR LLE KEAVERQRKSLKKRQ DKGDG+D E+GVQEED +I DEIYKSRLASI
Sbjct: 296 KDLNAHLRHLLEMKEAVERQRKSLKKRQSDKGDGIDAETGVQEEDFLIHDEIYKSRLASI 355
Query: 360 KREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEV 419
KREEE LRER+RYEL+KGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEV
Sbjct: 356 KREEETFLRERDRYELDKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEV 415
Query: 420 YKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479
YKAYDLVEHRYVACKLHGLNAQWSE+KKQSYIRHAIREYNIHKTLVHHHIVRLWD FEID
Sbjct: 416 YKAYDLVEHRYVACKLHGLNAQWSEEKKQSYIRHAIREYNIHKTLVHHHIVRLWDIFEID 475
Query: 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPG 539
N FCTVLEYCSGKDLDAVLKATP+LPEREARIIIVQIFQGL+YLNKR QKIIHYDLKPG
Sbjct: 476 HNAFCTVLEYCSGKDLDAVLKATPILPEREARIIIVQIFQGLVYLNKRTQKIIHYDLKPG 535
Query: 540 NVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKV 599
NVLFD+ GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKV
Sbjct: 536 NVLFDDLGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKV 595
Query: 600 DVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCL 659
DVWSAG+LFYQMLFGRRPFGHDQTQERILREDTII ARKVEFPSRPAVSNEAKDLIRRCL
Sbjct: 596 DVWSAGVLFYQMLFGRRPFGHDQTQERILREDTIINARKVEFPSRPAVSNEAKDLIRRCL 655
Query: 660 TYNQAERPDVLTLAQDPYLTYSKK 683
TYNQAERPDVLT+AQDPYLTYSKK
Sbjct: 656 TYNQAERPDVLTIAQDPYLTYSKK 679
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102943|ref|XP_002312863.1| predicted protein [Populus trichocarpa] gi|222849271|gb|EEE86818.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1124 bits (2906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 557/682 (81%), Positives = 612/682 (89%), Gaps = 9/682 (1%)
Query: 5 MLIHFSSNSSNQSDQSLPTKIAKLEARMVGKPPAAQQQQHQHQQHATWAALSSTSRSVAA 64
ML+HFSSNSSNQSDQSLPTKIAKLEARM GK P+ QQ W+++S +
Sbjct: 1 MLMHFSSNSSNQSDQSLPTKIAKLEARMAGKVPSVTP--GPPQQQPIWSSVSPGPK-FGP 57
Query: 65 AEDLAQESSSSDSDDDIGGEFLIQANTQKRQKVKEDDNSTVFDRVEV--VADGRQNTTET 122
E+LA+ SSDSDDD GGEFLIQANTQKRQ+++E++NS V + +E V DGRQ T ET
Sbjct: 58 PEELAE---SSDSDDDNGGEFLIQANTQKRQRLQENNNSAVIEHLETQAVNDGRQKTGET 114
Query: 123 LEAKA-SDVNRKKHGRGRGNSGSGRGRGSRANEQARSQISSSTVSPSNGQLESSHHKDNK 181
E K S+ NRKK GRGRG S SGRGRGSRAN+Q RSQ+S ST SPSNGQLE+S+ KDN+
Sbjct: 115 EETKGGSETNRKKQGRGRGQSNSGRGRGSRANDQIRSQVSVSTASPSNGQLENSYLKDNR 174
Query: 182 PKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQ 241
PKE F D+ SLEEE+ SL KV+ LEEDLRKSRQ A + +LCHQLEKELK++K+YEQ
Sbjct: 175 PKEHFRNDDHISLEEELASLRAKVSILEEDLRKSRQEASNNHDLCHQLEKELKELKDYEQ 234
Query: 242 QMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKD 301
QMKP+RTKIISDLLISVSKAERQEAR+K+RQ+S+RLG+VGVIRAGT+ISETWEDGQ LKD
Sbjct: 235 QMKPKRTKIISDLLISVSKAERQEARMKVRQDSLRLGSVGVIRAGTIISETWEDGQMLKD 294
Query: 302 LNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLASIKR 361
LN HLRQLLETKEA+ERQRKSLKKRQ DKGDG D ESGVQEED +IQDEI+KSRL S+KR
Sbjct: 295 LNIHLRQLLETKEAIERQRKSLKKRQSDKGDGTDAESGVQEEDFLIQDEIFKSRLVSMKR 354
Query: 362 EEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYK 421
EEE ILRER+RYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYK
Sbjct: 355 EEETILRERDRYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYK 414
Query: 422 AYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481
AYDLV+HRYVACKLHGLNAQWSEDKKQSYIRHA+REYNIHKTLVH+HIVRLWD FEIDQN
Sbjct: 415 AYDLVDHRYVACKLHGLNAQWSEDKKQSYIRHAMREYNIHKTLVHNHIVRLWDIFEIDQN 474
Query: 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNV 541
TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL+YLNKRAQKIIHYDLKPGNV
Sbjct: 475 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLVYLNKRAQKIIHYDLKPGNV 534
Query: 542 LFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDV 601
LFDEFG+AKVTDFGLSKIVE+DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDV
Sbjct: 535 LFDEFGIAKVTDFGLSKIVEEDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDV 594
Query: 602 WSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTY 661
WSAG+LFYQML+GRRPFGHDQTQERILREDTIIKAR+VEFPS+P +SNEAKDLIRRCLTY
Sbjct: 595 WSAGVLFYQMLYGRRPFGHDQTQERILREDTIIKARRVEFPSKPTISNEAKDLIRRCLTY 654
Query: 662 NQAERPDVLTLAQDPYLTYSKK 683
NQA+RPDVLT+AQDPYLTY K+
Sbjct: 655 NQADRPDVLTIAQDPYLTYVKR 676
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439168|ref|XP_004137359.1| PREDICTED: serine/threonine-protein kinase TOUSLED-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1104 bits (2855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/691 (79%), Positives = 608/691 (87%), Gaps = 16/691 (2%)
Query: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGK----PPAAQQQQHQHQQHATWAALS 56
MSDDML+HFSSNSSNQSDQSLPTK+AKLEARMVGK PP AQ Q +T ++S
Sbjct: 1 MSDDMLLHFSSNSSNQSDQSLPTKMAKLEARMVGKTSSIPPPAQSQ-------STRTSVS 53
Query: 57 STSRSVAAAEDLAQESSSSDSDDDIGGEFLIQANTQKRQKVKEDDNSTVFDRVEV---VA 113
S + AA E L + S+SSDSDD G FLIQANTQKRQK+++ ++ST+ +R E V
Sbjct: 54 SAGK-FAATESLIEPSTSSDSDDGTGDGFLIQANTQKRQKLQDANDSTLPERAEAFQAVE 112
Query: 114 DGRQNTTETLEAKAS-DVNRKKHGRGRGNSGSGRGRGSRANEQARSQISSSTVSPSNGQL 172
+G+QN ET+E+K + DVNRKK RGRG S S RGRGSR N+Q +SQIS ST+ P+NGQ
Sbjct: 113 EGKQNVVETIESKKNVDVNRKKQARGRGQSLSNRGRGSRVNDQMKSQISLSTIPPTNGQH 172
Query: 173 ESSHHKDNKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKE 232
+S + KD KEQ +DN S +EEE+ SL KVA+LEEDLRK RQ + +YQNL +LEKE
Sbjct: 173 DSLYLKDGMCKEQLRVDNRSPMEEELVSLRAKVASLEEDLRKLRQESSEYQNLYRELEKE 232
Query: 233 LKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISET 292
LK++KEYEQQMKP+RTK++SDLLISVSKAERQEAR+K+RQ+S+RLGNVGVIRAGTVISET
Sbjct: 233 LKEIKEYEQQMKPKRTKVLSDLLISVSKAERQEARMKVRQDSLRLGNVGVIRAGTVISET 292
Query: 293 WEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIY 352
WEDGQALKDLNAHL+QLLETKEA+ERQRKSLKKRQPDKGDG D E G QEED IQDEIY
Sbjct: 293 WEDGQALKDLNAHLKQLLETKEAIERQRKSLKKRQPDKGDGSDAEPGAQEEDSFIQDEIY 352
Query: 353 KSRLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLG 412
KSRLASIKREEE ILRER+RYE++KGRLIREMKRIRDEDGSRFNNFQILN RYALLNLLG
Sbjct: 353 KSRLASIKREEETILRERDRYEIDKGRLIREMKRIRDEDGSRFNNFQILNCRYALLNLLG 412
Query: 413 KGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472
KGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE+KKQSYIRHAIREYNIHKTLVH HIVRL
Sbjct: 413 KGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEEKKQSYIRHAIREYNIHKTLVHTHIVRL 472
Query: 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKII 532
WD FEIDQNTFCTVLEYCSGKDLDAVLK+TP+LPE+EARIIIVQIF GL+YLNKR QKII
Sbjct: 473 WDIFEIDQNTFCTVLEYCSGKDLDAVLKSTPILPEKEARIIIVQIFHGLVYLNKRTQKII 532
Query: 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT 592
HYDLKPGNVLFDE GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT
Sbjct: 533 HYDLKPGNVLFDELGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT 592
Query: 593 PLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAK 652
PLISSKVDVWSAG+L YQMLFGRRPFGHDQTQERILREDTIIKARKV+FP+RPAVSNEAK
Sbjct: 593 PLISSKVDVWSAGVLLYQMLFGRRPFGHDQTQERILREDTIIKARKVDFPTRPAVSNEAK 652
Query: 653 DLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
D IRRCLTYNQA+RPDVLT+AQD YLTY KK
Sbjct: 653 DFIRRCLTYNQADRPDVLTIAQDSYLTYLKK 683
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525144|ref|XP_004169578.1| PREDICTED: serine/threonine-protein kinase TOUSLED-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1102 bits (2851), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/691 (79%), Positives = 608/691 (87%), Gaps = 16/691 (2%)
Query: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGK----PPAAQQQQHQHQQHATWAALS 56
MSDDML+HFSSNSSNQSDQSLPTK+AKLEARMVGK PP AQ Q +T ++S
Sbjct: 1 MSDDMLLHFSSNSSNQSDQSLPTKMAKLEARMVGKTSSIPPPAQSQ-------STRTSVS 53
Query: 57 STSRSVAAAEDLAQESSSSDSDDDIGGEFLIQANTQKRQKVKEDDNSTVFDRVEV---VA 113
S + AA E L + S+SSDSDD G FLIQANTQKRQK+++ ++ST+ +R E V
Sbjct: 54 SAGK-FAATESLIEPSTSSDSDDGTGDGFLIQANTQKRQKLQDANDSTLPERAEAFQAVE 112
Query: 114 DGRQNTTETLEAKAS-DVNRKKHGRGRGNSGSGRGRGSRANEQARSQISSSTVSPSNGQL 172
+G+QN ET+E+K + DVNRKK RGRG S S RGRGSR N+Q +SQIS ST+ P+NGQ
Sbjct: 113 EGKQNVVETIESKKNVDVNRKKQARGRGQSLSNRGRGSRVNDQMKSQISLSTIPPTNGQH 172
Query: 173 ESSHHKDNKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKE 232
+S + KD KEQ +DN S +EEE+ SL KVA+LEEDLRK RQ + +YQNL +LEKE
Sbjct: 173 DSLYLKDGMCKEQLRVDNRSPMEEELVSLRAKVASLEEDLRKLRQESSEYQNLYRELEKE 232
Query: 233 LKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISET 292
+K++KEYEQQMKP+RTK++SDLLISVSKAERQEAR+K+RQ+S+RLGNVGVIRAGTVISET
Sbjct: 233 MKEIKEYEQQMKPKRTKVLSDLLISVSKAERQEARMKVRQDSLRLGNVGVIRAGTVISET 292
Query: 293 WEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIY 352
WEDGQALKDLNAHL+QLLETKEA+ERQRKSLKKRQPDKGDG D E G QEED IQDEIY
Sbjct: 293 WEDGQALKDLNAHLKQLLETKEAIERQRKSLKKRQPDKGDGSDAEPGAQEEDSFIQDEIY 352
Query: 353 KSRLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLG 412
KSRLASIKREEE ILRER+RYE++KGRLIREMKRIRDEDGSRFNNFQILN RYALLNLLG
Sbjct: 353 KSRLASIKREEETILRERDRYEIDKGRLIREMKRIRDEDGSRFNNFQILNCRYALLNLLG 412
Query: 413 KGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472
KGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE+KKQSYIRHAIREYNIHKTLVH HIVRL
Sbjct: 413 KGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEEKKQSYIRHAIREYNIHKTLVHTHIVRL 472
Query: 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKII 532
WD FEIDQNTFCTVL+YCSGKDLDAVLK+TP+LPE+EARIIIVQIF GL+YLNKR QKII
Sbjct: 473 WDIFEIDQNTFCTVLKYCSGKDLDAVLKSTPILPEKEARIIIVQIFHGLVYLNKRTQKII 532
Query: 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT 592
HYDLKPGNVLFDE GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT
Sbjct: 533 HYDLKPGNVLFDELGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT 592
Query: 593 PLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAK 652
PLISSKVDVWSAG+L YQMLFGRRPFGHDQTQERILREDTIIKARKV+FP+RPAVSNEAK
Sbjct: 593 PLISSKVDVWSAGVLLYQMLFGRRPFGHDQTQERILREDTIIKARKVDFPTRPAVSNEAK 652
Query: 653 DLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
D IRRCLTYNQA+RPDVLT+AQD YLTY KK
Sbjct: 653 DFIRRCLTYNQADRPDVLTIAQDSYLTYLKK 683
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132210|ref|XP_002328212.1| predicted protein [Populus trichocarpa] gi|222837727|gb|EEE76092.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1079 bits (2790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 546/694 (78%), Positives = 601/694 (86%), Gaps = 32/694 (4%)
Query: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKPPAA-----QQQQHQHQQHATWAAL 55
MSDDML+HFSSNSSNQSDQSLPTKIAKLEARM GK + Q Q Q Q+ W+++
Sbjct: 1 MSDDMLMHFSSNSSNQSDQSLPTKIAKLEARMAGKVSSVYPAPPVQLQQQQQKQPIWSSV 60
Query: 56 SSTSRSVAAAEDLAQESSSSDSDDDIGGEFLIQANTQKRQKVKEDDNSTVFDRVEVVADG 115
S R E+LA+ SSDSDDD GG FLIQANTQKR++++E+DNS VF+ +E+V DG
Sbjct: 61 SPGPR-FGPPEELAE---SSDSDDDNGGGFLIQANTQKRRRLQENDNSAVFEHLEIVNDG 116
Query: 116 RQNTTETLEAKAS-DVNRKKHGRGRGNSGSGRGRGSRANEQARSQISSSTVSPSNGQLES 174
+Q +T+E K S D NR+K GRGRG+S S RGRG RAN+Q RSQ S S PSNGQLE+
Sbjct: 117 KQKIGKTVETKVSTDANRRKQGRGRGHSNSSRGRGVRANDQTRSQSSVSAALPSNGQLEN 176
Query: 175 SHHKDNKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELK 234
S HK EE+TSLH KVAALE+DLRKS Q A + +LCHQLEKELK
Sbjct: 177 SCHK-----------------EELTSLHAKVAALEDDLRKSCQEASNNHDLCHQLEKELK 219
Query: 235 DVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWE 294
++K+ EQQMKP+RTKIISDLLISVSKAERQEAR+K+RQ+S+RLG+VGVIRAGT+ISETWE
Sbjct: 220 ELKDLEQQMKPKRTKIISDLLISVSKAERQEARMKVRQDSLRLGSVGVIRAGTIISETWE 279
Query: 295 DGQALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKS 354
DGQ LKDLN HLRQLLETKEAVERQRKSLKKRQ DKGDG D ESG QEED +IQDEI+KS
Sbjct: 280 DGQMLKDLNIHLRQLLETKEAVERQRKSLKKRQSDKGDGTDAESGAQEEDFLIQDEIFKS 339
Query: 355 RLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKG 414
RL SIKREEE ILRER+RYELEKGRLIRE+KRIRDE+GSRFNNFQILNHRYALLNLLGKG
Sbjct: 340 RLVSIKREEETILRERDRYELEKGRLIRELKRIRDENGSRFNNFQILNHRYALLNLLGKG 399
Query: 415 GFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474
GFSEVYKAYDLVEHRYVACKLHGLN QWSEDKKQSYI HA+REYNIHKTLVH+HIVRLWD
Sbjct: 400 GFSEVYKAYDLVEHRYVACKLHGLNVQWSEDKKQSYILHALREYNIHKTLVHNHIVRLWD 459
Query: 475 TFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHY 534
FEIDQNTFCT+LEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL+YLNKRAQKIIHY
Sbjct: 460 IFEIDQNTFCTILEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLVYLNKRAQKIIHY 519
Query: 535 DLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW-----YLPPECFEL 589
DLKPGNVLFDEFG+AKVTDFGLSKIVE+DVGSQGMELTSQGAGTYW YLPPECFEL
Sbjct: 520 DLKPGNVLFDEFGIAKVTDFGLSKIVEEDVGSQGMELTSQGAGTYWQVTLKYLPPECFEL 579
Query: 590 SKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSN 649
SKTPLISSKVDVWSAG+LFYQMLFGRRPFGHDQTQERILREDTIIKAR+VEFP++P +SN
Sbjct: 580 SKTPLISSKVDVWSAGVLFYQMLFGRRPFGHDQTQERILREDTIIKARRVEFPTKPTISN 639
Query: 650 EAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
EAKDLIR+CLTYNQAERPDVLT+AQDPYLTY KK
Sbjct: 640 EAKDLIRQCLTYNQAERPDVLTIAQDPYLTYLKK 673
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499255|ref|XP_003518457.1| PREDICTED: serine/threonine-protein kinase TOUSLED-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1057 bits (2733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 553/687 (80%), Positives = 614/687 (89%), Gaps = 11/687 (1%)
Query: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKPPAAQQQQHQHQQHATW--AALSST 58
MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGK + QQ + W A++ S
Sbjct: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKGSSTAAQQ------SGWSSASVPSA 54
Query: 59 SRSVAAAEDLAQESSSSDSDDDIGGEFLIQANTQKRQKVKEDDNSTVFDRVEVVADGRQN 118
+ AAE+LA+ S+SSDSDDD GG+FLIQANTQKRQK++ED +++VF+ VEVV DGRQ
Sbjct: 55 GKFGGAAENLAEPSTSSDSDDDNGGKFLIQANTQKRQKLQEDGSASVFECVEVVTDGRQT 114
Query: 119 TTETLEAKAS-DVNRKKHGRGRGNSGSGRGRGSRANEQARSQISSSTVSPSNGQLESSHH 177
+ E +E K + DVNRKKHGRGRG+SGSGRGRGSR +Q ++ IS TV SNG +E+ +H
Sbjct: 115 SLEAVETKNNIDVNRKKHGRGRGSSGSGRGRGSRVTDQTKTPISPPTVLASNGHIENVYH 174
Query: 178 KDNKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVK 237
KD + +QF DN +SLEE+V SL KV ALEE+LRKS+Q DYQNL QLEKELK++
Sbjct: 175 KDGRLSDQFHSDNSASLEEDVASLQAKVVALEEELRKSKQETADYQNLYRQLEKELKELN 234
Query: 238 EYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQ 297
++EQ+MKP+R KIISDLLISVSKAERQEARLK+RQ+S+RLGNVGVIRAGTVISETWEDGQ
Sbjct: 235 DHEQKMKPKRMKIISDLLISVSKAERQEARLKVRQDSLRLGNVGVIRAGTVISETWEDGQ 294
Query: 298 ALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGV-DVESGVQEEDLVIQDEIYKSRL 356
ALKDLNA L+QL+ETKEA+ERQRK LKK+Q DKGDG D E+G+ ED++I DEIYKSRL
Sbjct: 295 ALKDLNAQLKQLIETKEAIERQRKLLKKKQSDKGDGTADAEAGL-PEDILIHDEIYKSRL 353
Query: 357 ASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGF 416
AS+KREEE ILRERERYE+EKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGF
Sbjct: 354 ASLKREEENILRERERYEIEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGF 413
Query: 417 SEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476
SEVYKA+DLVEHRYVACKLHGLNAQWSE+KKQSYIRHAIREYNIHKTLVH HIVRLWD F
Sbjct: 414 SEVYKAFDLVEHRYVACKLHGLNAQWSEEKKQSYIRHAIREYNIHKTLVHRHIVRLWDIF 473
Query: 477 EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDL 536
EIDQNTFCTVLEYCSGKDLDAVLKATP+LPEREA++IIVQIFQGLIY+NKRAQKIIHYDL
Sbjct: 474 EIDQNTFCTVLEYCSGKDLDAVLKATPILPEREAKVIIVQIFQGLIYMNKRAQKIIHYDL 533
Query: 537 KPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLIS 596
KPGNVLFDE GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLIS
Sbjct: 534 KPGNVLFDELGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLIS 593
Query: 597 SKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIR 656
SKVDVWSAGIL+YQ+LFGRRPFGHDQTQERILREDTIIKARKVEFPSRP +SNEAKD IR
Sbjct: 594 SKVDVWSAGILYYQILFGRRPFGHDQTQERILREDTIIKARKVEFPSRPTISNEAKDFIR 653
Query: 657 RCLTYNQAERPDVLTLAQDPYLTYSKK 683
RCLTYNQAERPDVLT+AQDPYLT+SKK
Sbjct: 654 RCLTYNQAERPDVLTIAQDPYLTFSKK 680
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350539429|ref|NP_001234393.1| tousled-like protein [Solanum lycopersicum] gi|187884338|gb|ACD37257.1| tousled-like protein [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 1054 bits (2725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/689 (77%), Positives = 590/689 (85%), Gaps = 23/689 (3%)
Query: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKPPAAQQQQHQHQQHATWAALSSTSR 60
M+DDM+IHF+SNSSNQSDQSLPTKIAKLEARMVGK + Q + +W+
Sbjct: 1 MADDMVIHFASNSSNQSDQSLPTKIAKLEARMVGKASSVTSQAN------SWS------- 47
Query: 61 SVAAAEDLAQESSSSDSDDDI--GGEFLIQANTQKRQKVKEDDNSTVFDRVEVVADGRQN 118
S A E++A+ ++ S DD G E+LIQANTQKR+K+++DD+ST FD VE AD +
Sbjct: 48 SPAMFENVAEPATVSSDSDDDDNGVEYLIQANTQKRRKLEDDDSSTSFDHVETAADTGKK 107
Query: 119 TTETLEAK--ASDVNRKKHGRGRGNSGSGRGRGSRANEQARSQISSSTVSPSNGQLESSH 176
E E ASD NR+K R RG + SGRGRGSR +Q R Q VS SN E+S+
Sbjct: 108 MVENTETSKVASDGNRRKQSRSRGQTNSGRGRGSRVGDQTRLQ----AVSASNDLFENSY 163
Query: 177 HK--DNKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELK 234
K D+ PKEQ + ++ EEE+T+L K+ ALEE+LRKSRQ A DYQ C QLEKELK
Sbjct: 164 KKLQDSLPKEQLGHNGQTASEEEITTLRAKIVALEEELRKSRQEATDYQYRCQQLEKELK 223
Query: 235 DVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWE 294
D+K+YEQQ KP+RTKI+S+LLISVSKAERQEAR+K+RQES+RLGNVGVIRAGT+ISE WE
Sbjct: 224 DLKDYEQQTKPKRTKIMSELLISVSKAERQEARMKVRQESLRLGNVGVIRAGTIISEAWE 283
Query: 295 DGQALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKS 354
DGQALKDLNA LR LLETKEA+ERQRK LKKRQPDK DG DVE G+QEED IQDEIYKS
Sbjct: 284 DGQALKDLNAQLRNLLETKEAIERQRKLLKKRQPDKSDGGDVEGGLQEEDSFIQDEIYKS 343
Query: 355 RLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKG 414
RL SIKREE+ I+RER+RYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKG
Sbjct: 344 RLTSIKREEDMIMRERDRYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKG 403
Query: 415 GFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474
GFSEVYKA+DLV+HRYVACKLHGLNAQWSE+KKQSYIRHAIREYNIHKTLVHHHIVRLWD
Sbjct: 404 GFSEVYKAFDLVDHRYVACKLHGLNAQWSEEKKQSYIRHAIREYNIHKTLVHHHIVRLWD 463
Query: 475 TFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHY 534
FEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ+FQGLIYLNK++Q+IIHY
Sbjct: 464 IFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQVFQGLIYLNKKSQRIIHY 523
Query: 535 DLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPL 594
DLKPGNVLFDE GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPL
Sbjct: 524 DLKPGNVLFDELGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPL 583
Query: 595 ISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDL 654
ISS+VDVWSAGIL YQMLFG+RPFGHDQTQERILREDTIIKARKVEFP+RPAVSNEAK+
Sbjct: 584 ISSRVDVWSAGILLYQMLFGKRPFGHDQTQERILREDTIIKARKVEFPTRPAVSNEAKEF 643
Query: 655 IRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
IRRCLTYNQAERPDVLT+AQDPYLTY+KK
Sbjct: 644 IRRCLTYNQAERPDVLTIAQDPYLTYTKK 672
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553689|ref|XP_003545185.1| PREDICTED: serine/threonine-protein kinase TOUSLED-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1046 bits (2705), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 555/686 (80%), Positives = 614/686 (89%), Gaps = 10/686 (1%)
Query: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKPPAAQQQQHQHQQHATWAALS--ST 58
MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGK + QQ + W+++S S
Sbjct: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKGSSTTAQQ------SGWSSVSVPSA 54
Query: 59 SRSVAAAEDLAQESSSSDSDDDIGGEFLIQANTQKRQKVKEDDNSTVFDRVEVVADGRQN 118
+ AAE+LA+ S+SSDSDDD GGEFLIQANTQKRQK +ED +++VF+RVEVV D RQ
Sbjct: 55 GKLGGAAENLAEPSTSSDSDDDNGGEFLIQANTQKRQKFQEDGSASVFERVEVVTDARQM 114
Query: 119 TTETLEAKAS-DVNRKKHGRGRGNSGSGRGRGSRANEQARSQISSSTVSPSNGQLESSHH 177
+ ET+E K + D NRKKHGRGRG+SGSGRGRGSR +Q ++QIS TV SNGQ+ES +H
Sbjct: 115 SLETMETKINVDANRKKHGRGRGSSGSGRGRGSRVTDQTKTQISPPTVLASNGQIESVYH 174
Query: 178 KDNKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVK 237
KD +P +QF +N +SLEE+V SL KV ALEE+LRKS+Q DYQNL QLEKELK++
Sbjct: 175 KDGRPSDQFHRNNSASLEEDVASLEAKVVALEEELRKSKQETADYQNLYRQLEKELKELN 234
Query: 238 EYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQ 297
++EQQMKP+R KIISDLLISVSKAERQEARLK+RQ+S+RLGNVGVIRAGTVISETWEDGQ
Sbjct: 235 DHEQQMKPKRMKIISDLLISVSKAERQEARLKVRQDSLRLGNVGVIRAGTVISETWEDGQ 294
Query: 298 ALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLA 357
ALKDLNA L+QL+ETKEA+ERQRK KK+Q DK DG+D E+G+ ED++I DEIYKSRLA
Sbjct: 295 ALKDLNAQLKQLIETKEAIERQRKLFKKKQSDKSDGIDAEAGL-PEDILIHDEIYKSRLA 353
Query: 358 SIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFS 417
S+KREEE I RERERYE+EKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFS
Sbjct: 354 SLKREEEIIFRERERYEIEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFS 413
Query: 418 EVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477
EVYKA+DLVEHRYVACKLHGLNAQWSE+KKQSYIRHAIREYNIHKTLVH HIVRLWD FE
Sbjct: 414 EVYKAFDLVEHRYVACKLHGLNAQWSEEKKQSYIRHAIREYNIHKTLVHRHIVRLWDIFE 473
Query: 478 IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLK 537
IDQNTFCTVLE+CSGKDLDAVLKATPVLPEREA++IIVQIFQGLIY+NKR QKIIHYDLK
Sbjct: 474 IDQNTFCTVLEHCSGKDLDAVLKATPVLPEREAKVIIVQIFQGLIYMNKRTQKIIHYDLK 533
Query: 538 PGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISS 597
PGNVLFDE GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISS
Sbjct: 534 PGNVLFDELGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISS 593
Query: 598 KVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRR 657
KVDVWSAGIL+YQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP +SNEAKD IRR
Sbjct: 594 KVDVWSAGILYYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPTISNEAKDFIRR 653
Query: 658 CLTYNQAERPDVLTLAQDPYLTYSKK 683
CLTYNQAERPDVLT+AQDPYLT+SKK
Sbjct: 654 CLTYNQAERPDVLTIAQDPYLTFSKK 679
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493449|ref|XP_003617013.1| Tousled-like kinase [Medicago truncatula] gi|355518348|gb|AES99971.1| Tousled-like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1023 bits (2646), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 543/684 (79%), Positives = 600/684 (87%), Gaps = 15/684 (2%)
Query: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKPPAAQQQQHQHQQHATWAALSSTSR 60
MSDDML+HFSSNSSNQSDQSLPTKIAKLEARMVGK + QQ W ++SS +
Sbjct: 1 MSDDMLVHFSSNSSNQSDQSLPTKIAKLEARMVGKGSSTASQQQ------GWPSVSSAGK 54
Query: 61 -SVAAAEDLAQESSSSDSDDDIGGEFLIQANTQKRQKVKEDDNSTVFDRVEVVADGRQNT 119
S AAE++ + SSSDSDDD G +FLIQANT+KR K ED N VF+R EVV +GRQ +
Sbjct: 55 FSGVAAEEMVEPCSSSDSDDDNGADFLIQANTRKRLKPHED-NDDVFERAEVVTEGRQTS 113
Query: 120 TETLEAKASDVNRKKHGRGRGNSGSGRGRGSRANEQARSQISSSTVSPSNGQLESSHHKD 179
ET D NRKK GRGRG+SGS RGRGS+ N+Q R+QISSSTVS SNGQ E+ D
Sbjct: 114 LET--KNNVDANRKKSGRGRGSSGSSRGRGSKFNDQTRTQISSSTVSASNGQNEN----D 167
Query: 180 NKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEY 239
+ K+ F DN +SLEEE+ SL KV LEEDLRK++Q A +QN+C QLEKELK++K+
Sbjct: 168 GRLKDPFRNDNGASLEEEIASLRAKVVVLEEDLRKAKQEASQHQNICPQLEKELKELKDL 227
Query: 240 EQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQAL 299
E+QMKP+RTKIISDLLISVSKAERQEARLK+RQ+S+RLGNVGVIRAGTV+SETWEDGQAL
Sbjct: 228 EEQMKPKRTKIISDLLISVSKAERQEARLKVRQDSLRLGNVGVIRAGTVLSETWEDGQAL 287
Query: 300 KDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLASI 359
KDLNA L+QLLETKEA+ERQRK KK+Q DKGDG+D E+G+ E D++I +EIYKSRLASI
Sbjct: 288 KDLNAQLKQLLETKEAIERQRKLFKKKQSDKGDGIDAEAGLLE-DILIHEEIYKSRLASI 346
Query: 360 KREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEV 419
KREEE +LRER+RYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEV
Sbjct: 347 KREEEIVLRERDRYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEV 406
Query: 420 YKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479
YKA+DLVEHRYVACKLHGLNAQWSE+KKQSYIRHAIREYNIHKTLVH HIVRLWD FEID
Sbjct: 407 YKAFDLVEHRYVACKLHGLNAQWSEEKKQSYIRHAIREYNIHKTLVHRHIVRLWDIFEID 466
Query: 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPG 539
NTFCTVLEYCSGKDLDAVLKATP+LPE+EAR+I+VQIFQGLIY+NKRA KIIHYDLKPG
Sbjct: 467 PNTFCTVLEYCSGKDLDAVLKATPILPEKEARVILVQIFQGLIYMNKRALKIIHYDLKPG 526
Query: 540 NVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKV 599
NVLFDE G+AKVTDFGLSKIVE+DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKV
Sbjct: 527 NVLFDELGIAKVTDFGLSKIVENDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKV 586
Query: 600 DVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCL 659
DVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP VSNEAK+ IRRCL
Sbjct: 587 DVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPTVSNEAKEFIRRCL 646
Query: 660 TYNQAERPDVLTLAQDPYLTYSKK 683
TYNQAERPDVLT+AQDPYLTY KK
Sbjct: 647 TYNQAERPDVLTIAQDPYLTYVKK 670
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255573267|ref|XP_002527562.1| Serine/threonine-protein kinase plo1, putative [Ricinus communis] gi|223533054|gb|EEF34814.1| Serine/threonine-protein kinase plo1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1009 bits (2609), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/703 (75%), Positives = 590/703 (83%), Gaps = 35/703 (4%)
Query: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKPPAA---------QQQQHQHQQHAT 51
MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGK QQQ Q QQ
Sbjct: 1 MSDDMLIHFSSNSSNQSDQSLPTKIAKLEARMVGKTSTPVPPQLHQQQPQQQQQQQQQPI 60
Query: 52 WAALSSTSRSVAAAEDLAQESSSSDSDDDIGG-EFLIQANTQKRQKVKEDDNSTVFDRVE 110
W+++SS + EDL + SSSDSDDD FL+ ED ++++
Sbjct: 61 WSSVSSAVK-FGPTEDLVEHMSSSDSDDDKAELVFLVYQF--------EDFITSLY---- 107
Query: 111 VVADGRQNTTE---TLEAK-------ASDVNRKKHGRGRGNSGSGRGRGSRANEQARSQI 160
+G Q+ + TL+ +N K +G+ GRGSR N+Q +SQ
Sbjct: 108 --GNGLQHLSHIERTLDCCLHLRLGFLHCLNTKDILKGQIMERQQIGRGSRGNDQVKSQT 165
Query: 161 SSSTVSPSNGQLESSHHKDNKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAV 220
S++ PSNG +E+S+HKDN+ KE D+ S+E+EVTSL KVAALEE+LRKSRQ
Sbjct: 166 STAAAVPSNGHIENSYHKDNRHKENLHNDDHPSVEDEVTSLRAKVAALEEELRKSRQEGS 225
Query: 221 DYQNLCHQLEKELKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNV 280
D NLC+QLEKELK++K+YEQQMKP+RTK+ISDLLISVSKAERQEAR+K+RQ+S+RLGNV
Sbjct: 226 DNHNLCNQLEKELKELKDYEQQMKPKRTKMISDLLISVSKAERQEARMKVRQDSLRLGNV 285
Query: 281 GVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGV 340
GVIRAGT+ISETWEDGQ LKDLN HLR LLETKEAVERQRKSLKKRQ DKG+G+D ESG
Sbjct: 286 GVIRAGTIISETWEDGQVLKDLNTHLRHLLETKEAVERQRKSLKKRQSDKGEGIDAESGA 345
Query: 341 QEEDLVIQDEIYKSRLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQI 400
QEED+++QDEI+KSRLASIKREEE ILRER+RYELEKGRLIREMKRIRDEDGSRFNNFQI
Sbjct: 346 QEEDILLQDEIFKSRLASIKREEEIILRERDRYELEKGRLIREMKRIRDEDGSRFNNFQI 405
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
LNHRYALLNLLGKGGFSEVYKAYDLVEH+YVACKLHGLNAQWSEDKKQSYIRHAIREYNI
Sbjct: 406 LNHRYALLNLLGKGGFSEVYKAYDLVEHKYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 465
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
HKTLVH+HIVRLWD FEIDQNTFCTVLEYCSGKDLDAVLKATP+LPEREARIIIVQIFQG
Sbjct: 466 HKTLVHNHIVRLWDIFEIDQNTFCTVLEYCSGKDLDAVLKATPILPEREARIIIVQIFQG 525
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
LIYLNKR+QKIIHYDLKPGNVLFDEFG+AKVTDFGLSKIVE+DVGSQGMELTSQGAGTYW
Sbjct: 526 LIYLNKRSQKIIHYDLKPGNVLFDEFGIAKVTDFGLSKIVENDVGSQGMELTSQGAGTYW 585
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640
YLPPECFELSKTPLISSKVDVWSAG+LFYQMLFGRRPFGHDQTQERILREDTIIKAR+V+
Sbjct: 586 YLPPECFELSKTPLISSKVDVWSAGVLFYQMLFGRRPFGHDQTQERILREDTIIKARRVD 645
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
FP++P+VSNEAKDLIRRCLTYNQ ERPDVLTLAQDPYLTYSKK
Sbjct: 646 FPTKPSVSNEAKDLIRRCLTYNQTERPDVLTLAQDPYLTYSKK 688
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 683 | ||||||
| TAIR|locus:2147087 | 688 | TSL "TOUSLED" [Arabidopsis tha | 0.994 | 0.986 | 0.644 | 2e-230 | |
| ZFIN|ZDB-GENE-071008-2 | 730 | tlk1a "tousled-like kinase 1a" | 0.484 | 0.453 | 0.556 | 7e-113 | |
| UNIPROTKB|Q86UE8 | 772 | TLK2 "Serine/threonine-protein | 0.484 | 0.428 | 0.557 | 8.9e-113 | |
| UNIPROTKB|F1RRU6 | 748 | TLK2 "Uncharacterized protein" | 0.484 | 0.442 | 0.557 | 8.9e-113 | |
| ZFIN|ZDB-GENE-030131-4933 | 756 | tlk1b "tousled-like kinase 1b" | 0.484 | 0.437 | 0.550 | 1.8e-112 | |
| UNIPROTKB|F1P773 | 750 | TLK2 "Uncharacterized protein" | 0.759 | 0.692 | 0.436 | 1.2e-111 | |
| FB|FBgn0086899 | 1489 | tlk "Tousled-like kinase" [Dro | 0.483 | 0.221 | 0.571 | 1.6e-111 | |
| UNIPROTKB|E1BBU6 | 750 | TLK2 "Uncharacterized protein" | 0.759 | 0.692 | 0.436 | 2.6e-111 | |
| UNIPROTKB|J3QLK5 | 601 | TLK2 "Serine/threonine-protein | 0.759 | 0.863 | 0.436 | 2.6e-111 | |
| MGI|MGI:1346023 | 718 | Tlk2 "tousled-like kinase 2 (A | 0.759 | 0.722 | 0.436 | 2.6e-111 |
| TAIR|locus:2147087 TSL "TOUSLED" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2223 (787.6 bits), Expect = 2.0e-230, P = 2.0e-230
Identities = 446/692 (64%), Positives = 517/692 (74%)
Query: 1 MSDDMLIHFXXXXXXXXXXXLPTKIAKLEARMVGKPPXXXX----XXXXXXXXXTWAALS 56
MSDDM++HF LP KIAKLEAR+ GK P W++ S
Sbjct: 1 MSDDMVLHFSSNSSNQSDHSLPDKIAKLEARLTGKTPSSAKPPQQQQQQQQQVSLWSSAS 60
Query: 57 STSRSVAAAEDLAQEXXXXXXXXXIGGEFLIQANTQKRQKVKEDDNSTVFDRVE---VVA 113
+ + V + E G+FLI+ANT+KRQKV+E +N +V D VE
Sbjct: 61 AAVKVVTSTPPGLSETSISDSDDENTGDFLIRANTKKRQKVQESNNFSVVDHVEPQEAAY 120
Query: 114 DGRQNTTETLEAKASDVNRKKHXXXXXXXXXXXXXXXXANEQARSQISSSTVSPSNGQLE 173
DGR+N E+ DV++KK N+ +SQ + VS ++ QL+
Sbjct: 121 DGRKNDAES--KTGLDVSKKKQGRGRASSTGRGRGSKTNNDVTKSQFVVAPVSAAS-QLD 177
Query: 174 SSHHKDNKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKEL 233
+S KD +P Q CS +E++ SL K+A LEE+LRKSRQ++ +Y +L LE E+
Sbjct: 178 ASDQKDFRPDGQLRNGECSLQDEDLKSLRAKIAMLEEELRKSRQDSSEYHHLVRNLENEV 237
Query: 234 KDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETW 293
KD+K+ EQQ K + TK+ISDLLISVSK ERQEAR K+R ES+RLG+VGV+R GT+I+ETW
Sbjct: 238 KDLKDQEQQGKQKTTKVISDLLISVSKTERQEARTKVRNESLRLGSVGVLRTGTIIAETW 297
Query: 294 EDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQP-DKGDGVDVESGVQEEDLVIQDEIY 352
EDGQ LKDLNA LRQLLETKEA+ERQRK LKKRQ DK DG D ESG QEED +I DE+Y
Sbjct: 298 EDGQMLKDLNAQLRQLLETKEAIERQRKLLKKRQNGDKNDGTDTESGAQEED-IIPDEVY 356
Query: 353 KSRLASIKXXXXXXXXXXXXXXXXXXXXIREMKRIRDEDGSRFNNFQILNHRYALLNLLG 412
KSRL SIK +REMKRIRDEDGSRFN+F +LN RYALLNLLG
Sbjct: 357 KSRLTSIKREEEAVLRERERYTLEKGLLMREMKRIRDEDGSRFNHFPVLNSRYALLNLLG 416
Query: 413 KGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472
KGGFSEVYKAYDLV+HRYVACKLHGLNAQWSE+KKQSYIRHA RE IHK+LVHHHIVRL
Sbjct: 417 KGGFSEVYKAYDLVDHRYVACKLHGLNAQWSEEKKQSYIRHANRECEIHKSLVHHHIVRL 476
Query: 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKII 532
WD F ID +TFCTVLEYCSGKDLDAVLKAT LPE+EARIIIVQI QGL+YLNK++QKII
Sbjct: 477 WDKFHIDMHTFCTVLEYCSGKDLDAVLKATSNLPEKEARIIIVQIVQGLVYLNKKSQKII 536
Query: 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT 592
HYDLKPGNVLFDEFGVAKVTDFGLSKIVED+VGSQGMELTSQGAGTYWYLPPECFEL+KT
Sbjct: 537 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDNVGSQGMELTSQGAGTYWYLPPECFELNKT 596
Query: 593 PLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP-SRPAVSNEA 651
P+ISSKVDVWS G+LFYQMLFG+RPFGHDQ+QERILREDTIIKA+KVEFP +RPA+SNEA
Sbjct: 597 PMISSKVDVWSVGVLFYQMLFGKRPFGHDQSQERILREDTIIKAKKVEFPVTRPAISNEA 656
Query: 652 KDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
KDLIRRCLTYNQ +RPDVLT+AQDPYL YSKK
Sbjct: 657 KDLIRRCLTYNQEDRPDVLTMAQDPYLAYSKK 688
|
|
| ZFIN|ZDB-GENE-071008-2 tlk1a "tousled-like kinase 1a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 7.0e-113, Sum P(2) = 7.0e-113
Identities = 187/336 (55%), Positives = 237/336 (70%)
Query: 348 QDEIYKSRLASIKXXXXXXXXXXXXXXXXXXXXIREMKRIRDEDGSRFNNFQILNHRYAL 407
Q+EI+K RL +K IRE+KRI +ED S+F + LN RY L
Sbjct: 375 QEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRINNEDSSQFKDHPTLNERYLL 434
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
L+LLG+GGFSEVYKA+DL+E RY A K+H LN W E+KK++Y +HA REY IHK L H
Sbjct: 435 LHLLGRGGFSEVYKAFDLIEQRYAAVKIHQLNKNWREEKKENYHKHACREYRIHKQLDHP 494
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
IV+L+D F +D +TFCTVLEYC G DLD LK ++ E+EAR I++QI L YLN+
Sbjct: 495 RIVKLYDYFSLDTDTFCTVLEYCEGNDLDFYLKQHKLMTEKEARSIVMQIVNALRYLNEI 554
Query: 528 AQKIIHYDLKPGNVLFDE---FGVAKVTDFGLSKIVEDD-VGSQGMELTSQGAGTYWYLP 583
IIHYDLKPGN+L + G K+TDFGLSKI++DD G GM+LTSQGAGTYWYLP
Sbjct: 555 KPPIIHYDLKPGNILLVDGTACGEIKITDFGLSKIMDDDNYGVDGMDLTSQGAGTYWYLP 614
Query: 584 PECFELSKTP-LISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642
PECF + K P IS+KVDVWS G++F+Q L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+FP
Sbjct: 615 PECFVVGKEPPKISNKVDVWSVGVIFFQCLYGRKPFGHNQSQQDILQENTILKATEVQFP 674
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
S+P SNEAK IRRCL Y + +R DV L D YL
Sbjct: 675 SKPVASNEAKAFIRRCLAYRKEDRFDVHQLGSDSYL 710
|
|
| UNIPROTKB|Q86UE8 TLK2 "Serine/threonine-protein kinase tousled-like 2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 960 (343.0 bits), Expect = 8.9e-113, Sum P(2) = 8.9e-113
Identities = 188/337 (55%), Positives = 237/337 (70%)
Query: 348 QDEIYKSRLASIKXXXXXXXXXXXXXXXXXXXXIREMKRIRDEDGSRFNNFQILNHRYAL 407
Q+EI+K RL +K IRE+KRI +ED S+F + LN RY L
Sbjct: 405 QEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLL 464
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
L+LLG+GGFSEVYKA+DL E RYVA K+H LN W ++KK++Y +HA REY IHK L H
Sbjct: 465 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHP 524
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
IV+L+D F +D ++FCTVLEYC G DLD LK ++ E+EAR II+QI L YLN+
Sbjct: 525 RIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI 584
Query: 528 AQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQ--GMELTSQGAGTYWYL 582
IIHYDLKPGN+L G K+TDFGLSKI++DD + GMELTSQGAGTYWYL
Sbjct: 585 KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYL 644
Query: 583 PPECFELSKTP-LISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
PPECF + K P IS+KVDVWS G++FYQ L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+F
Sbjct: 645 PPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQF 704
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
P +P V+ EAK IRRCL Y + +R DV LA DPYL
Sbjct: 705 PPKPVVTPEAKAFIRRCLAYRKEDRIDVQQLACDPYL 741
|
|
| UNIPROTKB|F1RRU6 TLK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 960 (343.0 bits), Expect = 8.9e-113, Sum P(2) = 8.9e-113
Identities = 188/337 (55%), Positives = 237/337 (70%)
Query: 348 QDEIYKSRLASIKXXXXXXXXXXXXXXXXXXXXIREMKRIRDEDGSRFNNFQILNHRYAL 407
Q+EI+K RL +K IRE+KRI +ED S+F + LN RY L
Sbjct: 381 QEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLL 440
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
L+LLG+GGFSEVYKA+DL E RYVA K+H LN W ++KK++Y +HA REY IHK L H
Sbjct: 441 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHP 500
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
IV+L+D F +D ++FCTVLEYC G DLD LK ++ E+EAR II+QI L YLN+
Sbjct: 501 RIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI 560
Query: 528 AQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQ--GMELTSQGAGTYWYL 582
IIHYDLKPGN+L G K+TDFGLSKI++DD + GMELTSQGAGTYWYL
Sbjct: 561 KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYL 620
Query: 583 PPECFELSKTP-LISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
PPECF + K P IS+KVDVWS G++FYQ L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+F
Sbjct: 621 PPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQF 680
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
P +P V+ EAK IRRCL Y + +R DV LA DPYL
Sbjct: 681 PPKPVVTPEAKAFIRRCLAYRKEDRIDVQQLACDPYL 717
|
|
| ZFIN|ZDB-GENE-030131-4933 tlk1b "tousled-like kinase 1b" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 963 (344.1 bits), Expect = 1.8e-112, Sum P(2) = 1.8e-112
Identities = 185/336 (55%), Positives = 236/336 (70%)
Query: 348 QDEIYKSRLASIKXXXXXXXXXXXXXXXXXXXXIREMKRIRDEDGSRFNNFQILNHRYAL 407
Q+EI+K RL +K IRE+KRI +ED S+F + LN RY L
Sbjct: 393 QEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRINNEDSSQFKDHPTLNERYLL 452
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
L+LLG+GGFSEVYKA+DL E RY A K+H LN W E+KK++Y +HA REY IHK L H
Sbjct: 453 LHLLGRGGFSEVYKAFDLFEQRYAAVKIHQLNKNWREEKKENYHKHACREYRIHKQLDHP 512
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
IV+L+D F +D +TFCTVLE+C G DLD LK ++ E+EAR I++QI L YLN+
Sbjct: 513 RIVKLYDYFSLDTDTFCTVLEFCEGNDLDFYLKQHKLMSEKEARSIVMQIVNALRYLNEI 572
Query: 528 AQKIIHYDLKPGNVLFDE---FGVAKVTDFGLSKIVEDD-VGSQGMELTSQGAGTYWYLP 583
IIHYDLKPGN+L + G K+TDFGLSKI++DD G GM+LTSQGAGTYWYLP
Sbjct: 573 KPSIIHYDLKPGNILLVDGTACGEIKITDFGLSKIMDDDSYGVDGMDLTSQGAGTYWYLP 632
Query: 584 PECFELSKTP-LISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642
PECF + K P IS+KVDVWS G++F+Q L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+FP
Sbjct: 633 PECFVVGKEPPKISNKVDVWSVGVIFFQCLYGRKPFGHNQSQQDILQENTILKATEVQFP 692
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++P SNEAK IRRCL Y + +R DV L D YL
Sbjct: 693 AKPVASNEAKAFIRRCLAYRKEDRSDVHQLGSDSYL 728
|
|
| UNIPROTKB|F1P773 TLK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1102 (393.0 bits), Expect = 1.2e-111, P = 1.2e-111
Identities = 240/550 (43%), Positives = 332/550 (60%)
Query: 152 ANEQARSQISSSTVSPSNGQLESSHHKDNKPKEQFLIDNCSSLEEEVTS-LHRKVAALEE 210
A + + S S S + + + + I+ S+LE S L +K +++
Sbjct: 178 AQQNSPSSTGSGNTEHSGSSQKQISIQHRQTQSDLTIEKISALENSKNSDLEKKEGRIDD 237
Query: 211 DLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKI 270
LR N +L Q++++ K +++Y++++ R + LLI SK E+ R K
Sbjct: 238 LLRA---NC----DLRRQIDEQQKMLEKYKERLN-RCVTMSKKLLIEKSKQEKMACRDKS 289
Query: 271 RQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQP-- 328
Q+ +RLG+ +R G +E W DG A ++L ++ +E +ERQRK L KR+P
Sbjct: 290 MQDRLRLGHFTTVRHGASFTEQWTDGYAFQNLIKQQERINSQREEIERQRKMLAKRKPPA 349
Query: 329 ---------DKGDGVDVESGVQEEDLVI-----QDEIYKSRLASIKXXXXXXXXXXXXXX 374
++ +G + E L + Q+EI+K RL +K
Sbjct: 350 MGQAPPATNEQKQRKSKTNGAENETLTLAEYHEQEEIFKLRLGHLKKEEAEIQAELERLE 409
Query: 375 XXXXXXIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACK 434
IRE+KRI +ED S+F + LN RY LL+LLG+GGFSEVYKA+DL E RYVA K
Sbjct: 410 RVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVK 469
Query: 435 LHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKD 494
+H LN W ++KK++Y +HA REY IHK L H IV+L+D F +D ++FCTVLEYC G D
Sbjct: 470 IHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGND 529
Query: 495 LDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKV 551
LD LK ++ E+EAR II+QI L YLN+ IIHYDLKPGN+L G K+
Sbjct: 530 LDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 589
Query: 552 TDFGLSKIVEDDVGSQ--GMELTSQGAGTYWYLPPECFELSKTP-LISSKVDVWSAGILF 608
TDFGLSKI++DD + GMELTSQGAGTYWYLPPECF + K P IS+KVDVWS G++F
Sbjct: 590 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 649
Query: 609 YQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD 668
YQ L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+FP +P V+ EAK IRRCL Y + +R D
Sbjct: 650 YQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRID 709
Query: 669 VLTLAQDPYL 678
V LA DPYL
Sbjct: 710 VQQLACDPYL 719
|
|
| FB|FBgn0086899 tlk "Tousled-like kinase" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 993 (354.6 bits), Expect = 1.6e-111, Sum P(2) = 1.6e-111
Identities = 192/336 (57%), Positives = 238/336 (70%)
Query: 349 DEIYKSRLASIKXXXXXXXXXXXXXXXXXXXXIREMKRIRDEDGSRFNNFQILNHRYALL 408
DEI K R ++K IRE+KRI +ED SRFNN +LN RY LL
Sbjct: 1094 DEILKLRQNALKKEDADLQLEMEKLERERNLHIRELKRILNEDQSRFNNHPVLNDRYLLL 1153
Query: 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
LLGKGGFSEV+KA+DL E RYVACK+H LN W EDKK +YI+HA+REYNIHK L H
Sbjct: 1154 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 1213
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA 528
+V+L+D FEID N+FCTVLEYC G DLD LK +PEREAR II+Q+ L YLN+
Sbjct: 1214 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIPEREARSIIMQVVSALKYLNEIK 1273
Query: 529 QKIIHYDLKPGNVLFDEFGVA---KVTDFGLSKIVEDDVGS--QGMELTSQGAGTYWYLP 583
+IHYDLKPGN+L E V K+TDFGLSK+++D+ + GM+LTSQGAGTYWYLP
Sbjct: 1274 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDDENYNPDHGMDLTSQGAGTYWYLP 1333
Query: 584 PECFELSKTP-LISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642
PECF + K P ISSKVDVWS G++FYQ L+G++PFGH+Q+Q IL E+TI+KA +V+F
Sbjct: 1334 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFS 1393
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++P VSNEAK IR CL Y + +R DV LA+ Y+
Sbjct: 1394 NKPTVSNEAKSFIRGCLAYRKEDRMDVFALARHEYI 1429
|
|
| UNIPROTKB|E1BBU6 TLK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
Identities = 240/550 (43%), Positives = 332/550 (60%)
Query: 152 ANEQARSQISSSTVSPSNGQLESSHHKDNKPKEQFLIDNCSSLEEEVTS-LHRKVAALEE 210
A + + S S S + + + + I+ S+LE S L +K +++
Sbjct: 178 AQQNSPSSTGSGNTEHSCSSQKQISIQHRQTQSDLTIEKISALENSKNSDLEKKEGRIDD 237
Query: 211 DLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKI 270
LR N +L Q++++ K +++Y++++ R + LLI SK E+ R K
Sbjct: 238 LLRA---NC----DLRRQIDEQQKMLEKYKERLN-RCVTMSKKLLIEKSKQEKMACRDKS 289
Query: 271 RQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQP-- 328
Q+ +RLG+ +R G +E W DG A ++L ++ +E +ERQRK L KR+P
Sbjct: 290 MQDRLRLGHFTTVRHGASFTEQWTDGYAFQNLIKQQERINSQREEIERQRKMLAKRKPPA 349
Query: 329 ---------DKGDGVDVESGVQEEDLVI-----QDEIYKSRLASIKXXXXXXXXXXXXXX 374
++ +G + E L + Q+EI+K RL +K
Sbjct: 350 MGQAPPATNEQKQRKSKTNGAENETLTLAEYHEQEEIFKLRLGHLKKEEAEIQAELERLE 409
Query: 375 XXXXXXIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACK 434
IRE+KRI +ED S+F + LN RY LL+LLG+GGFSEVYKA+DL E RYVA K
Sbjct: 410 RVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVK 469
Query: 435 LHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKD 494
+H LN W ++KK++Y +HA REY IHK L H IV+L+D F +D ++FCTVLEYC G D
Sbjct: 470 IHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGND 529
Query: 495 LDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKV 551
LD LK ++ E+EAR II+QI L YLN+ IIHYDLKPGN+L G K+
Sbjct: 530 LDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 589
Query: 552 TDFGLSKIVEDDVGSQ--GMELTSQGAGTYWYLPPECFELSKTP-LISSKVDVWSAGILF 608
TDFGLSKI++DD + GMELTSQGAGTYWYLPPECF + K P IS+KVDVWS G++F
Sbjct: 590 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 649
Query: 609 YQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD 668
YQ L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+FP +P V+ EAK IRRCL Y + +R D
Sbjct: 650 YQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRID 709
Query: 669 VLTLAQDPYL 678
V LA DPYL
Sbjct: 710 VQQLACDPYL 719
|
|
| UNIPROTKB|J3QLK5 TLK2 "Serine/threonine-protein kinase tousled-like 2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
Identities = 240/550 (43%), Positives = 332/550 (60%)
Query: 152 ANEQARSQISSSTVSPSNGQLESSHHKDNKPKEQFLIDNCSSLEEEVTS-LHRKVAALEE 210
A + + S S S + + + + I+ S+LE S L +K +++
Sbjct: 29 AQQNSPSSTGSGNTEHSCSSQKQISIQHRQTQSDLTIEKISALENSKNSDLEKKEGRIDD 88
Query: 211 DLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKI 270
LR N +L Q++++ K +++Y++++ R + LLI SK E+ R K
Sbjct: 89 LLRA---NC----DLRRQIDEQQKMLEKYKERLN-RCVTMSKKLLIEKSKQEKMACRDKS 140
Query: 271 RQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQP-- 328
Q+ +RLG+ +R G +E W DG A ++L ++ +E +ERQRK L KR+P
Sbjct: 141 MQDRLRLGHFTTVRHGASFTEQWTDGYAFQNLIKQQERINSQREEIERQRKMLAKRKPPA 200
Query: 329 ---------DKGDGVDVESGVQEEDLVI-----QDEIYKSRLASIKXXXXXXXXXXXXXX 374
++ +G + E L + Q+EI+K RL +K
Sbjct: 201 MGQAPPATNEQKQRKSKTNGAENETLTLAEYHEQEEIFKLRLGHLKKEEAEIQAELERLE 260
Query: 375 XXXXXXIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACK 434
IRE+KRI +ED S+F + LN RY LL+LLG+GGFSEVYKA+DL E RYVA K
Sbjct: 261 RVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVK 320
Query: 435 LHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKD 494
+H LN W ++KK++Y +HA REY IHK L H IV+L+D F +D ++FCTVLEYC G D
Sbjct: 321 IHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGND 380
Query: 495 LDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKV 551
LD LK ++ E+EAR II+QI L YLN+ IIHYDLKPGN+L G K+
Sbjct: 381 LDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 440
Query: 552 TDFGLSKIVEDDVGSQ--GMELTSQGAGTYWYLPPECFELSKTP-LISSKVDVWSAGILF 608
TDFGLSKI++DD + GMELTSQGAGTYWYLPPECF + K P IS+KVDVWS G++F
Sbjct: 441 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 500
Query: 609 YQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD 668
YQ L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+FP +P V+ EAK IRRCL Y + +R D
Sbjct: 501 YQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRID 560
Query: 669 VLTLAQDPYL 678
V LA DPYL
Sbjct: 561 VQQLACDPYL 570
|
|
| MGI|MGI:1346023 Tlk2 "tousled-like kinase 2 (Arabidopsis)" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
Identities = 240/550 (43%), Positives = 332/550 (60%)
Query: 152 ANEQARSQISSSTVSPSNGQLESSHHKDNKPKEQFLIDNCSSLEEEVTS-LHRKVAALEE 210
A + + S S S + + + + I+ S+LE S L +K +++
Sbjct: 146 AQQNSPSSTGSGNTEHSCSSQKQISIQHRQTQSDLTIEKISALENSKNSDLEKKEGRIDD 205
Query: 211 DLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKI 270
LR N +L Q++++ K +++Y++++ R + LLI SK E+ R K
Sbjct: 206 LLRA---NC----DLRRQIDEQQKMLEKYKERLN-RCVTMSKKLLIEKSKQEKMACRDKS 257
Query: 271 RQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQP-- 328
Q+ +RLG+ +R G +E W DG A ++L ++ +E +ERQRK L KR+P
Sbjct: 258 MQDRLRLGHFTTVRHGASFTEQWTDGYAFQNLIKQQERINSQREEIERQRKMLAKRKPPA 317
Query: 329 ---------DKGDGVDVESGVQEEDLVI-----QDEIYKSRLASIKXXXXXXXXXXXXXX 374
++ +G + E L + Q+EI+K RL +K
Sbjct: 318 MGQAPPATNEQKQRKSKTNGAENETLTLAEYHEQEEIFKLRLGHLKKEEAEIQAELERLE 377
Query: 375 XXXXXXIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACK 434
IRE+KRI +ED S+F + LN RY LL+LLG+GGFSEVYKA+DL E RYVA K
Sbjct: 378 RVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVK 437
Query: 435 LHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKD 494
+H LN W ++KK++Y +HA REY IHK L H IV+L+D F +D ++FCTVLEYC G D
Sbjct: 438 IHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGND 497
Query: 495 LDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKV 551
LD LK ++ E+EAR II+QI L YLN+ IIHYDLKPGN+L G K+
Sbjct: 498 LDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 557
Query: 552 TDFGLSKIVEDDVGSQ--GMELTSQGAGTYWYLPPECFELSKTP-LISSKVDVWSAGILF 608
TDFGLSKI++DD + GMELTSQGAGTYWYLPPECF + K P IS+KVDVWS G++F
Sbjct: 558 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 617
Query: 609 YQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD 668
YQ L+GR+PFGH+Q+Q+ IL+E+TI+KA +V+FP +P V+ EAK IRRCL Y + +R D
Sbjct: 618 YQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRID 677
Query: 669 VLTLAQDPYL 678
V LA DPYL
Sbjct: 678 VQQLACDPYL 687
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q1ECX4 | TLK2_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.4318 | 0.8169 | 0.8005 | yes | no |
| Q39238 | TSL_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7113 | 0.9926 | 0.9854 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_IX0527 | hypothetical protein (676 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 683 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-79 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-50 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-50 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-48 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-45 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-41 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-40 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-40 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-37 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-36 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-35 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-33 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-33 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-32 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-31 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-30 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-29 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-28 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-27 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-24 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-23 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-22 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-22 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-21 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-20 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-20 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-19 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-18 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-15 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.001 | |
| pfam07218 | 790 | pfam07218, RAP1, Rhoptry-associated protein 1 (RAP | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 1e-79
Identities = 97/275 (35%), Positives = 136/275 (49%), Gaps = 22/275 (8%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y +L LG+G F +VY A D + VA K+ + K + +RE I K L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVI------KKKKIKKDRERILREIKILKKL 54
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
H +IVRL+D FE D++ V+EYC G DL +LK L E EAR + QI L YL
Sbjct: 55 KHPNIVRLYDVFE-DEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ + I+H DLKP N+L DE G K+ DFGL++ ++ E + GT Y+ P
Sbjct: 114 HS--KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPG------EKLTTFVGTPEYMAP 165
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
E L VD+WS G++ Y++L G+ PF D + + I K FP
Sbjct: 166 EV--LLGKG-YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK---KIGKPKPPFPPP 219
Query: 645 PA-VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+S EAKDLIR+ L + +R Q P+
Sbjct: 220 EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 3e-61
Identities = 105/278 (37%), Positives = 142/278 (51%), Gaps = 22/278 (7%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y LL LG G F VYKA + VA K +K + A RE I + L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVK-----ILKKRSEKSKKDQTARREIRILRRL 55
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
H +IVRL D FE D++ V+EYC G DL L L E EA+ I +QI +GL YL
Sbjct: 56 SHPNIVRLIDAFE-DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ + IIH DLKP N+L DE GV K+ DFGL+K + S + GT WY+ P
Sbjct: 115 H--SNGIIHRDLKPENILLDENGVVKIADFGLAKKLL---KSS--SSLTTFVGTPWYMAP 167
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHD--QTQERILREDTIIKARKVEFP 642
E L KVDVWS G++ Y++L G+ PF + Q +++R I +EF
Sbjct: 168 E--VLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRR---ILGPPLEFD 222
Query: 643 SR--PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ S EAKDLI++CL + ++RP + Q P+
Sbjct: 223 EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 6e-54
Identities = 85/268 (31%), Positives = 116/268 (43%), Gaps = 55/268 (20%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
LG+GGF VY A D + VA K ++ S + +RE I K L H +IV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIK------IIKKEDSSSLLEELLREIEILKKLNHPNIV 54
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQ 529
+L+ FE D+N V+EYC G L +LK L E E I++QI +GL YL+
Sbjct: 55 KLYGVFE-DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS--N 111
Query: 530 KIIHYDLKPGNVLFDE-FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
IIH DLKP N+L D G K+ DFGLSK++ D L GT Y+ PE
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD-----KSLLKTIVGTPAYMAPEVLL 166
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648
S K D+WS G++ Y++
Sbjct: 167 GKGY--YSEKSDIWSLGVILYEL------------------------------------- 187
Query: 649 NEAKDLIRRCLTYNQAERPDVLTLAQDP 676
E KDLIR+ L + +RP + +
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-50
Identities = 85/275 (30%), Positives = 122/275 (44%), Gaps = 25/275 (9%)
Query: 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
LLG+G F VY A D +A K L + + RE I +L H +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVEL-----SGDSEEELEALEREIRILSSLQHPN 60
Query: 469 IVR-LWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
IVR + ++NT LEY SG L ++LK LPE R QI +GL YL+
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH-- 118
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECF 587
+ I+H D+K N+L D GV K+ DFG +K + D +G T GT +++ PE
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG---TGSVRGTPYWMAPEVI 175
Query: 588 ELSKTPLISSKVDVWSAGILFYQMLFGRRPFGH--DQTQE--RILREDTIIKARKVEFPS 643
+ D+WS G +M G+ P+ + +I E P
Sbjct: 176 RGEEY---GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP-----EIPE 227
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+S EAKD +R+CL + +RP L Q P+L
Sbjct: 228 H--LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-50
Identities = 83/259 (32%), Positives = 115/259 (44%), Gaps = 27/259 (10%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
LGKG F +V + A K L + +K+ + H + E NI + H IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMK--VLKKKKIIKRKE--VEHTLTERNILSRINHPFIV 56
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQK 530
+L F+ + VLEY G +L + L E AR +I L YL+
Sbjct: 57 KLHYAFQ-TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS--LG 113
Query: 531 IIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS 590
II+ DLKP N+L D G K+TDFGL+K S T+ GT YL PE
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKE-----LSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 591 KTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIKARKVEFPSRPAV 647
VD WS G+L Y+ML G+ PF + E+IL++ + FP +
Sbjct: 169 G---YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP-------LRFPEF--L 216
Query: 648 SNEAKDLIRRCLTYNQAER 666
S EA+DLI L + +R
Sbjct: 217 SPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 8e-48
Identities = 80/279 (28%), Positives = 137/279 (49%), Gaps = 25/279 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y ++ +GKG F +VY + + K L+ ++++ A+ E I K
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERED-----ALNEVKILKK 55
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV----LPEREARIIIVQIFQ 519
L H +I++ +++FE ++ C V+EY G DL +K PE + VQ+
Sbjct: 56 LNHPNIIKYYESFE-EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
L YL+ R KI+H D+KP N+ G+ K+ DFG+SK++ V +L GT
Sbjct: 115 ALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-----DLAKTVVGTP 167
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639
+YL PE + P + K D+WS G + Y++ + PF + E L+ I+K +
Sbjct: 168 YYLSPELCQ--NKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALK---ILKGQYP 221
Query: 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
PS+ S+E ++L+ L + ERP + + Q P++
Sbjct: 222 PIPSQ--YSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 37/281 (13%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ +L +GKGGF EVYKA + VA K+ L S++KK+ I E I K
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE---SKEKKEKIIN----EIQILKKC 54
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIY 523
H +IV+ + ++ + ++ V+E+CSG L +LK+T L E + + ++ +GL Y
Sbjct: 55 KHPNIVKYYGSY-LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ IIH D+K N+L G K+ DFGLS + D M GT +++
Sbjct: 114 LHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM------VGTPYWMA 165
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV---- 639
PE ++ P K D+WS GI ++ G+ P+ E +KA
Sbjct: 166 PEV--INGKPY-DYKADIWSLGITAIELAEGKPPY----------SELPPMKALFKIATN 212
Query: 640 ---EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
+ S+E KD +++CL N +RP L + P+
Sbjct: 213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 93/288 (32%), Positives = 134/288 (46%), Gaps = 23/288 (7%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y +L LG+G F EVY A D + VA K+ + K + +RE I +L
Sbjct: 2 YRILRKLGEGSFGEVYLARD---RKLVALKVLAK----KLESKSKEVERFLREIQILASL 54
Query: 465 VHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP---VLPEREARIIIVQIFQG 520
H +IV+L+D F+ D+ + V+EY G L+ +LK L E EA I+ QI
Sbjct: 55 NHPPNIVKLYDFFQ-DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTDFGLSKIVEDDVGSQGM-ELTSQGAGT 578
L YL+ + IIH D+KP N+L D G V K+ DFGL+K++ D + + L S GT
Sbjct: 114 LEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 579 YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-------GHDQTQERILRED 631
Y+ PE SS D+WS GI Y++L G PF QT + IL
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
T A + + +S A DL+++ L + R + L
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 86/275 (31%), Positives = 121/275 (44%), Gaps = 45/275 (16%)
Query: 411 LGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIR-----HAIREYNIH 461
+ KG + V+ L + + A K+ KK IR + E +I
Sbjct: 1 ISKGAYGRVF----LAKKKSTGDIYAIKVI---------KKADMIRKNQVDQVLTERDIL 47
Query: 462 KTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
++V+L+ +F + V+EY G DL ++L+ L E ARI I +I L
Sbjct: 48 SQAQSPYVVKLYYSF-QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLAL 106
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA----- 576
YL + IIH DLKP N+L D G K+TDFGLSK VG ++
Sbjct: 107 EYL--HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSK-----VGLVRRQINLNDDEKEDK 159
Query: 577 ---GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633
GT Y+ PE S VD WS G + Y+ L G PF H +T E I +
Sbjct: 160 RIVGTPDYIAPEVILGQGH---SKTVDWWSLGCILYEFLVGIPPF-HGETPEEIFQN--- 212
Query: 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD 668
I K+E+P VS+EA DLI + L + +R
Sbjct: 213 ILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLG 247
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 31/280 (11%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y L +L+G+G F VYK +L +VA K L K+ ++ ++E ++ K
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE-----KIKEEALKSIMQEIDLLKN 55
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H +IV+ + E ++ +LEY L ++K PE + + Q+ QGL Y
Sbjct: 56 LKHPNIVKYIGSIE-TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT-YWYL 582
L++ Q +IH D+K N+L + GV K+ DFG++ + D + GT YW +
Sbjct: 115 LHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-----DASVVGTPYW-M 166
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE----RILREDTIIKARK 638
PE E+S S+ D+WS G ++L G P+ +D RI+++D
Sbjct: 167 APEVIEMSG---ASTASDIWSLGCTVIELLTGNPPY-YDLNPMAALFRIVQDDHP----- 217
Query: 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
P +S E KD + +C + RP L + P++
Sbjct: 218 -PLPEG--ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 81/267 (30%), Positives = 124/267 (46%), Gaps = 29/267 (10%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
+ LL ++GKG F +V V+ R A K +N Q +K S +R+ + E I
Sbjct: 2 FELLRVIGKGAFGKVCI----VQKRDTKKMFAMKY--MNKQ-KCVEKGS-VRNVLNERRI 53
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
+ L H +V LW +F+ ++N + V++ G DL L E + + I +I
Sbjct: 54 LQELNHPFLVNLWYSFQDEENMY-LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA 112
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
L YL ++ IIH D+KP N+L DE G +TDF ++ V D + +GT
Sbjct: 113 LEYL--HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST------SGTPG 164
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILREDTIIKARKV 639
Y+ PE S VD WS G+ Y+ L G+RP+ GH +T +R + V
Sbjct: 165 YMAPEVL---CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA--KQETADV 219
Query: 640 EFPSRPAVSNEAKDLIRRCLTYNQAER 666
+P S EA D I + L + +R
Sbjct: 220 LYP--ATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 93/311 (29%), Positives = 133/311 (42%), Gaps = 60/311 (19%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK----------LHGLNAQWSEDKKQSYIRH 453
RY LG+G ++ VYKA D R VA K G+N
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN------------FT 48
Query: 454 AIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARI 512
A+RE + + L H +I+ L D F N V E+ DL+ V+K VL + +
Sbjct: 49 ALREIKLLQELKHPNIIGLLDVFGHKSN-INLVFEFMET-DLEKVIKDKSIVLTPADIKS 106
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELT 572
++ +GL YL+ I+H DLKP N+L GV K+ DFGL++ GS ++T
Sbjct: 107 YMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARS----FGSPNRKMT 160
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GH---DQTQERI 627
Q T WY PE ++ VD+WS G +F ++L R PF G DQ +I
Sbjct: 161 HQ-VVTRWYRAPELLFGAR--HYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQL-GKI 215
Query: 628 LR------EDTIIKARK----VEFPSRP---------AVSNEAKDLIRRCLTYNQAERPD 668
E+ VEF P A S++A DL++R LT N +R
Sbjct: 216 FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT 275
Query: 669 VLTLAQDPYLT 679
+ PY +
Sbjct: 276 ARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 36/276 (13%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQ--WSEDKKQSYIRHAIREYNI-HKTLVH 466
++G+G FS V A + ++ A K+ L+ + E KK Y+ E + + H
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKI--LDKRQLIKE-KKVKYV---KIEKEVLTRLNGH 61
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526
I++L+ TF+ D+ VLEY +L ++ L E+ R +I L YL+
Sbjct: 62 PGIIKLYYTFQ-DEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA---------- 576
+ IIH DLKP N+L D+ K+TDFG +K+++ + + + +
Sbjct: 121 K--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 577 -----GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631
GT Y+ PE L++ P D+W+ G + YQML G+ PF + ++
Sbjct: 179 FASFVGTAEYVSPEL--LNEKP-AGKSSDLWALGCIIYQMLTGKPPF-RGSNEYLTFQK- 233
Query: 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
I + FP P +AKDLI + L + +R
Sbjct: 234 --ILKLEYSFP--PNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-35
Identities = 88/308 (28%), Positives = 127/308 (41%), Gaps = 60/308 (19%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRH----------A 454
Y L LG+G + VYKA D VA K IR A
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK---------------IRLDNEEEGIPSTA 45
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARII 513
+RE ++ K L H +IV+L D + V EYC DL L K L + I
Sbjct: 46 LREISLLKELKHPNIVKLLDVI-HTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSI 103
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
+ Q+ +GL Y + + +I+H DLKP N+L + GV K+ DFGL++ G T
Sbjct: 104 MYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARA----FGIPLRTYTH 157
Query: 574 QGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR---- 629
+ T WY PE L + S+ VD+WS G +F +M+ G+ F D +++ +
Sbjct: 158 EVV-TLWYRAPEI--LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQI 214
Query: 630 ----------EDTIIKARKVEFPSRPA---------VSNEAKDLIRRCLTYNQAERPDVL 670
T + K FP P + E DL+ + L YN A+R
Sbjct: 215 LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK 274
Query: 671 TLAQDPYL 678
+ PY
Sbjct: 275 EALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 93/274 (33%), Positives = 128/274 (46%), Gaps = 48/274 (17%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
+ + LG G F V LV H+ Y A K+ L+ KQ + H + E I
Sbjct: 3 FEFIKTLGTGSFGRVM----LVRHKGSGKYYALKI--LSKAKIVKLKQ--VEHVLNEKRI 54
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
+++ H +V L+ +F+ D N + V+EY G +L + L+ + PE AR Q+
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLY-LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA 113
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
L YL+ I++ DLKP N+L D G K+TDFG +K V+ T GT
Sbjct: 114 LEYLHSL--DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--------TYTLCGTPE 163
Query: 581 YLPPECFELSKTPLISSK-----VDVWSAGILFYQMLFGRRPFGHDQ---TQERILREDT 632
YL PE +I SK VD W+ GIL Y+ML G PF D E+IL
Sbjct: 164 YLAPE--------IILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL---- 211
Query: 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
KV FPS S +AKDLIR L + +R
Sbjct: 212 ---EGKVRFPSF--FSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 31/280 (11%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACK---LHGLNAQWSEDKKQSYIRHAIREYNIH 461
+ +LN +GKG F V+K + R A K L +N + E+ AI E +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREE--------AIDEARVL 53
Query: 462 KTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQ 519
L +I+R +++F +D+ V+EY DL +LK LPE + +QI
Sbjct: 54 AKLDSSYIIRYYESF-LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL 112
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
GL +L+ + KI+H D+K N+ D + K+ D G++K++ D+ + GT
Sbjct: 113 GLAHLHSK--KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-----NFANTIVGTP 165
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639
+YL P EL + + K DVW+ G++ Y+ G+ PF + IL+ II+
Sbjct: 166 YYLSP---ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK---IIRGV-- 217
Query: 640 EFPSRPA-VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
FP S + LI +CLT + +RPD L ++P L
Sbjct: 218 -FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 86/300 (28%), Positives = 130/300 (43%), Gaps = 43/300 (14%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYI-RHAIREYNIHKT 463
Y L +G+G + VYKA D + VA K + + I + A+RE + K
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK------KIKLRFESEGIPKTALREIKLLKE 54
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLI 522
L H +I++L D F + V E+ DL ++K LPE + + Q+ QGL
Sbjct: 55 LNHPNIIKLLDVFR-HKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
+ + I+H DLKP N+L + GV K+ DFGL++ GS T T WY
Sbjct: 113 FCHS--HGILHRDLKPENLLINTEGVLKLADFGLARS----FGSPVRPYTHYVV-TRWYR 165
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQE--RILR-------ED- 631
PE K S+ VD+WS G +F ++L R F G + + +I R E
Sbjct: 166 APELLLGDK--GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW 223
Query: 632 ----TIIKARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++ + K FP + P S +A DL+ + L Y+ +R PY
Sbjct: 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 11/275 (4%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
R+ N +G G F +VY A +L +A K + +D I+ E + +
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRI-----QDNDPKTIKEIADEMKVLEL 55
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H ++V+ + E+ + +EYCSG L+ +L+ +L E R+ +Q+ +GL Y
Sbjct: 56 LKHPNLVKYYGV-EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAY 114
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ I+H D+KP N+ D GV K+ DFG + ++++ + G E+ S AGT Y+
Sbjct: 115 LHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL-AGTPAYMA 171
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE K D+WS G + +M G+RP+ + +I+ + K P
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGAGHKPPIPD 229
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+S E KD + RCL + +RP L Q P++
Sbjct: 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 91/310 (29%), Positives = 134/310 (43%), Gaps = 59/310 (19%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK-KQSYIRHAIREYNIHKT 463
Y L +G+G + VYKA DL R+VA K + SE+ S +RE + K
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK--KVRVPLSEEGIPLS----TLREIALLKQ 54
Query: 464 LV---HHHIVRLWDTFEIDQNTFCT----VLEYCSGKDLDAVLK--ATPVLPEREARIII 514
L H +IVRL D + V E+ +DL L P LP + ++
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLM 113
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
Q+ +G+ +L+ + +I+H DLKP N+L G K+ DFGL++I + M LTS
Sbjct: 114 RQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-----MALTSV 166
Query: 575 GAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQE--RIL 628
T WY PE S TP VD+WS G +F ++ F RRP G + + +I
Sbjct: 167 VV-TLWYRAPEVLLQSSYATP-----VDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIF 219
Query: 629 R-----------EDTIIKARKVEFPSRPAVS---------NEAKDLIRRCLTYNQAERPD 668
+ + + FPS S E DL+++ LT+N +R
Sbjct: 220 DVIGLPSEEEWPRNVSLP--RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS 277
Query: 669 VLTLAQDPYL 678
Q PY
Sbjct: 278 AFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 87/266 (32%), Positives = 123/266 (46%), Gaps = 38/266 (14%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
LG GGF V ++R A K E +Q +I E I + H IV
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVK-KRHIVETGQQEHIF---SEKEILEECNHPFIV 56
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQK 530
+L+ TF+ D+ ++EYC G +L +L+ + E AR I + YL+ R
Sbjct: 57 KLYRTFK-DKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR--G 113
Query: 531 IIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS 590
II+ DLKP N+L D G K+ DFG +K + + + T GT Y+ PE
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL------KSGQKTWTFCGTPEYVAPE----- 162
Query: 591 KTPLISSK-----VDVWSAGILFYQMLFGRRPFGHDQ-----TQERILREDTIIKARKVE 640
+I +K VD WS GIL Y++L GR PFG D IL+ + K+E
Sbjct: 163 ---IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-----KLE 214
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAER 666
FP+ + AKDLI++ L N ER
Sbjct: 215 FPNY--IDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 79/287 (27%), Positives = 124/287 (43%), Gaps = 36/287 (12%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLN-AQWSEDKKQSYIRHAIREYNIHKT 463
Y +L +GKG F V K + + + K ++ +E +KQ + E NI +
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWK--EIDYGNMTEKEKQ----QLVSEVNILRE 55
Query: 464 LVHHHIVRLWDTFEIDQN-TFCTVLEYCSGKDLDAVL----KATPVLPEREARIIIVQIF 518
L H +IVR +D N T V+EYC G DL ++ K + E I+ Q+
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 519 QGLIYLNKRAQ---KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
L + R+ ++H DLKP N+ D K+ DFGL+KI+ D
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-----SSFAKTY 170
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDT 632
GT +Y+ PE +L+ K D+WS G L Y++ PF Q +I
Sbjct: 171 VGTPYYMSPE--QLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI----- 222
Query: 633 IIKARKVEFPSRPAV-SNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++ +F P S+E ++I+ L + +RP L Q P +
Sbjct: 223 ----KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 81/281 (28%), Positives = 118/281 (41%), Gaps = 33/281 (11%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACK-LHGLNAQWSEDKKQSYIRHAI-REYNIHKTLV--- 465
LG+G VYK + A K +H R + RE KTL
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDG--------DEEFRKQLLREL---KTLRSCE 57
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL- 524
++V+ + F + VLEY G L +LK +PE I QI +GL YL
Sbjct: 58 SPYVVKCYGAF-YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
KR IIH D+KP N+L + G K+ DFG+SK++E+ + T GT Y+ P
Sbjct: 117 TKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN---TLDQCNTFV--GTVTYMSP 169
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
E + ++ S D+WS G+ + G+ PF + + PS
Sbjct: 170 ERIQ-GES--YSYAADIWSLGLTLLECALGKFPFLPPGQPSFF---ELMQAICDGPPPSL 223
Query: 645 PA--VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
PA S E +D I CL + +RP L Q P++ +
Sbjct: 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 44/285 (15%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ +L LG+G + VYKA + VA K+ + E K E +I K
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK---------EISILKQC 55
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIY 523
+IV+ + ++ + + + V+EYC + ++K T L E E I+ Q +GL Y
Sbjct: 56 DSPYIVKYYGSYFKNTDLW-IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEY 114
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ K IH D+K GN+L +E G AK+ DFG+S + D M + GT +++
Sbjct: 115 LHSN--KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMA 167
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF-- 641
PE + ++K D+WS GI +M G+ P+ I + F
Sbjct: 168 PEVIQEIG---YNNKADIWSLGITAIEMAEGKPPYSD-------------IHPMRAIFMI 211
Query: 642 PSRPA--------VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
P++P S E D +++CL + ERP + L Q P++
Sbjct: 212 PNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 84/298 (28%), Positives = 131/298 (43%), Gaps = 56/298 (18%)
Query: 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ + LLGKG V+ + A K+ E K++ ++ + E I
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDK----KEMIKRNKVKRVLTEQEILA 56
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQG 520
TL H + L+ +F+ + C V++YC G +L +L+ P L E AR ++
Sbjct: 57 TLDHPFLPTLYASFQTETY-LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK---------------------- 558
L YL+ I++ DLKP N+L E G ++DF LSK
Sbjct: 116 LEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 559 --IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLI-----SSKVDVWSAGILFYQM 611
I + + ++ GT Y+ PE +I S VD W+ GIL Y+M
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPE--------VISGDGHGSAVDWWTLGILLYEM 225
Query: 612 LFGRRPF-GH--DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
L+G PF G D+T IL+++ V FP P VS+ A+DLIR+ L + ++R
Sbjct: 226 LYGTTPFKGSNRDETFSNILKKE-------VTFPGSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-30
Identities = 87/316 (27%), Positives = 127/316 (40%), Gaps = 65/316 (20%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI------RE 457
RY LL +G G + V A D R VA K K + I RE
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK-----------KISNVFDDLIDAKRILRE 49
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQ----NTFCTVLEYCSGKDLDAVLKATPVLPEREARII 513
+ + L H +I+ L D N V E DL V+K+ L + +
Sbjct: 50 IKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSPQPLTDDHIQYF 108
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
+ QI +GL YL+ A +IH DLKP N+L + K+ DFGL++ V+ D +G LT
Sbjct: 109 LYQILRGLKYLH-SA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF-LT- 164
Query: 574 QGAGTYWYLPPE----CFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHD------ 621
+ T WY PE +K +D+WS G +F ++L R+P G D
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKA------IDIWSVGCIFAELL-TRKPLFPGRDYIDQLN 217
Query: 622 --------QTQERILREDTIIKARK--VEFPSRPAV---------SNEAKDLIRRCLTYN 662
++E + + KAR P +P S EA DL+ + L ++
Sbjct: 218 LIVEVLGTPSEEDLKFITS-EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFD 276
Query: 663 QAERPDVLTLAQDPYL 678
+R PYL
Sbjct: 277 PKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 82/280 (29%), Positives = 134/280 (47%), Gaps = 29/280 (10%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ +L LGKG + VYK L ++++ A K L + S+ +++ A+ E I +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKERED----AVNEIRILAS 55
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL----KATPVLPEREARIIIVQIFQ 519
+ H +I+ + F +D N C V+EY DL + K ++PE+E I +Q+ +
Sbjct: 56 VNHPNIISYKEAF-LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
GL L+ QKI+H DLK N+L + K+ D G+SK++ + M T GT
Sbjct: 115 GLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNMAKTQ--IGTP 165
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639
Y+ PE + P S K D+WS G L Y+M PF Q+ LR K ++
Sbjct: 166 HYMAPEVW--KGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQD--LR----YKVQRG 216
Query: 640 EFPSRPAV-SNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++P P + S + ++ IR L RP+ + P +
Sbjct: 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 76/267 (28%), Positives = 121/267 (45%), Gaps = 36/267 (13%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYI-RHAIREYNIHKTLVH 466
L + KG F VY A Y A K+ KK I ++ + + ++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVL---------KKSDMIAKNQVTNVKAERAIMM 51
Query: 467 H-----HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
++ +L+ +F+ ++ V+EY +G D +++K LPE A+ I ++ G+
Sbjct: 52 IQGESPYVAKLYYSFQ-SKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGV 110
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
L++R IIH D+KP N+L D+ G K+TDFGLS+ + GT Y
Sbjct: 111 EDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNG---------LENKKFVGTPDY 159
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
L PE D WS G + ++ LFG PF H +T + + I +R++ +
Sbjct: 160 LAPETILGVGD---DKMSDWWSLGCVIFEFLFGYPPF-HAETPDAVFDN---ILSRRINW 212
Query: 642 PSR--PAVSNEAKDLIRRCLTYNQAER 666
P S EA DLI R L + A+R
Sbjct: 213 PEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 82/284 (28%), Positives = 127/284 (44%), Gaps = 39/284 (13%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y L +G+G EVYKA D + VA K L + + I I E I K
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR-----KQNKELI---INEILIMKDC 72
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLIY 523
H +IV +D++ + + V+EY G L ++ V + E + + ++ QGL Y
Sbjct: 73 KHPNIVDYYDSYLVG-DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA------G 577
L+ +Q +IH D+K N+L + G K+ DFG + +LT + + G
Sbjct: 132 LH--SQNVIHRDIKSDNILLSKDGSVKLADFGFA-----------AQLTKEKSKRNSVVG 178
Query: 578 T-YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636
T YW P E+ K KVD+WS GI+ +M G P+ +E LR +I
Sbjct: 179 TPYWMAP----EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY----LREPPLRALFLITT 230
Query: 637 RKV-EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ + + S E KD + +CL + +RP L Q P+L
Sbjct: 231 KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 83/274 (30%), Positives = 127/274 (46%), Gaps = 18/274 (6%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACK---LHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L+G G F VY + +A K L ++A S+D+K+S + RE + K L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSAS-SKDRKRSMLDALAREIALLKELQH 65
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526
+IV+ + +D + LEY G + A+L E R + QI +GL YL+
Sbjct: 66 ENIVQYLGS-SLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV--GSQGMELTSQGAGTYWYLPP 584
R IIH D+K N+L D G K++DFG+SK +E + S +W P
Sbjct: 125 R--GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP- 181
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
E+ K + K D+WS G L +ML G+ PF + I + I + E PS
Sbjct: 182 ---EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK---IGENASPEIPSN 235
Query: 645 PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+S+EA D + + + +RP L + P+L
Sbjct: 236 --ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 48/292 (16%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRH-AIREYNIHK 462
RY +L +G+G V+KA D VA K L + + I + A+RE +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALR------RLEGGIPNQALREIKALQ 54
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGL 521
H ++V+L D F F V+EY DL VL+ LPE + + + + +G+
Sbjct: 55 ACQHPYVVKLLDVFPHGSG-FVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGV 112
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
Y++ A I+H DLKP N+L GV K+ DFGL+++ ++ + Q T WY
Sbjct: 113 AYMH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL---YSHQ-VATRWY 166
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK------ 635
PE L VD+W+ G +F ++L G F + E++ + +
Sbjct: 167 RAPEL--LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI---VFRTLGTPN 221
Query: 636 ------------ARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAER 666
K+ FP P S EA DL++ L Y+ ++R
Sbjct: 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKR 273
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 76/275 (27%), Positives = 115/275 (41%), Gaps = 22/275 (8%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
L LG G V K + +A K L + Q I +RE +I
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE---INEAIQKQI---LRELDILHKCNSP 59
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNK 526
+IV + F + +EY G LD +LK +PER I V + +GL YL
Sbjct: 60 YIVGFYGAF-YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL-H 117
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
KIIH D+KP N+L + G K+ DFG+S + + + T GT Y+ PE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-----KTF--VGTSSYMAPER 170
Query: 587 FELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILRE-DTIIKARKVEFPSR 644
+ + S K D+WS G+ ++ GR P+ + + I I+ PS
Sbjct: 171 IQGND---YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG 227
Query: 645 PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
S + +D + CL + ERP L + P++
Sbjct: 228 K-FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 74/275 (26%), Positives = 120/275 (43%), Gaps = 42/275 (15%)
Query: 407 LLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L LG+G F EVYK VA K L SE++++ ++ E +I K
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT--LKEGASEEEREEFLE----EASIMK 56
Query: 463 TLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARI-IIVQI 517
L H +IVRL + V EY G DL L+ + + + +QI
Sbjct: 57 KLSHPNIVRL-----LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
+G+ YL + +H DL N L E V K++DFGLS+ + +D + + G
Sbjct: 112 AKGMEYLESK--NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED------DYYRKRGG 163
Query: 578 TY----WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDT 632
W PE + K +SK DVWS G+L +++ G +P+ + E +L +
Sbjct: 164 GKLPIKWM-APESLKDGK---FTSKSDVWSFGVLLWEIFTLGEQPYP-GMSNEEVL--EL 216
Query: 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ ++ P +E +L+ +C Y+ +RP
Sbjct: 217 LEDGYRLPRP--ENCPDELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 81/271 (29%), Positives = 129/271 (47%), Gaps = 10/271 (3%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE--DKKQSYIRHAIR-EYNIHKTLVH 466
L+GKG + VY A ++ +A K L A + D +Q + A+R E K L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526
+IV+ + FE + LEY G + + L+ E+ R Q+ +GL YL+
Sbjct: 68 LNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
+ I+H DLK N+L D G+ K++DFG+SK DD+ ++ Q G+ +++ PE
Sbjct: 127 --KGILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQ--GSVFWMAPEV 181
Query: 587 FELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPA 646
S + S+KVD+WS G + +M GRRP+ ++ + + A +
Sbjct: 182 IH-SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240
Query: 647 VSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
+S A D + C T N RP L Q P+
Sbjct: 241 LSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-28
Identities = 84/285 (29%), Positives = 124/285 (43%), Gaps = 44/285 (15%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ ++ ++G+G F EV+ D + A K+ + S+ K++ I H E +I
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKV----LRKSDMIKRNQIAHVRAERDI--- 54
Query: 464 LVHHH---IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
L IV+L+ +F+ D+ V+EY G DL +L V PE AR I ++
Sbjct: 55 LADADSPWIVKLYYSFQ-DEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK---------------------- 558
L ++K IH D+KP N+L D G K+ DFGL K
Sbjct: 114 LDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 559 --IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRR 616
+V Q + GT Y+ PE + D WS G++ Y+ML+G
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPY--GLECDWWSLGVILYEMLYGFP 228
Query: 617 PFGHDQTQERILREDTIIKARK-VEFPSRPAVSNEAKDLIRRCLT 660
PF D QE + II ++ + FP P VS EA DLI R L
Sbjct: 229 PFYSDTLQETYNK---IINWKESLRFPPDPPVSPEAIDLICRLLC 270
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 82/278 (29%), Positives = 131/278 (47%), Gaps = 29/278 (10%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE--DKKQSYIRHAIREYNIHK 462
+ + +GKG FS VYKA L++ R VA K Q E D K + ++E ++ K
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALK----KVQIFEMMDAKAR--QDCLKEIDLLK 57
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP----VLPEREARIIIVQIF 518
L H ++++ +F I+ N VLE DL ++K ++PER VQ+
Sbjct: 58 QLDHPNVIKYLASF-IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
L +++ + +I+H D+KP NV GV K+ D GL + S+ S GT
Sbjct: 117 SALEHMHSK--RIMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHSL-VGT 169
Query: 579 YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638
+Y+ PE + K D+WS G L Y+M + PF +++ K K
Sbjct: 170 PYYMSPERIHENGYNF---KSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKKIEK 222
Query: 639 VEFPSRPA--VSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
++P PA S E +DL+ RC+ + +RPD+ + Q
Sbjct: 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 19/270 (7%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LLG G F VY+ +L + + A K ++ Q ++ +E + L H +I
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKE--VSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ 529
V+ T E +++ LE G L +LK PE R+ QI GL YL+ +
Sbjct: 65 VQYLGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH--DR 121
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFEL 589
+H D+K N+L D GV K+ DFG++K V + ++ + G+ +++ PE +
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK------GSPYWMAPEV--I 173
Query: 590 SKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP-AVS 648
++ D+WS G +M G+ P+ + + + R E P P +S
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-----IGRSKELPPIPDHLS 228
Query: 649 NEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+EAKD I +CL + + RP L + P++
Sbjct: 229 DEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 77/270 (28%), Positives = 120/270 (44%), Gaps = 33/270 (12%)
Query: 407 LLNLLGKGGFSEVYKA--YDLVEHRY--VACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L LG+G F EVYK + VA K L SE + + ++R E I +
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT--LKEDASEQQIEEFLR----EARIMR 56
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGL 521
L H ++V+L ++ V+EY G DL + L+ P L + +QI +G+
Sbjct: 57 KLDHPNVVKLLG-VCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD--VGSQGMELTSQGAGTY 579
YL + IH DL N L E V K++DFGLS+ + DD +G +L
Sbjct: 116 EYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP-----IR 168
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARK 638
W + PE + K +SK DVWS G+L +++ G +P+ +E + E +K
Sbjct: 169 W-MAPESLKEGKF---TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--VLEY--LKNG- 219
Query: 639 VEFPSRPAVSNEA-KDLIRRCLTYNQAERP 667
+P DL+ +C + +RP
Sbjct: 220 -YRLPQPPNCPPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 81/290 (27%), Positives = 124/290 (42%), Gaps = 40/290 (13%)
Query: 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ LL +GKG F EVYKA D ++ VA K+ ++ + +ED+ I +E
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV--IDLEEAEDE----IEDIQQEIQFLS 54
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
+I + + +F + + ++EYC G +LK L E I+ ++ GL
Sbjct: 55 QCRSPYITKYYGSF-LKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLE 112
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG------A 576
YL++ + IH D+K N+L E G K+ DFG+S +LTS
Sbjct: 113 YLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSG-----------QLTSTMSKRNTFV 159
Query: 577 GT-YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT +W P E+ K K D+WS GI ++ G P R+L I K
Sbjct: 160 GTPFWMAP----EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RVLFL--IPK 212
Query: 636 ARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
PS S KD + CL + ERP L + ++ +KK
Sbjct: 213 N---NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 75/268 (27%), Positives = 116/268 (43%), Gaps = 29/268 (10%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI 455
+FQIL +G+GG+ +V+ A VA K + + ++ +RH +
Sbjct: 1 KDFQILTQ-------VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE----VRHVL 49
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIV 515
E +I T +V+L F+ D+ + +EY G D +L VL E AR +
Sbjct: 50 TERDILTTTKSEWLVKLLYAFQDDEYLYLA-MEYVPGGDFRTLLNNLGVLSEDHARFYMA 108
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
++F+ + L++ IH DLKP N L D G K+TDFGLSK + +
Sbjct: 109 EMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSK--------GIVTYANSV 158
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE---RILREDT 632
G+ Y+ PE VD WS G + Y+ L G PF E +
Sbjct: 159 VGSPDYMAPEVLRGKG---YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE 215
Query: 633 IIKARKVEFPSRPAVSNEAKDLIRRCLT 660
++ R V R +S+EA DLI + +
Sbjct: 216 TLQ-RPVYDDPRFNLSDEAWDLITKLIN 242
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 75/272 (27%), Positives = 115/272 (42%), Gaps = 36/272 (13%)
Query: 407 LLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L LG+G F EVYK + VA K L SE + + ++R E I +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT--LKEDASEQQIEEFLR----EARIMR 56
Query: 463 TLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQ 516
L H +IV+L + ++ V+EY G DL L+ L + +Q
Sbjct: 57 KLDHPNIVKL-----LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
I +G+ YL + IH DL N L E V K++DFGLS+ + DD G
Sbjct: 112 IARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD----YYKVKGGK 165
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIK 635
++ PE + K +SK DVWS G+L +++ G P+ E + E + K
Sbjct: 166 LPIRWMAPESLKEGKF---TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE--VLEY-LKK 219
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
++ P E L+ +C + +RP
Sbjct: 220 GYRLPKPPNC--PPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 75/276 (27%), Positives = 130/276 (47%), Gaps = 29/276 (10%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
LG G F +VYKA + A K+ + SE++ + ++ E +I H +IV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMV----EIDILSECKHPNIV 65
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQ 529
L++ + + N ++E+C G LD+++ L E + R + Q+ + L +L+ +
Sbjct: 66 GLYEAYFYE-NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH--SH 122
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPE---C 586
K+IH DLK GN+L G K+ DFG+S + ++ GT +++ PE C
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-----LQKRDTFIGTPYWMAPEVVAC 177
Query: 587 FELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP--SR 644
E K K D+WS GI ++ P H+ R+L +K K E P +
Sbjct: 178 -ETFKDNPYDYKADIWSLGITLIELA-QMEPPHHELNPMRVL-----LKILKSEPPTLDQ 230
Query: 645 PAV-SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
P+ S+ D ++ CL + +RP L + P+++
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y + +G+G + +VYKA + VA K + E++K+ + AIRE + + L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRM-----ENEKEGFPITAIREIKLLQKL 55
Query: 465 VHHHIVRLWD-TFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLI 522
H +IVRL + + + V EY DL +L + V E + + + Q+ +GL
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL+ I+H D+K N+L + GV K+ DFGL++ + T+ T WY
Sbjct: 115 YLHSN--GILHRDIKGSNILINNDGVLKLADFGLARPYTKR---NSADYTN-RVITLWYR 168
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHD-QTQ-ERILR---------- 629
PPE L +VD+WS G + ++ G+ F G Q E+I
Sbjct: 169 PPEL--LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226
Query: 630 ------EDTIIKARKVEFPSR------PAVSNEAKDLIRRCLTYNQAERPDV 669
K + R + A DL+ + LT + +R
Sbjct: 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 87/270 (32%), Positives = 126/270 (46%), Gaps = 39/270 (14%)
Query: 408 LNLLGKGGFSEVYKAYDLVEH---RYVACKLHGLNAQWSEDKKQSYIR------HAIREY 458
L +LGKGG+ +V++ + + A K+ KK + +R H E
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVL---------KKATIVRNQKDTAHTKAER 51
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIF 518
NI + + H IV L F+ + +LEY SG +L L+ + E A + +I
Sbjct: 52 NILEAVKHPFIVDLIYAFQTGGKLY-LILEYLSGGELFMHLEREGIFMEDTACFYLSEIS 110
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK--IVEDDVGSQGMELTSQGA 576
L +L++ Q II+ DLKP N+L D G K+TDFGL K I E V T
Sbjct: 111 LALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV-------THTFC 161
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636
GT Y+ PE S VD WS G L Y ML G PF + ++ I D I+K
Sbjct: 162 GTIEYMAPEILMRSGH---GKAVDWWSLGALMYDMLTGAPPFTAENRKKTI---DKILKG 215
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
K+ P P ++ EA+DL+++ L N + R
Sbjct: 216 -KLNLP--PYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 81/290 (27%), Positives = 124/290 (42%), Gaps = 35/290 (12%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
L+ LG+G V K A K + D + +RE I+K+
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKT------ITTDPNPDLQKQILRELEINKSCKSP 59
Query: 468 HIVRLWDTFEIDQNTFCTV-LEYCSGKDLDAVLKATPVLPEREARI-------IIVQIFQ 519
+IV+ + F + ++ + +EYC G LD++ K + +R RI I + +
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK---VKKRGGRIGEKVLGKIAESVLK 116
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
GL YL+ R KIIH D+KP N+L G K+ DFG+S + V S T GT
Sbjct: 117 GLSYLHSR--KIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFT----GTS 167
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE--DTIIKAR 637
+Y+ PE + K I+S DVWS G+ ++ R PF + E I+
Sbjct: 168 FYMAPERIQ-GKPYSITS--DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224
Query: 638 KVEFPSRPAV----SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
E P S E KD I++CL + RP + + P++ K
Sbjct: 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 43/284 (15%)
Query: 409 NLLGKGGFSEVYKA--YDLVEHRY-VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV 465
LG+G F EVYK VA K +A E++K ++E + K L
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-EEERKDF-----LKEARVMKKLG 54
Query: 466 HHHIVRL--WDTFEIDQNTFCTVLEYCSGKDLDAVLKAT---------PVLPEREARIII 514
H ++VRL T ++ VLEY G DL L+ + L ++
Sbjct: 55 HPNVVRLLGVCT---EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
+QI +G+ YL +K +H DL N L E V K++DFGLS+ V DD +
Sbjct: 112 IQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-----DYYRKK 164
Query: 575 GAG---TYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILRE 630
G W + PE K + +SK DVWS G+L +++ G P+ + E +L
Sbjct: 165 TGGKLPIRW-MAPESL---KDGIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEEVLE- 218
Query: 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+ K ++ P +E +L+ C + +RP L +
Sbjct: 219 -YLRKGYRLPKPEY--CPDELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 84/302 (27%), Positives = 124/302 (41%), Gaps = 42/302 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y +L ++G+G + V K + VA K ++ ED K++ A+RE + +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKT----ALREVKVLRQ 56
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLI 522
L H +IV L + F + V EY + L +L+A+P LP R I Q+ Q +
Sbjct: 57 LRHENIVNLKEAFRRKGRLY-LVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
Y + IIH D+KP N+L E GV K+ DFG ++ + LT A T WY
Sbjct: 115 YCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALR---ARPASPLTDYVA-TRWYR 168
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF----GHDQ-----------TQERI 627
PE L VDVW+ G + ++L G F DQ
Sbjct: 169 APEL--LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226
Query: 628 LREDTIIKARKVEFPS-----------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676
+ + V FP VS+ A D ++ CL + ER L Q P
Sbjct: 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286
Query: 677 YL 678
Y
Sbjct: 287 YF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 80/273 (29%), Positives = 120/273 (43%), Gaps = 24/273 (8%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LLG+G F VY YD+ R +A K + E KK+ + E + K L H I
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKE--VNALECEIQLLKNLQHERI 66
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ 529
V+ + D+ T +EY G + LKA L E R QI +G+ YL+
Sbjct: 67 VQYYGCLRDDE-TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS--N 123
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFEL 589
I+H D+K N+L D G K+ DFG SK ++ + S G + S GT +++ PE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-TICSSGTGMKSV-TGTPYWMSPE---- 177
Query: 590 SKTPLISS-----KVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
+IS K DVWS G +ML + P+ + I + I +
Sbjct: 178 ----VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLP 229
Query: 645 PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
VS +A++ +RR N +RP L + +
Sbjct: 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 73/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY ++ +G+G F ++Y A + + K L ++K+ S +E +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK-----KEVILLAK 55
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARII--IVQIFQGL 521
+ H +IV + +F+ + V+EYC G DL + + E +I+ VQI GL
Sbjct: 56 MKHPNIVTFFASFQ-ENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
+++ R KI+H D+K N+ + G VAK+ DFG+++ + D MEL GT +
Sbjct: 115 KHIHDR--KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-----MELAYTCVGTPY 167
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640
YL PE + + ++K D+WS G + Y++ + PF + + +L+ I +
Sbjct: 168 YLSPE---ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK---ICQGYFA- 220
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
P P S + + LI + + +RP + ++ + P+L
Sbjct: 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 91/320 (28%), Positives = 140/320 (43%), Gaps = 54/320 (16%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
L RY L LG G V+ A D + VA K L D + ++HA+RE I
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT-----DPQS--VKHALREIKI 55
Query: 461 HKTLVHHHIVRLWDTF-------------EIDQNTFCTVLEYCSGKDLDAVLKATPVLPE 507
+ L H +IV++++ + N+ V EY DL VL+ P L E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGP-LSE 113
Query: 508 REARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVEDDVGS 566
AR+ + Q+ +GL Y++ + ++H DLKP NV + E V K+ DFGL++IV+
Sbjct: 114 EHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
Query: 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFG------- 619
+G S+G T WY P LS + +D+W+AG +F +ML G+ F
Sbjct: 172 KGY--LSEGLVTKWYRSPRLL-LSPNNY-TKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227
Query: 620 -----------HDQTQERILREDTIIKARKVEFPSRP------AVSNEAKDLIRRCLTYN 662
++ + +L P RP V+ EA D + + LT+N
Sbjct: 228 MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFN 287
Query: 663 QAERPDVLTLAQDPYLT-YS 681
+R PY++ YS
Sbjct: 288 PMDRLTAEEALMHPYMSCYS 307
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 87/278 (31%), Positives = 137/278 (49%), Gaps = 21/278 (7%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ ++ LG G F +VYKA + A K+ SE++ + Y+ E +I +
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMV----EIDILASC 59
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAV-LKATPVLPEREARIIIVQIFQGLIY 523
H +IV+L D F + N + ++E+C+G +DAV L+ L E + R++ Q + L Y
Sbjct: 60 DHPNIVKLLDAFYYENNLW-ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNY 118
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L++ KIIH DLK GN+LF G K+ DFG+S ++ ++ GT +++
Sbjct: 119 LHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMA 171
Query: 584 PECF--ELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
PE E SK K DVWS GI +M P H+ R+L + + +
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSEPPTLAQ 230
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
PSR S+E KD +++CL N R L Q P++T
Sbjct: 231 PSR--WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 27/237 (11%)
Query: 401 LNHRYALL-NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQS--YIRH---- 453
++ RY LG+G + +V KAYD + + VA K + S D + +
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIE-ISNDVTKDRQLVGMCGIH 64
Query: 454 --AIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREAR 511
+RE I + H +I+ L D + ++ + V++ + DL V+ L E + +
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVY-VEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVK 122
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS----------KIVE 561
I++QI GL L+K +H DL P N+ + G+ K+ DFGL+ + +
Sbjct: 123 CILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
D+ + E+TS+ T WY PE L VD+WS G +F ++L G+ F
Sbjct: 181 DETMQRREEMTSK-VVTLWYRAPEL--LMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 83/278 (29%), Positives = 121/278 (43%), Gaps = 24/278 (8%)
Query: 405 YALLNLLGKGGFSEVYKA-YDLVEHRYVACK---LHGLNAQWSEDKKQSYIRHAIREYNI 460
YA+L LG G F VYK +A K +H + ++ I + E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 461 HK-TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPER--EARI--IIV 515
K L H +IVR + TF ++ + V++ G L + +R E RI I V
Sbjct: 62 IKEQLRHPNIVRYYKTF-LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ L YL+K ++I+H DL P N++ E +TDFGL+K +LTS
Sbjct: 121 QMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSV- 173
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT Y C E+ K K DVW+ G + YQM + PF +L T I
Sbjct: 174 VGTILY---SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF----YSTNMLSLATKIV 226
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673
E S + D+I CLT + RPD++ ++
Sbjct: 227 EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 84/270 (31%), Positives = 123/270 (45%), Gaps = 40/270 (14%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ +G G F V+ D + Y A K+ + KQ +H E + K +
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKV--MAIPEVIRLKQ--EQHVHNEKRVLKEV 58
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
H I+RL+ T E DQ ++EY G +L + L+ + +I L YL
Sbjct: 59 SHPFIIRLFWT-EHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ +++I++ DLKP N+L D+ G K+TDFG +K + D T GT YL P
Sbjct: 118 H--SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--------TWTLCGTPEYLAP 167
Query: 585 ECFELSKTPLISSK-----VDVWSAGILFYQMLFGRRPFGHDQT---QERILREDTIIKA 636
E +I SK VD W+ GIL Y+ML G PF D E+IL A
Sbjct: 168 E--------VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL-------A 212
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
K+EFP + AKDLI++ L ++ R
Sbjct: 213 GKLEFPRHLDLY--AKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 27/273 (9%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y L+ ++G G + VY A L + VA K L +K Q+ + +E
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL------EKCQTSVDELRKEVQAMSQC 56
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK---ATPVLPEREARIIIVQIFQGL 521
H ++V+ + +F + + V+ Y SG L ++K L E ++ ++ +GL
Sbjct: 57 NHPNVVKYYTSF-VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
YL+ Q IH D+K GN+L E G K+ DFG+S + D + GT +
Sbjct: 116 EYLHSNGQ--IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF-VGTPCW 172
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
+ PE E K D+WS GI ++ G P+ ++L + + +
Sbjct: 173 MAPEVMEQVHG--YDFKADIWSFGITAIELATGAAPY-SKYPPMKVL-----MLTLQNDP 224
Query: 642 PSRP------AVSNEAKDLIRRCLTYNQAERPD 668
PS S + +I CL + ++RP
Sbjct: 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 79/292 (27%), Positives = 132/292 (45%), Gaps = 41/292 (14%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
+G+G + VYKA + + VA K L+ + +E + AIRE ++ K L H +IV
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPST----AIREISLLKELNHPNIV 62
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV--LPEREARIIIVQIFQGLIYLNKRA 528
+L D +N V E+ +DL + A+P+ +P + + Q+ QGL + + +
Sbjct: 63 KLLDVIH-TENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--S 118
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
+++H DLKP N+L + G K+ DFGL++ V + E+ T WY PE
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI-- 171
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR---------ED-----TII 634
L S+ VD+WS G +F +M+ R F D +++ R E T +
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231
Query: 635 KARKVEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
K FP P + + +DL+ + L Y+ +R P+
Sbjct: 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 84/281 (29%), Positives = 129/281 (45%), Gaps = 32/281 (11%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHR-----YVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
Y + ++GKG + EV LV HR YV KL+ NA E K A +E
Sbjct: 2 YCFVRVVGKGSYGEV----SLVRHRTDGKQYVIKKLNLRNASRRERKA------AEQEAQ 51
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQI 517
+ L H +IV +++E + V+ +C G DL LK +LPE + VQI
Sbjct: 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI 111
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
L YL+++ I+H DLK NV + KV D G+++++E+ ++ S G
Sbjct: 112 AMALQYLHEK--HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-----DMASTLIG 164
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
T +Y+ PE F S P + K DVW+ G Y+M + F + R II+ +
Sbjct: 165 TPYYMSPELF--SNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR---IIEGK 218
Query: 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
P S E +LI L+ +RP V ++ + PY+
Sbjct: 219 LPPMPKD--YSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y L+ LG+G ++ VYK + + VA K L + + AIRE ++ K L
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE------EGAPFTAIREASLLKDL 60
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIY 523
H +IV L D + T V EY DL + L R+ + Q+ +GL Y
Sbjct: 61 KHANIVTLHDIIHTKK-TLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
++R +++H DLKP N+L E G K+ DFGL++ S + S T WY P
Sbjct: 119 CHQR--RVLHRDLKPQNLLISERGELKLADFGLAR-----AKSVPSKTYSNEVVTLWYRP 171
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILR 629
P+ L T S+ +D+W G +FY+M GR F G ++++ +
Sbjct: 172 PDVL-LGSTEY-STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 85/299 (28%), Positives = 135/299 (45%), Gaps = 41/299 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y L +G+G + V+KA + H VA K L +D + A+RE + K
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICLLKE 55
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPERE-ARIIIVQIFQGLI 522
L H +IVRL+D D V EYC +DL + + E + + Q+ +GL
Sbjct: 56 LKHKNIVRLYDVLHSD-KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
+ + + ++H DLKP N+L ++ G K+ DFGL++ V E+ T WY
Sbjct: 114 FCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYR 166
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHD-QTQ-ERILR------EDT 632
PP+ L L S+ +D+WSAG +F ++ RP G+D Q +RI R E++
Sbjct: 167 PPDV--LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES 224
Query: 633 IIKARKV----EFPSRPAVSN----------EAKDLIRRCLTYNQAERPDVLTLAQDPY 677
K+ +P PA ++ +DL++ L N +R Q PY
Sbjct: 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 83/276 (30%), Positives = 127/276 (46%), Gaps = 29/276 (10%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
+LGKG + VY A DL +A K ++ Y++ E +H L H +I
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIK-------EIPERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIV--QIFQGLIYLN 525
V+ + + F +E G L A+L++ P L + E II QI +GL YL+
Sbjct: 68 VQYLGSD-SENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLH 125
Query: 526 KRAQKIIHYDLKPGNVLFDEF-GVAKVTDFGLSKIVEDDVGSQGME-LTSQGAGTYWYLP 583
+I+H D+K NVL + + GV K++DFG SK + G+ T GT Y+
Sbjct: 126 D--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL------AGINPCTETFTGTLQYMA 177
Query: 584 PECFELSKTPL-ISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642
PE + K P + D+WS G +M G+ PF + + + + K E P
Sbjct: 178 PEVID--KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP-EIP 234
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++S EAK+ I RC + +R L QDP+L
Sbjct: 235 E--SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-22
Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 25/265 (9%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
+G+G FSEVY+A L++ + VA K Q E + ++E ++ K L H +++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALK----KVQIFEMMDAKARQDCVKEIDLLKQLNHPNVI 65
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVL----KATPVLPEREARIIIVQIFQGLIYLNK 526
+ D+F I+ N VLE DL ++ K ++PER VQ+ + +++
Sbjct: 66 KYLDSF-IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
R +++H D+KP NV GV K+ D GL + S GT +Y+ PE
Sbjct: 125 R--RVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPER 177
Query: 587 FELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPA 646
+ + K D+WS G L Y+M + PF D+ L + K + ++P P
Sbjct: 178 IHENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ----KIEQCDYPPLPT 230
Query: 647 --VSNEAKDLIRRCLTYNQAERPDV 669
S + ++L+ C+ + +RPD+
Sbjct: 231 EHYSEKLRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLN 525
H + +L F+ F V+EY +G DL ++ + E AR +I GL +L+
Sbjct: 55 HPFLTQLHSCFQTKDRLF-FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 526 KRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK--IVEDDVGSQGMELTSQGAGTYWYLP 583
+R II+ DLK NVL D G K+ DFG+ K I+ TS GT Y+
Sbjct: 114 ER--GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-------TSTFCGTPDYIA 164
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI---IKARKVE 640
PE LS P + VD W+ G+L Y+ML G+ PF D ED + I +V
Sbjct: 165 PEI--LSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDD-------EDELFQSILEDEVR 214
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAER 666
+P +S EAK +++ LT N +R
Sbjct: 215 YPR--WLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 84/311 (27%), Positives = 132/311 (42%), Gaps = 58/311 (18%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y L +G+G + +VYKA D + VA L E ++ A+RE ++ + L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVA-----LKKTRLEMDEEGIPPTALREISLLQML 57
Query: 465 VHH-HIVRLWDTFEIDQNT----FCTVLEYCSGKDLDAVLK----------ATPVLPERE 509
+IVRL D +++ V EY LD+ LK P LP +
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRP-LPAKT 111
Query: 510 ARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQG 568
+ + Q+ +G+ + +K ++H DLKP N+L D + G+ K+ D GL + V S
Sbjct: 112 IKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628
E+ T WY PE S S+ VD+WS G +F +M + F D +++L
Sbjct: 170 HEIV-----TLWYRAPEVLLGSTH--YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL 222
Query: 629 R---------EDTIIKARKV----EFP---------SRPAVSNEAKDLIRRCLTYNQAER 666
E K+ EFP + P +S E DL+++ L Y+ A+R
Sbjct: 223 HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKR 282
Query: 667 PDVLTLAQDPY 677
PY
Sbjct: 283 ISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 7e-22
Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 33/275 (12%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACK----LHGLNAQWSEDKKQSYIRHAIREYNI 460
+ + +G+G FSEVY+A L++ VA K ++A+ D I+E ++
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD--------CIKEIDL 55
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL----KATPVLPEREARIIIVQ 516
K L H ++++ + +F I+ N VLE DL ++ K ++PE+ VQ
Sbjct: 56 LKQLNHPNVIKYYASF-IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
+ L +++ R +++H D+KP NV GV K+ D GL + S
Sbjct: 115 LCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLV 167
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636
GT +Y+ PE + + K D+WS G L Y+M + PF D+ L + K
Sbjct: 168 GTPYYMSPERIHENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KI 220
Query: 637 RKVEFPSRPA--VSNEAKDLIRRCLTYNQAERPDV 669
+ ++P P+ S E + L+ C+ + +RPD+
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 8e-22
Identities = 86/305 (28%), Positives = 144/305 (47%), Gaps = 44/305 (14%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNA-QWSEDKKQSYIRHAIREYNIHK 462
+Y +L LGKG + V+KA D VA K +A + + D ++++ RE +
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALK-KIFDAFRNATDAQRTF-----REIMFLQ 61
Query: 463 TLVHH-HIVRLWDTFEIDQNT-FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
L H +IV+L + + + + V EY DL AV++A +L + R I+ Q+ +
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKA 119
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
L Y++ + +IH DLKP N+L + K+ DFGL++ + + + + + T W
Sbjct: 120 LKYIH--SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT--Q-ERIL-------RE 630
Y PE L + + VD+WS G + +ML G+ F T Q E+I+ E
Sbjct: 178 YRAPEI--LLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235
Query: 631 DTIIKARKVEF--------PSR---------PAVSNEAKDLIRRCLTYNQAERPDVLTLA 673
D I++ K F PSR P S++A DL+++ L +N +R
Sbjct: 236 D--IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293
Query: 674 QDPYL 678
+ PY+
Sbjct: 294 EHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 9e-22
Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 23/279 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY L LGKG F VY D K+ L + + A +E +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKV--LKEIPVGELNPNETVQANQEAQLLSK 58
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL----KATPVLPEREARIIIVQIFQ 519
L H IV+ +F ++++ FC + EYC G+DLD L L E + +Q+
Sbjct: 59 LDHPAIVKFHASF-LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
G+ Y+++R +I+H DLK N+ F + + K+ DFG+S+++ +GS +L + GT
Sbjct: 118 GVHYMHQR--RILHRDLKAKNI-FLKNNLLKIGDFGVSRLL---MGS--CDLATTFTGTP 169
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639
+Y+ PE K SK D+WS G + Y+M F +LR I++
Sbjct: 170 YYMSPEAL---KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR---IVEGPTP 223
Query: 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
P S + +++ L + + RP + ++P++
Sbjct: 224 SLPET--YSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 84/285 (29%), Positives = 132/285 (46%), Gaps = 29/285 (10%)
Query: 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
N + ++ LG G F +VYKA + A K+ E K + + + E I
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKV-------IETKSEEELEDYMVEIEIL 63
Query: 462 KTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAV-LKATPVLPEREARIIIVQIFQG 520
T H +IV+L F D ++E+C G +DA+ L+ L E + ++I Q+ +
Sbjct: 64 ATCNHPYIVKLLGAFYWD-GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA 122
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
L YL+ + KIIH DLK GNVL G K+ DFG+S + ++ GT +
Sbjct: 123 LQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNVKTLQRRDSFIGTPY 175
Query: 581 YLPPE---CFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
++ PE C + TP K D+WS GI +M P H+ R+L +K
Sbjct: 176 WMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPH-HELNPMRVL-----LKIA 228
Query: 638 KVEFP--SRPAV-SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
K E P S+P+ S E +D ++ L + RP L + P+++
Sbjct: 229 KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 24/260 (9%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
LGKGGF EV + ACK L+ + + K++ + A+ E I + + IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACK--KLDKKRLK-KRKGE-QMALNEKKILEKVSSRFIV 56
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLK--ATPVLPEREARIIIVQIFQGLIYLNKRA 528
L FE ++ C V+ +G DL + P PE A QI GL +L++R
Sbjct: 57 SLAYAFE-TKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR- 114
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
+I++ DLKP NVL D+ G +++D GL+ V +G + AGT Y+ P E
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA------VELKGGKKIKGRAGTPGYMAP---E 164
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT--IIKARKVEFPSRPA 646
+ + + VD ++ G Y+M+ GR PF Q +E++ +E+ VE+P +
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPF--RQRKEKVEKEELKRRTLEMAVEYPDK-- 220
Query: 647 VSNEAKDLIRRCLTYNQAER 666
S EAKDL L + +R
Sbjct: 221 FSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 71/276 (25%), Positives = 114/276 (41%), Gaps = 30/276 (10%)
Query: 411 LGKGGFSEVYKA-YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LG G F V K Y + + V + L ++ + + +RE ++ L H I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL----KQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ 529
VRL + + V+E L LK +P + + + Q+ G+ YL ++
Sbjct: 59 VRLIGVCKGEP--LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL--ESK 114
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WYLPPEC 586
+H DL NVL AK++DFG+S+ + GS + AG + WY PEC
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSD--YYRATTAGRWPLKWY-APEC 169
Query: 587 FELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVEFPSRP 645
K SSK DVWS G+ ++ +G +P+G + E I + ++ P
Sbjct: 170 INYGK---FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI---AMLESGERLPRPEE- 222
Query: 646 AVSNEAKDLIRRCLTYNQAERPD----VLTLAQDPY 677
E ++ C Y +RP T +DP
Sbjct: 223 -CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-21
Identities = 82/269 (30%), Positives = 120/269 (44%), Gaps = 34/269 (12%)
Query: 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ + LG G F V A Y A K L + E K ++H +E +I
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKC--LKKR--EILKMKQVQHVAQEKSILM 73
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
L H IV + +F+ D+N +LE+ G +L L+ P A+ ++
Sbjct: 74 ELSHPFIVNMMCSFQ-DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE 132
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL+ + II+ DLKP N+L D G KVTDFG +K V D T GT YL
Sbjct: 133 YLHSK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--------TFTLCGTPEYL 182
Query: 583 PPECFELSKTPLISSK-----VDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
PE +I SK VD W+ G+L Y+ + G PF D T RI + I A
Sbjct: 183 APE--------VIQSKGHGKAVDWWTMGVLLYEFIAGYPPF-FDDTPFRIYEK---ILAG 230
Query: 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+++FP+ A+DL++ L + +R
Sbjct: 231 RLKFPN--WFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 21/280 (7%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y L L+G+G + VY+ + R VA K+ L+ + D S I+ + + +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD---TPDDDVSDIQREVALLSQLRQS 59
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
+I + + ++ + ++EY G + ++KA P + E+ +II ++ L Y+
Sbjct: 60 QPPNITKYYGSY-LKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKYI 117
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+K +IH D+K N+L G K+ DFG++ ++ +Q S GT +++ P
Sbjct: 118 HKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALL-----NQNSSKRSTFVGTPYWMAP 170
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILREDTIIKARKVEFPS 643
E K +K D+WS GI Y+M G P+ D + +L I K++
Sbjct: 171 EVITEGKY--YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML----IPKSKPPRLED 224
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL-TYSK 682
S ++ + CL ER L + ++ +SK
Sbjct: 225 N-GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 82/310 (26%), Positives = 121/310 (39%), Gaps = 63/310 (20%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACK-LHGLNAQWSEDKKQSYIR----HAIREYN 459
Y ++ LG G F VY A + VA K + W E + ++R+ N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE-----CMNLREVKSLRKLN 55
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIF 518
H +IV+L + F + + V EY G + E R II QI
Sbjct: 56 EHP-----NIVKLKEVF-RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE------DDVGSQGMELT 572
QGL +++K H DLKP N+L V K+ DFGL++ + D V
Sbjct: 110 QGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV-------- 159
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQE--RILR 629
T WY PE L ++ SS VD+W+ G + ++ R F G + + +I
Sbjct: 160 ----STRWYRAPEI--LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213
Query: 630 ----------EDTIIKARKVEF------PSR-----PAVSNEAKDLIRRCLTYNQAERPD 668
+ A K+ F P+ P S EA DLI+ L ++ +RP
Sbjct: 214 VLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273
Query: 669 VLTLAQDPYL 678
Q PY
Sbjct: 274 ASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 84/278 (30%), Positives = 126/278 (45%), Gaps = 35/278 (12%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACK--LHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ + L+ G + VY LV H+ + + +N Q + Q I+ E +I
Sbjct: 3 FETIKLISNGAYGAVY----LVRHKETRQRFAMKKINKQNLILRNQ--IQQVFVERDILT 56
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
+ +V ++ +FE ++ C V+EY G D +LK LP AR+ + L
Sbjct: 57 FAENPFVVSMFCSFETKRH-LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI---------VEDDVGSQGME-LT 572
YL+ I+H DLKP N+L G K+TDFGLSKI E + E L
Sbjct: 116 YLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE---RILR 629
Q GT Y+ PE L + VD W+ GI+ Y+ L G PF D +E +++
Sbjct: 174 KQVCGTPEYIAPEVI-LRQG--YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230
Query: 630 EDTIIKARKVEFP-SRPAVSNEAKDLIRRCLTYNQAER 666
+D +E+P A+ +A+DLI R L N ER
Sbjct: 231 DD-------IEWPEGDEALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 85/308 (27%), Positives = 130/308 (42%), Gaps = 49/308 (15%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
F+I N RY L +G G F V A D + + VA K K++Y RE
Sbjct: 6 FEITN-RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-----RE 59
Query: 458 YNIHKTLVHHHIVRLWDTF--EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIV 515
+ K L H +I+ L D F ++ F T L G DL +L + P+ + + +
Sbjct: 60 LKLLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQF-IQYFLY 115
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
QI +GL Y++ + ++H DLKP N+L +E K+ DFGL++I Q ++T
Sbjct: 116 QILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDFGLARI-------QDPQMTGYV 166
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQ---------- 624
+ Y+ P K +VD+WSAG +F +ML G+ F G D
Sbjct: 167 STRYYRAPEIMLTWQK---YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG 223
Query: 625 -------ERILREDTI------IKARKVEFPSR-PAVSNEAKDLIRRCLTYNQAERPDVL 670
I E+T+ K V F + A DL+ + L ++ +R
Sbjct: 224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283
Query: 671 TLAQDPYL 678
PYL
Sbjct: 284 EALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 88/301 (29%), Positives = 136/301 (45%), Gaps = 44/301 (14%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y + +G+G + VYK + + VA K L E +++ AIRE ++ K L
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRL-----ESEEEGVPSTAIREISLLKEL 56
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV---LPEREARIIIVQIFQGL 521
H +IV L D + ++ + E+ S DL L + P + + + QI QG+
Sbjct: 57 QHPNIVCLQDVL-MQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
++ + R +++H DLKP N+L D GV K+ DFGL++ V E+ T WY
Sbjct: 115 LFCHSR--RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWY 167
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ----ERILR------ED 631
PE L +P S+ VD+WS G +F +M ++P H ++ RI R ED
Sbjct: 168 RAPEV--LLGSPRYSTPVDIWSIGTIFAEMA-TKKPLFHGDSEIDQLFRIFRILGTPTED 224
Query: 632 -----TIIKARKVEFPS------RPAVSN---EAKDLIRRCLTYNQAERPDVLTLAQDPY 677
T + K FP R AV N + DL+ + L Y+ A+R PY
Sbjct: 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
Query: 678 L 678
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 75/257 (29%), Positives = 120/257 (46%), Gaps = 21/257 (8%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LLGKG F +V + +Y A K+ ++D+ + H + E + + H +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE----VAHTLTESRVLQNTRHPFL 57
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ 529
L +F+ + C V+EY +G +L L V E AR +I L YL+
Sbjct: 58 TALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS--C 114
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFEL 589
+++ DLK N++ D+ G K+TDFGL K + + S G GT YL PE E
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGI-SDG-ATMKTFCGTPEYLAPEVLED 169
Query: 590 SKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSN 649
+ VD W G++ Y+M+ GR PF ++Q E++ +I ++ FP +S
Sbjct: 170 ND---YGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLF---ELILMEEIRFPRT--LSP 220
Query: 650 EAKDLIRRCLTYNQAER 666
EAK L+ L + +R
Sbjct: 221 EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 75/274 (27%), Positives = 119/274 (43%), Gaps = 18/274 (6%)
Query: 409 NLLGKGGFSEVYKAYDLVEH-RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
+LGKG + VY L + +A K L+ ++ Y E ++ K+L H
Sbjct: 6 EVLGKGAYGTVYCG--LTNQGQLIAVKQVELDTSNVLAAEKEY-EKLQEEVDLLKSLKHV 62
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
+IV+ T +D NT +E+ G + ++L LPE QI G+ YL+
Sbjct: 63 NIVQYLGTC-LDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGM--ELTSQGAGTYWYLPPE 585
++H D+K NV+ G+ K+ DFG ++ + VG G + GT +++ PE
Sbjct: 122 C--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW-VGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 586 CFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP 645
S K D+WS G ++M G+ P + I A + P P
Sbjct: 179 VINESGY---GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF----YIGAHRGLMPRLP 231
Query: 646 -AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ S A D + CLT +Q ERP L L + +L
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 75/292 (25%), Positives = 130/292 (44%), Gaps = 40/292 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ L+ ++G+G + +VYKA + VA K+ ++ E+++ I+ EYNI +
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKI--MDIIEDEEEE---IKE---EYNILRK 58
Query: 464 LVHHH-IVRLWDTF-----EIDQNTFCTVLEYCSGKDLDAVLKATPVLPER--EARI--I 513
+H I + F + + V+E C G + ++K +R E I I
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
+ + +GL YL++ K+IH D+K N+L + K+ DFG+S ++ +G + T
Sbjct: 119 LRETLRGLAYLHEN--KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN---TF 173
Query: 574 QGAGTYWYLPPE---CFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER---- 626
G YW + PE C + ++ DVWS GI ++ G+ P D R
Sbjct: 174 IGT-PYW-MAPEVIAC-DEQPDASYDARSDVWSLGITAIELADGKPPLC-DMHPMRALFK 229
Query: 627 ILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
I R ++ P S + D I CL N +RP + L + P++
Sbjct: 230 IPRN----PPPTLKSPEN--WSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-20
Identities = 84/283 (29%), Positives = 133/283 (46%), Gaps = 26/283 (9%)
Query: 403 HRYALLNLLGKGGFSEVYKAYD-LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
H Y L L+G+ + + A V K LN ++++ +Y R E +
Sbjct: 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYAR---SELHCL 119
Query: 462 KTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLP--EREARIIIVQI 517
H IV+ +D F+ D + ++EY SG DL+ +K LP E E ++ QI
Sbjct: 120 AACDHFGIVKHFDDFKSD-DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQI 178
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
L ++ R K++H DLK N+ G+ K+ DFG SK D V +++ S G
Sbjct: 179 VLALDEVHSR--KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV---SLDVASSFCG 233
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
T +YL PE +E + S K D+WS G++ Y++L RPF +Q I+++ ++ +
Sbjct: 234 TPYYLAPELWERKR---YSKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQ--VLYGK 287
Query: 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680
FP VS+ K L+ L+ N A RP L +L Y
Sbjct: 288 YDPFPC--PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328
|
Length = 478 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 78/260 (30%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH-KTLVHHHI 469
+GKG F +V A + ++ A K+ Q K+ +H + E N+ K + H +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV----LQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ 529
V L +F+ + VL+Y +G +L L+ PE AR +I L YL+ +
Sbjct: 59 VGLHYSFQTADKLY-FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH--SL 115
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFEL 589
II+ DLKP N+L D G +TDFGL K G + + TS GT YL PE L
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGIEHSKTTSTFCGTPEYLAPEV--L 168
Query: 590 SKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIKARKVEFPSRPA 646
K P + VD W G + Y+ML+G PF + + IL + + +P
Sbjct: 169 RKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL---------KPN 218
Query: 647 VSNEAKDLIRRCLTYNQAER 666
+S A+ L+ L ++ +R
Sbjct: 219 ISVSARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 74/232 (31%), Positives = 111/232 (47%), Gaps = 19/232 (8%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y L LG+G ++ VYK + + VA K+ + + + AIRE ++ K L
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE------EGVPFTAIREASLLKGL 60
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLIY 523
H +IV L D + T V EY DL + P L R+ + Q+ +GL Y
Sbjct: 61 KHANIVLLHDIIHT-KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
++ Q I+H DLKP N+L G K+ DFGL++ + SQ S T WY P
Sbjct: 119 IHG--QHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTY---SSEVVTLWYRP 171
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILREDTII 634
P+ L T SS +D+W AG +F +ML G+ F G E++ + T++
Sbjct: 172 PDVL-LGATDY-SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVL 221
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 80/281 (28%), Positives = 125/281 (44%), Gaps = 41/281 (14%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
+G+G + VYKA D + VA K L E + + AIRE ++ K L H +IV
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV--LPEREARIIIVQIFQGLIYLNKRA 528
RL D + + V E+ DL + ++P+ L + + Q+ QG+ Y +
Sbjct: 62 RLLDVVHSENKLY-LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
+++H DLKP N+L D G K+ DFGL++ V + E+ T WY PE
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI-- 170
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR---------ED-----TII 634
L + S+ VD+WS G +F +M+ R F D +++ R ED T +
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230
Query: 635 KARKVEFPSRPAVSN---------EAKDLIRRCLTYNQAER 666
K FP + DL+ + L Y+ A+R
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKR 271
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 76/287 (26%), Positives = 121/287 (42%), Gaps = 41/287 (14%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y L+ +G G + +VYKA D+ VA K+ L I+ +E ++ K
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL----EPGDDFEIIQ---QEISMLKE 56
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLI 522
H +IV + ++ + V+EYC G L + + T L E + + + +GL
Sbjct: 57 CRHPNIVAYFGSYLRRDKLW-IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA------ 576
YL+ IH D+K N+L E G K+ DFG+S +LT+ A
Sbjct: 116 YLH--ETGKIHRDIKGANILLTEDGDVKLADFGVSA-----------QLTATIAKRKSFI 162
Query: 577 GT-YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRP-FG-HDQTQERILREDTI 633
GT YW + PE + + K D+W+ GI ++ + P F H +R +
Sbjct: 163 GTPYW-MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH------PMRALFL 215
Query: 634 IKARKVEFPS---RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
I P + S D I++CLT + +RP L Q P+
Sbjct: 216 ISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-20
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 18/215 (8%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y L LG+G ++ V+K + VA K L + ++ AIRE ++ K L
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL------EHEEGAPCTAIREVSLLKDL 61
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIY 523
H +IV L D D+ + V EY KDL + ++ +I + QI +GL Y
Sbjct: 62 KHANIVTLHDIVHTDK-SLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
++R K++H DLKP N+L +E G K+ DFGL++ S + S T WY P
Sbjct: 120 CHRR--KVLHRDLKPQNLLINERGELKLADFGLAR-----AKSVPTKTYSNEVVTLWYRP 172
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
P+ L + S+++D+W G +F++M GR F
Sbjct: 173 PDV--LLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 88/305 (28%), Positives = 131/305 (42%), Gaps = 47/305 (15%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y + +G G + VYKA D +VA K + Q +ED +RE + K
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALK--SVRVQTNED---GLPLSTVREVALLKR 55
Query: 464 LV---HHHIVRLWD---TFEIDQNTFCTVLEYCSGKDLDAVLKATPV--LPEREARIIIV 515
L H +IVRL D T D+ T T++ +DL L P LP + ++
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMR 115
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q +GL +L+ A I+H DLKP N+L G K+ DFGL++I S M LT
Sbjct: 116 QFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVKLADFGLARIY-----SCQMALTPV- 167
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRP-FGHDQTQERILR----- 629
T WY PE L T ++ VD+WS G +F +M F R+P F + +++ +
Sbjct: 168 VVTLWYRAPEVL-LQST--YATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 223
Query: 630 ----ED---TIIKARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERPDVLTLA 673
ED + + F R P + L+ LT+N +R
Sbjct: 224 GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283
Query: 674 QDPYL 678
Q P+
Sbjct: 284 QHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 72/271 (26%), Positives = 113/271 (41%), Gaps = 51/271 (18%)
Query: 451 IRHAIREYNIHKTLVHH-----HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVL 505
I+ AIR I + V H +IV + F D +E+ G LD VLK +
Sbjct: 38 IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAGRI 96
Query: 506 PEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVG 565
PE I + + +GL YL + KI+H D+KP N+L + G K+ DFG+S + D
Sbjct: 97 PENILGKISIAVLRGLTYL-REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 152
Query: 566 SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF------- 618
+ + GT Y+ PE + + + S D+WS G+ +M GR P
Sbjct: 153 ----SMANSFVGTRSYMSPERLQGTHYTVQS---DIWSLGLSLVEMAIGRYPIPPPDAKE 205
Query: 619 ------------------------GHDQTQERILRE--DTIIKARKVEFPSRPAVSNEAK 652
D + + E D I+ + PS A S+E +
Sbjct: 206 LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSG-AFSDEFQ 264
Query: 653 DLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
D + +CL N ER D+ L + P++ ++
Sbjct: 265 DFVDKCLKKNPKERADLKELTKHPFIKRAEL 295
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 82/306 (26%), Positives = 138/306 (45%), Gaps = 48/306 (15%)
Query: 403 HRYALLNLLGKGGFSEVYKAYDLVEH-RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
+Y + +G+G + +V+KA DL R+VA K + Q E + IRE +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR--VRVQTGE---EGMPLSTIREVAVL 55
Query: 462 K---TLVHHHIVRLWDTFEI---DQNTFCTVLEYCSGKDLDAVLKATPV--LPEREARII 513
+ T H ++VRL+D + D+ T T++ +DL L P +P + +
Sbjct: 56 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 115
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
+ Q+ +GL +L+ + +++H DLKP N+L G K+ DFGL++I + +
Sbjct: 116 MFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM------ALT 167
Query: 574 QGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRP-FGHDQTQERILREDT 632
T WY PE S ++ VD+WS G +F +M F R+P F +++ +
Sbjct: 168 SVVVTLWYRAPEVLLQSS---YATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILD 223
Query: 633 IIKARKVE------------FPSRPA---------VSNEAKDLIRRCLTYNQAERPDVLT 671
+I E F S+ A + KDL+ +CLT+N A+R +
Sbjct: 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283
Query: 672 LAQDPY 677
PY
Sbjct: 284 ALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 72/233 (30%), Positives = 107/233 (45%), Gaps = 35/233 (15%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK---LHGLNAQWSEDKKQSYIRHAIREYNI 460
Y +L LG+G F EVYKA + R VA K +H ++K + A+RE I
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH--------NEKDGFPITALREIKI 60
Query: 461 HKTLVHHHIVRLWDTF-------EIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARI 512
K L H ++V L D + + + V Y DL +L+ V L E + +
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKC 119
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV---GSQGM 569
++Q+ +G+ YL+ I+H D+K N+L D G+ K+ DFGL++ + G
Sbjct: 120 YMLQLLEGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 570 ELTSQGAG---TYWYLPPECF--ELSKTPLISSKVDVWSAGILFYQMLFGRRP 617
T + T WY PPE E T VD+W G +F +M F RRP
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTT----AVDIWGIGCVFAEM-FTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 71/273 (26%), Positives = 113/273 (41%), Gaps = 14/273 (5%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LG G FS Y+A D+ +A K S ++++ +E + L H HI
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVV-EALRKEIRLMARLNHPHI 65
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ 529
+R+ D + F +E+ +G + +L E Q+ +GL YL++
Sbjct: 66 IRMLGATCEDSH-FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 530 KIIHYDLKPGNVLFDEFG-VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
+IIH D+K N+L D G ++ DFG + + G E Q GT ++ PE
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG-EFQGQLLGTIAFMAPEV-- 179
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK-ARKVEFPSRPA- 646
L S DVWS G + +M + P+ ++ + I K A PS P
Sbjct: 180 LRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASATTAPSIPEH 235
Query: 647 VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+S +D+ RCL +RP L + P
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 70/224 (31%), Positives = 109/224 (48%), Gaps = 18/224 (8%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y L+ LG+G ++ VYK + VA K L + ++ AIRE ++ K L
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL------EHEEGAPCTAIREVSLLKDL 61
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIY 523
H +IV L D + + V EY KDL L + ++ + Q+ +GL Y
Sbjct: 62 KHANIVTLHDIIHT-EKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
++R K++H DLKP N+L +E G K+ DFGL++ S + S T WY P
Sbjct: 120 CHRR--KVLHRDLKPQNLLINERGELKLADFGLAR-----AKSIPTKTYSNEVVTLWYRP 172
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627
P+ L T S+++D+W G +FY+M GR F +E++
Sbjct: 173 PDIL-LGSTDY-STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 20/228 (8%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ L LG+G ++ VYK + VA K L+A E+ S AIRE ++ K L
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA---EEGTPST---AIREISLMKEL 55
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV---LPEREARIIIVQIFQGL 521
H +IVRL D +N V EY KDL + V L + Q+ +G+
Sbjct: 56 KHENIVRLHDVIHT-ENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
+ ++ +++H DLKP N+L ++ G K+ DFGL++ V + E+ T WY
Sbjct: 114 AFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-----TLWY 166
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR 629
P+ S+T S+ +D+WS G + +M+ GR F ++++L+
Sbjct: 167 RAPDVLLGSRT--YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 84/310 (27%), Positives = 135/310 (43%), Gaps = 67/310 (21%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y L +G+G F EV+KA + VA K + E++K+ + A+RE I +
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM-----ENEKEGFPITALREIKILQL 67
Query: 464 LVHHHIVRLWDTFEI----------DQNTFCTVLEYCSGKDLDAVLKATPV---LPEREA 510
L H ++V L EI + +F V E+C DL +L V L E +
Sbjct: 68 LKHENVVNL---IEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKK 123
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
++ + GL Y+++ KI+H D+K N+L + G+ K+ DFGL++ S+
Sbjct: 124 --VMKMLLNGLYYIHR--NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 571 LTSQGAGTYWYLPPECF--ELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628
T++ T WY PPE E P +D+W AG + +M + R P T++ L
Sbjct: 180 YTNRVV-TLWYRPPELLLGERDYGP----PIDMWGAGCIMAEM-WTRSPIMQGNTEQHQL 233
Query: 629 REDTIIKA-------------------RKVEFPS----------RPAVSN-EAKDLIRRC 658
T+I +K+E P +P V + A DLI +
Sbjct: 234 ---TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKL 290
Query: 659 LTYNQAERPD 668
L + A+R D
Sbjct: 291 LVLDPAKRID 300
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 78/277 (28%), Positives = 119/277 (42%), Gaps = 23/277 (8%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
L+ LGKG + VYK +A K L ++ K + I I E +I V
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQI---IMELDILHKAVSP 59
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL---KATPVLPEREARIIIVQIFQGLIYL 524
+IV + F I+ + +EY LD + AT +PE R I + +GL +L
Sbjct: 60 YIVDFYGAFFIEGAVY-MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
K IIH D+KP NVL + G K+ DFG+S G+ L G Y+ P
Sbjct: 119 -KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS-------GNLVASLAKTNIGCQSYMAP 170
Query: 585 ECFE---LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
E + ++ P + + DVWS G+ +M GR P+ + + I+
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
P S++A+D + +CL RP L + P+L
Sbjct: 231 P--SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 77/274 (28%), Positives = 124/274 (45%), Gaps = 24/274 (8%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
+N +G G VYK V HR +L+ L + + + + R RE I + + H
Sbjct: 79 VNRIGSGAGGTVYK----VIHRPTG-RLYALKVIYG-NHEDTVRRQICREIEILRDVNHP 132
Query: 468 HIVRLWDTFEIDQNTFCTVL-EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526
++V+ D F D N VL E+ G L+ T + E+ + QI G+ YL++
Sbjct: 133 NVVKCHDMF--DHNGEIQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHR 186
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
R I+H D+KP N+L + K+ DFG+S+I+ +Q M+ + GT Y+ PE
Sbjct: 187 R--HIVHRDIKPSNLLINSAKNVKIADFGVSRIL-----AQTMDPCNSSVGTIAYMSPER 239
Query: 587 F--ELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
+L+ D+WS G+ + GR PFG + + I ++ E P
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP-- 297
Query: 645 PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
S E + I CL A+R + L Q P++
Sbjct: 298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 78/260 (30%), Positives = 120/260 (46%), Gaps = 27/260 (10%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LLGKG F +V + +Y A K+ ++D+ + H + E + K H +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE----VAHTLTESRVLKNTRHPFL 57
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ 529
L +F+ ++ C V+EY +G +L L V E R +I L YL+ +
Sbjct: 58 TSLKYSFQT-KDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH--SG 114
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFEL 589
KI++ DLK N++ D+ G K+TDFGL K D + GT YL PE E
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM-----KTFCGTPEYLAPEVLED 169
Query: 590 SKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIKARKVEFPSRPA 646
+ VD W G++ Y+M+ GR PF H++ E IL ED ++FP
Sbjct: 170 ND---YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-------IKFPR--T 217
Query: 647 VSNEAKDLIRRCLTYNQAER 666
+S +AK L+ L + +R
Sbjct: 218 LSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIR-HAIREYNIHKTLVH 466
LN +G+G + VY+A D VA K + D ++ I ++RE + L H
Sbjct: 12 LNRIGEGTYGIVYRARDTTSGEIVALK------KVRMDNERDGIPISSLREITLLLNLRH 65
Query: 467 HHIVRLWDTFEIDQ-NTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLIYL 524
+IV L + ++ V+EYC +DL ++L P E + + +++Q+ +GL YL
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
++ IIH DLK N+L + G K+ DFGL++ ++ T WY P
Sbjct: 125 HENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-----TLWYRAP 177
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGR 615
E T ++ +D+W+ G + ++L +
Sbjct: 178 ELLLGCTTY--TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-18
Identities = 81/261 (31%), Positives = 123/261 (47%), Gaps = 26/261 (9%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI-HKTLVHH-- 467
+GKG F +VY+ R A K+ L+ + KK+ + H I E NI +TL+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKV--LSKKEIVAKKE--VAHTIGERNILVRTLLDESP 56
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
IV L +F+ D + + V +Y SG +L L+ E A+ I ++ L +L+K
Sbjct: 57 FIVGLKFSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK- 114
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK--IVEDDVGSQGMELTSQGAGTYWYLPPE 585
I++ DLKP N+L D G + DFGLSK + ++ T+ GT YL PE
Sbjct: 115 -YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-------TTNTFCGTTEYLAPE 166
Query: 586 CFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP 645
K + VD WS G+L ++M G PF + TQ+ I KV FP +
Sbjct: 167 VLLDEKG--YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY----RNIAFGKVRFP-KN 219
Query: 646 AVSNEAKDLIRRCLTYNQAER 666
+S+E + ++ L N R
Sbjct: 220 VLSDEGRQFVKGLLNRNPQHR 240
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 71/272 (26%), Positives = 106/272 (38%), Gaps = 29/272 (10%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ L LG G F EV++ VA K+ + + Q E K L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLKQQDFQK-------EVQALKRL 59
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP---VLPEREARIIIVQIFQGL 521
H H++ L+ + + + E L A L +P VLP + Q+ +G+
Sbjct: 60 RHKHLISLFAVCSVGE-PVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGM 117
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
YL Q IH DL N+L E V KV DFGL++++++DV L+S Y +
Sbjct: 118 AYL--EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-----YLSSDKKIPYKW 170
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVE 640
PE S+K DVWS GIL Y+M +G+ P+ E +
Sbjct: 171 TAPEAASHGT---FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-----AGYR 222
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTL 672
P E ++ C +RP L
Sbjct: 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 71/228 (31%), Positives = 108/228 (47%), Gaps = 26/228 (11%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y L+ LG+G ++ V+K + VA K L + ++ AIRE ++ K L
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL------EHEEGAPCTAIREVSLLKNL 60
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK-----ATPVLPEREARIIIVQIFQ 519
H +IV L D ++ V EY LD+ LK ++ +I + Q+ +
Sbjct: 61 KHANIVTLHDIIHTER-CLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
GL Y +KR KI+H DLKP N+L +E G K+ DFGL++ S + S T
Sbjct: 115 GLSYCHKR--KILHRDLKPQNLLINEKGELKLADFGLAR-----AKSVPTKTYSNEVVTL 167
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627
WY PP+ L T S+ +D+W G + Y+M GR F +E +
Sbjct: 168 WYRPPDVL-LGSTEY-STPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 75/258 (29%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH-KTLVHHH 468
++GKG F +V A ++ + A K+ L + ++K+ +H + E N+ K + H
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQ--KHIMAERNVLLKNVKHPF 57
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA 528
+V L +F+ + + VL++ +G +L L+ PE AR +I L YL+ +
Sbjct: 58 LVGLHYSFQTTEKLY-FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH--S 114
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
I++ DLKP N+L D G +TDFGL K G + T+ GT YL PE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK-----EGIAQSDTTTTFCGTPEYLAPEV-- 167
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648
+ K P + VD W G + Y+ML+G PF E D I+ RP S
Sbjct: 168 IRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY---DNILHK---PLVLRPGAS 220
Query: 649 NEAKDLIRRCLTYNQAER 666
A ++ L ++ R
Sbjct: 221 LTAWSILEELLEKDRQRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 78/263 (29%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LLGKG F +V + RY A K+ ++D+ + H + E + + H +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQNTRHPFL 57
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ 529
L F+ + C V+EY +G +L L V E AR +I L YL+ ++
Sbjct: 58 TALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH--SR 114
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA------GTYWYLP 583
+++ D+K N++ D+ G K+TDFGL K E S GA GT YL
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEYLA 163
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE E + VD W G++ Y+M+ GR PF ++Q ER+ +I ++ FP
Sbjct: 164 PEVLEDND---YGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE---LILMEEIRFPR 216
Query: 644 RPAVSNEAKDLIRRCLTYNQAER 666
+S EAK L+ L + +R
Sbjct: 217 --TLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 58/184 (31%), Positives = 85/184 (46%), Gaps = 15/184 (8%)
Query: 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE 545
+L+Y +G +L L E E R+ I +I L +L++ II+ D+K N+L D
Sbjct: 83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL--GIIYRDIKLENILLDS 140
Query: 546 FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAG 605
G +TDFGLSK + E GT Y+ PE + VD WS G
Sbjct: 141 EGHVVLTDFGLSKEFLAEEE----ERAYSFCGTIEYMAPEVIR-GGSGGHDKAVDWWSLG 195
Query: 606 ILFYQMLFGRRPF---GHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYN 662
+L +++L G PF G +Q I R I K FP +S EA+D I++ L +
Sbjct: 196 VLTFELLTGASPFTVDGEQNSQSEISRR---ILKSKPPFPKT--MSAEARDFIQKLLEKD 250
Query: 663 QAER 666
+R
Sbjct: 251 PKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ ++ +G+G + +VYKA D VA K L +++K+ + AIRE I + L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL-----DNEKEGFPITAIREIKILRQL 63
Query: 465 VHHHIVRLWDT---------FEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIII 514
H +IV L + F+ D+ F V EY DL +L++ V E + +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-HDLMGLLESGLVHFSEDHIKSFM 122
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
Q+ +GL Y +K+ +H D+K N+L + G K+ DFGL+++ + +
Sbjct: 123 KQLLEGLNYCHKK--NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE----ESRPYTN 176
Query: 575 GAGTYWYLPPECF--ELSKTPLISSKVDVWSAGILFYQMLFGRRP 617
T WY PPE E P I DVWS G + + LF ++P
Sbjct: 177 KVITLWYRPPELLLGEERYGPAI----DVWSCGCILGE-LFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 70/277 (25%), Positives = 123/277 (44%), Gaps = 27/277 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y + ++G+G F V+ + + V K + Q ++D++ + A E + K
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE-QMTKDERLA----AQNECQVLKL 55
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL--KATPVLPEREARIIIVQIFQGL 521
L H +I+ ++ F ++ V+EY G L + + +L E VQI L
Sbjct: 56 LSHPNIIEYYENF-LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---L 111
Query: 522 IYLNKRAQK-IIHYDLKPGNVLFDEFG-VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
+ L+ K I+H DLK N+L D+ V K+ DFG+SKI + S+ T GT
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI----LSSKSKAYTV--VGTP 165
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639
Y+ P EL + + K D+W+ G + Y++ +R F +L+ I+
Sbjct: 166 CYISP---ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK---IMSGTFA 219
Query: 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676
R S + + LI L + ++RP + + P
Sbjct: 220 PISDR--YSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 70/254 (27%), Positives = 110/254 (43%), Gaps = 14/254 (5%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ L LLG+G F VY YD R +A K + + E K+ E + K L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC--EIQLLKNL 61
Query: 465 VHHHIVRLWDTF-EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
+H IV+ + + + T +E+ G + LK+ L E R QI +G+ Y
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ + I+H D+K N+L D G K+ DFG SK ++ + G + S YW P
Sbjct: 122 LH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ-TICLSGTGMKSVTGTPYWMSP 178
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
E+ K D+WS G +ML + P+ + I + T + P
Sbjct: 179 ----EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPTNPVLP- 231
Query: 644 RPAVSNEAKDLIRR 657
P VS+ +D ++R
Sbjct: 232 -PHVSDHCRDFLKR 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 84/310 (27%), Positives = 132/310 (42%), Gaps = 53/310 (17%)
Query: 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
RY L+ +G+G + V A VA K + S + Q++ + +RE I +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK------KISPFEHQTFCQRTLREIKILR 58
Query: 463 TLVHHHIVRLWDTFEIDQNTFCT------VLEYCSGKDLDAVLKATPVLPEREARIIIVQ 516
H +I+ + D I +F + V E DL ++K T L + + Q
Sbjct: 59 RFKHENIIGILDI--IRPPSFESFNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQ 114
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
I +GL Y++ + ++H DLKP N+L + K+ DFGL++I + + G LT A
Sbjct: 115 ILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF-LTEYVA 171
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFG----HDQ---------- 622
T WY PE SK + +D+WS G + +ML R F Q
Sbjct: 172 -TRWYRAPEIMLNSKG--YTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 623 -TQERILREDTIIKARKVEF----PSRPAVS---------NEAKDLIRRCLTYNQAERPD 668
+QE + + II R + P +P V +A DL+ + LT+N +R
Sbjct: 229 PSQEDL---NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT 285
Query: 669 VLTLAQDPYL 678
V PYL
Sbjct: 286 VEEALAHPYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 76/269 (28%), Positives = 115/269 (42%), Gaps = 15/269 (5%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LLG+G F VY YD+ R +A K + + E K+ E + K L H I
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC--EIQLLKNLQHERI 66
Query: 470 VRLWDTF-EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA 528
V+ + + + T +EY G + LKA L E R QI +G+ YL+ +
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH--S 124
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
I+H D+K N+L D G K+ DFG SK ++ + G + S YW P E
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-TICMSGTGIRSVTGTPYWMSP----E 179
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648
+ K DVWS G +ML + P+ + I + T + + PS +S
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTNPQLPSH--IS 235
Query: 649 NEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
A+D + C+ RP L + P+
Sbjct: 236 EHARDFL-GCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 17/270 (6%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIR-EYNIHKTLVHHH 468
LLG+G F EVY YD R +A K + E K+ +A+ E + K L H
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV---NALECEIQLLKNLRHDR 65
Query: 469 IVRLWDTF-EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
IV+ + + ++ +EY G + LKA L E R QI QG+ YL+
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH-- 123
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECF 587
+ I+H D+K N+L D G K+ DFG SK ++ + G + S YW P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ-TICMSGTGIKSVTGTPYWMSP---- 178
Query: 588 ELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647
E+ K DVWS +ML + P+ + I + T + K P V
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPMLPD--GV 234
Query: 648 SNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
S+ +D +++ + + RP L + P+
Sbjct: 235 SDACRDFLKQ-IFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 79/258 (30%), Positives = 126/258 (48%), Gaps = 22/258 (8%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH-KTLVHHH 468
++GKG F +V A E ++ A K+ L + KK+ +H + E N+ K + H
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEE--KHIMSERNVLLKNVKHPF 57
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA 528
+V L +F+ + VL+Y +G +L L+ E AR +I L YL+ +
Sbjct: 58 LVGLHFSFQTADKLY-FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH--S 114
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
I++ DLKP N+L D G +TDFGL K +++ G TS GT YL PE
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGT--TSTFCGTPEYLAPEV-- 167
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648
L K P VD W G + Y+ML+G PF T E + ++ + K ++ +P ++
Sbjct: 168 LHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYDNILNKPLQL----KPNIT 220
Query: 649 NEAKDLIRRCLTYNQAER 666
N A+ L+ L ++ +R
Sbjct: 221 NSARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 71/263 (26%), Positives = 118/263 (44%), Gaps = 28/263 (10%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRH----AIREYNIHKTLV 465
+LGKGGF EV + ACK +KK+ R A+ E I + +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACK--------KLEKKRIKKRKGEAMALNEKQILEKVN 58
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK--ATPVLPEREARIIIVQIFQGLIY 523
+V L +E ++ C VL +G DL + P E A +I GL
Sbjct: 59 SRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L++ ++I++ DLKP N+L D++G +++D GL+ + + E GT Y+
Sbjct: 118 LHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG------ETIRGRVGTVGYMA 169
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
P E+ K + D W G L Y+M+ G+ PF Q +E++ RE+ + ++ +
Sbjct: 170 P---EVVKNERYTFSPDWWGLGCLIYEMIEGKSPF--RQRKEKVKREEVERRVKEDQEEY 224
Query: 644 RPAVSNEAKDLIRRCLTYNQAER 666
S A+ + R+ LT + R
Sbjct: 225 SEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 75/257 (29%), Positives = 119/257 (46%), Gaps = 20/257 (7%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LLGKG F +V + RY A K+ ++D+ + H + E + + H +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE----VAHTLTENRVLQNSRHPFL 57
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ 529
L +F+ + C V+EY +G +L L V E AR +I L YL+ +
Sbjct: 58 TALKYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE-K 115
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFEL 589
+++ DLK N++ D+ G K+TDFGL K G + GT YL PE E
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPEVLED 170
Query: 590 SKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSN 649
+ VD W G++ Y+M+ GR PF ++Q E++ +I ++ FP +S
Sbjct: 171 ND---YGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE---LILMEEIRFPR--TLSP 221
Query: 650 EAKDLIRRCLTYNQAER 666
EAK L+ L + +R
Sbjct: 222 EAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 77/290 (26%), Positives = 120/290 (41%), Gaps = 43/290 (14%)
Query: 407 LLNLLGKGGFSEVYKA-YDLVEHR---YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ LG+G F +V YD + VA K LN E++ +S RE I +
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKS--LNHS-GEEQHRSDFE---REIEILR 61
Query: 463 TLVHHHIVRLWDTFEID-QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIV----QI 517
TL H +IV+ E + ++EY L L ++ ++ QI
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQI 118
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
+G+ YL +Q+ IH DL N+L + + K++DFGL+K++ +D + G
Sbjct: 119 CKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY----YYVKEPG 172
Query: 578 ---TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-----------GHDQT 623
+WY PEC SK SS DVWS G+ Y++ P G Q
Sbjct: 173 ESPIFWY-APECLRTSK---FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG 228
Query: 624 QERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673
Q + R ++K P P+ +E DL++ C +RP L
Sbjct: 229 QMIVTRLLELLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 60/314 (19%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIR 456
++ LN + +G + VY+A D VA K + E +K+ + ++R
Sbjct: 6 EYEKLNR-------IEEGTYGVVYRARDKKTGEIVALKKLKM-----EKEKEGFPITSLR 53
Query: 457 EYNIHKTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVL--KATPVLPEREA 510
E NI L H +IV + E+ + + V+EY DL +++ P L E
Sbjct: 54 EINILLKLQHPNIVTVK---EVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQS-EV 108
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
+ +++Q+ G+ +L+ I+H DLK N+L + G+ K+ DFGL++ + GS
Sbjct: 109 KCLMLQLLSGVAHLHDN--WILHRDLKTSNLLLNNRGILKICDFGLAR----EYGSPLKP 162
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GH---DQTQER 626
T Q T WY PE L S+ +D+WS G +F ++L + F G DQ +
Sbjct: 163 YT-QLVVTLWYRAPEL--LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NK 218
Query: 627 ILRE-----DTI-------IKARKVEFPSRP-----------AVSNEAKDLIRRCLTYNQ 663
I + + I A+K F P ++S+ DL+ R LTY+
Sbjct: 219 IFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDP 278
Query: 664 AERPDVLTLAQDPY 677
A+R + PY
Sbjct: 279 AKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 79/261 (30%), Positives = 124/261 (47%), Gaps = 28/261 (10%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYI--RHAIREYNIHKTLVHH 467
+LGKG F +V A + + A K + +D + + R + H L H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH- 60
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
L+ TF+ ++ F V+EY +G DL ++++ E AR +I GL +L+K+
Sbjct: 61 ----LFCTFQTKEHLF-FVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECF 587
II+ DLK NVL D+ G K+ DFG+ K +++ +G S GT Y+ PE
Sbjct: 116 G--IIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGK--ASTFCGTPDYIAPE-- 166
Query: 588 ELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILREDTIIKARKVEFPSRPA 646
+ K + VD WS G+L Y+ML G+ PF G D ED + + + P P
Sbjct: 167 -ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--------EDELFDSILNDRPHFPR 217
Query: 647 -VSNEAKDLIRRCLTYNQAER 666
+S EAKD + + + +R
Sbjct: 218 WISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 76/282 (26%), Positives = 121/282 (42%), Gaps = 24/282 (8%)
Query: 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
+Y +G+G VY A D+ + VA K L Q K+ I I E +
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ----PKKELI---INEILVM 70
Query: 462 KTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
+ H +IV D++ + + V+EY +G L V+ T + E + + + Q L
Sbjct: 71 RENKHPNIVNYLDSYLVGDELW-VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQAL 128
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
+L+ + ++IH D+K N+L G K+TDFG + + Q T G YW
Sbjct: 129 EFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGT-PYWM 182
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR-KVE 640
P E+ KVD+WS GI+ +M+ G P+ E LR +I E
Sbjct: 183 AP----EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY----LNENPLRALYLIATNGTPE 234
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682
+ +S +D + RCL + +R L Q P+L +K
Sbjct: 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 27/221 (12%)
Query: 468 HIVRLWDTFEIDQNTF-CT-VLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIY 523
+IV+ + F D + F C ++ C LD +LK P+ PE + V I + L Y
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTC----LDKLLKRIQGPI-PEDILGKMTVAIVKALHY 129
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L K +IH D+KP N+L D G K+ DFG+S + D ++ AG Y+
Sbjct: 130 L-KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK------TRSAGCAAYMA 182
Query: 584 PECFELSK-TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ----ERILREDTIIKARK 638
PE + P + DVWS GI ++ G+ P+ + +T+ +IL+E+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP------ 236
Query: 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
P S + + CLT + +RP L Q P++
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 33/293 (11%)
Query: 381 IREMKRIRDEDGSRF-------NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVAC 433
+R+ K I D SR+ ++ + ++ ++G+G F EV LV H+ +
Sbjct: 15 LRKNKNI-DNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEV----QLVRHK-SSK 68
Query: 434 KLHGLNAQWSEDK--KQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCS 491
+++ + S+ + K+S E +I IV+L F+ D V+EY
Sbjct: 69 QVYAMK-LLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-DDKYLYMVMEYMP 126
Query: 492 GKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKV 551
G DL ++ + PE+ AR ++ L ++ IH D+KP N+L D+ G K+
Sbjct: 127 GGDLVNLMSNYDI-PEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKL 183
Query: 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVWSAGILFYQ 610
DFG ++ + GM GT Y+ PE + + D WS G+ Y+
Sbjct: 184 ADFGTCMKMDAN----GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
Query: 611 MLFGRRPFGHDQ---TQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLT 660
ML G PF D T +I+ + FP +S +AKDLI LT
Sbjct: 240 MLVGDTPFYADSLVGTYSKIMDHKN-----SLTFPDDIEISKQAKDLICAFLT 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 68/222 (30%), Positives = 109/222 (49%), Gaps = 21/222 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y + +G+G + VYKA D V + +A K L E + + AIRE ++ K
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-----EQEDEGVPSTAIREISLLKE 57
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARII---IVQIFQG 520
+ H +IVRL D ++ + V EY DL + ++P + R+I + QI +G
Sbjct: 58 MQHGNIVRLQDVVHSEKRLY-LVFEYLD-LDLKKHMDSSPDF-AKNPRLIKTYLYQILRG 114
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVA-KVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
+ Y + +++H DLKP N+L D A K+ DFGL++ V + E+ T
Sbjct: 115 IAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-----TL 167
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHD 621
WY PE S+ S+ VD+WS G +F +M+ + F D
Sbjct: 168 WYRAPEILLGSRH--YSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 36/267 (13%)
Query: 411 LGKGGFSEVYKAY--DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
LG G F V K + VA K+ +++ + +RE N+ + L + +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILK-----NDNNDPALKDELLREANVMQQLDNPY 57
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA 528
IVR+ E + ++ V+E L+ L+ + E+ ++ Q+ G+ YL +
Sbjct: 58 IVRMIGICEAE--SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE-- 113
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WYLPPE 585
+H DL NVL AK++DFGLSK + D ++ G + WY PE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY----YKAKTHGKWPVKWY-APE 168
Query: 586 CFELSKTPLISSKVDVWSAGILFYQML-FGRRPF----GHDQTQERILREDTIIKARKVE 640
C K SSK DVWS G+L ++ +G++P+ G++ TQ I ++E
Sbjct: 169 CMNYYK---FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-------MIESGERME 218
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERP 667
P E DL++ C TY ERP
Sbjct: 219 CP--QRCPPEMYDLMKLCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-17
Identities = 70/210 (33%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH-KTLVHHH 468
++GKG F +V A + + A K+ L + KK+ H + E N+ K L H
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQ--NHIMAERNVLLKNLKHPF 57
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA 528
+V L +F+ + + VL+Y +G +L L+ E AR ++ + YL+ +
Sbjct: 58 LVGLHYSFQTAEKLY-FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH--S 114
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
II+ DLKP N+L D G +TDFGL K G + E TS GT YL PE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGVEPEETTSTFCGTPEYLAPEV-- 167
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
L K P VD W G + Y+ML+G PF
Sbjct: 168 LRKEPY-DRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY L+ +G G + +V A+D R VA K Q + K++Y RE + K
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-----RELRLLKH 70
Query: 464 LVHHHIVRLWDTFEIDQ--NTFCTV--LEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
+ H +++ L D F F V + + G DL+ ++K L + + ++ QI +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-CQKLSDDHIQFLVYQILR 129
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
GL Y++ + IIH DLKP N+ +E K+ DFGL++ +D E+T T
Sbjct: 130 GLKYIH--SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-------EMT-GYVATR 179
Query: 580 WYLPPECF----ELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
WY PE ++T VD+WS G + ++L G+ F
Sbjct: 180 WYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 66/277 (23%), Positives = 131/277 (47%), Gaps = 23/277 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y + +G+G F + + + K ++ +++++S +E +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR-----KEVAVLSN 55
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARII--IVQIFQGL 521
+ H +IV+ ++FE + N + V++YC G DL + A + E +I+ VQI L
Sbjct: 56 MKHPNIVQYQESFEENGNLY-IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
+++ R KI+H D+K N+ + G K+ DFG+++++ V EL GT +Y
Sbjct: 115 KHVHDR--KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-----ELARTCIGTPYY 167
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
L PE E P ++K D+W+ G + Y+M + F + +L+ II+
Sbjct: 168 LSPEICE--NRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK---IIRGSYPPV 221
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
S S + ++L+ + N +RP V ++ + ++
Sbjct: 222 SSH--YSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 24/265 (9%)
Query: 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
+L+G+G F EV + A K+ + +++ + E +I
Sbjct: 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEE----ERDILSISNSPW 62
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIYLNKR 527
I +L F+ D++ V+EY G DL ++L + E A+ + ++ + +++
Sbjct: 63 IPQLQYAFQ-DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECF 587
+H D+KP NVL D G K+ DFG + + + M + GT Y+ PE
Sbjct: 122 G--YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN----KMVNSKLPVGTPDYIAPEVL 175
Query: 588 ELSKTPLISS---KVDVWSAGILFYQMLFGRRPFGHD---QTQERILREDTIIKARKVEF 641
+ + D WS G++ Y+M++GR PF +T I+ +K F
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK-----F 230
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAER 666
P P VS++ DLI+ L Q ER
Sbjct: 231 PEDPKVSSDFLDLIQSLLC-GQKER 254
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 17/226 (7%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
Y L LG+G ++ VYK V + VA K+ L E++ + AIRE ++ K L
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ----EEEGTPFT--AIREASLLKGL 60
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
H +IV L D + T V EY + K L ++ + Q+ +GL Y+
Sbjct: 61 KHANIVLLHDIIHTKE-TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
++R I+H DLKP N+L + G K+ DFGL++ S S T WY PP
Sbjct: 120 HQRY--ILHRDLKPQNLLISDTGELKLADFGLAR-----AKSVPSHTYSNEVVTLWYRPP 172
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILR 629
+ L + S+ +D+W G +F +M+ G F G Q+++ R
Sbjct: 173 DV--LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 27/244 (11%)
Query: 445 DKKQSYIRHAIREYNIHKTLVHH----HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK 500
K S + +RE I +H +IV + F +++N C +E+ LD + K
Sbjct: 41 GAKSSVRKQILRELQI----MHECRSPYIVSFYGAF-LNENNICMCMEFMDCGSLDRIYK 95
Query: 501 ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560
+P I V + +GL YL +I+H D+KP N+L + G K+ DFG+S +
Sbjct: 96 KGGPIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154
Query: 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFG- 619
+ + + GT Y+ PE + K + K DVWS GI ++ G+ PF
Sbjct: 155 INSIADTFV-------GTSTYMSPERIQGGK---YTVKSDVWSLGISIIELALGKFPFAF 204
Query: 620 ----HDQTQERILREDTIIKARKVEFPSRPA--VSNEAKDLIRRCLTYNQAERPDVLTLA 673
D + + D + + + P P+ + +D + CL + ERP L
Sbjct: 205 SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264
Query: 674 QDPY 677
P
Sbjct: 265 AMPP 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 75/287 (26%), Positives = 120/287 (41%), Gaps = 36/287 (12%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ L +G G F VY A D+ + VA K + + S +K Q I+E +
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD----IIKEVRFLQQ 71
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYC--SGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
L H + + + + ++T V+EYC S D+ V K L E E I QGL
Sbjct: 72 LRHPNTIEYKGCY-LREHTAWLVMEYCLGSASDILEVHKKP--LQEVEIAAICHGALQGL 128
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
YL+ + + IH D+K GN+L E G K+ DFG + +V + GT ++
Sbjct: 129 AYLH--SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---------ANSFVGTPYW 177
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRP--FGHDQTQE--RILREDTIIKAR 637
+ PE KVDVWS GI + L R+P F + I + D+
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNDS----- 231
Query: 638 KVEFPSRPAV--SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682
P+ + S+ ++ + CL +RP L + ++ +
Sbjct: 232 ----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 78/280 (27%), Positives = 124/280 (44%), Gaps = 24/280 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y +G+G V+ A D+ + VA K L Q K+ I I E + K
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELI---INEILVMKE 72
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L + +IV D+F + F V+EY +G L V+ T + E + + + Q L +
Sbjct: 73 LKNPNIVNFLDSFLVGDELF-VVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEF 130
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ A ++IH D+K NVL G K+TDFG + + + S GT +++
Sbjct: 131 LH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-----STMVGTPYWMA 183
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV-EFP 642
P E+ KVD+WS GI+ +M+ G P+ E LR +I E
Sbjct: 184 P---EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY----LNENPLRALYLIATNGTPELQ 236
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682
+ +S +D + RCL + +R L Q P+L +K
Sbjct: 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 78/271 (28%), Positives = 121/271 (44%), Gaps = 25/271 (9%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
LGKGGF EV + ACK KK+S + A+ E I + + IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACK----KLDKKRLKKKSGEKMALLEKEILEKVNSPFIV 56
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIII--VQIFQGLIYLNKRA 528
L FE + C V+ +G DL + R+I QI G+++L+ +
Sbjct: 57 NLAYAFE-SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--S 113
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
I++ D+KP NVL D+ G +++D GL+ V + + +Q AGT Y+ PE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA------VELKDGKTITQRAGTNGYMAPEIL- 166
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648
K S VD ++ G Y+M+ GR PF +E++ +E+ +K R +E +
Sbjct: 167 --KEEPYSYPVDWFAMGCSIYEMVAGRTPF--KDHKEKVAKEE--LKRRTLEDEVKFEHQ 220
Query: 649 N---EAKDLIRRCLTYNQAERPDVLTLAQDP 676
N E+KD+ R L +R DP
Sbjct: 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 65/270 (24%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
+G+G V A D R VA K L +KQ E I + H +IV
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDL-------RKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQK 530
++ ++ + + V+E+ G L ++ T + E + + + + + L +L+ AQ
Sbjct: 80 EMYSSYLVGDELW-VVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLH--AQG 135
Query: 531 IIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS 590
+IH D+K ++L G K++DFG V +V + GT +++ PE +S
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR-----KSLVGTPYWMAPEV--IS 188
Query: 591 KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE--RILREDTIIKARKVEFPSRPAVS 648
+ P ++VD+WS GI+ +M+ G P+ ++ + + +R++ K++ + VS
Sbjct: 189 RLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPPKLKNLHK--VS 242
Query: 649 NEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ + R L + A+R L P+L
Sbjct: 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 83/267 (31%), Positives = 126/267 (47%), Gaps = 33/267 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L +LG+G F +V L E++ A K + D+ +S + R +
Sbjct: 3 CLAVLGRGHFGKVL----LAEYKKTGELYAIKALKKGDIIARDEVES-LMCEKRIFETAN 57
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
+ H +V L+ F+ + + C V+EY +G DL + T V E A + GL
Sbjct: 58 SERHPFLVNLFACFQTEDHV-CFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQ 115
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGM---ELTSQGAGTY 579
YL++ KI++ DLK N+L D G K+ DFGL K +GM + TS GT
Sbjct: 116 YLHEN--KIVYRDLKLDNLLLDTEGFVKIADFGLCK--------EGMGFGDRTSTFCGTP 165
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639
+L PE L++T + VD W G+L Y+ML G PF D +E + D+I+ +V
Sbjct: 166 EFLAPEV--LTETSYTRA-VDWWGLGVLIYEMLVGESPFPGD-DEEEVF--DSIV-NDEV 218
Query: 640 EFPSRPAVSNEAKDLIRRCLTYNQAER 666
+P +S EA ++RR L N R
Sbjct: 219 RYPR--FLSREAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 79/317 (24%), Positives = 128/317 (40%), Gaps = 55/317 (17%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYI-------R 452
+ RY + +G G + V A D + VA K K + +
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK------------KIPHAFDVPTLAK 49
Query: 453 HAIREYNIHKTLVHHHIVRLWDTFEIDQNTF---CTVLEYCSGKDLDAVLKATPVLPERE 509
+RE I + H +I+ + D F V++ DL ++ + L E
Sbjct: 50 RTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEH 108
Query: 510 ARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGM 569
R + Q+ +GL Y++ + +IH DLKP N+L +E ++ DFG+++ +
Sbjct: 109 IRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 570 ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHD---QTQ 624
+T A T WY PE L P ++ +D+WS G +F +ML GRR G + Q +
Sbjct: 167 FMTEYVA-TRWYRAPEL--LLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLK 222
Query: 625 ----------ERILREDTIIKARKV--EFPSRPAV---------SNEAKDLIRRCLTYNQ 663
E +L + RK P + V S EA DL+ + L ++
Sbjct: 223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDP 282
Query: 664 AERPDVLTLAQDPYLTY 680
ER V Q P+L
Sbjct: 283 EERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 74/309 (23%), Positives = 124/309 (40%), Gaps = 64/309 (20%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI------REY 458
Y +L +G+G FSEV KA +Y A K K+ + ++ RE
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKC----------MKKHF--KSLEQVNNLREI 48
Query: 459 NIHKTLVHH-HIVRLWDT-FEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ 516
+ L H +I+RL + F+ V E + + LPE+ + + Q
Sbjct: 49 QALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQ 108
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG--MELTSQ 574
+ + L ++++ I H D+KP N+L + K+ DFG + + S+ E S
Sbjct: 109 LLKSLDHMHRNG--IFHRDIKPENILIK-DDILKLADFGSCR----GIYSKPPYTEYIS- 160
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM-----LFGRRPFGHDQTQ----- 624
T WY PEC L K+D+W+ G +F+++ LF P ++ Q
Sbjct: 161 ---TRWYRAPEC--LLTDGYYGPKMDIWAVGCVFFEILSLFPLF---PGTNELDQIAKIH 212
Query: 625 -------ERILREDTIIKARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERPD 668
+L++ + FPS+ P S E DL+++ L Y+ ER
Sbjct: 213 DVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272
Query: 669 VLTLAQDPY 677
+ PY
Sbjct: 273 AKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 42/300 (14%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRH-AIREYNIHK 462
+Y L+ +G+G + V+K + + VA K ++ E + I+ A+RE + K
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIK------KFVESEDDPVIKKIALREIRMLK 55
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
L H ++V L + F + V EYC L+ + K +PE + II Q Q +
Sbjct: 56 QLKHPNLVNLIEVFR-RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
+ +K IH D+KP N+L + G K+ DFG ++I+ G + T A T WY
Sbjct: 115 FCHK--HNCIHRDVKPENILITKQGQIKLCDFGFARILT----GPGDDYTDYVA-TRWYR 167
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFG----------------RRPFG-----HD 621
PE L VDVW+ G +F ++L G R+ G H
Sbjct: 168 APEL--LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225
Query: 622 Q--TQERILREDTIIKARKVE-FPSR-PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
Q + + + +I + E S+ P +S+ A ++ CL + ER L + PY
Sbjct: 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 80/263 (30%), Positives = 119/263 (45%), Gaps = 27/263 (10%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHG-LNAQWSEDKKQSYIRHAIR---EYNIHKT 463
L +LG+G F +V+ LV R + G L A K +R +R E +I
Sbjct: 1 LKVLGQGSFGKVF----LV--RKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE 54
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
+ H IV+L F+ + + +L++ G DL L + E + + + ++ L +
Sbjct: 55 VNHPFIVKLHYAFQTEGKLY-LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 113
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ II+ DLKP N+L DE G K+TDFGLSK D GT Y+
Sbjct: 114 LHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-----AYSFCGTVEYMA 166
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE + D WS G+L ++ML G PF Q ++R I+KA K+ P
Sbjct: 167 PEVVNRRGH---TQSADWWSFGVLMFEMLTGSLPF---QGKDRKETMTMILKA-KLGMPQ 219
Query: 644 RPAVSNEAKDLIRRCLTYNQAER 666
+S EA+ L+R N A R
Sbjct: 220 --FLSPEAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 74/294 (25%), Positives = 122/294 (41%), Gaps = 68/294 (23%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKL--HGLNAQWSEDKKQSYIR----HAIREYNIHKTL 464
+G G F EV + K+ + L A + K +R H E +I
Sbjct: 9 IGIGAFGEVC----------LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA 58
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
+ +V+L+ +F+ N + V++Y G D+ ++L + E AR I ++ + +
Sbjct: 59 DNEWVVKLYYSFQDKDNLY-FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL---------SKIVE-------------- 561
+K IH D+KP N+L D G K+TDFGL SK +
Sbjct: 118 HKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 562 --DDVGSQGMELTSQGA-------------GTYWYLPPECFELSKTPLISSKVDVWSAGI 606
++ ++ + GT Y+ PE L +T D WS G+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV--LLRTGYTQL-CDWWSVGV 232
Query: 607 LFYQMLFGRRPFGHD---QTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRR 657
+ Y+ML G+ PF D +TQ +++ +T + PS+ +S EA DLI R
Sbjct: 233 ILYEMLVGQPPFLADTPAETQLKVINWETTL-----HIPSQAKLSREASDLILR 281
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 3e-16
Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 29/284 (10%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ L+ L+G G + +VYK + + A K+ + E+ KQ E N+ K
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ--------EINMLKKY 59
Query: 465 VHHHIVRLWDTFEIDQN------TFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQ 516
HH + + I +N V+E+C + ++K T L E I +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
I +GL +L++ K+IH D+K NVL E K+ DFG+S ++ VG + +
Sbjct: 120 ILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----- 172
Query: 577 GTYWYLPPECFELSKTP--LISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634
GT +++ PE + P K D+WS GI +M G P +R +I
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL----CDMHPMRALFLI 228
Query: 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
S + + I CL N ++RP L + P++
Sbjct: 229 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 36/273 (13%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L +GKG F +V + VA K + Q+++ A ++ TL H
Sbjct: 10 LGATIGKGEFGDVMLG--DYRGQKVAVK----CLKDDSTAAQAFLAEA----SVMTTLRH 59
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYL 524
++V+L + V EY + L L++ V+ + + + +G+ YL
Sbjct: 60 PNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED--DVGSQGMELTSQGAGTYWYL 582
+ +H DL NVL E VAKV+DFGL+K D G ++ T+
Sbjct: 119 --EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTA--------- 167
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVEF 641
PE K S+K DVWS GIL +++ FGR P+ ++ + + K ++E
Sbjct: 168 -PEALREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PHVEKGYRMEA 220
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
P E +++ C + A+RP L +
Sbjct: 221 PE--GCPPEVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 78/268 (29%), Positives = 122/268 (45%), Gaps = 30/268 (11%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH- 468
+LGKG F +V A R A K+ + +D + + E I +L +H
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD----VECTMTEKRI-LSLARNHP 56
Query: 469 -IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
+ +L+ F+ F V+E+ +G DL ++ + E AR +I L++L+ +
Sbjct: 57 FLTQLYCCFQTPDRLF-FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECF 587
II+ DLK NVL D G K+ DFG+ K G + TS GT Y+ PE
Sbjct: 116 G--IIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 588 ELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIKARKVEFPSR 644
+ L VD W+ G+L Y+ML G PF D E IL ++ + +P+
Sbjct: 169 Q---EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-------YPT- 217
Query: 645 PAVSNEAKDLIRRCLTYNQAERPDVLTL 672
+S +A D+++ +T N R LTL
Sbjct: 218 -WLSQDAVDILKAFMTKNPTMRLGSLTL 244
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 76/275 (27%), Positives = 118/275 (42%), Gaps = 28/275 (10%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
+LG G VYKAY L+ R +A K+ L D + + E I
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPL------DITVELQKQIMSELEILYKCDSP 59
Query: 468 HIVRLWDTFEIDQN-TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526
+I+ + F ++ + CT E+ G LD K +PE I V + +GL YL
Sbjct: 60 YIIGFYGAFFVENRISICT--EFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYL-- 111
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
+ KI+H D+KP N+L + G K+ DFG+S + + + + GT Y+ PE
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-------GTNAYMAPER 164
Query: 587 FELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPA 646
+ + S DVWS GI F ++ GR P+ Q + L +++ E P
Sbjct: 165 ISGEQYGIHS---DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP 221
Query: 647 V---SNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
V S + I +C+ ERP L P++
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 72/259 (27%), Positives = 116/259 (44%), Gaps = 20/259 (7%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
+LGKGGF EV + ACK + KK+ A+ E I + + +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACK----KLEKKRIKKRKGEAMALNEKRILEKVNSRFV 62
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVL--KATPVLPEREARIIIVQIFQGLIYLNKR 527
V L +E ++ C VL +G DL + P E+ A ++ GL L +
Sbjct: 63 VSLAYAYET-KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR- 120
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECF 587
++I++ DLKP N+L D+ G +++D GL+ + + +G GT Y+ PE
Sbjct: 121 -ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR------VGTVGYMAPEVI 173
Query: 588 ELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647
K D W G L Y+M+ G+ PF + +ER+ RE+ + ++ +
Sbjct: 174 NNEKYTF---SPDWWGLGCLIYEMIQGQSPF--RKRKERVKREEVDRRVKEDQEEYSEKF 228
Query: 648 SNEAKDLIRRCLTYNQAER 666
S +AK + R LT N ER
Sbjct: 229 SEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 68/271 (25%), Positives = 126/271 (46%), Gaps = 24/271 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y +L ++G+G F LV+H K + K S + + +E +
Sbjct: 1 QYNVLRVVGEGSFGRAL----LVQHVNSDQKY--AMKEIRLPKSSSAVEDSRKEAVLLAK 54
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGL 521
+ H +IV ++FE D + + V+EYC G DL +K + PE VQ+ G+
Sbjct: 55 MKHPNIVAFKESFEADGHLY-IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV 113
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
+++++ +++H D+K N+ + G K+ DFG ++++ + GT +Y
Sbjct: 114 QHIHEK--RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-----TSPGAYACTYVGTPYY 166
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
+PPE +E P ++K D+WS G + Y++ + PF + + IL+ + +
Sbjct: 167 VPPEIWE--NMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILK---VCQGSYKPL 220
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTL 672
PS S E + LI++ N RP T+
Sbjct: 221 PSH--YSYELRSLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 71/248 (28%), Positives = 121/248 (48%), Gaps = 24/248 (9%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
+LGKG F +V+ A +++ A K + +D + + + + + H +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTM---VEKRVLSLAWEHPFL 58
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ 529
L+ TF+ +N F V+EY +G DL +++ A +I GL +L+ +
Sbjct: 59 THLYCTFQTKENLF-FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG- 116
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFEL 589
I++ DLK N+L D G K+ DFG+ K E+ +G T GT Y+ PE
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAK---TCTFCGTPDYIAPEILLG 170
Query: 590 SKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILREDTIIKARKVEFPSRPA-V 647
K ++ VD WS G+L Y+ML G+ PF GHD E+ + ++ +++ P P +
Sbjct: 171 QK---YNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEELFQSIRMDNPCYPRWL 219
Query: 648 SNEAKDLI 655
+ EAKD++
Sbjct: 220 TREAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 79/339 (23%), Positives = 130/339 (38%), Gaps = 89/339 (26%)
Query: 404 RYALLNLLGKGGFSEVYKAY--DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
+Y + +G+G + VYKA + + + A K + + QS A RE +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQS----ACREIALL 56
Query: 462 KTLVHHHIVRLWDTFEIDQNTFCT--VLEYCSGKDLDAVLK-----ATPVLPEREARIII 514
+ L H ++V L + F ++ + +Y DL ++K +P + ++
Sbjct: 57 RELKHENVVSLVEVF-LEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVL----FDEFGVAKVTDFGLSKIV---------E 561
QI G+ YL+ + ++H DLKP N+L E GV K+ D GL+++
Sbjct: 115 WQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 562 DDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQML------F 613
D V T WY PE ++ T I D+W+ G +F ++L
Sbjct: 173 DPV-----------VVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFK 217
Query: 614 GRR-------PFGHDQTQERILR------ED---TIIK----------ARKVEFPS---- 643
GR PF DQ ERI E I K + +PS
Sbjct: 218 GREAKIKKSNPFQRDQL-ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLA 276
Query: 644 -----RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
++ DL+R+ L Y+ +R + PY
Sbjct: 277 KWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 72/260 (27%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
+LGKGGF EV + ACK + KK+ A+ E I + + +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACK----RLEKKRIKKRKGESMALNEKQILEKVNSQFV 62
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVL--KATPVLPEREARIIIVQIFQGLIYLNKR 527
V L +E ++ C VL +G DL + P E A +I GL L++
Sbjct: 63 VNLAYAYET-KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR- 120
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLS-KIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
+ ++ DLKP N+L D++G +++D GL+ KI E + GT Y+ PE
Sbjct: 121 -ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-------SIRGRVGTVGYMAPEV 172
Query: 587 FELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPA 646
+ L D W G L Y+M+ G+ PF +E++ RE+ + + E
Sbjct: 173 LNNQRYTL---SPDYWGLGCLIYEMIEGQSPF--RGRKEKVKREEVDRRVLETEEVYSAK 227
Query: 647 VSNEAKDLIRRCLTYNQAER 666
S EAK + + LT + +R
Sbjct: 228 FSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 74/261 (28%), Positives = 116/261 (44%), Gaps = 23/261 (8%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWS-EDKKQSYIRHAIREYNIHKT 463
Y ++ ++G+G F EV LV H+ K++ + E K+S E +I
Sbjct: 45 YEVVKVIGRGAFGEV----QLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
+V+L+ F+ D+ + V+EY G DL ++ V PE+ AR ++ L
Sbjct: 100 ANSPWVVQLFYAFQDDRYLY-MVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDA 157
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
++ + IH D+KP N+L D+ G K+ DFG + + GM GT Y+
Sbjct: 158 IH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE----GMVRCDTAVGTPDYIS 211
Query: 584 PECFELSKTP-LISSKVDVWSAGILFYQMLFGRRPFGHDQ---TQERILREDTIIKARKV 639
PE + + D WS G+ Y+ML G PF D T +I+ +
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-----SL 266
Query: 640 EFPSRPAVSNEAKDLIRRCLT 660
FP +S EAK+LI LT
Sbjct: 267 TFPDDNDISKEAKNLICAFLT 287
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 77/262 (29%), Positives = 122/262 (46%), Gaps = 23/262 (8%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ ++ ++G+G F EV R A K+ LN +W E K++ E N+
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKI--LN-KW-EMLKRAETACFREERNVLVNG 58
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIY 523
I L F+ D+N V++Y G DL +L K LPE AR I ++ +
Sbjct: 59 DCQWITTLHYAFQ-DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
+++ +H D+KP NVL D G ++ DFG + D G +S GT Y+
Sbjct: 118 IHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD----GTVQSSVAVGTPDYIS 171
Query: 584 PECFELSKTPL--ISSKVDVWSAGILFYQMLFGRRPFGHD---QTQERILREDTIIKARK 638
PE + + + + D WS G+ Y+ML+G PF + +T +I+ + +
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE-----ER 226
Query: 639 VEFPSRPA-VSNEAKDLIRRCL 659
+FPS VS EAKDLI+R +
Sbjct: 227 FQFPSHITDVSEEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 80/310 (25%), Positives = 134/310 (43%), Gaps = 50/310 (16%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY L+ LG+G + V A + + + +S K+ + A+RE
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALREL----K 53
Query: 464 LVHH-----HIVRLWDTFEIDQNTFCTVLEYCSGK----DLDAVLKATPVLPEREARIII 514
L+ H +I L+D + F + Y + DL ++++ L + + I
Sbjct: 54 LLRHFRGHKNITCLYDMDIVFPGNFNEL--YLYEELMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
QI GL Y++ + ++H DLKPGN+L + K+ DFGL++ ++ G +T
Sbjct: 112 YQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQE--RILR- 629
A T WY PE LS + +DVWS G + ++L GR+P G D + +IL+
Sbjct: 170 VA-TRWYRAPEIM-LSFQSY-TKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQV 225
Query: 630 -----EDTIIKA---------------RKVEFPSR-PAVSNEAKDLIRRCLTYNQAERPD 668
E+T+ + K F S P + A DL+ + L ++ +R
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285
Query: 669 VLTLAQDPYL 678
V + PYL
Sbjct: 286 VEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 72/261 (27%), Positives = 120/261 (45%), Gaps = 24/261 (9%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
+LGKGGF EV + ACK + KK+ A+ E I + + +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACK----KLEKKRIKKRKGESMALNEKQILEKVNSRFV 62
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVL--KATPVLPEREARIIIVQIFQGLIYLNKR 527
V L +E ++ C VL +G DL + E A +I GL L++
Sbjct: 63 VSLAYAYET-KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ- 120
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECF 587
++I++ DLKP N+L D+ G +++D GL+ V + +G GT Y+ P
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR------VGTVGYMAP--- 170
Query: 588 ELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT--IIKARKVEFPSRP 645
E+ K + D W+ G L Y+M+ G+ PF Q +++I RE+ ++K + E+ +
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPF--QQRKKKIKREEVERLVKEVQEEYSEK- 227
Query: 646 AVSNEAKDLIRRCLTYNQAER 666
S +A+ L + L + ER
Sbjct: 228 -FSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 69/212 (32%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
LGKGGF EV + ACK LN + KK+ A+ E I + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACK--KLNKK--RLKKRKGYEGAMVEKRILAKVHSRFIV 56
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLD----AVLKATPVLPEREARIIIVQIFQGLIYLNK 526
L F+ + C V+ +G DL V + P PE A QI GL +L++
Sbjct: 57 SLAYAFQT-KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
R +II+ DLKP NVL D G +++D GL+ ++D G T AGT ++ P
Sbjct: 116 R--RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD-----GQSKTKGYAGTPGFMAP-- 166
Query: 587 FELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
EL + VD ++ G+ Y+M+ R PF
Sbjct: 167 -ELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 48/303 (15%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRH-AIREYNIHK 462
+Y L L+G+G + V K + VA K ++ E + ++ A+RE + K
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIK------KFLESEDDKMVKKIAMREIRMLK 55
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
L H ++V L + F + V E+ LD + K L E R + QI +G+
Sbjct: 56 QLRHENLVNLIEVFR-RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE 114
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
+ + + IIH D+KP N+L + GV K+ DFG ++ + + E+ + T WY
Sbjct: 115 FCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-----AAPGEVYTDYVATRWYR 167
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK------- 635
PE L VD+W+ G L +ML G F D +++ IIK
Sbjct: 168 APEL--LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH---IIKCLGNLIP 222
Query: 636 -------------------ARKVEFPSR--PAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+++E + P +S DL ++CL + +RP L
Sbjct: 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
Query: 675 DPY 677
+
Sbjct: 283 HEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 71/269 (26%), Positives = 116/269 (43%), Gaps = 36/269 (13%)
Query: 410 LLGKGGFSEVYKA-YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
++G G F EV++ + + VA + L ++E ++Q ++ A +I HH+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEA----SIMGQFSHHN 67
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ-------IFQGL 521
I+RL + + EY LD L+ + + Q I G+
Sbjct: 68 IIRLEGVVTKFKPAM-IITEYMENGALDKYLR------DHDGEFSSYQLVGMLRGIAAGM 120
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
YL+ +H DL N+L + KV+DFGLS+++EDD +G TS G +
Sbjct: 121 KYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD--PEGTYTTSGGKIPIRW 176
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQ-MLFGRRPFGHDQTQERILREDTIIKARKVE 640
PE K +S DVWS GI+ ++ M FG RP+ E ++KA
Sbjct: 177 TAPEAIAYRK---FTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDG 226
Query: 641 F--PSRPAVSNEAKDLIRRCLTYNQAERP 667
F P+ + L+ +C ++A RP
Sbjct: 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRP 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 68/269 (25%), Positives = 116/269 (43%), Gaps = 26/269 (9%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
LG G F V K + + + + L + ++S +RE I L + +IV
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQ 529
R+ E + V+E SG L+ L + ++ Q+ G+ YL +
Sbjct: 59 RMIGVCEAE--ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK-- 114
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WYLPPEC 586
+H DL NVL AK++DFGLSK +G+ ++ AG + WY PEC
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKA----LGADDSYYKARSAGKWPLKWY-APEC 169
Query: 587 FELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVEFPSRP 645
K SS+ DVWS GI ++ +G++P+ + E + I + ++++ P
Sbjct: 170 INFRK---FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM---SFIEQGKRLDCP--A 221
Query: 646 AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
E L++ C Y +RP+ + +
Sbjct: 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEE 250
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 452 RHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPERE 509
R A+ E I L H +I+ ++ F +D NT +EY +G L + + E
Sbjct: 44 RDALNEIVILSLLQHPNIIAYYNHF-MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM 102
Query: 510 ARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGM 569
+ QI + Y++K I+H D+K N+ + G+ K+ DFG+SKI+ + M
Sbjct: 103 VLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---SM 157
Query: 570 ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR 629
T GT +Y+ PE + K + K D+W+ G + Y++L +R F +++
Sbjct: 158 AETV--VGTPYYMSPELCQGVK---YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212
Query: 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
I++ S S+E L+ L + +RP
Sbjct: 213 ---IVQGNYTPVVSV--YSSELISLVHSLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 467 HHIVRLWDTFE-IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLN 525
+ +L F+ +D+ F V+EY +G DL ++ E A +I GL +L+
Sbjct: 61 PFLTQLHSCFQTMDRLYF--VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 526 KRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK--IVEDDVGSQGMELTSQGAGTYWYLP 583
+ II+ DLK NV+ D G K+ DFG+ K I T GT Y+
Sbjct: 119 SKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-------TRTFCGTPDYIA 169
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE ++ P S VD W+ G+L Y+ML G+ PF + E I V +P
Sbjct: 170 PEI--IAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYPK 222
Query: 644 RPAVSNEAKDLIRRCLTYNQAER 666
++S EA + + LT + A+R
Sbjct: 223 --SLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 28/282 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y +G+G VY A D+ + VA K L Q K+ I I E + +
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELI---INEILVMRE 72
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
+ +IV D++ + + V+EY +G L V+ T + E + + + Q L +
Sbjct: 73 NKNPNIVNYLDSYLVGDELW-VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDF 130
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ + ++IH D+K N+L G K+TDFG + + + S GT +++
Sbjct: 131 LH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-----STMVGTPYWMA 183
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR---KVE 640
P E+ KVD+WS GI+ +M+ G P+ E LR +I +++
Sbjct: 184 P---EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY----LNENPLRALYLIATNGTPELQ 236
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682
P R +S +D + RCL + R L Q P+L +K
Sbjct: 237 NPER--LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 40/214 (18%)
Query: 494 DLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553
DL ++ + L ++ + QI +GL YL+ + I+H D+KPGN+L + V K+ D
Sbjct: 89 DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKICD 146
Query: 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF 613
FGL+++ E D S+ M +Q T +Y PE L + +S VD+WS G +F ++L
Sbjct: 147 FGLARVEEPD-ESKHM---TQEVVTQYYRAPEI--LMGSRHYTSAVDIWSVGCIFAELLG 200
Query: 614 GRRPFGHDQTQERILREDTII------------------KARKVEFPSRPA--------- 646
R F Q Q I + D I +A + P +P
Sbjct: 201 RRILF---QAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLS 257
Query: 647 --VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++EA L+ R L ++ +R PYL
Sbjct: 258 SQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 78/292 (26%), Positives = 127/292 (43%), Gaps = 57/292 (19%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHR-----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ ++G+G F EV LV+ + Y KL + SE ++ + H E +I
Sbjct: 6 IKVIGRGAFGEV----RLVQKKDTGHIYAMKKL-----RKSEMLEKEQVAHVRAERDILA 56
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
+ +V+L+ +F+ D+N ++EY G D+ +L E E R I + +
Sbjct: 57 EADNPWVVKLYYSFQ-DENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAID 115
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK------------IVEDDVGSQGME 570
++K IH D+KP N+L D G K++DFGL I+ + S ++
Sbjct: 116 SIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 571 LTSQ---------------------GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFY 609
S+ GT Y+ PE F + + + D WS G++ Y
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG---YNKECDWWSLGVIMY 230
Query: 610 QMLFGRRPFGHDQTQERILREDTIIKARK-VEFPSRPAVSNEAKDLIRRCLT 660
+ML G PF D QE + II ++ ++FP +S EAKDLI+R
Sbjct: 231 EMLVGYPPFCSDNPQETYRK---IINWKETLQFPDEVPLSPEAKDLIKRLCC 279
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 81/318 (25%), Positives = 120/318 (37%), Gaps = 70/318 (22%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHA------IRE 457
RY + ++GKG + V A D VA K K H +RE
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK-----------KINDVFEHVSDATRILRE 49
Query: 458 YNIHKTLVHHHIVRLWDTFEI-------DQNTF---CTVLEYCSGKDLDAVLKATPVLPE 507
+ + L H IV EI + F V E DL V+KA L
Sbjct: 50 IKLLRLLRHPDIV------EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTP 102
Query: 508 REARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567
+ + Q+ + L Y++ + H DLKP N+L + K+ DFGL+++ +D +
Sbjct: 103 EHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 568 GMELTSQGAGTYWYLPPE---CFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQT 623
+ T WY PE F TP I D+WS G +F ++L G+ F G +
Sbjct: 161 --IFWTDYVATRWYRAPELCGSFFSKYTPAI----DIWSIGCIFAEVLTGKPLFPGKNVV 214
Query: 624 QERILREDTI-------------IKARK----------VEFPSR-PAVSNEAKDLIRRCL 659
+ L D + KAR+ V F + P A L+ R L
Sbjct: 215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLL 274
Query: 660 TYNQAERPDVLTLAQDPY 677
++ +RP DPY
Sbjct: 275 AFDPKDRPTAEEALADPY 292
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLN 525
H +V L F+ + F V+EY +G DL ++ LPE AR +I L YL+
Sbjct: 55 HPFLVGLHSCFQTESRLF-FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 113
Query: 526 KRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPE 585
+R II+ DLK NVL D G K+TD+G+ K G + + TS GT Y+ PE
Sbjct: 114 ERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPE 166
Query: 586 CFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-------GHDQTQERILREDTIIKARK 638
VD W+ G+L ++M+ GR PF DQ E L + +I ++
Sbjct: 167 ILRGEDYGF---SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--VILEKQ 221
Query: 639 VEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+ P ++S +A +++ L + ER
Sbjct: 222 IRIPR--SLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 75/274 (27%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNA--QWSEDKKQSYIRHAIREYNIHK 462
+ LL +LG G + +V+ + H KL+ + + + +K + H E N+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHD--TGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 463 TLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
+ +V L F+ + +L+Y SG ++ L E E R +I L
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLH-LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
+L+K I++ D+K N+L D G +TDFGLSK + S+ E T GT Y
Sbjct: 119 EHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEEKERTYSFCGTIEY 172
Query: 582 LPPECFELSKTPLISSK------VDVWSAGILFYQMLFGRRPF---GHDQTQERILREDT 632
+ PE +I K VD WS GIL +++L G PF G TQ + R
Sbjct: 173 MAPE--------IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--- 221
Query: 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+ K + P + EA+DL+ + L + +R
Sbjct: 222 --RILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 457 EYNIHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIV 515
E +H+ + + + ++L+ + + +++Y DL +LK L E E + II
Sbjct: 58 EPMVHQLMKDNPNFIKLYYSVTTLKGHV-LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIR 116
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV-AKVTDFGLSKIVEDDVGSQGMELTSQ 574
Q+ + L L+K IIH D+K NVL+D + D+GL KI +G+
Sbjct: 117 QLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI----IGTPSC----- 165
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634
GT Y PE ++ S D W+ G+L Y++L G+ PF D+ +E L
Sbjct: 166 YDGTLDYFSPE--KIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR 222
Query: 635 KARKVEFPSRPAVSNEAKDLIRRCLTYN 662
+ +K+ F VS A D ++ L YN
Sbjct: 223 QQKKLPFIKN--VSKNANDFVQSMLKYN 248
|
Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-14
Identities = 68/241 (28%), Positives = 109/241 (45%), Gaps = 38/241 (15%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHA--IREYNIH 461
RY ++ L+GKGG EVY AYD V R VA K + ED ++ + +RE I
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALK------KIREDLSENPLLKKRFLREAKIA 56
Query: 462 KTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT---PVLP----EREARIII 514
L+H IV ++ + D + + Y G L ++LK+ L E+ +
Sbjct: 57 ADLIHPGIVPVY-SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 515 VQIF----QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG--LSKIVEDDV---- 564
+ IF + Y++ + ++H DLKP N+L FG + D+G + K +E++
Sbjct: 116 LSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 565 -----GSQGMELTSQG--AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRP 617
+T G GT Y+ PE L P S D+++ G++ YQML P
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPE--RLLGVP-ASESTDIYALGVILYQMLTLSFP 230
Query: 618 F 618
+
Sbjct: 231 Y 231
|
Length = 932 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 59/278 (21%)
Query: 451 IRHAIREYNIHKTLVHH-----HIVRLWDTFEID-QNTFCTVLEYCSGKDLDAVLKATPV 504
I+ AIR I + V H +IV + F D + + C +E+ G LD VLK
Sbjct: 42 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGR 99
Query: 505 LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564
+PE+ + + + +GL YL ++ KI+H D+KP N+L + G K+ DFG+S + D
Sbjct: 100 IPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156
Query: 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ 624
+ + GT Y+ PE + + S + D+WS G+ +M GR P +
Sbjct: 157 -----SMANSFVGTRSYMSPERLQGTH---YSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208
Query: 625 ERIL-----------REDTIIKARKVEFP-------SRPAV------------------- 647
E L +T + R P SRP +
Sbjct: 209 ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS 268
Query: 648 ---SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682
E +D + +CL N AER D+ L ++ S+
Sbjct: 269 GVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 40/275 (14%)
Query: 411 LGKGGFSEVYKAY-----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV 465
LG+G F VY+ VA K NA E + E ++ K
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE------RIEFLNEASVMKEFN 67
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------PVLPEREARIIIV 515
HH+VRL Q T V+E + DL + L++ ++ +
Sbjct: 68 CHHVVRLLGVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK-IVEDDVGSQGMELTSQ 574
+I G+ YL A+K +H DL N + E K+ DFG+++ I E D +G +
Sbjct: 127 EIADGMAYLA--AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG----GK 180
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTI 633
G ++ PE K + ++K DVWS G++ ++M +P+ + E +L+
Sbjct: 181 GLLPVRWMAPESL---KDGVFTTKSDVWSFGVVLWEMATLAEQPY-QGLSNEEVLK---F 233
Query: 634 IKARKV-EFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ + P ++ +L+R C YN RP
Sbjct: 234 VIDGGHLDLPENC--PDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 77/306 (25%), Positives = 126/306 (41%), Gaps = 51/306 (16%)
Query: 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKL----HGLNAQWSEDKKQSY 450
F++F + + ++ +GKG + +V+K + A K+ H ++ +
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA------ 63
Query: 451 IRHAIREYNIHKTLVHH-HIVRLWDTF----EIDQNTFCTVLEYCSGKDLDAVLKATPVL 505
EYNI K L H ++V+ + + + + VLE C+G + ++K
Sbjct: 64 ------EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR 117
Query: 506 PEREARIIIVQIFQ----GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561
ER II I GL +L+ K IH D+K N+L G K+ DFG+S
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGGVKLVDFGVSA--- 172
Query: 562 DDVGSQGMELTSQ------GAGTYWYLPPECF--ELSKTPLISSKVDVWSAGILFYQMLF 613
+LTS GT +++ PE E ++ DVWS GI ++
Sbjct: 173 --------QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224
Query: 614 GRRPFGHDQTQERILREDTIIKARKVEFPSRPAV-SNEAKDLIRRCLTYNQAERPDVLTL 672
G P + + I +P + SNE D IR+CLT + +RP V L
Sbjct: 225 GDPPLADLHPMRALFK----IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
Query: 673 AQDPYL 678
Q ++
Sbjct: 281 LQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLN 525
H +V L F+ + F V+E+ SG DL ++ LPE AR +I L +L+
Sbjct: 55 HPFLVGLHSCFQTESRLF-FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH 113
Query: 526 KRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPE 585
+R II+ DLK NVL D G K+TD+G+ K G + + TS GT Y+ PE
Sbjct: 114 ERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCK-----EGIRPGDTTSTFCGTPNYIAPE 166
Query: 586 CFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-------GHDQTQERILREDTIIKARK 638
VD W+ G+L ++M+ GR PF DQ E L + +I ++
Sbjct: 167 ILRGEDYGF---SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ--VILEKQ 221
Query: 639 VEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+ P ++S +A +++ L + ER
Sbjct: 222 IRIPR--SLSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 479 DQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLK 537
D+N V++Y G DL +L K LPE AR + ++ + +++ +H D+K
Sbjct: 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIK 129
Query: 538 PGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLI 595
P NVL D+ G ++ DFG + D G ++ GT Y+ PE + +
Sbjct: 130 PDNVLLDKNGHIRLADFGSCLRLLAD----GTVQSNVAVGTPDYISPEILQAMEDGKGRY 185
Query: 596 SSKVDVWSAGILFYQMLFGRRPFGHDQTQE---RILREDTIIKARKVEFPSR-PAVSNEA 651
+ D WS G+ Y+ML+G PF + E +I+ +FP VS EA
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-----EHFQFPPDVTDVSEEA 240
Query: 652 KDLIRRCL 659
KDLIRR +
Sbjct: 241 KDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 32/265 (12%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRH----AIREYNIHKTLV 465
++G+GGF EVY + A K DKK+ ++ A+ E I +LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK--------CLDKKRIKMKQGETLALNE-RIMLSLV 51
Query: 466 HH----HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
IV + F + C +L+ +G DL L V E+E R +I GL
Sbjct: 52 STGDCPFIVCMTYAFHT-PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGL 110
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
+++ R +++ DLKP N+L DE G +++D GL+ D + + GT+ Y
Sbjct: 111 EHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHAS---VGTHGY 161
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
+ PE L K S D +S G + +++L G PF +T+++ D + VE
Sbjct: 162 MAPEV--LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVEL 218
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAER 666
P + S E K L+ L + ++R
Sbjct: 219 PD--SFSPELKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 80/314 (25%), Positives = 139/314 (44%), Gaps = 40/314 (12%)
Query: 372 RYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYV 431
RYE +++R+++++ Q+ Y ++ ++G+G F EV LV H+
Sbjct: 27 RYE----KIVRKIRKL-----------QMKAEDYDVVKVIGRGAFGEV----QLVRHK-S 66
Query: 432 ACKLHGLNAQWS-EDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490
+ K++ + E K+S E +I +V+L+ F+ D+ + V+EY
Sbjct: 67 SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY-MVMEYM 125
Query: 491 SGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550
G DL ++ V PE+ A+ ++ L ++ + +IH D+KP N+L D+ G K
Sbjct: 126 PGGDLVNLMSNYDV-PEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLK 182
Query: 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTP-LISSKVDVWSAGILFY 609
+ DFG +++ GM GT Y+ PE + + D WS G+ +
Sbjct: 183 LADFGTCMKMDE----TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238
Query: 610 QMLFGRRPFGHDQ---TQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAE- 665
+ML G PF D T +I+ + FP +S AK+LI LT +
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKN-----SLNFPEDVEISKHAKNLICAFLTDREVRL 293
Query: 666 -RPDVLTLAQDPYL 678
R V + Q P+
Sbjct: 294 GRNGVEEIKQHPFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
++ L +G G F VY A D+ VA K + + S +K Q I+E + L
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----IIKEVRFLQKL 72
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
H + ++ + + ++T V+EYC G D + L E E + QGL YL
Sbjct: 73 RHPNTIQYRGCY-LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ + +IH D+K GN+L E G+ K+ DFG + I M + GT +++ P
Sbjct: 132 H--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------MAPANXFVGTPYWMAP 180
Query: 585 ECFELSKTPLISSKVDVWSAGI 606
E KVDVWS GI
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 81/273 (29%), Positives = 122/273 (44%), Gaps = 31/273 (11%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHA-IREYNIHKT 463
+ LL +LG G + +V+ + H + KL+ + KK + ++ A E+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHD--SGKLYAMKVL----KKATIVQKAKTTEHTRTER 55
Query: 464 LVHHHI------VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQI 517
V HI V L F+ D +L+Y +G +L L E+E +I +I
Sbjct: 56 QVLEHIRQSPFLVTLHYAFQTDTKLH-LILDYINGGELFTHLSQRERFKEQEVQIYSGEI 114
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK-IVEDDVGSQGMELTSQGA 576
L +L+K II+ D+K N+L D G +TDFGLSK ED+V E
Sbjct: 115 VLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-----ERAYSFC 167
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTI 633
GT Y+ P+ VD WS G+L Y++L G PF G +Q I R
Sbjct: 168 GTIEYMAPDIVRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---- 222
Query: 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+ K E P +S AKD+I+R L + +R
Sbjct: 223 -RILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA 528
+ L+ TF+ ++ F V+E+ +G DL ++ A +I GL +L+ +
Sbjct: 58 LTHLYCTFQTKEHLF-FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
II+ DLK NV+ D G K+ DFG+ K E+ G S GT Y+ PE +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNR---ASTFCGTPDYIAPEILQ 169
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPA-V 647
K + VD WS G+L Y+ML G+ PF D ED + ++ +V+ P P +
Sbjct: 170 GLK---YTFSVDWWSFGVLLYEMLIGQSPFHGDD-------EDELFESIRVDTPHYPRWI 219
Query: 648 SNEAKDLIRRCLTYNQAER 666
+ E+KD++ + + R
Sbjct: 220 TKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 72/267 (26%), Positives = 110/267 (41%), Gaps = 34/267 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L+ LG G F EV+ Y H VA K S + + E N+ K L H
Sbjct: 10 LVKKLGAGQFGEVWMGY-YNGHTKVAIK--------SLKQGSMSPEAFLAEANLMKQLQH 60
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARII--IVQIFQGLIYL 524
+VRL+ + Q + EY L LK + ++I QI +G+ ++
Sbjct: 61 PRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WY 581
++ IH DL+ N+L E K+ DFGL++++ED+ E T++ + W
Sbjct: 119 ERK--NYIHRDLRAANILVSETLCCKIADFGLARLIEDN------EYTAREGAKFPIKWT 170
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVE 640
P E + K DVWS GIL +++ +GR P+ E I + R
Sbjct: 171 AP----EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-----RGYR 221
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERP 667
P E +L+R C ERP
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY L +G G + V A D VA K + + + + + A RE + K
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLKH 70
Query: 464 LVHHHIVRLWDTFEIDQN-----TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIF 518
+ H +++ L D F D + F V+ + G DL ++K L E + ++ Q+
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-LSEDRIQFLVYQML 128
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
+GL Y++ A IIH DLKPGN+ +E K+ DFGL++ + ++ + T
Sbjct: 129 KGLKYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV--------T 178
Query: 579 YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQ 622
WY PE + + VD+WS G + +ML G+ F GHD
Sbjct: 179 RWYRAPEV--ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 76/264 (28%), Positives = 126/264 (47%), Gaps = 27/264 (10%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ +L ++G+G F EV + A K+ LN +W E K++ E ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKI--LN-KW-EMLKRAETACFREERDVLVNG 58
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIY 523
+ I L F+ + N + V++Y G DL +L K LPE AR + ++ +I
Sbjct: 59 DNQWITTLHYAFQDENNLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM---VIA 114
Query: 524 LNKRAQ-KIIHYDLKPGNVLFDEFGVAKVTDFGLS-KIVEDDVGSQGMELTSQGAGTYWY 581
++ Q +H D+KP N+L D G ++ DFG K++ED G +S GT Y
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-----GTVQSSVAVGTPDY 169
Query: 582 LPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHD---QTQERILREDTIIKA 636
+ PE + + + D WS G+ Y+ML+G PF + +T +I+
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK----- 224
Query: 637 RKVEFPSRPA-VSNEAKDLIRRCL 659
+ +FP++ VS +AKDLIRR +
Sbjct: 225 ERFQFPAQVTDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 25/233 (10%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY L+ +G G + V A+D VA K Q K++Y RE + K
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-----RELRLLKH 72
Query: 464 LVHHHIVRLWDTF----EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
+ H +++ L D F +++ ++ + G DL+ ++K L + + +I QI +
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILR 131
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
GL Y++ + IIH DLKP N+ +E K+ DFGL++ +D E+T A T
Sbjct: 132 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-------EMTGYVA-TR 181
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILR 629
WY PE + + VD+WS G + ++L GR F H + ILR
Sbjct: 182 WYRAPEI--MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 71/265 (26%), Positives = 115/265 (43%), Gaps = 32/265 (12%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRH----AIREYNIHKTLV 465
++G+GGF EVY + A K DKK+ ++ A+ E I +LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK--------CLDKKRIKMKQGETLALNE-RIMLSLV 51
Query: 466 HH----HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
IV + F + +L+ +G DL L V E E R +I GL
Sbjct: 52 STGDCPFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGL 110
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
+++ R +++ DLKP N+L DE G +++D GL+ D + + GT+ Y
Sbjct: 111 EHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHAS---VGTHGY 161
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
+ PE L K S D +S G + +++L G PF +T+++ D + VE
Sbjct: 162 MAPEV--LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVEL 218
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAER 666
P + S E + L+ L + R
Sbjct: 219 PD--SFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 59/188 (31%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 498 VLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557
V +PE I V I + L YL+ + +IH D+KP NVL + G K+ DFG+S
Sbjct: 93 VYDKGLTIPEDILGKIAVSIVKALEYLHSKL-SVIHRDVKPSNVLINRNGQVKLCDFGIS 151
Query: 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPL-ISSKVDVWSAGILFYQMLFGRR 616
+ D V + AG Y+ PE K DVWS GI ++ GR
Sbjct: 152 GYLVDSVAK------TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRF 205
Query: 617 PFGHDQTQERILREDTIIKARKVEFPSRPAV-----SNEAKDLIRRCLTYNQAERPDVLT 671
P+ +T + L++ VE PS P + S E +D + +CL N ERP+
Sbjct: 206 PYDSWKTPFQQLKQ-------VVEEPS-PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPE 257
Query: 672 LAQDPYLT 679
L Q P+
Sbjct: 258 LLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 27/283 (9%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ L+ ++G G + +VYK + + A K+ + E+ K + +++Y+ H+ +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEI--NMLKKYSHHRNI 75
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLI 522
++ + + + V+E+C + ++K T L E I +I +GL
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
+L+ A K+IH D+K NVL E K+ DFG+S ++ VG + + GT +++
Sbjct: 136 HLH--AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWM 188
Query: 583 PPECFELSKTP--LISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL-----REDTIIK 635
PE + P + D+WS GI +M G P D R L +K
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC-DMHPMRALFLIPRNPPPKLK 247
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++K S + D I CL N RP L + P++
Sbjct: 248 SKK--------WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 24/280 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y +G+G VY A D+ + VA + L Q K+ I I E + +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELI---INEILVMRE 73
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
+ +IV D++ + + V+EY +G L V+ T + E + + + Q L +
Sbjct: 74 NKNPNIVNYLDSYLVGDELW-VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEF 131
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ + ++IH D+K N+L G K+TDFG + + + S GT +++
Sbjct: 132 LH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-----STMVGTPYWMA 184
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV-EFP 642
P E+ KVD+WS GI+ +M+ G P+ E LR +I E
Sbjct: 185 P---EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY----LNENPLRALYLIATNGTPELQ 237
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682
+ +S +D + RCL + +R L Q +L +K
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 37/269 (13%)
Query: 405 YALLNLLGKGGFSEV----YKAYD---LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
+ + LG G F V YK D + R+ K+ KQ + H E
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI----------IKQKQVDHVFSE 81
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQI 517
I + H V L+ +F+ D++ VLE+ G + L+ P QI
Sbjct: 82 RKILNYINHPFCVNLYGSFK-DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
LI+ ++ I++ DLKP N+L D+ G K+TDFG +K+V+ T G
Sbjct: 141 V--LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--------TYTLCG 190
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
T Y+ PE D W+ GI Y++L G PF E +L I++
Sbjct: 191 TPEYIAPEILLNVGH---GKAADWWTLGIFIYEILVGCPPF---YANEPLLIYQKILEG- 243
Query: 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+ FP + N K L+++ L+++ +R
Sbjct: 244 IIYFPK--FLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 82/299 (27%), Positives = 129/299 (43%), Gaps = 74/299 (24%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKL--HGLNAQWSEDKK----QSYIRHAIREYNIHKTL 464
LG G F EV +ACK+ H L A + KK ++ + H E +I
Sbjct: 9 LGIGAFGEVC----------LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA 58
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
+ +V+L+ +F+ D++ V++Y G D+ ++L V PE AR I ++ + +
Sbjct: 59 DNEWVVKLYYSFQ-DKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL---------SKIVE-------------- 561
+K IH D+KP N+L D G K+TDFGL SK +
Sbjct: 118 HKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 562 --DDV-----GSQGMELTSQG------------AGTYWYLPPECFELSKTPLISSKVDVW 602
DDV G + L + GT Y+ PE L K + D W
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL-LRKG--YTQLCDWW 232
Query: 603 SAGILFYQMLFGRRPF---GHDQTQERILR-EDTIIKARKVEFPSRPAVSNEAKDLIRR 657
S G++ ++ML G+ PF +TQ +++ E+T+ P + +S EA DLI +
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL------HIPPQVKLSPEAVDLITK 285
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 28/271 (10%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
+G+G V A + R VA K+ L +KQ E I + H ++V
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDL-------RKQQRRELLFNEVVIMRDYQHQNVV 81
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQK 530
++ ++ + + + ++E+ G L ++ T L E + + + Q L YL+ +Q
Sbjct: 82 EMYKSYLVGEELW-VLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLH--SQG 137
Query: 531 IIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS 590
+IH D+K ++L G K++DFG + DV + GT +++ PE +S
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-----KSLVGTPYWMAPEV--IS 190
Query: 591 KTPLISSKVDVWSAGILFYQMLFGRRPFGHD---QTQERILREDTIIKARKVEFPSRPAV 647
+TP ++VD+WS GI+ +M+ G P+ D Q +R LR+ K + +
Sbjct: 191 RTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNAH-----KI 243
Query: 648 SNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
S +D + R LT ER L P+L
Sbjct: 244 SPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 62/273 (22%), Positives = 116/273 (42%), Gaps = 16/273 (5%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ L+ +G G + +VYKA ++ A K+ L Q +E + K
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ-------QEIIMMKDC 63
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
H +IV + ++ + ++ +E+C G L + T L E + + + QGL YL
Sbjct: 64 KHSNIVAYFGSY-LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYL 122
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ + + +H D+K N+L + G K+ DFG+S + + + + GT +++ P
Sbjct: 123 HSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMAP 175
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
E + + + D+W+ GI ++ + P D R L T + + +
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPM-FDLHPMRALFLMTKSNFQPPKLKDK 234
Query: 645 PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
SN ++ LT N +RP L Q P+
Sbjct: 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 43/272 (15%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L+ LG G F EV+ Y VA K + ++ + E N+ KTL H
Sbjct: 10 LVKKLGAGQFGEVWMGY-YNNSTKVAVK--------TLKPGTMSVQAFLEEANLMKTLQH 60
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIII-------VQIFQ 519
+VRL+ ++ + + EY + L LK+ + ++++ QI +
Sbjct: 61 DKLVRLYAVVTKEEPIY-IITEYMAKGSLLDFLKS-----DEGGKVLLPKLIDFSAQIAE 114
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
G+ Y+ ++ IH DL+ NVL E + K+ DFGL++++ED+ E T++ +
Sbjct: 115 GMAYIERK--NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN------EYTAREGAKF 166
Query: 580 ---WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIK 635
W P E + K DVWS GIL Y+++ +G+ P+ + +
Sbjct: 167 PIKWTAP----EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-----SAL 217
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
R P +E D+++ C ERP
Sbjct: 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 26/281 (9%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ L +GKG F EVYK D VA K+ ++ + +ED+ I +E +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKI--IDLEEAEDE----IEDIQQEITVLSQC 59
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
+I R + ++ + ++EY G +LK P L E I+ +I +GL YL
Sbjct: 60 DSPYITRYYGSY-LKGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYL 117
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ +++ IH D+K NVL E G K+ DFG++ + D + + GT +++ P
Sbjct: 118 H--SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-----NTFVGTPFWMAP 170
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS- 643
E + S K D+WS GI ++ G P D R+L K P+
Sbjct: 171 EVIKQSAYDF---KADIWSLGITAIELAKGEPPNS-DLHPMRVL-----FLIPKNSPPTL 221
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT-YSKK 683
S K+ + CL + RP L + ++T Y+KK
Sbjct: 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKK 262
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
H Y L+ +G G + +VYKA +L A K+ L S I+ +E + K
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL----EPGDDFSLIQ---QEIFMVK 61
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
H +IV + ++ + + +EYC G L + T L E + + + QGL
Sbjct: 62 ECKHCNIVAYFGSY-LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL+ + + +H D+K N+L + G K+ DFG++ + + + + GT +++
Sbjct: 121 YLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-----GTPYWM 173
Query: 583 PPECFELSKTPLISSKVDVWSAGI 606
PE + K + D+W+ GI
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLN 525
H + L F+ F V+EY +G DL ++ + E +R ++ L++L+
Sbjct: 55 HPFLTALHCCFQTKDRLF-FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 526 KRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPE 585
+ +I+ DLK N+L D G K+ DFG+ K G T+ GT Y+ PE
Sbjct: 114 RHG--VIYRDLKLDNILLDAEGHCKLADFGMCK-----EGILNGVTTTTFCGTPDYIAPE 166
Query: 586 CF-ELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ---ERILREDTIIKARKVEF 641
EL P VD W+ G+L Y+M+ G+ PF D E IL +D V +
Sbjct: 167 ILQELEYGP----SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-------VLY 215
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAER 666
P +S EA +++ +T N +R
Sbjct: 216 PV--WLSKEAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 451 IRHAIREYNIHKTLVHH-----HIVRLWDTFEID-QNTFCTVLEYCSGKDLDAVLKATPV 504
I+ AIR I + V H +IV + F D + + C +E+ G LD VLK
Sbjct: 42 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKEAKR 99
Query: 505 LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564
+PE + + + +GL YL ++ Q I+H D+KP N+L + G K+ DFG+S + D
Sbjct: 100 IPEEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156
Query: 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRP 617
+ + GT Y+ PE + + S + D+WS G+ ++ GR P
Sbjct: 157 -----SMANSFVGTRSYMSPERLQGTH---YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 27/200 (13%)
Query: 486 VLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNV 541
VL+Y + DL +K E EA ++ +Q+ + +++ + +IH D+K N+
Sbjct: 117 VLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK--HMIHRDIKSANI 174
Query: 542 LFDEFGVAKVTDFGLSKI----VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISS 597
L G+ K+ DFG SK+ V DDVG GT +Y+ PE + + P S
Sbjct: 175 LLCSNGLVKLGDFGFSKMYAATVSDDVG-------RTFCGTPYYVAPEIWR--RKPY-SK 224
Query: 598 KVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF-PSRPAVSNEAKDLIR 656
K D++S G+L Y++L +RPF + +E + K + P P++S E ++++
Sbjct: 225 KADMFSLGVLLYELLTLKRPFDGENMEE------VMHKTLAGRYDPLPPSISPEMQEIVT 278
Query: 657 RCLTYNQAERPDVLTLAQDP 676
L+ + RP L P
Sbjct: 279 ALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY L +G G + V AYD + VA K Q +++Y RE + K
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-----RELRLLKH 70
Query: 464 LVHHHIVRLWDTF----EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
+ H +++ L D F I+ ++ G DL+ ++K L + + +I Q+ +
Sbjct: 71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLR 129
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
GL Y++ + IIH DLKP NV +E ++ DFGL++ +D E+T A T
Sbjct: 130 GLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-------EMTGYVA-TR 179
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
WY PE + + VD+WS G + ++L G+ F
Sbjct: 180 WYRAPEI--MLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 72/285 (25%), Positives = 124/285 (43%), Gaps = 35/285 (12%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ L +GKG F EV+K D + VA K+ ++ + +ED+ I +E +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKI--IDLEEAEDE----IEDIQQEITVLSQC 59
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
++ + + ++ + ++EY G +L+A P E + ++ +I +GL YL
Sbjct: 60 DSPYVTKYYGSY-LKGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYL 117
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ ++K IH D+K NVL E G K+ DFG++ + D +Q T GT +++ P
Sbjct: 118 H--SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTF--VGTPFWMAP 170
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
E + S SK D+WS GI ++ G P D R+L P
Sbjct: 171 EVIQQSA---YDSKADIWSLGITAIELAKGEPP-NSDMHPMRVL----------FLIPKN 216
Query: 645 PA------VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
S K+ I CL + + RP L + ++ + K
Sbjct: 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 52/150 (34%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA 528
+V L F+ F V+EY +G DL ++ LPE AR +I L +L++R
Sbjct: 58 LVGLHSCFQTTSRLF-LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
II+ DLK NVL D G K+TD+G+ K G + TS GT Y+ PE
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
+ VD W+ G+L ++M+ GR PF
Sbjct: 170 GEEYGF---SVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-13
Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIV 515
RE + L H +IV L D+ E V EY G+ L VL A LP E +++
Sbjct: 27 RETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLML 86
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV---AKVTDFGLSKIVED--DVGSQGME 570
Q+ L + Q I+H DLKP N++ + GV AKV DFG+ ++ D +
Sbjct: 87 QVLDALACAH--NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630
T++ GT Y PE +L P ++ D+++ G++F + L G+R E + ++
Sbjct: 145 RTTEVLGTPTYCAPE--QLRGEP-VTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQ 201
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 8e-13
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ L +GKG F EV+K D + VA K+ ++ + +ED+ I +E +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI--IDLEEAEDE----IEDIQQEITVLSQC 59
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
++ + + ++ D + ++EY G +L+ P L E + I+ +I +GL YL
Sbjct: 60 DSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYL 117
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ ++K IH D+K NVL E G K+ DFG++ + D + + GT +++ P
Sbjct: 118 H--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-----NTFVGTPFWMAP 170
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRP 617
E + S SK D+WS GI ++ G P
Sbjct: 171 EVIKQSA---YDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 71/268 (26%), Positives = 114/268 (42%), Gaps = 38/268 (14%)
Query: 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
+ LG G + EVY+ VA K ED + + ++E + K + H +
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVK------TLKEDTME--VEEFLKEAAVMKEIKHPN 63
Query: 469 IVRLWD--TFEIDQNTFCTVLEY-CSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYL 524
+V+L T E F + E+ G LD + + + + QI + YL
Sbjct: 64 LVQLLGVCTRE---PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WY 581
K+ IH DL N L E + KV DFGLS+++ D T+ + W
Sbjct: 121 EKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT------YTAHAGAKFPIKW- 171
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQM-LFGRRPF-GHDQTQERILREDTIIKARKV 639
PE +K S K DVW+ G+L +++ +G P+ G D +Q L E K ++
Sbjct: 172 TAPESLAYNK---FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----KGYRM 224
Query: 640 EFPSRPAVSNEAKDLIRRCLTYNQAERP 667
E P + +L+R C +N ++RP
Sbjct: 225 ERP--EGCPPKVYELMRACWQWNPSDRP 250
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 59/199 (29%), Positives = 87/199 (43%), Gaps = 16/199 (8%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
L +G G F VY A D+ + VA K + + S +K Q I+E + + H
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD----IIKEVKFLQRIKHP 85
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
+ + + + ++T V+EYC G D + L E E I QGL YL+
Sbjct: 86 NSIEYKGCY-LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-- 142
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECF 587
+ +IH D+K GN+L E G K+ DFG + I + GT +++ PE
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---------ANSFVGTPYWMAPEVI 193
Query: 588 ELSKTPLISSKVDVWSAGI 606
KVDVWS GI
Sbjct: 194 LAMDEGQYDGKVDVWSLGI 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 410 LLGKGGFSEV-YKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
++G G F EV L R + + L A ++E +++ ++ A +I H +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEA----SIMGQFDHPN 66
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ-------IFQGL 521
I+ L + V EY LDA L+ + + + ++Q I G+
Sbjct: 67 IIHL-EGVVTKSKPVMIVTEYMENGSLDAFLR------KHDGQFTVIQLVGMLRGIASGM 119
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
YL+ +H DL N+L + V KV+DFGLS+++EDD + T G +
Sbjct: 120 KYLSDMGY--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEAAYTTRGGKIPIRW 175
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQ-MLFGRRPFGHDQTQERI 627
PE K +S DVWS GI+ ++ M +G RP+ Q+ I
Sbjct: 176 TAPEAIAYRK---FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
+G G F V+ Y L E R VA K A ED I E + L H +V
Sbjct: 12 IGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEED--------FIEEAQVMMKLSHPKLV 62
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARI-IIVQIFQGLIYLNKRAQ 529
+L+ +++ C V E+ L L+A +E + + + + +G+ YL
Sbjct: 63 QLYGVC-TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD--VGSQGMELTSQGAGTYWYLPPECF 587
+IH DL N L E V KV+DFG+++ V DD S G + + + PE F
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSS------PEVF 173
Query: 588 ELSKTPLISSKVDVWSAGILFYQMLF-GRRPF 618
SK SSK DVWS G+L +++ G+ P+
Sbjct: 174 SFSK---YSSKSDVWSFGVLMWEVFSEGKTPY 202
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 504 VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563
V+PE I V + L YL K KIIH D+KP N+L D G K+ DFG+S + D
Sbjct: 103 VIPEEILGKIAVATVKALNYL-KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161
Query: 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGH--- 620
+ ++ AG Y+ PE + S + DVWS GI Y++ G+ P+
Sbjct: 162 IAK------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
Query: 621 --DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
DQ + + + I+ S + I CL ++++RP L + P++
Sbjct: 216 VFDQLTQVVKGDPPILSNS-----EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270
Query: 679 TY 680
Sbjct: 271 KD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 33/238 (13%)
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQ-NTFCTVLEYCSGKDLDAVLKATPVLPEREARIII 514
+E I + L H +IV+ D N ++E+ L L P + +I +
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL------PRNKNKINL 108
Query: 515 -------VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567
VQI +G+ YL R + +H DL NVL + K+ DFGL+K +E D
Sbjct: 109 KQQLKYAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 166
Query: 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-----------FGRR 616
++ + +WY PEC SK + S DVWS G+ Y++L +
Sbjct: 167 TVK-DDLDSPVFWY-APECLIQSKFYIAS---DVWSFGVTLYELLTYCDSESSPMTLFLK 221
Query: 617 PFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
G Q + R +++ K P P E L+R+C + ++R L +
Sbjct: 222 MIGPTHGQMTVTRLVRVLEEGK-RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 65/231 (28%), Positives = 93/231 (40%), Gaps = 52/231 (22%)
Query: 406 ALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHA--IREYNIHKT 463
L LG G F EV+ VA K K + ++E I K
Sbjct: 9 KLERKLGAGQFGEVWMGTWN-GTTKVAVKT----------LKPGTMSPEAFLQEAQIMKK 57
Query: 464 LVHHHIVRLWDTFEIDQNTFCT-------VLEYCSGKDLDAVLKATP--VLPEREARIII 514
L H +V+L+ C+ V EY S L LK+ L + +
Sbjct: 58 LRHDKLVQLY--------AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD--VGSQGMEL- 571
QI +G+ YL R IH DL N+L E V K+ DFGL++++EDD +G +
Sbjct: 110 AQIAEGMAYLESR--NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP 167
Query: 572 ---TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
T+ A Y F + K DVWS GIL +++ +GR P+
Sbjct: 168 IKWTAPEAANY-----GRF--------TIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 36/212 (16%)
Query: 494 DLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553
DL +++++ L + + + Q+ +GL Y++ + ++H DLKP N+L + K+ D
Sbjct: 94 DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDLKICD 151
Query: 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF 613
FGL++ S+ + ++ T WY PE L+ + ++ +DVWS G +F ++L
Sbjct: 152 FGLAR-----TTSEKGDFMTEYVVTRWYRAPELL-LNCSEYTTA-IDVWSVGCIFAELL- 203
Query: 614 GRRPF--GHDQTQERIL--------REDTII-----KARK----------VEFPSR-PAV 647
GR+P G D + L E+ + KAR+ F P
Sbjct: 204 GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHA 263
Query: 648 SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ A DL+ + L ++ ++R V PYL
Sbjct: 264 NPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 25/185 (13%)
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIII 514
I E + L H ++V+L+ Q V EY + L L+ + +
Sbjct: 47 IEEAKVMMKLSHPNLVQLYGVC-TKQRPIFIVTEYMANGCLLNYLRERK---GKLGTEWL 102
Query: 515 V----QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD--VGSQG 568
+ + + + YL IH DL N L E V KV+DFGL++ V DD SQG
Sbjct: 103 LDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160
Query: 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFG---HDQTQ 624
+ + A PPE F+ S+ SSK DVWS G+L +++ G+ P+ + +
Sbjct: 161 TKFPVKWA------PPEVFDYSR---FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211
Query: 625 ERILR 629
E +
Sbjct: 212 ESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 407 LLNLLGKGGFSEVYKA-YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV 465
+ ++G G F EV + L + + + L A S+ ++ ++ A +I
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEA----SIMGQFD 63
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ-------IF 518
H +I+RL + EY LD L+ E + + + Q I
Sbjct: 64 HPNIIRLEGVV-TKSRPVMIITEYMENGSLDKFLR------ENDGKFTVGQLVGMLRGIA 116
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
G+ YL++ +H DL N+L + V KV+DFGLS+ +ED S+ T G
Sbjct: 117 SGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLED---SEATYTTKGGKIP 171
Query: 579 YWYLPPECFELSKTPLISSKVDVWSAGILFYQ-MLFGRRPFGHDQTQERI 627
+ PE K +S DVWS GI+ ++ M +G RP+ Q+ I
Sbjct: 172 IRWTAPEAIAYRK---FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 16/228 (7%)
Query: 443 SEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK-- 500
DK + ++E I +L H +++RL+ + + V E L L+
Sbjct: 32 KSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGV--VLTHPLMMVTELAPLGSLLDRLRKD 89
Query: 501 ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560
A VQI G+ YL + + IH DL N+L K+ DFGL + +
Sbjct: 90 ALGHFLISTLCDYAVQIANGMRYLESK--RFIHRDLAARNILLASDDKVKIGDFGLMRAL 147
Query: 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFG 619
+ + + PE +T S DVW G+ ++M +G P+
Sbjct: 148 --PQNEDHYVMEEHLKVPFAWCAPESL---RTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202
Query: 620 HDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ +IL++ I A + +++ +C +N A+RP
Sbjct: 203 G-LSGSQILKK---IDKEGERLERPEACPQDIYNVMLQCWAHNPADRP 246
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
L+ +G G F VY A + + VA K + + + +K Q I+E + L H
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD----IIKEVKFLQQLKHP 81
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527
+ + + + ++T V+EYC G D + L E E I QGL YL+
Sbjct: 82 NTIEYKGCY-LKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECF 587
+IH D+K GN+L E G K+ DFG + + GT +++ PE
Sbjct: 141 N--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---------ANSFVGTPYWMAPEVI 189
Query: 588 ELSKTPLISSKVDVWSAGI 606
KVDVWS GI
Sbjct: 190 LAMDEGQYDGKVDVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 61/185 (32%), Positives = 92/185 (49%), Gaps = 24/185 (12%)
Query: 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE 545
V+EY +G DL ++ E +A +I GL +L++R II+ DLK NV+ D
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDS 136
Query: 546 FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAG 605
G K+ DFG+ K E V G+ T GT Y+ PE ++ P S VD W+ G
Sbjct: 137 EGHIKIADFGMCK--EHMV--DGV-TTRTFCGTPDYIAPEI--IAYQPYGKS-VDWWAYG 188
Query: 606 ILFYQMLFGRRPF-GHDQTQERILREDTI---IKARKVEFPSRPAVSNEAKDLIRRCLTY 661
+L Y+ML G+ PF G D ED + I V +P ++S EA + + +T
Sbjct: 189 VLLYEMLAGQPPFDGED--------EDELFQSIMEHNVSYPK--SLSKEAVSICKGLMTK 238
Query: 662 NQAER 666
+ ++R
Sbjct: 239 HPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK-LHGLNAQWSEDKKQSYIRHAIREYNIHK 462
RY L +G G + V A D VA K L + + + + A RE + K
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLK 69
Query: 463 TLVHHHIVRLWDTFEI-----DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQI 517
+ H +++ L D F + F V+ Y DL ++ L E + + ++ Q+
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMGHP--LSEDKVQYLVYQM 126
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
GL Y++ IIH DLKPGN+ +E K+ DFGL++ E+T
Sbjct: 127 LCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGY-VV 176
Query: 578 TYWYLPPEC----FELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
T WY PE ++T VD+WS G + +ML G+ F
Sbjct: 177 TRWYRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 64/230 (27%), Positives = 91/230 (39%), Gaps = 35/230 (15%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
+GKG F +VYK L + VA K R ++E I K H +I
Sbjct: 2 KIGKGNFGDVYKGV-LKGNTEVAVK------TCRSTLPPDLKRKFLQEAEILKQYDHPNI 54
Query: 470 VRL----WDTFEIDQNTFCTVLEYCSGKD-LDAVLKATPVLPEREARIIIVQIFQGLIYL 524
V+L I V+E G L + K L ++ + + G+ YL
Sbjct: 55 VKLIGVCVQKQPI-----YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WY 581
+ IH DL N L E V K++DFG+S+ E G+ S G W
Sbjct: 110 ESK--NCIHRDLAARNCLVGENNVLKISDFGMSREEEG-----GIYTVSDGLKQIPIKWT 162
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF---GHDQTQERI 627
P E +S+ DVWS GIL ++ G P+ + QT+ERI
Sbjct: 163 AP----EALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 82/296 (27%), Positives = 124/296 (41%), Gaps = 72/296 (24%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIR----HAIREYNIHKTLVH 466
LG G F EV A R V K L A + KK +R H E +I +
Sbjct: 9 LGIGAFGEVCLA------RKVDTK--ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526
+VRL+ +F+ D++ V++Y G D+ ++L + PE AR I ++ + ++K
Sbjct: 61 EWVVRLYYSFQ-DKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK 119
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGL---------SKIVE--DDVGSQGMELTSQG 575
IH D+KP N+L D G K+TDFGL SK + D V M+ +++
Sbjct: 120 --MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE- 176
Query: 576 AGTYWYLPPEC----------------------FELSKTP-LISSKV----------DVW 602
W P C L TP I+ +V D W
Sbjct: 177 ----WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 603 SAGILFYQMLFGRRPFGHD---QTQERILREDTIIKARKVEFPSRPAVSNEAKDLI 655
S G++ Y+ML G+ PF +TQ +++ T + P + +S EA DLI
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQT-----SLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 59/192 (30%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL--KATPVLPEREARIIIVQIFQGLIY 523
H ++R+ DT T C VL + S DL L ++ P LP +A II QI +GL Y
Sbjct: 116 HPSVIRMKDTLVSGAIT-CMVLPHYSS-DLYTYLTKRSRP-LPIDQALIIEKQILEGLRY 172
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ AQ+IIH D+K N+ ++ + D G ++ G+ AGT
Sbjct: 173 LH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL------AGTVETNA 224
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQML------FGRRPFGHDQ----TQERILREDTI 633
PE K +SK D+WSAGI+ ++ML F P ++ +L+ +
Sbjct: 225 PEVLARDK---YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST 281
Query: 634 IKARKVEFPSRP 645
+K EFP P
Sbjct: 282 LKVHPEEFPRDP 293
|
Length = 357 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 13/161 (8%)
Query: 455 IREYNIHKTLVHHHIVRLWDTF-EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARII 513
+E NI KTL H +IV+ E ++EY L ++ P A+++
Sbjct: 54 KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP---LGSLRDYLPKHKLNLAQLL 110
Query: 514 IV--QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMEL 571
+ QI +G+ YL+ +Q IH DL NVL D + K+ DFGL+K V + G + +
Sbjct: 111 LFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE--GHEYYRV 166
Query: 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612
G ++ EC + +K S DVWS G+ Y++L
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYAS---DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 70/266 (26%), Positives = 115/266 (43%), Gaps = 40/266 (15%)
Query: 411 LGKGGFSEVYKA-YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LG G F EV+ A Y+ +H VA K + + + E N+ KTL H +
Sbjct: 14 LGAGQFGEVWMATYN--KHTKVAVK--------TMKPGSMSVEAFLAEANVMKTLQHDKL 63
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARII--IVQIFQGLIYLNKR 527
V+L + + + E+ + L LK+ + ++I QI +G+ ++ +R
Sbjct: 64 VKLHAV--VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WYLPP 584
IH DL+ N+L V K+ DFGL++++ED+ E T++ + W P
Sbjct: 122 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDN------EYTAREGAKFPIKWTAP- 172
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKA--RKVEF 641
E + K DVWS GIL +++ +GR P+ E +I+A R
Sbjct: 173 ---EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRM 222
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERP 667
P E +++ RC ERP
Sbjct: 223 PRPENCPEELYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 55/236 (23%), Positives = 111/236 (47%), Gaps = 19/236 (8%)
Query: 446 KKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVL 505
+KQ E I + H ++V +++++ + + V+E+ G L ++ T +
Sbjct: 56 RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW-VVMEFLEGGALTDIVTHTR-M 113
Query: 506 PEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVG 565
E + + + + + L L+ AQ +IH D+K ++L G K++DFG V +V
Sbjct: 114 NEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171
Query: 566 SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE 625
+ GT +++ PE +S+ P +VD+WS GI+ +M+ G P+ ++ +
Sbjct: 172 RR-----KSLVGTPYWMAPEL--ISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223
Query: 626 --RILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+++R++ K + + VS K + R L + A+R L + P+L
Sbjct: 224 AMKMIRDNLPPKLKNLH-----KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 48/279 (17%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
LL +GKG F +V L ++R V C + AQ + E ++
Sbjct: 10 LLQTIGKGEFGDVM----LGDYRGNKVAVKCIKNDATAQ-----------AFLAEASVMT 54
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQG 520
L H ++V+L ++ V EY + L L++ VL + + +
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE--DDVGSQGMELTSQGAGT 578
+ YL A +H DL NVL E VAKV+DFGL+K D G ++ T+
Sbjct: 115 MEYL--EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA----- 167
Query: 579 YWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKAR 637
PE + S+K DVWS GIL +++ FGR P+ ++ + R + K
Sbjct: 168 -----PEAL---REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGY 216
Query: 638 KVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
K++ P P V D++++C + A RP L L +
Sbjct: 217 KMDAPDGCPPVVY----DVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 4e-11
Identities = 82/316 (25%), Positives = 131/316 (41%), Gaps = 65/316 (20%)
Query: 389 DEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHR-------YVACKLHGLNAQ 441
D+ SR N ++++ +G G F EV+ LV+H+ + A GL +
Sbjct: 6 DDGESRLNEYEVIKK-------IGNGRFGEVF----LVKHKRTQEFFCWKAISYRGLKER 54
Query: 442 WSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL-EYCSGKDLDA-VL 499
+K Q I E N+ + L H +IVR D F N +L E+C DL +
Sbjct: 55 ---EKSQLVI-----EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ 106
Query: 500 KATPVLPEREARIII---VQIFQGLIYLNK-----RAQKIIHYDLKPGNVLF-------- 543
K + + E I+ Q+ L Y + ++++H DLKP N+
Sbjct: 107 KCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166
Query: 544 ---------DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPL 594
+ +AK+ DFGLSK ++G + M + G YW PE L +T
Sbjct: 167 KITAQANNLNGRPIAKIGDFGLSK----NIGIESMAHSCVGTPYYW--SPELL-LHETKS 219
Query: 595 ISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDL 654
K D+W+ G + Y++ G+ PF +++ E R + P + S E L
Sbjct: 220 YDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE----LKRGPDLPIK-GKSKELNIL 274
Query: 655 IRRCLTYNQAERPDVL 670
I+ L + ERP L
Sbjct: 275 IKNLLNLSAKERPSAL 290
|
Length = 1021 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 76/272 (27%), Positives = 114/272 (41%), Gaps = 32/272 (11%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
+G+G F EV+ ++ VA K D K +++ A I K H +IV
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEA----RILKQYSHPNIV 56
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQ 529
RL Q + V+E G D L+ P L +E ++ G+ YL ++
Sbjct: 57 RLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESK 113
Query: 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV--GSQGMELTSQGAGTYWYLPPECF 587
IH DL N L E V K++DFG+S+ ED V + GM+ W PE
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP----VKW-TAPEAL 168
Query: 588 ELSKTPLISSKVDVWSAGILFYQML-FGRRPFG---HDQTQERILREDTIIKARKVEFPS 643
+ SS+ DVWS GIL ++ G P+ + QT+E I + V P
Sbjct: 169 NYGR---YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI--------EQGVRLPC 217
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
+ L+ RC Y+ +RP T+ Q+
Sbjct: 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 67/282 (23%), Positives = 113/282 (40%), Gaps = 36/282 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRY-----VACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
LL LG G F EVY L R + + L SE + ++ A+ I
Sbjct: 10 LLRALGHGAFGEVY--EGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL----IM 63
Query: 462 KTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARI-------II 514
H +IVRL ++ +LE +G DL + L+ PER + +
Sbjct: 64 SKFNHQNIVRLIGV-SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG---VAKVTDFGLSKIVEDDVGSQGMEL 571
+ +G YL + IH D+ N L G VAK+ DFG+++ D +
Sbjct: 123 RDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR---DIYRASYYRK 177
Query: 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILRE 630
+ ++PPE F + +SK DVWS G+L +++ G P+ QE +
Sbjct: 178 GGRAMLPIKWMPPEAF---LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM--- 231
Query: 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTL 672
+ + +++ P ++ C + +RP+ T+
Sbjct: 232 EFVTGGGRLDPP--KGCPGPVYRIMTDCWQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 74/270 (27%), Positives = 114/270 (42%), Gaps = 28/270 (10%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
LLGKG F EV+K L + VA K ED Q + E I K H +I
Sbjct: 2 LLGKGNFGEVFKG-TLKDKTPVAVK------TCKEDLPQELKIKFLSEARILKQYDHPNI 54
Query: 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIYLNKRA 528
V+L Q + V+E G D + L K L ++ + G+ YL +
Sbjct: 55 VKLIGVCTQRQPIY-IVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ES 111
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV-GSQGMELTSQGAGTYWYLPPECF 587
+ IH DL N L E V K++DFG+S+ +D + S G++ + PE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP-----IKWTAPEAL 166
Query: 588 ELSKTPLISSKVDVWSAGILFYQML-FGRRPF-GHDQTQERILREDTIIKARKVEFPSRP 645
+ SS+ DVWS GIL ++ G P+ G Q R + + K ++ P +
Sbjct: 167 NYGR---YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR----EQVEKGYRMSCPQK- 218
Query: 646 AVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
++ +++RC Y RP L ++
Sbjct: 219 -CPDDVYKVMQRCWDYKPENRPKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 72/278 (25%), Positives = 110/278 (39%), Gaps = 31/278 (11%)
Query: 410 LLGKGGFSEVYKAY---DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
LG+G F EV+ A E + L ++ QS R RE ++ + L H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFR---RELDMFRKLSH 67
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT---------PVLPEREARIIIVQI 517
++VRL + +LEY DL L+AT P L ++ + QI
Sbjct: 68 KNVVRLLGLCR-EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
G+ +L+ + +H DL N L KV+ LSK DV +
Sbjct: 127 ALGMDHLSN--ARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALI 180
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKA 636
+L PE + S+K DVWS G+L +++ G PF + E +L ++A
Sbjct: 181 PLRWLAPEAVQEDD---FSTKSDVWSFGVLMWEVFTQGELPFY-GLSDEEVLNR---LQA 233
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
K+E P + L+ RC N +RP L
Sbjct: 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 73/289 (25%), Positives = 122/289 (42%), Gaps = 60/289 (20%)
Query: 408 LNLLGKGGFSEVYKAYDLVE-----HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L ++G+G F EV LV+ H Y L A E ++ ++IR E +I
Sbjct: 6 LKVIGRGAFGEV----RLVQKKDTGHIYAMKILR--KADMLEKEQVAHIR---AERDILV 56
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
+V+++ +F+ +N + ++E+ G D+ +L L E + I + +
Sbjct: 57 EADGAWVVKMFYSFQDKRNLY-LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE----------------DDVGS 566
+++ IH D+KP N+L D G K++DFGL ++ D
Sbjct: 116 AIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 567 QGM--------------ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612
Q M +L GT Y+ PE F + + D WS G++ Y+ML
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG---YNKLCDWWSLGVIMYEML 230
Query: 613 FGRRPFGHDQTQERILR----EDTIIKARKVEFPSRPAVSNEAKDLIRR 657
G PF + QE + ++T++ FP +S +AKDLI R
Sbjct: 231 IGYPPFCSETPQETYRKVMNWKETLV------FPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 71/259 (27%), Positives = 111/259 (42%), Gaps = 27/259 (10%)
Query: 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470
+GKG F +V + R A K + + +S + H + E + + IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALK----TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIV 56
Query: 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQK 530
L +F+ + + VL + +G +L L+ AR ++ L L+K
Sbjct: 57 PLKFSFQSPEKLY-LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF--N 113
Query: 531 IIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS 590
+I+ DLKP N+L D G + DFGL K+ D + T+ GT YL P EL
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-----DKTNTFCGTPEYLAP---ELL 165
Query: 591 KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE---RILREDTIIKARKVEFPSRPAV 647
+ VD W+ G+L Y+ML G PF + E +IL+E + FP
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-------PLRFPD--GF 216
Query: 648 SNEAKDLIRRCLTYNQAER 666
+AKDL+ L+ + R
Sbjct: 217 DRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 60/289 (20%)
Query: 408 LNLLGKGGFSEVYKAYDLVE-----HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L ++G+G F EV LV+ H Y L A E ++ +IR E +I
Sbjct: 6 LKVIGRGAFGEV----RLVQKKDTGHVYAMKILR--KADMLEKEQVGHIR---AERDILV 56
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
+V+++ +F+ N + ++E+ G D+ +L L E E + I + +
Sbjct: 57 EADSLWVVKMFYSFQDKLNLY-LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL----------------SKIVEDDVGS 566
+++ IH D+KP N+L D G K++DFGL + + D
Sbjct: 116 SIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 567 QGM--------------ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612
Q M +L GT Y+ PE F + + D WS G++ Y+ML
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG---YNKLCDWWSLGVIMYEML 230
Query: 613 FGRRPFGHDQTQERILR----EDTIIKARKVEFPSRPAVSNEAKDLIRR 657
G PF + QE + ++T+I FP +S +AKDLI R
Sbjct: 231 IGYPPFCSETPQETYKKVMNWKETLI------FPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 14/105 (13%)
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD--VGSQGMELTSQ 574
+ +G+ YL + + IH DL N L GV KV+DFG+++ V DD S G + +
Sbjct: 109 VCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK 166
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPF 618
+ PPE F SK SSK DVWS G+L +++ G+ PF
Sbjct: 167 ------WSPPEVFNFSK---YSSKSDVWSFGVLMWEVFTEGKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/186 (31%), Positives = 88/186 (47%), Gaps = 26/186 (13%)
Query: 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE 545
V+EY +G DL ++ E A +I GL +L+ + II+ DLK NV+ D
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDS 136
Query: 546 FGVAKVTDFGLSKI-VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSA 604
G K+ DFG+ K + D V T GT Y+ PE ++ P S VD W+
Sbjct: 137 EGHIKIADFGMCKENMWDGV------TTKTFCGTPDYIAPEI--IAYQPYGKS-VDWWAF 187
Query: 605 GILFYQMLFGRRPF-GHDQTQERILREDTI---IKARKVEFPSRPAVSNEAKDLIRRCLT 660
G+L Y+ML G+ PF G D ED + I V +P ++S EA + + +T
Sbjct: 188 GVLLYEMLAGQAPFEGED--------EDELFQSIMEHNVAYPK--SMSKEAVAICKGLMT 237
Query: 661 YNQAER 666
+ +R
Sbjct: 238 KHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 40/226 (17%)
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIV 515
RE +I KT+ H I+ L + ++T C V+ DL + + LP +A I
Sbjct: 135 REIDILKTISHRAIINLIHAYR-WKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQR 192
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
++ + L YL+ R IIH D+K N+ DE A + DFG + ++ +
Sbjct: 193 RLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT--------- 241
Query: 576 AGTYWYLPPECFELSKTPLISS-----------KVDVWSAGILFYQMLFGRRPFGHDQTQ 624
P+C+ S T +S K D+WSAG++ ++M Q +
Sbjct: 242 --------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293
Query: 625 ERILREDTIIKARKV---EFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ +II+ +V EFP N + +L + Y RP
Sbjct: 294 SSSSQLRSIIRCMQVHPLEFP-----QNGSTNLCKHFKQYAIVLRP 334
|
Length = 392 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 54/233 (23%), Positives = 107/233 (45%), Gaps = 15/233 (6%)
Query: 446 KKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVL 505
+KQ E I + H ++V +++++ + + V+E+ G L ++ T +
Sbjct: 58 RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW-VVMEFLEGGALTDIVTHTR-M 115
Query: 506 PEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVG 565
E + + + + + L YL+ Q +IH D+K ++L G K++DFG V +V
Sbjct: 116 NEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173
Query: 566 SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE 625
+ GT +++ PE +S+ P ++VD+WS GI+ +M+ G P+ ++ +
Sbjct: 174 KR-----KSLVGTPYWMAPEV--ISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225
Query: 626 RILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ R + R + +V DL+ L ++R L Q P+L
Sbjct: 226 AMRRIRDNLPPRVKDSHKVSSVLRGFLDLM---LVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 65/280 (23%), Positives = 115/280 (41%), Gaps = 25/280 (8%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKA-YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIR 456
++I L +G+G F +VY+ Y E+ +A + S ++ +++ A
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY- 59
Query: 457 EYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIV 515
I + H HIV+L I +N V+E +L + L+ L +
Sbjct: 60 ---IMRQFDHPHIVKLIGV--ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSY 114
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ L YL + + +H D+ NVL K+ DFGLS+ +ED+ + S+G
Sbjct: 115 QLSTALAYLESK--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK----ASKG 168
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTII 634
++ PE + +S DVW G+ +++L G +PF + + D I
Sbjct: 169 KLPIKWMAPESINFRR---FTSASDVWMFGVCMWEILMLGVKPF------QGVKNNDVIG 219
Query: 635 KARKVEFPSRPAVSNEA-KDLIRRCLTYNQAERPDVLTLA 673
+ E P L+ +C Y+ ++RP L
Sbjct: 220 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELK 259
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 68/261 (26%), Positives = 112/261 (42%), Gaps = 34/261 (13%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKA--YDLV-EHRYVACKLHGLNAQWSEDKKQSYIRHAI 455
I H L LG+G F +V+ A Y+L E + + L +K +
Sbjct: 1 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH----- 55
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL---------DAVLKAT---P 503
RE + L H HIV+ + ++ + V EY DL DAVL A P
Sbjct: 56 REAELLTNLQHEHIVKFYGVC-VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114
Query: 504 V-LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562
L + + I QI G++YL +Q +H DL N L E + K+ DFG+S+ D
Sbjct: 115 AELTQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---D 169
Query: 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHD 621
+ + ++PPE K +++ DVWS G++ +++ +G++P+
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSLGVVLWEIFTYGKQPWYQL 226
Query: 622 QTQERILREDTIIKARKVEFP 642
E I + I + R ++ P
Sbjct: 227 SNNEVI---ECITQGRVLQRP 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 21/181 (11%)
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIII 514
I E + L H +V+L+ + + V EY S L L+ + + +
Sbjct: 47 IEEAKVMMKLSHEKLVQLYGVCTKQRPIY-IVTEYMSNGCLLNYLREHGKRFQPSQLLEM 105
Query: 515 VQ-IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
+ + +G+ YL +++ IH DL N L D+ G KV+DFGLS+ V DD E TS
Sbjct: 106 CKDVCEGMAYL--ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD------EYTS 157
Query: 574 QGAGTY---WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRP---FGHDQTQER 626
+ W PPE SK SSK DVW+ G+L +++ G+ P F + +T E+
Sbjct: 158 SVGSKFPVRWS-PPEVLLYSK---FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
Query: 627 I 627
+
Sbjct: 214 V 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARI 512
+ E + L H ++VRL I N V+E S +L L+ ++ +
Sbjct: 47 LEETAVMTKLHHKNLVRLLGV--ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELT 572
+ + +G+ YL ++K++H DL N+L E GVAKV+DFGL++ VGS G++
Sbjct: 105 FSLDVAEGMEYL--ESKKLVHRDLAARNILVSEDGVAKVSDFGLAR-----VGSMGVD-- 155
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
+ W P E K SSK DVWS G+L +++ +GR P+
Sbjct: 156 NSKLPVKWTAP----EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 74/282 (26%), Positives = 128/282 (45%), Gaps = 44/282 (15%)
Query: 411 LGKGGFSEVYKAY------DLVEHRYVACKLHGLNAQWSEDKKQSYIRHA--IREYNIHK 462
LG+G F VY+ D E R VA K +N S ++ ++ A ++E+N H
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETR-VAIKT--VNEAASMRERIEFLNEASVMKEFNCH- 69
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA-------TPVL-PEREARIII 514
H+VRL Q T ++E + DL + L++ PV P ++I
Sbjct: 70 -----HVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 515 V--QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK-IVEDDVGSQGMEL 571
+ +I G+ YLN A K +H DL N + E K+ DFG+++ I E D +G
Sbjct: 124 MAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--- 178
Query: 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM-LFGRRPFGHDQTQERILRE 630
+G ++ PE K + ++ DVWS G++ +++ +P+ + E++LR
Sbjct: 179 -GKGLLPVRWMSPESL---KDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGMSNEQVLR- 232
Query: 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTL 672
+++ ++ P + +L+R C YN RP L +
Sbjct: 233 -FVMEGGLLDKPDN--CPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 22/214 (10%)
Query: 411 LGKGGFSEVYKAYDLVEHRY----VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
LG G F VYK + E VA K+ E+ + + E + ++ H
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKV------LREETSPKANKEILDEAYVMASVDH 68
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCS-GKDLDAVLKATPVLPEREARIIIVQIFQGLIYLN 525
H+VRL Q + + G LD V + + VQI +G+ YL
Sbjct: 69 PHVVRLLGICLSSQ--VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 526 KRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPE 585
++ +++H DL NVL K+TDFGL+K+++ D + G ++ E
Sbjct: 127 EK--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD---EKEYHAEGGKVPIKWMALE 181
Query: 586 CFELSKTPLISSKVDVWSAGILFYQ-MLFGRRPF 618
+ K DVWS G+ ++ M FG +P+
Sbjct: 182 SILHRI---YTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 408 LNLLGKGGFSEVYKA-YDLVEH---RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ LGKG F V YD ++ VA K Q S ++R RE I K+
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVK----KLQHS---TAEHLRDFEREIEILKS 61
Query: 464 LVHHHIVRLWDT-FEIDQNTFCTVLEYC-SGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
L H +IV+ + + V+EY G D + K L R+ + QI +G+
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG-AGTYW 580
YL +++ +H DL N+L + K+ DFGL+K++ D + ++ G + +W
Sbjct: 122 EYLG--SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD--KEYYKVREPGESPIFW 177
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQ------------MLFGRRPFGHD-QTQERI 627
Y PE SK S DVWS G++ Y+ F R G+D Q Q +
Sbjct: 178 Y-APESLTESK---FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM-MGNDKQGQMIV 232
Query: 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673
++K P+ P E +++ C + ++RP LA
Sbjct: 233 YHLIELLK-NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 46/271 (16%)
Query: 411 LGKGGFSEVYKA---YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
LG+G F +V+ A L E + + L + SE +Q + R A + L H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREA----ELLTVLQHQ 67
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA----TPVLPEREARI----------- 512
HIVR + + V EY DL+ L++ +L E
Sbjct: 68 HIVRFYGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK-IVEDD---VGSQG 568
I QI G++YL + +H DL N L + V K+ DFG+S+ I D VG +
Sbjct: 127 IASQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERI 627
M ++PPE K +++ D+WS G++ +++ +G++P+ E I
Sbjct: 185 MLPIR-------WMPPESILYRK---FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234
Query: 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRC 658
+ I + R++E P E +++ C
Sbjct: 235 ---ECITQGRELERPR--TCPPEVYAIMQGC 260
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 25/219 (11%)
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARII- 513
++E + K L H +V+L+ + + V EY S L LK R +++
Sbjct: 49 LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 106
Query: 514 -IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELT 572
QI G+ Y+ + +H DL+ N+L E V KV DFGL++++ED+ E T
Sbjct: 107 MAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN------EYT 158
Query: 573 SQGAGTY---WYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERIL 628
++ + W P E + + K DVWS GIL ++ GR P+ +E +
Sbjct: 159 ARQGAKFPIKWTAP----EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL- 213
Query: 629 REDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
D + R P P DL+ +C ERP
Sbjct: 214 --DQV--ERGYRMPCPPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV--GSQGMELTS 573
Q+ G+ YL AQ IH DL NVL E + KV DFGL++++++D+ +G +
Sbjct: 111 QVASGMAYL--EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI 168
Query: 574 QGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDT 632
+ + PE ++ S K DVWS GIL +++ +GR P+ E + + D
Sbjct: 169 K------WTAPEAALYNR---FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD- 218
Query: 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTL 672
+ P P E D++ C + +RP TL
Sbjct: 219 ----QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 410 LLGKGGFSEVYKAYDLVEHR---YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
++G G F EV + + + +VA K L + ++E +++ ++ A +I H
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKT--LKSGYTEKQRRDFLSEA----SIMGQFDH 64
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ-------IFQ 519
+I+ L + + E+ LD+ L+ + + + ++Q I
Sbjct: 65 PNIIHLEGVVTKSRPVM-IITEFMENGALDSFLR------QNDGQFTVIQLVGMLRGIAA 117
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
G+ YL++ +H DL N+L + V KV+DFGLS+ +EDD + G
Sbjct: 118 GMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQ-MLFGRRPFGHDQTQERI 627
+ PE K +S DVWS GI+ ++ M +G RP+ Q+ I
Sbjct: 176 RWTAPEAIAYRK---FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 19/218 (8%)
Query: 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+++ +L ++G+G + V K VA K +++ +E+ K++ +RE + +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKET----TLRELKMLR 55
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQG 520
TL +IV L + F + V EY K++ +L+ P V PE+ R I Q+ +
Sbjct: 56 TLKQENIVELKEAFR-RRGKLYLVFEYVE-KNMLELLEEMPNGVPPEK-VRSYIYQLIKA 112
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
+ + +K I+H D+KP N+L V K+ DFG ++ + + + E + T W
Sbjct: 113 IHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA----TRW 166
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
Y PE L P VD+WS G + ++ G+ F
Sbjct: 167 YRSPEL--LLGAPY-GKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 14/162 (8%)
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
VQI +G++YL +R +++H DL NVL K+TDFGL++++E D +
Sbjct: 116 VQIAKGMMYLEER--RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD---G 170
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQ-MLFGRRPFGHDQTQERILREDTI 633
G ++ EC K + + DVWS G+ ++ M FG +P+ T+E D +
Sbjct: 171 GKMPIKWMALECIHYRK---FTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL 224
Query: 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
K ++ P P + + ++ +C + RP LA +
Sbjct: 225 EKGERL--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 58/290 (20%)
Query: 411 LGKGGFSEVYKAY--DLVEHR---YVACKLHGLNAQWSEDKKQSYIRHA--IREYNIHKT 463
+G+G F V++A L+ + VA K+ L + S D + + R A + E++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFD---- 66
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--------------------- 502
H +IV+L + C + EY + DL+ L+
Sbjct: 67 --HPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 503 -PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561
L E I Q+ G+ YL++R K +H DL N L E V K+ DFGLS+
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSR--- 178
Query: 562 DDVGSQGMELTSQG-AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFG 619
++ S S+ A ++PPE ++ +++ DVW+ G++ +++ +G +P+
Sbjct: 179 -NIYSADYYKASENDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGMQPYY 234
Query: 620 HDQTQERI--LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+E I +R+ ++ P E +L+R C + ++RP
Sbjct: 235 GMAHEEVIYYVRDGNVLSCPD-NCPL------ELYNLMRLCWSKLPSDRP 277
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 34/235 (14%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIR 456
F +L RY L +G G V AYD V + VA K Q ++ + A R
Sbjct: 11 TFTVLK-RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-----NVTHAKRAYR 64
Query: 457 EYNIHKTLVHHHIVRLWDTFEIDQN--TFCTVLEYCSGKDLDAVLKATPVLPEREARI-- 512
E + K + H +I+ L + F ++ F V Y + +DA L + R+
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV--YLVMELMDANLCQVIQMDLDHERMSY 122
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELT 572
++ Q+ G+ +L+ + IIH DLKP N++ K+ DFGL++ +
Sbjct: 123 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF------MM 174
Query: 573 SQGAGTYWYLPPECFELSKTPLI-----SSKVDVWSAGILFYQMLFGRRPF-GHD 621
+ T +Y PE +I VD+WS G + +M+ G F G D
Sbjct: 175 TPYVVTRYYRAPE--------VILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 55/298 (18%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ ++ +GKG + +VYK + + A K+ + E+ + EYNI ++L
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA--------EYNILQSL 75
Query: 465 VHH-HIVRLWDTF-EIDQ---NTFCTVLEYCSGKDLDAVLKATPVLPER--EARI--IIV 515
+H ++V+ + F + D+ VLE C+G + ++K + +R EA I I+
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS-- 573
GL +L+ +IIH D+K N+L G K+ DFG+S +LTS
Sbjct: 136 GALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVSA-----------QLTSTR 182
Query: 574 ----QGAGTYWYLPPECFELSKTPLIS--SKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627
GT +++ PE + S ++ DVWS GI ++ G P
Sbjct: 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP---------- 232
Query: 628 LREDTIIKAR-KVEFPSRPAVSNEAK------DLIRRCLTYNQAERPDVLTLAQDPYL 678
L + +K K+ P + + K I +CL + RP V L + P++
Sbjct: 233 LFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 72/299 (24%), Positives = 118/299 (39%), Gaps = 56/299 (18%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ + ++GKG F EV + A K SE K+ + H E ++
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMK----TLLKSEMFKKDQLAHVKAERDVLAES 58
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
+V L+ +F+ D ++E+ G DL +L E R + + + +
Sbjct: 59 DSPWVVSLYYSFQ-DAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS-------------KIVEDD-------- 563
+K IH D+KP N+L D G K++DFGLS K+++
Sbjct: 118 HKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 564 -----VGSQGMELTSQGAGTYW----------------YLPPECFELSKTPLISSKVDVW 602
V S + ++S+ W Y+ PE F + D W
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG---YGQECDWW 232
Query: 603 SAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK-VEFPSRPAVSNEAKDLIRRCLT 660
S G + ++ L G PF + + E + II R+ + FP +S EA+DLIRR +T
Sbjct: 233 SLGAIMFECLIGWPPFCSENSHETYRK---IINWRETLYFPDDIHLSVEAEDLIRRLIT 288
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 45/282 (15%)
Query: 411 LGKGGFSEVYKA--YDLV---EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV 465
LG+G F +V+ A Y+L + VA K +D + + RE + L
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKA-------LKDPTLAARKDFQREAELLTNLQ 65
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA-----------TPVLPEREARI-- 512
H HIV+ + D + V EY DL+ L+A P + E +
Sbjct: 66 HEHIVKFYGVC-GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 513 ---IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGM 569
I QI G++YL +Q +H DL N L + K+ DFG+S+ D +
Sbjct: 125 MLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYY 179
Query: 570 ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERIL 628
+ ++PPE K +++ DVWS G++ +++ +G++P+ E I
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI- 235
Query: 629 REDTIIKARKVEFPSRPAV-SNEAKDLIRRCLTYNQAERPDV 669
+ I + R +E RP V E D++ C +R ++
Sbjct: 236 --ECITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 69/287 (24%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYK--AYDLVE---HRYVACKLHGLNAQWSEDKKQSYIR 452
+++ + LL LG+G F VY+ A D+++ VA K +N S ++ ++
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKT--VNESASLRERIEFLN 58
Query: 453 HAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA----------T 502
A ++ K HH+VRL Q T V+E + DL + L++
Sbjct: 59 EA----SVMKGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 503 PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK-IVE 561
P +E + +I G+ YLN A+K +H DL N + K+ DFG+++ I E
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM-LFGRRPFGH 620
D +G +G ++ PE K + ++ D+WS G++ +++ +P+
Sbjct: 172 TDYYRKG----GKGLLPVRWMAPESL---KDGVFTTSSDMWSFGVVLWEITSLAEQPY-Q 223
Query: 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ E++L+ ++ ++ P DL+R C +N RP
Sbjct: 224 GLSNEQVLK--FVMDGGYLDQPDN--CPERVTDLMRMCWQFNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 65/319 (20%), Positives = 127/319 (39%), Gaps = 61/319 (19%)
Query: 411 LGKGGFSEVYKAY---DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI---HKTL 464
+G+G + VYKA E Y ++ G S ++ + +R ++ N+ K
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRE-LKHPNVIALQKVF 67
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
+ H ++W F+ ++ ++++ + K LP + ++ QI G+ YL
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 525 NKRAQKIIHYDLKPGNVLF----DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
+ A ++H DLKP N+L E G K+ D G +++ + + + T+W
Sbjct: 125 H--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL--KPLADLDPVVVTFW 180
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGR-------------RPFGHDQ----- 622
Y PE ++ + +D+W+ G +F ++L PF HDQ
Sbjct: 181 YRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 623 ---------------------TQERILREDTIIKARKVEFPSRPAVSNEAKD--LIRRCL 659
T ++ R T + +++ + V ++K L+++ L
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298
Query: 660 TYNQAERPDVLTLAQDPYL 678
T + +R QDPY
Sbjct: 299 TMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 76/306 (24%), Positives = 122/306 (39%), Gaps = 65/306 (21%)
Query: 404 RYALLNLLGKGGFSEVYKA--YDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREY 458
R L LG+G F +V KA L VA K+ +A +K S + + E
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDLSDL---VSEM 66
Query: 459 NIHKTL-VHHHIVRLWDTFEIDQNTFCT-------VLEYCSGKDLDAVLKATPVLPEREA 510
+ K + H +I+ L CT V+EY + +L L+A E +
Sbjct: 67 EMMKMIGKHKNIINLLGV--------CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 511 RIIIV----------------QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554
Q+ +G+ +L ++K IH DL NVL E V K+ DF
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADF 176
Query: 555 GLSKIVEDDVGSQGM-ELTSQGAGTYWYLPPEC-FELSKTPLISSKVDVWSAGILFYQ-M 611
GL++ D+ T+ G ++ PE F+ T + DVWS G+L ++
Sbjct: 177 GLAR----DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT----HQSDVWSFGVLLWEIF 228
Query: 612 LFGRRPFGHDQTQE--RILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDV 669
G P+ +E ++L+E ++E P + E L+R C ++RP
Sbjct: 229 TLGGSPYPGIPVEELFKLLKE-----GYRMEKP--QNCTQELYHLMRDCWHEVPSQRPTF 281
Query: 670 LTLAQD 675
L +D
Sbjct: 282 KQLVED 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 66/244 (27%), Positives = 100/244 (40%), Gaps = 44/244 (18%)
Query: 406 ALLNLLGKGGFSEVYKA--YDLV---EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
L LG+G F +V+ Y L + VA K L S D ++ + R E +
Sbjct: 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFER----EAEL 61
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL---------DAVLKATPVLPEREAR 511
H +IV+ + + + V EY DL DA +P P E
Sbjct: 62 LTNFQHENIVKFYGVC-TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 512 I-----IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK-IVEDD-- 563
+ I VQI G++YL +Q +H DL N L V K+ DFG+S+ + D
Sbjct: 121 LSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 564 -VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRP-FGH 620
VG M W +PPE K S DVWS G++ +++ +G++P +G
Sbjct: 179 RVGGHTM------LPIRW-MPPESIMYRKFTTES---DVWSFGVVLWEIFTYGKQPWYGL 228
Query: 621 DQTQ 624
+
Sbjct: 229 SNEE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK-------ATPVLPE 507
++E I K L H +V L+ + + V E+ L LK P L +
Sbjct: 49 LQEAQIMKKLRHDKLVPLYAV--VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD 106
Query: 508 REARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567
A QI G+ Y+ + IH DL+ N+L + V K+ DFGL++++ED+
Sbjct: 107 MAA-----QIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN---- 155
Query: 568 GMELTSQGAGTY---WYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQT 623
E T++ + W P E + + K DVWS GIL +++ GR P+
Sbjct: 156 --EYTARQGAKFPIKWTAP----EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209
Query: 624 QERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+E + + + R P +L++ C + ERP
Sbjct: 210 REVLEQVE-----RGYRMPCPQGCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 72/298 (24%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 411 LGKGGFSEVYKAY-----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV 465
LG+G F +V KA + VA K+ NA SE +R + E+N+ K +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE------LRDLLSEFNLLKQVN 61
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK----------------ATPVLPERE 509
H H+++L+ D ++EY L + L+ + L +
Sbjct: 62 HPHVIKLYGACSQDGPLL-LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 510 ARIIIV--------QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV- 560
R + + QI +G+ YL + K++H DL NVL E K++DFGLS+ V
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 561 EDDVGSQGMELTSQG-AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
E+D + S+G W F+ + +++ DVWS G+L ++++ G P+
Sbjct: 179 EEDSYVK----RSKGRIPVKWMAIESLFD----HIYTTQSDVWSFGVLLWEIVTLGGNPY 230
Query: 619 GHDQTQERILREDTIIK-ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
+ R ++K ++E P S E +L+ C +RP ++++
Sbjct: 231 PGIAPE----RLFNLLKTGYRMERPEN--CSEEMYNLMLTCWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 70/278 (25%), Positives = 116/278 (41%), Gaps = 39/278 (14%)
Query: 409 NLLGKGGFSEVYK--AYDLV----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
N LG G F EVY+ A D++ VA K A E K+ H + +N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN--- 57
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA-------TPVLPEREARIIIV 515
H +IV+L + ++E G DL + L+ P+L +E I +
Sbjct: 58 ---HPNIVKLLGVC-LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-----VAKVTDFGLSKIVEDDVGSQGME 570
+ +G +YL + IH DL N L E G V K+ DFGL++ D S
Sbjct: 114 DVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYR 168
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILR 629
+G ++ PE +++ DVWS G+L +++L G++P+ QE +
Sbjct: 169 KEGEGLLPVRWMAPESL---LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL-- 223
Query: 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ +++ P ++ L+ C + +ERP
Sbjct: 224 -QHVTAGGRLQKP--ENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSG-------KDLDAVLKATPVLPE 507
+ E I K L H +V+L+ + + V EY S KD + P L +
Sbjct: 49 LEEAQIMKKLRHDKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD 106
Query: 508 REARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567
A Q+ G+ Y+ + IH DL+ N+L + V K+ DFGL++++ED+
Sbjct: 107 MAA-----QVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN---- 155
Query: 568 GMELTSQGAGTY---WYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQT 623
E T++ + W P E + + K DVWS GIL +++ GR P+
Sbjct: 156 --EYTARQGAKFPIKWTAP----EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209
Query: 624 QERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+E + + + + ++ P +S +L+ +C + ERP
Sbjct: 210 REVL---EQVERGYRMPCPQDCPIS--LHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 53/241 (21%), Positives = 91/241 (37%), Gaps = 50/241 (20%)
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK----ATPVLPEREA 510
++E I L +I RL +D C ++EY DL+ L+ T L
Sbjct: 67 LKEVKILSRLSDPNIARLLGVCTVDP-PLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 511 RI-------IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563
+ + QI G+ YL +H DL N L + K+ DFG+S+
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESL--NFVHRDLATRNCLVGKNYTIKIADFGMSR----- 178
Query: 564 VGSQGMELTSQGAGTYW-----------YLPPECFELSKTPLISSKVDVWSAGILFYQML 612
+ + Y+ ++ E L K ++K DVW+ G+ +++L
Sbjct: 179 ---------NLYSSDYYRVQGRAPLPIRWMAWESVLLGK---FTTKSDVWAFGVTLWEIL 226
Query: 613 -FGRR-PFGHDQTQERILREDTIIKARK----VEFPSRPAVSNEAKDLIRRCLTYNQAER 666
R P+ H Q+ I E+ R + P P + +L+ C ++ +R
Sbjct: 227 TLCREQPYEHLTDQQVI--ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284
Query: 667 P 667
P
Sbjct: 285 P 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 63/319 (19%), Positives = 126/319 (39%), Gaps = 61/319 (19%)
Query: 411 LGKGGFSEVYKAY---DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI---HKTL 464
+G+G + VYKA + Y ++ G S ++ + +R ++ N+ K
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRE-LKHPNVISLQKVF 67
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
+ H ++W F+ ++ ++++ + K LP + ++ QI G+ YL
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 525 NKRAQKIIHYDLKPGNVLF----DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
+ A ++H DLKP N+L E G K+ D G +++ + + + T+W
Sbjct: 125 H--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL--KPLADLDPVVVTFW 180
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGR-------------RPFGHDQ----- 622
Y PE ++ + +D+W+ G +F ++L P+ HDQ
Sbjct: 181 YRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 623 ---------------------TQERILREDTIIKARKVEFPSRPAVSNEAK--DLIRRCL 659
T + R +T +++ + V ++K L+++ L
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298
Query: 660 TYNQAERPDVLTLAQDPYL 678
T + +R QDPY
Sbjct: 299 TMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 30/74 (40%), Positives = 41/74 (55%), Gaps = 2/74 (2%)
Query: 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE 545
V+EY G D+ ++L E A I ++ L YL++ IIH DLKP N+L
Sbjct: 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISN 139
Query: 546 FGVAKVTDFGLSKI 559
G K+TDFGLSK+
Sbjct: 140 EGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 38/246 (15%)
Query: 388 RDEDGSRFNNFQILN------HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQ 441
R + + F + +I + RY L +G G V AYD + R VA K Q
Sbjct: 3 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 442 WSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA 501
Q++ + A RE + K + H +I+ L + F ++ Y + +DA L
Sbjct: 63 -----NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 502 TPVLPEREARI--IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559
+ R+ ++ Q+ G+ +L+ + IIH DLKP N++ K+ DFGL++
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175
Query: 560 VEDDVGSQGMELTSQGAGTYWYLPPECF-ELSKTPLI------SSKVDVWSAGILFYQML 612
AGT + + P + P + VD+WS G + +M+
Sbjct: 176 ----------------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 613 FGRRPF 618
G F
Sbjct: 220 KGGVLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 69/269 (25%), Positives = 114/269 (42%), Gaps = 38/269 (14%)
Query: 410 LLGKGGFSEVYKAY-DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
+LG G F E+ + L R + +H L A S+ +++ ++ A+ H +
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL----TLGQFDHSN 67
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIF-------QGL 521
IVRL + NT V EY S LD+ L+ + E +++ Q+ G+
Sbjct: 68 IVRL-EGVITRGNTMMIVTEYMSNGALDSFLR------KHEGQLVAGQLMGMLPGLASGM 120
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
YL++ +H L VL + V K++ F ++ ED S+ + T G +
Sbjct: 121 KYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDK--SEAIYTTMSGKSPVLW 174
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQ-MLFGRRPFGHDQTQERILREDTIIKARKVE 640
PE + SS DVWS GI+ ++ M +G RP+ Q+ +IKA +
Sbjct: 175 AAPEAIQYHH---FSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDG 224
Query: 641 F--PSRPAVSNEAKDLIRRCLTYNQAERP 667
F P+ N L+ C + ERP
Sbjct: 225 FRLPAPRNCPNLLHQLMLDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 21/220 (9%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI 455
+ F +L RY L +G G V AYD V R VA K Q Q++ + A
Sbjct: 11 STFTVLK-RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-----NQTHAKRAY 64
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLE-YCSGKDLDAVLKATPVLPEREARI-- 512
RE + K + H +I+ L + F Q + + Y + +DA L + R+
Sbjct: 65 RELVLMKCVNHKNIISLLNVF-TPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELT 572
++ Q+ G+ +L+ + IIH DLKP N++ K+ DFGL++ G+ M +T
Sbjct: 124 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFM-MT 176
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612
Y+ P + VD+WS G + +M+
Sbjct: 177 PYVVTRYYRAPEVILGMG----YKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 409 NLLGKGGFSEVYKAYDL-VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467
++GKG F VY + + + + C + LN D ++ + ++E I K H
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEE--VEQFLKEGIIMKDFSHP 56
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIII-VQIFQGLIYLNK 526
+++ L + + VL Y DL +++ P + I +Q+ +G+ YL
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL-- 114
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
++K +H DL N + DE KV DFGL++ + D E S T LP +
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK------EYYSVHNHTGAKLPVKW 168
Query: 587 FELS--KTPLISSKVDVWSAGILFYQML 612
L +T ++K DVWS G+L ++++
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +G+ YL +QK IH DL NVL E V K+ DFGL++ V + + T+ G
Sbjct: 145 QVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN---IDYYKKTTNG 199
Query: 576 A-GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQE--RILRED 631
W P F+ T + DVWS G+L +++ G P+ +E ++L+E
Sbjct: 200 RLPVKWMAPEALFDRVYT----HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE- 254
Query: 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
+++ P+ +NE ++R C + RP L +D
Sbjct: 255 ----GHRMDKPAN--CTNELYMMMRDCWHAIPSHRPTFKQLVED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 49/156 (31%), Positives = 73/156 (46%), Gaps = 20/156 (12%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +G+ YL R + IH DL NVL E V K+ DFGL++ V D + TS G
Sbjct: 142 QVARGMEYLESR--RCIHRDLAARNVLVTEDNVMKIADFGLARGVHD---IDYYKKTSNG 196
Query: 576 -AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQE--RILRED 631
W P F+ T + DVWS GIL +++ G P+ +E ++LRE
Sbjct: 197 RLPVKWMAPEALFDRVYT----HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE- 251
Query: 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+++ PS ++E L+R C +RP
Sbjct: 252 ----GHRMDKPSN--CTHELYMLMRECWHAVPTQRP 281
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 44/161 (27%), Positives = 72/161 (44%), Gaps = 29/161 (18%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD-----VGSQGME 570
Q+ +G+ +L R K IH DL N+L E V K+ DFGL++ + D GS +
Sbjct: 182 QVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERI-- 627
L W P F+ + +++ DVWS G+L +++ G P+ Q E
Sbjct: 240 LK-------WMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ 288
Query: 628 -LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
L++ T ++A + P E ++ C + ERP
Sbjct: 289 RLKDGTRMRAPENATP-------EIYRIMLACWQGDPKERP 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ QG+ +L ++ IH D+ NVL + VAK+ DFGL++ + +D S + +
Sbjct: 220 QVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND--SNYVVKGNAR 275
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W P F+ T + DVWS GIL +++ G+ P+
Sbjct: 276 LPVKWMAPESIFDCVYT----VQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 20/164 (12%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +G+ YL +QK IH DL NVL E V K+ DFGL++ V + + T+ G
Sbjct: 142 QVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN---IDYYKKTTNG 196
Query: 576 A-GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQE--RILRED 631
W P F+ T + DVWS G+L +++ G P+ +E ++L+E
Sbjct: 197 RLPVKWMAPEALFDRVYT----HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE- 251
Query: 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
+++ P+ ++E ++R C ++RP L +D
Sbjct: 252 ----GHRMDKPA--NCTHELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 457 EYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ 516
E +I + + H I++L TF ++ T C +L DL L A + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFT-CLILPRYK-TDLYCYLAAKRNIAICDILAIERS 190
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
+ + + YL++ +IIH D+K N+ + G + DFG + D ++ A
Sbjct: 191 VLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK----YYGWA 244
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM------LFGRRPFGHDQTQERILRE 630
GT PE L++ P VD+WSAGI+ ++M LF + D +R ++
Sbjct: 245 GTIATNAPEL--LARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK- 300
Query: 631 DTIIKARKV---EFPSRPAVSNEAKDLIRRC 658
II+ EFP +N + I
Sbjct: 301 -LIIRRSGTHPNEFPIDAQ-ANLDEIYIGLA 329
|
Length = 391 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 19/221 (8%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI 455
+ F +L RY L +G G V A+D V VA K Q Q++ + A
Sbjct: 15 STFTVLK-RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-----NQTHAKRAY 68
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARI--I 513
RE + K + H +I+ L + F ++ Y + +DA L + R+ +
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
+ Q+ G+ +L+ + IIH DLKP N++ K+ DFGL++ + + +
Sbjct: 129 LYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF------MMT 180
Query: 574 QGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFG 614
T +Y PE VD+WS G + +++ G
Sbjct: 181 PYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 63/243 (25%), Positives = 105/243 (43%), Gaps = 40/243 (16%)
Query: 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
N Y L N++G G F VY+A + VA K + Q+ RE I
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-----------RELLIM 113
Query: 462 KTLVHHHIVRLWDTF------EIDQNTFCT-VLEYCSG---KDLDAVLKATPVLPEREAR 511
K L H +I+ L D + + ++N F V+E+ K + + LP +
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK 173
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQGME 570
+ Q+ + L Y++ + I H DLKP N+L D K+ DFG +K +
Sbjct: 174 LYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL---------- 221
Query: 571 LTSQGAGTY----WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626
L Q + +Y +Y PE L T ++ +D+WS G + +M+ G F + ++
Sbjct: 222 LAGQRSVSYICSRFYRAPELM-LGATNY-TTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279
Query: 627 ILR 629
++R
Sbjct: 280 LVR 282
|
Length = 440 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +G+ YL ++K IH DL NVL E V K+ DFGL++ + + T+
Sbjct: 148 QVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYKKTTNGR 203
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQE--RILREDT 632
W P F+ + + + DVWS G+L +++ G P+ +E ++L+E
Sbjct: 204 LPVKWMAPEALFD----RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-- 257
Query: 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
+++ PS +NE ++R C ++RP L +D
Sbjct: 258 ---GHRMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 9/105 (8%)
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
VQI +G+ YL +R +++H DL NVL K+TDFGL+K++ D E
Sbjct: 116 VQIAKGMNYLEER--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD------EKEYH 167
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQ-MLFGRRPF 618
G + E + + + DVWS G+ ++ M FG +P+
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 43/178 (24%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 492 GKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKV 551
D ++ +P L + Q+ G+ +L ++ +H DL NVL E + K+
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKI 280
Query: 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM 611
DFGL++ + D S + S W P F L ++ DVWS GIL +++
Sbjct: 281 CDFGLARDIMRD--SNYISKGSTFLPLKWMAPESIFN----NLYTTLSDVWSFGILLWEI 334
Query: 612 L-FGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD 668
G P+ E+ + I + ++ P+ S+E +++++C RPD
Sbjct: 335 FTLGGTPYPELPMNEQFY--NAIKRGYRMAKPAH--ASDEIYEIMQKCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD-----VGSQGME 570
Q+ +G+ +L R K IH DL N+L E V K+ DFGL++ + D G +
Sbjct: 181 QVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQE---R 626
L W P F+ + +++ DVWS G+L +++ G P+ Q E R
Sbjct: 239 LK-------WMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287
Query: 627 ILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
L+E T + R E+ + E ++ C N +RP L +
Sbjct: 288 RLKEGT--RMRAPEY-----ATPEIYSIMLDCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 64/308 (20%), Positives = 121/308 (39%), Gaps = 78/308 (25%)
Query: 411 LGKGGFSEVY-----KAYDLVEHRY-----------VACKLHGLNAQWSEDKKQSYIRHA 454
LG+G F EV+ DL ++ VA K+ L +++ + +++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKI--LRPDANKNARNDFLK-- 68
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREAR--- 511
E I L +I+RL +D++ C + EY DL+ L + L ++E
Sbjct: 69 --EVKILSRLKDPNIIRLLGVC-VDEDPLCMITEYMENGDLNQFLSSH-HLDDKEENGND 124
Query: 512 -----------------IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554
+ +QI G+ YL+ + +H DL N L E K+ DF
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 555 GLSKIVEDDVGSQGMELTSQGAGTYW-----------YLPPECFELSKTPLISSKVDVWS 603
G+S+ + AG Y+ ++ EC + K ++ DVW+
Sbjct: 183 GMSRNLY--------------AGDYYRIQGRAVLPIRWMAWECILMGK---FTTASDVWA 225
Query: 604 AGILFYQMLF--GRRPFGHDQTQERILREDTIIKARKVE-FPSRPAVSNEA-KDLIRRCL 659
G+ +++L +P+G ++ I + + + + RP + +L+ +C
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCW 285
Query: 660 TYNQAERP 667
+ + ERP
Sbjct: 286 SRDCRERP 293
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 44/206 (21%), Positives = 93/206 (45%), Gaps = 11/206 (5%)
Query: 192 SSLEEEVTSLHRKVAALEEDLRKSR----QNAVDYQNLCHQLEK---ELKDVKEYEQQMK 244
LEEE+ SL ++ +LE+ L + R + + L +L EL+ ++ ++++
Sbjct: 684 EKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQSRLEELE 743
Query: 245 PRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKDLNA 304
++ +L + E E L+ +E++ + E L++L
Sbjct: 744 EELEELEEELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQE---ELEELEE 800
Query: 305 HLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLASIKREEE 364
L + +A+ER+ +SL++R+ ++ E + E+L + + + L +++E E
Sbjct: 801 ELEEAERRLDALERELESLEQRRERLEQEIE-ELEEEIEELEEKLDELEEELEELEKELE 859
Query: 365 AILRERERYELEKGRLIREMKRIRDE 390
+ E E E EK L E+K + +E
Sbjct: 860 ELKEELEELEAEKEELEDELKELEEE 885
|
Length = 1163 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 68/284 (23%), Positives = 118/284 (41%), Gaps = 52/284 (18%)
Query: 411 LGKGGFSEVYKAYDLV---EH-RYVACK-LHGLNA--QWSEDKKQSYIRHAIREYNIHKT 463
LG+ F ++YK + + +H + VA K L +N QW E ++ E ++
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ---------EASLMAE 63
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-------------------DAVLKATPV 504
L H +IV L +Q C + EY + DL D +K++
Sbjct: 64 LHHPNIVCLLGVVTQEQ-PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS-- 120
Query: 505 LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564
L + I +QI G+ YL+ + +H DL N+L E K++D GLS+ +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSREI---Y 175
Query: 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQT 623
+ + + ++PPE K SS D+WS G++ +++ FG +P+
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232
Query: 624 QERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
QE I +++ R++ P L+ C + RP
Sbjct: 233 QEVI----EMVRKRQL-LPCSEDCPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 19/194 (9%)
Query: 486 VLEYCSGKDLDAVL--KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF 543
+ EYC DL L K L + Q+ +G+ +L ++ IH DL NVL
Sbjct: 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNVLL 174
Query: 544 DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWS 603
+ K+ DFGL++ + +D S + + W P F + + + DVWS
Sbjct: 175 THGKIVKICDFGLARDIMND--SNYVVKGNARLPVKWMAPESIFNC----VYTFESDVWS 228
Query: 604 AGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVEFP-SRPA-VSNEAKDLIRRCLT 660
GIL +++ G P+ + + K K + ++P E D+++ C
Sbjct: 229 YGILLWEIFSLGSNPY------PGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWD 282
Query: 661 YNQAERPDVLTLAQ 674
+ +RP + Q
Sbjct: 283 ADPLKRPTFKQIVQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 21/170 (12%)
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
VQI +G+ YL + +++H DL NVL K+TDFGL+++++ D E
Sbjct: 116 VQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID------ETEYH 167
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQ-MLFGRRPFGHDQTQERILREDTI 633
G + E + + DVWS G+ ++ M FG +P+ D R + D +
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY--DGIPAREI-PDLL 224
Query: 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP-------DVLTLAQDP 676
K ++ P P + + ++ +C + RP + +A+DP
Sbjct: 225 EKGERL--PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 61/242 (25%), Positives = 98/242 (40%), Gaps = 53/242 (21%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT--- 463
L LG+G F +VYK +L G N + S S ++E K
Sbjct: 9 FLEELGEGAFGKVYKG-----------ELTGPNERLS---ATSVAIKTLKENAEPKVQQE 54
Query: 464 ----------LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATP---VLPERE 509
L H +IV L +Q T C + EY + DL L + +P V E
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPT-CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 510 ARI------------IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557
I +QI G+ YL+ + +H DL N L E K++DFGLS
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRR 616
+ D + + S+ ++PPE K +++ D+WS G++ +++ +G +
Sbjct: 172 R---DIYSADYYRVQSKSLLPVRWMPPEAILYGK---FTTESDIWSFGVVLWEIFSYGLQ 225
Query: 617 PF 618
P+
Sbjct: 226 PY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 22/130 (16%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD-----VGSQGME 570
Q+ +G+ +L R K IH DL N+L E V K+ DFGL++ + D G +
Sbjct: 187 QVAKGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQE---R 626
L W P F+ + + + DVWS G+L +++ G P+ + E R
Sbjct: 245 LK-------WMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 293
Query: 627 ILREDTIIKA 636
L+E T ++A
Sbjct: 294 RLKEGTRMRA 303
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 17/152 (11%)
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
+ +G+ YL+++ + IH DL N+L E VAK+ DFGLS+ G + + G
Sbjct: 133 VARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGR 184
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIK 635
++ E S + ++ DVWS G+L ++++ G P+ E + + +
Sbjct: 185 LPVRWMAIESLNYS---VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKLPQ 238
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
++E P +E DL+R+C ERP
Sbjct: 239 GYRLEKPLN--CDDEVYDLMRQCWREKPYERP 268
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 68/289 (23%), Positives = 114/289 (39%), Gaps = 41/289 (14%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEH---RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
+ L +LGKG F V +A E + VA K+ + S D I +RE
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-----IEEFLREAACM 55
Query: 462 KTLVHHHIVRLWDTFEIDQNTF------CTVLEYCSGKDLDAVLKATPV------LPERE 509
K H ++++L + +L + DL L + + LP +
Sbjct: 56 KEFDHPNVIKLIGV-SLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 510 ARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS-KIVEDDVGSQG 568
++ I G+ YL+ + IH DL N + +E V DFGLS KI D QG
Sbjct: 115 LVRFMIDIASGMEYLSSK--NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 569 MELTSQGAGTYWYLPPECFELSKTP--LISSKVDVWSAGILFYQ-MLFGRRPFGHDQTQE 625
S+ LP + L + ++ DVW+ G+ ++ M G+ P+ + E
Sbjct: 173 C--ASK-------LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223
Query: 626 RILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+ +IK +++ P P + +L+ +C + RP L
Sbjct: 224 IY---NYLIKGNRLKQP--PDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 64/277 (23%), Positives = 116/277 (41%), Gaps = 39/277 (14%)
Query: 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH- 467
+++G+G F +V +A + + + L SE+ + + E + L HH
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAG----ELEVLCKLGHHP 63
Query: 468 HIVRLWDTFEIDQNTFCTVLEYCS-GKDLD-----AVLKATP----------VLPEREAR 511
+I+ L E ++ +EY G LD VL+ P L ++
Sbjct: 64 NIINLLGACE-NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMEL 571
+ G+ YL+++ + IH DL NVL E +K+ DFGLS+ G +
Sbjct: 123 QFASDVATGMQYLSEK--QFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYVK 174
Query: 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILRE 630
+ G ++ E S + ++K DVWS G+L ++++ G P+ E
Sbjct: 175 KTMGRLPVRWMAIESLNYS---VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY--- 228
Query: 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ + + ++E P +E +L+R+C ERP
Sbjct: 229 EKLPQGYRMEKPRN--CDDEVYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 70/264 (26%), Positives = 114/264 (43%), Gaps = 26/264 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKK-QSYIRHAIREYNIHK 462
R+ +L+LLG+G F +V +A+D Y A K+ +++ D K + +R+ +
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPAD 189
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
I R F+ + C V+ LD ++K P R II Q L
Sbjct: 190 RFPLMKIQRY---FQNETGHMCIVMPKYGPCLLDWIMKHGP-FSHRHLAQIIFQTGVALD 245
Query: 523 YLNKRAQKIIHYDLKPGNVLFD--EFGVAKVTDFGLS----KIVEDDVGSQGMELTSQGA 576
Y + ++H DLKP N+L + + V VT+ L ++ D+G E S+ A
Sbjct: 246 YFHTELH-LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA 304
Query: 577 --GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFG-HDQTQERILREDTI 633
T Y PE L + S+ D+WS G + Y++ G+ + HD + L E T+
Sbjct: 305 IVSTRHYRSPEVV-LGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361
Query: 634 IKARKVEFPSRPAV---SNEAKDL 654
+ PS A + EA+ L
Sbjct: 362 GR-----LPSEWAGRCGTEEARLL 380
|
Length = 467 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 17/155 (10%)
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
G+ YL+++ + IH DL N+L E VAK+ DFGLS+ G + + G
Sbjct: 124 GMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGRLPV 175
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARK 638
++ E S + ++ DVWS G+L ++++ G P+ E + + + +
Sbjct: 176 RWMAIESLNYS---VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKLPQGYR 229
Query: 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673
+E P +E DL+R+C ERP +
Sbjct: 230 LEKPLN--CDDEVYDLMRQCWREKPYERPSFAQIL 262
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 60/299 (20%), Positives = 112/299 (37%), Gaps = 55/299 (18%)
Query: 411 LGKGGFSEVY--KAYDLVE----------HRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
LG+G F EV+ +A L E + V + L A ++ + +++ E
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK----EI 68
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA------------TPVLP 506
I L + +I+RL + + C + EY DL+ L P +
Sbjct: 69 KIMSRLKNPNIIRLLGVC-VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 507 EREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS 566
+ VQI G+ YL + +H DL N L K+ DFG+S+ +
Sbjct: 128 IANLLYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR---NLYSG 182
Query: 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM--LFGRRPFGHDQTQ 624
+ + ++ E L K ++ DVW+ G+ ++M L +P+
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGK---FTTASDVWAFGVTLWEMFTLCKEQPYS----- 234
Query: 625 ERILREDTII---------KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+L ++ +I + R++ P + L+ RC + + +RP +
Sbjct: 235 --LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 67/290 (23%), Positives = 106/290 (36%), Gaps = 59/290 (20%)
Query: 406 ALLNLLGKGGFSEVYKA---YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L +LG+G F V + D VA K L+ S I + E K
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-----TYSEIEEFLSEAACMK 56
Query: 463 TLVHHHIVRLWD-TFEI-DQNTF---CTVLEYCSGKDLDAVLKATPV------LPEREAR 511
H ++++L FE +L + DL + L + + LP +
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS-KIVEDDVGSQGME 570
+V I G+ YL+ R IH DL N + E V DFGLS KI D QG
Sbjct: 117 KFMVDIALGMEYLSNR--NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG-- 172
Query: 571 LTSQGAGTYWYLPPECFELSKTP------------LISSKVDVWSAGILFYQML-FGRRP 617
++K P + +SK DVW+ G+ +++ G+ P
Sbjct: 173 -----------------RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
Query: 618 FGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ + E D + +++ P +E DL+ C + +RP
Sbjct: 216 YPGVENHEIY---DYLRHGNRLKQP--EDCLDELYDLMYSCWRADPKDRP 260
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 37/215 (17%)
Query: 460 IHKTLVHH---HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ 516
T++ H ++V L + +++ VL++ G L + + +PE + +
Sbjct: 35 ERLTIIPHCVPNMVCLHKYI-VSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAE 93
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
+ L L++ + I+ DL P N+L D+ G ++T F VED + +E
Sbjct: 94 MVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE------ 145
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGR-----RPFGHDQTQERILRED 631
Y PE +S+ + D WS G + +++L G+ P G
Sbjct: 146 --NMYCAPEVGGISE---ETEACDWWSLGAILFELLTGKTLVECHPSG------------ 188
Query: 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
I + P VS EA+ L+++ L +N ER
Sbjct: 189 -INTHTTLNIPE--WVSEEARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 37/217 (17%)
Query: 444 EDKKQSYIRHAIR-EYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL------- 495
+DK + +R + E + L H +IV L +Q + YCS DL
Sbjct: 44 KDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-PLSMIFSYCSHSDLHEFLVMR 102
Query: 496 -----------DAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVL-F 543
D +K+T L + I+ QI G+ +L+ + ++H DL NVL F
Sbjct: 103 SPHSDVGSTDDDKTVKST--LEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVF 158
Query: 544 DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWS 603
D+ V K++D GL + V + +L ++ PE K + S D+WS
Sbjct: 159 DKLNV-KISDLGLFREV---YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS---DIWS 211
Query: 604 AGILFYQML-FGRRPFGHDQTQERILREDTIIKARKV 639
G++ +++ +G +P+ Q+ I +I+ R+V
Sbjct: 212 YGVVLWEVFSYGLQPYCGYSNQDVI----EMIRNRQV 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 9/104 (8%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +G+ +L ++ IH DL N+L + K+ DFGL++ + +D S + +
Sbjct: 222 QVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND--SNYVVKGNAR 277
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W P F T + DVWS GIL +++ G P+
Sbjct: 278 LPVKWMAPESIFNCVYT----FESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +G+ +L ++ +H DL NVL + + K+ DFGL++ + D S + S
Sbjct: 245 QVARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD--SNYVSKGSTF 300
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTII 634
W P F+ L ++ DVWS GIL +++ G P+ ++ + T
Sbjct: 301 LPVKWMAPESIFD----NLYTTLSDVWSYGILLWEIFSLGGTPY------PGMIVDSTFY 350
Query: 635 KARKVEFP-SRPA-VSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
K + ++P + E D++ +C +RP L L+
Sbjct: 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 41/199 (20%), Positives = 92/199 (46%), Gaps = 4/199 (2%)
Query: 194 LEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIISD 253
L ++ L +++ LEE+L + + + Q + EKE++++K ++++ ++ +
Sbjct: 230 LLAKLKELRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELREELEELQEE 289
Query: 254 LLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETK 313
LL + E E + + +E + + + E E +ALK+ LLE
Sbjct: 290 LLELKEEIEELEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEEL 349
Query: 314 EAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYK--SRLASIKREEEAILRERE 371
E + + + K+ +K + ++E +++E+ + + LA I+ E E + RE E
Sbjct: 350 EQLLAELEEAKEELEEKLS--ALLEELEELFEALREELAELEAELAEIRNELEELKREIE 407
Query: 372 RYELEKGRLIREMKRIRDE 390
E RL ++ +++E
Sbjct: 408 SLEERLERLSERLEDLKEE 426
|
Length = 1163 |
| >gnl|CDD|148679 pfam07218, RAP1, Rhoptry-associated protein 1 (RAP-1) | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 36/200 (18%), Positives = 71/200 (35%), Gaps = 1/200 (0%)
Query: 75 SDSDDDIGGEFLIQANTQKRQKVKEDDNSTVFDRVEVVADGRQNTTETLEAKASDVNRKK 134
+ + D G L + K S V ++ + +E KA+ K
Sbjct: 72 NKASKDDGNINLTDTSENGDASKKGHGKSRVRSASAAAILEEDDSKDDMEFKANPNEAGK 131
Query: 135 HGRGRGNSGSGRGRGSRANEQARSQISSSTVSPSNGQLESSHHKDNKPKEQFLIDNCSSL 194
G+ +GN G G S +A ++ S + S S + K +
Sbjct: 132 PGKPKGNQGEGLASSSDGKSKASAKSGSKSASKHGESNSSDESATDSGKASASVAGIVGA 191
Query: 195 EEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIISDL 254
+EE + E+L ++ N ++ +LE+E+ +K ++ + D
Sbjct: 192 DEEAPPAPKNTLTPLEELYETNVNLFALKHPLEKLEEEIDILKNDGDKVAEEEEFEL-DE 250
Query: 255 LISVSKAERQEARLKIRQES 274
++ +++EA KI E
Sbjct: 251 EHEEAEEDKKEALEKIGAEG 270
|
This family consists of several rhoptry-associated protein 1 (RAP-1) sequences which appear to be specific to Plasmodium falciparum. Length = 790 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 40/233 (17%)
Query: 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH-KTLVH 466
L LLG G F V+K + E + + + +Q++ I ++ + +L H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPV-AIKTIQDRSGRQTF--QEITDHMLAMGSLDH 68
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-------VLPEREA----RII-- 513
+IVRL L C G L V + +P V R++ R++
Sbjct: 69 AYIVRL--------------LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW 114
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
VQI +G+ YL + +++H +L N+L + ++ DFG++ ++ D S
Sbjct: 115 CVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD---DKKYFYS 169
Query: 574 QGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQE 625
+ ++ E + + + DVWS G+ ++M+ +G P+ + E
Sbjct: 170 EHKTPIKWMALESILFGR---YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 46/192 (23%), Positives = 75/192 (39%), Gaps = 41/192 (21%)
Query: 499 LKATPV-LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557
L P LP + + I G+ YL+ ++ IH DL N + +E V DFGLS
Sbjct: 102 LGDCPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNVCVADFGLS 159
Query: 558 -KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTP------------LISSKVDVWSA 604
KI D QG ++K P + ++K DVWS
Sbjct: 160 KKIYNGDYYRQG-------------------RIAKMPVKWIAIESLADRVYTTKSDVWSF 200
Query: 605 GILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQ 663
G+ +++ G+ P+ + E D + + +++ P P + L+ C N
Sbjct: 201 GVTMWEIATRGQTPYPGVENSEIY---DYLRQGNRLKQP--PDCLDGLYSLMSSCWLLNP 255
Query: 664 AERPDVLTLAQD 675
+RP TL +
Sbjct: 256 KDRPSFETLRCE 267
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 49/218 (22%), Positives = 79/218 (36%), Gaps = 40/218 (18%)
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIV-QIFQGLI 522
L H H+V+L+ D+N V EY LD L ++ + Q+ L
Sbjct: 58 LSHKHLVKLYGVCVRDENIM--VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALH 115
Query: 523 YLNKRAQKIIH------------YDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
YL + K++H Y L G V F K++D G+ V E
Sbjct: 116 YLEDK--KLVHGNVCGKNILVARYGLNEGYVPF-----IKLSDPGIPITV-----LSREE 163
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILR 629
+ ++ PEC + L + D WS G ++ G P + E+
Sbjct: 164 RVERIP----WIAPECIRNGQASL-TIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
Query: 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
++ P ++N LI +C TY+ +RP
Sbjct: 219 YQD---QHRLPMPDCAELAN----LINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 683 | |||
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.99 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.93 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.7 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.68 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.66 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.59 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.51 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.48 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.47 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.42 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.3 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.22 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.11 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.0 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.0 | |
| PF09726 | 697 | Macoilin: Transmembrane protein; InterPro: IPR0191 | 96.88 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.78 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.63 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.4 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.28 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.27 | |
| PLN02236 | 344 | choline kinase | 96.2 | |
| KOG1003 | 205 | consensus Actin filament-coating protein tropomyos | 95.94 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.9 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.89 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.86 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.5 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.04 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.69 | |
| PRK11637 | 428 | AmiB activator; Provisional | 94.38 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.37 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.91 | |
| PRK11637 | 428 | AmiB activator; Provisional | 93.89 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.83 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-96 Score=770.11 Aligned_cols=477 Identities=50% Similarity=0.850 Sum_probs=441.5
Q ss_pred HHHHHHHH----HHHHHhhhhhhhHHHHHHHHHHHH----HHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhc
Q 005678 203 RKVAALEE----DLRKSRQNAVDYQNLCHQLEKELK----DVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQES 274 (683)
Q Consensus 203 ~k~~~le~----~l~~~~~e~~~~~~~~~~~e~~l~----e~~~~~~~~~~k~~~~~~~~~~~~~~~~r~~~r~~~~~~~ 274 (683)
.|+++||- ||++++.+++++-+.+..+.+|+. -|.++++.+. ||..++|+|||+++++||..+|.+.|+++
T Consensus 229 ~k~~alE~~k~~DlEkkegriddllRancDlRRQIdEqqk~LEkyKerln-kcv~msKkLLIeKs~qEk~a~RdKsmqDr 307 (775)
T KOG1151|consen 229 EKISALENSKNSDLEKKEGRIDDLLRANCDLRRQIDEQQKMLEKYKERLN-KCVTMSKKLLIEKSKQEKMACRDKSMQDR 307 (775)
T ss_pred HHHHHHhhcccchhhhhcchHHHHHHhhhHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHhhhhhHHHHHhhhhhhhhhc
Confidence 38889884 799999999986655555555544 4555555553 67778899999999999999999999999
Q ss_pred hhcceeeEEeecccchhhcccchhHHHHHHHHHHHHHhHHHHHHHHHhhhccCCCCC--------------------CCc
Q 005678 275 VRLGNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKG--------------------DGV 334 (683)
Q Consensus 275 ~rlg~~~~~r~~~~~~e~w~dg~~~~~l~~~~~~~~e~~~~~e~~~k~~~~~~~~~~--------------------~~~ 334 (683)
+|||+|+++|+|++|+|.|+||+||++|.++++++..++++|+++++.++||+|+.. +|.
T Consensus 308 lRlGhFtTvRhGaSFteQWtDG~AFqnl~KqqE~iN~qReeIerqrklLaKRKPp~~gkvqap~~~ne~kqrkskntNGa 387 (775)
T KOG1151|consen 308 LRLGHFTTVRHGASFTEQWTDGYAFQNLIKQQERINSQREEIERQRKLLAKRKPPAMGKVQAPPATNEQKQRKSKNTNGA 387 (775)
T ss_pred ccccceeeeecCccHhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCCCCcCCCCCCccccccccccCCCcc
Confidence 999999999999999999999999999999999999999999999999999987621 111
Q ss_pred cc-------ccccchhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHhhcccCCCCCccccccccceeE
Q 005678 335 DV-------ESGVQEEDLVIQDEIYKSRLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYAL 407 (683)
Q Consensus 335 ~~-------~~~~~~~~~~~~~~~~~~r~~~l~~ee~~~~~~r~~~~~e~~~~~~e~~~~~~~~~~~f~~~~i~~~ry~l 407 (683)
.. -..++..+|.+++++|+.|+..|+++|.++..+.++++..+..+++|++|+..++++.|+++++++++|.+
T Consensus 388 enifrrpeep~~ltlaEYhEqeEIfKLRlgHLkKEEaeiqaElERLErvrnlHiRELKRi~NEdnSQFkDHptLn~RYLl 467 (775)
T KOG1151|consen 388 ENIFRRPEEPETLTLAEYHEQEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLL 467 (775)
T ss_pred cccccCCCCcccccHHHHHhHHHHHHHHHhhhhhhHHHHHHHHHHHHHHHHHHHHHHHhhcccchhhhccCcchHHHHHH
Confidence 11 02366778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEE
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.+||+|||++||+|+|....+|||||+++++..|.++++..|.++++||..|++.|.||.||++|++|.++.+.||.|+
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC---CCCcEEEEecCCccccccCc
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD---EFGVAKVTDFGLSKIVEDDV 564 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd---~~g~vKL~DFGls~~~~~~~ 564 (683)
|||+|.+|+.||+.+..+++.+++.|+.||+.||.||.+..++|||+||||.||||. ..|.+||+||||+++++.+.
T Consensus 548 EYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddS 627 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDS 627 (775)
T ss_pred eecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCc
Confidence 999999999999999999999999999999999999999989999999999999995 47899999999999998764
Q ss_pred C--CCcccccccCCCCCccCCcccccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 565 G--SQGMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 565 ~--~~~~~l~~~~~GT~~Y~APE~~~~~~-~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
. ..+|+++++++||+||+|||||..++ .|.+++++||||+|||||+|++|+.||++...+..|+...+|+++..+.|
T Consensus 628 y~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqF 707 (775)
T KOG1151|consen 628 YNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQF 707 (775)
T ss_pred cCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccC
Confidence 3 46899999999999999999998776 46799999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
|..|.++.++++||++||.|..++|.++.+|+.||||..
T Consensus 708 P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 708 PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 999999999999999999999999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=443.01 Aligned_cols=270 Identities=30% Similarity=0.443 Sum_probs=228.6
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+++.|.+.+.||+|+||.|-+|+++.+|+.||||++.................+.+|++||++|.|||||+++++|. .
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~-~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE-V 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee-c
Confidence 367889999999999999999999999999999999866543221111122344679999999999999999999997 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC---CcEEEEecCC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF---GVAKVTDFGL 556 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~---g~vKL~DFGl 556 (683)
.+..|+||||++||+|.+.+-.++.+.+...+.+++||+.||.|||+.| |+||||||+|||+..+ ..+||+|||+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence 7788999999999999999999999999999999999999999999966 9999999999999865 7899999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
|+..... .++.+.+|||.|.|||++...+...+..++|+||+||+||-||+|.+||........+. ..+..
T Consensus 326 AK~~g~~------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~---eQI~~ 396 (475)
T KOG0615|consen 326 AKVSGEG------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK---EQILK 396 (475)
T ss_pred hhccccc------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH---HHHhc
Confidence 9987533 45667799999999999987776666679999999999999999999997655443222 12233
Q ss_pred hccCC--CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 RKVEF--PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~~~~~--p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+.+.| +.|..++.++.+||.+||..||++|||+.++|+||||+.+
T Consensus 397 G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 397 GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 33333 4567899999999999999999999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=440.85 Aligned_cols=256 Identities=39% Similarity=0.588 Sum_probs=225.6
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
.+|...++||+|||+.||.+.+..+|..||+|++..... .+......+.+||.|++.|+|||||++|++|+ |.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l----~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE-Ds~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL----KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE-DSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh----cCcchHHHHHHHHHHHHhcCCCcEEeeeeEee-cCCc
Confidence 579999999999999999999999999999999865432 23334567889999999999999999999997 8899
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
.|||+|+|+.++|..++++.++++|.+++.++.||+.||.|||+.+ |||||||.+||||+++.++||+|||||..+..
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999999999999999999999999999999999999966 99999999999999999999999999998875
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
+. +...+.+|||.|+|||++...+ ++..+||||+||+||.||+|++||....-.+.+.. +....+.+|
T Consensus 171 ~~-----Erk~TlCGTPNYIAPEVl~k~g---HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~----Ik~~~Y~~P 238 (592)
T KOG0575|consen 171 DG-----ERKKTLCGTPNYIAPEVLNKSG---HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK----IKLNEYSMP 238 (592)
T ss_pred cc-----cccceecCCCcccChhHhccCC---CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH----HHhcCcccc
Confidence 42 1233459999999999998444 89999999999999999999999987666554422 344455555
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
. .+|.++++||.++|..||.+|||+.+++.|+||+
T Consensus 239 ~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 239 S--HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred c--ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 4 7999999999999999999999999999999994
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=419.76 Aligned_cols=264 Identities=28% Similarity=0.456 Sum_probs=224.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+.....+.+..||+|..|+||++.++.++..+|+|++..+.. ....+.+.+|+.|+...+||+||.+|++|..+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~------~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID------PALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC------HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 444567778999999999999999999999999999855432 34457889999999999999999999999744
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
...++|+||||++|+|+.+++..+.+++..+..|+.+|++||.|||.. ++||||||||+|||++..|.+||||||.++.
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 436999999999999999999989999999999999999999999963 4699999999999999999999999999998
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-chHHHHHH-HHHHHHhh
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHD-QTQERILR-EDTIIKAR 637 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~-~~~e~il~-~~~i~~~~ 637 (683)
+.+. +....+||..|||||.+.+.. |+.++||||||+.++||++|+.||... .....++. ...|....
T Consensus 229 lvnS-------~a~tfvGT~~YMsPERi~g~~---Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 229 LVNS-------IANTFVGTSAYMSPERISGES---YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP 298 (364)
T ss_pred hhhh-------hcccccccccccChhhhcCCc---CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence 7654 345569999999999998665 899999999999999999999999774 11112221 12333334
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.+.+|.. .+|+++.+||..||.+||.+|||+.++++|||++..
T Consensus 299 pP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 299 PPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred CCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 4455543 599999999999999999999999999999999853
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=421.95 Aligned_cols=269 Identities=28% Similarity=0.438 Sum_probs=234.6
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+-.+.|.++..||+|+||+||+|..+.||.++|+|++..+ +......+.|++.|-.||....+|+||+||..|+ +
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS----~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ-D 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS----EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ-D 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHH----HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec-C
Confidence 3457799999999999999999999999999999998664 3445566899999999999999999999999997 8
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
..++||||||++|||+..+|...+.|++..++.++.+++.||..||+.| ||||||||+|+|||..|++||+|||||..
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999999999999999999999999999999999999976 99999999999999999999999999964
Q ss_pred cccCc----------------CCCc--------c------------------cccccCCCCCccCCcccccccCCCCCCc
Q 005678 560 VEDDV----------------GSQG--------M------------------ELTSQGAGTYWYLPPECFELSKTPLISS 597 (683)
Q Consensus 560 ~~~~~----------------~~~~--------~------------------~l~~~~~GT~~Y~APE~~~~~~~~~~s~ 597 (683)
+.... .... . .+....+|||.|||||++.+.+ |+.
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg---Y~~ 367 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG---YGK 367 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC---CCc
Confidence 43210 0000 0 0111248999999999998665 899
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCC---CHHHHhc
Q 005678 598 KVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP---DVLTLAQ 674 (683)
Q Consensus 598 ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRP---S~~eLl~ 674 (683)
.+|+|||||||||||.|.+||......+.+-. .+.+...+.||....++.++++||.+||+ ||.+|. .+.+|-.
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rk--I~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRK--IVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999999999999999999888876643 44566678899999999999999999999 999998 5999999
Q ss_pred CcccCCC
Q 005678 675 DPYLTYS 681 (683)
Q Consensus 675 hP~l~~~ 681 (683)
||||+..
T Consensus 445 HPfF~~v 451 (550)
T KOG0605|consen 445 HPFFKGV 451 (550)
T ss_pred CCccccC
Confidence 9999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=407.88 Aligned_cols=259 Identities=32% Similarity=0.491 Sum_probs=223.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
-.+.|.++++||+|+||+||.++...+++.||+|++........ ..+++...|..||..++||.||.++..|+ +.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ-t~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK----KEVRHTKAERNILSKIKHPFIVKLIYSFQ-TE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh----hhHHHHHHHHHHHHhCCCCcEeeeEEecc-cC
Confidence 35689999999999999999999999999999999876544322 34678899999999999999999999997 78
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
..+|+|+||+.||.|..+|.+.+.+++..++.++.+|+.||.|||+.+ ||||||||+|||||..|+++|+|||||+..
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 899999999999999999999999999999999999999999999976 999999999999999999999999999965
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
-... ..+...+||+.|||||++...+ |+..||+|||||++|+||+|.+||........+- .+....
T Consensus 176 ~~~~-----~~t~tfcGT~eYmAPEil~~~g---y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~---~I~~~k--- 241 (357)
T KOG0598|consen 176 LKDG-----DATRTFCGTPEYMAPEILLGKG---YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD---KILKGK--- 241 (357)
T ss_pred ccCC-----CccccccCCccccChHHHhcCC---CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH---HHhcCc---
Confidence 4332 2244569999999999998665 9999999999999999999999998776654332 222222
Q ss_pred CCCCc-CCCHHHHHHHHHhcccCCCCCC----CHHHHhcCcccCC
Q 005678 641 FPSRP-AVSNEAKDLIRRCLTYNQAERP----DVLTLAQDPYLTY 680 (683)
Q Consensus 641 ~p~~~-~~s~el~dLI~rCL~~dP~kRP----S~~eLl~hP~l~~ 680 (683)
.+..+ .++.++++||.++|..+|++|. ++.++-+||||.-
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 22233 4899999999999999999995 7999999999964
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=396.01 Aligned_cols=259 Identities=31% Similarity=0.507 Sum_probs=220.6
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
..|.+...||+|+||+||+|..+.++..||||.+..... .......+..|+.||+.++|||||.|++++. .++.
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-----~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-~~~~ 83 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-----NKKLVELLLSEIKILKELKHPNIVRLLDCIE-DDDF 83 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-----CHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-cCCe
Confidence 468888889999999999999999999999998755422 1233567889999999999999999999987 7789
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC------CcEEEEecCC
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF------GVAKVTDFGL 556 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~------g~vKL~DFGl 556 (683)
+|+|||||.||||.++|...+.+++..++.++.||+.||.+||+.+ ||||||||.||||+.+ -.+||+|||+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999999999989999999999999999999999955 9999999999999864 4699999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
|+.+... .+..+.+|+|.|||||++...+ |+.|+|+||+|+|+|+|++|+.||......+-.. .+.+.
T Consensus 162 AR~L~~~------~~a~tlcGSplYMAPEV~~~~~---YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~---~~~k~ 229 (429)
T KOG0595|consen 162 ARFLQPG------SMAETLCGSPLYMAPEVIMSQQ---YDAKADLWSIGTILYQCLTGKPPFDAETPKELLL---YIKKG 229 (429)
T ss_pred hhhCCch------hHHHHhhCCccccCHHHHHhcc---ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH---HHhcc
Confidence 9998744 3345569999999999998666 9999999999999999999999998877766554 22233
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..+.......+++.+.+++...|..+|.+|.+..+-+.||++...
T Consensus 230 ~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 230 NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 332222234577788899999999999999999999999988643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=381.47 Aligned_cols=255 Identities=32% Similarity=0.490 Sum_probs=226.9
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
-+.|.++..||.|+||.|.+++.+.+|.++|+|++... ...+...+.|..+|..||+.+.||+++.|++.|. +..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~----~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ----KVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-DNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH----HHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-cCC
Confidence 45688999999999999999999999999999998543 3345566889999999999999999999999996 888
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|+||||.+||.|.++|++.+.+++..++.++.+|+.||.|||+.+ |++|||||+|||||.+|.+||+|||+|+.+.
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999999999999999999999999999999999999865 9999999999999999999999999999886
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.. +.+.+|||.|+|||.+...+ |...+|+|||||++|||+.|.+||......... .-+....+.|
T Consensus 196 ~r--------T~TlCGTPeYLAPEii~sk~---ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY----~KI~~~~v~f 260 (355)
T KOG0616|consen 196 GR--------TWTLCGTPEYLAPEIIQSKG---YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY----EKILEGKVKF 260 (355)
T ss_pred Cc--------EEEecCCccccChHHhhcCC---CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH----HHHHhCcccC
Confidence 42 45569999999999997655 889999999999999999999999888774332 2245567778
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTY 680 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~ 680 (683)
| +.++.++++||.++|+.|-.+|. -..+|-.||||.-
T Consensus 261 P--~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 261 P--SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred C--cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 7 46999999999999999999994 4678999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=402.95 Aligned_cols=263 Identities=31% Similarity=0.469 Sum_probs=223.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~ 481 (683)
+.|.+++.||.|+|++||+|.+..+++.||||++..... .++.-++.+.+|-.+|..| .||.|++||..|+ |..
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I----ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ-D~~ 147 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI----IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ-DEE 147 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH----HhhcccchhhHHHHHHHHhhCCCCeEEEEEEee-ccc
Confidence 468889999999999999999999999999999754322 2333356678899999999 8999999999997 888
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|+|+||+++|+|.++|++.+.|++.-++.++.+|+.||.|||+.| ||||||||+|||||.+|++||+|||.|+.+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999999999999999999999999999999999966 9999999999999999999999999999987
Q ss_pred cCcCCC------cc--cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 562 DDVGSQ------GM--ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 562 ~~~~~~------~~--~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
...... .. ......+||..|.+||++.... .++.+|||+||||||+|+.|.+||......-.+..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~---~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk---- 298 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP---AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK---- 298 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCC---CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH----
Confidence 653220 00 0114479999999999997554 78899999999999999999999987665433321
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+....+.|| +.+++.+.+||.++|..||.+|+++.+|-.||||...
T Consensus 299 I~~l~y~fp--~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 299 IQALDYEFP--EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred HHHhcccCC--CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 233344444 6899999999999999999999999999999999754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=381.80 Aligned_cols=262 Identities=24% Similarity=0.450 Sum_probs=219.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|+.+..+|+|+||.||+|+++.||..||||.+.-+. .....-+.++||+.+|++|+|||+|.|+.+|. ....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-----dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-rkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-----DDPVVKKIALREIRMLKQLKHENLVNLIEVFR-RKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-----ccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-hcce
Confidence 46888999999999999999999999999999985432 22334567899999999999999999999997 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++|+|||+..-|+.+-.....++...+..|++|++.|+.|+|+ +++|||||||+||||+.+|.+||||||+|+.+..
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99999999776565555555569999999999999999999998 4599999999999999999999999999998864
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh------
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA------ 636 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~------ 636 (683)
.. ..+...+.|.||.|||.+.+.. .|...+|||++||++.||++|.+.|.+..+.+.++........
T Consensus 154 pg-----d~YTDYVATRWYRaPELLvGDt--qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 154 PG-----DNYTDYVATRWYRAPELLVGDT--QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred Cc-----chhhhhhhhhhccChhhhcccC--cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH
Confidence 21 2344568999999999987643 3899999999999999999999999998888877653322111
Q ss_pred ---------hccCCCCC----------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 637 ---------RKVEFPSR----------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 637 ---------~~~~~p~~----------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
..+.+|.+ |.++.-+.+|+..||..||.+|++.++++.||||.
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 11223322 56778899999999999999999999999999995
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=399.16 Aligned_cols=265 Identities=32% Similarity=0.471 Sum_probs=222.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~ 478 (683)
....+|.+.+.||+|+||.|+.|.+..++..||+|++....... .. ......+.+|+.+++.++ ||||+++++++..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~-~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSS-KS-QKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccc-cc-cccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 45679999999999999999999999999999999875542211 11 123456668999999999 9999999999974
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC-CcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF-GVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~-g~vKL~DFGls 557 (683)
...+++|||||.||+|.+++...+.+++.+++.++.|++.|+.|||+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 92 -~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 92 -PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred -CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 5559999999999999999988889999999999999999999999966 9999999999999998 99999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
...... .......+||+.|+|||++..... .-..++||||+||+||.|++|..||........... +...
T Consensus 169 ~~~~~~-----~~~l~t~cGsp~Y~aPEvl~~~~~-Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----i~~~ 238 (370)
T KOG0583|consen 169 AISPGE-----DGLLKTFCGSPAYAAPEVLSGKGT-YSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----IRKG 238 (370)
T ss_pred cccCCC-----CCcccCCCCCcccCCHHHhCCCCC-cCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH----HhcC
Confidence 987411 134556699999999999975442 124789999999999999999999988554433322 4555
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.+.+|.+-. |.++.+||.+||..||.+|+++.+++.||||+.
T Consensus 239 ~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 239 EFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 566665422 999999999999999999999999999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=387.57 Aligned_cols=273 Identities=24% Similarity=0.382 Sum_probs=232.3
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
..|++....|.+...||.|..++||+|+...++.+||||++.+. +....+..+.+|+..++.++||||+.++.+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE------kc~~~ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE------KCNNDLDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh------hhhhhHHHHHHHHHHhhhcCCCCcceEEEE
Confidence 56788889999999999999999999999999999999998664 334457889999999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
|. .+..+++||.||.+|++.++++.. ..+.+..+..|+++++.||.|||..| .||||||+.||||+.+|.|||+|
T Consensus 93 Fv-v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLad 169 (516)
T KOG0582|consen 93 FV-VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLAD 169 (516)
T ss_pred EE-ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcC
Confidence 96 678899999999999999999654 34899999999999999999999966 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||.+-.+..........+ ...+|||+|||||++.....+ |+.|+||||||++.+||.+|..||....+...++..
T Consensus 170 Fgvsa~l~~~G~R~~~rf-~tfvgtp~wmAPEvl~q~~~G-YdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--- 244 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRF-NTFVGTPCWMAPEVLMQQLHG-YDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--- 244 (516)
T ss_pred ceeeeeecccCceeeEee-ccccCcccccChHHhhhcccC-ccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH---
Confidence 999887776543333333 677999999999996544433 999999999999999999999999988887766531
Q ss_pred HHhhcc-------CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 634 IKARKV-------EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 634 ~~~~~~-------~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
++...+ .......++..++.+|..||.+||.+|||+.++++|+||+.+|
T Consensus 245 Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 245 LQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred hcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 112111 1111245677899999999999999999999999999999886
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=386.08 Aligned_cols=262 Identities=29% Similarity=0.473 Sum_probs=212.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc-
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN- 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~- 481 (683)
.+|...+.||+|+||.||++.+..+|..+|||.......+. ...+.+|+.+|++++|||||++++......+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~ 89 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-------SESLEREIRILSRLNHPNIVQYYGSSSSREND 89 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-------HHHHHHHHHHHHhCCCCCEEeeCCccccccCe
Confidence 45788999999999999999999999999999876542211 4568899999999999999999997543444
Q ss_pred eEEEEEecccCCChhHHHhcCC-CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEEEecCCccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKVTDFGLSKI 559 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~-~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL~DFGls~~ 559 (683)
.++|+|||+++|+|.+++...+ .|++..++.+..||+.||.|||+++ ||||||||+|||++. +|.+||+|||+++.
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccc
Confidence 7999999999999999998776 7999999999999999999999865 999999999999999 79999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-chHHHHHHHHHHHHhhc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHD-QTQERILREDTIIKARK 638 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~-~~~e~il~~~~i~~~~~ 638 (683)
..... ..........||+.|||||++..+. ....++|||||||++.||+||.+||... .....++... ...
T Consensus 168 ~~~~~--~~~~~~~~~~Gtp~~maPEvi~~g~--~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig----~~~ 239 (313)
T KOG0198|consen 168 LESKG--TKSDSELSVQGTPNYMAPEVIRNGE--VARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG----RED 239 (313)
T ss_pred ccccc--ccccccccccCCccccCchhhcCCC--cCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh----ccC
Confidence 76311 1111233458999999999997522 1235899999999999999999999763 3333332211 111
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
...+.+..+|.++++||.+|+..+|..|||+.++|.|||++..
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1112334699999999999999999999999999999999764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=376.65 Aligned_cols=248 Identities=28% Similarity=0.527 Sum_probs=206.9
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc-ccccCCc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD-TFEIDQN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~-~f~~d~~ 481 (683)
..|.+++.||+|+||+||++.+..+|..||.|-++.... ..........|+.+|++|+|||||++|+ .|..+..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-----d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-----DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-----cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 458899999999999999999999999999998763322 1222457789999999999999999998 5654555
Q ss_pred eEEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhcCCc--eEecccCCcceEeCCCCcEEEEecC
Q 005678 482 TFCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRAQK--IIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~--IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
.++||||||.+|+|..+++ ....+++..++.++.|++.||..+|..-+. |+||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 5999999999999999994 446799999999999999999999984333 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+++.+.... ..+...+|||.||+||.+...+ |+.++||||+||++|||+.-++||....-.+ ...-+.
T Consensus 174 L~r~l~s~~-----tfA~S~VGTPyYMSPE~i~~~~---Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~----L~~KI~ 241 (375)
T KOG0591|consen 174 LGRFLSSKT-----TFAHSLVGTPYYMSPERIHESG---YNFKSDIWSLGCLLYEMCALQSPFYGDNLLS----LCKKIE 241 (375)
T ss_pred hHhHhcchh-----HHHHhhcCCCcccCHHHHhcCC---CCcchhHHHHHHHHHHHHhcCCCcccccHHH----HHHHHH
Confidence 999987543 3455669999999999997666 9999999999999999999999998774322 112222
Q ss_pred hhccCCCCC--cCCCHHHHHHHHHhcccCCCCCCCH
Q 005678 636 ARKVEFPSR--PAVSNEAKDLIRRCLTYNQAERPDV 669 (683)
Q Consensus 636 ~~~~~~p~~--~~~s~el~dLI~rCL~~dP~kRPS~ 669 (683)
.. .+|.. ...|.++..+|..|+..||..||+.
T Consensus 242 qg--d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 242 QG--DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred cC--CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 22 34422 3678999999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=392.47 Aligned_cols=265 Identities=29% Similarity=0.455 Sum_probs=224.0
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~ 478 (683)
++-++|.+++.||.|.||.||+|....+|..||||.++.....-++ -.-+||+..|++|+ |||||+|++++..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee------~~nLREvksL~kln~hpniikL~Evi~d 80 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE------CMNLREVKSLRKLNPHPNIIKLKEVIRD 80 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH------HHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence 4567999999999999999999999999999999987554332111 13478999999999 9999999999974
Q ss_pred CCceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
....+++|||||+ .+|..+++ +...|++..++.|+.||+.||+|+|.+| ++||||||+|||+.....+||+|||+|
T Consensus 81 ~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 81 NDRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred cCceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccc
Confidence 4449999999995 58999995 4578999999999999999999999966 999999999999998899999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH--
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK-- 635 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~-- 635 (683)
+-+... ......+.|.||.|||++.... .|+.++|||++|||++|+.+-++.|.+....+.++..-.++.
T Consensus 158 Rev~Sk------pPYTeYVSTRWYRAPEvLLrs~--~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP 229 (538)
T KOG0661|consen 158 REVRSK------PPYTEYVSTRWYRAPEVLLRSG--YYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP 229 (538)
T ss_pred cccccC------CCcchhhhcccccchHHhhhcc--ccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence 987643 3455668999999999987543 599999999999999999999999999998888876443322
Q ss_pred -------------hhccCCCCC---------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 636 -------------ARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 636 -------------~~~~~~p~~---------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.-.+.||.. +.++.++.++|.+||.+||.+|||+.++++||||+..
T Consensus 230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 122334432 4578999999999999999999999999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=395.18 Aligned_cols=258 Identities=28% Similarity=0.485 Sum_probs=228.3
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
..|.....||+|+.|.||.|....++..||||.+.+..+... +-++.|+.+|+...|+|||.+++.|.. ++.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k-------eLilnEi~Vm~~~~H~NiVnfl~Sylv-~de 344 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK-------ELLLNEILVMRDLHHPNIVNFLDSYLV-GDE 344 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch-------hhhHHHHHHHHhccchHHHHHHHHhcc-cce
Confidence 467778899999999999999999999999999877655433 367899999999999999999999974 578
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++|||||+||+|.+++.... +++.++..|+++++.||+|||..+ |||||||.+|||++.+|.+||+|||+|..+..
T Consensus 345 LWVVMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eEEEEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 999999999999999998765 999999999999999999999966 99999999999999999999999999988765
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
... .....+|||+|||||++.... |.+++||||||++++||+-|.+||-.......++ .|...+...+.
T Consensus 422 ~~~-----KR~TmVGTPYWMAPEVvtrk~---YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly---LIa~ng~P~lk 490 (550)
T KOG0578|consen 422 EQS-----KRSTMVGTPYWMAPEVVTRKP---YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNGTPKLK 490 (550)
T ss_pred ccC-----ccccccCCCCccchhhhhhcc---cCccccchhhhhHHHHHhcCCCCccCCChHHHHH---HHhhcCCCCcC
Confidence 532 234459999999999987554 8999999999999999999999998766655443 45667777888
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.+..+|..+++|+.+||..|+.+|+++.+||+||||+.++
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 8889999999999999999999999999999999998875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=386.73 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=210.4
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeE-EEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRY-VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~-VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
+.+......+...||.|+||+||+|. ..|.. ||||++......... ...|.+|+.+|.+++|||||+++|++
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~~~~-----~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFDDES-----RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcChHH-----HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34444555666779999999999995 56666 999998654332222 67899999999999999999999999
Q ss_pred ccCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-cEEEEe
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTD 553 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-~vKL~D 553 (683)
......++|||||+++|+|..++.. ...+++..+..++.+|+.||.|||+.++ ||||||||.|||++.++ ++||+|
T Consensus 109 ~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 109 TSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred cCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECC
Confidence 7444379999999999999999966 6789999999999999999999999654 99999999999999998 999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||+++...... . . .....||+.|||||++... ...|+.|+|||||||++|||+||..||........+.. ..
T Consensus 188 FGlsr~~~~~~--~--~-~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~--v~ 259 (362)
T KOG0192|consen 188 FGLSREKVISK--T--S-MTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA--VV 259 (362)
T ss_pred Cccceeecccc--c--c-ccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH--HH
Confidence 99998765431 1 1 1124899999999999854 33499999999999999999999999988777333321 22
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+.+| ..+++.+..||.+||..||..||++.+++.
T Consensus 260 ~~~~Rp~~p--~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 260 VGGLRPPIP--KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred hcCCCCCCC--ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 233333333 349999999999999999999999998863
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=366.76 Aligned_cols=261 Identities=22% Similarity=0.392 Sum_probs=210.7
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||+|+||.||+|.+..++..||||++....... .....+.+|+.+++.++||||++++++|. ..+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-----EVKETTLRELKMLRTLKQENIVELKEAFR-RRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-----cchhhHHHHHHHHHhCCCccccchhhhEe-cCCE
Confidence 47999999999999999999999999999999986543221 22456778999999999999999999996 6678
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||+++++|..+......+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9999999998888776665667999999999999999999999865 99999999999999999999999999987643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh------
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA------ 636 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~------ 636 (683)
.... ......||+.|+|||++.... ++.++|||||||++|+|++|++||......+.......+...
T Consensus 153 ~~~~----~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 153 GSNA----NYTEYVATRWYRSPELLLGAP---YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred cccc----cccccccccccCCcHHHcCCC---CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 2211 122347899999999986443 788999999999999999999999876554433221111100
Q ss_pred ---------hccCCCC-----------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 637 ---------RKVEFPS-----------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 637 ---------~~~~~p~-----------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
....++. ...+|.++.+||.+||.+||.+|||+.++++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0111111 12378889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=371.48 Aligned_cols=254 Identities=30% Similarity=0.437 Sum_probs=213.6
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||+|+||.||+|.+..+++.||||++.... .........+.+|+.+++.++||||+++++++. +.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE----VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH----HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-cCCe
Confidence 36889999999999999999999999999999875421 111223456889999999999999999999886 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999999999988888999999999999999999999965 99999999999999999999999999986643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
. .....||+.|+|||++.... ++.++|||||||++|+|++|..||.......... . +......+|
T Consensus 154 ~--------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~---~-i~~~~~~~~ 218 (291)
T cd05612 154 R--------TWTLCGTPEYLAPEVIQSKG---HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE---K-ILAGKLEFP 218 (291)
T ss_pred C--------cccccCChhhcCHHHHcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---H-HHhCCcCCC
Confidence 2 11236999999999986443 7899999999999999999999998765433221 1 122233333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~ 680 (683)
..++..+.+||.+||..||.+||+ +.+++.||||+.
T Consensus 219 --~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 219 --RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 457899999999999999999995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=385.47 Aligned_cols=273 Identities=29% Similarity=0.474 Sum_probs=223.9
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccch-------hhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE-------DKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~-------~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
-++|.++..||+|.||.|-+|++..+++.||||++........ .....-++...+|+.||+++.|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 3579999999999999999999999999999999865422111 011122457889999999999999999999
Q ss_pred cccc-CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 475 TFEI-DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 475 ~f~~-d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
+... ..+.+|||+|||..|.+...=.....+++.+++.|+.+++.||.|||..+ ||||||||+|+||+++|++||+|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcEEeec
Confidence 8752 35679999999988877655433334999999999999999999999855 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~-~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
||.+..................+|||.|+|||++..+. ....+.+.||||+||+||.|++|..||-.....+.. .
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~----~ 329 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF----D 329 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH----H
Confidence 99998775443222222333469999999999987654 233467889999999999999999999766554432 3
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
-+....+.||..+.+..++++||.+||++||..|.++.++..|||...
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 356778899999999999999999999999999999999999999864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=383.77 Aligned_cols=265 Identities=28% Similarity=0.444 Sum_probs=217.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+++.||+|+||+||+|.+..+++.||||++..... ........+.+|+.++..++||||++++++|. +.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM----LEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-DENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-cCCe
Confidence 368999999999999999999999999999999854211 12234567888999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.++|+|||++..+..
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999999999988888999999999999999999999965 99999999999999999999999999976532
Q ss_pred CcCCCcc---------------------------------cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHH
Q 005678 563 DVGSQGM---------------------------------ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFY 609 (683)
Q Consensus 563 ~~~~~~~---------------------------------~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILy 609 (683)
....... ......+||+.|+|||++.... ++.++|||||||++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ 230 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG---YNKECDWWSLGVIMY 230 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC---CCCeeeeecchhHHH
Confidence 2110000 0111246999999999986443 889999999999999
Q ss_pred HHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccCC
Q 005678 610 QMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD---VLTLAQDPYLTY 680 (683)
Q Consensus 610 ELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS---~~eLl~hP~l~~ 680 (683)
+|++|..||......+.... .+.....+.+|....+++++.+||.+||. +|.+|++ +.+++.||||..
T Consensus 231 el~~G~~Pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 231 EMLVGYPPFCSDNPQETYRK--IINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred HhhcCCCCCCCCCHHHHHHH--HHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99999999987765543321 11122334555555789999999999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=381.27 Aligned_cols=267 Identities=25% Similarity=0.415 Sum_probs=215.0
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+++.||+|+||+||+|.+..++..||||++.... .........+.+|+.++..++||||++++++|. +...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD----MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-DKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH----HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCe
Confidence 36889999999999999999999999999999985421 112233567888999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+++.+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999999999988888999999999999999999999865 99999999999999999999999999976532
Q ss_pred CcCCC------------------------------cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 563 DVGSQ------------------------------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 563 ~~~~~------------------------------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
..... ........+||+.|+|||++.... ++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~~~~~DvwSlGvil~ell 230 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG---YNKLCDWWSLGVIMYEML 230 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC---CCCchhhhhhHHHHHHHH
Confidence 11000 000112347999999999986543 889999999999999999
Q ss_pred cCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcc--cCCCCCCCHHHHhcCcccCCC
Q 005678 613 FGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLT--YNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 613 tG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~--~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+|..||......+.+.. .......+.+|....+++++++||.+++. .++..||++.++++||||+..
T Consensus 231 ~G~~Pf~~~~~~~~~~~--i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 231 IGYPPFCSETPQETYKK--VMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred hCCCCCCCCCHHHHHHH--HHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 99999987665443321 11112334566656789999999999765 233456899999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=378.34 Aligned_cols=255 Identities=30% Similarity=0.444 Sum_probs=215.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+.+.||+|+||.||+|.+..++..||||++.... .........+.+|+.+++.++||||++++++|. +.+.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE----ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-DENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH----HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-cCCE
Confidence 57999999999999999999999999999999875421 112233567889999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999999999988888999999999999999999999965 99999999999999999999999999986643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.. ....||+.|+|||++.... ++.++|||||||++|+|++|..||.......... .+....+.+|
T Consensus 171 ~~--------~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~i~~~~~~~p 235 (329)
T PTZ00263 171 RT--------FTLCGTPEYLAPEVIQSKG---HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE----KILAGRLKFP 235 (329)
T ss_pred Cc--------ceecCChhhcCHHHHcCCC---CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH----HHhcCCcCCC
Confidence 21 1237999999999986544 7889999999999999999999997665433221 1222333333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~~ 681 (683)
..++..+.+||.+||..||.+||+ +.+++.||||...
T Consensus 236 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 236 --NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred --CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 458899999999999999999996 7999999999763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=367.44 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=210.0
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
|.+.+.||+|+||.||+|.+..++..||||.+..... ........+.+|+.++..++||||++++++|. +.+.+|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI----KKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-TKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh----hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-cCCeEE
Confidence 7889999999999999999999999999998754321 11122345778999999999999999999986 667899
Q ss_pred EEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 485 TVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|||||++|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999999999988743 346899999999999999999999965 99999999999999999999999999987543
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.. ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.................. ....
T Consensus 155 ~~------~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~ 223 (285)
T cd05631 155 GE------TVRGRVGTVGYMAPEVINNEK---YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEE 223 (285)
T ss_pred CC------eecCCCCCCCccCHhhhcCCC---CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--cccc
Confidence 21 122347999999999986443 889999999999999999999999765442221111111111 1222
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~~ 681 (683)
....++.++.+||.+||..||.+||+ +.++++||||...
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 33468999999999999999999997 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=375.98 Aligned_cols=267 Identities=30% Similarity=0.450 Sum_probs=228.7
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
--+.|++++.||.|.-|+||++....++.++|+|++....... ..-+.++..|-.||+.++||.++.||..|+ ..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~----rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-t~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS----RKKLKRAQTEREILSLLDHPFLPTLYASFE-TD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh----hhHHHHHHHHHHHHHhcCCCccchhhheee-cc
Confidence 3457888999999999999999999999999999986543322 334677888999999999999999999997 67
Q ss_pred ceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+..|+|||||+||+|+.++++. +.+++..++.++.+|+.||.|||..| ||+|||||+||||.++|++.|+||.|+.
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccc
Confidence 8999999999999999999644 67999999999999999999999976 9999999999999999999999999985
Q ss_pred ccccCc-------------------------------C-CC-------------------cccccccCCCCCccCCcccc
Q 005678 559 IVEDDV-------------------------------G-SQ-------------------GMELTSQGAGTYWYLPPECF 587 (683)
Q Consensus 559 ~~~~~~-------------------------------~-~~-------------------~~~l~~~~~GT~~Y~APE~~ 587 (683)
...... . .. .-......+||-.|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 432100 0 00 00112234799999999999
Q ss_pred cccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCC
Q 005678 588 ELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667 (683)
Q Consensus 588 ~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRP 667 (683)
.+.+ .+..||+|+|||++||||+|..||.+....+.+.. +....+.||..+.++..+++||+++|.+||.+|.
T Consensus 308 ~G~G---HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N----Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 308 RGEG---HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN----IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred ecCC---CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH----HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 8766 78999999999999999999999999888777654 4567789999999999999999999999999999
Q ss_pred C----HHHHhcCcccCCC
Q 005678 668 D----VLTLAQDPYLTYS 681 (683)
Q Consensus 668 S----~~eLl~hP~l~~~ 681 (683)
. +.+|-+||||...
T Consensus 381 g~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 381 GSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred ccccchHHhhcCccccCC
Confidence 8 9999999999854
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=382.99 Aligned_cols=265 Identities=27% Similarity=0.409 Sum_probs=215.2
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|.+++.||+|+||+||+|.+..++..||||++..... ........+.+|+.++..++|||||+++++|. +.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~----~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV----LNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh----hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-cCCEE
Confidence 58899999999999999999999999999999854321 12234567899999999999999999999996 67889
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
|+|||||+||+|.+++.....+++..++.++.||+.||.|||..+ |+||||||+|||++.+|.+||+|||++..+...
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999999999988888999999999999999999999865 999999999999999999999999998643211
Q ss_pred cCCC------------------------------------------cccccccCCCCCccCCcccccccCCCCCCchhHH
Q 005678 564 VGSQ------------------------------------------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDV 601 (683)
Q Consensus 564 ~~~~------------------------------------------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDV 601 (683)
.... ........+||+.|+|||++.... ++.++||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~Di 231 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG---YTQLCDW 231 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC---CCCccce
Confidence 0000 000112347999999999986443 7899999
Q ss_pred HHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhc--ccCCCCCCCHHHHhcCcccC
Q 005678 602 WSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCL--TYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 602 WSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL--~~dP~kRPS~~eLl~hP~l~ 679 (683)
|||||++|+|++|..||......+.... .+.....+.+|....+++++.+||.+|| ..+|..||++.+++.||||+
T Consensus 232 wSlG~il~elltG~~Pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~ 309 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAPTPTETQLK--VINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309 (381)
T ss_pred eehhhHHHHHHhCCCCCcCCCHHHHHHH--HHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence 9999999999999999987665443321 1222334556665678999999999955 45566699999999999997
Q ss_pred C
Q 005678 680 Y 680 (683)
Q Consensus 680 ~ 680 (683)
.
T Consensus 310 ~ 310 (381)
T cd05626 310 E 310 (381)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=388.29 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=219.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||+|+||.||+|+.+.+...||||.+.+..... ..++.+.+|++|++.++|||||.+++.|+ ...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-----k~l~~l~~ev~i~r~lkHpniv~m~esfE-t~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-----KELKNLRQEVRILRSLKHPNIVEMLESFE-TSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-----HHHHHHHHHHHHHHhcCCcchhhHHHhhc-ccce
Confidence 46888899999999999999999999999999886544322 23678999999999999999999999998 6778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++|+|||.| +|..+|...+.+++..++.|+.+++.||.|||+.+ |+|||+||.|||++.+|.+|+||||+++.+..
T Consensus 76 ~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred EEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9999999966 99999999999999999999999999999999955 99999999999999999999999999998754
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
. . .+.....|||.|||||.+.... |+..+|+||||||+|||+.|++||....- ...-..+....+.+|
T Consensus 153 ~----t-~vltsikGtPlYmAPElv~e~p---yd~~sDlWslGcilYE~~~G~PPF~a~si----~~Lv~~I~~d~v~~p 220 (808)
T KOG0597|consen 153 N----T-SVLTSIKGTPLYMAPELVEEQP---YDHTSDLWSLGCILYELYVGQPPFYARSI----TQLVKSILKDPVKPP 220 (808)
T ss_pred C----c-eeeeeccCcccccCHHHHcCCC---ccchhhHHHHHHHHHHHhcCCCCchHHHH----HHHHHHHhcCCCCCc
Confidence 2 2 2234458999999999987444 99999999999999999999999965432 222233444445555
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+..+..+..|+..+|.+||..|.+..+++.|||+..
T Consensus 221 --~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 221 --STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred --ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 378999999999999999999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=375.73 Aligned_cols=252 Identities=29% Similarity=0.451 Sum_probs=209.6
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEe
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLE 488 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~E 488 (683)
+.||+|+||.||+|.+..+|+.||||++..... ........+.+|+.++..++||||++++++|. +.+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI----IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-THDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-cCCEEEEEEe
Confidence 369999999999999999999999999854321 11233567789999999999999999999886 6778999999
Q ss_pred cccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCc
Q 005678 489 YCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568 (683)
Q Consensus 489 y~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~ 568 (683)
|+++++|..++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---- 149 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---- 149 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----
Confidence 9999999999988888999999999999999999999965 9999999999999999999999999987532211
Q ss_pred ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCC
Q 005678 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648 (683)
Q Consensus 569 ~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s 648 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||......... . .+....+.+| ..++
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~---~~~~~~~~~p--~~~~ 219 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDND---YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-E---LILMEEIRFP--RTLS 219 (323)
T ss_pred -CcccceecCccccChhhhcCCC---CCccccCcccchhhhhhhcCCCCCCCCCHHHHH-H---HHHcCCCCCC--CCCC
Confidence 1122347999999999986443 789999999999999999999999765443222 1 1222333443 4689
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 649 NEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 649 ~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
.++.+||.+||..||.+|| ++.++++||||...
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=375.17 Aligned_cols=258 Identities=28% Similarity=0.417 Sum_probs=215.7
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||.||+|.+..++..||||++..... ........+..|+.++..++||||++++++|. +.+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL----FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH----hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-cCCE
Confidence 368999999999999999999999999999999854321 12233567889999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||++|++|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999999999988888999999999999999999999965 99999999999999999999999999976543
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
......||+.|+|||++... .++.++|||||||++|+|++|..||......+...... .....+..|
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~ 220 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGK---GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK--YWKETLQRP 220 (333)
T ss_pred --------ccCCcccCccccChhHhcCC---CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH--hccccccCC
Confidence 12334799999999998654 38899999999999999999999998766544332211 111112222
Q ss_pred CC----cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 643 SR----PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~----~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.. ..++.++.+||.+||..+|.+||++.++++||||..
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 22 257899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=392.85 Aligned_cols=256 Identities=31% Similarity=0.465 Sum_probs=219.9
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
-|.+++.||+|+.|.|-+|.+..||+.+|||++......+ ......+-+|+.||+-+.|||+++||++|+ +...+
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s----~s~~~~IerEIviMkLi~HpnVl~LydVwe-~~~~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS----SSQPAGIEREIVIMKLIEHPNVLRLYDVWE-NKQHL 87 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccc----cccccchhhhhHHHHHhcCCCeeeeeeeec-cCceE
Confidence 4889999999999999999999999999999986543222 223456788999999999999999999997 78899
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
|+|+||++||.|.+++-..+++++.++..++.||+.|+.|+|... |+||||||.|+|||..+++||+|||+|..-..+
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999999999999999999999999999999999865 999999999999999889999999999765433
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~ 643 (683)
.+..+.+|+|.|.+||++.+.++ -..++||||+|||||.||+|+.||++..-.. ++. -++.+.+..|
T Consensus 166 ------klLeTSCGSPHYA~PEIV~G~pY--dG~~sDVWSCGVILfALLtG~LPFdDdNir~-LLl---KV~~G~f~MP- 232 (786)
T KOG0588|consen 166 ------KLLETSCGSPHYAAPEIVSGRPY--DGRPSDVWSCGVILFALLTGKLPFDDDNIRV-LLL---KVQRGVFEMP- 232 (786)
T ss_pred ------ccccccCCCcccCCchhhcCCCC--CCCccccchhHHHHHHHHhCCCCCCCccHHH-HHH---HHHcCcccCC-
Confidence 23445599999999999986553 4678999999999999999999998554433 322 1334445555
Q ss_pred CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 644 ~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..+|.++++||++||..||.+|++..+|++|||++.
T Consensus 233 -s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 233 -SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred -CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 689999999999999999999999999999999974
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=370.45 Aligned_cols=267 Identities=25% Similarity=0.385 Sum_probs=208.9
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC---
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ--- 480 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~--- 480 (683)
+|.+.+.||+|+||.||+|.+..++..||||.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-----chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC
Confidence 589999999999999999999999999999987532211 112346789999999999999999999874322
Q ss_pred -ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 481 -NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 481 -~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
..+|+||||| +++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.
T Consensus 76 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 76 FKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred CceEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 3589999999 5699999988878999999999999999999999965 99999999999999999999999999986
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH--------
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED-------- 631 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~-------- 631 (683)
........ .......||+.|+|||++.... ..++.++|||||||++|+|++|++||.............
T Consensus 153 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 153 AFNDTPTA--IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred cccccCcc--ccccCCCCCCCcCCHHHHhccc-cccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 54322111 1223457999999999875421 247889999999999999999999997654332111000
Q ss_pred ------------HHHH----hhccCC-CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 632 ------------TIIK----ARKVEF-PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 632 ------------~i~~----~~~~~~-p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.... .....+ ...+.+++.+.+||.+||..+|.+||++.++++||||+..
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0000 000000 0124578889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=370.49 Aligned_cols=262 Identities=25% Similarity=0.422 Sum_probs=213.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+..++|.+++.||+|+||.||++.+..++..||+|++..... ......+.+|+.+++.++||||++++++|. +
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK------PAIRNQIIRELQVLHECNSPYIVGFYGAFY-S 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-E
Confidence 345789999999999999999999999999999999865321 123457889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+++||||+++++|.+++.....+++..+..++.|++.||.|||+. .+|+|+||||+|||++.++.+||+|||++..
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 678999999999999999998877899999999999999999999974 2599999999999999999999999999976
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH--------
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED-------- 631 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~-------- 631 (683)
..... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||......+......
T Consensus 154 ~~~~~-------~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (331)
T cd06649 154 LIDSM-------ANSFVGTRSYMSPERLQGTH---YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEE 223 (331)
T ss_pred ccccc-------cccCCCCcCcCCHhHhcCCC---CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccccc
Confidence 54321 22347999999999986443 8899999999999999999999997554332110000
Q ss_pred -----------------------------------HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 632 -----------------------------------TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 632 -----------------------------------~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
.+........+ ...++.++.+||.+||.+||++|||+.+|++||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 224 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC-CccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000111 124788999999999999999999999999999
Q ss_pred ccCC
Q 005678 677 YLTY 680 (683)
Q Consensus 677 ~l~~ 680 (683)
||+.
T Consensus 303 ~~~~ 306 (331)
T cd06649 303 FIKR 306 (331)
T ss_pred HHhh
Confidence 9974
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=381.85 Aligned_cols=264 Identities=27% Similarity=0.410 Sum_probs=215.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+++.||+|+||+||+|.+..++..||||++... ..........+.+|+.+++.++|||||+++++|. +.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~----~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK----DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH----HhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-eCCEE
Confidence 588999999999999999999999999999987532 1122344667889999999999999999999996 67889
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
|+|||||++|+|..++...+.+++..++.++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||++..+...
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999999999988778999999999999999999999965 999999999999999999999999998543210
Q ss_pred cCCC------------------------------------------cccccccCCCCCccCCcccccccCCCCCCchhHH
Q 005678 564 VGSQ------------------------------------------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDV 601 (683)
Q Consensus 564 ~~~~------------------------------------------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDV 601 (683)
.... ........+||+.|+|||++.... ++.++||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~Di 231 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG---YTQLCDW 231 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC---CCCeeeE
Confidence 0000 000112347999999999986444 8899999
Q ss_pred HHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccc
Q 005678 602 WSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD---VLTLAQDPYL 678 (683)
Q Consensus 602 WSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS---~~eLl~hP~l 678 (683)
|||||++|+|++|.+||......+.... .+.......+|....+++++.+||.+|+ .+|.+|++ +.++++||||
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~~~~--i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f 308 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLAQTPLETQMK--VINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFF 308 (382)
T ss_pred EechHHHHHHHhCCCCCCCCCHHHHHHH--HHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCc
Confidence 9999999999999999987665443322 1122234455666678999999999986 59999997 9999999999
Q ss_pred CC
Q 005678 679 TY 680 (683)
Q Consensus 679 ~~ 680 (683)
..
T Consensus 309 ~~ 310 (382)
T cd05625 309 KT 310 (382)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=383.05 Aligned_cols=266 Identities=26% Similarity=0.445 Sum_probs=220.0
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID- 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d- 479 (683)
-.+.|..++.||+|.||.||+|++..+|+.||+|.+..... +........|||.||++|+||||++|.+.....
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-----~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-----KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-----CCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 45678889999999999999999999999999998866543 233467889999999999999999999987644
Q ss_pred CceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.+.+|+|+|||+. ||..++... -.|++.++..|+.||+.||.|+|..+ |+|||||.+|||||.+|.+||+|||||+
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEecccccee
Confidence 5799999999954 999988654 36999999999999999999999976 9999999999999999999999999999
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh-
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR- 637 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~- 637 (683)
++...... .....+.|.||.|||.+.+.. .|+..+|+||+||||.||+.|++.|......+.+...-.+-...
T Consensus 267 ~y~~~~~~----~~T~rVvTLWYRpPELLLG~t--~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 267 FYTPSGSA----PYTSRVVTLWYRPPELLLGAT--SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred eccCCCCc----ccccceEEeeccChHHhcCCc--ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 87654322 133458899999999987543 59999999999999999999999998888777664322221110
Q ss_pred -----ccCCCC-----------------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 638 -----KVEFPS-----------------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 -----~~~~p~-----------------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
...+|. ...++..+.+|+..+|++||.+|.|+.++|+|+||+.
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 011111 0346788999999999999999999999999999953
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=375.98 Aligned_cols=265 Identities=31% Similarity=0.481 Sum_probs=219.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||+||+|.+..++..||||++..... ........+..|+.++..+.||||++++++|. +.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM----IKRNQIAHVRAERDILADADSPWIVKLYYSFQ-DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH----hhccHHHHHHHHHHHHHhcCCCCccchhhhee-cCCe
Confidence 469999999999999999999999999999999854321 11233567888999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||+++++|.+++...+.+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999999999987788999999999999999999999955 99999999999999999999999999987654
Q ss_pred CcCC------------------------CcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 005678 563 DVGS------------------------QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618 (683)
Q Consensus 563 ~~~~------------------------~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF 618 (683)
.... ..........||+.|+|||++... .++.++|||||||++|+|++|+.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---PYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC---CCCCceeeEecchhhhhhccCCCCC
Confidence 3200 000112344799999999998755 3899999999999999999999999
Q ss_pred CCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCcccCC
Q 005678 619 GHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD-VLTLAQDPYLTY 680 (683)
Q Consensus 619 ~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS-~~eLl~hP~l~~ 680 (683)
........... .........+|....+++++.+||.+||. +|.+||+ +.++++||||..
T Consensus 231 ~~~~~~~~~~~--i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 231 YSDTLQETYNK--IINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred CCCCHHHHHHH--HhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 87765443221 11112344566666689999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=356.11 Aligned_cols=263 Identities=30% Similarity=0.496 Sum_probs=217.7
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
.+|...+.||+|.||.||+|+|..+|+.||||.+..... +...-..++||+..|+.++||||+.|+|+|. ....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-----kdGi~~talREIK~Lqel~h~nIi~LiD~F~-~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-----KDGINRTALREIKLLQELKHPNIIELIDVFP-HKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-----ccCccHHHHHHHHHHHHccCcchhhhhhhcc-CCCc
Confidence 478889999999999999999999999999999876532 2223457899999999999999999999997 6778
Q ss_pred EEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+.||+|||+ .+|..+++. .-.++...+..++.++++||+|||... |+||||||.|+|++++|.+||+|||+++.+.
T Consensus 76 l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 76 LSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred eEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccC
Confidence 999999995 699999964 457999999999999999999999855 9999999999999999999999999999886
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH-HhhccC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII-KARKVE 640 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~-~~~~~~ 640 (683)
..... ....+-|.||.|||.+.+.+ .|+..+||||.|||+.||+.|.+-|.+..+.+.+-..-... ....-.
T Consensus 153 ~p~~~-----~~~~V~TRWYRAPELLfGsr--~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 153 SPNRI-----QTHQVVTRWYRAPELLFGSR--QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred CCCcc-----cccceeeeeccChHHhccch--hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence 54322 12227899999999987655 38999999999999999999998888877776653321111 111111
Q ss_pred CCC---------------C------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 641 FPS---------------R------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 641 ~p~---------------~------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
||. + +.+++++.+|+.+||.+||.+|+++.++++||||+.+
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 221 1 4567888999999999999999999999999999853
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.07 Aligned_cols=259 Identities=30% Similarity=0.490 Sum_probs=207.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||.||+|.+..++..||||++....... ....+.+|+.+++.++||||+++++++. +.+.
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~ 77 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG------APCTAIREVSLLKNLKHANIVTLHDIIH-TERC 77 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC------cchhHHHHHHHHHhCCCCCEeeEEEEEc-CCCe
Confidence 46999999999999999999999999999999885432111 1235678999999999999999999986 5678
Q ss_pred EEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+++||||+++ +|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 9999999975 898888644 45789999999999999999999865 9999999999999999999999999997654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh-----
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA----- 636 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~----- 636 (683)
.... ......||+.|+|||++... ..++.++|||||||++|+|++|++||......+.+.........
T Consensus 155 ~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 155 VPTK-----TYSNEVVTLWYRPPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred CCCc-----cccCceecccccChHHhcCC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 3211 12234789999999987532 33789999999999999999999999876654433221111000
Q ss_pred ----------hccCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 637 ----------RKVEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 637 ----------~~~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
....+|. .+.++.++.+||.+||.+||.+|||+.++++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0011111 24578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=380.75 Aligned_cols=265 Identities=26% Similarity=0.395 Sum_probs=214.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+++.||+|+||+||+|.+..++..||||++.... .........+.+|+.++..++|||||+++++|. +.+.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE----MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH----HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-cCCe
Confidence 36899999999999999999999999999999874321 112234567889999999999999999999996 6778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||++|++|..++...+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999999988888999999999999999999999966 99999999999999999999999999964321
Q ss_pred CcCCC-------------c------c-----------------------cccccCCCCCccCCcccccccCCCCCCchhH
Q 005678 563 DVGSQ-------------G------M-----------------------ELTSQGAGTYWYLPPECFELSKTPLISSKVD 600 (683)
Q Consensus 563 ~~~~~-------------~------~-----------------------~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksD 600 (683)
..... . . ......+||+.|+|||++.... ++.++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~D 230 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG---YGQECD 230 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC---CCCcee
Confidence 10000 0 0 0001246999999999986443 889999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcc
Q 005678 601 VWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER---PDVLTLAQDPY 677 (683)
Q Consensus 601 VWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kR---PS~~eLl~hP~ 677 (683)
||||||++|+|++|..||......+.+.. .......+.+|....++.++.+||.+||. +|.+| +++.+++.|||
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~~~~~--i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFCSENSHETYRK--IINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred eEecchhhhhhhcCCCCCCCCCHHHHHHH--HHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence 99999999999999999987665443221 11122345566666789999999999998 66665 59999999999
Q ss_pred cCC
Q 005678 678 LTY 680 (683)
Q Consensus 678 l~~ 680 (683)
|+.
T Consensus 308 ~~~ 310 (377)
T cd05629 308 FRG 310 (377)
T ss_pred cCC
Confidence 974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=380.96 Aligned_cols=264 Identities=27% Similarity=0.399 Sum_probs=215.0
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|.+++.||+|+||.||+|.+..++..||||++.... .........+.+|+.++..++||||+++++.|. +.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~----~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD----VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-DKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH----HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-cCCEE
Confidence 6899999999999999999999999999999874321 112233567889999999999999999999996 67899
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
|+|||||++|+|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 77 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999999999988888999999999999999999999965 999999999999999999999999998533210
Q ss_pred cCCC--------------------------------------cccccccCCCCCccCCcccccccCCCCCCchhHHHHHH
Q 005678 564 VGSQ--------------------------------------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAG 605 (683)
Q Consensus 564 ~~~~--------------------------------------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLG 605 (683)
.... ........+||+.|+|||++.... ++.++||||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG 231 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG---YTQLCDWWSVG 231 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC---CCcceeeeecc
Confidence 0000 000112347999999999986444 78999999999
Q ss_pred HHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccCC
Q 005678 606 ILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP---DVLTLAQDPYLTY 680 (683)
Q Consensus 606 vILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRP---S~~eLl~hP~l~~ 680 (683)
|++|+|++|..||......+.... .........++....++.++.+||.+|+ .+|.+|+ ++.++++||||..
T Consensus 232 vilyell~G~~Pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 232 VILYEMLVGQPPFLADTPAETQLK--VINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred ceeeehhhCCCCCCCCCHHHHHHH--HhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 999999999999987765443322 1112223445555678999999999987 4999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=364.02 Aligned_cols=263 Identities=28% Similarity=0.435 Sum_probs=206.0
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.++|.+.+.||.|+||.||+|.+..++..||||++...... .....+.+|+.+++.++||||+++++++. +..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE------GTPFTAIREASLLKGLKHANIVLLHDIIH-TKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc------ccchhHHHHHHHHhhCCCCCcCeEEEEEe-cCC
Confidence 36799999999999999999999999999999998543211 11235678999999999999999999986 677
Q ss_pred eEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+|+||||++ ++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++...
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAK 153 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceec
Confidence 8999999995 577777754 456899999999999999999999965 999999999999999999999999998754
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh--c
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR--K 638 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~--~ 638 (683)
..... ......||+.|+|||++... ..++.++|||||||++|+|++|..||.........+......... .
T Consensus 154 ~~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
T cd07869 154 SVPSH-----TYSNEVVTLWYRPPDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNE 226 (303)
T ss_pred cCCCc-----cCCCCcccCCCCChHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCCh
Confidence 32211 12234789999999987532 237889999999999999999999997654433222211100000 0
Q ss_pred cCCC-------------------------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 639 VEFP-------------------------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p-------------------------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..++ ....+++.+.+||.+||.+||.+|||+.++++||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0000 001245789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=368.86 Aligned_cols=250 Identities=28% Similarity=0.400 Sum_probs=207.9
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecc
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~ 490 (683)
||+|+||.||+|.+..++..||||++..... ........+.+|+.++..++||||++++++|. +.+.+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI----VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-cCCeEEEEEcCC
Confidence 7999999999999999999999998753211 12233567889999999999999999999886 678899999999
Q ss_pred cCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCccc
Q 005678 491 SGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570 (683)
Q Consensus 491 ~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~ 570 (683)
++++|..++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++...... .
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-----~ 148 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-----D 148 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-----C
Confidence 99999999988878999999999999999999999965 9999999999999999999999999997543221 1
Q ss_pred ccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHH
Q 005678 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNE 650 (683)
Q Consensus 571 l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~e 650 (683)
......||+.|+|||++.... ++.++|||||||++|+|++|..||......... . . .....+.+| ..++..
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-~--~-~~~~~~~~~--~~~~~~ 219 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHG---YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-R--K-ILQEPLRFP--DGFDRD 219 (312)
T ss_pred ccccccCCcccCCHHHHcCCC---CCCccceechhHHHHHHHhCCCCcCCCCHHHHH-H--H-HHcCCCCCC--CcCCHH
Confidence 123347999999999986543 889999999999999999999999766544322 1 1 122233333 468999
Q ss_pred HHHHHHHhcccCCCCCC---CHHHHhcCcccCCC
Q 005678 651 AKDLIRRCLTYNQAERP---DVLTLAQDPYLTYS 681 (683)
Q Consensus 651 l~dLI~rCL~~dP~kRP---S~~eLl~hP~l~~~ 681 (683)
+.+||.+||..||.+|| ++.+++.||||...
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999999999999997 57999999999853
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=373.88 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=215.8
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCC-eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEH-RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g-~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
..+..+.|.+.+.||+|+||.||+|.+..++ ..||+|.+..... ........+.+|+.++..++|||||+++++|
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI----IKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh----hhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 3445678999999999999999999876554 7899998754321 1223356788999999999999999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
. +.+.+|+||||+++|+|..++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+
T Consensus 101 ~-~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 101 K-DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred E-eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCC
Confidence 6 67789999999999999999988888999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+..+... .....||+.|+|||++.... ++.++|||||||++|+|++|..||.......... . +..
T Consensus 178 a~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~---~-i~~ 242 (340)
T PTZ00426 178 AKVVDTR--------TYTLCGTPEYIAPEILLNVG---HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ---K-ILE 242 (340)
T ss_pred CeecCCC--------cceecCChhhcCHHHHhCCC---CCccccccchhhHHHHHhcCCCCCCCCCHHHHHH---H-Hhc
Confidence 9866432 12347999999999986443 7889999999999999999999998665432221 1 122
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
....+| +.+++.+.+||.+||..+|.+|+ ++.++++||||...
T Consensus 243 ~~~~~p--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 243 GIIYFP--KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred CCCCCC--CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 223333 56899999999999999999995 89999999999753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=388.31 Aligned_cols=260 Identities=30% Similarity=0.458 Sum_probs=220.1
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~ 478 (683)
+--+.|.++.+||+|+||+|+++..+.++.+||||++++......+. +.....|-.|+.... ||.++.||.+|+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~----Ve~~~~EkrI~~la~~HPFL~~L~~~fQ- 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE----VESLMCEKRIFELANRHPFLVNLFSCFQ- 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc----HHHHHHHHHHHHHhccCCeEeecccccc-
Confidence 44578999999999999999999999999999999998876554432 556777888888775 999999999997
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
...++|+||||+.||++.. +.....+++..++.|+..|+.||.|||+.+ |||||||.+|||||..|++||+|||||+
T Consensus 440 T~~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred cCCeEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEeccccccc
Confidence 6789999999999999444 444457999999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
-.... -..+++.+|||.|||||++.... |+..+|+|||||+|||||.|..||..++..+.+-. +....
T Consensus 517 e~m~~-----g~~TsTfCGTpey~aPEil~e~~---Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds----I~~d~ 584 (694)
T KOG0694|consen 517 EGMGQ-----GDRTSTFCGTPEFLAPEVLTEQS---YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS----IVNDE 584 (694)
T ss_pred ccCCC-----CCccccccCChhhcChhhhccCc---ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HhcCC
Confidence 54321 13477889999999999997665 99999999999999999999999988776654421 23344
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~~ 681 (683)
+.+| ..+|.++.++++++|..+|.+|.- +.+|..||||+..
T Consensus 585 ~~yP--~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 585 VRYP--RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred CCCC--CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 4555 359999999999999999999984 6889999999864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=366.75 Aligned_cols=267 Identities=27% Similarity=0.409 Sum_probs=220.0
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc-
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI- 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~- 478 (683)
.+..+|..++.||+|+||.|+.+.+..+|..||||.+... .......++..||+.+|+.++|+||+.+++++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-----F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-----FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP 93 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-----hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence 4566787789999999999999999999999999976422 1223345788999999999999999999999865
Q ss_pred ---CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 479 ---DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 479 ---d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
.-+.+|+|+|+| +.+|..+++....|++..+..+++|++.||+|+|+.+ |+||||||+|+|++.++.+||||||
T Consensus 94 ~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEecccc
Confidence 245689999999 7799999999988999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH----
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED---- 631 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~---- 631 (683)
+|+..... ......+..+.|.||.|||.+... ..|+..+||||+||||.|||+|++.|.+......+...-
T Consensus 171 LAR~~~~~---~~~~~mTeYVaTRWYRAPElll~~--~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 171 LARYLDKF---FEDGFMTEYVATRWYRAPELLLNS--SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred ceeecccc---CcccchhcceeeeeecCHHHHhcc--ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99988654 112334566899999999988543 359999999999999999999999997766655542110
Q ss_pred ----------------HHHHhhccCCCC------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 632 ----------------TIIKARKVEFPS------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 632 ----------------~i~~~~~~~~p~------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..+.... ..|. -|..++.+.+|+.+||..||.+|+|++++|.||||..
T Consensus 246 tP~~e~l~~i~s~~ar~yi~slp-~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSLP-QIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhCC-CCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 0111111 1111 1577899999999999999999999999999999864
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=376.06 Aligned_cols=268 Identities=26% Similarity=0.404 Sum_probs=219.6
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+..+.|.+.+.||+|+||.||+|.+..++..||||++..... ........+..|+.+++.++||||++++++|.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~- 113 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM----IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ- 113 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh----hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-
Confidence 4456789999999999999999999999999999999743211 11222345778999999999999999999886
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+.+|+|||||+||+|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEecccee
Confidence 678899999999999999998765 4899999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~-~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
....... .......||+.|+|||++.... ...++.++|||||||++|+|++|..||........+.. .+....
T Consensus 191 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~--i~~~~~ 264 (370)
T cd05596 191 KMDANGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK--IMDHKN 264 (370)
T ss_pred eccCCCc----ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH--HHcCCC
Confidence 6543211 1123457999999999986433 23478999999999999999999999987665432211 111223
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAE--RPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~k--RPS~~eLl~hP~l~~ 680 (683)
.+.+|....+|.++.+||.+||..+|.+ ||++.++++||||+.
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 4566766678999999999999999988 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=367.85 Aligned_cols=251 Identities=29% Similarity=0.452 Sum_probs=208.4
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEe
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLE 488 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~E 488 (683)
+.||+|+||.||++.+..+|..||+|++..... ........+.+|+.+++.++||||++++++|. ..+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh----hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-cCCEEEEEEe
Confidence 369999999999999999999999999854321 11223557788999999999999999999986 6778999999
Q ss_pred cccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCc
Q 005678 489 YCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568 (683)
Q Consensus 489 y~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~ 568 (683)
|+++++|..++.....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--- 150 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--- 150 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---
Confidence 9999999999988878999999999999999999999965 99999999999999999999999999875322211
Q ss_pred ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCC
Q 005678 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648 (683)
Q Consensus 569 ~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s 648 (683)
......||+.|+|||++.... ++.++|||||||++|+|++|..||........... .......+| ..++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~----~~~~~~~~p--~~~~ 219 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDND---YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFP--RTLS 219 (323)
T ss_pred --ccccccCCcCcCCcccccCCC---CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCCCCCC--CCCC
Confidence 122347999999999986443 78999999999999999999999976554332211 122233333 4689
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 005678 649 NEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTY 680 (683)
Q Consensus 649 ~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~ 680 (683)
+++.+||.+||..||.+|| ++.++++||||..
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999999998 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=368.33 Aligned_cols=252 Identities=29% Similarity=0.460 Sum_probs=208.9
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEe
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLE 488 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~E 488 (683)
+.||+|+||.||++.+..++..||||++...... .......+.+|+.+++.++||||++++++|. +.+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-TKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-cCCEEEEEEe
Confidence 3689999999999999999999999998543221 1223567888999999999999999999886 6778999999
Q ss_pred cccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCc
Q 005678 489 YCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568 (683)
Q Consensus 489 y~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~ 568 (683)
|+++++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---- 149 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---- 149 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcc----
Confidence 9999999999988888999999999999999999999965 9999999999999999999999999987543221
Q ss_pred ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCC
Q 005678 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648 (683)
Q Consensus 569 ~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s 648 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||......... . .+....+.+| ..++
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-~---~~~~~~~~~p--~~~~ 219 (328)
T cd05593 150 -ATMKTFCGTPEYLAPEVLEDND---YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-E---LILMEDIKFP--RTLS 219 (328)
T ss_pred -cccccccCCcCccChhhhcCCC---CCccCCccccchHHHHHhhCCCCCCCCCHHHHH-H---HhccCCccCC--CCCC
Confidence 1122347999999999986443 789999999999999999999999765543322 1 1222233333 5689
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 649 NEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 649 ~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
.++.+||.+||..||.+|| ++.++++||||...
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=369.48 Aligned_cols=264 Identities=25% Similarity=0.387 Sum_probs=218.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+.+.||+|+||+||+|.+..++..||||++..... ........+.+|+.++..+.||||++++++|. +.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL----LAQETVSFFEEERDILSISNSPWIPQLQYAFQ-DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-cCCe
Confidence 368999999999999999999999999999999854321 12234567788999999999999999999886 6778
Q ss_pred EEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||.|||++.+|.+||+|||++..+.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 99999999999999999765 67999999999999999999999965 9999999999999999999999999998764
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSK---TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~---~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
.... .......||+.|+|||++.... ...++.++|||||||++|+|++|..||........+.. .+.....
T Consensus 154 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~--i~~~~~~ 227 (330)
T cd05601 154 ANKM----VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN--IMNFQRF 227 (330)
T ss_pred CCCc----eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH--HHcCCCc
Confidence 3211 1223347999999999986321 23478899999999999999999999977665443221 1111233
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..+|..+.++..+.+||.+||. +|.+||++.+++.||||..
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 228 LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 4567667899999999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=375.16 Aligned_cols=262 Identities=31% Similarity=0.479 Sum_probs=224.5
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFE 477 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~ 477 (683)
.-+...|.+.+.||.|.||.||+|..+.+|..||||++......... ....+.+|+.||+++. |||||.++++|+
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~----~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE----DREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc----cHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34567899999999999999999999999999999998655432221 2457889999999998 999999999997
Q ss_pred cCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC----CCcEEEEe
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE----FGVAKVTD 553 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~----~g~vKL~D 553 (683)
+...+++|||+|.||.|.+.+... .+++..+..++.|++.|+.|||+.| |+||||||+|+|+.. ++.+|++|
T Consensus 107 -~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 107 -DPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred -cCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEee
Confidence 677999999999999999999665 3999999999999999999999965 999999999999974 35799999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||++...... ......+||+.|+|||++.... |+..+||||+||++|.|++|.+||...........
T Consensus 183 FGla~~~~~~------~~~~~~~Gtp~y~APEvl~~~~---y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~---- 249 (382)
T KOG0032|consen 183 FGLAKFIKPG------ERLHTIVGTPEYVAPEVLGGRP---YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA---- 249 (382)
T ss_pred CCCceEccCC------ceEeeecCCccccCchhhcCCC---CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH----
Confidence 9999987652 2344569999999999986544 89999999999999999999999988876665542
Q ss_pred HHhhc--cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 634 IKARK--VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 ~~~~~--~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+.... +..+.++.+|..+++||++||..||..|+++.++|+|||++..
T Consensus 250 i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 250 ILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 22333 3445677899999999999999999999999999999999864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=372.88 Aligned_cols=265 Identities=25% Similarity=0.424 Sum_probs=215.7
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+++.||+|+||.||+|.+..++..||||++.... .........+..|+.++..++||||+++++.|. +.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD----MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH----HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCE
Confidence 36889999999999999999999999999999985321 112234567888999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+|||||+|++|..++...+.+++..++.++.|++.||.|||+.+ ||||||||+|||++.+|.+||+|||++..+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999999999988888999999999999999999999965 99999999999999999999999999875532
Q ss_pred CcCCC------------------------------cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 563 DVGSQ------------------------------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 563 ~~~~~------------------------------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
..... ........+||+.|+|||++.... ++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG---YNKLCDWWSLGVIMYEML 230 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC---CCCcceeccccceeeecc
Confidence 11000 000112347999999999986444 889999999999999999
Q ss_pred cCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccCC
Q 005678 613 FGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP---DVLTLAQDPYLTY 680 (683)
Q Consensus 613 tG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRP---S~~eLl~hP~l~~ 680 (683)
+|..||........... .......+.+|....++.++++||.+|+. +|.+|+ ++.+++.||||..
T Consensus 231 tG~~Pf~~~~~~~~~~~--i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 231 IGYPPFCSETPQETYRK--VMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred cCCCCCCCCCHHHHHHH--HHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 99999987665443321 11112334556555689999999999874 999998 4899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=355.36 Aligned_cols=259 Identities=28% Similarity=0.504 Sum_probs=201.4
Q ss_pred cceeEEEEecccCceEEEEEEEcc-CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc---CCCceeeecccccc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLV-EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL---VHHHIVRLWDTFEI 478 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~-~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L---~HpnIV~L~~~f~~ 478 (683)
.+|.+++.||+|+||.||+|.+.. ++..||||++......... ...+.+|+.+++.+ .||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~ 75 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----PLSTIREVAVLRHLETFEHPNVVRLFDVCTV 75 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-----hHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence 379999999999999999998854 5789999987654322111 22445666666655 69999999998742
Q ss_pred ----CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 479 ----DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 479 ----d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
....+++||||++ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEc
Confidence 3456899999995 6899888543 45899999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|||++...... .......||+.|+|||++.... ++.++|||||||++|+|++|.+||......+.+.....
T Consensus 153 Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 153 DFGLARIYSFQ------MALTSVVVTLWYRAPEVLLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred cccceEeccCC------cccccccccccccChHHHhCCC---CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 99999865432 1223347899999999986443 78899999999999999999999987766544322111
Q ss_pred HHH-hhccCCC--------------------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 633 IIK-ARKVEFP--------------------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 633 i~~-~~~~~~p--------------------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
... .....++ ..+.++..+.+||.+||.+||++||++.++++||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 100 0000010 013578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=365.52 Aligned_cols=263 Identities=28% Similarity=0.448 Sum_probs=213.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+..++|.+.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||++++++|. +
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK------PAIRNQIIRELQVLHECNSPYIVGFYGAFY-S 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC------HHHHHHHHHHHHHHHHCCCCcccceeEEEE-E
Confidence 456789999999999999999999999999999998765321 123456889999999999999999999997 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+|+||||+++++|.+++...+.+++..+..++.+++.||.|||+. .+|+|+||||+|||++.+|.+||+|||++..
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 778999999999999999998888899999999999999999999974 2599999999999999999999999999976
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH---------
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE--------- 630 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~--------- 630 (683)
..... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||............
T Consensus 154 ~~~~~-------~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (333)
T cd06650 154 LIDSM-------ANSFVGTRSYMSPERLQGTH---YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPA 223 (333)
T ss_pred hhhhc-------cccCCCCccccCHHHhcCCC---CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcc
Confidence 54321 12346899999999986433 789999999999999999999999754432211000
Q ss_pred --------------------------------HHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 631 --------------------------------DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 631 --------------------------------~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..+.......++ ...++.++.+||.+||.+||.+||++.+++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 224 ESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred ccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 000000000111 12367899999999999999999999999999999
Q ss_pred CCC
Q 005678 679 TYS 681 (683)
Q Consensus 679 ~~~ 681 (683)
+..
T Consensus 303 ~~~ 305 (333)
T cd06650 303 KRS 305 (333)
T ss_pred hcC
Confidence 764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=373.59 Aligned_cols=269 Identities=26% Similarity=0.409 Sum_probs=217.9
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+..++|.+.+.||+|+||.||+|.+..++..||+|++..... ........+.+|+.+++.++||||++++++|.
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~- 113 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM----IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ- 113 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-
Confidence 3456789999999999999999999999999999998743211 11122346778999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+...+|+|||||+||+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccce
Confidence 678899999999999999999765 4899999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~-~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
.+..... .......||+.|+|||++.... ...++.++|||||||++|+|++|..||........+.. .+....
T Consensus 191 ~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~--i~~~~~ 264 (370)
T cd05621 191 KMDETGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK--IMDHKN 264 (370)
T ss_pred ecccCCc----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH--HHhCCc
Confidence 7643211 1123457999999999986543 23478899999999999999999999987655433221 111223
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAE--RPDVLTLAQDPYLTYS 681 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~k--RPS~~eLl~hP~l~~~ 681 (683)
.+.+|....++..++++|.+||..++.+ |+++.++++||||+..
T Consensus 265 ~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 265 SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 4566666678999999999999855543 8999999999999853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=364.70 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=206.9
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||+||+|.+..+++.||||++..... ........+..|..++..+ .||||++++++|. +.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-TPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH----hhccHHHHHHHHHHHHHhccCCCchhceeeEEE-cCCEEEEEE
Confidence 369999999999999999999999998754321 1122345677888888876 6999999999986 678899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--- 150 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--- 150 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---
Confidence 99999999999988888999999999999999999999865 9999999999999999999999999987543221
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||........+. . +....+.+| ..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~---~-i~~~~~~~~--~~~ 219 (320)
T cd05590 151 --KTTSTFCGTPDYIAPEILQEML---YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE---A-ILNDEVVYP--TWL 219 (320)
T ss_pred --CcccccccCccccCHHHHcCCC---CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH---H-HhcCCCCCC--CCC
Confidence 1123347999999999986443 7889999999999999999999998766543221 1 112222333 458
Q ss_pred CHHHHHHHHHhcccCCCCCCCH------HHHhcCcccCCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDV------LTLAQDPYLTYS 681 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~------~eLl~hP~l~~~ 681 (683)
+.++.+||.+||..||.+||++ .++++||||...
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999999999998 999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=365.73 Aligned_cols=263 Identities=26% Similarity=0.375 Sum_probs=209.0
Q ss_pred ceeEEEEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 404 RYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
.|.+++.||+|+||.||++.+. .++..||+|++..... .........+..|+.++..+ .||||+.++++|. +
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL---VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ-T 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH---hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-c
Confidence 4889999999999999998763 4789999999854321 11223345678899999999 4999999999886 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+++||||+++++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 7789999999999999999987778999999999999999999999865 99999999999999999999999999976
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
+...... ......||+.|+|||++... ..++.++|||||||++|+|++|..||.............. .....
T Consensus 155 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~~~ 226 (332)
T cd05614 155 FLSEEKE----RTYSFCGTIEYMAPEIIRGK--GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--RILKC 226 (332)
T ss_pred ccccCCC----ccccccCCccccCHHHhcCC--CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--HHhcC
Confidence 5332111 12234799999999998632 2367899999999999999999999964322111100001 11112
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTY 680 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~ 680 (683)
..+.++.++..+.+||.+||..||.+|| ++.++++||||+.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 2233356899999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.07 Aligned_cols=256 Identities=26% Similarity=0.381 Sum_probs=209.9
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCC-ceeeeccccccCCce
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH-HIVRLWDTFEIDQNT 482 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hp-nIV~L~~~f~~d~~~ 482 (683)
.|.+++.||+|+||.||+|.+..++..||||++...... .......+..|..++..+.|+ +|+.++++|. +.+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-TMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-cCCE
Confidence 488999999999999999999999999999998543211 122345678899999999775 5788888875 6778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||+++++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999999999988878999999999999999999999965 99999999999999999999999999875322
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.. .......||+.|+|||++.... ++.++|||||||++|+|++|+.||......+.+.. +......+
T Consensus 154 ~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~----i~~~~~~~- 220 (324)
T cd05587 154 GG-----KTTRTFCGTPDYIAPEIIAYQP---YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSY- 220 (324)
T ss_pred CC-----CceeeecCCccccChhhhcCCC---CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCC-
Confidence 11 1122347999999999986443 78999999999999999999999987655433221 11222333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDV-----LTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~-----~eLl~hP~l~~ 680 (683)
+..++.++.+||.+||..+|.+|++. .++++||||..
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 221 -PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 34689999999999999999999976 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=355.78 Aligned_cols=263 Identities=30% Similarity=0.439 Sum_probs=221.4
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.+.|.+.+.||+|.|+.||++.+..+|+.+|+|++....-... ..+.+.+|+.|-..|+|||||+|.+.+. +
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-----~~e~l~rEarIC~~LqHP~IvrL~~ti~-~ 81 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-----DFQKLEREARICRKLQHPNIVRLHDSIQ-E 81 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-----cHHHHHHHHHHHHhcCCCcEeehhhhhc-c
Confidence 456789999999999999999999999999999999866543332 3567889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---CCcEEEEecCC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---FGVAKVTDFGL 556 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~g~vKL~DFGl 556 (683)
.+..|+|+|+|.|++|..-|-..-.+++..+-.++.||+.||.|+|..+ |||||+||.|+||-+ ..-+||+|||+
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred cceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccce
Confidence 7889999999999999877755456899999999999999999999955 999999999999953 44699999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+..+... ......+|||.|||||++.... |+..+|||+.|||||-||.|.+||..... .+++. ..+...
T Consensus 160 Ai~l~~g------~~~~G~~GtP~fmaPEvvrkdp---y~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye-~I~~g~ 228 (355)
T KOG0033|consen 160 AIEVNDG------EAWHGFAGTPGYLSPEVLKKDP---YSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYE-QIKAGA 228 (355)
T ss_pred EEEeCCc------cccccccCCCcccCHHHhhcCC---CCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHH-HHhccc
Confidence 9988733 2234458999999999987444 99999999999999999999999977443 33332 222333
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
-.+..|.++.+++++++||++||..||.+|.|+.++|+|||+...
T Consensus 229 yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 229 YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 344455688999999999999999999999999999999999753
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=363.87 Aligned_cols=253 Identities=31% Similarity=0.451 Sum_probs=207.2
Q ss_pred EEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEE
Q 005678 409 NLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT 485 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~L 485 (683)
+.||+|+||.||++.+. .+++.||||++...... ........+..|+.+++.++||||++++++|. ..+.+|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV---RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-TGGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH---hhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-cCCeEEE
Confidence 67999999999999863 47889999998543211 11223456778999999999999999999987 5678999
Q ss_pred EEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcC
Q 005678 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVG 565 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~ 565 (683)
||||+++++|..++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 9999999999999988888999999999999999999999865 9999999999999999999999999987543221
Q ss_pred CCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCc
Q 005678 566 SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP 645 (683)
Q Consensus 566 ~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~ 645 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||........+. .+ ... .++.++
T Consensus 155 ----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~---~~-~~~--~~~~~~ 221 (323)
T cd05584 155 ----TVTHTFCGTIEYMAPEILMRSG---HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID---KI-LKG--KLNLPP 221 (323)
T ss_pred ----CcccccCCCccccChhhccCCC---CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH---HH-HcC--CCCCCC
Confidence 1122347999999999986443 7889999999999999999999997765443221 11 112 233345
Q ss_pred CCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 646 AVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 646 ~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
.+++.+.+||.+||..+|.+|| ++.+++.||||...
T Consensus 222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 7899999999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.51 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=210.3
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|++.+.||+|+||+||++.+..+++.||||++..... ........+.+|+.+++.++||||++++++|. +.+.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI----KKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh----hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-CCCeE
Confidence 37889999999999999999989999999998754321 11222345678999999999999999999986 56789
Q ss_pred EEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
|+||||+++++|..++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999999999888532 46899999999999999999999965 9999999999999999999999999998764
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.... .....|++.|+|||++... .++.++|||||||++|+|++|..||...............+.....
T Consensus 154 ~~~~------~~~~~~~~~y~aPE~~~~~---~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 222 (285)
T cd05605 154 EGET------IRGRVGTVGYMAPEVVKNE---RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE-- 222 (285)
T ss_pred CCCc------cccccCCCCccCcHHhcCC---CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc--
Confidence 3211 1233789999999998643 3788999999999999999999999765443322111111111112
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
.....++..+.+||.+||..||.+|| ++.++++||||...
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 22346899999999999999999999 89999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=378.30 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=222.7
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
...|..+.+||+|+||.||+|+|..+++.||||++.+... ...+..+..|+.++.+++++||..+|++|- .+.
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~------~deIediqqei~~Ls~~~~~~it~yygsyl-~g~ 84 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA------EDEIEDIQQEISVLSQCDSPNITEYYGSYL-KGT 84 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc------chhhHHHHHHHHHHHhcCcchHHhhhhhee-ecc
Confidence 3467788999999999999999999999999999876533 223678889999999999999999999995 788
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.++++||||.||++.+.|+..+.+.+.++..|+.+++.||.|||..+ .+|||||+.|||+...|.+||+|||.+..+.
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeee
Confidence 89999999999999999999988899999999999999999999865 9999999999999999999999999998876
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... ......+|||.|||||++.... |+.|+||||||++.+||++|.+||........++. |.+...+.+
T Consensus 163 ~~~-----~rr~tfvGTPfwMAPEVI~~~~---Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl---Ipk~~PP~L 231 (467)
T KOG0201|consen 163 NTV-----KRRKTFVGTPFWMAPEVIKQSG---YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL---IPKSAPPRL 231 (467)
T ss_pred chh-----hccccccccccccchhhhcccc---ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe---ccCCCCCcc
Confidence 543 2235669999999999998444 99999999999999999999999987665322211 111111111
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K~ 683 (683)
. ..+|+.+++||..||.+||..||++.+|++|+|++.+|+
T Consensus 232 ~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k 271 (467)
T KOG0201|consen 232 D--GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKK 271 (467)
T ss_pred c--cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCC
Confidence 1 268999999999999999999999999999999999875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=366.25 Aligned_cols=253 Identities=29% Similarity=0.458 Sum_probs=207.9
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEe
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLE 488 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~E 488 (683)
+.||+|+||.||++.+..++..||||++...... ....+..+..|+.++..++||||++++++|. +.+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV----AKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-THDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-cCCEEEEEEe
Confidence 3699999999999999999999999998543211 1223456778999999999999999999886 6778999999
Q ss_pred cccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCc
Q 005678 489 YCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568 (683)
Q Consensus 489 y~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~ 568 (683)
|+++++|..++.....+++..+..++.||+.||.|||+. .+|+||||||+|||++.+|.+||+|||+++.......
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--- 151 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--- 151 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---
Confidence 999999999998888899999999999999999999972 2499999999999999999999999999875432211
Q ss_pred ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCC
Q 005678 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648 (683)
Q Consensus 569 ~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s 648 (683)
......||+.|+|||++.... ++.++|||||||++|+|++|..||......... . .+....+.+| ..++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-~---~i~~~~~~~p--~~~~ 220 (325)
T cd05594 152 --TMKTFCGTPEYLAPEVLEDND---YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-E---LILMEEIRFP--RTLS 220 (325)
T ss_pred --ccccccCCcccCCHHHHccCC---CCCccccccccceeeeeccCCCCCCCCCHHHHH-H---HHhcCCCCCC--CCCC
Confidence 122347999999999986443 789999999999999999999999765543222 1 1222333333 4689
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 649 NEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 649 ~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
+++.+||.+||..||.+|+ ++.++++||||...
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.89 Aligned_cols=255 Identities=30% Similarity=0.446 Sum_probs=206.1
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHH---HhhcCCCceeeeccccccCCc
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI---HKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~i---l~~L~HpnIV~L~~~f~~d~~ 481 (683)
|.+++.||+|+||.||+|.+..++..||||++...... .......+.+|+.+ ++.++||||++++++|. +.+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII----ARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-cCC
Confidence 67899999999999999999999999999998543211 11223445555554 45678999999999986 678
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|+||||+++++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD-VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 899999999999999888654 5999999999999999999999865 9999999999999999999999999987543
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... .......||+.|+|||++.... ++.++|||||||++|+|++|..||......+... .+ ......+
T Consensus 153 ~~~-----~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~---~i-~~~~~~~ 220 (324)
T cd05589 153 GFG-----DRTSTFCGTPEFLAPEVLTETS---YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD---SI-VNDEVRY 220 (324)
T ss_pred CCC-----CcccccccCccccCHhHhcCCC---CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH---HH-HhCCCCC
Confidence 211 1123347999999999986443 7889999999999999999999998765543221 11 1222333
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
| ..++..+.+||.+||..||.+|| ++.++++||||...
T Consensus 221 p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 221 P--RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred C--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 3 46899999999999999999999 79999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.27 Aligned_cols=258 Identities=31% Similarity=0.463 Sum_probs=220.3
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
-+.|.+.+.||+|-||.||.|+...++..||+|++..+- ......-..+.||+.|.+.|+||||+++|++|- +..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq----i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-d~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ----ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-DSK 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH----HHHhcchhhhhheeEeecccCCccHHhhhhhee-ccc
Confidence 357899999999999999999999999999999975432 222333456889999999999999999999994 888
Q ss_pred eEEEEEecccCCChhHHHh--cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 482 TFCTVLEYCSGKDLDAVLK--ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~--~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
..|+++||.+.|+|...|. ....+++..+..++.|++.||.|+|. ++||||||||.|+|++..|.+||+|||.+..
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999999999998 66789999999999999999999998 5699999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
.+.. ...+.+||..|+|||...+.. ++..+|+|++|++.||++.|.+||......+.+-. +....+
T Consensus 174 ~p~~-------kR~tlcgt~dyl~pEmv~~~~---hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr----I~k~~~ 239 (281)
T KOG0580|consen 174 APSN-------KRKTLCGTLDYLPPEMVEGRG---HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR----IRKVDL 239 (281)
T ss_pred cCCC-------CceeeecccccCCHhhcCCCC---ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH----HHHccc
Confidence 6522 133448999999999887555 89999999999999999999999987664333321 222334
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.+| +.++.++.++|.+||.++|.+|.+..+++.|||+...+
T Consensus 240 ~~p--~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~~ 280 (281)
T KOG0580|consen 240 KFP--STISGGAADLISRLLVKNPIERLALTEVMDHPWIVANG 280 (281)
T ss_pred cCC--cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhcC
Confidence 444 78999999999999999999999999999999997543
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=343.70 Aligned_cols=259 Identities=33% Similarity=0.557 Sum_probs=208.9
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
|++++.||+|+||+||++.+..++..||+|++...... ........+|+.+++.++||||+++++++. +...++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-----EEEREENIREIKILRRLRHPNIVQILDVFQ-DDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-----HHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-ESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-----ccccchhhhhhhcccccccccccccccccc-cccccc
Confidence 78999999999999999999999999999998654321 112234456999999999999999999986 577889
Q ss_pred EEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCc
Q 005678 485 TVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~ 564 (683)
+||||+++++|..++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc-
Confidence 99999999999999987777999999999999999999999965 999999999999999999999999999764111
Q ss_pred CCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH-HhhccCCCC
Q 005678 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII-KARKVEFPS 643 (683)
Q Consensus 565 ~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~-~~~~~~~p~ 643 (683)
........||+.|+|||++. ....++.++||||||+++|+|++|..||................ .........
T Consensus 152 ----~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T PF00069_consen 152 ----NENFNPFVGTPEYMAPEVLQ--QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ 225 (260)
T ss_dssp ----TSEBSSSSSSGGGSCHHHHT--TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS
T ss_pred ----cccccccccccccccccccc--ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc
Confidence 12234557999999999986 12237899999999999999999999998773222222111111 111112222
Q ss_pred CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 644 ~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
....+..+.++|.+||..+|.+||++.++++||||
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 22334899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=356.36 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=214.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc-CCc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-DQN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-d~~ 481 (683)
+.|..++.|++|+||.||+|.|+.+++.||+|.++..... ..+--..+|||.+|.+++|||||.+-.+..- +-+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-----~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-----EGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-----CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 4688899999999999999999999999999998765422 1223467899999999999999999877642 345
Q ss_pred eEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+|+|||||+ .||..++..- .+|...+++.++.|++.||+|||.. .|+||||||+|+|+...|.+||+|||+|+.+
T Consensus 151 ~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~--wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 151 KIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN--WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc--eeEecccchhheeeccCCcEEecccchhhhh
Confidence 6999999995 5999999654 4899999999999999999999985 4999999999999999999999999999987
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh-h--
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA-R-- 637 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~-~-- 637 (683)
.... ......+-|.||.|||.+.+.+ .|+..+|+||+|||+.||+++++.|.+....+.+...-.+... .
T Consensus 228 gsp~-----k~~T~lVVTLWYRaPELLLG~~--tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 228 GSPL-----KPYTPLVVTLWYRAPELLLGAK--TYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred cCCc-----ccCcceEEEeeecCHHHhcCCc--ccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 6541 1233447899999999987554 4999999999999999999999999887776665432221110 0
Q ss_pred ------------ccCCCCC-----------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 638 ------------KVEFPSR-----------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 ------------~~~~p~~-----------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.+.|+.. ..+++...+|+..+|.+||.+|.|+.++|+|+||.-
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 1111111 125688999999999999999999999999999974
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.48 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=205.2
Q ss_pred ccccccceeEEEEecccCceEEEEEEE-----ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceee
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYD-----LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVR 471 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d-----~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~ 471 (683)
|.+..++|.+.+.||+|+||.||+|.+ ..++..||||++..... ......+.+|+.++..+ +||||++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~ 75 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT------ASEHKALMSELKILIHIGNHLNVVN 75 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc------hHHHHHHHHHHHHHHHhccCcceee
Confidence 567788999999999999999999974 23457899998753321 12245788999999999 8999999
Q ss_pred eccccccCCceEEEEEecccCCChhHHHhcC-------------------------------------------------
Q 005678 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT------------------------------------------------- 502 (683)
Q Consensus 472 L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~------------------------------------------------- 502 (683)
++++|....+.+++||||+++|+|.+++...
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (338)
T cd05102 76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG 155 (338)
T ss_pred EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence 9998875667789999999999999998542
Q ss_pred -------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcc
Q 005678 503 -------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGM 569 (683)
Q Consensus 503 -------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~ 569 (683)
..+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||+++.+......
T Consensus 156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--- 230 (338)
T cd05102 156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--- 230 (338)
T ss_pred ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcch---
Confidence 24778888999999999999999865 999999999999999999999999999865432111
Q ss_pred cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCC
Q 005678 570 ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648 (683)
Q Consensus 570 ~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s 648 (683)
.......+++.|+|||++.... ++.++|||||||++|+|++ |..||......+.+.. .+.... ....+..++
T Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~--~~~~~~--~~~~~~~~~ 303 (338)
T cd05102 231 VRKGSARLPLKWMAPESIFDKV---YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ--RLKDGT--RMRAPENAT 303 (338)
T ss_pred hcccCCCCCccccCcHHhhcCC---CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH--HHhcCC--CCCCCCCCC
Confidence 1122235678899999886443 8899999999999999996 9999976554333322 111111 222335688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 649 NEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 649 ~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+.+.+||.+||..||.+|||+.++++
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=352.99 Aligned_cols=254 Identities=28% Similarity=0.374 Sum_probs=203.5
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecc
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~ 490 (683)
||+|+||+||+|.+..+++.||||.+..... ........+..|+.+++.++||||++++++|. ..+.+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL----KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-TKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH----hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-CCCeEEEEEeCC
Confidence 7999999999999999999999998754321 11223456788999999999999999999886 667899999999
Q ss_pred cCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCC
Q 005678 491 SGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS 566 (683)
Q Consensus 491 ~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~ 566 (683)
++++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++..+.....
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~- 152 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS- 152 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence 9999998873 3356899999999999999999999965 99999999999999999999999999976543211
Q ss_pred CcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcC
Q 005678 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPA 646 (683)
Q Consensus 567 ~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~ 646 (683)
......||+.|+|||++.... ++.++|||||||++|+|++|+.||..................... ..++.
T Consensus 153 ----~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~ 223 (280)
T cd05608 153 ----KTKGYAGTPGFMAPELLQGEE---YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV--TYPDK 223 (280)
T ss_pred ----cccccCCCcCccCHHHhcCCC---CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC--CCccc
Confidence 122347999999999987543 788999999999999999999999754332111110010111112 22346
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 647 VSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 647 ~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
++..+.+|+.+||..||.+|| ++.++++||||+..
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 899999999999999999999 88999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=342.46 Aligned_cols=262 Identities=28% Similarity=0.435 Sum_probs=214.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+.+.||.|+||.||.|.+..++..||+|.+........ ....+..+.+|+.+++.++||||+++++++. +...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPE--TKKEVNALECEIQLLKNLQHERIVQYYGCLR-DDET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchh--hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-cCCe
Confidence 458889999999999999999999999999998765432211 2233567889999999999999999999997 5679
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++||||+++++|.+++...+.+++..+..++.+++.||.|||+.+ |+|+||+|.|||++.++.++|+|||++.....
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 9999999999999999988888999999999999999999999865 99999999999999999999999999976543
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
..... .......|+..|+|||++.... ++.++|||||||++|+|++|+.||........+.. .........
T Consensus 157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~ 227 (263)
T cd06625 157 ICSSG--TGMKSVTGTPYWMSPEVISGEG---YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQ 227 (263)
T ss_pred ccccc--ccccCCCcCccccCcceeccCC---CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCC
Confidence 21110 1112346889999999987544 78999999999999999999999976554433321 111112222
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.+..++..+.+||.+||..+|.+||++.++++||||
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 334688999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=363.41 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=205.6
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||.||+|.+..++..||||++..... .....+..+.+|..++..+ +||||++++++|. +.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~----~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV----NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-TESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-cCCEEEEEE
Confidence 368999999999999999999999999854321 1123356678899999988 7999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
|||+|++|..++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 150 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--- 150 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCC---
Confidence 99999999999987788999999999999999999999965 9999999999999999999999999987532211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH-------HHHHHHHHHHHhhccC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ-------ERILREDTIIKARKVE 640 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-------e~il~~~~i~~~~~~~ 640 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||...... ..... .......+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 223 (329)
T cd05588 151 --DTTSTFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF--QVILEKQIR 223 (329)
T ss_pred --CccccccCCccccCHHHHcCCC---CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH--HHHHcCCCC
Confidence 1123347999999999986543 788999999999999999999999532111 11111 112222233
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCcccCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPD------VLTLAQDPYLTY 680 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS------~~eLl~hP~l~~ 680 (683)
+| ..++..+.+||.+||..||.+||+ +.++++||||..
T Consensus 224 ~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 224 IP--RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CC--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 33 468999999999999999999997 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=361.60 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=206.9
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||.||+|.+..++..||||++...... .......+..|..++..+ .||||++++++|. +.+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh----hhhHHHHHHHHHHHHHhccCCCCccceeeEEE-cCCeEEEEE
Confidence 3689999999999999999999999998543211 122345667788888866 7999999999996 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.......
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--- 150 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--- 150 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCC---
Confidence 99999999999988888999999999999999999999965 9999999999999999999999999987543221
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||........+.. +......+| ..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~----i~~~~~~~p--~~~ 219 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELE---YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES----ILHDDVLYP--VWL 219 (321)
T ss_pred --ccccccccCccccCHHHHcCCC---CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCCCCC--CCC
Confidence 1123347999999999986443 78899999999999999999999987665443321 112222333 458
Q ss_pred CHHHHHHHHHhcccCCCCCC-------CHHHHhcCcccCC
Q 005678 648 SNEAKDLIRRCLTYNQAERP-------DVLTLAQDPYLTY 680 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRP-------S~~eLl~hP~l~~ 680 (683)
+.++.+||.+||..+|.+|| ++.++++||||..
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 99999999999999999999 8999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=359.13 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=210.7
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCce
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~ 482 (683)
.|.+++.||+|+||.||+|.+..++..||||++...... .......+..|..++..+ .||+|+.++++|. +.+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI----QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-TMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-cCCE
Confidence 378899999999999999999999999999998643211 122244567788888777 5889999998886 6778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||+++|+|..++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999999999988778999999999999999999999865 99999999999999999999999999975432
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.. .......||+.|+|||++.... ++.++|||||||++|+|++|..||........... +......+|
T Consensus 154 ~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~----i~~~~~~~p 221 (323)
T cd05616 154 DG-----VTTKTFCGTPDYIAPEIIAYQP---YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYP 221 (323)
T ss_pred CC-----CccccCCCChhhcCHHHhcCCC---CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCC
Confidence 21 1123347999999999987443 89999999999999999999999987655433211 122333333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDV-----LTLAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~-----~eLl~hP~l~~~ 681 (683)
..++.++.+||.+||..+|.+|+++ .++++||||...
T Consensus 222 --~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 222 --KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred --CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 4689999999999999999999984 899999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=363.55 Aligned_cols=258 Identities=31% Similarity=0.511 Sum_probs=222.9
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
-+.++|.+.+.||+|.||.|-+|++...|+.||||.+..+.. +....+-++.||+.||+.|+||||+.+|.+|+ +
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI----kdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-N 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI----KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-N 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc----ccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-C
Confidence 467899999999999999999999999999999999876543 34455779999999999999999999999997 7
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.++|||||..+|.|++|+.+.+.|++.+++.+++||++|+.|+|..+ ++|||||..|||||.++++||+|||++..
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhh
Confidence 7889999999999999999999999999999999999999999999854 99999999999999999999999999988
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
+... .+..+++|+|.|.+||++.+.. .-.+.+|.|||||+||.|++|..||.+.+-...+ ..+..+.+
T Consensus 203 y~~~------kfLqTFCGSPLYASPEIvNG~P--Y~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv----rQIs~GaY 270 (668)
T KOG0611|consen 203 YADK------KFLQTFCGSPLYASPEIVNGTP--YKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV----RQISRGAY 270 (668)
T ss_pred hccc------cHHHHhcCCcccCCccccCCCC--CCCCccchhhHHHHHHHHhhcccccCCchHHHHH----HHhhcccc
Confidence 7654 3445669999999999986443 3467899999999999999999999876543322 12333333
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.- |..+.++.-||+.||..||++|.|+.+++.|=|+.
T Consensus 271 rE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 271 RE---PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred cC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 33 34567788999999999999999999999998875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=371.62 Aligned_cols=257 Identities=22% Similarity=0.263 Sum_probs=203.2
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
...+|.+++.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++|||||+++++|. ..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------------~~~~~~E~~il~~l~HpnIv~~~~~~~-~~ 155 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------------RGGTATEAHILRAINHPSIIQLKGTFT-YN 155 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------------hhhhHHHHHHHHhCCCCCCCCEeEEEE-EC
Confidence 4467999999999999999999999999999999642 124578999999999999999999996 56
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
...|+|+|++ +++|..++.....+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||++...
T Consensus 156 ~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 156 KFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred CeeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 7889999999 5789998877777999999999999999999999965 999999999999999999999999999754
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch-------HHHHHHH---
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT-------QERILRE--- 630 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-------~e~il~~--- 630 (683)
..... .......||+.|+|||++.... ++.++|||||||++|+|++|..||..... ...+...
T Consensus 233 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 233 VDINA----NKYYGWAGTIATNAPELLARDP---YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred ccccc----cccccccCccCCCChhhhcCCC---CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 32211 1122347999999999986443 89999999999999999999988743211 0000000
Q ss_pred ----------------HHHH--Hhhc-c----CCCC---CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 631 ----------------DTII--KARK-V----EFPS---RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 631 ----------------~~i~--~~~~-~----~~p~---~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..+. .... . ..+. ...++.++.+||.+||.+||.+|||+.++++||||+..
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0000 0000 0 0010 11356789999999999999999999999999999753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=349.13 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=200.8
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc---CCCceeeeccccccC-
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL---VHHHIVRLWDTFEID- 479 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L---~HpnIV~L~~~f~~d- 479 (683)
+|.+.+.||+|+||+||+|.+..++..||+|.+......... ...+.+|+.+++.+ +||||++++++|...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~ 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-----PLSTVREVALLKRLEAFDHPNIVRLMDVCATSR 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC-----chHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence 588999999999999999999999999999987653221111 12344566666555 799999999987532
Q ss_pred ---CceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 480 ---QNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 480 ---~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
...+++||||++ ++|..++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 76 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 76 TDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred CCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcc
Confidence 356899999996 4888888643 35899999999999999999999966 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
|++........ .....||+.|+|||++.... ++.++|||||||++|+|++|.+||........+.......
T Consensus 153 g~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 223 (288)
T cd07863 153 GLARIYSCQMA------LTPVVVTLWYRAPEVLLQST---YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223 (288)
T ss_pred CccccccCccc------CCCccccccccCchHhhCCC---CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHh
Confidence 99987643211 12346899999999986443 8899999999999999999999997765544332211111
Q ss_pred Hh-------hccC-----CC---------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 635 KA-------RKVE-----FP---------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 635 ~~-------~~~~-----~p---------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.. .... +. ..+.++..+.+||.+||.+||.+||++.+++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 224 GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0000 00 114578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=365.10 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=205.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
-..|.+++.||+|+||.||+|.+..++..||||++.... .......+.+|+.+++.++|+||++++++|. +.+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~ 145 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQICREIEILRDVNHPNVVKCHDMFD-HNG 145 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC------cHHHHHHHHHHHHHHHhCCCCCcceeeeEec-cCC
Confidence 346778899999999999999999999999999875432 1223457889999999999999999999986 677
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++|||||.+++|... ..+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||++..+.
T Consensus 146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 89999999999998653 23567788899999999999999865 9999999999999999999999999998764
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
... .......||+.|+|||++.... ....+.++|||||||++|+|++|+.||......+.......+... .
T Consensus 220 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~ 292 (353)
T PLN00034 220 QTM-----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS--Q 292 (353)
T ss_pred ccc-----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc--C
Confidence 321 1123347999999999875322 123456899999999999999999999743322111111111111 1
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.......++.++.+||.+||..||.+||++.++++||||...
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 122235688999999999999999999999999999999765
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=378.85 Aligned_cols=261 Identities=22% Similarity=0.343 Sum_probs=201.6
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC------Cceeee
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH------HHIVRL 472 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H------pnIV~L 472 (683)
.+..++|.+++.||+|+||+||+|.+..++..||||++.... .....+..|+.++..+.| ++|+.+
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--------KYTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--------hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 345688999999999999999999999999999999985321 112334556666666654 568999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-----
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG----- 547 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g----- 547 (683)
+++|..+..++|+||+++ |++|.+++...+.+++..+..|+.||+.||.|||.. .+||||||||+|||++.++
T Consensus 197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCccccc
Confidence 998876677899999999 778999988778899999999999999999999973 2499999999999998655
Q ss_pred -----------cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCC
Q 005678 548 -----------VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRR 616 (683)
Q Consensus 548 -----------~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~ 616 (683)
.+||+|||++...... ....+||+.|+|||++.... |+.++|||||||++|||++|+.
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~--------~~~~~gt~~Y~APE~~~~~~---~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERHS--------RTAIVSTRHYRSPEVVLGLG---WMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred ccccccCCCCceEEECCCCccccCccc--------cccccCCccccCcHHhhcCC---CCcHHHHHHHHHHHHHHHhCCC
Confidence 4999999988643221 22347999999999987544 8999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHHH--------------------hhccCCCC----------------CcCCCHHHHHHHHHhcc
Q 005678 617 PFGHDQTQERILREDTIIK--------------------ARKVEFPS----------------RPAVSNEAKDLIRRCLT 660 (683)
Q Consensus 617 PF~~~~~~e~il~~~~i~~--------------------~~~~~~p~----------------~~~~s~el~dLI~rCL~ 660 (683)
||......+.+.....+.. ......+. .......+.+||.+||.
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 9977655433321111100 00000000 00113567899999999
Q ss_pred cCCCCCCCHHHHhcCcccCC
Q 005678 661 YNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 661 ~dP~kRPS~~eLl~hP~l~~ 680 (683)
+||.+|||+.++++||||+.
T Consensus 424 ~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 424 YDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred cChhhCCCHHHHhcCccccc
Confidence 99999999999999999986
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=400.47 Aligned_cols=269 Identities=29% Similarity=0.425 Sum_probs=232.2
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+-.+.|.++++||+|+||+|.++..+.++..||+|++..- +..+.....-|..|-.||..-+.++||.|+.+|+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~----eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ- 145 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKW----EMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ- 145 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHH----HHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-
Confidence 34567799999999999999999999999999999987431 1222334556888999999999999999999997
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
|..++|+|||||+||||-.++.++..+|+.-+++|+..|+.||..||+.| +|||||||+|||||.+|++||+|||.|-
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHH
Confidence 88999999999999999999988889999999999999999999999976 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
.+..+ ++...+..+|||.|++||++.... .+.|...+|+||+||++||||+|..||....-.+.+-. .+...
T Consensus 224 km~~d----G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K--Im~hk 297 (1317)
T KOG0612|consen 224 KMDAD----GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK--IMNHK 297 (1317)
T ss_pred hcCCC----CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH--Hhchh
Confidence 77644 334566779999999999986543 26799999999999999999999999987776665532 22223
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccCCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD---VLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS---~~eLl~hP~l~~~ 681 (683)
..+.||....+|.++++||+++++ +|+.|.. +.++-.||||...
T Consensus 298 ~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 298 ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 467889778899999999999997 8889988 9999999999764
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=366.93 Aligned_cols=270 Identities=26% Similarity=0.407 Sum_probs=218.5
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
...+..++|.+.+.||+|+||.||+|.+..++..||+|++.... .........+.+|+.++..++||||++++++|
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~----~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE----MIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH----hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34455689999999999999999999999999999999874321 11122345677899999999999999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
. +...+|+|||||+|++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+
T Consensus 113 ~-~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 113 Q-DDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred E-cCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 6 678899999999999999999765 4899999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~-~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+..+.... ........||+.|+|||++.... .+.++.++|||||||++|+|++|..||........... .+..
T Consensus 189 a~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~--i~~~ 262 (371)
T cd05622 189 CMKMNKEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK--IMNH 262 (371)
T ss_pred eeEcCcCC----cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH--HHcC
Confidence 98764321 11123457999999999986543 23478999999999999999999999987655433211 1112
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAE--RPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~k--RPS~~eLl~hP~l~~ 680 (683)
.....+|..+.++..+++||.+||..++.+ |+++.++++||||..
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 263 KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 234566776789999999999999844433 789999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=354.23 Aligned_cols=262 Identities=28% Similarity=0.484 Sum_probs=208.1
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||+|+||.||+|.+..++..||||.+....... ....+.+|+.+++.++||||+++++++. ..+.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~ 78 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG------APCTAIREVSLLKDLKHANIVTLHDIVH-TDKS 78 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC------cchhHHHHHHHHHhCCCCCcceEEEEEe-eCCe
Confidence 57999999999999999999999999999999886543211 1234678999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+||||+++ +|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 9999999965 78877754 445899999999999999999999865 9999999999999999999999999997653
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH------
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK------ 635 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~------ 635 (683)
.... ......||+.|+|||++... ..++.++|||||||++|+|++|+.||......+..........
T Consensus 156 ~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07872 156 VPTK-----TYSNEVVTLWYRPPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228 (309)
T ss_pred CCcc-----ccccccccccccCCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 3211 12234689999999987532 2378899999999999999999999976654433221111000
Q ss_pred ---------hhccCCC---------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 636 ---------ARKVEFP---------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 636 ---------~~~~~~p---------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.....++ ..+.++.++.+||.+||.+||.+|||+.++++||||+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0001111 124578899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=375.97 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=202.7
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID- 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d- 479 (683)
...+|.+++.||+|+||.||+|.+..++..||||.+.... ....+|+.+++.++|||||+++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----------~~~~~Ei~il~~l~h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----------QYKNRELLIMKNLNHINIIFLKDYYYTEC 132 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----------chHHHHHHHHHhcCCCCCcceeeeEeecc
Confidence 3468999999999999999999999999999999874321 1234699999999999999998876321
Q ss_pred ------CceEEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-c
Q 005678 480 ------QNTFCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-V 548 (683)
Q Consensus 480 ------~~~~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-~ 548 (683)
...+++||||+++ +|..++. ....+++..++.++.||+.||.|||+.+ ||||||||+|||++.++ .
T Consensus 133 ~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~ 209 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHT 209 (440)
T ss_pred cccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCc
Confidence 2357799999975 6766653 3467999999999999999999999965 99999999999999654 7
Q ss_pred EEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Q 005678 549 AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628 (683)
Q Consensus 549 vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il 628 (683)
+||+|||+|+.+..... .....||+.|+|||++... ..|+.++|||||||++|+|++|.+||......+.+.
T Consensus 210 vkL~DFGla~~~~~~~~------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 281 (440)
T PTZ00036 210 LKLCDFGSAKNLLAGQR------SVSYICSRFYRAPELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281 (440)
T ss_pred eeeeccccchhccCCCC------cccCCCCcCccCHHHhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999987643211 1234789999999987532 248999999999999999999999998776655443
Q ss_pred HHHHHHH-------------hhccCCCC----------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 629 REDTIIK-------------ARKVEFPS----------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 629 ~~~~i~~-------------~~~~~~p~----------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
....... ...+.+|. +...+.++.+||.+||.++|.+|||+.+++.||||..
T Consensus 282 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 282 RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 3211100 01111221 1246789999999999999999999999999999964
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=360.05 Aligned_cols=251 Identities=30% Similarity=0.458 Sum_probs=203.2
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHH-HHhhcCCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN-IHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~-il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||+||+|.+..++..||||++..... ........+..|.. +++.++||||++++++|. +.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI----LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH----hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-eCCEEEEEE
Confidence 369999999999999999999999999854321 11122344555555 567899999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.......
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 150 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--- 150 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC---
Confidence 99999999999988888999999999999999999999965 9999999999999999999999999987542211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||......+... .+ ..... ...+.+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~---~i-~~~~~--~~~~~~ 219 (323)
T cd05575 151 --KTTSTFCGTPEYLAPEVLRKQP---YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD---NI-LNKPL--RLKPNI 219 (323)
T ss_pred --CccccccCChhhcChhhhcCCC---CCccccccccchhhhhhhcCCCCCCCCCHHHHHH---HH-HcCCC--CCCCCC
Confidence 1123347999999999986443 8899999999999999999999998765433221 11 11222 233568
Q ss_pred CHHHHHHHHHhcccCCCCCCCH----HHHhcCcccCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDV----LTLAQDPYLTY 680 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~----~eLl~hP~l~~ 680 (683)
+..+.+||.+||..||.+||++ .+++.||||..
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999999999987 69999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=362.05 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=204.7
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||.||+|.+..++..||+|++...... .......+.+|+.++..+ +||||++++++|. +.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN----DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc----chhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-eCCEEEEEE
Confidence 3699999999999999999999999998653211 122345677888888776 7999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++.....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--- 150 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--- 150 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC---
Confidence 99999999999988788999999999999999999999965 9999999999999999999999999987542211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH-------HHHHHHHHHHHhhccC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ-------ERILREDTIIKARKVE 640 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-------e~il~~~~i~~~~~~~ 640 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||...... ...+. ..+......
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~--~~i~~~~~~ 223 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--QVILEKQIR 223 (329)
T ss_pred --CccccccCCccccCHHHHcCCC---CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH--HHHhcCCCC
Confidence 1122347999999999986443 788999999999999999999999521110 11111 112222333
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCcccCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPD------VLTLAQDPYLTYS 681 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS------~~eLl~hP~l~~~ 681 (683)
+| ..++..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 224 ~p--~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 224 IP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred CC--CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 33 468899999999999999999998 5899999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.06 Aligned_cols=252 Identities=29% Similarity=0.427 Sum_probs=203.3
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhh-cCCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT-LVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~-L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||.||+|.+..++..||||++....... ......+..|..++.. ..||||++++++|. ..+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE----DDDVECTMVERRVLALAWEHPFLTHLFCTFQ-TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh----hhhHHHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEEE
Confidence 36999999999999999999999999986432111 1223345566667665 48999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||++|++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--- 150 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--- 150 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---
Confidence 99999999999988878999999999999999999999965 9999999999999999999999999997643221
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+.. +......+ +..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~----i~~~~~~~--~~~~ 219 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQK---YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS----ILNDRPHF--PRWI 219 (316)
T ss_pred --CccccccCCccccCHHHHcCCC---CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCC--CCCC
Confidence 1223347999999999986443 78999999999999999999999987665432211 11122222 3468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHH-HHhcCcccCCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDVL-TLAQDPYLTYS 681 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~~-eLl~hP~l~~~ 681 (683)
+.++.+||.+||..+|.+||++. +++.||||...
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 99999999999999999999864 88899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=361.67 Aligned_cols=261 Identities=25% Similarity=0.373 Sum_probs=203.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+.+.||+|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-----QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-----hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 457899999999999999999999999999999988543221 122456778999999999999999999886332
Q ss_pred -----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 -----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 -----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+|+||||+++ +|...+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCC
Confidence 357999999965 56666543 3888999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH---
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT--- 632 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~--- 632 (683)
++....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||........+.....
T Consensus 169 ~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 169 LARTACTNF------MMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred CccccccCc------cCCCCcccCCCCCchhccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 997643221 123347899999999986543 88999999999999999999999976554332211000
Q ss_pred -------------H--HHhhccC--------------CCC----CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 633 -------------I--IKARKVE--------------FPS----RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 633 -------------i--~~~~~~~--------------~p~----~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
+ ....... ++. ....+..+.+||.+||.+||.+|||+.+++.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 0 0000000 010 112467899999999999999999999999999986
Q ss_pred C
Q 005678 680 Y 680 (683)
Q Consensus 680 ~ 680 (683)
.
T Consensus 320 ~ 320 (359)
T cd07876 320 V 320 (359)
T ss_pred h
Confidence 3
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=356.91 Aligned_cols=252 Identities=29% Similarity=0.430 Sum_probs=206.9
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||+||+|.+..++..||||++..... ........+.+|..++..+ .||||++++++|. +.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI----LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH----hhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEEE
Confidence 369999999999999999999999999854321 1122345667888888887 6999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||++|++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 150 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--- 150 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCC---
Confidence 99999999999988878999999999999999999999865 9999999999999999999999999987532211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||......... . .+......+| ..+
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-~---~i~~~~~~~~--~~~ 219 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQP---YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-Q---SILEDEVRYP--RWL 219 (318)
T ss_pred --CcccceecCccccCHHHhcCCC---CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-H---HHHcCCCCCC--CcC
Confidence 1122346999999999986543 889999999999999999999999765543322 1 1122223333 468
Q ss_pred CHHHHHHHHHhcccCCCCCCCH-----HHHhcCcccCCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDV-----LTLAQDPYLTYS 681 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~-----~eLl~hP~l~~~ 681 (683)
+..+.+||.+||..||.+||++ .+++.||||...
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999999999999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=363.56 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=208.3
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC----
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ---- 480 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~---- 480 (683)
|.+.+.||+|+||.||+|.+..+++.||||.+..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-----NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-----chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence 6788999999999999999999999999998743211 1122457889999999999999999999986332
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
..+|+||||+. ++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 77 EEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred ceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 27899999995 689888877778999999999999999999999965 999999999999999999999999999865
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH-------
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI------- 633 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i------- 633 (683)
...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........+......
T Consensus 154 ~~~~~~----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 154 EPDESK----HMTQEVVTQYYRAPEILMGS--RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred ccCccc----cCCCCCcCCCcCCHHHHcCC--CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 433211 12234689999999988643 23788999999999999999999999766544322111000
Q ss_pred ------------HHhhccCC-------CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 634 ------------IKARKVEF-------PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 ------------~~~~~~~~-------p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
........ .....++.++.+||.+||.+||.+|||+.+++.||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00001111 1123468899999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=356.60 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=203.9
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||.||+|.+..++..||||++...... .......+..|..++..+ .||||++++++|. +.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL----IDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh----hcchHHHHHHHHHHHHhccCCCCccCeeEEEE-eCCEEEEEE
Confidence 3699999999999999999999999998543211 112234566777787754 8999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 150 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--- 150 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCC---
Confidence 99999999999988778999999999999999999999965 9999999999999999999999999987432211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||......... . .+......+| ..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~-~---~~~~~~~~~~--~~~ 219 (316)
T cd05620 151 --NRASTFCGTPDYIAPEILQGLK---YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF-E---SIRVDTPHYP--RWI 219 (316)
T ss_pred --CceeccCCCcCccCHHHHcCCC---CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-H---HHHhCCCCCC--CCC
Confidence 1123347999999999986444 889999999999999999999999766543322 1 1122222333 358
Q ss_pred CHHHHHHHHHhcccCCCCCCCH-HHHhcCcccCCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDV-LTLAQDPYLTYS 681 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~-~eLl~hP~l~~~ 681 (683)
+.++.+||.+||..||.+||++ .++++||||...
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 8999999999999999999997 588899999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=355.50 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=204.2
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhh-cCCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT-LVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~-L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||+||+|.+..++..||||++...... .......+..|..++.. +.||||++++++|. +.+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL----MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh----hcchHHHHHHHHHHHHhccCCCcCcceEEEEE-eCCEEEEEE
Confidence 3699999999999999999999999998543211 11223456677788876 48999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 150 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--- 150 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---
Confidence 99999999999987778999999999999999999999865 9999999999999999999999999987532211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||......+.... +......+| ..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~----i~~~~~~~~--~~~ 219 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQK---YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS----IRMDNPCYP--RWL 219 (316)
T ss_pred --CceeeecCCccccCHHHHcCCC---CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCC--ccC
Confidence 1122347999999999986443 88999999999999999999999976654332211 112222233 358
Q ss_pred CHHHHHHHHHhcccCCCCCCCHH-HHhcCcccCCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDVL-TLAQDPYLTYS 681 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~~-eLl~hP~l~~~ 681 (683)
+.++.+||.+||..+|.+||++. ++++||||...
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 89999999999999999999996 89999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=359.34 Aligned_cols=261 Identities=26% Similarity=0.376 Sum_probs=204.7
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||.||+|.+..++..||||.+...... ......+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-----QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-----hHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 457899999999999999999999999999999987543221 123456788999999999999999999886332
Q ss_pred -----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 -----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 -----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+|+||||+++ +|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999965 66666653 3888999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH-
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII- 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~- 634 (683)
+++...... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||......+.+.......
T Consensus 165 ~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 165 LARTAGTSF------MMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred ccccCCCcc------ccCCccccCCccCHHHHcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 998654321 123347899999999986443 8899999999999999999999997665443321110000
Q ss_pred ------------------Hh----hccC---------CC----CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 635 ------------------KA----RKVE---------FP----SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 635 ------------------~~----~~~~---------~p----~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.. .... ++ .....+..+.+||.+||..||.+|||+.++++||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 00 0000 00 0122456789999999999999999999999999997
Q ss_pred C
Q 005678 680 Y 680 (683)
Q Consensus 680 ~ 680 (683)
.
T Consensus 316 ~ 316 (355)
T cd07874 316 V 316 (355)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.58 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=209.3
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCce
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~~ 482 (683)
.|.+.+.||+|+||.||+|.+..+++.||||++..... ........+..|..++..+. ||+|++++++|. +.+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV----IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-TVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-cCCE
Confidence 36788999999999999999999999999999854321 11223456778888988886 567778888886 6678
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||++|++|..++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999999999988888999999999999999999999865 99999999999999999999999999875432
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.. .......||+.|+|||++.... ++.++|||||||++|+|++|..||.......... . +......+|
T Consensus 154 ~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~---~-i~~~~~~~p 221 (323)
T cd05615 154 DG-----VTTRTFCGTPDYIAPEIIAYQP---YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ---S-IMEHNVSYP 221 (323)
T ss_pred CC-----ccccCccCCccccCHHHHcCCC---CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---H-HHhCCCCCC
Confidence 21 1123346999999999986443 7899999999999999999999998765533221 1 122223333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~~ 681 (683)
..++.++.+||.+||..+|.+|++ ..++++||||+..
T Consensus 222 --~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 222 --KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred --ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 468999999999999999999997 5789999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=346.26 Aligned_cols=264 Identities=29% Similarity=0.444 Sum_probs=221.9
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccc-hhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCC
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWS-EDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~-~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~ 480 (683)
..|.--+.||.|+.+.|-+|....+|..+|+|++....... ..........-.+|+.||+++ .||+|+.|.|+|+ .+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye-s~ 95 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE-SD 95 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc-Cc
Confidence 35666788999999999999999999999999886554321 111334455667899999998 6999999999997 56
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
..+++|+|.|+.|.|.++|...-.+++.+.+.|+.|++.|+.|||.. +||||||||.|||++++-++||+|||++..+
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~--~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR--NIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh--hhhhcccChhheeeccccceEEeccceeecc
Confidence 77889999999999999999888899999999999999999999985 5999999999999999999999999999988
Q ss_pred ccCcCCCcccccccCCCCCccCCccccccc---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELS---KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~---~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
.... .....+|||+|+|||.+... ..+.|+..+|+|++|||||.||.|.+||.+....-.+ .++..+
T Consensus 174 ~~Ge------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML----R~ImeG 243 (411)
T KOG0599|consen 174 EPGE------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML----RMIMEG 243 (411)
T ss_pred CCch------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH----HHHHhc
Confidence 6542 23344899999999987543 3466999999999999999999999999775432221 234445
Q ss_pred ccCC--CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 638 KVEF--PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 638 ~~~~--p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.+.| |.|..+|...++||.+||..||.+|.|++++|.||||.
T Consensus 244 kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 244 KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 5544 56779999999999999999999999999999999994
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=359.48 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=205.5
Q ss_pred EEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEE
Q 005678 409 NLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT 485 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~L 485 (683)
+.||+|+||.||++.+. .+|..||||++..... .......+..|+.++.+++||||++++++|. +.+.+|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-----KVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-TEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-cCCEEEE
Confidence 57999999999999763 5789999999854321 1122345678999999999999999999986 6778999
Q ss_pred EEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcC
Q 005678 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVG 565 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~ 565 (683)
||||+++++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 9999999999999987778999999999999999999999965 9999999999999999999999999987654321
Q ss_pred CCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCc
Q 005678 566 SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP 645 (683)
Q Consensus 566 ~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~ 645 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||........+.. +..... ..+.
T Consensus 153 ----~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----i~~~~~--~~p~ 219 (318)
T cd05582 153 ----KKAYSFCGTVEYMAPEVVNRRG---HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM----ILKAKL--GMPQ 219 (318)
T ss_pred ----CceecccCChhhcCHHHHcCCC---CCCccceeccceEeeeeccCCCCCCCCCHHHHHHH----HHcCCC--CCCC
Confidence 1122347999999999986443 78899999999999999999999976654432211 111222 2335
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q 005678 646 AVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTY 680 (683)
Q Consensus 646 ~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~ 680 (683)
.++..+.+||.+||..||.+||+ +.+++.||||..
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 68999999999999999999999 788999999964
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=355.62 Aligned_cols=265 Identities=26% Similarity=0.407 Sum_probs=210.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||.||++.+..++..||||++... ..........+..|+.++..++||||++++++|. +.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW----EMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH----HHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-cCCe
Confidence 4689999999999999999999999999999998532 1122233456788999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+||||++|++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||.|||++.+|.+||+|||++..+.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999999999965 457999999999999999999999965 9999999999999999999999999987654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
.... .......||+.|+|||++.... ...++.++|||||||++|+|++|+.||......+.... ........
T Consensus 154 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~--i~~~~~~~ 227 (331)
T cd05597 154 ADGT----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK--IMNHKEHF 227 (331)
T ss_pred CCCC----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH--HHcCCCcc
Confidence 3211 1112236999999999986422 23478899999999999999999999976654433221 11111122
Q ss_pred CCCC-CcCCCHHHHHHHHHhcccCCC--CCCCHHHHhcCcccCC
Q 005678 640 EFPS-RPAVSNEAKDLIRRCLTYNQA--ERPDVLTLAQDPYLTY 680 (683)
Q Consensus 640 ~~p~-~~~~s~el~dLI~rCL~~dP~--kRPS~~eLl~hP~l~~ 680 (683)
.++. .+.++..+.+||.+||..++. .||++.++++||||..
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 3332 245899999999998865443 3789999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.50 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=205.0
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID- 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d- 479 (683)
+.++|.+.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.++||||++++++|...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-----QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-----chhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 457899999999999999999999999999999988543221 12245678899999999999999999987532
Q ss_pred ----CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 480 ----QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 480 ----~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
...+|+||||+++ +|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCC
Confidence 2457999999965 77777654 3788999999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH-
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII- 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~- 634 (683)
+++...... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||......+.+.......
T Consensus 172 ~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 242 (364)
T cd07875 172 LARTAGTSF------MMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242 (364)
T ss_pred CccccCCCC------cccCCcccCCcCCHHHHhCCC---CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 998654321 123347899999999986543 8899999999999999999999997665543322110000
Q ss_pred -----------------Hhhcc--------------CCCC----CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 635 -----------------KARKV--------------EFPS----RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 635 -----------------~~~~~--------------~~p~----~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
..... .++. ....+..+.+||.+||.+||.+|||+.++++||||.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00000 0010 112356789999999999999999999999999996
Q ss_pred C
Q 005678 680 Y 680 (683)
Q Consensus 680 ~ 680 (683)
.
T Consensus 323 ~ 323 (364)
T cd07875 323 V 323 (364)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=356.67 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=205.8
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||+||+|.+..++..||||++..... .....+..+.+|+.++..+ .||||+.++++|. +.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV----HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-eCCEEEEEE
Confidence 369999999999999999999999999854321 1223356788899999888 6999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 150 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--- 150 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCC---
Confidence 99999999999987778999999999999999999999965 9999999999999999999999999987532211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch------HHHHHHHHHHHHhhccCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT------QERILREDTIIKARKVEF 641 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~------~e~il~~~~i~~~~~~~~ 641 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||..... .+.+. .........+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~ 222 (327)
T cd05617 151 --DTTSTFCGTPNYIAPEILRGEE---YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF---QVILEKPIRI 222 (327)
T ss_pred --CceecccCCcccCCHHHHCCCC---CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH---HHHHhCCCCC
Confidence 1123347999999999986443 78999999999999999999999953211 11111 1122222333
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPD------VLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS------~~eLl~hP~l~~~ 681 (683)
| ..++..+.++|.+||.+||.+||+ +.+++.||||...
T Consensus 223 p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 223 P--RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred C--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 3 468899999999999999999997 5799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=346.54 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=207.4
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
|.+.+.||+|+||.||+|.+..+++.||||.+...... .......+..|+.++..++|+||+.+++.+. +.+.+|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK----KRKGESMALNEKQILEKVNSRFVVSLAYAYE-TKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc----chHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-cCCEEE
Confidence 67889999999999999999999999999987543221 1122345678999999999999999999986 567899
Q ss_pred EEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 485 TVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+||||++|++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999999999988533 35899999999999999999999855 99999999999999999999999999876543
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
... .....||+.|+|||++.... ++.++|||||||++|+|++|..||..............+.......
T Consensus 155 ~~~------~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 223 (285)
T cd05630 155 GQT------IKGRVGTVGYMAPEVVKNER---YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE-- 223 (285)
T ss_pred Ccc------ccCCCCCccccChHHHcCCC---CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhh--
Confidence 211 12237999999999986443 8899999999999999999999997643221111111111111111
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~ 680 (683)
....+++++.+||.+||..||.+||+ +.++++||||..
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 23468899999999999999999999 899999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=356.99 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=202.9
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHH-HHhhcCCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN-IHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~-il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||+||+|.+..+|..||||++...... .......+..|.. +++.++||||++++++|. ..+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL----NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-cCCEEEEEE
Confidence 3689999999999999999999999998543211 1122344555554 567799999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.......
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 150 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--- 150 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC---
Confidence 99999999999988888999999999999999999999865 9999999999999999999999999987532211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||......+.... +. .. .....+.+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~---~~-~~--~~~~~~~~ 219 (325)
T cd05604 151 --DTTTTFCGTPEYLAPEVIRKQP---YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN---IL-HK--PLVLRPGA 219 (325)
T ss_pred --CCcccccCChhhCCHHHHcCCC---CCCcCccccccceehhhhcCCCCCCCCCHHHHHHH---HH-cC--CccCCCCC
Confidence 1123347999999999986543 78899999999999999999999977654432211 11 11 22233568
Q ss_pred CHHHHHHHHHhcccCCCCCCCH----HHHhcCcccCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDV----LTLAQDPYLTY 680 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~----~eLl~hP~l~~ 680 (683)
+..+.++|.+||..+|.+||++ .+++.||||..
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 9999999999999999999976 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.17 Aligned_cols=262 Identities=27% Similarity=0.439 Sum_probs=206.5
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID- 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d- 479 (683)
+.++|.+++.||.|+||.||+|.+..++..||||.+..... .......+.+|+.+++.++||||++++++|...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-----SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-----hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 34689999999999999999999999999999998754321 112245677899999999999999999988532
Q ss_pred ----CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 480 ----QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 480 ----~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
...+|++++++ +++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCc
Confidence 24578999998 78998887654 5999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++...... .....||+.|+|||++... ..++.++|||||||++|+|++|..||......+.+........
T Consensus 164 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07878 164 LARQADDE--------MTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233 (343)
T ss_pred cceecCCC--------cCCccccccccCchHhcCC--ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence 99865432 1233789999999998642 2378899999999999999999999976554332221110000
Q ss_pred h------------------hc-cCCCC------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 636 A------------------RK-VEFPS------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 636 ~------------------~~-~~~p~------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
. .. ...+. ...+++.+.+||.+||..||.+|||+.+++.||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0 00 00110 12356778999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.01 Aligned_cols=253 Identities=28% Similarity=0.375 Sum_probs=199.7
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecc
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~ 490 (683)
||+|+||.||++.+..+|..||+|.+..... ........+..|+.+++.++||||++++++|. +...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL----KKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-SKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHh----hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-cCCeEEEEEecC
Confidence 7999999999999999999999998743221 11112334567999999999999999999986 677899999999
Q ss_pred cCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCc
Q 005678 491 SGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568 (683)
Q Consensus 491 ~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~ 568 (683)
+|++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.++|+|||++.......
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---- 149 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---- 149 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----
Confidence 999999888543 35888999999999999999999965 9999999999999999999999999987664321
Q ss_pred ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCC
Q 005678 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648 (683)
Q Consensus 569 ~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s 648 (683)
......||+.|+|||++.... ++.++|||||||++|+|++|..||....................+.++ ...++
T Consensus 150 --~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 223 (277)
T cd05607 150 --TITQRAGTNGYMAPEILKEEP---YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFT 223 (277)
T ss_pred --eeeccCCCCCccCHHHHccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCC
Confidence 112346899999999986443 899999999999999999999999754322111110000111112221 23689
Q ss_pred HHHHHHHHHhcccCCCCCCCH----HHHhcCcccCC
Q 005678 649 NEAKDLIRRCLTYNQAERPDV----LTLAQDPYLTY 680 (683)
Q Consensus 649 ~el~dLI~rCL~~dP~kRPS~----~eLl~hP~l~~ 680 (683)
.++.+||.+||.+||.+||++ .+++.||||..
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 999999999999999999999 67889999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.46 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=210.5
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|...+.||+|+||+||+|.+..+++.||||.+..... ........+.+|+.+++.++|+||+.++++|. .++.+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI----KKRKGESMALNEKQILEKVNSQFVVNLAYAYE-TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh----hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-cCCEE
Confidence 37788999999999999999999999999998754321 11222345778999999999999999998886 67789
Q ss_pred EEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
|+||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||.|||++.++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 999999999999988853 346999999999999999999999865 9999999999999999999999999997654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.... .....|++.|+|||++.... ++.++|||||||++|+|++|..||.............. .......
T Consensus 154 ~~~~------~~~~~g~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~--~~~~~~~ 222 (285)
T cd05632 154 EGES------IRGRVGTVGYMAPEVLNNQR---YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR--RVLETEE 222 (285)
T ss_pred CCCc------ccCCCCCcCccChHHhcCCC---CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hhhcccc
Confidence 3211 12347899999999986433 78899999999999999999999976554332222111 1111122
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~~ 681 (683)
...+.++..+.+||.+||..+|.+||+ +.+++.||||...
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 233568899999999999999999999 8899999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=372.85 Aligned_cols=263 Identities=24% Similarity=0.390 Sum_probs=213.6
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
...++|.+.+.||+|+||+||+|.+..++..||||++....... .....+.+|+.++..+.|+||++++..|...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-----~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-----ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-----HHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 45689999999999999999999999999999999986543221 2245678899999999999999998876432
Q ss_pred C-------ceEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc
Q 005678 480 Q-------NTFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV 548 (683)
Q Consensus 480 ~-------~~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~ 548 (683)
. ..+++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGL 181 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCC
Confidence 1 147899999999999999853 346899999999999999999999965 999999999999999999
Q ss_pred EEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Q 005678 549 AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628 (683)
Q Consensus 549 vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il 628 (683)
+||+|||+++.+...... .......||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+.
T Consensus 182 vkL~DFGls~~~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~~---~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSD---DVGRTFCGTPYYVAPEIWRRKP---YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255 (496)
T ss_pred EEEEecccCeeccccccc---cccccccCCcceeCHHHhCCCC---CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999999876432111 1223457999999999986543 8999999999999999999999998765433221
Q ss_pred HHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 629 REDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 629 ~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
. +... ...+.++.+++++.+||.+||..+|.+||++.+++.|||++.
T Consensus 256 ~---~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 256 K---TLAG--RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred H---HhcC--CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 1 1111 112334578999999999999999999999999999999753
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=345.92 Aligned_cols=263 Identities=29% Similarity=0.491 Sum_probs=209.0
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||.||+|.+..++..||+|.+....... ....+.+|+.+++.++||||+++++++. +.+.
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~E~~~l~~l~h~nI~~~~~~~~-~~~~ 78 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG------APCTAIREVSLLKDLKHANIVTLHDIIH-TEKS 78 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC------chhHHHHHHHHHHhcCCCCcceEEEEEe-cCCe
Confidence 46999999999999999999999999999999886543211 1235678999999999999999999996 6778
Q ss_pred EEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+||||++ ++|..++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 999999996 588888754 456899999999999999999999865 9999999999999999999999999997653
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH------
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK------ 635 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~------ 635 (683)
.... ......+++.|+|||++... ..++.++|||||||++|+|++|++||......+.+........
T Consensus 156 ~~~~-----~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 156 IPTK-----TYSNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred CCCC-----cccccceeecccCcHHHhCC--CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 3211 11223678999999987532 2378899999999999999999999977655433221111100
Q ss_pred ------h---hccCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 636 ------A---RKVEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 636 ------~---~~~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
. ....++. .+.+++.+++||.+||.+||.+|||+.++++||||+..+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 0011111 135788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=336.55 Aligned_cols=264 Identities=29% Similarity=0.473 Sum_probs=214.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccc--hhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWS--EDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~--~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
+|.+...||.|+||.||+|.+..++..||+|.+....... ..........+.+|+.+++.++||||+++++++. +.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL-DAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCC
Confidence 4778899999999999999998899999999876543322 1223345678899999999999999999999986 677
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++||||+++++|..++...+.+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.++|+|||+++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 88999999999999999988888999999999999999999999865 9999999999999999999999999998775
Q ss_pred cCcCCCcc-cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 562 DDVGSQGM-ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 562 ~~~~~~~~-~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
........ .......|++.|+|||++.... ++.++|||||||++|+|++|..||........+... .. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~--~~~ 229 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTS---YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI---GE--NAS 229 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCC---CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH---hc--cCC
Confidence 32211111 1112235889999999886433 788999999999999999999999766544333221 11 111
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
...+..++..+.++|.+||..+|.+||++.++++||||
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 12234688999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=353.31 Aligned_cols=265 Identities=26% Similarity=0.425 Sum_probs=211.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+.+.||+|+||.||++.+..++..||+|++.... .........+..|+.++..+.||||++++++|. +.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE----MLKRAETACFREERDVLVNGDNQWITTLHYAFQ-DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH----HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-cCCE
Confidence 36899999999999999999999999999999874321 112223445778999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999999999965 467899999999999999999999965 9999999999999999999999999987653
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH-hhc
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK-ARK 638 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~-~~~ 638 (683)
.... .......||+.|+|||++.... ...++.++|||||||++|+|++|+.||......+.+.. +.. ...
T Consensus 154 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~---i~~~~~~ 226 (332)
T cd05623 154 EDGT----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---IMNHKER 226 (332)
T ss_pred cCCc----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH---HhCCCcc
Confidence 3211 1122347999999999986321 23478899999999999999999999987655443321 111 122
Q ss_pred cCCCCC-cCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 005678 639 VEFPSR-PAVSNEAKDLIRRCLTYNQAE--RPDVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~-~~~s~el~dLI~rCL~~dP~k--RPS~~eLl~hP~l~~~ 681 (683)
..+|.. ..++.++.+||.+||..++.. |+++.++++||||+..
T Consensus 227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 333432 368999999999999654444 6899999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=357.36 Aligned_cols=251 Identities=31% Similarity=0.439 Sum_probs=203.5
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc---CCCceeeeccccccCCceEEEEE
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL---VHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L---~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
||+|+||+||+|.+..++..||||++..... .....+..+..|..++..+ .||||+.++++|. +...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI----VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-TDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH----hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-cCCeEEEEE
Confidence 7999999999999999999999999743211 1122344566677777766 6999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 150 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--- 150 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC---
Confidence 99999999999988888999999999999999999999965 9999999999999999999999999987543221
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......||+.|+|||++.... .++.++|||||||++|+|++|..||......+.+. .+......++. ..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~~~-~~~ 221 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEK--GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR----NIAFGKVRFPK-NVL 221 (330)
T ss_pred --CCccCccCCccccCHHHHcCCC--CCCCccceeccccEEEEeccCCCCCCCCCHHHHHH----HHHcCCCCCCC-ccC
Confidence 1123347999999999885332 37889999999999999999999997765543221 12222333432 357
Q ss_pred CHHHHHHHHHhcccCCCCCC----CHHHHhcCcccCC
Q 005678 648 SNEAKDLIRRCLTYNQAERP----DVLTLAQDPYLTY 680 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRP----S~~eLl~hP~l~~ 680 (683)
+.++.+||.+||..||.+|| ++.++++||||..
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 89999999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.39 Aligned_cols=251 Identities=30% Similarity=0.447 Sum_probs=202.4
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHH-HHhhcCCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN-IHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~-il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||+||+|.+..++..||+|++..... ........+..|.. +++.++||||++++++|. +.+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI----LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH----HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-cCCeEEEEE
Confidence 369999999999999999999999999854321 11112234444544 567889999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++.....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 99999999999988778999999999999999999999965 99999999999999999999999999975432211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
......||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+.. + .... ....+.+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i-~~~~--~~~~~~~ 219 (325)
T cd05602 152 ---TTSTFCGTPEYLAPEVLHKQP---YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN---I-LNKP--LQLKPNI 219 (325)
T ss_pred ---CcccccCCccccCHHHHcCCC---CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH---H-HhCC--cCCCCCC
Confidence 123347999999999986443 88999999999999999999999986655432211 1 1112 2234578
Q ss_pred CHHHHHHHHHhcccCCCCCCCHH----HHhcCcccCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDVL----TLAQDPYLTY 680 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~~----eLl~hP~l~~ 680 (683)
+..+.++|.+||..+|.+||++. ++++|+||..
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 99999999999999999999865 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.96 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=209.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|.+.+.||+|+||.||++.+..++..||+|.+...... ......+.+|+.+++.++||||+++++.|......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-----RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-----HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEE
Confidence 488999999999999999999999999999987543221 122456788999999999999999998886556678
Q ss_pred EEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
|+||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEec
Confidence 999999999999999965 346899999999999999999999865 9999999999999999999999999998764
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.... ......|++.|+|||.+.... ++.++|||||||++|+|++|..||........... +... ...
T Consensus 154 ~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~---~~~~--~~~ 220 (257)
T cd08223 154 NQCD-----MASTLIGTPYYMSPELFSNKP---YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR---IIEG--KLP 220 (257)
T ss_pred ccCC-----ccccccCCcCccChhHhcCCC---CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHhc--CCC
Confidence 3321 123346899999999886443 78899999999999999999999976554332211 1111 111
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
+....++..+.+||.+||..+|.+||++.+++.||||
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 2234688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=352.00 Aligned_cols=251 Identities=29% Similarity=0.411 Sum_probs=202.0
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHH-HHhhcCCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN-IHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~-il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|+||.||+|.+..++..||||++..... ........+..|.. +++.++||||++++++|. +.+.+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI----LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH----HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-cCCEEEEEE
Confidence 369999999999999999999999999754321 11122344555554 678899999999999886 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
|||+|++|..++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.......
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 150 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--- 150 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC---
Confidence 99999999999987778999999999999999999999865 9999999999999999999999999987532211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||......... . . +......+ ++..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~--~-i~~~~~~~--~~~~ 219 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEP---YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY-D--N-ILHKPLQL--PGGK 219 (321)
T ss_pred --CccccccCCcccCCHHHhcCCC---CCCcCcccccchhhhhhhcCCCCCCCCCHHHHH-H--H-HhcCCCCC--CCCC
Confidence 1123347999999999986433 788999999999999999999999776543322 1 1 11222333 3468
Q ss_pred CHHHHHHHHHhcccCCCCCCCH----HHHhcCcccCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDV----LTLAQDPYLTY 680 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~----~eLl~hP~l~~ 680 (683)
+..+.++|.+||..+|.+||+. .++++||||..
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 8999999999999999999864 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=373.33 Aligned_cols=262 Identities=26% Similarity=0.441 Sum_probs=222.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.+.|.|+..||.|+||.||+|.++.++-..|.|++... ...-+..++-|+.||..++||+||+||++|. ..+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-------seEELEDylVEIeILa~CdHP~ivkLl~ayy-~en 102 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-------SEEELEDYLVEIEILAECDHPVIVKLLSAYY-FEN 102 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-------chhHHhhhhhhhhhhhcCCChHHHHHHHHHh-ccC
Confidence 45677888899999999999999988888999987432 2334678899999999999999999999996 466
Q ss_pred eEEEEEecccCCChhHHH-hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L-~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.++|+.|||+||-.+.++ .-..+|++..+..++++++.||.|||+ ++|||||||.+|||++-+|.++|+|||.+-..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeecccccccc
Confidence 788999999999999887 445679999999999999999999998 56999999999999999999999999988543
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccc--cCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFEL--SKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~--~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
.. .......+.|||+|||||+... .+..+|++++||||||++|.+|.-+.+|.........++. +.+..+
T Consensus 181 ~~-----t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK---iaKSeP 252 (1187)
T KOG0579|consen 181 KS-----TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKSEP 252 (1187)
T ss_pred hh-----HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH---HhhcCC
Confidence 22 2233456689999999998754 3456799999999999999999999999887777665543 345555
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+.+-.+..++..+.+|+.+||..||..||++.+|++||||+++
T Consensus 253 PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 253 PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 6666667889999999999999999999999999999999965
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.75 Aligned_cols=264 Identities=25% Similarity=0.387 Sum_probs=212.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||+||+|.+ .++..||||.+........ ........+.+|+.+++.++|+||++++++|. +...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVL-AAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-DDNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchh-hHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-cCCeE
Confidence 477889999999999999975 5788999998765433222 22234567889999999999999999999986 66899
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
++||||+++++|..++.....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 999999999999999988778999999999999999999999865 999999999999999999999999998765322
Q ss_pred cCC-CcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 564 VGS-QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 564 ~~~-~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
... ..........|++.|+|||++.... ++.++|||||||++|+|++|..||............ ........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~ 229 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESG---YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI---GAHRGLMPR 229 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCC---CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh---hhccCCCCC
Confidence 111 1111223447899999999986443 788999999999999999999999765544333221 111111112
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
....++.++.+||++||..+|.+||++.+++.||||
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 334689999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=366.86 Aligned_cols=255 Identities=29% Similarity=0.427 Sum_probs=212.3
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
...|.+-...+.+++.||+|.||+||.|.. .....||+|.+...... ...|++|+.||++|+|+|||+||+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~--------~~~f~~Ea~iMk~L~H~~lV~l~g 268 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMS--------PEAFLREAQIMKKLRHEKLVKLYG 268 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccC--------hhHHHHHHHHHHhCcccCeEEEEE
Confidence 456677777888899999999999999963 33448999988654222 246779999999999999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
+|. ..+.+|||||||+.|+|.++|+. +..+.......++.|||.|++||.+. ++|||||-..|||+++++.+||+
T Consensus 269 V~~-~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~--~~IHRDLAARNiLV~~~~~vKIs 345 (468)
T KOG0197|consen 269 VCT-KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK--NYIHRDLAARNILVDEDLVVKIS 345 (468)
T ss_pred EEe-cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC--CccchhhhhhheeeccCceEEEc
Confidence 997 44579999999999999999975 56799999999999999999999985 59999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRED 631 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~ 631 (683)
||||++.+.++... ....+.--.-|.|||++...+ +|.++|||||||+||||+| |+.||......+.+..
T Consensus 346 DFGLAr~~~d~~Y~----~~~~~kfPIkWtAPEa~~~~~---FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-- 416 (468)
T KOG0197|consen 346 DFGLARLIGDDEYT----ASEGGKFPIKWTAPEALNYGK---FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-- 416 (468)
T ss_pred ccccccccCCCcee----ecCCCCCCceecCHHHHhhCC---cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH--
Confidence 99999965543211 111111233499999998666 9999999999999999997 9999998887765532
Q ss_pred HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 632 ~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
.......|.++.||+++.+++..||..+|++|||+..+.
T Consensus 417 ---le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 417 ---LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ---HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 235577888889999999999999999999999998775
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.34 Aligned_cols=260 Identities=22% Similarity=0.388 Sum_probs=210.5
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.++|.+.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++. +.+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-------EDFAVVQQEIIMMKDCKHSNIVAYFGSYL-RRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-------hHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCC
Confidence 3578888999999999999999999999999999865421 11345678999999999999999999986 678
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 89999999999999999988888999999999999999999999865 9999999999999999999999999987654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... .......|++.|+|||++.......++.++|||||||++|+|++|..||............. ........+
T Consensus 158 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~ 231 (267)
T cd06645 158 ATI-----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT-KSNFQPPKL 231 (267)
T ss_pred Ccc-----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh-ccCCCCCcc
Confidence 321 11233479999999999753333347889999999999999999999996554433222110 000111112
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~ 677 (683)
.....++..+.+||.+||..+|.+||++.+++.|||
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 222357889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=388.35 Aligned_cols=271 Identities=24% Similarity=0.427 Sum_probs=217.6
Q ss_pred CCccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 394 RFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 394 ~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
.|...++..++|.++..||.|+||+||+|.+..++..||+|++...... ......+..|+.++..|+|||||+++
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-----e~~~~~~~~EI~IL~~L~HPNIVrl~ 78 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-----EREKSQLVIEVNVMRELKHKNIVRYI 78 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-----HHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence 3445566778999999999999999999999999999999998654321 12245788899999999999999999
Q ss_pred ccccc-CCceEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcC-----CceEecccCCcceEe
Q 005678 474 DTFEI-DQNTFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRA-----QKIIHYDLKPGNVLF 543 (683)
Q Consensus 474 ~~f~~-d~~~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g-----~~IIHrDLKP~NILL 543 (683)
++|.. ....+||||||+++++|..+|.. ...+++..++.|+.||+.||.|||..+ .+|||+||||.||||
T Consensus 79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 98853 34678999999999999999854 356999999999999999999999854 359999999999999
Q ss_pred CC-----------------CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHH
Q 005678 544 DE-----------------FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGI 606 (683)
Q Consensus 544 d~-----------------~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGv 606 (683)
+. .+.+||+|||++..+.... ......||+.|+|||++.... ..++.++|||||||
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------~~~s~vGTp~YmAPEvL~ge~-~~~s~KSDVWSLG~ 231 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES------MAHSCVGTPYYWSPELLLHET-KSYDDKSDMWALGC 231 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccccc------cccccCCCccccCHHHHhccC-CCCCchhHHHHHHH
Confidence 64 3359999999998664321 122347999999999985432 33789999999999
Q ss_pred HHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 607 LFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 607 ILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
|||+|++|..||........++.. + . ....+| .+.++.++.+||..||..+|.+||++.+++.||||...
T Consensus 232 ILYELLTGk~PF~~~~~~~qli~~--l-k-~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 232 IIYELCSGKTPFHKANNFSQLISE--L-K-RGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHCCCCCCcCCcHHHHHHH--H-h-cCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 999999999999766554443321 1 1 111222 24578999999999999999999999999999999743
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=340.23 Aligned_cols=259 Identities=29% Similarity=0.507 Sum_probs=203.2
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||+|.+..+|..||+|.+...... ......+.+|+.+++.++||||+++++++. +.+.+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-----~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-----EGVPSSALREICLLKELKHKNIVRLYDVLH-SDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-----ccCccchhHHHHHHHhcCCCCeeeHHHHhc-cCCce
Confidence 588999999999999999999999999999988653221 112345678999999999999999999996 67789
Q ss_pred EEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
++|+||++ ++|..++.. .+.+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 75 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 75 TLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 99999996 578777753 567999999999999999999999965 99999999999999999999999999976543
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH-HH-------
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT-II------- 634 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~-i~------- 634 (683)
... ......+++.|+|||++... ..++.++|||||||++|+|++|..||.........+.... ..
T Consensus 152 ~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07839 152 PVR-----CYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES 224 (284)
T ss_pred CCC-----CcCCCccccCCcChHHHhCC--cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHH
Confidence 211 12233678999999987543 2368899999999999999999988644333322221100 00
Q ss_pred -----Hh-hccCCC----------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 635 -----KA-RKVEFP----------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 635 -----~~-~~~~~p----------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.. ....++ ..+.+++++.+||.+||..||.+|||+.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 000000 113578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=340.81 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=204.9
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|.+++.||.|+||.||+|.+..++..||+|++..+.. ......+.+|+.++++++||||++++++|. ..+.+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 74 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT------VELQKQIMSELEILYKCDSPYIIGFYGAFF-VENRI 74 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-ECCEE
Confidence 57888999999999999999999999999998754321 122356888999999999999999999997 56788
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
++||||+++++|..+ ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+...
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 899999999999765 24788899999999999999999965 999999999999999999999999999765432
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-H---HHHHHhhcc
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR-E---DTIIKARKV 639 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~-~---~~i~~~~~~ 639 (683)
. .....||+.|+|||++.... ++.++|||||||++|+|++|..||........... . ..+......
T Consensus 149 ~-------~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (279)
T cd06619 149 I-------AKTYVGTNAYMAPERISGEQ---YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218 (279)
T ss_pred c-------ccCCCCChhhcCceeecCCC---CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC
Confidence 1 22347899999999986443 78999999999999999999999965332111100 0 011111111
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.. .....+.++.+||.+||..+|.+||++.+++.||||+..+
T Consensus 219 ~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 219 VL-PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CC-CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 11 1235788999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=352.54 Aligned_cols=266 Identities=26% Similarity=0.398 Sum_probs=211.6
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||+|+||.||++.+..+++.||+|++.... .........+..|+.++..+.||||+.++++|. +.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE----MLKRAETACFREERNVLVNGDCQWITTLHYAFQ-DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH----HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCE
Confidence 47999999999999999999999999999999874321 112223456778999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+||||++||+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||.|||++.+|.+||+|||++....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999999976 467899999999999999999999865 9999999999999999999999999997664
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
.... .......||+.|+|||++.... ...++.++|||||||++|+|++|+.||......+.+.. .......+
T Consensus 154 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~--i~~~~~~~ 227 (331)
T cd05624 154 QDGT----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK--IMNHEERF 227 (331)
T ss_pred CCCc----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH--HHcCCCcc
Confidence 3211 1122347999999999886421 13478899999999999999999999976655433221 11111223
Q ss_pred CCCC-CcCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 005678 640 EFPS-RPAVSNEAKDLIRRCLTYNQAE--RPDVLTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~-~~~~s~el~dLI~rCL~~dP~k--RPS~~eLl~hP~l~~~ 681 (683)
.+|. ...++.++.+||.+||..++.+ |+++.++++||||...
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 3333 2357899999999999866544 5689999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.33 Aligned_cols=253 Identities=32% Similarity=0.552 Sum_probs=209.5
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|.+.+.||+|+||.||+|.+..++..|++|.+...... ......+.+|+.+++.++||||++++++|. +.+.+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-----RREREEAIDEARVLAKLDSSYIIRYYESFL-DKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-----HHHHHHHHHHHHHHHhcCCCCeehheeeec-cCCEE
Confidence 378889999999999999999999999999987543221 223457889999999999999999999986 67789
Q ss_pred EEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
|+||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 9999999999999999653 57899999999999999999999865 9999999999999999999999999998765
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.... ......|++.|+|||++.... ++.++|||||||++|+|++|..||.......... .+.. ..+
T Consensus 153 ~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~---~~~ 218 (256)
T cd08529 153 DNTN-----FANTIVGTPYYLSPELCEDKP---YNEKSDVWALGVVLYECCTGKHPFDANNQGALIL---KIIR---GVF 218 (256)
T ss_pred Cccc-----hhhccccCccccCHHHhcCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHc---CCC
Confidence 4321 122346899999999986443 7889999999999999999999998766433221 1111 112
Q ss_pred CCC-cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 642 PSR-PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 642 p~~-~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
+.. ..++..+.++|.+||..+|++||++.++++|||+
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 222 2678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=368.76 Aligned_cols=258 Identities=30% Similarity=0.468 Sum_probs=210.5
Q ss_pred ccceeEEEEecccCceEEEEEEEccC-CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVE-HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~-g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.++|||||+++++|. ..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-~~ 137 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-------ERQAAYARSELHCLAACDHFGIVKHFDDFK-SD 137 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-------HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-EC
Confidence 44599999999999999999998777 7889999764321 122346778999999999999999999996 67
Q ss_pred ceEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 481 NTFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
+.+||||||++||+|.+++.. ..++++..+..++.||+.||.|||+.+ ||||||||.|||++.++.+||+|||+
T Consensus 138 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgl 215 (478)
T PTZ00267 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGF 215 (478)
T ss_pred CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcC
Confidence 789999999999999988743 456899999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
++.+..... .......+||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+. .+...
T Consensus 216 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~---~~~~~ 286 (478)
T PTZ00267 216 SKQYSDSVS---LDVASSFCGTPYYLAPELWERKR---YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ---QVLYG 286 (478)
T ss_pred ceecCCccc---cccccccCCCccccCHhHhCCCC---CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhC
Confidence 987643211 12233457999999999986443 8999999999999999999999997655433221 11111
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.. .+.+..++.++.+||.+||..+|.+||++.+++.|||+..
T Consensus 287 ~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 287 KY--DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CC--CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 11 1223468899999999999999999999999999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=338.91 Aligned_cols=260 Identities=22% Similarity=0.387 Sum_probs=209.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
...|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.++..++||||++++++|. ..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-~~~ 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-------DDFSLIQQEIFMVKECKHCNIVAYFGSYL-SRE 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-------chHHHHHHHHHHHHhcCCCCeeeeeEEEE-eCC
Confidence 4579999999999999999999999999999998854321 11245778999999999999999999986 677
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ |+|+||+|.|||++.++.++|+|||++..+.
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 89999999999999999987778999999999999999999999865 9999999999999999999999999998664
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.... ......|++.|+|||.+.......++.++|||||||++|+|++|..||.............. .......+
T Consensus 158 ~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 231 (267)
T cd06646 158 ATIA-----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK-SNFQPPKL 231 (267)
T ss_pred cccc-----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec-CCCCCCCC
Confidence 3211 12234688999999987543344478899999999999999999999965443322211000 00011112
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~ 677 (683)
+....++..+.+||.+||..+|.+||++.++++|+|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 222357889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=352.64 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=209.6
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC-
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ- 480 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~- 480 (683)
.-.|.-.+++|.|+||.||.|....++..||||..-.+.. .-.+|+.||..++|||||+|..+|....
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----------~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----------YKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----------cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 4468889999999999999999999999999997533322 1236999999999999999998885432
Q ss_pred ---ceEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEEE
Q 005678 481 ---NTFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKVT 552 (683)
Q Consensus 481 ---~~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL~ 552 (683)
-..++||||||. +|..+++. +..++.-.++.+..||++||.|||..+ |+||||||.|||+|. .|.+|||
T Consensus 92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEec
Confidence 246689999965 89988863 567999999999999999999999955 999999999999995 5999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|||.|+.+.....+. ....|..|.|||.+.+.. .|+.++||||.||++.||+-|++-|.+....+.+...-.
T Consensus 169 DFGSAK~L~~~epni------SYicSRyYRaPELifga~--~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik 240 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNI------SYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK 240 (364)
T ss_pred cCCcceeeccCCCce------eEEEeccccCHHHHcCcc--ccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence 999999887653322 236788999999987544 499999999999999999999999988887776643222
Q ss_pred HHH---------h--h--ccCCC----------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 633 IIK---------A--R--KVEFP----------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 633 i~~---------~--~--~~~~p----------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+.. . . ...+| ....+++++.+|+.++|.++|.+|.++.+++.||||...
T Consensus 241 ~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 241 VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 111 0 0 01111 124578999999999999999999999999999999753
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.89 Aligned_cols=263 Identities=31% Similarity=0.517 Sum_probs=213.7
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCc-eeeeccccccCCc-
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH-IVRLWDTFEIDQN- 481 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn-IV~L~~~f~~d~~- 481 (683)
.|..++.||+|.||+||+|+++.+|..||+|.+...... +-.-....||+.+++.|+|+| ||.|++++..+..
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-----EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-----EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-----cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 466677899999999999999999999999998776432 112346789999999999999 9999999875443
Q ss_pred ----eEEEEEecccCCChhHHHhcCC----CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 482 ----TFCTVLEYCSGKDLDAVLKATP----VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 482 ----~~~LV~Ey~~ggsL~~~L~~~~----~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
.+++|+||+ ..+|..++...+ .++...++.++.||+.||.|||+++ |+||||||.||||++.|.+||+|
T Consensus 87 ~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 87 RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeec
Confidence 899999999 569999997654 4778899999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||+|+...-. +.....-++|.||.|||++.+.. .|+..+||||+|||+.||++++..|......+.+...-.+
T Consensus 164 FGlAra~~ip-----~~~yt~evvTlWYRaPEvLlGs~--~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 164 FGLARAFSIP-----MRTYTPEVVTLWYRAPEVLLGST--SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred cchHHHhcCC-----cccccccEEEeeccCHHHhcCCC--cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 9999865422 22244458999999999987554 3999999999999999999999999888876665543322
Q ss_pred HHh-hccC-------------CCCC----------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 634 IKA-RKVE-------------FPSR----------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 ~~~-~~~~-------------~p~~----------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
... ..-. |+.+ +....+..+++..||.++|.+|.|+..++.||||...
T Consensus 237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 211 1111 2211 2233589999999999999999999999999999754
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.53 Aligned_cols=259 Identities=30% Similarity=0.493 Sum_probs=204.9
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|.+.+.||.|+||.||+|.+..++..||||.+....... .....+.+|+.+++.++||||+++++++. +++.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-----GVPSTAIREISLLKELQHPNIVCLQDVLM-QESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-----CchHHHHHHHHHHHhcCCCCEeeeEEEEe-eCCeE
Confidence 4788999999999999999998999999999875532211 12346778999999999999999999986 67789
Q ss_pred EEEEecccCCChhHHHhcC---CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT---PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~---~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
|+||||++ ++|..++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.+|.++|+|||++...
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 99999996 5888887432 46899999999999999999999865 999999999999999999999999999765
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH-----
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK----- 635 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~----- 635 (683)
.... .......|++.|+|||++... ..++.++|||||||++|+|++|+.||.................
T Consensus 152 ~~~~-----~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd07861 152 GIPV-----RVYTHEVVTLWYRAPEVLLGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED 224 (285)
T ss_pred CCCc-----ccccCCcccccccChHHhcCC--CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 3321 112233678999999987533 2368899999999999999999999976654433322110000
Q ss_pred ---------hhccCCC---------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 636 ---------ARKVEFP---------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 636 ---------~~~~~~p---------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.....++ ....+++++.+||.+||..||.+|||+.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000000 123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.94 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=209.9
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-Cce
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID-QNT 482 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d-~~~ 482 (683)
.|...+.||+|+||.||+|.+..++..||+|.+........ .......+.+|+.+++.++||||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE--TSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch--hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 58889999999999999999999999999998765432221 223456788999999999999999999987643 467
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++++||+++++|.+++.....+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 8899999999999999987777999999999999999999999855 99999999999999999999999999876543
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
..... .......|+..|+|||++.... ++.++|||||||++|+|++|..||........+... ........+
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~- 230 (266)
T cd06651 159 ICMSG--TGIRSVTGTPYWMSPEVISGEG---YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI--ATQPTNPQL- 230 (266)
T ss_pred ccccC--CccccCCccccccCHHHhCCCC---CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH--hcCCCCCCC-
Confidence 21110 1112235889999999986433 788999999999999999999999766544333211 111111111
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+..++..+.+|| +||..+|.+||++.++++||||+.
T Consensus 231 -~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~~ 266 (266)
T cd06651 231 -PSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQL 266 (266)
T ss_pred -chhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccccC
Confidence 235788899998 688889999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=337.56 Aligned_cols=261 Identities=26% Similarity=0.448 Sum_probs=210.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+...||.|+||.||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||++++++|. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-----VIKKIALREIRMLKQLKHPNLVNLIEVFR-RKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-----cccHHHHHHHHHHHhCCCCCEeeeeeEEe-eCCE
Confidence 47999999999999999999999899999999875432111 11245778999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++||||+++++|..++.....+++..+..++.||+.||.|||+.+ |+|+||||.||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 8999999999999988877777999999999999999999999955 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh------
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA------ 636 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~------ 636 (683)
... ......|+..|+|||++... ..++.++|||||||++|+|++|..||......+...........
T Consensus 153 ~~~-----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 153 PGD-----DYTDYVATRWYRAPELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred Ccc-----cccCcccccccCCHHHHhCC--CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 321 12233688999999987532 23788999999999999999999999876655443321111000
Q ss_pred ---------hccCCCC----------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 637 ---------RKVEFPS----------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 637 ---------~~~~~p~----------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.....|. .+.++..+.+||.+||..+|++||++.+++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0001111 13568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.39 Aligned_cols=267 Identities=23% Similarity=0.375 Sum_probs=212.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|...+.||+|+||.||+|.+..++..||+|++...... ..........+.+|+.+++.++||||++++++|. +.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-EDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC-chhHHHHHHHHHHHHHHHHHcCCCceehhhceec-cCCeE
Confidence 377889999999999999999999999999988644321 1223345678899999999999999999999986 67789
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-cEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-~vKL~DFGls~~~~~ 562 (683)
++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+|+||+|.||+++.++ .++|+|||++.....
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999999988778999999999999999999999965 99999999999998766 699999999977654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
...... .......|+..|+|||.+... .++.++|||||||++|+|++|..||..............+. .......
T Consensus 157 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (268)
T cd06630 157 KGTGAG-EFQGQLLGTIAFMAPEVLRGE---QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA-SATTAPS 231 (268)
T ss_pred ccccCC-ccccccccccceeCHhHhccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh-ccCCCCC
Confidence 321111 112334689999999988543 37889999999999999999999996543322111110110 1111112
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.++.++.++.+||.+||..+|.+||++.++++||||+
T Consensus 232 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 232 IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 2346789999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=336.80 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=208.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
..+.|.+.+.||.|+||.||+|.+..++..||+|++..... ....+..|+.++..+ +||||++++++|...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--------EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 35678889999999999999999999999999999854321 123567899999998 699999999998642
Q ss_pred -----CceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 480 -----QNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 480 -----~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
...+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||.||+++.++.++|+
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEc
Confidence 24689999999999999999653 46899999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|||++........ ......|++.|+|||++.... ...++.++|||||||++|+|++|..||...........
T Consensus 154 Dfg~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~- 227 (272)
T cd06637 154 DFGVSAQLDRTVG-----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL- 227 (272)
T ss_pred cCCCceecccccc-----cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-
Confidence 9999986543211 122346899999999986432 23488899999999999999999999976544332221
Q ss_pred HHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 631 ~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.............++..+.+||.+||..+|.+||++.+++.||||
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 228 ---IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ---HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 111111222234678999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=337.74 Aligned_cols=259 Identities=28% Similarity=0.452 Sum_probs=214.6
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||.||+|.+..++..||+|++...... .....+.+|+.+++.++||||++++++|. +...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE------DEIEDIQQEIQFLSQCRSPYITKYYGSFL-KGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc------hHHHHHHHHHHHHHHcCCCCeeeeeEEEE-ECCe
Confidence 3688899999999999999999999999999998543211 22456788999999999999999999886 6688
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+|+||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999999999999766 6899999999999999999999865 99999999999999999999999999987754
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
... ......|++.|+|||++.... ++.++|||||||++|+|++|..||.......... .+........+
T Consensus 151 ~~~-----~~~~~~~~~~y~~PE~~~~~~---~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~---~~~~~~~~~~~ 219 (274)
T cd06609 151 TMS-----KRNTFVGTPFWMAPEVIKQSG---YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF---LIPKNNPPSLE 219 (274)
T ss_pred ccc-----ccccccCCccccChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH---HhhhcCCCCCc
Confidence 321 123347889999999986544 8999999999999999999999997655433221 11122222222
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K~ 683 (683)
. ..++..+.++|.+||..+|++||++.++++||||+.+++
T Consensus 220 ~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 220 G-NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred c-cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 2 127889999999999999999999999999999998864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.53 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=214.5
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
...+|.+.+.||.|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.+.||||+++++.|. ..
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-------~~~~~~~e~~~l~~~~h~~v~~~~~~~~-~~ 89 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-------KKELIINEILVMRENKNPNIVNYLDSYL-VG 89 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-------hHHHHHHHHHHHHhCCCCCEeeEEEEEE-eC
Confidence 456899999999999999999999999999999987553321 1346788999999999999999999886 57
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
..+|+||||+++++|..++... .+++..+..++.|++.||.|||..+ |+|+||||+|||++.++.++|+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 7899999999999999998654 4899999999999999999999865 999999999999999999999999998765
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......|++.|+|||++.... ++.++|||||||++|+|++|..||........+.. +.......
T Consensus 167 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~ 235 (296)
T cd06654 167 TPEQS-----KRSTMVGTPYWMAPEVVTRKA---YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPE 235 (296)
T ss_pred ccccc-----ccCcccCCccccCHHHHcCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH---HhcCCCCC
Confidence 43211 112336899999999886433 78899999999999999999999977665443322 11112222
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.+....++..+.+||.+||.++|.+||++.+++.||||..++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 233456889999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.56 Aligned_cols=260 Identities=28% Similarity=0.446 Sum_probs=209.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+.+.||+|+||.||++.+..++..||+|.+..... ......+.+|+.++..++||||++++++|. +.+.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK------PAIRNQIIRELKVLHECNSPYIVGFYGAFY-SDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCCE
Confidence 368999999999999999999999999999998754321 123456788999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||+++++|.+++...+.+++..+..++.|++.||.|||+. .+|+|+||||.|||++.++.++|+|||++..+..
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred EEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 999999999999999998878899999999999999999999973 2599999999999999999999999999876533
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-----------
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED----------- 631 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~----------- 631 (683)
.. .....|++.|+|||++.+. .++.++|||||||++|+|++|..||.............
T Consensus 153 ~~-------~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (308)
T cd06615 153 SM-------ANSFVGTRSYMSPERLQGT---HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222 (308)
T ss_pred cc-------cccCCCCcCccChhHhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCC
Confidence 21 2234789999999987543 37889999999999999999999996543222110000
Q ss_pred ----------------------HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 632 ----------------------TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 632 ----------------------~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.+........| ...++.++.+||.+||..+|++||++.++++||||...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cccccCCCCCccchhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000001111 12367899999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.35 Aligned_cols=266 Identities=27% Similarity=0.488 Sum_probs=214.0
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCccc---chhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQW---SEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~---~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+|.+.+.||.|+||.||+|.+..++..||||.+...... .........+.+..|+.+++.++||||+++++++. ..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET-TE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec-cC
Confidence 688899999999999999999889999999987543221 11222334567889999999999999999999886 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+.+++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 789999999999999999988788999999999999999999999855 999999999999999999999999999765
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
...... .......|+..|+|||.+.... ..++.++|+||||+++|+|++|..||........+.... .......
T Consensus 159 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~ 232 (272)
T cd06629 159 DDIYDN---DQNMSMQGSVFWMAPEVIHSYS-QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG--NKRSAPP 232 (272)
T ss_pred cccccc---cccccccCCccccCHHHhcccc-CCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh--ccccCCc
Confidence 432111 1122346889999999876433 236889999999999999999999997655544332211 1111222
Q ss_pred CCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 641 FPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 641 ~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
++. .+.++..+.+||.+||.++|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 222 24678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=339.53 Aligned_cols=262 Identities=27% Similarity=0.449 Sum_probs=211.3
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.++..++||||++++++|. ..+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD------ESKFNQIIMELDILHKAVSPYIVDFYGAFF-IEGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC------HHHHHHHHHHHHHHHhcCCCcHHhhhhhee-cCCe
Confidence 368889999999999999999988999999998754321 122457889999999999999999999886 5778
Q ss_pred EEEEEecccCCChhHHHhcC---CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT---PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~---~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+++||||+++++|..++... ..+++..+..++.+++.||.|||+. .+|+|+||||+|||++.++.++|+|||++..
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99999999999999998663 3689999999999999999999963 2599999999999999999999999999876
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSK---TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~---~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+... ......|++.|+|||++.... ...++.++|||||||++|+|++|..||..............+...
T Consensus 153 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 225 (286)
T cd06622 153 LVAS-------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG 225 (286)
T ss_pred ccCC-------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc
Confidence 5332 123346889999999885432 124688999999999999999999999765443322111111222
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
....+ ++.++.++.+||.+||..+|.+||++.+++.||||...
T Consensus 226 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 226 DPPTL--PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CCCCC--CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 22222 34589999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=330.72 Aligned_cols=264 Identities=29% Similarity=0.501 Sum_probs=218.1
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||+|.+..++..|++|.+...... ......+..|+.+++.++||||+++++.+. +.+.+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-----PKTIKEIADEMKVLELLKHPNLVKYYGVEV-HREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-----hHHHHHHHHHHHHHHhCCCCChhheeeeEe-cCCEE
Confidence 688999999999999999999889999999998655332 344678999999999999999999999875 67889
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
++|+||+++++|.+++.....+++..+..++.+++.||.|||+.+ |+|+||+|.||+++.++.+||+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999999999988777899999999999999999999865 999999999999999999999999999876544
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~ 643 (683)
..... .......|++.|+|||++.......++.++||||||+++|+|++|..||........... .+.......+|.
T Consensus 153 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~ 229 (264)
T cd06626 153 TTTMG-EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF--HVGAGHKPPIPD 229 (264)
T ss_pred CCccc-ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH--HHhcCCCCCCCc
Confidence 22111 112234688999999998754433478899999999999999999999975543322221 112223344555
Q ss_pred CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 644 ~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
...++..+.+||.+||..+|.+||++.+++.||||
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 55668999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.06 Aligned_cols=254 Identities=32% Similarity=0.476 Sum_probs=213.3
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||.||++.+..++..||||++..... ........+.+|+.+++.+.||||+++++++. +.+.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI----VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-cCCe
Confidence 368999999999999999999999999999998754321 12234567889999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||+|.|||++.+|.+||+|||++.....
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999999999988888999999999999999999999955 99999999999999999999999999987643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
. .....|++.|+|||.+.... ++.++||||||+++|+|++|..||......... . .+ ..... +
T Consensus 154 ~--------~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~--~~-~~~~~--~ 216 (290)
T cd05580 154 R--------TYTLCGTPEYLAPEIILSKG---YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY-E--KI-LEGKV--R 216 (290)
T ss_pred C--------CCCCCCCccccChhhhcCCC---CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-H--HH-hcCCc--c
Confidence 3 22336899999999886443 688999999999999999999999766532211 1 11 12222 2
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~ 680 (683)
.+..++..++++|.+||..+|.+|| ++.++++||||..
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 3346789999999999999999999 8999999999865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.21 Aligned_cols=266 Identities=29% Similarity=0.490 Sum_probs=217.1
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||.||+|.+..++..||||.+....... ......+..|+.++..++||||+++++.+. +...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK----RNKVKRVLTEQEILATLDHPFLPTLYASFQ-TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch----HHHHHHHHHHHHHHHhCCCCCchhheeeee-cCCE
Confidence 36899999999999999999999899999999886542211 224567889999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 99999999999999999653 56899999999999999999999865 999999999999999999999999998765
Q ss_pred ccCcCCCc------------------------ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCC
Q 005678 561 EDDVGSQG------------------------MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRR 616 (683)
Q Consensus 561 ~~~~~~~~------------------------~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~ 616 (683)
........ ........||..|+|||++.... ++.++|||||||++|+|++|..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG---HGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC---CCchHHHHHHHHHHHHHhhCCC
Confidence 43211000 00112336899999999986433 7889999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCcccCCCC
Q 005678 617 PFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD----VLTLAQDPYLTYSK 682 (683)
Q Consensus 617 PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS----~~eLl~hP~l~~~K 682 (683)
||........... .......++....++..+.+||.+||..+|.+||+ +.+++.||||+..+
T Consensus 231 pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 231 PFKGSNRDETFSN----ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CCCCCchHHHHHH----HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 9977665443322 12233445544457999999999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.24 Aligned_cols=260 Identities=30% Similarity=0.461 Sum_probs=211.9
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
-|.+.+.||.|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||++++++|. ..+.+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-~~~~~ 77 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-------EEELEDYMVEIDILASCDHPNIVKLLDAFY-YENNL 77 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-eCCEE
Confidence 3677889999999999999999999999999874431 123467888999999999999999999886 67789
Q ss_pred EEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccc
Confidence 999999999999988753 457999999999999999999999965 99999999999999999999999999876533
Q ss_pred CcCCCcccccccCCCCCccCCccccccc--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELS--KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~--~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
.. .......||+.|+|||++... ....++.++|||||||++|+|++|.+||........... +.......
T Consensus 156 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~~~ 227 (282)
T cd06643 156 TI-----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKSEPPT 227 (282)
T ss_pred cc-----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH---HhhcCCCC
Confidence 21 112234689999999997432 233478899999999999999999999976654443322 11222222
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.+.+..++..+.+||.+||..+|.+||++.++++||||...
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 33344688999999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.39 Aligned_cols=264 Identities=27% Similarity=0.402 Sum_probs=214.3
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
..++.|++++.||.|+||.||+|.+..++..|++|++.... ......+.+|+.+++.++||||++++++|. .
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 80 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-------EEELEDYMVEIEILATCNHPYIVKLLGAFY-W 80 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-------HHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-e
Confidence 34578999999999999999999999999999999975431 123567888999999999999999999986 5
Q ss_pred CceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.+.+|+||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccce
Confidence 6789999999999999988743 456899999999999999999999865 9999999999999999999999999987
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
....... ......|++.|+|||++.... ...++.++|||||||++|+|++|..||........... +...
T Consensus 159 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~ 230 (292)
T cd06644 159 KNVKTLQ-----RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKS 230 (292)
T ss_pred ecccccc-----ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH---HhcC
Confidence 5432211 112336889999999885322 23478899999999999999999999976554332221 1222
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.....+....++.++.+||.+||..+|++||++.++++||||...
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 231 EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 222333345688999999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=353.92 Aligned_cols=253 Identities=27% Similarity=0.389 Sum_probs=196.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
...|.+++.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||++++++|. ...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------------~~~~E~~~l~~l~h~~iv~~~~~~~-~~~ 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------------TTLIEAMLLQNVNHPSVIRMKDTLV-SGA 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------------ccHHHHHHHHhCCCCCCcChhheEE-eCC
Confidence 45799999999999999999999999999999975322 2245899999999999999999986 667
Q ss_pred eEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
..|+||||+. ++|..++. ....+++..+..|+.||+.||.|||..+ ||||||||.|||++.++.+||+|||++...
T Consensus 131 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 131 ITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred eeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 8899999995 57888774 4567999999999999999999999965 999999999999999999999999999754
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCchH-H--------HHHHH
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRP-FGHDQTQ-E--------RILRE 630 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~P-F~~~~~~-e--------~il~~ 630 (683)
.... ......||+.|+|||++.... ++.++|||||||++|+|+++..| |...... . .+...
T Consensus 208 ~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~ 278 (357)
T PHA03209 208 VVAP------AFLGLAGTVETNAPEVLARDK---YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278 (357)
T ss_pred ccCc------ccccccccccccCCeecCCCC---CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence 3221 122346999999999986443 89999999999999999985544 4332111 0 00000
Q ss_pred HHHHHhhccCCC----------------------------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 631 DTIIKARKVEFP----------------------------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 631 ~~i~~~~~~~~p----------------------------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..........++ ....++.++.+||.+||.+||.+|||+.++++||||+.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000000011111 01245677888999999999999999999999999985
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=349.06 Aligned_cols=267 Identities=18% Similarity=0.262 Sum_probs=204.6
Q ss_pred EEEEeccc--CceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 407 LLNLLGKG--GFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 407 l~~~LGkG--gfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
++.+||+| +||+||++.+..+|..||+|.+...... ......+.+|+.+++.++||||++++++|. ..+.+|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-----NEMVTFLQGELHVSKLFNHPNIVPYRATFI-ADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-----HHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-ECCEEE
Confidence 46789999 7899999999999999999998554321 122456778999999999999999999986 667899
Q ss_pred EEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 485 TVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+||||+++++|.+++..+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+.....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 999999999999999643 45899999999999999999999865 99999999999999999999999987654322
Q ss_pred CcCCC--cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh----
Q 005678 563 DVGSQ--GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA---- 636 (683)
Q Consensus 563 ~~~~~--~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~---- 636 (683)
..... .........++..|+|||++.... ..++.++|||||||++|+|++|..||..................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNL-QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 232 (327)
T ss_pred ccccccccccccccccceecccChHHhhccc-CCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence 11100 011122346788899999986432 23789999999999999999999999765443322211000000
Q ss_pred ------hc------------------------------cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 ------RK------------------------------VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ------~~------------------------------~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.. ...+....+++.+.+||.+||.+||.+|||+.++++||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 00 000111235778999999999999999999999999999987
Q ss_pred CC
Q 005678 681 SK 682 (683)
Q Consensus 681 ~K 682 (683)
.|
T Consensus 313 ~~ 314 (327)
T cd08227 313 IK 314 (327)
T ss_pred cc
Confidence 65
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.88 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=191.3
Q ss_pred EEEecccCceEEEEEEEc--cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc-CCceEE
Q 005678 408 LNLLGKGGFSEVYKAYDL--VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-DQNTFC 484 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~--~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-d~~~~~ 484 (683)
...||+|+||+||+|.+. .++..||+|.+..... ...+.+|+.+++.++||||++++++|.. ....+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---------SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 467999999999999865 4678999998754321 1246789999999999999999998853 345789
Q ss_pred EEEecccCCChhHHHhcC---------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe----CCCCcEEE
Q 005678 485 TVLEYCSGKDLDAVLKAT---------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVAKV 551 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~---------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL----d~~g~vKL 551 (683)
+||||++ ++|..++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEE
Confidence 9999995 5888877422 25899999999999999999999865 9999999999999 45679999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH-------
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ------- 624 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~------- 624 (683)
+|||++........ .........||+.|+|||++... ..++.++|||||||++|+|++|.+||......
T Consensus 154 ~DfG~a~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~ 229 (317)
T cd07868 154 ADMGFARLFNSPLK--PLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 229 (317)
T ss_pred eecCceeccCCCCc--cccccCCccccccccCCHHHcCC--CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccc
Confidence 99999987653321 11122345789999999988642 23788999999999999999999999643321
Q ss_pred --HH---HHHH---------HHHH----------HhhccCCC----------CCcCCCHHHHHHHHHhcccCCCCCCCHH
Q 005678 625 --ER---ILRE---------DTII----------KARKVEFP----------SRPAVSNEAKDLIRRCLTYNQAERPDVL 670 (683)
Q Consensus 625 --e~---il~~---------~~i~----------~~~~~~~p----------~~~~~s~el~dLI~rCL~~dP~kRPS~~ 670 (683)
.. ++.. ..+. ......+. .....+..+.+||.+||.+||.+|||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~ 309 (317)
T cd07868 230 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 309 (317)
T ss_pred cHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHH
Confidence 00 0000 0000 00000000 0112356789999999999999999999
Q ss_pred HHhcCccc
Q 005678 671 TLAQDPYL 678 (683)
Q Consensus 671 eLl~hP~l 678 (683)
++++||||
T Consensus 310 e~l~hp~f 317 (317)
T cd07868 310 QAMQDPYF 317 (317)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.17 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=215.2
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
...+|.+.+.||.|+||.||+|.+..++..|+||.+..... .....+.+|+.+++.++||||++++++|. +.
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-------PKKELIINEILVMKELKNPNIVNFLDSFL-VG 88 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-------chHHHHHHHHHHHHhcCCCceeeeeeeEe-cC
Confidence 44679999999999999999999999999999998754321 11346788999999999999999999986 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+.+|+|+||+++++|..++... .+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 7899999999999999998755 4899999999999999999999965 999999999999999999999999998765
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......|++.|+|||.+.... ++.++|||||||++|+|++|..||........... +.......
T Consensus 166 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~~~~~~~ 234 (296)
T cd06655 166 TPEQS-----KRSTMVGTPYWMAPEVVTRKA---YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGTPE 234 (296)
T ss_pred ccccc-----cCCCcCCCccccCcchhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCcc
Confidence 43211 112336899999999886443 78899999999999999999999987665443322 11122222
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
+..+..++..+.+||.+||..+|.+||++.+++.||||..++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 333456889999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=358.88 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=201.6
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
+.++...++.|.-.+.||+||||.||+|. ..+|..||||.+....... .++|.+|+.++.+++|||+|+|+|
T Consensus 67 ~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~-l~~~~~vAVK~~~~~~~~~-------~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 67 YDELRKATNNFSESNLIGEGGFGTVYKGV-LSDGTVVAVKRLSSNSGQG-------EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred HHHHHHHHhCCchhcceecCCCeEEEEEE-ECCCCEEEEEEecCCCCcc-------hhHHHHHHHHHhcCCCcCcccEEE
Confidence 34445567889889999999999999997 4556999999765432211 345999999999999999999999
Q ss_pred ccccCCc-eEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcC-CceEecccCCcceEeCCCCcEE
Q 005678 475 TFEIDQN-TFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRA-QKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 475 ~f~~d~~-~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g-~~IIHrDLKP~NILLd~~g~vK 550 (683)
+|. +.+ ..+||||||++|+|.++|.... +++|..+..|+.++|.||.|||... ++||||||||+|||||+++.+|
T Consensus 139 yC~-e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 139 YCL-EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEe-cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 996 555 5999999999999999996554 8999999999999999999999964 3799999999999999999999
Q ss_pred EEecCCcccccc-CcCCCcccccccC-CCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCc--hHHH
Q 005678 551 VTDFGLSKIVED-DVGSQGMELTSQG-AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQ--TQER 626 (683)
Q Consensus 551 L~DFGls~~~~~-~~~~~~~~l~~~~-~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~--~~e~ 626 (683)
|+|||+|+..+. ... .... .||.+|+|||++..+. ++.|+|||||||+|+||++|+.|..... ....
T Consensus 218 lsDFGLa~~~~~~~~~------~~~~~~gt~gY~~PEy~~~g~---lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~ 288 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTS------VSTTVMGTFGYLAPEYASTGK---LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS 288 (361)
T ss_pred ccCccCcccCCccccc------eeeecCCCCccCChhhhccCC---cCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence 999999976654 211 1111 7999999999987544 8999999999999999999999887543 1111
Q ss_pred HHH--HHHHHHhhccCCCCC----cCCC-----HHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 627 ILR--EDTIIKARKVEFPSR----PAVS-----NEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 627 il~--~~~i~~~~~~~~p~~----~~~s-----~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+.. ...+.......+.++ ...+ ..+..+..+|+..+|..||++.+++.
T Consensus 289 l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 289 LVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111 111111111111110 1122 23567888999999999999998754
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=330.76 Aligned_cols=263 Identities=27% Similarity=0.418 Sum_probs=209.9
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-Cc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID-QN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d-~~ 481 (683)
..|.+.+.||+|+||.||.|.+..++..||||.+........ ....+..+.+|+.+++.+.||||++++++|... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPE--TSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMER 79 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcc--cHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCc
Confidence 468899999999999999999999999999998754322211 122356788999999999999999999988643 35
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++||||+++++|.+++.....+++..+..++.+++.||.|||+.+ |+|+||||.|||++.++.++|+|||++....
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 78899999999999999988777899999999999999999999865 9999999999999999999999999987654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
...... .......|+..|+|||++.... ++.++|||||||++|+|++|+.||........+.. .. ......
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~-~~~~~~ 228 (265)
T cd06652 158 TICLSG--TGMKSVTGTPYWMSPEVISGEG---YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK---IA-TQPTNP 228 (265)
T ss_pred cccccc--cccccCCCCccccChhhhcCCC---CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH---Hh-cCCCCC
Confidence 221100 1122336889999999986433 78899999999999999999999976544333221 11 111111
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
..++.++..+.++|.+||. +|..||++.++++|||+.
T Consensus 229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 1234678889999999994 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=357.91 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=205.0
Q ss_pred cccccceeEEEEecccCceEEEEEEEc--cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDL--VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~--~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
.++..+|.++..||.|+||.||+|... .++..||+|.+... ....+|+.+++.++|||||+++++|
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------------~~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------------KTPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------------ccHHHHHHHHHhcCCCCccceeeeE
Confidence 456778999999999999999999753 45688999986432 1245799999999999999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
. ....+|+|||++. ++|..++.....+++..+..|+.||+.||.|||..+ ||||||||+|||++.++.++|+|||+
T Consensus 156 ~-~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 156 R-WKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred e-eCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCcc
Confidence 6 5678999999994 688888877778999999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ---ERILREDTI 633 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~---e~il~~~~i 633 (683)
+..+...... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||...... ..+......
T Consensus 232 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~ 305 (392)
T PHA03207 232 ACKLDAHPDT---PQCYGWSGTLETNSPELLALDP---YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305 (392)
T ss_pred ccccCccccc---ccccccccccCccCHhHhcCCC---CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence 9766443211 1122347999999999986443 889999999999999999999999654321 111110000
Q ss_pred HHhhccCCC-----------------------C-----CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 634 IKARKVEFP-----------------------S-----RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 ~~~~~~~~p-----------------------~-----~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.......++ . ...++.++.+||.+||.++|.+||++.+++.||||...
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 000001111 0 12346789999999999999999999999999999753
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.52 Aligned_cols=261 Identities=24% Similarity=0.402 Sum_probs=212.6
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+.+.||.|+||+||+|....++..||+|++....... ....+.+|+.+++.++||||+++++.+. ..+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT------SVDELRKEVQAMSQCNHPNVVKYYTSFV-VGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch------HHHHHHHHHHHHHhcCCCCEEEEEEEEe-eCCE
Confidence 46899999999999999999988899999999885432211 3567889999999999999999999886 6788
Q ss_pred EEEEEecccCCChhHHHhcC---CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT---PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~---~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 99999999999999999653 45899999999999999999999865 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
+....... ........|++.|+|||++... ..++.++|+|||||++|+|++|..||........... .......
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~---~~~~~~~ 225 (267)
T cd06610 152 LADGGDRT-RKVRKTFVGTPCWMAPEVMEQV--HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML---TLQNDPP 225 (267)
T ss_pred hccCcccc-ccccccccCChhhcChHHHccc--cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH---HhcCCCC
Confidence 76542211 0122334689999999988654 2378899999999999999999999976655432222 1111112
Q ss_pred CCCCC---cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 640 EFPSR---PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 640 ~~p~~---~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.++.. ..++..+.+||.+||..+|.+||++.+++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 22221 3678999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.42 Aligned_cols=257 Identities=30% Similarity=0.508 Sum_probs=224.9
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|..++.+|+|+||.++++..+..+..|++|.+.......... +.+..|+.+++++.|||||.+++.|..++..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-----~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-----RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-----HHHHHHHHHHHhccCCCeeeeccchhcCCce
Confidence 56889999999999999999999999999999988776654432 3788999999999999999999999866666
Q ss_pred EEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+||||+||+||+|...|++. ..++++.+..++.|++.|+.|||+. .|+|||||+.|||++.++.|+|+|||+|+.+
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~--~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN--RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh--hhhcccchhhhhhccccCceeecchhhhhhc
Confidence 99999999999999999543 4689999999999999999999974 5999999999999999999999999999998
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
.... .+..+.+|||.||+||.+.... |..|+|||||||++|||++-+++|.......-+.... ...-
T Consensus 157 ~~~~-----~~a~tvvGTp~YmcPEil~d~p---Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-----~~~~ 223 (426)
T KOG0589|consen 157 NPED-----SLASTVVGTPYYMCPEILSDIP---YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-----RGLY 223 (426)
T ss_pred CCch-----hhhheecCCCcccCHHHhCCCC---CCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-----hccC
Confidence 7653 3566779999999999997555 9999999999999999999999998887766554322 1224
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.|.+...+.++..+|..||..+|..||++.+||.+|.++
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 566678999999999999999999999999999999876
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.09 Aligned_cols=258 Identities=23% Similarity=0.393 Sum_probs=201.6
Q ss_pred cccceeEEEEecccCceEEEEEEEcc----------------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLV----------------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~----------------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L 464 (683)
..++|.+.+.||+|+||.||+|.+.. ++..||||++..... ......+.+|+.++..+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l 76 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN------KNARNDFLKEVKILSRL 76 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC------HHHHHHHHHHHHHHhhc
Confidence 45689999999999999999997532 345799998865321 12345788999999999
Q ss_pred CCCceeeeccccccCCceEEEEEecccCCChhHHHhcC-------------------CCcchHHHHHHHHHHHHHHHHHH
Q 005678 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-------------------PVLPEREARIIIVQIFQGLIYLN 525 (683)
Q Consensus 465 ~HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-------------------~~Lse~~~~~I~~qIa~aL~yLH 525 (683)
+||||++++++|. +.+.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||
T Consensus 77 ~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 155 (304)
T cd05096 77 KDPNIIRLLGVCV-DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155 (304)
T ss_pred CCCCeeEEEEEEe-cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999986 567899999999999999998543 23677889999999999999999
Q ss_pred hcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHH
Q 005678 526 KRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAG 605 (683)
Q Consensus 526 ~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLG 605 (683)
+.+ |+||||||+|||++.++.+||+|||+++.+..... ........+++.|+|||++.... ++.++||||||
T Consensus 156 ~~~--ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG 227 (304)
T cd05096 156 SLN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY---YRIQGRAVLPIRWMAWECILMGK---FTTASDVWAFG 227 (304)
T ss_pred HCC--ccccCcchhheEEcCCccEEECCCccceecccCce---eEecCcCCCCccccCHHHHhcCC---CCchhhhHHHH
Confidence 965 99999999999999999999999999986543211 11223345688899999986443 89999999999
Q ss_pred HHHHHHHc--CCCCCCCCchHHHHHHHHHHHHh--hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 606 ILFYQMLF--GRRPFGHDQTQERILREDTIIKA--RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 606 vILyELLt--G~~PF~~~~~~e~il~~~~i~~~--~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
|++|+|++ +..||........+......... .......++.++..+.+||.+||..+|.+|||+.++.
T Consensus 228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 99999986 66788766554433221111111 1111223457899999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.60 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=212.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
...+|.+++.||.|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||++++++|. ..
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~ 88 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-------KKELIINEILVMRENKNPNIVNYLDSYL-VG 88 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-------hHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 457899999999999999999999999999999988543221 1245788999999999999999999986 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+.+|+||||+++++|..++... .+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 7899999999999999998654 4899999999999999999999865 999999999999999999999999998765
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......|++.|+|||.+.... ++.++|||||||++|+|++|..||........... +.......
T Consensus 166 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~ 234 (297)
T cd06656 166 TPEQS-----KRSTMVGTPYWMAPEVVTRKA---YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGTPE 234 (297)
T ss_pred cCCcc-----CcCcccCCccccCHHHHcCCC---CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---eccCCCCC
Confidence 43221 112236899999999886433 78899999999999999999999976554332211 11111222
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
...+..++..+.+||.+||..+|.+||++.++++||||..++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 223346788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.52 Aligned_cols=262 Identities=25% Similarity=0.458 Sum_probs=214.9
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.++|.+++.||.|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++.|. +..
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-------EEELEDFMVEIDILSECKHPNIVGLYEAYF-YEN 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-------HHHHHHHHHHHHHHHhCCCCceeEEEEEEe-cCC
Confidence 356889999999999999999988899999999875431 123467888999999999999999999986 677
Q ss_pred eEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+|+||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhh
Confidence 89999999999999999865 356999999999999999999999965 999999999999999999999999998765
Q ss_pred ccCcCCCcccccccCCCCCccCCccccccc--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELS--KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~--~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
..... ......|++.|+|||++... ....++.++|||||||++|+|++|..||........+.. +.....
T Consensus 154 ~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~ 225 (280)
T cd06611 154 KSTLQ-----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK---ILKSEP 225 (280)
T ss_pred ccccc-----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH---HhcCCC
Confidence 43211 12234689999999987532 223478899999999999999999999977654433321 122222
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..+..+..++.++.+||.+||..+|.+||++.++++||||...
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 2333345688999999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=338.67 Aligned_cols=246 Identities=18% Similarity=0.232 Sum_probs=200.4
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc--C-CceEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI--D-QNTFCT 485 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~--d-~~~~~L 485 (683)
..||+|++|.||+|.+ +|+.||||.+..... .....++.+.+|+.++.+++|||||+++++|.. + ...+++
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK----GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc----ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEE
Confidence 5799999999999964 799999999865422 122335678899999999999999999998853 2 357899
Q ss_pred EEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcC
Q 005678 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVG 565 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~ 565 (683)
||||+++|+|.+++.....+++.....++.+++.||.|||.. .+++||||||.|||++.++.+||+|||+++.+....
T Consensus 100 v~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 100 ILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred EEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999999998888899999999999999999999974 248899999999999999999999999998654321
Q ss_pred CCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCc
Q 005678 566 SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP 645 (683)
Q Consensus 566 ~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~ 645 (683)
....||+.|+|||++.... ..++.++|||||||++|+|++|..||......+.. . . .......++.+.
T Consensus 178 -------~~~~~~~~y~aPE~~~~~~-~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~-~--~-i~~~~~~~~~~~ 245 (283)
T PHA02988 178 -------FKNVNFMVYFSYKMLNDIF-SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY-D--L-IINKNNSLKLPL 245 (283)
T ss_pred -------ccccCcccccCHHHhhhcc-ccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH-H--H-HHhcCCCCCCCC
Confidence 1236899999999986421 34899999999999999999999999876544322 1 1 111222333334
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 646 AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 646 ~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.++..+++||.+||..||.+|||+.+++.
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 68999999999999999999999999985
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=328.56 Aligned_cols=260 Identities=25% Similarity=0.433 Sum_probs=212.7
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.++|.+.+.||.|+||.||+|.+..++..+++|++..... .....+.+|+.+++.++||||+++++++. +.+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-------DDFEIIQQEISMLKECRHPNIVAYFGSYL-RRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-------hhHHHHHHHHHHHHhCCCCChhceEEEEE-eCC
Confidence 3679999999999999999999988999999999865422 13467889999999999999999999885 678
Q ss_pred eEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+|++|||+++++|..++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhh
Confidence 899999999999999999765 67999999999999999999999865 999999999999999999999999999766
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......|+..|+|||.+.....+.++.++|||||||++|+|++|..||.............. .......
T Consensus 152 ~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-~~~~~~~ 225 (262)
T cd06613 152 TATIA-----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-SNFPPPK 225 (262)
T ss_pred hhhhh-----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCCCcc
Confidence 43211 11223688999999998655333578899999999999999999999977665443322110 0001111
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~ 677 (683)
......++.++.+||.+||..+|..||++.+++.|||
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 1223456788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.23 Aligned_cols=261 Identities=26% Similarity=0.436 Sum_probs=209.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||.||+|.+..++..||+|++....... .....+.+|+.++..++||||++++++|. +...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-----MVKKIAMREIRMLKQLRHENLVNLIEVFR-RKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-----hhhHHHHHHHHHHHhcCCcchhhHHHhcc-cCCe
Confidence 46899999999999999999998899999999875433221 12346778999999999999999999996 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||+++++|..+......+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+..
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999999999988876667999999999999999999999865 99999999999999999999999999987643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh------
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA------ 636 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~------ 636 (683)
... ......|+.+|+|||++... ..++.++|||||||++|+|++|.+||......+...........
T Consensus 153 ~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 153 PGE-----VYTDYVATRWYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred Ccc-----ccCcccceeeccCcHHhccc--cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence 321 12234688999999988532 33678999999999999999999999765543322211100000
Q ss_pred ---------hccCCC----------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 637 ---------RKVEFP----------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 637 ---------~~~~~p----------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.....+ ..+.++..+.+||.+||..+|.+||++.+++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000111 124678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=335.11 Aligned_cols=266 Identities=25% Similarity=0.412 Sum_probs=212.1
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeec
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLW 473 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~ 473 (683)
|..+....++|.+++.||+|+||.||+|.+..++..||+|++..... ....+.+|+.++..+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~e~~~l~~l~~h~~i~~~~ 81 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--------IDEEIEAEYNILKALSDHPNVVKFY 81 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--------hHHHHHHHHHHHHHHhcCCCeeeee
Confidence 44556688999999999999999999999999999999998643211 123566799999999 699999999
Q ss_pred cccc----cCCceEEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC
Q 005678 474 DTFE----IDQNTFCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE 545 (683)
Q Consensus 474 ~~f~----~d~~~~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~ 545 (683)
++|. .+++.+++||||+++++|..++. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~ 159 (286)
T cd06638 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTT 159 (286)
T ss_pred eeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECC
Confidence 9873 24567999999999999998874 3356889999999999999999999865 999999999999999
Q ss_pred CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCch
Q 005678 546 FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQT 623 (683)
Q Consensus 546 ~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~ 623 (683)
++.++|+|||++..+..... ......|++.|+|||++.... ...++.++|||||||++|+|++|..||.....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred CCCEEEccCCceeecccCCC-----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 99999999999986643211 112336899999999885321 23478899999999999999999999976654
Q ss_pred HHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 624 QERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 624 ~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
...+... ..........+..++..+.+||.+||..+|++||++.++++||||
T Consensus 235 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 235 MRALFKI---PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred hHHHhhc---cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 4333211 111111222234568899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=326.95 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=211.5
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|...+.||.|+||.||+|.+..++..|++|.+....... ......+.+.+|+.+++.++||||+++++++. +...+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ--TGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-EEDNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc--cchHHHHHHHHHHHHHHhcCCCCchheeeeEe-cCCeE
Confidence 4777899999999999999998899999999875432211 12234567889999999999999999999886 67789
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999999999988778999999999999999999999865 999999999999999999999999998876433
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~ 643 (683)
. ......|++.|+|||.+.... .++.++|+|||||++|+|++|..||............. .. ......
T Consensus 156 ~------~~~~~~~~~~y~~pe~~~~~~--~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~-~~~~~~ 223 (258)
T cd06632 156 S------FAKSFKGSPYWMAPEVIAQQG--GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG---RS-KELPPI 223 (258)
T ss_pred c------cccccCCCcceeCHHHhcCCC--CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH---hc-ccCCCc
Confidence 2 122346899999999875332 37889999999999999999999997765433332211 10 111112
Q ss_pred CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 644 ~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
++.++..+.+||.+||..+|.+||++.+++.||||
T Consensus 224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 34678999999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=366.82 Aligned_cols=254 Identities=31% Similarity=0.478 Sum_probs=215.0
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEec
Q 005678 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEY 489 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey 489 (683)
+||+|.||+||.|+|..+....|||-+.. +...+.+-+..|+..++.|+|.|||+++|+|. .++++-|+||-
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe-------kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-enGf~kIFMEq 653 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE-------KDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-ENGFFKIFMEQ 653 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc-------ccchhhccHHHHHHHHHHHhhHhHHHHhhccC-CCCeEEEEeec
Confidence 69999999999999999999999997632 22334567889999999999999999999986 67799999999
Q ss_pred ccCCChhHHHh-cCCCc--chHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEEEecCCccccccCcC
Q 005678 490 CSGKDLDAVLK-ATPVL--PEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKVTDFGLSKIVEDDVG 565 (683)
Q Consensus 490 ~~ggsL~~~L~-~~~~L--se~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL~DFGls~~~~~~~~ 565 (683)
.|||+|.++|. .-+++ .+..+-.+.+||+.||.|||+ +.|||||||.+|||++. .|.+||+|||.|+.+..-
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-- 729 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-- 729 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhccC--
Confidence 99999999995 44777 788889999999999999998 45999999999999984 799999999999877532
Q ss_pred CCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCc
Q 005678 566 SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP 645 (683)
Q Consensus 566 ~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~ 645 (683)
. +.+-+..||..|||||++..+..+ |...+|||||||++.||.||++||....+....+-. ...-++..|.+.
T Consensus 730 -n--P~TETFTGTLQYMAPEvIDqG~RG-YG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---VGmyKvHP~iPe 802 (1226)
T KOG4279|consen 730 -N--PCTETFTGTLQYMAPEVIDQGPRG-YGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---VGMYKVHPPIPE 802 (1226)
T ss_pred -C--ccccccccchhhhChHhhccCCcC-CCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---hcceecCCCCcH
Confidence 1 335566899999999999876644 899999999999999999999999876665543321 122333445556
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 646 AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 646 ~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.+|.+++.||.+|+.++|.+||++.++|.+||++..+
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 7899999999999999999999999999999999874
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.95 Aligned_cols=254 Identities=28% Similarity=0.506 Sum_probs=210.9
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.++|.+.+.||.|+||.||+|....++..|++|.+..... ...+.+|+.+++.++||||++++++|. +..
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---------LQEIIKEISILKQCDSPYIVKYYGSYF-KNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---------HHHHHHHHHHHHhCCCCcEeeeeeeee-cCC
Confidence 3578899999999999999999888899999998743211 467889999999999999999999986 568
Q ss_pred eEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+|+++||+++++|.+++.. ...+++..+..++.+++.||.|||..+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhc
Confidence 89999999999999999964 457899999999999999999999865 999999999999999999999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......|+..|+|||++... .++.++|||||||++|+|++|+.||............ .......
T Consensus 150 ~~~~~-----~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~ 218 (256)
T cd06612 150 TDTMA-----KRNTVIGTPFWMAPEVIQEI---GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---PNKPPPT 218 (256)
T ss_pred ccCcc-----ccccccCCccccCHHHHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---ccCCCCC
Confidence 54321 12234588999999988644 3789999999999999999999999765554332211 1111122
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
+.....++.++.+||.+||..+|.+||++.+++.||||
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 23334678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=330.85 Aligned_cols=261 Identities=25% Similarity=0.433 Sum_probs=211.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~ 478 (683)
..+++|.+.+.||.|+||.||+|.+..++..|++|++..... ....+.+|+.+++.+ .||||++++++|..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--------EEEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--------hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 346899999999999999999999988999999999854321 134678899999999 79999999999853
Q ss_pred C-----CceEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcE
Q 005678 479 D-----QNTFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA 549 (683)
Q Consensus 479 d-----~~~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~v 549 (683)
. ...+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 75 KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred cCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeE
Confidence 2 3458999999999999998853 357899999999999999999999865 9999999999999999999
Q ss_pred EEEecCCccccccCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
+|+|||++....... .......|++.|+|||.+.... ...++.++|||||||+||+|++|..||........+
T Consensus 153 ~l~d~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 227 (275)
T cd06608 153 KLVDFGVSAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL 227 (275)
T ss_pred EECCCccceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH
Confidence 999999987654322 1123346899999999875432 345788999999999999999999999765443333
Q ss_pred HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 628 l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.. +.......+.....++..+.+||.+||..||.+|||+.+++.|||+
T Consensus 228 ~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 228 FK---IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HH---hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 22 1222222223333478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.33 Aligned_cols=262 Identities=26% Similarity=0.443 Sum_probs=212.5
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.+.|.+++.||+|+||+||++.+..++..||+|++..... ......+.+|+.++..++||||+++++++. +.+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 76 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK------SSVRKQILRELQIMHECRSPYIVSFYGAFL-NEN 76 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc------chHHHHHHHHHHHHHHcCCCCcceEeeeEe-cCC
Confidence 4678889999999999999999999999999998754321 223457889999999999999999999986 568
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++||||+++++|..++...+.+++..+..++.+++.||.|||+. ++|+|+||+|.||+++.++.++|+|||++....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 8999999999999999998877899999999999999999999973 249999999999999999999999999987553
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHH-------HHHH-HHHH
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE-------RILR-EDTI 633 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e-------~il~-~~~i 633 (683)
... .....|+..|+|||++... .++.++|||||||++|+|++|..||....... .+.. ...+
T Consensus 156 ~~~-------~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 156 NSI-------ADTFVGTSTYMSPERIQGG---KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred hhc-------cCccccCcccCCHHHHccC---CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 221 1234789999999988644 37889999999999999999999997554321 0111 0111
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.......++ ...++..+.+||.+||..||.+||++.++++||||..++
T Consensus 226 ~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 226 VQEPPPRLP-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhccCCCCC-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 111111121 123788999999999999999999999999999997764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=330.21 Aligned_cols=254 Identities=30% Similarity=0.488 Sum_probs=212.3
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||+|.+..++..||+|++....... ......+.+|+.++++++||||++++++|. ++..+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE----KGSVRNVLNERRILQELNHPFLVNLWYSFQ-DEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc----hhHHHHHHHHHHHHHhCCCCChHHHHHhhc-CCCeE
Confidence 4889999999999999999998899999999885432211 123567889999999999999999999986 67789
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
++|+||+.|++|..++.....+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999999999987778999999999999999999999865 999999999999999999999999998876443
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHHHhhccCC
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT--QERILREDTIIKARKVEF 641 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~--~e~il~~~~i~~~~~~~~ 641 (683)
. ......|+..|+|||++.... ++.++|+||||+++|+|++|..||..... ...+.. .......
T Consensus 154 ~------~~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~ 219 (258)
T cd05578 154 T------LTTSTSGTPGYMAPEVLCRQG---YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA-----KQETADV 219 (258)
T ss_pred c------cccccCCChhhcCHHHHcccC---CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH-----Hhccccc
Confidence 2 112336889999999986544 78899999999999999999999986654 222211 1111223
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCH--HHHhcCccc
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDV--LTLAQDPYL 678 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~--~eLl~hP~l 678 (683)
..++.++..+.++|.+||..+|.+||+. .+++.||||
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 3345688999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.20 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=208.5
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|.+.+.||.|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.+.||||+++++.|. ..+.+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~ 74 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE------AIQKQILRELDILHKCNSPYIVGFYGAFY-NNGDI 74 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh------HHHHHHHHHHHHHHHCCCCchhhhheeee-cCCEE
Confidence 577788999999999999999999999999988654321 23456788999999999999999999986 56889
Q ss_pred EEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHh-cCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNK-RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~-~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
++|+||+++++|.+++... ..+++..+..++.+++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999999999999765 779999999999999999999998 55 9999999999999999999999999987654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHH-HHHHHHhhcc
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT-QERILR-EDTIIKARKV 639 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~e~il~-~~~i~~~~~~ 639 (683)
.... ....|++.|+|||++... .++.++||||||+++|+|++|..||..... ...... ...+......
T Consensus 153 ~~~~-------~~~~~~~~y~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (265)
T cd06605 153 NSLA-------KTFVGTSSYMAPERIQGN---DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222 (265)
T ss_pred HHHh-------hcccCChhccCHHHHcCC---CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC
Confidence 3211 114788999999998654 378999999999999999999999965421 111111 1111111111
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..+. ..++.++.+||.+||..+|.+||++.+++.||||+.
T Consensus 223 ~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 223 RLPS-GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred CCCh-hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 2221 127889999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=333.34 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=210.1
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~ 478 (683)
...++|.+...||.|+||.||+|.+..++..||+|++..... ....+.+|+.++..+ +||||++++++|..
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--------~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--------VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--------HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 356789999999999999999999999999999998743211 123456788899998 89999999998853
Q ss_pred C----CceEEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 479 D----QNTFCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 479 d----~~~~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
. .+.+++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+|
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEE
Confidence 2 246899999999999999885 3456899999999999999999999865 99999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il 628 (683)
|+|||++......... .....|++.|+|||++.... ...++.++|||||||++|+|++|+.||........+.
T Consensus 169 l~dfg~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~ 243 (291)
T cd06639 169 LVDFGVSAQLTSTRLR-----RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243 (291)
T ss_pred Eeecccchhccccccc-----ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH
Confidence 9999998866432211 12236899999999875432 1236889999999999999999999997665443332
Q ss_pred HHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 629 REDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 629 ~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
. +.......+.....++..+.+||.+||..+|.+||++.++++||||+
T Consensus 244 ~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 244 K---IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred H---HhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2 11122222233345778999999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=331.02 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=204.5
Q ss_pred cccceeEEEEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
..+.|.+.+.||+|+||.||+|.+. ..+.+||+|++..... ......+.+|+.++..++||||+++++++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS------DKQRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC------HHHHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 4567999999999999999999764 4567899998865321 122457889999999999999999999986
Q ss_pred cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
..+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||.
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 77 -RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred -cCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcc
Confidence 677899999999999999999653 57899999999999999999999865 99999999999999999999999998
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
+....... ........+++.|+|||++.... ++.++|||||||++|+|++ |..||......+.+. .+.
T Consensus 154 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~---~~~- 222 (266)
T cd05064 154 LQEDKSEA----IYTTMSGKSPVLWAAPEAIQYHH---FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK---AVE- 222 (266)
T ss_pred cccccccc----hhcccCCCCceeecCHHHHhhCC---ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HHH-
Confidence 76542211 11122345678899999886443 8899999999999999775 999997765543221 111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+.+..++..+.+++.+||..+|.+||++.+|++
T Consensus 223 -~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 223 -DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 12234555678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=324.54 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=208.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc-CCce
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-DQNT 482 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-d~~~ 482 (683)
+|.+.+.||.|+||.||++.+..++..||+|++...... ......+..|+.+++.++||||+++++.+.. ....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-----EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-----HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCE
Confidence 488899999999999999999999999999987554221 1224567889999999999999999987753 3567
Q ss_pred EEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhc---CCceEecccCCcceEeCCCCcEEEEecC
Q 005678 483 FCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKR---AQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~---g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
++++|||+++++|.+++.. ...+++..++.++.+|+.||.|||.. ..+|+|+||+|+||+++.++.+||+|||
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccc
Confidence 8999999999999999954 35789999999999999999999933 2459999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++........ ......|++.|+|||.+.... ++.++||||||+++|+|++|..||....... ... .+..
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~~~~~pE~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~--~~~~ 224 (265)
T cd08217 156 LAKILGHDSS-----FAKTYVGTPYYMSPEQLNHMS---YDEKSDIWSLGCLIYELCALSPPFTARNQLQ-LAS--KIKE 224 (265)
T ss_pred ccccccCCcc-----cccccccCCCccChhhhcCCC---CCchhHHHHHHHHHHHHHHCCCcccCcCHHH-HHH--HHhc
Confidence 9987654321 122346899999999986443 7889999999999999999999998765322 211 1111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
. ...+.+..++..+.+++.+||..+|.+||++.++++|||+
T Consensus 225 ~--~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 G--KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred C--CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 1 1112234688999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.07 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=207.9
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||+|.+..++..||||.+....... .....+.+|+.+++.++||||+++++.+. ..+.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-----DERLAAQNECQVLKLLSHPNIIEYYENFL-EDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-----HHHHHHHHHHHHHhhCCCCchhheeeeEe-cCCEE
Confidence 5899999999999999999999999999999886543211 22457889999999999999999999886 67789
Q ss_pred EEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC-CcEEEEecCCcccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF-GVAKVTDFGLSKIV 560 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~-g~vKL~DFGls~~~ 560 (683)
++||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||+|.||+++.+ +.++|+|||++...
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 9999999999999999653 45899999999999999999999855 9999999999999854 56899999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... .....|++.|+|||++.... ++.++||||||+++|+|++|..||........... +... ..
T Consensus 153 ~~~~~------~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~---~~~~--~~ 218 (256)
T cd08220 153 SSKSK------AYTVVGTPCYISPELCEGKP---YNQKSDIWALGCVLYELASLKRAFEAANLPALVLK---IMSG--TF 218 (256)
T ss_pred CCCcc------ccccccCCcccCchhccCCC---CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH---HHhc--CC
Confidence 54321 12236889999999986433 78899999999999999999999977654432221 1111 11
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.+....++.++.+||.+||..+|.+|||+.+++.||||
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 22234588999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=374.43 Aligned_cols=267 Identities=29% Similarity=0.416 Sum_probs=220.0
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDT 475 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~ 475 (683)
-+.+-.+++++.+.|.+|||+.||+|.+...|..||||.+-.. .+.....+.+|+.+|+.|+ |+|||.++|.
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-------de~~L~~v~~EI~~MK~L~gh~nIV~yids 103 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-------DEEALNAVKREIDIMKLLSGHKNIVSYIDS 103 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-------CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence 3466778999999999999999999999888899999986443 2234678899999999997 9999999994
Q ss_pred ccc---C---CceEEEEEecccCCChhHHHh--cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC
Q 005678 476 FEI---D---QNTFCTVLEYCSGKDLDAVLK--ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 476 f~~---d---~~~~~LV~Ey~~ggsL~~~L~--~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g 547 (683)
... . .-.++|+||||.||.|-+++. ....|++.+++.|+.++|.|+.+||...++|||||||-+||||+.+|
T Consensus 104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG 183 (738)
T ss_pred ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence 321 1 235789999999999999995 33459999999999999999999999988999999999999999999
Q ss_pred cEEEEecCCccccccCc-CCCcc---cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch
Q 005678 548 VAKVTDFGLSKIVEDDV-GSQGM---ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT 623 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~-~~~~~---~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~ 623 (683)
..||||||.+.-.-... ....+ +---...-|+.|.+||++....+..++.|+|||+|||+||-|++..+||.....
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 99999999875332211 11111 001112469999999999887777799999999999999999999999977643
Q ss_pred HHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 624 QERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 624 ~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
. -+....+.||..+.++..+++||+.||..||.+||++-+++.+-+.
T Consensus 264 l--------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 264 L--------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred e--------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 1 1445678899989999999999999999999999999999876443
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=330.93 Aligned_cols=261 Identities=31% Similarity=0.508 Sum_probs=209.0
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||+++++++. +...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-----GGIPNQALREIKALQACQHPYVVKLLDVFP-HGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-----chhhHHHHHHHHHHHhCCCCCCcceeeEEe-cCCee
Confidence 588999999999999999999899999999988654321 122457889999999999999999999986 67789
Q ss_pred EEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
++||||+ +++|..++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 75 ~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 9999999 9999999854 456899999999999999999999865 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH-------
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK------- 635 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~------- 635 (683)
... .......|+.+|+|||++... ..++.++|||||||++|+|++|.+||........+........
T Consensus 152 ~~~----~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 152 EEP----RLYSHQVATRWYRAPELLYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW 225 (286)
T ss_pred CCC----CccccccCcccccCceeeecc--ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHH
Confidence 321 112334789999999987543 2368899999999999999999888876554332211110000
Q ss_pred --------hhccCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 636 --------ARKVEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 636 --------~~~~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.....++. .+.++..+.+||.+||.++|.+||++.+++.||||.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00111111 134678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=331.02 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=205.8
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|.+++.||.|+||.||+|.+..++..||||.+....... .....+..|+.+++.++||||+++++++. +.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-----GVPSTAIREISLLKELNHPNIVKLLDVIH-TENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-----ccchHHHHHHHHHHhcCCCCCcchhhhcc-cCCcE
Confidence 3788999999999999999999999999999876543211 12346778999999999999999999986 67789
Q ss_pred EEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
++||||+. ++|..++.. ...+++..+..++.+|+.||.|||..+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999995 688888854 356899999999999999999999865 9999999999999999999999999987654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH------
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK------ 635 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~------ 635 (683)
.... ......+++.|+|||++.... .++.++|||||||++|+|++|..||.................
T Consensus 152 ~~~~-----~~~~~~~~~~y~aPE~~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07860 152 VPVR-----TYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 224 (284)
T ss_pred cCcc-----ccccccccccccCCeEEecCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 3211 122235788999999885432 368899999999999999999999977655443322111000
Q ss_pred --------hhccCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 636 --------ARKVEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 636 --------~~~~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.....++. .+.++.++.+||.+||..||.+||++.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 225 WPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00001111 23578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=331.31 Aligned_cols=262 Identities=28% Similarity=0.466 Sum_probs=211.0
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||.||+|.+..++..||||.+..... .......+.+|+.+++.+.||||++++++|. +.+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-----DEDVKKTALREVKVLRQLRHENIVNLKEAFR-RKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-----cccchhHHHHHHHHHHhcCCCCeeehhheEE-ECCE
Confidence 369999999999999999999999999999998754322 1223456788999999999999999999996 5778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++||||++++.|..++.....+++..+..++.+|+.||.|||..+ |+|+||+|.||+++.++.+||+|||++.....
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9999999998888777766667999999999999999999999865 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh------
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA------ 636 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~------ 636 (683)
... .......|+++|+|||++... ..++.++||||||+++|+|++|..||......+.+.........
T Consensus 153 ~~~----~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 153 RPA----SPLTDYVATRWYRAPELLVGD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred Ccc----ccccCcccccCCcCCchhcCC--CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 321 112234688999999998654 14789999999999999999999999766554433321111100
Q ss_pred ---------hccCCC-----------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 637 ---------RKVEFP-----------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 637 ---------~~~~~p-----------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
....++ ....++.++.+||++||..+|++||++.+++.||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000010 112358899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.02 Aligned_cols=265 Identities=29% Similarity=0.460 Sum_probs=211.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+.+.||.|+||.||++.+..+++.|+||.+.... .........+.+|+.+++.++||||+++++.|. ..+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN----LILRNQIQQVFVERDILTFAENPFVVSMFCSFE-TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh----hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-cCCE
Confidence 36889999999999999999999999999999875432 112233457788999999999999999999986 6678
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||++|++|..++...+.+++..+..++.+++.||.|||+.+ |+|+||||.|||++.+|.++|+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999999999988788999999999999999999999865 99999999999999999999999999874221
Q ss_pred CcCCC----------cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 563 DVGSQ----------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 563 ~~~~~----------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
..... .........|++.|+|||.+.... ++.++|||||||++|+|++|..||......+ ++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~-- 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG---YGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQ-- 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH--
Confidence 11000 000111235788999999886433 7899999999999999999999997655433 2221
Q ss_pred HHHhhccCCCCC-cCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccCCC
Q 005678 633 IIKARKVEFPSR-PAVSNEAKDLIRRCLTYNQAERPD---VLTLAQDPYLTYS 681 (683)
Q Consensus 633 i~~~~~~~~p~~-~~~s~el~dLI~rCL~~dP~kRPS---~~eLl~hP~l~~~ 681 (683)
.......+|.. +.++.++.+||.+||..+|++||+ +.+++.||||...
T Consensus 228 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 228 -VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred -HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 11122223322 368899999999999999999998 7999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.42 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=224.7
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
-+.|..+++||+|.||.|.+|..+.++++||+|+++....... ..+.|-+.|-.+|+..+||.+..|...|+ ..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak----dEVAHTlTE~RVL~~~~HPFLt~LKYsFQ-t~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK----DEVAHTLTENRVLQNCRHPFLTSLKYSFQ-TQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh----HHhhhhhhHHHHHHhccCcHHHHhhhhhc-cCc
Confidence 3567888999999999999999999999999999877654332 33678889999999999999999998997 678
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|+||||..||.|..+|.+...+++..++.+-..|++||.|||+. +||+||||..|+|||.+|++||+|||+|+---
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~--~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR--NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC--CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999999999999888999999999999999999999985 49999999999999999999999999998532
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... ..++..+|||.|+|||++.... |...+|+|.+||++|||+||+.||...+.. .++ .++....+.|
T Consensus 320 ~~g-----~t~kTFCGTPEYLAPEVleDnD---YgraVDWWG~GVVMYEMmCGRLPFyn~dh~-kLF---eLIl~ed~kF 387 (516)
T KOG0690|consen 320 KYG-----DTTKTFCGTPEYLAPEVLEDND---YGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-KLF---ELILMEDLKF 387 (516)
T ss_pred ccc-----ceeccccCChhhcCchhhcccc---ccceeehhhhhHHHHHHHhccCcccccchh-HHH---HHHHhhhccC
Confidence 221 2356779999999999997555 899999999999999999999999765443 332 3456677888
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTY 680 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~ 680 (683)
|. .++++++.|+..+|..||.+|. ++.++.+|+||..
T Consensus 388 Pr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 388 PR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred Cc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 85 6999999999999999999997 6999999999974
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=330.99 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=203.6
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHH-HhhcCCCceeeeccccccCCc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI-HKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~i-l~~L~HpnIV~L~~~f~~d~~ 481 (683)
+.|.+.+.||+|+||.||+|.+..+|..||||.+........ ...+..|+.+ ++.+.||||+++++++. ..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~e~~~~~~~~~~~~iv~~~~~~~-~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE------QKRLLMDLDISMRSVDCPYTVTFYGALF-REG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH------HHHHHHHHHHHHHHcCCCCeeeeeEEEe-cCC
Confidence 368899999999999999999999999999998865432111 1234445554 66678999999999986 567
Q ss_pred eEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 482 TFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
.+|+||||++ ++|..++.. ...+++..+..++.||+.||.|||+. .+++|+||||+|||++.++.+||+|||++
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 7999999996 688777743 34689999999999999999999985 14999999999999999999999999998
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT-PLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
........ .....|+..|+|||++..... ..++.++|+|||||++|+|++|+.||.........+. .....
T Consensus 152 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~~~~ 223 (283)
T cd06617 152 GYLVDSVA------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK--QVVEE 223 (283)
T ss_pred cccccccc------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH--HHHhc
Confidence 86543211 122368899999998865332 3478899999999999999999999965332211111 11122
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
....++. ..+|.++.+||.+||..+|.+||++.+++.||||...+
T Consensus 224 ~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 224 PSPQLPA-EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CCCCCCc-cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 2222221 35789999999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=331.89 Aligned_cols=259 Identities=24% Similarity=0.403 Sum_probs=207.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc-
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI- 478 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~- 478 (683)
....|.+.+.||.|+||.||+|.+..++..||+|++.... .....+..|+.++..+ +||||++++++|..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4568899999999999999999999999999999874431 1134567889999998 69999999999842
Q ss_pred ----CCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 479 ----DQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 479 ----d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
....+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEe
Confidence 24678999999999999999964 345888889999999999999999865 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|||++........ ......|++.|+|||.+.... ...++.++|||||||++|+|++|..||........+..
T Consensus 164 dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~- 237 (282)
T cd06636 164 DFGVSAQLDRTVG-----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL- 237 (282)
T ss_pred eCcchhhhhcccc-----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-
Confidence 9999876543211 122346899999999875322 33478899999999999999999999976554433321
Q ss_pred HHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 631 ~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
+....... .....++..+.+||.+||..||.+||++.+|++||||
T Consensus 238 --~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 238 --IPRNPPPK-LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --HhhCCCCC-CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 11111111 1123578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=359.45 Aligned_cols=257 Identities=23% Similarity=0.279 Sum_probs=199.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
....|.+.+.||+|+||.||+|.+..++..||||.... ..+.+|+.+++.|+|||||++++++. ..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------------~~~~~E~~iL~~L~HpnIv~l~~~~~-~~ 232 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------------ASSVHEARLLRRLSHPAVLALLDVRV-VG 232 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------------cCHHHHHHHHHHCCCCCCCcEEEEEE-EC
Confidence 35579999999999999999999999999999995321 23467999999999999999999886 56
Q ss_pred ceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+..|+|||++ .++|..++.. ...+++..+..|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 7889999999 4688888754 356999999999999999999999865 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-Cch------HHHHHHHHH
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGH-DQT------QERILREDT 632 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~-~~~------~e~il~~~~ 632 (683)
+...... .......||+.|+|||++.... ++.++|||||||+||||++|..|+.. ... ...+.....
T Consensus 310 ~~~~~~~---~~~~~~~GT~~Y~APE~~~~~~---~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 310 ARGSWST---PFHYGIAGTVDTNAPEVLAGDP---YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred ccccccc---ccccccCCCcCCcCHHHHcCCC---CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 6432111 1122347999999999986543 89999999999999999998765422 111 111111000
Q ss_pred HHHhhccCCC--------------------------CC---cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 633 IIKARKVEFP--------------------------SR---PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 633 i~~~~~~~~p--------------------------~~---~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
........++ .+ ..++.++.+||.+||.+||.+|||+.++|+||||+.
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000111 11 135668999999999999999999999999999975
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.74 Aligned_cols=259 Identities=31% Similarity=0.460 Sum_probs=211.7
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-C-----Cceeee
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-H-----HHIVRL 472 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-H-----pnIV~L 472 (683)
+.+.-+|.++++||+|+||.|.+|+|..++..||||+++.. ..+......|+.||..|+ | -|||++
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--------KRFLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 45566999999999999999999999999999999998543 244567778999999997 4 389999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC--CCc
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE--FGV 548 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~--~g~ 548 (683)
+++|. ..+++|||+|.+ ..+|.++|+.+ ..|+...++.|+.||+.||.+||+.+ |||+||||+||||.. ...
T Consensus 254 ~d~F~-fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 254 LDYFY-FRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred eeccc-cccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCc
Confidence 99996 789999999999 67999999765 46899999999999999999999865 999999999999975 447
Q ss_pred EEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Q 005678 549 AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628 (683)
Q Consensus 549 vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il 628 (683)
+||+|||.|...... +. ...-+..|.|||+|.+.. |+.+.||||||||+.||++|.+.|.+....+.+.
T Consensus 330 vKVIDFGSSc~~~q~-------vy-tYiQSRfYRAPEVILGlp---Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~ 398 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQR-------VY-TYIQSRFYRAPEVILGLP---YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA 398 (586)
T ss_pred eeEEecccccccCCc-------ce-eeeeccccccchhhccCC---CCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence 999999999876532 11 446778899999998766 9999999999999999999999998887777664
Q ss_pred HHHHHHHh------------------------------------------------hccCCC-CC-------c-CCCHHH
Q 005678 629 REDTIIKA------------------------------------------------RKVEFP-SR-------P-AVSNEA 651 (683)
Q Consensus 629 ~~~~i~~~------------------------------------------------~~~~~p-~~-------~-~~s~el 651 (683)
....+... .....| .. + .-...+
T Consensus 399 ~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F 478 (586)
T KOG0667|consen 399 RIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLF 478 (586)
T ss_pred HHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHH
Confidence 32111100 000011 00 0 112357
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 652 KDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 652 ~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.+||.+||.+||..|+|+.++++||||+.
T Consensus 479 ~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 479 IDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred HHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 89999999999999999999999999983
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=347.60 Aligned_cols=256 Identities=26% Similarity=0.475 Sum_probs=222.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
-|.++..||+|+||.||+|+++.+|..||||.+... ..+++++.|+.|+.+++.|++|++|+.|. ....+
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---------sDLQEIIKEISIMQQC~S~yVVKYYGSYF-K~sDL 103 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---------TDLQEIIKEISIMQQCKSKYVVKYYGSYF-KHSDL 103 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---------chHHHHHHHHHHHHHcCCchhhhhhhhhc-cCCce
Confidence 467788999999999999999999999999987543 22578899999999999999999999986 45568
Q ss_pred EEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+||||||..|+..+++. +.++|++.++..++...+.||.|||... -||||||..||||+.+|.+||+|||.+..+.+
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 89999999999999995 5678999999999999999999999854 89999999999999999999999999987754
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
. |.......|||.|||||++..-+ |+.++||||||++..||.-|++||..-.+...++- +-......|.
T Consensus 182 T-----MAKRNTVIGTPFWMAPEVI~EIG---Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---IPT~PPPTF~ 250 (502)
T KOG0574|consen 182 T-----MAKRNTVIGTPFWMAPEVIEEIG---YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---IPTKPPPTFK 250 (502)
T ss_pred h-----HHhhCccccCcccccHHHHHHhc---cchhhhHhhhcchhhhhhcCCCCcccccccceeEe---ccCCCCCCCC
Confidence 4 33445568999999999997666 89999999999999999999999987666554432 2233445565
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.+...|.++.+||+.||-++|++|-++.+|++|||+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 5667899999999999999999999999999999999986
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.43 Aligned_cols=254 Identities=24% Similarity=0.459 Sum_probs=209.3
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||++.+..++..||+|.+....... .....+.+|+.+++.++||||++++++|. +.+.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-----KEREESRKEVAVLSNMKHPNIVQYQESFE-ENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-----HHHHHHHHHHHHHHhCCCCCeeeeEeeec-CCCeE
Confidence 5899999999999999999999999999999875432211 12357888999999999999999999986 67789
Q ss_pred EEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 9999999999999998643 35789999999999999999999865 9999999999999999999999999997654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... .......|++.|+|||++.... ++.++|+|||||++|+|++|..||......+.... +... ...
T Consensus 153 ~~~-----~~~~~~~~~~~~~~pe~~~~~~---~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~---~~~~--~~~ 219 (256)
T cd08218 153 STV-----ELARTCIGTPYYLSPEICENRP---YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK---IIRG--SYP 219 (256)
T ss_pred cch-----hhhhhccCCccccCHHHhCCCC---CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH---HhcC--CCC
Confidence 321 1122346889999999886433 78899999999999999999999976655433221 1111 111
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
+....++.++.++|.+||..+|.+||++.+++.||||
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 2334688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=333.81 Aligned_cols=265 Identities=31% Similarity=0.461 Sum_probs=209.1
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||+|.+..++..||||.+....... ........+..|+.+++.++||||++++++|. +.+.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE--AKDGINFTALREIKLLQELKHPNIIGLLDVFG-HKSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc--ccchhhHHHHHHHHHHhhcCCCCChhhhheee-cCCEE
Confidence 5888999999999999999998899999999986543221 11123456778999999999999999999997 57889
Q ss_pred EEEEecccCCChhHHHhcCC-CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~-~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
++||||+ +++|..++.... .+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.+|.++|+|||++.....
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999999 899999997765 7999999999999999999999965 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh------
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA------ 636 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~------ 636 (683)
... ......+++.|+|||.+... ..++.++|||||||++|+|++|.+||......+.+.........
T Consensus 155 ~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 155 PNR-----KMTHQVVTRWYRAPELLFGA--RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred CCc-----cccccccceeeeCHHHHhCC--CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence 311 12223578899999987432 23788999999999999999998888665543322111100000
Q ss_pred -------hccC---CC------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 -------RKVE---FP------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 -------~~~~---~p------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.... .+ ....++..+.+||.+||..+|.+||++.+++.||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0000 00 013457889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.84 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=210.8
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+++.||.|+||.||.+.+..++..|++|.+....... .....+.+|+.++++++||||++++++|. +.+.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-----KERRDALNEIVILSLLQHPNIIAYYNHFM-DDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-----hHHHHHHHHHHHHHhCCCCCeeEEEeEEe-cCCeE
Confidence 5899999999999999999999999999999875443211 22456789999999999999999999996 67889
Q ss_pred EEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
++||||+++++|..++... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 9999999999999999654 56899999999999999999999865 9999999999999999999999999998764
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.... ......|++.|+|||++.... ++.++||||||+++|+|++|..||......+.... +. .... .
T Consensus 153 ~~~~-----~~~~~~~~~~y~ape~~~~~~---~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~---~~-~~~~-~ 219 (256)
T cd08221 153 SEYS-----MAETVVGTPYYMSPELCQGVK---YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK---IV-QGNY-T 219 (256)
T ss_pred cccc-----cccccCCCccccCHhhcCCCC---CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HH-cCCC-C
Confidence 4321 122346899999999886443 68899999999999999999999976555443321 11 1111 1
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
+..+.++..+.+||.+||..+|.+||++.++++|||+
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 2235678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=337.57 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=190.2
Q ss_pred EEEecccCceEEEEEEEcc--CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc-CCceEE
Q 005678 408 LNLLGKGGFSEVYKAYDLV--EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-DQNTFC 484 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~--~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-d~~~~~ 484 (683)
...||+|+||+||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||++++++|.. ....+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 3679999999999998643 568899998754321 1346789999999999999999998743 456789
Q ss_pred EEEecccCCChhHHHhc---------CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe----CCCCcEEE
Q 005678 485 TVLEYCSGKDLDAVLKA---------TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVAKV 551 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~---------~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL----d~~g~vKL 551 (683)
+||||++ ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEE
Confidence 9999995 577777642 124889999999999999999999965 9999999999999 46689999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH----
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI---- 627 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i---- 627 (683)
+|||+++........ ........||+.|+|||++... ..++.++|||||||++|+|++|.+||.........
T Consensus 154 ~DfG~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~ 229 (317)
T cd07867 154 ADMGFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF 229 (317)
T ss_pred eeccceeccCCCccc--ccccCcceecccccCcHHhcCC--CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccc
Confidence 999999876543211 1122344789999999988542 23788999999999999999999999643321000
Q ss_pred --HHHHHHHHh-------------------------hccCC----------CCCcCCCHHHHHHHHHhcccCCCCCCCHH
Q 005678 628 --LREDTIIKA-------------------------RKVEF----------PSRPAVSNEAKDLIRRCLTYNQAERPDVL 670 (683)
Q Consensus 628 --l~~~~i~~~-------------------------~~~~~----------p~~~~~s~el~dLI~rCL~~dP~kRPS~~ 670 (683)
.....+... ..... ......+..+.+||.+||..||.+|||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 309 (317)
T cd07867 230 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSE 309 (317)
T ss_pred cHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHH
Confidence 000000000 00000 00123456788999999999999999999
Q ss_pred HHhcCccc
Q 005678 671 TLAQDPYL 678 (683)
Q Consensus 671 eLl~hP~l 678 (683)
++++||||
T Consensus 310 e~l~hp~f 317 (317)
T cd07867 310 QALQDPYF 317 (317)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=356.22 Aligned_cols=266 Identities=29% Similarity=0.495 Sum_probs=211.5
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeecccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTF 476 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f 476 (683)
+.+-+..|.+++.||+||.+.||++.... .+.||+|.+.. ...+...+.-++.|+..|.+|+ |.+||+|||+-
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~-----~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL-----LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH-----hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 35567889999999999999999997543 45555554322 2334455788999999999994 99999999875
Q ss_pred ccCCceEEEEEecccCCChhHHHhcCC-CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~~~-~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..++.+|+||||- ..+|..+|+... .++...++.|..||+.|+.++|.+| |||.||||.|+|+-. |.+||+|||
T Consensus 430 -v~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk-G~LKLIDFG 504 (677)
T KOG0596|consen 430 -VTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK-GRLKLIDFG 504 (677)
T ss_pred -ccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe-eeEEeeeec
Confidence 4688999999975 679999997654 3444588999999999999999977 999999999999987 999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCC--------CCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTP--------LISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~--------~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
+|..+..+.... .....+||+.||+||.+...... .++.++||||||||||+|++|++||+.......-
T Consensus 505 IA~aI~~DTTsI---~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK 581 (677)
T KOG0596|consen 505 IANAIQPDTTSI---VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK 581 (677)
T ss_pred hhcccCccccce---eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH
Confidence 999988765432 23345899999999998643321 3678999999999999999999999876644322
Q ss_pred HHHHHHHHh-hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 628 LREDTIIKA-RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 628 l~~~~i~~~-~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+ ..|... ..++||..+.-. ++.++++.||..||.+||++.+||+|||++.
T Consensus 582 l--~aI~~P~~~Iefp~~~~~~-~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 582 L--HAITDPNHEIEFPDIPEND-ELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred H--HhhcCCCccccccCCCCch-HHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 2 222222 556777654333 3999999999999999999999999999985
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.72 Aligned_cols=262 Identities=30% Similarity=0.487 Sum_probs=203.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~ 481 (683)
++|.+.+.||.|+||.||+|.+..++..||||.+....... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-----GIPPTALREISLLQMLSESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-----CCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence 46899999999999999999999999999999875542211 12346778999999995 6999999998864332
Q ss_pred ----eEEEEEecccCCChhHHHhc-----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEE
Q 005678 482 ----TFCTVLEYCSGKDLDAVLKA-----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKV 551 (683)
Q Consensus 482 ----~~~LV~Ey~~ggsL~~~L~~-----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL 551 (683)
.+|+||||+++ +|..++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+|||++. ++.+||
T Consensus 76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 76 NGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred CCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEE
Confidence 38999999975 78888743 235899999999999999999999865 999999999999998 899999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~ 631 (683)
+|||++......... .....++++|+|||++... ..++.++|||||||++|+|++|..||.............
T Consensus 153 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 153 ADLGLGRAFSIPVKS-----YTHEIVTLWYRAPEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred eecccceecCCCccc-----cCCcccccCCCChHHhhCC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 999998765332111 1223578999999987532 237889999999999999999999998765544332211
Q ss_pred HHHH-hhc------------cCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 632 TIIK-ARK------------VEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 632 ~i~~-~~~------------~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.... ... ..++. .+.++..+.+||.+||.+||.+||++.+++.||||.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 1000 000 00110 145789999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.65 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=214.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|.+.+.||.|+||.||+|.+..++..|+||++...... .....+.+|+.++..++||||++++++|. ..+.+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 74 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE------EFRKQLLRELKTLRSCESPYVVKCYGAFY-KEGEI 74 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-cCCeE
Confidence 588899999999999999999999999999988654321 23467889999999999999999999986 56889
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHh-cCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK-RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~-~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
++||||+++++|.+++.....+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999999877789999999999999999999998 66 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCc--hHHHHHHHHHHHHhhccC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQ--TQERILREDTIIKARKVE 640 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~--~~e~il~~~~i~~~~~~~ 640 (683)
.... .....|+..|+|||.+... .++.++||||||+++|+|++|..||.... ....... .+... ..
T Consensus 153 ~~~~-----~~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~--~~~~~--~~ 220 (264)
T cd06623 153 TLDQ-----CNTFVGTVTYMSPERIQGE---SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ--AICDG--PP 220 (264)
T ss_pred CCCc-----ccceeecccccCHhhhCCC---CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH--HHhcC--CC
Confidence 3211 1233688999999988654 37889999999999999999999997764 2222211 11111 11
Q ss_pred CCCCcC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 641 FPSRPA-VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 641 ~p~~~~-~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.+.... ++..+.++|.+||..+|.+||++.++++||||+.++
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 222234 789999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=327.31 Aligned_cols=250 Identities=34% Similarity=0.509 Sum_probs=206.6
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecc
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~ 490 (683)
||.|+||.||+|.+..++..||+|++....... ......+.+|+.+++.++||||+++++.+. ++..+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE----TGQQEHIFSEKEILEECNHPFIVKLYRTFK-DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh----hhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-cCCccEEEEecC
Confidence 799999999999998889999999986543221 123467889999999999999999999886 678899999999
Q ss_pred cCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCccc
Q 005678 491 SGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570 (683)
Q Consensus 491 ~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~ 570 (683)
++++|.+++.....+++..+..++.||+.||.|||+.+ ++|+||+|.||+++.++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------ 147 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------ 147 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc------
Confidence 99999999987777999999999999999999999855 9999999999999999999999999998765431
Q ss_pred ccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHHH-hhccCCCCCcCCC
Q 005678 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ-ERILREDTIIK-ARKVEFPSRPAVS 648 (683)
Q Consensus 571 l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-e~il~~~~i~~-~~~~~~p~~~~~s 648 (683)
......|++.|+|||.+.... ++.++|+||||+++|+|++|..||...... ...+. .+.. .....+| ..++
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~--~~~~ 220 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKG---YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN--DILKGNGKLEFP--NYID 220 (262)
T ss_pred ccccccCCcCccChhHhcCCC---CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH--HHhccCCCCCCC--cccC
Confidence 122336899999999876433 788999999999999999999999766521 11111 1111 2223333 4568
Q ss_pred HHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q 005678 649 NEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTY 680 (683)
Q Consensus 649 ~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~ 680 (683)
.++.+||.+||..+|.+||+ +.++++||||..
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 99999999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=325.01 Aligned_cols=257 Identities=29% Similarity=0.414 Sum_probs=203.1
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.+.....||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++. ..+.
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 79 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-------SRYVQPLHEEIALHSYLKHRNIVQYLGSDS-ENGF 79 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-------HHHHHHHHHHHHHHHhcCCCCeeeeeeeec-cCCE
Confidence 33444568999999999999999999999999875432 122457889999999999999999999886 6778
Q ss_pred EEEEEecccCCChhHHHhcC-CCc--chHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEEEecCCcc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT-PVL--PEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKVTDFGLSK 558 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~-~~L--se~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL~DFGls~ 558 (683)
+++|+||+++++|.+++... ..+ ++..+..++.||+.||.|||..+ |+|+||||.|||++. ++.++|+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999999653 445 78888999999999999999865 999999999999986 6799999999987
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
....... ......|++.|+|||++.... ..++.++|||||||++|+|++|..||............. ....
T Consensus 158 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~---~~~~ 228 (268)
T cd06624 158 RLAGINP-----CTETFTGTLQYMAPEVIDKGP-RGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV---GMFK 228 (268)
T ss_pred ecccCCC-----ccccCCCCccccChhhhcccc-ccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh---hhhc
Confidence 6543211 112236889999999985432 236889999999999999999999997544322221110 0111
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.....+..++.++.+||.+||..+|.+||++.+++.||||
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 1111234688999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.00 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=207.1
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc-CCc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-DQN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-d~~ 481 (683)
++|...+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||++++++|.. ..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN------PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence 468899999999999999999999999999998754321 1234568889999999999999999998753 345
Q ss_pred eEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 482 TFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
.+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccc
Confidence 78999999999999988742 356899999999999999999999865 999999999999999999999999998
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHH
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT----QERILREDTI 633 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~----~e~il~~~~i 633 (683)
....... .....++..|+|||.+.... ++.++|||||||++|+|++|..||..... ..... ..+
T Consensus 153 ~~~~~~~-------~~~~~~~~~y~~pE~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~ 220 (287)
T cd06621 153 GELVNSL-------AGTFTGTSFYMAPERIQGKP---YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL--SYI 220 (287)
T ss_pred ccccccc-------cccccCCccccCHHHhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH--HHH
Confidence 7654321 11235788999999886443 78899999999999999999999976521 11111 111
Q ss_pred HHhhccCCCCC----cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 634 IKARKVEFPSR----PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 634 ~~~~~~~~p~~----~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.......++.. ...++.+.+||.+||..+|.+|||+.+++.||||+..+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 221 VNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred hcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 11111111111 23467899999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=349.14 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=203.9
Q ss_pred cccccccceeEEEEecccCceEEEEEEE-----ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCcee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYD-----LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d-----~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV 470 (683)
.+.+..++|.+.+.||+|+||.||+|.+ ..++..||||++...... .....+.+|+.++..+ .|||||
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~~Ei~il~~l~~HpnIv 102 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL------TEREALMSELKVLSYLGNHINIV 102 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc------HHHHHHHHHHHHHHHhcCCccee
Confidence 3455567899999999999999999963 346778999998543221 1235678899999999 899999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcC------------------------------------------------
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT------------------------------------------------ 502 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~------------------------------------------------ 502 (683)
+++++|. +.+..++|||||++|+|.+++...
T Consensus 103 ~l~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 103 NLLGACT-VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeeec-cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 9999986 677889999999999999998532
Q ss_pred ---------------------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 503 ---------------------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 503 ---------------------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG 259 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFG 259 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCc
Confidence 14678889999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
++..+..... ........+++.|+|||++.... ++.++|||||||++|+|++ |..||........+... +.
T Consensus 260 ~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~--~~ 331 (375)
T cd05104 260 LARDIRNDSN---YVVKGNARLPVKWMAPESIFNCV---YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM--IK 331 (375)
T ss_pred cceeccCccc---ccccCCCCCCcceeChhHhcCCC---CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH--HH
Confidence 9987643321 11112234567899999986443 8899999999999999997 89999765544333221 11
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.. .....+...+.++.+||.+||..||.+||++.++++.
T Consensus 332 ~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 332 EG--YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred hC--ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 11 1222234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.66 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=213.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
..++|.+.+.||.|+||.||++.+..++..||+|.+..... .....+.+|+.+++.++||||+++++.|. +.
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~ 88 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-------PKKELIINEILVMRENKHPNIVNYLDSYL-VG 88 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-------hHHHHHHHHHHHHhhcCCCCeeehhheee-eC
Confidence 34789999999999999999999988999999998743211 12356788999999999999999999986 56
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+.+++|+||+++++|..++... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 7889999999999999999765 4889999999999999999999865 999999999999999999999999998765
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......|++.|+|||++.... ++.++|||||||++|+|++|..||........... +.......
T Consensus 166 ~~~~~-----~~~~~~~~~~y~~PE~~~~~~---~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~ 234 (293)
T cd06647 166 TPEQS-----KRSTMVGTPYWMAPEVVTRKA---YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGTPE 234 (293)
T ss_pred ccccc-----ccccccCChhhcCchhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---hhcCCCCC
Confidence 43221 112236889999999886433 78899999999999999999999976654332211 11122333
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
++....++..+.+||.+||..+|.+||++.+++.||||+.++
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 444456788999999999999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.33 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=210.5
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
....+|.+.+.||.|+||+||+|.+..++..||+|.+....... ......+.+|+.+++.++||||++++++|. +
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-~ 86 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS----NEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-R 86 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc----HHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-e
Confidence 34567999999999999999999998899999999875432221 123457889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.+..|+||||++ ++|.+++. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.
T Consensus 87 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 87 EHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred CCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcce
Confidence 778899999996 56766664 3456899999999999999999999855 9999999999999999999999999987
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
..... ....|++.|+|||++.......++.++||||||+++|+|++|..||........... +.....
T Consensus 164 ~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~---~~~~~~ 231 (307)
T cd06607 164 LVSPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNDS 231 (307)
T ss_pred ecCCC---------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH---HhcCCC
Confidence 65322 123688899999988544344588899999999999999999999976655443321 111111
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
...+ ...++..+.+||.+||..+|.+||++.+++.||||...
T Consensus 232 ~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 PTLS-SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred CCCC-chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 1111 23478899999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=352.29 Aligned_cols=270 Identities=26% Similarity=0.388 Sum_probs=226.1
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.....-|..++.||-|+||+|.++....+...||.|.+... +......+.|+..|..||...+.++||+||..|+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKa----DVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ- 699 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKA----DVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ- 699 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHH----HHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec-
Confidence 45567789999999999999999998899999999987543 2334456788999999999999999999999997
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
|++++|+||+|++||++..+|.+-+.|.+..++.++.++.+|+.++|..| +|||||||+|||||.+|++||+|||||.
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccc
Confidence 89999999999999999999999999999999999999999999999976 9999999999999999999999999996
Q ss_pred ccccCcC-----------CCcccc--------------------------cccCCCCCccCCcccccccCCCCCCchhHH
Q 005678 559 IVEDDVG-----------SQGMEL--------------------------TSQGAGTYWYLPPECFELSKTPLISSKVDV 601 (683)
Q Consensus 559 ~~~~~~~-----------~~~~~l--------------------------~~~~~GT~~Y~APE~~~~~~~~~~s~ksDV 601 (683)
-+..... ...|++ ....+||+.|+|||++...+ |+..+|+
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g---~~q~cdw 854 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG---YTQLCDW 854 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC---ccccchh
Confidence 4422110 011111 11247999999999997554 8999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccc
Q 005678 602 WSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD---VLTLAQDPYL 678 (683)
Q Consensus 602 WSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS---~~eLl~hP~l 678 (683)
||.|||||+|+.|+.||......+..+. .+.+...+.++....+|.++.++|.++++ ++++|.- ..++-.||||
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~tq~k--v~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfF 931 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGETQYK--VINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFF 931 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcceee--eeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccc
Confidence 9999999999999999987766554433 33455667888888999999999998765 7888873 6679999999
Q ss_pred CCC
Q 005678 679 TYS 681 (683)
Q Consensus 679 ~~~ 681 (683)
+..
T Consensus 932 kgI 934 (1034)
T KOG0608|consen 932 KGI 934 (1034)
T ss_pred ccc
Confidence 864
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.24 Aligned_cols=255 Identities=27% Similarity=0.482 Sum_probs=200.1
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCC--c
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQ--N 481 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~--~ 481 (683)
|.+++.||.|+||.||+|.+..++..||||.+........ .....+|+.++.++. ||||++++++|. +. +
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~-~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE------QVNNLREIQALRRLSPHPNILRLIEVLF-DRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch------hhhHHHHHHHHhhcCCCCCccceEEEEe-cCCCC
Confidence 6788999999999999999999999999998754322111 123457888898885 999999999986 44 7
Q ss_pred eEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+++||||+++ +|...+.. ...+++..+..++.|++.||.|||..+ |+|+||+|.||+++. +.+||+|||++..+
T Consensus 74 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 74 RLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred cEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 89999999964 77777754 457899999999999999999999865 999999999999999 99999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH-----
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK----- 635 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~----- 635 (683)
..... .....+++.|+|||++... ..++.++|||||||++|+|++|..||......+.+........
T Consensus 150 ~~~~~------~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
T cd07831 150 YSKPP------YTEYISTRWYRAPECLLTD--GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE 221 (282)
T ss_pred ccCCC------cCCCCCCcccCChhHhhcC--CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 43321 1123688999999986433 2368899999999999999999999976655443222111100
Q ss_pred ---------hhccCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 636 ---------ARKVEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 636 ---------~~~~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.....++. .+.++..+.+||.+||.++|.+||++.++++||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00111111 13568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.37 Aligned_cols=252 Identities=29% Similarity=0.393 Sum_probs=202.4
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecc
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~ 490 (683)
||.|+||+||+|.+..+|+.||||++..... ........+..|+.+++.++||||++++++|. ..+.+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL----KKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh----hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-cCCeEEEEEecC
Confidence 6999999999999999999999998754321 11223445678999999999999999999986 567899999999
Q ss_pred cCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCc
Q 005678 491 SGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568 (683)
Q Consensus 491 ~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~ 568 (683)
++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.++|+|||++........
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 150 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--- 150 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence 9999999996554 6899999999999999999999965 99999999999999999999999999876543211
Q ss_pred ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCC
Q 005678 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648 (683)
Q Consensus 569 ~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s 648 (683)
.....|+..|+|||++.... ++.++|||||||++|+|++|+.||.................. .....++.++
T Consensus 151 ---~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 222 (277)
T cd05577 151 ---IKGRAGTPGYMAPEVLQGEV---YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFS 222 (277)
T ss_pred ---cccccCCCCcCCHHHhcCCC---CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCC
Confidence 12336888999999986443 788999999999999999999999765431111110011111 1222334679
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 005678 649 NEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTY 680 (683)
Q Consensus 649 ~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~ 680 (683)
+.+.+||.+||..+|.+|| ++.+++.||||..
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 9999999999999999999 8899999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.64 Aligned_cols=259 Identities=30% Similarity=0.504 Sum_probs=201.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+.+.||.|+||.||+|.+..+++.||||.+........ ...+.+|+.+++.++||||+++++++. +.+.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 77 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA------PFTAIREASLLKDLKHANIVTLHDIIH-TKKT 77 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC------chhHHHHHHHHhhCCCcceeeEEEEEe-cCCe
Confidence 579999999999999999999988999999998865432111 124568999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+||||+++ +|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||.|||++.+|.+||+|||++....
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred EEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccC
Confidence 9999999975 899988543 46899999999999999999999865 9999999999999999999999999987543
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-HHHHHh----
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE-DTIIKA---- 636 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~-~~i~~~---- 636 (683)
.... ......+++.|+|||++... ..++.++|||||||++|+|++|..||.........+.. ......
T Consensus 155 ~~~~-----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 155 VPSK-----TYSNEVVTLWYRPPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred CCCc-----cccccccccccCCcHHhhcC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 2111 01122568899999987532 23788999999999999999999999765422211110 000000
Q ss_pred -----------hccCCC---------CCcCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 637 -----------RKVEFP---------SRPAVS--NEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 637 -----------~~~~~p---------~~~~~s--~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
....++ ..+.++ ..+.++|.+||..+|.+||++.+++.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000 012344 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=327.79 Aligned_cols=260 Identities=29% Similarity=0.434 Sum_probs=200.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
...|.+.+.||+|+||.||+|.+..++..||||++....... ....+.+|+.+++.++|+||+++++++. +.+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~ 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG------VPFTAIREASLLKGLKHANIVLLHDIIH-TKE 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC------CcHHHHHHHHHHHhcCCCCEeEEEEEEe-cCC
Confidence 357999999999999999999999999999999985542211 1234568999999999999999999986 667
Q ss_pred eEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+|+||||+. ++|..++. ....+++..+..++.||+.||.|||..+ |+|+||||+|||++.++.++|+|||+++..
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 77 TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 8999999995 56666654 3456888899999999999999999865 999999999999999999999999998764
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-HHHH----
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED-TIIK---- 635 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~-~i~~---- 635 (683)
..... ......+++.|+|||++... ..++.++|||||||++|+|++|..||.........+... ....
T Consensus 154 ~~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07870 154 SIPSQ-----TYSSEVVTLWYRPPDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE 226 (291)
T ss_pred CCCCC-----CCCCccccccccCCceeecC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCCh
Confidence 33211 11223578999999988532 236889999999999999999999997655432222110 0000
Q ss_pred --------hh---ccCCCC-----------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 636 --------AR---KVEFPS-----------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 636 --------~~---~~~~p~-----------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.. ...++. ....+..+.+|+.+||..||.+|||+.+++.||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 000000 01235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=348.95 Aligned_cols=259 Identities=23% Similarity=0.361 Sum_probs=203.4
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccC-----CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCcee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVE-----HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~-----g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV 470 (683)
.|.+..++|.+.+.||+|+||.||+|.+... +..||||++..... ......+.+|+.+++.+ +|||||
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~il~~l~~h~nIv 105 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH------TDEREALMSELKILSHLGQHKNIV 105 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC------HHHHHHHHHHHHHHHhhccCCcee
Confidence 4456677899999999999999999986443 35799999854422 11245688999999999 899999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcC------------------------------------------------
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT------------------------------------------------ 502 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~------------------------------------------------ 502 (683)
+++++|. ..+.+|+|||||++|+|.+++...
T Consensus 106 ~~~~~~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (374)
T cd05106 106 NLLGACT-HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM 184 (374)
T ss_pred eEeeEec-CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence 9999986 667899999999999999988432
Q ss_pred ----------------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 503 ----------------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 503 ----------------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
..+++..+..|+.||+.||.|||+.+ |+||||||.|||++.++.+||+|||+++.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~ 262 (374)
T cd05106 185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDI 262 (374)
T ss_pred CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeec
Confidence 24778889999999999999999965 999999999999999999999999999765
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
..... ........+++.|+|||++... .++.++|||||||++|+|++ |..||........+.. .+ ....
T Consensus 263 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~--~~--~~~~ 332 (374)
T cd05106 263 MNDSN---YVVKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK--MV--KRGY 332 (374)
T ss_pred cCCcc---eeeccCCCCccceeCHHHhcCC---CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH--HH--Hccc
Confidence 43211 1112223456789999988643 38999999999999999997 9999976544332221 11 1112
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
..+.+..++.++.++|.+||..+|.+|||+.++++
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 333 QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22333457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.68 Aligned_cols=267 Identities=26% Similarity=0.413 Sum_probs=206.5
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID- 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d- 479 (683)
+.++|.+.+.||+|+||.||+|.+..+|..||||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc------cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 4578999999999999999999999999999999874321 112345677899999999999999999876432
Q ss_pred ---CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 480 ---QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 480 ---~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
...+|+|+||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 77 FESFNDVYIVQELME-TDLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred ccccceEEEEehhcc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccc
Confidence 245899999995 5888887654 5999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH---
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI--- 633 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i--- 633 (683)
+.......... .......||+.|+|||.+... ..++.++|||||||++|+|++|+.||........+.....+
T Consensus 153 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~ 228 (336)
T cd07849 153 ARIADPEHDHT--GFLTEYVATRWYRAPEIMLNS--KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228 (336)
T ss_pred eeecccccccc--CCcCCcCcCCCccChHHhhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 98664332111 122334789999999986432 23788999999999999999999999655432221110000
Q ss_pred ---------HH------hhccCCC-------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 634 ---------IK------ARKVEFP-------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 ---------~~------~~~~~~p-------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.. ....... ..+.++..+.+||.+||..+|.+||++.+++.||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 0000000 013567889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=344.16 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=206.0
Q ss_pred ccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceee
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVR 471 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~ 471 (683)
|.+..++|.+.+.||.|+||.||+|.+. .+++.||+|++..... ......+..|+.++.++ .||||++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~------~~~~~~~~~E~~~~~~l~~h~niv~ 75 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT------ASEYKALMTELKILIHIGHHLNVVN 75 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC------HHHHHHHHHHHHHHHhhccCcchhh
Confidence 6677889999999999999999999643 3457899998854321 12245678899999999 8999999
Q ss_pred eccccccCCceEEEEEecccCCChhHHHhcC-------------------------------------------------
Q 005678 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT------------------------------------------------- 502 (683)
Q Consensus 472 L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~------------------------------------------------- 502 (683)
++++|......++++|||+++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (337)
T cd05054 76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155 (337)
T ss_pred eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence 9998876777899999999999999998431
Q ss_pred ------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCccc
Q 005678 503 ------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570 (683)
Q Consensus 503 ------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~ 570 (683)
..+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.++|+|||++..+...... .
T Consensus 156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~---~ 230 (337)
T cd05054 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---V 230 (337)
T ss_pred cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcch---h
Confidence 25789999999999999999999865 999999999999999999999999999876432111 1
Q ss_pred ccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCH
Q 005678 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSN 649 (683)
Q Consensus 571 l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~ 649 (683)
......++..|+|||++.... ++.++|||||||++|+|++ |..||......+.+.. .+... .....+..++.
T Consensus 231 ~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~ 303 (337)
T cd05054 231 RKGDARLPLKWMAPESIFDKV---YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR--RLKEG--TRMRAPEYATP 303 (337)
T ss_pred hccCCCCCccccCcHHhcCCC---CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH--HHhcc--CCCCCCccCCH
Confidence 122335677899999886443 8999999999999999997 9999976443332211 11111 12222346788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 650 EAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 650 el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
++.+++.+||..+|++||++.++++|
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.61 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=203.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCC-----eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEH-----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g-----~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
+.|.+.+.||+|+||.||+|.+...+ ..||+|.+..... ......+.+|+.++..++||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 78 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE------PKVQQEFRQEAELMSDLQHPNIVCLLGVCT 78 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC------HHHHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence 46888999999999999999876555 6899998754321 122456889999999999999999999886
Q ss_pred cCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcce
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNV 541 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NI 541 (683)
+....|++|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||
T Consensus 79 -~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Ni 155 (283)
T cd05048 79 -KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNC 155 (283)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceE
Confidence 667889999999999999999654 45788899999999999999999965 99999999999
Q ss_pred EeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 005678 542 LFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGH 620 (683)
Q Consensus 542 LLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~ 620 (683)
|++.++.++|+|||++........ ........+++.|+|||.+.... ++.++|||||||++|+|++ |..||..
T Consensus 156 l~~~~~~~~L~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 156 LVGEGLTVKISDFGLSRDIYSADY---YRVQSKSLLPVRWMPPEAILYGK---FTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred EEcCCCcEEECCCcceeecccccc---ccccCCCcccccccCHHHhccCc---CchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999986543211 12233446788999999886443 7899999999999999997 9999976
Q ss_pred CchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 621 ~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
....+... .+.. ....+.+..++.++.+|+.+||..+|.+||++.+++++
T Consensus 230 ~~~~~~~~---~i~~--~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 230 FSNQEVIE---MIRS--RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCHHHHHH---HHHc--CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55543221 1111 12223345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.80 Aligned_cols=270 Identities=26% Similarity=0.417 Sum_probs=211.7
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc---
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI--- 478 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~--- 478 (683)
..+|.+.+.||.|+||.||+|.+..++..||||.+...... ......+.+|+.+++.++||||++++++|..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-----PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-----ccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 46899999999999999999999999999999987543211 1234567789999999999999999998753
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
....+++||||+. ++|..++.....+++..+..++.||+.||.|||..+ |+|+||||+|||++.+|.+||+|||++.
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccce
Confidence 3457899999995 689999977777999999999999999999999865 9999999999999999999999999997
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH------
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT------ 632 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~------ 632 (683)
........ .........|+.+|+|||++... ..++.++|||||||++|+|++|+.||........+.....
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 156 GLSSSPTE-HKYFMTEYVATRWYRAPELLLSL--PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred eecccCcC-CCcccccccccccccChHHhcCC--cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 76443211 11112234789999999987542 2378899999999999999999999976554332211000
Q ss_pred -----------H---HHhhc--cCCC---CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 633 -----------I---IKARK--VEFP---SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 633 -----------i---~~~~~--~~~p---~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
+ ..... ...+ ..+.++.++.+||.+||..+|.+||++.+++.||||...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0 00000 0000 0145789999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=320.72 Aligned_cols=254 Identities=27% Similarity=0.506 Sum_probs=207.5
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||+|.+..++..||+|.+........ ....+.+|+.+++.++||||+++++.+. +...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~E~~~l~~~~h~~i~~~~~~~~-~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-----EKEASKKEVILLAKMKHPNIVTFFASFQ-ENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-----hhHHHHHHHHHHHhCCCCChhhhhheec-cCCeE
Confidence 58899999999999999999999999999998755322111 1345678999999999999999999886 67789
Q ss_pred EEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-cEEEEecCCcccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTDFGLSKIV 560 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-~vKL~DFGls~~~ 560 (683)
++|+||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||.||++++++ .++|+|||.+...
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 9999999999999999653 25789999999999999999999865 99999999999999875 4699999999766
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
.... .......|++.|+|||++.... ++.++|||||||++|+|++|..||........+.. +. ....
T Consensus 153 ~~~~-----~~~~~~~~~~~~~ape~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~--~~~~ 219 (257)
T cd08225 153 NDSM-----ELAYTCVGTPYYLSPEICQNRP---YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK---IC--QGYF 219 (257)
T ss_pred cCCc-----ccccccCCCccccCHHHHcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---Hh--cccC
Confidence 4321 1122346899999999876443 78899999999999999999999976654443321 11 1111
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.+..+.++..+.++|.+||..+|++||++.+++.||||
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 22345688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=321.95 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=210.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-Cc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID-QN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d-~~ 481 (683)
..|.+.+.||+|+||.||+|.+..++..||+|.+....... ........+.+|+.+++.++||||+++++++... .+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 79 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ--ETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEK 79 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccc--hhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCC
Confidence 46899999999999999999999999999999875432111 1123356788999999999999999999988533 45
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++|+||+++++|.+++...+.+++..+..++.+|+.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 68899999999999999987777999999999999999999999865 9999999999999999999999999998654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
...... .......|+..|+|||++.... ++.++|||||||++|+|++|+.||........+... . ......
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~-~~~~~~ 228 (264)
T cd06653 158 TICMSG--TGIKSVTGTPYWMSPEVISGEG---YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---A-TQPTKP 228 (264)
T ss_pred cccccC--ccccccCCcccccCHhhhcCCC---CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---H-cCCCCC
Confidence 321110 0112346899999999986543 788999999999999999999999876554433221 1 111111
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..+..+++.+.+||.+||. +|..||++.+++.|||.
T Consensus 229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 1235688999999999999 68999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.29 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=214.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~ 481 (683)
++|.+.+.||.|+||.||+|.+..++..||+|++....... ......+.+|+.++..+. ||||++++++|. +.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK----EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-DEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc----hHHHHHHHHHHHHHHhcccCCCchhHHHHhc-CCc
Confidence 46899999999999999999999999999999986533221 122356788999999998 999999999986 677
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+|.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 89999999999999999988878999999999999999999999865 9999999999999999999999999998665
Q ss_pred cCcCCC---------------cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH
Q 005678 562 DDVGSQ---------------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626 (683)
Q Consensus 562 ~~~~~~---------------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~ 626 (683)
...... .........|+..|+|||++.... ++.++||||||+++|+|++|..||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP---AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC---CChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 432110 012233446889999999876433 78899999999999999999999987654332
Q ss_pred HHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccc
Q 005678 627 ILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDV----LTLAQDPYL 678 (683)
Q Consensus 627 il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~----~eLl~hP~l 678 (683)
+. .+ . ......+..++..+.+||.+||..+|.+||++ .++++||||
T Consensus 231 ~~---~~-~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 231 FQ---KI-L--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HH---HH-H--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 21 11 1 22333335679999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=316.17 Aligned_cols=258 Identities=33% Similarity=0.479 Sum_probs=212.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC--c
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ--N 481 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~--~ 481 (683)
+|.+.+.||.|+||.||+|.+..++..|++|++...... ......+.+|+.++++++||||+++++.+. +. .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-----EEELEALEREIRILSSLQHPNIVRYYGSER-DEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-cCCCC
Confidence 478889999999999999999889999999998654322 234567889999999999999999999886 44 7
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++|+||+++++|.+++.....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 89999999999999999987778999999999999999999999955 9999999999999999999999999998776
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
..... .......++..|+|||.+.... ++.++||||||+++|+|++|..||........... .+. ......
T Consensus 153 ~~~~~---~~~~~~~~~~~y~~pE~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~-~~~~~~ 223 (260)
T cd06606 153 DIETG---EGTGSVRGTPYWMAPEVIRGEE---YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY--KIG-SSGEPP 223 (260)
T ss_pred ccccc---ccccCCCCCccccCHhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH--hcc-ccCCCc
Confidence 54221 0122346889999999886544 78999999999999999999999977652222211 111 001111
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..+..++..+.+||.+||..+|.+||++.+++.||||
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 2234678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.64 Aligned_cols=258 Identities=21% Similarity=0.350 Sum_probs=202.6
Q ss_pred ccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeee
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
|.+..++|.+.+.||+|+||.||+|.+. .++..||||.+..... ......+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~------~~~~~~~~~e~~~l~~l~~~~iv~~ 74 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS------MRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 5677889999999999999999999764 2457899998743211 1123468899999999999999999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcC----------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceE
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVL 542 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NIL 542 (683)
++++. +....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+|||
T Consensus 75 ~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil 151 (277)
T cd05062 75 LGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCM 151 (277)
T ss_pred EEEEc-CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEE
Confidence 99986 667899999999999999998542 23577888999999999999999865 999999999999
Q ss_pred eCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 005678 543 FDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHD 621 (683)
Q Consensus 543 Ld~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~ 621 (683)
+++++.++|+|||++......... .......+++.|+|||.+.... ++.++|||||||++|+|++ |..||...
T Consensus 152 ~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 152 VAEDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred EcCCCCEEECCCCCccccCCccee---ecCCCCccCHhhcChhHhhcCC---cCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999998765432111 1112235678899999986433 7899999999999999998 78999765
Q ss_pred chHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 622 QTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 622 ~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
...... . .+..... .+....++..+.+||.+||..+|.+||++.+++++
T Consensus 226 ~~~~~~-~--~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 226 SNEQVL-R--FVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CHHHHH-H--HHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 543222 1 1111111 12234688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.52 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=220.1
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+..-|.+.+.||+|.|..|-+|.+..+|..||||++....... ....++..|+..|+-++|||||+||.+.. ..
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-----~st~hlfqEVRCMKLVQHpNiVRLYEViD-TQ 89 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-----LSTGHLFQEVRCMKLVQHPNIVRLYEVID-TQ 89 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-----hhhhHHHHHHHHHHHhcCcCeeeeeehhc-cc
Confidence 3456888999999999999999999999999999987664322 22468899999999999999999999976 45
Q ss_pred ceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-CCCcEEEEecCCcc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSK 558 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-~~g~vKL~DFGls~ 558 (683)
..+|||+|+-.+|+|++||-++ ..+.+..+..++.||+.|+.|+|+. .+|||||||+||++- .-|-+||+|||++.
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL--HVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL--HVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh--hhhcccCCcceeEEeeecCceEeeeccccc
Confidence 6789999999999999999544 5699999999999999999999985 599999999999876 57899999999997
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
.+.... .....+|+..|-|||++.+... --+.+||||||||||.|+||++||....+.+.+ +++..-+
T Consensus 168 kf~PG~------kL~TsCGSLAYSAPEILLGDsY--DAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----TmImDCK 235 (864)
T KOG4717|consen 168 KFQPGK------KLTTSCGSLAYSAPEILLGDSY--DAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----TMIMDCK 235 (864)
T ss_pred cCCCcc------hhhcccchhhccCchhhhcCcc--CCcchhhhHHHHHHHHHHhCCCccccccchhhh----hhhhccc
Confidence 665431 2234589999999999986652 246799999999999999999999877766654 3455555
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
+..| ..+|.+|++||.+||..||.+|.++++|..++|++...
T Consensus 236 YtvP--shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 236 YTVP--SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred ccCc--hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 5555 47999999999999999999999999999999998753
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.82 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=197.4
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHH---HHHhhcCCCceeeeccccccCCceEEEE
Q 005678 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY---NIHKTLVHHHIVRLWDTFEIDQNTFCTV 486 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi---~il~~L~HpnIV~L~~~f~~d~~~~~LV 486 (683)
.||+|+||.||++.+..++..||||.+.......... ...+.+|. .++....||||+.++++|. ..+.+++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG----ETLALNERIMLSLVSTGDCPFIVCMTYAFH-TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH----HHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-cCCeEEEE
Confidence 4899999999999999999999999876543221111 11223333 3444457999999999886 56789999
Q ss_pred EecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCC
Q 005678 487 LEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS 566 (683)
Q Consensus 487 ~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~ 566 (683)
|||+++++|..++...+.+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999999999988888999999999999999999999965 9999999999999999999999999987543221
Q ss_pred CcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcC
Q 005678 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPA 646 (683)
Q Consensus 567 ~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~ 646 (683)
.....||+.|+|||.+... ..++.++|||||||++|+|++|..||.......... ....... .....++.
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~--~~~~~~~~ 221 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKG--TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--VNVELPDS 221 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCC--CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhhc--CCcCCccc
Confidence 1223689999999987532 237889999999999999999999996543221111 1111111 12222346
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 647 VSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 647 ~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
++.++.+||.+||..||.+|| ++.++++||||+..
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 899999999999999999999 69999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=321.85 Aligned_cols=251 Identities=29% Similarity=0.435 Sum_probs=201.3
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHH-HhhcCCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI-HKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~i-l~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||.|+||.||+|.+..++..||||++...... .......+..|..+ .....||||++++++|. ..+.+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI----AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh----HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-cCCeEEEEE
Confidence 5689999999999999899999999987543211 11122334445444 44568999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++...+.+++..+..++.||+.||.|||+.+ |+|+||+|.|||++.++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999999999988778999999999999999999999865 99999999999999999999999999875432
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC--CCc
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP--SRP 645 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p--~~~ 645 (683)
.....|++.|+|||.+.... ++.++||||||+++|+|++|..||........+.. .......++ ...
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 218 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVG---DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN----ILSRRINWPEEVKE 218 (260)
T ss_pred ----cccCCCCcCccChhhhcCCC---CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcccCCCCcccc
Confidence 12236889999999986443 78899999999999999999999976655432221 112222232 223
Q ss_pred CCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccCCCC
Q 005678 646 AVSNEAKDLIRRCLTYNQAERP---DVLTLAQDPYLTYSK 682 (683)
Q Consensus 646 ~~s~el~dLI~rCL~~dP~kRP---S~~eLl~hP~l~~~K 682 (683)
.++..+.+||.+||..+|++|| ++.+++.||||...|
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 5889999999999999999999 558999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.40 Aligned_cols=266 Identities=23% Similarity=0.402 Sum_probs=209.1
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+..+|.+.+.||+|+||.||+|.+..++..||||.+....... .....+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-----IDAKRTLREIKLLRHLDHENVIAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-----chhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence 4568999999999999999999999999999999875432111 12345678999999999999999999875322
Q ss_pred ----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 481 ----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 481 ----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
..+|+||||+. ++|..++...+.+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 78 REAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred ccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCcc
Confidence 35899999995 689999988788999999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH---
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI--- 633 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i--- 633 (683)
+....... .......|+..|+|||.+.... .++.++|||||||++|+|++|..||........+......
T Consensus 155 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 155 ARTTSEKG-----DFMTEYVVTRWYRAPELLLNCS--EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred ccccCCCc-----ccccccccccCccChHHHhcCC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 98764321 1122346889999999875422 2788999999999999999999999765432211110000
Q ss_pred -----------------HHh-hc---cCC-CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 634 -----------------IKA-RK---VEF-PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 -----------------~~~-~~---~~~-p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
... .. ..+ ...+.++..+.+||.+||..+|.+||++.++++||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 00 000 0124688999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=326.24 Aligned_cols=257 Identities=24% Similarity=0.461 Sum_probs=208.5
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC---CCceeeeccccccCC
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV---HHHIVRLWDTFEIDQ 480 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~---HpnIV~L~~~f~~d~ 480 (683)
.|.+.+.||.|+||.||+|.+..++..||||.+...... .....+.+|+.+++.+. ||||++++++|. ++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD------DDVSDIQREVALLSQLRQSQPPNITKYYGSYL-KG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc------hhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-eC
Confidence 477889999999999999999999999999987654221 12346778999999986 999999999886 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
..+|+||||+++++|.+++... .+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 7899999999999999998765 6899999999999999999999865 999999999999999999999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......|++.|+|||++.... .++.++|||||||++|+|++|..||........+.. +.......
T Consensus 152 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~--~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~ 221 (277)
T cd06917 152 NQNSS-----KRSTFVGTPYWMAPEVITEGK--YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML---IPKSKPPR 221 (277)
T ss_pred CCCcc-----ccccccCCcceeCHHHhccCC--ccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc---cccCCCCC
Confidence 54321 122336899999999875322 368899999999999999999999976654332211 11111111
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
++. ..++.++.+||.+||..+|.+||++.+++.||||+..
T Consensus 222 ~~~-~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 222 LED-NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred CCc-ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 111 1378899999999999999999999999999999754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=314.05 Aligned_cols=251 Identities=30% Similarity=0.532 Sum_probs=210.4
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
|.+.+.||.|+||.||++.+..++..|++|++..... .....+.+|+.+++.++||||++++++|. .....+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~ 73 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-------EKKEKIINEIQILKKCKHPNIVKYYGSYL-KKDELW 73 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHHHHhCCCCCEeEEEEEEe-cCCeEE
Confidence 7788999999999999999988999999999865432 23467889999999999999999999986 567889
Q ss_pred EEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 485 TVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
+++||+++++|.+++... ..+++..+..++.+++.||.|||..+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999999999999765 57999999999999999999999854 999999999999999999999999999876543
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~ 643 (683)
.. .....|+..|+|||.+.... ++.++||||||+++|+|++|..||............ .......++.
T Consensus 152 ~~------~~~~~~~~~~~~PE~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~ 219 (253)
T cd05122 152 KA------RNTMVGTPYWMAPEVINGKP---YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---ATNGPPGLRN 219 (253)
T ss_pred cc------ccceecCCcccCHHHHcCCC---CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---HhcCCCCcCc
Confidence 21 22346889999999986443 788999999999999999999999876544433321 1122223333
Q ss_pred CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 005678 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677 (683)
Q Consensus 644 ~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~ 677 (683)
...++..+.+||.+||..+|.+|||+.+++.|||
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 3445899999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.54 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=209.9
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
..|..++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.+.||||++++++|. +.+.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA------EDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-ECCE
Confidence 347778899999999999999988999999998754321 123467889999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||++|++|.+++... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEEecCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999999999998764 5899999999999999999999855 99999999999999999999999999976643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||........... +...... .
T Consensus 154 ~~~-----~~~~~~~~~~y~apE~~~~~~---~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~--~ 220 (277)
T cd06640 154 TQI-----KRNTFVGTPFWMAPEVIQQSA---YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL---IPKNNPP--T 220 (277)
T ss_pred Ccc-----ccccccCcccccCHhHhccCC---CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh---hhcCCCC--C
Confidence 211 112236888999999886433 78999999999999999999999976554332211 1111111 1
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
....++..+.+||.+||..+|.+||++.+++.||||....
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 1235778999999999999999999999999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.27 Aligned_cols=258 Identities=22% Similarity=0.379 Sum_probs=209.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.+.|.....||.|+||.||++.+..++..||||.+.... ......+.+|+.+++.++||||+++++.|. ..+
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-~~~ 92 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-------QQRRELLFNEVVIMRDYHHENVVDMYNSYL-VGD 92 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-------HHHHHHHHHHHHHHHhCCCCcHHHHHHhee-cCC
Confidence 344555677999999999999998899999999874321 122456788999999999999999999986 677
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
..|+||||+++++|..++... .+++..+..++.||+.||.|||+.+ |+|+||||.|||++.++.++|+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 899999999999999988654 5899999999999999999999865 9999999999999999999999999987654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.... ......|++.|+|||.+.... ++.++|||||||++|+|++|..||........+.. +.......+
T Consensus 170 ~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~ 238 (292)
T cd06658 170 KEVP-----KRKSLVGTPYWMAPEVISRLP---YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDNLPPRV 238 (292)
T ss_pred cccc-----cCceeecCccccCHHHHccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCcc
Confidence 3211 112236899999999885433 78899999999999999999999976554432221 111122233
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+....++..+.+||.+||..+|.+|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 3344678899999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=330.61 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=207.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|...+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||++++++|. ..+.
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 76 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA------EDEIEDIQQEITVLSQCDSPYITRYYGSYL-KGTK 76 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc------hHHHHHHHHHHHHHHcCCCCccHhhhcccc-cCCc
Confidence 346677889999999999999999999999998754321 123457889999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||+++++|..++... .+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred eEEEEEccCCCcHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999999999999998654 5899999999999999999999855 99999999999999999999999999976643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
... ......|+..|+|||++.... ++.++|||||||++|+|++|..||........... +.......
T Consensus 154 ~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~-- 220 (277)
T cd06642 154 TQI-----KRNTFVGTPFWMAPEVIKQSA---YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL---IPKNSPPT-- 220 (277)
T ss_pred cch-----hhhcccCcccccCHHHhCcCC---CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh---hhcCCCCC--
Confidence 211 112236889999999986443 78899999999999999999999975443322211 11111111
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
....++..+.+||.+||..+|.+||++.+++.||||..
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 12357889999999999999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=327.48 Aligned_cols=266 Identities=26% Similarity=0.429 Sum_probs=203.1
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC--
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID-- 479 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d-- 479 (683)
-++|.+...||.|+||.||+|.+..++..||||.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-----GFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-----CchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 357999999999999999999999999999999875432211 1123456799999999999999999987532
Q ss_pred -----CceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 480 -----QNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 480 -----~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
...+++||||+. ++|..++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECc
Confidence 245799999995 5888877543 46899999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||++.......... ........++..|+|||++... ..++.++||||||+++|+|++|+.||..............+
T Consensus 163 fg~~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 163 FGLARAFSLSKNSK-PNRYTNRVVTLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred CCCcccccCCcccC-CCCccCcccCccccCcHHhcCC--cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99998765432211 1112334678999999987533 23678999999999999999999999766543322111111
Q ss_pred HHh---------------hccCCCCC-----------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 634 IKA---------------RKVEFPSR-----------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 634 ~~~---------------~~~~~p~~-----------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
... ....++.. ...+..+.+||.+||..||.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 100 00011110 1235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.99 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=201.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCce
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~~ 482 (683)
.|.....||+|+||.||++.+..++..||||.+...... .....+.+|+.++.++. ||||+++++++. ..+.
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-~~~~ 77 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE------KEQKRLLMDLDVVMRSSDCPYIVKFYGALF-REGD 77 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-cCCc
Confidence 355667899999999999999999999999987643221 22456788999999996 999999999886 5677
Q ss_pred EEEEEecccCCChhHHH-----hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 483 FCTVLEYCSGKDLDAVL-----KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L-----~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
.+++|||++ ++|.++. .....+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.++|+|||++
T Consensus 78 ~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 78 CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 889999995 4655543 2345699999999999999999999974 25999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
..+..... .....|++.|+|||.+.......++.++|||||||++|+|++|..||.........+ ..+....
T Consensus 156 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~ 227 (288)
T cd06616 156 GQLVDSIA------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL--TQVVKGD 227 (288)
T ss_pred HHhccCCc------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHH--hhhcCCC
Confidence 76543211 122368899999999865422348899999999999999999999997544211111 1111111
Q ss_pred ccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 638 KVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 ~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
....+ ....++.++.+||.+||..+|.+||++.+++.||||+.
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 11111 22358899999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=356.10 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=219.7
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|.-++.||.|+||.||.|+|..+...||||.+..+...+..+ -..++.|+.+|.+++|||++.+-+||- -..+.
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EK----WqDIlKEVrFL~~l~HPntieYkgCyL-re~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK----WQDILKEVRFLRQLRHPNTIEYKGCYL-REHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHH----HHHHHHHHHHHHhccCCCcccccceee-ccchH
Confidence 3555677999999999999999999999999886654433333 457889999999999999999999985 67788
Q ss_pred EEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|||||| -|+-.+++.- .+++-+-++..|+.+.+.||.|||+++ .||||||.+||||++.|.|||+|||.+.++..
T Consensus 102 WLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 8999999 4577777743 356999999999999999999999965 99999999999999999999999999876643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
...++|||+|||||++.....+.|+-++||||||++-.||.-.++|+........++ .|..+..+.++
T Consensus 179 ---------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY---HIAQNesPtLq 246 (948)
T KOG0577|consen 179 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNESPTLQ 246 (948)
T ss_pred ---------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH---HHHhcCCCCCC
Confidence 344589999999999987777789999999999999999999999998887777665 34455555554
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.+..|..+..||..||.+-|.+|||..+++.|+|+...
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 35789999999999999999999999999999998754
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=324.17 Aligned_cols=258 Identities=29% Similarity=0.477 Sum_probs=204.4
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||+|.+..++..||||.+...... .....+.+|+.+++.++||||++++++|. +.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE------GTPSTAIREISLMKELKHENIVRLHDVIH-TENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc------cchHHHHHHHHHHHhhcCCCEeeeeeeEe-eCCcE
Confidence 488999999999999999999999999999988654321 11245678999999999999999999986 56788
Q ss_pred EEEEecccCCChhHHHhcC---CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT---PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~---~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
++||||+++ +|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++...
T Consensus 74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 999999975 888887543 35899999999999999999999865 999999999999999999999999999765
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH------
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII------ 634 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~------ 634 (683)
..... ......+++.|+|||++... ..++.++|||||||++|+|++|..||......+.........
T Consensus 151 ~~~~~-----~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07836 151 GIPVN-----TFSNEVVTLWYRAPDVLLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223 (284)
T ss_pred cCCcc-----ccccccccccccChHHhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 43211 11223678999999987543 236889999999999999999999998765544322111100
Q ss_pred ------Hhh--ccCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 635 ------KAR--KVEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 635 ------~~~--~~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
... ...++. .+.++..+.++|.+||..+|.+||++.++++||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000 000110 13467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=339.64 Aligned_cols=260 Identities=26% Similarity=0.387 Sum_probs=203.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+.+.||+|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||++++++|....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-----VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-----hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 567899999999999999999999999999999987543211 122345678999999999999999999885332
Q ss_pred -----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 -----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 -----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+|+||||+. ++|...+... +++..+..++.|++.||.|||..+ |+|+||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 5888887654 899999999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH---
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT--- 632 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~--- 632 (683)
++....... ......|++.|+|||++.... ++.++|||||||++|+|++|+.||........+.....
T Consensus 164 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 234 (353)
T cd07850 164 LARTAGTSF------MMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234 (353)
T ss_pred cceeCCCCC------CCCCCcccccccCHHHHhCCC---CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 998664321 122336889999999986443 88999999999999999999999976543322111000
Q ss_pred ----------------HHHhh-------------ccCCCC-----CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 633 ----------------IIKAR-------------KVEFPS-----RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 633 ----------------i~~~~-------------~~~~p~-----~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..... ...++. ....+..+.+||.+||..||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence 00000 000110 11346678999999999999999999999999998
Q ss_pred C
Q 005678 679 T 679 (683)
Q Consensus 679 ~ 679 (683)
.
T Consensus 315 ~ 315 (353)
T cd07850 315 N 315 (353)
T ss_pred h
Confidence 6
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=326.23 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=196.4
Q ss_pred ceeEEEE--ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCC
Q 005678 404 RYALLNL--LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 404 ry~l~~~--LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~ 480 (683)
.|.+.+. ||.|+||.||++.+..++..+|+|++....... .|+.+...+ +||||++++++|. ..
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------------~e~~~~~~~~~h~~iv~~~~~~~-~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------------IEPMVHQLMKDNPNFIKLYYSVT-TL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------------hhHHHHHHhhcCCCEEEEEEEEe-cC
Confidence 4445554 599999999999999999999999975432110 022222222 6999999999996 56
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-cEEEEecCCccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTDFGLSKI 559 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-~vKL~DFGls~~ 559 (683)
+.+|+||||+++++|..++.....+++..+..++.||+.||.|||+.+ |+|+||||.||+++.++ .++|+|||++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 789999999999999999987778999999999999999999999966 99999999999999888 999999999876
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
.... ....|++.|+|||++.... ++.++|||||||++|+|++|..||.......... ..+......
T Consensus 160 ~~~~---------~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~ 225 (267)
T PHA03390 160 IGTP---------SCYDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL--ESLLKRQQK 225 (267)
T ss_pred cCCC---------ccCCCCCcccChhhhcCCC---CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH--HHHHHhhcc
Confidence 5432 1236899999999986433 7889999999999999999999997543322111 111111122
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCcccCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPD-VLTLAQDPYLTY 680 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS-~~eLl~hP~l~~ 680 (683)
..+..+.++..+.+||.+||..+|.+||+ +.++++||||.+
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 22333478999999999999999999995 799999999964
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=326.53 Aligned_cols=262 Identities=27% Similarity=0.449 Sum_probs=205.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||+||+|.+..++..||||.+....... .....+.+|+.+++.++||||+++++++. +...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-----GVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-----cchHHHHHHHHHHHhccCCCEeeEEEEEe-cCCe
Confidence 46899999999999999999999999999999875432211 22356778999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEEEecCCccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKVTDFGLSKI 559 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL~DFGls~~ 559 (683)
+|+||||++ ++|..++.... .+++..+..++.||+.||.|||+.+ |+|+||+|+|||++. ++.+||+|||++..
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 999999995 57888775443 3578888899999999999999865 999999999999985 56799999999976
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh--
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR-- 637 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~-- 637 (683)
..... .......|++.|+|||++... ..++.++|||||||++|+|++|..||......+.+..........
T Consensus 153 ~~~~~-----~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (294)
T PLN00009 153 FGIPV-----RTFTHEVVTLWYRAPEILLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNE 225 (294)
T ss_pred cCCCc-----cccccCceeecccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 54321 111233678999999987542 237889999999999999999999998766554443211110000
Q ss_pred ---------------ccCCC------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 638 ---------------KVEFP------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 ---------------~~~~p------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
...++ ..+.++..+.+||.+||..+|.+||++.+++.||||..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00001 12457889999999999999999999999999999974
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=324.70 Aligned_cols=258 Identities=31% Similarity=0.499 Sum_probs=205.3
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
|.+.+.||.|++|.||+|.+..+|..||||++....... .....+.+|+.+++.++||||+++++++. +.+..|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-----GVPSTAIREISLLKELNHPNIVRLLDVVH-SENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-----cchhHHHHHHHHHHhcCCCCccCHhheec-cCCeEE
Confidence 567889999999999999999999999999886543211 12346778999999999999999999986 678899
Q ss_pred EEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 485 TVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+||||+ +++|..++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.....
T Consensus 75 iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 75 LVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGV 151 (283)
T ss_pred EEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence 999999 468999987655 6899999999999999999999854 99999999999999999999999999976543
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH--------
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII-------- 634 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~-------- 634 (683)
... ......+++.|+|||++... ..++.++|||||||++|+|++|..||................
T Consensus 152 ~~~-----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 152 PVR-----TYTHEVVTLWYRAPEILLGS--RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224 (283)
T ss_pred Ccc-----ccCccccccCCCCCceeecC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 211 11223578899999987542 236889999999999999999999997765543322210000
Q ss_pred ----H--hhccCCC---------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 635 ----K--ARKVEFP---------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 635 ----~--~~~~~~p---------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
. .....++ ..+.++..+.+||.+||..+|.+||++.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 0000011 124678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=321.53 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=205.2
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+....|.+.+.||.|+||.||+|.+..++..||+|++..+. .....+.+|+.++..++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 72 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------MEVEEFLKEAAVMKEIKHPNLVQLLGVCT- 72 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--------hHHHHHHHHHHHHHhCCCCChhheEEEEc-
Confidence 445567899999999999999999999999999999875321 11356788999999999999999999886
Q ss_pred CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
....+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcc
Confidence 567889999999999999999643 45899999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
+........ .......+++.|+|||.+.... ++.++|||||||++|+|++ |..||......+.. . .+..
T Consensus 151 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~--~~~~ 220 (263)
T cd05052 151 SRLMTGDTY----TAHAGAKFPIKWTAPESLAYNK---FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-E--LLEK 220 (263)
T ss_pred cccccccee----eccCCCCCccccCCHHHhccCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H--HHHC
Confidence 987653311 1111223467899999886443 7889999999999999998 99999765543322 1 1111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....+....++.++.++|.+||..+|.+||++.++++
T Consensus 221 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 221 --GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1223334578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.28 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=211.2
Q ss_pred EEEEecccCceEEEEEEEccCCeEEE---EEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-Cce
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVA---CKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID-QNT 482 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VA---VKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d-~~~ 482 (683)
....||+|+|-+||+|+|..+|-.|| ||+-... ........|..|+.+|+.|+|||||++|++|... ...
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~------q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT------QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhh------cChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 35789999999999999999998887 3322111 1122356889999999999999999999999632 345
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-CCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-~~g~vKL~DFGls~~~~ 561 (683)
+.+|+|+|.+|+|..|+++++.++.+.+..|++||+.||.|||++.+||||||||.+||||+ ..|.|||+|+|||..+.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 88999999999999999999999999999999999999999999999999999999999998 47899999999999886
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.... ....|||.|||||++. ..|+..+||||||++|+||+|+.+||........|++.- ....++.-
T Consensus 198 ~s~a-------ksvIGTPEFMAPEmYE----E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV--~SGiKP~s 264 (632)
T KOG0584|consen 198 KSHA-------KSVIGTPEFMAPEMYE----ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV--TSGIKPAA 264 (632)
T ss_pred cccc-------ceeccCccccChHHHh----hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH--HcCCCHHH
Confidence 5432 2348999999999985 338999999999999999999999999999888887632 22211110
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
-. ..-.+++++||.+||.. ...|||+.+||.||||...
T Consensus 265 l~-kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 265 LS-KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred hh-ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 00 12257899999999998 9999999999999999853
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=318.57 Aligned_cols=257 Identities=30% Similarity=0.444 Sum_probs=209.0
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecc
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~ 490 (683)
||.|+||.||++.+..++..|++|++..... ........+.+|+.++..++||||+++++.+. ....+|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh----hhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-cCcEEEEEEecC
Confidence 6999999999999988899999998754321 12344677889999999999999999999886 677899999999
Q ss_pred cCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC---
Q 005678 491 SGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ--- 567 (683)
Q Consensus 491 ~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~--- 567 (683)
++++|.+++...+.+++..+..++.||+.||.|||..+ |+|+||+|+|||++.++.++|+|||++..........
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99999999987778999999999999999999999865 9999999999999999999999999987654331100
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.........+++.|+|||++.... ++.++||||||+++|+|++|..||........... .......++....+
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~---~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 226 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQG---HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN----ILNGKIEWPEDVEV 226 (265)
T ss_pred ccccccCcccCccccCHHHhcCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCCcCCCccccC
Confidence 000122336888999999886443 78899999999999999999999976664432211 12233444443345
Q ss_pred CHHHHHHHHHhcccCCCCCCCH---HHHhcCcccCCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDV---LTLAQDPYLTYS 681 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~---~eLl~hP~l~~~ 681 (683)
+..+.+||.+||..+|.+||++ .++++||||...
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 8999999999999999999999 999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=323.04 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=204.9
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccC-----CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeee
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVE-----HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~-----g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
|++..++|.+.+.||.|+||.||+|.+... +..||+|.+..... ......+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~ 74 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS------MRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC------HHHHHHHHHHHHHHHhCCCCceeEE
Confidence 456778999999999999999999987644 48899998754321 1223567889999999999999999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcC----------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceE
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVL 542 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NIL 542 (683)
++++. +...+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||
T Consensus 75 ~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nil 151 (277)
T cd05032 75 LGVVS-TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCM 151 (277)
T ss_pred EEEEc-CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEE
Confidence 99986 567899999999999999999542 23678889999999999999999865 999999999999
Q ss_pred eCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 005678 543 FDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHD 621 (683)
Q Consensus 543 Ld~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~ 621 (683)
++.++.+||+|||+++.+..... ........++..|+|||.+.... ++.++|||||||++|+|++ |..||...
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 152 VAEDLTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWMAPESLKDGV---FTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred EcCCCCEEECCcccchhhccCcc---cccCCCCCccccccCHHHHhcCC---CCcccchHHHHHHHHHhhccCCCCCccC
Confidence 99999999999999986643321 11223346788999999885433 7889999999999999998 99999765
Q ss_pred chHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 622 QTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 622 ~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...... . .+..... .+.+..++..+.+||.+||..+|.+|||+.+++.
T Consensus 226 ~~~~~~-~--~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 226 SNEEVL-K--FVIDGGH--LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CHHHHH-H--HHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 543322 1 1122222 2233457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.19 Aligned_cols=263 Identities=23% Similarity=0.417 Sum_probs=201.3
Q ss_pred ceeEEEEecccCceEEEEEEEcc--CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC-
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLV--EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ- 480 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~--~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~- 480 (683)
+|.+.+.||.|+||.||+|.+.. ++..||||.+...... .......+.+|+.+++.++||||++++++|. +.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ----YTGISQSACREIALLRELKHENVVSLVEVFL-EHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc----ccCccHHHHHHHHHHHhcCCCCccceEEEEe-CCC
Confidence 58899999999999999999888 8999999998664321 1122346778999999999999999999986 44
Q ss_pred -ceEEEEEecccCCChhHHHhcC-----CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC----CCcEE
Q 005678 481 -NTFCTVLEYCSGKDLDAVLKAT-----PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE----FGVAK 550 (683)
Q Consensus 481 -~~~~LV~Ey~~ggsL~~~L~~~-----~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~----~g~vK 550 (683)
..+++||||+++ +|..++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++. ++.+|
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEE
Confidence 789999999965 676666322 36899999999999999999999865 999999999999998 99999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHH-----
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE----- 625 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e----- 625 (683)
|+|||++..+...... ........|+++|+|||++... ..++.++|||||||++|+|++|++||.......
T Consensus 153 l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 228 (316)
T cd07842 153 IGDLGLARLFNAPLKP--LADLDPVVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228 (316)
T ss_pred ECCCccccccCCCccc--ccccCCccccccccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence 9999999876543211 1112234689999999987532 236889999999999999999999996543321
Q ss_pred ----HHHHHHHH------------------H----HhhccCCC---------CCcCCCHHHHHHHHHhcccCCCCCCCHH
Q 005678 626 ----RILREDTI------------------I----KARKVEFP---------SRPAVSNEAKDLIRRCLTYNQAERPDVL 670 (683)
Q Consensus 626 ----~il~~~~i------------------~----~~~~~~~p---------~~~~~s~el~dLI~rCL~~dP~kRPS~~ 670 (683)
.+...... . ......++ .....+..+.++|.+||.+||++|||+.
T Consensus 229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ 308 (316)
T cd07842 229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE 308 (316)
T ss_pred hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 00000000 0 00000111 0014677899999999999999999999
Q ss_pred HHhcCccc
Q 005678 671 TLAQDPYL 678 (683)
Q Consensus 671 eLl~hP~l 678 (683)
+++.||||
T Consensus 309 eil~~~~f 316 (316)
T cd07842 309 EALEHPYF 316 (316)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=326.84 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=209.0
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|...+.||.|+||.||++.+..++..|++|.+..... .....+.+|+.+++.+.||||++++++|. ..+..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-~~~~~ 91 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-------QRRELLFNEVVIMRDYQHPNIVEMYSSYL-VGDEL 91 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-------hHHHHHHHHHHHHHHcCCCChheEEEEEE-cCCeE
Confidence 34556799999999999999988999999998743211 12345788999999999999999999886 67788
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
|+|+||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999999999999977 46899999999999999999999865 999999999999999999999999988765432
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~ 643 (683)
.. ......|++.|+|||.+.... ++.++|||||||++|+|++|..||........... +..........
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~---~~~~~~~~~~~ 237 (285)
T cd06648 169 VP-----RRKSLVGTPYWMAPEVISRLP---YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR---IRDNLPPKLKN 237 (285)
T ss_pred Cc-----ccccccCCccccCHHHhcCCC---CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH---HHhcCCCCCcc
Confidence 11 112236899999999886433 78899999999999999999999976554332221 11111222222
Q ss_pred CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 644 ~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
...++..+.+||.+||..+|.+||++.+++.||||..+.
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 345889999999999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=324.34 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=208.0
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
-|.+++.||.|+||.||+|.+..++..||||++..... ......+.+|+.++..++||||++++++|. +++.+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 77 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA------EDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KDTKL 77 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-eCCeE
Confidence 46778899999999999999988999999998743311 123467889999999999999999999986 67789
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
++||||+++++|..++... .+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 78 ~lv~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 78 WIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEEeCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 9999999999999998754 5899999999999999999999865 999999999999999999999999998766432
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~ 643 (683)
.. ......|+..|+|||.+.... ++.++|||||||++|+|++|..||........... +....... .
T Consensus 155 ~~-----~~~~~~~~~~y~~PE~~~~~~---~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~--~ 221 (277)
T cd06641 155 QI-----KRNTFVGTPFWMAPEVIKQSA---YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL---IPKNNPPT--L 221 (277)
T ss_pred hh-----hhccccCCccccChhhhccCC---CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH---HhcCCCCC--C
Confidence 11 112236889999999886433 78899999999999999999999976543322211 11111111 1
Q ss_pred CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 644 ~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
...++.++.++|.+||..+|.+||++.++++||||...
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 23578899999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.57 Aligned_cols=264 Identities=22% Similarity=0.380 Sum_probs=206.5
Q ss_pred ccccccceeEEEEecccCceEEEEEEEcc-----CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeee
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLV-----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~-----~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
|++..++|.+.+.||+|+||.||+|.+.. .+..||+|.+..... ......+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS------LRERIEFLNEASVMKGFTCHHVVRL 74 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC------HHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 45677899999999999999999997542 356899998753321 1112357789999999999999999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcC----------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceE
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVL 542 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NIL 542 (683)
++++. +.+..|+||||+++|+|.+++... ..++...+..++.||+.||.|||+.+ |+|+||||+|||
T Consensus 75 ~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nil 151 (288)
T cd05061 75 LGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCM 151 (288)
T ss_pred EEEEc-CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEE
Confidence 99886 667899999999999999999642 23466788899999999999999865 999999999999
Q ss_pred eCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 005678 543 FDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHD 621 (683)
Q Consensus 543 Ld~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~ 621 (683)
++.++.++|+|||+++........ .......++..|+|||++.... ++.++|||||||++|+|++ |..||...
T Consensus 152 i~~~~~~~L~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~---~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 152 VAHDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGV---FTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred EcCCCcEEECcCCccccccccccc---cccCCCcccccccCHHHhccCC---CChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999865432111 1112234577899999886433 7899999999999999998 78999765
Q ss_pred chHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CcccCCC
Q 005678 622 QTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ------DPYLTYS 681 (683)
Q Consensus 622 ~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~------hP~l~~~ 681 (683)
...+ +.. .+...... +....++..+.+||.+||..+|.+|||+.++++ ||||..+
T Consensus 226 ~~~~-~~~--~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 226 SNEQ-VLK--FVMDGGYL--DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CHHH-HHH--HHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 5433 221 11112122 223457899999999999999999999999986 8998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=330.49 Aligned_cols=264 Identities=24% Similarity=0.415 Sum_probs=206.9
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-C
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID-Q 480 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d-~ 480 (683)
.+.|.+.+.||.|+||.||+|.+..+|..||+|.+....... .....+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-----GIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-----CCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 357999999999999999999999999999999876442211 1122456799999999999999999998633 2
Q ss_pred ceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+.+++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 81 DSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred CeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeee
Confidence 56899999996 588888754 366899999999999999999999966 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh---
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA--- 636 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~--- 636 (683)
...... ......+++.|+|||++... ..++.++|||||||++|+|++|..||......+.+.........
T Consensus 158 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 158 YGLPAK-----PMTPKVVTLWYRAPELLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred cCCccC-----CCCcccccccccChhhhcCC--CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 653211 11223568889999987532 23788999999999999999999999876655443221111000
Q ss_pred ------------hccCCCCC---------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 ------------RKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ------------~~~~~p~~---------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..+..+.. ..+++.+.+||.+||.+||.+|||+.+++.||||+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 01111111 235888999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=332.96 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=202.4
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCe----EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~----~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
...|.+.+.||+|+||.||+|.+..++. .||||++..... ......+.+|+.+++.+.||||++++++|.
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS------PKANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 3569999999999999999998766655 489998753211 122456888999999999999999999886
Q ss_pred cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
....++|++|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 --~~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 80 --TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred --CCCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccc
Confidence 34577999999999999999764 46889999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
++.+....... ......++..|+|||++.... ++.++|||||||++|+|++ |..||......+ +.. ..
T Consensus 156 a~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~---~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~----~~ 224 (316)
T cd05108 156 AKLLGADEKEY---HAEGGKVPIKWMALESILHRI---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISS----IL 224 (316)
T ss_pred cccccCCCcce---eccCCccceeecChHHhccCC---CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HH
Confidence 98765432111 111224567899999986443 8999999999999999997 999997654432 211 11
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.....++..+.++.++.++|.+||..+|.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 225 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2233445556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.05 Aligned_cols=264 Identities=27% Similarity=0.413 Sum_probs=224.8
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
++-.+.|..-++||+||||+||-+....+|+-||+|.+... ..++.....-++.|-.||..+..|.||.|-.+|+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KK----RiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe- 255 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKK----RIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE- 255 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHH----HHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec-
Confidence 34456788899999999999999999999999999987443 2344444566889999999999999999988886
Q ss_pred CCceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
.++.+|+||..|.||+|..+|-..+ .+++..++.++.+|+.||.+||... ||+|||||.|||||+.|++.|+|+||
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccce
Confidence 7889999999999999999996554 7999999999999999999999966 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
|.-++... .....+||.+|||||++.... |+..+|+|||||+||+|+-|+.||............+.....
T Consensus 334 Avei~~g~------~~~~rvGT~GYMAPEvl~ne~---Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~ 404 (591)
T KOG0986|consen 334 AVEIPEGK------PIRGRVGTVGYMAPEVLQNEV---YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE 404 (591)
T ss_pred EEecCCCC------ccccccCcccccCHHHHcCCc---ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc
Confidence 98876542 233449999999999997554 999999999999999999999999766554444344444555
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTY 680 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~ 680 (683)
....++ ..+|+++++|.+.+|+.||.+|. .+.++-+||||+.
T Consensus 405 ~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 405 DPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred chhhcc--cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 556666 57999999999999999999998 4679999999974
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.76 Aligned_cols=254 Identities=27% Similarity=0.480 Sum_probs=203.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||.||+|.+..++..||||.+....... ......+.+|+.+++.++||||++++++|. +.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD----AKARQDCVKEIDLLKQLNHPNVIKYLDSFI-EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC----HHHHHHHHHHHHHHHhCCCcceeeeeeeEE-ECCe
Confidence 46899999999999999999999999999999875432211 223456788999999999999999999986 5678
Q ss_pred EEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 483 FCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+++|+||+++++|.+++. ....+++..+..++.+|+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccce
Confidence 899999999999998884 2345899999999999999999999865 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
....... ......|++.|+|||.+.... ++.++||||||+++|+|++|..||.........+. ..+ ..
T Consensus 155 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~-~~~---~~ 222 (267)
T cd08228 155 FFSSKTT-----AAHSLVGTPYYMSPERIHENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC-QKI---EQ 222 (267)
T ss_pred eccchhH-----HHhcCCCCccccChhhhccCC---CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH-HHH---hc
Confidence 7653221 112346889999999886443 78899999999999999999999965443211111 111 11
Q ss_pred cCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 639 VEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 639 ~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
..++. ...++..+.+||.+||..+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 12222 12577899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.29 Aligned_cols=257 Identities=29% Similarity=0.409 Sum_probs=211.8
Q ss_pred ccceeEE-EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc-
Q 005678 402 NHRYALL-NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI- 478 (683)
Q Consensus 402 ~~ry~l~-~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~- 478 (683)
.+.|.+- ++||-|-.|.|..|+.+.++..+|+|++.-. ..+.+|++.+-.. .|||||.++++|+.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 3445553 6899999999999999999999999987321 3567899888877 59999999999964
Q ss_pred --CCceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---CCcEEE
Q 005678 479 --DQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---FGVAKV 551 (683)
Q Consensus 479 --d~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~g~vKL 551 (683)
....+.+|||+|+||.|...+...+ .++++++..|+.||+.|+.|||+. +|.||||||+|+|+.. |..+||
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~--nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM--NIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc--chhhccCChhheeeecCCCCcceEe
Confidence 3557889999999999999996654 599999999999999999999985 5999999999999974 567999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~ 631 (683)
+|||+|+...... ....++-||+|.|||++...+ |+..+|+||+||++|-||||.+||........--.-.
T Consensus 206 tDfGFAK~t~~~~------~L~TPc~TPyYvaPevlg~eK---ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk 276 (400)
T KOG0604|consen 206 TDFGFAKETQEPG------DLMTPCFTPYYVAPEVLGPEK---YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_pred cccccccccCCCc------cccCCcccccccCHHHhCchh---cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH
Confidence 9999998654321 233458899999999986555 8999999999999999999999997544321111111
Q ss_pred HHHHhhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 632 TIIKARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 632 ~i~~~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.-+..+.+.||. |..+|++++++|+.+|..+|.+|.++.+++.|||+...
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 234566777775 56899999999999999999999999999999999753
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.27 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=204.4
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
|.+..+.|.+++.||+|+||.||+|.+ .++..||+|.+..... ....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM--------SVQAFLEEANLMKTLQHDKLVRLYAVVT 71 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch--------hHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 455677899999999999999999985 4567799998754211 1357888999999999999999999886
Q ss_pred cCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
+.+.+++||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||||+|||++.++.++|+|||
T Consensus 72 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg 148 (261)
T cd05072 72 -KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFG 148 (261)
T ss_pred -CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCc
Confidence 67788999999999999999954 356888999999999999999999855 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
++........ .......++..|+|||++.... ++.++|||||||++|+|++ |..||........... +
T Consensus 149 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~---~- 217 (261)
T cd05072 149 LARVIEDNEY----TAREGAKFPIKWTAPEAINFGS---FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA---L- 217 (261)
T ss_pred cceecCCCce----eccCCCccceecCCHHHhccCC---CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH---H-
Confidence 9987653211 1112234677899999886443 7889999999999999998 9999976554432211 1
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....++....++.++.+||.+||..+|++||++.++.+
T Consensus 218 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 218 -QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 122334445578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=313.82 Aligned_cols=254 Identities=28% Similarity=0.527 Sum_probs=213.2
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||++.+..++..|+||.+...... ......+.+|+.++..++||||+++++++. +.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-----EEALKSIMQEIDLLKNLKHPNIVKYIGSIE-TSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-----HHHHHHHHHHHHHHHhCCCCCccEEEEEEE-eCCEE
Confidence 488899999999999999999889999999998654321 234567899999999999999999999886 56889
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
++||||+++++|.+++.....+++..+..++.+++.||.|||+.+ |+|+||+|.||+++.++.++|+|||++......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999999999988788999999999999999999999865 999999999999999999999999999876543
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~ 643 (683)
... .....|++.|+|||++.... ++.++||||||+++|+|++|..||............ . .....+.
T Consensus 153 ~~~-----~~~~~~~~~y~~pe~~~~~~---~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~---~--~~~~~~~ 219 (254)
T cd06627 153 SKD-----DASVVGTPYWMAPEVIEMSG---ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI---V--QDDHPPL 219 (254)
T ss_pred ccc-----ccccccchhhcCHhhhcCCC---CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---h--ccCCCCC
Confidence 221 12336889999999876433 788999999999999999999999766543333221 1 1122223
Q ss_pred CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 644 ~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
++.++..+.+||.+||..+|++||++.+++.||||
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 35688999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.32 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=199.4
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEec
Q 005678 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEY 489 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey 489 (683)
.||+|+||.||+|.+..+++.||+|++.......... ............+++...||||+.++++|. +.+.+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh-HHHHHHHHHHHHHHHhCCCCcEeeeeeeee-cCCEEEEEEec
Confidence 4899999999999999999999999876532221111 111112223344555568999999999986 66789999999
Q ss_pred ccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcc
Q 005678 490 CSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGM 569 (683)
Q Consensus 490 ~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~ 569 (683)
++|++|..++...+.+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----- 151 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----- 151 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-----
Confidence 999999999988888999999999999999999999965 9999999999999999999999999987553221
Q ss_pred cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCH
Q 005678 570 ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSN 649 (683)
Q Consensus 570 ~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~ 649 (683)
.....|++.|+|||++.... .++.++|||||||++|+|++|..||........... ..........+ +..++.
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~--~~~~s~ 224 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGV--AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMAVEL--PDSFSP 224 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHhhccCCCC--CCcCCH
Confidence 12337999999999986322 378899999999999999999999976532211111 11111122222 345789
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 650 EAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 650 el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
.+.++|.+||..+|.+|| ++.++++||||...
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 999999999999999999 99999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=325.83 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=214.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
..+.|.+...||.|+||.||+|.+..++..|++|++..... ....+.+|+.++..++||||++++++|. ..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~ 87 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--------NKELIINEILIMKDCKHPNIVDYYDSYL-VG 87 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--------hHHHHHHHHHHHHHCCCCCeeEEEEEEE-EC
Confidence 45568888999999999999999988899999999854322 2456788999999999999999999986 56
Q ss_pred ceEEEEEecccCCChhHHHhcCC-CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~-~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+.+++|+||+++++|.+++.... .+++..+..++.+++.||.|||+.+ |+|+||+|.||+++.++.++|+|||++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 88999999999999999998775 7999999999999999999999855 99999999999999999999999999876
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
...... ......|++.|+|||.+.... ++.++|||||||++|+|++|..||........... +......
T Consensus 166 ~~~~~~-----~~~~~~~~~~y~~PE~~~~~~---~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~---~~~~~~~ 234 (286)
T cd06614 166 LTKEKS-----KRNSVVGTPYWMAPEVIKRKD---YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL---ITTKGIP 234 (286)
T ss_pred hccchh-----hhccccCCcccCCHhHhcCCC---CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCC
Confidence 543211 112235888999999876433 78899999999999999999999986655433221 1112222
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.++....++..+.+||.+||..+|.+||++.+++.||||..++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 2333345889999999999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.73 Aligned_cols=266 Identities=27% Similarity=0.379 Sum_probs=209.8
Q ss_pred ceeEEEEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 404 RYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
.|.+.+.||.|+||.||.|.+. .+|..||+|++..... ........++.+|+.++..+ .||||++++++|. .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI---VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-T 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh---hhcchHHHHHHHHHHHHHhcccCCChhceeeEee-c
Confidence 3788999999999999999874 4789999999754321 11122345678899999999 5999999999986 5
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
...+|+||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.+||+|||++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 6788999999999999999987778999999999999999999999865 99999999999999999999999999986
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
...... .......|+..|+|||++.... ..++.++||||||+++|+|++|..||.................. .
T Consensus 155 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~ 227 (290)
T cd05613 155 FHEDEV----ERAYSFCGTIEYMAPDIVRGGD-GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--S 227 (290)
T ss_pred cccccc----cccccccCCcccCChhhccCCC-CCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--c
Confidence 543211 1122346899999999875422 23678899999999999999999999643222111111111111 1
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYSK 682 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~K 682 (683)
..+.+..++..+.+|+.+||..+|.+|| ++.+++.||||+..+
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 2223356889999999999999999997 899999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=324.77 Aligned_cols=260 Identities=24% Similarity=0.404 Sum_probs=217.0
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~ 481 (683)
+....+..||.|+.|.||++..+.+|...|||.+..+.... ..+.++..+.++... ..|+||+.||+|..+.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke------e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~- 164 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE------ENKRILMDLDVVLKSHDCPYIVQCFGYFITNT- 164 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH------HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-
Confidence 34456678999999999999999999999999987664422 245677777777665 4899999999997544
Q ss_pred eEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
...|.||.| +..++.+++ -.+++++..+-.+..-+++||.||.++ ++|||||+||+|||||+.|++||||||++..+
T Consensus 165 dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 165 DVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred hHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeeccccccee
Confidence 455889998 556777774 346799999999999999999999875 57999999999999999999999999999877
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
-+... .+..+|.+.|||||.+.....+.|+-.+||||||++++||.||..||.........+. .+.......
T Consensus 243 vdSkA------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt--kvln~ePP~ 314 (391)
T KOG0983|consen 243 VDSKA------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT--KVLNEEPPL 314 (391)
T ss_pred ecccc------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH--HHHhcCCCC
Confidence 65533 2334899999999999877678899999999999999999999999988776655543 344555666
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
+|....+|+.+.+|+..||..|+.+||.+.+|++|||+.
T Consensus 315 L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 315 LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence 777677999999999999999999999999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=333.46 Aligned_cols=266 Identities=27% Similarity=0.403 Sum_probs=211.9
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC---
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ--- 480 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~--- 480 (683)
+|.+.+.||.|+||.||+|.+..++..||||.+...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-----LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-----chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccc
Confidence 588999999999999999999888999999987543211 122457888999999999999999999986433
Q ss_pred -ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 481 -NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 481 -~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
..+|+||+|++ ++|..++.....+++..+..++.+|+.||.|||+.+ |+|+||||.|||++.++.++|+|||++..
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred ccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 47899999996 589999987778999999999999999999999965 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh---
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA--- 636 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~--- 636 (683)
....... ........||++|+|||.+.... .++.++||||||+++|+|++|..||......+.+.........
T Consensus 153 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~--~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 153 VDPDEDE--KGFLTEYVVTRWYRAPELLLSSS--RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228 (330)
T ss_pred ecccccc--cccccccccccCcCCceeeeccc--CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence 6543211 01123346899999999986542 3788999999999999999999999776654432211110000
Q ss_pred -----------------hccC----C-CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 -----------------RKVE----F-PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 -----------------~~~~----~-p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.... + ...+.++..+.+||.+||..+|.+||++.+++.||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0000 0 0013478899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=330.56 Aligned_cols=252 Identities=24% Similarity=0.417 Sum_probs=206.1
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEE
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
...||.|+||.||+|.+..++..||||.+..... .....+.+|+.++..+.||||++++++|. .++.+|+||
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~iv~ 97 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-------QRRELLFNEVVIMRDYQHQNVVEMYKSYL-VGEELWVLM 97 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-------chHHHHHHHHHHHHhCCCCchhhhhhhee-eCCeEEEEE
Confidence 4469999999999999988999999998754321 11345778999999999999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++... .+++..+..++.|++.||.|||+.+ |+|+||||.|||++.++.++|+|||++........
T Consensus 98 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 98 EFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred ecCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 999999999987654 5899999999999999999999865 99999999999999999999999999876543321
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
......|++.|+|||++.... ++.++|||||||++|+|++|..||........... +.......+.....+
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 243 (297)
T cd06659 173 ---KRKSLVGTPYWMAPEVISRTP---YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDSPPPKLKNAHKI 243 (297)
T ss_pred ---cccceecCccccCHHHHccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhccCCCCccccCCC
Confidence 112346899999999986433 78899999999999999999999976654443321 111112222233467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+..+.+||.+||..+|.+||++.++++||||...
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 8899999999999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=323.84 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=201.7
Q ss_pred ccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
...|.+.+.||.|+||.||+|.+. .++..||||++..... ......+.+|+.+++.+.||||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS------NDARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC------HHHHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 356888999999999999999764 3467899998754321 12346788999999999999999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHhcC--------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceE
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKAT--------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVL 542 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~~--------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NIL 542 (683)
. ....+++||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||+|||
T Consensus 78 ~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nil 154 (280)
T cd05049 78 T-EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCL 154 (280)
T ss_pred e-cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEE
Confidence 6 567899999999999999999654 24788999999999999999999865 999999999999
Q ss_pred eCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 005678 543 FDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHD 621 (683)
Q Consensus 543 Ld~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~ 621 (683)
++.++.++|+|||++..+...... .......+++.|+|||.+.... ++.++|||||||++|+|++ |..||...
T Consensus 155 i~~~~~~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 155 VGYDLVVKIGDFGMSRDVYTTDYY---RVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EcCCCeEEECCcccceecccCcce---ecCCCCcccceecChhhhccCC---cchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999765332110 1122335678899999986444 8899999999999999998 99999765
Q ss_pred chHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 622 QTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 622 ~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...+... .+. .... .+....++..+.+||.+||..+|.+||++.+++.
T Consensus 229 ~~~~~~~---~~~-~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 229 SNEEVIE---CIT-QGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CHHHHHH---HHH-cCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5543221 111 1111 1223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.93 Aligned_cols=254 Identities=30% Similarity=0.551 Sum_probs=210.4
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||++.+..++..|++|.+...... ......+.+|+.+++.++|||++++++.+. +...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-----EKEREDALNEVKILKKLNHPNIIKYYESFE-EKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-----hHHHHHHHHHHHHHHhcCCCChhheEEEEe-cCCEE
Confidence 588999999999999999999889999999998654322 123456788999999999999999999986 56889
Q ss_pred EEEEecccCCChhHHHhcC----CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT----PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~----~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
++|+||+++++|..++... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceee
Confidence 9999999999999999653 67999999999999999999999865 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
..... .......|++.|+|||.+.... ++.++||||||+++|+|++|..||......... . ......
T Consensus 153 ~~~~~-----~~~~~~~~~~~y~~pe~~~~~~---~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-~--~~~~~~-- 219 (258)
T cd08215 153 LSSTV-----DLAKTVVGTPYYLSPELCQNKP---YNYKSDIWSLGCVLYELCTLKHPFEGENLLELA-L--KILKGQ-- 219 (258)
T ss_pred cccCc-----ceecceeeeecccChhHhccCC---CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH-H--HHhcCC--
Confidence 65432 1233347899999999876443 788999999999999999999999766533221 1 111111
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..+.+..++..+.++|.+||..+|++||++.+++.||||
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 112223688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.45 Aligned_cols=265 Identities=18% Similarity=0.300 Sum_probs=202.7
Q ss_pred EEeccc--CceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEE
Q 005678 409 NLLGKG--GFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTV 486 (683)
Q Consensus 409 ~~LGkG--gfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV 486 (683)
..||+| +||+||++.+..+|+.||+|++...... ....+.+.+|+.+++.++||||++++++|. .+..+|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-----EEHLKALQNEVVLSHFFRHPNIMTSWTVFT-TGSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-----HHHHHHHHHHHHHHHhCCCCCcceEeeeEe-cCCceEEE
Confidence 346666 9999999999999999999998654321 123567888999999999999999999997 56789999
Q ss_pred EecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCc
Q 005678 487 LEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564 (683)
Q Consensus 487 ~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~ 564 (683)
|||+.+++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++++|||.+.......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 9999999999998654 35899999999999999999999865 9999999999999999999999998654432221
Q ss_pred CCC--cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH---------
Q 005678 565 GSQ--GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI--------- 633 (683)
Q Consensus 565 ~~~--~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i--------- 633 (683)
... .........++..|+|||++.... ..++.++|||||||++|+|++|..||...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDL-YGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 111 111111234567799999986432 23788999999999999999999999766544333211000
Q ss_pred --------------------------------HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 634 --------------------------------IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 --------------------------------~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
........+....++..+.+||++||.+||.+|||+.++++||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 000001111223467789999999999999999999999999999876
Q ss_pred C
Q 005678 682 K 682 (683)
Q Consensus 682 K 682 (683)
+
T Consensus 315 ~ 315 (328)
T cd08226 315 K 315 (328)
T ss_pred H
Confidence 5
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.50 Aligned_cols=251 Identities=25% Similarity=0.451 Sum_probs=205.3
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||++.+..++..||+|.+..... ......+..|+.+++.++||||++++++|. +.+.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS------SSAVEDSRKEAVLLAKMKHPNIVAFKESFE-ADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc------hHHHHHHHHHHHHHHhCCCCCcceEEEEEE-ECCEE
Confidence 48899999999999999999999999999998754321 122456778999999999999999999986 67889
Q ss_pred EEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
|+||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+|+||||.|||++.++.++|+|||++....
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence 999999999999998853 346899999999999999999999865 9999999999999999999999999997664
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... .......|++.|+|||++.... ++.++|+||||+++|+|++|..||........... +... ...
T Consensus 152 ~~~-----~~~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~---~~~~--~~~ 218 (255)
T cd08219 152 SPG-----AYACTYVGTPYYVPPEIWENMP---YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK---VCQG--SYK 218 (255)
T ss_pred ccc-----cccccccCCccccCHHHHccCC---cCchhhhhhhchhheehhhccCCCCCCCHHHHHHH---HhcC--CCC
Confidence 321 1122346899999999986443 78899999999999999999999976554332211 1111 112
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
+....++..+.+||.+||..+|.+||++.+++.--
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence 23346889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=335.42 Aligned_cols=269 Identities=27% Similarity=0.444 Sum_probs=209.3
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
+.++|.+.+.||.|+||.||+|.+..++..||||.+....... .....+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-----TDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-----hhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 5678999999999999999999998899999999874321111 1234567899999999 999999999987543
Q ss_pred -CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 -QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 -~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
...+|+||||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.+|.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 457899999996 5999998766 6899999999999999999999865 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH-----
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI----- 633 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i----- 633 (683)
..................||++|+|||.+... ..++.++|||||||++|+|++|+.||...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeecc--ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 76544322111222334789999999987532 34688999999999999999999999765543322110000
Q ss_pred ---------------HH-hhccC---C-CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 634 ---------------IK-ARKVE---F-PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 634 ---------------~~-~~~~~---~-p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.. ..... + ...+.++.++.+||.+||..+|.+||++.++++||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 00 00000 0 011347889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=354.29 Aligned_cols=259 Identities=26% Similarity=0.433 Sum_probs=214.0
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
.+|.+..+.+.+...||.|.||+||+|.. .-.||||++.......+ ..+.|..|+.++++-+|.||+-+.|+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~-----qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPE-----QLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHH-----HHHHHHHHHHHHhhcchhhheeeehh
Confidence 67888888999999999999999999953 45799999977654433 47899999999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
|. .+ .+.||+.||+|.+|+.+|. ....|.....+.|+.||+.|+.|||.++ |||||||..||||++++.|||+||
T Consensus 457 ~~-~p-~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 457 CM-NP-PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred hc-CC-ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecc
Confidence 96 33 3489999999999999994 2245889999999999999999999865 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
||+.......+... ..++.|...|||||++......+|+..+|||||||++|||++|..||. ....+.|+- .
T Consensus 533 GLatvk~~w~g~~q---~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIif----m 604 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQ---LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIF----M 604 (678)
T ss_pred cceeeeeeeccccc---cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEE----E
Confidence 99976544333332 344578899999999998877789999999999999999999999998 444444321 1
Q ss_pred HhhccCCCC----CcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFPS----RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p~----~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....+-.|+ ...++.++++|+..||.+++++||.+.+|+.
T Consensus 605 VGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 605 VGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 112222222 2467889999999999999999999988875
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=325.97 Aligned_cols=260 Identities=27% Similarity=0.453 Sum_probs=205.0
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-Cc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID-QN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d-~~ 481 (683)
+.|.+.+.||.|+||.||+|.+..++..||||.+...... ......+.+|+.++..++||||+++++++..+ .+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-----EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-----ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 3688899999999999999999889999999988654322 12234567899999999999999999987532 27
Q ss_pred eEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 80 ~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 80 KIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred cEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 8999999996 5999888654 45899999999999999999999865 999999999999999999999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH-----
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK----- 635 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~----- 635 (683)
..... ......+++.|+|||.+.... .++.++|||||||++|+|++|..||........+........
T Consensus 157 ~~~~~-----~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 157 GSPLK-----PYTQLVVTLWYRAPELLLGAK--EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred cCCcc-----ccccccccccccCchhhcCCc--cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 54311 112336789999999875332 368899999999999999999999986655433321111000
Q ss_pred ----------hh--c----------cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 636 ----------AR--K----------VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 636 ----------~~--~----------~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.. . ..++. ..+++.+.+||.+||..+|++||++.+++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccc-cCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00 0 00110 1158889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.16 Aligned_cols=246 Identities=27% Similarity=0.421 Sum_probs=196.8
Q ss_pred EecccCceEEEEEEE--ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEE
Q 005678 410 LLGKGGFSEVYKAYD--LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d--~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
.||+|+||.||+|.+ ..++..||+|++..... .......+..|+.++..+.||||+++++++. ...+++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-----DPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-----cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEE
Confidence 589999999999954 45788999998754321 1233567889999999999999999998874 55788999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|.+++.....+++..+..++.|++.||.|||+.+ |+|+||||.|||++.++.+||+|||++..+......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~- 151 (257)
T cd05116 75 ELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY- 151 (257)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCe-
Confidence 99999999999987778999999999999999999999865 999999999999999999999999999876543211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPA 646 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~ 646 (683)
........+++.|+|||++... .++.++|||||||++|+|++ |..||.......... .+.... ..+.++.
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~i~~~~--~~~~~~~ 222 (257)
T cd05116 152 -YKAKTHGKWPVKWYAPECMNYY---KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ---MIESGE--RMECPQR 222 (257)
T ss_pred -eeecCCCCCCccccCHhHhccC---CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHCCC--CCCCCCC
Confidence 0111223456789999988543 37889999999999999997 999997655433221 122222 2233456
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 647 VSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 647 ~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
++.++.+||.+||.+||.+||++.+|..
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 8999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.13 Aligned_cols=268 Identities=25% Similarity=0.390 Sum_probs=209.6
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTF 476 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f 476 (683)
+.+..+.|.+.+.||.|+||.||+|.+..++..||||.+...... .....+..|+.++..+ .||||++++++|
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK------EENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh------HHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 345567899999999999999999999888999999998543211 1134556677766666 499999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. +...+|+||||++ ++|.+++.. ...+++..+..++.+++.||.|||+. ++|+|+||+|.||++++++.+||+|||
T Consensus 84 ~-~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 84 I-TDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred e-cCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccc
Confidence 6 6778999999994 577777754 45789999999999999999999973 259999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK-TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~-~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
++..+..... .....|++.|+|||++.... .+.++.++||||||+++|+|++|+.||.........+. .+.
T Consensus 161 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~~~ 232 (296)
T cd06618 161 ISGRLVDSKA------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT--KIL 232 (296)
T ss_pred cchhccCCCc------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH--HHh
Confidence 9876643211 12235788999999986443 23478899999999999999999999976433322222 122
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
......++....++.++.+||.+||..+|.+||++.+++.||||+..+
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred cCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 222233343345789999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=321.15 Aligned_cols=268 Identities=26% Similarity=0.390 Sum_probs=218.2
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
.-+.++||++.+.||+|||+-||++....++..||+|.+.... ...+..+++|+...++++|||+++++++.-
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-------~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-------QEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-------hHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 4567889999999999999999999999999999999875542 223578899999999999999999998763
Q ss_pred c----CCceEEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcE
Q 005678 478 I----DQNTFCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA 549 (683)
Q Consensus 478 ~----d~~~~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~v 549 (683)
. ..+..||+++|+..|+|.+.+. ++..+++..+..|+.+|++||.+||+..+++.||||||.|||+.+.+.+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence 2 2446899999999999999984 3347999999999999999999999988889999999999999999999
Q ss_pred EEEecCCccccccCcCCCcc-----cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH
Q 005678 550 KVTDFGLSKIVEDDVGSQGM-----ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ 624 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~~-----~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~ 624 (683)
+|+|||.+..++-...+... +.. .-..|..|.|||.|.......++.++|||||||+||.|++|..||......
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a-~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWA-EERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHH-HHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 99999998876543211110 111 124688899999998766667899999999999999999999999532211
Q ss_pred HHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 625 ERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 625 e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
-.-+. .-+....+.+|..+.+|..+.+||..||..||-+||++.+++.+
T Consensus 248 GgSla--LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLA--LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEE--EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 10000 01233467788888899999999999999999999999999853
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.13 Aligned_cols=245 Identities=28% Similarity=0.427 Sum_probs=195.3
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEec
Q 005678 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEY 489 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey 489 (683)
.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||++++++|. ....+++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~ 74 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL------PPDLKAKFLQEARILKQYSHPNIVRLIGVCT-QKQPIYIVMEL 74 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCCeEEEEee
Confidence 6899999999999999999999999864321 1123457889999999999999999999886 66789999999
Q ss_pred ccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCc
Q 005678 490 CSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568 (683)
Q Consensus 490 ~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~ 568 (683)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||.|||++.++.+||+|||++.........
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 150 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-- 150 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCccccccccc--
Confidence 9999999999653 46899999999999999999999865 999999999999999999999999998765422110
Q ss_pred ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 569 ~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.......++..|+|||.+.... ++.++|||||||++|+|++ |..||.......... .+.. ....+.+..+
T Consensus 151 -~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~---~~~~--~~~~~~~~~~ 221 (252)
T cd05084 151 -STGGMKQIPVKWTAPEALNYGR---YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE---AIEQ--GVRLPCPELC 221 (252)
T ss_pred -ccCCCCCCceeecCchhhcCCC---CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH---HHHc--CCCCCCcccC
Confidence 0011112346799999886443 7899999999999999997 999997654432211 1111 2223334567
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 648 SNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+..+.+||.+||..+|.+||++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=325.48 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=206.4
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccC-----CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCcee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVE-----HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~-----g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV 470 (683)
.+.+..++|.+.+.||+|+||.||++..... ...||+|++..... ......+.+|+.++..+ +||||+
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT------EKDLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC------HHHHHHHHHHHHHHHhhcCCCCee
Confidence 4566778999999999999999999987543 37899998754321 12245688999999999 899999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhc----------------CCCcchHHHHHHHHHHHHHHHHHHhcCCceEec
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA----------------TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHY 534 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~----------------~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHr 534 (683)
+++++|. ..+.+++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+|+
T Consensus 80 ~~~~~~~-~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~ 156 (293)
T cd05053 80 NLLGVCT-QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHR 156 (293)
T ss_pred eEEEEEc-CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence 9999886 56789999999999999999853 246889999999999999999999855 9999
Q ss_pred ccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-
Q 005678 535 DLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF- 613 (683)
Q Consensus 535 DLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt- 613 (683)
||||.|||++.++.+||+|||+++.+..... ........+++.|+|||.+.... ++.++|||||||++|+|++
T Consensus 157 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~~ 230 (293)
T cd05053 157 DLAARNVLVTEDHVMKIADFGLARDIHHIDY---YRKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLLWEIFTL 230 (293)
T ss_pred ccceeeEEEcCCCeEEeCccccccccccccc---eeccCCCCCCccccCHHHhccCC---cCcccceeehhhHHHHHhcC
Confidence 9999999999999999999999987654211 11122234567899999875443 7899999999999999997
Q ss_pred CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 614 GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 614 G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
|..||......+.. . .+. .....+.+..++..+.+||.+||..+|.+|||+.+++.+
T Consensus 231 g~~p~~~~~~~~~~-~--~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 231 GGSPYPGIPVEELF-K--LLK--EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCCCCCCCCHHHHH-H--HHH--cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 99999765543322 1 111 122223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.93 Aligned_cols=247 Identities=29% Similarity=0.443 Sum_probs=203.8
Q ss_pred EEecccCceEEEEEEEccC---CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVE---HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT 485 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~---g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~L 485 (683)
+.||+|+||.||+|.+... +..|++|++....... ....+.+|+.++..++||||+++++++. +...+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~l 73 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE------ERKDFLKEARVMKKLGHPNVVRLLGVCT-EEEPLYL 73 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh------HHHHHHHHHHHHhhcCCCChheeeeeec-CCCceEE
Confidence 3689999999999998766 8999999986543211 3567889999999999999999999886 5788999
Q ss_pred EEecccCCChhHHHhcC---------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 486 VLEYCSGKDLDAVLKAT---------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~---------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccc
Confidence 99999999999999764 77999999999999999999999955 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
+........ ........+++.|+|||.+... .++.++|||||||++|+|++ |..||......+.. . .+..
T Consensus 152 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~--~~~~ 222 (262)
T cd00192 152 SRDVYDDDY---YRKKTGGKLPIRWMAPESLKDG---IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL-E--YLRK 222 (262)
T ss_pred ccccccccc---cccccCCCcCccccCHHHhccC---CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH-H--HHHc
Confidence 987764321 1223344688999999988654 37899999999999999998 69999876543322 1 1111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
....+....++.++.++|.+||..+|.+||++.+++.+
T Consensus 223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 --GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 22333445789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.04 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=202.1
Q ss_pred cccceeEEEEecccCceEEEEEEEcc-----CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLV-----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~-----~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
.++.|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS------EQDESDFLMEALIMSKFNHQNIVRLIGV 77 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC------HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 45679999999999999999999876 778999998743321 1123468889999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcCC-------CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKATP-------VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG- 547 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~~-------~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g- 547 (683)
+. +.+..++||||++|++|.+++.... .+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++
T Consensus 78 ~~-~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~ 154 (277)
T cd05036 78 SF-ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGP 154 (277)
T ss_pred Ec-cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCC
Confidence 75 5677899999999999999996542 4889999999999999999999965 99999999999998655
Q ss_pred --cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchH
Q 005678 548 --VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQ 624 (683)
Q Consensus 548 --~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~ 624 (683)
.+||+|||+++.+...... .......+++.|+|||++.... ++.++|||||||++|+|++ |..||......
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~~g~~pf~~~~~~ 228 (277)
T cd05036 155 GRVAKIADFGMARDIYRASYY---RKGGRAMLPIKWMPPEAFLDGI---FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228 (277)
T ss_pred CcceEeccCccccccCCccce---ecCCCCCccHhhCCHHHHhcCC---cCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 5999999999876322110 0111223456799999986443 8999999999999999996 99999765544
Q ss_pred HHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 625 ERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 625 e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
... . .+...... +.+..++..+.+||.+||..+|++||++.++++|
T Consensus 229 ~~~-~--~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 229 EVM-E--FVTGGGRL--DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHH-H--HHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 322 1 12222222 2335689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.76 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=205.0
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-CceE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID-QNTF 483 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d-~~~~ 483 (683)
|.+.+.||.|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.+.||||+++++++... .+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE-----KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc-----cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcE
Confidence 6788999999999999999998999999999865431 112235677899999999999999999998743 2789
Q ss_pred EEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
++||||+++ +|..++... ..+++..+..++.+|+.||.|||..+ ++|+||+|+|||+++++.++|+|||++.....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred EEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 999999964 898888654 57999999999999999999999865 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh-hccCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA-RKVEF 641 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~-~~~~~ 641 (683)
... .......+++.|+|||++.... .++.++||||||+++|+|++|..||.................. ....+
T Consensus 153 ~~~----~~~~~~~~~~~y~~PE~~~~~~--~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 153 RNS----ADYTNRVITLWYRPPELLLGAT--RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226 (287)
T ss_pred CCc----ccccccccccccCCceeeEccc--cCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhc
Confidence 321 1122336788999999875322 3788999999999999999999999776654332211110000 00001
Q ss_pred CC-----------------------CcC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 642 PS-----------------------RPA-VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 642 p~-----------------------~~~-~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
+. ... ++..+.++|.+||..+|.+||++.+++.||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.40 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=204.7
Q ss_pred ccceeEEEEecccCceEEEEEEEccCC----------------eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEH----------------RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV 465 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g----------------~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~ 465 (683)
..+|.+++.||+|+||.||+|.+...+ ..||+|.+..... ......+.+|+.++..++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~------~~~~~~~~~e~~~l~~l~ 77 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS------DNAREDFLKEVKILSRLS 77 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC------HHHHHHHHHHHHHHHhcC
Confidence 467999999999999999999876543 5689998754422 133567889999999999
Q ss_pred CCceeeeccccccCCceEEEEEecccCCChhHHHhcCC-----------CcchHHHHHHHHHHHHHHHHHHhcCCceEec
Q 005678 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-----------VLPEREARIIIVQIFQGLIYLNKRAQKIIHY 534 (683)
Q Consensus 466 HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~-----------~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHr 534 (683)
||||++++++|. +...+++||||+++++|..++.... .+++..++.++.|++.||.|||+.+ |+|+
T Consensus 78 ~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~ 154 (296)
T cd05051 78 DPNIARLLGVCT-VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHR 154 (296)
T ss_pred CCCEeEEEEEEe-cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccc
Confidence 999999999886 5578999999999999999997654 6899999999999999999999865 9999
Q ss_pred ccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-
Q 005678 535 DLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF- 613 (683)
Q Consensus 535 DLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt- 613 (683)
||||+|||++.++.++|+|||++........ ........+++.|+|||++.... ++.++|||||||++|+|++
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 155 DLATRNCLVGKNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLLGK---FTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred ccchhceeecCCCceEEccccceeecccCcc---eeecCcCCCCceecCHHHhhcCC---CCccchhhhhHHHHHHHHhc
Confidence 9999999999999999999999976543211 11223345778899999886443 7899999999999999997
Q ss_pred -CCCCCCCCchHHHHHHHHHHHH--hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 614 -GRRPFGHDQTQERILREDTIIK--ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 614 -G~~PF~~~~~~e~il~~~~i~~--~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
|..||......+.+........ ......+..+.++.++.+||.+||..+|.+||++.++++
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 229 CREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 7789876554443322111110 112223344567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=344.03 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=205.1
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccC-----CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCcee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVE-----HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~-----g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV 470 (683)
.|.+..++|.+++.||+|+||.||+|.+... +..||||++..... ......+.+|+.++..+. |||||
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR------SSEKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCCCee
Confidence 5566788999999999999999999986433 35799998854321 122357889999999996 99999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcC------------------------------------------------
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT------------------------------------------------ 502 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~------------------------------------------------ 502 (683)
+++++|. +.+.+|+|||||++|+|.++|...
T Consensus 105 ~l~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (400)
T cd05105 105 NLLGACT-KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA 183 (400)
T ss_pred eEEEEEc-cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence 9999986 677899999999999999988432
Q ss_pred ------------------------------------------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEec
Q 005678 503 ------------------------------------------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHY 534 (683)
Q Consensus 503 ------------------------------------------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHr 534 (683)
..+++..+..++.||+.||.|||+.+ |+|+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~ 261 (400)
T cd05105 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHR 261 (400)
T ss_pred cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCC
Confidence 23778888999999999999999865 9999
Q ss_pred ccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-
Q 005678 535 DLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF- 613 (683)
Q Consensus 535 DLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt- 613 (683)
||||.|||++.++.+||+|||+++........ .......|++.|+|||++.... ++.++|||||||++|+|++
T Consensus 262 dikp~Nill~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 262 DLAARNVLLAQGKIVKICDFGLARDIMHDSNY---VSKGSTFLPVKWMAPESIFDNL---YTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred CCChHhEEEeCCCEEEEEeCCcceeccccccc---cccCCcCCCcceEChhhhcCCC---CCchhhHHHHHHHHHHHHHC
Confidence 99999999999999999999999865432111 1122235778899999886433 7899999999999999996
Q ss_pred CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 614 GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 614 G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
|..||........+... +. .....+....++..+.+||.+||..+|.+||++.++.+
T Consensus 336 g~~P~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 336 GGTPYPGMIVDSTFYNK--IK--SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CCCCCcccchhHHHHHH--Hh--cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 99999765443333221 11 12233444578999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.73 Aligned_cols=264 Identities=25% Similarity=0.416 Sum_probs=206.1
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
..++|.+.+.||.|+||.||+|.+..++..||||.+....... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-----GFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-----CchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 4567999999999999999999999899999999886543211 11245678999999999999999999885322
Q ss_pred ---------ceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 481 ---------NTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 481 ---------~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
..+|+|+||+++ +|...+.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEE
Confidence 379999999976 67666654 346899999999999999999999865 99999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|+|||++........ .......+++.|+|||++... ..++.++|||||||++|+|++|++||............
T Consensus 157 l~dfg~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~ 230 (302)
T cd07864 157 LADFGLARLYNSEES----RPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230 (302)
T ss_pred eCcccccccccCCcc----cccccceeccCccChHHhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 999999987654321 112223567889999987532 23688999999999999999999999866554433222
Q ss_pred HHHHHhhc-cCC-----------------------CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 631 DTIIKARK-VEF-----------------------PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 631 ~~i~~~~~-~~~-----------------------p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
........ ..+ .....++..+.+||.+||..+|.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 11111000 000 0123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=316.20 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=203.2
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
|.+..++|.+.+.||.|+||.||+|.+. ++..||||.+..... ....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM--------DPKDFLAEAQIMKKLRHPKLIQLYAVCT 71 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc--------cHHHHHHHHHHHHHCCCCCccceeEEEe
Confidence 3456778999999999999999999864 567899998754321 1245778999999999999999999886
Q ss_pred cCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+.+|+||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||
T Consensus 72 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 72 -LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred -cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcc
Confidence 667889999999999999999654 36899999999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
++......... ......++..|+|||++.... ++.++||||||+++|+|++ |+.||.......... .+.
T Consensus 149 ~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~ 218 (261)
T cd05068 149 LARVIKEDIYE----AREGAKFPIKWTAPEAALYNR---FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ---QVD 218 (261)
T ss_pred eEEEccCCccc----ccCCCcCceeccCccccccCC---CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHH
Confidence 99876532111 011112345799999886443 7899999999999999998 999997665433221 111
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+....++..+.+||.+||..+|.+||++.++++
T Consensus 219 --~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 219 --QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 12233444578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.85 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=203.6
Q ss_pred ccceeEEEEecccCceEEEEEEEccC---CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVE---HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~---g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.++|.+.+.||+|+||.||+|.+..+ ...||||++..... ......+.+|+.++..++||||+++++.+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS------DKQRLDFLTEASIMGQFDHPNIIRLEGVVT- 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC------hHHHHHHHHHHHHHHhCCCCCcceEeEEEe-
Confidence 35689999999999999999987543 45899998754321 122356788999999999999999999886
Q ss_pred CCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
..+.+++||||+++++|.+++... +.+++..+..++.+++.||.|||+.+ |+|+||||.|||++.++.++|+|||++
T Consensus 76 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 76 KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred cCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchh
Confidence 677899999999999999999653 46899999999999999999999855 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~ 636 (683)
......... .......+++.|+|||.+.... ++.++||||||+++|+|++ |..||......... . .+.
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~---~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-~--~~~-- 222 (266)
T cd05033 154 RRLEDSEAT---YTTKGGKIPIRWTAPEAIAYRK---FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-K--AVE-- 222 (266)
T ss_pred hcccccccc---eeccCCCCCccccChhhhccCC---CccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-H--HHH--
Confidence 887522111 1122335677899999886443 7899999999999999997 99999765543321 1 111
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.....+....++..+.+|+.+||..+|.+||++.+++++
T Consensus 223 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 223 DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 122334445789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.26 Aligned_cols=267 Identities=26% Similarity=0.423 Sum_probs=202.6
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC--
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID-- 479 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d-- 479 (683)
.++|.+.+.||.|+||.||+|.+..++..||||.+........ ....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-----FPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-----cchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 4689999999999999999999999999999998754322111 123456899999999999999999887532
Q ss_pred -----CceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 480 -----QNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 480 -----~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
...+++||+|+.+ +|...+. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.++|+|
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECc
Confidence 2347999999964 6766664 3457999999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCc------ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 554 FGLSKIVEDDVGSQG------MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 554 FGls~~~~~~~~~~~------~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
||++........... ........|++.|+|||++... ..++.++|||||||++|+|++|.+||.........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC--CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999986643321110 0112233678999999987532 23788999999999999999999999765554322
Q ss_pred HHHHHHHHh-hccC------------------CCC-----CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 628 LREDTIIKA-RKVE------------------FPS-----RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 628 l~~~~i~~~-~~~~------------------~p~-----~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
......... .... .+. ...++..+.+||.+||..+|.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 111000000 0000 000 12345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.04 Aligned_cols=276 Identities=27% Similarity=0.415 Sum_probs=210.9
Q ss_pred cccceeE-EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhH-H------HHHHHHHHHHHHHhhcCCCceeee
Q 005678 401 LNHRYAL-LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKK-Q------SYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 401 ~~~ry~l-~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~-~------~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
+.++|.. .+.||.|+||+||+|.+..++..||||.+........... . .....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3456764 5779999999999999999999999998755432211100 0 011246789999999999999999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
+++|. ..+.+|+||||+. ++|..++.....+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+
T Consensus 86 ~~~~~-~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 86 VDVYV-EGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred eEEEe-cCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEEC
Confidence 99986 6778999999996 699999987778999999999999999999999865 9999999999999999999999
Q ss_pred ecCCccccccCcCC---------CcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch
Q 005678 553 DFGLSKIVEDDVGS---------QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT 623 (683)
Q Consensus 553 DFGls~~~~~~~~~---------~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~ 623 (683)
|||++......... ..........+++.|+|||++.... .++.++|||||||++|+|++|..||.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE--KYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999766421100 0011112235788999999886432 368899999999999999999999987765
Q ss_pred HHHHHHHHHHHH-hhccCCC---------------------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 624 QERILREDTIIK-ARKVEFP---------------------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 624 ~e~il~~~~i~~-~~~~~~p---------------------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.+.......... .....|+ ..+.++..+.+||.+||..+|++||++.+++.||||+..
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 543321111100 0000010 013457889999999999999999999999999999865
Q ss_pred C
Q 005678 682 K 682 (683)
Q Consensus 682 K 682 (683)
.
T Consensus 320 ~ 320 (335)
T PTZ00024 320 P 320 (335)
T ss_pred C
Confidence 3
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.75 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=206.0
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
|++.-+...-++-||.|+-|.||+| ...++.||||.+.- .+ ..+|.-|++|+||||+.|.|+|.
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~G--rl~netVAVKKV~e-------lk-------ETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLG--RLHNETVAVKKVRE-------LK-------ETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeee--eccCceehhHHHhh-------hh-------hhhHHHHHhccCcceeeEeeeec
Confidence 4444444445677999999999999 46788999996521 11 12566788999999999999996
Q ss_pred cCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
....+|||||||..|-|..+|+...+++......+..+|+.|+.|||.+ +|||||||.-||||..+..|||+|||.+
T Consensus 183 -qsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h--KIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 183 -QSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH--KIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred -CCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh--hHhhhccCCCceEeeccceEEeccccch
Confidence 6678999999999999999999999999999999999999999999985 5999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
+....... ...++||..|||||++.... .+.|+|||||||+|||||||..||........|+. ....
T Consensus 260 ~e~~~~ST------kMSFaGTVaWMAPEvIrneP---csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG----VGsN 326 (904)
T KOG4721|consen 260 KELSDKST------KMSFAGTVAWMAPEVIRNEP---CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG----VGSN 326 (904)
T ss_pred Hhhhhhhh------hhhhhhhHhhhCHHHhhcCC---cccccceehhHHHHHHHHhcCCCccccchheeEEe----ccCC
Confidence 87765422 22348999999999997544 89999999999999999999999977655432221 1233
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
.+.+|.+..|++.++-||+.||.-.|..||++.+++.|-
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 456777789999999999999999999999999999883
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.77 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=203.9
Q ss_pred ccccccceeEEEEecccCceEEEEEEE-----ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceee
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYD-----LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVR 471 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d-----~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~ 471 (683)
|.+..++|.+.+.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.++..+ .||||++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------HSEHRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC------hHHHHHHHHHHHHHHhccCCccHhh
Confidence 455678999999999999999999974 35678999999854321 12245788999999999 6899999
Q ss_pred eccccccCCceEEEEEecccCCChhHHHhcC-------------------------------------------------
Q 005678 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT------------------------------------------------- 502 (683)
Q Consensus 472 L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~------------------------------------------------- 502 (683)
++++|...+..+++|||||++|+|.+++...
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (343)
T cd05103 76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE 155 (343)
T ss_pred hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence 9998876667889999999999999998532
Q ss_pred ------------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCc
Q 005678 503 ------------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564 (683)
Q Consensus 503 ------------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~ 564 (683)
..+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||++..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~ 233 (343)
T cd05103 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233 (343)
T ss_pred CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCc
Confidence 23677888899999999999999865 9999999999999999999999999998654321
Q ss_pred CCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCC
Q 005678 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPS 643 (683)
Q Consensus 565 ~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~ 643 (683)
.. .......+++.|+|||++.... ++.++|||||||++|+|++ |..||........+.. .+..... .+.
T Consensus 234 ~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--~~~~~~~--~~~ 303 (343)
T cd05103 234 DY---VRKGDARLPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--RLKEGTR--MRA 303 (343)
T ss_pred ch---hhcCCCCCCcceECcHHhcCCC---CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH--HHhccCC--CCC
Confidence 10 1112234567899999886443 7899999999999999996 9999976543332221 1111112 222
Q ss_pred CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 644 ~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+..+++++.+++.+||..+|.+||++.++++|
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 23478899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.89 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=197.5
Q ss_pred eeEEEEecccCceEEEEEEEccCCe--EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC---
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHR--YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID--- 479 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~--~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d--- 479 (683)
|.+.+.||+|+||.||+|.+..++. .||||.+..... .......+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-----TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 3567889999999999998877665 699998765422 122356788999999999999999999875321
Q ss_pred --CceEEEEEecccCCChhHHHhc------CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEE
Q 005678 480 --QNTFCTVLEYCSGKDLDAVLKA------TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKV 551 (683)
Q Consensus 480 --~~~~~LV~Ey~~ggsL~~~L~~------~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL 551 (683)
...+++||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEE
Confidence 2357899999999999988732 235889999999999999999999855 999999999999999999999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHH
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRE 630 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~ 630 (683)
+|||+++.+...... .......+++.|+|||++.... ++.++|||||||++|+|++ |..||....... ++.
T Consensus 154 ~Dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~---~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~- 225 (272)
T cd05075 154 ADFGLSKKIYNGDYY---RQGRIAKMPVKWIAIESLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYD- 225 (272)
T ss_pred CCCCcccccCcccce---ecCCcccCCcccCCHHHccCCC---cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH-
Confidence 999999876533110 1112235677899999886443 7899999999999999999 899997654432 221
Q ss_pred HHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 631 ~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.+... ..++..+.++..+.++|.+||..+|.+|||+.+++++
T Consensus 226 -~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 226 -YLRQG--NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -HHHcC--CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11111 2233445788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.69 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=208.2
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||.||+|.+..++..||||.+..... .......+.+|+.+++.++||||++++++|..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-----SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 57789999999999999999999999999999998754321 1122356788999999999999999999986443
Q ss_pred -----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 -----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 -----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+|+||+|+ +++|..++... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~~-~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecc
Confidence 2468999999 77999888754 5899999999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH-
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII- 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~- 634 (683)
++...... .....+++.|+|||++... ..++.++|||||||++|+|++|..||................
T Consensus 164 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 164 LARQTDSE--------MTGYVVTRWYRAPEVILNW--MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred cccccccC--------ccccccCCcccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99765432 1123678999999988532 237889999999999999999999998665433322110000
Q ss_pred -------------------H-hhccC---C-CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 635 -------------------K-ARKVE---F-PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 635 -------------------~-~~~~~---~-p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
. ...+. + ...+.++..+.++|.+||..||.+||++.+++.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0 00000 0 0124578889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.09 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=201.6
Q ss_pred cccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
-.+.|.+.+.||.|+||.||++.+. .++..||+|.+.... ......+.+|+.++..++||||++++++
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-------DNARKDFHREAELLTNLQHEHIVKFYGV 75 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-------HHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 3567999999999999999999752 345679999874321 1234578899999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcCC-------------CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceE
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKATP-------------VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVL 542 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~~-------------~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NIL 542 (683)
|. +.+.+++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 76 ~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nil 152 (288)
T cd05093 76 CV-EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCL 152 (288)
T ss_pred Ee-cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEE
Confidence 86 6778999999999999999996443 4899999999999999999999865 999999999999
Q ss_pred eCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 005678 543 FDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHD 621 (683)
Q Consensus 543 Ld~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~ 621 (683)
++.++.++|+|||++........ ........+++.|+|||.+.... ++.++|||||||++|+|++ |..||...
T Consensus 153 i~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 153 VGENLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred EccCCcEEeccCCccccccCCce---eecCCCCCccccccCHHHhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999986543211 11122345678899999886443 7889999999999999998 99999766
Q ss_pred chHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 622 QTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 622 ~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+. .+.... ..+....++.++.+||.+||..+|.+|||+.+++.
T Consensus 227 ~~~~~~~---~i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 227 SNNEVIE---CITQGR--VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CHHHHHH---HHHcCC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5443221 111111 12223458899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.42 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=200.5
Q ss_pred cceeEEEEecccCceEEEEEEEc----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDL----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
+.|.+.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~- 77 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN------PQQWGEFQQEASLMAELHHPNIVCLLGVVT- 77 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC------HHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-
Confidence 46888999999999999999753 3557899998753211 123456888999999999999999999886
Q ss_pred CCceEEEEEecccCCChhHHHhcC-----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcce
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT-----------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNV 541 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~-----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NI 541 (683)
.....|+||||+++++|.+++... ..+++..+..++.+|+.||.|||+.+ |+|+||||+||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~ni 155 (283)
T cd05090 78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNI 155 (283)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceE
Confidence 667899999999999999998422 24788889999999999999999865 99999999999
Q ss_pred EeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 005678 542 LFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGH 620 (683)
Q Consensus 542 LLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~ 620 (683)
|++.++.+||+|||+++.+...... .......++..|+|||++.... ++.++|||||||++|+|++ |..||..
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 156 LIGEQLHVKISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEAIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred EEcCCCcEEeccccccccccCCcce---ecccCCCccceecChHHhccCC---CCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999876432111 1122335677899999886433 7899999999999999998 9999976
Q ss_pred CchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 621 ~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
..... +.. . ... ....+.+..++..+.++|.+||..+|.+||++.+++++
T Consensus 230 ~~~~~-~~~--~-~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 230 FSNQE-VIE--M-VRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCHHH-HHH--H-HHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 54422 211 1 111 12233445789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.41 Aligned_cols=253 Identities=27% Similarity=0.473 Sum_probs=202.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||.||+|.+..++..||||.+..... ........+.+|+.+++.+.||||++++++|. +.+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL----MDAKARADCIKEIDLLKQLNHPNVIKYYASFI-EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh----hhHHHHHHHHHHHHHHHHccCCchhhhhheeE-eCCe
Confidence 357888999999999999999989999999998754321 12223467889999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 483 FCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+++||||+++++|.+++.. ...+++..+..++.+|+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhh
Confidence 9999999999999998853 356899999999999999999999865 9999999999999999999999999987
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
....... ......|++.|+|||++.... ++.++||||||+++|+|++|..||........... .....
T Consensus 155 ~~~~~~~-----~~~~~~~~~~~~ape~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~ 222 (267)
T cd08229 155 FFSSKTT-----AAHSLVGTPYYMSPERIHENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC----KKIEQ 222 (267)
T ss_pred ccccCCc-----ccccccCCcCccCHHHhcCCC---ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh----hhhhc
Confidence 6643211 112336899999999986443 78899999999999999999999965432211111 01111
Q ss_pred cCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 639 VEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 639 ~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
..++. ...++..+.+||.+||..+|.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 12222 2357889999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=328.57 Aligned_cols=264 Identities=27% Similarity=0.396 Sum_probs=209.0
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.++++|.+.+.||.|+||.||+|.+..++..||||.+....... ...+.+..|+.++..++||||++++++|...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-----VLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-----chhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 46789999999999999999999999999999999875432111 2235677899999999999999999998755
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
...+|+|+||+ +++|..++... .+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++..
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 67899999999 66898888754 4888899999999999999999965 99999999999999999999999999875
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH------
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI------ 633 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i------ 633 (683)
.... .....+++.|+|||.+... ..++.++|||||||++|+|++|..||...............
T Consensus 158 ~~~~--------~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 158 QDPQ--------MTGYVSTRYYRAPEIMLTW--QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred cCCC--------cCCCcccccccCceeeecc--CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 4321 1123678899999987532 23789999999999999999999999765442221110000
Q ss_pred --------------HHhhcc--CCC---CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 634 --------------IKARKV--EFP---SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 634 --------------~~~~~~--~~p---~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
...... ..| ..+.++..+.+||.+||..+|.+||++.+++.||||...+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 000000 011 1135788999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=314.18 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=197.2
Q ss_pred EEecccCceEEEEEEEccCC---eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEH---RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT 485 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g---~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~L 485 (683)
+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+++.+.|||||++++++. ...+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 72 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA------AGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLML 72 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEE
Confidence 36999999999999876554 78999987654321 23457888999999999999999999875 556899
Q ss_pred EEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcC
Q 005678 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVG 565 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~ 565 (683)
||||+++++|.+++...+.+++..+..++.|++.||.|||..+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 73 VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred EEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999999999987778999999999999999999999865 99999999999999999999999999987643321
Q ss_pred CCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCC
Q 005678 566 SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSR 644 (683)
Q Consensus 566 ~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~ 644 (683)
.........++..|+|||++.... ++.++|||||||++|+|++ |..||......+.. . .+... ...+.+
T Consensus 151 --~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-~--~~~~~--~~~~~~ 220 (257)
T cd05060 151 --YYRATTAGRWPLKWYAPECINYGK---FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-A--MLESG--ERLPRP 220 (257)
T ss_pred --ccccccCccccccccCHHHhcCCC---CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH-H--HHHcC--CcCCCC
Confidence 111111223456799999886443 8889999999999999997 99999776553322 1 11111 122344
Q ss_pred cCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 645 PAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 645 ~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
..++..+.+||.+||..+|.+||++.+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=324.79 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=206.8
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|...+.||.|+||+||+|.+..++..|+||.+...... .......+.+|+.+++.++||||++++++|. +....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 96 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ----TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-KEHTA 96 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC----chHHHHHHHHHHHHHHhCCCCCCccEEEEEE-eCCEE
Confidence 466778899999999999999999999999987543221 1223457888999999999999999999986 67788
Q ss_pred EEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
|+||||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 99999996 57777764 3456899999999999999999999865 99999999999999999999999999864321
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.....|++.|+|||++.......++.++|||||||++|+|++|..||............ ....... .
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~~~-~ 240 (313)
T cd06633 174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNDSPT-L 240 (313)
T ss_pred ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCC-C
Confidence 12346899999999986433345788999999999999999999999776554433221 1111111 1
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..+.++..+.+||.+||.++|.+||++.+++.||||+..
T Consensus 241 ~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 241 QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 124577889999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=311.30 Aligned_cols=251 Identities=29% Similarity=0.509 Sum_probs=208.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||.|+||.||++.+..++..|+||.+....... .....+.+|+.+++.++||||+++++++. +...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-----KEREDAVNEIRILASVNHPNIISYKEAFL-DGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-----HHHHHHHHHHHHHHhCCCCCchhhhhhhc-cCCEE
Confidence 4889999999999999999999999999999886543221 22356678999999999999999999986 56889
Q ss_pred EEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 484 CTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
++||||+++++|..++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|.||+++.++.+||+|||++..
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhh
Confidence 999999999999999855 356899999999999999999999865 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
.... ......|++.|+|||.+... .++.++|+||||+++|+|++|+.||.......... .+ ...
T Consensus 153 ~~~~-------~~~~~~~~~~~~~Pe~~~~~---~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~---~~---~~~ 216 (256)
T cd08530 153 LKKN-------MAKTQIGTPHYMAPEVWKGR---PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KV---QRG 216 (256)
T ss_pred hccC-------CcccccCCccccCHHHHCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH---hcC
Confidence 7543 12234688999999998643 37889999999999999999999997765432211 11 111
Q ss_pred CCC-CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 640 EFP-SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 640 ~~p-~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.++ ....++.++.++|.+||..+|.+||++.++++||++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 222 224678999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=324.43 Aligned_cols=259 Identities=23% Similarity=0.361 Sum_probs=206.5
Q ss_pred cccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCcee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV 470 (683)
++++..++|.+.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.+++++ +||||+
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv 102 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH------SSEREALMSELKIMSHLGNHENIV 102 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC------hHHHHHHHHHHHHHHhccCCCCcc
Confidence 45677889999999999999999999752 3456899998754321 12245788999999999 799999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV 548 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~ 548 (683)
+++++|. ..+.+++||||+++++|..++... ..+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.
T Consensus 103 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~ 179 (302)
T cd05055 103 NLLGACT-IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKI 179 (302)
T ss_pred eEEEEEe-cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCe
Confidence 9999886 667899999999999999999643 33899999999999999999999865 999999999999999999
Q ss_pred EEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHH
Q 005678 549 AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERI 627 (683)
Q Consensus 549 vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~i 627 (683)
++|+|||++......... .......+++.|+|||.+.... ++.++|||||||++|+|++ |..||........+
T Consensus 180 ~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~ 253 (302)
T cd05055 180 VKICDFGLARDIMNDSNY---VVKGNARLPVKWMAPESIFNCV---YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253 (302)
T ss_pred EEECCCcccccccCCCce---eecCCCCcccccCCHhhhccCC---CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence 999999999866433211 1122235678899999886443 7889999999999999998 99999766554433
Q ss_pred HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 628 l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
... .. .....+.....+..+.+||.+||..+|++||++.+++.
T Consensus 254 ~~~---~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 254 YKL---IK-EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHH---HH-cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 221 11 12222333467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=316.38 Aligned_cols=251 Identities=27% Similarity=0.375 Sum_probs=201.4
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+..++|.+.+.||+|+||.||+|.+..+ ..||||++..... ....+.+|+.+++.++||||+++++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--------~~~~~~~E~~~l~~l~~~~i~~~~~~~~- 71 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--------SPEAFLQEAQVMKKLRHEKLVQLYAVVS- 71 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--------CHHHHHHHHHHHHhCCCCCcceEEEEEC-
Confidence 45567899999999999999999987655 4599998754221 1235788999999999999999998874
Q ss_pred CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
...+++||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||.|||++.++.++|+|||+
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~ 148 (262)
T cd05071 72 -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL 148 (262)
T ss_pred -CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCc
Confidence 45688999999999999999653 45889999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
+..+...... ......++..|+|||+..... ++.++|||||||++|+|++ |..||........... +.
T Consensus 149 ~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~---~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~---~~- 217 (262)
T cd05071 149 ARLIEDNEYT----ARQGAKFPIKWTAPEAALYGR---FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VE- 217 (262)
T ss_pred eeeccccccc----cccCCcccceecCHhHhccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH---Hh-
Confidence 9876533211 112235677899999875433 7999999999999999999 8889976655432211 11
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+....++..+.+||.+||..+|.+||++.+++.
T Consensus 218 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 218 -RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 12223444578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=315.96 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=198.3
Q ss_pred eeEEEEecccCceEEEEEEEccC---CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC-
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVE---HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ- 480 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~---g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~- 480 (683)
|.+.+.||+|+||.||+|....+ +..||+|.+...... ...+..+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-----YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASS 75 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-----HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCc
Confidence 56788999999999999986543 478999988643221 223567899999999999999999998875322
Q ss_pred ----ceEEEEEecccCCChhHHHhcC------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 481 ----NTFCTVLEYCSGKDLDAVLKAT------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 481 ----~~~~LV~Ey~~ggsL~~~L~~~------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
..+++||||+++++|..++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+|
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEE
Confidence 2478999999999999998432 35899999999999999999999865 99999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILR 629 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~ 629 (683)
|+|||+++.+...... .......+++.|+|||.+... .++.++|||||||++|+|++ |..||......+.. .
T Consensus 154 l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~-~ 226 (273)
T cd05035 154 VADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADR---VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY-D 226 (273)
T ss_pred ECCccceeeccccccc---cccccccCCccccCHhhcccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-H
Confidence 9999999876433211 111223456789999987533 37889999999999999999 89999765544322 1
Q ss_pred HHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 630 ~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.+.... ..+.+..++..+.++|.+||..||.+||++.+++.+
T Consensus 227 --~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 227 --YLRHGN--RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --HHHcCC--CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222 223345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=325.28 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=208.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
..|...+.||+|+||.||+|.+..++..||+|.+....... ......+..|+.+++.++|||+++++++|. +.+.
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS----NEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-REHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc----hHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-eCCe
Confidence 44778899999999999999998899999999875442222 123457888999999999999999999886 6678
Q ss_pred EEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.++||||++| +|.+++. ....+++..+..++.+|+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 8999999965 7777764 3456899999999999999999999865 9999999999999999999999999987543
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.. ....|++.|+|||++.......++.++|||||||++|+|++|..||........+.. +.... ...
T Consensus 177 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~-~~~ 243 (317)
T cd06635 177 PA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNE-SPT 243 (317)
T ss_pred Cc---------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HHhcc-CCC
Confidence 21 223688999999998543334578999999999999999999999976554333321 11111 112
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.....++..+.+||.+||..+|.+||++.++++|||+...
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 2234678899999999999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=318.24 Aligned_cols=249 Identities=30% Similarity=0.513 Sum_probs=194.8
Q ss_pred eEEEEecccCceEEEEEEEc----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 406 ALLNLLGKGGFSEVYKAYDL----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 406 ~l~~~LGkGgfG~Vyka~d~----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.+.+.||.|.||.||+|... ..+..|+||++..... ......+.+|+.++++++||||+++++++. ..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS------EEEEEEFLNEIQILRKLRHPNIVKLYGFCI-ENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS------HHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-SSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc------cccceeeeeccccccccccccccccccccc-ccc
Confidence 46789999999999999876 4578899999844211 112567889999999999999999999987 666
Q ss_pred eEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+++|||||++|+|.++|... ..+++..+..|+.||+.||.|||+.+ |+|+||+|.|||++.++.+||+|||++..
T Consensus 75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccc
Confidence 799999999999999999775 67999999999999999999999965 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
..... .........+...|+|||++.... ++.++||||||+++|||++ |..||......+.. . .+.....
T Consensus 153 ~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~---~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~-~--~~~~~~~ 223 (259)
T PF07714_consen 153 ISEKS---KYKNDSSQQLPLRYLAPEVLKDGE---YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII-E--KLKQGQR 223 (259)
T ss_dssp TTTSS---SEEESTTSESGGGGS-HHHHHHSE---ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH-H--HHHTTEE
T ss_pred ccccc---cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c--ccccccc
Confidence 63221 112233345778899999987655 7999999999999999999 78999776544322 1 2222222
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.+....++..+.++|.+||..+|.+||++.++++
T Consensus 224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2334568999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=313.54 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=198.1
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+.+.||+|+||.||++.. ..+..||+|.+...... ...+..|+.+++.++||||++++++|. +...
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~-~~~~~~a~K~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 73 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKW-RAQIKVAIKAINEGAMS--------EEDFIEEAKVMMKLSHPKLVQLYGVCT-QQKP 73 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEe-ccCceEEEEecccCCcc--------HHHHHHHHHHHHHCCCCCceeEEEEEc-cCCC
Confidence 4688899999999999999975 44567999987533211 235778999999999999999999886 6778
Q ss_pred EEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+++||||+++++|.+++.. .+.+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 9999999999999999864 356899999999999999999999865 9999999999999999999999999998654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......++..|+|||++.... ++.++||||||+++|+|++ |+.||......+.+.. +.....
T Consensus 152 ~~~~~----~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~---i~~~~~-- 219 (256)
T cd05114 152 DDEYT----SSSGAKFPVKWSPPEVFNFSK---YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM---ISRGFR-- 219 (256)
T ss_pred CCcee----ccCCCCCchhhCChhhcccCc---cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHCCCC--
Confidence 32111 111224566899999986443 7889999999999999999 9999977655433221 111111
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.+.+...+..+.+||.+||..+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1223457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.20 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=202.9
Q ss_pred cceeEEEEecccCceEEEEEEEccCCe---EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHR---YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~---~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
..|.+.+.||+|+||.||+|.+..++. .||||++.... .......+..|+.+++.+.||||+++++++. +
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~ 76 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-K 76 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC------CHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-C
Confidence 358899999999999999998876654 69999875431 1223467889999999999999999999886 6
Q ss_pred CceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
...+++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCcccc
Confidence 7788999999999999999964 456899999999999999999999865 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
................+.++..|+|||++.... ++.++|||||||++|+|++ |..||......+.. . .+ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~-~--~i--~~ 226 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK---FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-N--AI--EQ 226 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCc---ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH-H--HH--Hc
Confidence 765432211111111112346799999986443 7889999999999999886 99999765544322 1 11 12
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....|..+.++..+.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2344555678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.94 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=205.2
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEcc-------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CC
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLV-------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VH 466 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~-------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~H 466 (683)
...|.+..++|.+.+.||+|+||.||+|.+.. +...||+|++..... ......+.+|+.++..+ +|
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~e~~~l~~l~~h 83 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT------EKDLSDLISEMEMMKMIGKH 83 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC------hHHHHHHHHHHHHHHHhcCC
Confidence 34567778999999999999999999997643 235799998864321 11245688899999999 79
Q ss_pred CceeeeccccccCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCc
Q 005678 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQK 530 (683)
Q Consensus 467 pnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~ 530 (683)
|||++++++|. +.+.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+
T Consensus 84 ~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-- 160 (307)
T cd05098 84 KNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-- 160 (307)
T ss_pred CCEeeEEEEEe-cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 99999999986 567889999999999999999643 24788999999999999999999865
Q ss_pred eEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHH
Q 005678 531 IIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQ 610 (683)
Q Consensus 531 IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyE 610 (683)
|+|+||||+|||++.++.+||+|||++......... .......+++.|+|||++.... ++.++|||||||++|+
T Consensus 161 i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~e 234 (307)
T cd05098 161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRI---YTHQSDVWSFGVLLWE 234 (307)
T ss_pred cccccccHHheEEcCCCcEEECCCcccccccccchh---hccccCCCccceeChHHhccCC---CCcHHHHHHHHHHHHH
Confidence 999999999999999999999999998765432110 1122234567899999886433 7899999999999999
Q ss_pred HHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 611 MLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 611 LLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
|++ |..||......+ +.. .+.. ....+.+..++.++.+||.+||..+|.+||++.+++.+
T Consensus 235 l~~~g~~p~~~~~~~~-~~~--~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 235 IFTLGGSPYPGVPVEE-LFK--LLKE--GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHcCCCCCCCcCCHHH-HHH--HHHc--CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 998 889997654432 221 1111 11223335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.22 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=204.3
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
....|.+.+.||.|+||.||+|.+.. +..||+|++..... .....+..|+.+++.++||||+++++++. +.
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~ 74 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-------LKQQDFQKEVQALKRLRHKHLISLFAVCS-VG 74 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-------hhHHHHHHHHHHHhcCCCcchhheeeeEe-cC
Confidence 34568899999999999999999876 89999998754321 11345778999999999999999999886 67
Q ss_pred ceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
..+++||||+++++|.+++.. ...+++..+..++.+|+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchh
Confidence 789999999999999999964 346899999999999999999999865 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
....... ......+++.|+|||.+... .++.++||||||+++|+|++ |+.||......+.+.. +. .
T Consensus 153 ~~~~~~~-----~~~~~~~~~~~~~PE~~~~~---~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~---~~--~ 219 (261)
T cd05148 153 LIKEDVY-----LSSDKKIPYKWTAPEAASHG---TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ---IT--A 219 (261)
T ss_pred hcCCccc-----cccCCCCceEecCHHHHccC---CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HH--h
Confidence 7643311 11233567789999988643 37889999999999999998 8999976654433221 11 2
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....+.+..++..+.++|.+||..+|.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2334445688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.48 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=197.6
Q ss_pred cceeEEEEecccCceEEEEEEEccCCe--EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHR--YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~--~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
+.|.+.+.||+|+||.||+|.+..++. .+++|.+.... .......+.+|+.++.++ .||||+++++++. +
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA------SENDHRDFAGELEVLCKLGHHPNIINLLGACE-N 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-c
Confidence 568899999999999999998877664 47888764321 112245688899999999 7999999999886 5
Q ss_pred CceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF 543 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL 543 (683)
.+.+++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+|+||||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEE
Confidence 67799999999999999999643 24888999999999999999999865 9999999999999
Q ss_pred CCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCc
Q 005678 544 DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQ 622 (683)
Q Consensus 544 d~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~ 622 (683)
+.++.+||+|||++....... ......++..|+|||++.... ++.++|||||||++|+|++ |..||....
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYV------KKTMGRLPVRWMAIESLNYSV---YTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred CCCCeEEECCcCCCcccccee------ccCCCCcCccccCchhhccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999986432110 111123356799999886433 7899999999999999997 999997765
Q ss_pred hHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 623 TQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 623 ~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
....... + ......+.+..++..+.+||.+||..+|.+||++.++++.
T Consensus 224 ~~~~~~~---~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 224 CAELYEK---L--PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHHH---H--hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5432211 1 1122233334689999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=319.13 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=199.0
Q ss_pred cceeEEEEecccCceEEEEEEEccCCe----EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~----~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
..|.+.+.||+|+||+||+|.+..++. .|++|.+.... .......+..|+.++..+.||||+++++++.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~- 79 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS------GRQTFQEITDHMLAMGSLDHAYIVRLLGICP- 79 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc------chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence 568889999999999999998877776 47777753221 1223456778888999999999999999874
Q ss_pred CCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
...+++|+||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccc
Confidence 4567899999999999999964 456899999999999999999999865 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+.+...... .......|+..|+|||.+.... ++.++|||||||++|+|++ |..||......... .+...
T Consensus 157 ~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~---~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~----~~~~~ 226 (279)
T cd05111 157 DLLYPDDKK---YFYSEHKTPIKWMALESILFGR---YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP----DLLEK 226 (279)
T ss_pred eeccCCCcc---cccCCCCCcccccCHHHhccCC---cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHC
Confidence 876433211 1123346778899999986443 8999999999999999998 99999765543211 11111
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....+....++.++..++.+||..+|.+||++.++++
T Consensus 227 -~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 -GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1222333457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=331.36 Aligned_cols=264 Identities=31% Similarity=0.491 Sum_probs=205.0
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC-
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ- 480 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~- 480 (683)
..+|.+.+.||.|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-------chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 5789999999999999999999999999999998754322 22456788999999999999999998875332
Q ss_pred ------------ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-CCC
Q 005678 481 ------------NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFG 547 (683)
Q Consensus 481 ------------~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-~~g 547 (683)
..+|+||||++ ++|..++... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++ .++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~ 152 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCc
Confidence 35789999996 5898888654 5899999999999999999999865 99999999999997 466
Q ss_pred cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
.++|+|||++..+....... .......|+..|+|||++... ..++.++|||||||++|+|++|..||.........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHK--GYLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred eEEECCcccceecCCccccc--cccccccccccccCHHHHhCc--cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 89999999997664321111 112334688999999986432 23788999999999999999999999765443322
Q ss_pred HHHHH--------------------HH-HhhccCCC---CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 628 LREDT--------------------II-KARKVEFP---SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 628 l~~~~--------------------i~-~~~~~~~p---~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..... .. .......+ ..+.++.++.+||.+||..+|.+||++.+++.||||+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 11000 00 00000000 01357889999999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=317.47 Aligned_cols=256 Identities=22% Similarity=0.293 Sum_probs=204.9
Q ss_pred ccccceeEEEEecccCceEEEEEEEcc----CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLV----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~----~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
+..++|.+.+.||+|+||.||+|.+.. ++..|++|++.... .......+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 76 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA------SEIQVTLLLQESCLLYGLSHQNILPILHV 76 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC------CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 456789999999999999999998765 36889999874321 12235678899999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC--------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT--------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~--------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g 547 (683)
+..++..++++++|+++++|..++... ..+++..+..++.+|+.||.|||+.+ |+|+||||+|||++.++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~ 154 (280)
T cd05043 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEEL 154 (280)
T ss_pred EecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCC
Confidence 765677889999999999999998543 45899999999999999999999855 99999999999999999
Q ss_pred cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHH
Q 005678 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQER 626 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~ 626 (683)
.+||+|||+++.+...... .......++..|+|||++.... ++.++|||||||++|++++ |..||......+
T Consensus 155 ~~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~---~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 227 (280)
T cd05043 155 QVKITDNALSRDLFPMDYH---CLGDNENRPVKWMALESLVNKE---YSSASDVWSFGVLLWELMTLGQTPYVEIDPFE- 227 (280)
T ss_pred cEEECCCCCcccccCCceE---EeCCCCCcchhccCHHHHhcCC---CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-
Confidence 9999999999865432211 1112224677899999886443 7899999999999999998 999997655433
Q ss_pred HHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 627 ILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 627 il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+.. .+. ....++....+++++.+++.+||..+|++|||+.+++.
T Consensus 228 ~~~--~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 228 MAA--YLK--DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHH--HHH--cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 211 111 12233344567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=317.51 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=200.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCe----EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~----~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
..+|.+.+.||.|+||+||+|....++. +||||++..... ......+.+|+.++..+.||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS------PKANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC------HHHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 4678999999999999999998766665 589998754321 122356788999999999999999999885
Q ss_pred cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
....+++++|+++|+|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 --~~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 80 --TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred --CCCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCc
Confidence 34577999999999999999653 56899999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
++.+...... .......+++.|+|||.+.... ++.++|||||||++|||++ |..||....... +.. . +.
T Consensus 156 ~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~--~-~~ 225 (279)
T cd05109 156 ARLLDIDETE---YHADGGKVPIKWMALESILHRR---FTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-IPD--L-LE 225 (279)
T ss_pred eeecccccce---eecCCCccchhhCCHHHhccCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH--H-HH
Confidence 9876533211 1122234577899999886443 8899999999999999998 999997654432 111 1 11
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+..+.++.++.++|.+||..||..||++.+++.
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 226 -KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12223344578999999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.11 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=201.4
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
|.+..++|.+.+.||+|+||.||+|.+. .+..||+|.+...... ...+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--------~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS--------PESFLEEAQIMKKLRHDKLVQLYAVVS 71 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC--------HHHHHHHHHHHHhcCCCceEEEEeEEC
Confidence 4567788999999999999999999754 5667999987653221 135788999999999999999998874
Q ss_pred cCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
....++||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||+|||+++++.++|+|||
T Consensus 72 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 72 --EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred --CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCce
Confidence 45678999999999999999643 45899999999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
++..+...... ......++..|+|||++.... ++.++||||||+++|+|++ |..||......+... .+.
T Consensus 148 ~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~~ 217 (260)
T cd05070 148 LARLIEDNEYT----ARQGAKFPIKWTAPEAALYGR---FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE---QVE 217 (260)
T ss_pred eeeeccCcccc----cccCCCCCccccChHHHhcCC---CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHH
Confidence 99876432111 111224567899999875433 7889999999999999999 899997655433221 111
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+....++..+.+||.+||..+|.+|||+.++..
T Consensus 218 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 218 --RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 12233444568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=315.79 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=203.3
Q ss_pred ccceeEEEEecccCceEEEEEEEccCC---eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEH---RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g---~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
..+|.+.+.||+|+||.||+|.+..++ ..||+|.+..... ......+.+|+.++..++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT------EKQRRDFLSEASIMGQFDHPNIIHLEGVVT- 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC------HHHHHHHHHHHHHHHhCCCCCcceEEEEEe-
Confidence 357889999999999999999876443 4799998754321 122457888999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
+.+.+|+||||+++++|.+++... +.+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 76 KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred cCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcc
Confidence 667899999999999999999654 56899999999999999999999865 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~ 636 (683)
..+..... .......+.++..|+|||++.... ++.++|||||||++|+|++ |..||......+... .+.
T Consensus 154 ~~~~~~~~--~~~~~~~~~~~~~y~~pe~~~~~~---~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~---~~~-- 223 (267)
T cd05066 154 RVLEDDPE--AAYTTRGGKIPIRWTAPEAIAYRK---FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK---AIE-- 223 (267)
T ss_pred cccccccc--eeeecCCCccceeecCHhHhccCc---cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH---HHh--
Confidence 87654321 111122234467899999986443 7899999999999999886 999997655433221 111
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....|....++..+.+|+.+||..+|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 224 EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 12334545578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.74 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=199.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccC--------------CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCC
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVE--------------HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH 467 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~--------------g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hp 467 (683)
..+|.+.+.||+|+||.||+|.+..+ ...||||.+..... ......+.+|+.+++.++||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~ei~~l~~l~h~ 77 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT------KTARNDFLKEIKIMSRLKNP 77 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC------HHHHHHHHHHHHHHHhCCCC
Confidence 46899999999999999999976432 23589998754321 12235688999999999999
Q ss_pred ceeeeccccccCCceEEEEEecccCCChhHHHhcC------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecc
Q 005678 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYD 535 (683)
Q Consensus 468 nIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrD 535 (683)
||++++++|. ..+.+++||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ ++|+|
T Consensus 78 ~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~d 154 (295)
T cd05097 78 NIIRLLGVCV-SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRD 154 (295)
T ss_pred CcCeEEEEEc-CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccc
Confidence 9999999986 667889999999999999998543 13688889999999999999999865 99999
Q ss_pred cCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc--
Q 005678 536 LKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-- 613 (683)
Q Consensus 536 LKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-- 613 (683)
|||+|||++.++.+||+|||++..+..... ........+++.|+|||++.... ++.++|||||||++|+|++
T Consensus 155 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwSlG~~l~el~~~~ 228 (295)
T cd05097 155 LATRNCLVGNHYTIKIADFGMSRNLYSGDY---YRIQGRAVLPIRWMAWESILLGK---FTTASDVWAFGVTLWEMFTLC 228 (295)
T ss_pred cChhhEEEcCCCcEEecccccccccccCcc---eeccCcCcCceeecChhhhccCC---cCchhhHHHHHHHHHHHHHcC
Confidence 999999999999999999999976543211 11122234577899999886443 7999999999999999987
Q ss_pred CCCCCCCCchHHHHHHHHHHHHh--hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 614 GRRPFGHDQTQERILREDTIIKA--RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 614 G~~PF~~~~~~e~il~~~~i~~~--~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
|..||........+......... ........+.+++.+.+||.+||..+|.+||++.++++
T Consensus 229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 229 KEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 67788765544333221111111 11122334567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=314.19 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=202.7
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
|.+..+.|.+++.||.|+||.||+|.+ .++..||+|.+...... ...+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS--------PEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc--------HHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 467788999999999999999999985 46788999987543221 235778999999999999999998874
Q ss_pred cCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
...+++||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 72 --~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 72 --QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred --cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCc
Confidence 4568999999999999999854 346899999999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
++......... ......+++.|+|||++.... ++.++|||||||++|+|++ |+.||......+.... +.
T Consensus 148 ~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~---~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~ 217 (260)
T cd05067 148 LARLIEDNEYT----AREGAKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN---LE 217 (260)
T ss_pred ceeecCCCCcc----cccCCcccccccCHHHhccCC---cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH---HH
Confidence 99776532111 111224567899999886433 7889999999999999998 9999976654332211 11
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+.+..++.++.+||.+||..+|++||++.+++.
T Consensus 218 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 218 --RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12233444568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=311.95 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=202.7
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||.|+||.||+|.+..++..||+|.+....... ......+.+|+.+++.++|+||++++++|. +.+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD----AKARQDCLKEIDLLKQLDHPNVIKYLASFI-ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc----hhhHHHHHHHHHHHHhCCCCCeeeeeeeee-cCCe
Confidence 57999999999999999999998899999999875432211 122457889999999999999999999996 5678
Q ss_pred EEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 483 FCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+++||||+++++|..++.. ...+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceee
Confidence 9999999999999999853 345899999999999999999999965 9999999999999999999999999987
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
........ .....|++.|+|||.+.... ++.++|||||||++|+|++|..||......-..+. ..+.....
T Consensus 155 ~~~~~~~~-----~~~~~~~~~y~apE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~ 225 (267)
T cd08224 155 FFSSKTTA-----AHSLVGTPYYMSPERIHENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-KKIEKCDY 225 (267)
T ss_pred eccCCCcc-----cceecCCccccCHHHhccCC---CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHH-hhhhcCCC
Confidence 65433211 12236889999999886433 78899999999999999999999965432111110 11111111
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...| .+.++..+.++|.+||..+|.+||++.++++
T Consensus 226 ~~~~-~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 226 PPLP-ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred CCCC-hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1111 1267889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.31 Aligned_cols=258 Identities=18% Similarity=0.246 Sum_probs=197.1
Q ss_pred CceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecccCCC
Q 005678 415 GFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKD 494 (683)
Q Consensus 415 gfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~~ggs 494 (683)
++|.||.+.+..++..||||++...... ......+.+|+.+++.++||||++++++|. +.+.++++|||+++++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCS-----KEDLKLLQQEIITSRQLQHPNILPYVTSFI-VDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccc-----hhHHHHHHHHHHHHHhcCCcchhhhhheee-cCCeEEEEEeccCCCC
Confidence 4455666666779999999998654221 223567889999999999999999999986 6778999999999999
Q ss_pred hhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCC--Cccc
Q 005678 495 LDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS--QGME 570 (683)
Q Consensus 495 L~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~--~~~~ 570 (683)
|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.+|.+||+|||.+......... ....
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99999653 45899999999999999999999865 999999999999999999999999998765432111 1112
Q ss_pred ccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH----------H-----
Q 005678 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII----------K----- 635 (683)
Q Consensus 571 l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~----------~----- 635 (683)
......++..|+|||++.... ..++.++|||||||++|+|++|..||.........+....-. .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNL-QGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred ccccccccccccCHHHhcCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 233446788999999986432 237889999999999999999999998765544332211000 0
Q ss_pred -------------hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 636 -------------ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 636 -------------~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
......+....++.++.+||.+||.+||++|||+.++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0000011112345678999999999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.01 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=199.5
Q ss_pred ccce-eEEEEecccCceEEEEEE----EccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 402 NHRY-ALLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 402 ~~ry-~l~~~LGkGgfG~Vyka~----d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
.++| .+++.||+|+||+||++. ...++..||+|++..... ......+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG------QQNTSGWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC------hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3456 889999999999998864 235678999998754321 11235678899999999999999999987
Q ss_pred ccC-CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 477 EID-QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 477 ~~d-~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
... ...+++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecc
Confidence 543 45688999999999999999765 4999999999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHH-HHHHH----
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE-RILRE---- 630 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e-~il~~---- 630 (683)
++......... ........++..|+|||++.... ++.++|||||||++|+|++|..||....... .....
T Consensus 153 ~~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05080 153 LAKAVPEGHEY--YRVREDGDSPVFWYAVECLKENK---FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ 227 (283)
T ss_pred cccccCCcchh--hccCCCCCCCceeeCHhHhcccC---CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccc
Confidence 99876543211 11222335677799999886433 7899999999999999999999986543211 00000
Q ss_pred ---HHH--HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 631 ---DTI--IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 631 ---~~i--~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
... ........+.+..++..+.+|+.+||..+|.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000 00111223334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=329.92 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=204.5
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+...||.|+||.||+|.+..++..||||.+...... ......+.+|+.+++.++||||++++++|....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-----EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-----ccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 356899999999999999999999899999999987543211 122346788999999999999999999886332
Q ss_pred -----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 -----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 -----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+|+|+||+. .+|..++. ..+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 88 SGDEFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred cCCCCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCC
Confidence 35789999995 47777653 35899999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH-
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII- 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~- 634 (683)
+++..... .....||+.|+|||++... ..++.++|||||||++|+|++|+.||........+.......
T Consensus 163 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 163 LARHADAE--------MTGYVVTRWYRAPEVILNW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred CCcCCCCC--------CCCceeeecccChhhhcCc--cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 98765322 1123678999999987542 237889999999999999999999997655433221110000
Q ss_pred ---------------H--hh-ccCCCC------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 635 ---------------K--AR-KVEFPS------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 635 ---------------~--~~-~~~~p~------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
. .. ...++. .+.++..+.+||.+||..||.+||++.+++.||||...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0 00 000110 135778899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=317.05 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=200.9
Q ss_pred ccceeEEEEecccCceEEEEEE----EccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~----d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
..+|.+++.||+|+||.||+|. +..++..||||.+.... ......+.+|+.++..++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-------AEHLRDFEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-------HHHHHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence 3578999999999999999986 44678899999875432 123467889999999999999999998764
Q ss_pred -cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 478 -IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 478 -~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
.+...+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 76 SAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred cCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCc
Confidence 2445789999999999999999654 46899999999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH-H------
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI-L------ 628 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i-l------ 628 (683)
++..+...... ........++..|+|||++.... ++.++|||||||++|+|++|..|+......... .
T Consensus 154 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05081 154 LTKVLPQDKEY--YKVREPGESPIFWYAPESLTESK---FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228 (284)
T ss_pred ccccccCCCcc--eeecCCCCCceEeeCHHHhccCC---cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc
Confidence 99876543211 11122234455699999886433 788999999999999999998776543221100 0
Q ss_pred --HHHHH--HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 629 --REDTI--IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 629 --~~~~i--~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
....+ .......++....++..+.+||.+||..+|.+|||+.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00000 011122344456789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=312.78 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=198.4
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+....|.+.+.||+|+||.||++. ..+..||+|.+.... ....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~--~~~~~~~~k~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDA---------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEE--EcCCcEEEEEeCCCc---------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 344678999999999999999995 458889999874321 134678899999999999999999986556
Q ss_pred CceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
.+.+++||||+++++|.+++.... .+++..+..++.+|+.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccc
Confidence 678899999999999999996543 4889999999999999999999865 999999999999999999999999998
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~ 636 (683)
....... ....++..|+|||++.... ++.++|||||||++|+|++ |+.||......... . .+..
T Consensus 150 ~~~~~~~--------~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~-~--~~~~- 214 (256)
T cd05082 150 KEASSTQ--------DTGKLPVKWTAPEALREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-P--RVEK- 214 (256)
T ss_pred eeccccC--------CCCccceeecCHHHHccCC---CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-H--HHhc-
Confidence 7553321 1224566799999886433 7889999999999999997 99999765443321 1 1111
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.......+.++..+.+||.+||..+|.+|||+.++++
T Consensus 215 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 -GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1222233578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=309.64 Aligned_cols=247 Identities=33% Similarity=0.468 Sum_probs=205.8
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecc
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~ 490 (683)
||.|+||.||++.+..++..||+|++..... ........+..|+.+++.++||||+++++.+. ++..+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI----IKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh----cchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-cCCeeEEEEecC
Confidence 6999999999999988899999998755422 11234567888999999999999999999986 678899999999
Q ss_pred cCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCccc
Q 005678 491 SGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570 (683)
Q Consensus 491 ~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~ 570 (683)
++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++....... .
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-----~ 148 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-----S 148 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCC-----C
Confidence 99999999988777999999999999999999999855 9999999999999999999999999997764431 1
Q ss_pred ccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHH
Q 005678 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNE 650 (683)
Q Consensus 571 l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~e 650 (683)
......|+..|+|||.+.... ++.++|+||||+++|+|++|..||....... ... .+. ...++.+..++..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~---~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~~--~~~---~~~~~~~~~~~~~ 219 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKG---YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-IYE--KIL---KDPLRFPEFLSPE 219 (250)
T ss_pred cccCCcCCccccChHHhCCCC---CCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHH--HHh---cCCCCCCCCCCHH
Confidence 123346889999999886443 6889999999999999999999997665422 111 111 1233444567999
Q ss_pred HHHHHHHhcccCCCCCCCH---HHHhcCccc
Q 005678 651 AKDLIRRCLTYNQAERPDV---LTLAQDPYL 678 (683)
Q Consensus 651 l~dLI~rCL~~dP~kRPS~---~eLl~hP~l 678 (683)
+.+||.+||..+|.+||++ .++++||||
T Consensus 220 l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=316.78 Aligned_cols=258 Identities=31% Similarity=0.483 Sum_probs=205.8
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
|.+.+.||.|++|.||+|.+..++..|++|.+....... .....+.+|+.+++.++||||+++++++. ++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-----GIPKTALREIKLLKELNHPNIIKLLDVFR-HKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-----hhHHHHHHHHHHHHHhcCCCcchHHHhhc-cCCCEE
Confidence 567889999999999999998899999999875443211 22456778999999999999999999986 678899
Q ss_pred EEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 485 TVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
+||||+++ +|..++.. ...+++..+..++.+|+.||.|||..+ |+|+||+|+||+++.++.++|+|||.+......
T Consensus 75 ~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 75 LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 99999965 88887754 467999999999999999999999865 999999999999999999999999998776543
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH--------
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK-------- 635 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~-------- 635 (683)
. .......++..|+|||.+... ..++.++||||||+++|+|++|+.||......+.+........
T Consensus 152 ~-----~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd05118 152 V-----RPYTHYVVTRWYRAPELLLGD--KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP 224 (283)
T ss_pred c-----ccccCccCcccccCcHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence 2 112223688999999988643 2378999999999999999999999976665443322111000
Q ss_pred -------hhccCCC---------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 636 -------ARKVEFP---------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 636 -------~~~~~~p---------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.....++ ..+.++..+.+||.+||..+|.+||++.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0001111 113478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=313.48 Aligned_cols=244 Identities=27% Similarity=0.426 Sum_probs=193.9
Q ss_pred ecccCceEEEEEEEc--cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEe
Q 005678 411 LGKGGFSEVYKAYDL--VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLE 488 (683)
Q Consensus 411 LGkGgfG~Vyka~d~--~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~E 488 (683)
||+|+||.||+|.+. ..+..||||++..... ......+.+|+.+++.++||||+++++++. ...+++|||
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e 74 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE------KSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVME 74 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccC------hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEE
Confidence 899999999999764 4566799998754321 223457889999999999999999999875 457899999
Q ss_pred cccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 489 YCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 489 y~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++.........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~- 151 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY- 151 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccc-
Confidence 9999999999964 457899999999999999999999865 999999999999999999999999999865433211
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPA 646 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~ 646 (683)
......+.+++.|+|||++.... ++.++|||||||++|+|++ |..||......+... .+.... ..+.++.
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~--~~~~~~~ 222 (257)
T cd05115 152 -YKARSAGKWPLKWYAPECINFRK---FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS---FIEQGK--RLDCPAE 222 (257)
T ss_pred -eeccCCCCCCcccCCHHHHccCC---CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HHHCCC--CCCCCCC
Confidence 11122234567899999886443 7889999999999999996 999997665543221 111222 2233356
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 647 VSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 647 ~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
++.++.++|.+||.++|.+||++.++++
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=377.99 Aligned_cols=267 Identities=25% Similarity=0.433 Sum_probs=227.4
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.-+|.-..+||.|.||.||-|.+..+|...|+|-+...... ...++.+.+|+.++..++|||||++||+-. +.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-----~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-HR 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-----HKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-HR 1306 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-----cccCcchHHHHHHHHhccCccccccCceee-cH
Confidence 456888889999999999999999999999999976543221 344677889999999999999999998754 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
...+|.||||.+|+|.+++..++..++...+.+..|++.|+.|||++| ||||||||.||||+.+|.+|++|||.|..+
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEe
Confidence 778899999999999999999888999999999999999999999976 999999999999999999999999999887
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
........-+ ....+|||.|||||+|.+.+.....-+.|||||||++.||+||+.||...+....|+. .+...+.+.
T Consensus 1385 ~~~~~~~~~e-l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy--~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1385 KNNAQTMPGE-LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY--HVAAGHKPQ 1461 (1509)
T ss_pred cCchhcCCHH-HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh--HHhccCCCC
Confidence 6553111111 2234899999999999877754466789999999999999999999998888777754 334445555
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+|. .+|.+..+||.+||..||.+|+++.+|+.|.|-..
T Consensus 1462 ~P~--~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1462 IPE--RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred Cch--hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 664 49999999999999999999999999999998654
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.98 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=200.0
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
++..++|.+...||.|+||.||+|.+..+ ..||+|.+..... ....+.+|+.+++.+.||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 71 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM--------MPEAFLQEAQIMKKLRHDKLVPLYAVVS- 71 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc--------cHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence 45567899999999999999999986554 4699998754321 1235778999999999999999998875
Q ss_pred CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
.+..++||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||+
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~ 148 (260)
T cd05069 72 -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGL 148 (260)
T ss_pred -CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCcc
Confidence 45688999999999999999653 34789999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
+......... ......++..|+|||...... ++.++|||||||++|+|++ |..||......+.... +.
T Consensus 149 ~~~~~~~~~~----~~~~~~~~~~y~~Pe~~~~~~---~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~- 217 (260)
T cd05069 149 ARLIEDNEYT----ARQGAKFPIKWTAPEAALYGR---FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ---VE- 217 (260)
T ss_pred ceEccCCccc----ccCCCccchhhCCHHHhccCC---cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HH-
Confidence 9766432111 111224677899999876433 7899999999999999999 9999977655432211 11
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+....++..+.+||.+||..+|.+||++.++++
T Consensus 218 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 218 -RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 12233334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=330.48 Aligned_cols=262 Identities=26% Similarity=0.440 Sum_probs=207.5
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+...||.|+||.||+|.+..++..||||++...... ......+.+|+.+++.+.||||+++++++..+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-----AIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-----hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 567899999999999999999999999999999987543211 122456778999999999999999999886333
Q ss_pred c-----eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 N-----TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 ~-----~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. .+|+|+||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEcccc
Confidence 2 489999999 67999998764 5999999999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++...... .....+++.|+|||.+.... .++.++|||||||++|+|++|+.||........+........
T Consensus 164 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 233 (343)
T cd07851 164 LARHTDDE--------MTGYVATRWYRAPEIMLNWM--HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233 (343)
T ss_pred cccccccc--------ccCCcccccccCHHHHhCCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence 99865432 12236889999999875322 368899999999999999999999976654432211100000
Q ss_pred h------------------hcc------CCC-CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 636 A------------------RKV------EFP-SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 636 ~------------------~~~------~~p-~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
. ... .+. ..+.++..+.+||.+||..+|.+|||+.+|+.||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 0 000 000 012468899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=313.63 Aligned_cols=249 Identities=26% Similarity=0.343 Sum_probs=199.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
..|.+.+.||.|+||.||+|.+. ++..+|||++...... ...+.+|+.+++.++||||+++++++. +.+.
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~ 73 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS--------EDDFIEEAKVMMKLSHPNLVQLYGVCT-KQRP 73 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC--------HHHHHHHHHHHHhCCCCCEEEEEEEEc-CCCc
Confidence 35788899999999999999864 5678999987533211 235678999999999999999999886 6678
Q ss_pred EEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++...
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecc
Confidence 9999999999999999965 346899999999999999999999965 9999999999999999999999999998664
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......++..|+|||++.... ++.++|||||||++|+|++ |..||......+... .+.. ...
T Consensus 152 ~~~~~----~~~~~~~~~~y~~Pe~~~~~~---~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~~~~--~~~ 219 (256)
T cd05059 152 DDQYT----SSQGTKFPVKWAPPEVFDYSR---FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE---SVSA--GYR 219 (256)
T ss_pred ccccc----ccCCCCCCccccCHHHhccCC---CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH---HHHc--CCc
Confidence 32111 111123456799999886444 7889999999999999998 899997655443221 1111 222
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.+.+..++..+.++|.+||..+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 33345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=320.88 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=205.6
Q ss_pred cccccccceeEEEEecccCceEEEEEEEc-------cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDL-------VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHH 468 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-------~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~Hpn 468 (683)
.|.+..++|.+.+.||+|+||.||+|... .++..||+|.+.... .......+.+|+.+++.+ +|||
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA------TEKDLSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc------chHHHHHHHHHHHHHHhhccCCC
Confidence 46778889999999999999999999742 235689999875321 112246788999999999 8999
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceE
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKII 532 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~II 532 (683)
|++++++|. ..+.+++||||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+
T Consensus 83 i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--iv 159 (304)
T cd05101 83 IINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CI 159 (304)
T ss_pred chheeEEEe-cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence 999999986 567889999999999999999643 24778889999999999999999865 99
Q ss_pred ecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
|+||||+|||++.++.+||+|||+++.+...... .......+++.|+|||++.... ++.++|||||||++|+|+
T Consensus 160 H~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~ 233 (304)
T cd05101 160 HRDLAARNVLVTENNVMKIADFGLARDVNNIDYY---KKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEIF 233 (304)
T ss_pred ecccccceEEEcCCCcEEECCCccceeccccccc---ccccCCCCCceeeCchhhccCC---CCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999876433211 1123345678899999886433 789999999999999999
Q ss_pred c-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 613 F-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 613 t-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+ |..||......+... .+... ........++..+.+||.+||..+|.+||++.++++.
T Consensus 234 ~~g~~p~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 234 TLGGSPYPGIPVEELFK---LLKEG--HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred cCCCCCcccCCHHHHHH---HHHcC--CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8 888997655443221 11111 2222335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.50 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=202.4
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCe---EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHR---YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~---~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
..+.|...+.||+|+||.||+|.+..++. .||+|.+..... ......+..|+.++..++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT------EKQRQDFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC------HHHHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 34578889999999999999998876554 799998754321 112356788999999999999999999986
Q ss_pred cCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
+.+.+++||||+++++|..++.. .+.+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 77 -KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred -cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcc
Confidence 66788999999999999999965 457899999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
+.......... ........++.|+|||++.... ++.++|||||||++|+|++ |..||......+.. . .+.
T Consensus 154 ~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~---~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~-~--~i~- 224 (268)
T cd05063 154 SRVLEDDPEGT--YTTSGGKIPIRWTAPEAIAYRK---FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-K--AIN- 224 (268)
T ss_pred ceecccccccc--eeccCCCcCceecCHHHhhcCC---cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-H--HHh-
Confidence 98665432111 1111223456799999886443 7899999999999999997 99999765443322 1 111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....|....++..+.+||.+||..+|.+||++.++++
T Consensus 225 -~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 225 -DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 12234444568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=361.02 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=202.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||+|+||.||+|.+..+++.||||++....... ......+.+|+.+++.++||||+++++++. +.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~----e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN----PLLKKRFLREAKIAADLIHPGIVPVYSICS-DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC----HHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-eCCE
Confidence 47999999999999999999999999999999986432211 223457889999999999999999999886 6778
Q ss_pred EEEEEecccCCChhHHHhcC-----------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEE
Q 005678 483 FCTVLEYCSGKDLDAVLKAT-----------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKV 551 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~-----------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL 551 (683)
.|+||||++|++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.++|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEE
Confidence 99999999999999998531 23566778889999999999999965 999999999999999999999
Q ss_pred EecCCccccccCcC-------------CCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 005678 552 TDFGLSKIVEDDVG-------------SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618 (683)
Q Consensus 552 ~DFGls~~~~~~~~-------------~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF 618 (683)
+|||+++....... ...+......+||+.|+|||++.... ++.++|||||||++|+|++|..||
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~---~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP---ASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC---CCcHhHHHHHHHHHHHHHHCCCCC
Confidence 99999987622110 01111222347999999999886443 799999999999999999999999
Q ss_pred CCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 619 GHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 619 ~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
........... ..+ .....+.....+++.+.+++.+||..||.+||+..+.+
T Consensus 232 ~~~~~~ki~~~-~~i--~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 232 RRKKGRKISYR-DVI--LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred CCcchhhhhhh-hhc--cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 76444322211 111 11112222346889999999999999999998755544
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=313.48 Aligned_cols=255 Identities=28% Similarity=0.503 Sum_probs=202.8
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+|.+.+.||+|+||.||++.+...+..+++|++......... ......+.+|+.+++.++||||+++++++. +...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN--PNETVQANQEAQLLSKLDHPAIVKFHASFL-ERDAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC--cchHHHHHHHHHHHHhCCCCcHHHHHHHHh-cCCce
Confidence 688999999999999999998888777888876543221111 111235667899999999999999999986 66789
Q ss_pred EEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 484 CTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++. +.++|+|||++..
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceee
Confidence 999999999999998843 356899999999999999999999865 999999999999985 6799999999877
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
..... .......|++.|+|||.+.... ++.++|+||||+++|+|++|..||........... +.. .
T Consensus 155 ~~~~~-----~~~~~~~~~~~~~~pe~~~~~~---~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~---~~~---~ 220 (260)
T cd08222 155 LMGSC-----DLATTFTGTPYYMSPEALKHQG---YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR---IVE---G 220 (260)
T ss_pred cCCCc-----ccccCCCCCcCccCHHHHccCC---CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HHc---C
Confidence 64321 1223346899999999875433 78899999999999999999999975543322211 111 1
Q ss_pred CCCC-CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 640 EFPS-RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 640 ~~p~-~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..+. ...++.++.++|.+||..+|++||++.++++||||
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 1222 24678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.49 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=201.6
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+..+.|.+.+.||.|+||.||+|.+ .|+.||||.+..... ..+.+.+|+.+++.++||||+++++++. +
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~ 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--------AAQAFLAEASVMTTLRHPNLVQLLGVVL-Q 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--------HHHHHHHHHHHHHhcCCcceeeeEEEEc-C
Confidence 4456789999999999999999964 589999998854321 3567889999999999999999999986 5
Q ss_pred CceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
.+.+++||||+++++|.+++.... .+++..+..++.|++.||.|||..+ |+|+||||+|||++.++.++|+|||++
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccc
Confidence 788999999999999999997654 6899999999999999999999865 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~ 636 (683)
........ ...++..|+|||++.... ++.++||||||+++|+|++ |..||......... . .+..
T Consensus 150 ~~~~~~~~--------~~~~~~~~~ape~~~~~~---~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~--~~~~- 214 (256)
T cd05039 150 KEASQGQD--------SGKLPVKWTAPEALREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-P--HVEK- 214 (256)
T ss_pred cccccccc--------cCCCcccccCchhhcCCc---CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-H--HHhc-
Confidence 87643211 224566799999886443 7889999999999999997 99999766443321 1 1111
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.........+++.+.+||.+||..+|.+||++.+++.
T Consensus 215 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 -GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 1122233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.62 Aligned_cols=253 Identities=29% Similarity=0.410 Sum_probs=204.3
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
|++..++|.+.+.||.|+||.||+|.+. ++..||||.+..... ....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM--------SPEAFLQEAQIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc--------CHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence 4577889999999999999999999864 567899998764322 1245788999999999999999999886
Q ss_pred cCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
+...+++||||+++++|.+++... ..+++..+..++.+|+.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 72 -~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 72 -EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred -cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccc
Confidence 567899999999999999999654 36899999999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
++........ .......++..|+|||.+.... ++.++|||||||++|+|++ |+.||........+.. +
T Consensus 149 ~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~---~- 217 (261)
T cd05034 149 LARLIEDDEY----TAREGAKFPIKWTAPEAANYGR---FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ---V- 217 (261)
T ss_pred cceeccchhh----hhhhccCCCccccCHHHhccCC---cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H-
Confidence 9987643211 1111223456899999886433 7889999999999999998 9999976554332211 1
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
......+....++..+.+++.+||..+|.+||++.++..
T Consensus 218 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 218 -ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 122334445567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.15 Aligned_cols=265 Identities=26% Similarity=0.367 Sum_probs=208.0
Q ss_pred ceeEEEEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 404 RYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
.|.+.+.||+|+||.||++.+. .++..||||++..... .........+..|+.++..+ .||||++++++|. .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~---~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~-~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI---VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ-T 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH---HhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-c
Confidence 3788999999999999999754 4678999998754321 12233456788899999999 5999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+..+|+||||+++++|..++.....+++..+..++.|++.||.|||..+ ++|+||+|.||+++.++.++|+|||++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 6788999999999999999977777999999999999999999999855 99999999999999999999999999876
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
+..... .......|++.|+|||++.... ..++.++||||||+++|+|++|..||.............. .....
T Consensus 155 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~ 227 (288)
T cd05583 155 FLAEEE----ERAYSFCGTIEYMAPEVIRGGS-GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR--RILKS 227 (288)
T ss_pred cccccc----cccccccCCccccCHHHhcCCC-CCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH--HHHcc
Confidence 543311 1122346899999999875432 2367899999999999999999999964332111111001 11112
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPD---VLTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS---~~eLl~hP~l~~~ 681 (683)
..+.+..++..+.+||.+||..+|++||| +.++++||||+..
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 23344568899999999999999999998 6778999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.61 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=198.7
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
..|.+.+.||+|+||.||.|... .+..||||.+..... . ...+.+|+.++..++||||++++++|. +...
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 73 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-S-------EDEFIEEAKVMMKLSHEKLVQLYGVCT-KQRP 73 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-c-------HHHHHHHHHHHhcCCCCCeeeEEEEEc-cCCC
Confidence 46889999999999999999653 345699998754321 1 235788999999999999999999886 5667
Q ss_pred EEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||.|||++.++.+||+|||+++...
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecC
Confidence 89999999999999999653 46899999999999999999999965 9999999999999999999999999987654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......++..|+|||++.... ++.++|||||||++|+|++ |..||.......... .+.... .
T Consensus 152 ~~~~~----~~~~~~~~~~y~~pe~~~~~~---~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~~~~~--~ 219 (256)
T cd05113 152 DDEYT----SSVGSKFPVRWSPPEVLLYSK---FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE---KVSQGL--R 219 (256)
T ss_pred CCcee----ecCCCccChhhCCHHHHhcCc---ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HHhcCC--C
Confidence 32111 111224567899999986443 7889999999999999998 999997655433221 111211 2
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.+.....+..+.+++.+||..+|.+||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 22234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.20 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=200.1
Q ss_pred cceeEEEEecccCceEEEEEEEccC-----CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVE-----HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~-----g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
..|.+.+.||+|+||.||+|.+..+ +..||||++..... ......+..|+.++..++||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 78 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE------GPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC------HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 3577788999999999999986543 57899999754321 123456788999999999999999999886
Q ss_pred cCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcce
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNV 541 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NI 541 (683)
+....++++||+++++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||.||
T Consensus 79 -~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Ni 155 (283)
T cd05091 79 -KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNV 155 (283)
T ss_pred -CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhhe
Confidence 566789999999999999998421 24788889999999999999999865 99999999999
Q ss_pred EeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 005678 542 LFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGH 620 (683)
Q Consensus 542 LLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~ 620 (683)
|++.++.+||+|||+++.+..... ........+++.|+|||.+.... ++.++|||||||++|+|++ |..||..
T Consensus 156 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 156 LVFDKLNVKISDLGLFREVYAADY---YKLMGNSLLPIRWMSPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred EecCCCceEecccccccccccchh---eeeccCccCCccccCHHHHhcCC---CCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999886643211 11223345678999999886443 7889999999999999998 8889976
Q ss_pred CchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 621 ~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
....+ ++. .+.... ..+....++..+.+||.+||+.+|.+||++.+++..
T Consensus 230 ~~~~~-~~~--~i~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 230 YSNQD-VIE--MIRNRQ--VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCHHH-HHH--HHHcCC--cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 55443 221 111111 123345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=315.88 Aligned_cols=256 Identities=30% Similarity=0.455 Sum_probs=202.1
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCceE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~~~ 483 (683)
|.+.+.||.|+||+||+|.+..++..|+||.+........ .....+|+..+..++ ||||++++++|. +++.+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~e~~~l~~~~~h~~i~~~~~~~~-~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE------ECMNLREVKSLRKLNEHPNIVKLKEVFR-ENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh------HHHHHHHHHHHHhccCCCCchhHHHHhh-cCCcE
Confidence 6788999999999999999988999999998754322111 123456889999999 999999999997 57889
Q ss_pred EEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
++||||+ +++|..++.... .+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~ 150 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIR 150 (283)
T ss_pred EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceecc
Confidence 9999999 789998886543 7899999999999999999999865 9999999999999999999999999998664
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH------
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK------ 635 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~------ 635 (683)
.... .....|+..|+|||++... ..++.++|+||||+++|+|++|.+||......+.+........
T Consensus 151 ~~~~------~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd07830 151 SRPP------YTDYVSTRWYRAPEILLRS--TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222 (283)
T ss_pred CCCC------cCCCCCcccccCceeeecC--cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhh
Confidence 3211 1223688999999987533 2368899999999999999999999976654443322111000
Q ss_pred ---------hhccCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 636 ---------ARKVEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 636 ---------~~~~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.....++. .+..+..+.+||++||..+|.+||++.+++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00000000 12336889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.87 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=196.7
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeE--EEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRY--VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~--VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
+.|.+.+.||+|+||.||+|.+..++.. +|+|.+.... .......+.+|+.++.++ +||||++++++|. +
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA------SKDDHRDFAGELEVLCKLGHHPNIINLLGACE-H 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC------CHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-C
Confidence 4688999999999999999998777754 5776653211 112345778899999999 8999999999986 5
Q ss_pred CceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF 543 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL 543 (683)
.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili 157 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV 157 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEe
Confidence 67899999999999999999643 25789999999999999999999865 9999999999999
Q ss_pred CCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCc
Q 005678 544 DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQ 622 (683)
Q Consensus 544 d~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~ 622 (683)
+.++.+||+|||++...... .......+++.|+|||++... .++.++|||||||++|+|++ |..||....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYS---VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred cCCCcEEeCccccCcccchh------hhcccCCCcccccCHHHHhcc---CCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 99999999999998643211 111122456779999987543 37889999999999999998 999997655
Q ss_pred hHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 623 TQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 623 ~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
..+.. . .+ ......+.+..++.++.+||.+||..+|.+||++.+++.+
T Consensus 229 ~~~~~-~--~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 229 CAELY-E--KL--PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hHHHH-H--HH--hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 43322 1 11 1112222334578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.88 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=203.2
Q ss_pred cccccccceeEEEEecccCceEEEEEEEc-------cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDL-------VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHH 468 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-------~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~Hpn 468 (683)
.|.+..++|.+.+.||+|+||.||+|.+. .....||+|++..... ......+..|+.+++.+ .|||
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT------DKDLADLISEMELMKLIGKHKN 79 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC------hHHHHHHHHHHHHHHhccCCCC
Confidence 45667789999999999999999999753 2345799998754321 12245688899999999 6999
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceE
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKII 532 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~II 532 (683)
|++++++|. +.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+
T Consensus 80 iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~ 156 (314)
T cd05099 80 IINLLGVCT-QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CI 156 (314)
T ss_pred eeeEEEEEc-cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence 999999886 667889999999999999999542 34888999999999999999999865 99
Q ss_pred ecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
|+||||+|||++.++.+||+|||+++........ .......+++.|+|||++.... ++.++|||||||++|+|+
T Consensus 157 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~ 230 (314)
T cd05099 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY---KKTSNGRLPVKWMAPEALFDRV---YTHQSDVWSFGILMWEIF 230 (314)
T ss_pred eccccceeEEEcCCCcEEEccccccccccccccc---cccccCCCCccccCHHHHccCC---cCccchhhHHHHHHHHHH
Confidence 9999999999999999999999999866432111 1122234557899999886433 789999999999999999
Q ss_pred c-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 613 F-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 613 t-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+ |..||......+.. . .+... ........++.++.+||.+||..+|.+||++.+++.
T Consensus 231 ~~g~~p~~~~~~~~~~-~--~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 231 TLGGSPYPGIPVEELF-K--LLREG--HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred hCCCCCCCCCCHHHHH-H--HHHcC--CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8 89999765543322 1 11111 112223568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=328.06 Aligned_cols=263 Identities=27% Similarity=0.407 Sum_probs=205.3
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
..+.++|.+.+.||+|+||.||+|.+..++..||||.+...... ......+.+|+.++..++||||++++++|..
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-----IIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-----hHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34568899999999999999999999999999999987543211 1123467789999999999999999998753
Q ss_pred C-----CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 479 D-----QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 479 d-----~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
. ...+|++++++ +++|..++... .+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEec
Confidence 2 23578888887 78998888655 5899999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||++...... .....|+++|+|||.+... ..++.++|||||||++|+|++|..||...............
T Consensus 164 fg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 164 FGLARHTDDE--------MTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred cccccccccc--------ccccccCCCccCHHHHhCc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9998765322 1223688999999987532 23788999999999999999999999655433322110000
Q ss_pred --------------------HHh----hccCCCC-CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 634 --------------------IKA----RKVEFPS-RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 634 --------------------~~~----~~~~~p~-~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
... ....+.. ....+.++.+||.+||.++|.+||++.+++.||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 000 0000000 1235788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=317.29 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=200.7
Q ss_pred cccceeEEEEecccCceEEEEEEE-----ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYD-----LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d-----~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
...+|.+...||+|+||.||++.. ..++..||+|.+.... ......+.+|+.+++.+.||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-------ESARQDFQREAELLTVLQHQHIVRFYGV 75 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-------HHHHHHHHHHHHHHhcCCCCCCceEEEE
Confidence 345788899999999999999964 2356789999864321 1224578899999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcCC---------------CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcc
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKATP---------------VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGN 540 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~~---------------~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~N 540 (683)
+. +.+.+++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+|+||||+|
T Consensus 76 ~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~n 152 (280)
T cd05092 76 CT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRN 152 (280)
T ss_pred Ee-cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhh
Confidence 86 6678999999999999999996542 4789999999999999999999865 9999999999
Q ss_pred eEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 005678 541 VLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFG 619 (683)
Q Consensus 541 ILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~ 619 (683)
||+++++.+||+|||++..+..... ........+++.|+|||++.... ++.++|||||||++|+|++ |.+||.
T Consensus 153 il~~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 153 CLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWMPPESILYRK---FTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EEEcCCCCEEECCCCceeEcCCCce---eecCCCccccccccCHHHhccCC---cCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999976543211 11122234578899999886444 7999999999999999998 999997
Q ss_pred CCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 620 HDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 620 ~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+.... +.... .......+++.+.+||.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 227 QLSNTEAIEC---ITQGR--ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCCHHHHHHH---HHcCc--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6554433211 11111 22333468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.09 Aligned_cols=256 Identities=32% Similarity=0.526 Sum_probs=198.6
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc---CCCceeeeccccccCCc
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL---VHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L---~HpnIV~L~~~f~~d~~ 481 (683)
|.+.+.||.|+||.||+|.+..++..||+|.+....... .....+.+|+.++..+ .||||++++++|. +..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~-~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-----GIPLSTLREIALLKQLESFEHPNIVRLLDVCH-GPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-----hhhhhHHHHHHHHHHhhccCCCCcceEEEEEe-ecc
Confidence 678899999999999999998889999999986543211 1123455677777666 5999999999986 334
Q ss_pred e-----EEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 482 T-----FCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 482 ~-----~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
. ++++|||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.++|+||
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEecc
Confidence 3 899999996 4898888653 35899999999999999999999965 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
|++........ .....+++.|+|||++.... ++.++|||||||++|+|++|.+||......+.+...-...
T Consensus 152 g~~~~~~~~~~------~~~~~~~~~~~~PE~~~~~~---~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07838 152 GLARIYSFEMA------LTSVVVTLWYRAPEVLLQSS---YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222 (287)
T ss_pred CcceeccCCcc------cccccccccccChHHhccCC---CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence 99977643311 12235788999999986443 7889999999999999999999997766544332111000
Q ss_pred H-hhccC-----------CCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 635 K-ARKVE-----------FPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 635 ~-~~~~~-----------~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
. ..... ++. .+.++..+.+||.+||..+|.+||++.+++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 00000 000 12456788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.15 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=200.7
Q ss_pred cccceeEEEEecccCceEEEEEEEcc----------------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLV----------------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~----------------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L 464 (683)
..++|.+.+.||+|+||.||++.+.. ++..||||++.... .......+.+|+.+++.+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~------~~~~~~~~~~E~~~l~~l 76 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA------NKNARNDFLKEIKIMSRL 76 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC------CHHHHHHHHHHHHHHHhC
Confidence 35679999999999999999985432 34579999875432 112245788999999999
Q ss_pred CCCceeeeccccccCCceEEEEEecccCCChhHHHhcCC-----------CcchHHHHHHHHHHHHHHHHHHhcCCceEe
Q 005678 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-----------VLPEREARIIIVQIFQGLIYLNKRAQKIIH 533 (683)
Q Consensus 465 ~HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~-----------~Lse~~~~~I~~qIa~aL~yLH~~g~~IIH 533 (683)
+||||+++++++. +.+.+++||||+++++|..++.... .+++..+..++.||+.||.|||+.+ |+|
T Consensus 77 ~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H 153 (296)
T cd05095 77 KDPNIIRLLAVCI-TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVH 153 (296)
T ss_pred CCCCcceEEEEEe-cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence 9999999999886 5677899999999999999986532 3677889999999999999999865 999
Q ss_pred cccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc
Q 005678 534 YDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF 613 (683)
Q Consensus 534 rDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt 613 (683)
+||||+|||++.++.++|+|||++..+..... ........+++.|++||+..... ++.++|||||||++|+|++
T Consensus 154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~---~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDY---YRIQGRAVLPIRWMSWESILLGK---FTTASDVWAFGVTLWEILT 227 (296)
T ss_pred ccCChheEEEcCCCCEEeccCcccccccCCcc---eeccCcCcCccccCCHHHHhcCC---ccchhhhhHHHHHHHHHHH
Confidence 99999999999999999999999986543211 11122234567899999875443 8999999999999999998
Q ss_pred --CCCCCCCCchHHHHHHHHHHHHh--hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 614 --GRRPFGHDQTQERILREDTIIKA--RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 614 --G~~PF~~~~~~e~il~~~~i~~~--~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
|..||......+.+......... ....++..+.++..+.+||.+||..||.+||++.++++
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 77899765544333221111111 12234445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.27 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=202.4
Q ss_pred ccccceeEEEEecccCceEEEEEEEccC---CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVE---HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~---g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
+..++|.+.+.||.|+||.||+|.+... ...||||....... ......+.+|+.+++.+.||||+++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS------PSVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC------HHHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 4566799999999999999999987544 45799998754321 12345788899999999999999999988
Q ss_pred ccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. ....++||||+++++|.+++... ..+++..+..++.+|+.||.|||+.+ ++|+||||+|||++.++.++|+|||
T Consensus 77 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 77 T--ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred c--CCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCc
Confidence 6 35678999999999999999754 35899999999999999999999855 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
++........ .......+++.|+|||.+.... ++.++|||||||++|+|++ |..||......+.... +.
T Consensus 153 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~---~~ 222 (270)
T cd05056 153 LSRYLEDESY----YKASKGKLPIKWMAPESINFRR---FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR---IE 222 (270)
T ss_pred eeeecccccc----eecCCCCccccccChhhhccCC---CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HH
Confidence 9987654311 1112234567899999875433 7899999999999999986 9999977665443221 11
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.. ...+.++.++..+.+||.+||..+|.+|||+.+++..
T Consensus 223 ~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 223 NG--ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred cC--CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 2233446789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.14 Aligned_cols=266 Identities=26% Similarity=0.404 Sum_probs=204.5
Q ss_pred ceeEEEEecccCceEEEEEEEccC--CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc--
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVE--HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI-- 478 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~--g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~-- 478 (683)
+|.+.+.||.|+||.||++.+..+ +..||||.+...... ....+.+.+|+.++..+ .||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-----KILAKRALRELKLLRHFRGHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-----chhHHHHHHHHHHHHHhcCCCChheeeeeeeecc
Confidence 488999999999999999998877 899999987532211 12245678899999999 59999999987532
Q ss_pred -CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 -DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 -d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
....++++++|+. ++|..++.....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++
T Consensus 76 ~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 76 GNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred ccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 2345788999985 699999987788999999999999999999999865 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH-----
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT----- 632 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~----- 632 (683)
.......... ........||+.|+|||.+... ..++.++|||||||++|+|++|.+||........+.....
T Consensus 153 ~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 153 RGFSENPGEN-AGFMTEYVATRWYRAPEIMLSF--QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred eecccccccc-cccccCcccCccccCcHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence 8665332111 1112234789999999987532 2378899999999999999999999976543221110000
Q ss_pred ---------------HHHh----hccCCC-CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 633 ---------------IIKA----RKVEFP-SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 633 ---------------i~~~----~~~~~p-~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.... ....++ ..+.++..+.+||.+||.++|.+|||+.+++.||||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 0000 001111 12356889999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.29 Aligned_cols=247 Identities=21% Similarity=0.308 Sum_probs=199.2
Q ss_pred EEecccCceEEEEEEEcc-CC--eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEE
Q 005678 409 NLLGKGGFSEVYKAYDLV-EH--RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT 485 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~-~g--~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~L 485 (683)
+.||.|+||.||+|.+.. .+ ..||||.+...... ...+.+.+|+.++++++||||+++++.+. + ..+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~-~~~~~ 72 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS------DIMDDFLKEAAIMHSLDHENLIRLYGVVL-T-HPLMM 72 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH------HHHHHHHHHHHHHhhcCCCCccceeEEEc-C-CeEEE
Confidence 368999999999998755 33 36999987554321 44678899999999999999999999986 3 88999
Q ss_pred EEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 486 VLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
||||+++++|..++... ..+++..+..++.|++.||.|||..+ ++|+||+|+|||++.++.+||+|||++..+...
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccccc
Confidence 99999999999999654 36899999999999999999999865 999999999999999999999999999877543
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
... ........++..|+|||++.... ++.++|||||||++|+|++ |..||......+..... ......++
T Consensus 151 ~~~--~~~~~~~~~~~~y~~pE~~~~~~---~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~ 221 (257)
T cd05040 151 EDH--YVMEEHLKVPFAWCAPESLRTRT---FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGERLE 221 (257)
T ss_pred ccc--eecccCCCCCceecCHHHhcccC---cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCcCC
Confidence 221 11222456788999999886444 7889999999999999998 99999766554422211 11222333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....++..+.+++.+||..+|.+||++.+++.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 34467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.47 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=198.1
Q ss_pred ceeEEEEecccCceEEEEEEEcc-----CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLV-----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~-----~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
+|.+.+.||+|+||.||+|.+.. ....|++|.+..... ......+.+|+.+++.++||||+++++.|.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~- 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS------SSELRDLLSEFNLLKQVNHPHVIKLYGACS- 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC------HHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 47788999999999999998643 336799998754321 122467889999999999999999999886
Q ss_pred CCceEEEEEecccCCChhHHHhcC------------------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEec
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT------------------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHY 534 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~------------------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHr 534 (683)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~ 151 (290)
T cd05045 74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHR 151 (290)
T ss_pred cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehh
Confidence 567788999999999999998532 24788899999999999999999865 9999
Q ss_pred ccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-
Q 005678 535 DLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF- 613 (683)
Q Consensus 535 DLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt- 613 (683)
||||+|||+++++.+||+|||++......... .......++..|+|||++... .++.++||||||+++|+|++
T Consensus 152 dikp~nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~---~~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSY---VKRSKGRIPVKWMAIESLFDH---IYTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred hhhhheEEEcCCCcEEeccccccccccCccch---hcccCCCCCccccCHHHHccC---CcchHhHHHHHHHHHHHHHhc
Confidence 99999999999999999999999765432111 011223456789999987543 37899999999999999998
Q ss_pred CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 614 GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 614 G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
|..||....... +... .......+.+..++.++.+||.+||..+|.+||++.+++.
T Consensus 226 g~~p~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 226 GGNPYPGIAPER-LFNL----LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCCCCCCCHHH-HHHH----HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 999997654433 2211 1122233444568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=322.94 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=207.1
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
...|...+.||.|+||.||+|.+..++..||||.+....... ......+.+|+.+++.++||||+++++++. +.+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS----NEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-REH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC----hHHHHHHHHHHHHHHhCCCCCcccEEEEEE-cCC
Confidence 345777888999999999999999999999999875432221 123456788999999999999999999886 667
Q ss_pred eEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+++||||+. ++|.+++. ....+++..+..++.+++.||.|||+.+ ++|+||+|.|||++.++.++|+|||++...
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceee
Confidence 8899999996 57777764 4456899999999999999999999865 999999999999999999999999998765
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
... ....|++.|+|||.+.......++.++|||||||++|+|++|..||........... +.... ..
T Consensus 166 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~-~~ 232 (308)
T cd06634 166 APA---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNE-SP 232 (308)
T ss_pred cCc---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH---HhhcC-CC
Confidence 322 123688999999997543333478899999999999999999999976554332221 11111 11
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
......++..+.+||.+||..+|.+||++.+++.|||+...
T Consensus 233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 11234688899999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=321.24 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=205.8
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEE
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
...||+|+||.||++.+..++..||||.+..... .....+.+|+.+++.++||||++++++|. ..+..++||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~ 96 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-------QRRELLFNEVVIMRDYQHENVVEMYNSYL-VGDELWVVM 96 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-------hHHHHHHHHHHHHHhcCCcchhheeeEEE-eCCEEEEEE
Confidence 4679999999999999989999999998743211 12356888999999999999999999986 677899999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
||+++++|..++... .+++..+..++.|++.||.|||+.+ |+|+||+|.||+++.++.++|+|||++.........
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~- 172 (292)
T cd06657 97 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 172 (292)
T ss_pred ecCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccccc-
Confidence 999999999987654 5899999999999999999999965 999999999999999999999999998765432111
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
.....|++.|+|||.+.... ++.++|+|||||++|+|++|..||........... +.......+.....+
T Consensus 173 ----~~~~~~~~~y~~pE~~~~~~---~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 242 (292)
T cd06657 173 ----RKSLVGTPYWMAPELISRLP---YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IRDNLPPKLKNLHKV 242 (292)
T ss_pred ----ccccccCccccCHHHhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhhCCcccCCcccC
Confidence 12236889999999875433 78899999999999999999999976554332211 111122223333467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
+..+.+||.+||..+|.+||++.+++.||||...+
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 89999999999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.07 Aligned_cols=260 Identities=24% Similarity=0.373 Sum_probs=206.0
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEcc-------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCC
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLV-------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHH 467 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~-------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~Hp 467 (683)
.+|.+...+|.+.+.||+|+||.||+|.+.. ....||+|++.... .......+.+|+.++.++ +||
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~E~~~l~~l~~h~ 78 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA------TDKDLSDLVSEMEMMKMIGKHK 78 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc------CHHHHHHHHHHHHHHHhhcCCC
Confidence 5678888899999999999999999997643 23479999875321 112356788999999999 799
Q ss_pred ceeeeccccccCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCce
Q 005678 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKI 531 (683)
Q Consensus 468 nIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~I 531 (683)
||++++++|. +.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||..+ |
T Consensus 79 ~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i 155 (334)
T cd05100 79 NIINLLGACT-QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--C 155 (334)
T ss_pred CeeeeeEEEc-cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence 9999999986 567889999999999999999643 24778888999999999999999865 9
Q ss_pred EecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHH
Q 005678 532 IHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM 611 (683)
Q Consensus 532 IHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyEL 611 (683)
+|+||||.|||++.++.+||+|||+++....... ......+.+++.|+|||.+.... ++.++|||||||++|+|
T Consensus 156 vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el 229 (334)
T cd05100 156 IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY---YKKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLLWEI 229 (334)
T ss_pred eccccccceEEEcCCCcEEECCcccceecccccc---cccccCCCcCceEcCHHHhccCC---cCchhhhHHHHHHHHHH
Confidence 9999999999999999999999999986543211 11122334567899999886443 78899999999999999
Q ss_pred Hc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 612 LF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 612 Lt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
++ |..||......+.. . .+. .....+....++..+.+||.+||..+|.+||++.+++.+
T Consensus 230 ~~~g~~p~~~~~~~~~~-~--~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 230 FTLGGSPYPGIPVEELF-K--LLK--EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HhcCCCCCCCCCHHHHH-H--HHH--cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 98 88999766543322 1 111 112223335678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=349.04 Aligned_cols=269 Identities=17% Similarity=0.241 Sum_probs=191.0
Q ss_pred cccceeEEEEecccCceEEEEEEEccC-CeEEEEEEeccCccc----------chhhHHHHHHHHHHHHHHHhhcCCCce
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVE-HRYVACKLHGLNAQW----------SEDKKQSYIRHAIREYNIHKTLVHHHI 469 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~-g~~VAVKi~~~~~~~----------~~~~~~~~i~~~~rEi~il~~L~HpnI 469 (683)
+..+|.+++.||+|+||+||+|..... +..+++|.+...... ...........+.+|+.++..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 456899999999999999999865432 222222211110000 000111234567899999999999999
Q ss_pred eeeccccccCCceEEEEEecccCCChhHHHhcC-----CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC
Q 005678 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-----PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD 544 (683)
Q Consensus 470 V~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-----~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd 544 (683)
|++++++. +.+..|+|++++ +++|..++... .......++.|+.||+.||.|||+.+ ||||||||+||||+
T Consensus 226 v~l~~~~~-~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILR-SEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEE-ECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence 99999987 567788999999 45777766332 22346677889999999999999865 99999999999999
Q ss_pred CCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCC-CCCCCc-
Q 005678 545 EFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRR-PFGHDQ- 622 (683)
Q Consensus 545 ~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~-PF~~~~- 622 (683)
.+|.+||+|||+++.+..... .......||+.|+|||++.... ++.++|||||||+||+|++|.. ||....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE----AFDYGWVGTVATNSPEILAGDG---YCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred CCCCEEEEeCCCceecCcccc----cccccccCCcCCCCchhhcCCC---CCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 999999999999987653321 1122347999999999987544 8999999999999999999875 554322
Q ss_pred -hHHHHHHHHHHHHhhccCCCC--------------------------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 623 -TQERILREDTIIKARKVEFPS--------------------------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 623 -~~e~il~~~~i~~~~~~~~p~--------------------------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
....+.............+|. ...++.++.++|.+||.+||.+||++.+++.|
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111121110000000001110 12356778899999999999999999999999
Q ss_pred cccCC
Q 005678 676 PYLTY 680 (683)
Q Consensus 676 P~l~~ 680 (683)
|||..
T Consensus 455 p~f~~ 459 (501)
T PHA03210 455 PLFSA 459 (501)
T ss_pred hhhhc
Confidence 99974
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.82 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=199.3
Q ss_pred cceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
..|.+.+.||+|+||.||+|.+. .++..|++|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-------LAARKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-------HHHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 46889999999999999999753 345679999874322 122356788999999999999999999986
Q ss_pred cCCceEEEEEecccCCChhHHHhcCC----------------CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcce
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKATP----------------VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNV 541 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~~----------------~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NI 541 (683)
+...+++||||+++++|.+++..++ .+++..++.++.||+.||.|||+.+ |+|+||||.||
T Consensus 78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Ni 154 (291)
T cd05094 78 -DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNC 154 (291)
T ss_pred -cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceE
Confidence 6678999999999999999996532 3789999999999999999999865 99999999999
Q ss_pred EeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 005678 542 LFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGH 620 (683)
Q Consensus 542 LLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~ 620 (683)
|++.++.++|+|||++........ ........|++.|+|||.+.... ++.++|||||||++|+|++ |..||..
T Consensus 155 l~~~~~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 155 LVGANLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred EEccCCcEEECCCCcccccCCCce---eecCCCCCcceeecChHHhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999976543211 11122345788899999886443 7889999999999999998 9999976
Q ss_pred CchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 621 ~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....+.+ . .+.... .......++..+.+||.+||..+|.+||++.++++
T Consensus 229 ~~~~~~~-~--~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 229 LSNTEVI-E--CITQGR--VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCHHHHH-H--HHhCCC--CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 5554322 1 111111 11223457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.09 Aligned_cols=258 Identities=33% Similarity=0.532 Sum_probs=205.9
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
|.+...||.|+||.||+|.+..++..||+|++..... .......+..|+.+++.++||||+++++++. +...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-----EEGIPSTALREISLLKELKHPNIVKLLDVIH-TERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-----cccccHHHHHHHHHHHhcCCCCHHHHHhhhh-cCCceE
Confidence 5677889999999999999999999999999865431 1122356678999999999999999999986 668899
Q ss_pred EEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 485 TVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
+||||++ ++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 75 ~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred EEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 9999997 5899999765 57999999999999999999999965 999999999999999999999999999876433
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH--------
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK-------- 635 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~-------- 635 (683)
.. ......++..|+|||++... ..++.++|||||||++|+|++|.+||........+........
T Consensus 152 ~~-----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07829 152 LR-----TYTHEVVTLWYRAPEILLGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224 (282)
T ss_pred cc-----ccCccccCcCcCChHHhcCC--cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence 21 12223567889999998643 2378899999999999999999999977665443322111000
Q ss_pred ----h--hccCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 636 ----A--RKVEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 636 ----~--~~~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
. ....++. .+.++..+.+||.+||..+|.+||++.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 0011111 13457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=322.33 Aligned_cols=267 Identities=26% Similarity=0.400 Sum_probs=217.5
Q ss_pred ceeE-EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCc
Q 005678 404 RYAL-LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 404 ry~l-~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~ 481 (683)
-|.+ .+.||+|+|+.|--|....+|..||||++..... .....+.||++++.+. .|+||+.|+++|+ +..
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-------HsR~RvfREVe~f~~Cqgh~nilqLiefFE-dd~ 149 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-------HSRSRVFREVETFYQCQGHKNILQLIEFFE-DDT 149 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc-------hHHHHHHHHHHHHHHhcCCccHHHHHHHhc-ccc
Confidence 3444 3679999999999999999999999999855421 1235788999999999 5999999999997 788
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC---cEEEEecCCcc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG---VAKVTDFGLSK 558 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g---~vKL~DFGls~ 558 (683)
.||||||-|.||+|..+|.+...+++.++..++.+|+.||.|||.+| |.||||||.|||..... -+|||||.+..
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeecccccc
Confidence 99999999999999999998889999999999999999999999977 99999999999997543 58999999875
Q ss_pred ccccCc--CCCcccccccCCCCCccCCcccccc--cCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH------
Q 005678 559 IVEDDV--GSQGMELTSQGAGTYWYLPPECFEL--SKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL------ 628 (683)
Q Consensus 559 ~~~~~~--~~~~~~l~~~~~GT~~Y~APE~~~~--~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il------ 628 (683)
-+.... .....+-...++|+..|||||+... +....|+.++|.||||||+|-||+|.+||-+.-..+.-+
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 443221 1111122335689999999998653 224569999999999999999999999995432211110
Q ss_pred -----HHHHHHHhhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 629 -----REDTIIKARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 629 -----~~~~i~~~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..-.-++.+.++||+ |..+|.+++++|..+|..++..|.++.++++|||++.
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 112335678899996 5689999999999999999999999999999999985
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.90 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=203.5
Q ss_pred ccceeEEEEecccCceEEEEEEEcc-----CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLV-----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~-----~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
...|.++..||.|+||.||+|.... ....|++|.+.... .......+.+|+.+++.++||||++++++|
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK------DENLQSEFRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc------chHHHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 3578899999999999999998643 35679999864321 123456788999999999999999999988
Q ss_pred ccCCceEEEEEecccCCChhHHHhcCC---------CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKATP---------VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~~~---------~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g 547 (683)
. +...+|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||.|||++.++
T Consensus 78 ~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~ 154 (275)
T cd05046 78 R-EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR 154 (275)
T ss_pred C-CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCC
Confidence 5 6678899999999999999997554 6899999999999999999999865 99999999999999999
Q ss_pred cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHH
Q 005678 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQER 626 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~ 626 (683)
.++|+|||++........ .......+++.|+|||++.... ++.++|||||||++|+|++ |..||.......
T Consensus 155 ~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~- 226 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEY----YKLRNALIPLRWLAPEAVQEDD---FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE- 226 (275)
T ss_pred cEEEcccccccccCcccc----cccCCceeEEeecChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCccccchHH-
Confidence 999999999875432211 1122335677899999876433 6889999999999999998 889996544432
Q ss_pred HHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 627 ILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 627 il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
++. ........++....++..+.++|.+||..+|.+||++.+++..
T Consensus 227 ~~~---~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 227 VLN---RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHH---HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 221 1222333445556789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.61 Aligned_cols=259 Identities=24% Similarity=0.328 Sum_probs=199.9
Q ss_pred ceeEEEEecccCceEEEEEEE----ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 404 RYALLNLLGKGGFSEVYKAYD----LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d----~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
-|.+++.||+|+||.||+|.. ..++..||+|.+..... ......+.+|+.+++.+.||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG------GNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc------HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 468899999999999999963 45688999998754321 12245788999999999999999999988644
Q ss_pred -CceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 480 -QNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 480 -~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
...+++||||++|++|.+++... ..+++..+..++.+|+.||.|||+.+ |+|+||||+|||++.++.++|+|||++
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccc
Confidence 36788999999999999999654 46899999999999999999999865 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH----------H
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER----------I 627 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~----------i 627 (683)
..+...... ........|+..|+|||++.... ++.++|||||||++|+|+++..|+........ .
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~---~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05079 157 KAIETDKEY--YTVKDDLDSPVFWYAPECLIQSK---FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT 231 (284)
T ss_pred cccccCccc--eeecCCCCCCccccCHHHhccCC---CCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccccc
Confidence 876543221 11223345777899999886433 78899999999999999998876533211100 0
Q ss_pred HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 628 l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.............++....++..+.+||.+||..+|.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 000000011112234445789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.19 Aligned_cols=250 Identities=20% Similarity=0.300 Sum_probs=191.3
Q ss_pred EEecccCceEEEEEEEcc---CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEE
Q 005678 409 NLLGKGGFSEVYKAYDLV---EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT 485 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~---~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~L 485 (683)
+.||+|+||.||+|.+.. ....||||.+.... .......+.+|+.+++.++||||+++++++...++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 368999999999998653 34679999864321 112245778899999999999999999977555667889
Q ss_pred EEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCc
Q 005678 486 VLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~ 564 (683)
||||+.+++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+....
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999999999999653 45677888889999999999999855 9999999999999999999999999997654321
Q ss_pred CCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCchHHHHHHHHHHHHhhccCCCC
Q 005678 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFG-RRPFGHDQTQERILREDTIIKARKVEFPS 643 (683)
Q Consensus 565 ~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~e~il~~~~i~~~~~~~~p~ 643 (683)
.. .........+++.|+|||++.... ++.++|||||||++|+|++| .+||......+ +.. .+... ...+.
T Consensus 153 ~~-~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~--~~~~~--~~~~~ 223 (262)
T cd05058 153 YY-SVHNHTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-ITV--YLLQG--RRLLQ 223 (262)
T ss_pred ce-eecccccCcCCccccChhHhccCc---cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH--HHhcC--CCCCC
Confidence 10 111122335677899999886443 78999999999999999994 66676544332 111 11111 12222
Q ss_pred CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 644 ~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
...++..+.++|.+||..+|++||++.+++..
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 34578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.12 Aligned_cols=260 Identities=30% Similarity=0.439 Sum_probs=219.5
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
+.-...|.+...||+|.|++|.+|++..++..||||++..+.... .....+.+|+.+|+.|+|||||++|.+..
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-----~~~~k~~rev~imk~l~HPnIvkl~~v~~- 125 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-----SKRQKLGREVDIMKSLNHPNIVKLFSVIE- 125 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-----HHHHHHHHHHHHHHhcCCcceeeeeeeee-
Confidence 334457999999999999999999999999999999986654322 22455889999999999999999999886
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
....+|+||||+.+|.++++|.+++.+.+.+++.++.|+++|+.|||.+. |||||||+.||||+.+-++||+|||++.
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccce
Confidence 67789999999999999999999999999999999999999999999965 9999999999999999999999999999
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
.+... .+....+|++.|.|||+|.+.. ...+.+|+||+|+++|-|++|..||....-.+ +....+ ...
T Consensus 204 ~~~~~------~~lqt~cgsppyAaPEl~~g~~--y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--Lr~rvl--~gk 271 (596)
T KOG0586|consen 204 FFDYG------LMLQTFCGSPPYAAPELFNGKK--YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--LRPRVL--RGK 271 (596)
T ss_pred eeccc------ccccccCCCCCccChHhhcCcc--cCCcceehhhhhhhheeeeecccccCCccccc--ccchhe--eee
Confidence 88643 2344568999999999997665 35789999999999999999999997654322 111111 122
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+..| -.++.++.++|+++|-++|.+|+++.++..|.|+..
T Consensus 272 ~rIp--~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 272 YRIP--FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred eccc--ceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 2222 347889999999999999999999999999999753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=353.28 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=212.3
Q ss_pred ccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeee
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
..+-.....+.+.||+|.||+||+|... .....||||.++... ......+|.||+.++..|+|||||+|
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a------~~~~~~dF~REaeLla~l~H~nIVrL 554 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA------ENQARQDFRREAELLAELQHPNIVRL 554 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc------cHHHHHHHHHHHHHHHhccCCCeEEE
Confidence 3455566777889999999999999642 234679999875432 22345789999999999999999999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcC--------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCC
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKP 538 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP 538 (683)
+|+|. .++.+|+|+|||..|||..+|... ++|+..+...|+.|||.|+.||-++ .+|||||-.
T Consensus 555 lGVC~-~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~--~FVHRDLAT 631 (774)
T KOG1026|consen 555 LGVCR-EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH--HFVHRDLAT 631 (774)
T ss_pred EEEEc-cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--cccccchhh
Confidence 99996 788999999999999999999533 1278889999999999999999984 599999999
Q ss_pred cceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 005678 539 GNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRP 617 (683)
Q Consensus 539 ~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~P 617 (683)
.|+|+.++..|||+||||++-+..... +.......--.+|||||.+..++ ||.++|||||||+|||+++ |..|
T Consensus 632 RNCLVge~l~VKIsDfGLsRdiYssDY---Yk~~~~t~lPIRWMppEsIly~k---FTteSDVWs~GVvLWEIFsyG~QP 705 (774)
T KOG1026|consen 632 RNCLVGENLVVKISDFGLSRDIYSSDY---YKVRGNTLLPIRWMPPESILYGK---FTTESDVWSFGVVLWEIFSYGKQP 705 (774)
T ss_pred hhceeccceEEEecccccchhhhhhhh---hcccCCceeeeecCCHHHhhcCc---ccchhhhhhhhhhhhhhhccccCc
Confidence 999999999999999999997764321 11111112346799999998777 9999999999999999996 9999
Q ss_pred CCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 618 FGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 618 F~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
|.....++.|.. +..+.+ ++.+..||.++.+|+..||..+|.+||++.+|-
T Consensus 706 y~glSn~EVIe~----i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 706 YYGLSNQEVIEC----IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ccccchHHHHHH----HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999888887743 455555 777789999999999999999999999999984
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.82 Aligned_cols=260 Identities=24% Similarity=0.345 Sum_probs=205.3
Q ss_pred cccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCcee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV 470 (683)
.|.+..++|.+.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.++..+. |||||
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~~E~~~l~~l~~H~niv 104 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR------SSEKQALMSELKIMSHLGPHLNIV 104 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC------hhHHHHHHHHHHHHHhcCCCCCeE
Confidence 56778889999999999999999999853 3567899999864322 112346789999999997 99999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcC------------------------------------------------
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT------------------------------------------------ 502 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~------------------------------------------------ 502 (683)
+++++|. ..+.+++|||||++|+|.+++...
T Consensus 105 ~~~~~~~-~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 105 NLLGACT-KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEEc-cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 9999986 566899999999999999998542
Q ss_pred --------------------------------------------------CCcchHHHHHHHHHHHHHHHHHHhcCCceE
Q 005678 503 --------------------------------------------------PVLPEREARIIIVQIFQGLIYLNKRAQKII 532 (683)
Q Consensus 503 --------------------------------------------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~II 532 (683)
..+++..+..|+.||+.||.|||+.+ |+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iv 261 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CV 261 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cC
Confidence 13567778889999999999999854 99
Q ss_pred ecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
||||||.|||++.++.+||+|||+++........ .......|++.|+|||++.... ++.++|||||||++|+|+
T Consensus 262 Hrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGvil~e~l 335 (401)
T cd05107 262 HRDLAARNVLICEGKLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNL---YTTLSDVWSFGILLWEIF 335 (401)
T ss_pred cccCCcceEEEeCCCEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCC---CCcHhHHHHHHHHHHHHH
Confidence 9999999999999999999999999865432111 1112235788999999886433 788999999999999999
Q ss_pred c-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 613 F-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 613 t-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+ |..||......+.... .+.. ....+.+..++.++.+||.+||..+|.+||++.+|+..
T Consensus 336 ~~g~~P~~~~~~~~~~~~--~~~~--~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 336 TLGGTPYPELPMNEQFYN--AIKR--GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HcCCCCCCCCCchHHHHH--HHHc--CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8 8999976554433221 1111 22233445689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.02 Aligned_cols=249 Identities=18% Similarity=0.296 Sum_probs=189.3
Q ss_pred EecccCceEEEEEEEc--cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEE
Q 005678 410 LLGKGGFSEVYKAYDL--VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~--~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
.||+|+||.||+|... .....+++|.+..... ......+.+|+.+++.++||||+++++.|. ....+++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT------PDEQLLFLQEVQPYRELNHPNVLQCLGQCI-ESIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC------hHHHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCceEEEE
Confidence 5899999999999643 2456788887643321 122356788999999999999999999886 667899999
Q ss_pred ecccCCChhHHHhcCC-----CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 488 EYCSGKDLDAVLKATP-----VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~-----~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||++.....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYP 152 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEecccccccccc
Confidence 9999999999996542 2467788899999999999999965 99999999999999999999999999865432
Q ss_pred CcCCCcccccccCCCCCccCCcccccccC----CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhh
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSK----TPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~----~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
... ........+++.|+|||++.... ...++.++|||||||++|+|++ |..||......+.+. ......
T Consensus 153 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~~~~~~ 226 (269)
T cd05042 153 EDY---YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK---QVVREQ 226 (269)
T ss_pred chh---eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH---HHhhcc
Confidence 210 01122335677899999975421 2346889999999999999998 788997665443221 112222
Q ss_pred ccCCCC---CcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 638 KVEFPS---RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 638 ~~~~p~---~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...++. ...++..+.+++..|| .+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 222222 2367889999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=314.61 Aligned_cols=268 Identities=17% Similarity=0.209 Sum_probs=193.5
Q ss_pred ccccceeEEEEecccCceEEEEEEEccC---CeEEEEEEeccCcccchhhH----HHHHHHHHHHHHHHhhcCCCceeee
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVE---HRYVACKLHGLNAQWSEDKK----QSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~---g~~VAVKi~~~~~~~~~~~~----~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
+...+|.+.+.||+|+||.||+|.+..+ +..+|+|+............ .........++..+..+.|+||+.+
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 5668999999999999999999998777 67788887543322111000 0011223345556677899999999
Q ss_pred ccccccCCc---eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcE
Q 005678 473 WDTFEIDQN---TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA 549 (683)
Q Consensus 473 ~~~f~~d~~---~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~v 549 (683)
++++..... ..+++++++ ..++.+.+......++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCcE
Confidence 987643322 346788887 4577777766656788889999999999999999865 9999999999999999999
Q ss_pred EEEecCCccccccCcCCCc--ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 550 KVTDFGLSKIVEDDVGSQG--MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~--~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
+|+|||+|+.+........ ........||+.|+|||++.... ++.++|||||||++|+|++|..||.........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~---~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC---VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC---CCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 9999999987643211110 01122346999999999886443 899999999999999999999999766332222
Q ss_pred HH---HHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 628 LR---EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 628 l~---~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.. .+.+........ ..+.++..+.+++..|+..+|++||++.++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhHHHHHHHhhhhhh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11 111111111111 12456889999999999999999999999875
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=313.64 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=199.5
Q ss_pred cccceeEEEEecccCceEEEEEEEcc-----CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLV-----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~-----~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
..++|.+...||.|+||.||+|.+.. ++..||+|++..... ......+.+|+.+++.+.||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------ADMQADFQREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC------HHHHHHHHHHHHHHHhcCCCchheEEEE
Confidence 35678999999999999999998643 678999998754321 1223568889999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC----------------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEe
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT----------------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIH 533 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIH 533 (683)
+. +...+|+||||+++++|..++... ..+++..+..++.+++.||.|||..+ ++|
T Consensus 77 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H 153 (288)
T cd05050 77 CA-VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVH 153 (288)
T ss_pred Ec-CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 86 567789999999999999999642 23678888999999999999999865 999
Q ss_pred cccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc
Q 005678 534 YDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF 613 (683)
Q Consensus 534 rDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt 613 (683)
+||||+|||++.++.++|+|||++..+...... .......+++.|+|||.+.... ++.++|||||||++|+|++
T Consensus 154 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 154 RDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KASENDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred ccccHhheEecCCCceEECccccceecccCccc---cccCCCccChhhcCHHHHhcCC---CCchhHHHHHHHHHHHHHh
Confidence 999999999999999999999998765432110 1111224566799999876443 8899999999999999997
Q ss_pred -CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 614 -GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 614 -G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
|..||......+... .+.... .++....++..+.+||.+||..+|.+||++.++++
T Consensus 228 ~~~~p~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 228 YGMQPYYGMAHEEVIY---YVRDGN--VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCCCCCCCCHHHHHH---HHhcCC--CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 888986554433221 111111 12333468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=311.46 Aligned_cols=242 Identities=25% Similarity=0.368 Sum_probs=189.8
Q ss_pred EecccCceEEEEEEEccCCe--EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCceEEEE
Q 005678 410 LLGKGGFSEVYKAYDLVEHR--YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNTFCTV 486 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~g~--~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~~~LV 486 (683)
.||+|+||.||+|.+..++. .+++|.+.... .......+.+|+.++.++ .||||++++++|. ..+.+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~~~~lv 74 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA------SKDDHRDFAGELEVLCKLGHHPNIINLLGACE-HRGYLYLA 74 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-cCCCceEE
Confidence 58999999999999877775 46888764321 112245678899999999 7999999999986 56678999
Q ss_pred EecccCCChhHHHhcCC----------------CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 487 LEYCSGKDLDAVLKATP----------------VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 487 ~Ey~~ggsL~~~L~~~~----------------~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEE
Confidence 99999999999996432 4788999999999999999999865 99999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILR 629 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~ 629 (683)
|+|||++....... ......+++.|+|||++.... ++.++|||||||++|+|++ |..||......... .
T Consensus 153 l~dfgl~~~~~~~~------~~~~~~~~~~y~apE~~~~~~---~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~ 222 (270)
T cd05047 153 IADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-E 222 (270)
T ss_pred ECCCCCccccchhh------hccCCCCccccCChHHHccCC---CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-H
Confidence 99999986332110 111123466799999885433 7899999999999999996 99999665443322 1
Q ss_pred HHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 630 ~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.+. .....+....++.++.+||.+||..+|.+||++.+++.
T Consensus 223 --~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 223 --KLP--QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred --HHh--CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 111 11222233457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=310.59 Aligned_cols=249 Identities=19% Similarity=0.282 Sum_probs=189.7
Q ss_pred EecccCceEEEEEEEc--cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEE
Q 005678 410 LLGKGGFSEVYKAYDL--VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~--~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||++++++|. +...+++||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~ 74 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV------QEQMKFLEEAQPYRSLQHSNLLQCLGQCT-EVTPYLLVM 74 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh------HHHHHHHHHHHHHHhCCCCCEeeEEEEEc-CCCCcEEEE
Confidence 5899999999999753 35567999987544211 12346888999999999999999999886 567789999
Q ss_pred ecccCCChhHHHhcC-----CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 488 EYCSGKDLDAVLKAT-----PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~-----~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||.|||++.++.+||+|||++.....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccC
Confidence 999999999998542 24567778889999999999999865 99999999999999999999999999875433
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCC----CCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhh
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKT----PLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~----~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
.... .......|++.|+|||++..... ..++.++|||||||++|+|++ |..||......+.... .....
T Consensus 153 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~ 226 (269)
T cd05087 153 EDYY---VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY---TVREQ 226 (269)
T ss_pred ccee---ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH---Hhhcc
Confidence 2110 11122357888999998853321 135789999999999999996 9999976655443211 11222
Q ss_pred ccCCCCC---cCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 638 KVEFPSR---PAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 638 ~~~~p~~---~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...++.+ ..++..+.+++.+|+ .+|.+|||+.+|+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 227 QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 2222221 256788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=309.88 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=201.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCe----EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~----~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
..+|.+.+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.++..++||||+++++++.
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS------PKANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC------HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 4678999999999999999998776654 689998754422 223467889999999999999999999886
Q ss_pred cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
. ...++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 80 -~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 80 -S-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred -c-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcc
Confidence 3 7889999999999999999653 46899999999999999999999855 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
++........ .......+++.|+|||.+.... ++.++|||||||++|+|++ |..||......+.. . .+..
T Consensus 156 ~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~--~~~~ 226 (279)
T cd05057 156 AKLLDVDEKE---YHAEGGKVPIKWMALESILHRI---YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-D--LLEK 226 (279)
T ss_pred cccccCcccc---eecCCCcccccccCHHHhhcCC---cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-H--HHhC
Confidence 9876533211 1111223467899999875433 7889999999999999998 99999776543321 1 1111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...++.++.++..+.+++.+||..+|..||++.+++.
T Consensus 227 --~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 227 --GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2233444568899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=304.21 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=194.1
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEec
Q 005678 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEY 489 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey 489 (683)
.||.|+||.||+|.. .++..||+|++..... ......+.+|+.+++.++||||+++++++. +.+.+++||||
T Consensus 2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~ 73 (250)
T cd05085 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP------QELKIKFLSEARILKQYDHPNIVKLIGVCT-QRQPIYIVMEL 73 (250)
T ss_pred ccCCCCCceEEEEEe-cCCcEEEEEecCCcCC------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-cCCccEEEEEC
Confidence 689999999999985 4688999998754321 112346788999999999999999999886 66788999999
Q ss_pred ccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCc
Q 005678 490 CSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568 (683)
Q Consensus 490 ~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~ 568 (683)
+++++|..++.. ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-- 149 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-- 149 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccc--
Confidence 999999999864 346889999999999999999999865 999999999999999999999999998754332111
Q ss_pred ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCC
Q 005678 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAV 647 (683)
Q Consensus 569 ~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~ 647 (683)
......+++.|+|||++.... ++.++|||||||++|+|++ |..||.......... .+.. .........+
T Consensus 150 --~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~---~~~~--~~~~~~~~~~ 219 (250)
T cd05085 150 --SSGLKQIPIKWTAPEALNYGR---YSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE---QVEK--GYRMSCPQKC 219 (250)
T ss_pred --cCCCCCCcccccCHHHhccCC---CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHHc--CCCCCCCCCC
Confidence 111224467799999986443 7889999999999999998 999997665443221 1111 1222233568
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 648 SNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 648 s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+..+.+||.+||..+|.+||++.++++.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 8999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=304.08 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=200.5
Q ss_pred eEEEEecccCceEEEEEEEccCC----eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 406 ALLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 406 ~l~~~LGkGgfG~Vyka~d~~~g----~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.+.+.||.|+||.||+|.+...+ ..||+|++...... .....+..|+.++..+.||||+++++++. +.+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~ 74 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE------QQIEEFLREARIMRKLDHPNIVKLLGVCT-EEE 74 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh------HHHHHHHHHHHHHHhcCCCchheEEEEEc-CCC
Confidence 56788999999999999987766 89999998544221 13567889999999999999999999986 567
Q ss_pred eEEEEEecccCCChhHHHhcCCC--cchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPV--LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~--Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.++++|||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCcee
Confidence 89999999999999999976544 899999999999999999999865 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
....... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||......... . .+....
T Consensus 153 ~~~~~~~----~~~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~-~--~~~~~~- 221 (258)
T smart00219 153 LYDDDYY----KKKGGKLPIRWMAPESLKD---GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL-E--YLKKGY- 221 (258)
T ss_pred ccccccc----ccccCCCcccccChHHhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H--HHhcCC-
Confidence 6543111 1112347889999998843 337899999999999999998 88998764443322 1 111111
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
..+....++.++.+++.+||..+|.+|||+.++++
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 222 -RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 22333458999999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.11 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=201.7
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
|++..++|.+.+.||+|+||.||++.+ ..+..||+|.+.... .....+.+|+.+++.+.|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS--------MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh--------hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 467788999999999999999999974 456679999864321 12356788999999999999999999986
Q ss_pred cCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
+ ..+++||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 72 -~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 72 -K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFG 147 (260)
T ss_pred -C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCc
Confidence 3 678999999999999999965 345788899999999999999999865 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
++........ .......++..|+|||.+... .++.++|||||||++|+|++ |..||.......... .+.
T Consensus 148 ~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~~ 217 (260)
T cd05073 148 LARVIEDNEY----TAREGAKFPIKWTAPEAINFG---SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---ALE 217 (260)
T ss_pred ceeeccCCCc----ccccCCcccccccCHhHhccC---CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHh
Confidence 9976543211 112223466789999988643 37889999999999999998 999997655433221 111
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+.....+.++.+++.+||..+|.+||++.+++.
T Consensus 218 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 218 --RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred --CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 22233344578899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=305.36 Aligned_cols=241 Identities=25% Similarity=0.396 Sum_probs=195.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
..|.+.+.||+|+||.||++. .++..||+|.+.... ....+.+|+.++..++||||+++++++.. +.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---------TAQAFLEETAVMTKLHHKNLVRLLGVILH--NG 72 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CC
Confidence 568999999999999999994 578899999875421 12467889999999999999999999863 34
Q ss_pred EEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+++||||+++++|..++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceec
Confidence 78999999999999999654 35789999999999999999999855 999999999999999999999999998764
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
.... .....+..|+|||++... .++.++|||||||++|+|++ |+.||......+... .+.. ..
T Consensus 151 ~~~~--------~~~~~~~~y~~pe~~~~~---~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~--~~ 214 (254)
T cd05083 151 SMGV--------DNSKLPVKWTAPEALKHK---KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE---CVEK--GY 214 (254)
T ss_pred cccC--------CCCCCCceecCHHHhccC---CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HHhC--CC
Confidence 3221 111345679999988643 37899999999999999997 999997765543221 1111 22
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
..+....++..+.+||.+||..+|..||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 23334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=309.32 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=201.8
Q ss_pred cceeEEEEecccCceEEEEEEEc----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDL----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
..|.+.+.||+|+||.||+|... .++..||||++...... .....+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~ 77 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE------QHRSDFEREIEILRTLDHENIVKYKGVCEK 77 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch------HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence 45778899999999999999754 34789999998654321 235678899999999999999999988753
Q ss_pred -CCceEEEEEecccCCChhHHHhcCC-CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 479 -DQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 479 -d~~~~~LV~Ey~~ggsL~~~L~~~~-~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
+...+++||||+++++|.+++.... .+++..+..++.+++.||.|||+.+ |+|+||||.|||++.++.++|+|||+
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccc
Confidence 2557899999999999999996543 6899999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH---------
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI--------- 627 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i--------- 627 (683)
+......... ........++..|+|||++... .++.++||||||+++|+|++|..||.........
T Consensus 156 ~~~~~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05038 156 AKVLPEDKDY--YYVKEPGESPIFWYAPECLRTS---KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230 (284)
T ss_pred ccccccCCcc--eeccCCCCCcccccCcHHHccC---CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccc
Confidence 9877532211 1112223456679999988644 3788999999999999999999998654332200
Q ss_pred -HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 628 -LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 628 -l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...-.........++....++.++.+|+.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 231 IVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000011122334445578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=314.97 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=199.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCe----EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~----~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
...|.+.+.||.|+||.||+|.+..++. .||+|++..... ......+.+|+.+++.+.||||++++++|.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG------PKANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 3567889999999999999999877775 578887743321 112345788999999999999999999885
Q ss_pred cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
....++|+||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 80 --~~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 80 --SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred --CCCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccc
Confidence 33567999999999999999654 35899999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
++.+...... .......++..|+|||++.... ++.++|||||||++|+|++ |..||......... .+..
T Consensus 156 ~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~---~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~----~~~~ 225 (303)
T cd05110 156 ARLLEGDEKE---YNADGGKMPIKWMALECIHYRK---FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP----DLLE 225 (303)
T ss_pred cccccCcccc---cccCCCccccccCCHHHhccCC---CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHH
Confidence 9876533211 1122235677899999886443 7899999999999999996 99999765433211 1111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
....++..+.++..+.++|.+||..+|.+||++.+++..
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 226 -KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 223344456688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=348.57 Aligned_cols=150 Identities=27% Similarity=0.424 Sum_probs=133.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||.||+|.+..+++.||||++...... .......+..|+.++..++||||+++++++. ..+.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI----NKNMVHQVQAERDALALSKSPFIVHLYYSLQ-SANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-ECCE
Confidence 5799999999999999999999999999999998543221 1233456888999999999999999998886 6778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+|+||||+.|++|..++...+.+++..++.|+.||+.||.|||..+ ||||||||.||||+.++.+||+|||+++.
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999999999987778999999999999999999999865 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.16 Aligned_cols=259 Identities=25% Similarity=0.434 Sum_probs=210.3
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCC----eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceee
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVR 471 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g----~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~ 471 (683)
..|++..+...+.+.||+|+||+||+|.....+ ..||||....... .....+..++.|.++++.++|||||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~----~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE----LTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc----ccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 457778888888899999999999999865542 2389998754221 22344789999999999999999999
Q ss_pred eccccccCCceEEEEEecccCCChhHHHhcCC-CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 472 L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~-~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
+||++. ....++||||+|.||+|.++|+..+ .++..+...++.+.+.||.|||+.. +|||||-..|+|++.++.+|
T Consensus 226 ~yGVa~-~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 226 FYGVAV-LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEEc-CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEE
Confidence 999885 7788999999999999999998776 5999999999999999999999854 99999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccc-cCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTS-QGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERIL 628 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~-~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il 628 (683)
|+|||+++.-..- .... ...--..|+|||.+... .|+.++|||||||++||+++ |..||......+...
T Consensus 303 ISDFGLs~~~~~~------~~~~~~~klPirWLAPEtl~~~---~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~ 373 (474)
T KOG0194|consen 303 ISDFGLSRAGSQY------VMKKFLKKLPIRWLAPETLNTG---IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA 373 (474)
T ss_pred eCccccccCCcce------eeccccccCcceecChhhhccC---ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH
Confidence 9999998754311 0111 01223569999998755 59999999999999999998 888998887764321
Q ss_pred HHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 629 REDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 629 ~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.+....+..+.+...+..+..++.+||..+|++||++.++.+
T Consensus 374 ----kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 374 ----KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 122233444555678899999999999999999999988864
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.34 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=201.3
Q ss_pred eeEEEEecccCceEEEEEEEcc-CCeEEEEEEeccCcccch---hhHHHHHHHHHHHHHHHhh-cCCCceeeeccccccC
Q 005678 405 YALLNLLGKGGFSEVYKAYDLV-EHRYVACKLHGLNAQWSE---DKKQSYIRHAIREYNIHKT-LVHHHIVRLWDTFEID 479 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~-~g~~VAVKi~~~~~~~~~---~~~~~~i~~~~rEi~il~~-L~HpnIV~L~~~f~~d 479 (683)
|.+.+.||+|+||.||+|.+.. ++..||+|.+........ ......+..+..|+.++.. ++||||++++++|. +
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-~ 80 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-E 80 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-c
Confidence 7788899999999999999877 688999998754322110 1223345667889988875 79999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
.+.+++||||+++++|.+++. ....+++..++.++.|++.||.|||+. .+|+|+||+|.|||++.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEeccc
Confidence 778999999999999998873 345689999999999999999999963 249999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++....... ......|+..|+|||++.... ++.++||||||+++|+|++|..||.......... .+..
T Consensus 160 ~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~---~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~---~~~~ 227 (269)
T cd08528 160 LAKQKQPES------KLTSVVGTILYSCPEIVKNEP---YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT---KIVE 227 (269)
T ss_pred ceeeccccc------ccccccCcccCcChhhhcCCC---CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH---HHhh
Confidence 998754332 123346899999999986433 7899999999999999999999997655433221 1111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
..........++..+.+||.+||..||.+||++.++..+
T Consensus 228 -~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 228 -AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 111111122578999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.86 Aligned_cols=229 Identities=22% Similarity=0.293 Sum_probs=186.9
Q ss_pred cCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecccCC
Q 005678 414 GGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGK 493 (683)
Q Consensus 414 GgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~~gg 493 (683)
|.||.||++.+..++..||+|.+.... ...+|...+....||||+++++++. +.+.+++||||++|+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------------~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------------EYSRERLTIIPHCVPNMVCLHKYIV-SEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------------hhhhHHHHHHhcCCCceeehhhhee-cCCeEEEEEecCCCC
Confidence 889999999999999999999875432 1223444455567999999999986 678899999999999
Q ss_pred ChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccc
Q 005678 494 DLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573 (683)
Q Consensus 494 sL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~ 573 (683)
+|.+++.....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+.... .
T Consensus 71 ~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--------~ 140 (237)
T cd05576 71 KLWSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--------D 140 (237)
T ss_pred CHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc--------c
Confidence 99999987777999999999999999999999865 9999999999999999999999999886554321 1
Q ss_pred cCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHH
Q 005678 574 QGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKD 653 (683)
Q Consensus 574 ~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~d 653 (683)
...++..|+|||.+.... ++.++||||+||++|+|++|..||...... +.......+ ++.++..+.+
T Consensus 141 ~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~~~~~~~--~~~~~~~~~~ 207 (237)
T cd05576 141 GEAVENMYCAPEVGGISE---ETEACDWWSLGAILFELLTGKTLVECHPSG--------INTHTTLNI--PEWVSEEARS 207 (237)
T ss_pred cCCcCccccCCcccCCCC---CCchhhHHHHHHHHHHHHHCcchhhcCchh--------cccccccCC--cccCCHHHHH
Confidence 225677899999875433 788999999999999999999988543221 001111222 3468899999
Q ss_pred HHHHhcccCCCCCCCH-----HHHhcCccc
Q 005678 654 LIRRCLTYNQAERPDV-----LTLAQDPYL 678 (683)
Q Consensus 654 LI~rCL~~dP~kRPS~-----~eLl~hP~l 678 (683)
||.+||..||.+||++ .++++||||
T Consensus 208 li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 208 LLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 9999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=323.05 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=218.6
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
-...|.++.+||+|+||.|.+|..+.+...||||+++.+....+... .--+.|-.+|.-. +-|.+++|+.+|+ .
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv----ectm~EKrvLAL~~kppFL~qlHScFQ-T 421 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV----ECTMVEKRVLALPGKPPFLVQLHSCFQ-T 421 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcc----cceehhhhheecCCCCchHHHHHHHhh-h
Confidence 34568899999999999999999888999999999988766544332 2223455566554 5679999999997 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
-+.+|+||||+.||+|...+...+.+.+..+..++.+|+-||-|||+.| ||+||||.+||||+..|++||+|||+|+-
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccc
Confidence 7889999999999999999999999999999999999999999999977 99999999999999999999999999974
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
--.+. ..+.+.+|||.|+|||++.+.. |+..+|+||+||+|||||.|++||...+..+.+.. +....+
T Consensus 500 ni~~~-----~TTkTFCGTPdYiAPEIi~YqP---YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a----I~ehnv 567 (683)
T KOG0696|consen 500 NIFDG-----VTTKTFCGTPDYIAPEIIAYQP---YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA----IMEHNV 567 (683)
T ss_pred cccCC-----cceeeecCCCcccccceEEecc---cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHHccC
Confidence 32221 2356679999999999998666 89999999999999999999999988777654422 345556
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~~ 681 (683)
.+| ..+|.++.+++...|..+|.+|.- -.++-.||||+..
T Consensus 568 syP--KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 568 SYP--KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred cCc--ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 666 479999999999999999999974 4678899999865
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.29 Aligned_cols=249 Identities=28% Similarity=0.444 Sum_probs=198.0
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
..|.+.+.||.|+||.||+|.+. .+..+|+|++...... ...+.+|+.+++.+.||||+++++++. ....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~ 73 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS--------EEDFIEEAQVMMKLSHPKLVQLYGVCT-ERSP 73 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC--------HHHHHHHHHHHHhCCCCCeeeEEEEEc-cCCc
Confidence 46888999999999999999864 4678999987543221 135678999999999999999999986 5678
Q ss_pred EEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+||||+++++|.+++... +.+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecc
Confidence 89999999999999999653 46899999999999999999999865 9999999999999999999999999987654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......++..|+|||++.... ++.++|||||||++|+|++ |..||......... . .+... ..
T Consensus 152 ~~~~~----~~~~~~~~~~~~aPe~~~~~~---~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~--~~~~~--~~ 219 (256)
T cd05112 152 DDQYT----SSTGTKFPVKWSSPEVFSFSK---YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV-E--TINAG--FR 219 (256)
T ss_pred cCccc----ccCCCccchhhcCHhHhccCC---cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-H--HHhCC--CC
Confidence 32111 111223567899999886443 7889999999999999998 99999765543322 1 11111 12
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
...+...+..+.+|+.+||..+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 22234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=307.36 Aligned_cols=239 Identities=21% Similarity=0.312 Sum_probs=186.1
Q ss_pred EEecccCceEEEEEEEcc------------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 409 NLLGKGGFSEVYKAYDLV------------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~------------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
+.||+|+||.||+|.... ....|++|++.... ......+..|+.++..++||||+++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~~~~l~~l~hp~iv~~~~~~ 73 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-------RDISLAFFETASMMRQVSHKHIVLLYGVC 73 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-------hhHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 368999999999997422 23368899864321 12345678889999999999999999988
Q ss_pred ccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc-------
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV------- 548 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~------- 548 (683)
. +....++||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.
T Consensus 74 ~-~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 74 V-RDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred e-cCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCce
Confidence 6 56678899999999999999864 456899999999999999999999865 999999999999986654
Q ss_pred EEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH-cCCCCCCCCchHHHH
Q 005678 549 AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERI 627 (683)
Q Consensus 549 vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL-tG~~PF~~~~~~e~i 627 (683)
++++|||++...... ....|+..|+|||++... ..++.++|||||||++|+|+ +|..||......+..
T Consensus 151 ~~l~d~g~~~~~~~~---------~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 219 (262)
T cd05077 151 IKLSDPGIPITVLSR---------QECVERIPWIAPECVEDS--KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219 (262)
T ss_pred eEeCCCCCCccccCc---------ccccccccccChhhhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH
Confidence 899999998755321 123678889999987532 23788999999999999998 588888654432211
Q ss_pred HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 628 l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
... . ..+......+.++.+||.+||..||.+||++.+|+++
T Consensus 220 ----~~~-~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 220 ----RFY-E--GQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----HHH-h--cCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 111 1 1122223456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=309.85 Aligned_cols=238 Identities=21% Similarity=0.337 Sum_probs=185.9
Q ss_pred EecccCceEEEEEEEcc------------------------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC
Q 005678 410 LLGKGGFSEVYKAYDLV------------------------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV 465 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~------------------------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~ 465 (683)
.||+|+||.||+|.... ....|++|++... .......+.+|+.+++.++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-------~~~~~~~~~~~~~~~~~l~ 74 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-------HRDIALAFFETASLMSQVS 74 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-------HHHHHHHHHHHHHHHhcCC
Confidence 59999999999997432 1245889987432 1223456788999999999
Q ss_pred CCceeeeccccccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC
Q 005678 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD 544 (683)
Q Consensus 466 HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd 544 (683)
||||+++++++. +....++||||+++++|..++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 75 h~niv~~~~~~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~ 151 (274)
T cd05076 75 HIHLAFVHGVCV-RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLA 151 (274)
T ss_pred CCCeeeEEEEEE-eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEe
Confidence 999999999885 66788999999999999999964 467899999999999999999999865 99999999999997
Q ss_pred CCC-------cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH-cCCC
Q 005678 545 EFG-------VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRR 616 (683)
Q Consensus 545 ~~g-------~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL-tG~~ 616 (683)
..+ .+||+|||++...... ....+++.|+|||++... ..++.++|||||||++|+|+ +|..
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---------~~~~~~~~~~aPe~~~~~--~~~~~~~Dv~slG~~l~el~~~g~~ 220 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---------EERVERIPWIAPECVPGG--NSLSTAADKWSFGTTLLEICFDGEV 220 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---------cccccCCcccCchhhcCC--CCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 543 4899999987643221 123578889999988543 33789999999999999995 6999
Q ss_pred CCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 617 PFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 617 PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
||......+... .. .....+| ...+..+.+||.+||..+|.+|||+.+++++
T Consensus 221 p~~~~~~~~~~~----~~-~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 221 PLKERTPSEKER----FY-EKKHRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CccccChHHHHH----HH-HhccCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 997654433211 11 1112222 2356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=306.66 Aligned_cols=245 Identities=25% Similarity=0.405 Sum_probs=192.8
Q ss_pred EecccCceEEEEEEEccCC------eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 410 LLGKGGFSEVYKAYDLVEH------RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~g------~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.||.|+||.||+|.+.... ..||||.+..... ......+.+|+.+++.++||||++++++|. +...+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-LNEPQ 74 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc------hhhHHHHHHHHHHHHhcCCCCeeeEeeeec-CCCCe
Confidence 5899999999999875443 7899998643211 122456788999999999999999999886 66789
Q ss_pred EEEEecccCCChhHHHhc-------CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-----cEEE
Q 005678 484 CTVLEYCSGKDLDAVLKA-------TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-----VAKV 551 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~-------~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-----~vKL 551 (683)
++||||+++++|.+++.. ...+++..+..++.+|+.||.|||+.+ ++|+||||+|||++.++ .++|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEE
Confidence 999999999999999953 234788999999999999999999865 99999999999999877 8999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHH
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRE 630 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~ 630 (683)
+|||++..+...... .......++..|+|||++.... ++.++|||||||++|+|++ |..||......+....
T Consensus 153 ~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~- 225 (269)
T cd05044 153 GDFGLARDIYKSDYY---RKEGEGLLPVRWMAPESLLDGK---FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH- 225 (269)
T ss_pred CCccccccccccccc---ccCcccCCCccccCHHHHccCC---cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-
Confidence 999999765432110 1112235678899999886443 7899999999999999997 9999976554432211
Q ss_pred HHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 631 ~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+.. ...+.....++..+.+||.+||..+|.+||++.++++
T Consensus 226 --~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 226 --VTA--GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred --Hhc--CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111 1222334568899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=308.20 Aligned_cols=238 Identities=23% Similarity=0.352 Sum_probs=187.0
Q ss_pred EecccCceEEEEEEEccCCeE-------EEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 410 LLGKGGFSEVYKAYDLVEHRY-------VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~g~~-------VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
.||.|+||.||+|.+...+.. ||+|.+... .......+..|+.+++.+.||||+++++++. .+..
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-~~~~ 73 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-------HRNYSESFFEAASMMSQLSHKHLVLNYGVCV-CGDE 73 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch-------hHHHHHHHHHHHHHHHhCCCCChhheeeEEE-eCCC
Confidence 589999999999987655443 888876322 1233457788999999999999999999986 5567
Q ss_pred EEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc--------EEEEe
Q 005678 483 FCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV--------AKVTD 553 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~--------vKL~D 553 (683)
.++||||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||.|||++.++. ++++|
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecc
Confidence 88999999999999999654 45899999999999999999999865 999999999999987664 69999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCC-CCCCCCchHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGR-RPFGHDQTQERILREDT 632 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~-~PF~~~~~~e~il~~~~ 632 (683)
||++..... .....|++.|+|||++.... .++.++|||||||++|+|++|. .||..........
T Consensus 152 ~g~~~~~~~---------~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~---- 216 (258)
T cd05078 152 PGISITVLP---------KEILLERIPWVPPECIENPQ--NLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---- 216 (258)
T ss_pred cccccccCC---------chhccccCCccCchhccCCC--CCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH----
Confidence 998865432 12236888999999986422 3688999999999999999984 6665544332111
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.......+| ...+.++.+||.+||..+|.+|||+.++++.
T Consensus 217 -~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 217 -FYEDRHQLP--APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -HHHccccCC--CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 111222233 3467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=353.16 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=207.3
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCe-----EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHR-----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~-----~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
+......+...||+|.||+||.|....... .||||.+.... ....+..|++|..+|+.++|||||+++|
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~------~~~~~~~Fl~Ea~~m~~f~HpNiv~liG 762 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS------SEQEVSDFLKEALLMSKFDHPNIVSLIG 762 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC------CHHHHHHHHHHHHHHhcCCCcceeeEEE
Confidence 345677888999999999999997654322 38888775432 2344678999999999999999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhcC-------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKAT-------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g 547 (683)
++- +....+|++|||.||+|..+|++. ..|+......++.+||+|+.||++. ++|||||...|+||+...
T Consensus 763 v~l-~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~--~fvHRDLAaRNCLL~~~r 839 (1025)
T KOG1095|consen 763 VCL-DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK--HFVHRDLAARNCLLDERR 839 (1025)
T ss_pred eec-CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC--CCcCcchhhhheeecccC
Confidence 986 688899999999999999999654 4689999999999999999999985 599999999999999999
Q ss_pred cEEEEecCCccccccC-cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHH
Q 005678 548 VAKVTDFGLSKIVEDD-VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQE 625 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~-~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e 625 (683)
.+||+|||||+.+... .... .....--..|||||.|.. ..++.++|||||||++||+++ |..||+...+.+
T Consensus 840 ~VKIaDFGlArDiy~~~yyr~----~~~a~lPvkWm~PEsl~d---~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~ 912 (1025)
T KOG1095|consen 840 VVKIADFGLARDIYDKDYYRK----HGEAMLPVKWMPPESLKD---GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE 912 (1025)
T ss_pred cEEEcccchhHhhhhchheec----cCccccceecCCHHHHhh---cccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence 9999999999944332 1111 001111246999999975 449999999999999999998 999999888766
Q ss_pred HHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 626 RILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 626 ~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.+.. ..... .++.++.|+..+.+++..||..+|++||++..|++
T Consensus 913 v~~~---~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 913 VLLD---VLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHH---HHhCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 5431 12222 66777889999999999999999999999999985
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.80 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=195.1
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEe
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLE 488 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~E 488 (683)
+.||.|+||.||+|.+.. +..||+|++...... .....+..|+.+++.+.||||+++++++. +...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP------DLKRKFLQEAEILKQYDHPNIVKLIGVCV-QKQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH------HHHHHHHHHHHHHHhCCCCCeEEEEEEEe-cCCCeEEEEE
Confidence 368999999999999877 999999987554321 23457889999999999999999999886 6778999999
Q ss_pred cccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCC
Q 005678 489 YCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567 (683)
Q Consensus 489 y~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~ 567 (683)
|+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.........
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 149 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT- 149 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcce-
Confidence 9999999999954 456889999999999999999999855 999999999999999999999999999765422110
Q ss_pred cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcC
Q 005678 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPA 646 (683)
Q Consensus 568 ~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~ 646 (683)
.......++..|+|||.+... .++.++|||||||++|+|++ |..||.......... .+. .....+.+..
T Consensus 150 --~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~---~~~--~~~~~~~~~~ 219 (251)
T cd05041 150 --VSDGLKQIPIKWTAPEALNYG---RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE---RIE--SGYRMPAPQL 219 (251)
T ss_pred --eccccCcceeccCChHhhccC---CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH---HHh--cCCCCCCCcc
Confidence 001112345679999988643 37899999999999999998 889997655432111 111 1123333456
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 647 VSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 647 ~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
++..+.+||.+||..+|.+||++.++++
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 8899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.11 Aligned_cols=238 Identities=22% Similarity=0.359 Sum_probs=188.7
Q ss_pred EEecccCceEEEEEEEccCC----------eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 409 NLLGKGGFSEVYKAYDLVEH----------RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g----------~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
+.||+|+||.||+|.+..++ ..|++|++..... ....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--------DSLAFFETASLMSQLSHKHLVKLYGVCVR 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--------hHHHHHHHHHHHHcCCCcchhheeeEEec
Confidence 36899999999999987776 3588887643211 14578889999999999999999998864
Q ss_pred CCceEEEEEecccCCChhHHHhcCC-CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-------cEE
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-------VAK 550 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~-~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-------~vK 550 (683)
...++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++ .+|
T Consensus 73 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 73 --DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred --CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEE
Confidence 66789999999999999997655 7899999999999999999999855 99999999999999877 799
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILR 629 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~ 629 (683)
|+|||++...... ....++..|+|||++.... ..++.++|||||||++|+|++ |..||..........
T Consensus 149 l~Dfg~a~~~~~~---------~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~- 217 (259)
T cd05037 149 LSDPGIPITVLSR---------EERVERIPWIAPECIRNGQ-ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER- 217 (259)
T ss_pred eCCCCcccccccc---------cccccCCCccChhhhcCCC-CCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-
Confidence 9999999865431 1235677899999986542 347899999999999999999 688886654322111
Q ss_pred HHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 630 ~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
... .....+ ......+.+||.+||..+|.+||++.++++.
T Consensus 218 --~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 218 --FYQ--DQHRLP--MPDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred --HHh--cCCCCC--CCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 111 111112 1233789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=351.71 Aligned_cols=260 Identities=30% Similarity=0.503 Sum_probs=203.0
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc----
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI---- 478 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~---- 478 (683)
..|+.+.+||+||||.||+++++-+|++||||.+.... .......+.+|+..+.+|+|||||++|..|..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA------SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 35677889999999999999999999999999987653 22335678999999999999999998855510
Q ss_pred -------------------------------------------------------------------------CC-----
Q 005678 479 -------------------------------------------------------------------------DQ----- 480 (683)
Q Consensus 479 -------------------------------------------------------------------------d~----- 480 (683)
++
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence 00
Q ss_pred ------------------------------------ceEEEEEecccCCChhHHHhcCCCc-chHHHHHHHHHHHHHHHH
Q 005678 481 ------------------------------------NTFCTVLEYCSGKDLDAVLKATPVL-PEREARIIIVQIFQGLIY 523 (683)
Q Consensus 481 ------------------------------------~~~~LV~Ey~~ggsL~~~L~~~~~L-se~~~~~I~~qIa~aL~y 523 (683)
..+||-||||+..+|.+++..+... ....++.++++|+.||.|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 2478899999998888888777644 467789999999999999
Q ss_pred HHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc---cC----c------CCCcccccccCCCCCccCCccccccc
Q 005678 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE---DD----V------GSQGMELTSQGAGTYWYLPPECFELS 590 (683)
Q Consensus 524 LH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~---~~----~------~~~~~~l~~~~~GT~~Y~APE~~~~~ 590 (683)
+|+.| ||||||||.||||++++.|||+|||+++... .. . ......-....+||..|+|||.+...
T Consensus 713 IH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 713 IHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99976 9999999999999999999999999998722 00 0 00111112345899999999999766
Q ss_pred CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCC-----cCCCHHHHHHHHHhcccCCCC
Q 005678 591 KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR-----PAVSNEAKDLIRRCLTYNQAE 665 (683)
Q Consensus 591 ~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~-----~~~s~el~dLI~rCL~~dP~k 665 (683)
....|+.|+|+||||||||||++ ||+... +++.. +...+...+|.+ +..+ .-..+|+.||..||.+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~i---L~~LR~g~iP~~~~f~~~~~~-~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASI---LTNLRKGSIPEPADFFDPEHP-EEASLIRWLLSHDPSK 861 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHH---HHhcccCCCCCCcccccccch-HHHHHHHHHhcCCCcc
Confidence 55569999999999999999995 776544 33322 223334444433 2233 4568999999999999
Q ss_pred CCCHHHHhcCcccC
Q 005678 666 RPDVLTLAQDPYLT 679 (683)
Q Consensus 666 RPS~~eLl~hP~l~ 679 (683)
|||+.+||++.||.
T Consensus 862 RPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 862 RPTATELLNSELLP 875 (1351)
T ss_pred CCCHHHHhhccCCC
Confidence 99999999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=330.17 Aligned_cols=249 Identities=31% Similarity=0.463 Sum_probs=209.2
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEe
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLE 488 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~E 488 (683)
+.||.|.||+||-|..+.+|+.||||++.+-.-.... ...+..|+.||..+.||.||.|-..|+ ..+..++|||
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-----esqlR~EVaILq~l~HPGiV~le~M~E-T~ervFVVME 643 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-----ESQLRNEVAILQNLHHPGIVNLECMFE-TPERVFVVME 643 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch-----HHHHHHHHHHHHhcCCCCeeEEEEeec-CCceEEEEeh
Confidence 6899999999999999999999999998654332221 246788999999999999999998886 6778889999
Q ss_pred cccCCChhHHH-hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---CCcEEEEecCCccccccCc
Q 005678 489 YCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---FGVAKVTDFGLSKIVEDDV 564 (683)
Q Consensus 489 y~~ggsL~~~L-~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~g~vKL~DFGls~~~~~~~ 564 (683)
-+.|.-|.-+| .+.+.|+++....++.||+.||.|||-. +|+|+||||+||||.+ .-.+||||||+++++....
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k--nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK--NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc--ceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 99554444444 4557899999999999999999999985 5999999999999974 4479999999999997653
Q ss_pred CCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC-
Q 005678 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS- 643 (683)
Q Consensus 565 ~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~- 643 (683)
+....+|||.|+|||++...+ |...-|+||+|||+|--|.|..||....+.. ..+++..+-+|.
T Consensus 722 ------FRrsVVGTPAYLaPEVLrnkG---yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn------dQIQNAaFMyPp~ 786 (888)
T KOG4236|consen 722 ------FRRSVVGTPAYLAPEVLRNKG---YNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN------DQIQNAAFMYPPN 786 (888)
T ss_pred ------hhhhhcCCccccCHHHHhhcc---ccccccceeeeEEEEEEecccccCCCccchh------HHhhccccccCCC
Confidence 344559999999999998665 8889999999999999999999997665432 224445555664
Q ss_pred -CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 644 -RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 644 -~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
|..++.++.+||..+|...-.+|.++...+.|||++.
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 4589999999999999999999999999999999985
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.50 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=195.8
Q ss_pred eeEEEEecccCceEEEEEEEcc---CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC-
Q 005678 405 YALLNLLGKGGFSEVYKAYDLV---EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ- 480 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~---~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~- 480 (683)
|.+.+.||+|+||.||+|.+.. ++..||||++....... .....+.+|+.+++.+.||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-----SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-----HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCC
Confidence 5677899999999999998543 57899999886543221 22456888999999999999999999875322
Q ss_pred ----ceEEEEEecccCCChhHHHhcC------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 481 ----NTFCTVLEYCSGKDLDAVLKAT------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 481 ----~~~~LV~Ey~~ggsL~~~L~~~------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
...+++++|+.+++|..++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEE
Confidence 1347889999999999887321 24788999999999999999999865 99999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILR 629 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~ 629 (683)
|+|||+++....... ........+++.|++||.+.... ++.++|||||||++|+|++ |.+||......+ +..
T Consensus 154 l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~---~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-~~~ 226 (273)
T cd05074 154 VADFGLSKKIYSGDY---YRQGCASKLPVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYN 226 (273)
T ss_pred ECcccccccccCCcc---eecCCCccCchhhcCHhHHhcCc---cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-HHH
Confidence 999999986643211 11122334567899999876443 7889999999999999999 899997655432 211
Q ss_pred HHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 630 ~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.+.... .....+.++..+.+++.+||..+|.+||++.+++..
T Consensus 227 --~~~~~~--~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 227 --YLIKGN--RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --HHHcCC--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112222 222335688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.21 Aligned_cols=249 Identities=18% Similarity=0.260 Sum_probs=186.9
Q ss_pred EecccCceEEEEEEEccC--CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEE
Q 005678 410 LLGKGGFSEVYKAYDLVE--HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~--g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
.||+|+||.||+|..... ...+++|.+..... ......+.+|+.++..++||||+++++.|. +...+|+||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS------SKEQNEFLQQGDPYRILQHPNILQCLGQCV-EAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC------hHHHHHHHHHHHHHhccCCcchhheEEEec-CCCccEEEE
Confidence 589999999999964333 34566776544321 122457889999999999999999999986 677889999
Q ss_pred ecccCCChhHHHhcC----CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 488 EYCSGKDLDAVLKAT----PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~----~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcc
Confidence 999999999999643 34667778899999999999999865 999999999999999999999999998643221
Q ss_pred cCCCcccccccCCCCCccCCcccccccC----CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSK----TPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~----~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
. .........|++.|+|||++.... ...++.++|||||||++|+|++ |..||......+.+.. +.....
T Consensus 153 ~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---~~~~~~ 226 (268)
T cd05086 153 D---YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH---VIKDQQ 226 (268)
T ss_pred h---hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHhhcc
Confidence 1 011122346889999999875321 1235789999999999999996 5778866554432221 122222
Q ss_pred cCCC---CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 639 VEFP---SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 639 ~~~p---~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...+ ....+++.+.+++..|| .+|.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 227 VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 2211 12357889999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.24 Aligned_cols=264 Identities=25% Similarity=0.429 Sum_probs=202.5
Q ss_pred ceeEEEEecccCceEEEEEEEccCC----eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g----~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.|.++..||+|.||.||+|.-..++ ..+|||.+.-..... ..-..++||+..++.++||||+.|..+|-..
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-----GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-----GISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-----CcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 5888999999999999999654443 268999875543211 1234689999999999999999999999765
Q ss_pred CceEEEEEecccCCChhHHHhcC-----CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC----CcEE
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKAT-----PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF----GVAK 550 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~-----~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~----g~vK 550 (683)
...+++++||.+ .+|..+|+-+ ..++...++.|+.||+.|+.|||+ +-|+||||||.|||+..+ |.||
T Consensus 100 d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 100 DKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred CceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCeeE
Confidence 788999999995 4999988433 468999999999999999999998 569999999999999876 8999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch-------
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT------- 623 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~------- 623 (683)
|+|||+++.+.+... .+.-....+.|.||.|||.+.+.+ .|+..+|||++|||+.|||+-.+.|.+...
T Consensus 177 IaDlGlaR~~~~plk--pl~s~d~VVVTiWYRAPELLLGa~--hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~P 252 (438)
T KOG0666|consen 177 IADLGLARLFNNPLK--PLASLDPVVVTIWYRAPELLLGAR--HYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNP 252 (438)
T ss_pred eecccHHHHhhcccc--ccccCCceEEEEEecChHHhcccc--cccchhhhHHHHHHHHHHHccCccccchhhhcccCCC
Confidence 999999998865421 111223447899999999987554 499999999999999999998777643211
Q ss_pred -----HHHHHHHHHHH-HhhccCCCC------------------------------CcCCCHHHHHHHHHhcccCCCCCC
Q 005678 624 -----QERILREDTII-KARKVEFPS------------------------------RPAVSNEAKDLIRRCLTYNQAERP 667 (683)
Q Consensus 624 -----~e~il~~~~i~-~~~~~~~p~------------------------------~~~~s~el~dLI~rCL~~dP~kRP 667 (683)
.++|+. +. ....-.||+ ...-++.+.+|+.++|++||.+|.
T Consensus 253 fq~dQl~rIf~---vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI 329 (438)
T KOG0666|consen 253 FQHDQLDRIFE---VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI 329 (438)
T ss_pred chHHHHHHHHH---HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc
Confidence 111111 00 000001111 012345588999999999999999
Q ss_pred CHHHHhcCcccCCCC
Q 005678 668 DVLTLAQDPYLTYSK 682 (683)
Q Consensus 668 S~~eLl~hP~l~~~K 682 (683)
|+.++++|+||+..+
T Consensus 330 ta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 330 TAEQALEHPYFTEDP 344 (438)
T ss_pred cHHHHhcccccccCC
Confidence 999999999998764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=285.26 Aligned_cols=261 Identities=29% Similarity=0.517 Sum_probs=211.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|..++.||+|.||+||+|.+..++..||+|....+... +..-..++||+-+++.++|.|||+++++.- ..+.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-----egvpssalreicllkelkhknivrl~dvlh-sdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-----EGVPSSALREICLLKELKHKNIVRLHDVLH-SDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-----CCCcHHHHHHHHHHHHhhhcceeehhhhhc-cCcee
Confidence 466678899999999999999999999999998765432 222456899999999999999999999984 67788
Q ss_pred EEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
.+|+||| ..+|..++. -++.+....++.++.|++.||.|+|++ ++.||||||.|+||+.+|.+||+|||+++.+.-
T Consensus 77 tlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh--nvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 77 TLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH--NVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred EEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh--hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9999999 458888884 457799999999999999999999984 599999999999999999999999999987643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH-hhccC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK-ARKVE 640 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~-~~~~~ 640 (683)
. +.-.+.-+.|.||.||.++.+.+ -|+...|+||.|||+.|+.. |++.|...+..+.+...-.... ...-.
T Consensus 154 p-----vrcysaevvtlwyrppdvlfgak--ly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 154 P-----VRCYSAEVVTLWYRPPDVLFGAK--LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred c-----eEeeeceeeeeeccCcceeeeee--hhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 2 23344557899999999987654 48999999999999999996 7888877776665544322221 11122
Q ss_pred CCCC----------------------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 641 FPSR----------------------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 641 ~p~~----------------------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
||.. |.++....++++++|.-+|..|.+++.+++||||.-
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 3221 334455789999999999999999999999999974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=332.80 Aligned_cols=268 Identities=24% Similarity=0.429 Sum_probs=224.2
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeec
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLW 473 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~ 473 (683)
|..++.-.+.|.+.+.||.|.+|.||++..+.+++.+|+||...+.... .++..|++|++.+ .|||++.+|
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--------eEiE~eynil~~~~~hpnv~~fy 82 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--------EEIELEYNMLKKYSHHPNVATFY 82 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--------HHHHHHHHHHHhccCCCCcceEE
Confidence 3445566788999999999999999999999999999999986654322 2445688999888 599999999
Q ss_pred ccccc----CCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC
Q 005678 474 DTFEI----DQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 474 ~~f~~----d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g 547 (683)
++|.. .++.++||||||.||+.-++++. +..+.|..+..|+..++.||.+||. +.+||||||-.|||++.+|
T Consensus 83 g~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~ 160 (953)
T KOG0587|consen 83 GAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENA 160 (953)
T ss_pred EEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccC
Confidence 99853 46789999999999999999964 4578899999999999999999998 4599999999999999999
Q ss_pred cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHH
Q 005678 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE 625 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e 625 (683)
.|||+|||++..+....+. ..+.+|||.|||||++.... ...|+..+|+||||++..||.-|.+|+.+.....
T Consensus 161 ~VKLvDFGvSaQldsT~gr-----RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLDSTVGR-----RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred cEEEeeeeeeeeeeccccc-----ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 9999999999888765433 44568999999999997655 3467889999999999999999999998887765
Q ss_pred HHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 626 RILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 626 ~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.++. |..+.++.+-.+...+..+.+||..||..|...||++.++++|||++-
T Consensus 236 aLF~---IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 236 ALFL---IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred hhcc---CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 5432 222333333334567899999999999999999999999999999973
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.93 Aligned_cols=256 Identities=25% Similarity=0.461 Sum_probs=209.7
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEcc----CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceee
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLV----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVR 471 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~----~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~ 471 (683)
.++.+......+.++||.|.||.||+|.... ..-.||||..+.+.. ++. .+.|+.|..+|+.++|||||+
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~-----tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDD-----TEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhh-----HHHHHHHHHHHHhCCCcchhh
Confidence 3556666677777899999999999997532 234589998765432 222 457899999999999999999
Q ss_pred eccccccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 472 L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
|+|+|. ....+||||+++-|.|..+|+.+ ..|+......++.||+.||.|||+. ++|||||-..|||+.+.-.+|
T Consensus 456 LIGv~~--e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk--rfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 456 LIGVCV--EQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK--RFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred eeeeee--ccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh--chhhhhhhhhheeecCcceee
Confidence 999996 56788999999999999999654 5699999999999999999999985 599999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILR 629 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~ 629 (683)
|+|||+++.+.++. +...+.+.-..-|||||.+.... ++..+|||.|||++||+|. |..||....+.+.|..
T Consensus 532 LaDFGLSR~~ed~~----yYkaS~~kLPIKWmaPESINfRr---FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~ 604 (974)
T KOG4257|consen 532 LADFGLSRYLEDDA----YYKASRGKLPIKWMAPESINFRR---FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH 604 (974)
T ss_pred ecccchhhhccccc----hhhccccccceeecCccccchhc---ccchhhHHHHHHHHHHHHHhcCCccccccccceEEE
Confidence 99999999987652 12222333345699999987555 8999999999999999985 9999987776655432
Q ss_pred HHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 630 ~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
. ...-..|.++.||+.+..|+.+||.++|.+||.+.+|.
T Consensus 605 i-----EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 605 I-----ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred e-----cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 1 12345677789999999999999999999999988874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=324.63 Aligned_cols=245 Identities=28% Similarity=0.442 Sum_probs=203.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
+.+.|.+...+|.|+||.|-.+.+..++..+++|++..... ...+|+.++... .||||++++++|. +
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----------~~~~e~~~~~~~~~h~niv~~~~v~~-~ 387 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----------DNQDEIPISLLVRDHPNIVKSHDVYE-D 387 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-----------ccccccchhhhhcCCCcceeecceec-C
Confidence 35678888899999999999999999999999999865421 122356555555 7999999999996 7
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe-CCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF-DEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL-d~~g~vKL~DFGls~ 558 (683)
+.+.++|||++.|+-|.+.+...+.+. .++..|+.+|+.|+.|||..| ||||||||+|||+ ++.|+++|+|||.++
T Consensus 388 ~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 388 GKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred CceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhh
Confidence 889999999999998888887766555 788889999999999999965 9999999999999 589999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
....+ ...++-|..|.|||+.... .|+..+||||||++||+||+|+.||........++. ....
T Consensus 465 ~~~~~--------~~tp~~t~~y~APEvl~~~---~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-----~i~~ 528 (612)
T KOG0603|consen 465 ELERS--------CDTPALTLQYVAPEVLAIQ---EYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-----RIQM 528 (612)
T ss_pred hCchh--------hcccchhhcccChhhhccC---CCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-----hhcC
Confidence 77654 2234678889999998733 499999999999999999999999977666533321 1122
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..|. ..+|..+++||..||..||.+||++.++..||||
T Consensus 529 ~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 529 PKFS--ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred Cccc--cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 2222 5799999999999999999999999999999999
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=282.30 Aligned_cols=243 Identities=38% Similarity=0.574 Sum_probs=199.3
Q ss_pred CceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecccCCC
Q 005678 415 GFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKD 494 (683)
Q Consensus 415 gfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~~ggs 494 (683)
+||.||+|.+..++..|++|++........ ...+.+|+.+++.++|+||+++++.+. .....++++||+++++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK------RERILREISILKKLKHPNIVRLYDVFE-DEDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH------HHHHHHHHHHHHhCCCCcHHHHHhhee-eCCEEEEEEeCCCCCC
Confidence 689999999888899999999865432211 467889999999999999999999986 5678899999999999
Q ss_pred hhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCccccccc
Q 005678 495 LDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574 (683)
Q Consensus 495 L~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~ 574 (683)
|..++.....+++..+..++.+++.+|.|||..+ |+|+||+|.||+++.++.++|+|||++....... ....
T Consensus 74 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~ 145 (244)
T smart00220 74 LFDLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------LLTT 145 (244)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc------cccc
Confidence 9999977666899999999999999999999965 9999999999999999999999999998776432 1233
Q ss_pred CCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCC-cCCCHHHHH
Q 005678 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR-PAVSNEAKD 653 (683)
Q Consensus 575 ~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~-~~~s~el~d 653 (683)
..|++.|++||.+... .++.++||||||+++|+|++|..||........+... ........... ..++..+.+
T Consensus 146 ~~~~~~~~~pE~~~~~---~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 219 (244)
T smart00220 146 FVGTPEYMAPEVLLGK---GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKK---IGKPKPPFPPPEWKISPEAKD 219 (244)
T ss_pred ccCCcCCCCHHHHccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HhccCCCCccccccCCHHHHH
Confidence 4688999999988633 3788999999999999999999999774443333221 11111111111 128899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 005678 654 LIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 654 LI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
|+.+||..+|.+||++.++++||||
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHccCCchhccCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.76 Aligned_cols=248 Identities=31% Similarity=0.451 Sum_probs=192.1
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC---
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID--- 479 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d--- 479 (683)
.-|...+.||+||||.||+|+++.+|+.||||.+...... .......+|++++++|+|||||+++++-+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~------r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL------RPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc------chHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 3456678899999999999999999999999998665422 1245788999999999999999999885432
Q ss_pred --CceEEEEEecccCCChhHHHhc---CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC--CCC--cEE
Q 005678 480 --QNTFCTVLEYCSGKDLDAVLKA---TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD--EFG--VAK 550 (683)
Q Consensus 480 --~~~~~LV~Ey~~ggsL~~~L~~---~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd--~~g--~vK 550 (683)
....++|||||.||||..+|.. ...|++.+.+.++..++.||.|||+. +||||||||.||++- .+| ..|
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn--~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN--GIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc--CceeccCCCCcEEEeecCCCceEEe
Confidence 2346799999999999999953 35699999999999999999999985 599999999999985 334 489
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHH----H
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE----R 626 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e----~ 626 (683)
|+|||.|+-++++. .....+||+.|++||.+.. ...|+.-+|.|||||++|++.||..||-+..... .
T Consensus 165 LtDfG~Arel~d~s------~~~S~vGT~~YLhPel~E~--q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~ 236 (732)
T KOG4250|consen 165 LTDFGAARELDDNS------LFTSLVGTEEYLHPELYER--QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI 236 (732)
T ss_pred eecccccccCCCCC------eeeeecCchhhcChHHHhh--ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh
Confidence 99999999887653 3444589999999999874 2348889999999999999999999996554432 2
Q ss_pred HHHHHHHHHh------------hcc----CCCCCcCCCHH----HHHHHHHhcccCCCCCC
Q 005678 627 ILREDTIIKA------------RKV----EFPSRPAVSNE----AKDLIRRCLTYNQAERP 667 (683)
Q Consensus 627 il~~~~i~~~------------~~~----~~p~~~~~s~e----l~dLI~rCL~~dP~kRP 667 (683)
.+...+ .+. +++ .+|.+..++.. +-..+..+|..+|.+|.
T Consensus 237 ~~~~~t-kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 237 MWHIIT-KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred hhhhhc-cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 222111 011 111 23333344443 34667788899999998
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=321.54 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=218.4
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
+.++..||-||||.|=++........+|+|+++..... +.....|+..|-+||..++.|.||+||..|. +..++|
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV----dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr-d~kyvY 496 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV----DTKQQEHVFSERNIMMECRSDFIVRLYRTFR-DSKYVY 496 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc----chhHHHHHHhHHHHHHhcCchHHHHHHHHhc-cchhhh
Confidence 45667899999999999865555556899987654332 2334578999999999999999999999997 788999
Q ss_pred EEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCc
Q 005678 485 TVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~ 564 (683)
++||-|-||.|+..|...+.|.+..++.++..++.|+.|||.++ ||+|||||.|.||+.+|.+||.|||+|+.+...
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 99999999999999999999999999999999999999999966 999999999999999999999999999988754
Q ss_pred CCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCC
Q 005678 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644 (683)
Q Consensus 565 ~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~ 644 (683)
..+.+.+|||.|.|||++...+ .+..+|.||||+++||||+|.+||...+....+-. .+.....+.||
T Consensus 574 -----~KTwTFcGTpEYVAPEIILnKG---HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~--ILkGid~i~~P-- 641 (732)
T KOG0614|consen 574 -----RKTWTFCGTPEYVAPEIILNKG---HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL--ILKGIDKIEFP-- 641 (732)
T ss_pred -----CceeeecCCcccccchhhhccC---cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH--HHhhhhhhhcc--
Confidence 3466779999999999987555 78999999999999999999999988776554321 12223345666
Q ss_pred cCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q 005678 645 PAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTY 680 (683)
Q Consensus 645 ~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~ 680 (683)
..++..+.+||++++..+|.+|.- +.+|-+|-||..
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 578999999999999999999985 899999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.34 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=204.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhh-cCCCceeeeccccccCC
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT-LVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~-L~HpnIV~L~~~f~~d~ 480 (683)
.+..+-+..||.|+||+|++..++.+|+..|||.+..+.. .+. .+.++.|.....+ -+.||||++||+.. ..
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~ke---q~rll~e~d~~mks~~cp~IVkfyGa~F-~E 135 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKE---QKRLLMEHDTVMKSSNCPNIVKFYGALF-SE 135 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHH---HHHHHHHHHHHHhhcCCcHHHHHhhhhh-cC
Confidence 3444556789999999999999999999999999876643 111 3456667665544 47999999999986 45
Q ss_pred ceEEEEEecccCCChhHHHh-----cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 NTFCTVLEYCSGKDLDAVLK-----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~-----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
+..+|.||+| ..+|+.+.+ ....+++..+..|....+.||.||-.. .+||||||||+||||+..|.+||||||
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeeccc
Confidence 5677999999 568776653 335699999999999999999999875 579999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+|..+.+.... +.-+|...|||||.+..... .|+-++||||||++|||+.||+.||..-.+....+. .+..
T Consensus 214 IcGqLv~SiAk------T~daGCrpYmAPERi~p~~~-gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~--~Vv~ 284 (361)
T KOG1006|consen 214 ICGQLVDSIAK------TVDAGCRPYMAPERIDPSDK-GYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC--QVVI 284 (361)
T ss_pred chHhHHHHHHh------hhccCCccccChhccCCccC-CcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH--HHHc
Confidence 99877654322 22378889999999976554 489999999999999999999999966544322222 2222
Q ss_pred hhc--cCCCC-CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARK--VEFPS-RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~--~~~p~-~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
... +.++. ...++..+..||.-||.+|..+||.+.+|.++||++.
T Consensus 285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 221 12222 2357899999999999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=330.71 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=215.6
Q ss_pred cccceeEEEEecccCceEEEEEEEccCC---eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEH---RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g---~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
......+.++||.|.||+||+|..+..| ..||||.++... . +.....|+.|..||.++.||||++|.|+..
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--t----ekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--T----EKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--c----HHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 3445678899999999999999877665 469999885432 1 123578999999999999999999999985
Q ss_pred cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
......||+|||++|+|+.+|+.+ +.|+.-++.-+++.|+.|++||.+.+ +|||||-..|||++.+..+|++||||
T Consensus 701 -ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 701 -KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred -cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccc
Confidence 667788999999999999999644 67999999999999999999999865 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH-cCCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL-tG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++.+.++. ....-+..+.--.+|.|||.+...+ ++..+|||||||+|||.+ +|.+||....+++.+-. .
T Consensus 778 SRvledd~--~~~ytt~GGKIPiRWTAPEAIa~RK---FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-----I 847 (996)
T KOG0196|consen 778 SRVLEDDP--EAAYTTLGGKIPIRWTAPEAIAYRK---FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-----I 847 (996)
T ss_pred eeecccCC--CccccccCCccceeecChhHhhhcc---cCchhhccccceEEEEecccCCCcccccchHHHHHH-----H
Confidence 99886654 1112222223346799999998777 999999999999999988 59999999988876643 2
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...+.+|.+..||..+..|+..||.++...||.+.+|+.
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 356788999999999999999999999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=309.20 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=210.5
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC--C----c
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH--H----H 468 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H--p----n 468 (683)
|..-.++.++|.++.++|+|.||.|-.+.|..++.+||||+++. ...|...++-|+.++.++.+ | .
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~--------V~kYreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN--------VDKYREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH--------HHHHhhHHHHHHHHHHHHHhcCCCCceE
Confidence 33445678999999999999999999999999999999998732 23455667789999999942 2 4
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE- 545 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~- 545 (683)
+|.+.++|+ -.++.|||+|.+ |.++.++|+.+ .+++...++.|+.|++.+++|||+.+ ++|-||||+|||+.+
T Consensus 153 cv~m~~wFd-yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss 228 (415)
T KOG0671|consen 153 CVQMRDWFD-YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSS 228 (415)
T ss_pred EEeeehhhh-ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEecc
Confidence 788888887 578899999999 77999999765 46889999999999999999999955 999999999999831
Q ss_pred -------------------CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHH
Q 005678 546 -------------------FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGI 606 (683)
Q Consensus 546 -------------------~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGv 606 (683)
+..++|+|||.|...... .+..+.|..|.|||++.+.+ ++.++||||+||
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--------hs~iVsTRHYRAPEViLgLG---wS~pCDvWSiGC 297 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--------HSTIVSTRHYRAPEVILGLG---WSQPCDVWSIGC 297 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccC--------cceeeeccccCCchheeccC---cCCccCceeeee
Confidence 345999999999876543 23447899999999999877 999999999999
Q ss_pred HHHHHHcCCCCCCCCchHHHHHHHHH-----------------HHHhhccCCCCC--------------------cCC--
Q 005678 607 LFYQMLFGRRPFGHDQTQERILREDT-----------------IIKARKVEFPSR--------------------PAV-- 647 (683)
Q Consensus 607 ILyELLtG~~PF~~~~~~e~il~~~~-----------------i~~~~~~~~p~~--------------------~~~-- 647 (683)
||+|+.+|...|....+.+.+.--.. ......+.||.. ...
T Consensus 298 IL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~ 377 (415)
T KOG0671|consen 298 ILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDL 377 (415)
T ss_pred EEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcH
Confidence 99999999999976665443311001 111112222211 000
Q ss_pred -CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 648 -SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 648 -s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
-..+.+||++||.+||.+|+|+.+++.||||...+
T Consensus 378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 378 EHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 12478999999999999999999999999998654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=317.99 Aligned_cols=258 Identities=23% Similarity=0.366 Sum_probs=207.1
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
...+..+.+.||+|-||+|.+|. ...+..||||+++..... .....|.+|+.+|.+|+|||||.|+++|. .+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~------~~r~~F~kEIkiLsqLkhPNIveLvGVC~-~D 607 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATK------NARNDFLKEIKILSRLKHPNIVELLGVCV-QD 607 (807)
T ss_pred chhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccch------hHHHHHHHHHHHHhccCCCCeeEEEeeee-cC
Confidence 45677888999999999999997 455799999998765432 22468999999999999999999999996 56
Q ss_pred ceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+|+|+|||++|+|..++.++ +.+.-.....|+.||++|++||.+ .++|||||.+.|+|++.++++||+|||+++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCccccc
Confidence 6899999999999999999877 333445566799999999999998 469999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH--cCCCCCCCCchHHHHHHHHHHHHh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML--FGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL--tG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
-+..... .......+-..+|||||++..++ ++.++|||+|||++||++ |...||....+.+.+.....+...
T Consensus 686 ~lysg~y---y~vqgr~vlpiRwmawEsillgk---FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~ 759 (807)
T KOG1094|consen 686 NLYSGDY---YRVQGRAVLPIRWMAWESILLGK---FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRD 759 (807)
T ss_pred ccccCCc---eeeecceeeeeeehhHHHHHhcc---ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCC
Confidence 6654321 11111123456799999998777 999999999999999987 588999877665544443333322
Q ss_pred h--ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 637 R--KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 637 ~--~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
. .+-.+.++.|+..+.++|.+||.++-++||+++++..
T Consensus 760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 2 2233445689999999999999999999999999854
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=328.92 Aligned_cols=264 Identities=19% Similarity=0.249 Sum_probs=176.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccC----CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVE----HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~----g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
..+.|.+.+.||+|+||.||+|.+..+ +..||||.+..... . .....+ .+....+.+++.++..|
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~------e~~~~e--~l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---V------EIWMNE--RVRRACPNSCADFVYGF 198 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---h------HHHHHH--HHHhhchhhHHHHHHhh
Confidence 457899999999999999999999888 89999998643211 0 011111 11122223333333222
Q ss_pred c-----cCCceEEEEEecccCCChhHHHhcCCC--------------------cchHHHHHHHHHHHHHHHHHHhcCCce
Q 005678 477 E-----IDQNTFCTVLEYCSGKDLDAVLKATPV--------------------LPEREARIIIVQIFQGLIYLNKRAQKI 531 (683)
Q Consensus 477 ~-----~d~~~~~LV~Ey~~ggsL~~~L~~~~~--------------------Lse~~~~~I~~qIa~aL~yLH~~g~~I 531 (683)
. .....+++||||+++++|.+++..... .....+..|+.||+.||.|||+.+ |
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--I 276 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--I 276 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--E
Confidence 1 245678999999999999999864321 123346679999999999999865 9
Q ss_pred EecccCCcceEeCC-CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCC-----------------
Q 005678 532 IHYDLKPGNVLFDE-FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTP----------------- 593 (683)
Q Consensus 532 IHrDLKP~NILLd~-~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~----------------- 593 (683)
|||||||+||||+. ++.+||+|||+++.+..... .......||+.|+|||.+......
T Consensus 277 iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~ 352 (566)
T PLN03225 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 352 (566)
T ss_pred EeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhc
Confidence 99999999999985 68999999999986543211 123345789999999976432211
Q ss_pred --CCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHHH-----HHHHHhhccCC--------CCCcCCCHHHHHHHHH
Q 005678 594 --LISSKVDVWSAGILFYQMLFGRRPFGHDQTQER-ILRE-----DTIIKARKVEF--------PSRPAVSNEAKDLIRR 657 (683)
Q Consensus 594 --~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~-il~~-----~~i~~~~~~~~--------p~~~~~s~el~dLI~r 657 (683)
.++.++|||||||+||||+++..|+........ .+.. ........... ......+..+.+||.+
T Consensus 353 ~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 353 QLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred cccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 244567999999999999998776543211100 0000 00000000000 0001123346689999
Q ss_pred hcccCCCCCCCHHHHhcCcccCCC
Q 005678 658 CLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 658 CL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
||.+||.+|||+.++++||||+..
T Consensus 433 mL~~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 433 MMRFKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred HccCCcccCCCHHHHhCCcCcCCC
Confidence 999999999999999999999753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=298.55 Aligned_cols=274 Identities=26% Similarity=0.434 Sum_probs=215.8
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
..|-.....|.-+.+||+|.||+||+|+...+|+.||+|+.-. ++.+..+-..+++|+.||..|+|+|++.++..
T Consensus 10 ~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlm-----eneKeGfpitalreikiL~~lkHenv~nliEi 84 (376)
T KOG0669|consen 10 EPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLM-----ENEKEGFPITALREIKILQLLKHENVVNLIEI 84 (376)
T ss_pred CCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHH-----hccccCCcHHHHHHHHHHHHhcchhHHHHHHH
Confidence 3444566788889999999999999999999999999986422 22233445678999999999999999999988
Q ss_pred ccc-------CCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC
Q 005678 476 FEI-------DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 476 f~~-------d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g 547 (683)
|.. +...+|+|+.+|+ .+|..+|... -.++..++..++.++..||.|+|.. .|+|||+||.|+||+.+|
T Consensus 85 c~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~--kilHRDmKaaNvLIt~dg 161 (376)
T KOG0669|consen 85 CRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN--KILHRDMKAANVLITKDG 161 (376)
T ss_pred HhhccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh--hHHhhcccHhhEEEcCCc
Confidence 753 3456999999995 5999998654 5699999999999999999999984 599999999999999999
Q ss_pred cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
.+||+|||+++.+........ .-+...+.|.||.+||.+.+.. .|+++.|||..|||+.+|++|.+-|.....+..+
T Consensus 162 ilklADFGlar~fs~~~n~~k-prytnrvvTLwYrppEllLG~r--~yg~~iDiWgAgCimaeMwtrspimqgnteqqql 238 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVK-PRYTNRVVTLWYRPPELLLGDR--EYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL 238 (376)
T ss_pred eEEeeccccccceecccccCC-CCcccceeeeecCCHHHhhccc--ccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence 999999999987654422221 1133446799999999987655 4899999999999999999999999888777766
Q ss_pred HHHHHHHHhh-ccCCCCC---------------------------c-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 628 LREDTIIKAR-KVEFPSR---------------------------P-AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 628 l~~~~i~~~~-~~~~p~~---------------------------~-~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.....+-... +-.||.. | .-.+++.+|+..+|.+||.+|+++.++++|.||
T Consensus 239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 4322221111 1111110 1 113478899999999999999999999999998
Q ss_pred CC
Q 005678 679 TY 680 (683)
Q Consensus 679 ~~ 680 (683)
-.
T Consensus 319 ~k 320 (376)
T KOG0669|consen 319 WK 320 (376)
T ss_pred hc
Confidence 53
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.80 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=213.0
Q ss_pred cccceeEEEEecccCceEEEEEEEcc-C--CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLV-E--HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~-~--g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
-.+...+.++||+|+||.|++|.... . .-.||||.+....... .+..|++|+.+|-+|+|||+++|||+.-
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~------~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA------IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch------hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 34567778999999999999996543 2 3469999987654332 4678999999999999999999999985
Q ss_pred cCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
+ ....+|||++++|+|.+.|.+ ...|....+..++.||+.|+.||-.+. +|||||-..||||-..-.|||+|||
T Consensus 182 -~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 182 -D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred -c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeeccc
Confidence 3 667799999999999999965 356888889999999999999999865 9999999999999998999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
|.+.+.... ..+.+..+..--+.|+|||++...+ ++.++|||+|||+||||++ |.-||.+......+...
T Consensus 258 LmRaLg~ne--d~Yvm~p~rkvPfAWCaPEsLrh~k---FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i---- 328 (1039)
T KOG0199|consen 258 LMRALGENE--DMYVMAPQRKVPFAWCAPESLRHRK---FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI---- 328 (1039)
T ss_pred ceeccCCCC--cceEecCCCcCcccccCHhHhcccc---ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc----
Confidence 999886542 2223333444556799999998666 9999999999999999996 89999887765533221
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
. ..-.++.++.|+.++.+++..||..+|.+||++..|..+-+++.
T Consensus 329 D-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 329 D-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred c-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 1 34456667789999999999999999999999999976655543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=313.52 Aligned_cols=275 Identities=20% Similarity=0.232 Sum_probs=196.3
Q ss_pred ccccceeEEEEecccCceEEEEEEEc----------------cCCeEEEEEEeccCcccchhhH-------HHHHHHHHH
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDL----------------VEHRYVACKLHGLNAQWSEDKK-------QSYIRHAIR 456 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~----------------~~g~~VAVKi~~~~~~~~~~~~-------~~~i~~~~r 456 (683)
+..+.|.+.+.||+|+||.||+|.+. ..++.||||.+........... .........
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45778999999999999999999752 2456799998755432111000 001123455
Q ss_pred HHHHHhhcCCCce-----eeecccccc-------CCceEEEEEecccCCChhHHHhcC----------------------
Q 005678 457 EYNIHKTLVHHHI-----VRLWDTFEI-------DQNTFCTVLEYCSGKDLDAVLKAT---------------------- 502 (683)
Q Consensus 457 Ei~il~~L~HpnI-----V~L~~~f~~-------d~~~~~LV~Ey~~ggsL~~~L~~~---------------------- 502 (683)
|+.++..++|.++ +.++++|.. ..+..++||||+++++|.+++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7778888877654 566666542 245689999999999999988532
Q ss_pred --CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCc
Q 005678 503 --PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580 (683)
Q Consensus 503 --~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~ 580 (683)
..+++..++.++.|++.||.|||..+ |+||||||.|||++.++.+||+|||++..+..... .....+.+|+.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~----~~~~~g~~tp~ 375 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN----FNPLYGMLDPR 375 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCc----cCccccCCCcc
Confidence 12356678889999999999999865 99999999999999999999999999976543211 11223456899
Q ss_pred cCCcccccccCCC-------------------CCCchhHHHHHHHHHHHHHcCCC-CCCCCchHHHHH-------HHHHH
Q 005678 581 YLPPECFELSKTP-------------------LISSKVDVWSAGILFYQMLFGRR-PFGHDQTQERIL-------REDTI 633 (683)
Q Consensus 581 Y~APE~~~~~~~~-------------------~~s~ksDVWSLGvILyELLtG~~-PF~~~~~~e~il-------~~~~i 633 (683)
|+|||.+...... ....++||||+|||+|+|++|.. ||.........+ .....
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 9999987543210 01235799999999999999875 775322211111 11112
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCcccCC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQ---AERPDVLTLAQDPYLTY 680 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP---~kRPS~~eLl~hP~l~~ 680 (683)
.....+.|+....+++.+++||.+||..+| .+|+|+.++|.||||..
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 233445666667889999999999999766 68999999999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.38 Aligned_cols=267 Identities=25% Similarity=0.381 Sum_probs=215.8
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWD 474 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~ 474 (683)
..+.+--+.|.++++||+|+|..|.++....+.+.||+|+++......++ .+.-...|-.+..+. +||.+|-|+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde----didwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE----DIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcc----cchhHHhhHHHHHhccCCCeEEehhh
Confidence 34555567899999999999999999999999999999998665332221 133344455555554 7999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
+|+ ....+++|.||.+||+|..++.....||+..++.+...|+.||.|||++| ||+||||.+|||||..|++||+|+
T Consensus 319 cfq-tesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 319 CFQ-TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred hhc-ccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeeccc
Confidence 997 56678899999999999999988888999999999999999999999987 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC------chHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHD------QTQERIL 628 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~------~~~e~il 628 (683)
|+|+---.+ -..+++.+|||.|+|||.+.+.. |...+|+|+|||++|||+.|+.||... .+.+.++
T Consensus 396 gmcke~l~~-----gd~tstfcgtpnyiapeilrgee---ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl 467 (593)
T KOG0695|consen 396 GMCKEGLGP-----GDTTSTFCGTPNYIAPEILRGEE---YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL 467 (593)
T ss_pred chhhcCCCC-----CcccccccCCCcccchhhhcccc---cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence 999753221 24577889999999999998655 889999999999999999999999531 2222222
Q ss_pred HHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCcccCCC
Q 005678 629 REDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD------VLTLAQDPYLTYS 681 (683)
Q Consensus 629 ~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS------~~eLl~hP~l~~~ 681 (683)
- .++....+..|. .+|-.+..+++..|.+||.+|.. +.++-.||||+..
T Consensus 468 f--qvilekqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 468 F--QVILEKQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred H--HHHhhhcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 1 233344455553 56777888999999999999973 6788999999864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.10 Aligned_cols=256 Identities=21% Similarity=0.363 Sum_probs=208.8
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
...|++-.....+...||-|.||+||.|+.+.-.-.||||.++.+. --+.+|+.|..+|+.+.|||+|+|++
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--------MeveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------MEVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--------hhHHHHHHHHHHHHhhcCccHHHHhh
Confidence 3566776777778899999999999999988888899999875432 22678999999999999999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
+|. ....||||+|||..|+|.+||.+. ..++.-.+..++.||.+|+.||..+ ++|||||-..|+|+.++..+||+
T Consensus 331 VCT-~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk--nFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 331 VCT-HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred hhc-cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhccccccceEEee
Confidence 997 556799999999999999999654 3467777788999999999999874 59999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRED 631 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~ 631 (683)
||||++++..+.... .....-.+-|.|||.+.... ++.|+|||+|||+||||.| |-.||...+-...+ .
T Consensus 408 DFGLsRlMtgDTYTA----HAGAKFPIKWTAPEsLAyNt---FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-~-- 477 (1157)
T KOG4278|consen 408 DFGLSRLMTGDTYTA----HAGAKFPIKWTAPESLAYNT---FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-G-- 477 (1157)
T ss_pred ccchhhhhcCCceec----ccCccCcccccCcccccccc---cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-H--
Confidence 999999987653211 11111234599999887555 8999999999999999996 88899765543322 1
Q ss_pred HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 632 ~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
.....+....+..|++.+.+|++.||.++|.+||++.++-
T Consensus 478 --LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 478 --LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred --HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 1223455555678999999999999999999999988874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.10 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=207.0
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC------CCceeee
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV------HHHIVRL 472 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~------HpnIV~L 472 (683)
+++..+|.+....|+|-||+|..|.|...|..|||||+..+. ...+.=++|+.||++|+ --|+++|
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--------~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--------VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--------HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 457889999999999999999999999999999999996542 22356678999999995 3489999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcCC---CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCc
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKATP---VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGV 548 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~---~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~ 548 (683)
+-.|. ..+++|||+|.+ ..+|..+|++.+ .|....++.++.|++.||..|-..+ |+|.||||+|||+++ ...
T Consensus 500 ~r~F~-hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFK-HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhh-hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcce
Confidence 99997 688999999998 679999997664 4889999999999999999999855 999999999999996 457
Q ss_pred EEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Q 005678 549 AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628 (683)
Q Consensus 549 vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il 628 (683)
+||||||.|..+....- ..+..+..|.|||++.+.. |++..|+||+||+||||.||+..|.+..+..++-
T Consensus 576 LKLCDfGSA~~~~enei-------tPYLVSRFYRaPEIiLG~~---yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI-------TPYLVSRFYRAPEIILGLP---YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred eeeccCccccccccccc-------cHHHHHHhccCcceeecCc---ccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 99999999987654311 1113455699999998665 9999999999999999999999998877666542
Q ss_pred H---------HHHHHHhh--------ccCC---------------------C---------CCcCCC-------HHHHHH
Q 005678 629 R---------EDTIIKAR--------KVEF---------------------P---------SRPAVS-------NEAKDL 654 (683)
Q Consensus 629 ~---------~~~i~~~~--------~~~~---------------------p---------~~~~~s-------~el~dL 654 (683)
. ...+.+.. .++| | ..+.++ ..+.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 1 00000000 0000 0 001122 358899
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 655 IRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 655 I~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+..||.+||++|.++.++|.||||+.
T Consensus 726 Ldkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHhccChhhcCCHHHHhcCCcccC
Confidence 99999999999999999999999974
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=332.49 Aligned_cols=245 Identities=19% Similarity=0.261 Sum_probs=185.1
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
..|.....||+|+||.||+|.+..++..||||.+..... ....|+.++++++|||||+++++|. +.+.
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~l~~l~HpnIv~~~~~~~-~~~~ 757 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----------IPSSEIADMGKLQHPNIVKLIGLCR-SEKG 757 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----------ccHHHHHHHhhCCCCCcceEEEEEE-cCCC
Confidence 346667889999999999999989999999998753221 1123578899999999999999996 5677
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc-CCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR-AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~-g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+|||||++|+|.+++.. +++..+..|+.+|+.||.|||.. .++|+||||||+|||++.++..++. ||......
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 8999999999999999963 88999999999999999999954 3569999999999999998888876 66654332
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHH-HHh---
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE-RILREDTI-IKA--- 636 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e-~il~~~~i-~~~--- 636 (683)
.. ....||+.|+|||++.... ++.++|||||||++|||++|+.||....... .+...... ...
T Consensus 834 ~~---------~~~~~t~~y~aPE~~~~~~---~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 901 (968)
T PLN00113 834 TD---------TKCFISSAYVAPETRETKD---ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL 901 (968)
T ss_pred cC---------CCccccccccCcccccCCC---CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccch
Confidence 11 1226899999999986443 8999999999999999999999985322110 01100000 000
Q ss_pred ---hccCC----CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 637 ---RKVEF----PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 637 ---~~~~~----p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
..... +.......++.+++.+||..+|.+||++.++++.
T Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00000 1111223357789999999999999999999753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=286.74 Aligned_cols=133 Identities=35% Similarity=0.512 Sum_probs=116.7
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-----CC---ceeee
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-----HH---HIVRL 472 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-----Hp---nIV~L 472 (683)
.+.||.+.++||.|.|++||+|+|..+.++||+|+.+. .+.|.+.++.||.+|++++ |+ +||+|
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS--------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS--------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh--------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 34899999999999999999999999999999999743 2456778899999999984 33 79999
Q ss_pred cccccc---CCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe
Q 005678 473 WDTFEI---DQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF 543 (683)
Q Consensus 473 ~~~f~~---d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL 543 (683)
+|.|.+ ++.++|+|+|++ |..|..+|+. +..++...++.|++||+.||.|||.. .+|||-||||.|||+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL 221 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence 999976 467899999999 7788888853 46799999999999999999999987 369999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=270.75 Aligned_cols=258 Identities=23% Similarity=0.445 Sum_probs=204.6
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeecccccc-
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEI- 478 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~- 478 (683)
..+.|++.+.+|+|.|++||.|++..++..++||+++.-. .+.+.||+.||..|. ||||++|+++...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----------KKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----------HHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 3568999999999999999999999999999999985421 356889999999997 9999999999853
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL~DFGls 557 (683)
....+.+|+||..+.+...+ .+.|+...++.++.+++.||.|+|+.| |+|||+||.|++||. .-.++|+|+|+|
T Consensus 106 ~SktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 106 ESKTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred cccCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchH
Confidence 34568899999988877666 345889999999999999999999977 999999999999994 567999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGH-DQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~-~~~~e~il~~~~i~~~ 636 (683)
.+..... + ....+.+..|--||.+.... .|+..-|+|||||+|..|++.+-||-+ .++.+.+.....+...
T Consensus 181 EFYHp~~-----e-YnVRVASRyfKGPELLVdy~--~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt 252 (338)
T KOG0668|consen 181 EFYHPGK-----E-YNVRVASRYFKGPELLVDYQ--MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT 252 (338)
T ss_pred hhcCCCc-----e-eeeeeehhhcCCchheeech--hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence 8875431 1 22336677899999987544 488999999999999999999999843 3344444332211100
Q ss_pred h---------ccC---------------------CCCC-cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 R---------KVE---------------------FPSR-PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~---------~~~---------------------~p~~-~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
. .+. .+.. .-+++++.+|+.++|.+|-.+|||+.+++.||||...
T Consensus 253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0 000 0111 2356899999999999999999999999999999753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=312.51 Aligned_cols=243 Identities=29% Similarity=0.454 Sum_probs=191.3
Q ss_pred EEEecccCceE-EEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCceEEE
Q 005678 408 LNLLGKGGFSE-VYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNTFCT 485 (683)
Q Consensus 408 ~~~LGkGgfG~-Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~~~L 485 (683)
-+.+|.|+.|+ ||+| ...|+.||||.+-. .....+.+|+..|..- .|||||++|+.- .+....||
T Consensus 514 ~eilG~Gs~Gt~Vf~G--~ye~R~VAVKrll~----------e~~~~A~rEi~lL~eSD~H~NviRyyc~E-~d~qF~YI 580 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRG--VYEGREVAVKRLLE----------EFFDFAQREIQLLQESDEHPNVIRYYCSE-QDRQFLYI 580 (903)
T ss_pred HHHcccCCCCcEEEEE--eeCCceehHHHHhh----------HhHHHHHHHHHHHHhccCCCceEEEEeec-cCCceEEE
Confidence 45689999885 7999 47899999997522 3345678999999988 599999999654 58889999
Q ss_pred EEecccCCChhHHHhcCC----CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---C--CcEEEEecCC
Q 005678 486 VLEYCSGKDLDAVLKATP----VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---F--GVAKVTDFGL 556 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~~----~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~--g~vKL~DFGl 556 (683)
..|+| ..+|.+++.... ....-..+.++.|++.||.+||+.+ ||||||||.||||+. + ..++|+|||+
T Consensus 581 alELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 581 ALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred EehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccc
Confidence 99999 569999997641 1111345778999999999999955 999999999999975 2 4799999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFG-RRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~e~il~~~~i~~ 635 (683)
|+.+..+.. .....+.+.||.+|+|||++.... -+..+|||||||++|++++| .+||+.....+.-+ ..
T Consensus 658 sKkl~~~~s--S~~r~s~~sGt~GW~APE~L~~~~---~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-----l~ 727 (903)
T KOG1027|consen 658 SKKLAGGKS--SFSRLSGGSGTSGWQAPEQLREDR---KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-----LT 727 (903)
T ss_pred ccccCCCcc--hhhcccCCCCcccccCHHHHhccc---cCcccchhhcCceEEEEecCCccCCCchHHhhhhh-----hc
Confidence 999876543 334467789999999999998666 36689999999999999985 89999876654321 11
Q ss_pred hhc--cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 636 ARK--VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 636 ~~~--~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
... +.....+.+ ++.+||.+|+.++|..||++.+++.||||
T Consensus 728 ~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 728 GNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred CccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 111 111111222 89999999999999999999999999976
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=280.78 Aligned_cols=261 Identities=21% Similarity=0.333 Sum_probs=192.2
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhh--cCCCceeeecccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT--LVHHHIVRLWDTF 476 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~--L~HpnIV~L~~~f 476 (683)
..+..+..+.+.||+|.||+||+| ...|..||||+|.... ...+.||.+|... |+|+||+.++++-
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~srd----------E~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSSRD----------ERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred HhhhheeEEEEEecCccccceeec--cccCCceEEEEecccc----------hhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 456778899999999999999999 6789999999984321 2356677777765 4999999999875
Q ss_pred ccCCc---eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc------CCceEecccCCcceEeCCCC
Q 005678 477 EIDQN---TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR------AQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 477 ~~d~~---~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~------g~~IIHrDLKP~NILLd~~g 547 (683)
-.+.+ .++||++|.+.|+|+++|.++ .++......++.-+++||++||.. .+.|.|||||+.|||+..+|
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 44443 588999999999999999985 589999999999999999999964 23599999999999999999
Q ss_pred cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCC--CCC-chhHHHHHHHHHHHHHc----------C
Q 005678 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTP--LIS-SKVDVWSAGILFYQMLF----------G 614 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~--~~s-~ksDVWSLGvILyELLt----------G 614 (683)
.+.|+|+|||.....+...-. ......+||.+|||||++...-.. .-+ ..+||||||+++||++. -
T Consensus 354 ~C~IADLGLAv~h~~~t~~id-i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTID-IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred cEEEeeceeeEEecccCCccc-CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999999987765532222 234456999999999998644321 112 24799999999999984 2
Q ss_pred CCCCCCCchHHHHHH-HHHHHHhh--ccCCCCCcC---CCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 615 RRPFGHDQTQERILR-EDTIIKAR--KVEFPSRPA---VSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 615 ~~PF~~~~~~e~il~-~~~i~~~~--~~~~p~~~~---~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
.+||....+.+.-+. -..+.-.. .+..|.... +-..+..+++-||..||.-|.|+..+-
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 567754322211111 01111111 122222111 123567889999999999999986653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=299.91 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=205.0
Q ss_pred cccccccceeEEEEecccCceEEEEEEEc----c---CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDL----V---EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHH 468 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~----~---~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~Hpn 468 (683)
.|++..+...+.+.||+|.||.||+|... . ....||||.+...... ...+.+..|+.+|+.+ .|||
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~------~~~~~~~~El~~m~~~g~H~n 363 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS------SEKKDLMSELNVLKELGKHPN 363 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc------HHHHHHHHHHHHHHHhcCCcc
Confidence 56677777778889999999999999632 1 2567999987655432 2256789999999999 5999
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhcCC----------------CcchHHHHHHHHHHHHHHHHHHhcCCceE
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP----------------VLPEREARIIIVQIFQGLIYLNKRAQKII 532 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~----------------~Lse~~~~~I~~qIa~aL~yLH~~g~~II 532 (683)
||.+++++. ..+.+++|+||+..|+|..+|+... .++......++.||+.|+.||++.. +|
T Consensus 364 iv~llG~~t-~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~v 440 (609)
T KOG0200|consen 364 IVNLLGACT-QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CV 440 (609)
T ss_pred hhhheeeec-cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--cc
Confidence 999999986 4788999999999999999996554 4889999999999999999999854 99
Q ss_pred ecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCC--CccCCcccccccCCCCCCchhHHHHHHHHHHH
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT--YWYLPPECFELSKTPLISSKVDVWSAGILFYQ 610 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT--~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyE 610 (683)
||||-..|||+..+..+||+|||+|+....... .......|+ ..|||||++.... |+.++|||||||+|||
T Consensus 441 HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~----y~~~~~~~~LP~kWmApEsl~~~~---ft~kSDVWSfGI~L~E 513 (609)
T KOG0200|consen 441 HRDLAARNVLITKNKVIKIADFGLARDHYNKDY----YRTKSSAGTLPVKWMAPESLFDRV---FTSKSDVWSFGILLWE 513 (609)
T ss_pred chhhhhhhEEecCCCEEEEccccceeccCCCCc----eEecCCCCccceeecCHHHhccCc---ccccchhhHHHHHHHH
Confidence 999999999999999999999999986544311 111222332 2399999997644 9999999999999999
Q ss_pred HHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 611 MLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 611 LLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
|++ |..||........++. .+....... .+..+++++.++++.||..+|.+||++.++..
T Consensus 514 ifsLG~~PYp~~~~~~~l~~--~l~~G~r~~--~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 514 IFTLGGTPYPGIPPTEELLE--FLKEGNRME--QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhhCCCCCCCCCCcHHHHHH--HHhcCCCCC--CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 997 8999987543333332 233333333 33568999999999999999999999988864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=274.22 Aligned_cols=260 Identities=26% Similarity=0.359 Sum_probs=205.1
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
....||.-+..+|.|.- .|..+.|...+++||+|........ ...-+.+.+|..++..+.|+||+.++.+|...
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-----~~~akra~rel~l~~~v~~~nii~l~n~ftP~ 87 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-----QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ 87 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-----CccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence 34568999999999998 8889999999999999987555322 22345678999999999999999999999643
Q ss_pred C-----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 480 Q-----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 480 ~-----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
. ..+|+||||| ..+|...+.. .+.-..+..|+.|++.|+.|||+.+ |+||||||+||++..++.+||.||
T Consensus 88 ~~l~~~~e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 88 KTLEEFQEVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred ccHHHHHhHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccc
Confidence 2 3588999999 5688888763 3677888999999999999999966 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH-
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI- 633 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i- 633 (683)
|+++....+ ...+..+.|..|.|||++.+.. |...+||||+|||+.||++|+..|.+..-.+.+......
T Consensus 163 g~ar~e~~~------~~mtpyVvtRyyrapevil~~~---~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l 233 (369)
T KOG0665|consen 163 GLARTEDTD------FMMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL 233 (369)
T ss_pred hhhcccCcc------cccCchhheeeccCchheeccC---CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence 999865432 1234458999999999998665 899999999999999999999998765444433211000
Q ss_pred --------------------------HHhhccCCCCC---------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 634 --------------------------IKARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 634 --------------------------~~~~~~~~p~~---------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.....-.||+. +.-+..+.+++.+||-.||++|.|+.++|+||||
T Consensus 234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 00000112221 1234568899999999999999999999999999
Q ss_pred C
Q 005678 679 T 679 (683)
Q Consensus 679 ~ 679 (683)
+
T Consensus 314 ~ 314 (369)
T KOG0665|consen 314 K 314 (369)
T ss_pred e
Confidence 6
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=275.06 Aligned_cols=262 Identities=23% Similarity=0.376 Sum_probs=203.0
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC----
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ---- 480 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~---- 480 (683)
..-.+.||-|+||.||.+.|..+|+.||+|.+..- .......+.+.+|+.++..++|.|++.++++.+...
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-----fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-----FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchH-----HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 33457799999999999999999999999976321 112233567899999999999999999988875221
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
..+|+|+|+| ..+|+.+|-....++...+..+++||+.||+|||+.+ |.||||||.|+|+++|..+||||||+++..
T Consensus 130 qEiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 130 QELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEeccccccccc
Confidence 1367889999 6799999988888999999999999999999999965 999999999999999999999999999987
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH-------
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI------- 633 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i------- 633 (683)
..+.. ..| .+-+.|-+|.|||.+.+.. .|+..+||||+|||+.|+|..+..|-.....+.+.-...+
T Consensus 207 e~d~~-~hM---TqEVVTQYYRAPEiLMGaR--hYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 207 DQRDR-LNM---THEVVTQYYRAPELLMGAR--RYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred chhhh-hhh---HHHHHHHHhccHHHhhcch--hhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 65432 222 2336788899999987544 5999999999999999999888888655554433211000
Q ss_pred ------------HHhhccCCCCC---------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 634 ------------IKARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 634 ------------~~~~~~~~p~~---------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+.......|+. ..-..+...++..+|..+|++|.++.+++.|+|+-.
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 00111112211 122346788899999999999999999999999753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=280.97 Aligned_cols=250 Identities=25% Similarity=0.327 Sum_probs=185.0
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhh--cCCCceeeecccccc---
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT--LVHHHIVRLWDTFEI--- 478 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~--L~HpnIV~L~~~f~~--- 478 (683)
...++++||+|.||.||+| ...++.||||++.. .. ...+..|.+|.+. ++|+||++++++-..
T Consensus 211 pl~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp~------~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKA--QLDNRLVAVKIFPE------QE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred chhhHHHhhcCccceeehh--hccCceeEEEecCH------HH----HHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 4567789999999999999 46779999999833 22 3456777777765 589999999977542
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc-------CCceEecccCCcceEeCCCCcEEE
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR-------AQKIIHYDLKPGNVLFDEFGVAKV 551 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~-------g~~IIHrDLKP~NILLd~~g~vKL 551 (683)
+...+.||++|.+.|+|.++|+.+ .++|.+...|+.-|+.||+|||+. .++|+|||||..|||+.+++.+.|
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 123688999999999999999988 499999999999999999999974 246999999999999999999999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCC---CCCchhHHHHHHHHHHHHHcCCC------------
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTP---LISSKVDVWSAGILFYQMLFGRR------------ 616 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~---~~s~ksDVWSLGvILyELLtG~~------------ 616 (683)
+|||+|..+...... .-+...+||.+|||||++.+.-.- .--..+||||+|.+||||++...
T Consensus 358 aDFGLAl~~~p~~~~---~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql 434 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQ---GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL 434 (534)
T ss_pred eccceeEEecCCCCC---cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence 999999888643211 112225899999999998653321 11135899999999999997433
Q ss_pred CCC----CCchHHHHHHHHHHHHhhccCCCCCc---CCCHHHHHHHHHhcccCCCCCCCHH
Q 005678 617 PFG----HDQTQERILREDTIIKARKVEFPSRP---AVSNEAKDLIRRCLTYNQAERPDVL 670 (683)
Q Consensus 617 PF~----~~~~~e~il~~~~i~~~~~~~~p~~~---~~s~el~dLI~rCL~~dP~kRPS~~ 670 (683)
||. .....+.. ....+....++.+|+.. .-...+.+.|..||..||+-|.|+.
T Consensus 435 pfe~evG~hPt~e~m-q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEM-QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred chhHHhcCCCCHHHH-HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 231 11111111 11122233344454321 2234678999999999999999964
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=293.63 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=202.0
Q ss_pred ceeEEEEecccCceEEEEEEEccCCe----EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~----~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.....+.||.|+||+||+|...-.|. +||||++....... ...+++.|+-+|.+|+|||+++|++++..+
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~------~s~e~LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK------ASIELLDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch------hhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence 34556889999999999998765554 68899875543322 235789999999999999999999999743
Q ss_pred CceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.+.||++||++|+|.++++.+ ..+..+....|+.||++||.|||.. .+|||||-..|||+.+...+||+|||+++
T Consensus 771 --~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q--rlVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 771 --TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ--RLVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred --hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc--chhhhhhhhhheeecCCCeEEEEecchhh
Confidence 477999999999999999655 5688999999999999999999985 59999999999999999999999999999
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
.+..+... ..+..+.-.+-|||-|++.... |+.++|||||||++||++| |..|+......+.- +.+...
T Consensus 847 ll~~d~~e---y~~~~gK~pikwmale~i~~~~---~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~---dlle~g- 916 (1177)
T KOG1025|consen 847 LLAPDEKE---YSAPGGKVPIKWMALESIRIRK---YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP---DLLEKG- 916 (1177)
T ss_pred ccCccccc---ccccccccCcHHHHHHHhhccC---CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh---HHHhcc-
Confidence 88765322 1222333445699999987555 9999999999999999997 99999776654311 112222
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
.+++.+|.++-++.-++.+||..|+..||.+.++.
T Consensus 917 -eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 917 -ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred -ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 34677789999999999999999999999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=297.41 Aligned_cols=264 Identities=23% Similarity=0.372 Sum_probs=221.4
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
..+.|.++..+|.|.||.||+++|+.++...|+|++++..... +..+..|+-+++..+|||||.+++.|- -.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-------~~~iqqei~~~~dc~h~nivay~gsyl-r~ 84 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-------FSGIQQEIGMLRDCRHPNIVAYFGSYL-RR 84 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-------ccccccceeeeecCCCcChHHHHhhhh-hh
Confidence 3568999999999999999999999999999999987764322 345677999999999999999999995 66
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
..+++.||||.||+|.+.-.-.+++++.++..++++.+.||+|||+.| -+|||||-.|||+++.|.+|++|||.+-.+
T Consensus 85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhh
Confidence 778999999999999999998999999999999999999999999865 899999999999999999999999998766
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
... +.......|||+|||||+......+.|...+|||++|++..|+---++|..........+- -..-....+.
T Consensus 163 tat-----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-mTkS~~qpp~ 236 (829)
T KOG0576|consen 163 TAT-----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-MTKSGFQPPT 236 (829)
T ss_pred hhh-----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-hhccCCCCCc
Confidence 433 2334556899999999998777767799999999999999999888877544444332211 1111122334
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..++...++-+.+|++.||..+|++||+++.++.|||++.
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 4456678999999999999999999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=255.92 Aligned_cols=216 Identities=25% Similarity=0.353 Sum_probs=177.9
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTF 476 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f 476 (683)
|++..+...-+..||+|+||.|-+.++..+|...|+|.+.......+ .+..++|+.+..+. ..|.+|.+||.+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~------q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE------QKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH------HHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 55666666677889999999999999999999999998866544222 35677888877665 699999999998
Q ss_pred ccCCceEEEEEecccCCChhHHH----hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVL----KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L----~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
. .....+|.||.| ..+|+.+. +.++.+++..+-.|+.-++.||.|||+. ..|||||+||+|||++.+|.+|||
T Consensus 115 ~-regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 115 F-REGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred h-ccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEc
Confidence 6 566788999999 56887654 6678899999999999999999999996 479999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTP-LISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~-~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il 628 (683)
|||+|..+.+.... +..+|...|||||.+...... .|+-++||||||++++||.+++.||..-.+....+
T Consensus 192 DFGIsG~L~dSiAk------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 192 DFGISGYLVDSIAK------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred ccccceeehhhhHH------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 99999887654322 123788889999998765433 69999999999999999999999997665554433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-29 Score=240.36 Aligned_cols=213 Identities=40% Similarity=0.640 Sum_probs=182.7
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecc
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~ 490 (683)
||.|+||.||++.+..++..+++|++....... ....+.+|+.+++.+.|++|+++++++. .....++++||+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS------LLEELLREIEILKKLNHPNIVKLYGVFE-DENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh------HHHHHHHHHHHHHhcCCCCeeeEeeeee-cCCeEEEEEecC
Confidence 689999999999988889999999986543221 2457889999999999999999999986 457899999999
Q ss_pred cCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEEEecCCccccccCcCCCc
Q 005678 491 SGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKVTDFGLSKIVEDDVGSQG 568 (683)
Q Consensus 491 ~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL~DFGls~~~~~~~~~~~ 568 (683)
+|++|..++... ..+++..+..++.+++.+|.|||..+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--- 148 (215)
T cd00180 74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--- 148 (215)
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---
Confidence 999999999765 46899999999999999999999965 999999999999998 89999999999986654321
Q ss_pred ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCC
Q 005678 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVS 648 (683)
Q Consensus 569 ~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s 648 (683)
......+...|++||.+... ..++.+.|+|++|+++|+|
T Consensus 149 --~~~~~~~~~~~~~pe~~~~~--~~~~~~~D~~~lg~~~~~l------------------------------------- 187 (215)
T cd00180 149 --LLKTIVGTPAYMAPEVLLGK--GYYSEKSDIWSLGVILYEL------------------------------------- 187 (215)
T ss_pred --hhhcccCCCCccChhHhccc--CCCCchhhhHHHHHHHHHH-------------------------------------
Confidence 12223678889999988644 2478899999999999999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 649 NEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 649 ~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
..+.+++.+|+..+|.+||++.++++++
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4788999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=276.92 Aligned_cols=267 Identities=25% Similarity=0.457 Sum_probs=203.6
Q ss_pred ccccccceeEEEEecccCceEEEEEEEcc---CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeec
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLV---EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLW 473 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~---~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~ 473 (683)
++.+.+.|..++.||.|.|++||++.+.. ..++||+|.+..... ...+..|+.+|..+ .+.||+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---------p~ri~~El~~L~~~gG~~ni~~~~ 101 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---------PSRILNELEMLYRLGGSDNIIKLN 101 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---------chHHHHHHHHHHHhccchhhhcch
Confidence 34566778999999999999999999887 789999998766543 23577899999999 589999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-CCCcEEEE
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVT 552 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-~~g~vKL~ 552 (683)
+++. .++..++||||++..+..+++.. ++..+++.++..++.||.++|..| ||||||||+|+|++ ..+.-.|+
T Consensus 102 ~~~r-nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 102 GCFR-NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred hhhc-cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEE
Confidence 9986 67889999999999988888764 678999999999999999999966 99999999999998 46788999
Q ss_pred ecCCccccccCc-----------------CC-------------Ccc---------cccccCCCCCccCCcccccccCCC
Q 005678 553 DFGLSKIVEDDV-----------------GS-------------QGM---------ELTSQGAGTYWYLPPECFELSKTP 593 (683)
Q Consensus 553 DFGls~~~~~~~-----------------~~-------------~~~---------~l~~~~~GT~~Y~APE~~~~~~~~ 593 (683)
|||++....... +. .+. ...-..+||++|.|||++. +.+
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~--k~~ 253 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF--RCP 253 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh--hcc
Confidence 999997221110 00 000 0011237999999999986 445
Q ss_pred CCCchhHHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHHHh----------hc------c----------CC-----
Q 005678 594 LISSKVDVWSAGILFYQMLFGRRPFGHDQTQE-RILREDTIIKA----------RK------V----------EF----- 641 (683)
Q Consensus 594 ~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e-~il~~~~i~~~----------~~------~----------~~----- 641 (683)
..++++||||.|||++.++++++||......- .+...-.+... +. . .|
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 57899999999999999999999985433222 22111111000 00 0 00
Q ss_pred ----C----------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 642 ----P----------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 642 ----p----------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+ .....+..+.+|+.+||+.||.+|.+++++|+||||.-+
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0 012234578999999999999999999999999999854
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=237.38 Aligned_cols=201 Identities=37% Similarity=0.619 Sum_probs=171.6
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
|.+.+.||.|+||.||+|.+..++..||+|.+...... .....+.+|+..+..++|+|++++++.+. .....+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-~~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE------KQREEFLREIRILKKLKHPNIVKLYGVFE-DPEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch------HHHHHHHHHHHHHHhCCCCChhhheeeee-cCCceE
Confidence 56789999999999999998888999999998654322 23567888999999999999999999875 567889
Q ss_pred EEEecccCCChhHHHhcCCC-cchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 485 TVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~~~-Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
+++||+++++|.+++..... +++..+..++.+++.+|.|||..+ ++|+||+|.||+++.++.++|+|||++......
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 99999999999999987666 899999999999999999999865 999999999999999999999999999877544
Q ss_pred cCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005678 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGH 620 (683)
Q Consensus 564 ~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~ 620 (683)
... ......++..|++||.+. ....++.++|||+||+++|+|++|+.||..
T Consensus 152 ~~~----~~~~~~~~~~~~~pe~~~--~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 152 LAA----LLKTVKGTPFYLAPEVLL--GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccc----cccceeccCCcCCHhHhc--CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 210 122336788999999885 334477899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=271.63 Aligned_cols=202 Identities=30% Similarity=0.481 Sum_probs=172.6
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcc----cchhhHHHHHHHHHHHHHHHhhcC---CCceeeecccc
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQ----WSEDKKQSYIRHAIREYNIHKTLV---HHHIVRLWDTF 476 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~----~~~~~~~~~i~~~~rEi~il~~L~---HpnIV~L~~~f 476 (683)
.|.+++.||.|+||.|++|.++.+...|+||.+.+... |.++.+ +-.+-.|+.||..|+ |+||++++++|
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrk---LGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRK---LGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccc---cCccchhHHHHHHhhhcCccchhhhhhee
Confidence 48999999999999999999999999999998755432 222111 223556999999997 99999999999
Q ss_pred ccCCceEEEEEeccc-CCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 477 EIDQNTFCTVLEYCS-GKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~-ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
+ +.+++||+||-.. |.+|.++|..++.+++.++..|+.||+.|+++||+.| |||||||-+||.++.+|.+||+|||
T Consensus 639 E-ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 E-DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred e-cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeecc
Confidence 7 7889999999764 5699999999999999999999999999999999966 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGH 620 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~ 620 (683)
.+-..... .....+||..|.|||++.+.+. ....-|||++|++||.+++...||..
T Consensus 716 saa~~ksg-------pfd~f~gtv~~aapevl~g~~y--~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSG-------PFDVFVGTVDYAAPEVLGGEKY--LGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCC-------CcceeeeeccccchhhhCCCcc--CCCcchhhhhhheeeEEEeccCCCcC
Confidence 98776543 2344589999999999876553 46678999999999999999999853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=289.99 Aligned_cols=205 Identities=18% Similarity=0.190 Sum_probs=145.0
Q ss_pred hcCC-Cceeeecccccc------CCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEec
Q 005678 463 TLVH-HHIVRLWDTFEI------DQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHY 534 (683)
Q Consensus 463 ~L~H-pnIV~L~~~f~~------d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHr 534 (683)
.+.| +||+.+++.|.. ....+++++||+ +++|..+|.. ...+++..+..|+.||+.||.|||+.+ ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 4456 588888887732 234678889988 6699999964 456999999999999999999999865 9999
Q ss_pred ccCCcceEeCCCCcE-------------------EEEecCCccccccCcC-----------CCcccccccCCCCCccCCc
Q 005678 535 DLKPGNVLFDEFGVA-------------------KVTDFGLSKIVEDDVG-----------SQGMELTSQGAGTYWYLPP 584 (683)
Q Consensus 535 DLKP~NILLd~~g~v-------------------KL~DFGls~~~~~~~~-----------~~~~~l~~~~~GT~~Y~AP 584 (683)
||||+||||+..|.+ ||+|||+++....... ..........+||++||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999655544 4555555543211000 0000001124689999999
Q ss_pred ccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCC
Q 005678 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQA 664 (683)
Q Consensus 585 E~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~ 664 (683)
|++.... |+.++|||||||+||||++|.+||.........+. .. ...+........+..++.+||.++|.
T Consensus 185 E~~~~~~---~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~~~L~~~P~ 254 (793)
T PLN00181 185 EEDNGSS---SNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLR------HR-VLPPQILLNWPKEASFCLWLLHPEPS 254 (793)
T ss_pred hhhccCC---CCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHH------Hh-hcChhhhhcCHHHHHHHHHhCCCChh
Confidence 9986544 89999999999999999999988753221111110 00 11111112345677999999999999
Q ss_pred CCCCHHHHhcCcccCC
Q 005678 665 ERPDVLTLAQDPYLTY 680 (683)
Q Consensus 665 kRPS~~eLl~hP~l~~ 680 (683)
+||++.++++||||..
T Consensus 255 ~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 255 CRPSMSELLQSEFINE 270 (793)
T ss_pred hCcChHHHhhchhhhh
Confidence 9999999999999975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-28 Score=243.70 Aligned_cols=258 Identities=21% Similarity=0.373 Sum_probs=196.7
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d 479 (683)
+.+.|.+.+.||+|.||.+-+|.++.+...+++|.+... ...++.|.+|...--.|. |.||+.-|++....
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--------~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--------QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--------hhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 567899999999999999999999999999999987543 234678899988877774 89999999875556
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC--CCCcEEEEecCCc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD--EFGVAKVTDFGLS 557 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd--~~g~vKL~DFGls 557 (683)
.+.+++++||+|.|+|..-+...+ +.+.....++.|+++||.|+|+. ++||||||.+||||- +.-.+||||||+.
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsk--nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSK--NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred CceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhcc--chhhcccccceEEEecCCccEEEeeecccc
Confidence 778889999999999999987765 89999999999999999999985 599999999999995 3458999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHH
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTP--LISSKVDVWSAGILFYQMLFGRRPFGHDQTQER-ILREDTII 634 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~--~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~-il~~~~i~ 634 (683)
+....... ..--+..|.|||.......+ ...+.+|||.||+|+|.||+|..||-.....+. ........
T Consensus 171 ~k~g~tV~--------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 171 RKVGTTVK--------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL 242 (378)
T ss_pred cccCceeh--------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh
Confidence 86543211 11234559999987654433 246678999999999999999999964332222 22211222
Q ss_pred HhhccCCCCC-cCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcc
Q 005678 635 KARKVEFPSR-PAVSNEAKDLIRRCLTYNQAER---PDVLTLAQDPY 677 (683)
Q Consensus 635 ~~~~~~~p~~-~~~s~el~dLI~rCL~~dP~kR---PS~~eLl~hP~ 677 (683)
.......|.. ..+++.+..+.++-|..+|.+| .++.......|
T Consensus 243 ~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 243 KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 2222233332 3578899999999999999999 44444444444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=222.16 Aligned_cols=163 Identities=21% Similarity=0.267 Sum_probs=126.7
Q ss_pred CChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccc
Q 005678 493 KDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMEL 571 (683)
Q Consensus 493 gsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l 571 (683)
|+|.+++.. ...+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~------- 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ------- 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc-------
Confidence 689999975 456999999999999999999999854 999999999999999 99998764321
Q ss_pred cccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC---CCCcCCC
Q 005678 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF---PSRPAVS 648 (683)
Q Consensus 572 ~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~---p~~~~~s 648 (683)
..||+.|+|||++.... ++.++|||||||++|+|++|..||.........+... +........ +....++
T Consensus 64 ---~~g~~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 136 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQS---YTEKADIYSLGITLYEALDYELPYNEERELSAILEIL-LNGMPADDPRDRSNLESVS 136 (176)
T ss_pred ---CCCcccccChHHhcCCC---CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHH-HHHhccCCccccccHHHHH
Confidence 26899999999986544 8899999999999999999999997654433222211 111111100 1112233
Q ss_pred H--HHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 649 N--EAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 649 ~--el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
. .+.+||.+||..+|.+||++.+++.|+|+.
T Consensus 137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 137 AARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 3 699999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=240.79 Aligned_cols=257 Identities=19% Similarity=0.237 Sum_probs=199.4
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeE-----EEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRY-----VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~-----VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
.+-..|+++.-++-+|.||.||.|+......+ |.+|.++.. ..+-.+..++.|.-.+..+.|||++.+.
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~------AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH------ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc------ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 34456677888899999999999976655443 445543221 1223355678888889999999999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcC--------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKAT--------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE 545 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~ 545 (683)
+++..+...++++|.++.-|+|..+|.-. ..++-.+...++.|++.|+.|||.++ |||.||-..|.+|++
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDD 431 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehh
Confidence 99877888899999999889999999511 34677788889999999999999976 999999999999999
Q ss_pred CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchH
Q 005678 546 FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQ 624 (683)
Q Consensus 546 ~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~ 624 (683)
...+||+|=.+++.+...... .+...-.....||+||.+.... |+..+|||||||+||||+| |+.|+..-++.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYh---cLGDnEnRPvkWMslEal~n~~---yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYH---CLGDNENRPVKWMSLEALQNSH---YSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred heeEEeccchhccccCccccc---ccCCCCCCcccccCHHHHhhhh---hcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 999999999999865433211 1111112234599999987554 9999999999999999997 99999887776
Q ss_pred HHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 625 ERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 625 e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+... .+... .+...+-.||+++..++.-||...|++||++.++..
T Consensus 506 Em~~---ylkdG--yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 506 EMEH---YLKDG--YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHH---HHhcc--ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 6442 22222 333344579999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-24 Score=217.64 Aligned_cols=263 Identities=35% Similarity=0.551 Sum_probs=202.8
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCC-ceeeeccccccCCceE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH-HIVRLWDTFEIDQNTF 483 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hp-nIV~L~~~f~~d~~~~ 483 (683)
|.+...||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +|+++++.+. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKS----KEVERFLREIQILASLNHPPNIVKLYDFFQ-DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccch----hHHHHHHHHHHHHHHccCCcceeeEEEEEe-cCCEE
Confidence 778899999999999999876 7889998765543322 2456789999999999988 7999999994 56668
Q ss_pred EEEEecccCCChhHHHhcCC---CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-cEEEEecCCccc
Q 005678 484 CTVLEYCSGKDLDAVLKATP---VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTDFGLSKI 559 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~---~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-~vKL~DFGls~~ 559 (683)
+++++|+.+++|..++.... .++......++.+++.++.|+|..+ ++||||||.|||++..+ .++++|||++..
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 99999999999997777664 6999999999999999999999966 99999999999999888 799999999986
Q ss_pred cccCcCCCcc-cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHHH
Q 005678 560 VEDDVGSQGM-ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT---QERILREDTIIK 635 (683)
Q Consensus 560 ~~~~~~~~~~-~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~---~e~il~~~~i~~ 635 (683)
.......... .......||.+|++||.+.......++...|+||+|++++++++|..||..... ...... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~---~~~ 228 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK---IIL 228 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH---HHH
Confidence 5543221111 134556899999999988652112378899999999999999999999876653 222211 111
Q ss_pred hhcc---CCCCCcCC----CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARKV---EFPSRPAV----SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~~---~~p~~~~~----s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.... ..+..... ...+.+++.+|+..+|..|.+......++|...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred hcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 1111 11111111 257899999999999999999998888766543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-26 Score=262.07 Aligned_cols=268 Identities=23% Similarity=0.362 Sum_probs=203.6
Q ss_pred eEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEE
Q 005678 406 ALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT 485 (683)
Q Consensus 406 ~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~L 485 (683)
....++|.|.||.|+.+........++.|.+... ..+......+...+..|+.+-..+.|||++..+..+..-...+ .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~-~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL-Q 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch-h
Confidence 4567899999998888877777776777755422 1122233344445888999999999999988877775333333 4
Q ss_pred EEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcC
Q 005678 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVG 565 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~ 565 (683)
+||||++ +|..++...+.++..++..++.|++.|+.|||..| |.||||||+|+|+..+|.+||+|||.+........
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 4999999 99999998878999999999999999999999976 99999999999999999999999999987654422
Q ss_pred CCcccccccCCCCCccCCcccccccCCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC---
Q 005678 566 SQGMELTSQGAGTYWYLPPECFELSKTPLIS-SKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF--- 641 (683)
Q Consensus 566 ~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s-~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~--- 641 (683)
..+......+|+..|+|||.+.... |+ ..+||||.|++++.|.+|+.||......+..+..........+..
T Consensus 476 -~~~~~~~g~~gS~pY~apE~~~~~~---ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 476 -KNIHESSGIVGSDPYLAPEVLTGKE---YDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred -hhhhhhcCcccCCcCcCcccccccc---cCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 2233455568999999999987555 44 458999999999999999999976554432211000000011111
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
+....++...+.+|.+||+++|.+|.++.+|++++||+..+
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 11245788899999999999999999999999999998653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=222.92 Aligned_cols=256 Identities=21% Similarity=0.238 Sum_probs=189.8
Q ss_pred ceeEEEEecccCceEEEEEEEccCC-eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC----Cceeeecccccc
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEH-RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH----HHIVRLWDTFEI 478 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g-~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H----pnIV~L~~~f~~ 478 (683)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++.+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~ 91 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS 91 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-------ccchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence 8999999999999999999987774 6899998654322111 024457777777762 588888887743
Q ss_pred CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC-----CcEEE
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF-----GVAKV 551 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~-----g~vKL 551 (683)
.....++||+.+ |.+|.++.... +.++..++..|+.|++.+|.+||+.| +|||||||.|+++... -.+.|
T Consensus 92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEE
Confidence 566788999999 89999988544 57999999999999999999999977 9999999999999854 36999
Q ss_pred EecCCcc--ccccCcCCC--cccc-cccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH
Q 005678 552 TDFGLSK--IVEDDVGSQ--GMEL-TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626 (683)
Q Consensus 552 ~DFGls~--~~~~~~~~~--~~~l-~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~ 626 (683)
.|||+++ ......+.. .... .....||..|+++.+..... .+.+.|+||++.++.+|+.|..||........
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e---~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE---QGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc---cCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 9999998 332222211 1111 22346999999999876444 78899999999999999999999966554322
Q ss_pred HHHHHHHHHhhccCCC-CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 627 ILREDTIIKARKVEFP-SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 627 il~~~~i~~~~~~~~p-~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....... ....... .....+..+..+...+-..++..+|++..+..
T Consensus 246 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 246 KSKFEKD--PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHHHHHH--hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 2211111 1111111 22345678888888888899999999887753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=207.52 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=197.0
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC-Cceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH-HHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H-pnIV~L~~~f~~ 478 (683)
+...+|.+++.||.|+||.+|.|....+|..||||+-...... ..+..|..+...|+| ..|..+..++ .
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---------pqL~yEskvY~iL~~g~GiP~i~~y~-~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---------PQLLYESKVYRILQGGVGIPHIRHYG-T 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---------cchhHHHHHHHHhccCCCCchhhhhc-c
Confidence 4677999999999999999999999999999999986444332 245678888888865 4666665444 4
Q ss_pred CCceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC---CCCcEEEEec
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD---EFGVAKVTDF 554 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd---~~g~vKL~DF 554 (683)
+..+-.+||+++ |.+|.+++. ....++..++..++.|++.-++|+|.++ +|||||||+|+|.. ....+.|+||
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEec
Confidence 778888999999 899999995 4467999999999999999999999965 99999999999986 3457999999
Q ss_pred CCccccccCcCCCcccc--cccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMEL--TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l--~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|+|+...+......+.. ...-.||..|.+--...+- ..+...|+-|+|.+|+++.-|..||-.............
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~---eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI---EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhh---hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence 99998766544433322 3344799999886654322 257889999999999999999999977665544433222
Q ss_pred HHHhhccCCC---CCcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 005678 633 IIKARKVEFP---SRPAVSNEAKDLIRRCLTYNQAERPDVLTL 672 (683)
Q Consensus 633 i~~~~~~~~p---~~~~~s~el~dLI~rCL~~dP~kRPS~~eL 672 (683)
|. ..+...| -+..+|.++.-.+.-|-..--++-|+..-|
T Consensus 236 I~-EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 236 IS-EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred HH-HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 22 1222222 245788999999999998888888986543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=215.79 Aligned_cols=260 Identities=19% Similarity=0.258 Sum_probs=197.6
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDT 475 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~ 475 (683)
..-+.+-.|.+.+.||+|+||++|.|.+..++.+||||.-..... ...+..|+...+.|. .++|...|.
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---------APQLrdEYr~YKlL~g~~GIP~vYY- 91 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---------APQLRDEYRTYKLLGGTEGIPQVYY- 91 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEeccccCC---------cchHHHHHHHHHHHcCCCCCCceee-
Confidence 445778899999999999999999999999999999998644322 124556777777774 688988884
Q ss_pred cccCCceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC-----CcE
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF-----GVA 549 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~-----g~v 549 (683)
|..++.+-.||+|++ |.+|.+++. ....|+..++..|+.|++.-+.|+|++. +|.|||||+|+||... ..+
T Consensus 92 FGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~I 168 (449)
T KOG1165|consen 92 FGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVI 168 (449)
T ss_pred eccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceE
Confidence 445777778999999 899999995 4567999999999999999999999965 9999999999999743 359
Q ss_pred EEEecCCccccccCcCCCccc--ccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 550 KVTDFGLSKIVEDDVGSQGME--LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~~~--l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
.|+|||+++...+...+..+. -.+...||.+||+--...+ ...|...|+-|||-+|++.|-|..||-.......-
T Consensus 169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG---rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK 245 (449)
T KOG1165|consen 169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG---REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK 245 (449)
T ss_pred EEEeccchhhhcCccccccCccccccccccceeeeEeecccc---chhhhhhhHHHhhhhhhhhccCCCccccccCcchH
Confidence 999999999987766655543 3455689999998765543 33788999999999999999999999654443322
Q ss_pred HHHHHHHHhhccCC--CCCcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 005678 628 LREDTIIKARKVEF--PSRPAVSNEAKDLIRRCLTYNQAERPDVLTL 672 (683)
Q Consensus 628 l~~~~i~~~~~~~~--p~~~~~s~el~dLI~rCL~~dP~kRPS~~eL 672 (683)
.....|-....... ..+..+|.++...++-.-..+..+-|+++-+
T Consensus 246 ~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 246 EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 22112111111110 0124577788888887777788888886543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=229.12 Aligned_cols=178 Identities=21% Similarity=0.183 Sum_probs=133.8
Q ss_pred ccccccceeEEEEecccCceEEEEEEEcc-CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceee-eccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLV-EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVR-LWDT 475 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~-~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~-L~~~ 475 (683)
...+.++|.+.+.||+|+||+||+|++.. ++..||||.+.....+.. .......+.+|+.+++.++|+||++ +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~--~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS--KPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc--cHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 35677899999999999999999998776 788899998643211101 1123456889999999999999985 443
Q ss_pred cccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEeccc-CCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDL-KPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDL-KP~NILLd~~g~vKL~DF 554 (683)
+ +..|+|||||+|++|... ... . ...++.+++.||.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 90 ~----~~~~LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 T----GKDGLVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred c----CCcEEEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 2 357899999999999732 211 1 1467889999999999965 999999 999999998899999999
Q ss_pred CCccccccCcCCCcc---cccccCCCCCccCCcccccccC
Q 005678 555 GLSKIVEDDVGSQGM---ELTSQGAGTYWYLPPECFELSK 591 (683)
Q Consensus 555 Gls~~~~~~~~~~~~---~l~~~~~GT~~Y~APE~~~~~~ 591 (683)
|+|+.+........+ .-.....|++.|+|||.+....
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 999987654322111 1112447889999999986443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-23 Score=233.58 Aligned_cols=240 Identities=28% Similarity=0.376 Sum_probs=196.4
Q ss_pred EecccCceEEEEEEE---ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCceEEE
Q 005678 410 LLGKGGFSEVYKAYD---LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQNTFCT 485 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d---~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~~~~L 485 (683)
.+|.|.||.|+++.. ...+..+|+|+........... .+...|..++..++ ||.+|.++.+|+ .....++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-----~~t~~er~il~~~~~~~f~v~lhyafq-t~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-----THTKQERIILAFVHNTPFLVKLHYAFQ-TDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc-----cccccHHHHHhhccCCCceeeeeeeec-cccchhH
Confidence 379999999998742 2346778888875544332221 15566888888887 999999999997 5667889
Q ss_pred EEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcC
Q 005678 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVG 565 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~ 565 (683)
+++|..||+|...+.....+.+.....+...++.|+.++|+.+ |+|||+|++||+++.+|++++.|||+++..-...
T Consensus 75 ~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~- 151 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK- 151 (612)
T ss_pred hhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence 9999999999999988888999999999999999999999976 9999999999999999999999999998765431
Q ss_pred CCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCc
Q 005678 566 SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP 645 (683)
Q Consensus 566 ~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~ 645 (683)
..+||+-|||||++. + .+..+|+||||+++|+|++|..||.. .... ......++.+.
T Consensus 152 --------~~cgt~eymApEI~~--g---h~~a~D~ws~gvl~felltg~~pf~~-~~~~---------~Il~~~~~~p~ 208 (612)
T KOG0603|consen 152 --------IACGTYEYRAPEIIN--G---HLSAADWWSFGVLAFELLTGTLPFGG-DTMK---------RILKAELEMPR 208 (612)
T ss_pred --------hcccchhhhhhHhhh--c---cCCcccchhhhhhHHHHhhCCCCCch-HHHH---------HHhhhccCCch
Confidence 118999999999986 2 57789999999999999999999987 1111 11222445556
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 005678 646 AVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTYS 681 (683)
Q Consensus 646 ~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~~ 681 (683)
.++..+.+++..++..+|..|.- +.++.+|+||+..
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 78999999999999999999973 6899999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=205.58 Aligned_cols=237 Identities=23% Similarity=0.295 Sum_probs=153.5
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC----------CCceeeecc
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV----------HHHIVRLWD 474 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~----------HpnIV~L~~ 474 (683)
+.....||.|+|+.||.+.|..++..+|+|++........ ..++.+.+|.-....+. |-.++.-++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~----~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA----NEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT----THHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccch----HHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 4556889999999999999999999999999866653222 22455555554444432 222332233
Q ss_pred ccccC-----------Cc-----eEEEEEecccCCChhHHHhc----CC---CcchHHHHHHHHHHHHHHHHHHhcCCce
Q 005678 475 TFEID-----------QN-----TFCTVLEYCSGKDLDAVLKA----TP---VLPEREARIIIVQIFQGLIYLNKRAQKI 531 (683)
Q Consensus 475 ~f~~d-----------~~-----~~~LV~Ey~~ggsL~~~L~~----~~---~Lse~~~~~I~~qIa~aL~yLH~~g~~I 531 (683)
...+. .. +.+++|+-+ .++|..++.. .. .+.......+..|++..+++||..| |
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--l 166 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--L 166 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--e
Confidence 32211 11 346788887 5688888631 11 1334444566699999999999977 9
Q ss_pred EecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCccccccc-----CCCCCCchhHHHHHHH
Q 005678 532 IHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS-----KTPLISSKVDVWSAGI 606 (683)
Q Consensus 532 IHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~-----~~~~~s~ksDVWSLGv 606 (683)
||+||+|+|+|++.+|.++|+||+......... . ....+..|.|||..... ..-.++.+.|.|+||+
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-------~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-------R-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-------E-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCcee-------e-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999998776543221 1 12445779999976543 1234788999999999
Q ss_pred HHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCC
Q 005678 607 LFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666 (683)
Q Consensus 607 ILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kR 666 (683)
++|.|+||..||+....... ....|..+..+|+.++.||..+|.+||.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999999999987654211 111455555899999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=190.05 Aligned_cols=147 Identities=21% Similarity=0.194 Sum_probs=111.6
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhh-------------------HHHHHHHHHHHHHHHhhcCCCc
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK-------------------KQSYIRHAIREYNIHKTLVHHH 468 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~-------------------~~~~i~~~~rEi~il~~L~Hpn 468 (683)
...||+|+||.||+|.+. +|++||||++.......... ..........|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999886 89999999987653211110 0001123356999999998887
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHH-HhcCCceEecccCCcceEeCCCC
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL-NKRAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yL-H~~g~~IIHrDLKP~NILLd~~g 547 (683)
+...+.... . ..+|||||++|++|...+.....+++..+..++.|++.+|.|| |..+ |+||||||+|||++. +
T Consensus 81 v~~p~~~~~--~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~~-~ 154 (190)
T cd05147 81 IPCPEPILL--K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYHD-G 154 (190)
T ss_pred CCCCcEEEe--c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEEC-C
Confidence 644332221 1 2379999999888776644456789999999999999999999 6755 999999999999984 8
Q ss_pred cEEEEecCCccccc
Q 005678 548 VAKVTDFGLSKIVE 561 (683)
Q Consensus 548 ~vKL~DFGls~~~~ 561 (683)
.++|+|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=223.87 Aligned_cols=227 Identities=29% Similarity=0.414 Sum_probs=170.6
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
....|..+++|-.|+||.||...++.+...+|+|+-+.+ .++ .||+.+- +
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-------------lil-----------Rnilt~a------~ 130 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-------------LIL-----------RNILTFA------G 130 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccc-------------hhh-----------hcccccc------C
Confidence 456789999999999999999999999999999753211 011 1233221 1
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+ .+.| ||-...++.-+.++..- +.+++|||..| |+|||+||+|.||..-|++|++|||+++..
T Consensus 131 n-pfvv------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 131 N-PFVV------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred C-ccee------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhh
Confidence 1 1222 56666676666666533 88999999976 999999999999999999999999999764
Q ss_pred ccCcCCC----------cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 561 EDDVGSQ----------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 561 ~~~~~~~----------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
....... ......+.+|||.|+|||++...+ |...+|||+||+|+|+.+.|..||..+...+-+-
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg---ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg-- 268 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG---YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG-- 268 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc---cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh--
Confidence 3321111 012244669999999999998766 8889999999999999999999998887765432
Q ss_pred HHHHHhhccCCCCC-cCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccCCC
Q 005678 631 DTIIKARKVEFPSR-PAVSNEAKDLIRRCLTYNQAERP---DVLTLAQDPYLTYS 681 (683)
Q Consensus 631 ~~i~~~~~~~~p~~-~~~s~el~dLI~rCL~~dP~kRP---S~~eLl~hP~l~~~ 681 (683)
......+.||.. ..++++++++|.++|..+|..|. .+.++-+|+||+..
T Consensus 269 --~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 269 --QVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred --hhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 122334455543 46889999999999999999996 57888899999853
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=184.89 Aligned_cols=148 Identities=18% Similarity=0.165 Sum_probs=112.7
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchh-------------------hHHHHHHHHHHHHHHHhhcCCCc
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSED-------------------KKQSYIRHAIREYNIHKTLVHHH 468 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~-------------------~~~~~i~~~~rEi~il~~L~Hpn 468 (683)
...||+|+||.||+|.+. +|+.||||++......... ........+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999876 8999999998765321110 00011123457999999999998
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHh-cCCceEecccCCcceEeCCCC
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK-RAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~-~g~~IIHrDLKP~NILLd~~g 547 (683)
|.....+.. . ..++||||++|+++.........++...+..++.+++.+|.+||. .| |+||||||.|||++ ++
T Consensus 81 i~~p~~~~~-~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILL-K--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEe-c--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CC
Confidence 754433322 2 237999999988655443233457888999999999999999998 66 99999999999999 79
Q ss_pred cEEEEecCCcccccc
Q 005678 548 VAKVTDFGLSKIVED 562 (683)
Q Consensus 548 ~vKL~DFGls~~~~~ 562 (683)
.++|+|||++..+..
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-21 Score=193.78 Aligned_cols=181 Identities=13% Similarity=0.160 Sum_probs=133.6
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHH--HHHHHHHHHHHhhcCCCceeeecccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSY--IRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~--i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
.++.++|.++++||.|+||.||++.+ ++..+|||++.............. -..+.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 35788999999999999999999754 577899999865433222111110 12257899999999999999998886
Q ss_pred ccC-------CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcE
Q 005678 477 EID-------QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA 549 (683)
Q Consensus 477 ~~d-------~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~v 549 (683)
... .+..+|||||++|.+|.++.. +++ ..+.+++.+|..||..| |+|+||||+||+++.+| +
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-E
Confidence 532 245789999999999988732 333 24569999999999966 99999999999999988 9
Q ss_pred EEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
+|+|||.+.......... .+.... .|..++|+|||||++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~d------------------~~vler--~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKD------------------RIDLER--HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHH------------------HHHHHh--HhcccccccceeEeehHHH
Confidence 999999887654322111 111111 1556899999999887544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.4e-21 Score=192.72 Aligned_cols=246 Identities=18% Similarity=0.284 Sum_probs=191.1
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
...++..|.+...|+.|+| +..|..+++|++......... -+.|..|.-.++-+.||||++++++|. .+.++
T Consensus 191 ~lnl~tkl~e~hsgelwrg--rwqgndivakil~vr~~t~ri-----srdfneefp~lrifshpnilpvlgacn-sppnl 262 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRG--RWQGNDIVAKILNVREVTARI-----SRDFNEEFPALRIFSHPNILPVLGACN-SPPNL 262 (448)
T ss_pred hhhhhhhhccCCCcccccc--cccCcchhhhhhhhhhcchhh-----cchhhhhCcceeeecCCchhhhhhhcc-CCCCc
Confidence 3455677889999999999 467778888887554332222 246778888899999999999999996 66788
Q ss_pred EEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE--ecCCccc
Q 005678 484 CTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT--DFGLSKI 559 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~--DFGls~~ 559 (683)
.++..||+.|+|+.+|.... .+.-.++..++.+|+.|+.|||+..+-|.-.-|.+..|++|++..++|. |--++..
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence 89999999999999997553 3567788899999999999999987667777899999999998877764 3222221
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
.. ...-.|.||+||.+.......--..+|+|||++++||+.|...||..-.+.+.-.. +....+
T Consensus 343 ---e~---------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk----ialegl 406 (448)
T KOG0195|consen 343 ---EV---------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----IALEGL 406 (448)
T ss_pred ---cc---------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----hhhccc
Confidence 11 11346789999998654433345679999999999999999999988877665433 333445
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
....+|.++..+..|+.-|+..||.+||.+..++
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 5556689999999999999999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-20 Score=194.01 Aligned_cols=197 Identities=24% Similarity=0.354 Sum_probs=144.8
Q ss_pred CCCceeeecccccc--------------------------CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHH
Q 005678 465 VHHHIVRLWDTFEI--------------------------DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIF 518 (683)
Q Consensus 465 ~HpnIV~L~~~f~~--------------------------d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa 518 (683)
+|||||.++.+|+. .+..+|+||..++ .+|+.++.... .+....+.|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 69999999998853 2346899999985 49999996554 67888889999999
Q ss_pred HHHHHHHhcCCceEecccCCcceEeC--CC--CcEEEEecCCccccccCcCCCccccc---ccCCCCCccCCcccccccC
Q 005678 519 QGLIYLNKRAQKIIHYDLKPGNVLFD--EF--GVAKVTDFGLSKIVEDDVGSQGMELT---SQGAGTYWYLPPECFELSK 591 (683)
Q Consensus 519 ~aL~yLH~~g~~IIHrDLKP~NILLd--~~--g~vKL~DFGls~~~~~~~~~~~~~l~---~~~~GT~~Y~APE~~~~~~ 591 (683)
.|+.|||.+| |.|||+|++|||+. ++ -.+.|+|||+|-.-... + -...+. -...|+...||||++....
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~h-G-lqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNH-G-LQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeecccc-c-cccccccccccCCCcceecchhhhhcCC
Confidence 9999999966 99999999999983 33 35889999988543221 1 111111 1225788899999987665
Q ss_pred CCCC---CchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC-CcCCCHHHHHHHHHhcccCCCCCC
Q 005678 592 TPLI---SSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS-RPAVSNEAKDLIRRCLTYNQAERP 667 (683)
Q Consensus 592 ~~~~---s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~-~~~~s~el~dLI~rCL~~dP~kRP 667 (683)
++.. -.+.|.|+.|.+.||++....||..... ..+..... ..-.+|. +..+++.+.+++..+|..||.+|+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~r~Y---qe~qLPalp~~vpp~~rqlV~~lL~r~pskRv 502 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDTRTY---QESQLPALPSRVPPVARQLVFDLLKRDPSKRV 502 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccch--heechhhh---hhhhCCCCcccCChHHHHHHHHHhcCCccccC
Confidence 4421 2479999999999999999999976322 11211111 1223333 347999999999999999999999
Q ss_pred CHHHH
Q 005678 668 DVLTL 672 (683)
Q Consensus 668 S~~eL 672 (683)
++.=+
T Consensus 503 sp~iA 507 (598)
T KOG4158|consen 503 SPNIA 507 (598)
T ss_pred CccHH
Confidence 86433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-20 Score=215.30 Aligned_cols=257 Identities=20% Similarity=0.242 Sum_probs=183.5
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
.|...+.||.+.|=.|.+|.+. ...|+||++-.....- .-.. +...+.|+. ...++|||.+++.-+-. .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p~~--sL~~-~~qrL~~ik-~~l~~~pn~lPfqk~~~-t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDPTI--SLRP-FKQRLEEIK-FALMKAPNCLPFQKVLV-TDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--CceEEEEEEeccCCCC--CchH-HHHHHHHHH-HHhhcCCcccchHHHHH-hhHHH
Confidence 6778899999999999999653 3349999875443111 1111 233445555 55678999999876644 45567
Q ss_pred EEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc--c
Q 005678 484 CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV--E 561 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~--~ 561 (683)
|+|-+|. ..+|++.|...+.+..-+.+.|+.|++.||.-+|..| |+|+|||.+||||++-+.+.|+||...+.. +
T Consensus 97 ylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCC
Confidence 7888998 5699999998888999999999999999999999966 999999999999999999999999877653 2
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccC--------CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHH
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSK--------TPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDT 632 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--------~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~ 632 (683)
.+.......+..+..--.+|+|||-|.... .+..+++.||||+||++.||++ |++||...+-- .++..
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~--aYr~~- 250 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL--AYRSG- 250 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH--hHhcc-
Confidence 332222222333334455799999986522 2347889999999999999998 89999532211 01100
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
. ....++--..--+..+..+|..|+..||++|.++++.|+-
T Consensus 251 -~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 -N-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -C-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 0000000000012368899999999999999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-19 Score=177.90 Aligned_cols=196 Identities=18% Similarity=0.069 Sum_probs=142.7
Q ss_pred eEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCceEE
Q 005678 406 ALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 406 ~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~~~~ 484 (683)
.+...|++|+||+||.+. ..+..|+.+-+.....|.... .-..+.+|+.+|++|. |++|+.++++ +..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~---~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGV---AWWLARREALALRQLDGLPRTPRLLHW-----DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEee--cCCceeeecccccchhhhhhH---HHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEE
Confidence 457889999999999884 477888888776655543321 1225788999999995 4788888875 2358
Q ss_pred EEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEeccc-CCcceEeCCCCcEEEEecCCccccccC
Q 005678 485 TVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDL-KPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDL-KP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
++|+|+.|.+|...+.. . ...++.+++.+|.++|..| |||||| ||.|||++.+|.++|+|||++......
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99999999998765321 1 1347789999999999966 999999 799999999999999999999865432
Q ss_pred cCC------Ccc--cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005678 564 VGS------QGM--ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHD 621 (683)
Q Consensus 564 ~~~------~~~--~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~ 621 (683)
... ..+ -+......++.|++|+.......+. -...++++.|+-+|.++|+..|+-.+
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~-~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTS-WIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccch-hHHHHHHHhcchHHHHHhccCCcccc
Confidence 210 000 0011123688899998765443221 14679999999999999999887443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=173.53 Aligned_cols=135 Identities=20% Similarity=0.198 Sum_probs=104.9
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-----CCCceeeeccccccCC--
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-----VHHHIVRLWDTFEIDQ-- 480 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-----~HpnIV~L~~~f~~d~-- 480 (683)
..+||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ .||||+++|+++..+.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc-------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 46899999999996 5666665 69987553211 134689999999999 6799999999998653
Q ss_pred ce-EEEEEec--ccCCChhHHHhcCCCcchHHHHHHHHHHHHHH-HHHHhcCCceEecccCCcceEeCC----CCcEEEE
Q 005678 481 NT-FCTVLEY--CSGKDLDAVLKATPVLPEREARIIIVQIFQGL-IYLNKRAQKIIHYDLKPGNVLFDE----FGVAKVT 552 (683)
Q Consensus 481 ~~-~~LV~Ey--~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL-~yLH~~g~~IIHrDLKP~NILLd~----~g~vKL~ 552 (683)
+. +.+|+|| +++++|.++++.. .+++. ..++.+++.++ .|||+.+ ||||||||+|||++. ++.++|+
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 23 4478999 5579999999765 36655 35678888887 8999965 999999999999974 3479999
Q ss_pred ecCCc
Q 005678 553 DFGLS 557 (683)
Q Consensus 553 DFGls 557 (683)
||+-+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=202.58 Aligned_cols=201 Identities=21% Similarity=0.219 Sum_probs=158.6
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC---CCceeee
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV---HHHIVRL 472 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~---HpnIV~L 472 (683)
..+++-+..|-|.+.||+|+||.||+|.... |+.||+|+-.....|.--.. ..++.+|+ -+.|+.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~----------~q~~~RLk~~~~~~~~~~ 759 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC----------LQVMERLKPQMLPSIMHI 759 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh----------HHHHHhhchhhhcchHHH
Confidence 4567778899999999999999999998766 99999999888877754322 22333443 2456666
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-------C
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-------E 545 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-------~ 545 (683)
+.++. -.+.-+||+||.+.|+|.+++...+.+++..+..++.||+..+..||..+ |||+||||+|+||. .
T Consensus 760 ~~a~~-~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 760 SSAHV-FQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHHc-cCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCc
Confidence 66654 34556799999999999999998889999999999999999999999966 99999999999994 2
Q ss_pred CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCC
Q 005678 546 FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRR 616 (683)
Q Consensus 546 ~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~ 616 (683)
+..++|+|||.+.-+.--.. + ......++|-.+-.+|+..+.. +++.+|.|.|+.+++-||+|++
T Consensus 837 ~~~l~lIDfG~siDm~lfp~--~-~~F~~~~~td~f~C~EM~~grp---WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPD--G-TKFKAVWHTDLFDCIEMREGRP---WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceEEEecccceeeeEcCC--C-cEEeeeeccccchhHHHhcCCC---CchhhhhHHHHHHHHHHHHHHH
Confidence 34699999998865432111 1 1223347888898999876444 9999999999999999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-18 Score=174.91 Aligned_cols=149 Identities=19% Similarity=0.129 Sum_probs=112.8
Q ss_pred eeEEEEecccCceEEEEEE-EccCCeEEEEEEeccCcccch-----------------hhHHHHHHHHHHHHHHHhhcCC
Q 005678 405 YALLNLLGKGGFSEVYKAY-DLVEHRYVACKLHGLNAQWSE-----------------DKKQSYIRHAIREYNIHKTLVH 466 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~-d~~~g~~VAVKi~~~~~~~~~-----------------~~~~~~i~~~~rEi~il~~L~H 466 (683)
|.+.+.||+|+||.||+|. +..+|..||||++........ .........+.+|+.++..+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7788999999999999998 667999999999865432100 0011112345689999999976
Q ss_pred Cc--eeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC
Q 005678 467 HH--IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD 544 (683)
Q Consensus 467 pn--IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd 544 (683)
.+ +..+++. ...++||||++|.+|...+.....+....+..++.+|+.+|.|||..+ .|+|+||||+|||++
T Consensus 110 ~~i~~p~~~~~-----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~ 183 (237)
T smart00090 110 AGVPVPKPIAW-----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH 183 (237)
T ss_pred cCCCCCeeeEe-----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE
Confidence 33 3333322 124799999999888776544445677777899999999999999842 399999999999999
Q ss_pred CCCcEEEEecCCcccc
Q 005678 545 EFGVAKVTDFGLSKIV 560 (683)
Q Consensus 545 ~~g~vKL~DFGls~~~ 560 (683)
++.++|+|||++...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 789999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-17 Score=163.78 Aligned_cols=141 Identities=21% Similarity=0.208 Sum_probs=112.1
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccch-hhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE-DKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~-~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~ 487 (683)
+.||+|++|.||+|.. .|..|++|+......... .........+.+|+.++..+.|++|+....++. +....++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-DPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-eCCCCEEEE
Confidence 5799999999999975 778899997654322111 111122346788999999999998876655553 456778999
Q ss_pred ecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 488 Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
||++|++|.+++..... ....++.+++.+|.+||..+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999865432 77889999999999999965 99999999999999 78999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6e-17 Score=160.51 Aligned_cols=138 Identities=20% Similarity=0.155 Sum_probs=106.7
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeccCccc-chhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEe
Q 005678 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQW-SEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLE 488 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~-~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~E 488 (683)
+||+|+||.||+|. .++..|++|........ ...........+.+|+.++..+.|+++.....++. +.+..++|||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-DPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-ECCCCEEEEE
Confidence 48999999999996 57789999986543211 11112223466788999999999887544333332 4556789999
Q ss_pred cccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 489 YCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 489 y~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
|++|++|.+++..... .++.+++.+|.+||..+ ++|+|++|.|||++ ++.++|+|||++...
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999998765421 78999999999999966 99999999999999 799999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.4e-17 Score=183.54 Aligned_cols=205 Identities=27% Similarity=0.367 Sum_probs=154.8
Q ss_pred HhhcCCCceeeeccccccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCc
Q 005678 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPG 539 (683)
Q Consensus 461 l~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~ 539 (683)
|+.+.|.|+.++++.+. ++..+++|.+||..|+|.+.+.. .-.+++.....++++|+.||.|||... -..|+.|++.
T Consensus 1 l~~l~h~n~~~f~g~~~-~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASV-DGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEe-cCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeeccc
Confidence 35788999999999985 67899999999999999999976 456888889999999999999999864 2399999999
Q ss_pred ceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCC----CCchhHHHHHHHHHHHHHcCC
Q 005678 540 NVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPL----ISSKVDVWSAGILFYQMLFGR 615 (683)
Q Consensus 540 NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~----~s~ksDVWSLGvILyELLtG~ 615 (683)
|.+++....+||+|||+.......... .......-..-|.|||.+....... .+.+.||||||++++|+++..
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~---~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEP---EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccc---cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999998876431000 0011112334599999987653322 477899999999999999999
Q ss_pred CCCCCCchHH----HHHHHHHHHH-hhccCCCCC---cCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 616 RPFGHDQTQE----RILREDTIIK-ARKVEFPSR---PAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 616 ~PF~~~~~~e----~il~~~~i~~-~~~~~~p~~---~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
.||....... .++. +.. ...+..|.- ..+++++..++.+||..+|..||++.++-
T Consensus 156 ~~~~~~~~~~~~~eii~~---~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILR---VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CccccccccCChHHHHHH---HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 9997533222 2222 112 111122221 14566799999999999999999998875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=159.70 Aligned_cols=144 Identities=26% Similarity=0.276 Sum_probs=108.8
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhh--H-------------HHHHHHHHHHHHHHhhcCCCc
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK--K-------------QSYIRHAIREYNIHKTLVHHH 468 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~--~-------------~~~i~~~~rEi~il~~L~Hpn 468 (683)
-|.+.+.||.|+||.||+|.. .+|+.||||++.......... . ......+.+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 377789999999999999976 479999999976543111100 0 001123677999999998874
Q ss_pred --eeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC
Q 005678 469 --IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF 546 (683)
Q Consensus 469 --IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~ 546 (683)
++..++ .+..++||||++|++|..+... .....++.+++.++.++|..+ |+|+||||.|||++.+
T Consensus 95 i~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 95 FPVPKPID-----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCceee-----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCC
Confidence 333332 2345899999999998776431 345678899999999999965 9999999999999999
Q ss_pred CcEEEEecCCccccc
Q 005678 547 GVAKVTDFGLSKIVE 561 (683)
Q Consensus 547 g~vKL~DFGls~~~~ 561 (683)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-17 Score=183.56 Aligned_cols=211 Identities=23% Similarity=0.339 Sum_probs=150.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeecc-------ccc----cCCceEEEEEecccCCChhHHHhcC---CCcchHHHHHHHHH
Q 005678 451 IRHAIREYNIHKTLVHHHIVRLWD-------TFE----IDQNTFCTVLEYCSGKDLDAVLKAT---PVLPEREARIIIVQ 516 (683)
Q Consensus 451 i~~~~rEi~il~~L~HpnIV~L~~-------~f~----~d~~~~~LV~Ey~~ggsL~~~L~~~---~~Lse~~~~~I~~q 516 (683)
.....+++..+....|-+..-+.+ .+. ....++||.|++|.-.+|.++|... ...++.....++.|
T Consensus 288 ~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q 367 (516)
T KOG1033|consen 288 CKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQ 367 (516)
T ss_pred hhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHh
Confidence 334555666666655544444433 110 0134688999999999999999643 34677788899999
Q ss_pred HHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCc-CCCcccccccCCCCCccCCcccccccCCCCC
Q 005678 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV-GSQGMELTSQGAGTYWYLPPECFELSKTPLI 595 (683)
Q Consensus 517 Ia~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~-~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~ 595 (683)
++.|+.| ++ .+|+|+||.||++..+..+||+|||+........ ......-..+.+||.+||+||.+.+.. |
T Consensus 368 ~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~---y 439 (516)
T KOG1033|consen 368 IAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ---Y 439 (516)
T ss_pred hccchhh---cc--chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhh---h
Confidence 9999999 44 9999999999999999999999999988776543 111112345568999999999998666 9
Q ss_pred CchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 005678 596 SSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTL 672 (683)
Q Consensus 596 s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eL 672 (683)
+.++||||||+||+|++. -..+|.... ..-......+| ..... +.-..|+..+|.+.|.+||++.+.
T Consensus 440 ~~kvdIyaLGlil~EL~~~f~T~~er~~---------t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 440 SEKVDIYALGLILAELLIQFSTQFERIA---------TLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhcchhhHHHHHHHHHHHhccHHHHHH---------hhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 999999999999999996 333332111 11111222233 11122 234589999999999999988888
Q ss_pred hcCcccC
Q 005678 673 AQDPYLT 679 (683)
Q Consensus 673 l~hP~l~ 679 (683)
..|+|++
T Consensus 510 ~~~~~~~ 516 (516)
T KOG1033|consen 510 ALHEFLQ 516 (516)
T ss_pred hhhhhcC
Confidence 8888864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-18 Score=199.34 Aligned_cols=266 Identities=26% Similarity=0.380 Sum_probs=205.2
Q ss_pred ccceeEEEEecccCceEEEEEEEc-cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccC
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDL-VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEID 479 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~-~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d 479 (683)
...|.+.+.||+|+|+.|-..... .....+|+|.+.... +......+...|..+-+.+. |+|++.+++... +
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-----~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-----KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-S 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-----CccchhhhcCccccccccccccccccccCCccC-C
Confidence 456888888999999999888653 334557777654443 12223456667888888887 999999999885 7
Q ss_pred CceEEEEEecccCCChhHHH-hcCC-CcchHHHHHHHHHHHHHHHHHH-hcCCceEecccCCcceEeCCCC-cEEEEecC
Q 005678 480 QNTFCTVLEYCSGKDLDAVL-KATP-VLPEREARIIIVQIFQGLIYLN-KRAQKIIHYDLKPGNVLFDEFG-VAKVTDFG 555 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L-~~~~-~Lse~~~~~I~~qIa~aL~yLH-~~g~~IIHrDLKP~NILLd~~g-~vKL~DFG 555 (683)
....+++++|..|+++...+ .... ..+...+..++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCch
Confidence 78889999999999999998 5554 6788888999999999999999 645 99999999999999999 99999999
Q ss_pred CccccccCcCCCcccccccCCC-CCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAG-TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~G-T~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
+|..+....+.. ......+| ++.|+|||.+.... ...+..|+||.|+++.-+++|..||.........+.. -+.
T Consensus 171 ~At~~~~~~g~~--~~~~~~~g~s~~y~a~E~~~~~~--~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~-~~~ 245 (601)
T KOG0590|consen 171 LATAYRNKNGAE--RSLKDRCGSSPPYGAPEHLSGKA--YRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS-WKS 245 (601)
T ss_pred hhccccccCCcc--eeeecccCCCCCCCCcccccchh--hcCCCcccccccccccccccCCCCcccccccccccee-ecc
Confidence 998876622222 22334467 99999999886532 2456789999999999999999999765543321110 000
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.........+..++....+++.+++..+|..|.+..++-.+||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1112234455678899999999999999999999999999999986
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.8e-16 Score=177.96 Aligned_cols=145 Identities=22% Similarity=0.194 Sum_probs=110.2
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCc-ccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNA-QWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~-~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
...|...+.||+|+||+||+|.. .+..+++|...... .............+.+|+.++..++|++|+..+.++. +.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~--~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~ 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEY--LGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV-DP 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEee--cCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE-eC
Confidence 34556788999999999999965 34445555432211 1111112223456889999999999999887665443 45
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
...++||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|||+++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 56789999999999999875 34678999999999999965 9999999999999 5789999999999753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-15 Score=147.98 Aligned_cols=143 Identities=24% Similarity=0.260 Sum_probs=98.7
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHH-----------------HHHHHHHHHHHhhcCCCc--
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSY-----------------IRHAIREYNIHKTLVHHH-- 468 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~-----------------i~~~~rEi~il~~L~Hpn-- 468 (683)
.+.||+|+||.||+|.+. ++..||||++.............. ......|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999875 799999999865433221111100 001134666666665443
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHH-HhcCCCcchHHHHHHHHHHHHHHHHHHh-cCCceEecccCCcceEeCCC
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAV-LKATPVLPEREARIIIVQIFQGLIYLNK-RAQKIIHYDLKPGNVLFDEF 546 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~-L~~~~~Lse~~~~~I~~qIa~aL~yLH~-~g~~IIHrDLKP~NILLd~~ 546 (683)
+.+.+++ ...++||||++|+++... +.... .. ..+..++.+++.++.++|. .+ |+|+||||+|||++ +
T Consensus 81 ~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 81 VPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-D 150 (187)
T ss_pred CCceEec-----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-C
Confidence 3334432 235899999998544321 21111 11 6678899999999999998 55 99999999999999 8
Q ss_pred CcEEEEecCCccccc
Q 005678 547 GVAKVTDFGLSKIVE 561 (683)
Q Consensus 547 g~vKL~DFGls~~~~ 561 (683)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=149.92 Aligned_cols=142 Identities=18% Similarity=0.167 Sum_probs=104.0
Q ss_pred EEec-ccCceEEEEEEEccCCeEEEEEEeccCcccchhhH------HHHHHHHHHHHHHHhhcCCCce--eeeccccccC
Q 005678 409 NLLG-KGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKK------QSYIRHAIREYNIHKTLVHHHI--VRLWDTFEID 479 (683)
Q Consensus 409 ~~LG-kGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~------~~~i~~~~rEi~il~~L~HpnI--V~L~~~f~~d 479 (683)
..|| .||.|+||.+.. .+..++||.+........... ......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888988854 477899998754221100000 1123567889999999998875 5566554322
Q ss_pred Cce---EEEEEecccC-CChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 480 QNT---FCTVLEYCSG-KDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 480 ~~~---~~LV~Ey~~g-gsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
... .++||||++| .+|..++... .+++. .+.+|+.+|.+||..| |+|+||||.|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECC
Confidence 222 3599999997 6999888654 35544 3568999999999966 9999999999999988999999999
Q ss_pred Cccc
Q 005678 556 LSKI 559 (683)
Q Consensus 556 ls~~ 559 (683)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=132.37 Aligned_cols=134 Identities=23% Similarity=0.263 Sum_probs=108.4
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC--CceeeeccccccCCceEE
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH--HHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H--pnIV~L~~~f~~d~~~~~ 484 (683)
+++.||.|+++.||++.+ .+..+++|....... ...+..|+.++..+.| +++++++..+. ..+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~---------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-~~~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK---------GADREREVAILQLLARKGLPVPKVLASGE-SDGWSY 69 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCc---------hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-CCCccE
Confidence 457899999999999975 347899998754321 2357788899999976 48888887765 456789
Q ss_pred EEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcC-CceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 485 TVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA-QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g-~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
++|||++|+.+..+ +......++.+++.+|.+||... .+++|+||+|.|||++..+.++++|||++..
T Consensus 70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999998877654 45666778999999999999852 3599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9e-14 Score=155.44 Aligned_cols=263 Identities=20% Similarity=0.262 Sum_probs=194.6
Q ss_pred cccccceeEEEEecc--cCceEEEEEEE--ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeec
Q 005678 399 QILNHRYALLNLLGK--GGFSEVYKAYD--LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLW 473 (683)
Q Consensus 399 ~i~~~ry~l~~~LGk--GgfG~Vyka~d--~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~ 473 (683)
.+....+.+...+|. |.+|.||.+.. ..++..+|+|.-.......... ..-.+|+.....++ |+|.|+.+
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~-----~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS-----KRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc-----ccccchhhcccccCccccccccC
Confidence 455677888899999 99999999987 7889999999743333322221 12345666677774 99999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHH----HHHHHHhcCCceEecccCCcceEeCCC-C
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQ----GLIYLNKRAQKIIHYDLKPGNVLFDEF-G 547 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~----aL~yLH~~g~~IIHrDLKP~NILLd~~-g 547 (683)
..|. +.+..++-+|+| +.+|..+.... ..++...++.++.+... ||.++|. .+++|-|+||.||++..+ .
T Consensus 185 ~~~e-~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 185 PAWE-GSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred cccc-cCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccc
Confidence 8886 778888999999 56777777543 45899999999999999 9999998 459999999999999998 8
Q ss_pred cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
.++++|||+...+....-...........|...|++||... +.++...|+|+||.++.+-.+|-.++....... +
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~----~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W 335 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN----GLATFASDIFSLGEVILEAILGSHLPSVGKNSS-W 335 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc----cccchHhhhcchhhhhHhhHhhcccccCCCCCC-c
Confidence 99999999998876654332222234447888899999874 336889999999999999988876654331110 0
Q ss_pred HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 628 l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
...+... ...++ ....+..+...+..++..+|..|++...+..++++.
T Consensus 336 ~~~r~~~--ip~e~--~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 336 SQLRQGY--IPLEF--CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred ccccccc--Cchhh--hcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 0100000 11111 123455666689999999999999999999999875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.3e-13 Score=142.30 Aligned_cols=207 Identities=21% Similarity=0.275 Sum_probs=142.5
Q ss_pred HHHhhcCCCceeeecccccc----CCceEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCc
Q 005678 459 NIHKTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQK 530 (683)
Q Consensus 459 ~il~~L~HpnIV~L~~~f~~----d~~~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~ 530 (683)
.-+-++.|.|||+++.+|.. +.....+++|||..|+|..+|++ ...+......+++-||++||.|||+..++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 34445679999999988852 23457789999999999999954 35688888899999999999999999999
Q ss_pred eEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHH
Q 005678 531 IIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQ 610 (683)
Q Consensus 531 IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyE 610 (683)
|+|+++..+-|++..+|-+||+---.....+ ........-.....|-++|.+||+=. ....+-.+|||+||.+..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~-s~~~~~~~Ek~~~~~~~g~~a~~sg~---~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHP-SVNSTREAEKSVNTSLPGFSAPESGT---TTNTTGASDIYKFGMCALE 274 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccch-hhhhhhHhhhhccccCCccccCCcCc---ccccccchhhhhhhHHHHH
Confidence 9999999999999999988875321111110 00000001122235778999999533 3335678999999999999
Q ss_pred HHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHH-HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 611 MLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNE-AKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 611 LLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~e-l~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
|.-+..--+...+ ....+..+ ....+. +++. -..+|.+|+...|..||++..++.||-+
T Consensus 275 mailEiq~tnseS--~~~~ee~i---a~~i~~----len~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 275 MAILEIQSTNSES--KVEVEENI---ANVIIG----LENGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred HHHheeccCCCcc--eeehhhhh---hhheee----ccCccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 9877643222111 01111111 111111 1111 2468999999999999999999999965
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.3e-14 Score=163.16 Aligned_cols=268 Identities=26% Similarity=0.306 Sum_probs=201.0
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
...-+.+.+.+-+-.|.||.++.+.-..+|...++|++....... ...++...++-.++-...||.++..+..|.
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~----~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~- 874 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR----TNDYESIRSKSNILITPRSPAVVRSFPSFP- 874 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhc----cccccccCCccCccccCCCCceecccCCCC-
Confidence 345566778888999999999999766677677777654432111 111334445555555566788887766643
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.....++|++|+.+++|...|...+..+..-++..+..++.++.|||... ++|+|++|.|+|...+|..+++|||...
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccc
Confidence 56678899999999999999988888888889999999999999999853 8999999999999999999999998433
Q ss_pred ccccC---cCC------------------Cc-----ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 559 IVEDD---VGS------------------QG-----MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 559 ~~~~~---~~~------------------~~-----~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
.+..- .+. .. ........||+.|++||...+.. ..+.+|+|++|+++++.+
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~---hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR---HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc---CCCcchhhhhhhhhhhhh
Confidence 22110 000 00 01122357999999999886554 567889999999999999
Q ss_pred cCCCCCCCCchHHHHHHHHHHHHhhccCCCCCc-CCCHHHHHHHHHhcccCCCCCCCHH---HHhcCcccCC
Q 005678 613 FGRRPFGHDQTQERILREDTIIKARKVEFPSRP-AVSNEAKDLIRRCLTYNQAERPDVL---TLAQDPYLTY 680 (683)
Q Consensus 613 tG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~-~~s~el~dLI~rCL~~dP~kRPS~~---eLl~hP~l~~ 680 (683)
+|.+||.....+..+- -+......+|..+ ..+.++++++.+.|..+|.+|..+. ++-.||||+-
T Consensus 1030 ~g~pp~na~tpq~~f~----ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFE----NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred cCCCCCCCcchhhhhh----ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCC
Confidence 9999998877765441 1333445566544 5788999999999999999999887 7888999974
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.6e-12 Score=145.52 Aligned_cols=148 Identities=18% Similarity=0.188 Sum_probs=98.0
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHH---------------------------HHHH------HHH
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQ---------------------------SYIR------HAI 455 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~---------------------------~~i~------~~~ 455 (683)
+.||.|++|.||+|.. .+|+.||||+........-..+. .+.. .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999974 57999999998665321110000 0001 244
Q ss_pred HHHHHHhhcC----CCceeeeccccccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHH-HHHHHHhcCC
Q 005678 456 REYNIHKTLV----HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQ-GLIYLNKRAQ 529 (683)
Q Consensus 456 rEi~il~~L~----HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~-aL~yLH~~g~ 529 (683)
+|...+..+. |.+-|.+-.+|.......+|||||++|++|.++.... ..+ ....++..++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC-
Confidence 5555555552 2222332223322233468999999999999886432 112 23345555555 467788755
Q ss_pred ceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
++|+|++|.||+++.+|.++|+|||++..+..
T Consensus 278 -~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 -FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.9e-12 Score=147.51 Aligned_cols=149 Identities=18% Similarity=0.228 Sum_probs=95.9
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccc---------------------------hhhHHHHHHHHHHH
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWS---------------------------EDKKQSYIRHAIRE 457 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~---------------------------~~~~~~~i~~~~rE 457 (683)
|.. +.||.|++|.||+|....+|+.||||+........ ......+.+.+.+|
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 444 67999999999999987779999999987653210 00011222333333
Q ss_pred HH------HHhhcC----CCceeeeccccccCCceEEEEEecccCCChhHH--HhcCC----CcchHHHHHHHHHHHHHH
Q 005678 458 YN------IHKTLV----HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAV--LKATP----VLPEREARIIIVQIFQGL 521 (683)
Q Consensus 458 i~------il~~L~----HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~--L~~~~----~Lse~~~~~I~~qIa~aL 521 (683)
+. .+.++. +.+.+.+-.+|..-....+|||||+.|+.+.++ +...+ .+.+..+..++.|++
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--- 277 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--- 277 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH---
Confidence 33 333332 333333222332223345799999999999875 33333 244555555555554
Q ss_pred HHHHhcCCceEecccCCcceEeCCCC----cEEEEecCCccccccC
Q 005678 522 IYLNKRAQKIIHYDLKPGNVLFDEFG----VAKVTDFGLSKIVEDD 563 (683)
Q Consensus 522 ~yLH~~g~~IIHrDLKP~NILLd~~g----~vKL~DFGls~~~~~~ 563 (683)
.. +++|+|+||+||+++.+| .++++|||++..++..
T Consensus 278 ----~~--GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 ----RD--GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----hC--CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 23 499999999999999887 9999999999877543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.3e-11 Score=121.94 Aligned_cols=145 Identities=16% Similarity=0.105 Sum_probs=101.1
Q ss_pred EEecccCceEEEEEEEcc------CCeEEEEEEeccCcccchhh-------------------HHHHHHHHHHHHHHHhh
Q 005678 409 NLLGKGGFSEVYKAYDLV------EHRYVACKLHGLNAQWSEDK-------------------KQSYIRHAIREYNIHKT 463 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~------~g~~VAVKi~~~~~~~~~~~-------------------~~~~i~~~~rEi~il~~ 463 (683)
..||.|--+.||.|.... .+..+|||++......-... ......-+.+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999997543 35899999987653321100 11111123479999999
Q ss_pred cCC--CceeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHH-HhcCCceEecccCCcc
Q 005678 464 LVH--HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL-NKRAQKIIHYDLKPGN 540 (683)
Q Consensus 464 L~H--pnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yL-H~~g~~IIHrDLKP~N 540 (683)
+.. -++..++++ ..-+|||||+.+..+....-....++......++.+++.+|.+| |..+ |||+||+|.|
T Consensus 83 l~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence 853 455555543 23468999997654432222222456666777889999999999 7755 9999999999
Q ss_pred eEeCCCCcEEEEecCCccccc
Q 005678 541 VLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 541 ILLd~~g~vKL~DFGls~~~~ 561 (683)
||++. +.++|+|||.+....
T Consensus 156 IL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC-CcEEEEECCCceeCC
Confidence 99974 789999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.1e-11 Score=134.97 Aligned_cols=170 Identities=22% Similarity=0.246 Sum_probs=128.4
Q ss_pred EEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecccCCChhHHHh
Q 005678 421 KAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK 500 (683)
Q Consensus 421 ka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~ 500 (683)
.|..+.++.+|.|..+..... .....+.+-+.-++.++||||++++++++ ..+.+|||+|-+ -.|..+++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~-------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-~~~~~ylvTErV--~Pl~~~lk 99 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG-------EVTELAKRAVKRLKTLRHPNILSYLDTTE-EEGTLYLVTERV--RPLETVLK 99 (690)
T ss_pred ccceeccCCceEEEEEeCCCc-------hhhHHHHHHHHHhhhccCchhhhhhhhhc-ccCceEEEeecc--ccHHHHHH
Confidence 466678899999998865432 22344567788899999999999999997 556899999998 47888887
Q ss_pred cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCc
Q 005678 501 ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580 (683)
Q Consensus 501 ~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~ 580 (683)
.- +.......+.||+.||.|||..+ +++|++|.-+-|+++..|..||++|-++......... .....--..
T Consensus 100 ~l---~~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-----~~~~~~~~s 170 (690)
T KOG1243|consen 100 EL---GKEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-----AKSLYLIES 170 (690)
T ss_pred Hh---HHHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-----cccchhhhc
Confidence 64 46777788999999999999764 7999999999999999999999999988654332110 000111223
Q ss_pred cCCcccccccCCCCCCchhHHHHHHHHHHHHHcC
Q 005678 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFG 614 (683)
Q Consensus 581 Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG 614 (683)
|..|+.+... ....|.|-|||++|+++.|
T Consensus 171 ~~~P~~~~~s-----~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 171 FDDPEEIDPS-----EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccChhhcCcc-----ccchhhhhHHHHHHHHhCc
Confidence 6677654321 1346999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.5e-11 Score=118.14 Aligned_cols=129 Identities=19% Similarity=0.177 Sum_probs=93.7
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceee-eccccccCCceEEEE
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVR-LWDTFEIDQNTFCTV 486 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~-L~~~f~~d~~~~~LV 486 (683)
++.|+.|.++.||++.. .+..|++|+....... ...+..|+.++..+.+.++++ ++..+ ....++|
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~--------~~~~~~E~~~l~~l~~~~~~P~~~~~~---~~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTEL--------LINRENEAENSKLAAEAGIGPKLYYFD---PETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCccc--------ccCHHHHHHHHHHHHHhCCCCceEEEe---CCCCeEE
Confidence 46789999999999964 4788999987543210 113456888888886655544 44332 2335799
Q ss_pred EecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCC---ceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 487 LEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ---KIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 487 ~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~---~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
|||++|.++... . . ....++.+++.+|..||..+. .++|+|++|.||+++ ++.++|+|||.+.
T Consensus 70 ~e~i~G~~l~~~----~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTE----D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCccccc----c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999999887653 0 1 123456799999999998642 369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.7e-11 Score=133.23 Aligned_cols=251 Identities=20% Similarity=0.228 Sum_probs=178.2
Q ss_pred cccceeEEEEecccCceEEEEEEEc-cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDL-VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI 478 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~-~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~ 478 (683)
....|.++..||.|.|+.||.+... .++..|++|-........... ...+.|+.+...+ .|.+++.++..|.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-----i~sl~ev~l~~~l~~~~~~~g~~~~W~- 336 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-----IFSLGEVILEAILGSHLPSVGKNSSWS- 336 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-----hcchhhhhHhhHhhcccccCCCCCCcc-
Confidence 3456888999999999999987644 678889999664443332221 1234566666665 4889999888886
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC-CcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF-GVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~-g~vKL~DFGls 557 (683)
.....|+-.|||.++++...+.-...+.+...+.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||+.
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccc
Confidence 44556689999999998887755556888899999999999999999855 9999999999999876 88999999988
Q ss_pred cccccCcCCCcccccccCCCCCccCC-cccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLP-PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~A-PE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
..+..... ...++-++.| +|.+.. ...+-.+.|++|||+.+.+.++|... ........ .+
T Consensus 415 t~~~~~~~--------~~~~~~r~~p~~~~~~e--~~~~~~~~~~~sl~~~~~e~~~~~~l-s~~~~~~~-----~i--- 475 (524)
T KOG0601|consen 415 TRLAFSSG--------VFHHIDRLYPIAEILLE--DYPHLSKADIFSLGLSVDEAITGSPL-SESGVQSL-----TI--- 475 (524)
T ss_pred cccceecc--------cccccccccccchhhcc--ccccccccccccccccccccccCccc-Ccccccce-----ee---
Confidence 64322111 0123334442 444332 22367799999999999999987632 22211110 01
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..-..|..+..+..+..+...++..++..||.+.++..|+=|
T Consensus 476 ~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 476 RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111234445566788899999999999999999999887643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.9e-09 Score=116.00 Aligned_cols=213 Identities=19% Similarity=0.208 Sum_probs=155.5
Q ss_pred ceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc---CCceEEEEEecccC
Q 005678 416 FSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI---DQNTFCTVLEYCSG 492 (683)
Q Consensus 416 fG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~---d~~~~~LV~Ey~~g 492 (683)
-.+.|+++...+|..|++|.++.+..-...+. ..-+++++++.|+|||++.++|.. +...+++||+|+|+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~-------t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKD-------TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccc-------hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 35789999999999999998854433333222 224678899999999999988852 46689999999997
Q ss_pred -CChhHHHhc---------------CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 493 -KDLDAVLKA---------------TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 493 -gsL~~~L~~---------------~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
++|.++... +..+++..+|.++.|+..||.++|+.| +..+-|.|.+||++.+-.++|..+|+
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i 439 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGI 439 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccc
Confidence 677766521 124788999999999999999999977 88899999999999888999998888
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRP-FGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~P-F~~~~~~e~il~~~~i~~ 635 (683)
...+..+.+ +-+.. -.+-|.=.||.+++.|.||..- +.....+..-+. .+
T Consensus 440 ~Dvl~~d~~-------------------~~le~------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--~I-- 490 (655)
T KOG3741|consen 440 MDVLQEDPT-------------------EPLES------QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--RI-- 490 (655)
T ss_pred eeeecCCCC-------------------cchhH------HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--Hh--
Confidence 776654320 11221 2256999999999999999633 222222221111 11
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.+.++.++.++|.-+...++++ -++.+++.+
T Consensus 491 --------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 --------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1347788999999999888886 677777654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-09 Score=107.96 Aligned_cols=136 Identities=21% Similarity=0.240 Sum_probs=97.5
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcc-cchhhHHHHHHHHHHHHHHHhhcCCCce--eeeccccccCCceEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQ-WSEDKKQSYIRHAIREYNIHKTLVHHHI--VRLWDTFEIDQNTFCT 485 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~-~~~~~~~~~i~~~~rEi~il~~L~HpnI--V~L~~~f~~d~~~~~L 485 (683)
.++++|+-+.+|.+. .-|..+.+|.-..... -+.....-....-.+|..++..+.--.| ..+|+ .+.+...|
T Consensus 2 ~~i~~GAEa~i~~~~--~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d---vD~~~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTD--FLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD---VDPDNGLI 76 (204)
T ss_pred chhhCCcceeEEeee--ccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE---EcCCCCEE
Confidence 357899999999994 3555677775322211 1222222223456789999998864433 33333 35677789
Q ss_pred EEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 486 VLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 486 V~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+|||++|..|.+++... ...++..+-.-+.-||..| |||+||.++||++.. +.+.++||||+.+
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~-~~i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSG-GRIYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeC-CcEEEEECCcccc
Confidence 99999999999998765 2456777888889999966 999999999999987 4499999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-09 Score=108.80 Aligned_cols=143 Identities=23% Similarity=0.254 Sum_probs=105.0
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCC--ceeeeccccccCC--ceEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH--HIVRLWDTFEIDQ--NTFC 484 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hp--nIV~L~~~f~~d~--~~~~ 484 (683)
+.||.|.++.||++.. .+|..+++|+....... .....+..|+.++..+.+. ++.+++.+..... +..+
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALL------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccC------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 6789999999999975 33578999986543221 0123567899999998753 3455665543211 3568
Q ss_pred EEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 005678 485 TVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR------------------------------------- 527 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~------------------------------------- 527 (683)
+||||++|.+|...+.. ..+++.....++.+++.+|.+||+.
T Consensus 77 ~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 77 YVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 99999999988876542 3467777778888888888888842
Q ss_pred -----------------CCceEecccCCcceEeCC--CCcEEEEecCCccc
Q 005678 528 -----------------AQKIIHYDLKPGNVLFDE--FGVAKVTDFGLSKI 559 (683)
Q Consensus 528 -----------------g~~IIHrDLKP~NILLd~--~g~vKL~DFGls~~ 559 (683)
...+||+|+.|.|||++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134899999999999998 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2e-08 Score=98.81 Aligned_cols=149 Identities=19% Similarity=0.153 Sum_probs=103.2
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEeccCcc-cchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEE
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQ-WSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT 485 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~-~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~L 485 (683)
.+.+|-+|+-+.|+++ ...|+.+.||.-..... -+....+-..+.-.+|...+.++.--.|...--+| .|...-+|
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~-~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF-IDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE-EecCCCeE
Confidence 5678899999999999 57888888884322211 12222233345667889998888644433222123 25555678
Q ss_pred EEecccC-CChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC---cEEEEecCCccc
Q 005678 486 VLEYCSG-KDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG---VAKVTDFGLSKI 559 (683)
Q Consensus 486 V~Ey~~g-gsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g---~vKL~DFGls~~ 559 (683)
+|||++| .++.+++... ..........++..|-..|.-||..+ |||+||..+||+|..+| .+.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999977 5788887433 22333334678899999999999855 99999999999998655 358999999864
Q ss_pred c
Q 005678 560 V 560 (683)
Q Consensus 560 ~ 560 (683)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5e-08 Score=105.81 Aligned_cols=244 Identities=16% Similarity=0.175 Sum_probs=154.8
Q ss_pred eEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceee--------ecccc
Q 005678 406 ALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVR--------LWDTF 476 (683)
Q Consensus 406 ~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~--------L~~~f 476 (683)
.....||+||.+.+|-.- .-+-.+.|+++....-... .-+..|... .||-+-. |||.-
T Consensus 14 ~~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa~~a----------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPAAQA----------QKVAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred CCCccccCCccceeeecc---hhhchhheeecCCCchHHH----------HHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 345779999999999662 2233455776554321111 122233333 4553322 33321
Q ss_pred ccCCceEEEEEecccCC-ChhHHH------hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcE
Q 005678 477 EIDQNTFCTVLEYCSGK-DLDAVL------KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA 549 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~gg-sL~~~L------~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~v 549 (683)
......++|..++|. ....++ ...+...|..+.+.++.++.+...||..| .+-+|+.++|+|+.+++.+
T Consensus 81 --~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V 156 (637)
T COG4248 81 --RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKV 156 (637)
T ss_pred --ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceE
Confidence 233467888888774 233333 23356889999999999999999999977 8899999999999999999
Q ss_pred EEEecCCccccccCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcC-CCCCCCC-----
Q 005678 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFG-RRPFGHD----- 621 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG-~~PF~~~----- 621 (683)
.|.|-....+-.++ .....++|.+.|+|||.-.... .-.-+...|.|.|||++|++|.| ++||...
T Consensus 157 ~LVdsDsfqi~~ng------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ 230 (637)
T COG4248 157 VLVDSDSFQINANG------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD 230 (637)
T ss_pred EEEcccceeeccCC------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence 99985433322211 3456779999999999754211 11246678999999999999986 9999542
Q ss_pred --chHHHHHHHHHHHHh---hc-cC----CCCCcCCCHHHHHHHHHhccc--CCCCCCCHHHH
Q 005678 622 --QTQERILREDTIIKA---RK-VE----FPSRPAVSNEAKDLIRRCLTY--NQAERPDVLTL 672 (683)
Q Consensus 622 --~~~e~il~~~~i~~~---~~-~~----~p~~~~~s~el~dLI~rCL~~--dP~kRPS~~eL 672 (683)
...+.-+........ .. .. -+...-+++++..+..+|++. ++.-||+++..
T Consensus 231 ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 231 APNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred CCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 122211111110000 00 00 111245788999999999964 46789997654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.2e-08 Score=99.96 Aligned_cols=132 Identities=25% Similarity=0.310 Sum_probs=84.1
Q ss_pred EEEEEEEccCCeEEEEEEeccCcccch-------------------hhHHHHHHHHHHHHHHHhhcCCC--ceeeecccc
Q 005678 418 EVYKAYDLVEHRYVACKLHGLNAQWSE-------------------DKKQSYIRHAIREYNIHKTLVHH--HIVRLWDTF 476 (683)
Q Consensus 418 ~Vyka~d~~~g~~VAVKi~~~~~~~~~-------------------~~~~~~i~~~~rEi~il~~L~Hp--nIV~L~~~f 476 (683)
.||.|.. .+|.+||||++......-. ...........+|+..|..+..- ++..++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899975 6788999999876432211 01112234567899999999765 455555432
Q ss_pred ccCCceEEEEEeccc--CCChhHHHhcCCCcchHHHHHHHHHHHHHHHH-HHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 477 EIDQNTFCTVLEYCS--GKDLDAVLKATPVLPEREARIIIVQIFQGLIY-LNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~--ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~y-LH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
. -+|||||++ |..+..+.... ++......++.+++..+.. +|..| |||+||.+.|||++++ .+.|+|
T Consensus 80 ---~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--
T ss_pred ---C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEe
Confidence 2 259999998 66665544322 2355667788888886666 46655 9999999999999985 999999
Q ss_pred cCCcccc
Q 005678 554 FGLSKIV 560 (683)
Q Consensus 554 FGls~~~ 560 (683)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.7e-09 Score=123.23 Aligned_cols=159 Identities=18% Similarity=0.267 Sum_probs=112.4
Q ss_pred HHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCC----CcccccccCCCCCccCCcccccccC
Q 005678 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS----QGMELTSQGAGTYWYLPPECFELSK 591 (683)
Q Consensus 516 qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~----~~~~l~~~~~GT~~Y~APE~~~~~~ 591 (683)
+++.|+.|+|.. .++||++|.|.+|.++.+|..||+.|+++........- ..+.+.....-...|.|||++....
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 445999999986 47999999999999999999999999988655432110 0111122223456699999986533
Q ss_pred CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHH
Q 005678 592 TPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVL 670 (683)
Q Consensus 592 ~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~ 670 (683)
.+.++|+||+||++|.+.. |+.-|........ +. ........-.+.....++.++.+=+.+++..++.-||++.
T Consensus 186 ---~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~-~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 186 ---NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YS-FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred ---ccccccceeeeeEEEEEecCCcchhhccCCcch-hh-hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence 6789999999999999995 4444433221111 11 1111122223334467999999999999999999999999
Q ss_pred HHhcCcccCC
Q 005678 671 TLAQDPYLTY 680 (683)
Q Consensus 671 eLl~hP~l~~ 680 (683)
.+...|||+-
T Consensus 261 ~l~~~~ff~D 270 (700)
T KOG2137|consen 261 LLLSIPFFSD 270 (700)
T ss_pred hhhcccccCC
Confidence 9999999974
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.8e-08 Score=101.49 Aligned_cols=143 Identities=27% Similarity=0.282 Sum_probs=97.9
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhh--HH-------------HHHHHHHHHHHHHhhcCCC--
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK--KQ-------------SYIRHAIREYNIHKTLVHH-- 467 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~--~~-------------~~i~~~~rEi~il~~L~Hp-- 467 (683)
+.+...||-|--|.||.|.+ ..|.++|||++......-... .. .....+.+|+.+|..|.--
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 56778999999999999986 478999999986653221100 00 1123577899999998543
Q ss_pred ceeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC
Q 005678 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 468 nIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g 547 (683)
.+...++. +.=++||||++|..|...- ++......|+..|+.-+.-+-..| |||+|+++-|||++++|
T Consensus 172 ~VP~P~~~-----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg 239 (304)
T COG0478 172 KVPKPIAW-----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCCcccc-----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCC
Confidence 45555532 3346899999987665542 123333344444444444444444 99999999999999999
Q ss_pred cEEEEecCCcccc
Q 005678 548 VAKVTDFGLSKIV 560 (683)
Q Consensus 548 ~vKL~DFGls~~~ 560 (683)
.+.++||--+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999766543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.1e-07 Score=100.22 Aligned_cols=137 Identities=18% Similarity=0.058 Sum_probs=92.0
Q ss_pred EEEEEEEccCCeEEEEEEeccCcccchhhHH-----HHHHHHHHHHHHHhhcCCCcee--eecccccc--C--CceEEEE
Q 005678 418 EVYKAYDLVEHRYVACKLHGLNAQWSEDKKQ-----SYIRHAIREYNIHKTLVHHHIV--RLWDTFEI--D--QNTFCTV 486 (683)
Q Consensus 418 ~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~-----~~i~~~~rEi~il~~L~HpnIV--~L~~~f~~--d--~~~~~LV 486 (683)
.|+++ ...|+.|.||.+... .|....+. .-...+.+|+..+..|..-+|. .+..+++. + ...-+||
T Consensus 37 rvvr~--~~~g~~~~vKr~~~~-~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRF--ELAGKSYFLKWHRGT-GWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEE--EECCEEEEEEEecCC-cHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 35565 356788999976332 22111110 0011477888888877432222 22222221 1 2346799
Q ss_pred EecccCC-ChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-------CCcEEEEecCC
Q 005678 487 LEYCSGK-DLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-------FGVAKVTDFGL 556 (683)
Q Consensus 487 ~Ey~~gg-sL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-------~g~vKL~DFGl 556 (683)
||++++. +|.+++.. ....+......++.+++..+.-||..| |+|+|++|+|||++. ++.+.|+||+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 9999886 89998853 234566777889999999999999966 999999999999975 46899999998
Q ss_pred ccc
Q 005678 557 SKI 559 (683)
Q Consensus 557 s~~ 559 (683)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.4e-07 Score=90.96 Aligned_cols=106 Identities=21% Similarity=0.192 Sum_probs=79.7
Q ss_pred HHHHHHHHHhhcCC-----CceeeeccccccCCceEEEEEecccCC-ChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHh
Q 005678 453 HAIREYNIHKTLVH-----HHIVRLWDTFEIDQNTFCTVLEYCSGK-DLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526 (683)
Q Consensus 453 ~~~rEi~il~~L~H-----pnIV~L~~~f~~d~~~~~LV~Ey~~gg-sL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~ 526 (683)
.+.+|...+..|.. |.+|-+...-.......+||+|++++. +|.+++.....++......++.+++..+.-||.
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 56777777777743 333332211110113457999999884 899999875557777888999999999999999
Q ss_pred cCCceEecccCCcceEeCCCC---cEEEEecCCcccc
Q 005678 527 RAQKIIHYDLKPGNVLFDEFG---VAKVTDFGLSKIV 560 (683)
Q Consensus 527 ~g~~IIHrDLKP~NILLd~~g---~vKL~DFGls~~~ 560 (683)
.| |+|+|++|.|||++.++ .+.|+||+-++..
T Consensus 137 ~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 137 AG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred Cc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 66 99999999999999876 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.8e-06 Score=89.09 Aligned_cols=144 Identities=22% Similarity=0.223 Sum_probs=96.0
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHH------------------HHHHHHHHHHhhcC--CC
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYI------------------RHAIREYNIHKTLV--HH 467 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i------------------~~~~rEi~il~~L~--Hp 467 (683)
...|..|--+.||+|.. .++.+||+|++......... ...++ .=...|+.-|+++. +-
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~-~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKR-IRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhh-HHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 44677888889999963 67899999998765443221 11111 11345777777763 34
Q ss_pred ceeeeccccccCCceEEEEEecccCCChh-HHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC
Q 005678 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLD-AVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF 546 (683)
Q Consensus 468 nIV~L~~~f~~d~~~~~LV~Ey~~ggsL~-~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~ 546 (683)
.+.+-++++. -.|||||++...+- -.|+.- .+...++..+..+++..+.-|-.. .++||+||+.-|||+. +
T Consensus 131 rvP~Pi~~~~-----nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~-a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 131 RVPEPIAFRN-----NVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKE-AGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCCceeecC-----CeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHh-cCcccccchhhheEEE-C
Confidence 4455554432 35899999553111 112222 233446778888898888888763 2599999999999999 7
Q ss_pred CcEEEEecCCccccc
Q 005678 547 GVAKVTDFGLSKIVE 561 (683)
Q Consensus 547 g~vKL~DFGls~~~~ 561 (683)
+.+.|+|||-|....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 999999999887554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.4e-06 Score=99.36 Aligned_cols=148 Identities=16% Similarity=0.212 Sum_probs=93.1
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHH---------------------------HHH------HHH
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQS---------------------------YIR------HAI 455 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~---------------------------~i~------~~~ 455 (683)
..|+.++-|.||+|.. .+|+.||||+.+++....-..+-. +.+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5689999999999984 569999999987764321111111 111 134
Q ss_pred HHHHHHhhcC-----CCceeeeccccccCCceEEEEEecccCCChhHHH--hcCCCcchHHHHHHHHHHHHHHHHHHhcC
Q 005678 456 REYNIHKTLV-----HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL--KATPVLPEREARIIIVQIFQGLIYLNKRA 528 (683)
Q Consensus 456 rEi~il~~L~-----HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L--~~~~~Lse~~~~~I~~qIa~aL~yLH~~g 528 (683)
+|..-+.+++ .|+|. +=.+|..-.+.-+++|||++|..+.+.. +. ..++...+.....+++--.-+-|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~d--- 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLRD--- 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHhc---
Confidence 4555555542 33322 1122222234556999999999998884 44 33554443333333222222222
Q ss_pred CceEecccCCcceEeCCCCcEEEEecCCccccccC
Q 005678 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563 (683)
Q Consensus 529 ~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~ 563 (683)
+++|.|..|+||+++.+|.+.+.|||+...++..
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 4999999999999999999999999998776543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.9e-06 Score=83.37 Aligned_cols=141 Identities=12% Similarity=-0.007 Sum_probs=97.7
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEecc--CcccchhhHHHHHHHHHHHHHHHhhcCCCc--eeeeccccccC----Cce
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGL--NAQWSEDKKQSYIRHAIREYNIHKTLVHHH--IVRLWDTFEID----QNT 482 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~--~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn--IV~L~~~f~~d----~~~ 482 (683)
-|+||.|-|+... ..|..+-+|.-.. ...+.. ..-...|.+|+..+..|..-+ +.+.. ++... ...
T Consensus 26 ~~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~---P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r 99 (216)
T PRK09902 26 YRRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRY---PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR 99 (216)
T ss_pred cCCCCcceEEEEE--eCCcEEEEEeccCcccccccC---CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence 3779999999874 3444677886431 111110 112357888999888885332 33333 22111 223
Q ss_pred EEEEEecccC-CChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc--EEEEecCCc
Q 005678 483 FCTVLEYCSG-KDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV--AKVTDFGLS 557 (683)
Q Consensus 483 ~~LV~Ey~~g-gsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~--vKL~DFGls 557 (683)
-+||+|-++| .+|.+++... .+.+......++.+|+.+|.-||..| +.|+|+-+.|||++..|. ++++||--+
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 6689997754 6899988654 34577777899999999999999976 999999999999986666 999999866
Q ss_pred cc
Q 005678 558 KI 559 (683)
Q Consensus 558 ~~ 559 (683)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 54
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.6e-05 Score=81.14 Aligned_cols=147 Identities=17% Similarity=0.242 Sum_probs=91.7
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHH--HHHHHHHHHHhhcC---CCceeeecc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYI--RHAIREYNIHKTLV---HHHIVRLWD 474 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i--~~~~rEi~il~~L~---HpnIV~L~~ 474 (683)
++...|.+.+.+-.....-|.+. ..+|..+.+|.......-....-.+.+ ..+.+.+..+..+. -..+..++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 46778888888887777777766 467788999976432211111111110 11233444343432 223333222
Q ss_pred cccc----CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 475 TFEI----DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 475 ~f~~----d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
+..- -....++||||++|..|.++.. +++ .+...++.++.-||..| ++|+|+.|+|++++. +.++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~-~~i~ 174 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSN-NGIR 174 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEEC-CcEE
Confidence 2210 1245668999999988876642 222 24456778899999977 999999999999996 4599
Q ss_pred EEecCCccc
Q 005678 551 VTDFGLSKI 559 (683)
Q Consensus 551 L~DFGls~~ 559 (683)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.4e-05 Score=82.16 Aligned_cols=135 Identities=19% Similarity=0.237 Sum_probs=78.4
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce--eeeccccccCCceEEEE
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI--VRLWDTFEIDQNTFCTV 486 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI--V~L~~~f~~d~~~~~LV 486 (683)
..||.|..+.||+. .+..+++|+..... . .....+|..++..+..-++ .+.+++.. +.+.+.+|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~-------~~~i~~E~~~l~~l~~~glpvP~~~~~~~-~~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--D-------KETIKREFDASRKVFSLGIPTPHPFDLVE-DGGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC--C-------HHHHHHHHHHHHHHHHcCCCCCceEEEEe-cCCeeeee
Confidence 56899999999984 24467789875422 1 1234678888888754333 34444443 45667899
Q ss_pred EecccCCC-hhHHH---------------------hcC--CCcchHHHH-HHHH----------HHHH-HHHHHH--hcC
Q 005678 487 LEYCSGKD-LDAVL---------------------KAT--PVLPEREAR-IIIV----------QIFQ-GLIYLN--KRA 528 (683)
Q Consensus 487 ~Ey~~ggs-L~~~L---------------------~~~--~~Lse~~~~-~I~~----------qIa~-aL~yLH--~~g 528 (683)
||+++|.+ +...+ ... ...+..... .+.. .+.. ...+|. ...
T Consensus 73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 99999863 21111 000 001111000 0000 0111 122222 123
Q ss_pred CceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 529 ~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
..++|+|+.|.||++++++ +.|+||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 3589999999999999878 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.4e-05 Score=78.07 Aligned_cols=140 Identities=22% Similarity=0.237 Sum_probs=78.7
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCc--eeeeccccc--cCCceE
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH--IVRLWDTFE--IDQNTF 483 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn--IV~L~~~f~--~d~~~~ 483 (683)
++.|+.|..+.||+..... ..+++|+.... .....+.+|..++..+.... +..++.... ......
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~ 70 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFP 70 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccc
Confidence 5789999999999996433 58999986332 12345567777777774332 344444221 123457
Q ss_pred EEEEecccCCChhH----------------HHh---cC----CCcchHH------HHHH---------------HHHHHH
Q 005678 484 CTVLEYCSGKDLDA----------------VLK---AT----PVLPERE------ARII---------------IVQIFQ 519 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~----------------~L~---~~----~~Lse~~------~~~I---------------~~qIa~ 519 (683)
+++|++++|..+.. .+. .. ..+.... ...+ +..+..
T Consensus 71 ~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (239)
T PF01636_consen 71 YLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEE 150 (239)
T ss_dssp EEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred eEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHH
Confidence 89999999988877 111 11 1111000 0000 111222
Q ss_pred -HHHHHHh-----cCCceEecccCCcceEeC-CCCcEEEEecCCcc
Q 005678 520 -GLIYLNK-----RAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSK 558 (683)
Q Consensus 520 -aL~yLH~-----~g~~IIHrDLKP~NILLd-~~g~vKL~DFGls~ 558 (683)
.+..++. ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 151 RLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3333332 223599999999999999 66777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.7e-05 Score=90.54 Aligned_cols=145 Identities=14% Similarity=0.183 Sum_probs=91.1
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHH------------------------HH------HHHHHH
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSY------------------------IR------HAIREY 458 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~------------------------i~------~~~rEi 458 (683)
+.||.-+.|.||+|.. .+|..||||+.+.........+-.. -+ .|.+|.
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5689999999999985 5599999999766533211000000 00 123333
Q ss_pred HHH----hhcCCCc------eeeeccccccCCceEEEEEecccCCChhHHH--hcCCCcchHHHHHHHHHHHHHHHHHHh
Q 005678 459 NIH----KTLVHHH------IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL--KATPVLPEREARIIIVQIFQGLIYLNK 526 (683)
Q Consensus 459 ~il----~~L~Hpn------IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L--~~~~~Lse~~~~~I~~qIa~aL~yLH~ 526 (683)
+-. +.+.|-+ |.++|..+ ....+|+||||+|..+.+.- .+.+ ++...+..-+.++..-+-+.|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~qIf~~- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQIFKT- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHHHHhc-
Confidence 333 3334555 44444333 44677999999998776654 4444 555554444333333333332
Q ss_pred cCCceEecccCCcceEeCC----CCcEEEEecCCcccccc
Q 005678 527 RAQKIIHYDLKPGNVLFDE----FGVAKVTDFGLSKIVED 562 (683)
Q Consensus 527 ~g~~IIHrDLKP~NILLd~----~g~vKL~DFGls~~~~~ 562 (683)
+++|+|-.|+||++.. ++.+.+-|||+...+..
T Consensus 321 ---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 ---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 4999999999999983 67899999999876654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.1e-05 Score=91.49 Aligned_cols=207 Identities=22% Similarity=0.317 Sum_probs=139.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeccccccC--Cc-eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc
Q 005678 451 IRHAIREYNIHKTLVHHHIVRLWDTFEID--QN-TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR 527 (683)
Q Consensus 451 i~~~~rEi~il~~L~HpnIV~L~~~f~~d--~~-~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~ 527 (683)
+....-|...+....|+|++.++.+--.. .+ ...+..++|...++...+..-+.++....+.+..++..||.|+|..
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 44455578888888999999988654221 11 2224458899999999998888899999999999999999999986
Q ss_pred CCceEecccCCc---ceEeCCCCcEEEE--ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHH
Q 005678 528 AQKIIHYDLKPG---NVLFDEFGVAKVT--DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVW 602 (683)
Q Consensus 528 g~~IIHrDLKP~---NILLd~~g~vKL~--DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVW 602 (683)
. ..|.-|..+ +...+..+.+.++ ||+.+...+....... -.-+..|.+||...... ...+...|+|
T Consensus 306 ~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~------~~~~~~~~~~e~~~~~~-~~~~r~~dL~ 376 (1351)
T KOG1035|consen 306 S--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS------DLLAEIRNADEDLKENT-AKKSRLTDLW 376 (1351)
T ss_pred c--cceeEEecccccccccCccceeecchhhhcccccCCCcccchh------hcCcccccccccccccc-chhhhhhHHH
Confidence 3 444444433 3344455666666 8988876654322111 12233466676553222 1123346999
Q ss_pred HHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 603 SAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 603 SLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.+|.++..+..|..+-........++. . .......++..+|+.-++++|+++.+++.|||++..
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~~~~~l~---------~------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAVPVSLLD---------V------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HHHHHHhhhhhcCcccccccchhhhhc---------c------ccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 999999999988765432222111110 0 111167789999999999999999999999998753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.95 E-value=7.2e-05 Score=76.83 Aligned_cols=135 Identities=16% Similarity=0.076 Sum_probs=77.6
Q ss_pred ecccCc-eEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCceEEEEEe
Q 005678 411 LGKGGF-SEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQNTFCTVLE 488 (683)
Q Consensus 411 LGkGgf-G~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~~~~LV~E 488 (683)
|-.|.+ ..||+... .+..+.||+..... ...+.+|+.++..+. +--+.++++++. ..+..++||+
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~-~~~~~~lv~e 72 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP----------TYELEREAERLRWLAGKLPVPEVIDYGS-DDGRAWLLTS 72 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc----------ccchHHHHHHHHHHHhcCCCCeEEEEEe-cCCccEEEEE
Confidence 445555 78999953 34688899864321 123456777777773 333445565554 3456789999
Q ss_pred cccCCChhHHHh-------------------cCC----CcchH--HHHHHHH--------------------HHHHHHHH
Q 005678 489 YCSGKDLDAVLK-------------------ATP----VLPER--EARIIIV--------------------QIFQGLIY 523 (683)
Q Consensus 489 y~~ggsL~~~L~-------------------~~~----~Lse~--~~~~I~~--------------------qIa~aL~y 523 (683)
+++|.+|..... .-+ ++... ....... .+...+..
T Consensus 73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T cd05150 73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE 152 (244)
T ss_pred eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence 999987764310 000 01100 0000000 01111222
Q ss_pred HHh-----cCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 524 LNK-----RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 524 LH~-----~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
|-. ..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 211 12359999999999999997778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.1e-06 Score=97.53 Aligned_cols=239 Identities=15% Similarity=0.129 Sum_probs=154.5
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCc-eeeeccccccCCceE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH-IVRLWDTFEIDQNTF 483 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn-IV~L~~~f~~d~~~~ 483 (683)
|...+-+++|+++.+|+.+...+...+ .+++... ....-++++|.+++||| .+..++.++ .....
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------------l~~rl~~eLLdK~n~P~~~v~~~~d~~-~E~~~ 309 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------------LSRRLAIELLDKVNNPNPVVRYLEDYD-GEDYL 309 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------------hhhHHHHHHHHHccCCCCcccccccCC-ccccc
Confidence 444556799999999999766555444 5544221 23345788999999999 666666664 45678
Q ss_pred EEEEecccCC-ChhHHH-hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 484 CTVLEYCSGK-DLDAVL-KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 484 ~LV~Ey~~gg-sL~~~L-~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.++++++.++ +-.... ...-.+.......+++.-..+++|||+.. =+|+| ||+..+ +..+..||+....+.
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccC
Confidence 8999999876 222111 11112344445556677778899999842 38888 888776 889999999887665
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc--c
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK--V 639 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~--~ 639 (683)
... ......+|+.++|||+..... +....|+|++|+-..+|.-|-+|-......... +.... .
T Consensus 383 ~~~------~~~t~~~~~~~~~pev~~~~~---~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~------~g~~p~s~ 447 (829)
T KOG0576|consen 383 RTM------KPRTAIGTPEPLAPEVIQENT---IDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLPM------IGNGPNSP 447 (829)
T ss_pred ccc------ccccCCCCCCCCCchhhcccc---cccCCCccCCCcchhhcCCCCCCCCCCccccCC------CCCCCCcc
Confidence 432 234558999999999876444 788999999998777777777776442211000 00000 0
Q ss_pred CCCCCcCCCHHHH-HHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 640 EFPSRPAVSNEAK-DLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 640 ~~p~~~~~s~el~-dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.+......+.... ++...|+..-|..++....++.|-+|.
T Consensus 448 ~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfn 488 (829)
T KOG0576|consen 448 MLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFN 488 (829)
T ss_pred ccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhc
Confidence 0000000111111 477788888898888888888776664
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00014 Score=73.39 Aligned_cols=144 Identities=22% Similarity=0.272 Sum_probs=95.6
Q ss_pred CCCCccccccccceeEEEEecccCc-eEEEEEEEccCCeEEEEEEecc---Cccc---ch--------hhHHHHHHHHHH
Q 005678 392 GSRFNNFQILNHRYALLNLLGKGGF-SEVYKAYDLVEHRYVACKLHGL---NAQW---SE--------DKKQSYIRHAIR 456 (683)
Q Consensus 392 ~~~f~~~~i~~~ry~l~~~LGkGgf-G~Vyka~d~~~g~~VAVKi~~~---~~~~---~~--------~~~~~~i~~~~r 456 (683)
+..+..|..-+..+..++.||.|.. |.||++. -.|..||+|++.. .... .. .....+..-|..
T Consensus 26 gPKL~~F~~h~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ 103 (207)
T PF13095_consen 26 GPKLEPFTHHGDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNC 103 (207)
T ss_pred CCCcCCcCCCCCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHH
Confidence 3444444444578999999999999 9999994 6788999999321 1110 00 011134445666
Q ss_pred HHHHHhhc---CCCce--eeeccccccC-----------------CceEEEEEecccCCChhHHHhcCCCcchHHHHHHH
Q 005678 457 EYNIHKTL---VHHHI--VRLWDTFEID-----------------QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIII 514 (683)
Q Consensus 457 Ei~il~~L---~HpnI--V~L~~~f~~d-----------------~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~ 514 (683)
|.+...+| .+.++ |+.||+.-.+ .....||.||.+... .+.. .-+
T Consensus 104 ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~ 170 (207)
T PF13095_consen 104 ECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDI 170 (207)
T ss_pred HHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHH
Confidence 66666666 45555 8888776433 123567888776543 1222 335
Q ss_pred HHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 515 ~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
.+|.+-|..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 171 ~~~~~dl~~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 171 PQMLRDLKILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence 57778888999866 999999999986 4589999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.86 E-value=9.9e-05 Score=75.65 Aligned_cols=29 Identities=38% Similarity=0.552 Sum_probs=25.3
Q ss_pred ceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.+||+|+.|.|||++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 49999999999999976666799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00027 Score=85.63 Aligned_cols=82 Identities=13% Similarity=0.161 Sum_probs=52.6
Q ss_pred EEEecccCceEEEEEEEccCC--eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCce--eeeccccccC--C
Q 005678 408 LNLLGKGGFSEVYKAYDLVEH--RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHI--VRLWDTFEID--Q 480 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g--~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnI--V~L~~~f~~d--~ 480 (683)
+..|+.|.+..+|+......+ ..+++|+......... ...+.+|+.+++.+. |++| .+++.++... .
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~ 116 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI 116 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC
Confidence 577899999999998653322 3566776533221111 124678999999985 6664 5666555321 1
Q ss_pred ceEEEEEecccCCCh
Q 005678 481 NTFCTVLEYCSGKDL 495 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL 495 (683)
+..|+||||++|..+
T Consensus 117 G~~flVME~v~G~~~ 131 (822)
T PLN02876 117 GTAFYIMEYLEGRIF 131 (822)
T ss_pred CCceEEEEecCCccc
Confidence 467899999988643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00013 Score=72.01 Aligned_cols=131 Identities=19% Similarity=0.199 Sum_probs=88.0
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
....+.||+|.+|.||+|. ..|.++|+|+-..+.. ...+..|..++..+.--++-+=...+. .+ .
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds~---------r~~l~kEakiLeil~g~~~~p~vy~yg--~~--~ 88 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDSP---------RRNLEKEAKILEILAGEGVTPEVYFYG--ED--F 88 (201)
T ss_pred hhhhhhhhcccccEEEEee--ccCceEEEEEecCCcc---------hhhHHHHHHHHHHhhhcCCCceEEEec--hh--h
Confidence 3446789999999999994 6788999998644321 346778999999887666654332221 22 2
Q ss_pred EEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccC-CcceEeCCCCcEEEEecCCccc
Q 005678 485 TVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLK-PGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLK-P~NILLd~~g~vKL~DFGls~~ 559 (683)
+.|||+.|..|....... . +.-+..++.+---|-..| |-|..|. |..++|.+++.+.|+||.-|..
T Consensus 89 i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 559999998887765432 1 222334455533344434 8899886 6666666667999999998863
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00034 Score=70.63 Aligned_cols=134 Identities=25% Similarity=0.349 Sum_probs=87.8
Q ss_pred EEecccCceEEEEEEEccCCeEEEEEEeccCcccchh---------hHHHHHHHHHHHHHHHhhcC------CCceeeec
Q 005678 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSED---------KKQSYIRHAIREYNIHKTLV------HHHIVRLW 473 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~---------~~~~~i~~~~rEi~il~~L~------HpnIV~L~ 473 (683)
..||.|+.-.||.- ......+||+.......... ......+...+|+.....+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57999999999976 34556789998766511000 00112344556666666665 78999999
Q ss_pred cccccCCceEEEEEecccC------CChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC--
Q 005678 474 DTFEIDQNTFCTVLEYCSG------KDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-- 545 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~g------gsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-- 545 (683)
|..+.+.+ +.+|+|.+.+ .+|.+++.... ++. .....+.++.. ||-. ..|+.+||+|.||++..
T Consensus 84 G~veT~~G-~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~L~~f~~---~l~~--~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVETNLG-LGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQALDEFKR---YLLD--HHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEecCCc-eEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHHHHHHHH---HHHH--cCCeecCCCcccEEEEecC
Confidence 99875544 4677777543 46888886654 665 55555555544 4444 23999999999999963
Q ss_pred CC--cEEEEe
Q 005678 546 FG--VAKVTD 553 (683)
Q Consensus 546 ~g--~vKL~D 553 (683)
++ .+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 22 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=4.7e-05 Score=81.27 Aligned_cols=144 Identities=23% Similarity=0.310 Sum_probs=99.7
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhH--HHHH-------------HHHHHHHHHHhhcCC-C
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKK--QSYI-------------RHAIREYNIHKTLVH-H 467 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~--~~~i-------------~~~~rEi~il~~L~H-p 467 (683)
-+.+++.||-|.-+-||.+-+ ..|++.++|++.+...+-...+ ..|. -.+.+|+..|+.|.- -
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 356788899999999999975 5689999998866543322111 1111 135678999998843 2
Q ss_pred c-eeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC
Q 005678 468 H-IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF 546 (683)
Q Consensus 468 n-IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~ 546 (683)
. +.+.+ +.+.-|+|||++.|..|...-.- ..+..+...+..-+.-|..+| +||+|..-.||+++++
T Consensus 172 fpVPkpi-----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 172 FPVPKPI-----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCcc-----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcC--ceecccchheeEEecC
Confidence 2 33333 34456799999998877665321 122335555666666777756 9999999999999999
Q ss_pred CcEEEEecCCccccc
Q 005678 547 GVAKVTDFGLSKIVE 561 (683)
Q Consensus 547 g~vKL~DFGls~~~~ 561 (683)
+.++++||--+....
T Consensus 239 ~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 239 DKIVVIDFPQMVSTS 253 (465)
T ss_pred CCEEEeechHhhccC
Confidence 999999998665443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00076 Score=68.68 Aligned_cols=75 Identities=23% Similarity=0.352 Sum_probs=45.6
Q ss_pred EEEecccCceEEEEEEEcc-CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce-eeeccccccCCceEEE
Q 005678 408 LNLLGKGGFSEVYKAYDLV-EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI-VRLWDTFEIDQNTFCT 485 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~-~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI-V~L~~~f~~d~~~~~L 485 (683)
++.|..|-...||++.... .+..|++|+........ -...+|+.++..+...++ ++++..+. . .+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~--------~d~~~E~~~~~~l~~~gl~P~v~~~~~--~---~~ 69 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI--------IDRERELRIHKLLSKHGLAPKLYATFQ--N---GL 69 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce--------ecHHHHHHHHHHHHhCCCCCeEEEEeC--C---cE
Confidence 4567778888999985332 25678899865432110 112357778888754333 33443322 2 37
Q ss_pred EEecccCCCh
Q 005678 486 VLEYCSGKDL 495 (683)
Q Consensus 486 V~Ey~~ggsL 495 (683)
||||++|.++
T Consensus 70 l~e~i~G~~l 79 (235)
T cd05157 70 IYEFIPGRTL 79 (235)
T ss_pred EEEeeCCCcC
Confidence 9999999776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00032 Score=70.19 Aligned_cols=102 Identities=19% Similarity=0.161 Sum_probs=80.6
Q ss_pred HHHHHHhhcCC-CceeeeccccccCCceEEEEEecccCCChhH---HHhcCCCcchHHHHHHHHHHHHHHHHHHhcCC-c
Q 005678 456 REYNIHKTLVH-HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDA---VLKATPVLPEREARIIIVQIFQGLIYLNKRAQ-K 530 (683)
Q Consensus 456 rEi~il~~L~H-pnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~---~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~-~ 530 (683)
.|.-++..+.+ +++++++|+|. . ++|.||.+.+++.. .+...-..+|..+..|+.+++..+.+|+.... .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47888888876 69999999984 2 46889998776642 12222346899999999999999999987421 4
Q ss_pred eEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 531 IIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 531 IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+.-.|++|+|+-++++|.+|++|...+.....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~ 114 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVEDK 114 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhHH
Confidence 88899999999999999999999998765543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0018 Score=72.00 Aligned_cols=79 Identities=19% Similarity=0.215 Sum_probs=51.0
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCc-----ccchhhHHHHHHHHHHHHHHHhhcC---CCceeeeccccccC
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNA-----QWSEDKKQSYIRHAIREYNIHKTLV---HHHIVRLWDTFEID 479 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~-----~~~~~~~~~~i~~~~rEi~il~~L~---HpnIV~L~~~f~~d 479 (683)
.+.||-|.+..||++.+...++.|.||.-.... .|.. .......|...|..+. -.+++++|.+ +
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl-----~~eR~~~Eae~L~~l~~~~p~~VPkV~~~---D 102 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPL-----TLDRARIEAEALKIQAKYVPDLVPKVYHY---D 102 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccc-----cHHHHHHHHHHHHHHHhhCCCCCCeEEEE---C
Confidence 467999999999999875444689999743211 1121 1234556777777652 2345666644 3
Q ss_pred CceEEEEEecccCCC
Q 005678 480 QNTFCTVLEYCSGKD 494 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggs 494 (683)
....++||||+++..
T Consensus 103 ~~~~~lVME~L~~~~ 117 (401)
T PRK09550 103 EELAVTVMEDLSDHK 117 (401)
T ss_pred CCCCEEEEecCCCcc
Confidence 455779999998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0016 Score=69.70 Aligned_cols=79 Identities=10% Similarity=0.088 Sum_probs=51.3
Q ss_pred eEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC---Cceeeecccccc--CC
Q 005678 406 ALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH---HHIVRLWDTFEI--DQ 480 (683)
Q Consensus 406 ~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H---pnIV~L~~~f~~--d~ 480 (683)
.-.+.||.|..+.||...+ .++ .+.+|+..... . ...+..|...++.|.- ..+.++++++.. ..
T Consensus 17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~--~-------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 17 SRVECISEQPYAALWALYD-SQG-NPMPLMARSFS--T-------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred heeeecCCccceeEEEEEc-CCC-CEEEEEecccc--c-------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 3457799999999999853 233 46778753210 1 1246678888877742 346666665532 24
Q ss_pred ceEEEEEecccCCCh
Q 005678 481 NTFCTVLEYCSGKDL 495 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL 495 (683)
+..+||||+++|.++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 568899999998764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.001 Score=72.42 Aligned_cols=150 Identities=19% Similarity=0.185 Sum_probs=98.1
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhh------------------HHHHHHH-HHHHHHHHhhcCCC
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK------------------KQSYIRH-AIREYNIHKTLVHH 467 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~------------------~~~~i~~-~~rEi~il~~L~Hp 467 (683)
+-..|..|--+.||.|. ..+|..+|||+++.+...-... ....++. +-.|+.-|++|...
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 34678889999999996 5678889999986654332111 0011111 34577777777554
Q ss_pred ceeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC
Q 005678 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 468 nIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g 547 (683)
.|.-.--+.- .+ -+|||+|+.....-.-.-+.-.++...+..+..+++..+.-|-.. ..+||.||+--|+|+.+ |
T Consensus 227 GIP~PePIlL--k~-hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 227 GIPCPEPILL--KN-HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLYHD-G 301 (520)
T ss_pred CCCCCCceee--ec-ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheEEC-C
Confidence 4322111110 12 248999995433222222333578888888889999998888654 36999999999999987 8
Q ss_pred cEEEEecCCcccccc
Q 005678 548 VAKVTDFGLSKIVED 562 (683)
Q Consensus 548 ~vKL~DFGls~~~~~ 562 (683)
.+.|+|-+-+.-.+.
T Consensus 302 ~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEEccccccCCC
Confidence 999999887764443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.36 E-value=9.9e-05 Score=90.70 Aligned_cols=213 Identities=13% Similarity=-0.011 Sum_probs=137.3
Q ss_pred HHHHHHHHhhcCCCceeeecccccc-CCceEEEEEecccCCChhHHHhcC----CCcchHHHHHHHHHHHHHHHHHHhc-
Q 005678 454 AIREYNIHKTLVHHHIVRLWDTFEI-DQNTFCTVLEYCSGKDLDAVLKAT----PVLPEREARIIIVQIFQGLIYLNKR- 527 (683)
Q Consensus 454 ~~rEi~il~~L~HpnIV~L~~~f~~-d~~~~~LV~Ey~~ggsL~~~L~~~----~~Lse~~~~~I~~qIa~aL~yLH~~- 527 (683)
.+.|..-++...|++++..+.-... .....+.+++|+.+|.+.+.|-++ +.+...-+.....+.+.+..-+|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555556789998877654321 234567899999999999999433 3344434444444446666666654
Q ss_pred --CCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHH
Q 005678 528 --AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAG 605 (683)
Q Consensus 528 --g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLG 605 (683)
|+-.+|++||+-|.+|..+-.+|++++|+.++..... ......++++.|+.|+....-+ ++.++|+|+.|
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-----sf~Gl~l~sp~~v~qli~N~ik---~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-----SFFGLELCSPIYVLQLIKNEIK---FTKRSDILRRS 1427 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH-----hhhhhhhCCHHHHHHHHHHHHh---hhhHHHHHHHH
Confidence 4458999999999999999999999999999544332 2233347888899999876555 67789999999
Q ss_pred HHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 606 ILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 606 vILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
+.+|...-|..||..-. ...- +.++..+. .+...--.|.++...+..+|-.....||.....+.-|++-
T Consensus 1428 ~~ly~rs~~n~~fi~fl---q~~L-kgiidn~t-f~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIFFL---QPAL-KGIIDNHT-FFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHhcccHHHHHHH---HHHH-cCcccccc-cccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999998888873211 0000 01111111 1111112234444555566666677788877777666553
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00089 Score=69.45 Aligned_cols=134 Identities=15% Similarity=0.143 Sum_probs=73.4
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCcee-eeccccccCCceEEEEEec
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV-RLWDTFEIDQNTFCTVLEY 489 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV-~L~~~f~~d~~~~~LV~Ey 489 (683)
+..|-.+.+|+.. .++..+++|+......... -...+|..+++.+...+++ .++..+ . -++||||
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~-------~~r~~E~~~l~~l~~~g~~P~~i~~~---~--~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG-------VDRQREYQILQALSALGLAPKPILVN---E--HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccccc-------CcHHHHHHHHHHHHhcCCCCceEEEe---C--CEEEEEe
Confidence 4557777899885 5566788897543211110 0234577788877543332 233222 2 2589999
Q ss_pred ccCCChhHH--------------H---hcCC----CcchH-HHHHHHHHH---------HHHHHHHHhc------CCceE
Q 005678 490 CSGKDLDAV--------------L---KATP----VLPER-EARIIIVQI---------FQGLIYLNKR------AQKII 532 (683)
Q Consensus 490 ~~ggsL~~~--------------L---~~~~----~Lse~-~~~~I~~qI---------a~aL~yLH~~------g~~II 532 (683)
++|..+... + ...+ +++.. .+..+..++ ...+..+-.. ...++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 998765421 1 1111 11111 111111111 1112222111 23599
Q ss_pred ecccCCcceEeCCCCcEEEEecCCccc
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
|+|+.|.|||++.++ +.|+||..+..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0012 Score=69.70 Aligned_cols=140 Identities=18% Similarity=0.108 Sum_probs=78.6
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCc--eeeeccccc-----cCC
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH--IVRLWDTFE-----IDQ 480 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn--IV~L~~~f~-----~d~ 480 (683)
++.|..|....+|+.. ..+..+++|++... . ...+..|+.++..+.+.+ +++++.... ...
T Consensus 19 i~~i~~G~~n~~y~v~--~~~~~~vLr~~~~~---~-------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~ 86 (296)
T cd05153 19 FEGISAGIENTNYFVT--TDSGRYVLTLFEKV---S-------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA 86 (296)
T ss_pred eecccCccccceEEEE--eCCCcEEEEEcCCC---C-------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence 5667778778999985 34456888987431 1 123444666666664322 334332210 123
Q ss_pred ceEEEEEecccCCChhH----H-------H---h----cCC-------CcchHHHH----------HHHHHHHHHHHHHH
Q 005678 481 NTFCTVLEYCSGKDLDA----V-------L---K----ATP-------VLPEREAR----------IIIVQIFQGLIYLN 525 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~----~-------L---~----~~~-------~Lse~~~~----------~I~~qIa~aL~yLH 525 (683)
+..++|++|++|..+.. . + . ... ...+.... .....+..++.++.
T Consensus 87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~ 166 (296)
T cd05153 87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD 166 (296)
T ss_pred CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence 45678999999876532 0 1 0 000 00111100 01111233444444
Q ss_pred h-----cCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 526 K-----RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 526 ~-----~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
. ....+||+|+.|.|||+++++.+.|+||+.+..
T Consensus 167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 2 123599999999999999877789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0022 Score=72.26 Aligned_cols=162 Identities=21% Similarity=0.320 Sum_probs=101.2
Q ss_pred HHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceE
Q 005678 453 HAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKII 532 (683)
Q Consensus 453 ~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~II 532 (683)
.++....+++.+.|+|+..++++-........+|+|++ +.+|.+++..+. +-..... ++++.
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~----------------~~~~~ 89 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL----------------AHGVL 89 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc----------------ccccc
Confidence 45667889999999999999988765566788999999 789999987664 2211111 23344
Q ss_pred ecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
|- +.++++| .+. |. | |- ...+|+||||+|.++.++.
T Consensus 90 ~~------------~~~~~td-----~~~----------------t~-~--~~--------~~~pKsdVwsl~~i~~el~ 125 (725)
T KOG1093|consen 90 HL------------NIIYITD-----HFL----------------TK-Y--PS--------PIGPKSDVWSLGFIILELY 125 (725)
T ss_pred ee------------hhhhccc-----ccc----------------cc-C--CC--------CCCcchhhhhHHHHHHHHH
Confidence 42 2334444 000 00 1 10 0124899999999999999
Q ss_pred cCCCCCCCCchHHHHHHHHHHHHhhccCCC---------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 613 FGRRPFGHDQTQERILREDTIIKARKVEFP---------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 613 tG~~PF~~~~~~e~il~~~~i~~~~~~~~p---------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.|...|......+.... +.+....... ....++.-+..+...|+...|..||...++.+++-|.
T Consensus 126 L~~~l~~~~~~s~~l~~---i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ 198 (725)
T KOG1093|consen 126 LGISLEAELTESEYLEI---LLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT 198 (725)
T ss_pred HhhHHHHHHHHHHHHHH---HHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence 98877644333222211 0010000000 0023455677889999999999999999999888664
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.005 Score=65.30 Aligned_cols=30 Identities=27% Similarity=0.348 Sum_probs=26.8
Q ss_pred CceEecccCCcceEeCCC----CcEEEEecCCcc
Q 005678 529 QKIIHYDLKPGNVLFDEF----GVAKVTDFGLSK 558 (683)
Q Consensus 529 ~~IIHrDLKP~NILLd~~----g~vKL~DFGls~ 558 (683)
..++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 469999999999999974 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0052 Score=65.58 Aligned_cols=141 Identities=19% Similarity=0.146 Sum_probs=76.8
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCc--eeeecccc-----ccC
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH--IVRLWDTF-----EID 479 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn--IV~L~~~f-----~~d 479 (683)
.+..++.|....||+... .++ .+++|++..... . ..+..|+.++..|...+ +.+++... ...
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~--~-------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVK--A-------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCCC--H-------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 456677777789998853 344 566787644211 1 12334555555553222 23333221 112
Q ss_pred CceEEEEEecccCCChh-----------HHH---hc-CCCc-----------chHHHH------------HHHHHHHHHH
Q 005678 480 QNTFCTVLEYCSGKDLD-----------AVL---KA-TPVL-----------PEREAR------------IIIVQIFQGL 521 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~-----------~~L---~~-~~~L-----------se~~~~------------~I~~qIa~aL 521 (683)
.+..++|++|++|..+. ..+ .. ...+ .|.... .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 45678999999885432 111 00 0001 011100 0011233345
Q ss_pred HHHHh-----cCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 522 IYLNK-----RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 522 ~yLH~-----~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.++.. ....+||+|+.+.||+++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 55542 12459999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF09726 Macoilin: Transmembrane protein; InterPro: IPR019130 This entry represents the multi-pass transmembrane protein Macoilin, which is highly conserved in eukaryotes | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.12 Score=61.63 Aligned_cols=61 Identities=16% Similarity=0.308 Sum_probs=30.7
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHH
Q 005678 193 SLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIISD 253 (683)
Q Consensus 193 ~~~~~~~~~~~k~~~le~~l~~~~~e~~~~~~~~~~~e~~l~e~~~~~~~~~~k~~~~~~~ 253 (683)
.|+.|+..||..|...-+.-+++|+.+.-+.+.-+++..+|+.+++..+++..|+++..+.
T Consensus 422 rLE~dvkkLraeLq~~Rq~E~ELRsqis~l~~~Er~lk~eL~qlr~ene~Lq~Kl~~L~~a 482 (697)
T PF09726_consen 422 RLEADVKKLRAELQSSRQSEQELRSQISSLTNNERSLKSELSQLRQENEQLQNKLQNLVQA 482 (697)
T ss_pred HHHHHHHHHHHHHHhhhhhHHHHHHHHhhccccchHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3444444444444443333333344333333333555566666666666666666655543
|
; GO: 0016021 integral to membrane |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0059 Score=66.99 Aligned_cols=82 Identities=24% Similarity=0.256 Sum_probs=49.9
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeccC-----cccchhhHHHHHHHHHHHHHHHhhcC--CCc-eeeeccccccCCc
Q 005678 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLN-----AQWSEDKKQSYIRHAIREYNIHKTLV--HHH-IVRLWDTFEIDQN 481 (683)
Q Consensus 410 ~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~-----~~~~~~~~~~~i~~~~rEi~il~~L~--Hpn-IV~L~~~f~~d~~ 481 (683)
.||-|...-||++.+...++.|+||.-... ..|+.. +.+..-|...|.... -|. ++++| .| +..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~-----~~R~~~E~~~L~~~~~~~P~~vP~vy-~~--D~e 73 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLT-----LDRARIESSALIRQGEHVPHLVPRIF-HF--DTE 73 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCC-----ccHHHHHHHHHHHhhccCccccCeEE-EE--ccc
Confidence 478999999999987544478999963211 122222 234445777776653 343 44454 33 566
Q ss_pred eEEEEEecccC-CChhHHH
Q 005678 482 TFCTVLEYCSG-KDLDAVL 499 (683)
Q Consensus 482 ~~~LV~Ey~~g-gsL~~~L 499 (683)
..++|||+++. ..|...|
T Consensus 74 ~~~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 74 MAVTVMEDLSHHKIARKGL 92 (370)
T ss_pred cceehHhhCccchHHHHHH
Confidence 77799999965 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.012 Score=62.45 Aligned_cols=30 Identities=33% Similarity=0.598 Sum_probs=25.2
Q ss_pred ceEecccCCcceEeCCCCc-EEEEecCCccc
Q 005678 530 KIIHYDLKPGNVLFDEFGV-AKVTDFGLSKI 559 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~~g~-vKL~DFGls~~ 559 (683)
.+||+|+.|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4999999999999997454 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.024 Score=60.63 Aligned_cols=31 Identities=32% Similarity=0.399 Sum_probs=26.4
Q ss_pred CceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 529 ~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3699999999999999766668999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.012 Score=65.31 Aligned_cols=84 Identities=18% Similarity=0.267 Sum_probs=53.9
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEe----ccCcccchhhHHHHHHHHHHHHHHHhhcC--CCc-eeeeccccccCC
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLH----GLNAQWSEDKKQSYIRHAIREYNIHKTLV--HHH-IVRLWDTFEIDQ 480 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~----~~~~~~~~~~~~~~i~~~~rEi~il~~L~--Hpn-IV~L~~~f~~d~ 480 (683)
+..||-|.-.-||++.+...++.|+||.- .....|+.. ..+..-|..+|+.+. -|. ++++| +| +.
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~-----~~R~~~E~~aL~~~~~~~P~~VP~vy-~~--D~ 105 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLS-----TNRIRIESDVLQLEEELAPGLVPKVY-LF--DS 105 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCC-----hHHHHHHHHHHHHHHhhCCCcCCeEE-EE--Cc
Confidence 67889999999999987444678999952 333334333 334555777777663 354 44455 33 56
Q ss_pred ceEEEEEecccCC-ChhHHH
Q 005678 481 NTFCTVLEYCSGK-DLDAVL 499 (683)
Q Consensus 481 ~~~~LV~Ey~~gg-sL~~~L 499 (683)
...++|||+++.. .|...|
T Consensus 106 e~~~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 106 VMNCCVMEDLSDHTILRTAL 125 (409)
T ss_pred HHhhHHHHhCcccHHHHHHH
Confidence 6777999999653 344444
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.045 Score=59.29 Aligned_cols=31 Identities=29% Similarity=0.508 Sum_probs=28.1
Q ss_pred ceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.++|+|+.+.||+++..+-+=|.||+++..-
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 5999999999999998888999999998754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.061 Score=60.13 Aligned_cols=83 Identities=14% Similarity=0.103 Sum_probs=50.5
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEecc-----CcccchhhHHHHHHHHHHHHHHHhhcC---CCceeeecccccc
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGL-----NAQWSEDKKQSYIRHAIREYNIHKTLV---HHHIVRLWDTFEI 478 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~-----~~~~~~~~~~~~i~~~~rEi~il~~L~---HpnIV~L~~~f~~ 478 (683)
..+.||-|....||+..+ .+..|+||.-.. ...|+.. +.....|...|..+. ..++.++|.++.
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~-----~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de- 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMT-----KERAYFEATALREHGRLCPDHVPEVYHFDR- 107 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCC-----ccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence 467889999999999875 345688997542 2222222 223344555665553 236666775543
Q ss_pred CCceEEEEEecccC--CChhHHH
Q 005678 479 DQNTFCTVLEYCSG--KDLDAVL 499 (683)
Q Consensus 479 d~~~~~LV~Ey~~g--gsL~~~L 499 (683)
+..+++|||+++ ..+...+
T Consensus 108 --d~~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 108 --TMALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred --CCCEEEEeecCCcceehhhhh
Confidence 445689999977 3454444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.055 Score=59.13 Aligned_cols=142 Identities=20% Similarity=0.198 Sum_probs=79.5
Q ss_pred eeEEEEecccCceEEEEEEEcc----CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCcee-eeccccccC
Q 005678 405 YALLNLLGKGGFSEVYKAYDLV----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV-RLWDTFEID 479 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~----~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV-~L~~~f~~d 479 (683)
..-+..|-.|-.-.+|++.... .+..|++|+........ + .-..|..++..+..-++- ++++.|.
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-------i-dR~~E~~~~~~l~~~gl~P~~~~~~~-- 107 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-------F-DRDDEIRTFECMSRHGQGPRLLGRFP-- 107 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-------e-chHHHHHHHHHHHHcCCCCceEEEEC--
Confidence 3344556557777899985322 24689999876543211 1 124577777777543333 3445553
Q ss_pred CceEEEEEecccCCChhHH--------------H---hcCC------CcchHHHHHHHHHH-----------------HH
Q 005678 480 QNTFCTVLEYCSGKDLDAV--------------L---KATP------VLPEREARIIIVQI-----------------FQ 519 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~--------------L---~~~~------~Lse~~~~~I~~qI-----------------a~ 519 (683)
++ .|++|+++.+|... + .... ...+..+..++.++ ..
T Consensus 108 ~g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~ 184 (344)
T PLN02236 108 NG---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLED 184 (344)
T ss_pred Cc---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHH
Confidence 22 57999988776421 0 0000 11122222222111 11
Q ss_pred HHHHH----Hh--cCCceEecccCCcceEeCC-CCcEEEEecCCccc
Q 005678 520 GLIYL----NK--RAQKIIHYDLKPGNVLFDE-FGVAKVTDFGLSKI 559 (683)
Q Consensus 520 aL~yL----H~--~g~~IIHrDLKP~NILLd~-~g~vKL~DFGls~~ 559 (683)
.+..| .. ....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 185 ~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 185 EINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12222 11 1235999999999999986 57899999998864
|
|
| >KOG1003 consensus Actin filament-coating protein tropomyosin [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=95.94 E-value=1.1 Score=44.73 Aligned_cols=130 Identities=22% Similarity=0.268 Sum_probs=92.3
Q ss_pred hhccccchHHHHHHHHHHHHHHHHHHHHHhhhhhhhH--------------HHHHHHHHHHHHHHHHHHHhhhHHHHHHH
Q 005678 187 LIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQ--------------NLCHQLEKELKDVKEYEQQMKPRRTKIIS 252 (683)
Q Consensus 187 ~~~~~~~~~~~~~~~~~k~~~le~~l~~~~~e~~~~~--------------~~~~~~e~~l~e~~~~~~~~~~k~~~~~~ 252 (683)
.|..++.|++++..-+++++.+=+.|...++..++.+ ..+..++.+|+|.+.-.+.-..||..|.+
T Consensus 9 lnrri~~leeele~aqErl~~a~~KL~Eaeq~~dE~er~~Kv~enr~~kdEE~~e~~e~qLkEAk~iaE~adrK~eEVar 88 (205)
T KOG1003|consen 9 LNRRIQLLEEELDRAQERLATALQKLEEAEQAADESERGMKVIENRAQKLEEKMEAQEAQLKEAKHIAEKADRKYEEVAR 88 (205)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4666778888888777777777777777766655433 34466778889988888888899999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhchhcceeeEEeecccchhhcccchhHHHHHHHHHHHHHhHHHHHHHHHhhhcc
Q 005678 253 DLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKR 326 (683)
Q Consensus 253 ~~~~~~~~~~r~~~r~~~~~~~~rlg~~~~~r~~~~~~e~w~dg~~~~~l~~~~~~~~e~~~~~e~~~k~~~~~ 326 (683)
+|.|-....|+.+-|..+-+.... ..--+.-.-|...+.|...-.+..+..+..+.+-+.+..+
T Consensus 89 kL~iiE~dLE~~eeraE~~Es~~~----------eLeEe~~~~~~nlk~l~~~ee~~~q~~d~~e~~ik~ltdK 152 (205)
T KOG1003|consen 89 KLVIIEGELERAEERAEAAESQSE----------ELEEDLRILDSNLKSLSAKEEKLEQKEEKYEEELKELTDK 152 (205)
T ss_pred HHHHHHhHHHHHHHHHHHHHHHHH----------HHHHHHHHhHhHHHHHHHHHHHHhhhHHHHHHHHHHHHHH
Confidence 999999999999999777665433 0011222336666777777777777777776666655444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.09 Score=57.09 Aligned_cols=30 Identities=30% Similarity=0.454 Sum_probs=26.3
Q ss_pred ceEecccCCcceEeCC-CCcEEEEecCCccc
Q 005678 530 KIIHYDLKPGNVLFDE-FGVAKVTDFGLSKI 559 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~-~g~vKL~DFGls~~ 559 (683)
.++|.|+.|.|||+++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4899999999999974 57899999998864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.062 Score=57.51 Aligned_cols=30 Identities=20% Similarity=0.307 Sum_probs=27.3
Q ss_pred ceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
++||+|+.++|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999989999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.062 Score=56.92 Aligned_cols=29 Identities=24% Similarity=0.367 Sum_probs=25.5
Q ss_pred CceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 529 ~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
..+||+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 35999999999999997 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.023 Score=57.14 Aligned_cols=30 Identities=37% Similarity=0.630 Sum_probs=21.4
Q ss_pred ceEecccCCcceEe-CCCCcEEEEecCCccc
Q 005678 530 KIIHYDLKPGNVLF-DEFGVAKVTDFGLSKI 559 (683)
Q Consensus 530 ~IIHrDLKP~NILL-d~~g~vKL~DFGls~~ 559 (683)
.++|.||.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 59999999999999 7889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.091 Score=54.12 Aligned_cols=86 Identities=23% Similarity=0.407 Sum_probs=59.5
Q ss_pred HHHHHHHHHhhcCCCceeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceE
Q 005678 453 HAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKII 532 (683)
Q Consensus 453 ~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~II 532 (683)
.+..++.++.++ -.|++|..- ++..+.+++|+|-. +.....- ++.-=+.+|.-.|+...+.+
T Consensus 104 ~y~nky~v~Arm--hGilrL~ND---n~~~yGvIlE~Cy~------------~~i~~~N-~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 104 LYFNKYRVFARM--HGILRLKND---NNYKYGVILERCYK------------IKINFSN-FITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhHHHHh--hheeEeecC---CCceeEEEEeeccC------------cccchhH-HHHHhHHHHHHhhccCCCee
Confidence 345677787776 367777632 45567789999832 1111111 12122567888897666899
Q ss_pred ecccCCcceEeCCCCcEEEEecCC
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGl 556 (683)
|+|..|+|||-|..|.+||.|=+.
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred cCCCChhheeecCCCCEEecChhh
Confidence 999999999999999999999653
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.066 Score=58.68 Aligned_cols=74 Identities=20% Similarity=0.232 Sum_probs=57.8
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.-+.|++|++. |++|..+ ....+.++..|+.+.+..+.-+-.. -++-|||+.-+||||+ .|++.|+||-+|+
T Consensus 297 e~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred CceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEeeeee
Confidence 455677888887 5555433 2245778888998888877777653 4799999999999999 7999999999998
Q ss_pred c
Q 005678 559 I 559 (683)
Q Consensus 559 ~ 559 (683)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
| >PRK11637 AmiB activator; Provisional | Back alignment and domain information |
|---|
Probab=94.38 E-value=2.9 Score=47.13 Aligned_cols=26 Identities=15% Similarity=0.344 Sum_probs=13.2
Q ss_pred hhHHHHHHHHHHHHHhHHHHHHHHHh
Q 005678 297 QALKDLNAHLRQLLETKEAVERQRKS 322 (683)
Q Consensus 297 ~~~~~l~~~~~~~~e~~~~~e~~~k~ 322 (683)
..+.++....+++.+.+.+++.+...
T Consensus 170 ~~l~~l~~~~~~L~~~k~~le~~~~~ 195 (428)
T PRK11637 170 ETIAELKQTREELAAQKAELEEKQSQ 195 (428)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 44455555555555555555544433
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.1 Score=58.04 Aligned_cols=61 Identities=25% Similarity=0.319 Sum_probs=45.7
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD 544 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd 544 (683)
...+|-+|..|.++..+++..+ .++.....++.-.+.|+.-+--- .+++|.|+.|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~v-DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIV-DNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHh-hcceecccCCCcEEEE
Confidence 3457778898999998887554 56666667777777777655432 3799999999999995
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.24 Score=52.96 Aligned_cols=75 Identities=15% Similarity=0.092 Sum_probs=41.3
Q ss_pred eEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC---CCceeeeccccccCCce
Q 005678 406 ALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV---HHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 406 ~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~---HpnIV~L~~~f~~d~~~ 482 (683)
.-.+.||-|....+|+.. .++..+.||+-.... ...+..|..-|+.|. --.+++.+.+...+ +.
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~----------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-~~ 86 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG----------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-DD 86 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG----------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-SC
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh----------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-CC
Confidence 345778989999999984 778889999864111 123455666666662 33455666655433 34
Q ss_pred EEEEEecccCC
Q 005678 483 FCTVLEYCSGK 493 (683)
Q Consensus 483 ~~LV~Ey~~gg 493 (683)
.+|||||++.+
T Consensus 87 ~fLlle~l~~~ 97 (288)
T PF03881_consen 87 AFLLLEFLEMG 97 (288)
T ss_dssp CEEEEE-----
T ss_pred ceEEEEeecCC
Confidence 47999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11637 AmiB activator; Provisional | Back alignment and domain information |
|---|
Probab=93.89 E-value=3.2 Score=46.79 Aligned_cols=14 Identities=29% Similarity=0.449 Sum_probs=5.5
Q ss_pred HHHhHHHHHHHHHh
Q 005678 309 LLETKEAVERQRKS 322 (683)
Q Consensus 309 ~~e~~~~~e~~~k~ 322 (683)
+...+.+++.+++.
T Consensus 175 l~~~~~~L~~~k~~ 188 (428)
T PRK11637 175 LKQTREELAAQKAE 188 (428)
T ss_pred HHHHHHHHHHHHHH
Confidence 33344444443333
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.74 Score=51.23 Aligned_cols=79 Identities=19% Similarity=0.283 Sum_probs=46.1
Q ss_pred eeEEEEecccCceEEEEEEEccCC------eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce-eeeccccc
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEH------RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI-VRLWDTFE 477 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g------~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI-V~L~~~f~ 477 (683)
...+..|..|-...+|++...... +.|.+++....... .-.-.+|+.+++.+...++ .++++.|.
T Consensus 52 ~i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l--------~IdR~~E~~i~~~Ls~~glgP~l~~~f~ 123 (383)
T PTZ00384 52 FIEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSL--------VIDNDLQYNIAKLLGDNNFGPKIIGRFG 123 (383)
T ss_pred cEEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCce--------EeccHHHHHHHHHHHhCCCCCeEEEecC
Confidence 334556656888899998533221 23555554222111 1123458888888865444 45565553
Q ss_pred cCCceEEEEEecccCCChh
Q 005678 478 IDQNTFCTVLEYCSGKDLD 496 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~ 496 (683)
+ ++|+||++|.+|.
T Consensus 124 --~---g~l~efIeGr~l~ 137 (383)
T PTZ00384 124 --D---FTIQEWVEGNTMG 137 (383)
T ss_pred --C---EEEEEEeccccCC
Confidence 1 4899999997764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 683 | ||||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-25 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-25 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-24 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-22 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-22 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-22 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-22 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-22 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-22 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-22 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-22 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-22 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-21 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-21 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-20 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-20 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-19 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-19 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-19 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-19 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-18 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-18 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-17 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-16 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-16 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-16 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-16 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-16 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-16 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-16 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-16 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-16 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-16 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-15 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-14 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-13 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-09 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 7e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 9e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-05 |
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-69
Identities = 76/301 (25%), Positives = 128/301 (42%), Gaps = 29/301 (9%)
Query: 390 EDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQS 449
+ F + + Y++L +G GG S+V++ + + + A K L E+
Sbjct: 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL-----EEADNQ 68
Query: 450 YIRHAIREYNIHKTLVHH--HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPE 507
+ E L H I+RL+D V+E C DL++ LK +
Sbjct: 69 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-TDQYIYMVME-CGNIDLNSWLKKKKSIDP 126
Query: 508 REARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567
E + + + + + I+H DLKP N L + G+ K+ DFG++ ++ D +
Sbjct: 127 WERKSYWKNMLEAVHTI--HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD--TT 181
Query: 568 GMELTSQGAGTYWYLPPECFELSKTPL--------ISSKVDVWSAGILFYQMLFGRRPFG 619
+ SQ GT Y+PPE + + IS K DVWS G + Y M +G+ PF
Sbjct: 182 SVVKDSQ-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
Query: 620 HDQTQERILREDTIIKAR-KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
Q L II ++EFP + +D+++ CL + +R + L PY+
Sbjct: 241 QIINQISKLHA--IIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
Query: 679 T 679
Sbjct: 297 Q 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-65
Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 27/294 (9%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI 455
+ Y++L +G GG S+V++ + + + A K L E+ +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNL-----EEADNQTLDSYR 55
Query: 456 REYNIHKTLVHH--HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARII 513
E L H I+RL+D V+E + DL++ LK + E +
Sbjct: 56 NEIAYLNKLQQHSDKIIRLYDYEI-TDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSY 113
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
+ + + + I+H DLKP N L + G+ K+ DFG++ ++ D + + S
Sbjct: 114 WKNMLEAVHTI--HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD--TTSVVKDS 168
Query: 574 QGAGTYWYLPPECFELSKTPL--------ISSKVDVWSAGILFYQMLFGRRPFGHDQTQE 625
Q GT Y+PPE + + IS K DVWS G + Y M +G+ PF Q
Sbjct: 169 Q-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 626 RILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
L I E + +D+++ CL + +R + L PY+
Sbjct: 228 SKLHA---IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 6e-64
Identities = 72/297 (24%), Positives = 120/297 (40%), Gaps = 27/297 (9%)
Query: 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIR 452
S + Y++L +G GG S+V++ + + + A K L E+ +
Sbjct: 46 SANECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNL-----EEADNQTLD 99
Query: 453 HAIREYNIHKTLVHH--HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREA 510
E L H I+RL+D V+E C DL++ LK + E
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEI-TDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
+ + + + + I+H DLKP N L + G+ K+ DFG++ ++ D + +
Sbjct: 158 KSYWKNMLEAVHTI--HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD--TTSVV 212
Query: 571 LTSQGAGTYWYLPPECFELSKTPL--------ISSKVDVWSAGILFYQMLFGRRPFGHDQ 622
SQ G Y+PPE + + IS K DVWS G + Y M +G+ PF
Sbjct: 213 KDSQ-VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271
Query: 623 TQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
Q L I E + +D+++ CL + +R + L PY+
Sbjct: 272 NQISKLHA---IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-60
Identities = 67/290 (23%), Positives = 115/290 (39%), Gaps = 23/290 (7%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
I N Y + LG+GGFS V L + + A K + +D+++ A RE
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR--ILCHEQQDREE-----AQRE 76
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNT---FCTVLEYCSGKDLDAVLKATPV----LPEREA 510
++H+ H +I+RL ++ +L + L ++ L E +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
+++ I +GL ++ + H DLKP N+L + G + D G V
Sbjct: 137 LWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 571 LTSQGA----GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626
LT Q T Y PE F + +I + DVWS G + Y M+FG P+ +
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
Query: 627 ILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676
+ + ++ P P S+ L+ +T + +RP + L
Sbjct: 255 SVA---LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 4e-60
Identities = 75/310 (24%), Positives = 130/310 (41%), Gaps = 48/310 (15%)
Query: 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIR 452
R+ + + + +LG+G F +V KA + ++ RY A K + +
Sbjct: 2 LRYAS------DFEEIAVLGQGAFGQVVKARNALDSRYYAIK--------KIRHTEEKLS 47
Query: 453 HAIREYNIHKTLVHHHIVRLWDTFEIDQN------------TFCTVLEYCSGKDL-DAVL 499
+ E + +L H ++VR + + +N T +EYC L D +
Sbjct: 48 TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107
Query: 500 KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559
E + QI + L Y++ Q IIH DLKP N+ DE K+ DFGL+K
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 560 VEDDVGSQGMELTSQGA---------GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQ 610
V + ++ + GT Y+ E L T + K+D++S GI+F++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV--LDGTGHYNEKIDMYSLGIIFFE 223
Query: 611 MLFGRRPFGHDQTQERILREDTIIKARKVEFPSR--PAVSNEAKDLIRRCLTYNQAERPD 668
M++ PF + IL+ +++ +EFP K +IR + ++ +RP
Sbjct: 224 MIY---PFSTGMERVNILK---KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277
Query: 669 VLTLAQDPYL 678
TL +L
Sbjct: 278 ARTLLNSGWL 287
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 9e-58
Identities = 87/276 (31%), Positives = 124/276 (44%), Gaps = 21/276 (7%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY LGKGGF++ ++ D A K+ + S K E +IH++
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKI--VP--KSLLLKPHQREKMSMEISIHRS 71
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H H+V FE + F VLE C + L + K L E EAR + QI G Y
Sbjct: 72 LAHQHVVGFHGFFEDNDFVFV-VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L++ ++IH DLK GN+ +E K+ DFGL+ VE D + GT Y+
Sbjct: 131 LHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVL--CGTPNYIA 183
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE LSK S +VDVWS G + Y +L G+ PF + IK + P
Sbjct: 184 PEV--LSKK-GHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLR---IKKNEYSIPK 236
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
++ A LI++ L + RP + L D + T
Sbjct: 237 H--INPVAASLIQKMLQTDPTARPTINELLNDEFFT 270
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-57
Identities = 79/286 (27%), Positives = 122/286 (42%), Gaps = 21/286 (7%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACK-LHGLNAQWSEDKKQSYIRHAIREYN 459
L Y + LG G EV A++ + VA + + ++ + E
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIF 518
I K L H I+++ + F+ + VLE G +L D V+ L E ++ Q+
Sbjct: 193 ILKKLNHPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQML 249
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
+ YL++ IIH DLKP NVL +E + K+TDFG SKI+ + L
Sbjct: 250 LAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET------SLMRTL 301
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT YL PE T + VD WS G++ + L G PF +TQ + + I
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ---IT 358
Query: 636 ARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ K F VS +A DL+++ L + R + P+L
Sbjct: 359 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-57
Identities = 87/277 (31%), Positives = 124/277 (44%), Gaps = 21/277 (7%)
Query: 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
RY LGKGGF++ ++ D A K+ + S K E +IH+
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKI--VP--KSLLLKPHQREKMSMEISIHR 96
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
+L H H+V FE + F VLE C + L + K L E EAR + QI G
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFV-VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL++ ++IH DLK GN+ +E K+ DFGL+ VE D + GT Y+
Sbjct: 156 YLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVL--CGTPNYI 208
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642
PE LSK S +VDVWS G + Y +L G+ PF + IK + P
Sbjct: 209 APEV--LSKKGH-SFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLR---IKKNEYSIP 261
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
++ A LI++ L + RP + L D + T
Sbjct: 262 KH--INPVAASLIQKMLQTDPTARPTINELLNDEFFT 296
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-56
Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 26/283 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y +L +G G + K + + + K + +K+ + E N+ +
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-----LVSEVNLLRE 61
Query: 464 LVHHHIVRLWDTF-EIDQNTFCTVLEYCSGKDLDAVLKATP----VLPEREARIIIVQIF 518
L H +IVR +D + T V+EYC G DL +V+ L E ++ Q+
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 519 QGLIYL---NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
L + ++H DLKP NV D K+ DFGL++I+ +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----NHDTSFAKTF 176
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT +Y+ PE + + K D+WS G L Y++ PF +E + I +
Sbjct: 177 VGTPYYMSPEQMN--RMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---IRE 230
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ P R S+E ++I R L RP V + ++P +
Sbjct: 231 GKFRRIPYR--YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 78/318 (24%), Positives = 120/318 (37%), Gaps = 58/318 (18%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
L +Y L +G+G + V A + A K+ N + K + E +
Sbjct: 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD--VERIKTEVRL 81
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL------------------------- 495
K L H +I RL++ +E D+ C V+E C G L
Sbjct: 82 MKKLHHPNIARLYEVYE-DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 496 ---------------DAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGN 540
V E+ I+ QIF L YL Q I H D+KP N
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL--HNQGICHRDIKPEN 198
Query: 541 VLF--DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSK 598
LF ++ K+ DFGLSK + +T++ AGT +++ PE + K
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK-AGTPYFVAPEVLNTTNES-YGPK 256
Query: 599 VDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRP--AVSNEAKDLIR 656
D WSAG+L + +L G PF + + + +K+ F + +S A+DL+
Sbjct: 257 CDAWSAGVLLHLLLMGAVPF-PGVNDADTISQ---VLNKKLCFENPNYNVLSPLARDLLS 312
Query: 657 RCLTYNQAERPDVLTLAQ 674
L N ER +
Sbjct: 313 NLLNRNVDER---FDAMR 327
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-55
Identities = 80/286 (27%), Positives = 124/286 (43%), Gaps = 21/286 (7%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACK-LHGLNAQWSEDKKQSYIRHAIREYN 459
L Y + LG G EV A++ + VA K + ++ + E
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIF 518
I K L H I+++ + F+ ++ + VLE G +L D V+ L E ++ Q+
Sbjct: 68 ILKKLNHPCIIKIKNFFD-AEDYY-IVLELMEGGELFDKVVGNKR-LKEATCKLYFYQML 124
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
+ YL++ IIH DLKP NVL +E + K+TDFG SKI+ + L
Sbjct: 125 LAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET------SLMRTL 176
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT YL PE T + VD WS G++ + L G PF +TQ + + I
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ---IT 233
Query: 636 ARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ K F VS +A DL+++ L + R + P+L
Sbjct: 234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 81/286 (28%), Positives = 136/286 (47%), Gaps = 33/286 (11%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI-REYN 459
+ + + +LG G FSEV+ + + A K K ++ ++ E
Sbjct: 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK--------CIKKSPAFRDSSLENEIA 58
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIF 518
+ K + H +IV L D +E + V++ SG +L D +L+ V E++A ++I Q+
Sbjct: 59 VLKKIKHENIVTLEDIYE-STTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVL 116
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
+ YL++ I+H DLKP N+L+ +E +TDFGLSK+ ++ + S
Sbjct: 117 SAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-------MSTA 167
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT Y+ PE L++ P S VD WS G++ Y +L G PF +++T+ ++ + IK
Sbjct: 168 CGTPGYVAPEV--LAQKPY-SKAVDCWSIGVITYILLCGYPPF-YEETESKLFEK---IK 220
Query: 636 ARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
EF S +S AKD I L + ER P++
Sbjct: 221 EGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-55
Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 34/300 (11%)
Query: 388 RDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACK------LHGLNAQ 441
RD ++ Y +LG+G S V + + A K +A+
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 442 WSEDKKQSYIRHAIREYNIHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVL 499
++ +++ ++E +I + + H +I++L DT+E F V + +L D +
Sbjct: 62 EVQELREA----TLKEVDILRKVSGHPNIIQLKDTYE-TNTFFFLVFDLMKKGELFDYLT 116
Query: 500 KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559
+ L E+E R I+ + + + L+K I+H DLKP N+L D+ K+TDFG S
Sbjct: 117 EKV-TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLI---SSKVDVWSAGILFYQMLFGRR 616
++ E + GT YL PE E S +VD+WS G++ Y +L G
Sbjct: 174 LDPG------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
Query: 617 PFGHDQTQERILREDTIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
PF + Q +LR I + +F S S+ KDL+ R L +R T +
Sbjct: 228 PF-WHRKQMLMLRM---IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKR---YTAEE 280
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-55
Identities = 62/277 (22%), Positives = 126/277 (45%), Gaps = 23/277 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y L +G+G F + + R K ++ S+++++ + RE +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-----SRREVAVLAN 79
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGL 521
+ H +IV+ ++FE + + V++YC G DL + A + E + VQI L
Sbjct: 80 MKHPNIVQYRESFE-ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
+++ R KI+H D+K N+ + G ++ DFG+++++ + +EL GT +Y
Sbjct: 139 KHVHDR--KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-----NSTVELARACIGTPYY 191
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
L PE E ++K D+W+ G + Y++ + F + +L+ II
Sbjct: 192 LSPEICENKPY---NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK---IISGSFPPV 245
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
S + + L+ + N +RP V ++ + ++
Sbjct: 246 SLH--YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-55
Identities = 82/290 (28%), Positives = 125/290 (43%), Gaps = 39/290 (13%)
Query: 392 GSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYI 451
GS + N Y L N +G+G + EV A A K K
Sbjct: 1 GSTKGDI---NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK--------KIPKYFVED 49
Query: 452 RHAI-REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPERE 509
+E I K+L H +I+RL++TFE D V+E C+G +L + V+ E +
Sbjct: 50 VDRFKQEIEIMKSLDHPNIIRLYETFE-DNTDIYLVMELCTGGELFERVVHKRV-FRESD 107
Query: 510 ARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGS 566
A I+ + + Y +K + H DLKP N LF K+ DFGL+ +
Sbjct: 108 AARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--- 162
Query: 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626
++ GT +Y+ P+ E P + D WSAG++ Y +L G PF T
Sbjct: 163 ---KMMRTKVGTPYYVSPQVLEGLYGP----ECDEWSAGVMMYVLLCGYPPF-SAPTDSE 214
Query: 627 ILREDTIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
++ + I+ FP + VS +A+ LIRR LT + +R +T Q
Sbjct: 215 VMLK---IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQR---ITSLQ 258
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-55
Identities = 86/280 (30%), Positives = 139/280 (49%), Gaps = 32/280 (11%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
RY ++ +LGKG F EV K D + + A K+ + ++D RE +
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-----REVEL 74
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIFQ 519
K L H +I++L++ E D ++F V E +G +L D ++K E +A II Q+F
Sbjct: 75 LKKLDHPNIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFS 132
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
G+ Y++K I+H DLKP N+L ++ K+ DFGLS + +
Sbjct: 133 GITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN------TKMKDRI 184
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636
GT +Y+ PE + K DVWSAG++ Y +L G PF + + + IL+ ++
Sbjct: 185 GTAYYIAPEVLRGTYDE----KCDVWSAGVILYILLSGTPPF-YGKNEYDILKR---VET 236
Query: 637 RKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
K F +S++AKDLIR+ LT++ + R +T Q
Sbjct: 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR---ITATQ 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-55
Identities = 66/298 (22%), Positives = 122/298 (40%), Gaps = 41/298 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ + LG+GGF V++A + V+ A K L + +K +RE
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK------VMREVKALAK 59
Query: 464 LVHHHIVRLWDTFEIDQNTF-----------CTVLEYCSGKDLDAVLKATPVLPEREARI 512
L H IVR ++ + T ++ C ++L + + ERE +
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 513 II---VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD------ 563
+ +QI + + +L+ + ++H DLKP N+ F V KV DFGL ++ D
Sbjct: 120 CLHIFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 564 -VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQ 622
+ GT Y+ PE ++ S KVD++S G++ +++L PF
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPE--QIHGNS-YSHKVDIFSLGLILFELL---YPFSTQM 231
Query: 623 TQERILREDTIIKARKVEFPSRPA-VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ R L R ++FP +++ L+ + ERP+ + + ++
Sbjct: 232 ERVRTLT-----DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 8e-55
Identities = 56/292 (19%), Positives = 110/292 (37%), Gaps = 49/292 (16%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ + L+G GGF +V+KA ++ + K K + A RE
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIK---------RVKYNN--EKAEREVKALAK 60
Query: 464 LVHHHIVRLWDTFE---------------IDQNTFCTVLEYCSGKDLDAVLKA--TPVLP 506
L H +IV ++ +E+C L+ ++ L
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 507 EREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS 566
+ A + QI +G+ Y++ + K+I+ DLKP N+ + K+ DFGL +++D
Sbjct: 121 KVLALELFEQITKGVDYIHSK--KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--- 175
Query: 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626
+ T GT Y+ PE +S +VD+++ G++ ++L +
Sbjct: 176 --GKRTRS-KGTLRYMSPEQ--ISSQD-YGKEVDLYALGLILAELLHVCDTA-FE----- 223
Query: 627 ILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
R + K L+++ L+ +RP+ + + +
Sbjct: 224 --TSKFFTDLRDGIISDI--FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-54
Identities = 83/365 (22%), Positives = 153/365 (41%), Gaps = 27/365 (7%)
Query: 318 RQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLASIKREEEAILRERERYELEK 377
K K+R+ + + + + +E+ + S EA + + +
Sbjct: 11 VDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTE 70
Query: 378 GRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHG 437
+ M +++ + + +Y +++G+G S V + A K+
Sbjct: 71 NLYFQSMGP--EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME 128
Query: 438 LNAQWSEDKKQSYIRHAI-REYNIHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDL 495
+ A+ ++ +R A RE +I + + H HI+ L D++E + V + +L
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE-SSSFMFLVFDLMRKGEL 187
Query: 496 -DAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554
D + + L E+E R I+ + + + +L+ I+H DLKP N+L D+ +++DF
Sbjct: 188 FDYLTEKVA-LSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDF 244
Query: 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISS---KVDVWSAGILFYQM 611
G S +E E + GT YL PE + S +VD+W+ G++ + +
Sbjct: 245 GFSCHLEPG------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298
Query: 612 LFGRRPFGHDQTQERILREDTIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDV 669
L G PF + Q +LR I + +F S S+ KDLI R L + R
Sbjct: 299 LAGSPPF-WHRRQILMLRM---IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEAR--- 351
Query: 670 LTLAQ 674
LT Q
Sbjct: 352 LTAEQ 356
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-54
Identities = 86/283 (30%), Positives = 127/283 (44%), Gaps = 37/283 (13%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHA---IRE 457
+ Y + LGKG FS V + A K + K+ R RE
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--------IINTKKLSARDFQKLERE 55
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQ 516
I + L H +IVRL D+ + +++ V + +G +L + ++ E +A I Q
Sbjct: 56 ARICRKLQHPNIVRLHDSIQ-EESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQ 113
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
I + + Y + I+H +LKP N+L + K+ DFGL+ V D E
Sbjct: 114 ILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS------EAWH 165
Query: 574 QGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633
AGT YL PE L K P S VD+W+ G++ Y +L G PF D+ Q R+ +
Sbjct: 166 GFAGTPGYLSPEV--LKKDPY-SKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQ--- 218
Query: 634 IKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
IKA ++PS V+ EAK LI LT N +R +T Q
Sbjct: 219 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR---ITADQ 258
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 7e-54
Identities = 71/284 (25%), Positives = 130/284 (45%), Gaps = 38/284 (13%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI--REY 458
++ + LG G F +V+ + K + +K +S + E
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK--------TINKDRSQVPMEQIEAEI 71
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPV---LPEREARIII 514
+ K+L H +I+++++ FE D + V+E C G +L + ++ A L E ++
Sbjct: 72 EVLKSLDHPNIIKIFEVFE-DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM 130
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMEL 571
Q+ L Y + Q ++H DLKP N+LF K+ DFGL+++ + D E
Sbjct: 131 KQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD------EH 182
Query: 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631
++ AGT Y+ PE F+ T K D+WSAG++ Y +L G PF + E + ++
Sbjct: 183 STNAAGTALYMAPEVFKRDVTF----KCDIWSAGVVMYFLLTGCLPF-TGTSLEEVQQK- 236
Query: 632 TIIKARKVEFPSRPA-VSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
++ + ++ +A DL+++ LT + R + AQ
Sbjct: 237 --ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERR---PSAAQ 275
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 9e-54
Identities = 66/308 (21%), Positives = 120/308 (38%), Gaps = 30/308 (9%)
Query: 385 KRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE 444
+D+ + + + ++LG G + + ++R VA K
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVK--------RI 56
Query: 445 DKKQSYIRHAIREYNIHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP 503
+ A RE + + H +++R + T + D+ +E C+ + V +
Sbjct: 57 LPEC--FSFADREVQLLRESDEHPNVIRYFCTEK-DRQFQYIAIELCAATLQEYVEQKDF 113
Query: 504 VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-----VAKVTDFGLSK 558
E ++ Q GL +L+ I+H DLKP N+L A ++DFGL K
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRP 617
+ S S GT ++ PE + VD++SAG +FY ++ G P
Sbjct: 172 KLAVGRHS--FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
Query: 618 FGHD-QTQERILREDTIIKARKVEFPSRPA-VSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
FG Q Q IL + A ++ A++LI + + + +RP + +
Sbjct: 230 FGKSLQRQANIL-----LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284
Query: 676 PYLTYSKK 683
P+ +K
Sbjct: 285 PFFWSLEK 292
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-53
Identities = 77/290 (26%), Positives = 124/290 (42%), Gaps = 28/290 (9%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACK------LHGLNAQWSEDKKQSYIRHA 454
+ Y + LG G + EV + H A K + +
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIII 514
E ++ K+L H +I++L+D FE D+ F V E+ G +L + E +A I+
Sbjct: 94 YNEISLLKSLDHPNIIKLFDVFE-DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMEL 571
QI G+ YL+K I+H D+KP N+L + K+ DFGLS D
Sbjct: 153 KQILSGICYLHK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD------YK 204
Query: 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631
GT +Y+ PE + + K DVWS G++ Y +L G PF Q + I+++
Sbjct: 205 LRDRLGTAYYIAPEVLKKK----YNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKK- 258
Query: 632 TIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
++ K F +S+EAK+LI+ LTY+ +R ++
Sbjct: 259 --VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-53
Identities = 84/277 (30%), Positives = 130/277 (46%), Gaps = 22/277 (7%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ + NLLGKG F+ VY+A + VA K+ ++ K ++ E IH
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKM--ID--KKAMYKAGMVQRVQNEVKIHCQ 67
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLI 522
L H I+ L++ FE + VLE C +++ LK E EAR + QI G++
Sbjct: 68 LKHPSILELYNYFEDSNYVYL-VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL+ I+H DL N+L K+ DFGL+ ++ T GT Y+
Sbjct: 127 YLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP---HEKHYTL--CGTPNYI 179
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642
PE +++ + DVWS G +FY +L GR PF T + L + + E P
Sbjct: 180 SPEI--ATRSAH-GLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNK---VVLADYEMP 232
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
S +S EAKDLI + L N A+R + ++ P+++
Sbjct: 233 SF--LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-53
Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 25/281 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ + +G+G FSEVY+A L++ VA K + + I+E ++ K
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD----CIKEIDLLKQ 88
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----PVLPEREARIIIVQIFQ 519
L H ++++ + +F I+ N VLE DL ++K ++PER VQ+
Sbjct: 89 LNHPNVIKYYASF-IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
L +++ R +++H D+KP NV GV K+ D GL + S GT
Sbjct: 148 ALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTP 200
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639
+Y+ PE + + K D+WS G L Y+M + PF D+ L K +
Sbjct: 201 YYMSPERIHENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL----CKKIEQC 253
Query: 640 EFPSRPA--VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++P P+ S E + L+ C+ + +RPDV +
Sbjct: 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-53
Identities = 78/289 (26%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI----- 455
Y L ++GKG FS V + + + A K D + +
Sbjct: 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVK--------IVDVAKFTSSPGLSTEDL 73
Query: 456 -REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLK---ATPVLPEREA 510
RE +I L H HIV L +T+ V E+ G DL ++K A V E A
Sbjct: 74 KREASICHMLKHPHIVELLETYS-SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQ 567
+ QI + L Y + IIH D+KP VL + K+ FG++ + +
Sbjct: 133 SHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES---- 186
Query: 568 GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627
+ GT ++ PE + + P VDVW G++ + +L G PF T+ER+
Sbjct: 187 -GLVAGGRVGTPHFMAPEV--VKREPY-GKPVDVWGCGVILFILLSGCLPFYG--TKERL 240
Query: 628 LREDTIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
I K + R +S AKDL+RR L + AER +T+ +
Sbjct: 241 FEG---IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER---ITVYE 283
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-53
Identities = 70/289 (24%), Positives = 110/289 (38%), Gaps = 32/289 (11%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
++ R + +L +GGF+ VY+A D+ R A K L + E + I+E
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKR--LLSNEEEKNRA-----IIQE 75
Query: 458 YNIHKTLVHH-HIVRLWDTFEIDQNT-------FCTVLEYCSGKDLDAVLKATPV--LPE 507
K L H +IV+ I + F + E C G+ ++ + K L
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 508 REARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV--- 564
I Q + + +++++ IIH DLK N+L G K+ DFG + +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 565 ----GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGH 620
+E T Y PE +L I K D+W+ G + Y + F + PF
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-E 254
Query: 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDV 669
D + RI+ K P LIR L N ER +
Sbjct: 255 DGAKLRIVN-------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSI 296
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 6e-53
Identities = 85/292 (29%), Positives = 129/292 (44%), Gaps = 34/292 (11%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI----R 456
+ RY +LGKG F EV D + + A K K+Q + R
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--------VISKRQVKQKTDKESLLR 75
Query: 457 EYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ 516
E + K L H +I++L++ FE D+ F V E +G +L + + E +A II Q
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ 134
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
+ G+ Y++K KI+H DLKP N+L + ++ DFGLS E +
Sbjct: 135 VLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS------KKMK 186
Query: 574 QGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633
GT +Y+ PE + K DVWS G++ Y +L G PF + + IL++
Sbjct: 187 DKIGTAYYIAPEVLHGT----YDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKK--- 238
Query: 634 IKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
++ K F VS AKDLIR+ LTY + R ++ K
Sbjct: 239 VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-52
Identities = 84/295 (28%), Positives = 130/295 (44%), Gaps = 34/295 (11%)
Query: 391 DGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSY 450
DGS + + + + + LG+G S VY+ + A K+ KK
Sbjct: 44 DGSNRDAL---SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL---------KKTVD 91
Query: 451 IRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPERE 509
+ E + L H +I++L + FE VLE +G +L D +++ ER+
Sbjct: 92 KKIVRTEIGVLLRLSHPNIIKLKEIFE-TPTEISLVLELVTGGELFDRIVEKG-YYSERD 149
Query: 510 ARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGS 566
A + QI + + YL++ I+H DLKP N+L+ K+ DFGLSKIVE
Sbjct: 150 AADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--- 204
Query: 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626
L GT Y PE L +VD+WS GI+ Y +L G PF ++ +
Sbjct: 205 ---VLMKTVCGTPGYCAPEI--LRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQF 258
Query: 627 ILREDTIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ R I + F S VS AKDL+R+ + + +R Q P++T
Sbjct: 259 MFRR---ILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-52
Identities = 84/284 (29%), Positives = 138/284 (48%), Gaps = 27/284 (9%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
RY ++ +LGKG F EV K D + + A K+ + ++D I RE +
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST--IL---REVEL 74
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
K L H +I++L++ E D ++F V E +G +L + E +A II Q+F G
Sbjct: 75 LKKLDHPNIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 521 LIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
+ Y++K I+H DLKP N+L ++ K+ DFGLS + + G
Sbjct: 134 ITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN------TKMKDRIG 185
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
T +Y+ PE + K DVWSAG++ Y +L G PF + + + IL+ ++
Sbjct: 186 TAYYIAPEVLRGT----YDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKR---VETG 237
Query: 638 KVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
K F +S++AKDLIR+ LT++ + R + P++
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-52
Identities = 76/278 (27%), Positives = 118/278 (42%), Gaps = 33/278 (11%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ + LGKG F VY A + +A K+ L ++ +K RE I
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFK--AQLEKAGVEHQLRREVEIQSH 65
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H +I+RL+ F + +LEY + L+ E+ I ++ L Y
Sbjct: 66 LRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 124
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
+ + ++IH D+KP N+L G K+ DFG S GT YLP
Sbjct: 125 CHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDL--CGTLDYLP 175
Query: 584 PECFELSKTPLISSK-----VDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638
PE +I + VD+WS G+L Y+ L G+ PF T + + I +
Sbjct: 176 PE--------MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKR---ISRVE 223
Query: 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676
FP V+ A+DLI R L +N ++RP + + + P
Sbjct: 224 FTFPDF--VTEGARDLISRLLKHNPSQRPMLREVLEHP 259
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-52
Identities = 83/284 (29%), Positives = 133/284 (46%), Gaps = 27/284 (9%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
L+ Y + LG G + EV D V H A K+ + + + + E +
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK--LL---EEVAV 89
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
K L H +I++L+D FE D+ + V+E G +L + E +A +II Q+ G
Sbjct: 90 LKLLDHPNIMKLYDFFE-DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 521 LIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
+ YL+K I+H DLKP N+L ++ + K+ DFGLS + E+ + + G
Sbjct: 149 VTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ------KKMKERLG 200
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
T +Y+ PE K DVWS G++ + +L G PF QT + ILR+ ++
Sbjct: 201 TAYYIAPEVLRKK----YDEKCDVWSIGVILFILLAGYPPF-GGQTDQEILRK---VEKG 252
Query: 638 KVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
K F S VS AKDLI++ L ++ R + P++
Sbjct: 253 KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-52
Identities = 83/272 (30%), Positives = 126/272 (46%), Gaps = 28/272 (10%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
+ Y + LGKG FS V + A K+ + D ++ + RE I
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--LE---REARI 81
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIFQ 519
+ L H +IVRL D+ + +++ V + +G +L + ++ E +A I QI +
Sbjct: 82 CRKLQHPNIVRLHDSIQ-EESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILE 139
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
+ Y + I+H +LKP N+L + K+ DFGL+ V D E A
Sbjct: 140 SIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS------EAWHGFA 191
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636
GT YL PE L K P S VD+W+ G++ Y +L G PF D+ Q R+ + IKA
Sbjct: 192 GTPGYLSPEV--LKKDPY-SKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQ---IKA 244
Query: 637 RKVEFPSRP--AVSNEAKDLIRRCLTYNQAER 666
++PS V+ EAK LI LT N +R
Sbjct: 245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-52
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 29/288 (10%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
L +Y + LG+G F V++ + + K K + +E +I
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK--------FVKVKGTDQVLVKKEISI 54
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIFQ 519
H +I+ L ++FE + E+ SG D+ + + + L ERE + Q+ +
Sbjct: 55 LNIARHRNILHLHESFE-SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLF--DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
L +L+ I H+D++P N+++ K+ +FG ++ ++ +
Sbjct: 114 ALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG------DNFRLLFT 165
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
Y PE +S+ D+WS G L Y +L G PF +T ++I+ I
Sbjct: 166 APEYYAPEV--HQHDV-VSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIEN---IMNA 218
Query: 638 KVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
+ F +S EA D + R L + R Q P+L +
Sbjct: 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 8e-52
Identities = 78/332 (23%), Positives = 132/332 (39%), Gaps = 37/332 (11%)
Query: 353 KSRLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLG 412
K + I + YE + + + ++ + Y +L LG
Sbjct: 10 HGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGS---------VYDYYDILEELG 60
Query: 413 KGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472
G F V++ + R K +N + DK E +I L H ++ L
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYT-----VKNEISIMNQLHHPKLINL 113
Query: 473 WDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKI 531
D FE D+ +LE+ SG +L D + + E E + Q +GL ++++ I
Sbjct: 114 HDAFE-DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE--HSI 170
Query: 532 IHYDLKPGNVLF--DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFEL 589
+H D+KP N++ + K+ DFGL+ + D E+ T + PE +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD------EIVKVTTATAEFAAPEI--V 222
Query: 590 SKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR--PAV 647
+ P + D+W+ G+L Y +L G PF + L+ +K EF +V
Sbjct: 223 DREP-VGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQN---VKRCDWEFDEDAFSSV 277
Query: 648 SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
S EAKD I+ L +R V + P+L
Sbjct: 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-51
Identities = 80/307 (26%), Positives = 132/307 (42%), Gaps = 34/307 (11%)
Query: 384 MKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWS 443
M+ + + + Y + LG G F+ V K + A K + + S
Sbjct: 2 MEPFKQQK---------VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKF--IKKRQS 50
Query: 444 EDKKQSYIRHAI-REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT 502
++ R I RE +I + ++HH+++ L D +E ++ +LE SG +L L
Sbjct: 51 RASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-NRTDVVLILELVSGGELFDFLAQK 109
Query: 503 PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVAKVTDFGLSK 558
L E EA I QI G+ YL+ +KI H+DLKP N++ K+ DFGL+
Sbjct: 110 ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
+ED GT ++ PE ++ P + + D+WS G++ Y +L G PF
Sbjct: 168 EIEDG------VEFKNIFGTPEFVAPEI--VNYEP-LGLEADMWSIGVITYILLSGASPF 218
Query: 619 GHDQTQERILREDTIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676
T++ L I + +F S AKD IR+ L +R + + P
Sbjct: 219 -LGDTKQETLAN---ITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 677 YLTYSKK 683
++T
Sbjct: 275 WITPVDN 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-51
Identities = 81/284 (28%), Positives = 131/284 (46%), Gaps = 38/284 (13%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI----R 456
Y L LGKG FS V + ++ + A + + R
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMII---------NTKKLSARDHQKLER 59
Query: 457 EYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIV 515
E I + L H +IVRL D+ ++ + + +G +L + ++ E +A I
Sbjct: 60 EARICRLLKHPNIVRLHDSIS-EEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQ 117
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELT 572
QI + +++ ++ ++H +LKP N+L + K+ DFGL+ VE + +
Sbjct: 118 QILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-----QQAW 170
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632
AGT YL PE L K P VD+W+ G++ Y +L G PF D+ Q R+ ++
Sbjct: 171 FGFAGTPGYLSPEV--LRKDPY-GKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQ-- 224
Query: 633 IIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
IKA +FPS V+ EAKDLI + LT N ++R +T A+
Sbjct: 225 -IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKR---ITAAE 264
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-51
Identities = 70/311 (22%), Positives = 118/311 (37%), Gaps = 43/311 (13%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
Q L + +LG G V + R VA K + A+ E
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR----------MLIDFCDIALMEI 59
Query: 459 NIHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK------ATPVLPEREAR 511
+ H +++R + + LE C+ D V + E
Sbjct: 60 KLLTESDDHPNVIRYYCSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-------------EFGVAKVTDFGLSK 558
++ QI G+ +L+ KIIH DLKP N+L E ++DFGL K
Sbjct: 119 SLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLI----SSKVDVWSAGILFYQML-F 613
++ S L + +GT + PE E S + +D++S G +FY +L
Sbjct: 177 KLDSGQSSFRTNLNN-PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 614 GRRPFGHD-QTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTL 672
G+ PFG + I+R I +++ ++ EA DLI + + ++ +RP + +
Sbjct: 236 GKHPFGDKYSRESNIIRG--IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
Query: 673 AQDPYLTYSKK 683
+ P K
Sbjct: 294 LRHPLFWPKSK 304
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 69/304 (22%), Positives = 120/304 (39%), Gaps = 50/304 (16%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
NH + L ++LG+G + V++ A K+ N S + RE+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKV--FN-NISFLRPVDVQM---REF 58
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNT-FCTVLEYCSGKDLDAVLKA---TPVLPEREARIII 514
+ K L H +IV+L+ E ++E+C L VL+ LPE E I++
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVAKVTDFGLSKIVEDDVGSQGME 570
+ G+ +L R I+H ++KPGN++ D V K+TDFG ++ +EDD E
Sbjct: 119 RDVVGGMNHL--RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD------E 170
Query: 571 LTSQGAGTYWYLPPECFELSKTPLI-----SSKVDVWSAGILFYQMLFGRRPF------- 618
GT YL P+ +E + + VD+WS G+ FY G PF
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 619 GHDQTQERILRED--------TIIKARKVEFPSR--------PAVSNEAKDLIRRCLTYN 662
+ + +I+ + +++ + ++ L +
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290
Query: 663 QAER 666
Q +
Sbjct: 291 QEKC 294
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-51
Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 27/291 (9%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI-REYN 459
+ Y + LG G F+ V K + A K + + ++ R I RE N
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKF--IKKRRLSSSRRGVSREEIEREVN 60
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIF 518
I + + H +I+ L D FE ++ +LE SG +L D + + L E EA + QI
Sbjct: 61 ILREIRHPNIITLHDIFE-NKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQIL 118
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
G+ YL+ ++I H+DLKP N++ K+ DFG++ +E
Sbjct: 119 DGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG------NEFKN 170
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634
GT ++ PE ++ P + + D+WS G++ Y +L G PF +T++ L I
Sbjct: 171 IFGTPEFVAPEI--VNYEP-LGLEADMWSIGVITYILLSGASPF-LGETKQETLTN---I 223
Query: 635 KARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
A +F S AKD IRR L + R + + ++ ++
Sbjct: 224 SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-50
Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 27/287 (9%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI-REYN 459
+ Y + LG G F+ V K + A K + + S ++ R I RE +
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKF--IKKRQSRASRRGVCREEIEREVS 67
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIF 518
I + ++H +I+ L D +E ++ +LE SG +L D + + L E EA I QI
Sbjct: 68 ILRQVLHPNIITLHDVYE-NRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQIL 125
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
G+ YL+ +KI H+DLKP N++ K+ DFGL+ +ED
Sbjct: 126 DGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG------VEFKN 177
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634
GT ++ PE ++ P + + D+WS G++ Y +L G PF T++ L I
Sbjct: 178 IFGTPEFVAPEI--VNYEP-LGLEADMWSIGVITYILLSGASPF-LGDTKQETLAN---I 230
Query: 635 KARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
A +F S AKD IR+ L +R + + P++T
Sbjct: 231 TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-50
Identities = 72/274 (26%), Positives = 122/274 (44%), Gaps = 27/274 (9%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI-REYN 459
++ Y LG G F+ V K + A K + + ++ ++ R I RE +
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVS 66
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIF 518
I K + H +++ L + +E ++ +LE +G +L D + + L E EA + QI
Sbjct: 67 ILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQIL 124
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
G+ YL+ +I H+DLKP N++ K+ DFGL+ ++
Sbjct: 125 NGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG------NEFKN 176
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634
GT ++ PE ++ P + + D+WS G++ Y +L G PF T++ L +
Sbjct: 177 IFGTPEFVAPEI--VNYEP-LGLEADMWSIGVITYILLSGASPF-LGDTKQETLAN---V 229
Query: 635 KARKVEFPSRP--AVSNEAKDLIRRCLTYNQAER 666
A EF S AKD IRR L + +R
Sbjct: 230 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-50
Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ + LGKG F VY A + +A K+ L S+ +K+ RE I
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKV--LFK--SQLEKEGVEHQLRREIEIQSH 70
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H +I+R+++ F + + +LE+ +L L+ E+ + + ++ L Y
Sbjct: 71 LRHPNILRMYNYFHDRKRIYL-MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY 129
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
++R K+IH D+KP N+L G K+ DFG S GT YLP
Sbjct: 130 CHER--KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-------LRRRTMCGTLDYLP 180
Query: 584 PECFELSKTPLISSK-----VDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIK 635
PE +I K VD+W AG+L Y+ L G PF H +T RI+ D
Sbjct: 181 PE--------MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD---- 228
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
++FP P +S+ +KDLI + L Y+ +R L L
Sbjct: 229 ---LKFP--PFLSDGSKDLISKLLRYHPPQR---LPLKG 259
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-50
Identities = 57/277 (20%), Positives = 101/277 (36%), Gaps = 28/277 (10%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ L+ LG G + EV+K + R A K + +D+ + E H+
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-----ARKLAEVGSHEK 112
Query: 464 LVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGL 521
+ H VRL +E + E C L +A LPE + + L
Sbjct: 113 VGQHPCCVRLEQAWE-EGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
+L+ + ++H D+KP N+ G K+ DFGL + + E G Y
Sbjct: 171 AHLHSQ--GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE------GDPRY 222
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
+ PE + S DV+S G+ ++ + +++ + EF
Sbjct: 223 MAPELLQGSYGT----AADVFSLGLTILEVACNMELPHGGEGWQQLRQ-----GYLPPEF 273
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ +S+E + ++ L + R L P L
Sbjct: 274 TAG--LSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-49
Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 30/276 (10%)
Query: 401 LNHRYALLN-LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
N+ Y L + LG+G F+ V + + A K + + + + + E
Sbjct: 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-----ILHEIA 80
Query: 460 IHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVL-KATPVLPEREARIIIVQ 516
+ + ++ L + +E + + +LEY +G ++ L + ++ E + +I Q
Sbjct: 81 VLELAKSCPRVINLHEVYE-NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
I +G+ YL++ I+H DLKP N+L G K+ DFG+S+ +
Sbjct: 140 ILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA------CELR 191
Query: 574 QGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633
+ GT YL PE L+ P I++ D+W+ GI+ Y +L PF + +
Sbjct: 192 EIMGTPEYLAPEI--LNYDP-ITTATDMWNIGIIAYMLLTHTSPF-VGEDNQETYLN--- 244
Query: 634 IKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERP 667
I V++ +VS A D I+ L N +RP
Sbjct: 245 ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP 280
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 70/276 (25%), Positives = 126/276 (45%), Gaps = 30/276 (10%)
Query: 401 LNHRYAL--LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
+N Y + +LG G F +V+K + +A K+ + + +DK++ E
Sbjct: 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI--IKTRGMKDKEE-----VKNEI 137
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQI 517
++ L H ++++L+D FE +N V+EY G +L D ++ + L E + + + QI
Sbjct: 138 SVMNQLDHANLIQLYDAFE-SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA--KVTDFGLSKIVEDDVGSQGMELTSQG 575
+G+ ++++ I+H DLKP N+L K+ DFGL++ + E
Sbjct: 197 CEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR------EKLKVN 248
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT +L PE ++ +S D+WS G++ Y +L G PF L I
Sbjct: 249 FGTPEFLAPEV--VNYDF-VSFPTDMWSVGVIAYMLLSGLSPF-LGDNDAETLNN---IL 301
Query: 636 ARKVEFPSR--PAVSNEAKDLIRRCLTYNQAERPDV 669
A + + +S EAK+ I + L ++ R
Sbjct: 302 ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISA 337
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 73/289 (25%), Positives = 117/289 (40%), Gaps = 36/289 (12%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
Y + +G G +S + + A K DK + E I
Sbjct: 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK--------IIDKSKRDPT---EEIEI 68
Query: 461 HKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIF 518
H +I+ L D ++ D V E G +L D +L+ EREA ++ I
Sbjct: 69 LLRYGQHPNIITLKDVYD-DGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTIT 126
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
+ + YL+ Q ++H DLKP N+L+ ++ DFG +K + + L
Sbjct: 127 KTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-----NGLLMT 179
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQERILREDT 632
T ++ PE L + + D+WS G+L Y ML G PF G D T E IL
Sbjct: 180 PCYTANFVAPEV--LERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR-- 234
Query: 633 IIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
I + K +VS+ AKDL+ + L + +R + + P++
Sbjct: 235 -IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-49
Identities = 71/284 (25%), Positives = 116/284 (40%), Gaps = 28/284 (9%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
+ Y + LG G F V++ + A K + DK+ +E
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF--VMTPHESDKET-----VRKEIQT 207
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIFQ 519
L H +V L D FE D N + E+ SG +L + V + E EA + Q+ +
Sbjct: 208 MSVLRHPTLVNLHDAFE-DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVA--KVTDFGLSKIVEDDVGSQGMELTSQGAG 577
GL ++++ +H DLKP N++F K+ DFGL+ ++ + G
Sbjct: 267 GLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK------QSVKVTTG 318
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
T + PE P + D+WS G+L Y +L G PF + + LR +K+
Sbjct: 319 TAEFAAPEV--AEGKP-VGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRN---VKSC 371
Query: 638 KVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+S + KD IR+ L + R + + P+LT
Sbjct: 372 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-49
Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 32/296 (10%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK-------------------LHGLNAQWSE 444
+Y L + +GKG + V AY+ ++ Y A K A
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 445 DKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-DQNTFCTVLEYCSGKDLDAVLKATP 503
+ + I +E I K L H ++V+L + + +++ V E + + V P
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 504 VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563
L E +AR + +G+ YL+ QKIIH D+KP N+L E G K+ DFG+S +
Sbjct: 134 -LSEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 564 VGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT 623
L S GT ++ PE ++ +DVW+ G+ Y +FG+ PF D+
Sbjct: 191 DA-----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-MDER 244
Query: 624 QERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ + IK++ +EFP +P ++ + KDLI R L N R V + P++T
Sbjct: 245 IMCLHSK---IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-48
Identities = 69/304 (22%), Positives = 120/304 (39%), Gaps = 50/304 (16%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
NH + L ++LG+G + V++ A K+ N S + RE+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKV--FN-NISFLRPVDVQM---REF 58
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNT-FCTVLEYCSGKDLDAVLKA---TPVLPEREARIII 514
+ K L H +IV+L+ E ++E+C L VL+ LPE E I++
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVAKVTDFGLSKIVEDDVGSQGME 570
+ G+ +L R I+H ++KPGN++ D V K+TDFG ++ +EDD E
Sbjct: 119 RDVVGGMNHL--RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD------E 170
Query: 571 LTSQGAGTYWYLPPECFELSKTPLI-----SSKVDVWSAGILFYQMLFGRRPF------- 618
GT YL P+ +E + + VD+WS G+ FY G PF
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 619 GHDQTQERILRED--------TIIKARKVEFPSR--------PAVSNEAKDLIRRCLTYN 662
+ + +I+ + +++ + ++ L +
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290
Query: 663 QAER 666
Q +
Sbjct: 291 QEKC 294
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-48
Identities = 63/306 (20%), Positives = 116/306 (37%), Gaps = 53/306 (17%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKL----------HGLNAQWSEDKKQSYIRH 453
Y ++ L +G F+++ ++++ A K + + +S
Sbjct: 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 454 AIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL--------KATPVL 505
E I + + + + + + + EY + T +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIIT-NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 506 PEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVG 565
P + + II + Y++ + I H D+KP N+L D+ G K++DFG S+ + D
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNE-KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--- 204
Query: 566 SQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE 625
S GTY ++PPE F +++ +KVD+WS GI Y M + PF +
Sbjct: 205 --KKIKGS--RGTYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259
Query: 626 RILREDTIIKARKVEFPSRPA-----------------VSNEAKDLIRRCLTYNQAERPD 668
+ I+ + +E+P +SNE D ++ L N AER
Sbjct: 260 ELFNN---IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER-- 314
Query: 669 VLTLAQ 674
+T
Sbjct: 315 -ITSED 319
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 54/354 (15%), Positives = 103/354 (29%), Gaps = 44/354 (12%)
Query: 359 IKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHR---YALLNLLGKGG 415
+KREEE I RE E ++ + + +L+ L+ L G
Sbjct: 15 LKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGD 74
Query: 416 FSEVYKAYDLVEHRYVACKLHGLNAQWSED-----KKQSYIRHAIREYNIHKTLVHHHIV 470
S V+ D+ A K+ + A+ S + ++ + + + ++
Sbjct: 75 RSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134
Query: 471 RLWDTFEIDQ----------------NTFCTVLEYCSG------KDLDAVLKATPVLPER 508
D + + ++ S LD V
Sbjct: 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGIL 194
Query: 509 EARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568
I+ Q+ + L ++ ++H P N+ G + D V
Sbjct: 195 ALHILTAQLIRLAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG------- 245
Query: 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHD---QTQE 625
+ Y P E S + ++ W G+ Y++ PFG
Sbjct: 246 -TRGPASSVPVTYAPREFLNASTAT-FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 626 RILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ + F S + + K LI R L +++ R L + P
Sbjct: 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-47
Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 401 LNHRYALLN-LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIR-HAIREY 458
Y L +LG+G + V +L+ + A K +K+ +IR RE
Sbjct: 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVK--------IIEKQPGHIRSRVFREV 61
Query: 459 NIHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQ 516
+ H +++ L + FE +++ F V E G + + K E EA +++
Sbjct: 62 EMLYQCQGHRNVLELIEFFE-EEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQD 119
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVE--DDVGSQGMEL 571
+ L +L+ + I H DLKP N+L ++ K+ DF L ++ D
Sbjct: 120 VASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 572 TSQGAGTYWYLPPECFELSKTPLIS--SKVDVWSAGILFYQMLFGRRPFGHD-------- 621
G+ Y+ PE E + D+WS G++ Y +L G PF
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 622 ------QTQERILREDTIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLA 673
Q + I+ K EFP + +S AKDLI + L + +R L+ A
Sbjct: 238 RGEACPACQNMLFES---IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQR---LSAA 291
Query: 674 Q 674
Q
Sbjct: 292 Q 292
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 9e-47
Identities = 71/280 (25%), Positives = 116/280 (41%), Gaps = 35/280 (12%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
LG+G FS K ++ A K+ + ++ + +E K
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKI-------ISKRMEANTQ---KEITALKLC 62
Query: 465 VHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIFQGLI 522
H +IV+L + F DQ V+E +G +L + + K E EA I+ ++ +
Sbjct: 63 EGHPNIVKLHEVFH-DQLHTFLVMELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVS 120
Query: 523 YLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
+++ ++H DLKP N+LF ++ K+ DFG +++ D L + T
Sbjct: 121 HMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD----NQPLKTP-CFTL 173
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI---IKA 636
Y PE L++ D+WS G++ Y ML G+ PF I IK
Sbjct: 174 HYAAPEL--LNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230
Query: 637 RKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
F VS EAKDLI+ LT + +R L ++
Sbjct: 231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKR---LKMSG 267
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 65/329 (19%), Positives = 112/329 (34%), Gaps = 30/329 (9%)
Query: 364 EAILRERERYELEKGRLIREMKRIRDEDGSRFNN--------FQILNHRYALLNLLGKGG 415
++ + + +L R D +G ++ H +G+G
Sbjct: 11 HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGS 70
Query: 416 FSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475
F EV++ D A K L E + E L IV L+
Sbjct: 71 FGEVHRMKDKQTGFQCAVKKVRL-----EVFRV-------EELVACAGLSSPRIVPLYG- 117
Query: 476 FEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYD 535
+ +E G L ++K LPE A + Q +GL YL+ ++I+H D
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH--TRRILHGD 175
Query: 536 LKPGNVLFDEFGV-AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPL 594
+K NVL G A + DFG + ++ D + + GT ++ PE
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-- 233
Query: 595 ISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDL 654
+KVD+WS+ + ML G P+ + + + I P+ +
Sbjct: 234 -DAKVDIWSSCCMMLHMLNGCHPW-TQYFRGPLCLK--IASEPPPIREIPPSCAPLTAQA 289
Query: 655 IRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
I+ L R + L + +
Sbjct: 290 IQEGLRKEPVHRASAMELRRKVGKALQEV 318
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-45
Identities = 83/291 (28%), Positives = 120/291 (41%), Gaps = 39/291 (13%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLN----AQWSEDKKQSYIRHA 454
+ Y L LLGKGGF V+ + L + VA K+ + WS
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKV--IPRNRVLGWSPLSDSVTCP-- 82
Query: 455 IREYNIHKTL----VHHHIVRLWDTFEIDQNTFCTVLEY-CSGKDLDAVLKATPVLPERE 509
E + + H ++RL D FE Q F VLE +DL + L E
Sbjct: 83 -LEVALLWKVGAGGGHPGVIRLLDWFE-TQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 510 ARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQG 568
+R Q+ + + + R ++H D+K N+L D G AK+ DFG ++ D
Sbjct: 141 SRCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-----E 193
Query: 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628
GT Y PPE S+ + VWS GIL Y M+ G PF D + IL
Sbjct: 194 PYTDF--DGTRVYSPPEWI--SRHQYHALPATVWSLGILLYDMVCGDIPFERD---QEIL 246
Query: 629 REDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
++ FP+ VS + LIRRCL + RP + + DP++
Sbjct: 247 E-------AELHFPAH--VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 75/282 (26%), Positives = 123/282 (43%), Gaps = 24/282 (8%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
+I+N RY +++ LG GG S VY A D + + VA K + E + ++ RE
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA--IFIPPREK--EETLKRFEREV 62
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIF 518
+ L H +IV + D E D + V+EY G L +++ L A QI
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQIL 121
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
G+ + + +I+H D+KP N+L D K+ DFG++K + + T+ GT
Sbjct: 122 DGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKA----LSETSLTQTNHVLGT 175
Query: 579 YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI----LREDTII 634
Y P E +K D++S GI+ Y+ML G PF + T I +++
Sbjct: 176 VQYFSP---EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE-TAVSIAIKHIQDSVPN 231
Query: 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP-DVLTLAQD 675
V R + ++I R ++A R + + D
Sbjct: 232 VTTDV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 79/282 (28%), Positives = 121/282 (42%), Gaps = 31/282 (10%)
Query: 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKL----HGLNAQWSEDKKQSYIRHAIREY 458
+Y+ ++ LG G F V+ A D +++ V K L W ED K + E
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT---LEI 80
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLE-YCSGKDLDAVLKATPVLPEREARIIIVQI 517
I + H +I+++ D FE +Q F V+E + SG DL A + P L E A I Q+
Sbjct: 81 AILSRVEHANIIKVLDIFE-NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
+ YL R + IIH D+K N++ E K+ DFG + +E +L G
Sbjct: 140 VSAVGYL--RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG------KLFYTFCG 191
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
T Y PE L P ++++WS G+ Y ++F PF + +E
Sbjct: 192 TIEYCAPEV--LMGNPYRGPELEMWSLGVTLYTLVFEENPF--CELEE--------TVEA 239
Query: 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ P VS E L+ L R + L DP++T
Sbjct: 240 AIHPPYL--VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 78/286 (27%), Positives = 119/286 (41%), Gaps = 37/286 (12%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLN----AQWSEDKKQSYIRHA 454
+ L +Y + LLG GGF VY + ++ VA K + + W E + +
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH--VEKDRISDWGELPNGTRVP-- 94
Query: 455 IREYNIHKTLVHH--HIVRLWDTFEIDQNTFCTVLEYCSGK-DLDAVLKATPVLPEREAR 511
E + K + ++RL D FE ++F +LE DL + L E AR
Sbjct: 95 -MEVVLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELAR 152
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQGME 570
Q+ + + + + ++H D+K N+L D G K+ DFG +++D +
Sbjct: 153 SFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVY 205
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630
GT Y PPE VWS GIL Y M+ G PF + E I+R
Sbjct: 206 TDF--DGTRVYSPPEWI--RYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHDEEIIR- 257
Query: 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676
+V F R VS+E + LIR CL ++RP + P
Sbjct: 258 ------GQVFFRQR--VSSECQHLIRWCLALRPSDRPTFEEIQNHP 295
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-45
Identities = 71/307 (23%), Positives = 115/307 (37%), Gaps = 43/307 (14%)
Query: 382 REMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQ 441
++ + + G + I++ +LG G +V + ++ A K
Sbjct: 41 QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK------- 93
Query: 442 WSEDKKQSYIRHAIREYNIHKTLVHH-HIVRLWDTFE---IDQNTFCTVLEYCSGKDL-D 496
A RE +H HIVR+ D +E + V+E G +L
Sbjct: 94 -MLQDCPK----ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS 148
Query: 497 AVL-KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVT 552
+ + EREA I+ I + + YL+ I H D+KP N+L+ + K+T
Sbjct: 149 RIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLT 206
Query: 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612
DFG +K T +Y+ PE L D+WS G++ Y +L
Sbjct: 207 DFGFAKETTSHNSLTTP------CYTPYYVAPEV--LGPEKY-DKSCDMWSLGVIMYILL 257
Query: 613 FGRRPF---GHDQTQERILREDTIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERP 667
G PF + I+ + EFP+ VS E K LIR L +R
Sbjct: 258 CGYPPFYSNHGLAISPGMKTR---IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR- 313
Query: 668 DVLTLAQ 674
+T+ +
Sbjct: 314 --MTITE 318
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 83/294 (28%), Positives = 129/294 (43%), Gaps = 29/294 (9%)
Query: 392 GSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYI 451
GS L+ RY L +LG GG SEV+ A DL +HR VA K+ L A + D S+
Sbjct: 1 GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLARD--PSFY 56
Query: 452 RHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT---VLEYCSGKDLDAVLKATPVLPER 508
RE L H IV ++DT E + V+EY G L ++ + +
Sbjct: 57 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 509 EARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568
A +I Q L + ++ IIH D+KP N++ KV DFG+++ + D
Sbjct: 117 RAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD--SGNS 172
Query: 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI- 627
+ T+ GT YL P E ++ + ++ DV+S G + Y++L G PF D + +
Sbjct: 173 VTQTAAVIGTAQYLSP---EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVA 228
Query: 628 ---LREDTIIKARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERP-DVLTLAQD 675
+RED PS +S + ++ + L N R + D
Sbjct: 229 YQHVRED-------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 72/289 (24%), Positives = 113/289 (39%), Gaps = 45/289 (15%)
Query: 401 LNHRYALLN-LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
+ Y L +LG G +V + + + A K A +E +
Sbjct: 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK--------LLYDSPK----ARQEVD 73
Query: 460 IHKTLVHH-HIVRLWDTFE---IDQNTFCTVLEYCSGKDL-DA-VLKATPVLPEREARII 513
H HIV + D +E + ++E G +L + EREA I
Sbjct: 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI 133
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGME 570
+ I + +L+ I H D+KP N+L+ ++ V K+TDFG +K +
Sbjct: 134 MRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN------A 185
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERI 627
L + T +Y+ PE L D+WS G++ Y +L G PF +
Sbjct: 186 LQTP-CYTPYYVAPEV--LGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241
Query: 628 LREDTIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
R I+ + FP+ VS +AK LIR L + ER LT+ Q
Sbjct: 242 KRR---IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER---LTITQ 284
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-44
Identities = 72/277 (25%), Positives = 113/277 (40%), Gaps = 26/277 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y L L+G+GG +VY+A D V R VA KL ++ S D + RE
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKL--MSETLSSD--PVFRTRMQREARTAGR 90
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H+V + D EID + + +G DL A+L+ L A I+ QI L
Sbjct: 91 LQEPHVVPIHDFGEIDGQLY-VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
+ A H D+KP N+L A + DFG++ D + + GT +Y+
Sbjct: 150 AH--AAGATHRDVKPENILVSADDFAYLVDFGIASATTD----EKLTQLGNTVGTLYYMA 203
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI--LREDTIIKARKVEF 641
PE F + + D+++ + Y+ L G P+ DQ + + +
Sbjct: 204 PERF---SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA-------IPR 253
Query: 642 PS--RPAVSNEAKDLIRRCLTYNQAER-PDVLTLAQD 675
PS RP + +I R + N +R L+
Sbjct: 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 22/276 (7%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y LL +GKG F++V A ++ R VA K+ ++ + ++ RE I K
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKI--ID---KTQLNPTSLQKLFREVRIMKI 70
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H +IV+L++ E ++ + ++EY SG ++ L A + E+EAR QI + Y
Sbjct: 71 LNHPNIVKLFEVIETEKTLYL-IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
+++ +I+H DLK N+L D K+ DFG S G Y
Sbjct: 130 CHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG------GKLDAFCGAPPYAA 181
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE F +VDVWS G++ Y ++ G PF Q + + + K P
Sbjct: 182 PELF--QGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRER---VLRGKYRIPF 235
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+S + ++L++R L N +R + + +D ++
Sbjct: 236 Y--MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 78/277 (28%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSY 450
F++F+ +L +GKG F +V +V+ + A K +N Q ++ +
Sbjct: 14 FDHFE-------ILRAIGKGSFGKVC----IVQKNDTKKMYAMKY--MNKQKCVERNE-- 58
Query: 451 IRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREA 510
+R+ +E I + L H +V LW +F+ D+ V++ G DL L+ E
Sbjct: 59 VRNVFKELQIMQGLEHPFLVNLWYSFQ-DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV 117
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
++ I ++ L YL + Q+IIH D+KP N+L DE G +TDF ++ ++ +
Sbjct: 118 KLFICELVMALDYL--QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE------T 169
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILR 629
+ AGT Y+ PE F K S VD WS G+ Y++L GRRP+ T + +
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
Query: 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+ V +P A S E L+++ L N +R
Sbjct: 230 H--TFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQR 262
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 67/299 (22%), Positives = 106/299 (35%), Gaps = 64/299 (21%)
Query: 390 EDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQS 449
+ G + I++ +LG G +V + ++ A K
Sbjct: 5 KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPK 56
Query: 450 YIRHAIREYNIHKTLVHH-HIVRLWDTFE---IDQNTFCTVLEYCSGKDL-DAVL-KATP 503
A RE +H HIVR+ D +E + V+E G +L + +
Sbjct: 57 ----ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 504 VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIV 560
EREA I+ I + + YL+ I H D+KP N+L+ + K+TDFG +K
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
Query: 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-- 618
Y D+WS G++ Y +L G PF
Sbjct: 171 T--------------GEKY----------------DKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 619 -GHDQTQERILREDTIIKARKVEFPSRP--AVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+ I+ + EFP+ VS E K LIR L +R +T+ +
Sbjct: 201 NHGLAISPGMKTR---IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR---MTITE 253
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-43
Identities = 70/271 (25%), Positives = 121/271 (44%), Gaps = 20/271 (7%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ L+ LG+G + EV A + V VA K+ ++ + + +E I+K
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI--VD----MKRAVDCPENIKKEICINKM 61
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H ++V+ + + N LEYCSG +L ++ +PE +A+ Q+ G++Y
Sbjct: 62 LNHENVVKFYGHRR-EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ I H D+KP N+L DE K++DFGL+ + + + + GT Y+
Sbjct: 121 LHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKM--CGTLPYVA 175
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE L + + VDVWS GI+ ML G P+ + + K +K
Sbjct: 176 PEL--LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNP 230
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+ + L+ + L N + R +T+
Sbjct: 231 WKKIDSAPLALLHKILVENPSAR---ITIPD 258
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-43
Identities = 59/305 (19%), Positives = 107/305 (35%), Gaps = 53/305 (17%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ L +G G F V+K ++ A K S D++ A+RE H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQN-----ALREVYAHAV 66
Query: 464 LVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP----VLPEREARIIIVQIF 518
L H H+VR + + + + EYC+G L + E E + +++Q+
Sbjct: 67 LGQHSHVVRYFSAWA-EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGV-------------------AKVTDFGLSKI 559
+GL Y++ ++H D+KP N+ + K+ D G
Sbjct: 126 RGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFG 619
+ Q E G +L E + + T L K D+++ +
Sbjct: 184 ISS---PQVEE------GDSRFLANEVLQENYTHL--PKADIFALALTVVCAAGAEPLPR 232
Query: 620 HDQTQERILREDTIIKARKVEFPSRPAV-SNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ I R+ P P V S E +L++ + + RP + L + L
Sbjct: 233 NGDQWHEI---------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283
Query: 679 TYSKK 683
+ +
Sbjct: 284 LSASR 288
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 35/268 (13%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
+LG+G FS V A +L R A K+ L + + + + + RE ++ L H
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENK--VPYVTRERDVMSRLDH 89
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526
V+L+ TF+ D L Y +L ++ E R +I L YL+
Sbjct: 90 PFFVKLYFTFQ-DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
+ IIH DLKP N+L +E ++TDFG +K++ + + GT Y+ PE
Sbjct: 149 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ---ARANSFVGTAQYVSPE- 202
Query: 587 FELSKTPLISSK-----VDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIKARK 638
L++ K D+W+ G + YQ++ G PF ++I++ +
Sbjct: 203 -------LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------E 248
Query: 639 VEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+FP +A+DL+ + L + +R
Sbjct: 249 YDFP--EKFFPKARDLVEKLLVLDATKR 274
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 75/305 (24%), Positives = 116/305 (38%), Gaps = 35/305 (11%)
Query: 389 DEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQ 448
+ S + +LGKG + VY DL +A K + E +
Sbjct: 8 GDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIK------EIPERDSR 61
Query: 449 SYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPE 507
+ E +HK L H +IV+ + +E G L A+L++ L +
Sbjct: 62 Y-SQPLHEEIALHKHLKHKNIVQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 508 REA--RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF-GVAKVTDFGLSKIVEDDV 564
E QI +GL YL +I+H D+K NVL + + GV K++DFG SK +
Sbjct: 120 NEQTIGFYTKQILEGLKYL--HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG-- 175
Query: 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ 624
T GT Y+ PE + D+WS G +M G+ PF ++ +
Sbjct: 176 ---INPCTETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPF-YELGE 230
Query: 625 E-----RILREDTIIKARKVEFPSRPA-VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++ P P +S EAK I +C + +R L D +L
Sbjct: 231 PQAAMFKVGMFKVH--------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282
Query: 679 TYSKK 683
S K
Sbjct: 283 KVSSK 287
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 22/272 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ L+ LG+G + EV A + V VA K+ ++ + + +E I+K
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI--VD----MKRAVDCPENIKKEICINKM 61
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H ++V+ + + N LEYCSG +L ++ +PE +A+ Q+ G++Y
Sbjct: 62 LNHENVVKFYGHRR-EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMEL-TSQGAGTYWYL 582
L+ I H D+KP N+L DE K++DFGL+ + ++ L GT Y+
Sbjct: 121 LHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRY--NNRERLLNKM--CGTLPYV 174
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642
PE L + + VDVWS GI+ ML G P+ + + K +K
Sbjct: 175 APEL--LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLN 229
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+ + L+ + L N + R +T+
Sbjct: 230 PWKKIDSAPLALLHKILVENPSAR---ITIPD 258
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-41
Identities = 67/275 (24%), Positives = 104/275 (37%), Gaps = 27/275 (9%)
Query: 410 LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469
+G+G F VYK D VA ++++ E + K L H +I
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-----FKEEAEMLKGLQHPNI 87
Query: 470 VRL---WDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526
VR W++ + V E + L LK V+ + R QI +GL +L+
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 527 RAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT-YWYLPP 584
R IIH DLK N+ G K+ D GL+ + GT + + P
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-------FAKAVIGTPEF-MAP 199
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
E +E VDV++ G+ +M P+ Q +I R V+ S
Sbjct: 200 EMYEEKYDE----SVDVYAFGMCMLEMATSEYPYSECQNAAQIYR----RVTSGVKPASF 251
Query: 645 PAV-SNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
V E K++I C+ N+ ER + L +
Sbjct: 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 73/274 (26%), Positives = 107/274 (39%), Gaps = 26/274 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY + +G G F D + VA K ++ + + RE H++
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI--------ERGAAIDENVQREIINHRS 72
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H +IVR + ++EY SG +L + E EAR Q+ G+ Y
Sbjct: 73 LRHPNIVRFKEVIL-TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 524 LNKRAQKIIHYDLKPGNVLFDE--FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
+ +I H DLK N L D K+ DFG SK ++ GT Y
Sbjct: 132 CHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKST--VGTPAY 183
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE-DTIIKARKVE 640
+ PE L + DVWS G+ Y ML G PF D + R R+ I + K
Sbjct: 184 IAPEV--LLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYS 240
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
P +S E LI R + A R +++ +
Sbjct: 241 IPDDIRISPECCHLISRIFVADPATR---ISIPE 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 44/310 (14%), Positives = 93/310 (30%), Gaps = 59/310 (19%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK----------------------LHGLNAQ 441
+LG+ +A D L L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 442 WSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCS-------GKD 494
++ + + ++R I +++ K ++R+ L G+
Sbjct: 134 KNQKQAKVHLRF-IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 192
Query: 495 LDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554
L + L + +Q+ + L L+ ++H L+P +++ D+ G +T F
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPE--------CFELSKTPLISSKVDVWSAGI 606
G + S + + PPE + + L++ D W+ G+
Sbjct: 251 EHLV-------RDGARVVSS--VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301
Query: 607 LFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+ Y + P D + + F S + + L+ L Y + +R
Sbjct: 302 VIYWIWCADLPITK----------DAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDR 351
Query: 667 PDVLTLAQDP 676
L + P
Sbjct: 352 LLPLQAMETP 361
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-40
Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 21/277 (7%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y + +LLG+G + +V + D A K+ L + + + + +E + +
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKI--LKKK-KLRRIPNGEANVKKEIQLLRR 62
Query: 464 LVHHHIVRLWDTFEIDQNT-FCTVLEYCSGKD---LDAVLKATPVLPEREARIIIVQIFQ 519
L H ++++L D ++ V+EYC LD+V + P +A Q+
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLID 120
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
GL YL+ + I+H D+KPGN+L G K++ G+++ + TSQ G+
Sbjct: 121 GLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TSQ--GSP 175
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639
+ PPE KVD+WSAG+ Y + G PF ++ I
Sbjct: 176 AFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFEN---IGKGSY 230
Query: 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676
P DL++ L Y A+R + + Q
Sbjct: 231 AIP--GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-39
Identities = 67/309 (21%), Positives = 108/309 (34%), Gaps = 46/309 (14%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ + LG GGF V + VA K Q ++ E I K
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIK------QCRQELSPKNRERWCLEIQIMKK 68
Query: 464 LVHHHIVRLWDTFEIDQNTFCT-----VLEYCSGKDLDAVLKA---TPVLPEREARIIIV 515
L H ++V + + Q +EYC G DL L L E R ++
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG---VAKVTDFGLSKIVEDDVGSQGMELT 572
I L YL +IIH DLKP N++ + K+ D G +K ++ EL
Sbjct: 129 DISSALRYL--HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG------ELC 180
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR--- 629
++ GT YL PE E K + VD WS G L ++ + G RPF + +
Sbjct: 181 TEFVGTLQYLAPELLEQKK---YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 630 -------------EDTIIKARKVEFPSR--PAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+ + + P+ ++ + + ++ L ++Q +R
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297
Query: 675 DPYLTYSKK 683
Sbjct: 298 VGCFQALDS 306
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 81/270 (30%), Positives = 119/270 (44%), Gaps = 40/270 (14%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ + LG G F V + A K+ L+ Q KQ I H + E I + +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQ--IEHTLNEKRILQAV 98
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
+V+L +F+ D + V+EY +G ++ + L+ E AR QI YL
Sbjct: 99 NFPFLVKLEFSFK-DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ +I+ DLKP N+L D+ G +VTDFG +K V+ T GT L P
Sbjct: 158 HSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--------RTWTLCGTPEALAP 207
Query: 585 ECFELSKTPLISSK-----VDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIKA 636
E +I SK VD W+ G+L Y+M G PF Q E+I+
Sbjct: 208 E--------IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------ 253
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
KV FPS S++ KDL+R L + +R
Sbjct: 254 -KVRFPSH--FSSDLKDLLRNLLQVDLTKR 280
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-39
Identities = 84/360 (23%), Positives = 143/360 (39%), Gaps = 50/360 (13%)
Query: 315 AVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLASIKREEEAILRERERYE 374
+ E + + + D V+ + + D ++ D + R+ + I RY+
Sbjct: 1 SFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDF-----PALRKNKNIDNFLSRYK 55
Query: 375 LEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEH----RY 430
++ R++ ED ++++ ++G+G F EV LV H +
Sbjct: 56 DTINKI--RDLRMKAED------YEVVK-------VIGRGAFGEVQ----LVRHKSTRKV 96
Query: 431 VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490
A KL L+ + E +I +V+L+ F+ D V+EY
Sbjct: 97 YAMKL--LSKFEMIKRSD--SAFFWEERDIMAFANSPWVVQLFYAFQ-DDRYLYMVMEYM 151
Query: 491 SGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550
G DL ++ +PE+ AR ++ L ++ IH D+KP N+L D+ G K
Sbjct: 152 PGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLK 208
Query: 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSK-VDVWSAGILFY 609
+ DFG + + GM GT Y+ PE + + D WS G+ Y
Sbjct: 209 LADFGTCMKMNKE----GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264
Query: 610 QMLFGRRPF---GHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+ML G PF T +I+ + FP +S EAK+LI LT ++ R
Sbjct: 265 EMLVGDTPFYADSLVGTYSKIMNHK-----NSLTFPDDNDISKEAKNLICAFLT-DREVR 318
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 5e-39
Identities = 46/348 (13%), Positives = 93/348 (26%), Gaps = 49/348 (14%)
Query: 362 EEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLN---LLGKGGFSE 418
R E + + G F L R L +LG+
Sbjct: 34 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 93
Query: 419 VYKAYDLVEHRYVACKLHGLNAQWSEDKKQSY------IRHAIREYNIHKTLVHHHIVRL 472
+A D + + + + +R N + VH +
Sbjct: 94 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153
Query: 473 WDTFEIDQN----------------TFCTVLEYCSG------KDLDAVLKATPVLPEREA 510
+D + Q + + + L + L
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 213
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
+ +Q+ + L L+ ++H L+P +++ D+ G +T F G+ +
Sbjct: 214 LQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR----DGASAVS 267
Query: 571 LTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628
+G + L++ D W+ G+ Y + P D
Sbjct: 268 PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS- 326
Query: 629 REDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676
+ F S + + L+ L Y + +R L + P
Sbjct: 327 --------EWI-FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 365
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 54/311 (17%), Positives = 109/311 (35%), Gaps = 31/311 (9%)
Query: 384 MKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGL----N 439
+KRIR +R + + L L G + A+ ++ +
Sbjct: 36 IKRIRLP--NRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDE 93
Query: 440 AQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL 499
+ S + + + V ++ C ++L +
Sbjct: 94 STDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPK-VYLYIQMQLCRKENLKDWM 152
Query: 500 K---ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556
+ I +QI + + +L+ + ++H DLKP N+ F V KV DFGL
Sbjct: 153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGL 210
Query: 557 SKIVEDDV-------GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFY 609
++ D + GT Y+ PE ++ S KVD++S G++ +
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE--QIHGNN-YSHKVDIFSLGLILF 267
Query: 610 QMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV-SNEAKDLIRRCLTYNQAERPD 668
++L+ ER+ I R ++FP + +++ L+ + ERP+
Sbjct: 268 ELLYSFSTQ-----MERV---RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319
Query: 669 VLTLAQDPYLT 679
+ ++
Sbjct: 320 ATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 12/87 (13%)
Query: 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIR 452
SR+ + + +G+GGF V++A + V+ A K L + +K
Sbjct: 2 SRYLT------DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK----- 50
Query: 453 HAIREYNIHKTLVHHHIVRLWDTFEID 479
+RE L H IVR ++ +
Sbjct: 51 -VMREVKALAKLEHPGIVRYFNAWLET 76
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-39
Identities = 74/276 (26%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y L + LG G F +V + VA K+ LN Q + + + RE K
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKI--LNRQ--KIRSLDVVGKIKREIQNLKL 67
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
H HI++L+ + F V+EY SG +L + + E EAR + QI + Y
Sbjct: 68 FRHPHIIKLYQVISTPTDFFM-VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
++ ++H DLKP NVL D AK+ DFGLS ++ D TS G+ Y
Sbjct: 127 CHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG----EFLRTS--CGSPNYAA 178
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE S +VD+WS G++ Y +L G PF D+ + ++ I+ P
Sbjct: 179 PEVI--SGRLYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKK---IRGGVFYIP- 231
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
++ L+ L + +R + + + +
Sbjct: 232 -EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 59/268 (22%), Positives = 100/268 (37%), Gaps = 20/268 (7%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
+GKGGF V+K + + VA K L E + + RE I L H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIYLN 525
+IV+L + + N V+E+ DL L + +++ I G+ Y+
Sbjct: 83 PNIVKL---YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 526 KRAQKIIHYDLKPGNVLFDEFG-----VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
+ I+H DL+ N+ AKV DFGLS+ V G +
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG--------LLGNFQ 191
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640
++ PE + + K D +S ++ Y +L G PF + + +
Sbjct: 192 WMAPETIGAEEES-YTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPD 668
P +++I C + + +RP
Sbjct: 251 IPED--CPPRLRNVIELCWSGDPKKRPH 276
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 37/280 (13%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKA-YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHA 454
+ I + ++G+G F V KA + + VA K + +S +
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQI---------ESESERKAF 48
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL---KATPVLPEREAR 511
I E + H +IV+L + N C V+EY G L VL + P A
Sbjct: 49 IVELRQLSRVNHPNIVKL---YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM 105
Query: 512 IIIVQIFQGLIYL-NKRAQKIIHYDLKPGNVLFDE-FGVAKVTDFGLSKIVEDDVGSQGM 569
+Q QG+ YL + + + +IH DLKP N+L V K+ DFG + ++
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT------- 158
Query: 570 ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERIL 628
+T+ G+ ++ PE FE S S K DV+S GI+ ++++ R+PF RI
Sbjct: 159 HMTN-NKGSAAWMAPEVFEGSN---YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI- 213
Query: 629 REDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD 668
+ + + + L+ RC + + ++RP
Sbjct: 214 -MWAVHNGTRPPLIK--NLPKPIESLMTRCWSKDPSQRPS 250
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 19/290 (6%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIR 456
+Q + L +G G +V+K +A K + ++ I +
Sbjct: 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRI---LM 72
Query: 457 EYNI-HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIV 515
+ ++ K+ +IV+ + TF I +E + +PER + V
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTF-ITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
I + L YL K +IH D+KP N+L DE G K+ DFG+S + DD +
Sbjct: 132 AIVKALYYL-KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK------DRS 184
Query: 576 AGTYWYLPPECFELSKTPLI--SSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633
AG Y+ PE + + DVWS GI ++ G+ P+ + +T +L +
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL--TKV 242
Query: 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
++ P S + + ++ CLT + +RP L + ++ +
Sbjct: 243 LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 68/316 (21%), Positives = 120/316 (37%), Gaps = 45/316 (14%)
Query: 367 LRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKA-YDL 425
++ + I + + + ++ I + +G G F V++A +
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH- 59
Query: 426 VEHRYVACKLHGLNAQ-WSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI----DQ 480
VA K+ L Q + ++ ++R E I K L H +IV +
Sbjct: 60 --GSDVAVKI--LMEQDFHAERVNEFLR----EVAIMKRLRHPNIVLF-----MGAVTQP 106
Query: 481 NTFCTVLEYCSGKDLDAVL---KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLK 537
V EY S L +L A L ER + + +G+ YL+ R I+H +LK
Sbjct: 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK 166
Query: 538 PGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISS 597
N+L D+ KV DFGLS++ S + AGT ++ PE + +
Sbjct: 167 SPNLLVDKKYTVKVCDFGLSRLKASTFLS-----SKSAAGTPEWMAPEVLRDEPS---NE 218
Query: 598 KVDVWSAGILFYQMLFGRRPF-GHDQTQERILREDTIIKARKVEFPSRPAVSNEA----K 652
K DV+S G++ +++ ++P+ + Q + A R +
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQ---------VVAAVGFKCKRLEIPRNLNPQVA 269
Query: 653 DLIRRCLTYNQAERPD 668
+I C T +RP
Sbjct: 270 AIIEGCWTNEPWKRPS 285
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 76/335 (22%), Positives = 130/335 (38%), Gaps = 53/335 (15%)
Query: 345 LVIQDEIYKSRLASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHR 404
L + E+ S LA K + + K R++ +D F
Sbjct: 22 LGVHQELGASELAQDKYVADFLQWAEPIVVRLKEV------RLQRDD---FE-------- 64
Query: 405 YALLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
+L ++G+G FSEV +V+ + A K+ +N + + + E ++
Sbjct: 65 --ILKVIGRGAFSEVA----VVKMKQTGQVYAMKI--MNKWDMLKRGE--VSCFREERDV 114
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQ 519
I +L F+ D+N V+EY G DL +L K +P AR + +I
Sbjct: 115 LVNGDRRWITQLHFAFQ-DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM 173
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
+ +++ +H D+KP N+L D G ++ DFG + + G + GT
Sbjct: 174 AIDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGSCL----KLRADGTVRSLVAVGTP 227
Query: 580 WYLPPECFELSKTPLISSK----VDVWSAGILFYQMLFGRRPF---GHDQTQERILREDT 632
YL PE + + D W+ G+ Y+M +G+ PF +T +I+
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287
Query: 633 IIKARKVEFPSRP-AVSNEAKDLIRRCLTYNQAER 666
+ P V EA+D I+R L R
Sbjct: 288 HLS-----LPLVDEGVPEEARDFIQRLLC-PPETR 316
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 68/292 (23%), Positives = 112/292 (38%), Gaps = 22/292 (7%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIR 456
+ ++ + LG+G + V K + + +A K ++Q + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRL---LM 54
Query: 457 EYNI-HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSG---KDLDAVLKATPVLPEREARI 512
+ +I +T+ V + + +E K V+ +PE
Sbjct: 55 DLDISMRTVDCPFTVTFYGAL-FREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK 113
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELT 572
I V I + L +L +IH D+KP NVL + G K+ DFG+S + DDV
Sbjct: 114 IAVSIVKALEHL-HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD----I 168
Query: 573 SQGAGTYWYLPPECFELSKTPLI-SSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631
AG Y+ PE S K D+WS GI ++ R P+ T + L
Sbjct: 169 D--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL--K 224
Query: 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
+++ + P+ S E D +CL N ERP L Q P+ T +
Sbjct: 225 QVVEEPSPQLPADKF-SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 83/272 (30%), Positives = 130/272 (47%), Gaps = 48/272 (17%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+L LG G F V+ L+ RY A K+ L + KQ + H E +
Sbjct: 10 ILRTLGTGSFGRVH----LIRSRHNGRYYAMKV--LKKEIVVRLKQ--VEHTNDERLMLS 61
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
+ H I+R+W TF+ D +++Y G +L ++L+ + P A+ ++ L
Sbjct: 62 IVTHPFIIRMWGTFQ-DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL+ + II+ DLKP N+L D+ G K+TDFG +K V D +T GT Y+
Sbjct: 121 YLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--------VTYTLCGTPDYI 170
Query: 583 PPECFELSKTPLISSK-----VDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTII 634
PE ++S+K +D WS GIL Y+ML G PF +T E+IL
Sbjct: 171 APE--------VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA---- 218
Query: 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
++ FP P + + KDL+ R +T + ++R
Sbjct: 219 ---ELRFP--PFFNEDVKDLLSRLITRDLSQR 245
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 80/354 (22%), Positives = 136/354 (38%), Gaps = 60/354 (16%)
Query: 368 RERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVE 427
++ E EL++ ++ KR+ + ++ + + ++ LG G V+K
Sbjct: 2 KKLEELELDE----QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPS 57
Query: 428 HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487
+A KL L + + IRE + +IV + F +
Sbjct: 58 GLVMARKLIHLEIKPAI------RNQIIRELQVLHECNSPYIVGFYGAF-YSDGEISICM 110
Query: 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547
E+ G LD VLK +PE+ + + + +GL YL + KI+H D+KP N+L + G
Sbjct: 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL-REKHKIMHRDVKPSNILVNSRG 169
Query: 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGIL 607
K+ DFG+S + D + + + GT Y+ PE + + S + D+WS G+
Sbjct: 170 EIKLCDFGVSGQLIDSMAN-----SF--VGTRSYMSPERLQGTH---YSVQSDIWSMGLS 219
Query: 608 FYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAV-------------------- 647
+M GR P +E L ++ E P RP
Sbjct: 220 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFE 279
Query: 648 ------------------SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
S E +D + +CL N AER D+ L ++ S
Sbjct: 280 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 47/281 (16%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRY---VACKLHGLNAQ-WSEDKKQSYIRHAIREYNIHK 462
+ L+GKG F +VY R+ VA +L ++ + +ED+ +++ R E ++
Sbjct: 37 IGELIGKGRFGQVYHG------RWHGEVAIRL--IDIERDNEDQLKAFKR----EVMAYR 84
Query: 463 TLVHHHIVRLWDTFE---IDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIF 518
H ++V F + + C G+ L +V+ A VL + R I +I
Sbjct: 85 QTRHENVVL----FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
+G+ YL+ A+ I+H DLK NV +D G +TDFGL I + + G
Sbjct: 141 KGMGYLH--AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 579 YWYLPPECFELSKTPLI------SSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632
+L PE S DV++ G ++Y++ PF Q E I
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-KTQPAEAI----- 251
Query: 633 IIKARKVEFPSRPAVSN-----EAKDLIRRCLTYNQAERPD 668
++ +P +S E D++ C + Q ERP
Sbjct: 252 ---IWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPT 289
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 22/266 (8%)
Query: 407 LLNLLGKGGFSEVYKA-YDLVEHRYVACKLHGLNAQ-WSEDKKQSYIRHAIREYNIHKTL 464
+ +G G F VYK + H VA K+ LN + + Q++ E + +
Sbjct: 28 VGQRIGSGSFGTVYKGKW----HGDVAVKM--LNVTAPTPQQLQAFKN----EVGVLRKT 77
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIY 523
H +I+ V ++C G L L + ++ I Q +G+ Y
Sbjct: 78 RHVNILLFMGY--STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ A+ IIH DLK N+ E K+ DFGL+ GS E Q +G+ ++
Sbjct: 136 LH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE---QLSGSILWMA 190
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE + + S + DV++ GI+ Y+++ G+ P+ + +++I+ E + +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-EMVGRGSLSPDLSK 249
Query: 644 RPAVSNEA-KDLIRRCLTYNQAERPD 668
+ + K L+ CL + ERP
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPS 275
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 65/295 (22%), Positives = 122/295 (41%), Gaps = 24/295 (8%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIR 456
++ L +G+G + V K + +A K ++K+Q + +
Sbjct: 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST---VDEKEQKQL---LM 69
Query: 457 EYNI-HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSG---KDLDAVLKATP-VLPEREAR 511
+ ++ ++ +IV+ + + +E S K V V+PE
Sbjct: 70 DLDVVMRSSDCPYIVQFYGAL-FREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMEL 571
I + + L +L K KIIH D+KP N+L D G K+ DFG+S + D +
Sbjct: 129 KITLATVKALNHL-KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA------ 181
Query: 572 TSQGAGTYWYLPPECFELSKTPLI-SSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630
++ AG Y+ PE + S + + DVWS GI Y++ GR P+ + L
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-- 239
Query: 631 DTIIKARKVEFPSRPAV--SNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
++K + + S + + CLT ++++RP L + P++ ++
Sbjct: 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 53/296 (17%), Positives = 99/296 (33%), Gaps = 37/296 (12%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIR 456
FQ+ + + +LLG+G F++VY+A + + L Q + + YI +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT--Q 116
Query: 457 EYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK-----ATPVLPEREAR 511
K + H ++ + QN V E S L + V+P+
Sbjct: 117 LMERLKPSMQHMFMKFYSAHL-FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF-----------DEFGVAKVTDFGLSKIV 560
+++ + ++ +IIH D+KP N + D + D G S +
Sbjct: 176 SFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGH 620
+ + +G T++ T + E LS P + ++D + Y MLFG
Sbjct: 234 K--LFPKGTIFTAK-CETSGFQCVE--MLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVK 287
Query: 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676
++ E R + + L L L +
Sbjct: 288 NEGGECKPEGLF----------RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-36
Identities = 65/267 (24%), Positives = 110/267 (41%), Gaps = 30/267 (11%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNI-- 460
+ ++G+GGF EVY A K L+ + + K+ A+ E +
Sbjct: 193 VHRIIGRGGFGEVY----GCRKADTGKMYAMKC--LDKKRIKMKQG--ETLALNERIMLS 244
Query: 461 -HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
T IV + F + +L+ +G DL L V E + R +I
Sbjct: 245 LVSTGDCPFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 303
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
GL +++ R +++ DLKP N+L DE G +++D GL+ GT+
Sbjct: 304 GLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTH 354
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639
Y+ PE L K S D +S G + +++L G PF +T+++ + + V
Sbjct: 355 GYMAPEV--LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AV 411
Query: 640 EFPSRPAVSNEAKDLIRRCLTYNQAER 666
E P + S E + L+ L + R
Sbjct: 412 ELP--DSFSPELRSLLEGLLQRDVNRR 436
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 27/272 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLN-AQWSEDKKQSYIRHAIREYNIHK 462
Y + LG+G F +V A + VA K ++ + + RE + K
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKF--ISRQLLKKSDMHMRVE---REISYLK 64
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
L H HI++L+D + V+EY G+ D +++ + E E R QI +
Sbjct: 65 LLRHPHIIKLYDVITTPTDIVM-VIEYAGGELFDYIVEKKR-MTEDEGRRFFQQIICAIE 122
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
Y ++ KI+H DLKP N+L D+ K+ DFGLS I+ D TS G+ Y
Sbjct: 123 YCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG----NFLKTS--CGSPNYA 174
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642
PE + +VDVWS GI+ Y ML GR PF D+ + ++ + + P
Sbjct: 175 APEVI--NGKLYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKK---VNSCVYVMP 228
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+S A+ LIRR + + +R +T+ +
Sbjct: 229 --DFLSPGAQSLIRRMIVADPMQR---ITIQE 255
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 7e-36
Identities = 60/276 (21%), Positives = 100/276 (36%), Gaps = 45/276 (16%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDL-VEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
I+ +Y + + GG +Y A D V R V K GL S D A+ E
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK--GLVH--SGD--AEAQAMAMAE 129
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCT----VLEYCSGKDLDAVLKATPVLPEREARII 513
+VH IV++++ E V+EY G+ L LP EA
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAY 187
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
+++I L YL+ + +++ DLKP N++ E + K+ D G + S
Sbjct: 188 LLEILPALSYLH--SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS-----------RINS 233
Query: 574 QGA--GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631
G GT + PE + P +++ D+++ G + L ED
Sbjct: 234 FGYLYGTPGFQAPE--IVRTGPTVAT--DIYTVGRTLAALTLDLPTRNGRYVDG--LPED 287
Query: 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ L+RR + + +R
Sbjct: 288 ----------DPVLKTYDSYGRLLRRAIDPDPRQRF 313
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-36
Identities = 76/271 (28%), Positives = 118/271 (43%), Gaps = 24/271 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y L + LG G F +V + VA K+ LN Q + + + RE K
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKI--LNRQ--KIRSLDVVGKIRREIQNLKL 72
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
H HI++L+ + F V+EY SG +L + L E+E+R + QI G+ Y
Sbjct: 73 FRHPHIIKLYQVISTPSDIFM-VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
++ ++H DLKP NVL D AK+ DFGLS ++ D TS G+ Y
Sbjct: 132 CHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG----EFLRTS--CGSPNYAA 183
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE S +VD+WS+G++ Y +L G PF D + + K F +
Sbjct: 184 PEVI--SGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFK-----KICDGIFYT 235
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
++ L++ L + +R T+
Sbjct: 236 PQYLNPSVISLLKHMLQVDPMKR---ATIKD 263
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-36
Identities = 41/271 (15%), Positives = 94/271 (34%), Gaps = 36/271 (13%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRY----VACKLHGLNAQ-WSEDKKQSYIRHAIREYNIH 461
L L + E++K R+ + K+ L + WS K + + E
Sbjct: 14 FLTKLNENHSGELWKG------RWQGNDIVVKV--LKVRDWSTRKSRDFNE----ECPRL 61
Query: 462 KTLVHHHIVRLW-DTFEIDQNTFCTVLEYCSGKDLDAVL--KATPVLPEREARIIIVQIF 518
+ H +++ + + + L VL V+ + +A + +
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
+G+ +L+ I + L +V+ DE A+++ + +
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----------PGRMYA 171
Query: 579 YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILREDTIIKAR 637
++ PE + D+WS +L ++++ PF + + ++
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---IGMKVALEGL 228
Query: 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPD 668
+ P P +S L++ C+ + A+RP
Sbjct: 229 RPTIP--PGISPHVSKLMKICMNEDPAKRPK 257
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 88/357 (24%), Positives = 148/357 (41%), Gaps = 46/357 (12%)
Query: 315 AVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLASIKREEEAILRERERYE 374
+ E + + L++ D + + E L I +Y S R E+ IL E +
Sbjct: 1 SGEVRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAK 60
Query: 375 LEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEH----RY 430
++ + R+ ED F+ +L ++G+G F EV +V+ +
Sbjct: 61 PFTSKV--KQMRLHRED------FE-------ILKVIGRGAFGEVA----VVKLKNADKV 101
Query: 431 VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYC 490
A K+ LN + + E ++ I L F+ D N V++Y
Sbjct: 102 FAMKI--LNKWEMLKRAE--TACFREERDVLVNGDSKWITTLHYAFQ-DDNNLYLVMDYY 156
Query: 491 SGKDLDAVL-KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA 549
G DL +L K LPE AR + ++ + +++ +H D+KP N+L D G
Sbjct: 157 VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHI 214
Query: 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLI--SSKVDVWSAGIL 607
++ DFG + +D G +S GT Y+ PE + + + D WS G+
Sbjct: 215 RLADFGSCLKLMED----GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 608 FYQMLFGRRPF---GHDQTQERILREDTIIKARKVEFPS-RPAVSNEAKDLIRRCLT 660
Y+ML+G PF +T +I+ + +FP+ VS AKDLIRR +
Sbjct: 271 MYEMLYGETPFYAESLVETYGKIMNHKE-----RFQFPTQVTDVSENAKDLIRRLIC 322
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ ++ LG G F +VYKA + A K+ SE++ + YI E I T
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIV----EIEILAT 72
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLI 522
H +IV+L + D ++E+C G +DA++ L E + +++ Q+ + L
Sbjct: 73 CDHPYIVKLLGAYYHD-GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA------ 576
+L+ ++IIH DLK GNVL G ++ DFG+S +
Sbjct: 132 FLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSA-----------KNLKTLQKRDSFI 178
Query: 577 GT-YWYLPPE---CFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632
GT YW + PE C + TP K D+WS GI +M P H+ R+L
Sbjct: 179 GTPYW-MAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPH-HELNPMRVLL--K 233
Query: 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
I K+ + S E +D ++ L N RP L + P+++
Sbjct: 234 IAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-34
Identities = 81/382 (21%), Positives = 147/382 (38%), Gaps = 38/382 (9%)
Query: 301 DLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGV----DVESGVQEEDLVIQDEIYKSRL 356
L + + + V + ++ G + +G V + +
Sbjct: 72 ATRPELSRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQ 131
Query: 357 ASIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHR------YALLNL 410
+ + + +E R E + + +RF ++ L + + +
Sbjct: 132 RLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRV 191
Query: 411 LGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
LGKGGF EV + R ACK L + + +K A+ E I + +
Sbjct: 192 LGKGGFGEVC----ACQVRATGKMYACKK--LEKKRIKKRKG--EAMALNEKQILEKVNS 243
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK--ATPVLPEREARIIIVQIFQGLIYL 524
+V L +E ++ C VL +G DL + PE A +I GL L
Sbjct: 244 RFVVSLAYAYE-TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
++ +I++ DLKP N+L D+ G +++D GL+ V + + GT Y+ P
Sbjct: 303 HRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG------QTIKGRVGTVGYMAP 354
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
E + S D W+ G L Y+M+ G+ PF + + + + ++K E+
Sbjct: 355 EV--VKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS-- 409
Query: 645 PAVSNEAKDLIRRCLTYNQAER 666
S +A+ L + L + AER
Sbjct: 410 ERFSPQARSLCSQLLCKDPAER 431
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 75/284 (26%), Positives = 110/284 (38%), Gaps = 56/284 (19%)
Query: 407 LLNLLGKGGFSEVYKA-YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV 465
L ++G GGF +VY+A + VA K ED Q+ I + +E + L
Sbjct: 11 LEEIIGIGGFGKVYRAFWI---GDEVAVKA--ARHDPDEDISQT-IENVRQEAKLFAMLK 64
Query: 466 HHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
H +I+ L + C V+E+ G L+ VL +P VQI +G+
Sbjct: 65 HPNIIAL-----RGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGM 118
Query: 522 IYL-NKRAQKIIHYDLKPGNVLFDEFG--------VAKVTDFGLSKIVEDDVGSQGMELT 572
YL ++ IIH DLK N+L + + K+TDFGL++
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT------TKM 172
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQ------E 625
S AG Y ++ PE S S DVWS G+L +++L G PF G D
Sbjct: 173 S-AAGAYAWMAPEVIRASM---FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 626 RILREDTIIKARKVEFPSRPAVSNEA-KDLIRRCLTYNQAERPD 668
L P+ E L+ C + RP
Sbjct: 229 NKLA------------LPIPSTCPEPFAKLMEDCWNPDPHSRPS 260
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 73/268 (27%), Positives = 112/268 (41%), Gaps = 29/268 (10%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+LG+GGF EV+ + + ACK LN + + +K + A+ E I
Sbjct: 189 DFRVLGRGGFGEVF----ACQMKATGKLYACKK--LNKKRLKKRKG--YQGAMVEKKILA 240
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL----DAVLKATPVLPEREARIIIVQIF 518
+ IV L FE + C V+ +G D+ V + P E A QI
Sbjct: 241 KVHSRFIVSLAYAFE-TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
GL +L++R II+ DLKP NVL D+ G +++D GL+ G T AGT
Sbjct: 300 SGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVE-----LKAGQTKTKGYAGT 352
Query: 579 YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638
++ PE L S VD ++ G+ Y+M+ R PF + + +
Sbjct: 353 PGFMAPEL--LLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
Query: 639 VEFPSRPAVSNEAKDLIRRCLTYNQAER 666
V +P S +KD L + +R
Sbjct: 410 VTYP--DKFSPASKDFCEALLQKDPEKR 435
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 70/283 (24%), Positives = 109/283 (38%), Gaps = 26/283 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
++ L +G G F VY A D+ VA K + + S +K Q I+ E +
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK----EVRFLQK 110
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H + ++ + + + V+EYC G D + L E E + QGL Y
Sbjct: 111 LRHPNTIQYRGCYLREHTAW-LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG--AGT-YW 580
L+ +IH D+K GN+L E G+ K+ DFG S + GT YW
Sbjct: 170 LHS--HNMIHRDVKAGNILLSEPGLVKLGDFG--------SASI---MAPANSFVGTPYW 216
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640
+ PE KVDVWS GI ++ + P + L I +
Sbjct: 217 -MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALY--HIAQNESPA 272
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
S S ++ + CL +RP L + ++ +
Sbjct: 273 LQS-GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 27/294 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y L ++G G + V AY + VA K + + +K Q+ + ++E
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIK------RINLEKCQTSMDELLKEIQAMSQ 69
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--------VLPEREARIIIV 515
H +IV + +F + ++ V++ SG + ++K VL E I+
Sbjct: 70 CHHPNIVSYYTSF-VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
++ +GL YL+K IH D+K GN+L E G ++ DFG+S + ++
Sbjct: 129 EVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 576 AGT-YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER----ILRE 630
GT W + PE E + K D+WS GI ++ G P+ H + L+
Sbjct: 187 VGTPCW-MAPEVMEQVRG--YDFKADIWSFGITAIELATGAAPY-HKYPPMKVLMLTLQN 242
Query: 631 DT-IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
D ++ + + +I CL + +RP L + + +K
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 69/270 (25%), Positives = 112/270 (41%), Gaps = 40/270 (14%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L +LGKG F +V+ L E ++ A K L + + E +
Sbjct: 21 LHKMLGKGSFGKVF----LAEFKKTNQFFAIKA--LKKDVVLMDDD--VECTMVEKRVLS 72
Query: 463 TLVHHH-IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
H + ++ TF+ + V+EY +G DL +++ A +I GL
Sbjct: 73 LAWEHPFLTHMFCTFQ-TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK--IVEDDVGSQGMELTSQGAGTY 579
+L+ + I++ DLK N+L D+ G K+ DFG+ K ++ D T+ GT
Sbjct: 132 QFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-------TNTFCGTP 182
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIKA 636
Y+ PE L S VD WS G+L Y+ML G+ PF ++ I +
Sbjct: 183 DYIAPEI--LLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------ 233
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+P + EAKDL+ + +R
Sbjct: 234 -NPFYP--RWLEKEAKDLLVKLFVREPEKR 260
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 60/287 (20%), Positives = 117/287 (40%), Gaps = 36/287 (12%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+G+G V A + R VA K+ L Q +++ E I +
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFN----EVVIMRD 98
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
H ++V ++ ++ + + + ++E+ G L ++ L E + + + Q L Y
Sbjct: 99 YQHFNVVEMYKSYLVGEELW-VLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAY 156
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA------G 577
L+ Q +IH D+K ++L G K++DFG +++ G
Sbjct: 157 LHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCA-----------QISKDVPKRKSLVG 203
Query: 578 T-YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636
T YW P E+ L +++VD+WS GI+ +M+ G P+ + + ++ + +
Sbjct: 204 TPYWMAP----EVISRSLYATEVDIWSLGIMVIEMVDGEPPY-FSDSPVQAMK--RLRDS 256
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
+ + VS +D + R L + ER L P+L +
Sbjct: 257 PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGL 303
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 72/301 (23%), Positives = 113/301 (37%), Gaps = 44/301 (14%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y + +G+G + V+K + + VA K + KK A+RE + K
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKI-----ALREIRMLKQ 58
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLI 522
L H ++V L + F + V EYC + L +PE + I Q Q +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLH-LVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
+ +K IH D+KP N+L + V K+ DFG +++ + + A T WY
Sbjct: 117 FCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARL----LTGPSDYYDDEVA-TRWYR 169
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQE--RILR------EDT 632
PE L VDVW+ G +F ++L P G + I +
Sbjct: 170 SPEL--LVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226
Query: 633 ---IIK---ARKVEFPSR----------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676
V+ P P +S A L++ CL + ER L P
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286
Query: 677 Y 677
Y
Sbjct: 287 Y 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 37/287 (12%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ L +GKG F EV+K D + VA K+ ++ + +ED+ + + E +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI--IDLEEAEDEIEDIQQ----EITVLSQ 76
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
++ + + ++ D + ++EY G +L+ P L E + I+ +I +GL Y
Sbjct: 77 CDSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDY 134
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA------G 577
L+ +K IH D+K NVL E G K+ DFG++ +LT G
Sbjct: 135 LHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAG-----------QLTDTQIKRNTFVG 181
Query: 578 T-YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636
T +W P E+ K SK D+WS GI ++ G P + ++L I K
Sbjct: 182 TPFWMAP----EVIKQSAYDSKADIWSLGITAIELARGEPPH-SELHPMKVLF--LIPKN 234
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
S K+ + CL + RP L + ++ + K
Sbjct: 235 NPPTLEGN--YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 76/296 (25%), Positives = 124/296 (41%), Gaps = 55/296 (18%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK-------LHGLNAQWSEDKKQSYIRHAIR 456
+Y L +G+G + V+KA + H VA K G+ + A+R
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS------------ALR 50
Query: 457 EYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIV 515
E + K L H +IVRL D V E+C +DL + L + +
Sbjct: 51 EICLLKELKHKNIVRLHDVL-HSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +GL + + R ++H DLKP N+L + G K+ +FGL++ G +++
Sbjct: 109 QLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARA----FGIPVRCYSAEV 162
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQE--RILR-- 629
T WY PP+ L L S+ +D+WSAG +F ++ RP G+D + RI R
Sbjct: 163 V-TLWYRPPDV--LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
Query: 630 ----EDTIIKARK----VEFPSR----------PAVSNEAKDLIRRCLTYNQAERP 667
E+ K +P P ++ +DL++ L N +R
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 38/288 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ +L LG+G + VYKA + VA K + + E I+E +I +
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE---------IIKEISIMQQ 80
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLI 522
H+V+ + ++ V+EYC + +++ L E E I+ +GL
Sbjct: 81 CDSPHVVKYYGSY-FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA------ 576
YL+ + IH D+K GN+L + G AK+ DFG++ +LT A
Sbjct: 140 YLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAG-----------QLTDTMAKRNTVI 186
Query: 577 GT-YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT +W P E+ + + D+WS GI +M G+ P+ D R + I
Sbjct: 187 GTPFWMAP----EVIQEIGYNCVADIWSLGITAIEMAEGKPPY-ADIHPMRAIFM--IPT 239
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
F S+ D +++CL + +R L Q P++ +K
Sbjct: 240 NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-33
Identities = 80/267 (29%), Positives = 120/267 (44%), Gaps = 34/267 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L LLGKG F +V LV+ RY A K+ L + K + + H + E + +
Sbjct: 152 YLKLLGKGTFGKVI----LVKEKATGRYYAMKI--LKKEVIVAKDE--VAHTLTENRVLQ 203
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI 522
H + L +F+ + C V+EY +G +L L V E AR +I L
Sbjct: 204 NSRHPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL+ + +++ DLK N++ D+ G K+TDFGL K G + GT YL
Sbjct: 263 YLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYL 316
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIKARKV 639
PE L + VD W G++ Y+M+ GR PF H++ E IL E ++
Sbjct: 317 APEV--LEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------EI 366
Query: 640 EFPSRPAVSNEAKDLIRRCLTYNQAER 666
FP + EAK L+ L + +R
Sbjct: 367 RFP--RTLGPEAKSLLSGLLKKDPKQR 391
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 76/315 (24%), Positives = 120/315 (38%), Gaps = 45/315 (14%)
Query: 392 GSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYI 451
G+ FQ + +Y L L+G+G + V K + R VA K + KK
Sbjct: 15 GTENLYFQSME-KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI--- 70
Query: 452 RHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREA 510
A+RE + K L H ++V L + + + + V E+ + L+ P L +
Sbjct: 71 --AMREIKLLKQLRHENLVNLLEVCKKKKRWY-LVFEFVD-HTILDDLELFPNGLDYQVV 126
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
+ + QI G+ + + IIH D+KP N+L + GV K+ DFG ++ + + G
Sbjct: 127 QKYLFQIINGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFART----LAAPGEV 180
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQE--R 626
+ A T WY PE L VDVW+ G L +M P G +
Sbjct: 181 YDDEVA-TRWYRAPEL--LVGDVKYGKAVDVWAIGCLVTEMF-MGEPLFPGDSDIDQLYH 236
Query: 627 ILR------EDT---IIK---ARKVEFPSR----------PAVSNEAKDLIRRCLTYNQA 664
I+ K V P P +S DL ++CL +
Sbjct: 237 IMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD 296
Query: 665 ERPDVLTLAQDPYLT 679
+RP L +
Sbjct: 297 KRPFCAELLHHDFFQ 311
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 72/281 (25%), Positives = 120/281 (42%), Gaps = 24/281 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y +G+G VY A D+ + VA + L Q KK+ I E + +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIIN----EILVMRE 73
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
+ +IV D++ + + V+EY +G L V+ T + E + + + Q L +
Sbjct: 74 NKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 131
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT-YWYL 582
L+ ++IH D+K N+L G K+TDFG + + + S GT YW
Sbjct: 132 LHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-----STMVGTPYWMA 184
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642
P E+ KVD+WS GI+ +M+ G P+ ++ R L I E
Sbjct: 185 P----EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY-LNENPLRALY--LIATNGTPELQ 237
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
+ +S +D + RCL + +R L Q +L +K
Sbjct: 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 37/271 (13%), Positives = 71/271 (26%), Gaps = 47/271 (17%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
+I N RY LL G + ++A D R VA ++ Q ++ +
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTF--VDPQGVLP--DDVLQETLSRT 82
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIF 518
+ + R+ D V E+ G L V +P P R + +
Sbjct: 83 LRLSRIDKPGVARVLDVVHTRAGGLV-VAEWIRGGSLQEVADTSP-SPVGAIRAM-QSLA 139
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
+ P V G +
Sbjct: 140 AAADAA--HRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------- 174
Query: 579 YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638
+P + + D+ G Y +L R P + + + +
Sbjct: 175 --TMPDA----------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 639 VEFPS--RPAVSNEAKDLIRRCLTYNQAERP 667
+E P+ + + + R + + R
Sbjct: 223 IE-PADIDRDIPFQISAVAARSVQGDGGIRS 252
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 81/325 (24%), Positives = 129/325 (39%), Gaps = 54/325 (16%)
Query: 358 SIKREEEAILRERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFS 417
S + ++EL L +++ E+ F LL +LG G +
Sbjct: 22 SADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN---FE----------LLKVLGTGAYG 68
Query: 418 EVYKAYDLVEH-------RYVACKLHGLN-AQWSEDKKQSYIRHAIREYNIHKTLVHHH- 468
+V+ LV + A K+ L A + K H E + + +
Sbjct: 69 KVF----LVRKISGHDTGKLYAMKV--LKKATIVQKAKT--TEHTRTERQVLEHIRQSPF 120
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA 528
+V L F+ + +L+Y +G +L L E E +I + +I L +L+K
Sbjct: 121 LVTLHYAFQ-TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-- 177
Query: 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
II+ D+K N+L D G +TDFGLSK D E GT Y+ P+
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET----ERAYDFCGTIEYMAPDIVR 233
Query: 589 LSKTPLISSKVDVWSAGILFYQMLFGRRPF-------GHDQTQERILREDTIIKARKVEF 641
+ + VD WS G+L Y++L G PF + RIL+ + +
Sbjct: 234 GGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------EPPY 285
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAER 666
P +S AKDLI+R L + +R
Sbjct: 286 P--QEMSALAKDLIQRLLMKDPKKR 308
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 82/269 (30%), Positives = 117/269 (43%), Gaps = 39/269 (14%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L LLGKG F +V LV RY A K+ L + K + + H + E + +
Sbjct: 9 YLKLLGKGTFGKVI----LVREKATGRYYAMKI--LRKEVIIAKDE--VAHTVTESRVLQ 60
Query: 463 TLVHHHIVRLWDTFEIDQNT--FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
H + L F Q C V+EY +G +L L V E AR +I
Sbjct: 61 NTRHPFLTALKYAF---QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
L YL+ R +++ D+K N++ D+ G K+TDFGL K G GT
Sbjct: 118 LEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKE-----GISDGATMKTFCGTPE 170
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIKAR 637
YL PE L + VD W G++ Y+M+ GR PF H++ E IL E
Sbjct: 171 YLAPEV--LEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------- 220
Query: 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
++ FP +S EAK L+ L + +R
Sbjct: 221 EIRFP--RTLSPEAKSLLAGLLKKDPKQR 247
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-32
Identities = 80/272 (29%), Positives = 119/272 (43%), Gaps = 44/272 (16%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L ++GKG F +V L H + A K+ L + KK+ +H + E N+
Sbjct: 42 FLKVIGKGSFGKVL----LARHKAEEVFYAVKV--LQKKAILKKKE--EKHIMSERNVLL 93
Query: 463 TLVHHH-IVRLWDTFEIDQNT--FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
V H +V L +F Q VL+Y +G +L L+ E AR +I
Sbjct: 94 KNVKHPFLVGLHFSF---QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS 150
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK--IVEDDVGSQGMELTSQGAG 577
L YL+ I++ DLKP N+L D G +TDFGL K I + TS G
Sbjct: 151 ALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-------TTSTFCG 201
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTII 634
T YL PE L K P + VD W G + Y+ML+G PF + + IL +
Sbjct: 202 TPEYLAPEV--LHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---- 254
Query: 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
++ P ++N A+ L+ L ++ +R
Sbjct: 255 ---PLQLK--PNITNSARHLLEGLLQKDRTKR 281
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 83/271 (30%), Positives = 124/271 (45%), Gaps = 39/271 (14%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEH-------RYVACKLHGLN-AQWSEDKKQSYIRHAIREY 458
LL +LGKGG+ +V+ V + A K+ L A + K H E
Sbjct: 21 LLRVLGKGGYGKVF----QVRKVTGANTGKIFAMKV--LKKAMIVRNAKD--TAHTKAER 72
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIF 518
NI + + H IV L F+ +LEY SG +L L+ + E A + +I
Sbjct: 73 NILEEVKHPFIVDLIYAFQ-TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS 131
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
L +L++ + II+ DLKP N++ + G K+TDFGL K +T GT
Sbjct: 132 MALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHTFCGT 184
Query: 579 YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIK 635
Y+ PE L ++ + VD WS G L Y ML G PF +T ++IL+
Sbjct: 185 IEYMAPEI--LMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC----- 236
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
K+ P P ++ EA+DL+++ L N A R
Sbjct: 237 --KLNLP--PYLTQEARDLLKKLLKRNAASR 263
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 40/270 (14%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ +LGKG F +V L A K+ L + + E I
Sbjct: 27 FIRVLGKGSFGKVM----LARVKETGDLYAVKV--LKKDVILQDDD--VECTMTEKRILS 78
Query: 463 TLVHHH-IVRLWDTFEIDQNT--FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
+H + +L+ F Q V+E+ +G DL ++ + E AR +I
Sbjct: 79 LARNHPFLTQLFCCF---QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
L++L+ + II+ DLK NVL D G K+ DFG+ K G T+ GT
Sbjct: 136 ALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-----GICNGVTTATFCGTP 188
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTIIKA 636
Y+ PE L + + VD W+ G+L Y+ML G PF D E IL +
Sbjct: 189 DYIAPEI--LQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------ 239
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+V +P + +A +++ +T N R
Sbjct: 240 -EVVYP--TWLHEDATGILKSFMTKNPTMR 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 71/272 (26%), Positives = 109/272 (40%), Gaps = 44/272 (16%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L +LGKG F +V L E A K+ L + + E +
Sbjct: 24 FLMVLGKGSFGKVM----LSERKGTDELYAVKI--LKKDVVIQDDD--VECTMVEKRVLA 75
Query: 463 TLVHHH-IVRLWDTFEIDQNT--FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
+ +L F Q V+EY +G DL ++ E A +I
Sbjct: 76 LPGKPPFLTQLHSCF---QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK--IVEDDVGSQGMELTSQGAG 577
GL +L + II+ DLK NV+ D G K+ DFG+ K I + T G
Sbjct: 133 GLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-------TKTFCG 183
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILREDTII 634
T Y+ PE ++ P S VD W+ G+L Y+ML G+ PF D+ + I+
Sbjct: 184 TPDYIAPEI--IAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH---- 236
Query: 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
V +P ++S EA + + +T + +R
Sbjct: 237 ---NVAYP--KSMSKEAVAICKGLMTKHPGKR 263
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 35/272 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
LL ++G+G +++V LV R A K+ + + D + I E ++ +
Sbjct: 13 LLRVIGRGSYAKVL----LVRLKKTDRIYAMKV--VKKELVNDDED--IDWVQTEKHVFE 64
Query: 463 TLVHHH-IVRLWDTFEIDQNT--FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
+H +V L F Q V+EY +G DL ++ LPE AR +I
Sbjct: 65 QASNHPFLVGLHSCF---QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
L YL++ + II+ DLK NVL D G K+TD+G+ K G + + TS GT
Sbjct: 122 ALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-----GLRPGDTTSTFCGTP 174
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT-----II 634
Y+ PE L S VD W+ G+L ++M+ GR PF + + + +I
Sbjct: 175 NYIAPEI--LRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231
Query: 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
+++ P ++S +A +++ L + ER
Sbjct: 232 LEKQIRIP--RSLSVKAASVLKSFLNKDPKER 261
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 76/279 (27%), Positives = 118/279 (42%), Gaps = 57/279 (20%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEH-------RYVACKLHGLNAQWSEDKKQSYIR----HAI 455
LL +LG+G F +V+ LV+ + A K+ L KK +
Sbjct: 28 LLKVLGQGSFGKVF----LVKKISGSDARQLYAMKV--L-------KKATLKVRDRVRTK 74
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIV 515
E +I + H IV+L F+ + +L++ G DL L + E + + +
Sbjct: 75 MERDILVEVNHPFIVKLHYAFQ-TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 133
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
++ L +L+ II+ DLKP N+L DE G K+TDFGLSK +
Sbjct: 134 ELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSF 186
Query: 576 AGTYWYLPPECFELSKTPLISSK-----VDVWSAGILFYQMLFGRRPF---GHDQTQERI 627
GT Y+ PE +++ + D WS G+L ++ML G PF +T I
Sbjct: 187 CGTVEYMAPE--------VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238
Query: 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAER 666
L+ K+ P +S EA+ L+R N A R
Sbjct: 239 LKA-------KLGMP--QFLSPEAQSLLRMLFKRNPANR 268
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 73/295 (24%), Positives = 120/295 (40%), Gaps = 55/295 (18%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK---LH----GLNAQWSEDKKQSYIRHAIR 456
+Y L +G+G + VYKA + A K L G+ + IR
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPST------------TIR 49
Query: 457 EYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIV 515
E +I K L H +IV+L+D + V E+ +DL +L L A+ ++
Sbjct: 50 EISILKELKHSNIVKLYDVI-HTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLL 107
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ G+ Y + R +++H DLKP N+L + G K+ DFGL++ G + T +
Sbjct: 108 QLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARA----FGIPVRKYTHEI 161
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQE--RILR--- 629
T WY P+ L + S+ +D+WS G +F +M+ G F G + + RI R
Sbjct: 162 V-TLWYRAPDV--LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
Query: 630 ---ED-----TIIKARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERP 667
T + F + DL+ + L + +R
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 82/311 (26%), Positives = 124/311 (39%), Gaps = 54/311 (17%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK---LHGLNAQWSEDKKQSYI-RHAIREYN 459
RY + +G G + VYKA D +VA K + + + +RE
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP------NGGGGGGGLPISTVREVA 63
Query: 460 IHKTL---VHHHIVRLWDTFEIDQNTFCT----VLEYCSGKDLDAVLKATPV--LPEREA 510
+ + L H ++VRL D + V E+ +DL L P LP
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETI 122
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
+ ++ Q +GL +L+ I+H DLKP N+L G K+ DFGL++I M
Sbjct: 123 KDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-----MA 175
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQE--R 626
LT T WY PE L T ++ VD+WS G +F +M R+P G+ + + +
Sbjct: 176 LTPV-VVTLWYRAPEVL-LQST--YATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGK 230
Query: 627 ILR------EDT---IIKARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERPD 668
I ED + + FP R P + L+ LT+N +R
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 669 VLTLAQDPYLT 679
Q YL
Sbjct: 291 AFRALQHSYLH 301
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 78/294 (26%), Positives = 126/294 (42%), Gaps = 54/294 (18%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK---LH---GLNAQWSEDKKQSYIRHAIRE 457
Y L+ LG+G ++ VYK + VA K L G AIRE
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT------------AIRE 50
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQ 516
++ K L H +IV L D + + V EY KDL L + ++ + Q
Sbjct: 51 VSLLKDLKHANIVTLHDII-HTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
+ +GL Y +++ K++H DLKP N+L +E G K+ DFGL++ ++
Sbjct: 109 LLRGLAYCHRQ--KVLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYDNEVV 162
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQE--RILR---- 629
T WY PP+ L + S+++D+W G +FY+M GR F G ++ I R
Sbjct: 163 -TLWYRPPDI--LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219
Query: 630 --EDT---IIK---ARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAER 666
E+T I+ + +P P + ++ DL+ + L + R
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNR 273
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 75/306 (24%), Positives = 117/306 (38%), Gaps = 61/306 (19%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ L+ L+G G + +VYK + + A K+ + E+ KQ E N+ K
Sbjct: 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ--------EINMLKK 76
Query: 464 LVHH-HIVRLWDTFEIDQNTFCT-----VLEYCSGKDLDAVLKATP--VLPEREARIIIV 515
HH +I + F V+E+C + ++K T L E I
Sbjct: 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
+I +GL +L++ K+IH D+K NVL E K+ DFG+S +L
Sbjct: 137 EILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSA-----------QLDRTV 183
Query: 576 A------GT-YWYLPPECFELSKTPLIS--SKVDVWSAGILFYQMLFGRRPFGHDQTQER 626
GT YW + PE + P + K D+WS GI +M G P
Sbjct: 184 GRRNTFIGTPYW-MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD------ 236
Query: 627 ILREDTIIKARKVEF--PSRPA-------VSNEAKDLIRRCLTYNQAERPDVLTLAQDPY 677
+ + F P PA S + + I CL N ++RP L + P+
Sbjct: 237 -------MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289
Query: 678 LTYSKK 683
+
Sbjct: 290 IRDQPN 295
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 86/287 (29%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY L+ LG+G F+ VYKA D ++ VA K L + + K R A+RE + +
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR--SEAKDGINRTALREIKLLQE 68
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLI 522
L H +I+ L D F ++ V ++ DL+ ++K + L + ++ QGL
Sbjct: 69 LSHPNIIGLLDAF-GHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL++ I+H DLKP N+L DE GV K+ DFGL+K GS T Q T WY
Sbjct: 127 YLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKS----FGSPNRAYTHQVV-TRWYR 179
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQE--RILR------EDT 632
PE L + VD+W+ G + ++L R PF G + RI E+
Sbjct: 180 APEL--LFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQ 236
Query: 633 IIKARK----VEFPSR---------PAVSNEAKDLIRRCLTYNQAER 666
V F S A ++ DLI+ +N R
Sbjct: 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 283
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 77/303 (25%), Positives = 119/303 (39%), Gaps = 65/303 (21%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRH---------- 453
RY + LG+G + EVYKA D V + VA K IR
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIK---------------RIRLEHEEEGVPGT 79
Query: 454 AIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARII 513
AIRE ++ K L H +I+ L + + EY DL + P + R +
Sbjct: 80 AIREVSLLKELQHRNIIELKSVI-HHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSF 137
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-----EFGVAKVTDFGLSKIVEDDVGSQG 568
+ Q+ G+ + + R + +H DLKP N+L E V K+ DFGL++ G
Sbjct: 138 LYQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA----FGIPI 191
Query: 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQE-- 625
+ T + T WY PPE L + S+ VD+WS ++ +ML F G + +
Sbjct: 192 RQFTHEII-TLWYRPPEI--LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248
Query: 626 RILR------EDT---IIKAR--KVEFPSRPA----------VSNEAKDLIRRCLTYNQA 664
+I + T + K FP + +E DL+ L +
Sbjct: 249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV 308
Query: 665 ERP 667
+R
Sbjct: 309 KRI 311
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 80/361 (22%), Positives = 134/361 (37%), Gaps = 53/361 (14%)
Query: 316 VERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLASIKREEEAILRERERYEL 375
+++ + + +G V E +E+ + + + E+ +
Sbjct: 267 LQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTI 326
Query: 376 EKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEH----RYV 431
K R++ D FN L +LGKG F +V L E
Sbjct: 327 SKFDNNGNRDRMKLTD---FN----------FLMVLGKGSFGKVM----LSERKGTDELY 369
Query: 432 ACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH-IVRLWDTFEIDQNTFCTVLEYC 490
A K+ L + + E + + +L F+ V+EY
Sbjct: 370 AVKI--LKKDVVIQDDD--VECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-LYFVMEYV 424
Query: 491 SGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550
+G DL ++ E A +I GL +L + II+ DLK NV+ D G K
Sbjct: 425 NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIK 482
Query: 551 VTDFGLSK--IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILF 608
+ DFG+ K I + T GT Y+ PE ++ P S VD W+ G+L
Sbjct: 483 IADFGMCKENIWDGVT-------TKTFCGTPDYIAPEI--IAYQPYGKS-VDWWAFGVLL 532
Query: 609 YQMLFGRRPF---GHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAE 665
Y+ML G+ PF D+ + I+ V +P ++S EA + + +T + +
Sbjct: 533 YEMLAGQAPFEGEDEDELFQSIMEH-------NVAYP--KSMSKEAVAICKGLMTKHPGK 583
Query: 666 R 666
R
Sbjct: 584 R 584
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 56/296 (18%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK---LH----GLNAQWSEDKKQSYIRHAIR 456
+Y L +G+G + VYKA D + R VA K L G+ + AIR
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPST------------AIR 68
Query: 457 EYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIV 515
E ++ K L H +IV L D + V E+ KDL VL L + + +I +
Sbjct: 69 EISLLKELHHPNIVSLIDVI-HSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLY 126
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +G+ + ++ +I+H DLKP N+L + G K+ DFGL++ G T +
Sbjct: 127 QLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLARA----FGIPVRSYTHEV 180
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQE--RILR--- 629
T WY P+ L + S+ VD+WS G +F +M+ G+ F G + +I
Sbjct: 181 V-TLWYRAPDV--LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237
Query: 630 ---EDT---IIK---ARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERP 667
+ + ++ F P E DL+ L ++ +R
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI 293
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 35/310 (11%)
Query: 369 ERERYELEKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEH 428
E ++ G I E K + S + + + LL ++G+G +++V LV
Sbjct: 18 ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVL----LVRL 73
Query: 429 ----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH-IVRLWDTFEIDQNT- 482
R A ++ + + D + I E ++ + +H +V L F Q
Sbjct: 74 KKTDRIYAMRV--VKKELVNDDED--IDWVQTEKHVFEQASNHPFLVGLHSCF---QTES 126
Query: 483 -FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNV 541
V+EY +G DL ++ LPE AR +I L YL++ + II+ DLK NV
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNV 184
Query: 542 LFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDV 601
L D G K+TD+G+ K G + + TS GT Y+ PE L S VD
Sbjct: 185 LLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEI--LRGEDYGFS-VDW 236
Query: 602 WSAGILFYQMLFGRRPFGHDQTQERILREDT-----IIKARKVEFPSRPAVSNEAKDLIR 656
W+ G+L ++M+ GR PF + + + +I +++ P ++S +A +++
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASVLK 294
Query: 657 RCLTYNQAER 666
L + ER
Sbjct: 295 SFLNKDPKER 304
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 74/304 (24%), Positives = 119/304 (39%), Gaps = 63/304 (20%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACK---LH---GLNAQWSEDKKQSYIRHAIRE 457
++ L LG G ++ VYK + YVA K L G + AIRE
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST------------AIRE 53
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV------LPEREAR 511
++ K L H +IVRL+D +N V E+ DL + + V L +
Sbjct: 54 ISLMKELKHENIVRLYDVI-HTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMEL 571
Q+ QGL + ++ KI+H DLKP N+L ++ G K+ DFGL++ G
Sbjct: 112 YFQWQLLQGLAFCHEN--KILHRDLKPQNLLINKRGQLKLGDFGLARA----FGIPVNTF 165
Query: 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQE--RIL 628
+S+ T WY P+ L + S+ +D+WS G + +M+ G+ F G + ++ I
Sbjct: 166 SSEVV-TLWYRAPDV--LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222
Query: 629 R------ED-----TIIKARKVEFP--------------SRPAVSNEAKDLIRRCLTYNQ 663
E T + ++ + D + L N
Sbjct: 223 DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNP 282
Query: 664 AERP 667
R
Sbjct: 283 DMRL 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 52/277 (18%), Positives = 97/277 (35%), Gaps = 36/277 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
+LGKG F + K + K ++ E+ ++++++ E + + L H
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKE---LIRFDEETQRTFLK----EVKVMRCLEH 66
Query: 467 HHIVRLWDTFE---IDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLI 522
++++ F + EY G L ++ P + I G+
Sbjct: 67 PNVLK----FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG------- 575
YL+ IIH DL N L E V DFGL++++ D+ + +
Sbjct: 123 YLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 576 --AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQERILREDT 632
G +++ PE KVDV+S GI+ +++ + D
Sbjct: 181 TVVGNPYWMAPEMINGRSY---DEKVDVFSFGIVLCEIIGRVNADPDYLPRT-----MDF 232
Query: 633 IIKARKVEFPSRPAVSNEA-KDLIRRCLTYNQAERPD 668
+ R P + + RC + +RP
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPS 269
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 70/322 (21%), Positives = 112/322 (34%), Gaps = 74/322 (22%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
R+ + + G+G F V + VA K K R RE I +
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----------KVIQDPRFRNRELQIMQD 72
Query: 464 LVH-HH--IVRLWDTF------EIDQNTFCTVLEYCSGKDLDAVLKATP----VLPEREA 510
L HH IV+L F + V+EY L + P
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILI 131
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF-GVAKVTDFGLSKIVEDDVGSQGM 569
++ + Q+ + + L+ + + H D+KP NVL +E G K+ DFG +K + S
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-----SPSE 186
Query: 570 ELTSQGAGTYWYLPPECFELSKTPLI------SSKVDVWSAGILFYQMLFGRRPF----G 619
+ + +Y PE LI ++ VD+WS G +F +M+ G F
Sbjct: 187 PNVAYIC-SRYYRAPE--------LIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237
Query: 620 HDQTQERILR------EDTI--IKARKVE--FPSRPAV-------------SNEAKDLIR 656
Q E I+R + + + + + + + EA DL+
Sbjct: 238 AGQLHE-IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296
Query: 657 RCLTYNQAERPDVLTLAQDPYL 678
L Y ER PY
Sbjct: 297 ALLQYLPEERMKPYEALCHPYF 318
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 47/300 (15%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y L +G+G F EV+KA + VA K + E++K+ + A+RE I +
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-----ENEKEGFPITALREIKILQL 72
Query: 464 LVHHHIVRLWD-------TFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIV 515
L H ++V L + + + + V ++C DL +L V E + ++
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
+ GL Y+++ KI+H D+K NVL GV K+ DFGL++ SQ T++
Sbjct: 132 MLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GH-DQTQ-ERILR-- 629
T WY PPE L +D+W AG + +M + R P G+ +Q Q I +
Sbjct: 190 V-TLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQLC 245
Query: 630 ----EDT---IIK---ARKVEFPSRP-----------AVSNEAKDLIRRCLTYNQAERPD 668
+ + K+E A DLI + L + A+R D
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 74/346 (21%), Positives = 135/346 (39%), Gaps = 73/346 (21%)
Query: 377 KGRLIREMKRIRDEDGSRFNNFQIL---NHRYALLNLLGKGGFSEVYKAYDLVEHRYVAC 433
+ R+ ++ R + + + + Y L+ LG+G +SEV++A ++ + V
Sbjct: 7 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 66
Query: 434 KLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH-HIVRLWDTFEIDQNTFCTVL--EYC 490
K+ L KK+ RE I + L +I+ L D D + L E+
Sbjct: 67 KI--LK---PVKKKK-----IKREIKILENLRGGPNIITLADIV-KDPVSRTPALVFEHV 115
Query: 491 SGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVA 549
+ D + L + + R + +I + L Y + I+H D+KP NV+ D E
Sbjct: 116 NNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKL 170
Query: 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSK-----VDVWSA 604
++ D+GL+ + G E + A + ++ PE L+ + +D+WS
Sbjct: 171 RLIDWGLA-----EFYHPGQEYNVRVA-SRYFKGPEL-------LVDYQMYDYSLDMWSL 217
Query: 605 GILFYQMLFGRRPF--GHDQTQE--RILR----------------------EDTIIKARK 638
G + M+F + PF GHD + RI + D + + +
Sbjct: 218 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR 277
Query: 639 VEFPS------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ + VS EA D + + L Y+ R + PY
Sbjct: 278 KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 60/293 (20%), Positives = 104/293 (35%), Gaps = 48/293 (16%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT--L 464
LL +GKG + EV++ + VA K+ S ++S+ R E ++ T L
Sbjct: 12 LLECVGKGRYGEVWRG--SWQGENVAVKIF------SSRDEKSWFR----ETELYNTVML 59
Query: 465 VHHHIVRL--WDTFEIDQNT-FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
H +I+ D +T + Y L L+ L I++ I GL
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGL 118
Query: 522 IYL------NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
+L + I H DLK N+L + G + D GL+ + + +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR- 177
Query: 576 AGTYWYLPPECFE---LSKTPLISSKVDVWSAGILFYQMLFGRRPFG---------HDQT 623
GT Y+ PE + +VD+W+ G++ +++ G +D
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 624 QERILREDTIIKARKVEFPSRPAVSNEA---------KDLIRRCLTYNQAERP 667
ED ++ RP + N L++ C N + R
Sbjct: 238 PNDPSFED--MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 59/291 (20%), Positives = 100/291 (34%), Gaps = 44/291 (15%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT--L 464
++ +GKG + EV+ VA K+ RE I++T +
Sbjct: 41 MVKQIGKGRYGEVWMG--KWRGEKVAVKV--FFTTEEASWF--------RETEIYQTVLM 88
Query: 465 VHHHIVRLW--DTFEIDQNT-FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
H +I+ D T + +Y L LK + L + + GL
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-STTLDAKSMLKLAYSSVSGL 147
Query: 522 IYL------NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
+L + I H DLK N+L + G + D GL+ D + ++
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR- 206
Query: 576 AGTYWYLPPECFELSKTPLI---SSKVDVWSAGILFYQMLFGRRPFGH------------ 620
GT Y+PPE + S D++S G++ +++ G
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266
Query: 621 -DQTQERILREDTIIKARKVEFPSRPAVSN---EAKDLIRRCLTYNQAERP 667
+RE IK + FP+R + + L+ C +N A R
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 87/353 (24%), Positives = 133/353 (37%), Gaps = 78/353 (22%)
Query: 375 LEKGRLIREMKRIRDEDGSRF---------NNFQILNHRYALLNLLGKGGFSEVYKAYDL 425
+++ MK RD+DGS+ + Y ++G G F VY+A
Sbjct: 17 VQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLC 76
Query: 426 VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT 485
VA K + +DK+ RE I + L H +IVRL F
Sbjct: 77 DSGELVAIK------KVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125
Query: 486 -----VLEYCSGKDLDAVLKATP----VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDL 536
VL+Y + + V + LP ++ + Q+F+ L Y+ + I H D+
Sbjct: 126 VYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI--HSFGICHRDI 182
Query: 537 KPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLI 595
KP N+L D + V K+ DFG +K + +G S + +Y PE LI
Sbjct: 183 KPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYIC-SRYYRAPE--------LI 228
Query: 596 ------SSKVDVWSAGILFYQMLFGRRPF----GHDQTQERILR------EDTII----K 635
+S +DVWSAG + ++L G+ F G DQ E I++ + I
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE-IIKVLGTPTREQIREMNPN 287
Query: 636 ARKVEFPSRPAV----------SNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ +FP A EA L R L Y R L +
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 82/303 (27%), Positives = 134/303 (44%), Gaps = 64/303 (21%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVE-HRYVACK---LH----GLNAQWSEDKKQSYIRHAI 455
+Y + +G+G + +V+KA DL R+VA K + G+ I
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS------------TI 59
Query: 456 REYNIHKTL---VHHHIVRLWDTFEIDQNTFCT----VLEYCSGKDLDAVLKA--TPVLP 506
RE + + L H ++VRL+D + + T V E+ +DL L P +P
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVP 118
Query: 507 EREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS 566
+ ++ Q+ +GL +L+ +++H DLKP N+L G K+ DFGL++I
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--- 173
Query: 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQ 624
M LTS T WY PE L + ++ VD+WS G +F +M R+P G
Sbjct: 174 --MALTSVVV-TLWYRAPEVL-LQSS--YATPVDLWSVGCIFAEMFR-RKPLFRGSSDVD 226
Query: 625 E--RILR------EDT---IIKARKVEFPSR---------PAVSNEAKDLIRRCLTYNQA 664
+ +IL E+ + + F S+ + KDL+ +CLT+N A
Sbjct: 227 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 286
Query: 665 ERP 667
+R
Sbjct: 287 KRI 289
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 53/326 (16%), Positives = 91/326 (27%), Gaps = 57/326 (17%)
Query: 405 YALLNLLGKG--GFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
Y LL ++GKG V A YV + L E + E ++ K
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL-----EACSNEMVTFLQGELHVSK 81
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQG 520
H +IV TF I N V + + ++ + E I+ + +
Sbjct: 82 LFNHPNIVPYRATF-IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG--MELTSQGAGT 578
L Y++ +H +K ++L G ++ + + Q +
Sbjct: 141 LDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 579 -YWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF------------------- 618
W L PE + + +K D++S GI ++ G PF
Sbjct: 199 LPW-LSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256
Query: 619 ---------------------GHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRR 657
+ P S + +
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316
Query: 658 CLTYNQAERPDVLTLAQDPYLTYSKK 683
CL N RP TL + K+
Sbjct: 317 CLQRNPDARPSASTLLNHSFFKQIKR 342
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 79/329 (24%), Positives = 134/329 (40%), Gaps = 72/329 (21%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK----KQSYIR 452
F + + RY L LG GG V+ A D + VA K K ++
Sbjct: 6 GFDLGS-RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----------KIVLTDPQSVK 53
Query: 453 HAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCS------------GKDLDAVLK 500
HA+RE I + L H +IV++++ + + + DL VL+
Sbjct: 54 HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 501 ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTDFGLSKI 559
P+L E AR+ + Q+ +GL Y++ + ++H DLKP N+ + V K+ DFGL++I
Sbjct: 114 QGPLLEEH-ARLFMYQLLRGLKYIH--SANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSK-----VDVWSAGILFYQMLFG 614
++ +G L+ T WY P L+S +D+W+AG +F +ML
Sbjct: 171 MDPHYSHKGH-LSEGLV-TKWYRSPRL-------LLSPNNYTKAIDMWAAGCIFAEML-T 220
Query: 615 RRPF--GHDQTQ--ERIL------REDTI--------------IKARKVEFPSR-PAVSN 649
+ G + + + IL E+ + P +S
Sbjct: 221 GKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 650 EAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
EA D + + LT++ +R PY+
Sbjct: 281 EAVDFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-27
Identities = 85/325 (26%), Positives = 131/325 (40%), Gaps = 66/325 (20%)
Query: 394 RFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK-----KQ 448
R F + RY L+ +G+G + V AYD + VA K K Q
Sbjct: 19 RGQVFDVGP-RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----------KISPFEHQ 66
Query: 449 SYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ----NTFCTVLEYCSGKDLDAVLKATPV 504
+Y + +RE I H +I+ + D V + DL +LK
Sbjct: 67 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH- 124
Query: 505 LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564
L + QI +GL Y++ + ++H DLKP N+L + K+ DFGL+++ + D
Sbjct: 125 LSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSK-----VDVWSAGILFYQMLFGRRPF- 618
G LT A T WY PE +++SK +D+WS G + +ML RP
Sbjct: 183 DHTGF-LTEYVA-TRWYRAPEI-------MLNSKGYTKSIDIWSVGCILAEML-SNRPIF 232
Query: 619 -GHDQTQ--ERILR------EDTII-----KARKV--EFPSR---------PAVSNEAKD 653
G IL ++ + KAR P + P ++A D
Sbjct: 233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 292
Query: 654 LIRRCLTYNQAERPDVLTLAQDPYL 678
L+ + LT+N +R +V PYL
Sbjct: 293 LLDKMLTFNPHKRIEVEQALAHPYL 317
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 70/345 (20%), Positives = 115/345 (33%), Gaps = 87/345 (25%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
+ RY L+ LG G FS V+ A D+V + +VA K+ + Y A E
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKI--------VRGDKVYTEAAEDEIK 67
Query: 460 IHKTLV-----------HHHIVRLWDTFEIDQNT---FCTVLEYCSGKDLDAVLKATP-- 503
+ + + +HI++L D F V E G++L A++K
Sbjct: 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR 126
Query: 504 VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA------KVTDFGLS 557
+P + I Q+ GL Y+++R IIH D+KP NVL + K+ D G +
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 558 KIVEDDVGSQGMELTSQGAGTYWYLPPE-CFELSKTPLISSKVDVWSAGILFYQMLFGRR 616
++ + T Y PE D+WS L ++++ G
Sbjct: 186 CWYDEHY--------TNSIQTREYRSPEVLLGAP----WGCGADIWSTACLIFELITGDF 233
Query: 617 PF-GHDQTQ-----------ERIL-------------------REDTIIKARKVEFPSRP 645
F + +L + K++F
Sbjct: 234 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 293
Query: 646 AVSNEA-----------KDLIRRCLTYNQAERPDVLTLAQDPYLT 679
V E D + L + +R D L P+L
Sbjct: 294 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 338
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 66/266 (24%), Positives = 104/266 (39%), Gaps = 28/266 (10%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L +G+G F EV+ ++ VA K D K +++ E I K H
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKS--CRETLPPDLKAKFLQ----EARILKQYSH 171
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARI-IIVQIFQGLIYLN 525
+IVRL + V+E G D L+ + + ++ G+ YL
Sbjct: 172 PNIVRLIG-VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 526 KRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WYL 582
+ IH DL N L E V K++DFG+S+ D V + S G W
Sbjct: 231 S--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA-----SGGLRQVPVKW-T 282
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVEF 641
PE + SS+ DVWS GIL ++ G P+ + Q+ + + K ++
Sbjct: 283 APEALNYGRY---SSESDVWSFGILLWETFSLGASPYPNLSNQQTR---EFVEKGGRLPC 336
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERP 667
P + L+ +C Y +RP
Sbjct: 337 P--ELCPDAVFRLMEQCWAYEPGQRP 360
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 64/302 (21%), Positives = 109/302 (36%), Gaps = 55/302 (18%)
Query: 407 LLNLLGKGGFSEVYKA-YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT-- 463
LL L+G+G + VYK D R VA K+ + +Q++I E NI++
Sbjct: 17 LLELIGRGRYGAVYKGSLD---ERPVAVKV--FSFAN----RQNFIN----EKNIYRVPL 63
Query: 464 LVHHHIVRL----WDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
+ H +I R + + V+EY L L R+ + +
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTR 122
Query: 520 GLIYL-------NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMEL- 571
GL YL + I H DL NVL G ++DFGLS + + + E
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 572 --TSQGAGTYWYLPPECFE----LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT-- 623
GT Y+ PE E L +VD+++ G++++++ ++
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 624 ------QERILREDTIIKARKV--------EFPSRPAVSNEA----KDLIRRCLTYNQAE 665
Q + T + + +FP ++ A K+ I C +
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 666 RP 667
R
Sbjct: 303 RL 304
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 53/291 (18%), Positives = 100/291 (34%), Gaps = 44/291 (15%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT--L 464
L +GKG F EV++ VA K+ +++ +++ RE I++T L
Sbjct: 46 LQESIGKGRFGEVWRG--KWRGEEVAVKI--FSSR---EERS-----WFREAEIYQTVML 93
Query: 465 VHHHIVRL---WDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
H +I+ + V +Y L L + + + GL
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGL 152
Query: 522 IYLNKRAQ------KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
+L+ I H DLK N+L + G + D GL+ + + + +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR- 211
Query: 576 AGTYWYLPPECFELSKTPLI---SSKVDVWSAGILFYQMLFGRRPFGHD----------- 621
GT Y+ PE + S + D+++ G++F+++ G
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271
Query: 622 --QTQERILREDTIIKARKVEFPSRPA---VSNEAKDLIRRCLTYNQAERP 667
+R+ + + P+R ++R C N A R
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 58/293 (19%), Positives = 107/293 (36%), Gaps = 48/293 (16%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT-LV 465
LL + +G F V+KA + + YVA K+ + KQS+ EY ++ +
Sbjct: 28 LLEVKARGRFGCVWKAQ--LLNEYVAVKI------FPIQDKQSWQN----EYEVYSLPGM 75
Query: 466 HH-HIVRL--WDTFEIDQNT-FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
H +I++ + + + + L LK V+ E I + +GL
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGL 134
Query: 522 IYL--------NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTS 573
YL + I H D+K NVL A + DFGL+ E +
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT--HG 192
Query: 574 QGAGTYWYLPPECFE--LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631
Q GT Y+ PE E ++ ++D+++ G++ +++ + + E+
Sbjct: 193 Q-VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 632 TI--------IKARKVEFPSRPAVSNEA---------KDLIRRCLTYNQAERP 667
I ++ V RP + + + I C ++ R
Sbjct: 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 75/332 (22%), Positives = 125/332 (37%), Gaps = 70/332 (21%)
Query: 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK-----K 447
+ + I + + L +LLG+G + V A VA K K K
Sbjct: 2 PKRIVYNISS-DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----------KIEPFDK 49
Query: 448 QSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ----NTFCTVLEYCSGKDLDAVLKATP 503
+ +RE I K H +I+ +++ D N + E DL V+
Sbjct: 50 PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQM 108
Query: 504 VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563
L + + I Q + + L+ +IH DLKP N+L + KV DFGL++I+++
Sbjct: 109 -LSDDHIQYFIYQTLRAVKVLH--GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 564 VGSQGMELTSQGAGT-Y----WYLPPECFELSKTPLISSK-----VDVWSAGILFYQMLF 613
Q + WY PE +++S +DVWS G + ++
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEV-------MLTSAKYSRAMDVWSCGCILAELF- 217
Query: 614 GRRPF--GHDQTQ--ERIL-------REDTII-----KARKV--EFPSR---------PA 646
RRP G D I ++ + +AR+ P P
Sbjct: 218 LRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR 277
Query: 647 VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
V+ + DL++R L ++ A+R + PYL
Sbjct: 278 VNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 81/338 (23%), Positives = 131/338 (38%), Gaps = 75/338 (22%)
Query: 383 EMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQW 442
K I+ Q Y ++G G F V++A + E VA K +
Sbjct: 21 PNKVIKVLASDGKTGEQREI-AYTNCKVIGNGSFGVVFQAKLV-ESDEVAIK------KV 72
Query: 443 SEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF--------EIDQNTFCTVLEYCSGKD 494
+DK+ RE I + + H ++V L F E+ N VLEY +
Sbjct: 73 LQDKRFKN-----RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL---VLEYV-PET 123
Query: 495 LDAVLKATP----VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVA 549
+ + +P ++ + Q+ + L Y+ + I H D+KP N+L D GV
Sbjct: 124 VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI--HSIGICHRDIKPQNLLLDPPSGVL 181
Query: 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLI------SSKVDVWS 603
K+ DFG +KI+ G S + +Y PE LI ++ +D+WS
Sbjct: 182 KLIDFGSAKIL-----IAGEPNVSYIC-SRYYRAPE--------LIFGATNYTTNIDIWS 227
Query: 604 AGILFYQMLFGRRPF----GHDQTQE--RIL---REDTI--IKARKVE--FPS------- 643
G + +++ G+ F G DQ E ++L + I + +E FP
Sbjct: 228 TGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFS 287
Query: 644 ---RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
RP +A DLI R L Y + R + P+
Sbjct: 288 KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 81/317 (25%), Positives = 126/317 (39%), Gaps = 58/317 (18%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI 455
+++ RY L+ +G G + V A+D VA K Q K++Y
Sbjct: 23 TIWEVPE-RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----- 76
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQ-----NTFCTVLEYCSGKDLDAVLKATPVLPEREA 510
RE + K + H +++ L D F + N V G DL+ ++K L +
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHV 134
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
+ +I QI +GL Y++ + IIH DLKP N+ +E K+ DFGL++ D E
Sbjct: 135 QFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-------E 185
Query: 571 LTSQGAGTYWYLPPE----CFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQ- 624
+T A T WY PE ++T VD+WS G + ++L GR F G D
Sbjct: 186 MTGYVA-TRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGRTLFPGTDHIDQ 238
Query: 625 -ERILR------EDTIIK-----ARKV--EFPSR---------PAVSNEAKDLIRRCLTY 661
+ ILR + + K AR + A DL+ + L
Sbjct: 239 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 298
Query: 662 NQAERPDVLTLAQDPYL 678
+ +R Y
Sbjct: 299 DSDKRITAAQALAHAYF 315
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 71/323 (21%), Positives = 125/323 (38%), Gaps = 71/323 (21%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK------KQS 449
+++ Y +G G + V A D VA K K +
Sbjct: 18 TAWELPK-TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----------KLSRPFQSEI 65
Query: 450 YIRHAIREYNIHKTLVHHHIVRLWDTF-----EIDQNTFCTVLEYCSGKDLDAVLKATPV 504
+ + A RE + K + H +++ L D F + F V+ + DL ++
Sbjct: 66 FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK-- 122
Query: 505 LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564
E + + ++ Q+ +GL Y++ + ++H DLKPGN+ +E K+ DFGL++ + +
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179
Query: 565 GSQGMELTSQGAGTYWYLPPE----CFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-G 619
+T T WY PE ++T VD+WS G + +ML G+ F G
Sbjct: 180 ------MTGYVV-TRWYRAPEVILSWMHYNQT------VDIWSVGCIMAEMLTGKTLFKG 226
Query: 620 HDQTQ--ERILR------EDTIIK-----ARKV--EFPSR---------PAVSNEAKDLI 655
D +IL+ + + K A+ P P S +A DL+
Sbjct: 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 286
Query: 656 RRCLTYNQAERPDVLTLAQDPYL 678
+ L + +R P+
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFF 309
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 75/360 (20%), Positives = 120/360 (33%), Gaps = 97/360 (26%)
Query: 389 DEDGS-RFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKK 447
D+ GS + +RY +L ++GKG F +V KAYD H++VA K+ +
Sbjct: 82 DDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM--------VRNE 133
Query: 448 QSYIRHAIREYNIHKTLVH------HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA 501
+ + R A E I + L +++ + + F +N C E S +L ++K
Sbjct: 134 KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-TFRNHICMTFELLS-MNLYELIKK 191
Query: 502 TPV--LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA--KVTDFGLS 557
R I Q L L+K +IIH DLKP N+L + G + KV DFG S
Sbjct: 192 NKFQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
Query: 558 KIVEDDVGSQGMELTSQGAGTY----WYLPPE-CFELSKTPLISSKVDVWSAG------- 605
V TY +Y PE +D+WS G
Sbjct: 250 CYEHQRV------------YTYIQSRFYRAPEVILGAR----YGMPIDMWSLGCILAELL 293
Query: 606 ---ILF-----YQML------------------------FGRRPFGHDQTQERILREDTI 633
L L + + T + +
Sbjct: 294 TGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVV 353
Query: 634 IKARK-------VEFPSRPAVSNEAK-------DLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ + SR + D +++CL ++ A R + P+L
Sbjct: 354 LNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 65/324 (20%), Positives = 106/324 (32%), Gaps = 60/324 (18%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACK-LHGLNAQWSEDK---KQSYI 451
+ + Y + + G + V D E VA K + +
Sbjct: 16 ELHAMQS-PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 452 RHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT----VLEYCSGKDLDAVLKAT-PVLP 506
+ +RE + H +I+ L D F + V E DL V+ V+
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVIS 132
Query: 507 EREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS 566
+ + + I GL L+ ++H DL PGN+L + + DF L++ D
Sbjct: 133 PQHIQYFMYHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--- 187
Query: 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSK-----VDVWSAGILFYQMLFGRRPF--G 619
T WY PE ++ K VD+WSAG + +M R+ G
Sbjct: 188 --ANKTHYVT-HRWYRAPEL-------VMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRG 236
Query: 620 HDQTQ--ERILR------EDTII-----KARK---VEFPSRPAV---------SNEAKDL 654
+I+ + ++ AR + PA A DL
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296
Query: 655 IRRCLTYNQAERPDVLTLAQDPYL 678
I + L +N R + PY
Sbjct: 297 IAKMLEFNPQRRISTEQALRHPYF 320
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 74/315 (23%), Positives = 124/315 (39%), Gaps = 54/315 (17%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI 455
+++ Y L +G G + V A D VA K Q K++Y
Sbjct: 19 TAWEVRA-VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----- 72
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQ-----NTFCTVLEYCSGKDLDAVLKATPVLPEREA 510
RE + K + H +++ L D F D+ F V+ + G DL ++K L E
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK-LGEDRI 130
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
+ ++ Q+ +GL Y++ A IIH DLKPGN+ +E K+ DFGL++ + E
Sbjct: 131 QFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-------E 181
Query: 571 LTSQGAGTYWYLPPE-CFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQ--E 625
+T T WY PE + + VD+WS G + +M+ + G D +
Sbjct: 182 MTGYVV-TRWYRAPEVILNWMR---YTQTVDIWSVGCIMAEMI-TGKTLFKGSDHLDQLK 236
Query: 626 RILR------EDTIIK-----ARKV--EFPSR---------PAVSNEAKDLIRRCLTYNQ 663
I++ + + + A+ P S A +L+ + L +
Sbjct: 237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 296
Query: 664 AERPDVLTLAQDPYL 678
+R PY
Sbjct: 297 EQRVTAGEALAHPYF 311
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 28/235 (11%)
Query: 392 GSRFNNFQILNHRYALLNLLGKGGFSEVYKAY---DLVEHRYVACKLHGLNAQWSEDKKQ 448
GS +++I R L +G+G F +V++ VA K S+ ++
Sbjct: 4 GSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVRE 61
Query: 449 SYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPE 507
+++ E + H HIV+L I +N ++E C+ +L + L+ L
Sbjct: 62 KFLQ----EALTMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKYSLDL 115
Query: 508 REARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQ 567
+ Q+ L YL +++ +H D+ NVL K+ DFGLS+ +ED
Sbjct: 116 ASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---- 169
Query: 568 GMELTSQGAGTY---WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
G W PE + +S DVW G+ +++L G +PF
Sbjct: 170 --TYYKASKGKLPIKWM-APESINFRR---FTSASDVWMFGVCMWEILMHGVKPF 218
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 69/384 (17%), Positives = 117/384 (30%), Gaps = 125/384 (32%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
+ N RY ++ LG G FS V+ ++D+ ++VA K+ + + + Y A+ E
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKV--VKSA------EHYTETALDEI 84
Query: 459 NIHKTLV--------HHHIVRLWDTFEIDQNT---FCTVLEYCSGKDLDAVLKATP--VL 505
+ K++ +V+L D F+I C V E G L + + L
Sbjct: 85 RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGL 143
Query: 506 PEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---------------------- 543
P + II Q+ QGL YL+ + + IIH D+KP N+L
Sbjct: 144 PLPCVKKIIQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 544 ---------------------------DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
E K+ D G + V
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ------- 255
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQT-----------Q 624
T Y E S ++ D+WS + +++ G F H
Sbjct: 256 -TRQYRSLEVLIGSG---YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI 311
Query: 625 ERIL-------------------REDTIIKARKVEFPSRPAVSNE-----------AKDL 654
+L ++ + K++ V E D
Sbjct: 312 IELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDF 371
Query: 655 IRRCLTYNQAERPDVLTLAQDPYL 678
+ L +R + P+L
Sbjct: 372 LLPMLELIPEKRATAAECLRHPWL 395
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 71/353 (20%), Positives = 127/353 (35%), Gaps = 101/353 (28%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
+ + +Y+L LG G F V + +D+ + A K K R+ RE
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----------KVLQDPRYKNRE 50
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCT-------------------------------- 485
+I K L H +I++L D F +
Sbjct: 51 LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110
Query: 486 -----VLEYCSGKDLDAVLKATP----VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDL 536
++EY L VLK+ +P I I Q+F+ + ++ + I H D+
Sbjct: 111 KYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI--HSLGICHRDI 167
Query: 537 KPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLI 595
KP N+L + + K+ DFG +K + + + +Y PE L+
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKL-----IPSEPSVAYIC-SRFYRAPE--------LM 213
Query: 596 ------SSKVDVWSAGILFYQMLFGRRPF----GHDQTQERILR------EDTIIK---- 635
+ +D+WS G +F +++ G+ F DQ I++ ++ +I+
Sbjct: 214 LGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVR-IIQIMGTPTKEQMIRMNPH 272
Query: 636 ARKVEFPSRPAVS----------NEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+V FP+ A + A DL+ + L Y R + P+
Sbjct: 273 YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 407 LLNLLGKGGFSEVYKAY---DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
L +LG+G F EVY+ E VA K + D K+ ++ E I K
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMS----EAVIMKN 69
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLI 522
L H HIV+L I++ ++E +L L+ L + +QI + +
Sbjct: 70 LDHPHIVKLIGI--IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY--- 579
YL + +H D+ N+L K+ DFGLS+ +ED+ +
Sbjct: 128 YLE--SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTRLPIK 179
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W PE + ++ DVW + +++L FG++PF
Sbjct: 180 WM-SPESINFRR---FTTASDVWMFAVCMWEILSFGKQPF 215
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 74/284 (26%), Positives = 116/284 (40%), Gaps = 36/284 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L LG+G F EV+ R VA K E ++E + K L H
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA--------FLQEAQVMKKLRH 238
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYL 524
+V+L+ + + V EY S L LK L + + QI G+ Y+
Sbjct: 239 EKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WY 581
+ +H DL+ N+L E V KV DFGL++++ED+ E T++ + W
Sbjct: 297 ER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWT 348
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVE 640
PE + + K DVWS GIL ++ GR P+ +E + D + + ++
Sbjct: 349 -APEAALYGR---FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQVERGYRMP 401
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ--DPYLTYSK 682
P P DL+ +C ERP L + Y T ++
Sbjct: 402 CP--PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 84/368 (22%), Positives = 131/368 (35%), Gaps = 95/368 (25%)
Query: 394 RFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRH 453
+++QI + RY + +L+G G + V +AYD +E R VA K + D K
Sbjct: 45 PHSDWQIPD-RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK-----R 98
Query: 454 AIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT----VLEYCSGKDLDAVLKATPVLPERE 509
+RE I L H H+V++ D VLE D + + L E
Sbjct: 99 ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELH 157
Query: 510 ARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGM 569
+ ++ + G+ Y++ + I+H DLKP N L ++ KV DFGL++ V+
Sbjct: 158 IKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 570 ELTSQGAG----------------------TYWYLPPECFELSKTPLISSKVDVWSAGIL 607
S T WY PE L + + +DVWS G +
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN--YTEAIDVWSIGCI 273
Query: 608 FYQML----------FGRRPF-------------------------GHDQTQERILR--- 629
F ++L R P DQ I
Sbjct: 274 FAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQL-NVIFNILG 332
Query: 630 ---EDTII-----KARKV--EFPSR---------PAVSNEAKDLIRRCLTYNQAERPDVL 670
E+ I A++ FP R PA S +A L++R L +N +R +
Sbjct: 333 TPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITIN 392
Query: 671 TLAQDPYL 678
P+
Sbjct: 393 ECLAHPFF 400
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 407 LLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
++G G F EVYK + VA K L A ++E ++ ++ A I
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDFLGEA----GIMG 101
Query: 463 TLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQI 517
HH+I+RL + EY LD L+ + ++ I
Sbjct: 102 QFSHHNIIRL-----EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 156
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
G+ YL +H DL N+L + V KV+DFGLS+++EDD + T+ G
Sbjct: 157 AAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA---TYTTSGG- 210
Query: 578 TYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
+P PE K +S DVWS GI+ ++++ +G RP+
Sbjct: 211 ---KIPIRWTAPEAISYRK---FTSASDVWSFGIVMWEVMTYGERPY 251
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 68/271 (25%), Positives = 111/271 (40%), Gaps = 42/271 (15%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L LG G F EV+ A + VA K + E + E N+ KTL H
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEA--------FLAEANVMKTLQH 242
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYL 524
+V+L + + + E+ + L LK+ P + QI +G+ ++
Sbjct: 243 DKLVKLHAV--VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WY 581
+ + IH DL+ N+L V K+ DFGL++++ED+ E T++ + W
Sbjct: 301 EQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN------EYTAREGAKFPIKWT 352
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVE 640
PE + K DVWS GIL +++ +GR P+ + + I R +E
Sbjct: 353 -APEAINFGS---FTIKSDVWSFGILLMEIVTYGRIPY------PGMSNPEVI---RALE 399
Query: 641 ----FPSRPAVSNEAKDLIRRCLTYNQAERP 667
P E +++ RC ERP
Sbjct: 400 RGYRMPRPENCPEELYNIMMRCWKNRPEERP 430
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 72/353 (20%), Positives = 132/353 (37%), Gaps = 68/353 (19%)
Query: 374 ELEKGRLIREMKRIRDEDGSRFNNFQILNH------RYALLNLLGKGGFSEVYKAYDLVE 427
+++ + + + + ++F + ++ + RY L +G G V AYD V
Sbjct: 27 QVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL 86
Query: 428 HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ-----NT 482
R VA K Q K++Y RE + K + H +I+ L + F +
Sbjct: 87 DRNVAIKKLSRPFQNQTHAKRAY-----RELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141
Query: 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVL 542
V+E +L V++ L ++ Q+ G+ +L+ IIH DLKP N++
Sbjct: 142 VYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIV 196
Query: 543 FDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPE-CFELSKTPLISSKVDV 601
K+ DFGL++ +T T +Y PE + VD+
Sbjct: 197 VKSDCTLKILDFGLARTAGTS-----FMMTPYVV-TRYYRAPEVILGMGYKE----NVDI 246
Query: 602 WSAGILFYQMLFGRRPF-GHDQTQ--ERILR------EDTII----KARKV--EFPSRPA 646
WS G + +M+ + F G D +++ + + R P
Sbjct: 247 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 306
Query: 647 VS---------------------NEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
++ ++A+DL+ + L + A+R V Q PY+
Sbjct: 307 LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ ++G G EV V + VA K L A ++E +++ ++ E +I
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQRRDFLS----EASIMGQ 106
Query: 464 LVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIF 518
H +I+RL V EY LD L+ + ++ +
Sbjct: 107 FDHPNIIRL-----EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG- 577
G+ YL+ +H DL NVL D V KV+DFGLS+++EDD T+ G
Sbjct: 162 AGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD---PDAAYTTTGGKI 216
Query: 578 -TYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W PE SS DVWS G++ +++L +G RP+
Sbjct: 217 PIRWT-APEAIAFRT---FSSASDVWSFGVVMWEVLAYGERPY 255
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 411 LGKGGFSEVYKAYDLVEHRY--VA---CKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV 465
LG G F V K Y ++ VA K + ++ + E N+ + L
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE--------LLAEANVMQQLD 76
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLN 525
+ +IVR+ + ++ V+E L+ L+ + ++ ++ Q+ G+ YL
Sbjct: 77 NPYIVRMIGI--CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 526 KRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WYL 582
+ +H DL NVL AK++DFGLSK + D +Q G + WY
Sbjct: 135 E--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD----ENYYKAQTHGKWPVKWY- 187
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFG 619
PEC K SSK DVWS G+L ++ +G++P+
Sbjct: 188 APECINYYK---FSSKSDVWSFGVLMWEAFSYGQKPYR 222
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 63/296 (21%), Positives = 108/296 (36%), Gaps = 52/296 (17%)
Query: 407 LLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ +LG G F VYK VA K L S + + A +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEA----YVMA 72
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGL 521
++ + H+ RL +T + + L ++ + + VQI +G+
Sbjct: 73 SVDNPHVCRLLGI--CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT--- 578
YL R +++H DL NVL K+TDFGL+K++ + E G
Sbjct: 131 NYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYHAEGGKVP 182
Query: 579 -YWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKA 636
W E + + DVWS G+ ++++ FG +P+ E
Sbjct: 183 IKWM-ALESILHRI---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------- 229
Query: 637 RKVEFPSR----PAVSNEAKDLIRRCLTYNQAERP------DVLT-LAQDP--YLT 679
+E R P + + ++R+C + RP + +A+DP YL
Sbjct: 230 SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
N+LG+GGF +VYK L + VA K + E++ Q E + VH +
Sbjct: 36 NILGRGGFGKVYKGR-LADGTLVAVK------RLKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL----KATPVLPEREARI-IIVQIFQGLIY 523
++RL F + V Y + + + L ++ P L + R I + +GL Y
Sbjct: 89 LLRLRG-FCMTPTERLLVYPYMANGSVASCLRERPESQPPL-DWPKRQRIALGSARGLAY 146
Query: 524 LNKRAQ-KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
L+ KIIH D+K N+L DE A V DFGL+K+++ +T+ GT ++
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD----THVTTAVRGTIGHI 202
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618
P E T S K DV+ G++ +++ G+R F
Sbjct: 203 AP---EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 74/327 (22%), Positives = 124/327 (37%), Gaps = 67/327 (20%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI 455
+ F +L RY L +G G V AYD + R VA K Q K++Y
Sbjct: 19 STFTVLK-RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----- 72
Query: 456 REYNIHKTLVHHHIVRLWDTF--EIDQNTFCT---VLEYCSGKDLDAVLKATPVLPEREA 510
RE + K + H +I+ L + F + F V+E +L V++ L
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERM 129
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
++ Q+ G+ +L+ + IIH DLKP N++ K+ DFGL++
Sbjct: 130 SYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS------F 181
Query: 571 LTSQGAGTYWYLPPE---CFELSKTPLISSKVDVWSAGILFYQMLFGRRPF-GHDQTQ-- 624
+ + T +Y PE + VD+WS G + +M+ G F G D
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKEN------VDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235
Query: 625 ERILR------EDTIIK----ARKV--EFPSRPAVS---------------------NEA 651
+++ + + K R P S ++A
Sbjct: 236 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 295
Query: 652 KDLIRRCLTYNQAERPDVLTLAQDPYL 678
+DL+ + L + ++R V Q PY+
Sbjct: 296 RDLLSKMLVIDASKRISVDEALQHPYI 322
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 29/218 (13%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L+ LG G F EV+ Y H VA K + + + E N+ K L H
Sbjct: 17 LVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDA--------FLAEANLMKQLQH 67
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYL 524
+VRL+ + Q + EY L LK L + + QI +G+ ++
Sbjct: 68 QRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WY 581
+ + IH DL+ N+L + K+ DFGL++++ED+ E T++ + W
Sbjct: 126 EE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN------EYTAREGAKFPIKWT 177
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
PE + K DVWS GIL +++ GR P+
Sbjct: 178 -APEAINYGT---FTIKSDVWSFGILLTEIVTHGRIPY 211
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 35/221 (15%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L LG G F V VA K+ + ++ I E + L H
Sbjct: 28 FLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE--------FIEEAKVMMNLSH 78
Query: 467 HHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGL 521
+V+L Q + EY + L L+ ++ + + + +
Sbjct: 79 EKLVQL-----YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY-- 579
YL ++ +H DL N L ++ GV KV+DFGLS+ V DD E TS +
Sbjct: 134 EYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD------EYTSSVGSKFPV 185
Query: 580 -WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W PPE SK SSK D+W+ G+L +++ G+ P+
Sbjct: 186 RWS-PPEVLMYSK---FSSKSDIWAFGVLMWEIYSLGKMPY 222
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 61/271 (22%), Positives = 111/271 (40%), Gaps = 40/271 (14%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHA--IREYNIHKTL 464
+ + LG G + EVY+ VA K K+ + ++E + K +
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----------KEDTMEVEEFLKEAAVMKEI 273
Query: 465 VHHHIVRLWDTFEI--DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQG 520
H ++V+L + + F + E+ + +L L+ + + QI
Sbjct: 274 KHPNLVQL---LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY- 579
+ YL K + IH +L N L E + KV DFGLS+++ D T+ +
Sbjct: 331 MEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFP 382
Query: 580 --WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKA 636
W PE +K S K DVW+ G+L +++ +G P+ + + + K
Sbjct: 383 IKWT-APESLAYNK---FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELLEKD 435
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
++E P + +L+R C +N ++RP
Sbjct: 436 YRMERP--EGCPEKVYELMRACWQWNPSDRP 464
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 74/284 (26%), Positives = 116/284 (40%), Gaps = 36/284 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L LG+G F EV+ R VA K E ++E + K L H
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA--------FLQEAQVMKKLRH 321
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYL 524
+V+L+ + + V EY S L LK L + + QI G+ Y+
Sbjct: 322 EKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WY 581
+ +H DL+ N+L E V KV DFGL++++ED+ E T++ + W
Sbjct: 380 ER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWT 431
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVE 640
PE + + K DVWS GIL ++ GR P+ +E + D + + ++
Sbjct: 432 -APEAALYGR---FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQVERGYRMP 484
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ--DPYLTYSK 682
P P DL+ +C ERP L + Y T ++
Sbjct: 485 CP--PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-23
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
+ +G G F V+ Y + VA K A ED I E + L H
Sbjct: 12 FVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEED--------FIEEAEVMMKLSH 62
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLN 525
+V+L+ ++Q C V E+ L L+ + + + + +G+ YL
Sbjct: 63 PKLVQLYGVC-LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 526 KRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WYL 582
+ +IH DL N L E V KV+DFG+++ V DD + TS + W
Sbjct: 122 E--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD------QYTSSTGTKFPVKWA- 172
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
PE F S+ SSK DVWS G+L +++ G+ P+
Sbjct: 173 SPEVFSFSR---YSSKSDVWSFGVLMWEVFSEGKIPY 206
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 72/287 (25%), Positives = 113/287 (39%), Gaps = 34/287 (11%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI 455
NNF N +G+GGF VYK Y V + VA K L A ++ +
Sbjct: 25 NNFDE-RPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKK--LAAMVDITTEELK-QQFD 78
Query: 456 REYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL---KATPVLPEREARI 512
+E + H ++V L F D + C V Y L L TP L R
Sbjct: 79 QEIKVMAKCQHENLVELLG-FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS-WHMRC 136
Query: 513 -IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMEL 571
I G+ +L++ IH D+K N+L DE AK++DFGL++ E +
Sbjct: 137 KIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKF---AQTVM 191
Query: 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE------ 625
TS+ GT Y+ PE I+ K D++S G++ +++ G + +
Sbjct: 192 TSRIVGTTAYMAPEAL----RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 626 -RILRE----DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
I E + I + + S + +CL + +RP
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSV--EAMYSVASQCLHEKKNKRP 292
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 63/310 (20%), Positives = 115/310 (37%), Gaps = 32/310 (10%)
Query: 319 QRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLASIKREEEAILRERERYELEKG 378
+R+ G+ V G D + E + L E + ++
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69
Query: 379 RLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAY---DLVEHRYVACKL 435
L E+ + ++ + ++G+G F VY + + + A K
Sbjct: 70 ALNPELVQAVQHVVIGPSSLIV-----HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124
Query: 436 HGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL 495
LN + ++ E I K H +++ L + + VL Y DL
Sbjct: 125 --LNRITDIGEVSQFLT----EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 496 DAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554
++ T ++ +Q+ +G+ +L ++K +H DL N + DE KV DF
Sbjct: 179 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADF 236
Query: 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFY 609
GL++ + D E S T LP E + K ++K DVWS G+L +
Sbjct: 237 GLARDMYDK------EFDSVHNKTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLW 287
Query: 610 QML-FGRRPF 618
+++ G P+
Sbjct: 288 ELMTRGAPPY 297
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 55/221 (24%), Positives = 84/221 (38%), Gaps = 35/221 (15%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
LL LG G F V VA K+ + + + +E L H
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKM--IKEGSMSEDE------FFQEAQTMMKLSH 62
Query: 467 HHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGL 521
+V+ + V EY S L L++ L + + + +G+
Sbjct: 63 PKLVKF-----YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY-- 579
+L + IH DL N L D KV+DFG+++ V DD + S +
Sbjct: 118 AFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD------QYVSSVGTKFPV 169
Query: 580 -WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W PE F K SSK DVW+ GIL +++ G+ P+
Sbjct: 170 KWS-APEVFHYFK---YSSKSDVWAFGILMWEVFSLGKMPY 206
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
+ + LG G + EVY+ VA K + E+ ++E + K + H
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLKEAAVMKEIKH 68
Query: 467 HHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQG 520
++V+L + + F + E+ + +L L+ + + QI
Sbjct: 69 PNLVQL-----LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY- 579
+ YL K + IH DL N L E + KV DFGLS+++ D T+ +
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFP 175
Query: 580 --WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W PE +K S K DVW+ G+L +++ +G P+
Sbjct: 176 IKW-TAPESLAYNK---FSIKSDVWAFGVLLWEIATYGMSPY 213
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-22
Identities = 80/381 (20%), Positives = 128/381 (33%), Gaps = 102/381 (26%)
Query: 384 MKRIRDEDGSRFNNFQILNH------RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHG 437
M R N + Y + +L+G+G + VY AYD + VA K
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--- 57
Query: 438 LNAQWSEDK------KQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCT----VL 487
K + +RE I L +I+RL+D D VL
Sbjct: 58 --------KVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547
E DL + K L E + I+ + G +++ IIH DLKP N L ++
Sbjct: 110 EIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDC 166
Query: 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAG-----------------TYWYLPPECFELS 590
KV DFGL++ + + + + + T WY PE L
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 591 KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL---------------------- 628
+ + +D+WS G +F ++L + +D T L
Sbjct: 227 EN--YTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKS 284
Query: 629 ---------------REDTII-----KARKV--EFPSR---------PAVSNEAKDLIRR 657
ED + + K FP R P++S++ +L+
Sbjct: 285 NRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344
Query: 658 CLTYNQAERPDVLTLAQDPYL 678
L +N +R + PYL
Sbjct: 345 MLKFNPNKRITIDQALDHPYL 365
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 78/365 (21%), Positives = 121/365 (33%), Gaps = 100/365 (27%)
Query: 389 DEDGS-RFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKK 447
D++ N + RY + +L+GKG F +V KAYD VE +VA K+ K
Sbjct: 39 DDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKI--------IKNK 90
Query: 448 QSYIRHAIREYNIHKTLVH------HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA 501
++++ A E + + + ++IV L F +N C V E S +L +L+
Sbjct: 91 KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-RNHLCLVFEMLS-YNLYDLLRN 148
Query: 502 TPV--LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA--KVTDFGLS 557
T + R Q+ L++L IIH DLKP N+L + K+ DFG S
Sbjct: 149 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
Query: 558 KIVEDDVGSQGMELTSQGAGTY----WYLPPE-CFELSKTPLISSKVDVWSAG------- 605
+ + Y +Y PE + +D+WS G
Sbjct: 209 CQLGQRIY------------QYIQSRFYRSPEVLLGMP----YDLAIDMWSLGCILVEMH 252
Query: 606 ---ILF-----YQML------FGRRP-------------FGHDQTQERILREDTIIKARK 638
LF + G P F L++ K
Sbjct: 253 TGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREY 312
Query: 639 VEFPSRP--------------AVSNEA----------KDLIRRCLTYNQAERPDVLTLAQ 674
+R + E+ KDLI R L Y+ R Q
Sbjct: 313 KPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ 372
Query: 675 DPYLT 679
+
Sbjct: 373 HSFFK 377
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 27/222 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
++GKG F VY + + + A K L+ + ++++R E + +
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS--LSRITEMQQVEAFLR----EGLLMRG 78
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLI 522
L H +++ L + +L Y DL +++ ++ +Q+ +G+
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL QK +H DL N + DE KV DFGL++ + D E S + L
Sbjct: 139 YLA--EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR------EYYSVQQHRHARL 190
Query: 583 P-----PECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
P E + + ++K DVWS G+L +++L G P+
Sbjct: 191 PVKWTALESLQTYR---FTTKSDVWSFGVLLWELLTRGAPPY 229
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 74/353 (20%), Positives = 125/353 (35%), Gaps = 95/353 (26%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK------KQSY 450
+ +L +Y L+ LGKG + V+K+ D VA K K +
Sbjct: 4 DRHVLR-KYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----------KIFDAFQNSTD 51
Query: 451 IRHAIREYNIHKTLVHH-HIVRLWDTFEIDQ-NTFCTVLEYCSGKDLDAVLKATPVLPER 508
+ RE I L H +IV L + D V +Y DL AV++A L
Sbjct: 52 AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI-LEPV 109
Query: 509 EARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568
+ ++ Q+ + + YL+ + ++H D+KP N+L + KV DFGLS+ +
Sbjct: 110 HKQYVVYQLIKVIKYLH--SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 569 MELTSQGAG----------------TYWYLPPECFELSKTPLISSK-----VDVWSAGIL 607
S T WY PE L+ S +D+WS G +
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEI-------LLGSTKYTKGIDMWSLGCI 220
Query: 608 FYQMLFGRRPF--GHDQTQ--ERILR------EDTII-----KARKV--EFPSRPAV--- 647
++L +P G ERI+ + + A+ + + +
Sbjct: 221 LGEIL-CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQS 279
Query: 648 ----------------------SNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ EA DL+ + L +N +R + P++
Sbjct: 280 NKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 25/216 (11%)
Query: 411 LGKGGFSEVYKAY--DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
LG G F V + + VA K+ L + + +R E I L + +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMR----EAQIMHQLDNPY 71
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKR 527
IVRL V+E G L L +P ++ Q+ G+ YL +
Sbjct: 72 IVRLIGV--CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE- 128
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WYLPP 584
+ +H DL NVL AK++DFGLSK + D T++ AG + WY P
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD----DSYYTARSAGKWPLKWY-AP 182
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFG 619
EC K SS+ DVWS G+ ++ L +G++P+
Sbjct: 183 ECINFRK---FSSRSDVWSYGVTMWEALSYGQKPYK 215
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 27/222 (12%)
Query: 407 LLNLLGKGGFSEVYKAY---DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
++G+G F VY + + + A K LN + ++ E I K
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLT----EGIIMKD 82
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLI 522
H +++ L + + VL Y DL ++ T ++ +Q+ +G+
Sbjct: 83 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL ++K +H DL N + DE KV DFGL++ + D E S T L
Sbjct: 143 YLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK------EYYSVHNKTGAKL 194
Query: 583 P-----PECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
P E + K ++K DVWS G+L ++++ G P+
Sbjct: 195 PVKWMALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPPY 233
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 31/223 (13%)
Query: 407 LLNLLGKGGFSEVYKAY---DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ ++G G F EV + VA K L ++E +++ ++ A +I
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEA----SIMGQ 102
Query: 464 LVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIF 518
H +I+RL V EY LD+ L+ + ++ I
Sbjct: 103 FDHPNIIRL-----EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG- 577
G+ YL+ +H DL N+L + V KV+DFGL +++EDD + T++G
Sbjct: 158 SGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA---AYTTRGGKI 212
Query: 578 -TYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W PE K +S DVWS GI+ ++++ +G RP+
Sbjct: 213 PIRWT-SPEAIAYRK---FTSASDVWSYGIVLWEVMSYGERPY 251
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 60/220 (27%), Positives = 88/220 (40%), Gaps = 26/220 (11%)
Query: 407 LLNLLGKGGFSEVYKA-YDLV---EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ LG+G F +V YD VA K L A + + + E +I +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQ----EIDILR 88
Query: 463 TLVHHHIVRLWDT-FEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
TL H HI++ + + V+EY L L + + + QI +G+
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGM 147
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY-- 579
YL+ AQ IH DL NVL D + K+ DFGL+K V + + G
Sbjct: 148 AYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE----YYRVREDGDSPV 201
Query: 580 -WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRP 617
WY PEC + K DVWS G+ Y++L
Sbjct: 202 FWY-APECLKEYK---FYYASDVWSFGVTLYELLTHCDSS 237
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 28/233 (12%)
Query: 407 LLNLLGKGGFSEVYKA-YDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ LG+G F +V YD VA K L + + + E I +
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKK----EIEILR 78
Query: 463 TLVHHHIVRLWD--TFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQ 519
L H +IV+ T + ++E+ L L + ++ VQI +
Sbjct: 79 NLYHENIVKYKGICTEDGGNG-IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
G+ YL +++ +H DL NVL + K+ DFGL+K +E D T +
Sbjct: 138 GMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE----YYTVKDDRDS 191
Query: 580 ---WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERIL 628
WY PEC SK DVWS G+ +++L + +++
Sbjct: 192 PVFWY-APECLMQSK---FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 54/274 (19%), Positives = 95/274 (34%), Gaps = 38/274 (13%)
Query: 407 LLNLLGKGGFSEVYKAY---DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
LL LG G F V + + VA K + + +IR N +
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV----NAMHS 77
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLI 522
L H +++RL+ + V E L L+ VQ+ +G+
Sbjct: 78 LDHRNLIRLYGV--VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY--- 579
YL + + IH DL N+L + K+ DFGL + + + Q
Sbjct: 136 YLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD----HYVMQEHRKVPFA 189
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARK 638
W PE + S D W G+ ++M +G+ P+ + + K
Sbjct: 190 WC-APESLKTRT---FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---------HK 236
Query: 639 VEFP----SRPAV-SNEAKDLIRRCLTYNQAERP 667
++ RP + +++ +C + +RP
Sbjct: 237 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 270
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-21
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 28/220 (12%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
L +G+G F +V++ + VA K S+ ++ +++ E +
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNCTSDSVREKFLQ----EALTMRQ 447
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLI 522
H HIV+L I +N ++E C+ +L + L+ L + Q+ L
Sbjct: 448 FDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY--- 579
YL +++ +H D+ NVL K+ DFGLS+ +ED G
Sbjct: 506 YLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIK 557
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W PE + +S DVW G+ +++L G +PF
Sbjct: 558 WM-APESINFRR---FTSASDVWMFGVCMWEILMHGVKPF 593
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 5e-21
Identities = 74/275 (26%), Positives = 112/275 (40%), Gaps = 38/275 (13%)
Query: 411 LGKGGFSEVYKAY--DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
LG G F V + + VA K+ L + + +R E I L + +
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMR----EAQIMHQLDNPY 397
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKR 527
IVRL V+E G L L +P ++ Q+ G+ YL +
Sbjct: 398 IVRLIGV--CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE- 454
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY---WYLPP 584
+ +H +L NVL AK++DFGLSK + D T++ AG + WY P
Sbjct: 455 -KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD----DSYYTARSAGKWPLKWY-AP 508
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVEFPS 643
EC K SS+ DVWS G+ ++ L +G++P+ + E + +E
Sbjct: 509 ECINFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---------AFIEQGK 556
Query: 644 R----PAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
R P E L+ C Y +RPD LT+ Q
Sbjct: 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 57/271 (21%), Positives = 101/271 (37%), Gaps = 35/271 (12%)
Query: 407 LLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
+ +LG G F VYK VA K L S + + A +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEA----YVMA 72
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGL 521
++ + H+ RL +T + + L ++ + + VQI +G+
Sbjct: 73 SVDNPHVCRLLGI--CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT--- 578
YL R +++H DL NVL K+TDFGL+K++ + E G
Sbjct: 131 NYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYHAEGGKVP 182
Query: 579 -YWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKA 636
W E + + DVWS G+ ++++ FG +P+ E + K
Sbjct: 183 IKWM-ALESILHRI---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKG 235
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
++ P P + + ++ +C + RP
Sbjct: 236 ERLPQP--PICTIDVYMIMVKCWMIDADSRP 264
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 26/220 (11%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L +LG G F V+K + E V K+ + + Q+ H
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHM----LAIG 70
Query: 463 TLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGL 521
+L H HIVRL ++ V +Y L ++ L + VQI +G+
Sbjct: 71 SLDHAHIVRLLGL--CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT--Y 579
YL + ++H +L NVL +V DFG++ ++ D +L A T
Sbjct: 129 YYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD----DKQLLYSEAKTPIK 182
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W E K + + DVWS G+ ++++ FG P+
Sbjct: 183 WM-ALESIHFGK---YTHQSDVWSYGVTVWELMTFGAEPY 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 48/236 (20%), Positives = 83/236 (35%), Gaps = 47/236 (19%)
Query: 407 LLNLLGKGGFSEVYKAY---DLVEHRYVACK-LHGLNAQWSEDKKQSYIRHAIREYNIHK 462
L +LG+G F V + + VA K + N+ S+ + + ++ E K
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLS----EAACMK 91
Query: 463 TLVHHHIVRL----WDTFEIDQNTFCTVLEYCSGKDLDAVLKA------TPVLPEREARI 512
H +++RL + +L + DL L +P +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD----VGSQG 568
+V I G+ YL+ + +H DL N + + V DFGLSK + G
Sbjct: 152 FMVDIALGMEYLS--NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 569 MELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
+P E +SK DVW+ G+ +++ G P+
Sbjct: 210 K------------MPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 73/364 (20%), Positives = 127/364 (34%), Gaps = 92/364 (25%)
Query: 376 EKGRLIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAY--DLVEHRYVAC 433
K +L E +R+ D F+ + +G+G + VYKA D + + A
Sbjct: 7 FKVKLSSERERVEDL-------FEYEGCK------VGRGTYGHVYKAKRKDGKDDKDYAL 53
Query: 434 KLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT-FCTVLEYCSG 492
K + + A RE + + L H +++ L F + + +Y
Sbjct: 54 K---------QIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103
Query: 493 KDLDAVLKATP---------VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVL- 542
DL ++K LP + ++ QI G+ YL+ ++H DLKP N+L
Sbjct: 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILV 161
Query: 543 ---FDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG--TYWYLPPECFELSKTPLISS 597
E G K+ D G +++ + L T+WY PE L +
Sbjct: 162 MGEGPERGRVKIADMGFARLFNSPLKP----LADLDPVVVTFWYRAPEL--LLGARHYTK 215
Query: 598 KVDVWSAGILFYQMLFGR-------------RPFGHDQTQERILR------EDT------ 632
+D+W+ G +F ++L P+ HDQ +RI +
Sbjct: 216 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL-DRIFNVMGFPADKDWEDIKK 274
Query: 633 -----------------IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
K + ++A L+++ LT + +R QD
Sbjct: 275 MPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334
Query: 676 PYLT 679
PY
Sbjct: 335 PYFL 338
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 60/222 (27%), Positives = 86/222 (38%), Gaps = 41/222 (18%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHA-IREYNIHKTLV 465
LL +GKG F +V VA K K A + E ++ L
Sbjct: 25 LLQTIGKGEFGDVMLGD--YRGNKVAVKCI----------KNDATAQAFLAEASVMTQLR 72
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIY 523
H ++V+L ++ V EY + L L++ VL + + + + Y
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK-IVEDDVGSQGMELTSQGAGTYWYL 582
L +H DL NVL E VAKV+DFGL+K + L
Sbjct: 133 LEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--------------L 176
Query: 583 P-----PECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
P PE K S+K DVWS GIL +++ FGR P+
Sbjct: 177 PVKWTAPEALREKK---FSTKSDVWSFGILLWEIYSFGRVPY 215
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 36/280 (12%)
Query: 407 LLNLLGKGGFSEVYKA-YDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIHK 462
++ LGKG F V YD + VA K L D+++ + R I K
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHS-GPDQQRDFQREI----QILK 79
Query: 463 TLVHHHIVRLWDT-FEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQG 520
L IV+ + + + V+EY L L+ L + QI +G
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY- 579
+ YL +++ +H DL N+L + K+ DFGL+K++ D + G
Sbjct: 140 MEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD----YYVVREPGQSP 193
Query: 580 --WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF-GHDQTQERILREDTIIK 635
WY PE + S + DVWS G++ Y++ + + + + E +
Sbjct: 194 IFWY-APESLSDNI---FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249
Query: 636 ARKV-EF-------PSRPAVSNEAKDLIRRCLTYNQAERP 667
++ E P+ PA E +L++ C + +RP
Sbjct: 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 69/305 (22%), Positives = 114/305 (37%), Gaps = 51/305 (16%)
Query: 387 IRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAY---DLVEHRYVACKLHGLNAQWS 443
I DE + + I ++ L +LGKG F V +A + VA K+ L A
Sbjct: 7 ISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADII 64
Query: 444 EDKKQSYIRHAIREYNIHKTLVHHHIVRLW-----DTFEIDQNTFCTVLEYCSGKDLDAV 498
I +RE K H H+ +L + +L + DL A
Sbjct: 65 ASSD---IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
Query: 499 LKAT------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552
L A+ LP + +V I G+ YL+ ++ IH DL N + E V
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNCMLAEDMTVCVA 179
Query: 553 DFGLSKIVEDD----VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWS 603
DFGLS+ + G LP E + + DVW+
Sbjct: 180 DFGLSRKIYSGDYYRQGCASK------------LPVKWLALESLADNL---YTVHSDVWA 224
Query: 604 AGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYN 662
G+ ++++ G+ P+ + E + +I +++ P P E DL+ +C + +
Sbjct: 225 FGVTMWEIMTRGQTPYAGIENAEIY---NYLIGGNRLKQP--PECMEEVYDLMYQCWSAD 279
Query: 663 QAERP 667
+RP
Sbjct: 280 PKQRP 284
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 58/234 (24%), Positives = 90/234 (38%), Gaps = 31/234 (13%)
Query: 407 LLNLLGKGGFSEVYKA-YDLVEHRY---VACKL--HGLNAQWSEDKKQSYIRHAIREYNI 460
L LGKG F V YD ++ VA K H + RE I
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEI 64
Query: 461 HKTLVHHHIVRLWDT-FEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIF 518
K+L H +IV+ + + ++EY L L+ + + QI
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
+G+ YL + + IH DL N+L + K+ DFGL+K++ D + G
Sbjct: 125 KGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE----FFKVKEPGE 178
Query: 579 Y---WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERIL 628
WY PE SK S DVWS G++ Y++ + + R++
Sbjct: 179 SPIFWY-APESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 64/362 (17%), Positives = 108/362 (29%), Gaps = 94/362 (25%)
Query: 389 DEDGS-RFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKK 447
DE + +LN+ + ++ +G G F V + +Y A K+
Sbjct: 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKV--------VRNI 71
Query: 448 QSYIRHAIREYNIHKTLVH-----HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT 502
+ Y R A E +I K + + ++IV+ F + C + E G L ++
Sbjct: 72 KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-YDHMCLIFEPL-GPSLYEIITRN 129
Query: 503 PV--LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560
+ ++ ++I + L YL K + H DLKP N+L D+ K
Sbjct: 130 NYNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187
Query: 561 ED---------------DVGSQGMELTSQGAGTY----WYLPPECFELSKTPLI-----S 596
D G + S G+ Y PE +I
Sbjct: 188 GKKIQIYRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPE--------VILNLGWD 237
Query: 597 SKVDVWSAG----------ILF-----YQML------FGRRP---------------FGH 620
D+WS G +LF + L P
Sbjct: 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297
Query: 621 DQTQERILREDTIIKARKVEFPSRPAVS----NEAKDLIRRCLTYNQAERPDVLTLAQDP 676
D+ + + I + K P D + L + RP L +
Sbjct: 298 DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357
Query: 677 YL 678
+L
Sbjct: 358 FL 359
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 58/234 (24%), Positives = 89/234 (38%), Gaps = 31/234 (13%)
Query: 407 LLNLLGKGGFSEVYKA-YDLV---EHRYVACKL--HGLNAQWSEDKKQSYIRHAIREYNI 460
L LGKG F V YD + VA K H + RE I
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEI 95
Query: 461 HKTLVHHHIVRLWDT-FEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIF 518
K+L H +IV+ + + ++EY L L+ + + QI
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGT 578
+G+ YL ++ IH DL N+L + K+ DFGL+K++ D + G
Sbjct: 156 KGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD----KEYYKVKEPGE 209
Query: 579 Y---WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERIL 628
WY PE SK S DVWS G++ Y++ + + R++
Sbjct: 210 SPIFWY-APESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 21/223 (9%)
Query: 409 NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
L+G G F +VYK L + VA K + + + Q E H H
Sbjct: 45 FLIGHGVFGKVYKGV-LRDGAKVALK------RRTPESSQGI-EEFETEIETLSFCRHPH 96
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL--KATPVLP-EREARI-IIVQIFQGLIYL 524
+V L F ++N + +Y +L L P + E R+ I + +GL YL
Sbjct: 97 LVSLIG-FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ RA IIH D+K N+L DE V K+TDFG+SK + + L++ GT Y+ P
Sbjct: 156 HTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH---LSTVVKGTLGYIDP 210
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627
E F ++ K DV+S G++ +++L R +E +
Sbjct: 211 EYF---IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 72/359 (20%), Positives = 113/359 (31%), Gaps = 92/359 (25%)
Query: 389 DEDGS-RFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVE-HRYVACKLHGLNAQWSEDK 446
D++G L RY ++ LG+G F +V + D VA K+
Sbjct: 4 DKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKI--------IRN 55
Query: 447 KQSYIRHAIREYNIHKTLVH------HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK 500
Y A E N+ K + V + D F C E GK+ LK
Sbjct: 56 VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-FHGHMCIAFE-LLGKNTFEFLK 113
Query: 501 ATPV--LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558
P R + Q+ L +L++ ++ H DLKP N+LF + + S
Sbjct: 114 ENNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSC 171
Query: 559 IVED---------DVGSQGMELTSQGAGTY----WYLPPECFELSKTPLI-----SSKVD 600
+ D GS + + T Y PPE +I + D
Sbjct: 172 EEKSVKNTSIRVADFGSATFD--HEHHTTIVATRHYRPPE--------VILELGWAQPCD 221
Query: 601 VWSAG----------ILF-----YQMLF-------------------------GRRPFGH 620
VWS G LF + L G +
Sbjct: 222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE 281
Query: 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ + R ++E+ K K + DL+RR L ++ A+R + P+
Sbjct: 282 NSSDGRYVKENC--KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 45/239 (18%), Positives = 79/239 (33%), Gaps = 58/239 (24%)
Query: 407 LLNLLGKGGFSEVYKA-------YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
LG+G F++++K Y + V K+ L+ + +S+ A +
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV--LDKA-HRNYSESFFEAA----S 64
Query: 460 IHKTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIII 514
+ L H H+V + V E+ LD LK + +
Sbjct: 65 MMSKLSHKHLVLN-----YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVL--------FDEFGVAKVTDFGLSKIVEDDVGS 566
Q+ + +L +IH ++ N+L K++D G+S V
Sbjct: 120 KQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--- 174
Query: 567 QGMELTSQGAGTY------WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPF 618
W PPEC E K ++ D WS G +++ G +P
Sbjct: 175 -----------DILQERIPWV-PPECIENPKN--LNLATDKWSFGTTLWEICSGGDKPL 219
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 60/241 (24%), Positives = 86/241 (35%), Gaps = 57/241 (23%)
Query: 407 LLNLLGKGGFSEVYK--AYDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
L+ LG G F EVY+ + VA K L SE + ++ E I
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLM----EALII 87
Query: 462 KTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKAT-------PVLPEREA 510
H +IVR I ++E +G DL + L+ T L +
Sbjct: 88 SKFNHQNIVRC-----IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG---VAKVTDFGLSKIVEDD---- 563
+ I G YL IH D+ N L G VAK+ DFG+++ +
Sbjct: 143 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 564 VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQML-FGRRP 617
G M LP PE F +SK D WS G+L +++ G P
Sbjct: 201 KGGCAM------------LPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 245
Query: 618 F 618
+
Sbjct: 246 Y 246
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 71/269 (26%), Positives = 106/269 (39%), Gaps = 42/269 (15%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHA-IREYNIHKTLV 465
LL +GKG F +V VA K K A + E ++ L
Sbjct: 197 LLQTIGKGEFGDVMLGD--YRGNKVAVKCI----------KNDATAQAFLAEASVMTQLR 244
Query: 466 HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIY 523
H ++V+L ++ V EY + L L++ VL + + + + Y
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L +H DL NVL E VAKV+DFGL+K E +L + W
Sbjct: 305 LEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVK-----WT-A 354
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVE-- 640
PE K S+K DVWS GIL +++ FGR P+ RI +D + +VE
Sbjct: 355 PEALREKK---FSTKSDVWSFGILLWEIYSFGRVPY------PRIPLKDVV---PRVEKG 402
Query: 641 --FPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ D+++ C + A RP
Sbjct: 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRP 431
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 52/241 (21%), Positives = 96/241 (39%), Gaps = 57/241 (23%)
Query: 407 LLNLLGKGGFSEVYK--AYDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
+ LG+G F VY+ A +V+ VA K +N S ++ ++ E ++
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT--VNEAASMRERIEFLN----EASVM 82
Query: 462 KTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA----------TPVLPE 507
K HH+VRL + ++E + DL + L++
Sbjct: 83 KEFNCHHVVRL-----LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 508 REARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD---- 563
+ + +I G+ YLN A K +H DL N + E K+ DFG+++ + +
Sbjct: 138 SKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 564 VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQML-FGRRP 617
G +G+ LP PE + ++ DVWS G++ +++ +P
Sbjct: 196 KGGKGL------------LPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIATLAEQP 240
Query: 618 F 618
+
Sbjct: 241 Y 241
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 61/241 (25%), Positives = 85/241 (35%), Gaps = 57/241 (23%)
Query: 407 LLNLLGKGGFSEVYK--AYDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
L+ LG G F EVY+ + VA K L SE + ++ E I
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLM----EALII 128
Query: 462 KTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA-------TPVLPEREA 510
H +IVR I +LE +G DL + L+ L +
Sbjct: 129 SKFNHQNIVRC-----IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG---VAKVTDFGLSK-IVEDD--- 563
+ I G YL IH D+ N L G VAK+ DFG+++ I
Sbjct: 184 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 564 VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQML-FGRRP 617
G M LP PE F +SK D WS G+L +++ G P
Sbjct: 242 KGGCAM------------LPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 618 F 618
+
Sbjct: 287 Y 287
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 73/349 (20%), Positives = 117/349 (33%), Gaps = 87/349 (24%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDL-VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
+L+ RY +++ LG+G F +V + D R+VA K+ Y A E
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKI--------VKNVDRYCEAARSEI 62
Query: 459 NIHKTLVH------HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV--LPEREA 510
+ + L V++ + FE C V E G +K
Sbjct: 63 QVLEHLNTTDPNSTFRCVQMLEWFE-HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHI 120
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED-------- 562
R + QI + + +L+ K+ H DLKP N+LF + + + + +
Sbjct: 121 RKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 563 -DVGSQGMELTSQGAGTY----WYLPPECFELSKTPLI-----SSKVDVWSAGILFYQML 612
D GS + + T Y PE +I S DVWS G + +
Sbjct: 179 VDFGSATYD--DEHHSTLVSTRHYRAPE--------VILALGWSQPCDVWSIGCILIEYY 228
Query: 613 FGRRPF-GHDQTQ-----ERIL-----------------------REDTIIKARKVEFPS 643
G F HD + ERIL ++ R V
Sbjct: 229 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC 288
Query: 644 RP---------AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
+P DLI++ L Y+ A+R + + P+ KK
Sbjct: 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 49/247 (19%), Positives = 86/247 (34%), Gaps = 63/247 (25%)
Query: 407 LLNLLGKGGFSEVYK--AYDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
+ LG+ F +VYK + VA K L + ++ + E +
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRH----EAMLR 66
Query: 462 KTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARI----- 512
L H ++V L + + YCS DL L + +
Sbjct: 67 ARLQHPNVVCL-----LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 513 -----------IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561
++ QI G+ YL+ + ++H DL NVL + K++D GL + V
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 562 DD----VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQML 612
+ + LP PE K S D+WS G++ +++
Sbjct: 180 AADYYKLLGNSL------------LPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVF 224
Query: 613 -FGRRPF 618
+G +P+
Sbjct: 225 SYGLQPY 231
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-18
Identities = 59/247 (23%), Positives = 95/247 (38%), Gaps = 64/247 (25%)
Query: 407 LLNLLGKGGFSEVYKAY-----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
L LG+G F +V+ A + VA K L + ++ + R E +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA--LKDP-TLAARKDFQR----EAELL 71
Query: 462 KTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA---------TPVLPER 508
L H HIV+ D + V EY DL+ L+A +
Sbjct: 72 TNLQHEHIVKF-----YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 509 EARI-------IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561
+ + I QI G++YL +Q +H DL N L + K+ DFG+S+ V
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 562 DD----VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQML 612
VG M LP PE K +++ DVWS G++ +++
Sbjct: 185 STDYYRVGGHTM------------LPIRWMPPESIMYRK---FTTESDVWSFGVILWEIF 229
Query: 613 -FGRRPF 618
+G++P+
Sbjct: 230 TYGKQPW 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 61/246 (24%), Positives = 98/246 (39%), Gaps = 63/246 (25%)
Query: 407 LLNLLGKGGFSEVYK--AYDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
L LG+G F +V+ ++L+ + VA K L SE +Q + R E +
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEA-SESARQDFQR----EAELL 97
Query: 462 KTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA---------------T 502
L H HIVR + V EY DL+ L++
Sbjct: 98 TMLQHQHIVRF-----FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 503 PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK-IVE 561
L + + Q+ G++YL +H DL N L + V K+ DFG+S+ I
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 562 DD---VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQML- 612
D VG + M LP PE K +++ DVWS G++ +++
Sbjct: 211 TDYYRVGGRTM------------LPIRWMPPESILYRK---FTTESDVWSFGVVLWEIFT 255
Query: 613 FGRRPF 618
+G++P+
Sbjct: 256 YGKQPW 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 56/255 (21%), Positives = 98/255 (38%), Gaps = 71/255 (27%)
Query: 407 LLNLLGKGGFSEVYK--AYDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
+ +G+G F V++ A L+ + VA K+ L + S D + + R E +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQR----EAALM 104
Query: 462 KTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA---------------- 501
+ +IV+L + C + EY + DL+ L++
Sbjct: 105 AEFDNPNIVKL-----LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 502 --------TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553
P L E I Q+ G+ YL+ +K +H DL N L E V K+ D
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIAD 217
Query: 554 FGLS-KIVEDD---VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSA 604
FGLS I D +P PE ++ +++ DVW+
Sbjct: 218 FGLSRNIYSADYYKADGNDA------------IPIRWMPPESIFYNR---YTTESDVWAY 262
Query: 605 GILFYQML-FGRRPF 618
G++ +++ +G +P+
Sbjct: 263 GVVLWEIFSYGLQPY 277
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 61/245 (24%), Positives = 89/245 (36%), Gaps = 62/245 (25%)
Query: 407 LLNLLGKGGFSEVYKA--YDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
LG G F +V +A + L + VA K+ L + D+K++ + E I
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LKSTAHADEKEALMS----ELKIM 103
Query: 462 KTLVHH-HIVRLWDTFEI----DQNTFCTVLEYCSGKDL--------------DAVLKAT 502
L H +IV L + + EYC DL A A
Sbjct: 104 SHLGQHENIVNL-----LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 503 PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS-KIVE 561
R+ Q+ QG+ +L ++ IH D+ NVL VAK+ DFGL+ I+
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 562 DD---VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQML- 612
D V LP PE + + DVWS GIL +++
Sbjct: 217 DSNYIVKGNAR------------LPVKWMAPESIFDCV---YTVQSDVWSYGILLWEIFS 261
Query: 613 FGRRP 617
G P
Sbjct: 262 LGLNP 266
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 62/297 (20%), Positives = 106/297 (35%), Gaps = 59/297 (19%)
Query: 403 HRYALLNLLGKGGFSEVYKAY-----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
R L LG+G F +V +A R VA K+ L + + ++ + E
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMS----E 80
Query: 458 YNIHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA--------------- 501
I + HH ++V L ++E+C +L L++
Sbjct: 81 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 502 -TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS-KI 559
L Q+ +G+ +L ++K IH DL N+L E V K+ DFGL+ I
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 560 VEDDV---GSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQM 611
+D LP PE + + DVWS G+L +++
Sbjct: 199 YKDPDYVRKGDAR------------LPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEI 243
Query: 612 L-FGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
G P+ + E R + + ++ P + E + C ++RP
Sbjct: 244 FSLGASPYPGVKIDEEFCRR--LKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP 296
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 54/249 (21%), Positives = 90/249 (36%), Gaps = 66/249 (26%)
Query: 407 LLNLLGKGGFSEVYKA--YDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
LG G F +V +A Y L++ VA K+ L ++++ + E +
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTEREALMS----ELKVL 80
Query: 462 KTLVHH-HIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA----------TPVLP 506
L +H +IV L + + EYC DL L+ +P +
Sbjct: 81 SYLGNHMNIVNL-----LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 507 EREARIIIV--------QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS- 557
E + + + Q+ +G+ +L ++ IH DL N+L + K+ DFGL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 558 KIVEDDV---GSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFY 609
I D LP PE + + DVWS GI +
Sbjct: 194 DIKNDSNYVVKGNAR------------LPVKWMAPESIFNCV---YTFESDVWSYGIFLW 238
Query: 610 QML-FGRRP 617
++ G P
Sbjct: 239 ELFSLGSSP 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 59/249 (23%), Positives = 89/249 (35%), Gaps = 66/249 (26%)
Query: 407 LLNLLGKGGFSEVYKAY-------DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
L LG+G F +V A E VA K+ L +E + E
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVS----EME 92
Query: 460 IHKTLVHH-HIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKAT------------ 502
+ K + H +I+ L + ++EY S +L L+A
Sbjct: 93 MMKMIGKHKNIINL-----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 503 ----PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS- 557
+ ++ Q+ +G+ YL +QK IH DL NVL E V K+ DFGL+
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 558 KIVEDD---VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFY 609
I D + G LP PE + + DVWS G+L +
Sbjct: 206 DINNIDYYKKTTNGR------------LPVKWMAPEALFDRV---YTHQSDVWSFGVLMW 250
Query: 610 QML-FGRRP 617
++ G P
Sbjct: 251 EIFTLGGSP 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 59/259 (22%), Positives = 94/259 (36%), Gaps = 71/259 (27%)
Query: 403 HRYALLNLLGKGGFSEVYKA--YDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIRE 457
L LG+G F +V KA + L VA K+ L S + + + E
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLS----E 76
Query: 458 YNIHKTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA------------ 501
+N+ K + H H+++L ++EY L L+
Sbjct: 77 FNVLKQVNHPHVIKL-----YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 502 ------------TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA 549
L + QI QG+ YL K++H DL N+L E
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILVAEGRKM 189
Query: 550 KVTDFGLS-KIVEDDV---GSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVD 600
K++DFGLS + E+D SQG +P E +++ D
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGR------------IPVKWMAIESLFDHI---YTTQSD 234
Query: 601 VWSAGILFYQML-FGRRPF 618
VWS G+L ++++ G P+
Sbjct: 235 VWSFGVLLWEIVTLGGNPY 253
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 57/250 (22%), Positives = 91/250 (36%), Gaps = 66/250 (26%)
Query: 407 LLNLLGKGGFSEVYKAY-------DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
L LG+G F +V A E VA K+ L +E + E
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVS----EME 138
Query: 460 IHKTLVHH-HIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKAT------------ 502
+ K + H +I+ L + ++EY S +L L+A
Sbjct: 139 MMKMIGKHKNIINL-----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 503 ----PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558
+ ++ Q+ +G+ YL +QK IH DL NVL E V K+ DFGL++
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 559 IVEDD----VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFY 609
+ + + G LP PE + + DVWS G+L +
Sbjct: 252 DINNIDYYKKTTNGR------------LPVKWMAPEALFDRV---YTHQSDVWSFGVLMW 296
Query: 610 QML-FGRRPF 618
++ G P+
Sbjct: 297 EIFTLGGSPY 306
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 57/249 (22%), Positives = 89/249 (35%), Gaps = 66/249 (26%)
Query: 407 LLNLLGKGGFSEVYKAY-------DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
L LG+G F +V A VA K+ L + +E I E
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LKSDATEKDLSDLIS----EME 126
Query: 460 IHKTLVHH-HIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKA------------- 501
+ K + H +I+ L + ++EY S +L L+A
Sbjct: 127 MMKMIGKHKNIINL-----LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 502 ---TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558
L ++ Q+ +G+ YL ++K IH DL NVL E V K+ DFGL++
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 559 IVEDD----VGSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFY 609
+ + G LP PE + + DVWS G+L +
Sbjct: 240 DIHHIDYYKKTTNGR------------LPVKWMAPEALFDRI---YTHQSDVWSFGVLLW 284
Query: 610 QML-FGRRP 617
++ G P
Sbjct: 285 EIFTLGGSP 293
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 55/243 (22%), Positives = 91/243 (37%), Gaps = 62/243 (25%)
Query: 407 LLNLLGKGGFSEVYKAY--DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+++G+G F +V KA A K + S+D + + E + L
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAG----ELEVLCKL 82
Query: 465 VHH-HIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARI------- 512
HH +I+ L + + +EY +L L+ + VL A
Sbjct: 83 GHHPNIINL-----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 513 ---------IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDD 563
+ +G+ YL+ ++ IH DL N+L E VAK+ DFGLS+ +
Sbjct: 138 TLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQE 193
Query: 564 V---GSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSAGILFYQML-FG 614
V + G LP E S ++ DVWS G+L ++++ G
Sbjct: 194 VYVKKTMGR------------LPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLG 238
Query: 615 RRP 617
P
Sbjct: 239 GTP 241
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 1e-13
Identities = 40/235 (17%), Positives = 67/235 (28%), Gaps = 55/235 (23%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQ-WSEDKKQSYIRHAIREYNIHK 462
+ +G+G F EV++ +H VA K+ + Q + E I K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 463 T-----------------LVHHHIVR---------LWDTF------------EIDQNTFC 484
L H V+ WD + +
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 485 TVLEYC-SGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF 543
VLE+ G DL+ + + A+ I+ Q+ L + H DL GNVL
Sbjct: 139 IVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASL-RFEHRDLHWGNVLL 195
Query: 544 DEFGVAKVTDFGLSK----------IVEDDVGSQGMELTSQGAGTYWYLPPECFE 588
+ + K+ K + D +E + + F
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 55/254 (21%), Positives = 85/254 (33%), Gaps = 71/254 (27%)
Query: 407 LLNLLGKGGFSEVYKA--YDLVEHRY---VACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
+LG G F +V A Y + + VA K+ L + ++++ + E +
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM--LKEKADSSEREALMS----ELKMM 102
Query: 462 KTLVHH-HIVRLWDTFEI----DQNTFCTVLEYCSGKDL--------------------- 495
L H +IV L + + EYC DL
Sbjct: 103 TQLGSHENIVNL-----LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 496 --DAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553
+ VL + Q+ +G+ +L + +H DL NVL V K+ D
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICD 215
Query: 554 FGLS-KIVEDDV---GSQGMELTSQGAGTYWYLP-----PECFELSKTPLISSKVDVWSA 604
FGL+ I+ D LP PE + K DVWS
Sbjct: 216 FGLARDIMSDSNYVVRGNAR------------LPVKWMAPESLFEGI---YTIKSDVWSY 260
Query: 605 GILFYQML-FGRRP 617
GIL +++ G P
Sbjct: 261 GILLWEIFSLGVNP 274
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 31/173 (17%), Positives = 66/173 (38%), Gaps = 32/173 (18%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
++ Y + +G+G F +++ +L+ ++ VA K E ++ EY
Sbjct: 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--------FEPRRSDA-PQLRDEY 56
Query: 459 NIHKTLVH-HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-------VLPEREA 510
+K L I ++ F + V++ G L+ +L V
Sbjct: 57 RTYKLLAGCTGIPNVYY-FGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVA----- 109
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK-----VTDFGLSK 558
+ Q+ + +++++ +++ D+KP N L V DFG+ K
Sbjct: 110 -MAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.6 bits (146), Expect = 1e-09
Identities = 89/582 (15%), Positives = 177/582 (30%), Gaps = 182/582 (31%)
Query: 52 WAALSSTSRSVAAA-EDLAQES----SSSDSDDDIGGEFLIQANTQKRQKVKEDDNSTVF 106
W LS V E++ + + S + + + ++R ++ D + VF
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND--NQVF 126
Query: 107 DRVEVVADGRQNTTETLEAKASDVNRKK----HGRGRGNSGSGRGRGSRANEQARSQISS 162
+ V R L ++ K G G G+ A + S
Sbjct: 127 AKYNVS---RLQPYLKLRQALLELRPAKNVLIDGVL------GSGKTWVALDVCLSY--- 174
Query: 163 STVSPSNGQLESSHHKDNKPKEQFLID--NCSSLEEEVTSLHRKVAALEEDLRKSRQNAV 220
V + + F ++ NC+S E + L
Sbjct: 175 -KV------------QCKMDFKIFWLNLKNCNSPETVLEML------------------- 202
Query: 221 DYQNLCHQLEKELKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNV 280
Q L +Q++ ++ + R I L + K++ E L + L NV
Sbjct: 203 --QKLLYQIDPNWTSRSDHSSNI-KLRIHSIQAELRRLLKSKPYENCLLV------LLNV 253
Query: 281 GVIRAGTVISETWEDGQALKDLNAHLRQLLETKEA-VERQRKSLKKRQPDKGDGVDVESG 339
+ +A N + LL T+ V +
Sbjct: 254 ------------Q-NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI---SLDHHSMT 297
Query: 340 VQEEDLVIQDEIYKSRLASIKREEEAILRERERYELEKG-----RLIREMKRIRDEDGSR 394
+ +++ KS L L E+ +I E R + +
Sbjct: 298 LTPDEV-------KSLLLKYLDCRPQDLPR----EVLTTNPRRLSIIAESIR---DGLAT 343
Query: 395 FNNFQILNHRYAL-------LNLLGKGGFSEVYKAYDLV--------------------- 426
++N++ +N L LN+L + +++ L
Sbjct: 344 WDNWKHVNC-DKLTTIIESSLNVLEPAEYRKMFD--RLSVFPPSAHIPTILLSLIWFDVI 400
Query: 427 --EHRYVACKLH--GLNAQWSEDKKQSYIRHAI---------REYNIHKTLV-HHHIVRL 472
+ V KLH L + K+ + +I EY +H+++V H++I +
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQP--KESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458
Query: 473 WDTFEI----DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR- 527
+D+ ++ F + + + L + ER + +F+ +++L+ R
Sbjct: 459 FDSDDLIPPYLDQYFYSHIGH----HLKNIEHP-----ER------MTLFR-MVFLDFRF 502
Query: 528 -AQKIIHYDL---KPGNVLFDEFGVAKVTDFGLSK--IVEDD 563
QKI H G++L + K I ++D
Sbjct: 503 LEQKIRHDSTAWNASGSILNT------LQQLKFYKPYICDND 538
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 3e-04
Identities = 49/380 (12%), Positives = 107/380 (28%), Gaps = 113/380 (29%)
Query: 334 VDVESGVQE---------------EDLVIQD--EIYKSRLASIKREEEAILRERERYELE 376
+D E+G + ++ +D ++ KS L+ K E + I+ ++
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILS--KEEIDHIIMSKDAVS-- 62
Query: 377 KGRLIREMKRIRDEDGSRFNNF--QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVAC- 433
+R + + F ++L Y L + ++ Y+
Sbjct: 63 --GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL----MSPIKTEQRQPSMMTRMYIEQR 116
Query: 434 -KLHGLNAQWSED-----KKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVL 487
+L+ N +++ + +R A+ E K ++ ++
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG---------------- 160
Query: 488 EYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547
SGK + A V ++ F + +LN + L+ L +
Sbjct: 161 ---SGK---TWV-ALDVC--LSYKVQCKMDF-KIFWLNLKNCNSPETVLEMLQKLLYQI- 209
Query: 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKV-------- 599
D + + +S L + L+ SK
Sbjct: 210 --------------DPNWTSRSDHSSNI-----KLRIHSIQAELRRLLKSKPYENCLLVL 250
Query: 600 -DVWSAGILFYQMLFGRRPFGHDQTQERIL---REDTIIKARKVEFPSRPAVSN------ 649
+V +A F +IL R + + ++ +
Sbjct: 251 LNVQNAKAW--------NAFNL---SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 650 --EAKDLIRRCLTYNQAERP 667
E K L+ + L + P
Sbjct: 300 PDEVKSLLLKYLDCRPQDLP 319
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 38/156 (24%), Positives = 66/156 (42%), Gaps = 19/156 (12%)
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +G+ +L R K IH DL N+L E V K+ DFGL++ + D + +G
Sbjct: 201 QVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-----PDYVRKG 253
Query: 576 AGTY---WYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILRED 631
W + PE + + DVWS G+L +++ G P+ + E R
Sbjct: 254 DARLPLKW-MAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR- 308
Query: 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+ + ++ P + E + C ++RP
Sbjct: 309 -LKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP 341
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 39/172 (22%), Positives = 65/172 (37%), Gaps = 32/172 (18%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
++ + + +G G F E+ +L + YVA KL E K EY
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--------EPMKSRA-PQLHLEYR 56
Query: 460 IHKTLVH-HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-------VLPEREAR 511
+K L I +++ F VLE G L+ + VL
Sbjct: 57 FYKQLGSGDGIPQVYY-FGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVL------ 108
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK-----VTDFGLSK 558
+I +Q+ + Y++ + +I+ D+KP N L G + DF L+K
Sbjct: 109 MIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 36/173 (20%), Positives = 63/173 (36%), Gaps = 18/173 (10%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
+ +RY L +G G F ++Y D+ VA K + + K E
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQL----HIESK 56
Query: 460 IHKTLVH-HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQI 517
I+K + I + + + V+E G L+ + + ++ Q+
Sbjct: 57 IYKMMQGGVGIPTIRW-CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQM 114
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK---VTDFGLSKIVEDDVGSQ 567
+ Y++ + IH D+KP N L + DFGL+K D Q
Sbjct: 115 ISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 26/178 (14%), Positives = 61/178 (34%), Gaps = 29/178 (16%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
+ +++ L +G GGF +Y A+ + A + + E ++ + E
Sbjct: 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLF---SELK 85
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCS-----------------GKDLDAVLKAT 502
++ + ++ W + + G DL +
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN 145
Query: 503 PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT--DFGLSK 558
+ + +++ L Y+++ + +H D+K N+L +V D+GLS
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHEN--EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 28/176 (15%), Positives = 67/176 (38%), Gaps = 22/176 (12%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDL--------VEHRYVACKLHGLNAQWSEDKKQSYI 451
++ L + + +Y+A + + + KL + + ++ +
Sbjct: 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQN-FFQ 97
Query: 452 RHA----IREYNIHKTLVHHHIVRLWDTFEIDQNTF-CTVLEYCSGKDLDAVLKATP--V 504
R A + ++ + I F + Q+ + VL G+ L + L +P V
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMG-FGVHQDKYRFLVLPSL-GRSLQSALDVSPKHV 155
Query: 505 LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT--DFGLSK 558
L ER + ++ L +L++ + +H ++ N+ D ++VT +G +
Sbjct: 156 LSERSVLQVACRLLDALEFLHEN--EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 33/164 (20%), Positives = 68/164 (41%), Gaps = 18/164 (10%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
+ +++ L +G G F E+Y ++ + VA K E+ K + + E
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------LENVKTKH-PQLLYESK 54
Query: 460 IHKTLV-HHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQI 517
I++ L I + F ++ + V++ G L+ + L + ++ Q+
Sbjct: 55 IYRILQGGTGIPNVRW-FGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 112
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK---VTDFGLSK 558
+ +++ + +H D+KP N L A + DFGL+K
Sbjct: 113 INRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 33/214 (15%), Positives = 80/214 (37%), Gaps = 17/214 (7%)
Query: 187 LIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPR 246
L LEE + + ++ EE ++ + Q LE++L++ + Q+++
Sbjct: 918 LAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEEEAARQKLQLE 977
Query: 247 RTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHL 306
+ K ++ E + I ++ +S+ + ++ +L
Sbjct: 978 KVTAD-------GKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNL 1030
Query: 307 RQL----------LETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRL 356
+L LE + E + + ++ K +G + Q +L Q K++L
Sbjct: 1031 TKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQL 1090
Query: 357 ASIKREEEAILRERERYELEKGRLIREMKRIRDE 390
A + E +A L E +K +++++ +
Sbjct: 1091 AKKEEELQAALARLEDETSQKNNALKKIRELESH 1124
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 34/223 (15%), Positives = 83/223 (37%), Gaps = 33/223 (14%)
Query: 168 SNGQLESSHHKDNKPKEQFLIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCH 227
+ +L+ + K + + D+ +E++ L ++ LEE + N + +
Sbjct: 970 ARQKLQLEKVTADG-KIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAK 1028
Query: 228 QLEKELKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGT 287
L K ++E IS+L + + K E+ L+ + +
Sbjct: 1029 NLTKL---KNKHESM--------ISELEVRLKKEEKSRQELEKIKRKL------------ 1065
Query: 288 VISETWEDGQALKDLNAHLRQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVI 347
E DL+ + +L ++ Q ++ ++ E+ + L
Sbjct: 1066 ---EGE-----SSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDETSQKNNALKK 1117
Query: 348 QDEIYKSRLASIKREEEAILRERERYELEKGRLIREMKRIRDE 390
E+ +S ++ ++ + E+ R + E +K L E++ ++ E
Sbjct: 1118 IREL-ESHISDLQEDLESEKAARNKAEKQKRDLSEELEALKTE 1159
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 24/188 (12%), Positives = 69/188 (36%), Gaps = 26/188 (13%)
Query: 187 LIDNCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPR 246
LE ++ L RK+ ++ + L ++ ++++
Sbjct: 919 YKKLHIGLENKIMQLQRKIDEQNKEYKS----------LLEKMNNLEITYSTETEKLR-- 966
Query: 247 RTKIISDLLISVSKAERQEARLKIRQESVRLGNVGVIRAGTVISETWEDGQALKDLNAHL 306
+ L +S +A+ R+ QE + + + +T + + +++
Sbjct: 967 --SDVERLRMSEEEAKNATNRVLSLQEEIA-------KLRKELHQTQTEKKTIEEWADKY 1017
Query: 307 RQLLETKEAVERQRKSLKKRQPDKGDGVDVESGVQEEDLVIQDEIYKSRLASIKREEEAI 366
+ E + +++ +L K + ++ + + ++ I + + K + K+ E +
Sbjct: 1018 KHETEQLVSELKEQNTLLKTEKEE-----LNRRIHDQAKEITETMEKKLVEETKQLELDL 1072
Query: 367 LRERERYE 374
ER RY+
Sbjct: 1073 NDERLRYQ 1080
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 26/184 (14%), Positives = 57/184 (30%), Gaps = 38/184 (20%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAY-----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHA 454
+ + + +G+GGF +Y A + K+ D +
Sbjct: 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE------PSDNGPLF---- 81
Query: 455 IREYNIHKTLVHHHIVRLWDTFE-IDQNTFCTVLEYCS----------------GKDLDA 497
E ++ ++ W + G DL
Sbjct: 82 -TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK 140
Query: 498 VLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT--DF 554
+ +A + + ++I L Y+++ + +H D+K N+L + +V D+
Sbjct: 141 IYEANAKRFSRKTVLQLSLRILDILEYIHEH--EYVHGDIKASNLLLNYKNPDQVYLVDY 198
Query: 555 GLSK 558
GL+
Sbjct: 199 GLAY 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 683 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.32 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.09 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.97 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.85 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.84 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.46 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.53 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.63 | |
| 3na7_A | 256 | HP0958; flagellar biogenesis, flagellum export, C4 | 91.14 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.77 | |
| 2b9c_A | 147 | Striated-muscle alpha tropomyosin; alpha-helix, co | 87.41 | |
| 3nmd_A | 72 | CGMP dependent protein kinase; leucine zipper, coi | 87.19 | |
| 3na7_A | 256 | HP0958; flagellar biogenesis, flagellum export, C4 | 85.57 | |
| 3tnu_B | 129 | Keratin, type II cytoskeletal 5; coiled-coil, stru | 85.42 | |
| 3a7p_A | 152 | Autophagy protein 16; coiled-coil, coiled coil, cy | 85.25 | |
| 3tnu_A | 131 | Keratin, type I cytoskeletal 14; coiled-coil, stru | 84.73 | |
| 3q8t_A | 96 | Beclin-1; autophagy, ATG14L uvrag, apoptosis; 1.90 | 84.49 | |
| 3u1c_A | 101 | Tropomyosin alpha-1 chain; anti-parallel coiled co | 84.3 | |
| 2v4h_A | 110 | NF-kappa-B essential modulator; transcription, met | 83.71 | |
| 3efg_A | 78 | Protein SLYX homolog; xanthomonas campestris PV. c | 80.96 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.83 | |
| 3u59_A | 101 | Tropomyosin beta chain; muscle contraction, actin, | 80.75 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 80.73 | |
| 3u1c_A | 101 | Tropomyosin alpha-1 chain; anti-parallel coiled co | 80.62 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=482.16 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=221.9
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
...|.+++.||+|+||+||+|.+..+|+.||||++....... ...+.+|+.+|+.++|||||++|++|. +.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-------~~~~~~Ei~il~~l~HpnIV~l~~~~~-~~~ 144 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-------RELLFNEVVIMRDYQHENVVEMYNSYL-VGD 144 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-------GGGGHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-------HHHHHHHHHHHHhCCCCCCCcEEEEEE-ECC
Confidence 457999999999999999999999999999999986543221 235778999999999999999999997 678
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|||||||+||+|.+++... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 899999999999999999765 5999999999999999999999965 9999999999999999999999999998775
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... ......+||++|||||++.... |+.++||||||||+|||++|.+||......+.+. .+.......+
T Consensus 222 ~~~-----~~~~~~~GTp~YmAPEvl~~~~---y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~~~~~~~ 290 (346)
T 4fih_A 222 KEV-----PRRKSLVGTPYWMAPELISRLP---YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDNLPPRL 290 (346)
T ss_dssp SSS-----CCBCCCCSCGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSSCCCC
T ss_pred CCC-----CcccccccCcCcCCHHHHCCCC---CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHcCCCCCC
Confidence 432 2234568999999999986444 8999999999999999999999998766554332 2233333445
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+.+..+|+++++||.+||.+||.+|||+.++++||||+.+
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 5567899999999999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=470.12 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=214.9
Q ss_pred cce-eEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc---
Q 005678 403 HRY-ALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI--- 478 (683)
Q Consensus 403 ~ry-~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~--- 478 (683)
.+| .+.+.||+|+||+||+|.+..++..||||++....... .....+.+|+.+++.|+|||||++|++|..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-----SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-----HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 344 67788999999999999999999999999986543221 224678999999999999999999999853
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL~DFGls 557 (683)
....+|||||||+||+|.+++...+.+++..++.|+.||+.||.|||+.+++||||||||+||||+. +|.+||+|||+|
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 2456899999999999999998888899999999999999999999997667999999999999984 799999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
+..... .....+|||.|||||++.. .|+.++|||||||+||+|+||++||........++.. +...
T Consensus 180 ~~~~~~-------~~~~~~GTp~YmAPE~~~~----~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~---i~~~ 245 (290)
T 3fpq_A 180 TLKRAS-------FAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSG 245 (290)
T ss_dssp GGCCTT-------SBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTT
T ss_pred EeCCCC-------ccCCcccCccccCHHHcCC----CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH---HHcC
Confidence 865432 2334589999999998852 3899999999999999999999999766655444321 1111
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
......+..+++++++||.+||..||.+|||+.++++||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1111123467899999999999999999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=474.34 Aligned_cols=260 Identities=26% Similarity=0.422 Sum_probs=222.3
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+++.||+|+||+||+|.+..+|+.||||++..... ........+.+|+.+++.++|||||++|++|. +.+.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-DDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCE
Confidence 569999999999999999999999999999999854321 12233567899999999999999999999997 7788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|||||||+||+|.+++...+.+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999999999988888999999999999999999999965 99999999999999999999999999998754
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.... ......+||+.|||||++.... |+.++|||||||++|+|++|++||......+.+.. +....+.+|
T Consensus 185 ~~~~---~~~~~~~GTp~YmAPEvl~~~~---y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~----i~~~~~~~p 254 (311)
T 4aw0_A 185 ESKQ---ARANSFVGTAQYVSPELLTEKS---ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK----IIKLEYDFP 254 (311)
T ss_dssp TTTC---CCBCCCCSCGGGCCHHHHHHSC---BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCC
T ss_pred CCCc---ccccCcccCcccCCHHHHcCCC---CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCCC
Confidence 3211 2344568999999999997554 89999999999999999999999987665443221 223345555
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLT------LAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~e------Ll~hP~l~~~ 681 (683)
..+|+++++||.+||.+||.+|||+.+ +++||||+..
T Consensus 255 --~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 255 --EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp --TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred --cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 469999999999999999999999988 5899999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=480.66 Aligned_cols=257 Identities=25% Similarity=0.444 Sum_probs=213.3
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.+++.|+|||||+++++|. +.+.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~-~~~~ 97 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-----KEREESRREVAVLANMKHPNIVQYRESFE-ENGS 97 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-----HHHHHHHHHHHHHHHCCCCCCCcEEEEEE-ECCE
Confidence 68999999999999999999999999999999986653322 22567899999999999999999999997 6788
Q ss_pred EEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+|||||||+||+|.++|... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceee
Confidence 99999999999999999543 45799999999999999999999965 999999999999999999999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
.... ......+||+.|||||++.... |+.++||||||||||+|++|++||......+.+.. +.... +
T Consensus 176 ~~~~-----~~~~~~~GT~~YmAPE~l~~~~---y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~---i~~~~-~- 242 (350)
T 4b9d_A 176 NSTV-----ELARACIGTPYYLSPEICENKP---YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK---IISGS-F- 242 (350)
T ss_dssp CHHH-----HHHHHHHSCCTTCCHHHHTTCC---CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHTC-C-
T ss_pred cCCc-----ccccccCCCccccCHHHHCCCC---CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH---HHcCC-C-
Confidence 5321 2233457999999999987544 89999999999999999999999987766543322 22221 1
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.+.+..+|+++++||.+||..||.+|||+.++++||||+.
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 1334579999999999999999999999999999999964
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=484.28 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=222.6
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
...|.+++.||+|+||.||+|.+..+|+.||||++....... ...+.+|+.+|+.++|||||++|++|. +.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-------~~~~~~Ei~il~~l~HpnIV~l~~~~~-~~~ 221 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-------RELLFNEVVIMRDYQHENVVEMYNSYL-VGD 221 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-------GGGHHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-------HHHHHHHHHHHHhCCCCCCCceEEEEE-ECC
Confidence 467999999999999999999999999999999986543321 235789999999999999999999997 678
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|||||||+||+|.+++... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 899999999999999999765 4999999999999999999999965 9999999999999999999999999998775
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... ......+||++|||||++.... |+.++||||||||+|||++|.+||......+.+. .+.......+
T Consensus 299 ~~~-----~~~~~~~GTp~YmAPEvl~~~~---y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~~~~~~~ 367 (423)
T 4fie_A 299 KEV-----PRRKSLVGTPYWMAPELISRLP---YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDNLPPRL 367 (423)
T ss_dssp SSC-----CCBCCCEECTTTCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSCCCCC
T ss_pred CCC-----ccccccccCcCcCCHHHHCCCC---CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHcCCCCCC
Confidence 432 2234458999999999986544 8999999999999999999999998766554332 2333334455
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+.+..+|+++++||.+||..||.+|||+.+|++||||+.+
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 5667899999999999999999999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=460.40 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=204.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||+||+|.+..+|+.||||++....... ......+.+|+.+++.++|||||+++++|. +.+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK----SDMQGRIEREISYLRLLRHPHIIKLYDVIK-SKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-ECCE
Confidence 47999999999999999999999999999999986543221 223457889999999999999999999997 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+||||| +|+|.+++...+.+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+....
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 99999999 6799999988888999999999999999999999965 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.. .....+||+.|||||++.... .++.++|||||||++|+|++|+.||........+ . .+....+.+|
T Consensus 165 ~~------~~~~~~GT~~Y~APE~~~~~~--y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~-~---~i~~~~~~~p 232 (275)
T 3hyh_A 165 GN------FLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF-K---NISNGVYTLP 232 (275)
T ss_dssp ----------------CTTSCHHHHSSSS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-H---HHHHTCCCCC
T ss_pred CC------ccCCeeECcccCChhhhcCCC--CCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-H---HHHcCCCCCC
Confidence 31 223458999999999986443 2467999999999999999999999876544322 1 1223334444
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..+|+++++||.+||.+||.+|||+.++++||||+.
T Consensus 233 --~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 233 --KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 569999999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-55 Score=467.78 Aligned_cols=261 Identities=25% Similarity=0.294 Sum_probs=212.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
..+.|.+.+.||+|+||+||+|.+..+|+.||||++..... ..+|+.+++.++|||||++|++|. +.
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------------~~~E~~il~~l~HpnIV~l~~~~~-~~ 122 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------------RVEELVACAGLSSPRIVPLYGAVR-EG 122 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------------CTHHHHTTTTCCCTTBCCEEEEEE-ET
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------------HHHHHHHHHhCCCCCCCcEEEEEE-EC
Confidence 34578999999999999999999999999999999865321 246999999999999999999997 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-cEEEEecCCccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTDFGLSKI 559 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-~vKL~DFGls~~ 559 (683)
+.+|||||||+||+|.++|+..+.+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+| .+||+|||+|+.
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred CEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 889999999999999999988888999999999999999999999865 99999999999999887 699999999998
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
+...............+||+.|||||++.... |+.++|||||||+||+|++|++||........+.. +......
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~---y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---i~~~~~~ 274 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP---CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK---IASEPPP 274 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH---HHHSCCG
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCC---CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---HHcCCCC
Confidence 76543222222233458999999999997544 89999999999999999999999976554332221 1221111
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHH-------------hcCcccCCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTL-------------AQDPYLTYSK 682 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eL-------------l~hP~l~~~K 682 (683)
....++.+|+++.+||.+||.+||.+|||+.++ ++|||+...+
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 112346799999999999999999999999997 5799997543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=465.53 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=211.4
Q ss_pred ccceeEEEEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.++|.+++.||+|+||+||+|.+. .+++.||||++......... ...+.+|+.+++.++|||||+++++|.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~E~~il~~l~HpnIv~l~~~~~- 96 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-----RVRTKMERDILVEVNHPFIVKLHYAFQ- 96 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-----CC------CCCCCCCCTTEECEEEEEE-
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-----HHHHHHHHHHHHHCCCCCCCeEEEEEE-
Confidence 367999999999999999999874 46889999998654322211 125678999999999999999999997
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+.+|||||||+||+|.+++...+.+++..++.|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccce
Confidence 67889999999999999999988888999999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
...... ......+||+.|||||++.... |+.++|||||||++|+|++|++||......+.+.. +....
T Consensus 175 ~~~~~~-----~~~~~~~GT~~YmAPE~~~~~~---y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~ 242 (304)
T 3ubd_A 175 ESIDHE-----KKAYSFCGTVEYMAPEVVNRRG---HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM----ILKAK 242 (304)
T ss_dssp C----------CCCCSCCCCGGGCCHHHHHTSC---CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCC
T ss_pred eccCCC-----ccccccccCcccCCHHHhccCC---CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH----HHcCC
Confidence 654322 1233458999999999987544 89999999999999999999999987666543321 22233
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~~ 681 (683)
+.+ +..+|+++++||.+||..||.+||| ++++++||||+..
T Consensus 243 ~~~--p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 243 LGM--PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp CCC--CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCC--CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 334 3579999999999999999999998 5899999999853
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=449.51 Aligned_cols=266 Identities=24% Similarity=0.371 Sum_probs=211.9
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
..|++..++|.+.+.||+|+||+||+|.. ...||||++....... ...+.|.+|+.++++++|||||+++++
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~---~~~vAvK~~~~~~~~~-----~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKW---HGDVAVKILKVVDPTP-----EQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEES---SSEEEEEECCCSSCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEE---CCcEEEEEEEecCCCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 45788889999999999999999999963 2359999986543221 235689999999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
+. .+.+|||||||+||+|.++|.. ...+++..+..|+.||+.||.|||+.+ ||||||||+||||++++.+||+||
T Consensus 101 ~~--~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 101 MT--KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp EC--SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCC
T ss_pred EE--CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeec
Confidence 74 4568999999999999999964 457999999999999999999999955 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
|+|+........ ......+||+.|||||++.......|+.++|||||||+||||+||+.||........+... .
T Consensus 177 Gla~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~---~ 250 (307)
T 3omv_A 177 GLATVKSRWSGS---QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM---V 250 (307)
T ss_dssp SSCBC---------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---H
T ss_pred cCceecccCCcc---eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH---H
Confidence 999876543221 2234558999999999997655556999999999999999999999999876655443221 1
Q ss_pred HhhccCCC----CCcCCCHHHHHHHHHhcccCCCCCCCHHHH------hcCcccCC
Q 005678 635 KARKVEFP----SRPAVSNEAKDLIRRCLTYNQAERPDVLTL------AQDPYLTY 680 (683)
Q Consensus 635 ~~~~~~~p----~~~~~s~el~dLI~rCL~~dP~kRPS~~eL------l~hP~l~~ 680 (683)
. .....| .++.+|+++.+||.+||..||.+|||+.++ ++||+-+.
T Consensus 251 ~-~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk~ 305 (307)
T 3omv_A 251 G-RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305 (307)
T ss_dssp H-TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC-
T ss_pred h-cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCCC
Confidence 1 112222 235789999999999999999999999876 46776543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=461.68 Aligned_cols=269 Identities=23% Similarity=0.400 Sum_probs=217.7
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc--
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-- 478 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-- 478 (683)
+.++|.+++.||+|+||+||+|.+..+|+.||||++...... ....+.+.+|+.+|+.|+|||||+++++|..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-----VTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-----HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-----hHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 467899999999999999999999999999999998654322 1234678899999999999999999998753
Q ss_pred ---CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 479 ---DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 479 ---d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
+.+.+|||||||+ |+|.+++...+.+++..++.|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||
T Consensus 127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 127 PYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCT
T ss_pred ccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecc
Confidence 3467999999995 689999988889999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+|+.+....... .......+||++|||||++.... .|+.++||||+|||+|+|++|++||......+.+........
T Consensus 204 la~~~~~~~~~~-~~~~~~~~GT~~Y~APEv~~~~~--~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 204 MARGLCTSPAEH-QYFMTEYVATRWYRAPELMLSLH--EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp TCBCC--------CCCCCSSCCCCTTCCHHHHTTCS--CCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred eeeecccCcccc-ccccccceeChHhcCHHHhcCCC--CCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 998765432111 12234568999999999876433 379999999999999999999999987776654432211110
Q ss_pred hhc----------------cCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARK----------------VEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~----------------~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
... ..+|. .+.+++++.+||.+||.+||.+|||+.++++||||+.
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 000 00111 1357899999999999999999999999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=443.09 Aligned_cols=258 Identities=24% Similarity=0.431 Sum_probs=197.5
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC---
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ--- 480 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~--- 480 (683)
.|.+++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.|+|||||++|++|....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR------ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 48999999999999999999999999999999865421 122457889999999999999999999986432
Q ss_pred --------ceEEEEEecccCCChhHHHhcCCCcc---hHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcE
Q 005678 481 --------NTFCTVLEYCSGKDLDAVLKATPVLP---EREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA 549 (683)
Q Consensus 481 --------~~~~LV~Ey~~ggsL~~~L~~~~~Ls---e~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~v 549 (683)
..+|+|||||+||+|.+++.....++ +..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcE
Confidence 24799999999999999998765544 4557889999999999999965 9999999999999999999
Q ss_pred EEEecCCccccccCcCCCc-------ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCc
Q 005678 550 KVTDFGLSKIVEDDVGSQG-------MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQ 622 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~-------~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~ 622 (683)
||+|||+|+.+........ .......+||+.|||||++.... |+.++|||||||++|||++ ||....
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~---y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS---YSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCC---CCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC---CCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 9999999998765422111 11123457999999999987543 8999999999999999996 886433
Q ss_pred hHHHHHHHHHHHHhhccCCCC-CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 623 TQERILREDTIIKARKVEFPS-RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 623 ~~e~il~~~~i~~~~~~~~p~-~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..... +.......+|. .+..++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 232 ~~~~~-----~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 232 ERVRT-----LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHH-----HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHH-----HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 22111 12222333432 2346678899999999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=437.07 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=208.4
Q ss_pred cccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
.+..+.|.+.+.||+|+||+||+|.+. .++..||||++.... ....+.|.+|+.++++++|||||++|
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-------DNARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-------hHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 345678999999999999999999764 368899999985431 12346789999999999999999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcC-------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcc
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKAT-------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGN 540 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~N 540 (683)
++|. +++.+|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+.+ ||||||||+|
T Consensus 82 g~~~-~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~N 158 (299)
T 4asz_A 82 GVCV-EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRN 158 (299)
T ss_dssp EEEC-SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EEEe-eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhh
Confidence 9996 677899999999999999999653 36999999999999999999999955 9999999999
Q ss_pred eEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 005678 541 VLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFG 619 (683)
Q Consensus 541 ILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~ 619 (683)
|||+.++.+||+|||+|+....... ........||+.|||||++.... |+.++|||||||++|||+| |+.||.
T Consensus 159 ILl~~~~~~Ki~DFGla~~~~~~~~---~~~~~~~~gt~~ymAPE~~~~~~---~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 159 CLVGENLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGC---EEETTTEEECGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEECCCCcEEECCcccceecCCCCc---eeecCceecChhhcCHHHHcCCC---CCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999987654321 12233346999999999997554 9999999999999999998 999998
Q ss_pred CCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 620 HDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 620 ~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
.....+.+. .+..... .+.+..+|+++.+||.+||..||.+|||+.++.
T Consensus 233 ~~~~~~~~~---~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 233 QLSNNEVIE---CITQGRV--LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp TSCHHHHHH---HHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCHHHHHH---HHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 776654332 2222222 333457999999999999999999999999984
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=443.26 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=208.5
Q ss_pred ccccccceeEEEEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeec
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLW 473 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~ 473 (683)
++-+.++|.+.+.||+|+||+||+|.+. .+++.||||.+..... ...+.+|+.++..+ .|||||+++
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---------~~~~~~E~~~l~~~~~h~nIv~l~ 86 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---------PIRIAAELQCLTVAGGQDNVMGVK 86 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---------HHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---------HHHHHHHHHHHHHhcCCCCCceEE
Confidence 3456789999999999999999999875 4678999998754321 23577899999998 699999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC-CcEEEE
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF-GVAKVT 552 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~-g~vKL~ 552 (683)
++|. +.+++|+|||||+|++|.+++. .+++.+++.|+.||+.||.|||+.+ ||||||||+||||+.+ +.+||+
T Consensus 87 ~~~~-~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 87 YCFR-KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp EEEE-ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEEC
T ss_pred EEEE-ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEEC
Confidence 9997 6789999999999999999985 4899999999999999999999966 9999999999999876 899999
Q ss_pred ecCCccccccCcCCC-----------------------cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQ-----------------------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFY 609 (683)
Q Consensus 553 DFGls~~~~~~~~~~-----------------------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILy 609 (683)
|||+|+......... ........+||++|+|||++... +.|+.++||||+|||+|
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC--PNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCCccchhhhHHHHH
Confidence 999998654321100 00112345799999999998643 34899999999999999
Q ss_pred HHHcCCCCCCCCchHHHHHH-HHHHHH------------------------------------------------hhccC
Q 005678 610 QMLFGRRPFGHDQTQERILR-EDTIIK------------------------------------------------ARKVE 640 (683)
Q Consensus 610 ELLtG~~PF~~~~~~e~il~-~~~i~~------------------------------------------------~~~~~ 640 (683)
+|++|+.||....+....+. ...+.. .....
T Consensus 239 ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 318 (361)
T 4f9c_A 239 SLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN 318 (361)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccc
Confidence 99999999965443322211 100000 00011
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.+.+..+|+++++||.+||.+||.+|||+.++++||||+.
T Consensus 319 ~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 319 LEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp ---CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred ccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 1234568999999999999999999999999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=435.22 Aligned_cols=256 Identities=22% Similarity=0.319 Sum_probs=210.2
Q ss_pred ccccceeEEEEecccCceEEEEEEE-----ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYD-----LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d-----~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
+....+.+++.||+|+||+||+|.. ..+++.||||++..... ....+.|.+|+.++++++|||||++++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~------~~~~~~f~~E~~il~~l~HpNIV~l~g 96 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE------GPLREEFRHEAMLRARLQHPNVVCLLG 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC------C-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC------hHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence 3446688899999999999999974 34678999999864322 122457899999999999999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCC
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKP 538 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP 538 (683)
+|. +.+.+|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+.+ ||||||||
T Consensus 97 ~~~-~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~ 173 (308)
T 4gt4_A 97 VVT-KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLAT 173 (308)
T ss_dssp EEC-SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEE-ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccc
Confidence 986 677899999999999999999542 35899999999999999999999965 99999999
Q ss_pred cceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 005678 539 GNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRP 617 (683)
Q Consensus 539 ~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~P 617 (683)
+||||++++.+||+|||+|+.+..... ........||+.|||||++.... |+.++|||||||+||||+| |..|
T Consensus 174 ~NILl~~~~~~Ki~DFGlar~~~~~~~---~~~~~~~~gt~~ymAPE~l~~~~---~s~ksDVwSfGvvl~El~t~g~~P 247 (308)
T 4gt4_A 174 RNVLVYDKLNVKISDLGLFREVYAADY---YKLLGNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQP 247 (308)
T ss_dssp GGEEECGGGCEEECCSCCBCGGGGGGC---BCSSSSSCBCGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cceEECCCCCEEECCcccceeccCCCc---eeEecccccCCcccCHHHHhCCC---CCccchhhhHHHHHHHHHhCCCCC
Confidence 999999999999999999987654321 12334558999999999997554 9999999999999999998 8999
Q ss_pred CCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 618 FGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 618 F~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
|......+.+. .+.. ....|.++.+|+.+.+||.+||..||.+|||+.+|+++
T Consensus 248 f~~~~~~~~~~---~i~~--~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 248 YCGYSNQDVVE---MIRN--RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTTCCHHHHHH---HHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHH---HHHc--CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 98776654332 1222 22344556899999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=437.28 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=204.1
Q ss_pred cccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
.+..+.|.+.+.||+|+||+||+|... .++..||||++.... ....+.|.+|+.++++++|||||++|
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~f~~E~~il~~l~HpnIV~l~ 109 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-------ESARQDFQREAELLTMLQHQHIVRFF 109 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-------HHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 345678999999999999999999754 468999999985421 12346799999999999999999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcC---------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCC
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKAT---------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKP 538 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~---------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP 538 (683)
++|. +.+.+|||||||++|+|.++|... .++++..+..|+.||+.||.|||+.+ ||||||||
T Consensus 110 g~~~-~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp 186 (329)
T 4aoj_A 110 GVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLAT 186 (329)
T ss_dssp EEEC-SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred EEEE-ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccH
Confidence 9986 677899999999999999999653 35899999999999999999999955 99999999
Q ss_pred cceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 005678 539 GNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRP 617 (683)
Q Consensus 539 ~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~P 617 (683)
.||||+.++.+||+|||+|+.+..... ........||+.|||||++.... |+.++|||||||+||||+| |+.|
T Consensus 187 ~NILl~~~~~~Ki~DFGla~~~~~~~~---~~~~~~~~gt~~ymAPE~~~~~~---~~~~sDvwS~Gvvl~Ellt~G~~P 260 (329)
T 4aoj_A 187 RNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWMPPESILYRK---FTTESDVWSFGVVLWEIFTYGKQP 260 (329)
T ss_dssp GGEEEETTTEEEECCCC-------------------CCCCGGGCCHHHHTTCC---CCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred hhEEECCCCcEEEcccccceeccCCCc---ceecCcccccccccChhhhcCCC---CCccccccchHHHHHHHHcCCCCC
Confidence 999999999999999999987654321 12234457999999999987544 8999999999999999998 9999
Q ss_pred CCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 618 FGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 618 F~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
|......+.+. .+.... ..+.+..+|+++.+||.+||..||.+|||+.+++.+
T Consensus 261 f~~~~~~~~~~---~i~~g~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 261 WYQLSNTEAID---CITQGR--ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCSSCHHHHHH---HHHHTC--CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCHHHHHH---HHHcCC--CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 98776654332 222332 334446799999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=440.49 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=216.5
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccC-----CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC-Cce
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVE-----HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH-HHI 469 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~-----g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H-pnI 469 (683)
..|++..++|.+.+.||+|+||+||+|.+... ++.||||.+..... ....+.+.+|+.++.++.| |||
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~------~~~~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------HSEHRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC------hHHHHHHHHHHHHHHHcCCCCcE
Confidence 35778889999999999999999999987543 47899999864322 1224678999999999976 899
Q ss_pred eeeccccccCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEe
Q 005678 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIH 533 (683)
Q Consensus 470 V~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIH 533 (683)
|+++++|..+++.+|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+.+ |||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiH 208 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIH 208 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eec
Confidence 999999865667899999999999999999642 34899999999999999999999965 999
Q ss_pred cccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc
Q 005678 534 YDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF 613 (683)
Q Consensus 534 rDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt 613 (683)
|||||.||||++++.+||+|||+|+.+..+.. ...+....||+.|||||++.... |+.++|||||||+||||+|
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~---~~~~~~~~gt~~ymAPE~l~~~~---y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTT---SEEETTEEECGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHTT
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCC---ceeeccccccccccCHHHHhcCC---CCCcccEeehHHHHHHHHh
Confidence 99999999999999999999999987654321 12234457999999999997554 9999999999999999998
Q ss_pred -CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 614 -GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 614 -G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
|..||......+.+.. .+... ...+.+..+++++.+||.+||..||.+|||+.+|++|
T Consensus 283 ~G~~Pf~~~~~~~~~~~--~i~~g--~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 283 LGASPYPGVKIDEEFCR--RLKEG--TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp TSCCSSTTCCCSHHHHH--HHHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHH--HHHcC--CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999987655443332 12222 2334446799999999999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=466.55 Aligned_cols=265 Identities=23% Similarity=0.374 Sum_probs=216.7
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
--+.|.+++.||+|+||+||+|.+..+|+.||||++....... ............++.+++.++|||||+++++|. +.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~-~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~-~~ 264 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TP 264 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-CS
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcch-hhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE-EC
Confidence 3457999999999999999999999999999999985432111 111222334445577788889999999999997 77
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+.+|||||||+||+|..+|...+.+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 899999999999999999988888999999999999999999999965 999999999999999999999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
.... +...+||+.|||||++... ..|+.++||||||||||+|++|.+||......... .....+....+.
T Consensus 343 ~~~~-------~~t~~GTp~YmAPEvl~~~--~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~~i~~~~~~ 412 (689)
T 3v5w_A 343 SKKK-------PHASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVE 412 (689)
T ss_dssp SSCC-------CCSCCSCGGGCCHHHHSTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHHHHHHCCCC
T ss_pred CCCC-------CCCccCCcCccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhcCCCCC
Confidence 5432 2345899999999998532 23899999999999999999999999754322211 111122333344
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTYS 681 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~~ 681 (683)
+| ..+|+++++||.+||..||.+|++ +.+|++||||+..
T Consensus 413 ~p--~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 413 LP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp CC--TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred CC--ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 44 579999999999999999999998 7999999999863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=459.20 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=219.0
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
-++|.+++.||+|+||+||+|.+..+|+.||||++..... .....+.+|+.+|+.|+|||||+|+++|. +.+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~ 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-------SDKETVRKEIQTMSVLRHPTLVNLHDAFE-DDN 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-------HHHHHHHHHHHHHHHTCCTTBCCEEEEEE-CSS
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-------hhHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECC
Confidence 3589999999999999999999999999999998855321 12356789999999999999999999997 788
Q ss_pred eEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC--CCcEEEEecCCcc
Q 005678 482 TFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE--FGVAKVTDFGLSK 558 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~--~g~vKL~DFGls~ 558 (683)
.+|||||||+||+|.++|. ..+.+++..++.|+.||+.||.|||+.+ ||||||||+||||+. .|.+||+|||+|+
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeecccee
Confidence 9999999999999999985 4567999999999999999999999965 999999999999985 4899999999999
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
.+.... .....+||++|||||++.... |+.++||||||||||+|++|.+||......+.+.. +....
T Consensus 306 ~~~~~~------~~~~~~GT~~y~APEv~~~~~---y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~----i~~~~ 372 (573)
T 3uto_A 306 HLDPKQ------SVKVTTGTAEFAAPEVAEGKP---VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCD 372 (573)
T ss_dssp ECCTTS------EEEEECSSGGGCCHHHHTTCC---BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHTTC
T ss_pred EccCCC------ceeeeEECccccCHHHhCCCC---CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHhCC
Confidence 875431 123348999999999987544 89999999999999999999999987776554322 22333
Q ss_pred cCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 639 VEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 639 ~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+.++. ++.+|+++++||.+||.+||.+||++.++++||||+.
T Consensus 373 ~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 373 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 34433 3579999999999999999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=412.03 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=193.2
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC-
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ- 480 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~- 480 (683)
..+|.+.+.||+|+||+||+|.+ +|+.||||++.... ... .....|+.++..++|||||+++++|..+.
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~------~~~--~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERS--WFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG------HHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhh--HHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence 35689999999999999999964 79999999984321 111 12234667777899999999999986443
Q ss_pred --ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc------CCceEecccCCcceEeCCCCcEEEE
Q 005678 481 --NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR------AQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 481 --~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~------g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
..+|||||||+||+|.++|...+ +++..+..|+.|++.||.|||+. .++||||||||+||||+.+|.+||+
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~~~-l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCCcHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 26899999999999999998764 89999999999999999999975 2369999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCch------
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK---TPLISSKVDVWSAGILFYQMLFGRRPFGHDQT------ 623 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~---~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~------ 623 (683)
|||+|+.......... ......+||++|||||++.... ...|+.++|||||||+||||+||.+||+....
T Consensus 151 DFGla~~~~~~~~~~~-~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~ 229 (303)
T 3hmm_A 151 DLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCTTCEEEETTTTEES-CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred eCCCCccccCCCCcee-eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence 9999987764322111 1123457999999999986432 12367899999999999999999877643211
Q ss_pred --------HHHHHHHHHHHHhhc--cCCCCC---cCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 624 --------QERILREDTIIKARK--VEFPSR---PAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 624 --------~e~il~~~~i~~~~~--~~~p~~---~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.+.+. ....... ..+|.. ..++..+.+||.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~---~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 230 DLVPSDPSVEEMR---KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTSCSSCCHHHHH---HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hcccccchHHHHH---HHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11111 1111111 222221 123457899999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=398.81 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=222.1
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
..++|.+++.||+|+||+||+|.+..++..||||++....... ...+.+|+.+++.++||||++++++|. +.
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~ 89 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-------KELIINEILVMRENKNPNIVNYLDSYL-VG 89 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEE-ET
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-------HHHHHHHHHHHhcCCCCCCCeEeEEEE-EC
Confidence 4678999999999999999999999999999999986543221 245788999999999999999999986 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+.+|+|||||+|++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 7899999999999999999776 4899999999999999999999965 999999999999999999999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......||+.|+|||++.... ++.++|||||||++|+|++|..||........... +.......
T Consensus 167 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~~~~~ 235 (297)
T 3fxz_A 167 TPEQS-----KRSTMVGTPYWMAPEVVTRKA---YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPE 235 (297)
T ss_dssp CSTTC-----CBCCCCSCGGGCCHHHHHCSC---BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHHCSCC
T ss_pred CCccc-----ccCCccCCcCccChhhhcCCC---CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhCCCCC
Confidence 54321 123457999999999987544 89999999999999999999999987766554332 22333344
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
+..+..++..+.+||.+||..||.+|||+.++++||||+.++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 455568999999999999999999999999999999998765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=404.77 Aligned_cols=261 Identities=29% Similarity=0.420 Sum_probs=220.1
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
...-++|.+++.||+|+||.||+|.+..+|..||||++...... ......+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~- 84 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-----PTSLQKLFREVRIMKILNHPNIVKLFEVIE- 84 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-
Confidence 34456899999999999999999999999999999998654321 123567889999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 67789999999999999999987778999999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
...... .....+||++|+|||++.... ..+.++|||||||++|+|++|..||.......... .+....
T Consensus 163 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~i~~~~ 230 (328)
T 3fe3_A 163 EFTVGG------KLDAFCGAPPYAAPELFQGKK--YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE----RVLRGK 230 (328)
T ss_dssp GGSSSC------GGGTTSSSGGGCCHHHHHTCC--CCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCC
T ss_pred ecCCCC------ccccccCCcceeCcccccCCC--cCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCC
Confidence 664331 233458999999999986443 23579999999999999999999998766543221 122223
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..+ +..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 231 ~~~--p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 231 YRI--PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp CCC--CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred CCC--CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 333 34689999999999999999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=407.48 Aligned_cols=265 Identities=29% Similarity=0.439 Sum_probs=221.9
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
..+.++|.+.+.||+|+||.||+|.+..+|..||||++......... .......+.+|+.+++.++||||++++++|.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~- 85 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR-RGVCREEIEREVSILRQVLHPNIITLHDVYE- 85 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCS-SSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccccc-chhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-
Confidence 34678999999999999999999999999999999998665332111 0012356889999999999999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC----cEEEEec
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG----VAKVTDF 554 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g----~vKL~DF 554 (683)
+.+.+|+|||||+|++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 67889999999999999999988888999999999999999999999965 99999999999998776 7999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
|++..+.... ......||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+.. +
T Consensus 164 G~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~----i 230 (361)
T 2yab_A 164 GLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEP---LGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----I 230 (361)
T ss_dssp SSCEECCTTC------CCCCCCSCGGGCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----H
T ss_pred CCceEcCCCC------ccccCCCCccEECchHHcCCC---CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----H
Confidence 9998765431 123447999999999986443 89999999999999999999999987665543321 2
Q ss_pred HhhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 635 KARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 635 ~~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
....+.++. ++.++..+++||.+||..||.+|||+.++++||||+.
T Consensus 231 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 231 TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 223333332 2578999999999999999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=392.42 Aligned_cols=268 Identities=28% Similarity=0.483 Sum_probs=216.1
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchh-------------------hHHHHHHHHHHHHHH
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSED-------------------KKQSYIRHAIREYNI 460 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~-------------------~~~~~i~~~~rEi~i 460 (683)
+..++|.+.+.||+|+||.||+|.+..+++.||||++......... ........+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4457899999999999999999999999999999998654321110 011224568899999
Q ss_pred HhhcCCCceeeecccccc-CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCc
Q 005678 461 HKTLVHHHIVRLWDTFEI-DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPG 539 (683)
Q Consensus 461 l~~L~HpnIV~L~~~f~~-d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~ 539 (683)
++.++||||++++++|.. ....+|+||||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 999999999999999864 25689999999999999987654 46999999999999999999999965 999999999
Q ss_pred ceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005678 540 NVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFG 619 (683)
Q Consensus 540 NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~ 619 (683)
|||++.++.+||+|||++....... .......||+.|+|||++.......++.++|||||||++|+|++|..||.
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD-----ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS-----CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HEEECCCCCEEEecCCCcccccccc-----ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999998765331 12234579999999999865443234788999999999999999999998
Q ss_pred CCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 620 HDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 620 ~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
........ ..+......++..+.+++.+.+||.+||..||.+||++.++++||||+
T Consensus 242 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 242 DERIMCLH----SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp CSSHHHHH----HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CccHHHHH----HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 76543322 122334456666678999999999999999999999999999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=398.59 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=218.6
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
-++|.+++.||+|+||.||+|.+..+++.||||++..... ........+.+|+.+++.++||||++++++|. +.+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh----hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-eCC
Confidence 4689999999999999999999999999999999854211 11223567889999999999999999999996 677
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|+||||++||+|..++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++...
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 89999999999999999988778999999999999999999999965 9999999999999999999999999998643
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... ......+||+.|+|||++.... ++.++|||||||++|+|++|..||.......... .+....+.+
T Consensus 157 ~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~ 224 (337)
T 1o6l_A 157 SDG-----ATMKTFCGTPEYLAPEVLEDND---YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRF 224 (337)
T ss_dssp CTT-----CCBCCCEECGGGCCGGGGSSSC---BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCC
T ss_pred cCC-----CcccccccChhhCChhhhcCCC---CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH----HHHcCCCCC
Confidence 221 1233457999999999986443 8999999999999999999999998765543221 122234444
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
| ..+++++.+||.+||..||.+|| ++.++++||||...
T Consensus 225 p--~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 225 P--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp C--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred C--CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 4 46899999999999999999999 99999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=403.92 Aligned_cols=262 Identities=27% Similarity=0.382 Sum_probs=209.0
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
....++|.+++.||+|+||+||+|.+..++..||||++....... ..+.+|+.+++.++||||++++++|.
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~- 86 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID--------ENVQREIINHRSLRHPNIVRFKEVIL- 86 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC--------HHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc--------HHHHHHHHHHHhCCCCCCCcEEEEEe-
Confidence 345689999999999999999999999999999999986543221 35678999999999999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc--EEEEecCC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV--AKVTDFGL 556 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~--vKL~DFGl 556 (683)
+.+.+|+|||||++++|..++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred eCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 67889999999999999999987778999999999999999999999965 999999999999987665 99999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSK-VDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~k-sDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++...... ......||++|+|||++.... ++.+ +|||||||++|+|++|+.||...............+.
T Consensus 165 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 235 (361)
T 3uc3_A 165 SKSSVLHS------QPKSTVGTPAYIAPEVLLRQE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235 (361)
T ss_dssp C---------------------CTTSCHHHHHCSS---CCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH
T ss_pred cccccccC------CCCCCcCCCCcCChhhhcCCC---CCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 97543221 123347999999999986543 5444 8999999999999999999976543222222112233
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.....+|....+++++.+||.+||..||.+|||+.++++||||..
T Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 445566666789999999999999999999999999999999954
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=402.24 Aligned_cols=260 Identities=30% Similarity=0.433 Sum_probs=219.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+.+.||+|+||.||+|.+..++..||||++....... .....+.+|+.+++.++|||||+++++|. +
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~ 99 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLHDSIQ-E 99 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEE-e
Confidence 45678999999999999999999999999999999986543321 22457889999999999999999999996 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC---CcEEEEecCC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF---GVAKVTDFGL 556 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~---g~vKL~DFGl 556 (683)
.+.+|+|||||+|++|.+++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 100 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 7889999999999999999988888999999999999999999999965 9999999999999864 4599999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+....... ......||+.|+|||++.... ++.++|||||||++|+|++|..||.......... .+..
T Consensus 178 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----~i~~ 244 (362)
T 2bdw_A 178 AIEVNDSE------AWHGFAGTPGYLSPEVLKKDP---YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA----QIKA 244 (362)
T ss_dssp CBCCTTCC------SCCCSCSCTTTCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHH
T ss_pred ceEecCCc------ccccCCCCccccCHHHHccCC---CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHh
Confidence 98765331 123347999999999986443 8999999999999999999999998765543221 1223
Q ss_pred hccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 RKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
....++. +..+++++.+||.+||..||.+||++.++++||||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp TCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 3344443 3578999999999999999999999999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=394.91 Aligned_cols=265 Identities=28% Similarity=0.404 Sum_probs=220.6
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+.+.||+|+||.||+|.+..++..||||++......... .......+.+|+.+++.++||||++++++|. +
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~ 85 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR-RGVSREDIEREVSILKEIQHPNVITLHEVYE-N 85 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCS-SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-e
Confidence 4567899999999999999999999999999999998654332111 0011356889999999999999999999996 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC----cEEEEecC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG----VAKVTDFG 555 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g----~vKL~DFG 555 (683)
...+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 7789999999999999999988888999999999999999999999965 99999999999999877 89999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++..+..... .....||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+.. +.
T Consensus 164 ~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----~~ 230 (326)
T 2y0a_A 164 LAHKIDFGNE------FKNIFGTPEFVAPEIVNYEP---LGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VS 230 (326)
T ss_dssp TCEECCTTSC------CCCCCSCTTTCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HH
T ss_pred CCeECCCCCc------cccccCCcCcCCceeecCCC---CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HH
Confidence 9987653321 23347999999999986443 89999999999999999999999987665443322 11
Q ss_pred hhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 636 ARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 636 ~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.....++. .+.++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 22233332 24689999999999999999999999999999999854
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=383.74 Aligned_cols=264 Identities=27% Similarity=0.443 Sum_probs=210.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||+||+|.+..++..||||++....... .....+.+|+.+++.++||||++++++|. +.+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-----GVPSSALREICLLKELKHKNIVRLHDVLH-SDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-----THHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-----CcchHHHHHHHHHhcCCCCCEeeEEeEEE-eCCE
Confidence 47999999999999999999999999999999987654322 22456789999999999999999999996 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++||||++++.+..+....+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9999999976444444455678999999999999999999999965 99999999999999999999999999987643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-HHHHh-hccC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED-TIIKA-RKVE 640 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~-~i~~~-~~~~ 640 (683)
.. .......||+.|+|||++... ..++.++|||||||++|+|++|..||.........+... ..... ....
T Consensus 154 ~~-----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~ 226 (292)
T 3o0g_A 154 PV-----RCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CC-----SCCCSCCSCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cc-----ccccCCccccCCcChHHHcCC--CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 21 123345789999999998643 237999999999999999999888864444433332211 11000 0000
Q ss_pred C----------------------CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 641 F----------------------PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 641 ~----------------------p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+ ...+.++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 0 1123578999999999999999999999999999999853
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=402.76 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=215.7
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~ 478 (683)
+.-++|.+++.||+|+||.||+|.+..++..||||++..... ........+.+|..++..+ .||||++++++|.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~----~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~- 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ- 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH----HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh----cchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-
Confidence 345689999999999999999999999999999999854311 1223356788999999988 7999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+.+|+|||||+||+|..++...+.+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEcccccee
Confidence 67789999999999999999988788999999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
...... ......+||+.|+|||++.... |+.++|||||||++|+|++|..||......+.+.. +....
T Consensus 173 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~----i~~~~ 240 (353)
T 3txo_A 173 EGICNG-----VTTATFCGTPDYIAPEILQEML---YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDE 240 (353)
T ss_dssp CSCC--------------CCGGGCCHHHHHHHH---CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCC
T ss_pred ecccCC-----ccccccCCCcCeEChhhcCCCC---cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH----HHcCC
Confidence 543221 1233458999999999987554 89999999999999999999999987765543321 22334
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDV------LTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~------~eLl~hP~l~~~ 681 (683)
+.+| ..++.++.+||.+||..||.+||++ .++++||||+..
T Consensus 241 ~~~p--~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 241 VVYP--TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp CCCC--TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred CCCC--CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 4444 4689999999999999999999998 899999999853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=393.18 Aligned_cols=256 Identities=30% Similarity=0.505 Sum_probs=218.5
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
-++|.+++.||+|+||.||+|.+..+|+.||||++..... ........+.+|+.+++.++||||++++++|. +..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-eCC
Confidence 3679999999999999999999999999999999854211 11223567889999999999999999999996 678
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|+||||++|++|.+++.....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++...
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 89999999999999999988888999999999999999999999865 9999999999999999999999999998764
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.. ....+||+.|+|||++.... ++.++|||||||++|+|++|..||........+. . +....+.+
T Consensus 158 ~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~-i~~~~~~~ 222 (318)
T 1fot_A 158 DV--------TYTLCGTPDYIAPEVVSTKP---YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE---K-ILNAELRF 222 (318)
T ss_dssp SC--------BCCCCSCTTTCCHHHHTTCC---BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---H-HHHCCCCC
T ss_pred Cc--------cccccCCccccCHhHhcCCC---CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---H-HHhCCCCC
Confidence 32 23347999999999986443 8999999999999999999999998766544332 1 12233444
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
| +.++.++.+||.+||..||.+|| ++.++++||||+..
T Consensus 223 p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 223 P--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp C--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred C--CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 4 57899999999999999999999 99999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=379.90 Aligned_cols=261 Identities=29% Similarity=0.437 Sum_probs=219.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++||||++++++|. +.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 77 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLHDSIQ-EE 77 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEEE-CS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-----HHHHHHHHHHHHHHHcCCCCcCeEEEEEE-cC
Confidence 5789999999999999999999999999999999986543221 22457889999999999999999999986 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc---EEEEecCCc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV---AKVTDFGLS 557 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~---vKL~DFGls 557 (683)
+..++||||+++++|...+.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++. +||+|||++
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 788999999999999999987778999999999999999999999966 999999999999986554 999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
........ .....||+.|+|||++.... ++.++||||||+++|+|++|..||........... ....
T Consensus 156 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~ 222 (284)
T 3kk8_A 156 IEVNDSEA------WHGFAGTPGYLSPEVLKKDP---YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAG 222 (284)
T ss_dssp EECCSSCB------CCCSCSCGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHT
T ss_pred EEcccCcc------ccCCCCCcCCcCchhhcCCC---CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH----HHhc
Confidence 77654321 22347999999999986443 79999999999999999999999987665443321 2222
Q ss_pred ccCC--CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 638 KVEF--PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 638 ~~~~--p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
...+ +....+++++.+||.+||..||.+|||+.++++||||+..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 223 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 3333 33457899999999999999999999999999999998765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=405.20 Aligned_cols=267 Identities=27% Similarity=0.445 Sum_probs=222.2
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+..++|.+++.||+|+||.||+|.+..++..||||++..... ........+.+|+.+++.++|||||+++++|.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~- 85 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC----VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ- 85 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc----ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-
Confidence 4556889999999999999999999999999999999754221 12223567889999999999999999999997
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+.+|+|||||.||+|..++.....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||++.
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceee
Confidence 67789999999999999999998888999999999999999999999966 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
.+.... .....+||+.|+|||++.......|+.++|||||||++|+|++|..||............ .......
T Consensus 164 ~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-~~~~~~~ 236 (384)
T 4fr4_A 164 MLPRET------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-HTFETTV 236 (384)
T ss_dssp ECCTTC------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH-HHHHHCC
T ss_pred eccCCC------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH-HHHhhcc
Confidence 765432 233458999999999987554455899999999999999999999999743322111111 1122223
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPD-VLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS-~~eLl~hP~l~~~ 681 (683)
..+ +..++..+.+||.+||..||.+||+ +.++++||||...
T Consensus 237 ~~~--p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 237 VTY--PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp CCC--CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred cCC--CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 333 3578999999999999999999998 9999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=411.86 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=218.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+++.||+|+||.||+|.+..+|..||+|++...... ......+.+|+.+++.++|||||+++++|. +
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~ 81 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-----ARDHQKLEREARICRLLKHPNIVRLHDSIS-E 81 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-----HHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-C
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-----HHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-E
Confidence 4567899999999999999999999999999999998654321 122456889999999999999999999996 7
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC---CCCcEEEEecCC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD---EFGVAKVTDFGL 556 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd---~~g~vKL~DFGl 556 (683)
.+.+|+|||||+||+|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 7889999999999999999988888999999999999999999999965 99999999999998 468899999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+........ ......||+.|+|||++.... |+.++|||||||++|+|++|.+||........... +..
T Consensus 160 a~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~---~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~ 227 (444)
T 3soa_A 160 AIEVEGEQQ-----AWFGFAGTPGYLSPEVLRKDP---YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKA 227 (444)
T ss_dssp CBCCCTTCC-----BCCCSCSCGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHH
T ss_pred eEEecCCCc-----eeecccCCcccCCHHHhcCCC---CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHh
Confidence 987654321 123357999999999986443 89999999999999999999999987665443321 223
Q ss_pred hccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 637 RKVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 637 ~~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
....++ .++.+++++.+||.+||..||.+|||+.++++||||+
T Consensus 228 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 228 GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 333333 3468999999999999999999999999999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=395.13 Aligned_cols=264 Identities=27% Similarity=0.439 Sum_probs=217.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||+||+|.+..++..||||++...... .....+.+|+.+++.++||||++++++|. +.
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~ 77 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV------DCPENIKKEICINKMLNHENVVKFYGHRR-EG 77 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------CHHHHHHHHHHCCCTTBCCEEEEEE-CS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc------chHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 346899999999999999999999999999999998544221 12346788999999999999999999986 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+.+|+|||||+|++|.+++.....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeecccee
Confidence 889999999999999999988878999999999999999999999965 999999999999999999999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
...... .......||+.|+|||++.... .++.++|||||||++|+|++|..||.........+. ........
T Consensus 156 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~ 227 (323)
T 3tki_A 156 RYNNRE---RLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTY 227 (323)
T ss_dssp EETTEE---CCBCSCCSCGGGSCHHHHHCSS--BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTT
T ss_pred ccCCcc---cccCCCccCcCccCcHHhccCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhccccc
Confidence 433211 2233458999999999986433 247789999999999999999999976554322221 12222333
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.+....++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 44456799999999999999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=396.74 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=216.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++||||++++++|. +.
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~ 73 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--------TDQVLVKKEISILNIARHRNILHLHESFE-SM 73 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--------HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-ET
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--------ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-cC
Confidence 4678999999999999999999999999999999985431 11345788999999999999999999996 67
Q ss_pred ceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC--CCcEEEEecCCc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE--FGVAKVTDFGLS 557 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~--~g~vKL~DFGls 557 (683)
+.+++|||||+|++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 7899999999999999999755 46999999999999999999999965 999999999999987 789999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
..+.... ......||+.|+|||++.... ++.++|||||||++|+|++|..||........+.. +...
T Consensus 152 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~ 218 (321)
T 1tki_A 152 RQLKPGD------NFRLLFTAPEYYAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNA 218 (321)
T ss_dssp EECCTTC------EEEEEESCGGGSCHHHHTTCE---ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHT
T ss_pred eECCCCC------ccccccCChhhcCcHHhcCCC---CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHcC
Confidence 8765431 122347999999999986443 78999999999999999999999987665443321 1222
Q ss_pred ccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 638 KVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 638 ~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
...++. ++.+|.++.+||.+||..||.+|||+.++++||||+..
T Consensus 219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 333332 24789999999999999999999999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=410.40 Aligned_cols=270 Identities=26% Similarity=0.406 Sum_probs=224.6
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
+.+..++|.+++.||+|+||+||+|.+..++..||+|++..... ........+.+|+.++..++|||||+++++|.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM----IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH----HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh----hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34566789999999999999999999999999999999753211 11111235778999999999999999999997
Q ss_pred cCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
+...+|+|||||+||+|.+++... .+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|
T Consensus 140 -~~~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 140 -DDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp -CSSEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred -ECCEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEecccee
Confidence 778899999999999999999765 4899999999999999999999966 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT-PLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+.+.... .......+||+.|+|||++..... +.|+.++|||||||++|+|++|..||........+.. .+...
T Consensus 216 ~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~--i~~~~ 289 (410)
T 3v8s_A 216 MKMNKEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK--IMNHK 289 (410)
T ss_dssp EECCTTS----EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HHTHH
T ss_pred EeeccCC----cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHH--HHhcc
Confidence 8765331 122345589999999999875432 2378899999999999999999999987665543322 12223
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAE--RPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~k--RPS~~eLl~hP~l~~~ 681 (683)
..+.+|..+.++.++++||.+||..+|.+ ||++.++++||||+..
T Consensus 290 ~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 290 NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 34677877789999999999999999988 9999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=382.71 Aligned_cols=266 Identities=25% Similarity=0.434 Sum_probs=214.6
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
-++|.+++.||+|+||+||+|.+..++..||||++..... .......+.+|+.+++.++||||++++++|. +.+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-----DPVIKKIALREIRMLKQLKHPNLVNLLEVFR-RKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-----chHHHHHHHHHHHHHHhCCCCCccchhheee-cCC
Confidence 3689999999999999999999999999999998855432 1233456789999999999999999999996 677
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++||||+++++|..++.....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred eEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 89999999999999999988888999999999999999999999966 9999999999999999999999999998765
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh-----
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA----- 636 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~----- 636 (683)
... .......||+.|+|||++... ..++.++|||||||++|+|++|..||......+...........
T Consensus 154 ~~~-----~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
T 4agu_A 154 GPS-----DYYDDEVATRWYRSPELLVGD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226 (311)
T ss_dssp -----------------GGGCCHHHHHTC--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred Ccc-----cccCCCcCCccccChHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence 322 112344799999999998642 23799999999999999999999999887766554332211100
Q ss_pred ----------hccCCCC----------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 637 ----------RKVEFPS----------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 637 ----------~~~~~p~----------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.....+. .+.++..+.+||.+||..||.+|||+.++++||||+..+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 0011111 146889999999999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=387.53 Aligned_cols=267 Identities=30% Similarity=0.476 Sum_probs=211.7
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
-+.+.++|.+++.||+|+||+||+|.+. +++.||||++...... ......+.+|+.+++.++||||++++++|.
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-----EGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-----------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccccc-----chhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 3567889999999999999999999984 5899999998654221 122457789999999999999999999986
Q ss_pred cCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
+...+++|||||++ +|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 -~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 90 -SERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp -CSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred -cCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcC
Confidence 67789999999975 77777754 456999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+....... .......||+.|+|||++... ..++.++|||||||++|+|++|..||......+.+.....+...
T Consensus 166 a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 238 (311)
T 3niz_A 166 ARAFGIPV-----RSYTHEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238 (311)
T ss_dssp CEETTSCC-----C---CCCCCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCC
T ss_pred ceecCCCc-----ccccCCcccCCcCCHHHhcCC--CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCC
Confidence 98764321 112334789999999998642 23799999999999999999999999776655443322111110
Q ss_pred hc-cCCC-----------------------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 RK-VEFP-----------------------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~~-~~~p-----------------------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.. ..++ ..+.+++++.+||.+||.+||.+|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 00 0000 013578899999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=395.53 Aligned_cols=258 Identities=29% Similarity=0.401 Sum_probs=219.7
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
..-++|.+++.||+|+||.||+|.+..+|..||||++.... .........+.+|+.+++.++||||++++++|. +
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK----VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-D 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH----HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH----hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-c
Confidence 34578999999999999999999999999999999985421 112223567889999999999999999999996 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
...+|+||||++|++|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEccccccee
Confidence 7889999999999999999987778999999999999999999999965 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
.... ....+||+.|+|||++.... ++.++|||||||++|+|++|..||......+... . +....+
T Consensus 191 ~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~-i~~~~~ 255 (350)
T 1rdq_E 191 VKGR--------TWTLCGTPEALAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE---K-IVSGKV 255 (350)
T ss_dssp CSSC--------BCCCEECGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H-HHHCCC
T ss_pred ccCC--------cccccCCccccCHHHhcCCC---CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH---H-HHcCCC
Confidence 6432 22347999999999987543 8999999999999999999999998766544321 1 222334
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~~ 681 (683)
.+| ..++.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 256 ~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 256 RFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred CCC--CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 444 568999999999999999999998 9999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=398.24 Aligned_cols=276 Identities=19% Similarity=0.259 Sum_probs=218.2
Q ss_pred ccccccceeEEEEeccc--CceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 398 FQILNHRYALLNLLGKG--GFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkG--gfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
+....++|.+++.||+| +||.||+|.+..++..||||++...... ......+.+|+.+++.++|||||+++++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-----NEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-----HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-----hHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 34567899999999999 9999999999999999999998654321 2345678899999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
|. +.+.+|+|||||++++|.+++... ..+++..++.|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|
T Consensus 95 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 95 FI-ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EE-ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECC
T ss_pred EE-ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcc
Confidence 96 677899999999999999999765 67999999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCC--cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQ--GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631 (683)
Q Consensus 554 FGls~~~~~~~~~~--~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~ 631 (683)
||++.......... .........||+.|+|||++.... ..++.++|||||||++|+|++|..||........+....
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL-QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 99987654321111 112233347999999999986531 238999999999999999999999997655443332110
Q ss_pred HHHH----------------------------------------hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHH
Q 005678 632 TIIK----------------------------------------ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLT 671 (683)
Q Consensus 632 ~i~~----------------------------------------~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~e 671 (683)
.... ......+....+++.+.+||.+||.+||.+|||+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 0000 000011223468899999999999999999999999
Q ss_pred HhcCcccCCCC
Q 005678 672 LAQDPYLTYSK 682 (683)
Q Consensus 672 Ll~hP~l~~~K 682 (683)
+++||||+..+
T Consensus 331 ll~hp~f~~~~ 341 (389)
T 3gni_B 331 LLNHSFFKQIK 341 (389)
T ss_dssp HTTSGGGGGC-
T ss_pred HhcCHHHHHHh
Confidence 99999998653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=412.04 Aligned_cols=272 Identities=25% Similarity=0.403 Sum_probs=223.4
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
...+..++|.+++.||+|+||+||+|.+..++..||||++..... ........+.+|+.++..++|||||+++++|
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM----LKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH----HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh----hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345567899999999999999999999999999999999853211 1111223478899999999999999999999
Q ss_pred ccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. +.+.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||
T Consensus 144 ~-~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 Q-DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp E-CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred e-eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchh
Confidence 6 67889999999999999999976 567999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCccccccc--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS--KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~--~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
+|+....... ......+||++|+|||++... ....|+.++|||||||++|+|++|..||......+.+.. .+
T Consensus 221 la~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~--i~ 294 (437)
T 4aw2_A 221 SCLKLMEDGT----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK--IM 294 (437)
T ss_dssp TCEECCTTSC----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HH
T ss_pred hhhhcccCCC----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHh--hh
Confidence 9987643321 123345899999999998631 123489999999999999999999999987766554322 11
Q ss_pred HHhhccCCCCC-cCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 005678 634 IKARKVEFPSR-PAVSNEAKDLIRRCLTYNQAE--RPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 ~~~~~~~~p~~-~~~s~el~dLI~rCL~~dP~k--RPS~~eLl~hP~l~~~ 681 (683)
.....+.+|.. +.+++++++||.+||..+|.+ ||++.++++||||+..
T Consensus 295 ~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 295 NHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp THHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred hccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 22334556654 569999999999999888888 9999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=403.24 Aligned_cols=265 Identities=26% Similarity=0.386 Sum_probs=215.9
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~ 478 (683)
+.-++|.+++.||+|+||+||+|.+..+++.||||++....... ...+..+.+|..++..+ +|||||+++++|.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~----~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~- 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ- 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC--------CCHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC----HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-
Confidence 44568999999999999999999999999999999986543221 12234677899999887 8999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+.+|+|||||+||+|..++...+.+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceee
Confidence 67889999999999999999988778999999999999999999999966 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH-----HHHHHH
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI-----LREDTI 633 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i-----l~~~~i 633 (683)
...... ......+||+.|+|||++.... ++.++|||||||++|+|++|..||......+.. ......
T Consensus 202 ~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~---~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 202 EGLRPG-----DTTSTFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCCCTT-----CCBCCCCBCGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred ecccCC-----CccccccCCcccCCchhhcCCC---CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 533221 1234458999999999987544 899999999999999999999999643211100 000112
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCcccCCC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDV------LTLAQDPYLTYS 681 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~------~eLl~hP~l~~~ 681 (683)
+....+.+| ..++.++.+||.+||..||.+||++ .++++||||+..
T Consensus 274 i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 274 ILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHHCCCCCC--TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HhccccCCC--CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 223344444 4699999999999999999999984 799999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=392.10 Aligned_cols=261 Identities=28% Similarity=0.411 Sum_probs=216.2
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
.-++|.+++.||+|+||.||+|.+..+++.||||++....... ......+.+|..++..+ +|||||+++++|. +
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-~ 81 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-T 81 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-C
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc----hHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-e
Confidence 3467999999999999999999999999999999986543222 23356788999999988 8999999999996 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+|+||||++|++|..++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 7889999999999999999987778999999999999999999999965 99999999999999999999999999986
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH-------HHHHHHHH
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ-------ERILREDT 632 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-------e~il~~~~ 632 (683)
..... ......+||+.|+|||++.... ++.++|||||||++|+|++|..||...... ...+. .
T Consensus 160 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~ 229 (345)
T 3a8x_A 160 GLRPG-----DTTSTFCGTPNYIAPEILRGED---YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--Q 229 (345)
T ss_dssp SCCTT-----CCBCCCCSCGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH--H
T ss_pred ccCCC-----CcccccCCCccccCccccCCCC---CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH--H
Confidence 43221 1234458999999999986543 899999999999999999999999642211 11111 1
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCcccCC
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDV------LTLAQDPYLTY 680 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~------~eLl~hP~l~~ 680 (683)
.+....+.+| ..++.++.+||.+||..||.+||++ .++++||||+.
T Consensus 230 ~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 230 VILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHHHCCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHHcCCCCCC--CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 1223334444 4689999999999999999999995 89999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=396.12 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=217.7
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFE 477 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~ 477 (683)
.+..++|.+.+.||+|+||.||+|.+..+++.||||++..... ........+..|..++..+ +||||++++++|.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh----hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 3456789999999999999999999999999999999854321 1112345678899999877 9999999999996
Q ss_pred cCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
+.+.+|+|||||+||+|..++...+.+++..++.++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||++
T Consensus 89 -~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 89 -TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp -CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred -eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 67789999999999999999987778999999999999999999999965 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
+...... ......+||+.|+|||++.... ++.++|||||||++|+|++|..||......+.... +...
T Consensus 166 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~----i~~~ 233 (345)
T 1xjd_A 166 KENMLGD-----AKTNTFCGTPDYIAPEILLGQK---YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMD 233 (345)
T ss_dssp BCCCCTT-----CCBCCCCSCGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHC
T ss_pred hhcccCC-----CcccCCCCCcccCChhhhcCCC---CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHhC
Confidence 8643221 1234458999999999986543 89999999999999999999999987665443211 2223
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCcccCCC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVL-TLAQDPYLTYS 681 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~-eLl~hP~l~~~ 681 (683)
...+| ..++.++.+||.+||..||.+||++. ++++||||+..
T Consensus 234 ~~~~p--~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 234 NPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp CCCCC--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred CCCCC--cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 33444 46899999999999999999999998 99999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=384.56 Aligned_cols=268 Identities=27% Similarity=0.449 Sum_probs=206.9
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc---CCCceeeecccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL---VHHHIVRLWDTF 476 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L---~HpnIV~L~~~f 476 (683)
++.++|.+++.||+|+||+||+|.+..+++.||||++.......... .....+.+|+.+++.+ .||||++++++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG--GLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS--CCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc--ccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 46789999999999999999999999999999999986433211100 0112345666666666 499999999998
Q ss_pred ccCCc----eEEEEEecccCCChhHHHhcCCC--cchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 477 EIDQN----TFCTVLEYCSGKDLDAVLKATPV--LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 477 ~~d~~----~~~LV~Ey~~ggsL~~~L~~~~~--Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
..... .+++||||+. ++|.+++..... +++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEE
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEE
Confidence 64332 5899999996 599999976643 999999999999999999999966 99999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|+|||++........ .....||+.|+|||++.... ++.++|||||||++|+|++|.+||......+.+...
T Consensus 161 l~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 231 (308)
T 3g33_A 161 LADFGLARIYSYQMA------LTPVVVTLWYRAPEVLLQST---YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231 (308)
T ss_dssp ECSCSCTTTSTTCCC------SGGGGCCCSSCCHHHHHTSC---CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred EeeCccccccCCCcc------cCCccccccccCchHHcCCC---CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999987653321 23347999999999987544 899999999999999999999999887765544332
Q ss_pred HHHHHhh-ccCCC--------------------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 631 DTIIKAR-KVEFP--------------------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 631 ~~i~~~~-~~~~p--------------------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
....... ...++ ..+.++..+.+||.+||.+||.+|||+.++++||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 1111100 00011 014678999999999999999999999999999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=379.08 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=208.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||.||+|.+ .++..||||++....... .....+.+|+.+++.++||||++++++|. +.+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-----GIPSTTIREISILKELKHSNIVKLYDVIH-TKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGG-----CCCHHHHHHHHGGGGCCCTTBCCEEEEEE-CSSC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccccc-----ccchhHHHHHHHHHhcCCCCEeeeeeEEc-cCCe
Confidence 5799999999999999999998 678999999986543211 11346778999999999999999999996 6778
Q ss_pred EEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+++||||+++ +|..++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++....
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp EEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred EEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 9999999975 89988865 367999999999999999999999965 9999999999999999999999999998764
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh-ccC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR-KVE 640 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~-~~~ 640 (683)
.... ......||+.|+|||++... ..++.++|||||||++|+|++|..||......+.+.......... ...
T Consensus 152 ~~~~-----~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 152 IPVR-----KYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp C--------------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccc-----ccccccccccccCchheeCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence 3211 12234789999999998532 237999999999999999999999998776655443322111100 000
Q ss_pred CC----------------------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 641 FP----------------------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 641 ~p----------------------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
++ ....++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00 013578999999999999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=396.40 Aligned_cols=263 Identities=29% Similarity=0.424 Sum_probs=212.9
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
++.++|.+.+.||+|+||+||+|.+..+++.||||++......... ......+.+|+.+++.++||||++++++|. +
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~ 97 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP--GLSTEDLKREASICHMLKHPHIVELLETYS-S 97 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS--SCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-E
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc--cchHHHHHHHHHHHHhCCCCCCCcEEEEEE-e
Confidence 4678999999999999999999999999999999997532111000 001356889999999999999999999996 6
Q ss_pred CceEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc---EEEE
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV---AKVT 552 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~---vKL~ 552 (683)
.+.+|+|||||+|++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEe
Confidence 7789999999999999888743 235899999999999999999999965 999999999999986554 9999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|||++....... .......||+.|+|||++.... ++.++|||||||++|+|++|..||..... .++. .
T Consensus 176 Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~--~ 243 (351)
T 3c0i_A 176 GFGVAIQLGESG-----LVAGGRVGTPHFMAPEVVKREP---YGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFE--G 243 (351)
T ss_dssp CCTTCEECCTTS-----CBCCCCCSCGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHH--H
T ss_pred cCcceeEecCCC-----eeecCCcCCcCccCHHHHcCCC---CCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHH--H
Confidence 999998765431 1123447999999999986443 89999999999999999999999976432 2211 1
Q ss_pred HHHhhccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 633 IIKARKVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 633 i~~~~~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+. .....++ .++.++.++.+||.+||..||.+||++.++++||||+.
T Consensus 244 i~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 244 II-KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HH-HTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HH-cCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 11 1222222 12468999999999999999999999999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=393.62 Aligned_cols=260 Identities=30% Similarity=0.450 Sum_probs=205.8
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
...+.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++||||++++++|.
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~ 118 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---------DKKIVRTEIGVLLRLSHPNIIKLKEIFE 118 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------------CHHHHHCCCTTBCCEEEEEE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---------hHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence 3557789999999999999999999999999999999986432 1245778999999999999999999996
Q ss_pred cCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---CCcEEEEec
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---FGVAKVTDF 554 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~g~vKL~DF 554 (683)
+.+.+++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 119 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 119 -TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp -CSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred -cCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccC
Confidence 67789999999999999999988888999999999999999999999965 999999999999975 889999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
|+++...... ......||+.|+|||++.... ++.++|||||||++|+|++|..||.........+. .+.
T Consensus 196 g~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~i~ 264 (349)
T 2w4o_A 196 GLSKIVEHQV------LMKTVCGTPGYCAPEILRGCA---YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR--RIL 264 (349)
T ss_dssp C----------------------CGGGSCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH--HHH
T ss_pred ccccccCccc------ccccccCCCCccCHHHhcCCC---CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH--HHH
Confidence 9998764321 123447999999999986443 89999999999999999999999976655443322 111
Q ss_pred HhhccCC--CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 635 KARKVEF--PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 635 ~~~~~~~--p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.....+ +.++.++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 265 -~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 265 -NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp -TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred -hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 222222 3346789999999999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=398.09 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=213.0
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
-++|.+.+.||+|+||.||+|.+..++..||||++..... ........+.+|+.+++.++||||++++++|. +.+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL----KKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-TPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH----HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-CSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc----cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCC
Confidence 4689999999999999999999999999999999753211 11122346789999999999999999999997 677
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++||||+ +|+|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 899999999 7899999877778999999999999999999999976 9999999999999999999999999998765
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... .....+||+.|+|||++.... ..+.++|||||||++|+|++|..||......... .......+
T Consensus 160 ~~~------~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------~~i~~~~~ 225 (336)
T 3h4j_B 160 DGN------FLKTSCGSPNYAAPEVINGKL--YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------KKVNSCVY 225 (336)
T ss_dssp TSB------TTCCCTTSTTTSCGGGSCCSG--GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------CCCCSSCC
T ss_pred CCc------ccccccCCcCcCCHHHHcCCC--CCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------HHHHcCCC
Confidence 432 233457999999999986433 2378999999999999999999999764432110 01111122
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..+..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 334568999999999999999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=388.04 Aligned_cols=263 Identities=31% Similarity=0.451 Sum_probs=209.6
Q ss_pred cccccceeEEEEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
.+..++|.+++.||+|+||.||+|.+. .++..||||++....... .......+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR---NAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-----------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 456688999999999999999999875 689999999986543211 11224567889999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
|. +.+.+|+|||||+|++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||
T Consensus 90 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 90 FQ-TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp EE-CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EE-cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCC
Confidence 96 67789999999999999999987778999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+++...... .......||+.|+|||++.... ++.++|||||||++|+|++|..||........+.. + .
T Consensus 167 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i-~ 234 (327)
T 3a62_A 167 LCKESIHDG-----TVTHTFCGTIEYMAPEILMRSG---HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK---I-L 234 (327)
T ss_dssp CC---------------CTTSSCCTTSCHHHHTTSC---CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---H-H
T ss_pred cccccccCC-----ccccccCCCcCccCHhhCcCCC---CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH---H-H
Confidence 997643321 1233457999999999986443 79999999999999999999999987665443311 1 1
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
.....+ ++.++.++.+||.+||..||.+|| ++.++++||||+..
T Consensus 235 ~~~~~~--p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 235 KCKLNL--PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HTCCCC--CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred hCCCCC--CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 222333 357899999999999999999999 89999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=376.52 Aligned_cols=264 Identities=25% Similarity=0.340 Sum_probs=217.4
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
+...+..|.+...||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++||||++++++|.
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-----SERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-----HHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence 3455677999999999999999999999999999999886543221 22567889999999999999999999875
Q ss_pred c---CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-CCCcEEEEe
Q 005678 478 I---DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTD 553 (683)
Q Consensus 478 ~---d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-~~g~vKL~D 553 (683)
. +...+|+||||+++++|.+++...+.+++..+..++.||+.||.|||+.+.+|+|+||||+|||++ .++.+||+|
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred cccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEee
Confidence 3 356789999999999999999887789999999999999999999998655699999999999998 789999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||++...... ......||+.|+|||++.. .++.++|||||||++|+|++|..||........+...
T Consensus 176 fg~~~~~~~~-------~~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--- 241 (290)
T 1t4h_A 176 LGLATLKRAS-------FAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--- 241 (290)
T ss_dssp TTGGGGCCTT-------SBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---
T ss_pred CCCccccccc-------ccccccCCcCcCCHHHHhc----cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH---
Confidence 9999755432 1223479999999998752 3799999999999999999999999876655444321
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.............+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 11111111123457789999999999999999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=393.89 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=217.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~ 478 (683)
+.-++|.+++.||+|+||.||+|.+..+++.||||++..... ........+..|..++..+ .||||++++++|.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~- 91 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ- 91 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH----HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh----hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-
Confidence 345689999999999999999999999999999999854321 1122346788899999988 7999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+.+|+||||++||+|..++...+.+++..++.++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+++
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 67789999999999999999987778999999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
...... ......+||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+. . +....
T Consensus 170 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~---~-i~~~~ 237 (353)
T 2i0e_A 170 ENIWDG-----VTTKTFCGTPDYIAPEIIAYQP---YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---S-IMEHN 237 (353)
T ss_dssp CCCCTT-----CCBCCCCSCGGGCCHHHHTTCC---BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H-HHHCC
T ss_pred ccccCC-----cccccccCCccccChhhhcCCC---cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH---H-HHhCC
Confidence 643221 1233458999999999986443 8999999999999999999999998766543321 1 22233
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTY 680 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~ 680 (683)
+.+| ..++.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 238 ~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 238 VAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp CCCC--TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred CCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 4444 479999999999999999999994 699999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=376.92 Aligned_cols=259 Identities=25% Similarity=0.458 Sum_probs=210.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+.+.||+|+||.||+|.+..++..||+|++....... ....+.+|+.+++.++||||++++++|. +
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~ 91 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV------PMEQIEAEIEVLKSLDHPNIIKIFEVFE-D 91 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS------CHHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch------hHHHHHHHHHHHHhCCCchHHhHHHhee-c
Confidence 36789999999999999999999999999999999986543211 1356788999999999999999999996 6
Q ss_pred CceEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe---CCCCcEEEE
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVT 552 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL---d~~g~vKL~ 552 (683)
...+|+||||+++++|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEE
Confidence 7789999999999999998843 367999999999999999999999965 9999999999999 456889999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||......+....
T Consensus 170 Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~--- 236 (285)
T 3is5_A 170 DFGLAELFKSDE------HSTNAAGTALYMAPEVFK----RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK--- 236 (285)
T ss_dssp CCCCCCC----------------CTTGGGCCHHHHT----TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---
T ss_pred eeecceecCCcc------cCcCcccccCcCChHHhc----cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh---
Confidence 999998765432 123347999999999874 2378999999999999999999999987665443211
Q ss_pred HHHhhccCCC-CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 633 IIKARKVEFP-SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 633 i~~~~~~~~p-~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.......++ ....+++.+.+||.+||..||.+|||+.++++||||+.+
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 237 -ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp -HHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred -hccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 111122222 224589999999999999999999999999999999865
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=382.64 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=215.7
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
..|.....||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||++++++|. ..+.
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~ 116 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-------RRELLFNEVVIMRDYQHFNVVEMYKSYL-VGEE 116 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------SHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-------HHHHHHHHHHHHHhCCCCCcceEEEEEE-ECCE
Confidence 3477888999999999999999889999999998654321 1346789999999999999999999986 5678
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++||||+++++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 117 ~~lv~e~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 117 LWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp EEEEECCCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence 99999999999999998764 5999999999999999999999965 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
... ......||+.|+|||++... .++.++|||||||++|+|++|..||........+. .+.......+.
T Consensus 194 ~~~-----~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~ 262 (321)
T 2c30_A 194 DVP-----KRKSLVGTPYWMAPEVISRS---LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPPPKLK 262 (321)
T ss_dssp SSC-----CBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSSCCCCT
T ss_pred Ccc-----ccccccCCccccCHhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhcCCCCCcC
Confidence 321 12344799999999998644 38899999999999999999999998766544332 22222223334
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
....+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 263 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 263 NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 445789999999999999999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=399.42 Aligned_cols=271 Identities=26% Similarity=0.420 Sum_probs=207.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||.||+|.+..++..||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-----DLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-----SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-----ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 46799999999999999999999999999999999864322 1223467889999999999999999999986443
Q ss_pred ----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 481 ----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 481 ----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
..+|+||||++ ++|..++.....+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCC
Confidence 57999999995 699999998888999999999999999999999966 99999999999999999999999999
Q ss_pred ccccccCcCCCc-----------------ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCC-
Q 005678 557 SKIVEDDVGSQG-----------------MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF- 618 (683)
Q Consensus 557 s~~~~~~~~~~~-----------------~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF- 618 (683)
++.......... .......+||++|+|||++... ..|+.++||||||||+|+|++|..||
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ--ENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTC--SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC--CCCCcccccchHHHHHHHHHhcccccc
Confidence 987654321100 0123456899999999986433 23899999999999999999854443
Q ss_pred ----------CCCch-----------------HHHHHHH--------------------HHHHHhhccCCCC-----CcC
Q 005678 619 ----------GHDQT-----------------QERILRE--------------------DTIIKARKVEFPS-----RPA 646 (683)
Q Consensus 619 ----------~~~~~-----------------~e~il~~--------------------~~i~~~~~~~~p~-----~~~ 646 (683)
..... ...+... ...........+. .+.
T Consensus 254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (432)
T 3n9x_A 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333 (432)
T ss_dssp SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 22210 0100000 0000000011110 146
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 647 VSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 647 ~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+++++.+||.+||.+||.+|||+.++++||||+..
T Consensus 334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 89999999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=390.18 Aligned_cols=274 Identities=30% Similarity=0.429 Sum_probs=216.2
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
..+.++|.+.+.||+|+||.||+|.+..++..||||++....... ........+.+|+.+++.++||||++++++|.
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~- 98 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ--INPKDVERIKTEVRLMKKLHHPNIARLYEVYE- 98 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-----CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc--cCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-
Confidence 456789999999999999999999999999999999975432110 01123467889999999999999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhc----------------------------------------CCCcchHHHHHHHHHHH
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKA----------------------------------------TPVLPEREARIIIVQIF 518 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~----------------------------------------~~~Lse~~~~~I~~qIa 518 (683)
+.+.+|+|||||+|++|.+++.. ...+++..++.|+.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 67889999999999999999852 11246788889999999
Q ss_pred HHHHHHHhcCCceEecccCCcceEeCCCC--cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCC
Q 005678 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFG--VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLIS 596 (683)
Q Consensus 519 ~aL~yLH~~g~~IIHrDLKP~NILLd~~g--~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s 596 (683)
.||.|||+.+ |+||||||+|||++.++ .+||+|||++..+....... ........||+.|+|||++.... ..++
T Consensus 179 ~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~ 254 (345)
T 3hko_A 179 SALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-YYGMTTKAGTPYFVAPEVLNTTN-ESYG 254 (345)
T ss_dssp HHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------CCCGGGCCHHHHTCSS-SCCC
T ss_pred HHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccc-cccccccCCCccccCchhhccCC-CCCC
Confidence 9999999965 99999999999998766 89999999998765432211 11233457999999999986432 3488
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 597 SKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 597 ~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
.++|||||||++|+|++|..||......+.+.. .......+..+....+++.+.+||.+||..||.+||++.++++||
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ--VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHH--HHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 999999999999999999999987776554422 111112222233346899999999999999999999999999999
Q ss_pred ccCCC
Q 005678 677 YLTYS 681 (683)
Q Consensus 677 ~l~~~ 681 (683)
||+..
T Consensus 333 ~~~~~ 337 (345)
T 3hko_A 333 WISQF 337 (345)
T ss_dssp HHHTT
T ss_pred hhccC
Confidence 99754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=405.83 Aligned_cols=262 Identities=28% Similarity=0.451 Sum_probs=211.1
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+..++|.+++.||+|+||.||+|.+..++..||||++..... ........+.+|+.+++.++||||++++++|.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~- 218 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI----VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ- 218 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH----C-------------CCCCCSCTTSCCEEEEEE-
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh----hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-
Confidence 3456789999999999999999999999999999999854211 11223456788999999999999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHh-cCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK-RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~-~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
+.+.+|+|||||++++|..++.....+++..+..++.||+.||.|||+ .+ ||||||||+||||+.+|.+||+|||++
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCc
Confidence 677899999999999999999887889999999999999999999997 55 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
+...... ......+||+.|+|||++.... ++.++|||||||++|+|++|..||.......... .+...
T Consensus 297 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~ 364 (446)
T 4ejn_A 297 KEGIKDG-----ATMKTFCGTPEYLAPEVLEDND---YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILME 364 (446)
T ss_dssp CTTCC----------CCSSSCGGGCCHHHHHTSC---CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHC
T ss_pred eeccCCC-----cccccccCCccccCHhhcCCCC---CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH----HHHhC
Confidence 8643321 1233458999999999986444 8999999999999999999999998766543321 12223
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
...+| ..+++++.+||.+||.+||.+|| ++.++++||||+..
T Consensus 365 ~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 365 EIRFP--RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp CCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCCC--ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 33444 56899999999999999999999 99999999999853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=383.42 Aligned_cols=265 Identities=29% Similarity=0.441 Sum_probs=220.4
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+.+.||+|+||.||+|.+..++..||||++......... .......+.+|+.+++.+.||||++++++|. +
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~ 86 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR-RGVSREEIEREVSILRQVLHHNVITLHDVYE-N 86 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCS-SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccc-cchhHHHHHHHHHHHHhCCCCCcceEEEEEe-c
Confidence 4577899999999999999999999999999999998654332211 0012356889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC----cEEEEecC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG----VAKVTDFG 555 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g----~vKL~DFG 555 (683)
.+.+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++ .+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 7889999999999999999988888999999999999999999999965 99999999999999887 79999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++........ .....||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+.. +.
T Consensus 165 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----i~ 231 (321)
T 2a2a_A 165 LAHEIEDGVE------FKNIFGTPEFVAPEIVNYEP---LGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----IT 231 (321)
T ss_dssp TCEECCTTCC------CCCCCSCGGGCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HH
T ss_pred cceecCcccc------ccccCCCCCccCcccccCCC---CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HH
Confidence 9987654321 23347999999999986443 89999999999999999999999987665543321 11
Q ss_pred hhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 636 ARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 636 ~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.....++. .+.++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 232 SVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred hcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 22222221 14688999999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=404.41 Aligned_cols=271 Identities=27% Similarity=0.425 Sum_probs=198.7
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc--
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-- 478 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-- 478 (683)
+.++|.+++.||+|+||+||+|.+..+++.||||++..... .....+.+.+|+.+++.++|||||+++++|..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-----DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-----SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-----CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 46799999999999999999999999999999998854322 12235678899999999999999999999843
Q ss_pred --CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 479 --DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 479 --d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
....+|+||||+ +++|..++.....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeeccccc
Confidence 235789999998 6799999988888999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCc----------------------ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-
Q 005678 557 SKIVEDDVGSQG----------------------MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF- 613 (683)
Q Consensus 557 s~~~~~~~~~~~----------------------~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt- 613 (683)
++.+........ .......+||++|+|||++... ..|+.++||||||||||||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ--ENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC--CCCCcHhHHHHHHHHHHHHHHh
Confidence 987653321100 0123345799999999986432 238999999999999999998
Q ss_pred ----------CCCCCCCCch--------------------HHHHHHHHHHHH----------------hhccCCC-----
Q 005678 614 ----------GRRPFGHDQT--------------------QERILREDTIIK----------------ARKVEFP----- 642 (683)
Q Consensus 614 ----------G~~PF~~~~~--------------------~e~il~~~~i~~----------------~~~~~~p----- 642 (683)
|.+||..... .+.+.....+.. .....++
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 6666644321 011000000000 0000011
Q ss_pred ----CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 643 ----SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 643 ----~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..+.+++++.+||.+||.+||.+|||+.++++||||+..
T Consensus 361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 124579999999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=403.49 Aligned_cols=269 Identities=25% Similarity=0.385 Sum_probs=219.2
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
..+..++|.+++.||+|+||+||+|.+..+++.||||++.... .........+.+|+.++..++||||++++++|.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD----MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH----HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH----hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3456788999999999999999999999999999999985321 111222446788999999999999999999996
Q ss_pred cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
+.+.+|+|||||+||+|..++... ..+++..++.++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+
T Consensus 132 -~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 132 -DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp -CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred -eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechh
Confidence 678899999999999999999764 47999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccC----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK----TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
++....... ......+||+.|+|||++.... ...|+.++|||||||++|+|++|+.||......+.+.. .
T Consensus 209 a~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~--i 282 (412)
T 2vd5_A 209 CLKLRADGT----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK--I 282 (412)
T ss_dssp CEECCTTSC----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--H
T ss_pred heeccCCCc----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH--H
Confidence 987654321 1123458999999999986321 23489999999999999999999999987766543322 1
Q ss_pred HHHhhccCCCC-CcCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcccCC
Q 005678 633 IIKARKVEFPS-RPAVSNEAKDLIRRCLTYNQAER---PDVLTLAQDPYLTY 680 (683)
Q Consensus 633 i~~~~~~~~p~-~~~~s~el~dLI~rCL~~dP~kR---PS~~eLl~hP~l~~ 680 (683)
+.....+.+|. ...+|.++++||.+||. +|.+| |++.++++||||+.
T Consensus 283 ~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 283 VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp HTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred HhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 11122344553 35799999999999999 99998 59999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=375.58 Aligned_cols=258 Identities=31% Similarity=0.467 Sum_probs=215.0
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+..++|.+.+.||+|+||.||+|.+..++..||||++.... .........+.+|+.+++.++||||++++++|. +
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-D 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH----HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc----cchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-c
Confidence 44578999999999999999999999999999999874321 111223456889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+++||||+++++|..++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEecccccc
Confidence 7789999999999999999987778999999999999999999999865 99999999999999999999999999865
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
..... .....||+.|+|||++.... ++.++||||||+++|+|++|..||......+.... .. ..
T Consensus 159 ~~~~~-------~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~--~~ 222 (279)
T 3fdn_A 159 APSSR-------RTDLCGTLDYLPPEMIEGRM---HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR----IS--RV 222 (279)
T ss_dssp C---------------CCCCTTCCHHHHTTCC---CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HH--HT
T ss_pred CCccc-------ccccCCCCCccCHhHhccCC---CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH----HH--hC
Confidence 44321 22347999999999986443 78899999999999999999999987665443321 11 22
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.++.+..++..+.+||.+||..||.+||++.++++||||+.
T Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 33334568999999999999999999999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=394.44 Aligned_cols=269 Identities=26% Similarity=0.422 Sum_probs=204.6
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d 479 (683)
+.++|.+++.||+|+||.||+|.+..++..||||++...... ......+.+|+.++..+. ||||++++++|..+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-----STDAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-----hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 456899999999999999999999999999999987543221 123457789999999997 99999999998643
Q ss_pred -CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 -QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 -~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
...+|+|||||+ ++|..++... .+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCCEEEEEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 347899999996 6999999764 5899999999999999999999966 9999999999999999999999999998
Q ss_pred ccccCcCC----------------CcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCc
Q 005678 559 IVEDDVGS----------------QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQ 622 (683)
Q Consensus 559 ~~~~~~~~----------------~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~ 622 (683)
.+...... .........+||++|+|||++... ..++.++||||||||+|+|++|++||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 76431100 001123345899999999998642 348999999999999999999999998776
Q ss_pred hHHHHHHHHHHHHhh---------------------------c--------------cCCCCCcCCCHHHHHHHHHhccc
Q 005678 623 TQERILREDTIIKAR---------------------------K--------------VEFPSRPAVSNEAKDLIRRCLTY 661 (683)
Q Consensus 623 ~~e~il~~~~i~~~~---------------------------~--------------~~~p~~~~~s~el~dLI~rCL~~ 661 (683)
....+.......... . ........+++++.+||.+||.+
T Consensus 236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 655443211110000 0 00011236789999999999999
Q ss_pred CCCCCCCHHHHhcCcccCC
Q 005678 662 NQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 662 dP~kRPS~~eLl~hP~l~~ 680 (683)
||.+|||+.++++||||+.
T Consensus 316 dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 316 NPNKRISANDALKHPFVSI 334 (388)
T ss_dssp SGGGSCCHHHHTTSTTTTT
T ss_pred CcccCCCHHHHhCCHHHHH
Confidence 9999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=386.74 Aligned_cols=267 Identities=27% Similarity=0.448 Sum_probs=208.2
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
...-++|.+++.||+|+||+||+|.+..++..||||++...... ......+.+|+.+++.++||||++++++|.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~- 103 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-----EGVPGTAIREVSLLKELQHRNIIELKSVIH- 103 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-------------CHHHHHHGGGCCCTTBCCEEEEEE-
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-----cccchhHHHHHHHHHHcCCCCcceEEEEEe-
Confidence 34567899999999999999999999999999999998654321 223456778999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-----CCCcEEEEe
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-----EFGVAKVTD 553 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-----~~g~vKL~D 553 (683)
+.+.+|+||||++ ++|.+++...+.+++..++.|+.||+.||.|||+.+ ||||||||+|||++ ..+.+||+|
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred cCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECc
Confidence 6788999999997 599999988888999999999999999999999965 99999999999994 455699999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||++....... .......||+.|+|||++... ..++.++|||||||++|+|++|..||......+.+......
T Consensus 181 fg~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 181 FGLARAFGIPI-----RQFTHEIITLWYRPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp TTHHHHHC----------------CCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCCccccCCcc-----cccCCCcCCccccCHHHhcCC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 99998764321 112334789999999998642 23799999999999999999999999887766554332211
Q ss_pred HHhh-ccCCCC-----------------------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 634 IKAR-KVEFPS-----------------------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 ~~~~-~~~~p~-----------------------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.... ...++. ...+++++.+||.+||.+||.+|||+.++++||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 1100 000100 01278999999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=373.14 Aligned_cols=256 Identities=31% Similarity=0.477 Sum_probs=216.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||++++++|. +.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 78 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-------DVDRFKQEIEIMKSLDHPNIIRLYETFE-DN 78 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-------CHHHHHHHHHHHHTCCCTTBCCEEEEEE-CS
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-------hHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 567899999999999999999999999999999988553221 1346788999999999999999999996 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe---CCCCcEEEEecCCc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLS 557 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL---d~~g~vKL~DFGls 557 (683)
..+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||+ +.++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 889999999999999999987778999999999999999999999966 9999999999999 78899999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
....... ......||+.|+|||++.. .++.++||||||+++|+|++|..||......+.... ....
T Consensus 157 ~~~~~~~------~~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~ 222 (277)
T 3f3z_A 157 ARFKPGK------MMRTKVGTPYYVSPQVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREG 222 (277)
T ss_dssp EECCTTS------CBCCCCSCTTTCCHHHHTT----CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHC
T ss_pred eeccCcc------chhccCCCCCccChHHhcc----cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhC
Confidence 8765432 1233479999999998752 278999999999999999999999987766543322 1222
Q ss_pred ccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 638 KVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 ~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
...++. ...+++.+.+||.+||..||.+||++.++++||||+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 233332 1368999999999999999999999999999999964
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=382.50 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=198.4
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.++|.+++.||+|+||.||+|.+..++..||||++....... ....+.+|+.+++.++||||++++++|. +.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG------TPSTAIREISLMKELKHENIVRLYDVIH-TEN 76 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC------SCHHHHHHHHHHTTCCBTTBCCEEEEEC-CTT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc------cHHHHHHHHHHHHhcCCCCcceEEEEEE-ECC
Confidence 357999999999999999999999999999999986543211 1245778999999999999999999996 677
Q ss_pred eEEEEEecccCCChhHHHhcC------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 482 TFCTVLEYCSGKDLDAVLKAT------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
.+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||
T Consensus 77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg 153 (317)
T 2pmi_A 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCS
T ss_pred eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCc
Confidence 8999999997 5999988532 35899999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++....... .......||+.|+|||++... ..++.++|||||||++|+|++|..||......+.+........
T Consensus 154 ~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 226 (317)
T 2pmi_A 154 LARAFGIPV-----NTFSSEVVTLWYRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226 (317)
T ss_dssp SCEETTSCC-----CCCCCCCSCCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cceecCCCc-----ccCCCCcccccccCchHhhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 998764321 112334799999999998642 2379999999999999999999999987766554322111110
Q ss_pred hhc-cC-------------C--------------CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARK-VE-------------F--------------PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~-~~-------------~--------------p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
... .. + .....++.++.+||.+||..||.+|||+.++++||||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 000 00 0 011257889999999999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=408.65 Aligned_cols=261 Identities=31% Similarity=0.523 Sum_probs=217.6
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+++.||+|+||+||+|.+..++..||||++....... .....+.+|+.+++.++|||||+++++|. +
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~ 92 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-----KDTSTILREVELLKKLDHPNIMKLFEILE-D 92 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-----hHHHHHHHHHHHHHhCCCCCcCeEEEEEE-c
Confidence 46789999999999999999999999999999999985432111 12356889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC---CCCcEEEEecCC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD---EFGVAKVTDFGL 556 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd---~~g~vKL~DFGl 556 (683)
...+|+|||||.+++|.+++...+.+++..+..|+.||+.||.|||+.+ ||||||||+|||++ .++.+||+|||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 7889999999999999999977778999999999999999999999966 99999999999995 456899999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+....... .....+||+.|+|||++.. .|+.++||||||||+|+|++|.+||......+.+.. .....
T Consensus 171 a~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--i~~~~ 238 (486)
T 3mwu_A 171 STCFQQNT------KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR--VETGK 238 (486)
T ss_dssp TTTBCCC----------CCTTGGGGCCGGGGGS----CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHTC
T ss_pred CeECCCCC------ccCCCcCCCCCCCHHHhCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhCC
Confidence 98765431 1233479999999999853 389999999999999999999999987665543321 11111
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.....|.+..+|+++++||.+||.+||.+|||+.++++||||+.
T Consensus 239 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 22333445679999999999999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=391.20 Aligned_cols=267 Identities=26% Similarity=0.414 Sum_probs=222.1
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCccc-chhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQW-SEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFE 477 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~-~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~ 477 (683)
.+.++|.+.+.||.|+||.||+|.+..+|..||||++...... ...........+.+|+.++..+ +||||++++++|.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 3557899999999999999999999889999999998765432 2223334456788999999999 7999999999986
Q ss_pred cCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
....+|+||||++|++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.+|.+||+|||++
T Consensus 171 -~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 -SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp -BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred -eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcc
Confidence 67789999999999999999987778999999999999999999999966 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK---TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~---~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
..+.... ......||+.|+|||++.... ...++.++|||||||++|+|++|..||........+.. +
T Consensus 248 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~----i 317 (365)
T 2y7j_A 248 CHLEPGE------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----I 317 (365)
T ss_dssp EECCTTC------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----H
T ss_pred cccCCCc------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH----H
Confidence 8765432 123458999999999986432 23478999999999999999999999987655432211 1
Q ss_pred HhhccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 635 KARKVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 635 ~~~~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
......++ .+..++..+.+||.+||..||.+||++.++++||||+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 22222222 2357899999999999999999999999999999997
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=390.55 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=211.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
+.++|.+.+.||+|+||.||+|.+..++..||||++..... ...+|+.++.++ .||||++++++|. +
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----------~~~~E~~~l~~~~~hp~iv~~~~~~~-~ 87 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----------DPTEEIEILLRYGQHPNIITLKDVYD-D 87 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----------CCHHHHHHHHHHTTSTTBCCEEEEEE-C
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----------ChHHHHHHHHHhcCCCCcCeEEEEEE-c
Confidence 56789999999999999999999999999999999865432 123577888887 7999999999996 7
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-C---CcEEEEecC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-F---GVAKVTDFG 555 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~---g~vKL~DFG 555 (683)
.+.+|+|||||+||+|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||+.. + +.+||+|||
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 7889999999999999999988888999999999999999999999965 999999999999853 2 359999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCc--hHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQ--TQERILREDTI 633 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~--~~e~il~~~~i 633 (683)
+++....... .....+||+.|+|||++.... |+.++|||||||++|+|++|..||.... ....++. .
T Consensus 166 ~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~ 234 (342)
T 2qr7_A 166 FAKQLRAENG-----LLMTPCYTANFVAPEVLERQG---YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---R 234 (342)
T ss_dssp TCEECBCTTC-----CBCCSSCCSSCCCHHHHHHHH---HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---H
T ss_pred CcccCcCCCC-----ceeccCCCccccCHHHhcCCC---CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---H
Confidence 9987654321 233458999999999987544 7889999999999999999999997532 2222221 1
Q ss_pred HHhhccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 634 IKARKVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 634 ~~~~~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+....+.++ .++.++.++.+||.+||..||.+||++.++++||||..
T Consensus 235 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 222333333 34679999999999999999999999999999999953
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=371.43 Aligned_cols=269 Identities=28% Similarity=0.414 Sum_probs=222.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCccc--chhhHHHHHHHHHHHHHHHhhcC-CCceeeecccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQW--SEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTF 476 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~--~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f 476 (683)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++...... ...........+.+|+.++..+. ||||++++++|
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3567999999999999999999999999999999998655321 22223344567889999999995 99999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
. +.+.+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 94 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 E-TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp E-CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred c-cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccc
Confidence 6 67889999999999999999987778999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCccccccc---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS---KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~---~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
+....... ......||+.|+|||++... ....++.++||||||+++|+|++|..||.......... .
T Consensus 171 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~- 240 (298)
T 1phk_A 171 SCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR---M- 240 (298)
T ss_dssp CEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H-
T ss_pred hhhcCCCc------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH---H-
Confidence 98765331 12334799999999998532 23347899999999999999999999997765543221 1
Q ss_pred HHhhccCC--CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 634 IKARKVEF--PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 634 ~~~~~~~~--p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+......+ +..+.++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 12222333 3335789999999999999999999999999999999854
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=408.84 Aligned_cols=261 Identities=31% Similarity=0.488 Sum_probs=221.1
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.++.++|.+.+.||+|+||.||+|.+..++..||||++........ .....+.+|+.+++.++|||||+++++|.
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~- 96 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK----TDKESLLREVQLLKQLDHPNIMKLYEFFE- 96 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS----SCHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc----hHHHHHHHHHHHHHhCCCCCCCcEEEEEE-
Confidence 4577899999999999999999999999999999999865432211 12457889999999999999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe---CCCCcEEEEecC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFG 555 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL---d~~g~vKL~DFG 555 (683)
+.+.+|+|||||.+++|.+++...+.+++..+..|+.||+.||.|||+.+ ||||||||+|||+ +.++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 67889999999999999999988888999999999999999999999965 9999999999999 467899999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++..+.... ......||+.|+|||++.. .++.++|||||||++|+|++|.+||......+.+.. +.
T Consensus 175 ~a~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~ 240 (484)
T 3nyv_A 175 LSTHFEASK------KMKDKIGTAYYIAPEVLHG----TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK----VE 240 (484)
T ss_dssp HHHHBCCCC------SHHHHTTGGGTCCHHHHHT----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH
T ss_pred eeEEccccc------ccccCCCCccccCceeecC----CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HH
Confidence 998765431 1223479999999999853 389999999999999999999999987766543321 22
Q ss_pred hhcc--CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARKV--EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~~--~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
...+ ..|.+..+|+++++||.+||.++|.+|||+.++++||||+.
T Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 2222 33445679999999999999999999999999999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=394.83 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=215.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++|||||+++++|. +.
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~ 120 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-------LDKYTVKNEISIMNQLHHPKLINLHDAFE-DK 120 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-------HHHHHHHHHHHHHTTCCSTTBCCEEEEEE-CS
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-------hhHHHHHHHHHHHHhCCCcCCCeEEEEEE-eC
Confidence 45789999999999999999999999999999999854321 11246789999999999999999999996 67
Q ss_pred ceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC--CCcEEEEecCCc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE--FGVAKVTDFGLS 557 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~--~g~vKL~DFGls 557 (683)
..+|+|||||+|++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||++
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccc
Confidence 8899999999999999999654 46999999999999999999999965 999999999999974 578999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
....... ......||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+.. +...
T Consensus 199 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----i~~~ 265 (387)
T 1kob_A 199 TKLNPDE------IVKVTTATAEFAAPEIVDREP---VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRC 265 (387)
T ss_dssp EECCTTS------CEEEECSSGGGCCHHHHTTCC---BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHC
T ss_pred eecCCCc------ceeeeccCCCccCchhccCCC---CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH----HHhC
Confidence 8765431 122337999999999986443 89999999999999999999999987665443321 1122
Q ss_pred ccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 638 KVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 638 ~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
...++ ....+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 266 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 266 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 22222 235789999999999999999999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=384.64 Aligned_cols=264 Identities=23% Similarity=0.369 Sum_probs=214.3
Q ss_pred CCCccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-----CC
Q 005678 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-----HH 467 (683)
Q Consensus 393 ~~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-----Hp 467 (683)
..+..-.++.++|.+++.||+|+||+||+|.+..+++.||||++... ......+..|+.+++.+. ||
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--------KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--------HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--------hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 45566678899999999999999999999999999999999998532 122345677999999986 99
Q ss_pred ceeeeccccccCCceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC
Q 005678 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE 545 (683)
Q Consensus 468 nIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~ 545 (683)
|||+++++|. ..+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+ ||||||||+|||++.
T Consensus 97 ~iv~~~~~~~-~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 97 NIVKYHGKFM-YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDD 172 (360)
T ss_dssp GBCCEEEEEE-ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESC
T ss_pred Ceecccceee-ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEcc
Confidence 9999999986 567899999999 999999996553 5999999999999999999999965 999999999999975
Q ss_pred -------------------------CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhH
Q 005678 546 -------------------------FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVD 600 (683)
Q Consensus 546 -------------------------~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksD 600 (683)
++.+||+|||++...... .....||+.|+|||++.... ++.++|
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~D 241 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--------HGSIINTRQYRAPEVILNLG---WDVSSD 241 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--------CCSCCSCGGGCCHHHHTTCC---CCTTHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--------CcCccCcccccCcHHHcCCC---CCCccc
Confidence 789999999999865432 22347999999999987544 899999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh----------------------ccCCCCC--------------
Q 005678 601 VWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR----------------------KVEFPSR-------------- 644 (683)
Q Consensus 601 VWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~----------------------~~~~p~~-------------- 644 (683)
||||||++|+|++|..||......+.+.....+.... ...+|..
T Consensus 242 iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 321 (360)
T 3llt_A 242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321 (360)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCC
T ss_pred hHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcc
Confidence 9999999999999999998766554432211110000 0001110
Q ss_pred ----cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 645 ----PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 645 ----~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
...++.+.+||.+||.+||.+|||+.++++||||+
T Consensus 322 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 11247788999999999999999999999999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=407.34 Aligned_cols=259 Identities=31% Similarity=0.529 Sum_probs=213.4
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+++.||+|+||+||+|.+..++..||||++......... ...+.+|+.+++.++|||||+++++|. +
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~-~ 107 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-----NSKLLEEVAVLKLLDHPNIMKLYDFFE-D 107 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-----THHHHHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-----HHHHHHHHHHHHhCCCCCCCeEEEEEE-e
Confidence 3566899999999999999999999999999999998654322211 346789999999999999999999996 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---CCcEEEEecCC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---FGVAKVTDFGL 556 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~g~vKL~DFGl 556 (683)
...+|+|||||++++|.+++.....+++..+..|+.||+.||.|||+.+ ||||||||+|||++. ++.+||+|||+
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 7889999999999999999977778999999999999999999999965 999999999999975 45599999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+....... ......||++|+|||++. ..|+.++|||||||++|+|++|.+||......+.+.. +..
T Consensus 186 a~~~~~~~------~~~~~~gt~~y~aPE~l~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~ 251 (494)
T 3lij_A 186 SAVFENQK------KMKERLGTAYYIAPEVLR----KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK----VEK 251 (494)
T ss_dssp CEECBTTB------CBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHH
T ss_pred CeECCCCc------cccccCCCcCeeCHHHHc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHh
Confidence 98765432 123447999999999874 2389999999999999999999999987766543321 222
Q ss_pred hccCC--CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 RKVEF--PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ~~~~~--p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
....+ +.+..+|+.+.+||.+||.++|.+|||+.++++||||+.
T Consensus 252 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 252 GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp TCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred CCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 33333 334578999999999999999999999999999999963
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=369.35 Aligned_cols=255 Identities=20% Similarity=0.321 Sum_probs=208.1
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
+.++|.+++.||+|+||.||+|.+..++..||||++........ ....+.+|+.++..+ +||||++++++|. +
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-~ 82 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-----DEQNALREVYAHAVLGQHSHVVRYFSAWA-E 82 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-----HHHHHHHHHHHHHHSCSCTTBCCEEEEEE-E
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-----HHHHHHHHHHHHHHhCCCCCeeeeeeeee-c
Confidence 45789999999999999999999999999999999865433222 245678899999999 9999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcC----CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC---------
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKAT----PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF--------- 546 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~----~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~--------- 546 (683)
.+.+++||||+++++|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-----------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccc
Confidence 77899999999999999999654 66999999999999999999999965 9999999999999844
Q ss_pred ----------CcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCC
Q 005678 547 ----------GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRR 616 (683)
Q Consensus 547 ----------g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~ 616 (683)
+.+||+|||++....... ...||+.|+|||++... ..++.++|||||||++|+|++|.+
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---------~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSPQ---------VEEGDSRFLANEVLQEN--YTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCSC---------CCCCCGGGCCHHHHTTC--CTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred cccccccCCceEEEEcccccccccCCcc---------ccCCCccccChhHhcCC--CCCCchhhHHHHHHHHHHHhcCCC
Confidence 479999999998765321 23699999999998643 236789999999999999999998
Q ss_pred CCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 617 PFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 617 PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
|+........+ ...... ..+..++..+.+||.+||..||.+|||+.++++||||+.+.
T Consensus 230 ~~~~~~~~~~~------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 230 LPRNGDQWHEI------RQGRLP--RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp CCSSSHHHHHH------HTTCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred CCcchhHHHHH------HcCCCC--CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 87654432211 111111 22347899999999999999999999999999999998764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=402.24 Aligned_cols=267 Identities=28% Similarity=0.410 Sum_probs=207.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccch-hhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE-DKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~-~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+.++|.+.+.||+|+||+||+|.+..++..||||++........ .........+.+|+.+++.++|||||+++++|.
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-- 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 46789999999999999999999999999999999865432111 111122335788999999999999999999985
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC---CcEEEEecCC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF---GVAKVTDFGL 556 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~---g~vKL~DFGl 556 (683)
...+|+|||||++++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 5568999999999999999988888999999999999999999999965 9999999999999754 4599999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
++...... ......||+.|+|||++.......++.++|||||||++|+|++|..||........+.. .+..
T Consensus 289 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~---~i~~ 359 (419)
T 3i6u_A 289 SKILGETS------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---QITS 359 (419)
T ss_dssp TTSCC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH---HHHT
T ss_pred ceecCCCc------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH---HHhc
Confidence 98765331 22345799999999998654445589999999999999999999999976543322211 1222
Q ss_pred hccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 RKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
....++. +..+++.+.+||.+||.+||.+||++.++++||||+.
T Consensus 360 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 360 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 2222221 2468999999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=372.65 Aligned_cols=265 Identities=26% Similarity=0.368 Sum_probs=202.7
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
+++..++|.+++.||+|+||+||+|.+..+++.||||++...... ......+..+...++.+.||||++++++|.
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-----QEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-----HHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 356778999999999999999999999999999999998654221 122334555666688899999999999986
Q ss_pred cCCceEEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhc-CCceEecccCCcceEeCCCCcEEEE
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKR-AQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~-g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
+.+.+++||||++ ++|.+++. ....+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 77 -~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~ 152 (290)
T 3fme_A 77 -REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMC 152 (290)
T ss_dssp -CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBC
T ss_pred -ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEe
Confidence 6778999999996 48877764 456799999999999999999999996 6 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCccccccc-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS-KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~-~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~ 631 (683)
|||++........ .....||+.|+|||++... ....++.++|||||||++|+|++|..||.........+.
T Consensus 153 Dfg~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-- 224 (290)
T 3fme_A 153 DFGISGYLVDDVA------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK-- 224 (290)
T ss_dssp CC---------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH--
T ss_pred ecCCccccccccc------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH--
Confidence 9999987654321 2233799999999997432 233489999999999999999999999976444332222
Q ss_pred HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 632 ~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.......... ....++.++.+||.+||..||.+|||+.++++||||+.
T Consensus 225 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 225 QVVEEPSPQL-PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHSCCCCC-CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHhccCCCCc-ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 1122222222 23468999999999999999999999999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=384.93 Aligned_cols=267 Identities=25% Similarity=0.422 Sum_probs=211.3
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC--Cceeeeccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH--HHIVRLWDT 475 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H--pnIV~L~~~ 475 (683)
+.+.+++|.+++.||+|+||.||+|.+ .++..||||++...... ......+.+|+.++..+.| |||++++++
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD-----NQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCC-----HHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccc-----hHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 456788999999999999999999987 56899999998654321 2235678899999999987 999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
+. +.+.+|+|||+ .+++|.+++...+.+++..+..|+.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||
T Consensus 78 ~~-~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG 152 (343)
T 3dbq_A 78 EI-TDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFG 152 (343)
T ss_dssp EE-CSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred Ee-eCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecc
Confidence 86 67889999995 58899999988888999999999999999999999965 99999999999997 5889999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCccccccc--------CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS--------KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~--------~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
++..+...... .......||+.|+|||++... ....++.++|||||||++|+|++|..||.........
T Consensus 153 ~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 229 (343)
T 3dbq_A 153 IANQMQPDTTS---VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229 (343)
T ss_dssp SSCCC---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred cccccCccccc---ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence 99876543211 122345799999999998641 1134899999999999999999999999765443222
Q ss_pred HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 628 l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+. .+ .........+...+.++.+||.+||..||.+|||+.++++||||+..
T Consensus 230 ~~--~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 230 LH--AI-IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HH--HH-HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HH--HH-hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 21 11 11122223334678899999999999999999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=381.42 Aligned_cols=255 Identities=21% Similarity=0.295 Sum_probs=203.0
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~ 478 (683)
++.++|.+++.||+|+||+||+|.+..+++.||||++......... ......|+..+..+ .||||++++++|.
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~~~~~~~h~~iv~l~~~~~- 127 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-----RARKLAEVGSHEKVGQHPCCVRLEQAWE- 127 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-----HHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-----HHHHHHHHHHHHHhcCCCcEEEEEEEEE-
Confidence 4568999999999999999999999999999999987554332211 23444555555555 8999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
+.+.+|+||||+ +++|..++.. ...+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||++
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceee
Confidence 678899999999 6788888854 456999999999999999999999965 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
....... ......||+.|+|||++.. .++.++|||||||++|+|++|..||........+ ...
T Consensus 205 ~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-------~~~ 267 (311)
T 3p1a_A 205 VELGTAG------AGEVQEGDPRYMAPELLQG----SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------RQG 267 (311)
T ss_dssp EECC------------CCCCCGGGCCGGGGGT----CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH-------TTT
T ss_pred eecccCC------CCcccCCCccccCHhHhcC----CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-------hcc
Confidence 8764332 1233479999999998853 3899999999999999999997766543322211 111
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.........++.++.+||.+||..||.+|||+.++++||||+.
T Consensus 268 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1111112468999999999999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=369.46 Aligned_cols=263 Identities=27% Similarity=0.443 Sum_probs=218.0
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.++|.+.+.||+|+||.||+|.+..++..||||++...... .....+.+|+.+++.++||||+++++++. +.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 78 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV------DCPENIKKEICINKMLNHENVVKFYGHRR-EGN 78 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT------THHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETT
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch------hhhHHHHHHHHHHHhcCCCCceeeeeEEE-cCC
Confidence 45799999999999999999999999999999998543221 12457889999999999999999999986 677
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 89999999999999999987778999999999999999999999965 9999999999999999999999999998764
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
..... .......||+.|+|||++.... .++.++|||||||++|+|++|..||.........+. . ........
T Consensus 157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~-~~~~~~~~ 228 (276)
T 2yex_A 157 YNNRE---RLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--D-WKEKKTYL 228 (276)
T ss_dssp ETTEE---CCBCCCCSCGGGCCGGGGTCSS--BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH--H-HHTTCTTS
T ss_pred CCcch---hcccCCccccCccChHHHhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH--H-hhhccccc
Confidence 33211 1233457999999999986433 247789999999999999999999976554322221 1 12222333
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+....++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 4446789999999999999999999999999999999865
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=387.27 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=216.4
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+..++|.+++.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||++++++|.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~- 101 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK------PAIRNQIIRELQVLHECNSPYIVGFYGAFY- 101 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC------HHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-
Confidence 4567899999999999999999999999999999999865421 223467889999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc-CCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR-AQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~-g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
+.+.+|+||||+++++|.+++...+.+++..+..++.+|+.||.|||+. + |+|+||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCC
Confidence 6778999999999999999998877899999999999999999999985 5 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE------- 630 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~------- 630 (683)
....... .....||+.|+|||++.... ++.++|||||||++|+|++|..||......+.....
T Consensus 180 ~~~~~~~-------~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (360)
T 3eqc_A 180 GQLIDSM-------ANSFVGTRSYMSPERLQGTH---YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249 (360)
T ss_dssp HHHHHHC-----------CCCCTTCCHHHHTTCC---CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------
T ss_pred ccccccc-------ccCCCCCCCeECHHHHcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc
Confidence 7654321 22347999999999986543 899999999999999999999999776544321110
Q ss_pred --------------------------------HHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 631 --------------------------------DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 631 --------------------------------~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..+... .........++.++.+||.+||..||.+|||+.++++||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE-PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp ------------------------CCCHHHHHHHHHHS-CCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCCCCcccCCCcccccccCCCCcccchhhhhHHhcc-CCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 001111 11111123578999999999999999999999999999999
Q ss_pred CC
Q 005678 679 TY 680 (683)
Q Consensus 679 ~~ 680 (683)
+.
T Consensus 329 ~~ 330 (360)
T 3eqc_A 329 KR 330 (360)
T ss_dssp HH
T ss_pred hc
Confidence 74
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=382.13 Aligned_cols=271 Identities=25% Similarity=0.405 Sum_probs=221.3
Q ss_pred CCCCccccccccceeEE-EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCce
Q 005678 392 GSRFNNFQILNHRYALL-NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHI 469 (683)
Q Consensus 392 ~~~f~~~~i~~~ry~l~-~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnI 469 (683)
+..|...+.+.++|.+. +.||+|+||.||+|.+..++..||||++........ ....+.+|+.++..+. ||||
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~~i 91 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-----CRAEILHEIAVLELAKSCPRV 91 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-----CHHHHHHHHHHHHHTTTCTTB
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-----HHHHHHHHHHHHHhccCCCCE
Confidence 34566777889999998 899999999999999999999999999865433221 2356788999999995 6999
Q ss_pred eeeccccccCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC--
Q 005678 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-- 545 (683)
Q Consensus 470 V~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-- 545 (683)
++++++|. +.+.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 92 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 92 INLHEVYE-NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIY 168 (327)
T ss_dssp CCEEEEEE-CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBT
T ss_pred EEEEEEEE-eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCC
Confidence 99999996 67789999999999999999854 367999999999999999999999966 999999999999997
Q ss_pred -CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH
Q 005678 546 -FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ 624 (683)
Q Consensus 546 -~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~ 624 (683)
++.+||+|||++........ .....||+.|+|||++.... ++.++|||||||++|+|++|..||......
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 239 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACE------LREIMGTPEYLAPEILNYDP---ITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239 (327)
T ss_dssp TBCCEEECCGGGCEEC---------------CCCGGGCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCcEEEeeCccccccCCccc------cccccCCcCccCCeeecCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCch
Confidence 78999999999987654321 22347999999999986443 899999999999999999999999877665
Q ss_pred HHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 625 ERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 625 e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+...... ........+....++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 240 ~~~~~i~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 240 ETYLNIS--QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHH--HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHHHH--hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 5443211 111122223345789999999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=382.09 Aligned_cols=260 Identities=23% Similarity=0.388 Sum_probs=204.3
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC-
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ- 480 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~- 480 (683)
.++|.+++.||+|+||.||+|.+..++..||||++...... .....+.+|+.+++.++|||||+++++|....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE------LAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT------THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 45799999999999999999999999999999998654321 12457889999999999999999999875322
Q ss_pred -------------------------------------------------------ceEEEEEecccCCChhHHHhcCCC-
Q 005678 481 -------------------------------------------------------NTFCTVLEYCSGKDLDAVLKATPV- 504 (683)
Q Consensus 481 -------------------------------------------------------~~~~LV~Ey~~ggsL~~~L~~~~~- 504 (683)
..+++|||||++++|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 248999999999999999976643
Q ss_pred --cchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCc-------ccccccC
Q 005678 505 --LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG-------MELTSQG 575 (683)
Q Consensus 505 --Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~-------~~l~~~~ 575 (683)
.++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........... .......
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 344568899999999999999965 99999999999999999999999999988765422111 1122344
Q ss_pred CCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC-CcCCCHHHHHH
Q 005678 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS-RPAVSNEAKDL 654 (683)
Q Consensus 576 ~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~-~~~~s~el~dL 654 (683)
.||+.|+|||++.... ++.++|||||||++|+|++|..|+.. .... +.......+|. ....++.+.+|
T Consensus 237 ~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~~~~~~~~---~~~~-----~~~~~~~~~~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNN---YSHKVDIFSLGLILFELLYSFSTQME---RVRI-----ITDVRNLKFPLLFTQKYPQEHMM 305 (332)
T ss_dssp C-CGGGSCHHHHHCCC---CCTHHHHHHHHHHHHHHHSCCCCHHH---HHHH-----HHHHHTTCCCHHHHHHCHHHHHH
T ss_pred CCCcCccChHHhcCCC---CcchhhHHHHHHHHHHHHHcCCChhH---HHHH-----HHHhhccCCCcccccCChhHHHH
Confidence 7999999999987543 89999999999999999998777521 1111 11112222222 13567889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 655 IRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 655 I~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
|.+||..||.+|||+.++++||||+.
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHccCCCCcCCCHHHHhhchhhhc
Confidence 99999999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=385.47 Aligned_cols=273 Identities=27% Similarity=0.382 Sum_probs=214.3
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
+..-..+.++|.+.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.++..++||||+++++
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 79 (311)
T 3ork_A 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR----DPSFYLRFRREAQNAAALNHPAIVAVYD 79 (311)
T ss_dssp CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT----SHHHHHHHHHHHTTCCCCCCTTBCCEEE
T ss_pred CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC----CHHHHHHHHHHHHHHHcCCCCCcceEEE
Confidence 334456788999999999999999999999999999999998654322 2234567889999999999999999999
Q ss_pred ccccCC---ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEE
Q 005678 475 TFEIDQ---NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKV 551 (683)
Q Consensus 475 ~f~~d~---~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL 551 (683)
++.... ..+|+||||++|++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEE
T ss_pred eeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEE
Confidence 986432 245899999999999999987778999999999999999999999965 999999999999999999999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~ 631 (683)
+|||++..+...... ........||+.|+|||++.... ++.++|||||||++|+|++|..||............
T Consensus 158 ~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~- 231 (311)
T 3ork_A 158 MDFGIARAIADSGNS--VTQTAAVIGTAQYLSPEQARGDS---VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH- 231 (311)
T ss_dssp CCCSCC--------------------CCTTCCHHHHHTCC---CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-
T ss_pred eeccCcccccccccc--cccccccCcCcccCCHHHhcCCC---CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-
Confidence 999999876543211 12233447999999999986543 899999999999999999999999877665433221
Q ss_pred HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 632 ~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
............+.++.++.+||.+||..||.+||+..+++.|+|++.
T Consensus 232 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 232 -VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -HHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -hcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 111100000112468999999999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=396.15 Aligned_cols=256 Identities=28% Similarity=0.414 Sum_probs=201.1
Q ss_pred cceeEE-EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHh-hcCCCceeeecccccc--
Q 005678 403 HRYALL-NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK-TLVHHHIVRLWDTFEI-- 478 (683)
Q Consensus 403 ~ry~l~-~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~-~L~HpnIV~L~~~f~~-- 478 (683)
+.|.+. +.||+|+||+||+|.+..++..||||++... ..+.+|+.++. ..+||||++++++|..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 456565 7999999999999999999999999998421 23567888774 4589999999998853
Q ss_pred -CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---CCcEEEE
Q 005678 479 -DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---FGVAKVT 552 (683)
Q Consensus 479 -d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~g~vKL~ 552 (683)
+...+|+|||||+||+|.+++... ..+++..++.|+.||+.||.|||+.+ ||||||||+|||++. ++.+||+
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEEC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEE
Confidence 356789999999999999999764 35999999999999999999999965 999999999999997 7899999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|||+++...... .....+||+.|+|||++... .|+.++||||||||+|+|++|..||..............
T Consensus 207 DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 277 (400)
T 1nxk_A 207 DFGFAKETTSHN------SLTTPCYTPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277 (400)
T ss_dssp CCTTCEECC-----------------CTTCCGGGSCCC---CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH
T ss_pred ecccccccCCCC------ccccCCCCCCccCHhhcCCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH
Confidence 999998654321 12345799999999998644 389999999999999999999999976443211000011
Q ss_pred HHHhhccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 633 IIKARKVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 633 i~~~~~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.+....+.++ .+..++.++.+||.+||..||.+|||+.++++||||...
T Consensus 278 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1223334443 345799999999999999999999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=384.73 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=192.7
Q ss_pred cceeEE---EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeecccccc
Q 005678 403 HRYALL---NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEI 478 (683)
Q Consensus 403 ~ry~l~---~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~ 478 (683)
++|.+. +.||+|+||.||+|.+..++..||||++... ....+.+|+.+++.+. ||||++++++|.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~e~~~l~~l~~h~niv~~~~~~~- 76 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----------MEANTQKEITALKLCEGHPNIVKLHEVFH- 76 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----------GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----------hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-
Confidence 456664 7899999999999999999999999997432 1245678999999997 999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC---cEEEEecC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG---VAKVTDFG 555 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g---~vKL~DFG 555 (683)
+...+|+|||||+|++|.+++...+.+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCT
T ss_pred cCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccc
Confidence 77889999999999999999988888999999999999999999999965 99999999999998655 89999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH---HHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI---LREDT 632 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i---l~~~~ 632 (683)
++....... .......||+.|+|||++.... ++.++|||||||++|+|++|..||......... .....
T Consensus 155 ~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 226 (325)
T 3kn6_A 155 FARLKPPDN-----QPLKTPCFTLHYAAPELLNQNG---YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226 (325)
T ss_dssp TCEECCC---------------------------CC---CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH
T ss_pred cceecCCCC-----CcccccCCCcCccCHHHhcCCC---CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH
Confidence 998664432 1123447899999999986443 899999999999999999999999754331110 00011
Q ss_pred HHHhhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 633 IIKARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 633 i~~~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.+....+.++. +..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 227 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 227 KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 12222233322 24689999999999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=388.79 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=208.4
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||.||+|.+..+|..||||++..... .......+.+|+.+++.++||||++++++|....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-----SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-----SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-----CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 56799999999999999999999999999999999854322 1233567889999999999999999999986432
Q ss_pred -----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 -----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 -----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+|+||||+ +++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccccCceEEEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeee
Confidence 3569999999 88999999774 5999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+++..... ....+||++|+|||++... ..++.++|||||||++|+|++|+.||......+.+........
T Consensus 174 ~a~~~~~~--------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 174 LARQADSE--------MTGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp TCEECCSS--------CCSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccccc--------cCcCcCCCCcCCHHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99875432 2234799999999998642 2389999999999999999999999987766544322111100
Q ss_pred --------------------h-hc---cCCC-CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 636 --------------------A-RK---VEFP-SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 636 --------------------~-~~---~~~p-~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
. .. ..+. ..+.+++.+.+||.+||.+||.+|||+.++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0 00 0000 124678999999999999999999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=406.59 Aligned_cols=264 Identities=30% Similarity=0.489 Sum_probs=216.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccch------hhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE------DKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~------~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
.+.++|.+++.||+|+||+||+|.+..++..||||++........ .........+.+|+.+++.++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 467899999999999999999999999999999999865432110 00112346788999999999999999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC---cEE
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG---VAK 550 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g---~vK 550 (683)
++|. +...+|+|||||+|++|.+++.....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+|
T Consensus 113 ~~~~-~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFE-DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEE-CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEE-cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEE
Confidence 9996 77889999999999999999977778999999999999999999999965 99999999999999765 699
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||......+.+..
T Consensus 190 l~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~- 258 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY------KLRDRLGTAYYIAPEVLK----KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK- 258 (504)
T ss_dssp ECCCTTCEECCTTS------CBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred EEECCCCEEcCCCC------ccccccCCcCCCCHHHhc----cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 99999998765432 123347999999999975 2389999999999999999999999987766543321
Q ss_pred HHHHHhhccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 631 DTIIKARKVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 631 ~~i~~~~~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+....+.++ .++.+|+++.+||.+||.+||.+|||+.++++||||+.
T Consensus 259 ---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 259 ---VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp ---HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ---HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 122223222 23578999999999999999999999999999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=392.46 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=211.3
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHH-HhhcCCCceeeeccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI-HKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~i-l~~L~HpnIV~L~~~f~ 477 (683)
.+..++|.+++.||+|+||.||+|.+..++..||||++....... ......+.+|..+ ++.++|||||+++++|.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~----~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-----------------CCBCCCCCTTBCCEEEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh----hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 345578999999999999999999999999999999986543221 1224466777777 57789999999999996
Q ss_pred cCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
+.+.+|+||||++||+|..++...+.+++..++.++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||++
T Consensus 110 -~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 110 -TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred -eCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccc
Confidence 67889999999999999999988778999999999999999999999965 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
+...... ......+||+.|+|||++.... ++.++|||||||++|+|++|..||......+... . +...
T Consensus 187 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~---~-i~~~ 254 (373)
T 2r5t_A 187 KENIEHN-----STTSTFCGTPEYLAPEVLHKQP---YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD---N-ILNK 254 (373)
T ss_dssp GGGBCCC-----CCCCSBSCCCCCCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH---H-HHHS
T ss_pred cccccCC-----CccccccCCccccCHHHhCCCC---CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH---H-HHhc
Confidence 8643221 1233458999999999986443 8999999999999999999999998766544332 1 1223
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCcccCCC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDV----LTLAQDPYLTYS 681 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~----~eLl~hP~l~~~ 681 (683)
.+.++ +.++..+.+||.+||..||.+||++ .++++||||+..
T Consensus 255 ~~~~~--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 255 PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp CCCCC--SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred ccCCC--CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 33343 5799999999999999999999986 699999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=386.30 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=216.2
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
...+|.+++.||+|+||.||+|.+..++..||||++....... ......+.+|+.+++.++|||||+++++|. +.
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~ 126 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS----NEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-RE 126 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ET
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-EC
Confidence 3467999999999999999999999999999999986543222 233567889999999999999999999986 67
Q ss_pred ceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+.+++||||+. |+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 78999999996 57777774 4567999999999999999999999965 99999999999999999999999999976
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
.... ....||+.|+|||++.......++.++|||||||++|+|++|..||........+.. +.....
T Consensus 204 ~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~---~~~~~~- 270 (348)
T 1u5q_A 204 MAPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNES- 270 (348)
T ss_dssp SSSB---------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHSCC-
T ss_pred cCCC---------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhcCC-
Confidence 5432 234799999999998654445589999999999999999999999987665544322 122211
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.......++..+.+||.+||..||.+|||+.++++||||...
T Consensus 271 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 271 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 112235689999999999999999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=370.58 Aligned_cols=258 Identities=33% Similarity=0.500 Sum_probs=194.9
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+.+.||+|+||.||+|.+..++..||||++.... .........+.+|+.++..++||||++++++|. +.+.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA----MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-DSNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH----HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-CSSE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh----hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-cCCe
Confidence 57999999999999999999999999999999974321 111223467889999999999999999999986 6788
Q ss_pred EEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+++||||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999999764 67999999999999999999999965 9999999999999999999999999998764
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.... ......||+.|+|||++.... ++.++|||||||++|+|++|..||.......... ......+
T Consensus 164 ~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~ 229 (278)
T 3cok_A 164 MPHE-----KHYTLCGTPNYISPEIATRSA---HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVLADY 229 (278)
T ss_dssp ------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSCC
T ss_pred CCCC-----cceeccCCCCcCCcchhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHhhccc
Confidence 3221 122347999999999986443 7889999999999999999999997655432211 1111222
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..+..++.++.+||.+||..||.+||++.++++||||+..
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 3345689999999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=371.19 Aligned_cols=259 Identities=28% Similarity=0.440 Sum_probs=217.4
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+..++|.+.+.||+|+||.||+|.+..++..||||++..... ........+.+|+.+++.++||||++++++|. +
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL----EKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-D 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc----chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-c
Confidence 445789999999999999999999999999999998743211 11122456889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 7889999999999999999987778999999999999999999999865 99999999999999999999999999876
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
..... .....||+.|+|||++.... ++.++||||||+++|+|++|..||......+... . +.....
T Consensus 164 ~~~~~-------~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~-~~~~~~ 229 (284)
T 2vgo_A 164 APSLR-------RRTMCGTLDYLPPEMIEGKT---HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR---R-IVNVDL 229 (284)
T ss_dssp CSSSC-------BCCCCSCGGGCCHHHHTTCC---BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---H-HHTTCC
T ss_pred Ccccc-------cccccCCCCcCCHHHhccCC---CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH---H-Hhcccc
Confidence 54321 22347999999999986443 7899999999999999999999998766544221 1 122222
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..++.++..+.+||.+||..||.+||++.++++||||+..
T Consensus 230 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 --KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 3335789999999999999999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=381.73 Aligned_cols=268 Identities=24% Similarity=0.412 Sum_probs=208.6
Q ss_pred cccceeEE-EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc
Q 005678 401 LNHRYALL-NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI 478 (683)
Q Consensus 401 ~~~ry~l~-~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~ 478 (683)
+.++|.+. +.||+|+||.||+|.+..++..||||++...... ....+.+|+.++.++ +||||++++++|.
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~~~~h~~i~~~~~~~~- 81 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-------IRSRVFREVEMLYQCQGHRNVLELIEFFE- 81 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC-------CHHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch-------hHHHHHHHHHHHHHhcCCCCeeeEEEEEe-
Confidence 56789885 7899999999999999999999999998654221 134678899999985 7999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc---EEEEecC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV---AKVTDFG 555 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~---vKL~DFG 555 (683)
+.+.+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred eCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 67789999999999999999987778999999999999999999999965 999999999999997765 9999999
Q ss_pred CccccccCcCCC--cccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH-------
Q 005678 556 LSKIVEDDVGSQ--GMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ------- 624 (683)
Q Consensus 556 ls~~~~~~~~~~--~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~------- 624 (683)
++.......... .........||+.|+|||++.... ...++.++|||||||++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 998664321111 011122346999999999986421 123688999999999999999999999764321
Q ss_pred -------HHHHHHHHHHHhhccCCCCC--cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 625 -------ERILREDTIIKARKVEFPSR--PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 625 -------e~il~~~~i~~~~~~~~p~~--~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..+. ..+......+|.. ..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 240 ~~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 240 EACPACQNMLF---ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp -CCHHHHHHHH---HHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred ccchhHHHHHH---HHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 1111 1122233344422 4689999999999999999999999999999999853
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=382.31 Aligned_cols=270 Identities=24% Similarity=0.360 Sum_probs=212.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID- 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d- 479 (683)
.-++|.+++.||+|+||.||+|.+..++..||||++......... ...+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-----PITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS-----CHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc-----hHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 347899999999999999999999999999999988655332211 23567899999999999999999998643
Q ss_pred ------CceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 480 ------QNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 480 ------~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
.+.+|+||||+++ +|...+.. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEEC
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEc
Confidence 4578999999975 77666643 467999999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|||++..+........ .......||+.|+|||++... ..++.++|||||||++|+|++|..||..............
T Consensus 167 Dfg~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQP-NRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp CCTTCEECCCCSSSSC-CCCCSSCSCGGGCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cchhcccccccccccc-cccCCcccccCccCchhhcCC--CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999987654322211 223345799999999988543 2378999999999999999999999988776554433222
Q ss_pred HHHhhcc-CCCCCc-------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 633 IIKARKV-EFPSRP-------------------------AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 633 i~~~~~~-~~p~~~-------------------------~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
....... .++... ..++.+.+||.+||.+||.+|||+.++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 1111111 011100 026789999999999999999999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=375.26 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=214.7
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||++++++|. +.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 78 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-------RDSSLENEIAVLKKIKHENIVTLEDIYE-ST 78 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------------HHHHHHHHHHHCCCTTBCCEEEEEE-CS
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-------chHHHHHHHHHHHhCCCCCeeehhhhcc-cC
Confidence 567899999999999999999999999999999998654221 1245778999999999999999999986 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe---CCCCcEEEEecCCc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLS 557 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL---d~~g~vKL~DFGls 557 (683)
+.+|+||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+|+||||+|||+ +.++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 789999999999999999987778999999999999999999999965 9999999999999 77899999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
...... ......||+.|+|||++... .++.++|||||||++|+|++|..||.......... . +...
T Consensus 157 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~-i~~~ 222 (304)
T 2jam_A 157 KMEQNG-------IMSTACGTPGYVAPEVLAQK---PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE---K-IKEG 222 (304)
T ss_dssp CCCCCB-------TTHHHHSCCCBCCTTTBSSC---SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---H-HHHC
T ss_pred eecCCC-------ccccccCCCCccChHHhccC---CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH---H-HHcC
Confidence 765322 12233699999999998644 38999999999999999999999998765543221 1 1222
Q ss_pred ccCC--CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 638 KVEF--PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 638 ~~~~--p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
...+ +..+.++..+.+||.+||..||.+||++.++++||||+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 223 YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 2222 3346789999999999999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=388.80 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=214.0
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchh-hHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSED-KKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~-~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+.++|.+++.||+|+||.||+|.+..++..||||++......... ........+.+|+.+++.++||||++++++|. +
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-N 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-e
Confidence 457899999999999999999999999999999998765432110 00011234567999999999999999999996 6
Q ss_pred CceEEEEEecccCC-ChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGK-DLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~gg-sL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.+.+++||||+.+| +|..++...+.+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 78899999999776 99999998888999999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
.+..... .....||+.|+|||++.... .++.++|||||||++|+|++|..||..... ...
T Consensus 179 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~ 238 (335)
T 3dls_A 179 YLERGKL------FYTFCGTIEYCAPEVLMGNP--YRGPELEMWSLGVTLYTLVFEENPFCELEE------------TVE 238 (335)
T ss_dssp ECCTTCC------BCEECSCGGGCCHHHHTTCC--BCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------GTT
T ss_pred ECCCCCc------eeccCCCccccChhhhcCCC--CCCCcccchhHHHHHHHHHhCCCchhhHHH------------HHh
Confidence 7654321 22347999999999986433 248899999999999999999999965322 111
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.....+..++.++.+||.+||..||.+|||+.++++||||+.
T Consensus 239 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 239 AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 122334468999999999999999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=402.61 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=204.0
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++|||||+++++|....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-----NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-----SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-----ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 45799999999999999999999999999999999864321 2233567889999999999999999999986332
Q ss_pred -----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 -----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 -----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+|+|||||++ +|...+.. .+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 135 ~~~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred ccccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEE
Confidence 468999999965 56666654 3899999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+++...... .....+||++|+|||++.... |+.++||||||||+|+|++|+.||......+.+........
T Consensus 210 ~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg 280 (464)
T 3ttj_A 210 LARTAGTSF------MMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280 (464)
T ss_dssp CC-----CC------CC----CCCTTCCHHHHTTCC---CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eeeecCCCc------ccCCCcccccccCHHHHcCCC---CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 998765321 233458999999999987543 89999999999999999999999987766554432111100
Q ss_pred hh---------------ccCCCCC---------c------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 636 AR---------------KVEFPSR---------P------------AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 636 ~~---------------~~~~p~~---------~------------~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.. ....+.. + ..++++.+||.+||.+||.+|||+.++++||||+
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 00 0000000 0 0156799999999999999999999999999997
Q ss_pred C
Q 005678 680 Y 680 (683)
Q Consensus 680 ~ 680 (683)
.
T Consensus 361 ~ 361 (464)
T 3ttj_A 361 V 361 (464)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=369.94 Aligned_cols=261 Identities=33% Similarity=0.485 Sum_probs=220.6
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
....+|.+.+.||+|+||.||+|.+..++..||+|++....... ......+.+|+.+++.+.||||++++++|. +
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----PHQREKMSMEISIHRSLAHQHVVGFHGFFE-D 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC----HHHHHHHHHHHHHHHhCCCCCEeeeeeeec-c
Confidence 45679999999999999999999999999999999986543222 223457888999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 7789999999999999999987778999999999999999999999965 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
...... ......||+.|+|||++.... ++.++||||||+++|+|++|..||......+.... ....
T Consensus 165 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~-- 230 (294)
T 2rku_A 165 VEYDGE-----RKKVLCGTPNYIAPEVLSKKG---HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR----IKKN-- 230 (294)
T ss_dssp CCSTTC-----CBCCCCSCCSSCCHHHHTTSC---BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHTT--
T ss_pred cccCcc-----ccccccCCCCcCCcchhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----Hhhc--
Confidence 643221 123347999999999986443 78899999999999999999999987765543321 1122
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.++.+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 231 EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 233345789999999999999999999999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=403.41 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=219.0
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+..++|.+.+.||+|+||.||+|.+..+|..||||++.... .........+.+|+.+++.++||||+++++++. +
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~----~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK----IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-T 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH----HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh----ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-E
Confidence 45578999999999999999999999999999999985421 111223567889999999999999999999996 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+|+|||||+|++|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhh
Confidence 7789999999999999999988888999999999999999999999865 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
..... .....+||+.|+|||++.... .++.++|||||||++|+|++|..||.......... . +...
T Consensus 166 ~~~~~------~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~---~-i~~~-- 231 (476)
T 2y94_A 166 MSDGE------FLRTSCGSPNYAAPEVISGRL--YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK---K-ICDG-- 231 (476)
T ss_dssp CCTTC------CBCCCCSCSTTCCHHHHTTCC--BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH---H-HHTT--
T ss_pred ccccc------cccccCCCcCeEChhhccCCC--CCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH---H-HhcC--
Confidence 65421 233458999999999986433 24789999999999999999999998765543221 1 1222
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.+..+..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 232 ~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 232 IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 23334568999999999999999999999999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=373.30 Aligned_cols=264 Identities=28% Similarity=0.420 Sum_probs=215.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
++.++|.+.+.||+|+||.||+|.+..++..||||++......... .......+.+|+.+++.++||||++++++|. +
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR-RGVSREEIEREVNILREIRHPNIITLHDIFE-N 79 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS-SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccc-cchHHHHHHHHHHHHHhCCCCCeeehhheec-C
Confidence 4567899999999999999999999999999999998655332111 1112456889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC----cEEEEecC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG----VAKVTDFG 555 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g----~vKL~DFG 555 (683)
...+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++ .+||+|||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 7789999999999999999987778999999999999999999999965 99999999999998776 89999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++....... ......||+.|+|||++.... ++.++||||||+++|+|++|..||......+.... +.
T Consensus 158 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~ 224 (283)
T 3bhy_A 158 IAHKIEAGN------EFKNIFGTPEFVAPEIVNYEP---LGLEADMWSIGVITYILLSGASPFLGETKQETLTN----IS 224 (283)
T ss_dssp TCEECC--------------CCCGGGCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HH
T ss_pred cceeccCCC------cccccCCCcCccCcceecCCC---CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH----hH
Confidence 998764331 122347999999999986443 88999999999999999999999987665443221 11
Q ss_pred hhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.....++. .+.++..+.+||.+||..||.+||++.++++||||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 225 AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 22222221 2468899999999999999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=412.35 Aligned_cols=261 Identities=27% Similarity=0.433 Sum_probs=218.3
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
++..++|.+.+.||+|+||.||+|.+..+|..||||++.... .........+.+|+.++..++|||||+++++|.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~- 254 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR----IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE- 254 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH----HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHh----hhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-
Confidence 356678999999999999999999999999999999985421 111223456889999999999999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
+.+.+|+|||||+||+|..++...+ .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEeccc
Confidence 6788999999999999999997653 4999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT---QERILREDTI 633 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~---~e~il~~~~i 633 (683)
++.+.... .....+||+.|+|||++.... |+.++|||||||++|+|++|..||..... ...+. ..
T Consensus 333 a~~~~~~~------~~~~~~GT~~Y~APEvl~~~~---~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~---~~ 400 (576)
T 2acx_A 333 AVHVPEGQ------TIKGRVGTVGYMAPEVVKNER---YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RL 400 (576)
T ss_dssp CEECCTTC------CEECCCSCGGGCCHHHHTTCE---ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH---HH
T ss_pred ceecccCc------cccccCCCccccCHHHHcCCC---CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH---HH
Confidence 98765431 123348999999999987543 89999999999999999999999976532 12221 12
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTY 680 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~ 680 (683)
+......++ ..++.++.+||.+||..||.+|| ++.++++||||+.
T Consensus 401 i~~~~~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 401 VKEVPEEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred hhcccccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 223333444 57999999999999999999999 8999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=384.26 Aligned_cols=266 Identities=27% Similarity=0.453 Sum_probs=214.3
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+..+|.+++.||+|+||.||+|.+..++..||||++.... .......+.+|+.++..++||||++++++|....
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc------CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 4679999999999999999999999999999999985421 1233467889999999999999999999986332
Q ss_pred ----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 481 ----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 481 ----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
..+|+||||++ ++|..++... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 99 IEQMKDVYIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcc
Confidence 47899999996 5999998765 4999999999999999999999966 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+.......... .......||++|+|||++.... .++.++|||||||++|+|++|..||......+.+.........
T Consensus 175 a~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 175 ARVADPDHDHT--GFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CEECCGGGCBC--CTTCCCCSCGGGCCHHHHHTBC--SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred eEecCCCCCcc--ccccccccccCCCCCHHhcCCC--CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 98765432211 1233458999999999875332 3789999999999999999999999876654443221110000
Q ss_pred ----------------hccCCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 ----------------RKVEFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ----------------~~~~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
....++. .+.++.++.+||.+||.+||.+|||+.++++||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 0000111 1457899999999999999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=375.43 Aligned_cols=264 Identities=24% Similarity=0.354 Sum_probs=208.0
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
..+.+..++|.+.+.||+|+||+||+|.+ ++..||||++...... ......+.+|+.+++.++||||++++++
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-----AERVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-----HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 45567788999999999999999999964 7899999998654322 1235678899999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhcCCC---cchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKATPV---LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~---Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
|. +.+.+++||||+++++|.+++...+. +++..+..++.||+.||.|||+.+++|+||||||+|||++.++.+||+
T Consensus 103 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 103 VT-QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp EC-STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred EE-ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 96 66778999999999999999977653 899999999999999999999965559999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|||+++...... .......||+.|+|||++.... ++.++|||||||++|+|++|..||......+....
T Consensus 182 Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~--- 250 (309)
T 3p86_A 182 DFGLSRLKASTF-----LSSKSAAGTPEWMAPEVLRDEP---SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA--- 250 (309)
T ss_dssp CCC----------------------CCTTSCHHHHTTCC---CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---
T ss_pred CCCCCccccccc-----cccccCCCCccccChhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence 999998654321 1123347999999999986544 78999999999999999999999987765543322
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CcccC
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ--DPYLT 679 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~--hP~l~ 679 (683)
........+.+..+++.+.+||.+||..+|.+|||+.++++ .+++.
T Consensus 251 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 251 -VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11122233444679999999999999999999999999987 44443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=380.06 Aligned_cols=265 Identities=26% Similarity=0.412 Sum_probs=213.6
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
.-++|.+++.||+|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||++++++|. +.
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~ 96 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-----KMVKKIAMREIKLLKQLRHENLVNLLEVCK-KK 96 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ET
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-----hHHHHHHHHHHHHHhhCCCCCEeeEEEEee-cC
Confidence 456899999999999999999999999999999988554321 122456789999999999999999999996 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+.+|+||||+++++|..++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 889999999999999999887778999999999999999999999965 999999999999999999999999999866
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH-----
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK----- 635 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~----- 635 (683)
.... .......||++|+|||++... ..++.++|||||||++|+|++|..||......+.+........
T Consensus 175 ~~~~-----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 175 AAPG-----EVYDDEVATRWYRAPELLVGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTC--TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cCCc-----cccCCCcCCccccCcccccCC--CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 4331 122344799999999998643 2478999999999999999999999988776554432211100
Q ss_pred ------h----hccCCCC----------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ------A----RKVEFPS----------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ------~----~~~~~p~----------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
. ....++. .+.+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0 0011111 1367899999999999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=382.43 Aligned_cols=262 Identities=28% Similarity=0.493 Sum_probs=205.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||+||+|.+..++..||||++....... ....+.+|+.+++.++||||++++++|. +.+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG------APCTAIREVSLLKDLKHANIVTLHDIIH-TEKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------------CCCCCCCHHHHSCCCCTTBCCEEEEEE-CSSC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc------cchhHHHHHHHHHhcCCCCCCeeeeEEe-eCCE
Confidence 47999999999999999999999999999999985432211 1123457999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+||||++ ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++....
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 75 LTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred EEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 999999996 588888865 456999999999999999999999966 9999999999999999999999999997654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh-c--
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR-K-- 638 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~-~-- 638 (683)
... .......||++|+|||++... ..++.++|||||||++|+|++|..||......+............ .
T Consensus 152 ~~~-----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 152 IPT-----KTYDNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224 (324)
T ss_dssp ----------------CGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCc-----cccccccCcccccChhhhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHh
Confidence 321 112334789999999998642 237999999999999999999999998877655443222111100 0
Q ss_pred ------------cCCC---------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 639 ------------VEFP---------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ------------~~~p---------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..++ ..+.+++++.+||.+||.+||.+|||+.++++||||...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0111 113578999999999999999999999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=378.79 Aligned_cols=274 Identities=23% Similarity=0.377 Sum_probs=195.1
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
...+.+..++|.+.+.||+|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 80 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC------QTSMDELLKEIQAMSQCHHPNIVSYYT 80 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------------CCCCCCCTTBCCEEE
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc------chhHHHHHHHHHHHhhcCCCCEeeEEE
Confidence 34677888999999999999999999999888999999998754321 123456889999999999999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhc--------CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKA--------TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF 546 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~--------~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~ 546 (683)
+|. ..+.+++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.+
T Consensus 81 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~ 157 (303)
T 2vwi_A 81 SFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED 157 (303)
T ss_dssp EEE-SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT
T ss_pred EEe-ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCC
Confidence 986 56788999999999999999963 456999999999999999999999965 9999999999999999
Q ss_pred CcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH
Q 005678 547 GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626 (683)
Q Consensus 547 g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~ 626 (683)
+.+||+|||++...................||+.|+|||++.... .++.++|||||||++|+|++|..||........
T Consensus 158 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR--GYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235 (303)
T ss_dssp CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHH--CCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcccc--CCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence 999999999998765432111112233457999999999986422 278999999999999999999999987655443
Q ss_pred HHHHHHHHHhhccCC-------CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 627 ILREDTIIKARKVEF-------PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 627 il~~~~i~~~~~~~~-------p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
... ......... .....++.++.+||.+||..||.+||++.++++||||+..+
T Consensus 236 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 236 LML---TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp HHH---HHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred HHH---HhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 321 111111111 11246789999999999999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=372.73 Aligned_cols=260 Identities=25% Similarity=0.463 Sum_probs=213.6
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
...++|.+++.||+|+||.||+|.+..+|..||||++..... ...+.+|+.++..++||||+++++++. +
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---------LQEIIKEISIMQQCDSPHVVKYYGSYF-K 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---------CHHHHHHHHHHHTCCCTTBCCEEEEEE-E
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---------HHHHHHHHHHHHhCCCCCCccEEEEEE-e
Confidence 356789999999999999999999999999999999865321 246788999999999999999999986 5
Q ss_pred CceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.+.+|+||||+++++|.+++. ....+++..+..++.+|+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccch
Confidence 778999999999999999996 4567999999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
....... ......||+.|+|||++.... ++.++|||||||++|+|++|..||........+.. +.....
T Consensus 174 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~ 242 (314)
T 3com_A 174 QLTDTMA-----KRNTVIGTPFWMAPEVIQEIG---YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM---IPTNPP 242 (314)
T ss_dssp ECBTTBS-----CBCCCCSCGGGCCHHHHSSSC---BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHSCC
T ss_pred hhhhhcc-----ccCccCCCCCccChhhcCCCC---CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HhcCCC
Confidence 7654321 123347999999999986543 78999999999999999999999987665443321 222233
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
..+.....++..+.+||.+||..||.+||++.++++||||+..+
T Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 33444456899999999999999999999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=380.15 Aligned_cols=268 Identities=29% Similarity=0.405 Sum_probs=211.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccch-hhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE-DKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~-~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+.++|.+.+.||+|+||.||+|.+..++..||||++........ .........+.+|+.+++.++||||+++++++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc-
Confidence 356789999999999999999999999999999999865422110 111122345788999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc---EEEEecC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV---AKVTDFG 555 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~---vKL~DFG 555 (683)
...+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 86 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 86 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -SSSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -CCceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 3348999999999999999988888999999999999999999999965 999999999999987554 9999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++....... ......||+.|+|||++.......++.++|||||||++|+|++|..||........+.. .+.
T Consensus 163 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~ 233 (322)
T 2ycf_A 163 HSKILGETS------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---QIT 233 (322)
T ss_dssp TCEECCCCH------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH---HHH
T ss_pred cceeccccc------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH---HHH
Confidence 998764321 12234699999999998543444589999999999999999999999975443222211 112
Q ss_pred hhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.....+.. +..++..+.+||.+||..||.+||++.++++||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 22222211 2468999999999999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=377.89 Aligned_cols=261 Identities=32% Similarity=0.482 Sum_probs=220.7
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
....+|.+.+.||+|+||.||+|.+..++..||+|++....... ......+.+|+.+++.++||||++++++|. +
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~ 112 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----PHQREKMSMEISIHRSLAHQHVVGFHGFFE-D 112 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 45679999999999999999999999999999999986543222 223457889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 7789999999999999999987778999999999999999999999965 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
...... ......||+.|+|||++.... ++.++|||||||++|+|++|..||......+.... .....
T Consensus 191 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~- 257 (335)
T 2owb_A 191 VEYDGE-----RKKVLCGTPNYIAPEVLSKKG---HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR----IKKNE- 257 (335)
T ss_dssp CCSTTC-----CBCCCCSCCSSCCHHHHHTSC---BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTC-
T ss_pred cccCcc-----cccccCCCccccCHHHhccCC---CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HhcCC-
Confidence 653321 123347999999999986543 78999999999999999999999987665443322 11222
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+.....++..+.+||.+||..||.+||++.++++||||+..
T Consensus 258 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 258 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 23335789999999999999999999999999999999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=389.41 Aligned_cols=257 Identities=27% Similarity=0.423 Sum_probs=207.8
Q ss_pred cccceeE--EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 401 LNHRYAL--LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 401 ~~~ry~l--~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
+...|.+ .+.||+|+||.||+|.+..+|..||||++..... .....+.+|+.++..++|||||+++++|.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~- 156 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-------KDKEEVKNEISVMNQLDHANLIQLYDAFE- 156 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-------HHHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-------ccHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence 4455655 6789999999999999999999999999865321 12356889999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe--CCCCcEEEEecC
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF--DEFGVAKVTDFG 555 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL--d~~g~vKL~DFG 555 (683)
+.+.+++|||||++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 157 ~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG 234 (373)
T 2x4f_A 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFG 234 (373)
T ss_dssp CSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCC
Confidence 677899999999999999988543 46899999999999999999999965 9999999999999 567899999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++....... ......||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+.. +.
T Consensus 235 ~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---i~- 301 (373)
T 2x4f_A 235 LARRYKPRE------KLKVNFGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN---IL- 301 (373)
T ss_dssp SCEECCTTC------BCCCCCSSCTTCCHHHHTTCB---CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HH-
T ss_pred CceecCCcc------ccccccCCCcEeChhhccCCC---CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH-
Confidence 998765432 122347999999999986443 89999999999999999999999987765543321 11
Q ss_pred hhccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARKVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.....++ ..+.+++++.+||.+||.+||.+||++.++++||||+.
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 302 ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred hccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 1222222 23568999999999999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=366.10 Aligned_cols=261 Identities=26% Similarity=0.423 Sum_probs=210.1
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+..++|.+.+.||+|+||.||+|.+..+++.||||++.... .........+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 81 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK----IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS- 81 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc----ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-
Confidence 345678999999999999999999999999999999975321 112223567889999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+.+++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeeccccc
Confidence 67789999999999999999987778999999999999999999999976 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
...... ......||+.|+|||++.... ..+.++||||||+++|+|++|..||.......... . +....
T Consensus 160 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~-~~~~~ 227 (276)
T 2h6d_A 160 MMSDGE------FLRTSCGSPNYAAPEVISGRL--YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK---K-IRGGV 227 (276)
T ss_dssp CCCC-------------------CCTGGGTTSC--CCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H-HHHCC
T ss_pred ccCCCc------ceecccCCccccCHHHHcCCC--CCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---H-hhcCc
Confidence 764321 123347999999999986433 23689999999999999999999997765443221 1 11222
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
++.+..++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 228 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 228 --FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred --ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 2233568999999999999999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=388.32 Aligned_cols=267 Identities=25% Similarity=0.428 Sum_probs=211.3
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC--CCceeeeccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV--HHHIVRLWDT 475 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~--HpnIV~L~~~ 475 (683)
..+...+|.+++.||+|+||.||+|.+.. +..||||++...... ......+.+|+.++..+. |||||+++++
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-----~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-----NQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-----HHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-----HHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 45566789999999999999999998754 899999998654321 233567899999999997 5999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
+. ..+.+|+||| +.+++|.+++.....+++..+..|+.||+.||.|||+.+ ||||||||+|||++ ++.+||+|||
T Consensus 125 ~~-~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG 199 (390)
T 2zmd_A 125 EI-TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFG 199 (390)
T ss_dssp EE-CSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCS
T ss_pred Ee-cCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecC
Confidence 86 6678999999 558899999988888999999999999999999999865 99999999999996 5899999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccC--------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--------TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--------~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
+++.+...... ......+||+.|+|||++.... ...++.++||||||||||+|++|..||.........
T Consensus 200 ~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 276 (390)
T 2zmd_A 200 IANQMQPDTTS---VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276 (390)
T ss_dssp SSCCC------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred ccccccCCCcc---ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH
Confidence 99876543211 1233457999999999986421 134899999999999999999999999765443222
Q ss_pred HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 628 l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+. .+ ......++.+...+.++.+||.+||..||.+||++.++++||||+..
T Consensus 277 ~~--~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 277 LH--AI-IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HH--HH-HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HH--HH-hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 21 11 11222333334568899999999999999999999999999999753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=373.98 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=210.7
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.++.++|.+++.||+|+||.||+|.+..++..||||++....... ......+.+|+.++..++||||+++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~- 81 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK----EETLKRFEREVHNSSQLSHQNIVSMIDVDE- 81 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC----HHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc----HHHHHHHHHHHHHHhcCCCCCCceEEEeee-
Confidence 356889999999999999999999999999999999886543322 234567899999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAK 159 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence 67889999999999999999988788999999999999999999999966 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
....... .......||+.|+|||++.... ++.++|||||||++|+|++|..||............ .....
T Consensus 160 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~---~~~~~ 229 (294)
T 4eqm_A 160 ALSETSL----TQTNHVLGTVQYFSPEQAKGEA---TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH---IQDSV 229 (294)
T ss_dssp TC-----------------CCSSCCHHHHHTCC---CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH---HSSCC
T ss_pred ccccccc----cccCccccCccccCHhHhcCCC---CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hhccC
Confidence 7643321 1233447999999999986544 789999999999999999999999877655433221 11111
Q ss_pred cC--CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 639 VE--FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 639 ~~--~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
.. ....+.+++.+.++|.+||..||.+||+..+.+.++|.
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 11 11235689999999999999999999955555555543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=371.25 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=209.4
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d 479 (683)
..++|.+++.||+|+||+||+|.+..+++.||||++.... ...+.+|+.++..+. ||||+++++++...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------KKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 3578999999999999999999999999999999985321 246788999999997 99999999998642
Q ss_pred -CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-cEEEEecCCc
Q 005678 480 -QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTDFGLS 557 (683)
Q Consensus 480 -~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-~vKL~DFGls 557 (683)
...+++||||+++++|..++.. +++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 104 ~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 104 VSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp TTCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 5678999999999999999864 889999999999999999999966 99999999999999766 8999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-HHH---
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE-DTI--- 633 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~-~~i--- 633 (683)
........ .....||+.|+|||++... ..++.++|||||||++|+|++|..||.........+.. ...
T Consensus 179 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~ 250 (330)
T 3nsz_A 179 EFYHPGQE------YNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250 (330)
T ss_dssp EECCTTCC------CCSCCSCGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred eEcCCCCc------cccccccccccChhhhcCC--CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCC
Confidence 87654321 2334799999999998642 34899999999999999999999999554333222111 000
Q ss_pred ------HHhhccC----------------------CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 634 ------IKARKVE----------------------FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 634 ------~~~~~~~----------------------~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
....... ......+++++.+||.+||.+||.+|||+.++++||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0000000 111233799999999999999999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=379.48 Aligned_cols=268 Identities=28% Similarity=0.463 Sum_probs=208.0
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
..++|.+++.||+|+||.||+|.+..+|..||||++....... ........+.+|+.+++.++||||++++++|. +.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~ 84 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE--AKDGINRTALREIKLLQELSHPNIIGLLDAFG-HK 84 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-CT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch--hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-eC
Confidence 3568999999999999999999999999999999986543211 11122346789999999999999999999996 67
Q ss_pred ceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+.+++||||+++ +|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++..
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 789999999975 888888654 46899999999999999999999966 99999999999999999999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh-hc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA-RK 638 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~-~~ 638 (683)
+.... .......||++|+|||++... ..++.++|||||||++|+|++|.+||......+.+......... ..
T Consensus 162 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 162 FGSPN-----RAYTHQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 234 (346)
T ss_dssp TTSCC-----CCCCCSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccCCc-----ccCCcccccccccCchHhhCC--CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 64332 112344799999999998532 23789999999999999999999999877665544321111100 00
Q ss_pred cCCCC---------------------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 639 VEFPS---------------------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~---------------------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..++. ...++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 11111 13567899999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=369.41 Aligned_cols=265 Identities=26% Similarity=0.408 Sum_probs=214.4
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
...++|.+++.||+|+||.||+|.+..++..||+|++..... .....+.+|+.++..++||||++++++|. +
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 87 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-------EELEDYIVEIEILATCDHPYIVKLLGAYY-H 87 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-------HHHHHHHHHHHHHhcCCCCCEeeeeeeee-e
Confidence 467899999999999999999999999999999999854321 12457888999999999999999999986 5
Q ss_pred CceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.+.+++||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 6789999999999999999854 566999999999999999999999965 9999999999999999999999999876
Q ss_pred ccccCcCCCcccccccCCCCCccCCccccccc--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELS--KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~--~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
...... .......||+.|+|||++... ....++.++|||||||++|+|++|..||........+.. +...
T Consensus 166 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~ 237 (302)
T 2j7t_A 166 KNLKTL-----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKS 237 (302)
T ss_dssp HHHHHH-----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHS
T ss_pred cccccc-----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH---Hhcc
Confidence 433211 112234799999999998421 233478999999999999999999999987665543322 2222
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
..........++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 2223334467899999999999999999999999999999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=405.04 Aligned_cols=261 Identities=27% Similarity=0.392 Sum_probs=216.7
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+..+.|.+++.||+|+||.||+|.+..+|+.||||++.... .........+.+|+.++..++||||++++++|. +
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR----LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-T 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH----HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH----hhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-e
Confidence 44578999999999999999999999999999999985421 112223567889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcC----CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKAT----PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~----~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
...+|+||||++||+|..++... ..+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecc
Confidence 77899999999999999999653 46999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT---QERILREDT 632 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~---~e~il~~~~ 632 (683)
+++.+.... ......+||+.|+|||++.... |+.++|||||||++|+|++|..||..... ...+..
T Consensus 335 la~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~---~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~--- 403 (543)
T 3c4z_A 335 LAVELKAGQ-----TKTKGYAGTPGFMAPELLLGEE---YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--- 403 (543)
T ss_dssp TCEECCTTC-----CCBCCCCSCTTTSCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---
T ss_pred eeeeccCCC-----cccccccCCccccChhhhcCCC---CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---
Confidence 998765432 1133448999999999987543 89999999999999999999999976432 122211
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTY 680 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~ 680 (683)
.+......+| +.++..+.+||.+||..||.+||+ +.++++||||+.
T Consensus 404 ~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 404 RVLEQAVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHhhcccCCC--cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 1222333444 579999999999999999999996 589999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=385.25 Aligned_cols=260 Identities=25% Similarity=0.427 Sum_probs=206.7
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
....++|.+++.||+|+||+||+|.+..+|..||||++...... ..+|+.+++.++|||||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----------~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----------KNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----------CCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----------HHHHHHHHHHcCCCCccchhheeee
Confidence 45678999999999999999999999999999999987544221 2369999999999999999999843
Q ss_pred -------------------------------------CCceEEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHH
Q 005678 479 -------------------------------------DQNTFCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQI 517 (683)
Q Consensus 479 -------------------------------------d~~~~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qI 517 (683)
+...+++||||+++ +|...+. ....+++..++.++.||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 23458899999974 7776663 45679999999999999
Q ss_pred HHHHHHHHhcCCceEecccCCcceEeC-CCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCC
Q 005678 518 FQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLIS 596 (683)
Q Consensus 518 a~aL~yLH~~g~~IIHrDLKP~NILLd-~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s 596 (683)
+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++... ..++
T Consensus 151 ~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~t~~y~aPE~~~~~--~~~~ 220 (383)
T 3eb0_A 151 FRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP------SVAYICSRFYRAPELMLGA--TEYT 220 (383)
T ss_dssp HHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC------CCCCCCCSSCCCHHHHTTC--SSCC
T ss_pred HHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC------CcCcccCCCccCHHHhcCC--CCCC
Confidence 99999999865 99999999999998 689999999999987644321 2234789999999988632 2379
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh-------------hccCCCC----------CcCCCHHHHH
Q 005678 597 SKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA-------------RKVEFPS----------RPAVSNEAKD 653 (683)
Q Consensus 597 ~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~-------------~~~~~p~----------~~~~s~el~d 653 (683)
.++|||||||++|+|++|..||......+.+......... ....+|. +..++.++.+
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence 9999999999999999999999887766654332111100 1111221 2357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 654 LIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 654 LI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
||.+||.+||.+|||+.++++||||+.
T Consensus 301 li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 999999999999999999999999963
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=371.27 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=210.9
Q ss_pred cccccceeEEEEecccCceEEEEEEE-ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCc------eee
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYD-LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH------IVR 471 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d-~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn------IV~ 471 (683)
.++.++|.+.+.||+|+||.||+|.+ ..+++.||||++... ......+.+|+.++..++|++ |++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--------CchhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 46788999999999999999999998 568999999998532 123456788999999887765 999
Q ss_pred eccccccCCceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC----
Q 005678 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---- 545 (683)
Q Consensus 472 L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---- 545 (683)
++++|. +.+.+|+||||+ +++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 82 ~~~~~~-~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 82 MLEWFE-HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp EEEEEE-ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEE
T ss_pred eecccc-cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccc
Confidence 999886 667899999999 889999997654 6899999999999999999999965 999999999999987
Q ss_pred ---------------CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHH
Q 005678 546 ---------------FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQ 610 (683)
Q Consensus 546 ---------------~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyE 610 (683)
++.+||+|||++...... .....||+.|+|||++.... ++.++|||||||++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~e 226 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--------HSTLVSTRHYRAPEVILALG---WSQPCDVWSIGCILIE 226 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC--------CCSSCSCGGGCCHHHHTTSC---CCTHHHHHHHHHHHHH
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc--------cccccCCccccChHHhhCCC---CCcchhhHHHHHHHHH
Confidence 678999999999865432 22347999999999986443 8999999999999999
Q ss_pred HHcCCCCCCCCchHHHHHHHHHHHHhh-----------------ccCC---------------------CCCcCCCHHHH
Q 005678 611 MLFGRRPFGHDQTQERILREDTIIKAR-----------------KVEF---------------------PSRPAVSNEAK 652 (683)
Q Consensus 611 LLtG~~PF~~~~~~e~il~~~~i~~~~-----------------~~~~---------------------p~~~~~s~el~ 652 (683)
|++|..||......+.......+.... ...+ ......+..+.
T Consensus 227 l~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 306 (339)
T 1z57_A 227 YYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306 (339)
T ss_dssp HHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHH
Confidence 999999998776655432221111100 0000 11123457899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 653 DLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 653 dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
+||.+||..||.+|||+.++++||||+..+
T Consensus 307 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 307 DLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 999999999999999999999999998765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=385.01 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=205.0
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC--------CCcee
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV--------HHHIV 470 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~--------HpnIV 470 (683)
.++.++|.+++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++ ||||+
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--------EHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--------CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 45778999999999999999999999999999999998532 123456788999999996 78899
Q ss_pred eecccccc---CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhc-CCceEecccCCcceEeC
Q 005678 471 RLWDTFEI---DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKR-AQKIIHYDLKPGNVLFD 544 (683)
Q Consensus 471 ~L~~~f~~---d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~-g~~IIHrDLKP~NILLd 544 (683)
+++++|.. +...+|+||||+ +++|...+... ..+++..++.|+.||+.||.|||+. + ||||||||+||||+
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~ 181 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLS 181 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEEC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEe
Confidence 99999863 456899999999 55666665332 5699999999999999999999996 5 99999999999999
Q ss_pred CCC-------------------------------------------------cEEEEecCCccccccCcCCCcccccccC
Q 005678 545 EFG-------------------------------------------------VAKVTDFGLSKIVEDDVGSQGMELTSQG 575 (683)
Q Consensus 545 ~~g-------------------------------------------------~vKL~DFGls~~~~~~~~~~~~~l~~~~ 575 (683)
.++ .+||+|||++...... ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--------~~~~ 253 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--------FTED 253 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------SCSC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------CccC
Confidence 775 7999999999876432 2234
Q ss_pred CCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch------HHHHHHHHHHHH--------hhcc--
Q 005678 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT------QERILREDTIIK--------ARKV-- 639 (683)
Q Consensus 576 ~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~------~e~il~~~~i~~--------~~~~-- 639 (683)
.||+.|+|||++.... ++.++|||||||++|+|++|..||..... ...+.....+.. ....
T Consensus 254 ~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 254 IQTRQYRSLEVLIGSG---YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330 (397)
T ss_dssp CSCGGGCCHHHHHTSC---CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG
T ss_pred CCCCcccCChhhcCCC---CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc
Confidence 7999999999987544 89999999999999999999999975432 111111000000 0000
Q ss_pred --------------------------CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 640 --------------------------EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 640 --------------------------~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.+.....++..+.+||.+||.+||.+|||+.++++||||+
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0011233456789999999999999999999999999997
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=375.67 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=208.5
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
..+++++|.+.+.||+|+||+||+|.+..++..||||++...... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL------RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG------SCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc------chHHHHHHHHHHHHhcCCCCcceEEEEee
Confidence 346788999999999999999999999999999999998543221 11356779999999999999999999886
Q ss_pred cC-CceEEEEEecccCCChhHHHhcCC---CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe----CCCCcE
Q 005678 478 ID-QNTFCTVLEYCSGKDLDAVLKATP---VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVA 549 (683)
Q Consensus 478 ~d-~~~~~LV~Ey~~ggsL~~~L~~~~---~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL----d~~g~v 549 (683)
.. ...+|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp CTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceE
Confidence 43 337899999999999999996543 3999999999999999999999965 9999999999999 778889
Q ss_pred EEEecCCccccccCcCCCcccccccCCCCCccCCccccccc-----CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH
Q 005678 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS-----KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ 624 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~-----~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~ 624 (683)
||+|||+++....... .....||+.|+|||++... ....++.++|||||||++|+|++|..||......
T Consensus 156 kL~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 156 KLTDFGAARELEDDEQ------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp EECCCTTCEECCTTCC------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred EEccCCCceecCCCCc------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 9999999987654321 2234799999999988531 1234889999999999999999999999643221
Q ss_pred ---HHHHHHHHHHHhhcc------------------CCCC----CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 625 ---ERILREDTIIKARKV------------------EFPS----RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 625 ---e~il~~~~i~~~~~~------------------~~p~----~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
..++. .+...... .++. ...++..+.+||.+||..||.+|||+.++++||
T Consensus 230 ~~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 230 RRNKEVMY--KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp GGCHHHHH--HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred chhHHHHH--HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 11111 11111110 1121 123456789999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=380.59 Aligned_cols=265 Identities=23% Similarity=0.347 Sum_probs=216.5
Q ss_pred CCCccccccccceeEEEEecccCceEEEEEE-----EccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CC
Q 005678 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAY-----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VH 466 (683)
Q Consensus 393 ~~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~-----d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~H 466 (683)
.....|.+..++|.+.+.||+|+||.||+|. +..+++.||||++..... ......+.+|+.++..+ .|
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h 85 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------HSEHRALMSELKILIHIGHH 85 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC------HHHHHHHHHHHHHHHhhcCC
Confidence 3446778889999999999999999999998 456779999999864321 12246789999999999 78
Q ss_pred CceeeeccccccCCceEEEEEecccCCChhHHHhcCCC------------------------------------------
Q 005678 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV------------------------------------------ 504 (683)
Q Consensus 467 pnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~------------------------------------------ 504 (683)
||||+++++|......+++|||||++|+|.+++.....
T Consensus 86 pniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (359)
T 3vhe_A 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS 165 (359)
T ss_dssp TTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------
T ss_pred cceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccc
Confidence 99999999987666679999999999999999965432
Q ss_pred ------------------------cchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 505 ------------------------LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 505 ------------------------Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||++..+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 166 GFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp ------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred ccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 899999999999999999999965 999999999999999999999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
...... .......||+.|+|||++.... ++.++|||||||++|+|++ |..||........+.. .+... .
T Consensus 244 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--~~~~~--~ 313 (359)
T 3vhe_A 244 YKDPDY---VRKGDARLPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--RLKEG--T 313 (359)
T ss_dssp TSCTTC---EEC--CEECGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH--HHHHT--C
T ss_pred cccccc---hhccccCCCceeEChhhhcCCC---CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH--HHHcC--C
Confidence 433211 2233447899999999987544 8999999999999999998 9999977654443322 11222 2
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
..+.+..+++++.+||.+||..||.+|||+.++++|
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 333445789999999999999999999999999876
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=391.49 Aligned_cols=258 Identities=14% Similarity=0.170 Sum_probs=200.2
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHH---HHHhhcCCCceeeec
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY---NIHKTLVHHHIVRLW 473 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi---~il~~L~HpnIV~L~ 473 (683)
.+....++|.+.+.||+|+||+||+|.+..+|+.||||++........ ...+.+.+|+ .+++.++|||||+++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS----NAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT----THHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch----HHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 344456899999999999999999999989999999999865422221 1245678899 555566899999998
Q ss_pred -------cccccCCc----------------eEEEEEecccCCChhHHHhcCCCcch-------HHHHHHHHHHHHHHHH
Q 005678 474 -------DTFEIDQN----------------TFCTVLEYCSGKDLDAVLKATPVLPE-------REARIIIVQIFQGLIY 523 (683)
Q Consensus 474 -------~~f~~d~~----------------~~~LV~Ey~~ggsL~~~L~~~~~Lse-------~~~~~I~~qIa~aL~y 523 (683)
+++...+. ..|+||||+ +|+|.+++...+.+++ ..+..|+.||+.||.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 44432211 388999999 6799999975443444 7888899999999999
Q ss_pred HHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccC--------CCCC
Q 005678 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--------TPLI 595 (683)
Q Consensus 524 LH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--------~~~~ 595 (683)
||+.+ ||||||||+||||+.+|.+||+|||+++.... ......| +.|+|||++.... ...+
T Consensus 222 LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~ 290 (377)
T 3byv_A 222 LHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEARRATISYHRDRRTLM 290 (377)
T ss_dssp HHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC
T ss_pred HHhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCC--------cccCCCC-cCccChhhhcccccccccccccccC
Confidence 99965 99999999999999999999999999985432 1233467 9999999987650 0138
Q ss_pred CchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 596 SSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 596 s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+.++|||||||++|+|++|..||........ ....+...+.+++++.+||.+||..||.+||++.++++|
T Consensus 291 ~~~~DvwSlG~il~elltg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 291 TFSFDAWALGLVIYWIWCADLPITKDAALGG----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCCC------CC----------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred ChhhhHHHHHHHHHHHHHCCCCCcccccccc----------hhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999999999999999965433211 111122336789999999999999999999999999999
Q ss_pred cccCC
Q 005678 676 PYLTY 680 (683)
Q Consensus 676 P~l~~ 680 (683)
|||+.
T Consensus 361 p~f~~ 365 (377)
T 3byv_A 361 PEYEQ 365 (377)
T ss_dssp HHHHH
T ss_pred hHHHH
Confidence 99964
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=370.95 Aligned_cols=268 Identities=24% Similarity=0.407 Sum_probs=212.8
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeec
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLW 473 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~ 473 (683)
+..+....++|.+++.||+|+||.||+|.+..++..||||++...... ...+.+|+.++..+ .||||++++
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--------EEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--------THHHHHHHHHHHHHCCSTTBCCEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--------HHHHHHHHHHHHhccCCCCeeeee
Confidence 445566788999999999999999999999999999999998654221 23577899999999 799999999
Q ss_pred cccccC-----CceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC
Q 005678 474 DTFEID-----QNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF 546 (683)
Q Consensus 474 ~~f~~d-----~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~ 546 (683)
++|... .+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.+
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN 165 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCC
Confidence 998643 46899999999999999999754 56899999999999999999999965 9999999999999999
Q ss_pred CcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchH
Q 005678 547 GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ 624 (683)
Q Consensus 547 g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~ 624 (683)
+.+||+|||++........ ......||+.|+|||++.... ...++.++|||||||++|+|++|..||......
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVG-----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp CCEEECCCTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CCEEEeeCcCceecCcCcc-----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 9999999999987643211 123347999999999986322 234789999999999999999999999776654
Q ss_pred HHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 625 ERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 625 e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..... +.. ..........++..+.+||.+||..||.+||++.++++||||+..
T Consensus 241 ~~~~~---~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 241 RALFL---IPR-NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHH---HHH-SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHHHH---hhc-CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 43321 111 111122235689999999999999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=372.42 Aligned_cols=271 Identities=24% Similarity=0.319 Sum_probs=197.2
Q ss_pred CCCccccccccceeEEEEecccCceEEEEEEEccCCe---EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce
Q 005678 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHR---YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469 (683)
Q Consensus 393 ~~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~---~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI 469 (683)
..+.++.+..++|.+.+.||+|+||.||+|.+..++. .||||++....... .....+.+|+.+++.++||||
T Consensus 13 ~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i 87 (323)
T 3qup_A 13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-----SDIEEFLREAACMKEFDHPHV 87 (323)
T ss_dssp ---CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-----HHHHHHHHHHHHHTTCCCTTB
T ss_pred HHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-----HHHHHHHHHHHHHHHCCCCce
Confidence 4456777889999999999999999999998777665 89999986543222 225678999999999999999
Q ss_pred eeeccccccCCc-----eEEEEEecccCCChhHHHhcCC------CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCC
Q 005678 470 VRLWDTFEIDQN-----TFCTVLEYCSGKDLDAVLKATP------VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKP 538 (683)
Q Consensus 470 V~L~~~f~~d~~-----~~~LV~Ey~~ggsL~~~L~~~~------~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP 538 (683)
+++++++..... .+++||||+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||
T Consensus 88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp 165 (323)
T 3qup_A 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAA 165 (323)
T ss_dssp CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCc
Confidence 999999863322 2389999999999999995332 5899999999999999999999966 99999999
Q ss_pred cceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 005678 539 GNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRP 617 (683)
Q Consensus 539 ~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~P 617 (683)
+|||++.++.+||+|||++......... .......||+.|+|||++.... ++.++|||||||++|+|++ |..|
T Consensus 166 ~NIli~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~ell~~g~~p 239 (323)
T 3qup_A 166 RNCMLAEDMTVCVADFGLSRKIYSGDYY---RQGCASKLPVKWLALESLADNL---YTVHSDVWAFGVTMWEIMTRGQTP 239 (323)
T ss_dssp GGEEECTTSCEEECCCCC--------------------CCGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ceEEEcCCCCEEEeeccccccccccccc---cccccccCcccccCchhhcCCC---CCCccchhhHHHHHHHHHhCCCCC
Confidence 9999999999999999999876543211 1222346788999999986544 8999999999999999999 9999
Q ss_pred CCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCcccCCC
Q 005678 618 FGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPD-------VLTLAQDPYLTYS 681 (683)
Q Consensus 618 F~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS-------~~eLl~hP~l~~~ 681 (683)
|......+... .+.. ....+..+.++.++.+||.+||..||.+||| +.+++.|||+...
T Consensus 240 ~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 240 YAGIENAEIYN---YLIG--GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp TTTCCGGGHHH---HHHT--TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ccccChHHHHH---HHhc--CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 98766544321 1111 2233445679999999999999999999999 8888899998753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=384.91 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=195.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID- 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d- 479 (683)
+.++|.+++.||+|+||.||+|.+..+|..||||++...... ......+.+|+.+++.++||||++++++|...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-----IIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 568999999999999999999999999999999998653221 12346788999999999999999999998532
Q ss_pred ----CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 480 ----QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 480 ----~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
...+|+|+||+ +++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC--
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecc
Confidence 25689999999 7899999876 45999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+++..... .....||++|+|||++... ..++.++|||||||++|+|++|+.||......+.+........
T Consensus 178 ~a~~~~~~--------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 178 LARHTADE--------MTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ---------------------CCCTTCCHHHHTTC--CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccccc--------CCCcCcCcCccChHHHcCC--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99865432 2234799999999998642 2488999999999999999999999987766544322111100
Q ss_pred h------------------hc-cCCCC------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 A------------------RK-VEFPS------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~------------------~~-~~~p~------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
. .. ...+. .+.+++.+.+||.+||.+||.+|||+.++++||||+.
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 0 00 00111 1356889999999999999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=365.60 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=216.1
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
..++|.+++.||+|+||.||+|.+..++..||||++...... .....+.+|+.+++.+.||||++++++|. +.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 92 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE------DEIEDIQQEITVLSQCDSPYVTKYYGSYL-KD 92 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS------TTHHHHHHHHHHHHHCCCTTBCCEEEEEE-ET
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH------HHHHHHHHHHHHHHhCCCCCEeEEEEEEe-cC
Confidence 457899999999999999999999999999999998654321 12457889999999999999999999986 67
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
..+++||||+++++|.+++... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CeEEEEEEeCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceec
Confidence 7899999999999999999764 5999999999999999999999966 999999999999999999999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......||+.|+|||++.... ++.++|||||||++|+|++|..||........... +.....
T Consensus 170 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~-- 236 (303)
T 3a7i_A 170 TDTQI-----KRNTFVGTPFWMAPEVIKQSA---YDSKADIWSLGITAIELARGEPPHSELHPMKVLFL---IPKNNP-- 236 (303)
T ss_dssp BTTBC-----CBCCCCSCGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHSCC--
T ss_pred Ccccc-----ccCccCCCcCccCHHHHhcCC---CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH---hhcCCC--
Confidence 54321 123447999999999986443 78999999999999999999999987665443221 111111
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
......++..+.+||.+||..||.+|||+.++++||||..
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 1223578999999999999999999999999999999964
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=383.41 Aligned_cols=263 Identities=18% Similarity=0.217 Sum_probs=192.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc--CCCceeeecccc---
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL--VHHHIVRLWDTF--- 476 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L--~HpnIV~L~~~f--- 476 (683)
...|.+.+.||+|+||.||+|.+..++..||||++....... ......+.+|+.++..| +||||++++..|
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS----RSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH----HHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc----ccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 446999999999999999999999999999999987653321 22344566775444444 699988865333
Q ss_pred ----ccCC----------------ceEEEEEecccCCChhHHHhcC-CCcchHHH------HHHHHHHHHHHHHHHhcCC
Q 005678 477 ----EIDQ----------------NTFCTVLEYCSGKDLDAVLKAT-PVLPEREA------RIIIVQIFQGLIYLNKRAQ 529 (683)
Q Consensus 477 ----~~d~----------------~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~------~~I~~qIa~aL~yLH~~g~ 529 (683)
...+ ..+|+|||||+ ++|.+++... ..+++..+ ..++.||+.||.|||+.+
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~- 214 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG- 214 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence 2111 45899999998 8999999653 33555555 677799999999999965
Q ss_pred ceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHH
Q 005678 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFY 609 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILy 609 (683)
||||||||+||||+.+|.+||+|||+++..... .....||+.|+|||++.... ..++.++|||||||++|
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~ 284 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--------GPASSVPVTYAPREFLNAST-ATFTHALNAWQLGLSIY 284 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE--------EEGGGSCGGGCCHHHHTCSE-EECCHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC--------ccCccCCcCCcChhhccCCC-CCcCccccHHHHHHHHH
Confidence 999999999999999999999999999866432 11336779999999986411 23899999999999999
Q ss_pred HHHcCCCCCCCCchHHHH-HHHH--HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 610 QMLFGRRPFGHDQTQERI-LRED--TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 610 ELLtG~~PF~~~~~~e~i-l~~~--~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+|++|+.||......... +... .........++..+.+++.+.+||.+||.+||.+||++.++++||||+.
T Consensus 285 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 285 RVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp HHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred HHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 999999999765322100 0000 0011123445555689999999999999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=388.58 Aligned_cols=260 Identities=26% Similarity=0.396 Sum_probs=208.9
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc------CCCceeee
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL------VHHHIVRL 472 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L------~HpnIV~L 472 (683)
..+..+|.+++.||+|+||+||+|.+..++..||||++.... .....+.+|+.++..+ .|+||+.+
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--------RFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--------chHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 457789999999999999999999999999999999985421 2234566777777777 57799999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc--
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV-- 548 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~-- 548 (683)
+++|. ..+.+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.
T Consensus 165 ~~~~~-~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~ 240 (429)
T 3kvw_A 165 LENFT-FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSG 240 (429)
T ss_dssp EEEEE-ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCC
T ss_pred Eeecc-cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcc
Confidence 99986 5788999999995 6999998654 35999999999999999999999976 999999999999999887
Q ss_pred EEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Q 005678 549 AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628 (683)
Q Consensus 549 vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il 628 (683)
+||+|||++...... .....||+.|+|||++.... ++.++|||||||++|+|++|.+||......+.+.
T Consensus 241 vkL~DFG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~ 309 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQR--------VYTYIQSRFYRAPEVILGAR---YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309 (429)
T ss_dssp EEECCCTTCEETTCC--------CCSSCSCGGGCCHHHHHTBC---CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eEEeecccceecCCc--------ccccCCCCCccChHHHhCCC---CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999765432 22347999999999987554 8999999999999999999999998877655443
Q ss_pred HHHHHHHhhc----------------cCCC-------------------------------------CCcCCCHHHHHHH
Q 005678 629 REDTIIKARK----------------VEFP-------------------------------------SRPAVSNEAKDLI 655 (683)
Q Consensus 629 ~~~~i~~~~~----------------~~~p-------------------------------------~~~~~s~el~dLI 655 (683)
.......... ..+| .....++.+.+||
T Consensus 310 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli 389 (429)
T 3kvw_A 310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389 (429)
T ss_dssp HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence 2211110000 0000 0012478899999
Q ss_pred HHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 656 RRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 656 ~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.+||.+||.+|||+.++++||||+..
T Consensus 390 ~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 390 KQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp HHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred HHHCCCChhhCCCHHHHhCChhhccC
Confidence 99999999999999999999999854
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=371.54 Aligned_cols=270 Identities=26% Similarity=0.410 Sum_probs=213.1
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+.+.||+|+||.||+|.+..+|..||||++.... .......+.+|+.+++.++||||+++++++..+
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD------KPLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc------cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 35789999999999999999999999999999999985421 122345678999999999999999999987533
Q ss_pred ----CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 480 ----QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 480 ----~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
...+|+||||+. ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQ-TDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CSTTCCCEEEEECCCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCT
T ss_pred ccCccceEEEEEeccC-ccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecc
Confidence 367899999996 6999998764 5999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCc-----ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 556 LSKIVEDDVGSQG-----MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 556 ls~~~~~~~~~~~-----~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
++........... ........||+.|+|||++... ..++.++|||||||++|+|++|..||........+...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS--AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSC--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccC--CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 9987654321110 0112234799999999987532 34899999999999999999999999877655443321
Q ss_pred HHHHHhh--------------------ccCCCC------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 631 DTIIKAR--------------------KVEFPS------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 631 ~~i~~~~--------------------~~~~p~------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..+.... ...++. .+.+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 1111000 000111 14689999999999999999999999999999999853
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=361.80 Aligned_cols=262 Identities=22% Similarity=0.337 Sum_probs=211.1
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+..++|.+.+.||+|+||.||+|.+..++..||||++.................+.+|+.+++.++||||++++++|.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH- 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET-
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec-
Confidence 3567899999999999999999999999999999999866544333222222367889999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc-----EEEE
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV-----AKVT 552 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~-----vKL~ 552 (683)
+.. ++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+.+|+|+||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 332 689999999999888854 45799999999999999999999996555999999999999988776 9999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|||+++..... .....||+.|+|||++.... ..++.++|||||||++|+|++|..||............
T Consensus 172 Dfg~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-- 240 (287)
T 4f0f_A 172 DFGLSQQSVHS--------VSGLLGNFQWMAPETIGAEE-ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN-- 240 (287)
T ss_dssp CCTTCBCCSSC--------EECCCCCCTTSCGGGSSCSS-CEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH--
T ss_pred CCCcccccccc--------ccccCCCccccCchhhccCC-CCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH--
Confidence 99999754322 23347999999999984332 33789999999999999999999999765543322211
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.........+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 122223333444678999999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=378.87 Aligned_cols=261 Identities=25% Similarity=0.409 Sum_probs=208.2
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+.+.||+|+||.||+|.+..+|..||||++...... ......+.+|+.+++.++||||++++++|....
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-----EIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-----hhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 568999999999999999999999999999999998654321 233567889999999999999999999986433
Q ss_pred c-----eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 N-----TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 ~-----~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. .+|+||||+. ++|..++.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred CcccceeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecC
Confidence 2 2489999996 688888754 3899999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++...... .....||++|+|||++... ..++.++|||||||++|+|++|..||......+.+........
T Consensus 190 ~a~~~~~~--------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 190 LARHADAE--------MTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp CC----------------CTTCCCTTSCHHHHSCC--SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccccC--------cCCcccCccccCHHHhcCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99865432 2234789999999998642 2388999999999999999999999987765554432211100
Q ss_pred hh------------------c-cCCC------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 636 AR------------------K-VEFP------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 636 ~~------------------~-~~~p------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.. . ...+ ..+.+++.+.+||.+||.+||.+|||+.++++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 00 0 0000 014578999999999999999999999999999999853
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=371.70 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=210.4
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCC---eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEH---RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g---~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
.+..++|.+.+.||+|+||+||+|.+..++ ..||||++..... ......+.+|+.+++.++||||++++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT------ERQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC------HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC------HHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 567789999999999999999999987544 4699999864321 1224678899999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
|. +.+.+|+||||+++++|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 119 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 119 VT-RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp EC-GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred EE-eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCC
Confidence 86 677889999999999999999644 57999999999999999999999965 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i 633 (683)
|+++........ ........||+.|+|||++.... ++.++|||||||++|+|++ |..||......+.... +
T Consensus 196 g~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~ 267 (325)
T 3kul_A 196 GLSRVLEDDPDA--AYTTTGGKIPIRWTAPEAIAFRT---FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS---V 267 (325)
T ss_dssp SSCEECC----C--CEECC---CCGGGSCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---H
T ss_pred CcccccccCccc--eeeccCCCCcccccCHhHhcCCC---CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---H
Confidence 999877543211 12233446788999999986544 8999999999999999998 9999987666543321 1
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
......+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 268 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 268 --EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 122344555689999999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=383.40 Aligned_cols=267 Identities=27% Similarity=0.363 Sum_probs=211.4
Q ss_pred cccceeEEEEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTF 476 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f 476 (683)
..++|.+++.||+|+||.||+|.+. .+++.||||++......... .....+.+|+.++..+ .||||++++++|
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA---KTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE---SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh---hHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3478999999999999999999884 58999999998643211110 1123456789999999 699999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
. +.+.+++|||||++++|.+++.....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 129 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 129 Q-TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp E-ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred e-eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 6 66789999999999999999987778999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
++.+..... .......||+.|+|||++.... ..++.++|||||||++|+|++|..||..................
T Consensus 206 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 280 (355)
T 1vzo_A 206 SKEFVADET----ERAYDFCGTIEYMAPDIVRGGD-SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280 (355)
T ss_dssp EEECCGGGG----GGGCGGGSCCTTCCHHHHTTCC----CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred CeecccCCC----CcccCcccCcCccChhhhcCCC-CCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc
Confidence 986543221 1123347999999999986432 23788999999999999999999999643321111111111111
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTY 680 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~ 680 (683)
...+.++.++..+.+||.+||..||.+|| ++.++++||||+.
T Consensus 281 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 281 --SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred --cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 22333457899999999999999999999 9999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=409.19 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=219.0
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d 479 (683)
.-++|.+++.||+|+||.||+|.+..+++.||||++..... ........+..|..++..+ .||||+.++++|. +
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-T 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH----HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-C
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-e
Confidence 34679999999999999999999999999999999854311 1122345778899999988 7999999999996 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+||||||++||+|..++...+.+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+++.
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 7889999999999999999988778999999999999999999999965 99999999999999999999999999986
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
..... ......+||+.|+|||++.... |+.++||||||||||||++|..||......+.+.. +....+
T Consensus 492 ~~~~~-----~~~~~~~GT~~Y~APE~l~~~~---~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~~~ 559 (674)
T 3pfq_A 492 NIWDG-----VTTKTFCGTPDYIAPEIIAYQP---YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNV 559 (674)
T ss_dssp CCCTT-----CCBCCCCSCSSSCCHHHHTCCC---BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHSSCC
T ss_pred cccCC-----cccccccCCCcccCHhhhcCCC---CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH----HHhCCC
Confidence 43221 1234458999999999986444 89999999999999999999999987665443321 223344
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCcccCCC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDV-----LTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~-----~eLl~hP~l~~~ 681 (683)
.+| ..++.++.+||.+||..||.+||++ .+|++||||+..
T Consensus 560 ~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 560 AYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp CCC--TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred CCC--ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 444 4799999999999999999999997 999999999853
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=364.93 Aligned_cols=259 Identities=31% Similarity=0.537 Sum_probs=214.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+++.||+|+||.||+|.+..++..||||++........ ....+.+|+.+++.++||||+++++++. +
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 92 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----DTSTILREVELLKKLDHPNIMKLFEILE-D 92 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-----HHHHHHHHHHHHHhccCCCccEEEEEEe-C
Confidence 356789999999999999999999999999999999865432211 2456889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC---CcEEEEecCC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF---GVAKVTDFGL 556 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~---g~vKL~DFGl 556 (683)
.+.+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.+ +.+||+|||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCc
Confidence 7889999999999999999977677999999999999999999999965 9999999999999753 4799999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+........ .....||+.|+|||++.. .++.++||||||+++|+|++|..||......+... . +..
T Consensus 171 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~-~~~ 236 (287)
T 2wei_A 171 STCFQQNTK------MKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK---R-VET 236 (287)
T ss_dssp GGTBCCCSS------CSCHHHHHTTCCHHHHTT----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H-HHH
T ss_pred ceeecCCCc------cccccCcccccChHHhcC----CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH---H-HHc
Confidence 987653321 122358999999998753 27899999999999999999999998766543221 1 122
Q ss_pred hccC--CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 RKVE--FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ~~~~--~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.... .+....++.++.+||.+||..+|.+|||+.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 2222 2333578999999999999999999999999999999964
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=377.02 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=212.4
Q ss_pred cccccccceeEEEEecccCceEEEEEEEc-------cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDL-------VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHH 468 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-------~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~Hpn 468 (683)
.+.+..++|.+.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.+ +|||
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~~hpn 148 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA------TEKDLSDLVSEMEMMKMIGKHKN 148 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC------BHHHHHHHHHHHHHHHHSCCCTT
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc------CHHHHHHHHHHHHHHHHhcCCCC
Confidence 45667789999999999999999999864 356789999986542 123356789999999999 8999
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhcCC----------------CcchHHHHHHHHHHHHHHHHHHhcCCceE
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP----------------VLPEREARIIIVQIFQGLIYLNKRAQKII 532 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~----------------~Lse~~~~~I~~qIa~aL~yLH~~g~~II 532 (683)
|++++++|. +.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ ||
T Consensus 149 Iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iv 225 (370)
T 2psq_A 149 IINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CI 225 (370)
T ss_dssp BCCEEEEEC-SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EeeEEEEEc-cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 999999986 6778999999999999999996543 4789999999999999999999965 99
Q ss_pred ecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
||||||+|||++.+|.+||+|||+++.+..... ........||+.|+|||++.... ++.++|||||||++|+|+
T Consensus 226 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslG~il~ell 299 (370)
T 2psq_A 226 HRDLAARNVLVTENNVMKIADFGLARDINNIDY---YKKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEIF 299 (370)
T ss_dssp CSCCCGGGEEECTTCCEEECCCSSCEETTCCCT---TCTTTTTTSCGGGCCHHHHHTCC---CCHHHHHHHHHHHHHHHH
T ss_pred ccccchhhEEECCCCCEEEccccCCcccCcccc---eecccCCCcccceECHhHhcCCC---CCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999987654321 12234457889999999986443 899999999999999999
Q ss_pred c-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 613 F-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 613 t-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+ |..||......+... .+... ...+.+..++..+.+||.+||..+|.+||++.+++++
T Consensus 300 t~g~~p~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 300 TLGGSPYPGIPVEELFK---LLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TTSCCSSTTCCGGGHHH---HHHTT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHH---HHhcC--CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9 999998765543221 11111 2233345789999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=377.33 Aligned_cols=272 Identities=22% Similarity=0.328 Sum_probs=206.8
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccc----hhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWS----EDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~----~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
...+.++|.+.+.||+|+||.||+|.+. ++..||||++....... ..........+.+|+.+++.++||||++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 3456789999999999999999999875 49999999875533221 112233457889999999999999999999
Q ss_pred ccccc----CCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc
Q 005678 474 DTFEI----DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV 548 (683)
Q Consensus 474 ~~f~~----d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~ 548 (683)
++|.. ....+|+||||++ ++|..++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNND 172 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCC
Confidence 99843 3447899999997 5777777543 47999999999999999999999965 999999999999999999
Q ss_pred EEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Q 005678 549 AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628 (683)
Q Consensus 549 vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il 628 (683)
+||+|||++....... ......||++|+|||++... ..++.++|||||||++|+|++|..||......+.+.
T Consensus 173 ~kl~Dfg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 173 ITICDFNLAREDTADA------NKTHYVTHRWYRAPELVMQF--KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp EEECCTTC---------------------CGGGCCHHHHTTC--TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEEEecCccccccccc------ccceecccceecCcHHhcCC--CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999997554332 12334799999999988642 237999999999999999999999998776554432
Q ss_pred HHHHHHH--------------------hhccCCCC------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 629 REDTIIK--------------------ARKVEFPS------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 629 ~~~~i~~--------------------~~~~~~p~------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
....... ......+. .+.+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 2111100 00001111 24578899999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=361.58 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=212.3
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc-C
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-D 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-d 479 (683)
..++|.+++.||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++||||++++++|.. .
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-----AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-----HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 3568999999999999999999999999999999986543221 224678899999999999999999998742 4
Q ss_pred CceEEEEEecccCCChhHHHhcC----CCcchHHHHHHHHHHHHHHHHHHhcC---CceEecccCCcceEeCCCCcEEEE
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKAT----PVLPEREARIIIVQIFQGLIYLNKRA---QKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~----~~Lse~~~~~I~~qIa~aL~yLH~~g---~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ .+|+|+||||+|||++.++.+||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 66899999999999999999543 35999999999999999999999965 239999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|||++....... .......||+.|+|||++.... ++.++||||||+++|+|++|..||.......... .
T Consensus 159 dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~ 227 (279)
T 2w5a_A 159 DFGLARILNHDT-----SFAKTFVGTPYYMSPEQMNRMS---YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---K 227 (279)
T ss_dssp CCCHHHHC---C-----HHHHHHHSCCTTCCHHHHHCC----CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H
T ss_pred cCchheeecccc-----ccccccCCCccccChHHhccCC---CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH---H
Confidence 999998764321 1122346899999999986543 8999999999999999999999998765433221 1
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+...... +.+..++.++.+||.+||..||.+||++.++++|||+..
T Consensus 228 i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 228 IREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp HHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred Hhhcccc--cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 2222111 223468999999999999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=360.64 Aligned_cols=264 Identities=28% Similarity=0.367 Sum_probs=209.0
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
..-+.|.....||+|+||.||+|.+..++..||||++..... .....+.+|+.+++.++||||++++++|. +
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 90 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-------RYSQPLHEEIALHKHLKHKNIVQYLGSFS-E 90 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----------HHHHHHHHHHHTCCCTTBCCEEEEEE-E
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-------HHHHHHHHHHHHHHhCCCCCEeeEeeEEE-e
Confidence 333445555689999999999999999999999998865321 22456889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcC---CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEEEecC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKAT---PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKVTDFG 555 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~---~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL~DFG 555 (683)
.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++. ++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg 168 (295)
T 2clq_A 91 NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFG 168 (295)
T ss_dssp TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTT
T ss_pred CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecc
Confidence 77899999999999999999654 24678889999999999999999965 999999999999987 8999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++....... .......||+.|+|||++.... ..++.++|||||||++|+|++|..||............. .
T Consensus 169 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~ 239 (295)
T 2clq_A 169 TSKRLAGIN-----PCTETFTGTLQYMAPEIIDKGP-RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---G 239 (295)
T ss_dssp TCEESCC----------CCCCCCGGGCCHHHHHHGG-GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---H
T ss_pred cccccCCCC-----CcccccCCCccccChhhhcCCC-CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---c
Confidence 998764321 1123347999999999986432 227889999999999999999999996543332221111 1
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
........+..++.++.+||.+||..||.+||++.++++||||+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred cccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 11222223457899999999999999999999999999999998764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=383.23 Aligned_cols=258 Identities=28% Similarity=0.405 Sum_probs=205.7
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc--
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-- 478 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-- 478 (683)
...+|.+++.||+|+||.||+|.+..++..||||++..... ...+|+.+++.++|||||+++++|..
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----------SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----------hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 44579999999999999999999999999999998754321 12369999999999999999988742
Q ss_pred ---CCceEEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC-CcEE
Q 005678 479 ---DQNTFCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF-GVAK 550 (683)
Q Consensus 479 ---d~~~~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~-g~vK 550 (683)
+...+++||||+++ +|..++. ....+++..++.++.||+.||.|||+.+ ||||||||+||||+.+ +.+|
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~k 197 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLK 197 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEE
Confidence 22347799999975 6665553 3567999999999999999999999865 9999999999999954 6789
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|+|||+++.+..... .....||++|+|||++... ..|+.++||||||||||+|++|+.||......+.+...
T Consensus 198 l~DFG~a~~~~~~~~------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i 269 (420)
T 1j1b_A 198 LCDFGSAKQLVRGEP------NVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269 (420)
T ss_dssp ECCCTTCEECCTTCC------CCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eccchhhhhcccCCC------ceeeeeCCCcCCHHHHcCC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999987643321 2234799999999998643 23899999999999999999999999887766554332
Q ss_pred HHHH---------Hh----hccCCCC----------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 631 DTII---------KA----RKVEFPS----------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 631 ~~i~---------~~----~~~~~p~----------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.... .. ..+.+|. .+.++.++.+||.+||.+||.+||++.++++||||..
T Consensus 270 ~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 270 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 2110 00 1112221 2457899999999999999999999999999999964
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=355.15 Aligned_cols=255 Identities=15% Similarity=0.208 Sum_probs=209.9
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+..++|.+.+.||+|+||.||+|.+ .+..||||++....... .....+.+|+.+++.++||||++++++|..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWST-----RKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCH-----HHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCH-----HHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 45567899999999999999999976 48999999986643222 224578899999999999999999999864
Q ss_pred C-CceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 479 D-QNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 479 d-~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. .+.+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+.+|+|+||||+|||++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~ 158 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD 158 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred CCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecc
Confidence 3 367899999999999999997664 5899999999999999999999866669999999999999999999999998
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
++..... ....||+.|+|||++.......++.++|||||||++|+|++|..||........... ..
T Consensus 159 ~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~ 224 (271)
T 3kmu_A 159 VKFSFQS----------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VA 224 (271)
T ss_dssp SCCTTSC----------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HH
T ss_pred ceeeecc----------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HH
Confidence 8764322 123789999999998765444456689999999999999999999987665543321 11
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
......+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222233344679999999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=364.44 Aligned_cols=265 Identities=28% Similarity=0.487 Sum_probs=209.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEc-cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc---CCCceeeeccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDL-VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL---VHHHIVRLWDT 475 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~-~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L---~HpnIV~L~~~ 475 (683)
...++|.+++.||+|+||.||+|.+. .+++.||||++......... ...+.+|+.+++.+ .||||++++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----PLSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-----BCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-----CchhhHHHHHHHhhhccCCCCeEeeeee
Confidence 45689999999999999999999985 67899999988654322111 11344566666665 89999999998
Q ss_pred ccc----CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcE
Q 005678 476 FEI----DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA 549 (683)
Q Consensus 476 f~~----d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~v 549 (683)
|.. ....+++||||++ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred eeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCE
Confidence 852 4567999999997 6999999654 34999999999999999999999966 9999999999999999999
Q ss_pred EEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Q 005678 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR 629 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~ 629 (683)
||+|||++....... ......||+.|+|||++.... ++.++|||||||++|+|++|..||........+..
T Consensus 160 kl~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 230 (326)
T 1blx_A 160 KLADFGLARIYSFQM------ALTSVVVTLWYRAPEVLLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230 (326)
T ss_dssp EECSCCSCCCCCGGG------GGCCCCCCCTTCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EEecCcccccccCCC------CccccccccceeCHHHHhcCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 999999998764321 123447999999999986443 89999999999999999999999987766544322
Q ss_pred HHHHHHh-hccCCC--------------------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 630 EDTIIKA-RKVEFP--------------------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 630 ~~~i~~~-~~~~~p--------------------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
....... ....++ ..+.++..+.+||.+||..||.+||++.++++||||+..
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 1111100 000111 124688999999999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=381.75 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=204.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
....+|.+++.||+|+||.||+|.+..++. ||+|.+...... ..+|+.+++.++|||||+++++|...
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----------~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----------KNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----------CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----------HHHHHHHHHhCCCCCcceEEEEEEec
Confidence 356789999999999999999999877666 788866433221 12699999999999999999998532
Q ss_pred -----CceEEEEEecccCCChhHHH---hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-CCCcEE
Q 005678 480 -----QNTFCTVLEYCSGKDLDAVL---KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAK 550 (683)
Q Consensus 480 -----~~~~~LV~Ey~~ggsL~~~L---~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-~~g~vK 550 (683)
...+|+|||||+++.+.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEE
T ss_pred CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEE
Confidence 23488999999775444333 33567999999999999999999999965 99999999999999 799999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|+|||+++....... .....||++|+|||++... ..++.++|||||||++|+|++|+.||......+.+...
T Consensus 183 L~DFG~a~~~~~~~~------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i 254 (394)
T 4e7w_A 183 LIDFGSAKILIAGEP------NVSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254 (394)
T ss_dssp ECCCTTCEECCTTCC------CCSSCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EeeCCCcccccCCCC------CcccccCcCccCHHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999987644321 2234789999999988543 23899999999999999999999999887766554432
Q ss_pred HHHH---------H----hhccCCCC----------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 631 DTII---------K----ARKVEFPS----------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 631 ~~i~---------~----~~~~~~p~----------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.... . .....+|. .+.+++++.+||.+||.+||.+|||+.+++.||||+..
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 2110 0 00011111 23588999999999999999999999999999999854
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=380.26 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=200.3
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||++++++|....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-----QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-----hHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence 457899999999999999999999999999999998654221 223467889999999999999999999986433
Q ss_pred -----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 -----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 -----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+|+|||||+ ++|..++.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp STTTCCEEEEEEECCS-EEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccccccceEEEEEcCC-CCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEee
Confidence 37899999996 478888863 4899999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH-
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII- 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~- 634 (683)
++....... ......||+.|+|||++.... ++.++|||||||++|+|++|..||........+.......
T Consensus 173 ~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 243 (371)
T 2xrw_A 173 LARTAGTSF------MMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243 (371)
T ss_dssp C----------------------CTTCCHHHHTTCC---CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred ccccccccc------ccCCceecCCccCHHHhcCCC---CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 998664321 123347999999999987543 8999999999999999999999998766544332110000
Q ss_pred -----------------HhhccC--------------CCCC----cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 635 -----------------KARKVE--------------FPSR----PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 635 -----------------~~~~~~--------------~p~~----~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
...... +|.. ..++.++.+||.+||..||.+|||+.++++||||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 000000 0100 01256899999999999999999999999999997
Q ss_pred C
Q 005678 680 Y 680 (683)
Q Consensus 680 ~ 680 (683)
.
T Consensus 324 ~ 324 (371)
T 2xrw_A 324 V 324 (371)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=363.76 Aligned_cols=265 Identities=23% Similarity=0.403 Sum_probs=211.0
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc-cC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE-ID 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~-~d 479 (683)
+.++|.+.+.||+|+||.||+|.+..++..||||++...... ........+.+|+.+++.++||||+++++++. .+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR---RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH---HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc---ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 346899999999999999999999999999999998543110 11123467889999999999999999999874 24
Q ss_pred CceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
...+|+||||++++ |.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccc
Confidence 56789999999776 7777753 456999999999999999999999965 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
......... .......||+.|+|||++.... ..++.++|||||||++|+|++|..||........... +...
T Consensus 157 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----i~~~ 228 (305)
T 2wtk_C 157 EALHPFAAD---DTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN----IGKG 228 (305)
T ss_dssp EECCTTCSS---CEECCCCSCGGGCCHHHHTCCS-CEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHC
T ss_pred cccCccccc---cccccCCCCCCCcChhhccCcc-cCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----HhcC
Confidence 876532211 1223447999999999986432 2247899999999999999999999987655432211 1122
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.++.+..++..+.+||.+||..||.+||++.++++||||+..
T Consensus 229 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 229 --SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp --CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred --CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 233345789999999999999999999999999999999754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=363.04 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=214.0
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCcee
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV 470 (683)
..+.+..++|.+.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.+++.++||||+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv 89 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS------PSELRDLLSEFNVLKQVNHPHVI 89 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC------HHHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC------HHHHHHHHHHHHHHhhCCCCcee
Confidence 456778899999999999999999999873 4568999999864321 22356788999999999999999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcCC------------------------CcchHHHHHHHHHHHHHHHHHHh
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP------------------------VLPEREARIIIVQIFQGLIYLNK 526 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~------------------------~Lse~~~~~I~~qIa~aL~yLH~ 526 (683)
+++++|. +.+.+++||||+++++|.+++.... .+++..+..++.||+.||.|||+
T Consensus 90 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 90 KLYGACS-QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp CEEEEEC-SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEe-cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999986 6778999999999999999997543 38999999999999999999999
Q ss_pred cCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHH
Q 005678 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGI 606 (683)
Q Consensus 527 ~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGv 606 (683)
.+ |+||||||+|||++.++.+||+|||++........ ........||+.|+|||++.... ++.++|||||||
T Consensus 169 ~~--ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~ 240 (314)
T 2ivs_A 169 MK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS---YVKRSQGRIPVKWMAIESLFDHI---YTTQSDVWSFGV 240 (314)
T ss_dssp TT--EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC---EECSSCCCSCGGGCCHHHHHHCE---ECHHHHHHHHHH
T ss_pred CC--CcccccchheEEEcCCCCEEEcccccccccccccc---ceeccCCCCcccccChhhhcCCC---cCchhhHHHHHH
Confidence 65 99999999999999999999999999987654321 12233457889999999987544 899999999999
Q ss_pred HHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 607 LFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 607 ILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
++|+|++ |..||.......... .+... ...+.+..+++.+.+||.+||..||.+||++.+++++
T Consensus 241 il~el~t~g~~p~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 241 LLWEIVTLGGNPYPGIPPERLFN---LLKTG--HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHHH---HHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHH---HhhcC--CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999 999997765543221 11111 2233345789999999999999999999999999865
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.39 Aligned_cols=266 Identities=31% Similarity=0.489 Sum_probs=205.5
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc-
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI- 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~- 478 (683)
.+.++|.+++.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-------PQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-------HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-------hHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 35789999999999999999999999999999999875431 1235678899999999999999999988742
Q ss_pred ------------CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-C
Q 005678 479 ------------DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-E 545 (683)
Q Consensus 479 ------------d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-~ 545 (683)
+...+|+||||++ ++|.+++... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++ .
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG-PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTE 156 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhcC-CccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC
Confidence 3468899999997 5999999754 5899999999999999999999965 99999999999997 5
Q ss_pred CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHH
Q 005678 546 FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE 625 (683)
Q Consensus 546 ~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e 625 (683)
++.+||+|||++.......... .......||++|+|||++... ..++.++|||||||++|+|++|..||......+
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 232 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYSHK--GHLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232 (320)
T ss_dssp TTEEEECCCTTCBCC----------CCCGGGSCCTTCCHHHHHCT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCeEEEccCccccccCCCcccc--cccccccccccccCcHHhcCc--ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 6799999999998765332111 122344689999999987542 238999999999999999999999998776544
Q ss_pred HHHHHHHHH------------------HhhccCCCC------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 626 RILREDTII------------------KARKVEFPS------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 626 ~il~~~~i~------------------~~~~~~~p~------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
......... .......+. .+.++.++.+||.+||..||.+||++.++++||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 332111000 000001111 1468999999999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=365.33 Aligned_cols=257 Identities=20% Similarity=0.275 Sum_probs=206.6
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+..++|.+.+.||+|+||+||+|.+..++..||+|++.... ......+.+|+.+++.++||||++++++|. +
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~ 78 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-------EETQRTFLKEVKVMRCLEHPNVLKFIGVLY-K 78 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-E
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-------HHHHHHHHHHHHHHHhCCCcCcccEEEEEe-c
Confidence 44679999999999999999999999999999999874321 223467889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.+.+++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccce
Confidence 7789999999999999999976 567999999999999999999999966 9999999999999999999999999998
Q ss_pred ccccCcCCCc---------ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH-
Q 005678 559 IVEDDVGSQG---------MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL- 628 (683)
Q Consensus 559 ~~~~~~~~~~---------~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il- 628 (683)
.......... ........||+.|+|||++... .++.++|||||||++|+|++|..||..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~ 233 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR---SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCC---CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh
Confidence 7654322110 0111245799999999998654 38999999999999999999999986533211100
Q ss_pred -HHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 629 -REDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 629 -~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....... ...++.+++.+.+||.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 234 LNVRGFLD-----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp BCHHHHHH-----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhcccc-----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000000 1123568889999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.72 Aligned_cols=266 Identities=24% Similarity=0.402 Sum_probs=215.8
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhh----------HHHHHHHHHHHHHHHhhcCCCc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDK----------KQSYIRHAIREYNIHKTLVHHH 468 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~----------~~~~i~~~~rEi~il~~L~Hpn 468 (683)
.+..++|.+.+.||+|+||.||+|.+ ++..||||++.......... .......+.+|+.++..++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 45568999999999999999999987 99999999975432111000 0011257889999999999999
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHH------Hhc--CCCcchHHHHHHHHHHHHHHHHHHh-cCCceEecccCCc
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAV------LKA--TPVLPEREARIIIVQIFQGLIYLNK-RAQKIIHYDLKPG 539 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~------L~~--~~~Lse~~~~~I~~qIa~aL~yLH~-~g~~IIHrDLKP~ 539 (683)
|++++++|. +.+.+++||||+++++|.++ +.. ...+++..+..++.||+.||.|||+ .+ |+|+||||+
T Consensus 105 i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~ 181 (348)
T 2pml_X 105 CLTCEGIIT-NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPS 181 (348)
T ss_dssp BCCCSEEEE-SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGG
T ss_pred cceEEEEEe-eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChH
Confidence 999999986 67789999999999999998 655 5679999999999999999999998 66 999999999
Q ss_pred ceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCc-hhHHHHHHHHHHHHHcCCCCC
Q 005678 540 NVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISS-KVDVWSAGILFYQMLFGRRPF 618 (683)
Q Consensus 540 NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~-ksDVWSLGvILyELLtG~~PF 618 (683)
|||++.++.+||+|||++...... ......||+.|+|||++.... .++. ++|||||||++|+|++|..||
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNES--SYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCC--CEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred hEEEcCCCcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCC--CCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999876432 123447999999999986432 2555 999999999999999999999
Q ss_pred CCCchHHHHHHHHHHHHhhccCCCCC-----------------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 619 GHDQTQERILREDTIIKARKVEFPSR-----------------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 619 ~~~~~~e~il~~~~i~~~~~~~~p~~-----------------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
........+.. .+......+|.. +.++.++.+||.+||..||.+||++.++++||||+..
T Consensus 253 ~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 253 SLKISLVELFN---NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CCSSCSHHHHH---HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred CCCCcHHHHHH---HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 87665332221 122223334421 5689999999999999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.01 Aligned_cols=263 Identities=26% Similarity=0.463 Sum_probs=204.1
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc--
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-- 478 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-- 478 (683)
+.++|.+++.||+|+||.||+|.+..++..||||++... ......+.+|+.+++.++||||++++++|..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence 356899999999999999999999999999999988432 1234678899999999999999999998753
Q ss_pred ----------CCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC
Q 005678 479 ----------DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 479 ----------d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g 547 (683)
....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESR 153 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTS
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCC
Confidence 246789999999999999999744 45788999999999999999999965 99999999999999999
Q ss_pred cEEEEecCCccccccCcCCC---------cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 005678 548 VAKVTDFGLSKIVEDDVGSQ---------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~---------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF 618 (683)
.+||+|||++.......... .........||+.|+|||++... +.++.++|||||||++|+|++ ||
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT--GHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC--SCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC--CCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999998764321000 01112344799999999998633 247899999999999999998 66
Q ss_pred CCCchHHHHHHHHHHHHhhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 619 GHDQTQERILREDTIIKARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 619 ~~~~~~e~il~~~~i~~~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
........... ........+|. ...++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 229 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 229 STGMERVNILK---KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp SSHHHHHHHHH---HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred CCchhHHHHHH---hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 54333222221 11222233332 34677889999999999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=369.09 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=208.5
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+.+.||+|+||.||+|.+..+|..||||++...... ......+.+|+.+++.++||||++++++|....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-----EIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-----hHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 467899999999999999999999999999999998654321 223567889999999999999999999986433
Q ss_pred c-----eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 N-----TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 ~-----~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. .+|+||||+. ++|..++.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred ccccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecc
Confidence 2 3599999996 688888754 4899999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH-
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII- 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~- 634 (683)
++...... .....||+.|+|||++... ..++.++|||||||++|+|++|..||......+.+.......
T Consensus 172 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 172 LARHADAE--------MTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp CTTC----------------CCSBCCSCHHHHSCC--SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred cccCCCCC--------ccccccCcCcCCHHHHhCc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99865432 1234789999999988642 237899999999999999999999998766544332211100
Q ss_pred -------------------Hhh----ccCCC-CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 635 -------------------KAR----KVEFP-SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 635 -------------------~~~----~~~~p-~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
... ...++ ..+.++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000 00111 124679999999999999999999999999999999753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=354.61 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=211.1
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
.|.+..++|.+.+.||+|+||.||+|.+. ++..||||++...... ...+.+|+.+++.++||||++++++|
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~ 74 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--------EEDFIEEAEVMMKLSHPKLVQLYGVC 74 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC--------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC--------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45667789999999999999999999875 5788999998654321 13578899999999999999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. +.+.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 75 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg 151 (269)
T 4hcu_A 75 L-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFG 151 (269)
T ss_dssp C-SSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTT
T ss_pred e-cCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccc
Confidence 6 67789999999999999999954 456899999999999999999999966 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
++........ .......||+.|+|||++.... ++.++|||||||++|+|++ |..||......+.... +.
T Consensus 152 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~---~~ 221 (269)
T 4hcu_A 152 MTRFVLDDQY----TSSTGTKFPVKWASPEVFSFSR---YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---IS 221 (269)
T ss_dssp GGGGBCCHHH----HSTTSTTCCGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HH
T ss_pred cccccccccc----ccccCcccccccCCHHHhcCCC---CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---Hh
Confidence 9987644311 1122346788999999986544 8999999999999999999 9999987666543321 11
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
. ......+..++..+.+||.+||..+|.+||++.+++++
T Consensus 222 ~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 222 T--GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp T--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c--CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1 22333445689999999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=372.33 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=195.4
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC-
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID- 479 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d- 479 (683)
.-++|.+.+.||+|+||.||+|.+..++..||||++....... ..+.+++..+..++||||++++++|...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR--------NRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC--------CHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc--------HHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 3468999999999999999999999999999999875543221 2455678888889999999999998532
Q ss_pred -----CceEEEEEecccCCChhHHH----hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcE
Q 005678 480 -----QNTFCTVLEYCSGKDLDAVL----KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVA 549 (683)
Q Consensus 480 -----~~~~~LV~Ey~~ggsL~~~L----~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~v 549 (683)
...+++||||+++ +|...+ .....+++..+..++.||+.||.|||.+..+|+||||||+|||++. ++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 2238899999976 544433 3566789999999999999999999933345999999999999996 8999
Q ss_pred EEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Q 005678 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR 629 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~ 629 (683)
||+|||++..+..... .....||+.|+|||++... ..++.++|||||||++|+|++|..||........+..
T Consensus 172 kl~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP------NVAYICSRYYRAPELIFGN--QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp EECCCTTCBCCCTTSC------CCSTTSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEeeCCCceecCCCCC------cccccCCcceeCHHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 9999999987654321 2234789999999988532 2379999999999999999999999988766554432
Q ss_pred HHHHHHh--------hc-----cC------------C-CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 630 EDTIIKA--------RK-----VE------------F-PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 630 ~~~i~~~--------~~-----~~------------~-p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
....... .. .. + .....++.++.+||.+||.+||.+|||+.++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 2111000 00 00 0 1112367899999999999999999999999999999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=361.99 Aligned_cols=267 Identities=25% Similarity=0.392 Sum_probs=200.6
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
.|.+.-++|.+++.||+|+||.||+|.+..+++.||||++...... ......+..+..+++.++||||++++++|
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-----EENKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-----HHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-----hHHHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 4566678999999999999999999999999999999998654321 12223445555678888999999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhc-CCceEecccCCcceEeCCCCcEEEEec
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKR-AQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~-g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
. +.+.+++||||+ ++.+..++. ....+++..+..++.||+.||.|||+. + |+|+||||.|||++.++.+||+||
T Consensus 94 ~-~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 94 I-TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp E-CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred e-cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEEC
Confidence 6 677899999999 556666654 356799999999999999999999984 6 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCccccccc--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS--KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~--~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|++........ .....||+.|+|||++... ....++.++|||||||++|+|++|..||.........+. .
T Consensus 170 g~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~ 241 (318)
T 2dyl_A 170 GISGRLVDDKA------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT--K 241 (318)
T ss_dssp TTC--------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH--H
T ss_pred CCchhccCCcc------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH--H
Confidence 99976644321 2234799999999998532 123478999999999999999999999987544433322 2
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+.......++....++.++.+||.+||..||.+||++.++++||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 242 VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 233334445555678999999999999999999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=360.02 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=201.5
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccC---CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceee
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVE---HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVR 471 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~---g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~ 471 (683)
..++.+..++|.+.+.||+|+||.||+|.+..+ +..||+|++.... .......+.+|+.+++.++||||++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~ 80 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT------SDSVREKFLQEALTMRQFDHPHIVK 80 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT------SHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC------CHHHHHHHHHHHHHHHhCCCCccce
Confidence 456788999999999999999999999988653 5679999875432 1223467889999999999999999
Q ss_pred eccccccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 472 L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
+++++. .+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 81 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~k 156 (281)
T 1mp8_A 81 LIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVK 156 (281)
T ss_dssp EEEEEC--SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEE
T ss_pred EEEEEc--cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEE
Confidence 999884 55788999999999999999754 36999999999999999999999965 99999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILR 629 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~ 629 (683)
|+|||++........ .......||+.|+|||++.... ++.++|||||||++|+|++ |..||......+...
T Consensus 157 l~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~- 228 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTY----YKASKGKLPIKWMAPESINFRR---FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG- 228 (281)
T ss_dssp ECC-----------------------CCGGGCCHHHHHHCC---CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-
T ss_pred ECccccccccCcccc----cccccCCCcccccChhhcccCC---CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH-
Confidence 999999987654321 1233446788999999986544 8999999999999999996 999998766544321
Q ss_pred HHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 630 ~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.+... ...+.++.+++.+.+||.+||..||.+|||+.+++++
T Consensus 229 --~i~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 229 --RIENG--ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp --HHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHcC--CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11122 2234456799999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.02 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=205.7
Q ss_pred cccccceeEEEEecccCceEEEEEE----EccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~----d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
.+..++|.+++.||+|+||+||+|. +..++..||||++.... ......+.+|+.+++.++||||+++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-------EEHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-------HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-------HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4577899999999999999999998 56789999999985431 123467889999999999999999999
Q ss_pred cccc-CCceEEEEEecccCCChhHHHhcCC-CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 475 TFEI-DQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 475 ~f~~-d~~~~~LV~Ey~~ggsL~~~L~~~~-~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
+|.. +...+++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~ 156 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIG 156 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEEC
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEc
Confidence 8753 2356899999999999999997653 4999999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH-----
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI----- 627 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i----- 627 (683)
|||++......... ........||+.|+|||++.... ++.++|||||||++|+|++|..||.........
T Consensus 157 Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 231 (295)
T 3ugc_A 157 DFGLTKVLPQDKEF--FKVKEPGESPIFWYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231 (295)
T ss_dssp CCCSCC---------------CTTCGGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT
T ss_pred cCcccccccCCcce--eeeccCCCCccceeCcHHhcCCC---CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc
Confidence 99999877543211 12233446888899999987554 899999999999999999999998654322100
Q ss_pred ------HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 628 ------LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 628 ------l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
..............+.+..+++++.+||.+||..||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00000011122344555689999999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.77 Aligned_cols=272 Identities=26% Similarity=0.442 Sum_probs=212.9
Q ss_pred CCCccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC--CCcee
Q 005678 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV--HHHIV 470 (683)
Q Consensus 393 ~~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~--HpnIV 470 (683)
..|..+.+...+|.+++.||+|+||.||+|.+. ++..||||++...... ......+.+|+.++..+. ||||+
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-----NQTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-----HHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-----ccchHHHHHHHHHHHhccccCCceE
Confidence 446677888999999999999999999999874 5889999998654321 123567889999999997 49999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
++++++. +.+.+++||| +.+++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||+++ +.+|
T Consensus 92 ~~~~~~~-~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 92 RLYDYEI-TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp CEEEEEE-CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEE
T ss_pred EEEEEee-cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEE
Confidence 9999886 6778999999 458899999988888999999999999999999999965 999999999999975 8999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccC--------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCc
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK--------TPLISSKVDVWSAGILFYQMLFGRRPFGHDQ 622 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~--------~~~~s~ksDVWSLGvILyELLtG~~PF~~~~ 622 (683)
|+|||++......... .......||+.|+|||++.... ...++.++|||||||++|+|++|..||....
T Consensus 167 L~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 167 LIDFGIANQMQPDTTS---VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp ECCCSSSCC-----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EeeccccccccCcccc---ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 9999999876543211 1123447999999999986421 1348899999999999999999999997654
Q ss_pred hHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 623 TQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 623 ~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.....+. .+ .......+.+..++..+.+||.+||..||.+||++.++++||||+..
T Consensus 244 ~~~~~~~--~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 244 NQISKLH--AI-IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp SHHHHHH--HH-HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHH--HH-HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 4332221 11 11222223334678999999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=352.78 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=210.4
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
+.+..++|.+++.||+|+||.||+|.+ .++..||||++...... ...+.+|+.++..++||||++++++|.
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMS--------EDEFFQEAQTMMKLSHPKLVKFYGVCS 73 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTBC--------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eEechhheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCCc--------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 466788999999999999999999975 46778999998654321 135788999999999999999999986
Q ss_pred cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
+.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 74 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 74 -KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGM 150 (268)
T ss_dssp -SSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTC
T ss_pred -cCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCcc
Confidence 677899999999999999999654 45999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
+........ .......||+.|+|||++.... ++.++||||||+++|+|++ |..||........... +.
T Consensus 151 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~- 219 (268)
T 3sxs_A 151 TRYVLDDQY----VSSVGTKFPVKWSAPEVFHYFK---YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK---VS- 219 (268)
T ss_dssp EEECCTTCE----EECCSCCCCGGGCCHHHHHHSE---EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HH-
T ss_pred ceecchhhh----hcccCCCcCcccCCHHHHhccC---CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH---HH-
Confidence 987654321 1223346788899999986544 7889999999999999998 9999987766543322 11
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.......+..+++.+.+||.+||..+|.+|||+.+++++
T Consensus 220 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 220 -QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 122233345689999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.71 Aligned_cols=262 Identities=23% Similarity=0.391 Sum_probs=199.3
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
+..+++..++|.+.+.||+|+||+||+|.+ ...||||++....... .....+.+|+.+++.++||||+++++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTP-----QQLQAFKNEVGVLRKTRHVNILLFMG 87 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCH-----HHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence 466789999999999999999999999964 2359999986653321 23567889999999999999999998
Q ss_pred ccccCCceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
++ ....+++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 88 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~D 163 (289)
T 3og7_A 88 YS--TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGD 163 (289)
T ss_dssp EE--CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECC
T ss_pred ec--cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEcc
Confidence 65 3566889999999999999995 4456999999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||++......... .......||+.|+|||++.......++.++|||||||++|+|++|..||........+...
T Consensus 164 fg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--- 237 (289)
T 3og7_A 164 FGLATEKSRWSGS---HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM--- 237 (289)
T ss_dssp CC---------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH---
T ss_pred ceecccccccccc---ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH---
Confidence 9999865432211 1223447999999999987544455899999999999999999999999876665544322
Q ss_pred HHhhccCC--C-CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 634 IKARKVEF--P-SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 634 ~~~~~~~~--p-~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
........ + ....+++.+.+||.+||..+|.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11111111 1 12468999999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.21 Aligned_cols=261 Identities=22% Similarity=0.339 Sum_probs=212.4
Q ss_pred cccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCcee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV 470 (683)
+|.+..++|.+.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.++..+ .||||+
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD------SSEREALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC------HHHHHHHHHHHHHHHhhcCCCCee
Confidence 56777899999999999999999999873 4677899999864321 12245788999999999 899999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcCC-----------------------CcchHHHHHHHHHHHHHHHHHHhc
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-----------------------VLPEREARIIIVQIFQGLIYLNKR 527 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~-----------------------~Lse~~~~~I~~qIa~aL~yLH~~ 527 (683)
+++++|. +.+.+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 113 ~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 191 (344)
T 1rjb_A 113 NLLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 191 (344)
T ss_dssp CEEEEEC-SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEe-eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999986 5678999999999999999996542 379999999999999999999996
Q ss_pred CCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHH
Q 005678 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGIL 607 (683)
Q Consensus 528 g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvI 607 (683)
+ |+||||||+|||++.++.+||+|||++........ ........||+.|+|||++.... ++.++|||||||+
T Consensus 192 ~--ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~i 263 (344)
T 1rjb_A 192 S--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN---YVVRGNARLPVKWMAPESLFEGI---YTIKSDVWSYGIL 263 (344)
T ss_dssp T--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT---SEEETTEEECGGGCCHHHHHHCC---CCHHHHHHHHHHH
T ss_pred C--cccCCCChhhEEEcCCCcEEeCCCccCcccccCcc---ceeccCccCccCccCHHHhccCC---CChhHhHHHHHHH
Confidence 5 99999999999999999999999999987654321 12233446789999999986544 8999999999999
Q ss_pred HHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 608 FYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 608 LyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
+|+|++ |..||........+.. . .......+.+..+++++.+||.+||..||.+|||+.+++++.
T Consensus 264 l~el~t~g~~p~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 264 LWEIFSLGVNPYPGIPVDANFYK--L--IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHTTTSCCSSTTCCCSHHHHH--H--HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCCCCCcccCCcHHHHHH--H--HhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999998 9999977655443322 1 112233444567899999999999999999999999998764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=374.26 Aligned_cols=264 Identities=28% Similarity=0.388 Sum_probs=207.4
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CC-----cee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HH-----HIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-Hp-----nIV 470 (683)
.-..+.++|.+.+.||+|+||+||+|.+..++..||||++.... .....+.+|+.++..+. |+ +|+
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--------AFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--------HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--------HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 33456789999999999999999999999999999999985321 22455677888888775 44 499
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC--CC
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD--EF 546 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd--~~ 546 (683)
.++++|. ..+.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||.+..+||||||||+||||+ .+
T Consensus 120 ~~~~~~~-~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 120 HLKRHFM-FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp CEEEEEE-ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS
T ss_pred Eeeeeec-cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC
Confidence 9999886 5678999999995 5999999654 469999999999999999999996445699999999999995 47
Q ss_pred CcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH
Q 005678 547 GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626 (683)
Q Consensus 547 g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~ 626 (683)
+.+||+|||++...... .....||+.|+|||++.... ++.++|||||||++|+|++|..||......+.
T Consensus 198 ~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 266 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR--------IYQYIQSRFYRSPEVLLGMP---YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266 (382)
T ss_dssp CCEEECCCTTCEETTCC--------CCSSCSCGGGCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CcEEEEeccCceecccc--------cccccCCccccChHHHcCCC---CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 88999999999876432 22347999999999987543 89999999999999999999999987766554
Q ss_pred HHHHHHHHHhhc--------------cCCCC-------------------Cc-------------------------CCC
Q 005678 627 ILREDTIIKARK--------------VEFPS-------------------RP-------------------------AVS 648 (683)
Q Consensus 627 il~~~~i~~~~~--------------~~~p~-------------------~~-------------------------~~s 648 (683)
+........... ...|. .. ..+
T Consensus 267 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (382)
T 2vx3_A 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADY 346 (382)
T ss_dssp HHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHH
T ss_pred HHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhh
Confidence 432111100000 00000 00 001
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 649 NEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 649 ~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+++.+||.+||.+||.+|||+.++++||||+..
T Consensus 347 ~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 347 LKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 478999999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=366.06 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=206.7
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCC-eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCc------eee
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEH-RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH------IVR 471 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g-~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn------IV~ 471 (683)
.++.++|.+++.||+|+||.||+|.+..++ ..||||++.... .....+.+|+.+++.+.|++ ++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--------KYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--------HHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--------cchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 457899999999999999999999998776 799999985321 22356778999999998776 888
Q ss_pred eccccccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe------
Q 005678 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF------ 543 (683)
Q Consensus 472 L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL------ 543 (683)
++++|. ..+.+|+||||+ +++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 87 ~~~~~~-~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 87 MSDWFN-FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp EEEEEE-ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEE
T ss_pred eeeeee-eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccc
Confidence 888886 567899999999 66777776543 46999999999999999999999865 9999999999999
Q ss_pred -------------CCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHH
Q 005678 544 -------------DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQ 610 (683)
Q Consensus 544 -------------d~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyE 610 (683)
+.++.+||+|||++...... .....||+.|+|||++.... ++.++|||||||++|+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~e 231 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--------HTTIVATRHYRPPEVILELG---WAQPCDVWSIGCILFE 231 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSC--------CCSSCSCGGGCCHHHHTTCC---CCTHHHHHHHHHHHHH
T ss_pred ccccccccccccccCCCcEEEeecCcccccccc--------ccCCcCCCcccCCeeeecCC---CCCccchHHHHHHHHH
Confidence 56789999999999865432 12347999999999986443 8999999999999999
Q ss_pred HHcCCCCCCCCchHHHHHHHHHHHHhhc-----------------cC---------------------CCCCcCCCHHHH
Q 005678 611 MLFGRRPFGHDQTQERILREDTIIKARK-----------------VE---------------------FPSRPAVSNEAK 652 (683)
Q Consensus 611 LLtG~~PF~~~~~~e~il~~~~i~~~~~-----------------~~---------------------~p~~~~~s~el~ 652 (683)
|++|..||......+.+.....+..... .. .......+..+.
T Consensus 232 l~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 9999999987766554432222111000 00 011122356889
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 653 DLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 653 dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+||.+||..||.+|||+.++++||||+..
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 99999999999999999999999999853
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=354.85 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=211.5
Q ss_pred CCCccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeee
Q 005678 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 393 ~~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
..+..|.+..++|.+++.||+|+||.||+|.+. ++..||||++...... ...+.+|+.++..++||||+++
T Consensus 14 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~ 84 (283)
T 3gen_A 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--------EDEFIEEAKVMMNLSHEKLVQL 84 (283)
T ss_dssp --CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCCCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--------HHHHHHHHHHHhcCCCCCEeeE
Confidence 345778888999999999999999999999764 6788999998654321 1357889999999999999999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEE
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKV 551 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL 551 (683)
+++|. +.+.+++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 85 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl 161 (283)
T 3gen_A 85 YGVCT-KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKV 161 (283)
T ss_dssp EEEEC-SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEE
T ss_pred EEEEe-cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEE
Confidence 99986 67789999999999999999965 456999999999999999999999965 999999999999999999999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHH
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRE 630 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~ 630 (683)
+|||++........ .......||+.|+|||++.... ++.++||||||+++|+|++ |..||...........
T Consensus 162 ~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~- 233 (283)
T 3gen_A 162 SDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEVLMYSK---FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH- 233 (283)
T ss_dssp CSTTGGGGBCCHHH----HSTTSTTSCGGGCCHHHHHHCC---CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-
T ss_pred cccccccccccccc----ccccCCccCcccCCHHHhccCC---CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-
Confidence 99999987644311 1122336788999999987554 8999999999999999998 9999987665443321
Q ss_pred HHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 631 ~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+.. ......+..+++.+.+||.+||..+|.+|||+.++++|
T Consensus 234 --~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 234 --IAQ--GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --HHT--TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --Hhc--ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 111 22333345689999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=352.86 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=199.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+..++|.+.+.||+|+||.||+|.+ ++..||||++...... ........+.+|+.+++.++||||++++++|. +
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 77 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDE---DISQTIENVRQEAKLFAMLKHPNIIALRGVCL-K 77 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC-------------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcc---cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-c
Confidence 4457899999999999999999975 5899999997654221 11233567889999999999999999999986 6
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCC-ceEecccCCcceEeCC--------CCcEE
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQ-KIIHYDLKPGNVLFDE--------FGVAK 550 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~-~IIHrDLKP~NILLd~--------~g~vK 550 (683)
.+.+++||||+++++|.+++... .+++..+..++.||+.||.|||+.+. +|+||||||+|||++. ++.+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred CCceEEEEEcCCCCCHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 77889999999999999998654 69999999999999999999999653 3999999999999985 67899
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|+|||++....... .....||+.|+|||++.... ++.++||||||+++|+|++|..||...........
T Consensus 157 l~Dfg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~- 225 (271)
T 3dtc_A 157 ITDFGLAREWHRTT-------KMSAAGAYAWMAPEVIRASM---FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG- 225 (271)
T ss_dssp ECCCCC--------------------CCGGGSCHHHHHHCC---CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-
T ss_pred EccCCccccccccc-------ccCCCCccceeCHHHhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh-
Confidence 99999998664332 12347999999999986544 89999999999999999999999987665443322
Q ss_pred HHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 631 ~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
........+.+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 226 ---VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 222334445556789999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=365.52 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=212.4
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCcee
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV 470 (683)
..+.+..++|.+++.||+|+||.||+|.+. .++..||||++..... ......+.+|+.+++.++||||+
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv 113 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------ADMQADFQREAALMAEFDNPNIV 113 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC------HHHHHHHHHHHHHHHTCCCTTBC
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC------HHHHHHHHHHHHHHHhCCCCCEE
Confidence 345677889999999999999999999886 4568999999864321 22356788999999999999999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcC------------------------CCcchHHHHHHHHHHHHHHHHHHh
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT------------------------PVLPEREARIIIVQIFQGLIYLNK 526 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~------------------------~~Lse~~~~~I~~qIa~aL~yLH~ 526 (683)
+++++|. +.+.+|+||||+++++|.+++... ..+++..++.|+.||+.||.|||+
T Consensus 114 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 192 (343)
T 1luf_A 114 KLLGVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 192 (343)
T ss_dssp CEEEEEC-SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEc-cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999986 677899999999999999999653 568999999999999999999999
Q ss_pred cCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHH
Q 005678 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGI 606 (683)
Q Consensus 527 ~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGv 606 (683)
.+ |+||||||+|||++.++.+||+|||++......... .......||+.|+|||++.... ++.++|||||||
T Consensus 193 ~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~ 264 (343)
T 1luf_A 193 RK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGV 264 (343)
T ss_dssp TT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---C----CCBCGGGCCHHHHHHCC---CCHHHHHHHHHH
T ss_pred CC--eecCCCCcceEEECCCCeEEEeecCCCcccccCccc---cccCCCcccceecChhhhccCC---cCcccccHHHHH
Confidence 65 999999999999999999999999999876433211 1223447899999999987544 899999999999
Q ss_pred HHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 607 LFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 607 ILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
++|+|++ |..||......+... .+.... ..+.+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 265 il~el~t~g~~p~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 265 VLWEIFSYGLQPYYGMAHEEVIY---YVRDGN--ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHH---HHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCcCCCCChHHHHH---HHhCCC--cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9999998 999998766544322 111221 122345789999999999999999999999998763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.68 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=204.8
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~ 478 (683)
+++++|.+.+.||+|+||.||+|.+..++..||||++...... ..+.+|+.+++.+ .||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~E~~~l~~l~~h~~i~~~~~~~~- 75 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---------PQLHLEYRFYKQLGSGDGIPQVYYFGP- 75 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---------CCHHHHHHHHHHHCSCTTSCCEEEEEE-
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---------HHHHHHHHHHHHhhCCCCCCEEEEEEe-
Confidence 5678999999999999999999999999999999998654221 2467899999999 9999999999886
Q ss_pred CCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc-----EEEE
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV-----AKVT 552 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~-----vKL~ 552 (683)
+.+.+++||||+ +++|.+++.. ...+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++. +||+
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 76 CGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred cCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEE
Confidence 677899999999 9999999975 467999999999999999999999965 999999999999998887 9999
Q ss_pred ecCCccccccCcCCCcc--cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGM--ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~--~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|||+++.+......... .......||+.|+|||++.... ++.++|||||||++|+|++|..||............
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~ 229 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE---QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY 229 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC---CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC---CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH
Confidence 99999876544322111 1124558999999999987543 899999999999999999999999764322211111
Q ss_pred HHHHHhhccCCCC---CcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 631 DTIIKARKVEFPS---RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 631 ~~i~~~~~~~~p~---~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
..+... ....+. ...++ ++.+||.+||..+|.+||++.++.+
T Consensus 230 ~~i~~~-~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 230 QKIGDT-KRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHH-HHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhh-hccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111111 111111 12344 9999999999999999999988875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=363.05 Aligned_cols=263 Identities=23% Similarity=0.351 Sum_probs=215.3
Q ss_pred CccccccccceeEEEEecccCceEEEEEEE-----ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCc
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYD-----LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHH 468 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d-----~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~Hpn 468 (683)
...|.+..++|.+.+.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.++..+ .|||
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------HSEHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC------cHHHHHHHHHHHHHHhcccCCC
Confidence 356778889999999999999999999985 35679999999865421 12245788999999999 6999
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhcCCC----------------cchHHHHHHHHHHHHHHHHHHhcCCceE
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV----------------LPEREARIIIVQIFQGLIYLNKRAQKII 532 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~----------------Lse~~~~~I~~qIa~aL~yLH~~g~~II 532 (683)
|++++++|......+++||||+++++|.+++..... +++..+..++.||+.||.|||+.+ |+
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~ 170 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CI 170 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 999999987666779999999999999999976543 899999999999999999999965 99
Q ss_pred ecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
||||||+|||++.++.+||+|||++......... .......||+.|+|||++.... ++.++|||||||++|+|+
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~ 244 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEIF 244 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHH
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccc---eeccCCCcceeecCchhhcccc---ccchhHHHHHHHHHHHHH
Confidence 9999999999999999999999999876543211 1223346889999999986544 899999999999999999
Q ss_pred c-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 613 F-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 613 t-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+ |..||........+.. .+... ...+.+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 245 t~g~~p~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 245 SLGASPYPGVKIDEEFCR--RLKEG--TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TTSCCSSTTCCCSHHHHH--HHHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCCcccchhHHHHH--HhccC--ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8 9999977654443322 11222 2233345689999999999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=360.91 Aligned_cols=261 Identities=21% Similarity=0.338 Sum_probs=214.9
Q ss_pred ccccccccceeEEEEecccCceEEEEEEE-----ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCce
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYD-----LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHI 469 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d-----~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnI 469 (683)
..|.+..++|.+.+.||+|+||.||+|.+ ..++..||||++..... ......+.+|+.+++.+ +||||
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~i 89 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH------LTEREALMSELKVLSYLGNHMNI 89 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh------HHHHHHHHHHHHHHhhcccCCCe
Confidence 45778889999999999999999999985 45788999999865422 12245788999999999 99999
Q ss_pred eeeccccccCCceEEEEEecccCCChhHHHhcCC------------------CcchHHHHHHHHHHHHHHHHHHhcCCce
Q 005678 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP------------------VLPEREARIIIVQIFQGLIYLNKRAQKI 531 (683)
Q Consensus 470 V~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~------------------~Lse~~~~~I~~qIa~aL~yLH~~g~~I 531 (683)
++++++|. +.+.+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |
T Consensus 90 ~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i 166 (313)
T 1t46_A 90 VNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--C 166 (313)
T ss_dssp CCEEEEEC-SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred eeEEEEEe-cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence 99999986 6678899999999999999996543 4899999999999999999999965 9
Q ss_pred EecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHH
Q 005678 532 IHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM 611 (683)
Q Consensus 532 IHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyEL 611 (683)
+|+||||+|||++.++.+||+|||++........ ........||+.|+|||++.... ++.++|||||||++|+|
T Consensus 167 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el 240 (313)
T 1t46_A 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSN---YVVKGNARLPVKWMAPESIFNCV---YTFESDVWSYGIFLWEL 240 (313)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT---SEECSSSEECGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHH
T ss_pred ecCCCccceEEEcCCCCEEEcccccccccccccc---ceeccCCCCcceeeChHHhcCCC---CChHHHHHHHHHHHHHH
Confidence 9999999999999999999999999987654321 12233446788999999986544 89999999999999999
Q ss_pred Hc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 612 LF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 612 Lt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
++ |..||............ .......+....++..+.+||.+||..||.+|||+.+++++
T Consensus 241 lt~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 241 FSLGSSPYPGMPVDSKFYKM----IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HTTTCCSSTTCCSSHHHHHH----HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCCCcccchhHHHHH----hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 98 99999776554433221 11223334456789999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.49 Aligned_cols=259 Identities=22% Similarity=0.367 Sum_probs=217.7
Q ss_pred CCCccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeee
Q 005678 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 393 ~~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
..|..|.+..++|.+.+.||+|+||.||+|.+..++..||||++..... ....+.+|+.+++.++||||+++
T Consensus 3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~ 74 (288)
T 3kfa_A 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------EVEEFLKEAAVMKEIKHPNLVQL 74 (288)
T ss_dssp TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 4567889999999999999999999999999999999999999854321 14568899999999999999999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
+++|. +.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 75 ~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~ 151 (288)
T 3kfa_A 75 LGVCT-REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVK 151 (288)
T ss_dssp EEEEC-SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEc-cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEE
Confidence 99986 677899999999999999999753 45899999999999999999999976 99999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILR 629 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~ 629 (683)
|+|||++........ .......||+.|+|||++.... ++.++||||||+++|+|++ |..||..........
T Consensus 152 l~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~- 223 (288)
T 3kfa_A 152 VADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNK---FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE- 223 (288)
T ss_dssp ECCCCGGGTSCSSSS----EEETTEEECGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-
T ss_pred EccCccceeccCCcc----ccccCCccccCcCChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-
Confidence 999999987654321 1223336788999999986544 8999999999999999999 999997765543221
Q ss_pred HHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 630 EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 630 ~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.+ ......+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 224 --~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 224 --LL--EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp --HH--HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HH--hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 11 122334445679999999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=380.52 Aligned_cols=261 Identities=23% Similarity=0.380 Sum_probs=189.4
Q ss_pred cccceeE-EEEecccCceEEEEEEEc--cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 401 LNHRYAL-LNLLGKGGFSEVYKAYDL--VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 401 ~~~ry~l-~~~LGkGgfG~Vyka~d~--~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
+.+.|.+ .++||+|+||+||+|.+. .++..||||++..... ...+.+|+.+++.++|||||+++++|.
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---------SMSACREIALLRELKHPNVISLQKVFL 88 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---------CHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---------CHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 3456776 457999999999999865 5788999999854322 135678999999999999999999984
Q ss_pred c-CCceEEEEEecccCCChhHHHhcC---------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe----
Q 005678 478 I-DQNTFCTVLEYCSGKDLDAVLKAT---------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---- 543 (683)
Q Consensus 478 ~-d~~~~~LV~Ey~~ggsL~~~L~~~---------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL---- 543 (683)
. ....+|+||||++ ++|..++... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~ 165 (405)
T 3rgf_A 89 SHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEG 165 (405)
T ss_dssp ETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSS
T ss_pred cCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCC
Confidence 2 4678999999995 5888777421 24899999999999999999999966 9999999999999
Q ss_pred CCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCch
Q 005678 544 DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQT 623 (683)
Q Consensus 544 d~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~ 623 (683)
+.++.+||+|||+++.+...... .......+||++|+|||++... ..++.++||||||||+|+|++|.+||.....
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 166 PERGRVKIADMGFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp TTTTCEEECCTTCCC------------------CCCTTCCHHHHTTC--CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCCCcEEEEECCCceecCCCCcc--cccCCCceecCcccCchhhcCC--CcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 67889999999999876543111 1123345899999999998642 2389999999999999999999999965443
Q ss_pred H---------HHHHHHHHHHHh-hccCCCC----------------------------------CcCCCHHHHHHHHHhc
Q 005678 624 Q---------ERILREDTIIKA-RKVEFPS----------------------------------RPAVSNEAKDLIRRCL 659 (683)
Q Consensus 624 ~---------e~il~~~~i~~~-~~~~~p~----------------------------------~~~~s~el~dLI~rCL 659 (683)
. +.+. .+... ....... ....+..+.+||.+||
T Consensus 242 ~~~~~~~~~~~~l~---~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L 318 (405)
T 3rgf_A 242 DIKTSNPYHHDQLD---RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 318 (405)
T ss_dssp -----CCCCHHHHH---HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHS
T ss_pred cccccccchHHHHH---HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHc
Confidence 2 1111 11110 0000000 0123678999999999
Q ss_pred ccCCCCCCCHHHHhcCcccCC
Q 005678 660 TYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 660 ~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.+||.+|||+.++++||||+.
T Consensus 319 ~~dP~~R~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 319 TMDPIKRITSEQAMQDPYFLE 339 (405)
T ss_dssp CSSGGGSCCHHHHHTSGGGTS
T ss_pred cCCcccCCCHHHHhcChhhcc
Confidence 999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=376.55 Aligned_cols=260 Identities=23% Similarity=0.309 Sum_probs=209.7
Q ss_pred cccccceeEEEEecccCceEEEEEE-----EccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAY-----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~-----d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
.+..++|.+++.||+|+||+||+|. +..++..||||++..... ......+.+|+.+++.++|||||+++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~ 140 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS------EQDELDFLMEALIISKFNHQNIVRCI 140 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC------hhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence 4567899999999999999999998 456788999999854321 12234688899999999999999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcC-------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKAT-------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF 546 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~ 546 (683)
++|. +....++|||||+|++|.+++... ..+++..+..++.||+.||.|||+.+ ||||||||+|||++.+
T Consensus 141 ~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~ 217 (367)
T 3l9p_A 141 GVSL-QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCP 217 (367)
T ss_dssp EEEC-SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCS
T ss_pred EEEe-cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecC
Confidence 9986 667789999999999999999643 35899999999999999999999965 9999999999999955
Q ss_pred C---cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCc
Q 005678 547 G---VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQ 622 (683)
Q Consensus 547 g---~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~ 622 (683)
| .+||+|||+++.+...... .......||+.|+|||++.... ++.++|||||||++|+|++ |..||....
T Consensus 218 ~~~~~~kL~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 218 GPGRVAKIGDFGMARDIYRAGYY---RKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp STTCCEEECCCHHHHHHHHHSSC---TTCCGGGSCGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCceEEECCCcccccccccccc---ccCCCcCCcccEECHHHhcCCC---CCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 5 5999999999865432111 1223346899999999987544 8999999999999999998 999998776
Q ss_pred hHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 623 TQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 623 ~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..+... .+... ...+....++..+.+||.+||..+|.+||++.+++++.++
T Consensus 292 ~~~~~~---~i~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 292 NQEVLE---FVTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHHHHH---HHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHH---HHHcC--CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 554321 11222 2233345789999999999999999999999999988764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=355.91 Aligned_cols=260 Identities=18% Similarity=0.242 Sum_probs=206.9
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFE 477 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~ 477 (683)
.++.++|.+.+.||+|+||.||+|.+..++..||||++..... ...+.+|+.++..+ .||||+.+++++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---------APQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---------SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---------cHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 4678899999999999999999999999999999998754322 12466789999999 7999999998885
Q ss_pred cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc-----EEE
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV-----AKV 551 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~-----vKL 551 (683)
+...+++||||+ +++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||
T Consensus 77 -~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 77 -EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred -CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEE
Confidence 678899999999 99999999754 45999999999999999999999865 999999999999987765 999
Q ss_pred EecCCccccccCcCCCcc--cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Q 005678 552 TDFGLSKIVEDDVGSQGM--ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR 629 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~--~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~ 629 (683)
+|||++............ .......||+.|+|||++.... ++.++|||||||++|+|++|..||...........
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 229 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE---QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 229 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC---CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCC---CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence 999999877654322111 1234557999999999986443 89999999999999999999999976432111111
Q ss_pred HHHHHHhh-ccCC-CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 630 EDTIIKAR-KVEF-PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 630 ~~~i~~~~-~~~~-p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...+.... .... ...+.+++++.+||.+||..+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 230 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11111111 0110 112468999999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=369.52 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=183.6
Q ss_pred ccccceeEEE-EecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 400 ILNHRYALLN-LLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~-~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+.++|.+.+ .||+|+||.||+|.+..+++.||||++.... . ........+..+.||||++++++|..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~-------~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----K-------ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----H-------HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----H-------HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 4677899865 6999999999999999999999999985421 0 11122233566799999999999863
Q ss_pred ---CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---CCcEE
Q 005678 479 ---DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---FGVAK 550 (683)
Q Consensus 479 ---d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~g~vK 550 (683)
+...+++|||||+|++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+|
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEE
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEE
Confidence 245689999999999999999765 36999999999999999999999965 999999999999985 45699
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|+|||++....... .....||+.|+|||++.... ++.++|||||||++|+|++|..||............
T Consensus 172 l~Dfg~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 241 (336)
T 3fhr_A 172 LTDFGFAKETTQNA-------LQTPCYTPYYVAPEVLGPEK---YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241 (336)
T ss_dssp ECCCTTCEEC-----------------------------CH---HHHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred Eeccccceeccccc-------cccCCCCcCccChhhhCCCC---CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH
Confidence 99999998654321 22347899999999985443 788999999999999999999999765443221111
Q ss_pred HHHHHhhcc--CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 631 DTIIKARKV--EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 631 ~~i~~~~~~--~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
......... ..+....++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 242 KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 111111222 223345789999999999999999999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=376.10 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=212.6
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
..|.+..++|.+.+.||+|+||+||+|.+..++..||||++..... ......+.+|+.+++.++|||||+++++
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP------PDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC------HHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC------HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4567778899999999999999999999988999999999854321 1224567899999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
|. +.+.+|+|||||++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 181 ~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 181 CT-QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp EC-SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCG
T ss_pred Ee-cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcC
Confidence 86 667889999999999999999654 45899999999999999999999965 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i 633 (683)
|+++........ .......+++.|+|||++.... ++.++|||||||++|||++ |..||......+... .+
T Consensus 258 G~s~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~---~~ 328 (377)
T 3cbl_A 258 GMSREEADGVYA---ASGGLRQVPVKWTAPEALNYGR---YSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE---FV 328 (377)
T ss_dssp GGCEECTTSEEE---CCSSCCEEEGGGSCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH---HH
T ss_pred CCceecCCCcee---ecCCCCCCCcCcCCHhHhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH
Confidence 999865432110 0011123577899999987544 8999999999999999998 999998766544321 11
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
. .....+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 329 ~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 329 E--KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp H--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H--cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1 22334455678999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=367.91 Aligned_cols=267 Identities=23% Similarity=0.378 Sum_probs=191.9
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHH-HHhhcCCCceeeecc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN-IHKTLVHHHIVRLWD 474 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~-il~~L~HpnIV~L~~ 474 (683)
..|.+..++|.+++.||+|+||.||+|.+..++..||||++...... .....+..|+. +++.++||||+++++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE------KEQKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH------HHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc------hHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence 45667788999999999999999999999999999999998654221 11234555555 777889999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhc-----CCCcchHHHHHHHHHHHHHHHHHHhc-CCceEecccCCcceEeCCCCc
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKA-----TPVLPEREARIIIVQIFQGLIYLNKR-AQKIIHYDLKPGNVLFDEFGV 548 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~-----~~~Lse~~~~~I~~qIa~aL~yLH~~-g~~IIHrDLKP~NILLd~~g~ 548 (683)
+|. +.+.+++||||+++ +|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.
T Consensus 89 ~~~-~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~ 164 (327)
T 3aln_A 89 ALF-REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGN 164 (327)
T ss_dssp EEE-CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTE
T ss_pred EEE-eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCC
Confidence 986 67789999999975 88887753 56799999999999999999999996 5 999999999999999999
Q ss_pred EEEEecCCccccccCcCCCcccccccCCCCCccCCccccccc-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 549 AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS-KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 549 vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~-~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
+||+|||++........ .....||+.|+|||++... ....++.++|||||||++|+|++|..||.........
T Consensus 165 ~kl~Dfg~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 238 (327)
T 3aln_A 165 IKLCDFGISGQLVDSIA------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238 (327)
T ss_dssp EEECCCSSSCC------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred EEEccCCCceecccccc------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH
Confidence 99999999987654311 2233799999999998432 1234889999999999999999999999764432111
Q ss_pred HHHHHHHHhhccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 628 LREDTIIKARKVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 628 l~~~~i~~~~~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+. .+.......++ ....++..+.+||.+||..||.+||++.++++||||..
T Consensus 239 ~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 239 LT--QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp -C--CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HH--HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 11 00111111122 12468999999999999999999999999999999963
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=369.58 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=214.6
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEcc-------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CC
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLV-------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VH 466 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~-------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~H 466 (683)
...+.+..++|.+.+.||+|+||.||+|.+.. .+..||||++..... ......+.+|+.+++.+ +|
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h 134 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT------EKDLSDLISEMEMMKMIGKH 134 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC------HHHHHHHHHHHHHHHHhcCC
Confidence 34567888999999999999999999998753 346899999865421 22346788999999999 99
Q ss_pred CceeeeccccccCCceEEEEEecccCCChhHHHhcCC----------------CcchHHHHHHHHHHHHHHHHHHhcCCc
Q 005678 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP----------------VLPEREARIIIVQIFQGLIYLNKRAQK 530 (683)
Q Consensus 467 pnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~----------------~Lse~~~~~I~~qIa~aL~yLH~~g~~ 530 (683)
||||+++++|. +.+.+++||||+++++|.+++.... .+++..+..|+.||+.||.|||+.+
T Consensus 135 pnIv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 211 (382)
T 3tt0_A 135 KNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-- 211 (382)
T ss_dssp TTBCCEEEEEC-SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred chhhhheeeec-cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999986 6778899999999999999996543 4899999999999999999999965
Q ss_pred eEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHH
Q 005678 531 IIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQ 610 (683)
Q Consensus 531 IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyE 610 (683)
||||||||+||||+.++.+||+|||+++....... ........||+.|+|||++.... ++.++|||||||++|+
T Consensus 212 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwslG~il~e 285 (382)
T 3tt0_A 212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRI---YTHQSDVWSFGVLLWE 285 (382)
T ss_dssp CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCT---TCCCTTCCCGGGGSCHHHHHSCC---CCHHHHHHHHHHHHHH
T ss_pred EecCCCCcceEEEcCCCcEEEcccCcccccccccc---cccccCCCCCcceeCHHHhcCCC---CCchhHHHHHHHHHHH
Confidence 99999999999999999999999999987654321 12233457889999999986443 8999999999999999
Q ss_pred HHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 611 MLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 611 LLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
|++ |..||......+... .+... .....+..+++++.+||.+||..+|.+|||+.+++++
T Consensus 286 llt~g~~p~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 286 IFTLGGSPYPGVPVEELFK---LLKEG--HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHTTSCCSSTTCCHHHHHH---HHHTT--CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHH---HHHcC--CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999 999998766543221 11222 2333346799999999999999999999999999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=370.28 Aligned_cols=264 Identities=26% Similarity=0.389 Sum_probs=205.7
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC----------
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV---------- 465 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~---------- 465 (683)
..-++...+|.+.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.++..+.
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~~~~~ 83 (373)
T 1q8y_A 12 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--------VYTEAAEDEIKLLQRVNDADNTKEDSM 83 (373)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--------HHHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred cCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--------cchhhhhHHHHHHHHhhcccccchhcc
Confidence 334556789999999999999999999999999999999985321 12346778888888886
Q ss_pred -CCceeeeccccccC---CceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhc-CCceEecccCC
Q 005678 466 -HHHIVRLWDTFEID---QNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKR-AQKIIHYDLKP 538 (683)
Q Consensus 466 -HpnIV~L~~~f~~d---~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~-g~~IIHrDLKP 538 (683)
||||++++++|... ...+++||||+ +++|.+++... ..+++..+..|+.||+.||.|||+. + |+||||||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp 160 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKP 160 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSG
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCh
Confidence 89999999998642 23789999999 89999999653 4599999999999999999999996 5 99999999
Q ss_pred cceEeC------CCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 539 GNVLFD------EFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 539 ~NILLd------~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
+|||++ ..+.+||+|||++...... .....||+.|+|||++.... ++.++|||||||++|+|+
T Consensus 161 ~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~el~ 229 (373)
T 1q8y_A 161 ENVLMEIVDSPENLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAP---WGCGADIWSTACLIFELI 229 (373)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCC---CCTHHHHHHHHHHHHHHH
T ss_pred HHeEEeccCCCcCcceEEEcccccccccCCC--------CCCCCCCccccCcHHHhCCC---CCchHhHHHHHHHHHHHH
Confidence 999994 4458999999999876432 22347999999999987543 899999999999999999
Q ss_pred cCCCCCCCCchH------HHHHHHHHHHHh------------------------------------hccCCCCCcCCCHH
Q 005678 613 FGRRPFGHDQTQ------ERILREDTIIKA------------------------------------RKVEFPSRPAVSNE 650 (683)
Q Consensus 613 tG~~PF~~~~~~------e~il~~~~i~~~------------------------------------~~~~~p~~~~~s~e 650 (683)
+|..||...... ..+......... ....+.....++.+
T Consensus 230 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (373)
T 1q8y_A 230 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309 (373)
T ss_dssp HSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHH
T ss_pred hCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHH
Confidence 999999754321 111110000000 00011122345778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 651 AKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 651 l~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+.+||.+||..||.+|||+.++++||||+..
T Consensus 310 ~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 9999999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=364.36 Aligned_cols=255 Identities=21% Similarity=0.313 Sum_probs=201.7
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEE----EEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYV----ACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~V----AVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
+..++|.+++.||+|+||+||+|.+..++..| |+|.+.... .......+.+|+.+++.++||||++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT------SPKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc------CHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 34678999999999999999999988777654 777654321 12234678899999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
|. + ...++|++|+++++|.+++.. ...+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+||
T Consensus 86 ~~-~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 86 CL-T-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EE-S-SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCT
T ss_pred Ee-c-CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccC
Confidence 86 3 347899999999999999965 457999999999999999999999965 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i 633 (683)
|+++........ .......||+.|+|||++.... ++.++|||||||++|+|++ |..||.......... .
T Consensus 162 g~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---~- 231 (327)
T 3poz_A 162 GLAKLLGAEEKE---YHAEGGKVPIKWMALESILHRI---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---I- 231 (327)
T ss_dssp THHHHHTTTCC----------CCCGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---H-
T ss_pred cceeEccCCccc---ccccCCCccccccChHHhccCC---CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH---H-
Confidence 999877543221 1223346788999999987544 8999999999999999999 999998765543221 1
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
. ......+..+.++.++.+||.+||..+|.+||++.+++.+
T Consensus 232 ~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 232 L-EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp H-HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred H-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1 1223345556799999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=357.04 Aligned_cols=260 Identities=21% Similarity=0.338 Sum_probs=196.9
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhh--cCCCceeeecccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT--LVHHHIVRLWDTF 476 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~--L~HpnIV~L~~~f 476 (683)
.++.++|.+++.||+|+||+||+|.+ ++..||||++.... ...+.+|..++.. ++||||+++++++
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----------~~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----------EKSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----------HHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----------chhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 35678999999999999999999975 79999999974321 2344556666666 7999999999886
Q ss_pred cc---CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHH--------hcCCceEecccCCcceEeCC
Q 005678 477 EI---DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLN--------KRAQKIIHYDLKPGNVLFDE 545 (683)
Q Consensus 477 ~~---d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH--------~~g~~IIHrDLKP~NILLd~ 545 (683)
.. ....+++||||+++++|.+++... .+++..+..++.||+.||.||| + ++|+||||||+|||++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill~~ 148 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILVKK 148 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTTC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEECT
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhhc-ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEEcC
Confidence 42 245689999999999999999654 5999999999999999999999 6 45999999999999999
Q ss_pred CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCC---CCCchhHHHHHHHHHHHHHcC--------
Q 005678 546 FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTP---LISSKVDVWSAGILFYQMLFG-------- 614 (683)
Q Consensus 546 ~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~---~~s~ksDVWSLGvILyELLtG-------- 614 (683)
++.+||+|||++........... .......||+.|+|||++...... .++.++|||||||++|+|++|
T Consensus 149 ~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 149 NGQCCIADLGLAVMHSQSTNQLD-VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp TSCEEECCCTTCEEEETTTTEEE-CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCEEEeeCCCeeeccccccccc-ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 99999999999987654322111 112334799999999998654321 245799999999999999999
Q ss_pred --CCCCCCCchHHHHHH-HHHHHHhh--ccCCCC---CcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 615 --RRPFGHDQTQERILR-EDTIIKAR--KVEFPS---RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 615 --~~PF~~~~~~e~il~-~~~i~~~~--~~~~p~---~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
..||........... ........ ...+|. ...++..+.+||.+||..||.+|||+.++++
T Consensus 228 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 888854322111111 01111111 111111 1225578999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.39 Aligned_cols=261 Identities=20% Similarity=0.329 Sum_probs=213.7
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI 469 (683)
...|.+..++|.+.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.+++.++||||
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS------MRERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC------HHHHHHHHHHHHHGGGCCCTTB
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC------HHHHHHHHHHHHHHHhcCCCCE
Confidence 3567888999999999999999999999876 4678999999854321 1224568899999999999999
Q ss_pred eeeccccccCCceEEEEEecccCCChhHHHhcC----------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCc
Q 005678 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPG 539 (683)
Q Consensus 470 V~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~ 539 (683)
+++++++. +.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 91 ~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~ 167 (322)
T 1p4o_A 91 VRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAAR 167 (322)
T ss_dssp CCEEEEEC-SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGG
T ss_pred eeeEEEEc-cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccc
Confidence 99999986 677889999999999999999542 35789999999999999999999965 999999999
Q ss_pred ceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 005678 540 NVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPF 618 (683)
Q Consensus 540 NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF 618 (683)
|||++.++.+||+|||++........ ........||+.|+|||++.... ++.++|||||||++|+|++ |..||
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~~g~~p~ 241 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIATLAEQPY 241 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGC---EEGGGSSEECGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred eEEEcCCCeEEECcCccccccccccc---cccccCCCCCCCccChhhhccCC---CCchhhHHHHHHHHHHHHhcCCCcc
Confidence 99999999999999999986643321 12233446789999999987544 8999999999999999999 89999
Q ss_pred CCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 619 GHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 619 ~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.......... .+... ...+....++..+.+||.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~---~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 242 QGLSNEQVLR---FVMEG--GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTSCHHHHHH---HHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHH---HHHcC--CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7765543221 11111 1223345789999999999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=364.35 Aligned_cols=266 Identities=20% Similarity=0.240 Sum_probs=203.7
Q ss_pred CCccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 394 RFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 394 ~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
+..++-+..++|.+.+.||+|+||+||+|.+ .++.||||++.... .......+|+.++..++|||||+++
T Consensus 15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~ 84 (322)
T 3soc_A 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD--------KQSWQNEYEVYSLPGMKHENILQFI 84 (322)
T ss_dssp CCCCEEETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG--------HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred CccccccchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc--------hHHHHHHHHHHHHhcCCCCCchhhc
Confidence 4466777889999999999999999999975 48999999985421 1123455699999999999999999
Q ss_pred cccccC---CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc--------CCceEecccCCcceE
Q 005678 474 DTFEID---QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR--------AQKIIHYDLKPGNVL 542 (683)
Q Consensus 474 ~~f~~d---~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~--------g~~IIHrDLKP~NIL 542 (683)
++|... ...+|+|||||++++|.+++.... +++..+..++.||+.||.|||+. .++|+||||||+|||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nil 163 (322)
T 3soc_A 85 GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL 163 (322)
T ss_dssp EEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEE
T ss_pred ceeccCCCCCceEEEEEecCCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEE
Confidence 998743 334799999999999999997754 99999999999999999999985 115999999999999
Q ss_pred eCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCC--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005678 543 FDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT--PLISSKVDVWSAGILFYQMLFGRRPFGH 620 (683)
Q Consensus 543 Ld~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~ 620 (683)
++.++.+||+|||+++.+...... .......||+.|+|||++..... ..++.++|||||||++|+|++|+.||..
T Consensus 164 l~~~~~~kL~DFg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 164 LKNNLTACIADFGLALKFEAGKSA---GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp ECTTCCEEECCCTTCEEECTTSCC---CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred ECCCCeEEEccCCcccccccccCc---cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999876543221 12233579999999999865321 2356789999999999999999999965
Q ss_pred CchHHH------------HHHHHHHHHhhccCCCCC------cCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 621 DQTQER------------ILREDTIIKARKVEFPSR------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 621 ~~~~e~------------il~~~~i~~~~~~~~p~~------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...... ............ ..|.. ...+..+.+||.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcchhccchhhhhccCCchhhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 321100 000000111111 11111 123456999999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=359.70 Aligned_cols=265 Identities=26% Similarity=0.342 Sum_probs=195.9
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeecc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWD 474 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~ 474 (683)
..+.+...+|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..+. ||||+++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 93 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-------EEKNRAIIQEVCFMKKLSGHPNIVQFCS 93 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-------HHHHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-------hHHHHHHHHHHHHHHHhccCCChhhccc
Confidence 345667789999999999999999999999999999999874331 122457889999999996 999999999
Q ss_pred ccc-------cCCceEEEEEecccCCChhHHHhc---CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC
Q 005678 475 TFE-------IDQNTFCTVLEYCSGKDLDAVLKA---TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD 544 (683)
Q Consensus 475 ~f~-------~d~~~~~LV~Ey~~ggsL~~~L~~---~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd 544 (683)
+|. .....+++||||+. |+|.+++.. .+.+++..+..|+.||+.||.|||+.+++|+|+||||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~ 172 (337)
T 3ll6_A 94 AASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS 172 (337)
T ss_dssp EEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC
T ss_pred cccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC
Confidence 883 34566899999995 689888853 5679999999999999999999998655699999999999999
Q ss_pred CCCcEEEEecCCccccccCcCCC-------cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCC
Q 005678 545 EFGVAKVTDFGLSKIVEDDVGSQ-------GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRP 617 (683)
Q Consensus 545 ~~g~vKL~DFGls~~~~~~~~~~-------~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~P 617 (683)
.++.+||+|||++.......... .........||+.|+|||++.......++.++|||||||++|+|++|..|
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 99999999999998765432110 00111234699999999998544445589999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 618 FGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 618 F~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
|....... ........+....++..+.+||.+||..||.+||++.+++++.
T Consensus 253 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 253 FEDGAKLR--------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp C--------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CcchhHHH--------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 96543321 1122344455567888999999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.88 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=212.3
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEc-------cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCC
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDL-------VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHH 467 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-------~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~Hp 467 (683)
..|.+..++|.+.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.+++.+ +||
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~hp 101 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT------EKDLSDLVSEMEMMKMIGKHK 101 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC------HHHHHHHHHHHHHHHHHCCCT
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc------HHHHHHHHHHHHHHHHhhcCC
Confidence 566788899999999999999999999875 4678899999864321 22356788999999999 899
Q ss_pred ceeeeccccccCCceEEEEEecccCCChhHHHhcCC----------------CcchHHHHHHHHHHHHHHHHHHhcCCce
Q 005678 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP----------------VLPEREARIIIVQIFQGLIYLNKRAQKI 531 (683)
Q Consensus 468 nIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~----------------~Lse~~~~~I~~qIa~aL~yLH~~g~~I 531 (683)
||++++++|. +.+.+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |
T Consensus 102 ~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i 178 (334)
T 2pvf_A 102 NIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--C 178 (334)
T ss_dssp TBCCEEEEEC-SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred CEeeEEEEEc-cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 9999999986 6778899999999999999997543 3899999999999999999999965 9
Q ss_pred EecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHH
Q 005678 532 IHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM 611 (683)
Q Consensus 532 IHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyEL 611 (683)
+|+||||+|||++.++.+||+|||++........ ........||+.|+|||++.... ++.++|||||||++|+|
T Consensus 179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el 252 (334)
T 2pvf_A 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDY---YKKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEI 252 (334)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECTTTSS---EECCSCCCCCGGGCCHHHHHHCE---ECHHHHHHHHHHHHHHH
T ss_pred eCCCCccceEEEcCCCCEEEcccccccccccccc---ccccCCCCcccceeChHHhcCCC---cChHHHHHHHHHHHHHH
Confidence 9999999999999999999999999987654321 12233446889999999986544 79999999999999999
Q ss_pred Hc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 612 LF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 612 Lt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
++ |..||......+... .+... ...+....++..+.+||.+||..+|.+||++.+++++
T Consensus 253 lt~g~~p~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 253 FTLGGSPYPGIPVEELFK---LLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HTTSCCSSTTCCHHHHHH---HHHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCcCcCCHHHHHH---HHhcC--CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99 999998765543221 11122 2233345789999999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=360.37 Aligned_cols=260 Identities=31% Similarity=0.458 Sum_probs=203.6
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc----CCCceeee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL----VHHHIVRL 472 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L----~HpnIV~L 472 (683)
....+.++|.+.+.||+|+||.||+|.+..++..||||++......... .......+.+|+.++..+ +||||+++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS-PLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC---------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccc-cchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 3456788999999999999999999999999999999998654332111 111223456789999988 89999999
Q ss_pred ccccccCCceEEEEEec-ccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-CCCcEE
Q 005678 473 WDTFEIDQNTFCTVLEY-CSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAK 550 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey-~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-~~g~vK 550 (683)
+++|. +.+.+++|||| +.+++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+|||++ .++.+|
T Consensus 104 ~~~~~-~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 104 LDWFE-TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEEC------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEE
T ss_pred EEEEe-cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEE
Confidence 99986 56778899999 789999999987778999999999999999999999976 99999999999999 789999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|+|||++....... .....||+.|+|||++.... ..+.++|||||||++|+|++|+.||..... +
T Consensus 181 l~dfg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~--- 245 (312)
T 2iwi_A 181 LIDFGSGALLHDEP-------YTDFDGTRVYSPPEWISRHQ--YHALPATVWSLGILLYDMVCGDIPFERDQE---I--- 245 (312)
T ss_dssp ECCCSSCEECCSSC-------BCCCCSCTTTSCHHHHHHSC--BCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---H---
T ss_pred EEEcchhhhcccCc-------ccccCCcccccCceeeecCC--CCCccchHHHHHHHHHHHHHCCCCCCChHH---H---
Confidence 99999998765431 22347999999999886443 235589999999999999999999965321 1
Q ss_pred HHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 631 ~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
......+ ...++..+.+||.+||..||.+||++.++++||||+..
T Consensus 246 ----~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 246 ----LEAELHF--PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp ----HHTCCCC--CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred ----hhhccCC--cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 1122233 35689999999999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.23 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=208.7
Q ss_pred cccccccceeEEE-EecccCceEEEEEEE--ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 397 NFQILNHRYALLN-LLGKGGFSEVYKAYD--LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 397 ~~~i~~~ry~l~~-~LGkGgfG~Vyka~d--~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
++.+...+|.+.. .||+|+||.||+|.+ ..++..||||++..... .......+.+|+.+++.++||||++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~ 84 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-----DPALKDELLAEANVMQQLDNPYIVRMI 84 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------CHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-----CHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 4456678999998 999999999999954 55678999999865422 123356788999999999999999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
+++. .+.+++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 85 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 85 GICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp EEEE--SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECC
T ss_pred EEEC--CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEcc
Confidence 9983 5678899999999999999988888999999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDT 632 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~ 632 (683)
||++......... ........||+.|+|||++.... ++.++||||||+++|+|++ |..||......+... .
T Consensus 161 fg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~ 232 (291)
T 1xbb_A 161 FGLSKALRADENY--YKAQTHGKWPVKWYAPECINYYK---FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---M 232 (291)
T ss_dssp CTTCEECCTTCSE--EEC----CCCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---H
T ss_pred CCcceeeccCCCc--ccccccCCCCceeeChHHhccCC---CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---H
Confidence 9999876543211 11223346789999999986544 7889999999999999999 999998766544221 1
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+.... ..+.+..++..+.+||.+||..||.+||++.++++
T Consensus 233 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 233 LEKGE--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHTTC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11222 22334578999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=361.35 Aligned_cols=260 Identities=22% Similarity=0.348 Sum_probs=212.7
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCe-----EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCcee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHR-----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~-----~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV 470 (683)
.+.+..++|.+.+.||+|+||.||+|.+..++. .||+|++..... ......+.+|+.+++.+ +||||+
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv 113 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH------ADEKEALMSELKIMSHLGQHENIV 113 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC------hHHHHHHHHHHHHHHhhcCCCCee
Confidence 567788999999999999999999999876654 799999865421 12246788999999999 899999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhc--------------CCCcchHHHHHHHHHHHHHHHHHHhcCCceEeccc
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA--------------TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDL 536 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~--------------~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDL 536 (683)
+++++|. +.+.+++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||
T Consensus 114 ~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dl 190 (333)
T 2i1m_A 114 NLLGACT-HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDV 190 (333)
T ss_dssp CEEEEEC-SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred eEEEEEe-cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCc
Confidence 9999986 66789999999999999999953 345899999999999999999999965 999999
Q ss_pred CCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CC
Q 005678 537 KPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GR 615 (683)
Q Consensus 537 KP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~ 615 (683)
||+|||++.++.+||+|||++........ ........||+.|+|||++.... ++.++|||||||++|+|++ |.
T Consensus 191 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~t~g~ 264 (333)
T 2i1m_A 191 AARNVLLTNGHVAKIGDFGLARDIMNDSN---YIVKGNARLPVKWMAPESIFDCV---YTVQSDVWSYGILLWEIFSLGL 264 (333)
T ss_dssp SGGGCEEEGGGEEEBCCCGGGCCGGGCTT---SEECSSCEECGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHTTTSC
T ss_pred ccceEEECCCCeEEECccccccccccccc---eeecCCCCCCccccCHHHhccCC---CChHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999987654321 12233346788999999987544 8999999999999999998 99
Q ss_pred CCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 616 RPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 616 ~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.||........+.. ........+.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 265 ~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 265 NPYPGILVNSKFYK----LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CSSTTCCSSHHHHH----HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccchhHHHHH----HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 99977654443322 111223334445689999999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=363.77 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=204.9
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeE----EEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRY----VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~----VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
+..++|.+++.||+|+||+||+|.+..++.. ||+|.+....... ....+.+|+.++..++||||++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ------SFQAVTDHMLAIGSLDHAHIVRLLGL 83 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS------CBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH------HHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 3467899999999999999999998888775 7777764332111 12346679999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
|. ...+++||||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 84 ~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 84 CP--GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp EC--BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSC
T ss_pred Ec--CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCC
Confidence 85 56688999999999999999764 57999999999999999999999966 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i 633 (683)
|+++.+...... .......||+.|+|||++.... ++.++|||||||++|+|++ |..||......+... .+
T Consensus 160 g~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~ 230 (325)
T 3kex_A 160 GVADLLPPDDKQ---LLYSEAKTPIKWMALESIHFGK---YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD---LL 230 (325)
T ss_dssp SGGGGSCCCTTC---CC-----CCTTTSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH---HH
T ss_pred CcccccCccccc---ccccCCCCcccccChHHhccCC---CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH---HH
Confidence 999887544221 1233447888999999987544 8999999999999999999 999998765443221 11
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
... ...+.+..++.++.+||.+||..||.+||++.+++++
T Consensus 231 ~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 231 EKG--ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HTT--CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HcC--CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 122 2233345688899999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=363.53 Aligned_cols=261 Identities=30% Similarity=0.454 Sum_probs=212.1
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC--CCceeeec
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV--HHHIVRLW 473 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~--HpnIV~L~ 473 (683)
.....+.++|.+.+.||+|+||.||+|.+..++..||||++.......... ......+.+|+.+++.+. ||||++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE-CTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh-hhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344567889999999999999999999999999999999986543221000 001124567899999996 59999999
Q ss_pred cccccCCceEEEEEecccC-CChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-CCCcEEE
Q 005678 474 DTFEIDQNTFCTVLEYCSG-KDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKV 551 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~g-gsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-~~g~vKL 551 (683)
++|. +.+.+++||||+.+ ++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 115 ~~~~-~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 115 DWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EEEE-CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEE
T ss_pred EEEe-cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEE
Confidence 9996 67789999999976 899999987778999999999999999999999965 99999999999999 7899999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~ 631 (683)
+|||++....... .....||+.|+|||++.... .++.++|||||||++|+|++|..||..... +
T Consensus 192 ~Dfg~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~---~---- 255 (320)
T 3a99_A 192 IDFGSGALLKDTV-------YTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVCGDIPFEHDEE---I---- 255 (320)
T ss_dssp CCCTTCEECCSSC-------BCCCCSCGGGSCHHHHHHSC--BCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---H----
T ss_pred eeCcccccccccc-------ccCCCCCccCCChHHhccCC--CCCccchHHhHHHHHHHHHHCCCCCCChhh---h----
Confidence 9999998765321 22347999999999986443 247889999999999999999999965321 1
Q ss_pred HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 632 ~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
. .... .....++.++.+||.+||..||.+||++.++++||||+..
T Consensus 256 --~-~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 256 --I-RGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp --H-HCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --h-cccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 1 1122 2335789999999999999999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=361.55 Aligned_cols=265 Identities=24% Similarity=0.353 Sum_probs=208.1
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||++++++|..
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-------QQDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-------HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-------HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 456789999999999999999999999999999999875421 1234578899999999999999999998853
Q ss_pred ---CCceEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEE
Q 005678 479 ---DQNTFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKV 551 (683)
Q Consensus 479 ---d~~~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL 551 (683)
....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEE
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEE
Confidence 34578999999999999999964 467999999999999999999999965 999999999999999999999
Q ss_pred EecCCccccccCcCCC----cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Q 005678 552 TDFGLSKIVEDDVGSQ----GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI 627 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~----~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i 627 (683)
+|||++.......... .........||+.|+|||++.......++.++|||||||++|+|++|..||.........
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 255 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence 9999987653221100 000112336899999999986543334688999999999999999999999431111000
Q ss_pred HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 628 LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 628 l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.. ........++..+.++..+.+||.+||..||.+||++.+++++
T Consensus 256 ~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 256 VA---LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HH---HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hh---HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00 1112234556667899999999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.64 Aligned_cols=268 Identities=16% Similarity=0.206 Sum_probs=203.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccC-----CeEEEEEEeccCcccchhh----HHHHHHHHHHHHHHHhhcCCCcee
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVE-----HRYVACKLHGLNAQWSEDK----KQSYIRHAIREYNIHKTLVHHHIV 470 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~-----g~~VAVKi~~~~~~~~~~~----~~~~i~~~~rEi~il~~L~HpnIV 470 (683)
+..++|.+.+.||+|+||.||+|.+..+ +..||||++.......... .......+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456999999999999999999988664 5889999986543211000 001112355677888899999999
Q ss_pred eeccccccC---CceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC--
Q 005678 471 RLWDTFEID---QNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-- 544 (683)
Q Consensus 471 ~L~~~f~~d---~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-- 544 (683)
++++++..+ ...+|+||||| |++|.+++... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence 999998643 25689999999 99999999765 67999999999999999999999965 99999999999999
Q ss_pred CCCcEEEEecCCccccccCcCCCcc--cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCc
Q 005678 545 EFGVAKVTDFGLSKIVEDDVGSQGM--ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQ 622 (683)
Q Consensus 545 ~~g~vKL~DFGls~~~~~~~~~~~~--~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~ 622 (683)
.++.+||+|||+++.+......... .......||+.|+|||++.... ++.++|||||||++|+|++|..||....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA---PSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC---CCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC---CCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8899999999999877543221111 1123346999999999986444 8999999999999999999999997533
Q ss_pred hHHHHHHHHHHHHh------hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 623 TQERILREDTIIKA------RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 623 ~~e~il~~~~i~~~------~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.............. ....+ ....++.++.+||..||..+|.+||++.+|++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCF-PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHS-CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhc-ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 32222211111000 00111 12468999999999999999999999998874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=354.49 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=204.2
Q ss_pred CCCccccccccceeEEEEecccCceEEEEEEEcc---CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce
Q 005678 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLV---EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI 469 (683)
Q Consensus 393 ~~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~---~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI 469 (683)
..+..+.+..++|.+.+.||+|+||.||+|.+.. ++..||||++...... ......+.+|+.+++.++||||
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i 98 (313)
T 3brb_A 24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-----QREIEEFLSEAACMKDFSHPNV 98 (313)
T ss_dssp CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-----HHHHHHHHHHHHHHHTCCCTTB
T ss_pred hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-----hhHHHHHHHHHHHHhcCCCCCe
Confidence 3456777888999999999999999999998765 5668999998654322 1235678899999999999999
Q ss_pred eeeccccccCCc----eEEEEEecccCCChhHHHh------cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCc
Q 005678 470 VRLWDTFEIDQN----TFCTVLEYCSGKDLDAVLK------ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPG 539 (683)
Q Consensus 470 V~L~~~f~~d~~----~~~LV~Ey~~ggsL~~~L~------~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~ 539 (683)
++++++|..... .+++||||+++++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 99 v~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~ 176 (313)
T 3brb_A 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAAR 176 (313)
T ss_dssp CCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGG
T ss_pred eeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcc
Confidence 999999864322 4689999999999999983 3356999999999999999999999865 999999999
Q ss_pred ceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 005678 540 NVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPF 618 (683)
Q Consensus 540 NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF 618 (683)
|||++.++.+||+|||++......... .......|++.|+|||++.... ++.++|||||||++|+|++ |..||
T Consensus 177 NIli~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~~g~~p~ 250 (313)
T 3brb_A 177 NCMLRDDMTVCVADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGMTPY 250 (313)
T ss_dssp GEEECTTSCEEECSCSCC-------------------CCGGGSCHHHHHSSC---CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eEEEcCCCcEEEeecCcceeccccccc---CcccccCCCccccCchhhcCCC---ccchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999876543211 1123346788999999986443 8999999999999999999 99999
Q ss_pred CCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 619 GHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 619 ~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.......... .+... ...+.+..++..+.+||.+||..||.+||++.+++++
T Consensus 251 ~~~~~~~~~~---~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 251 PGVQNHEMYD---YLLHG--HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TTCCGGGHHH---HHHTT--CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHH---HHHcC--CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7766543221 11122 2233345789999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=353.83 Aligned_cols=249 Identities=20% Similarity=0.306 Sum_probs=201.7
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCC-------eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceee
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEH-------RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVR 471 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g-------~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~ 471 (683)
.+..++|.+.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~ 76 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-------RNYSESFFEAASMMSKLSHKHLVL 76 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-------GGGHHHHHHHHHHHHTSCCTTBCC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-------HHHHHHHHHHHHHHHhCCCCCEeE
Confidence 356789999999999999999999988776 579999985422 122457889999999999999999
Q ss_pred eccccccCCceEEEEEecccCCChhHHHhcCCC-cchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc--
Q 005678 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV-- 548 (683)
Q Consensus 472 L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~-Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~-- 548 (683)
++++|. +.+..++||||+++++|.+++...+. +++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 77 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 77 NYGVCV-CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp EEEEEC-CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGG
T ss_pred EEEEEE-eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCccc
Confidence 999986 66778999999999999999976644 899999999999999999999966 999999999999998776
Q ss_pred ------EEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCC-CCCCCC
Q 005678 549 ------AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGR-RPFGHD 621 (683)
Q Consensus 549 ------vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~-~PF~~~ 621 (683)
+||+|||++...... ....||+.|+|||++... ..++.++|||||||++|+|++|. +||...
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~~~~~~~ 222 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLPK---------DILQERIPWVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSAL 222 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSCH---------HHHHHTTTTSCHHHHHCG--GGCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccceeeeccCcccccccCc---------cccCCcCcccCHHHhCCC--CCCCchhHHHHHHHHHHHHHcCCCCCcccc
Confidence 999999998755322 112578999999998742 23799999999999999999954 555444
Q ss_pred chHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 622 QTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 622 ~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
...... . ...... ..+..++.++.+||.+||..||.+|||+.+++++
T Consensus 223 ~~~~~~-~----~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 223 DSQRKL-Q----FYEDRH--QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CHHHHH-H----HHHTTC--CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred chHHHH-H----HhhccC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 433221 1 111122 2234568889999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=344.12 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=209.7
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
|.+..++|.+.+.||+|+||.||+|.+. ++..||||++...... ...+.+|+.+++.++||||++++++|.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 73 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--------EEDFIEEAEVMMKLSHPKLVQLYGVCL 73 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 5566789999999999999999999875 6789999998654321 145788999999999999999999986
Q ss_pred cCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
+.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 74 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 74 -EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp -SSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred -cCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccc
Confidence 667899999999999999999654 56899999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
+........ .......||+.|+|||++.... ++.++||||||+++|+|++ |..||.......... .+..
T Consensus 151 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~i~~ 220 (267)
T 3t9t_A 151 TRFVLDDQY----TSSTGTKFPVKWASPEVFSFSR---YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---DIST 220 (267)
T ss_dssp GGGBCCHHH----HSTTSTTCCGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HHHT
T ss_pred ccccccccc----cccccccccccccChhhhcCCC---ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH---HHhc
Confidence 987643211 1122346788999999986544 7999999999999999999 899998766544321 1111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
. .....+..++..+.+||.+||..+|.+||++.+++++
T Consensus 221 ~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 221 G--FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp T--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C--CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 2233345689999999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=350.07 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=209.3
Q ss_pred ccccccccceeEEEEecccCceEEEEEE----EccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceee
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVR 471 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~----d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~ 471 (683)
....+...+|.+++.||+|+||.||+|. +..++..||||++..... ......+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~ 87 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG------GNHIADLKKEIEILRNLYHENIVK 87 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----------CCHHHHHHHHHHHHTCCCTTBCC
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc------chhHHHHHHHHHHHHhCCCCCeee
Confidence 3444567789999999999999999998 567899999999865421 122457889999999999999999
Q ss_pred eccccccC-CceEEEEEecccCCChhHHH-hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcE
Q 005678 472 LWDTFEID-QNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVA 549 (683)
Q Consensus 472 L~~~f~~d-~~~~~LV~Ey~~ggsL~~~L-~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~v 549 (683)
++++|..+ ...+++||||+++++|.+++ .....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp EEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEE
T ss_pred eeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCE
Confidence 99998643 26689999999999999999 44567999999999999999999999965 9999999999999999999
Q ss_pred EEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH--
Q 005678 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI-- 627 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i-- 627 (683)
||+|||++........ .........||+.|+|||++.... ++.++|||||||++|+|++|..||.........
T Consensus 166 kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 240 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKE--YYTVKDDRDSPVFWYAPECLMQSK---FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240 (302)
T ss_dssp EECCCTTCEECCTTCC--EEECCCCTTCCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred EECcccccccccCCCc--ceeccCCCCCCccccCCeeecCCC---CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc
Confidence 9999999987754321 112334457899999999986554 789999999999999999999987432211000
Q ss_pred --------HHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 628 --------LREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 628 --------l~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
..............+.++.+++.+.+||.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00000011122344455689999999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=350.45 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=211.2
Q ss_pred cccccccceeEEE-EecccCceEEEEEEEc--cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 397 NFQILNHRYALLN-LLGKGGFSEVYKAYDL--VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 397 ~~~i~~~ry~l~~-~LGkGgfG~Vyka~d~--~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
++.+..++|.+.. .||+|+||.||+|.+. .++..||||++..... ......+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~ 76 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE------KADTEEMMREAQIMHQLDNPYIVRLI 76 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc------hhHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 3456678888887 9999999999999753 4688999999865421 22356788999999999999999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
+++. .+.+++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 77 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~ 152 (287)
T 1u59_A 77 GVCQ--AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKIS 152 (287)
T ss_dssp EEEE--SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEEC
T ss_pred EEec--CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEEC
Confidence 9984 5568999999999999999954 356999999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRED 631 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~ 631 (683)
|||++......... ........||+.|+|||++.... ++.++|||||||++|+|++ |..||......+...
T Consensus 153 Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--- 224 (287)
T 1u59_A 153 DFGLSKALGADDSY--YTARSAGKWPLKWYAPECINFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA--- 224 (287)
T ss_dssp CCTTCEECTTCSCE--ECCCCSSCCCGGGCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH---
T ss_pred cccceeeeccCcce--eeccccccccccccCHHHhccCC---CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH---
Confidence 99999876543211 11233446789999999986544 7899999999999999998 999998766544221
Q ss_pred HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 632 ~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
.+.... ..+.++.+++.+.+||.+||..+|.+||++.+++++.
T Consensus 225 ~i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 225 FIEQGK--RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHhcCC--cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 122222 2233457999999999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=370.08 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=198.7
Q ss_pred cccccceeEEEEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
.+...+|.+.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.++..++||||++++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT------EKQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC------HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC------HHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 455678999999999999999999876 4677899999865321 1234678999999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
|. +.+.+++||||+++++|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 115 ~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 115 VT-KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp EC-SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC
T ss_pred Ee-eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcC
Confidence 86 677889999999999999999765 46999999999999999999999965 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i 633 (683)
|+++........ ......+.+|+.|+|||++.... ++.++|||||||++|+|++ |..||......+.... +
T Consensus 192 g~a~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~---i 263 (373)
T 2qol_A 192 GLGRVLEDDPEA--AYTTRGGKIPIRWTSPEAIAYRK---FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA---V 263 (373)
T ss_dssp ------------------------CTTSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH---H
T ss_pred ccccccccCCcc--ceeccCCCcCCCccChhhhccCC---cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H
Confidence 999877543211 11122345688999999987544 8999999999999999997 9999987665443211 1
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
......+....++..+.+||.+||..+|.+||++.++++
T Consensus 264 --~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 264 --DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 122344555678999999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=365.25 Aligned_cols=266 Identities=17% Similarity=0.210 Sum_probs=201.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEcc---CCeEEEEEEeccCcccchhh----HHHHHHHHHHHHHHHhhcCCCceeee
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLV---EHRYVACKLHGLNAQWSEDK----KQSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~---~g~~VAVKi~~~~~~~~~~~----~~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
+..++|.+.+.||+|+||.||+|.+.. ++..||||++.......... .......+.+|+.++..+.||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 456799999999999999999999887 78899999986543211110 01112346789999999999999999
Q ss_pred ccccccC---CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC--
Q 005678 473 WDTFEID---QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-- 547 (683)
Q Consensus 473 ~~~f~~d---~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-- 547 (683)
++++... ...+|+||||+ +++|.+++...+.+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCC
Confidence 9998642 67899999999 9999999987778999999999999999999999965 99999999999999777
Q ss_pred cEEEEecCCccccccCcCCCc--ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCc-hH
Q 005678 548 VAKVTDFGLSKIVEDDVGSQG--MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQ-TQ 624 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~~--~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~-~~ 624 (683)
.+||+|||+++.+........ ........||+.|+|||++... .++.++|||||||++|+|++|..||.... ..
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV---ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC---CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC---CCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 999999999987754321111 1112445899999999998754 38999999999999999999999995422 21
Q ss_pred HHHHHHHHHHHhhccCCC-------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 625 ERILREDTIIKARKVEFP-------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 625 e~il~~~~i~~~~~~~~p-------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
........ .....++ ....++.++.+||.+||..||.+||++.++++
T Consensus 268 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 268 VAVQTAKT---NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHH---HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHH---hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11111111 1111111 11268999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.99 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=206.0
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+.+.||+|+||.||+|.+..++..||||++...... ..+.+|+.+++.+.|++++..+..+..+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---------PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---------CHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---------hHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 568999999999999999999999999999999987654321 24678999999999999888877776678
Q ss_pred ceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC---CCCcEEEEecCC
Q 005678 481 NTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD---EFGVAKVTDFGL 556 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd---~~g~vKL~DFGl 556 (683)
+.+++||||+ +++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 8899999999 999999996 4457999999999999999999999965 99999999999994 789999999999
Q ss_pred ccccccCcCCCc--ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQG--MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 557 s~~~~~~~~~~~--~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
+........... ........||+.|+|||++.... ++.++|||||||++|+|++|+.||..............+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE---QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC---CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCC---CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence 987765432211 11234457999999999987444 8999999999999999999999997533211000000000
Q ss_pred HhhccCCC---CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFP---SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p---~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
......+ ..+.+|+++.+||.+||..||.+|||+.++++
T Consensus 232 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 232 -EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -ccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1111111 12468899999999999999999999998875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.56 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=202.4
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+.+.||+|+||.||+|.+..++..||||++...... ..+.+|+.++..+.|++++..+..+..+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---------PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---------CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---------hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 567899999999999999999999999999999986543221 24677999999999999888887776678
Q ss_pred ceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe---CCCCcEEEEecCC
Q 005678 481 NTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGL 556 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL---d~~g~vKL~DFGl 556 (683)
+.+++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 8999999999 9999999973 457999999999999999999999966 9999999999999 7889999999999
Q ss_pred ccccccCcCCCcc--cccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGM--ELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 557 s~~~~~~~~~~~~--~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
+............ .......||+.|+|||++.... ++.++|||||||++|+|++|..||..............+
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~- 230 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE---QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI- 230 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC---CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH-
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCC---CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh-
Confidence 9877654322111 1233458999999999987444 899999999999999999999999754322110000010
Q ss_pred HhhccCCC---CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFP---SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p---~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.......+ ....+++++.+||.+||..+|.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11111111 12457899999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=374.23 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=206.7
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
.|.+..++|.+.+.||+|+||.||+|.+ .+..||||++.... ....+.+|+.+++.++|||||++++++
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~ 255 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---------TAQAFLAEASVMTQLRHSNLVQLLGVI 255 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT---------TSHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch---------HHHHHHHHHHHHHhccCCCEEEEEEEE
Confidence 4667788999999999999999999965 58899999986532 134688999999999999999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
....+.+|+|||||++|+|.+++...+ .+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+||
T Consensus 256 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~Df 333 (450)
T 1k9a_A 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDF 333 (450)
T ss_dssp ECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCC
T ss_pred EcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeC
Confidence 655668999999999999999996543 3799999999999999999999965 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i 633 (683)
|+++..... .....+++.|+|||++.... ++.++|||||||++|+|++ |..||......+... .+
T Consensus 334 G~a~~~~~~--------~~~~~~~~~y~aPE~~~~~~---~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i 399 (450)
T 1k9a_A 334 GLTKEASST--------QDTGKLPVKWTAPEALREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RV 399 (450)
T ss_dssp TTCEECC--------------CCCTTTSCHHHHHSSC---CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH---HH
T ss_pred CCccccccc--------ccCCCCCcceeCHHHhcCCC---CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH
Confidence 999854322 12236788999999987544 8999999999999999998 999998765543221 11
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
. .....+.+..+++.+.+||.+||..||.+|||+.+++.
T Consensus 400 ~--~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 400 E--KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp H--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H--cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2 22334455679999999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=345.72 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=209.8
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
.+|.+..++|.+++.||+|+||.||+|.+ .++..||||++...... ...+.+|+.+++.++||||++++++
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS--------PDAFLAEANLMKQLQHQRLVRLYAV 76 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC--------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCccc--------HHHHHHHHHHHHhCCCcCcceEEEE
Confidence 46788899999999999999999999986 46788999998654321 2467889999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
+. .+.+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 77 ~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 77 VT--QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EC--SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECC
T ss_pred Ec--CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECC
Confidence 85 456889999999999999996542 6899999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDT 632 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~ 632 (683)
||++........ .......||+.|+|||++.... ++.++|||||||++|+|++ |..||......+.+. .
T Consensus 153 fg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---~ 222 (279)
T 1qpc_A 153 FGLARLIEDNEY----TAREGAKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ---N 222 (279)
T ss_dssp CTTCEECSSSCE----ECCTTCCCCTTTSCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---H
T ss_pred CcccccccCccc----ccccCCCCccCccChhhhccCC---CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH---H
Confidence 999987654321 1223346788999999986444 7899999999999999999 999998766544321 1
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+. .......+..++..+.+||.+||..+|.+|||+.++++
T Consensus 223 ~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 223 LE--RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hh--cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 12233344578999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=348.05 Aligned_cols=255 Identities=20% Similarity=0.290 Sum_probs=203.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCe---EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHR---YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~---~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
..|.+.+.||+|+||+||+|.+..++. .||+|++..... ......+.+|+.+++.++||||++++++|...
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE------MQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS------HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 367778999999999999998755544 799998854221 22356788999999999999999999999755
Q ss_pred CceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
....++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 6666899999999999999975 456899999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCC-CCCCCchHHHHHHHHHHHHhh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRR-PFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~-PF~~~~~~e~il~~~~i~~~~ 637 (683)
........ .........||+.|+|||.+.... ++.++|||||||++|+|++|.. ||......+.. . .+. .
T Consensus 173 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~-~--~~~--~ 243 (298)
T 3pls_A 173 DILDREYY-SVQQHRHARLPVKWTALESLQTYR---FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT-H--FLA--Q 243 (298)
T ss_dssp TTTTGGGG-CSCCSSCTTCGGGGSCHHHHTTCC---CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH-H--HHH--T
T ss_pred cccCCccc-ccccCcCCCCCccccChhhhccCC---CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH-H--Hhh--c
Confidence 66443211 112233457899999999986443 8999999999999999999554 45444433211 1 111 2
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....+....+++.+.+||.+||..||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 244 GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2234445678999999999999999999999998875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=355.39 Aligned_cols=257 Identities=26% Similarity=0.352 Sum_probs=200.4
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
.-++|.+.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||++++++|. +.
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS----DPVFRTRMQREARTAGRLQEPHVVPIHDFGE-ID 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ET
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc----CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-eC
Confidence 346899999999999999999999999999999998654221 2234567889999999999999999999986 57
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
+.+|+||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 789999999999999999987778999999999999999999999965 999999999999999999999999999876
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... .......||+.|+|||++.... ++.++||||||+++|+|++|..||....... + . ..+.......
T Consensus 185 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~-~-~~~~~~~~~~ 254 (309)
T 2h34_A 185 TDEKL----TQLGNTVGTLYYMAPERFSESH---ATYRADIYALTCVLYECLTGSPPYQGDQLSV-M-G-AHINQAIPRP 254 (309)
T ss_dssp ----------------CCGGGCCGGGTCC-------CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-H-H-HHHHSCCCCG
T ss_pred ccccc----ccccccCCCcCccCHHHHcCCC---CCchHhHHHHHHHHHHHHHCCCCCCCchHHH-H-H-HHhccCCCCc
Confidence 54321 1123347999999999986443 7889999999999999999999998765431 1 1 1111111111
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERP-DVLTLAQ 674 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRP-S~~eLl~ 674 (683)
....+.++..+.+||.+||..||.+|| ++.+++.
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 122357899999999999999999999 7887764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.68 Aligned_cols=260 Identities=23% Similarity=0.345 Sum_probs=208.2
Q ss_pred CCCcccccc-ccceeEEEEecccCceEEEEEEEccCCeEE--EEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCc
Q 005678 393 SRFNNFQIL-NHRYALLNLLGKGGFSEVYKAYDLVEHRYV--ACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHH 468 (683)
Q Consensus 393 ~~f~~~~i~-~~ry~l~~~LGkGgfG~Vyka~d~~~g~~V--AVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~Hpn 468 (683)
.....|+.+ .++|.+.+.||+|+||.||+|.+..++..+ |||.+..... ......+.+|+.++..+ +|||
T Consensus 14 ~~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~E~~~l~~l~~hp~ 87 (327)
T 1fvr_A 14 PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------KDDHRDFAGELEVLCKLGHHPN 87 (327)
T ss_dssp --CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------CHHHHHHHHHTTCCCCTT
T ss_pred CCCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc------hHHHHHHHHHHHHHHhccCCCc
Confidence 334555654 479999999999999999999999898865 8998754211 12245688999999999 8999
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhcCC----------------CcchHHHHHHHHHHHHHHHHHHhcCCceE
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP----------------VLPEREARIIIVQIFQGLIYLNKRAQKII 532 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~----------------~Lse~~~~~I~~qIa~aL~yLH~~g~~II 532 (683)
|++++++|. +.+.+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+
T Consensus 88 iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iv 164 (327)
T 1fvr_A 88 IINLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FI 164 (327)
T ss_dssp BCCEEEEEE-ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred hhhhceeee-eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 999999986 6778999999999999999997653 6999999999999999999999965 99
Q ss_pred ecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
||||||+|||++.++.+||+|||++...... .......+++.|+|||++.... ++.++|||||||++|+|+
T Consensus 165 H~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~ell 235 (327)
T 1fvr_A 165 HRDLAARNILVGENYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIV 235 (327)
T ss_dssp CSCCSGGGEEECGGGCEEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCE---ECHHHHHHHHHHHHHHHH
T ss_pred CCCCccceEEEcCCCeEEEcccCcCcccccc------ccccCCCCCccccChhhhcccc---CCchhcchHHHHHHHHHH
Confidence 9999999999999999999999998743321 1122346788999999986543 789999999999999999
Q ss_pred c-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 613 F-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 613 t-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+ |..||......+... .+ ......+.+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 236 t~g~~pf~~~~~~~~~~---~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 236 SLGGTPYCGMTCAELYE---KL--PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TTSCCTTTTCCHHHHHH---HG--GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCcHHHHHH---Hh--hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8 999998766543221 11 1222334446789999999999999999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=349.15 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=206.6
Q ss_pred cccccccceeEEEEecccCceEEEEEEEcc---CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLV---EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~---~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
.+.+..++|.+.+.||+|+||.||+|.+.. ++..||||++..... ......+.+|+.+++.++||||++++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT------LDNKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC------HHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC------chHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456778899999999999999999998654 345799999865421 12246788999999999999999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
+++. .+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 80 ~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 80 GIIE--EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp EEEC--SSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEEC
T ss_pred EEEc--CCCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeC
Confidence 9985 34568999999999999999653 46999999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRED 631 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~ 631 (683)
|||++........ .......||+.|+|||++.... ++.++|||||||++|+|++ |+.||..........
T Consensus 156 Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~--- 225 (281)
T 3cc6_A 156 DFGLSRYIEDEDY----YKASVTRLPIKWMSPESINFRR---FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG--- 225 (281)
T ss_dssp CCCGGGCC-------------CCCCCGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH---
T ss_pred ccCCCcccccccc----cccccCCCCcceeCchhhccCC---CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH---
Confidence 9999987654321 1123346788999999986444 8999999999999999998 999997655443221
Q ss_pred HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 632 ~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.+... ...+.+..+++.+.+||.+||..||.+||++.+++++
T Consensus 226 ~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 226 VLEKG--DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcC--CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 11122 2334456789999999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=378.70 Aligned_cols=257 Identities=22% Similarity=0.371 Sum_probs=215.6
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
+..|.+....|.+.+.||+|+||.||+|.+..++..||||++..... ....+.+|+.+++.++|||||++++
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~ 283 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------EVEEFLKEAAVMKEIKHPNLVQLLG 283 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--------chHHHHHHHHHHHhcCCCCEeeEEE
Confidence 56678888999999999999999999999998999999999865422 1356889999999999999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
+|. +...+|+|||||++|+|.+++... ..+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+
T Consensus 284 ~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~ 360 (495)
T 1opk_A 284 VCT-REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVA 360 (495)
T ss_dssp EEC-SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEEC
T ss_pred EEe-cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEe
Confidence 986 667889999999999999999753 45899999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRED 631 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~ 631 (683)
|||+++...... ........+++.|+|||++.... ++.++|||||||+||+|++ |..||......+...
T Consensus 361 DFG~a~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~--- 430 (495)
T 1opk_A 361 DFGLSRLMTGDT----YTAHAGAKFPIKWTAPESLAYNK---FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--- 430 (495)
T ss_dssp CTTCEECCTTCC----EECCTTCCCCGGGCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---
T ss_pred ecccceeccCCc----eeecCCCcCCcceeCHhHHhcCC---CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence 999998764321 11222335778999999987544 8999999999999999998 999998765543221
Q ss_pred HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 632 ~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.+ ......+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 431 ~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 431 LL--EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HH--HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH--HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 11 123344445679999999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=356.56 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=210.1
Q ss_pred cccceeEEEEecccCceEEEEEE----EccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~----d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
..++|.+++.||+|+||.||+|. +..++..||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-------PDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-------HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-------HHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 45799999999999999999998 56789999999986432 12245688999999999999999999987
Q ss_pred cc-CCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 477 EI-DQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 477 ~~-d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
.. +...+|+||||+++++|.+++.. ...+++..+..|+.||+.||.|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccc
Confidence 53 46678999999999999999965 346999999999999999999999965 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHH------
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL------ 628 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il------ 628 (683)
|++........ .........||+.|+|||++.... ++.++|||||||++|+|++|..||..........
T Consensus 172 g~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 246 (327)
T 3lxl_A 172 GLAKLLPLDKD--YYVVREPGQSPIFWYAPESLSDNI---FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246 (327)
T ss_dssp GGCEECCTTCS--EEECSSCCCSCGGGSCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----
T ss_pred ccceecccCCc--cceeeccCCccccccCHHHhccCC---CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccc
Confidence 99987754321 112234457899999999986544 7899999999999999999999996543321100
Q ss_pred ----HHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 629 ----REDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 629 ----~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.............+.++.+++.+.+||.+||..||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 247 VPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000111223344556899999999999999999999999999653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=362.44 Aligned_cols=255 Identities=15% Similarity=0.201 Sum_probs=202.0
Q ss_pred ccceeEEEEecccCceEEEEEEEcc--------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceee--
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLV--------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVR-- 471 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~--------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~-- 471 (683)
.++|.+.+.||+|+||.||+|.+.. .+..||||++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------------~~~~~E~~~l~~l~h~niv~~~ 108 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------------GRLFNEQNFFQRAAKPLQVNKW 108 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------------STHHHHHHHHHHHCCHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------------chHHHHHHHHHHhcccchhhhh
Confidence 5799999999999999999999887 4889999997543 24678999999999999998
Q ss_pred -------------eccccccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEeccc
Q 005678 472 -------------LWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDL 536 (683)
Q Consensus 472 -------------L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDL 536 (683)
+++++..+...+|+||||+ +++|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||
T Consensus 109 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Di 185 (352)
T 2jii_A 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNV 185 (352)
T ss_dssp HHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCC
T ss_pred hhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCC
Confidence 4445544478899999999 99999999765 67999999999999999999999965 999999
Q ss_pred CCcceEeCCCC--cEEEEecCCccccccCcCCCc--ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 537 KPGNVLFDEFG--VAKVTDFGLSKIVEDDVGSQG--MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 537 KP~NILLd~~g--~vKL~DFGls~~~~~~~~~~~--~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
||+|||++.++ .+||+|||+++.+........ ........||+.|+|||++.... ++.++|||||||++|+|+
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG---PSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC---CCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC---CCchhhHHHHHHHHHHHH
Confidence 99999999988 999999999987654322111 11223448999999999986543 899999999999999999
Q ss_pred cCCCCCCCCc-hHHHHHHHHHHHHhhccCCC----CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 613 FGRRPFGHDQ-TQERILREDTIIKARKVEFP----SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 613 tG~~PF~~~~-~~e~il~~~~i~~~~~~~~p----~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+|..||.... ....+.............++ .+..++..+.+||.+||..||.+||++.++++
T Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 263 YGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 9999997654 33333322221122212111 12357999999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.71 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=205.6
Q ss_pred cccccceeEEEEecccCceEEEEEE-----EccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAY-----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~-----d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
.+..++|.+++.||+|+||.||+|. +..++..||||++..... ......+.+|+.+++.++||||++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS------EQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc------hhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 4677899999999999999999998 556788999999853321 12245688999999999999999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcC-------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKAT-------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE- 545 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~- 545 (683)
+++. +...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 100 GVSL-QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCP 176 (327)
T ss_dssp EEEC-SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCS
T ss_pred EEEc-CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecC
Confidence 9986 667789999999999999999755 34899999999999999999999965 999999999999984
Q ss_pred --CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCc
Q 005678 546 --FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQ 622 (683)
Q Consensus 546 --~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~ 622 (683)
++.+||+|||++......... .......||+.|+|||++.... ++.++|||||||++|+|++ |..||....
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYY---RKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp STTCCEEECCCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCcceEEECcccccccccccccc---ccCCCcCCCcceeCHhHhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 446999999999865433211 1122346899999999986544 8999999999999999998 999998766
Q ss_pred hHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 623 TQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 623 ~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
...... .+... ...+....++..+.+||.+||..||.+||++.++++++|+
T Consensus 251 ~~~~~~---~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 251 NQEVLE---FVTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHHHH---HHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHH---HHhcC--CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 543221 11122 1223345789999999999999999999999999998775
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=347.71 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=200.2
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
..|.+..++|.+.+.||+|+||.||+|.+ ++..||||++.... ....+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---------TAQAFLAEASVMTQLRHSNLVQLLGV 82 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----------HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 45677789999999999999999999965 58999999985432 13568899999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
+....+.+++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECC
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEee
Confidence 7655668899999999999999996543 3789999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDT 632 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~ 632 (683)
||++...... .....+++.|+|||++.... ++.++||||||+++|+|++ |..||......+... .
T Consensus 161 fg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~---~ 226 (278)
T 1byg_A 161 FGLTKEASST--------QDTGKLPVKWTAPEALREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---R 226 (278)
T ss_dssp CCC--------------------CCTTTSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH---H
T ss_pred cccccccccc--------ccCCCccccccCHHHhCCCC---CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H
Confidence 9999765432 12236789999999986543 8999999999999999998 999998765433221 1
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+. .....+.+..+++.+.+||.+||..||.+||++.++++
T Consensus 227 ~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 227 VE--KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HT--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hh--cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 11 12233444678999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=349.33 Aligned_cols=248 Identities=21% Similarity=0.364 Sum_probs=205.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc-
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI- 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~- 478 (683)
.+..+|.+++.||+|+||.||+|.+..++..||||++.... ..+.+|+.+++.++||||++++++|..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----------EKAEREVKALAKLDHVNIVHYNGCWDGF 76 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----------GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence 35678999999999999999999999899999999986542 135679999999999999999998752
Q ss_pred --------------CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceE
Q 005678 479 --------------DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVL 542 (683)
Q Consensus 479 --------------d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NIL 542 (683)
....+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil 154 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIF 154 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEE
Confidence 245689999999999999999543 57999999999999999999999965 999999999999
Q ss_pred eCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCc
Q 005678 543 FDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQ 622 (683)
Q Consensus 543 Ld~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~ 622 (683)
++.++.+||+|||++........ .....||+.|+|||++.... ++.++|||||||++|+|++|..||....
T Consensus 155 ~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~~~~~~~~~~ 225 (284)
T 2a19_B 155 LVDTKQVKIGDFGLVTSLKNDGK------RTRSKGTLRYMSPEQISSQD---YGKEVDLYALGLILAELLHVCDTAFETS 225 (284)
T ss_dssp EEETTEEEECCCTTCEESSCCSC------CCCCCSCCTTSCHHHHHCSC---CCTHHHHHHHHHHHHHHHSCCSSHHHHH
T ss_pred EcCCCCEEECcchhheecccccc------ccccCCcccccChhhhccCC---CcchhhhHHHHHHHHHHHhcCCcchhHH
Confidence 99999999999999987654321 22347999999999986443 7999999999999999999999874211
Q ss_pred hHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 623 TQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 623 ~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.... ...... ....++..+.+||.+||..||.+||++.+++++++.-
T Consensus 226 ---~~~~-----~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 226 ---KFFT-----DLRDGI--ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ---HHHH-----HHHTTC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHH-----Hhhccc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 111111 2246889999999999999999999999999997653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=373.06 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=211.6
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
..|.+..++|.+.+.||+|+||+||+|.+. ++..||||++..... ....+.+|+.+++.++|||||+++++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--------SVEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB--------CHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc--------cHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 457788899999999999999999999864 578899999865432 13578899999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
+. ...+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|
T Consensus 252 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D 327 (454)
T 1qcf_A 252 VT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIAD 327 (454)
T ss_dssp EC--SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECS
T ss_pred Ee--CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEee
Confidence 85 56789999999999999999643 35889999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDT 632 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~ 632 (683)
||+++....... .......+|+.|+|||++.... ++.++|||||||+||+|++ |..||......+.+..
T Consensus 328 FG~a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~--- 397 (454)
T 1qcf_A 328 FGLARVIEDNEY----TAREGAKFPIKWTAPEAINFGS---FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA--- 397 (454)
T ss_dssp TTGGGGBCCHHH----HTTCSSSSCGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---
T ss_pred CCCceEcCCCce----eccCCCcccccccCHHHhccCC---CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 999987643211 1122335788899999987544 8999999999999999999 9999987665543321
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+. .....+.+..+++++.+||.+||..||.+|||+.+++.
T Consensus 398 i~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 398 LE--RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HH--HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH--cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 11 23445556689999999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=359.93 Aligned_cols=265 Identities=25% Similarity=0.339 Sum_probs=208.5
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
+.++....++|.+.+.||+|+||.||+|.+ .++..||||++..... .....+.+|+.+++.++||||+++++
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~ 102 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS-------QGIEEFETEIETLSFCRHPHLVSLIG 102 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS-------SHHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh-------HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 445566788999999999999999999985 5789999998755321 12456889999999999999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhcCC----CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKATP----VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~----~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
+|. +.+.+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 103 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~k 179 (321)
T 2qkw_B 103 FCD-ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPK 179 (321)
T ss_dssp ECC-CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEE
T ss_pred EEc-CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEE
Confidence 986 6778899999999999999996542 5899999999999999999999965 99999999999999999999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHH--H
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERI--L 628 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~i--l 628 (683)
|+|||++......... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||......+.. .
T Consensus 180 l~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~ 253 (321)
T 2qkw_B 180 ITDFGISKKGTELDQT---HLSTVVKGTLGYIDPEYFIKGR---LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253 (321)
T ss_dssp ECCCTTCEECSSSSCC---CCBCCCEEETTTCCHHHHHHCB---CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred Eeeccccccccccccc---ccccccCCCccccCHHHhcCCC---CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence 9999999865432111 1223346899999999987544 899999999999999999999999654332110 0
Q ss_pred HH-HHHHHhhcc--------CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 629 RE-DTIIKARKV--------EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 629 ~~-~~i~~~~~~--------~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
.. ........+ .....+.++..+.+||.+||..||.+|||+.+++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00 000011111 0111234567899999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=356.83 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=200.3
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEE----EEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYV----ACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~V----AVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
+..++|.+++.||+|+||.||+|.+..++..| |+|.+...... .....+.+|+.+++.++||||++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP------KANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC------CCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH------HHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence 34688999999999999999999998887755 66665432211 123568899999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
|.. ...++|++|+.+++|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~--~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 86 CLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EES--SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCT
T ss_pred Eec--CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccC
Confidence 863 347899999999999999965 457999999999999999999999965 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i 633 (683)
|+++........ .......||+.|+|||++.... ++.++|||||||++|+|++ |..||.......... .
T Consensus 162 G~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~- 231 (327)
T 3lzb_A 162 GLAKLLGAEEKE---YHAEGGKVPIKWMALESILHRI---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---I- 231 (327)
T ss_dssp TC-------------------CCCGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---H-
T ss_pred cceeEccCcccc---ccccCCCccccccCHHHHcCCC---CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---H-
Confidence 999876543221 1223346788999999987544 8999999999999999999 999998765543221 1
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.......+.++.++.++.+||.+||..||.+||++.++++
T Consensus 232 -~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 232 -LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1122344555679999999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.29 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=196.0
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
...+|.+.+.||+|+||.||+|.+..++..||||++....... ......+.+|+.+++.++||||++++++|. +.
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD----AKARADCIKEIDLLKQLNHPNVIKYYASFI-ED 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ET
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-cC
Confidence 3458999999999999999999999999999999986533222 223467889999999999999999999986 67
Q ss_pred ceEEEEEecccCCChhHHHhc----CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 481 NTFCTVLEYCSGKDLDAVLKA----TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~----~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
+.+++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.+|.+||+|||+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 789999999999999999853 456899999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+........ ......||+.|+|||++.... ++.++|||||||++|+|++|..||.........+.. . ...
T Consensus 183 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~-~~~ 252 (310)
T 2wqm_A 183 GRFFSSKTT-----AAHSLVGTPYYMSPERIHENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-K-IEQ 252 (310)
T ss_dssp ---------------------CCSSCCHHHHTTCC---CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH-H-HHT
T ss_pred eeeecCCCc-----cccccCCCeeEeChHHhCCCC---CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH-H-hhc
Confidence 987653321 122347999999999986443 899999999999999999999999654322111111 1 111
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
..........++.++.+||.+||..||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 111111235689999999999999999999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=355.44 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=203.6
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCC----eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g----~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
++...+|.+.+.||+|+||.||+|.+..++ ..||||++..... ......+.+|+.++..++||||+++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT------EKQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC------HHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 567789999999999999999999876543 4699999864321 122456889999999999999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
++. +.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 114 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 114 VIS-KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp EEC-SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECC
T ss_pred EEe-cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECC
Confidence 986 677899999999999999999654 67999999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDT 632 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~ 632 (683)
||++......... ........||+.|+|||++.... ++.++|||||||++|+|++ |..||......+... .
T Consensus 191 fg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~---~ 262 (333)
T 1mqb_A 191 FGLSRVLEDDPEA--TYTTSGGKIPIRWTAPEAISYRK---FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---A 262 (333)
T ss_dssp CCC-------------------CCCGGGSCHHHHHSCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---H
T ss_pred CCcchhhcccccc--ccccCCCCccccccCchhcccCC---CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH---H
Confidence 9999876543211 11223346788999999986443 8999999999999999998 999997766543221 1
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+. .....+....++..+.+||.+||..+|.+||++.+++++
T Consensus 263 ~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 263 IN--DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HH--TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HH--CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 223445556799999999999999999999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=359.80 Aligned_cols=269 Identities=24% Similarity=0.344 Sum_probs=207.2
Q ss_pred CCCccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeee
Q 005678 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 393 ~~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
..+..+.+..++|.+.+.||+|+||.||+|.+ .++..||||++........ ...+.+|+.+++.++||||+++
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG------ELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C------CCHHHHHHHGGGTCCCTTBCCC
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH------HHHHHHHHHHHHhccCCCccce
Confidence 34556678899999999999999999999974 5689999999865432111 1257889999999999999999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcC----CCcchHHHHHHHHHHHHHHHHHHhc-CCceEecccCCcceEeCCCC
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----PVLPEREARIIIVQIFQGLIYLNKR-AQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----~~Lse~~~~~I~~qIa~aL~yLH~~-g~~IIHrDLKP~NILLd~~g 547 (683)
+++|. +.+..++||||+++++|.+++... ..+++..+..|+.||+.||.|||+. .++|+||||||+|||++.++
T Consensus 93 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 93 RGFCM-TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CEEEC-CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred EEEEe-cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 99986 667788999999999999999654 3499999999999999999999996 11499999999999999999
Q ss_pred cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH-
Q 005678 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER- 626 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~- 626 (683)
.+||+|||++........ .......||+.|+|||++.... ++.++|||||||++|+|++|..||........
T Consensus 172 ~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDT----HVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244 (326)
T ss_dssp CEEECCCSSCEECCSSSS----CEECCCCSCGGGCCHHHHHHSE---ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred CEEeccCccccccCcccc----cccccccCCcCccCHHHhccCC---CCccccchhHHHHHHHHHhCCCccccccccccc
Confidence 999999999987654322 2233446999999999986544 79999999999999999999999952110000
Q ss_pred -HHHHHHHHH---hhc--------cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 005678 627 -ILREDTIIK---ARK--------VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDP 676 (683)
Q Consensus 627 -il~~~~i~~---~~~--------~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP 676 (683)
......+.. ... ......+..+..+.+||.+||..||.+|||+.++++|.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp CSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred chhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 000000000 000 00011123457899999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=346.60 Aligned_cols=257 Identities=20% Similarity=0.291 Sum_probs=202.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccC---CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVE---HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~---g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
...+|.+.+.||+|+||.||+|.+..+ ...||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------IGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS------HHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC------HHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 345799999999999999999986543 34689998754321 223567889999999999999999999866
Q ss_pred cCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
.+.+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccc
Confidence 567788999999999999999965 456899999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~ 635 (683)
+......... .........||+.|+|||++.... ++.++|||||||++|+|++ |.+||......+... .+..
T Consensus 175 a~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~---~~~~ 247 (298)
T 3f66_A 175 ARDMYDKEYY-SVHNKTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQ 247 (298)
T ss_dssp GCCCSCGGGC-BC-----CCBCGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH---HHHT
T ss_pred cccccccchh-ccccccCCCCCccccChHHhcCCC---CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HHhc
Confidence 9876543211 112233446889999999986544 8999999999999999999 666776554433221 1111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
. .....+..++..+.+||.+||..+|.+|||+.++++
T Consensus 248 ~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 248 G--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp T--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C--CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 222334568999999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=354.14 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=207.7
Q ss_pred cccccce-eEEEEecccCceEEEEEE----EccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 399 QILNHRY-ALLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 399 ~i~~~ry-~l~~~LGkGgfG~Vyka~----d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
.++.++| .+++.||+|+||+||+|. +..++..||||++..... ......+.+|+.+++.++||||++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG------PQHRSGWKQEIDILRTLYHEHIIKYK 99 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC------hHHHHHHHHHHHHHHhCCCcchhhEE
Confidence 4566677 999999999999998874 345789999999865421 12345788999999999999999999
Q ss_pred cccccC-CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 474 DTFEID-QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 474 ~~f~~d-~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
++|... ...+++||||+++++|.+++...+ +++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEEC
Confidence 998744 467899999999999999998765 999999999999999999999966 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH------
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER------ 626 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~------ 626 (683)
|||++........ .........||+.|+|||++.... ++.++|||||||++|+|++|..||........
T Consensus 177 Dfg~a~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 251 (318)
T 3lxp_A 177 DFGLAKAVPEGHE--YYRVREDGDSPVFWYAPECLKEYK---FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251 (318)
T ss_dssp CGGGCEECCTTCS--EEEC---CCCCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred Ccccccccccccc--ccccccCCCCCceeeChHHhcCCC---CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccc
Confidence 9999987754321 112234457899999999987544 78999999999999999999999965432211
Q ss_pred -----HHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 627 -----ILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 627 -----il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...... ........+.+..++.++.+||.+||..||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 252 QGQMTVLRLTE-LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CHHHHHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHHH-HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001111 11122334455679999999999999999999999999984
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=371.25 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=204.5
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.+++++|.+.+.||+|+||+||+|.+..++..||||++...... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL------RPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc------chHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 46788999999999999999999999999999999998543211 123567789999999999999999998864
Q ss_pred C-CceEEEEEecccCCChhHHHhcCC---CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe----CCCCcEE
Q 005678 479 D-QNTFCTVLEYCSGKDLDAVLKATP---VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF----DEFGVAK 550 (683)
Q Consensus 479 d-~~~~~LV~Ey~~ggsL~~~L~~~~---~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL----d~~g~vK 550 (683)
. ...+|+|||||++++|.+++.... .+++..++.++.||+.||.|||+.+ ||||||||+|||+ +.++.+|
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 156 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYK 156 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEE
Confidence 3 337899999999999999996543 3999999999999999999999965 9999999999999 7778899
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCch--
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK-----TPLISSKVDVWSAGILFYQMLFGRRPFGHDQT-- 623 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~-----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-- 623 (683)
|+|||+++...... ......||+.|+|||++.... ...++.++|||||||++|+|++|..||.....
T Consensus 157 L~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~ 230 (396)
T 4eut_A 157 LTDFGAARELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (396)
T ss_dssp ECCGGGCEECCCGG------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred EecCCCceEccCCC------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence 99999998765432 122347999999999986421 02367899999999999999999999964221
Q ss_pred -HHHHHHHHHHHHhhcc------------------CCCCC----cCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 624 -QERILREDTIIKARKV------------------EFPSR----PAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 624 -~e~il~~~~i~~~~~~------------------~~p~~----~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
...++. .+...... .++.. ..++..+.+||.+||..||.+||++.+++++
T Consensus 231 ~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 231 RNKEVMY--KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TCHHHHH--HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred chHHHHH--HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 111111 11111110 11111 2345678899999999999999999998653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.14 Aligned_cols=264 Identities=21% Similarity=0.301 Sum_probs=194.4
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc--CCCceeeeccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL--VHHHIVRLWDT 475 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L--~HpnIV~L~~~ 475 (683)
...+.++|.+.+.||+|+||.||+|.+ ++..||||++.... ...+.+|..++..+ +||||++++++
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----------~~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE----------EASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG----------HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc----------cchhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 345778999999999999999999975 48999999874321 12334455555554 89999999999
Q ss_pred cccCC---ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc------CCceEecccCCcceEeCCC
Q 005678 476 FEIDQ---NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR------AQKIIHYDLKPGNVLFDEF 546 (683)
Q Consensus 476 f~~d~---~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~------g~~IIHrDLKP~NILLd~~ 546 (683)
+.... ..+++||||+++++|.+++... .+++..+..++.|++.||.|||+. .++||||||||+|||++.+
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 86432 6899999999999999999766 599999999999999999999986 1259999999999999999
Q ss_pred CcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCC---CCchhHHHHHHHHHHHHHcC---------
Q 005678 547 GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPL---ISSKVDVWSAGILFYQMLFG--------- 614 (683)
Q Consensus 547 g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~---~s~ksDVWSLGvILyELLtG--------- 614 (683)
+.+||+|||++..+........ .......||+.|+|||++....... ++.++|||||||++|+|++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVD-IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp SCEEECCCTTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCEEEEeCCCceeecccccccc-CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999977654322111 1122447999999999986544211 11249999999999999999
Q ss_pred -CCCCCCCchHHHHHH-HHHHHHhhc--cCCCC---CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 615 -RRPFGHDQTQERILR-EDTIIKARK--VEFPS---RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 615 -~~PF~~~~~~e~il~-~~~i~~~~~--~~~p~---~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
..||........... ......... ..++. ...+++.+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 777754321111000 111111111 12221 12567789999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.87 Aligned_cols=250 Identities=18% Similarity=0.181 Sum_probs=197.0
Q ss_pred ccccccccceeEEEEecccCceEEEEE-----EEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC---CC
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKA-----YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV---HH 467 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka-----~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~---Hp 467 (683)
..+.+..++|.+.+.||+|+||+||+| .+..+++.||||++.... ...+.+|+.++..+. |+
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~e~~~~~~l~~~~~~ 127 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----------PWEFYIGTQLMERLKPSMQH 127 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----------HHHHHHHHHHHHHSCGGGGG
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----------hhHHHHHHHHHHHhhhhhhh
Confidence 456677899999999999999999999 467889999999985432 224566777777776 99
Q ss_pred ceeeeccccccCCceEEEEEecccCCChhHHHh-----cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceE
Q 005678 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK-----ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVL 542 (683)
Q Consensus 468 nIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~-----~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NIL 542 (683)
||+.+++++. ..+..|+|||||+||+|.+++. ....+++..+..|+.||+.||.|||+.+ ||||||||+|||
T Consensus 128 ~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIl 204 (365)
T 3e7e_A 128 MFMKFYSAHL-FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFI 204 (365)
T ss_dssp GBCCEEEEEE-CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEE
T ss_pred hhhhhheeee-cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEE
Confidence 9999999986 6678899999999999999996 3467999999999999999999999965 999999999999
Q ss_pred eCC-----------CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHH
Q 005678 543 FDE-----------FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM 611 (683)
Q Consensus 543 Ld~-----------~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyEL 611 (683)
|+. ++.+||+|||+|+.+...... ......+||++|+|||++.... ++.++|||||||++|+|
T Consensus 205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el 278 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG---TIFTAKCETSGFQCVEMLSNKP---WNYQIDYFGVAATVYCM 278 (365)
T ss_dssp ECGGGTCC------CTTEEECCCTTCEEGGGSCTT---EEECCSSCTTSCCCHHHHTTCC---BSTHHHHHHHHHHHHHH
T ss_pred ecccccCccccccccCCEEEeeCchhhhhhccCCC---ceeeeecCCCCCCChHHhcCCC---CCccccHHHHHHHHHHH
Confidence 988 899999999999765432111 2234458999999999986544 89999999999999999
Q ss_pred HcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 612 LFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 612 LtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
++|+.||....... ......++. ...++.+.+|+..||..+|.+|++..+.+.
T Consensus 279 ltg~~pf~~~~~~~---------~~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 279 LFGTYMKVKNEGGE---------CKPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp HHSSCCCEEEETTE---------EEECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred HhCCCccccCCCCc---------eeechhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 99999995433210 000111111 235678999999999999999976544443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=371.08 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=195.3
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~ 478 (683)
.+.+.|.+.+.||+|+||+||.+ ...+|+.||||++.... ...+.+|+.++..+ +|||||++++++.
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----------~~~~~~E~~~l~~l~~HpnIv~~~~~~~- 79 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----------CDIALMEIKLLTESDDHPNVIRYYCSET- 79 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----------HHHHHHHHHHHHHHTTSTTBCCEEEEEE-
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----------HHHHHHHHHHHHhccCCCCcCeEEEEEe-
Confidence 35677888899999999999876 35789999999874321 23567899999886 8999999999886
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCc-------chHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC-----
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVL-------PEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF----- 546 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~L-------se~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~----- 546 (683)
+.+.+|+|||||. ++|.+++...... ++..+..|+.||+.||.|||+.+ ||||||||+|||++.+
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~ 156 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTA 156 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHS
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccc
Confidence 6788999999995 6999999765432 33356779999999999999965 9999999999999754
Q ss_pred --------CcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccC----CCCCCchhHHHHHHHHHHHHHc-
Q 005678 547 --------GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK----TPLISSKVDVWSAGILFYQMLF- 613 (683)
Q Consensus 547 --------g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~----~~~~s~ksDVWSLGvILyELLt- 613 (683)
+.+||+|||+++.+........ .......||+.|+|||++.... ...++.++|||||||++|+|++
T Consensus 157 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~ 235 (434)
T 2rio_A 157 DQQTGAENLRILISDFGLCKKLDSGQSSFR-TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235 (434)
T ss_dssp CCTTCCCSCEEEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccCCCceEEEEcccccceecCCCCccce-eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence 4899999999988754321111 1123457999999999986521 2458999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHHHhhccCCCC-----CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 614 GRRPFGHDQTQERILREDTIIKARKVEFPS-----RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 614 G~~PF~~~~~~e~il~~~~i~~~~~~~~p~-----~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
|..||......... +. .....++. ...++.++.+||.+||..||.+||++.++++||||..
T Consensus 236 g~~Pf~~~~~~~~~-----i~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 236 GKHPFGDKYSRESN-----II-RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp SCCTTCSTTTHHHH-----HH-HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCCCCchhhHHH-----Hh-cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 99999765443311 11 11222221 2345688999999999999999999999999999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=345.24 Aligned_cols=260 Identities=21% Similarity=0.306 Sum_probs=200.8
Q ss_pred cccccceeEEEEecccCceEEEEEEEcc-CC--eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLV-EH--RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~-~g--~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
.+..++|.+.+.||+|+||+||+|.+.. ++ ..||||++...... .......+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS----QPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 4567899999999999999999997543 33 36999987543221 12345678899999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
+.. ..+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 90 ~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 90 VLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp ECS--SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred Ecc--CCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccc
Confidence 863 3488999999999999999653 56899999999999999999999965 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i 633 (683)
|++......... ........||+.|+|||++.... ++.++||||||+++|+|++ |..||........+..
T Consensus 166 g~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---- 236 (291)
T 1u46_A 166 GLMRALPQNDDH--YVMQEHRKVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK---- 236 (291)
T ss_dssp TTCEECCC-CCE--EEC-----CCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----
T ss_pred cccccccccccc--hhhhccCCCCceeeCchhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHH----
Confidence 999876543211 12233446888999999986544 7899999999999999999 9999987765443221
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.......++....++..+.+||.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 237 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 222333455556899999999999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=346.50 Aligned_cols=247 Identities=27% Similarity=0.396 Sum_probs=194.0
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
+..++|.+.+.||+|+||.||+|.+ .+..||||++... .....+.+|+.+++.++||||+++++++.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 71 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE---------SERKAFIVELRQLSRVNHPNIVKLYGACL-- 71 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST---------THHHHHHHHHHHHHHCCCTTBCCEEEBCT--
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh---------hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--
Confidence 3457899999999999999999965 5889999997432 12356889999999999999999999885
Q ss_pred CceEEEEEecccCCChhHHHhcCC---CcchHHHHHHHHHHHHHHHHHHhcC-CceEecccCCcceEeCCCCc-EEEEec
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATP---VLPEREARIIIVQIFQGLIYLNKRA-QKIIHYDLKPGNVLFDEFGV-AKVTDF 554 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~---~Lse~~~~~I~~qIa~aL~yLH~~g-~~IIHrDLKP~NILLd~~g~-vKL~DF 554 (683)
+..|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.. .+|+||||||+|||++.++. +||+||
T Consensus 72 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 72 -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp -TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred -CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 34789999999999999997654 3678899999999999999999842 35999999999999998886 799999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
|++...... .....||+.|+|||++... .++.++|||||||++|+|++|+.||............ .+
T Consensus 151 g~~~~~~~~--------~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~- 217 (307)
T 2eva_A 151 GTACDIQTH--------MTNNKGSAAWMAPEVFEGS---NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW-AV- 217 (307)
T ss_dssp CC--------------------CCTTSSCHHHHTCC---CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH-HH-
T ss_pred ccccccccc--------cccCCCCCceEChhhhCCC---CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH-HH-
Confidence 999765432 1223699999999998644 3899999999999999999999999754332211111 11
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
......+....++..+.+||.+||..||.+|||+.++++
T Consensus 218 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 218 -HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp -HTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111222334578999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=352.19 Aligned_cols=266 Identities=24% Similarity=0.359 Sum_probs=206.3
Q ss_pred CCCccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeee
Q 005678 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 393 ~~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
.....+.+..++|.+.+.||+|+||.||+|.+.. .||+|++......... ...+.+|+.+++.++||||+++
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQ-----LKAFKREVMAYRQTRHENVVLF 94 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCC-----CCCCCTTGGGGTTCCCTTBCCC
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHH-----HHHHHHHHHHHhcCCCCCEeEE
Confidence 3457788889999999999999999999997643 4999998654322211 2346679999999999999999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcCC-CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEE
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKV 551 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~-~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL 551 (683)
++++. +.+.+++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+|+||||+|||++ ++.+||
T Consensus 95 ~~~~~-~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l 170 (319)
T 2y4i_B 95 MGACM-SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVI 170 (319)
T ss_dssp CEEEE-CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEE
T ss_pred EEEEe-cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEE
Confidence 99986 6678999999999999999997654 6999999999999999999999965 99999999999998 689999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccC------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHH
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSK------TPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE 625 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~------~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e 625 (683)
+|||++...................||+.|+|||++.... ...++.++|||||||++|+|++|..||.......
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 250 (319)
T 2y4i_B 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250 (319)
T ss_dssp CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH
T ss_pred eecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999987654322111112233447999999999986422 2347899999999999999999999998766544
Q ss_pred HHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 626 RILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 626 ~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.... +. ...........++.++.+||.+||..||.+|||+.++++
T Consensus 251 ~~~~---~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 251 IIWQ---MG-TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHH---HH-TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHH---hc-cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3321 11 111111222468889999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.01 Aligned_cols=254 Identities=27% Similarity=0.376 Sum_probs=206.0
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
..|.+..++|.+.+.||+|+||.||+|.+.. +..||||++...... ...+.+|+.+++.++||||++++++
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~ 247 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--------PEAFLQEAQVMKKLRHEKLVQLYAV 247 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC--------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC--------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4577888999999999999999999998754 567999998654321 2467899999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
+. .+.+|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|
T Consensus 248 ~~--~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 248 VS--EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp EC--SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred Ec--CCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECC
Confidence 85 3678999999999999999963 356899999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDT 632 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~ 632 (683)
||+++....... .......|++.|+|||++.... ++.++|||||||++|+|++ |..||......+.+..
T Consensus 324 fG~a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~--- 393 (452)
T 1fmk_A 324 FGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGR---FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--- 393 (452)
T ss_dssp CCTTC------------------CCGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---
T ss_pred CccceecCCCce----ecccCCcccccccCHhHHhcCC---CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 999987653211 1122335788999999987544 8999999999999999999 9999987665443221
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+ ......+.++.++..+.+||.+||..||.+|||+.+++.
T Consensus 394 i--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 394 V--ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp H--HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H--HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 122344555689999999999999999999999999876
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=359.82 Aligned_cols=257 Identities=19% Similarity=0.288 Sum_probs=195.4
Q ss_pred ccceeEEEEecccCceEEEEEEEccC---CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVE---HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~---g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
...|.+.+.||+|+||+||+|.+..+ +..||||.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------IGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC------SHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC------HHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 34688999999999999999987543 34689998754221 1235678999999999999999999998755
Q ss_pred CCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
..+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 162 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccc
Confidence 667889999999999999999754 46899999999999999999999965 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+.+....... ........||+.|+|||++.... ++.++|||||||++|+|++ |.+||......+... .+...
T Consensus 240 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~~~ 312 (373)
T 3c1x_A 240 RDMYDKEFDS-VHNKTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQG 312 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHHTT
T ss_pred cccccccccc-ccccCCCCCcccccChHHhcCCC---CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHHcC
Confidence 8764332111 11122346788999999987544 8999999999999999999 778886654433221 11122
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
...+.+..++..+.+||.+||..+|.+||++.+++++
T Consensus 313 --~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 313 --RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2223345789999999999999999999999999853
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.71 Aligned_cols=240 Identities=28% Similarity=0.436 Sum_probs=188.2
Q ss_pred cccccccceeEE-EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHH-hhcCCCceeeecc
Q 005678 397 NFQILNHRYALL-NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH-KTLVHHHIVRLWD 474 (683)
Q Consensus 397 ~~~i~~~ry~l~-~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il-~~L~HpnIV~L~~ 474 (683)
...++. +|.+. +.||+|+||.||+|.+..++..||||++... ..+.+|+.++ +.+.||||+++++
T Consensus 12 ~~~~~~-~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~e~~~~~~~~~h~~i~~~~~ 78 (299)
T 3m2w_A 12 KNAIID-DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------PKARREVELHWRASQCPHIVRIVD 78 (299)
T ss_dssp CSCGGG-TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred cccccc-chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------------HHHHHHHHHHHHhccCCCchhHHh
Confidence 334444 45565 8899999999999999999999999998431 2456788887 5669999999999
Q ss_pred cccc---CCceEEEEEecccCCChhHHHhcCC--CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---C
Q 005678 475 TFEI---DQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---F 546 (683)
Q Consensus 475 ~f~~---d~~~~~LV~Ey~~ggsL~~~L~~~~--~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~ 546 (683)
+|.. +...+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++. +
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 156 (299)
T 3m2w_A 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPN 156 (299)
T ss_dssp EEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTT
T ss_pred hhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCC
Confidence 9863 2667999999999999999997653 6999999999999999999999965 999999999999997 7
Q ss_pred CcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH
Q 005678 547 GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626 (683)
Q Consensus 547 g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~ 626 (683)
+.+||+|||++..... ..++.++|||||||++|+|++|..||........
T Consensus 157 ~~~kl~Dfg~a~~~~~------------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 157 AILKLTDFGFAKETTG------------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp CCEEECCCTTCEECTT------------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred CcEEEecccccccccc------------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 8999999999864321 1267899999999999999999999976543221
Q ss_pred HHHHHHHHHhhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 627 ILREDTIIKARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 627 il~~~~i~~~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..............++. ...+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 207 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp -CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 10000000111111121 14689999999999999999999999999999999765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.05 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=207.4
Q ss_pred cccccceeEEEEecccCceEEEEEE----EccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~----d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
.+...+|.+++.||+|+||.||+|. +..++..||||++.... ......+.+|+.+++.++||||+++++
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-------EEHLRDFEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-------SHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-------HHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 4567889999999999999999997 45689999999986532 123457889999999999999999999
Q ss_pred ccccC-CceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 475 TFEID-QNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 475 ~f~~d-~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
++... ...+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~ 187 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIG 187 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEEC
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEe
Confidence 87533 34789999999999999999765 46999999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH------
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER------ 626 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~------ 626 (683)
|||++........ .........|++.|+|||++.... ++.++|||||||++|+|++|..||........
T Consensus 188 Dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~ 262 (326)
T 2w1i_A 188 DFGLTKVLPQDKE--YYKVKEPGESPIFWYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262 (326)
T ss_dssp CCTTCEECCSSCS--EEECSSCCSCCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT
T ss_pred cCcchhhcccccc--ccccccCCCCceeEECchhhcCCC---CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc
Confidence 9999987754321 111223446888999999987544 78999999999999999999999864321100
Q ss_pred ----HHHHHH-HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 627 ----ILREDT-IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 627 ----il~~~~-i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...... .........+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 263 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000000 011112234455679999999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.85 Aligned_cols=271 Identities=20% Similarity=0.300 Sum_probs=194.6
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHH--HHHHHHhhcCCCceeeecccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI--REYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~--rEi~il~~L~HpnIV~L~~~f 476 (683)
.+.-++|.+++.||+|+||.||+|. .++..||||++.... ...+. .++..+..++||||+++++.+
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 76 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFAN----------RQNFINEKNIYRVPLMEHDNIARFIVGD 76 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEE--ETTEEEEEEEEEGGG----------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEE--ECCeEEEEEEeeccc----------hhhHHHHHHHHHHHhccCcchhhheecc
Confidence 4556789999999999999999995 478999999985321 11223 344445568999999998643
Q ss_pred c----cCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc-------CCceEecccCCcceEeCC
Q 005678 477 E----IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR-------AQKIIHYDLKPGNVLFDE 545 (683)
Q Consensus 477 ~----~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~-------g~~IIHrDLKP~NILLd~ 545 (683)
. .....+|+|||||++++|.+++.... +++..+..|+.||+.||.|||+. .++||||||||+|||++.
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp EEECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred cccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 2 24557899999999999999997765 68999999999999999999986 114999999999999999
Q ss_pred CCcEEEEecCCccccccCcCCC---cccccccCCCCCccCCcccccccCC----CCCCchhHHHHHHHHHHHHHcCCCCC
Q 005678 546 FGVAKVTDFGLSKIVEDDVGSQ---GMELTSQGAGTYWYLPPECFELSKT----PLISSKVDVWSAGILFYQMLFGRRPF 618 (683)
Q Consensus 546 ~g~vKL~DFGls~~~~~~~~~~---~~~l~~~~~GT~~Y~APE~~~~~~~----~~~s~ksDVWSLGvILyELLtG~~PF 618 (683)
++.+||+|||+++.+....... .........||+.|+|||++..... ..++.++|||||||++|+|++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9999999999998765432110 0112234479999999999864211 23567899999999999999997776
Q ss_pred CCCchHHHH--------------HHHHHHHHh--hccCCCC----CcCCCHHHHHHHHHhcccCCCCCCCHHHHh-----
Q 005678 619 GHDQTQERI--------------LREDTIIKA--RKVEFPS----RPAVSNEAKDLIRRCLTYNQAERPDVLTLA----- 673 (683)
Q Consensus 619 ~~~~~~e~i--------------l~~~~i~~~--~~~~~p~----~~~~s~el~dLI~rCL~~dP~kRPS~~eLl----- 673 (683)
......... ......... ....+|. ...+++.+.+||.+||..||.+|||+.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 332211000 000001111 1112221 123556899999999999999999999994
Q ss_pred -cCcccCCCC
Q 005678 674 -QDPYLTYSK 682 (683)
Q Consensus 674 -~hP~l~~~K 682 (683)
-++|.++.+
T Consensus 316 ll~~~~~~~~ 325 (336)
T 3g2f_A 316 LMMIWERNKS 325 (336)
T ss_dssp HHHCCCC---
T ss_pred HHHHHHhccc
Confidence 567777654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=367.38 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=197.6
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDT 475 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~ 475 (683)
.+.+-..+|.+.+.||+|+||+||.. ...+++.||||++..... ..+.+|+.+++.+ +|||||+++++
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~----------~~~~~E~~~l~~l~~HpnIv~l~~~ 86 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF----------SFADREVQLLRESDEHPNVIRYFCT 86 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE----------EECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH----------HHHHHHHHHHHhccCCCCcCeEEEE
Confidence 34455678999999999999996643 367899999998854321 1245799999999 79999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-----CCcE
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-----FGVA 549 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-----~g~v 549 (683)
+. +...+|+|||||+ ++|.+++... ..+++..+..++.||+.||.|||+.+ ||||||||+|||++. ...+
T Consensus 87 ~~-~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~ 162 (432)
T 3p23_A 87 EK-DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKA 162 (432)
T ss_dssp EE-ETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCE
T ss_pred Ee-cCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeE
Confidence 86 6788999999995 5999999654 34666678899999999999999965 999999999999953 2358
Q ss_pred EEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHH
Q 005678 550 KVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERIL 628 (683)
Q Consensus 550 KL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il 628 (683)
||+|||+++........ ........||++|+|||++.......++.++|||||||++|+|++ |..||+........
T Consensus 163 kL~DFG~a~~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~- 239 (432)
T 3p23_A 163 MISDFGLCKKLAVGRHS--FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN- 239 (432)
T ss_dssp EECCTTEEECC--------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-
T ss_pred EEecccceeeccCCCcc--eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-
Confidence 89999999876543211 122334579999999999875434457889999999999999999 99999765443221
Q ss_pred HHHHHHHhhccCC-CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 629 REDTIIKARKVEF-PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 629 ~~~~i~~~~~~~~-p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.+........ ......+..+.+||.+||..||.+|||+.++++||||..
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 240 ---ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ---HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ---HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 1111111111 112234567899999999999999999999999999964
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.61 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=200.1
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
|...+.||+|+||.||+|. .++..||||++........ ......+.+|+.+++.++||||+++++++. +.+.++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITT---EELKQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEE--SSSCEEEEEEECCCTTSCT---TTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCE
T ss_pred cccCCccccCCCeEEEEEE--ECCceEEEEEEecccCcch---HHHHHHHHHHHHHHHhcCCCCeEEEEEEEe-cCCceE
Confidence 4455899999999999996 4789999999865432211 123457889999999999999999999986 667889
Q ss_pred EEEecccCCChhHHHh---cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 485 TVLEYCSGKDLDAVLK---ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~---~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 184 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASE 184 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccc
Confidence 9999999999999985 3456999999999999999999999965 9999999999999999999999999998765
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh----
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR---- 637 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~---- 637 (683)
..... .......||+.|+|||++.. .++.++|||||||++|+|++|..||........+..........
T Consensus 185 ~~~~~---~~~~~~~g~~~y~aPE~~~~----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (307)
T 2nru_A 185 KFAQT---VMTSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTI 257 (307)
T ss_dssp SCSSC---EECSSCCSCGGGCCHHHHTT----EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCH
T ss_pred ccccc---ccccccCCCcCcCChHHhcC----CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhh
Confidence 43211 22334579999999998753 26889999999999999999999997654332111111101110
Q ss_pred ----ccCCC-CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 638 ----KVEFP-SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 638 ----~~~~p-~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
...++ ....++..+.+||.+||..+|.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 258 EDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00111 123456789999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=379.91 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=202.2
Q ss_pred ccceeEE-EEecccCceEEEEEEE--ccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 402 NHRYALL-NLLGKGGFSEVYKAYD--LVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 402 ~~ry~l~-~~LGkGgfG~Vyka~d--~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
...+.+. +.||+|+||.||+|.+ ..++..||||++...... ......+.+|+.++..++|||||+++++|.
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~- 440 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-----PALKDELLAEANVMQQLDNPYIVRMIGICE- 440 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-----GGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 3444443 4799999999999965 456789999998654221 123467899999999999999999999885
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
.+.+++|||||++++|.+++.....+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++
T Consensus 441 -~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~ 517 (635)
T 4fl3_A 441 -AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK 517 (635)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHH
T ss_pred -cCCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCcc
Confidence 4568899999999999999988888999999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhh
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
.+...... ........||+.|+|||++.... ++.++|||||||++|+|++ |..||......+... .+...
T Consensus 518 ~~~~~~~~--~~~~~~~~~t~~y~APE~~~~~~---~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~---~i~~~- 588 (635)
T 4fl3_A 518 ALRADENY--YKAQTHGKWPVKWYAPECINYYK---FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---MLEKG- 588 (635)
T ss_dssp HTTC---------------CGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHTT-
T ss_pred ccccCccc--cccccCCCCceeeeChhhhcCCC---CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcC-
Confidence 77543211 12233346789999999996544 8999999999999999998 999998776654321 12222
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
...+.+..++.++.+||.+||..||.+||++.++++
T Consensus 589 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 589 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 223344579999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=375.18 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=202.8
Q ss_pred ccccccceeEEE-EecccCceEEEEEEEc--cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 398 FQILNHRYALLN-LLGKGGFSEVYKAYDL--VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 398 ~~i~~~ry~l~~-~LGkGgfG~Vyka~d~--~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
+.+..+.|.+.. .||+|+||.||+|.+. .++..||||++...... .....+.+|+.+++.++|||||++++
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~~E~~il~~l~hpniv~l~~ 403 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK------ADTEEMMREAQIMHQLDNPYIVRLIG 403 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS------TTHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh------HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344556677776 8999999999999775 35678999998654221 12457889999999999999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
+|. .+.+++|||||++|+|.+++.. ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|
T Consensus 404 ~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~D 479 (613)
T 2ozo_A 404 VCQ--AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISD 479 (613)
T ss_dssp EEE--SSSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC
T ss_pred Eec--cCCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEee
Confidence 986 3568999999999999999964 456999999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDT 632 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~ 632 (683)
||+++.+...... ......+.+|+.|+|||++.... ++.++|||||||+||||++ |..||......+... .
T Consensus 480 FGla~~~~~~~~~--~~~~~~~~~~~~y~APE~~~~~~---~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~---~ 551 (613)
T 2ozo_A 480 FGLSKALGADDSY--YTARSAGKWPLKWYAPECINFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA---F 551 (613)
T ss_dssp CSTTTTCC----------------CCTTSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH---H
T ss_pred ccCcccccCCCce--eeeccCCCCccceeCHhhhcCCC---CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---H
Confidence 9999876533211 11223345678999999986544 8999999999999999998 999998776654321 2
Q ss_pred HHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 633 i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+.... ..+.++.++.++.+||.+||..+|.+||++.++++
T Consensus 552 i~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 552 IEQGK--RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHTTC--CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHcCC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22222 23344579999999999999999999999999853
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.13 Aligned_cols=260 Identities=18% Similarity=0.270 Sum_probs=204.9
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+++.||+|+||.||+|.+..++..||||++...... ..+.+|+.++..+.|++++..+..|..+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---------~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---------CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 4678999999999999999999999999999999987654322 2367899999999986666555566667
Q ss_pred CceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe---CCCCcEEEEecC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFG 555 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL---d~~g~vKL~DFG 555 (683)
.+..||||||+ +++|.+++.. ...+++..++.|+.||+.||.|||+.+ ||||||||+|||| +.++.+||+|||
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCC
Confidence 88999999999 9999999964 567999999999999999999999965 9999999999999 578999999999
Q ss_pred CccccccCcCCCc--ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQG--MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 556 ls~~~~~~~~~~~--~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
+++.+........ ........||+.|+|||++.... ++.++||||||||||+|++|..||..............+
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC---CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCC---CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 9988765432221 12233558999999999987544 899999999999999999999999764432111111111
Q ss_pred HHhhccC--CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 634 IKARKVE--FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 634 ~~~~~~~--~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....... ......++.++.+||.+||..+|.+||++.+|++
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 229 SEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111000 0111467899999999999999999999988764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=370.81 Aligned_cols=256 Identities=27% Similarity=0.365 Sum_probs=211.5
Q ss_pred CccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecc
Q 005678 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWD 474 (683)
Q Consensus 395 f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~ 474 (683)
...|.+..++|.+.+.||+|+||.||+|.+.. +..||||++...... ...+.+|+.+++.++|||||++++
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--------PEAFLQEAQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC--------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC--------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 35678889999999999999999999998754 567999998654321 246889999999999999999999
Q ss_pred ccccCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 475 TFEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 475 ~f~~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
++. .+.+|||||||++++|.+++.. ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+
T Consensus 330 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 330 VVS--EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp EEC--SSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEe--eccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEc
Confidence 885 3678999999999999999964 356899999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRED 631 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~ 631 (683)
|||+++.+.... ........+++.|+|||++.... ++.++|||||||+||+|++ |..||......+.+..
T Consensus 406 DFG~a~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-- 476 (535)
T 2h8h_A 406 DFGLARLIEDNE----YTARQGAKFPIKWTAPEAALYGR---FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-- 476 (535)
T ss_dssp CTTSTTTCCCHH----HHTTCSTTSCGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH--
T ss_pred ccccceecCCCc----eecccCCcCcccccCHHHhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--
Confidence 999998764321 11122335788999999987544 8999999999999999999 9999987665443221
Q ss_pred HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 632 ~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+. .....+....++..+.+||.+||..||.+|||+.+|+..
T Consensus 477 -i~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 477 -VE--RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp -HH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HH--cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 223445556899999999999999999999999998763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=346.50 Aligned_cols=260 Identities=22% Similarity=0.306 Sum_probs=199.9
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhh--cCCCceeeecccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT--LVHHHIVRLWDTF 476 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~--L~HpnIV~L~~~f 476 (683)
..+.++|.+.+.||+|+||.||+|.+ +++.||||++... ....+.+|+.++.. ++||||+++++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----------EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----------GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----------hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 34678999999999999999999975 6999999998432 12456778888887 7899999999998
Q ss_pred ccCC---ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc------CCceEecccCCcceEeCCCC
Q 005678 477 EIDQ---NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR------AQKIIHYDLKPGNVLFDEFG 547 (683)
Q Consensus 477 ~~d~---~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~------g~~IIHrDLKP~NILLd~~g 547 (683)
.... ..+++||||+++++|.+++... .+++..+..++.||+.||.|||.. ..+|+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 7443 2789999999999999999775 499999999999999999999921 14599999999999999999
Q ss_pred cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCC---CCCchhHHHHHHHHHHHHHcC----------
Q 005678 548 VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTP---LISSKVDVWSAGILFYQMLFG---------- 614 (683)
Q Consensus 548 ~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~---~~s~ksDVWSLGvILyELLtG---------- 614 (683)
.+||+|||++........... .......||+.|+|||++...... .++.++|||||||++|+|++|
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEE-ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CEEEEECCCceeccccccccc-cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 999999999987654321110 122345799999999998654211 134789999999999999999
Q ss_pred CCCCCCCch----HHHHHHHHHHHHhhc--cCCCC---CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 615 RRPFGHDQT----QERILREDTIIKARK--VEFPS---RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 615 ~~PF~~~~~----~e~il~~~~i~~~~~--~~~p~---~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
..||..... ...+.. ...... ..++. ...++..+.+||.+||..||.+|||+.+++++
T Consensus 264 ~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRK---VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHH---HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCccccCcCcccHHHHHH---HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 788865422 111111 111111 11221 12345689999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=371.35 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=208.0
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccC---CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeee
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVE---HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRL 472 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~---g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L 472 (683)
..+.+..++|.+.+.||+|+||.||+|.+..+ +..||||.+..... ......+.+|+.+++.++||||+++
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l 456 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS------DSVREKFLQEALTMRQFDHPHIVKL 456 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC------HHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 35667788999999999999999999987543 56799998754321 2234678899999999999999999
Q ss_pred ccccccCCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEE
Q 005678 473 WDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKV 551 (683)
Q Consensus 473 ~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL 551 (683)
++++. .+.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 457 ~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL 532 (656)
T 2j0j_A 457 IGVIT--ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKL 532 (656)
T ss_dssp EEEEC--SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEE
T ss_pred EEEEe--cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEE
Confidence 99884 45688999999999999999754 36899999999999999999999965 999999999999999999999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHH
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRE 630 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~ 630 (683)
+|||+++....... .......||+.|+|||++.... ++.++|||||||++|+|++ |..||......+.+..
T Consensus 533 ~DFG~a~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~- 604 (656)
T 2j0j_A 533 GDFGLSRYMEDSTY----YKASKGKLPIKWMAPESINFRR---FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR- 604 (656)
T ss_dssp CCCCCCCSCCC--------------CCGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-
T ss_pred EecCCCeecCCCcc----eeccCCCCCcceeCHHHhcCCC---CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-
Confidence 99999987654321 1223456789999999986543 8999999999999999997 9999987665543321
Q ss_pred HHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 631 ~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+... ...+.++.+++.+.+||.+||..||.+||++.++++
T Consensus 605 --i~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 605 --IENG--ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp --HHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHcC--CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2222 223444679999999999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.44 Aligned_cols=253 Identities=15% Similarity=0.136 Sum_probs=194.7
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC-Cceeeec-------
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH-HHIVRLW------- 473 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H-pnIV~L~------- 473 (683)
...|.+.+.||+|+||+||+|.+..+|+.||||++........ ...+.+.+|+.++..+.| +|+..++
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS----NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC--------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH----HHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 3458889999999999999999999999999999864332221 224568899999999977 2221111
Q ss_pred --------------ccccc----CCceEEEEEecccCCChhHHHh-------cCCCcchHHHHHHHHHHHHHHHHHHhcC
Q 005678 474 --------------DTFEI----DQNTFCTVLEYCSGKDLDAVLK-------ATPVLPEREARIIIVQIFQGLIYLNKRA 528 (683)
Q Consensus 474 --------------~~f~~----d~~~~~LV~Ey~~ggsL~~~L~-------~~~~Lse~~~~~I~~qIa~aL~yLH~~g 528 (683)
.++.. ....++++|+++ +++|.+++. ....+++..+..|+.||+.||.|||+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 11110 123467788877 789999884 1345888899999999999999999965
Q ss_pred CceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCccccccc-------CCCCCCchhHH
Q 005678 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELS-------KTPLISSKVDV 601 (683)
Q Consensus 529 ~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~-------~~~~~s~ksDV 601 (683)
||||||||+||||+.+|.+||+|||+++..... ....+| +.|+|||++... ....++.++||
T Consensus 232 --iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred --cccCCcccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 999999999999999999999999998865432 233467 999999998422 22347889999
Q ss_pred HHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 602 WSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 602 WSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
|||||++|+|++|+.||........ ....+...+.+|..+.+||.+||..||.+||++.++++||||+.
T Consensus 301 wSlGvil~elltg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 301 WTLGLAIYWIWCADLPNTDDAALGG----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHHHHHHHSSCCCCTTGGGSC----------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCcchhhh----------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999976554221 11223445678999999999999999999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=349.79 Aligned_cols=254 Identities=17% Similarity=0.224 Sum_probs=192.3
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccch-hhHHHHHHHHHHHHHHHhhcC-------------
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE-DKKQSYIRHAIREYNIHKTLV------------- 465 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~-~~~~~~i~~~~rEi~il~~L~------------- 465 (683)
+..++|.+++.||+|+||+||+|.+ +|+.||||++........ .........+.+|+.+++.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4467899999999999999999986 789999999876532110 001122356788888888886
Q ss_pred -------------CCceeeecccccc------------CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHH
Q 005678 466 -------------HHHIVRLWDTFEI------------DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520 (683)
Q Consensus 466 -------------HpnIV~L~~~f~~------------d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~a 520 (683)
||||++++++|.. +.+.+|+|||||++|++...+.. ..+++..++.|+.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 6666667766653 26789999999999976666644 458999999999999999
Q ss_pred HHHHH-hcCCceEecccCCcceEeCCCC--------------------cEEEEecCCccccccCcCCCcccccccCCCCC
Q 005678 521 LIYLN-KRAQKIIHYDLKPGNVLFDEFG--------------------VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579 (683)
Q Consensus 521 L~yLH-~~g~~IIHrDLKP~NILLd~~g--------------------~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~ 579 (683)
|.||| +.+ ||||||||+||||+.++ .+||+|||+|+..... ..+||+
T Consensus 174 L~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------~~~gt~ 241 (336)
T 2vuw_A 174 LAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------IVVFCD 241 (336)
T ss_dssp HHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----------EEECCC
T ss_pred HHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----------cEEEee
Confidence 99999 866 99999999999999877 8999999999876532 237999
Q ss_pred ccCCcccccccCCCCCCchhHHHHHHHH-HHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCC----CcCCCHHHHHH
Q 005678 580 WYLPPECFELSKTPLISSKVDVWSAGIL-FYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS----RPAVSNEAKDL 654 (683)
Q Consensus 580 ~Y~APE~~~~~~~~~~s~ksDVWSLGvI-LyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~----~~~~s~el~dL 654 (683)
.|+|||++.+. .+.++||||||++ .++++.|..||......... ...+.......... .+.+++++.+|
T Consensus 242 ~y~aPE~~~g~----~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 242 VSMDEDLFTGD----GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYL--TDKMLKQMTFKTKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp CTTCSGGGCCC----SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHH--HHHHHHTCCCSSCCCSHHHHHHHHHHHHH
T ss_pred cccChhhhcCC----CccceehhhhhCCCCcccccccCCCcchhhhhHH--HHhhhhhhccCcccchhhhhhcCHHHHHH
Confidence 99999998633 2789999998777 77888999998432111111 11111111111111 23578899999
Q ss_pred HHHhcccCCCCCCCHHHHh-cCcccC
Q 005678 655 IRRCLTYNQAERPDVLTLA-QDPYLT 679 (683)
Q Consensus 655 I~rCL~~dP~kRPS~~eLl-~hP~l~ 679 (683)
|.+||.+| |+.+++ +||||+
T Consensus 316 i~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHHhccC-----CHHHHHhcCCCcC
Confidence 99999976 999999 999996
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=379.37 Aligned_cols=262 Identities=26% Similarity=0.338 Sum_probs=204.0
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc---
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI--- 478 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~--- 478 (683)
.++|.+.+.||.|+||.||+|.+..+|..||||++..... ......+.+|+.+++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~------~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS------PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC------HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC------HHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 4789999999999999999999989999999998754321 1234678899999999999999999998753
Q ss_pred --CCceEEEEEecccCCChhHHHhcCC---CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCc---EE
Q 005678 479 --DQNTFCTVLEYCSGKDLDAVLKATP---VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV---AK 550 (683)
Q Consensus 479 --d~~~~~LV~Ey~~ggsL~~~L~~~~---~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~---vK 550 (683)
+.+.+|+|||||+|++|.+++.... .+++..++.|+.+|+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEE
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEE
Confidence 2667899999999999999997643 6999999999999999999999965 999999999999997664 99
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR- 629 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~- 629 (683)
|+|||++....... ......||+.|+|||++.... ++.++|||||||++|+|++|..||........+..
T Consensus 165 L~DFG~a~~~~~~~------~~~~~~gt~~Y~APE~l~~~~---~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~ 235 (676)
T 3qa8_A 165 IIDLGYAKELDQGE------LCTEFVGTLQYLAPELLEQKK---YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235 (676)
T ss_dssp ECSCCCCCBTTSCC------CCCCCCSCCTTCSSCSSCCSC---CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT
T ss_pred Eccccccccccccc------ccccccCCcccCChHHhccCC---CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh
Confidence 99999998765432 123457999999999986443 89999999999999999999999976543322110
Q ss_pred -----HHHHH----HhhccCCCC--------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 630 -----EDTII----KARKVEFPS--------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 630 -----~~~i~----~~~~~~~p~--------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
...+. ....+.++. .+.++..+.+||.+||.+||.+||++.++++||||+.
T Consensus 236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00000 001111111 1246789999999999999999999999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=369.17 Aligned_cols=245 Identities=20% Similarity=0.247 Sum_probs=198.1
Q ss_pred cccccceeEEEEecccCceEEEEEEEcc-CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLV-EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~-~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
.++.++|.+.+.||+|+||.||+|.+.. +++.||||++..... ......+.+|+.++..++|||||+++++|.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD------AEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC------HHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC------HHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 4677899999999999999999999976 799999998754321 123457889999999999999999999987
Q ss_pred cCCce----EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 478 IDQNT----FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 478 ~d~~~----~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
..... +||||||++|++|..++.. .+++..+..|+.||+.||.|||+.+ ||||||||+|||++. +.+||+|
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~-~~~kl~D 224 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTE-EQLKLID 224 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECS-SCEEECC
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeC-CcEEEEe
Confidence 54332 7999999999999998765 6999999999999999999999966 999999999999998 4999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||+++..... ....||+.|+|||++... ++.++|||||||++|+|++|..||.......
T Consensus 225 FG~a~~~~~~---------~~~~gt~~y~aPE~~~~~----~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------- 283 (681)
T 2pzi_A 225 LGAVSRINSF---------GYLYGTPGFQAPEIVRTG----PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------- 283 (681)
T ss_dssp CTTCEETTCC---------SCCCCCTTTSCTTHHHHC----SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------
T ss_pred cccchhcccC---------CccCCCccccCHHHHcCC----CCCceehhhhHHHHHHHHhCCCCCccccccc--------
Confidence 9999876432 234799999999998643 4889999999999999999999986422100
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.........+++.+.+||.+||..||.+||+..+++.|+|+.
T Consensus 284 ----~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 ----LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000000113467899999999999999999988888888764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=328.05 Aligned_cols=229 Identities=15% Similarity=0.133 Sum_probs=185.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
++.++|.+.+.||+|+||.||+|.+..+++.||||++....... ......+.+|+.++..++||||+++++++. +
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~ 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP----DDVLQETLSRTLRLSRIDKPGVARVLDVVH-T 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-E
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC----HHHHHHHHHHHHHHhcCCCCCcceeeEEEE-E
Confidence 78899999999999999999999999999999999987654322 233567889999999999999999999996 5
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+.+|+||||++|++|.+++... ....++..|+.||+.||.|||+.+ |+||||||+|||++.+|.+||+++|
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred CCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc----
Confidence 67899999999999999999654 355578889999999999999966 9999999999999999999998443
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
|++| ++.++|||||||++|+|++|+.||........+..... ......
T Consensus 175 ---------------------~~~~----------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-~~~~~~ 222 (286)
T 3uqc_A 175 ---------------------TMPD----------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-DTAGQP 222 (286)
T ss_dssp ---------------------CCTT----------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-CTTSCB
T ss_pred ---------------------ccCC----------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-HhccCC
Confidence 3332 68899999999999999999999976554221100000 000000
Q ss_pred CC--CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 640 EF--PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 640 ~~--p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.. ...+.+++++.+||.+||..||.+| |+.++++
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00 0124689999999999999999999 9999885
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-31 Score=306.71 Aligned_cols=192 Identities=17% Similarity=0.132 Sum_probs=137.0
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeccCccc---chhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccccCCceEEEE
Q 005678 411 LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQW---SEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEIDQNTFCTV 486 (683)
Q Consensus 411 LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~---~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~d~~~~~LV 486 (683)
++.|++|.+..+.....|..||||++.....+ .....+...+.+.+|+.+|+++ .|+||++++++|+ +.+.+|||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e-d~~~~yLV 320 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE-NAQSGWLV 320 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE-CSSEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-ECCEEEEE
Confidence 56777777777766778899999998765433 2334455567899999999999 6999999999997 78899999
Q ss_pred EecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCC
Q 005678 487 LEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS 566 (683)
Q Consensus 487 ~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~ 566 (683)
|||++|++|.++|...+++++. .|+.||+.||.|||+.| ||||||||+||||+.+|.+||+|||+|+.......
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~- 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS- 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---C-
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-
Confidence 9999999999999988888765 47899999999999966 99999999999999999999999999987654321
Q ss_pred CcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCC
Q 005678 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRP 617 (683)
Q Consensus 567 ~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~P 617 (683)
.....+||++|||||++.+. +...+|+||+|+++|.|+++..|
T Consensus 395 ----~~~t~vGTp~YmAPE~l~g~----~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 ----WPTNLVQSFFVFVNELFAEN----KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CSHHHHHHHHHHHHHHC---------------------CCCCTTHHH
T ss_pred ----cccCceechhhccHHHhCCC----CCCcccccccccchhhhccccch
Confidence 12334799999999998532 56789999999998877655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-26 Score=258.86 Aligned_cols=197 Identities=20% Similarity=0.131 Sum_probs=145.0
Q ss_pred eEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccc-hhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEE
Q 005678 406 ALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWS-EDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 406 ~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~-~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~ 484 (683)
...+.||+|+||.||+| ...+..+++|......... ........+.+.+|+.+++.++||||+.+..++. +.+..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-DLDNKR 415 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-ETTTTE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-eCCccE
Confidence 34578999999999999 5678899999765432221 1222333567899999999999999994443332 455679
Q ss_pred EEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCc
Q 005678 485 TVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~ 564 (683)
+|||||+|++|.+++.. +..|+.||+.||.|||+.+ ||||||||+|||++. .+||+|||+++......
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999999876 5679999999999999965 999999999999998 99999999999875431
Q ss_pred CCC--cccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 005678 565 GSQ--GMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618 (683)
Q Consensus 565 ~~~--~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF 618 (683)
... .........||+.|||||++..... .|+..+|+||..+-..+..-++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~-~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLE-GYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHH-HHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHH-HHHHHHhHHHHHHHHHHHHHhcccc
Confidence 110 0011234579999999999975221 2778889999999888888777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=217.74 Aligned_cols=153 Identities=21% Similarity=0.206 Sum_probs=119.0
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchh---hH--------HHHHHHHHHHHHHHhhcCCCcee
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSED---KK--------QSYIRHAIREYNIHKTLVHHHIV 470 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~---~~--------~~~i~~~~rEi~il~~L~HpnIV 470 (683)
...|.+.+.||+|+||.||+|.+ .+|..||||++......... .. ......+.+|+.+++.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34566789999999999999998 88999999998653221110 00 012457889999999998 5 6
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEE
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAK 550 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vK 550 (683)
++++++. .+..|+|||||+|++|.. +.. .....++.||+.||.|||+.+ ||||||||.|||++ +|.+|
T Consensus 165 ~v~~~~~--~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 165 AVPKVYA--WEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp SSCCEEE--EETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEE
T ss_pred CcCeEEe--ccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEE
Confidence 6776654 356789999999999998 422 334579999999999999966 99999999999999 99999
Q ss_pred EEecCCccccccCcCCCcccccccCCCCCccCCccccc
Q 005678 551 VTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFE 588 (683)
Q Consensus 551 L~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~ 588 (683)
|+|||+|+. +..|+|||++.
T Consensus 233 l~DFG~a~~------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 233 IIDFPQSVE------------------VGEEGWREILE 252 (282)
T ss_dssp ECCCTTCEE------------------TTSTTHHHHHH
T ss_pred EEECCCCeE------------------CCCCCHHHHHH
Confidence 999999863 23478899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=186.83 Aligned_cols=145 Identities=14% Similarity=0.194 Sum_probs=109.8
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeE--EEEEEeccCcccchh-----------------hHHHHHHHHHHHHHHHhhc
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRY--VACKLHGLNAQWSED-----------------KKQSYIRHAIREYNIHKTL 464 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~--VAVKi~~~~~~~~~~-----------------~~~~~i~~~~rEi~il~~L 464 (683)
-|.+...||+|+||.||+|.+..+|.. ||||++......... ........+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999998788999 999997654211100 0111224678899999999
Q ss_pred CCCce--eeeccccccCCceEEEEEecccC-C----ChhHHHhcCCCcchHHHHHHHHHHHHHHHHHH-hcCCceEeccc
Q 005678 465 VHHHI--VRLWDTFEIDQNTFCTVLEYCSG-K----DLDAVLKATPVLPEREARIIIVQIFQGLIYLN-KRAQKIIHYDL 536 (683)
Q Consensus 465 ~HpnI--V~L~~~f~~d~~~~~LV~Ey~~g-g----sL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH-~~g~~IIHrDL 536 (683)
.|++| +.+++. +..+|||||+++ | +|.++... +++..+..++.||+.||.||| ..+ ||||||
T Consensus 128 ~~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred HhCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence 98864 333321 346799999942 3 67666432 346678899999999999999 755 999999
Q ss_pred CCcceEeCCCCcEEEEecCCcccc
Q 005678 537 KPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 537 KP~NILLd~~g~vKL~DFGls~~~ 560 (683)
||.|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.7e-17 Score=180.81 Aligned_cols=146 Identities=17% Similarity=0.215 Sum_probs=100.3
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccch-----------hhHHHHH----HHHHHHHHHHhhcCCCc
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE-----------DKKQSYI----RHAIREYNIHKTLVHHH 468 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~-----------~~~~~~i----~~~~rEi~il~~L~Hpn 468 (683)
-|.+...||.|+||.||+|.+ .+|+.||||++........ ......+ ..+.+|+..|.++.+++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 389999999999999999986 5799999999865432110 0000000 11234555666654433
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG- 547 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g- 547 (683)
+... ..+.. ...+|||||++|++|..+.. ......++.||+.+|.|||..| ||||||||.|||++++|
T Consensus 175 v~vp-~p~~~--~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 175 FPVP-EPIAQ--SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CSCC-CEEEE--ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEEC
T ss_pred CCCC-eeeec--cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCC
Confidence 3211 11111 12369999999988866532 2345678899999999999865 99999999999998766
Q ss_pred ---------cEEEEecCCccccc
Q 005678 548 ---------VAKVTDFGLSKIVE 561 (683)
Q Consensus 548 ---------~vKL~DFGls~~~~ 561 (683)
.+.|+||+-+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=3.6e-11 Score=122.05 Aligned_cols=140 Identities=15% Similarity=0.087 Sum_probs=106.7
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCce
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~~ 482 (683)
.|.+...+|.|+++.||++. ..+..+++|+........ ...+.+|+.+++.+. +..+.++++++. +.+.
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~--~~~~~~vlK~~~~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~-~~~~ 84 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT-------TYDVEREKDMMLWLEGKLPVPKVLHFER-HDGW 84 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEE--CSSCEEEEEEECGGGTTS-------TTCHHHHHHHHHHHTTTSCCCCEEEEEE-ETTE
T ss_pred cceeEeeccCCCCCeEEEEE--CCCCcEEEEeCCcccCCC-------HHHHHHHHHHHHHHhcCCCCCeEEEEEe-cCCc
Confidence 47888889999999999995 346889999875421111 123677888998884 667778887775 5678
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA---------------------------------- 528 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g---------------------------------- 528 (683)
.|+||||++|.+|...+. +......++.+++.+|..||...
T Consensus 85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 899999999999987632 22334568889999999999810
Q ss_pred -----------------------CceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 529 -----------------------QKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 529 -----------------------~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 349999999999999876566799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=3e-10 Score=113.92 Aligned_cols=135 Identities=13% Similarity=0.047 Sum_probs=94.4
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce--eeeccccccCCc
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI--VRLWDTFEIDQN 481 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI--V~L~~~f~~d~~ 481 (683)
.|.+..+.+.|.++.||++. ..+|..|++|+..... ...+.+|+.+++.+.+.++ .++++++. +.+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~----------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-~~~ 88 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA----------LNELQDEAARLSWLATTGVPCAAVLDVVT-EAG 88 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT----------TSCHHHHHHHHHHHHTTTCCBCCEEEEEE-CSS
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc----------chhhhHHHHHHHHHHhCCCCCCeEEEecc-CCC
Confidence 34444443456669999995 4567789999864421 1235678888888865444 44776664 456
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA--------------------------------- 528 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g--------------------------------- 528 (683)
..++||||++|.+|. ... .. ...++.+++..|..||...
T Consensus 89 ~~~~v~e~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 788999999998884 211 11 2356777888888888642
Q ss_pred -----------------------CceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 529 -----------------------QKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 529 -----------------------~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
..++|+|++|.|||++.++.+.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999876667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.2e-09 Score=116.35 Aligned_cols=143 Identities=17% Similarity=0.223 Sum_probs=103.1
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEec--cCcccchhhHHHHHHHHHHHHHHHhhcC--CCceeeeccccccCC--
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHG--LNAQWSEDKKQSYIRHAIREYNIHKTLV--HHHIVRLWDTFEIDQ-- 480 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~--~~~~~~~~~~~~~i~~~~rEi~il~~L~--HpnIV~L~~~f~~d~-- 480 (683)
.++.|+.|.++.||++.. .+..+++|+.. ...... ....+.+|+.+++.|. +..+++++.++. +.
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~------~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~-~~~~ 112 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLP------SAHAIEREYRVMDALAGTDVPVAKMYALCE-DESV 112 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------------CHHHHHHHHHHHTTSSSCCCCEEEEEC-CTTT
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCC------cHHHHHHHHHHHHHhhcCCCCCCcEEEECC-CCCc
Confidence 467889999999999853 34678888764 221100 1235677999999887 345677776664 33
Q ss_pred -ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc--------------------------------
Q 005678 481 -NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR-------------------------------- 527 (683)
Q Consensus 481 -~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~-------------------------------- 527 (683)
+..++||||++|..+.+.. ...++......++.+++.+|..||..
T Consensus 113 ~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 113 IGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp TSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred cCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 4578999999998875422 12367888888999999999999973
Q ss_pred ------------------------CCceEecccCCcceEeCCCCc--EEEEecCCcccc
Q 005678 528 ------------------------AQKIIHYDLKPGNVLFDEFGV--AKVTDFGLSKIV 560 (683)
Q Consensus 528 ------------------------g~~IIHrDLKP~NILLd~~g~--vKL~DFGls~~~ 560 (683)
...+||+|++|.|||++.++. +.|+||+.+..-
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 146999999999999997653 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.6e-09 Score=112.93 Aligned_cols=189 Identities=19% Similarity=0.179 Sum_probs=119.4
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCc--eeeeccccccCC--ce
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHH--IVRLWDTFEIDQ--NT 482 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-Hpn--IV~L~~~f~~d~--~~ 482 (683)
++.++.|.+..||++. ..+++|+.... .....+.+|+.++..+. +.. +..++....... ..
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~ 90 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQM 90 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH---------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc---------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCc
Confidence 3558999999999872 45788875321 12346778999998873 332 233333322111 23
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRA---------------------------------- 528 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g---------------------------------- 528 (683)
.|+||+|++|.+|...... .++..+...++.+++..|..||...
T Consensus 91 ~~~vm~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp SCEEEECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred ceEEEcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 4789999999988764432 3677777888888988888888611
Q ss_pred ----------------------CceEecccCCcceEeCC--CCcEEEEecCCccccccCcCCCcccccccCCCCCccCCc
Q 005678 529 ----------------------QKIIHYDLKPGNVLFDE--FGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584 (683)
Q Consensus 529 ----------------------~~IIHrDLKP~NILLd~--~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~AP 584 (683)
..++|+|++|.|||++. .+.+.|+||+.+..-+.. ..+....... .-..|
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-----~Dl~~~~~~~-~~~~~ 242 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-----NDFISLMEDD-EEYGM 242 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-----HHHHTTCCTT-TSCCH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-----HHHHHHHhhc-cccCH
Confidence 24899999999999997 566889999998754321 0111000000 00223
Q ss_pred cccccc--CCCCC---------CchhHHHHHHHHHHHHHcCCCCC
Q 005678 585 ECFELS--KTPLI---------SSKVDVWSAGILFYQMLFGRRPF 618 (683)
Q Consensus 585 E~~~~~--~~~~~---------s~ksDVWSLGvILyELLtG~~PF 618 (683)
+.+... ..+.. ..-.+.|++|.++|.+.+|..||
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 221100 00001 11258999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1e-06 Score=92.15 Aligned_cols=137 Identities=18% Similarity=0.132 Sum_probs=91.0
Q ss_pred EEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCC---ceeeeccccccCCceEE
Q 005678 408 LNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH---HIVRLWDTFEIDQNTFC 484 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hp---nIV~L~~~f~~d~~~~~ 484 (683)
+..++.|....||+. +..+++|+... . .....+.+|+.++..|.+. .+...+.++....+..+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~ 89 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPF 89 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceE
Confidence 456888998999988 45678887421 1 1234678899999998652 23444444432345678
Q ss_pred EEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 005678 485 TVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR------------------------------------- 527 (683)
Q Consensus 485 LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~------------------------------------- 527 (683)
+||+|++|.+|....-. .++......++.++...|..||..
T Consensus 90 ~v~e~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 90 VGYRKVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp EEEECCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred EEEeccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 99999999888764221 134444445555555555555532
Q ss_pred ---------------------CCceEecccCCcceEeCC---CCc-EEEEecCCcccc
Q 005678 528 ---------------------AQKIIHYDLKPGNVLFDE---FGV-AKVTDFGLSKIV 560 (683)
Q Consensus 528 ---------------------g~~IIHrDLKP~NILLd~---~g~-vKL~DFGls~~~ 560 (683)
...+||+|+.|.|||++. ++. +.|+||+.+..-
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 224799999999999987 455 589999988654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.6e-06 Score=85.26 Aligned_cols=134 Identities=16% Similarity=0.092 Sum_probs=92.0
Q ss_pred ecccCce-EEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCceEEEEEe
Q 005678 411 LGKGGFS-EVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQNTFCTVLE 488 (683)
Q Consensus 411 LGkGgfG-~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~~~~LV~E 488 (683)
+..|..| .||+......+..+.+|+.... ....+.+|..+|+.+. +--+.+++.++. +.+..++|||
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-~~~~~~lvme 100 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----------VANDVTDEMVRLNWLTAFMPLPTIKHFIR-TPDDAWLLTT 100 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH----------HHHHHHHHHHHHHHHTTTSCCCCEEEEEE-ETTEEEEEEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC----------CHhHHHHHHHHHHHhccCCCcCeEEEEEE-ECCeEEEEEE
Confidence 4445444 6999876667788999985321 1234677888888774 223455665554 5678889999
Q ss_pred cccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 005678 489 YCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR----------------------------------------- 527 (683)
Q Consensus 489 y~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~----------------------------------------- 527 (683)
+++|.++....... ......++.+++..|.-||..
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 99998887765432 123334566666667666641
Q ss_pred ---------------CCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 528 ---------------AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 528 ---------------g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
...++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11389999999999999877778999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=3.5e-06 Score=90.87 Aligned_cols=83 Identities=24% Similarity=0.181 Sum_probs=47.9
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEeccCcc-cchhhHHHHHHHHHHHHHHHhhcCC--Ccee-eeccccccCCce
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQ-WSEDKKQSYIRHAIREYNIHKTLVH--HHIV-RLWDTFEIDQNT 482 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~-~~~~~~~~~i~~~~rEi~il~~L~H--pnIV-~L~~~f~~d~~~ 482 (683)
..+.||.|.++.||++.+..+++.|+||....... .... .......+..|..++..+.. |.++ .++. + +...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~-~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~-~--d~~~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES-WPLTIDRARIESSALIRQGEHVPHLVPRVFY-S--DTEM 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-E--ETTT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCC-CcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE-E--cCCc
Confidence 35789999999999997555678899997643211 0000 00012245668888887742 4444 4443 3 2344
Q ss_pred EEEEEecccCC
Q 005678 483 FCTVLEYCSGK 493 (683)
Q Consensus 483 ~~LV~Ey~~gg 493 (683)
.++||||++|.
T Consensus 110 ~~lvmE~l~g~ 120 (397)
T 2olc_A 110 AVTVMEDLSHL 120 (397)
T ss_dssp TEEEECCCTTS
T ss_pred cEEEEEeCCCc
Confidence 67999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=8.6e-06 Score=86.21 Aligned_cols=87 Identities=8% Similarity=-0.029 Sum_probs=50.5
Q ss_pred eEEEEe-cccCceEEEEEEEc--c----CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-C--Cceeeeccc
Q 005678 406 ALLNLL-GKGGFSEVYKAYDL--V----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-H--HHIVRLWDT 475 (683)
Q Consensus 406 ~l~~~L-GkGgfG~Vyka~d~--~----~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-H--pnIV~L~~~ 475 (683)
...+.| +.|....+|+.... . ++..+++|+........... ...+.+|+.+++.|. + ..+.+++.+
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~----~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP----TYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS----CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc----hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 345778 88888999988542 0 26678899864322000000 012455777777663 2 234556655
Q ss_pred cccCC--ceEEEEEecccCCChh
Q 005678 476 FEIDQ--NTFCTVLEYCSGKDLD 496 (683)
Q Consensus 476 f~~d~--~~~~LV~Ey~~ggsL~ 496 (683)
+.... +..++||||++|..+.
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCCC
T ss_pred ccCCCccCCceEEEEecCCCChh
Confidence 43221 3567899999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.6e-05 Score=80.03 Aligned_cols=32 Identities=25% Similarity=0.316 Sum_probs=28.0
Q ss_pred CCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 528 g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
...+||+|+.|.|||++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 35699999999999998778999999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.88 E-value=6.8e-05 Score=81.68 Aligned_cols=81 Identities=15% Similarity=0.086 Sum_probs=48.2
Q ss_pred CCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccC-CCCCccCCcccccccCCCCCCchhHHHHHHH
Q 005678 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG-AGTYWYLPPECFELSKTPLISSKVDVWSAGI 606 (683)
Q Consensus 528 g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~-~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGv 606 (683)
.+.++|+|++|.|||++.++ ++|+||+.+..-+.. ..+.... .-...|++|+.........-....++.++..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-----~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-----FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIE 304 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-----HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-----HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHH
Confidence 45799999999999999766 999999998754321 1110000 0012356665543111111122355668888
Q ss_pred HHHHHHcC
Q 005678 607 LFYQMLFG 614 (683)
Q Consensus 607 ILyELLtG 614 (683)
.+|..+++
T Consensus 305 ~~~~~y~~ 312 (420)
T 2pyw_A 305 QTWNLFNK 312 (420)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 88887754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0013 Score=67.53 Aligned_cols=81 Identities=12% Similarity=-0.021 Sum_probs=53.1
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCC---ceeeecccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH---HIVRLWDTFEI 478 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hp---nIV~L~~~f~~ 478 (683)
+....-+..+|.|..+.||+.. ..+|+.|.+|+......... ..+.+|+..|+.|.-. -+++++.+
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~-------~~~~~Ea~~L~~L~~~~~vpvP~v~~~--- 82 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALD-------GLFRAEALGLDWLGRSFGSPVPQVAGW--- 82 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCT-------THHHHHHHHHHHHTCSTTCCSCCEEEE---
T ss_pred CCCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchh-------hHHHHHHHHHHHHHhhCCCCcceEEec---
Confidence 3456668889999999999996 46789999998643322111 1356788888877421 23333332
Q ss_pred CCceEEEEEecccCCCh
Q 005678 479 DQNTFCTVLEYCSGKDL 495 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL 495 (683)
+. -++||||++++..
T Consensus 83 ~~--~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 83 DD--RTLAMEWVDERPP 97 (288)
T ss_dssp ET--TEEEEECCCCCCC
T ss_pred cC--ceEEEEeecccCC
Confidence 22 3588999987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00091 Score=70.48 Aligned_cols=76 Identities=16% Similarity=0.070 Sum_probs=54.3
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC---CCceeeeccccccCCceE
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV---HHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~---HpnIV~L~~~f~~d~~~~ 483 (683)
-.+.|+.|.+..+|+.. .++..+++|+.... ....+.+|+..|+.|. ...+++++..+. ..+..
T Consensus 40 ~~~~l~gG~~n~~y~v~--~~~~~~vlK~~~~~----------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-~~g~~ 106 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIN--DEVQTVFVKINERS----------YRSMFRAEADQLALLAKTNSINVPLVYGIGN-SQGHS 106 (312)
T ss_dssp EEEEECCSSSSEEEEEE--SSSCEEEEEEEEGG----------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-CSSEE
T ss_pred eeEEeCCccceeeeEEE--ECCCeEEEEeCCcc----------cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-cCCce
Confidence 35778999999999985 35677888986421 1235677888888773 245666666554 45678
Q ss_pred EEEEecccCCCh
Q 005678 484 CTVLEYCSGKDL 495 (683)
Q Consensus 484 ~LV~Ey~~ggsL 495 (683)
++||||++|..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0018 Score=64.96 Aligned_cols=136 Identities=15% Similarity=0.072 Sum_probs=89.8
Q ss_pred CChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccc
Q 005678 493 KDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMEL 571 (683)
Q Consensus 493 gsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l 571 (683)
-+|.++|. .+.+|++.+++.++.|.+.+|.-+-....+ ..+=+.|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC-CCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC-CceecCCcceEEecCCceeccc-cccc-------------
Confidence 37899995 557899999999999999998776321111 1333457999999999988764 2211
Q ss_pred cccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHH
Q 005678 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEA 651 (683)
Q Consensus 572 ~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el 651 (683)
.....+.|||.+. ...+.+.=|||||++||.-+--..| .. ..+.+|+.+
T Consensus 98 ----~~~~~~~~pe~~~----~~~te~~~IysLG~tLY~ALDygL~----e~-------------------eE~eLS~~L 146 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY----SQCMETEVIESLGIIIYKALDYGLK----EN-------------------EERELSPPL 146 (229)
T ss_dssp -------------CCSS----SSSCHHHHHHHHHHHHHHHHTTTCC----TT-------------------EEECCCHHH
T ss_pred ----ccccCCCChhhcc----ccchHHHHHHHHHHHHHHHhhcCCC----cc-------------------cchhhCHHH
Confidence 0122366888763 1247889999999999988832222 11 124689999
Q ss_pred HHHHHHhccc-------------------------CCCCCCCHHHHhc
Q 005678 652 KDLIRRCLTY-------------------------NQAERPDVLTLAQ 674 (683)
Q Consensus 652 ~dLI~rCL~~-------------------------dP~kRPS~~eLl~ 674 (683)
..||..|..- .+..|+++.++++
T Consensus 147 E~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 147 EQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp HHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred HHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 9999999755 2467888888774
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0022 Score=66.43 Aligned_cols=143 Identities=13% Similarity=0.025 Sum_probs=75.7
Q ss_pred eEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCc--eeeecccc-----cc
Q 005678 406 ALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH--IVRLWDTF-----EI 478 (683)
Q Consensus 406 ~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn--IV~L~~~f-----~~ 478 (683)
.-++.|+.|....||+... .++ .+++|+...... . ..+..|+.++..|...+ +..++... ..
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~-~--------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~ 93 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVE-K--------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 93 (322)
T ss_dssp EEEEEECC---EEEEEEEE-SSC-CEEEEEECC----C--------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCC-H--------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEE
Confidence 3456788888899999863 334 577898754211 0 12334566665553212 22233211 01
Q ss_pred CCceEEEEEecccCCChhH------------------HHhcCC-C----c---chHHHHH------------HHHHHHHH
Q 005678 479 DQNTFCTVLEYCSGKDLDA------------------VLKATP-V----L---PEREARI------------IIVQIFQG 520 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~------------------~L~~~~-~----L---se~~~~~------------I~~qIa~a 520 (683)
..+..++||+|++|..+.. ...... . . .|..... +...+...
T Consensus 94 ~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~ 173 (322)
T 2ppq_A 94 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 173 (322)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred ECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHH
Confidence 2356789999999865321 101100 0 0 1111000 01123444
Q ss_pred HHHHHhc-----CCceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 521 LIYLNKR-----AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 521 L~yLH~~-----g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
+.+|... ...+||+|+.|.|||++.++.+.|+||+.+..
T Consensus 174 ~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 174 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 5555532 23599999999999999866668999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00061 Score=70.46 Aligned_cols=30 Identities=23% Similarity=0.134 Sum_probs=25.4
Q ss_pred ceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.++|+|+.|.||| ..++.+.|+||..+..-
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 5999999999999 55677899999988643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.006 Score=63.26 Aligned_cols=29 Identities=21% Similarity=0.217 Sum_probs=25.4
Q ss_pred CceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 529 ~~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
..+||+|++|.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999999 4 899999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0033 Score=65.66 Aligned_cols=32 Identities=25% Similarity=0.291 Sum_probs=27.8
Q ss_pred CceEecccCCcceEeCCC----CcEEEEecCCcccc
Q 005678 529 QKIIHYDLKPGNVLFDEF----GVAKVTDFGLSKIV 560 (683)
Q Consensus 529 ~~IIHrDLKP~NILLd~~----g~vKL~DFGls~~~ 560 (683)
..+||+|+.|.|||++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 68999999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0023 Score=70.24 Aligned_cols=75 Identities=17% Similarity=0.181 Sum_probs=48.2
Q ss_pred EEEEecccCceEEEEEEEcc-------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce-eeecccccc
Q 005678 407 LLNLLGKGGFSEVYKAYDLV-------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI-VRLWDTFEI 478 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~-------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI-V~L~~~f~~ 478 (683)
-++.|+.|....||++.... .+..|++|+.... . . ...+.+|..++..|...++ +++++.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~-~-------~~~li~E~~~l~~L~~~g~~P~l~~~~~- 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-T-------ESHLVAESVIFTLLSERHLGPKLYGIFS- 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-C-------HHHHHHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-C-c-------HHHHHHHHHHHHHHHhCCCCCcEEEEeC-
Confidence 45778888889999996532 2578999987431 1 1 0234468888887753333 45665553
Q ss_pred CCceEEEEEecccCCCh
Q 005678 479 DQNTFCTVLEYCSGKDL 495 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL 495 (683)
+ .+|++|++|.+|
T Consensus 147 -~---g~v~e~l~G~~l 159 (429)
T 1nw1_A 147 -G---GRLEEYIPSRPL 159 (429)
T ss_dssp -T---EEEECCCCEEEC
T ss_pred -C---CEEEEEeCCccc
Confidence 2 289999987444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0051 Score=65.37 Aligned_cols=76 Identities=18% Similarity=0.223 Sum_probs=42.3
Q ss_pred EEEEecccCceEEEEEEEcc--------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce-eeeccccc
Q 005678 407 LLNLLGKGGFSEVYKAYDLV--------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI-VRLWDTFE 477 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~--------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI-V~L~~~f~ 477 (683)
.+..|+.|....||++.... .+..|++|+........ .....|..++..+...++ .++++.+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~--------~~~~~E~~~l~~L~~~g~~P~~~~~~- 107 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL--------YNTISEFEVYKTMSKYKIAPQLLNTF- 107 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT--------SCHHHHHHHHHHHHHTTSSCCEEEEE-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce--------ecHHHHHHHHHHHHhcCCCCceEEec-
Confidence 45678888888999986432 13688999875432110 012456777776643333 3555443
Q ss_pred cCCceEEEEEecccCCCh
Q 005678 478 IDQNTFCTVLEYCSGKDL 495 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL 495 (683)
.+ ++||+|++|.++
T Consensus 108 --~~--~~v~e~i~G~~l 121 (369)
T 3c5i_A 108 --NG--GRIEEWLYGDPL 121 (369)
T ss_dssp --TT--EEEEECCCSEEC
T ss_pred --CC--cEEEEEecCCcC
Confidence 22 579999988543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0055 Score=67.94 Aligned_cols=76 Identities=18% Similarity=0.223 Sum_probs=47.3
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce-eeeccccccCCceEEE
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI-VRLWDTFEIDQNTFCT 485 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI-V~L~~~f~~d~~~~~L 485 (683)
-++.|+.|-...+|++.....+..|++|+......... ...+|..++..|...++ .+++++|. + .+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i--------dR~~E~~vl~~L~~~gl~P~ll~~~~--~---G~ 178 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII--------NREREKKISCILYNKNIAKKIYVFFT--N---GR 178 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS--------CHHHHHHHHHHHTTSSSBCCEEEEET--T---EE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc--------CHHHHHHHHHHHHhcCCCCCEEEEeC--C---eE
Confidence 45678888889999997543358899998754321110 11368888888865444 45666552 2 25
Q ss_pred EEecccCCCh
Q 005678 486 VLEYCSGKDL 495 (683)
Q Consensus 486 V~Ey~~ggsL 495 (683)
||||++|.+|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999988554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0064 Score=65.74 Aligned_cols=139 Identities=17% Similarity=0.155 Sum_probs=78.8
Q ss_pred EEEecccCceEEEEEEEcc-------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCc-eeeeccccccC
Q 005678 408 LNLLGKGGFSEVYKAYDLV-------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH-IVRLWDTFEID 479 (683)
Q Consensus 408 ~~~LGkGgfG~Vyka~d~~-------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn-IV~L~~~f~~d 479 (683)
++.|.-|-...+|++.... ++..|++|+...... ......+|..+++.|.-.+ ..++++.+.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~--------~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-- 124 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ--------GVDSLVLESVMFAILAERSLGPQLYGVFP-- 124 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C--------CHHHHHHHHHHHHHHHHTTSSCCEEEEET--
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc--------hHHHHHHHHHHHHHHHhcCCCCeEEEEcC--
Confidence 4567667777899986432 357899998633211 1224457888888774222 345565553
Q ss_pred CceEEEEEecccCCChhHH--------------H---hcC-----CCc--chHHHHHHHHHHHH----------------
Q 005678 480 QNTFCTVLEYCSGKDLDAV--------------L---KAT-----PVL--PEREARIIIVQIFQ---------------- 519 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~--------------L---~~~-----~~L--se~~~~~I~~qIa~---------------- 519 (683)
+ .+||||++|.+|... | ... +.. -+..+..++.++..
T Consensus 125 ~---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 125 E---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp T---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred C---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 2 289999998655311 1 111 111 23444445443321
Q ss_pred ---HHHHHH----hc--CCceEecccCCcceEeCCC----CcEEEEecCCccc
Q 005678 520 ---GLIYLN----KR--AQKIIHYDLKPGNVLFDEF----GVAKVTDFGLSKI 559 (683)
Q Consensus 520 ---aL~yLH----~~--g~~IIHrDLKP~NILLd~~----g~vKL~DFGls~~ 559 (683)
.+..|. .. ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 223332 22 2259999999999999876 7899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.048 Score=57.43 Aligned_cols=33 Identities=21% Similarity=0.311 Sum_probs=28.6
Q ss_pred CceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 529 QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 529 ~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
..++|+|+.|.|||++.++.+.|+||+.+...+
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 359999999999999987889999999886543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.97 E-value=0.58 Score=51.12 Aligned_cols=29 Identities=28% Similarity=0.425 Sum_probs=26.2
Q ss_pred ceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.++|+|+.+.||| +.++.+.|+||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 5999999999999 7778999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.63 E-value=0.49 Score=50.88 Aligned_cols=30 Identities=30% Similarity=0.398 Sum_probs=25.5
Q ss_pred ceEecccCCcceEe------CCCCcEEEEecCCccc
Q 005678 530 KIIHYDLKPGNVLF------DEFGVAKVTDFGLSKI 559 (683)
Q Consensus 530 ~IIHrDLKP~NILL------d~~g~vKL~DFGls~~ 559 (683)
.++|+|+.+.|||+ ++++.+.++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 37899999999999 3467899999998864
|
| >3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} | Back alignment and structure |
|---|
Probab=91.14 E-value=9 Score=38.66 Aligned_cols=18 Identities=22% Similarity=0.525 Sum_probs=7.9
Q ss_pred HHHHHHHHHHHHHHHHHH
Q 005678 356 LASIKREEEAILRERERY 373 (683)
Q Consensus 356 ~~~l~~ee~~~~~~r~~~ 373 (683)
+..+..+...+..+|+.+
T Consensus 152 ~~e~~~e~~~l~~~r~~l 169 (256)
T 3na7_A 152 VKNIKETQQIIFKKKEDL 169 (256)
T ss_dssp HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHH
Confidence 344444444444444444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.77 E-value=1 Score=44.73 Aligned_cols=114 Identities=14% Similarity=0.117 Sum_probs=78.3
Q ss_pred CCCceeeeccccccCCceEEEEEecccC-CChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEe
Q 005678 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSG-KDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLF 543 (683)
Q Consensus 465 ~HpnIV~L~~~f~~d~~~~~LV~Ey~~g-gsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILL 543 (683)
.||++++.- +- .+.+.+.+.++.-+. .++.. ++ .++..+.++++.+|+....+++. =+|.=|.|.||++
T Consensus 43 ~~~~Fl~~~-I~-e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDAE-LT-ELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCEE-EE-ECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred cCCcccceE-EE-EcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence 588888662 33 345677676665542 23333 33 26788888999999988866664 4788899999999
Q ss_pred CCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 005678 544 DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618 (683)
Q Consensus 544 d~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF 618 (683)
+.++.++|.-.|+-..+ +|.- ++...=+-.+=|++..+++++..|
T Consensus 113 ~~~~~p~i~~RGik~~l----------------------~P~~--------~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVV----------------------DPLP--------VSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CTTSCEEESCCEETTTB----------------------SCCC--------CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred cCCCCEEEEEccCccCC----------------------CCCC--------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999987764322 2221 233333457778999999998887
|
| >2b9c_A Striated-muscle alpha tropomyosin; alpha-helix, coiled coil, alanine, axial stagger, radius, SIDE-chain packing, crystal packing; 2.30A {Rattus norvegicus} SCOP: h.1.5.1 | Back alignment and structure |
|---|
Probab=87.41 E-value=9.3 Score=35.57 Aligned_cols=81 Identities=19% Similarity=0.256 Sum_probs=61.2
Q ss_pred HHHHHHHHHHHHHHHH-------HHHHhhhhhhhHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHH
Q 005678 196 EEVTSLHRKVAALEED-------LRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIISDLLISVSKAERQEARL 268 (683)
Q Consensus 196 ~~~~~~~~k~~~le~~-------l~~~~~e~~~~~~~~~~~e~~l~e~~~~~~~~~~k~~~~~~~~~~~~~~~~r~~~r~ 268 (683)
+.++....|+.+++.. +.-++.........+.+|+.+|++.+...+.-..||..+.+++.+-....+|.+-|.
T Consensus 17 erl~~a~~kLeeaek~adE~eR~~k~lE~r~~~deEr~~~lE~qLkeak~~aeeadrKyeE~~RKl~~~E~dLeraeeRa 96 (147)
T 2b9c_A 17 ERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERA 96 (147)
T ss_dssp TTTTHHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHH
Confidence 3344444455555432 444555555677788999999999999999999999999999999999999999988
Q ss_pred HHHhhchh
Q 005678 269 KIRQESVR 276 (683)
Q Consensus 269 ~~~~~~~r 276 (683)
..-+...+
T Consensus 97 e~aE~k~~ 104 (147)
T 2b9c_A 97 ELSEGKCA 104 (147)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 76654443
|
| >3nmd_A CGMP dependent protein kinase; leucine zipper, coiled-coil, structural genomics, berkeley S genomics center, BSGC, dimerization; HET: MSE; 2.27A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.19 E-value=1.6 Score=35.78 Aligned_cols=19 Identities=32% Similarity=0.317 Sum_probs=7.7
Q ss_pred hHHHHHHHHHHHHHHHHHH
Q 005678 222 YQNLCHQLEKELKDVKEYE 240 (683)
Q Consensus 222 ~~~~~~~~e~~l~e~~~~~ 240 (683)
.+..++.++++|.+.....
T Consensus 38 kd~~I~eLEk~L~ekd~eI 56 (72)
T 3nmd_A 38 RDALIDELELELDQKDELI 56 (72)
T ss_dssp HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHH
Confidence 3333444444444444333
|
| >3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} | Back alignment and structure |
|---|
Probab=85.57 E-value=29 Score=34.91 Aligned_cols=7 Identities=29% Similarity=-0.088 Sum_probs=4.0
Q ss_pred cCceEEE
Q 005678 414 GGFSEVY 420 (683)
Q Consensus 414 GgfG~Vy 420 (683)
||-|.|.
T Consensus 189 ~g~avv~ 195 (256)
T 3na7_A 189 KNTSIVT 195 (256)
T ss_dssp GGGSEEE
T ss_pred CCceEEE
Confidence 5566554
|
| >3tnu_B Keratin, type II cytoskeletal 5; coiled-coil, structural support, cytosolic protein; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.42 E-value=4.5 Score=36.66 Aligned_cols=62 Identities=18% Similarity=0.294 Sum_probs=37.1
Q ss_pred cccchHHHHHHHHHHHHHHHHHHHHHhhh----hhhhHHHHHHHHHHHHHHHHHHHHhhhHHHHHH
Q 005678 190 NCSSLEEEVTSLHRKVAALEEDLRKSRQN----AVDYQNLCHQLEKELKDVKEYEQQMKPRRTKII 251 (683)
Q Consensus 190 ~~~~~~~~~~~~~~k~~~le~~l~~~~~e----~~~~~~~~~~~e~~l~e~~~~~~~~~~k~~~~~ 251 (683)
.++.|+.+|..++...+.||..|...+.. +.+++..+..+|.+|..++..-+.....|+..+
T Consensus 44 ~iq~L~~el~~l~~~~~~LE~~l~e~e~~~~~~l~~~q~~i~~lE~eL~~~r~e~~~ql~EYq~Ll 109 (129)
T 3tnu_B 44 MIQRLRAEIDNVKKQCANLQNAIADAEQRGELALKDARNKLAELEEALQKAKQDMARLLREYQELM 109 (129)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHH
Confidence 34566777777777777777666665543 335556666666666666655554444554433
|
| >3a7p_A Autophagy protein 16; coiled-coil, coiled coil, cytoplasmic vesicle, protein transport, transport, vacuole; 2.80A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=85.25 E-value=5.3 Score=37.29 Aligned_cols=70 Identities=11% Similarity=0.106 Sum_probs=52.6
Q ss_pred cccchHHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHH
Q 005678 190 NCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKIISDLLISVSK 260 (683)
Q Consensus 190 ~~~~~~~~~~~~~~k~~~le~~l~~~~~e~~~~~~~~~~~e~~l~e~~~~~~~~~~k~~~~~~~~~~~~~~ 260 (683)
.+..|+.+++.++.||..|+++++.+.+-+...+..+.-|.-|+..+.+....++.-. +.+-++.+....
T Consensus 69 ~I~~L~~El~~l~~ki~dLeeel~eK~K~~e~l~DEl~aLqlq~n~lE~kl~kLq~EN-~~LV~RWM~rk~ 138 (152)
T 3a7p_A 69 TLAILQKELKSKEQEIRRLKEVIALKNKNTERLNAALISGTIENNVLQQKLSDLKKEH-SQLVARWLKKTE 138 (152)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHH
Confidence 5678999999999999999999999998888888888888888887777776665434 334444444443
|
| >3tnu_A Keratin, type I cytoskeletal 14; coiled-coil, structural support, cytosolic protein; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.73 E-value=5.1 Score=36.46 Aligned_cols=63 Identities=19% Similarity=0.249 Sum_probs=41.8
Q ss_pred ccccchHHHHHHHHHHHHHHHHHHHHHhhh----hhhhHHHHHHHHHHHHHHHHHHHHhhhHHHHHH
Q 005678 189 DNCSSLEEEVTSLHRKVAALEEDLRKSRQN----AVDYQNLCHQLEKELKDVKEYEQQMKPRRTKII 251 (683)
Q Consensus 189 ~~~~~~~~~~~~~~~k~~~le~~l~~~~~e----~~~~~~~~~~~e~~l~e~~~~~~~~~~k~~~~~ 251 (683)
..++.|+.+|..++...+.||..|...+.. +.+++..+..+|.+|..++..-+.....|+..+
T Consensus 45 r~iq~L~~el~~l~~~~~sLE~~l~e~e~~~~~~l~~~q~~i~~lE~eL~~~r~em~~ql~EYq~Ll 111 (131)
T 3tnu_A 45 RTMQNLEIELQSQLSMKASLENSLEETKGRYCMQLAQIQEMIGSVEEQLAQLRCEMEQQNQEYKILL 111 (131)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 345677888888888888888777666554 445666667777777777666655555555444
|
| >3q8t_A Beclin-1; autophagy, ATG14L uvrag, apoptosis; 1.90A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=84.49 E-value=14 Score=31.87 Aligned_cols=58 Identities=16% Similarity=0.198 Sum_probs=49.9
Q ss_pred cccchHHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHHHHHHHHHHHHhhhHH
Q 005678 190 NCSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRR 247 (683)
Q Consensus 190 ~~~~~~~~~~~~~~k~~~le~~l~~~~~e~~~~~~~~~~~e~~l~e~~~~~~~~~~k~ 247 (683)
+..++++++..|....+.|-++|.+++++-...+..+..++.+...+.+++.++=..|
T Consensus 5 ~~~~l~~eL~~l~~eE~~L~~eL~~lEke~~~l~~el~~le~E~~~L~~eE~~~w~ey 62 (96)
T 3q8t_A 5 DSEQLQRELKELALEEERLIQELEDVEKNRKVVAENLEKVQAEAERLDQEEAQYQREY 62 (96)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHhhHHHHHHHHH
Confidence 4467889999998888899999999999999999999999999999998887666555
|
| >3u1c_A Tropomyosin alpha-1 chain; anti-parallel coiled coil, contractIle protein; 1.80A {Gallus gallus} PDB: 3u1a_A | Back alignment and structure |
|---|
Probab=84.30 E-value=16 Score=31.74 Aligned_cols=51 Identities=14% Similarity=0.094 Sum_probs=33.1
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHHHHHHHHHHHHhh
Q 005678 194 LEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMK 244 (683)
Q Consensus 194 ~~~~~~~~~~k~~~le~~l~~~~~e~~~~~~~~~~~e~~l~e~~~~~~~~~ 244 (683)
..+++..+..++..+|....+++.++..++.-++++|.++..........+
T Consensus 21 a~drae~~e~~~k~~e~~~~~~E~Ei~sL~kk~~~lE~eld~~ee~L~ea~ 71 (101)
T 3u1c_A 21 ALDRAEQAEADKKAAEERSKQLEDDIVQLEKQLRVTEDSRDQVLEELHKSE 71 (101)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 345566666666777777777777777777777777777766555544433
|
| >2v4h_A NF-kappa-B essential modulator; transcription, metal-binding, NEMO - IKK gamma - NFKB pathwa darpin, transcription regulation; 2.9A {Mus musculus} | Back alignment and structure |
|---|
Probab=83.71 E-value=6.8 Score=34.56 Aligned_cols=38 Identities=13% Similarity=0.148 Sum_probs=30.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHHH
Q 005678 196 EEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKEL 233 (683)
Q Consensus 196 ~~~~~~~~k~~~le~~l~~~~~e~~~~~~~~~~~e~~l 233 (683)
.++++|..++...|+-|.++..+++++.+.+-+++..+
T Consensus 24 ~ei~~L~~~L~~AEeaL~~Kq~~idelk~ei~q~~~~l 61 (110)
T 2v4h_A 24 MQLEDLRQQLQQAEEALVAKQELIDKLKEEAEQHKIVM 61 (110)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 48999999999999999998888777777776666633
|
| >3efg_A Protein SLYX homolog; xanthomonas campestris PV. campestris, coiled-coil, structur genomics, PSI-2, protein structure initiative; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=80.96 E-value=3 Score=34.77 Aligned_cols=53 Identities=13% Similarity=0.132 Sum_probs=41.3
Q ss_pred ccchHHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHHHHHHHHHHHHh
Q 005678 191 CSSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQM 243 (683)
Q Consensus 191 ~~~~~~~~~~~~~k~~~le~~l~~~~~e~~~~~~~~~~~e~~l~e~~~~~~~~ 243 (683)
...+++.|+.|..|+|=.|.-++.+...+..-+..+..|+++++.+.++...+
T Consensus 9 ~~~le~Ri~~LE~klAfqE~tIeeLn~~v~~Qq~~Id~L~~ql~~L~~rl~~~ 61 (78)
T 3efg_A 9 DQELEARLVELETRLSFQEQALTELSEALADARLTGARNAELIRHLLEDLGKV 61 (78)
T ss_dssp CTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTC---
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 35688899999999999999999999988877778888888887777655433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.83 E-value=3.7 Score=40.82 Aligned_cols=114 Identities=12% Similarity=0.092 Sum_probs=76.4
Q ss_pred CCCceeeeccccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHH-HHHhcCCceEecccCCcceEe
Q 005678 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLI-YLNKRAQKIIHYDLKPGNVLF 543 (683)
Q Consensus 465 ~HpnIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~-yLH~~g~~IIHrDLKP~NILL 543 (683)
.||++ +.- ...+.+.+.+.++.-+++.=...++ .++..+.++++.+|+.... +++. -+|.=|.|+||++
T Consensus 48 ~~~~f-~~~--I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI-VRD--IDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS-EEE--EEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEEE
T ss_pred cCCCC-CeE--EEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEEE
Confidence 57877 322 2235677777777654433333333 3678888889999888777 6654 5778889999999
Q ss_pred CCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 005678 544 DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF 618 (683)
Q Consensus 544 d~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF 618 (683)
+.++.++|.-.|+-.. +||.- ++..-=+-++=|++..++.++..|
T Consensus 118 ~~~~~p~i~hRGi~~~----------------------lpP~e--------~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 118 NRALEPFFLHVGVKES----------------------LPPDE--------WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CTTCCEEESCCEETTT----------------------BSSCS--------CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred eCCCcEEEEEcCCccc----------------------CCCCC--------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999998776432 33331 222222446778888888888777
|
| >3u59_A Tropomyosin beta chain; muscle contraction, actin, contractIle protein; 2.50A {Gallus gallus} | Back alignment and structure |
|---|
Probab=80.75 E-value=22 Score=30.65 Aligned_cols=46 Identities=11% Similarity=0.092 Sum_probs=25.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHHHHHHHHHH
Q 005678 195 EEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYE 240 (683)
Q Consensus 195 ~~~~~~~~~k~~~le~~l~~~~~e~~~~~~~~~~~e~~l~e~~~~~ 240 (683)
.+.+..+..++..+|....+.+.++..++.-++.++.++.......
T Consensus 22 ~d~ae~~e~~~k~~e~~~~~~E~ei~sL~kKiq~lE~eld~~~e~l 67 (101)
T 3u59_A 22 IDRAEQAEADKKQAEDRCKQLEEEQQGLQKKLKGTEDEVEKYSESV 67 (101)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3445555555555555566666666555555555555555444433
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A | Back alignment and structure |
|---|
Probab=80.73 E-value=6.5 Score=48.40 Aligned_cols=40 Identities=15% Similarity=0.162 Sum_probs=14.9
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHHHHHH
Q 005678 197 EVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDV 236 (683)
Q Consensus 197 ~~~~~~~k~~~le~~l~~~~~e~~~~~~~~~~~e~~l~e~ 236 (683)
++..+++++.+++..+...+.++.++...+..++.++.++
T Consensus 858 El~~L~~eL~el~~~L~~le~~l~ele~~l~~Le~e~~~l 897 (1184)
T 1i84_S 858 EMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLL 897 (1184)
T ss_dssp HCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3333334444444433333333333333333333333333
|
| >3u1c_A Tropomyosin alpha-1 chain; anti-parallel coiled coil, contractIle protein; 1.80A {Gallus gallus} PDB: 3u1a_A | Back alignment and structure |
|---|
Probab=80.62 E-value=23 Score=30.67 Aligned_cols=60 Identities=17% Similarity=0.173 Sum_probs=41.5
Q ss_pred cchHHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHHHHHHHHHHHHhhhHHHHHH
Q 005678 192 SSLEEEVTSLHRKVAALEEDLRKSRQNAVDYQNLCHQLEKELKDVKEYEQQMKPRRTKII 251 (683)
Q Consensus 192 ~~~~~~~~~~~~k~~~le~~l~~~~~e~~~~~~~~~~~e~~l~e~~~~~~~~~~k~~~~~ 251 (683)
++|+.+......+...+|.++...+.+.....+.+..|.+.++.+.+..+....++....
T Consensus 12 ~~lk~e~e~a~drae~~e~~~k~~e~~~~~~E~Ei~sL~kk~~~lE~eld~~ee~L~ea~ 71 (101)
T 3u1c_A 12 QMLKLDKENALDRAEQAEADKKAAEERSKQLEDDIVQLEKQLRVTEDSRDQVLEELHKSE 71 (101)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 466677777777778888888888887777777777777777777666655554444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 683 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-63 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-60 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-59 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-57 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-57 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-56 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-55 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-50 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-46 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-45 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-44 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-42 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-40 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-17 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 5e-65
Identities = 73/320 (22%), Positives = 121/320 (37%), Gaps = 56/320 (17%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
++ + + ++ LG G V+K +A K + K + IRE
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK------LIHLEIKPAIRNQIIRE 54
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQI 517
+ +IV + F +E+ G LD VLK +PE+ + + +
Sbjct: 55 LQVLHECNSPYIVGFYGAFY-SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
+GL YL ++ KI+H D+KP N+L + G K+ DFG+S + D + + G
Sbjct: 114 IKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-------ANSFVG 165
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
T Y+ PE + + S + D+WS G+ +M GR P +E L ++
Sbjct: 166 TRSYMSPERLQGTH---YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
Query: 638 KVEFPSRP--------------------------------------AVSNEAKDLIRRCL 659
E P RP S E +D + +CL
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 660 TYNQAERPDVLTLAQDPYLT 679
N AER D+ L ++
Sbjct: 283 IKNPAERADLKQLMVHAFIK 302
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-64
Identities = 79/279 (28%), Positives = 124/279 (44%), Gaps = 21/279 (7%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ ++ LG G F +VYKA + A K+ + K + + + E +I +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-------DTKSEEELEDYMVEIDILAS 65
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLI 522
H +IV+L D F +N ++E+C+G +DAV+ + L E + +++ Q L
Sbjct: 66 CDHPNIVKLLDAFY-YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL+ KIIH DLK GN+LF G K+ DFG+S ++ GT +++
Sbjct: 125 YLHDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-----IQRRDSFIGTPYWM 177
Query: 583 PPECF--ELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640
PE E SK K DVWS GI +M P +L+ I K+
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK---IAKSEPPT 234
Query: 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
S+ KD +++CL N R L Q P++T
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-63
Identities = 80/276 (28%), Positives = 122/276 (44%), Gaps = 23/276 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ + LGKG F VY A + +A K+ ++ +K RE I
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKV----LFKAQLEKAGVEHQLRREVEIQSH 62
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H +I+RL+ F D +LEY + L+ E+ I ++ L Y
Sbjct: 63 LRHPNILRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
+ +++IH D+KP N+L G K+ DFG S + GT YLP
Sbjct: 122 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------RRTTLCGTLDYLP 172
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE E KVD+WS G+L Y+ L G+ PF + QE T + +VEF
Sbjct: 173 PEMIEGRM---HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVEFTF 223
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
V+ A+DLI R L +N ++RP + + + P++T
Sbjct: 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (537), Expect = 2e-63
Identities = 64/278 (23%), Positives = 110/278 (39%), Gaps = 20/278 (7%)
Query: 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIH 461
++ L +G G F VY A D+ VA K ++ + ++ + I+E
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKK--MSYSGKQSNEK--WQDIIKEVRFL 69
Query: 462 KTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
+ L H + ++ + ++T V+EYC G D + L E E + QGL
Sbjct: 70 QKLRHPNTIQYRGCYL-REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
YL+ +IH D+K GN+L E G+ K+ DFG + I+ + GT ++
Sbjct: 129 AYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---------ANSFVGTPYW 177
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
+ PE KVDVWS GI ++ + P + + I +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPA 233
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
S ++ + CL +RP L + ++
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 206 bits (524), Expect = 5e-62
Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 21/283 (7%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKL--HGLNAQWSEDKKQSYIRHAIREYNIH 461
Y +LG+G S V + + A K+ +S ++ Q ++E +I
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 462 KTL-VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
+ + H +I++L DT+E F V + +L L L E+E R I+ + +
Sbjct: 64 RKVSGHPNIIQLKDTYE-TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 521 LIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
+ L+K I+H DLKP N+L D+ K+TDFG S ++ E + GT
Sbjct: 123 ICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------EKLREVCGTPS 174
Query: 581 YLPPE---CFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
YL PE C P +VD+WS G++ Y +L G PF H + + I +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSG 230
Query: 638 KVEF--PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+F P S+ KDL+ R L +R P+
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 9e-62
Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 17/276 (6%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ L+ LG+G + EV A + V VA K + + +E I+K
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK------IVDMKRAVDCPENIKKEICINKM 59
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H ++V+ + N LEYCSG +L ++ +PE +A+ Q+ G++Y
Sbjct: 60 LNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ I H D+KP N+L DE K++DFGL+ + + L ++ GT Y+
Sbjct: 119 LHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN---NRERLLNKMCGTLPYVA 173
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE L + + VDVWS GI+ ML G P+ + K +K
Sbjct: 174 PEL--LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNP 228
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ + L+ + L N + R + + +D +
Sbjct: 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 9e-62
Identities = 67/283 (23%), Positives = 108/283 (38%), Gaps = 24/283 (8%)
Query: 401 LNHRYALLNL-LGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
+ R+ ++ +G+G F VYK D VA +S + E
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL-----QDRKLTKSERQRFKEEAE 60
Query: 460 IHKTLVHHHIVRLWDTFE---IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ 516
+ K L H +IVR +D++E + V E + L LK V+ + R Q
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 120
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLF-DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
I +GL +L+ R IIH DLK N+ G K+ D GL+ +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-------FAKAV 173
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT ++ PE +E VDV++ G+ +M P+ Q +I R +
Sbjct: 174 IGTPEFMAPEMYEEK----YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVT 226
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ E K++I C+ N+ ER + L +
Sbjct: 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-61
Identities = 66/279 (23%), Positives = 116/279 (41%), Gaps = 22/279 (7%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y +G+G VY A D+ + VA + L ++Q I E + +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-------QQQPKKELIINEILVMRE 73
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
+ +IV D++ + V+EY +G L V+ T + E + + + Q L +
Sbjct: 74 NKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEF 131
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ ++IH D+K N+L G K+TDFG + + S GT +++
Sbjct: 132 LHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMA 184
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE KVD+WS GI+ +M+ G P+ ++ + I E +
Sbjct: 185 PEVVTRKA---YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQN 238
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682
+S +D + RCL + +R L Q +L +K
Sbjct: 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-60
Identities = 73/294 (24%), Positives = 124/294 (42%), Gaps = 33/294 (11%)
Query: 393 SRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIR 452
SR ++++L +G G + K + + + K + +K +
Sbjct: 1 SRAEDYEVLY-------TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-----Q 48
Query: 453 HAIREYNIHKTLVHHHIVRLWDTF-EIDQNTFCTVLEYCSGKDLDAVL----KATPVLPE 507
+ E N+ + L H +IVR +D + T V+EYC G DL +V+ K L E
Sbjct: 49 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 108
Query: 508 REARIIIVQIFQGLIYLNKR---AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDV 564
++ Q+ L ++R ++H DLKP NV D K+ DFGL++I+ D
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD- 167
Query: 565 GSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQ 624
GT +Y+ PE + K D+WS G L Y++ PF +Q
Sbjct: 168 ----TSFAKAFVGTPYYMSPEQMNRMS---YNEKSDIWSLGCLLYELCALMPPF-TAFSQ 219
Query: 625 ERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ + + I + + P R S+E ++I R L RP V + ++P +
Sbjct: 220 KELAGK--IREGKFRRIPYR--YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-59
Identities = 62/278 (22%), Positives = 109/278 (39%), Gaps = 16/278 (5%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
++I + + + +G G F VYK H VA K+ + A + ++ E
Sbjct: 3 WEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQ-----LQAFKNE 54
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQ 516
+ + H +I+ V ++C G L L + I Q
Sbjct: 55 VGVLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
QG+ YL+ + IIH DLK N+ E K+ DFGL+ + GS Q +
Sbjct: 113 TAQGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH---QFEQLS 167
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636
G+ ++ PE + S + DV++ GI+ Y+++ G+ P+ + +++I+
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
R K L+ CL + ERP +
Sbjct: 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-59
Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 19/275 (6%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ +LG+G FS V A +L R A K+ E+K + + RE ++
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSR 64
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H V+L+ TF+ D L Y +L ++ E R +I L Y
Sbjct: 65 LDHPFFVKLYFTFQ-DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ + IIH DLKP N+L +E ++TDFG +K++ + + GT Y+
Sbjct: 124 LHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQARANSFVGTAQYVS 178
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE D+W+ G + YQ++ G PF + I ++ I + +FP
Sbjct: 179 PELLTEKS---ACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQK---IIKLEYDFPE 231
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ +A+DL+ + L + +R + L
Sbjct: 232 K--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 2e-57
Identities = 76/283 (26%), Positives = 122/283 (43%), Gaps = 25/283 (8%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
+ Y ++LG G FSEV A D + VA K ++ + E +
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIK------CIAKKALEGKEGSMENEIAV 60
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
+ H +IV L D +E +++ SG +L + ER+A +I Q+
Sbjct: 61 LHKIKHPNIVALDDIYE-SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 521 LIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
+ YL+ I+H DLKP N+L+ DE ++DFGLSK+ + + S G
Sbjct: 120 VKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG------SVLSTACG 171
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
T Y+ PE S VD WS G++ Y +L G PF + + + I+KA
Sbjct: 172 TPGYVAPEVLAQKP---YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ---ILKAE 225
Query: 638 -KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ + P +S+ AKD IR + + +R Q P++
Sbjct: 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 6e-57
Identities = 75/295 (25%), Positives = 118/295 (40%), Gaps = 34/295 (11%)
Query: 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
L+ LG+G F+ VYKA D ++ VA K + + K R A+RE + + L H
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKK--IKLGHRSEAKDGINRTALREIKLLQELSH 59
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526
+I+ L D F ++ V ++ + + VL + ++ QGL YL++
Sbjct: 60 PNIIGLLDAFG-HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
I+H DLKP N+L DE GV K+ DFGL+K + T WY PE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----NRAYTHQVVTRWYRAPE- 170
Query: 587 FELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR-------------EDTI 633
L + VD+W+ G + ++L D +++ R D
Sbjct: 171 -LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 634 IKARKVEFPSRP---------AVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
V F S P A ++ DLI+ +N R + Y +
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 194 bits (495), Expect = 7e-57
Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 29/286 (10%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
+L+ Y + LG G F V++ + A K +S +E
Sbjct: 23 HVLD-HYDIHEELGTGAFGVVHRVTERATGNNFAAKF-------VMTPHESDKETVRKEI 74
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQI 517
L H +V L D FE D N + E+ SG +L + + E EA + Q+
Sbjct: 75 QTMSVLRHPTLVNLHDAFE-DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLF--DEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
+GL ++++ +H DLKP N++F K+ DFGL+ ++ +
Sbjct: 134 CKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP------KQSVKVT 185
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT + PE E + D+WS G+L Y +L G PFG + E + +K
Sbjct: 186 TGTAEFAAPEVAEGKP---VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VK 238
Query: 636 ARKVEFPSR--PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ +S + KD IR+ L + R + + P+LT
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 191 bits (486), Expect = 1e-56
Identities = 76/272 (27%), Positives = 117/272 (43%), Gaps = 20/272 (7%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
L+ RY L +LG GG SEV+ A DL HR VA K+ L A + D + RE
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV--LRADLARDPS--FYLRFRREAQN 60
Query: 461 HKTLVHHHIVRLWDTFEIDQN---TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQI 517
L H IV ++DT E + V+EY G L ++ + + A +I
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
Q L + ++ IIH D+KP N++ KV DFG+++ + D + T+ G
Sbjct: 121 CQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS--GNSVTQTAAVIG 176
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
T YL PE + + ++ DV+S G + Y++L G PF D +
Sbjct: 177 TAQYLSPEQA---RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ----HVRE 229
Query: 638 KVEFPS--RPAVSNEAKDLIRRCLTYNQAERP 667
PS +S + ++ + L N R
Sbjct: 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRY 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-55
Identities = 62/281 (22%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y + LG+G F V++ + + K K + +E +I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--------KVKGTDQVLVKKEISILNI 57
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV-LPEREARIIIVQIFQGLI 522
H +I+ L ++FE + E+ SG D+ + + L ERE + Q+ + L
Sbjct: 58 ARHRNILHLHESFE-SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 523 YLNKRAQKIIHYDLKPGNVLFD--EFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
+L+ I H+D++P N+++ K+ +FG ++ ++ +
Sbjct: 117 FLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG------DNFRLLFTAPE 168
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640
Y PE + ++S+ D+WS G L Y +L G PF + Q+ I I +
Sbjct: 169 YYAPEVH---QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYT 221
Query: 641 FPSR--PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
F +S EA D + R L + R Q P+L
Sbjct: 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-55
Identities = 77/282 (27%), Positives = 118/282 (41%), Gaps = 29/282 (10%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
L +Y + LLG GGF VY + ++ VA K + S+ + E +
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV-EKDRISDWGELPNGTRVPMEVVL 60
Query: 461 HKTLVHHH--IVRLWDTFEIDQNTFCTVLEYCSGK-DLDAVLKATPVLPEREARIIIVQI 517
K + ++RL D F ++F +LE DL + L E AR Q+
Sbjct: 61 LKKVSSGFSGVIRLLDWF-ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
+ + + + ++H D+K N+L D G K+ DFG +++D V +
Sbjct: 120 LEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-------YTDFD 170
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636
GT Y PPE + VWS GIL Y M+ G PF HD+ I
Sbjct: 171 GTRVYSPPEW--IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIR 218
Query: 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+V F R VS+E + LIR CL ++RP + P++
Sbjct: 219 GQVFFRQR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-55
Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 21/276 (7%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ L +LGKG F +V+ A +++ A K + +D + + + +
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV---EKRVLSLA 59
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
H + ++ TF+ + V+EY +G DL +++ A +I GL +
Sbjct: 60 WEHPFLTHMFCTFQ-TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ + I++ DLK N+L D+ G K+ DFG+ K T+ GT Y+
Sbjct: 119 LHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-----DAKTNTFCGTPDYIA 171
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE K + VD WS G+L Y+ML G+ PF H Q +E + I+ +P
Sbjct: 172 PEILLGQK---YNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFH---SIRMDNPFYPR 224
Query: 644 RPAVSNEAKDLIRRCLTYNQAERPDVLT-LAQDPYL 678
+ EAKDL+ + +R V + Q P
Sbjct: 225 W--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 188 bits (478), Expect = 2e-54
Identities = 73/281 (25%), Positives = 118/281 (41%), Gaps = 28/281 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y +L LG G F V++ + R K +N + DK E +I
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYT-----VKNEISIMNQ 82
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIFQGLI 522
L H ++ L D FE D+ +LE+ SG +L D + + E E + Q +GL
Sbjct: 83 LHHPKLINLHDAFE-DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEF--GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
++++ I+H D+KP N++ + K+ DFGL+ + D E+ T
Sbjct: 142 HMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD------EIVKVTTATAE 193
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640
+ PE + + D+W+ G+L Y +L G PF + E + +K E
Sbjct: 194 FAAPEIVDREP---VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWE 246
Query: 641 FPSR--PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
F +VS EAKD I+ L +R V + P+L
Sbjct: 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 7e-53
Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 25/285 (8%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI-REYN 459
++ Y LG G F+ V K + A K + + ++ ++ R I RE +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVS 65
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
I K + H +++ L + +E ++ +LE +G +L L L E EA + QI
Sbjct: 66 ILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVA----KVTDFGLSKIVEDDVGSQGMELTSQG 575
G+ YL+ +I H+DLKP N++ + V K+ DFGL+ ++
Sbjct: 125 GVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG------NEFKNI 176
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
GT ++ PE + + D+WS G++ Y +L G PF D QE + +
Sbjct: 177 FGTPEFVAPEIVNYEP---LGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VS 229
Query: 636 ARKVEFPSR--PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
A EF S AKD IRR L + +R + Q P++
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 182 bits (462), Expect = 1e-52
Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 24/263 (9%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ +L LG G F V+ RY A K+ L + KQ + H E + +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQ--VEHTNDERLMLSIV 61
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
H I+R+W TF+ D +++Y G +L ++L+ + P A+ ++ L YL
Sbjct: 62 THPFIIRMWGTFQ-DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ + II+ DLKP N+L D+ G K+TDFG +K V D + GT Y+ P
Sbjct: 121 HS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL--------CGTPDYIAP 170
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
E + +D WS GIL Y+ML G PF T + + I ++ FP
Sbjct: 171 EVVSTKP---YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILNAELRFP-- 221
Query: 645 PAVSNEAKDLIRRCLTYNQAERP 667
P + + KDL+ R +T + ++R
Sbjct: 222 PFFNEDVKDLLSRLITRDLSQRL 244
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-51
Identities = 70/309 (22%), Positives = 118/309 (38%), Gaps = 43/309 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y L +G+G F EV+KA + VA K E++K+ + A+RE I +
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALREIKILQL 65
Query: 464 LVHHHIVRLWDTFE-------IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQ 516
L H ++V L + + + V ++C + E + ++
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 517 IFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGA 576
+ GL Y+++ KI+H D+K NVL GV K+ DFGL++ SQ T++
Sbjct: 126 LLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR-V 182
Query: 577 GTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE----------- 625
T WY PPE L +D+W AG + +M + Q
Sbjct: 183 VTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 626 ------------RILREDTIIKARKVEFPSR---PAVSNEAKDLIRRCLTYNQAERPDVL 670
+ + ++K +K + R A DLI + L + A+R D
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 671 TLAQDPYLT 679
+
Sbjct: 301 DALNHDFFW 309
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-51
Identities = 64/273 (23%), Positives = 103/273 (37%), Gaps = 30/273 (10%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
LL +GKG F +V VA K K + + + E ++
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI---------KNDATAQAFLAEASVMTQ 56
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGL 521
L H ++V+L ++ V EY + L L++ VL + + + +
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 522 IYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWY 581
YL +H DL NVL E VAKV+DFGL+K G +
Sbjct: 117 EYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--------QDTGKLPVKW 166
Query: 582 LPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641
PE K S+K DVWS GIL +++ R + ++ + K K++
Sbjct: 167 TAPEALREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--VEKGYKMDA 221
Query: 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
P ++++ C + A RP L L +
Sbjct: 222 P--DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-51
Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 25/275 (9%)
Query: 409 NLLGKGGFSEVYKAYDLVEH--RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH 466
LG G F V K Y ++ + VA K+ +E + + E N+ + L +
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-----KNEANDPALKDELLAEANVMQQLDN 67
Query: 467 HHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK 526
+IVR+ E + ++ V+E L+ L+ + ++ ++ Q+ G+ YL +
Sbjct: 68 PYIVRMIGICEAE--SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPEC 586
+H DL NVL AK++DFGLSK + D + + G + PEC
Sbjct: 126 S--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPEC 181
Query: 587 FELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVEFPSRP 645
K SSK DVWS G+L ++ +G++P+ + E + K ++ P
Sbjct: 182 INYYKF---SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---LEKGERMGCP--A 233
Query: 646 AVSNEAKDLIRRCLTYNQAERP---DVLTLAQDPY 677
E DL+ C TY+ RP V ++ Y
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-51
Identities = 77/316 (24%), Positives = 131/316 (41%), Gaps = 45/316 (14%)
Query: 392 GSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYI 451
G F+ + RY L+ +G+G + V AYD V VA K + S + Q+Y
Sbjct: 1 GQVFD----VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYC 50
Query: 452 RHAIREYNIHKTLVHHHIVRLWDTFE---IDQNTFCTVLEYCSGKDLDAVLKATPVLPER 508
+ +RE I H +I+ + D I+Q ++ + G DL +LK L
Sbjct: 51 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSND 109
Query: 509 EARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQG 568
+ QI +GL Y++ ++H DLKP N+L + K+ DFGL+++ + D
Sbjct: 110 HICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD--HDH 165
Query: 569 MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERIL 628
++ T WY PE + + + +D+WS G + +ML R F +++
Sbjct: 166 TGFLTEYVATRWYRAPEI--MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 223
Query: 629 REDTIIKARKVEFPSR-------------------------PAVSNEAKDLIRRCLTYNQ 663
I+ + E + P ++A DL+ + LT+N
Sbjct: 224 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 283
Query: 664 AERPDVLTLAQDPYLT 679
+R +V PYL
Sbjct: 284 HKRIEVEQALAHPYLE 299
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 7e-51
Identities = 73/295 (24%), Positives = 114/295 (38%), Gaps = 34/295 (11%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
I++ +LG G +V + ++ A K A RE
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK------------MLQDCPKARREVE 56
Query: 460 IHKTLVHH-HIVRLWDTFE---IDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARII 513
+H HIVR+ D +E + V+E G +L + ++ EREA I
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 514 IVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF---GVAKVTDFGLSKIVEDDVGSQGME 570
+ I + + YL+ I H D+KP N+L+ + K+TDFG +K
Sbjct: 117 MKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH------N 168
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630
+ T +Y+ PE K D+WS G++ Y +L G PF +
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEK---YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225
Query: 631 DTIIKARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSKK 683
T I+ + EFP+ VS E K LIR L +R + P++ S K
Sbjct: 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 7e-51
Identities = 74/280 (26%), Positives = 117/280 (41%), Gaps = 27/280 (9%)
Query: 411 LGKGGFSEVYKAYDLV--EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468
LG G F V + + + VA K + +++ +RE I L + +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIK------VLKQGTEKADTEEMMREAQIMHQLDNPY 70
Query: 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKR 527
IVRL + V+E G L L +P ++ Q+ G+ YL ++
Sbjct: 71 IVRLIGVCQ--AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 128
Query: 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECF 587
+H DL NVL AK++DFGLSK + D S G + PEC
Sbjct: 129 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECI 184
Query: 588 ELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVEFPSRPA 646
K SS+ DVWS G+ ++ L +G++P+ + E + I + +++E P P
Sbjct: 185 NFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQGKRMECP--PE 236
Query: 647 VSNEAKDLIRRCLTYNQAERPDVLTLAQ---DPYLTYSKK 683
E L+ C Y +RPD LT+ Q Y + + K
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 178 bits (452), Expect = 1e-50
Identities = 58/264 (21%), Positives = 107/264 (40%), Gaps = 16/264 (6%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+++ ++G+GGF EVY + A K + + ++ + ++ T
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVST 63
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
IV + F + +L+ +G DL L V E + R +I GL +
Sbjct: 64 GDCPFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
++ R +++ DLKP N+L DE G +++D GL+ GT+ Y+
Sbjct: 123 MHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------KPHASVGTHGYMA 173
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE L K S D +S G + +++L G PF +T++ + + +
Sbjct: 174 PEV--LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMAVEL 228
Query: 644 RPAVSNEAKDLIRRCLTYNQAERP 667
+ S E + L+ L + R
Sbjct: 229 PDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-50
Identities = 64/285 (22%), Positives = 110/285 (38%), Gaps = 29/285 (10%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
+++ L+ LG G F EV+ Y H VA K + + E
Sbjct: 8 WEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSL--------KQGSMSPDAFLAE 58
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP--VLPEREARIIIV 515
N+ K L H +VRL+ Q + EY L LK L + +
Sbjct: 59 ANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
QI +G+ ++ +R IH DL+ N+L + K+ DFGL++++ED+
Sbjct: 117 QIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGA 170
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
+ PE + K DVWS GIL +++ R T +++ + +
Sbjct: 171 KFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--LER 225
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP---DVLTLAQDPY 677
++ P E L+R C +RP + ++ +D +
Sbjct: 226 GYRMVRPDN--CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 8e-50
Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 24/272 (8%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ +G G F V+ Y L VA K + I E +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI--------REGAMSEEDFIEEAEVMMK 56
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQIFQGLI 522
L H +V+L+ +Q C V E+ L D + + + + + +G+
Sbjct: 57 LSHPKLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
YL + +IH DL N L E V KV+DFG+++ V DD ++ +
Sbjct: 116 YLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWA 169
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642
PE F S+ SSK DVWS G+L +++ + +++ ++ + I ++ P
Sbjct: 170 SPEVFSFSR---YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--ISTGFRLYKP 224
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
S ++ C +RP L +
Sbjct: 225 RL--ASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 5e-49
Identities = 77/263 (29%), Positives = 119/263 (45%), Gaps = 21/263 (7%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
+ L LLGKG F +V + RY A K+ L + K + + H + E + +
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDE--VAHTVTESRVLQNT 62
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYL 524
H + L F+ + C V+EY +G +L L V E AR +I L YL
Sbjct: 63 RHPFLTALKYAFQ-THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 525 NKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPP 584
+ + +++ D+K N++ D+ G K+TDFGL K D GT YL P
Sbjct: 122 HS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-----GATMKTFCGTPEYLAP 174
Query: 585 ECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSR 644
E E + VD W G++ Y+M+ GR PF ++Q ER+ +I ++ FP
Sbjct: 175 EVLEDND---YGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE---LILMEEIRFPRT 227
Query: 645 PAVSNEAKDLIRRCLTYNQAERP 667
+S EAK L+ L + +R
Sbjct: 228 --LSPEAKSLLAGLLKKDPKQRL 248
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 9e-49
Identities = 68/286 (23%), Positives = 105/286 (36%), Gaps = 28/286 (9%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
++I L LG+G F EV+ R VA K ++E
Sbjct: 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTL--------KPGTMSPEAFLQE 62
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIV 515
+ K L H +V+L+ + V EY S L LK L + +
Sbjct: 63 AQVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
QI G+ Y+ +H DL+ N+L E V KV DFGL++++ED+
Sbjct: 121 QIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGA 174
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635
+ PE + + K DVWS GIL ++ R +L + + +
Sbjct: 175 KFPIKWTAPEAALYGR---FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--VER 229
Query: 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ--DPYLT 679
++ P P DL+ +C ERP L + Y T
Sbjct: 230 GYRMPCP--PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 25/283 (8%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRY---VACKLHGLNAQWSEDKKQSYIRH 453
+++I R L +G+G F +V++ + VA K S
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK------TCKNCTSDSVREK 54
Query: 454 AIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARI 512
++E + H HIV+L +N ++E C+ +L + L +
Sbjct: 55 FLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 112
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELT 572
Q+ L YL + + +H D+ NVL K+ DFGLS+ +ED
Sbjct: 113 YAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKA 166
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632
S+G ++ PE + +S DVW G+ +++L ++
Sbjct: 167 SKGKLPIKWMAPESINFRR---FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-- 221
Query: 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
I ++ P P L+ +C Y+ + RP L
Sbjct: 222 IENGERLPMP--PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 2e-48
Identities = 71/300 (23%), Positives = 116/300 (38%), Gaps = 39/300 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y L +G+G + V+KA + H VA K L +D + A+RE + K
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICLLKE 57
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H +IVRL D V E+C L + + Q+ +GL +
Sbjct: 58 LKHKNIVRLHDVLH-SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
+ + ++H DLKP N+L + G K+ +FGL++ + S T WY P
Sbjct: 117 CHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----VRCYSAEVVTLWYRP 169
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR-------------- 629
P+ L L S+ +D+WSAG +F ++ RP + L+
Sbjct: 170 PD--VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227
Query: 630 ----------EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
+ A P ++ +DL++ L N +R Q PY +
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-48
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 39/299 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+ + +G+G + VYKA + + VA K L + + + AIRE ++ K
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-----DTETEGVPSTAIREISLLKE 57
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAV-LKATPVLPEREARIIIVQIFQGLI 522
L H +IV+L D +N V E+ + A +P + + Q+ QGL
Sbjct: 58 LNHPNIVKLLDVIH-TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 523 YLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYL 582
+ + +++H DLKP N+L + G K+ DFGL++ + + T WY
Sbjct: 117 FCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-----VRTYTHEVVTLWYR 169
Query: 583 PPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR------------- 629
PE L S+ VD+WS G +F +M+ R F D +++ R
Sbjct: 170 APE--ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 630 -EDTIIKARKVEFPSR---------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
T + K FP P + + + L+ + L Y+ +R P+
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 4e-48
Identities = 51/281 (18%), Positives = 92/281 (32%), Gaps = 21/281 (7%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
+ +RY L +G G F ++Y D+ VA KL ++ E I
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE---------CVKTKHPQLHIESKI 55
Query: 461 HKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
+K + + + + V+E D + + ++ Q+
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115
Query: 521 LIYLNKRAQKIIHYDLKPGNVLF---DEFGVAKVTDFGLSKIVEDDVGSQGMEL--TSQG 575
+ Y++ + IH D+KP N L + + + DFGL+K D Q +
Sbjct: 116 IEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF--GHDQTQERILREDTI 633
GT Y S + D+ S G + G P+ T+ + +
Sbjct: 174 TGTARYASINTH---LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
K +E + C + ++PD L Q
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 5e-48
Identities = 60/284 (21%), Positives = 113/284 (39%), Gaps = 20/284 (7%)
Query: 396 NNF--QILNHRYALLNLLGKGGFSEVYKAYDLVE-HRYVACKLHGLNAQWSEDKKQSYIR 452
F +I + ++G G F EV + + R + + L + ++E ++ R
Sbjct: 17 REFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR----R 72
Query: 453 HAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAV-LKATPVLPEREAR 511
+ E +I H +++ L + E+ LD+ + +
Sbjct: 73 DFLSEASIMGQFDHPNVIHLEGVVT-KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV 131
Query: 512 IIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMEL 571
++ I G+ YL +H DL N+L + V KV+DFGLS+ +EDD
Sbjct: 132 GMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 189
Query: 572 TSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILRE 630
G + PE + K +S DVWS GI+ ++++ +G RP+ D T + ++
Sbjct: 190 ALGGKIPIRWTAPEAIQYRK---FTSASDVWSYGIVMWEVMSYGERPY-WDMTNQDVINA 245
Query: 631 DTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
I + ++ P + L+ C ++ RP +
Sbjct: 246 --IEQDYRLPPPMD--CPSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-47
Identities = 63/295 (21%), Positives = 117/295 (39%), Gaps = 38/295 (12%)
Query: 398 FQILN-HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIR 456
+ +L+ + +++G+G F +V KA + + + + S+D R
Sbjct: 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAG 59
Query: 457 EYNIHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPV----------- 504
E + L HH +I+ L E + +EY +L L+ + V
Sbjct: 60 ELEVLCKLGHHPNIINLLGACEHRGYLYL-AIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 505 -----LPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559
L ++ + +G+ YL+++ + IH DL N+L E VAK+ DFGLS+
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRG 176
Query: 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFG 619
E V + G ++ E S ++ DVWS G+L ++++
Sbjct: 177 QEVYV------KKTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLGGTPY 227
Query: 620 HDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
T + + + + ++E P +E DL+R+C ERP +
Sbjct: 228 CGMTCAELYEK--LPQGYRLEKPLN--CDDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 2e-47
Identities = 55/278 (19%), Positives = 103/278 (37%), Gaps = 16/278 (5%)
Query: 399 QILNHR-YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
+IL + + +LG G F VYK + E V + + E + + E
Sbjct: 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV--AIKELREATSPKANKEILDE 61
Query: 458 YNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQI 517
+ ++ + H+ RL G LD V + + + VQI
Sbjct: 62 AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
+G+ YL R +++H DL NVL K+TDFGL+K++ + + G
Sbjct: 121 AKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKV 175
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
++ E + + + DVWS G+ ++++ I + K
Sbjct: 176 PIKWMALESI---LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--LEKGE 230
Query: 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675
++ P P + + ++ +C + RP L +
Sbjct: 231 RLPQP--PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 55/277 (19%), Positives = 97/277 (35%), Gaps = 16/277 (5%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKA-YDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREY 458
I LL LG G F V + +D + V+ + L + + IRE
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREV 62
Query: 459 NIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDL-DAVLKATPVLPEREARIIIVQI 517
N +L H +++RL+ V E L D + K VQ+
Sbjct: 63 NAMHSLDHRNLIRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 518 FQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAG 577
+G+ YL + + IH DL N+L + K+ DFGL + + + +
Sbjct: 121 AEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN--DDHYVMQEHRKV 176
Query: 578 TYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637
+ + PE + S D W G+ ++M + +IL + I
Sbjct: 177 PFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK---IDKE 230
Query: 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
P + +++ +C + +RP + L
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 166 bits (420), Expect = 5e-47
Identities = 45/284 (15%), Positives = 96/284 (33%), Gaps = 23/284 (8%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYN 459
++ Y + +G+G F +++ +L+ ++ VA K ++S EY
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE---------PRRSDAPQLRDEYR 52
Query: 460 IHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
+K L + F + V++ D + + + Q+
Sbjct: 53 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDE-----FGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
+ ++++ +++ D+KP N L + V DFG+ K D V Q + +
Sbjct: 113 RVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 575 G--AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632
+GT Y+ + S + D+ + G +F L G P+ + + +
Sbjct: 171 KNLSGTARYMSINTHLGRE---QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227
Query: 633 IIKARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
I + ++ E + PD L
Sbjct: 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 9e-47
Identities = 59/310 (19%), Positives = 110/310 (35%), Gaps = 48/310 (15%)
Query: 394 RFNNFQILNHRYALLNLLGKGGFSEVYKAY-----DLVEHRYVACKLHGLNAQWSEDKKQ 448
+ + + + + +G+G F V++A VA K E+
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK------MLKEEASA 57
Query: 449 SYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK-------- 500
RE + + +IV+L C + EY + DL+ L+
Sbjct: 58 DMQADFQREAALMAEFDNPNIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 501 ----------------ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD 544
P L E I Q+ G+ YL++ +K +H DL N L
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVG 174
Query: 545 EFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSA 604
E V K+ DFGLS+ + + A ++PPE +++ DVW+
Sbjct: 175 ENMVVKIADFGLSRNIYSA---DYYKADGNDAIPIRWMPPESI---FYNRYTTESDVWAY 228
Query: 605 GILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQA 664
G++ +++ + E ++ + + P E +L+R C + A
Sbjct: 229 GVVLWEIFSYGLQPYYGMAHEEVIYY--VRDGNILACPEN--CPLELYNLMRLCWSKLPA 284
Query: 665 ERPDVLTLAQ 674
+RP ++ +
Sbjct: 285 DRPSFCSIHR 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 164 bits (416), Expect = 1e-46
Identities = 63/298 (21%), Positives = 115/298 (38%), Gaps = 39/298 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
+Y L +G+G + VYKA + + K+ E + + IRE +I K
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKE 56
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
L H +IV+L+D + V E+ + L A+ ++Q+ G+ Y
Sbjct: 57 LKHSNIVKLYDVI-HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
+ ++++H DLKP N+L + G K+ DFGL++ V E+ T WY
Sbjct: 116 CHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRA 168
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILR-------------- 629
P+ L + S+ +D+WS G +F +M+ G F ++++R
Sbjct: 169 PDV--LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 630 ---------EDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678
+ + + DL+ + L + +R + Y
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-46
Identities = 57/299 (19%), Positives = 112/299 (37%), Gaps = 29/299 (9%)
Query: 380 LIREMKRIRDEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLH 436
L++ ++ + S +F ++G+G F VY L + + A K
Sbjct: 13 LVQAVQHVVIGPSSLIVHFN---------EVIGRGHFGCVYHGTLLDNDGKKIHCAVK-- 61
Query: 437 GLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLD 496
+ + + E I K H +++ L + + VL Y DL
Sbjct: 62 ----SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117
Query: 497 AVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555
++ T ++ +Q+ +G+ + ++K +H DL N + DE KV DFG
Sbjct: 118 NFIRNETHNPTVKDLIGFGLQVAKGMKF--LASKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGR 615
L++ + D T ++ E +T ++K DVWS G+L ++++
Sbjct: 176 LARDMYDKEFDSVHNKTG-AKLPVKWMALESL---QTQKFTTKSDVWSFGVLLWELMTRG 231
Query: 616 RPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
P D I +++ R++ P + +++ +C RP L
Sbjct: 232 APPYPDVNTFDITVY--LLQGRRLLQPEY--CPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (413), Expect = 5e-46
Identities = 55/282 (19%), Positives = 105/282 (37%), Gaps = 24/282 (8%)
Query: 395 FNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHA 454
++ +++ + + LG G + EVY+ VA K + +
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTMEVEEF 60
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL--KATPVLPEREARI 512
++E + K + H ++V+L + F + E+ + +L L +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCT-REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELT 572
+ QI + YL K+ IH DL N L E + KV DFGLS+++ D
Sbjct: 120 MATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAH 173
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632
+ + PE +K S K DVW+ G+L +++ ++
Sbjct: 174 AGAKFPIKWTAPESLAYNK---FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--- 227
Query: 633 IIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+ + + +L+R C +N ++RP + Q
Sbjct: 228 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 8e-46
Identities = 58/307 (18%), Positives = 98/307 (31%), Gaps = 49/307 (15%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHR-----YVACKLHGLNAQWSEDKKQSYIR 452
++ +LG G F +V A + VA K+ E S
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML------KEKADSSERE 85
Query: 453 HAIREYNIHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK----------- 500
+ E + L H +IV L + EYC DL L+
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 501 ------------ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGV 548
VL + Q+ +G+ +L + +H DL NVL V
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKV 202
Query: 549 AKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILF 608
K+ DFGL++ + D + ++ PE + K DVWS GIL
Sbjct: 203 VKICDFGLARDIMSD---SNYVVRGNARLPVKWMAPESLFEGI---YTIKSDVWSYGILL 256
Query: 609 YQML-FGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+++ G P+ + + + + E +++ C ++ +RP
Sbjct: 257 WEIFSLGVNPYPGIPVDANFYK----LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312
Query: 668 DVLTLAQ 674
L
Sbjct: 313 SFPNLTS 319
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 8e-46
Identities = 61/280 (21%), Positives = 105/280 (37%), Gaps = 21/280 (7%)
Query: 399 QILNHRYALLNLLGKGGFSEVYKAY----DLVEHRYVACKLHGLNAQWSEDKKQSYIRHA 454
+I ++G G F EVYK + VA K L A ++E ++
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRV----DF 56
Query: 455 IREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIII 514
+ E I HH+I+RL + +G + + + ++
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116
Query: 515 VQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
I G+ YL +H DL N+L + V KV+DFGLS+++EDD + TS
Sbjct: 117 RGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEATYTTSG 172
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634
G + PE K S DVWS GI+ ++++ + + +++
Sbjct: 173 GKIPIRWTAPEAISYRKFT---SASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----A 225
Query: 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
P+ + L+ +C +A RP +
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 9e-46
Identities = 71/268 (26%), Positives = 113/268 (42%), Gaps = 17/268 (6%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEH---RYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
+ LL +LG G + +V+ + H + A K+ L K + H E +
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV--LKKATIVQKAK-TTEHTRTERQV 81
Query: 461 HKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
+ + +V L F+ + +L+Y +G +L L E E +I + +I
Sbjct: 82 LEHIRQSPFLVTLHYAFQ-TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
L +L+K II+ D+K N+L D G +TDFGLSK + E GT
Sbjct: 141 ALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV----ADETERAYDFCGTI 194
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639
Y+ P+ + VD WS G+L Y++L G PF D + I +
Sbjct: 195 EYMAPDIVRGGDSG-HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253
Query: 640 EFPSRPAVSNEAKDLIRRCLTYNQAERP 667
+P +S AKDLI+R L + +R
Sbjct: 254 PYPQE--MSALAKDLIQRLLMKDPKKRL 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 74/307 (24%), Positives = 114/307 (37%), Gaps = 53/307 (17%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y ++G G F VY+A VA K + +DK+ RE I +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRF-----KNRELQIMRK 69
Query: 464 LVHHHIVRLWDTF-----EIDQNTFCTVLEYCSGKDLDAVL---KATPVLPEREARIIIV 515
L H +IVRL F + D+ VL+Y +A LP ++ +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
Q+F+ L Y++ I H D+KP N+L D + V K+ DFG +K + E
Sbjct: 130 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVS 181
Query: 575 GAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI- 633
+ +Y P + +S +DVWSAG + ++L G+ F D ++++ +
Sbjct: 182 YICSRYYRAP--ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 634 ----------------------IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLT 671
IKA RP EA L R L Y R L
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299
Query: 672 LAQDPYL 678
+
Sbjct: 300 ACAHSFF 306
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 70/304 (23%), Positives = 123/304 (40%), Gaps = 40/304 (13%)
Query: 402 NHRYALLNLLGKGGFSEVYKAYDLVE-HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
+ +Y + +G+G + +V+KA DL R+VA K + Q E+ +
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR--VRVQTGEEGMPLSTIREVAVLRH 63
Query: 461 HKTLVHHHIVRLWDTFEI----DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIV 515
+T H ++VRL+D + + V E+ + K P +P + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +GL +L+ +++H DLKP N+L G K+ DFGL++I +
Sbjct: 124 QLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF------QMALTSV 175
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQE---------- 625
T WY PE S ++ VD+WS G +F +M + F +
Sbjct: 176 VVTLWYRAPEVLLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 626 -----------RILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+ R+ K+ + + KDL+ +CLT+N A+R +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
Query: 675 DPYL 678
PY
Sbjct: 293 HPYF 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 61/266 (22%), Positives = 99/266 (37%), Gaps = 26/266 (9%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL 464
L LG G F V VA K+ + I E + L
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI--------KEGSMSEDEFIEEAKVMMNL 56
Query: 465 VHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIY 523
H +V+L+ Q + EY + L L + ++ + + + + Y
Sbjct: 57 SHEKLVQLYGVCT-KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L + + +H DL N L ++ GV KV+DFGLS+ V DD + + P
Sbjct: 116 LESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWSP 169
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQML-FGRRPFGHDQTQERILREDTIIKARKVEFP 642
PE SK SSK D+W+ G+L +++ G+ P+ E I + ++ P
Sbjct: 170 PEVLMYSK---FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQGLRLYRP 223
Query: 643 SRPAVSNEAKDLIRRCLTYNQAERPD 668
S + ++ C ERP
Sbjct: 224 HL--ASEKVYTIMYSCWHEKADERPT 247
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 161 bits (409), Expect = 4e-45
Identities = 62/311 (19%), Positives = 114/311 (36%), Gaps = 58/311 (18%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
Y L+ LG+G +SEV++A ++ + V K+ K + RE I +
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----------KPVKKKKIKREIKILEN 85
Query: 464 LVHH-HIVRLWDTFE-IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGL 521
L +I+ L D + T V E+ + D + + L + + R + +I + L
Sbjct: 86 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKAL 142
Query: 522 IYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYW 580
Y + I+H D+KP NV+ D E ++ D+GL++ + + + +
Sbjct: 143 DYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG------QEYNVRVASRY 194
Query: 581 YLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVE 640
+ PE + +D+WS G + M+F + PF H L + +
Sbjct: 195 FKGPELLV--DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252
Query: 641 F--------------------------------PSRPAVSNEAKDLIRRCLTYNQAERPD 668
+ ++ VS EA D + + L Y+ R
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312
Query: 669 VLTLAQDPYLT 679
+ PY
Sbjct: 313 AREAMEHPYFY 323
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 8e-44
Identities = 58/292 (19%), Positives = 110/292 (37%), Gaps = 34/292 (11%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYD-----LVEHRYVACKLHGLNAQWSEDKKQSYIR 452
+++ + + LG+G F VY+ VA K +E
Sbjct: 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK------TVNEAASMRERI 68
Query: 453 HAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK----------AT 502
+ E ++ K HH+VRL Q T ++E + DL + L+
Sbjct: 69 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 503 PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562
+ + +I G+ YLN K +H DL N + E K+ DFG+++ + +
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185
Query: 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQ 622
+G ++ PE + ++ DVWS G++ +++
Sbjct: 186 T---DYYRKGGKGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIATLAEQPYQGL 239
Query: 623 TQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+ E++LR +++ ++ P + +L+R C YN RP L +
Sbjct: 240 SNEQVLRF--VMEGGLLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 9e-44
Identities = 70/309 (22%), Positives = 121/309 (39%), Gaps = 49/309 (15%)
Query: 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNI 460
+ Y L +G G + V A D VA K + + + + + A RE +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK-----LYRPFQSELFAKRAYRELRL 70
Query: 461 HKTLVHHHIVRLWDTFEIDQ-----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIV 515
K + H +++ L D F D+ F V+ + G DL ++K L E + ++
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK-LGEDRIQFLVY 128
Query: 516 QIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQG 575
Q+ +GL Y++ IIH DLKPGN+ +E K+ DFGL++ + + +
Sbjct: 129 QMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--------MTGY 178
Query: 576 AGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHD---QTQERILRED- 631
T WY PE + + VD+WS G + +M+ G+ F + I++
Sbjct: 179 VVTRWYRAPE--VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 632 --------------------TIIKARKVEFPSR-PAVSNEAKDLIRRCLTYNQAERPDVL 670
+ + K +F S S A +L+ + L + +R
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 671 TLAQDPYLT 679
PY
Sbjct: 297 EALAHPYFE 305
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 62/302 (20%), Positives = 111/302 (36%), Gaps = 41/302 (13%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHR-------YVACKLHGLNAQWSEDKKQS 449
+++ R L LG+G F +V A + + VA K D +
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK------MLKSDATEK 60
Query: 450 YIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK--------- 500
+ I E + K + H + ++EY S +L L+
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 501 -------ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553
L ++ Q+ +G+ YL + K IH DL NVL E V K+ D
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIAD 178
Query: 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF 613
FGL++ + + T+ G ++ PE + + DVWS G+L +++
Sbjct: 179 FGLARDIHHI---DYYKKTTNGRLPVKWMAPEALFDRI---YTHQSDVWSFGVLLWEIFT 232
Query: 614 GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673
E + + + + +++ PS +NE ++R C ++RP L
Sbjct: 233 LGGSPYPGVPVEELFKL--LKEGHRMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 674 QD 675
+D
Sbjct: 289 ED 290
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (394), Expect = 8e-43
Identities = 77/264 (29%), Positives = 116/264 (43%), Gaps = 24/264 (9%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
++ + LG G F V + A K+ L+ Q KQ I H + E I +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQ--IEHTLNEKRILQA 97
Query: 464 LVHHHIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIY 523
+ +V+L +F D + V+EY +G ++ + L+ E AR QI Y
Sbjct: 98 VNFPFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 524 LNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLP 583
L+ +I+ DLKP N+L D+ G +VTDFG +K V+ + GT L
Sbjct: 157 LHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC--------GTPEALA 206
Query: 584 PECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFPS 643
PE + VD W+ G+L Y+M G PF DQ + I + KV FPS
Sbjct: 207 PEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVSGKVRFPS 259
Query: 644 RPAVSNEAKDLIRRCLTYNQAERP 667
S++ KDL+R L + +R
Sbjct: 260 H--FSSDLKDLLRNLLQVDLTKRF 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 59/299 (19%), Positives = 106/299 (35%), Gaps = 40/299 (13%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
L +GKG F EV++ VA K+ S +++S+ R A E
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIF------SSREERSWFREA--EIYQTVM 53
Query: 464 LVHHHIVRLWDTFEIDQNTF---CTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQG 520
L H +I+ D T+ V +Y L L V E ++ + G
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-STASG 112
Query: 521 LIYLNKRA------QKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQ 574
L +L+ I H DLK N+L + G + D GL+ + + + +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 575 GAGTYWYLPPECFE---LSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER----- 626
GT Y+ PE + K + D+++ G++F+++ G + +
Sbjct: 173 -VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 627 --------ILREDTIIKARKVEFPSR---PAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+R+ + + P+R ++R C N A R L + +
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 53/302 (17%), Positives = 99/302 (32%), Gaps = 42/302 (13%)
Query: 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHR-----YVACKLHGLNAQWSEDKKQSYI 451
++ +R + LG G F +V +A + VA K +
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK------MLKPSAHLTER 70
Query: 452 RHAIREYNIHKTLVHH-HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK---------- 500
+ E + L +H +IV L + EYC DL L+
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 501 --------ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552
L + Q+ +G+ +L + IH DL N+L + K+
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKIC 187
Query: 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612
DFGL++ +++D + ++ PE + + + DVWS GI +++
Sbjct: 188 DFGLARDIKND---SNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFLWELF 241
Query: 613 FGRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTL 672
+ + + S E D+++ C + +RP +
Sbjct: 242 SLGSSPYPGMPVDSKFYK---MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 673 AQ 674
Q
Sbjct: 299 VQ 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 47/305 (15%)
Query: 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKT 463
RY L+ +G G + V A+D VA K Q K+ RE + K
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-----TYRELRLLKH 73
Query: 464 LVHHHIVRLWDTFE----IDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQ 519
+ H +++ L D F +++ ++ + G DL+ ++K L + + +I QI +
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILR 132
Query: 520 GLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTY 579
GL Y++ IIH DLKP N+ +E K+ DFGL++ +D++ T
Sbjct: 133 GLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA--------TR 182
Query: 580 WYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPF---GHDQTQERILRE------ 630
WY PE + + VD+WS G + ++L GR F H + ILR
Sbjct: 183 WYRAPE--IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240
Query: 631 ---------------DTIIKARKVEFPSR-PAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
++ + K+ F + + A DL+ + L + +R
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
Query: 675 DPYLT 679
Y
Sbjct: 301 HAYFA 305
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-40
Identities = 56/294 (19%), Positives = 99/294 (33%), Gaps = 29/294 (9%)
Query: 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIRE 457
++ R L LG+G F +V +A + C+ + E S R + E
Sbjct: 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMSE 66
Query: 458 YNIHKTLVHHH-IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLK---------------- 500
I + HH +V L ++E+C +L L+
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 501 ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560
L Q+ +G+ +L R K IH DL N+L E V K+ DFGL++ +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGH 620
D ++ PE + + DVWS G+L +++
Sbjct: 185 YKD---PDYVRKGDARLPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEIFSLGASPYP 238
Query: 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674
+ + + ++ P + E + C ++RP L +
Sbjct: 239 GVKIDEEFCRR-LKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-40
Identities = 67/325 (20%), Positives = 116/325 (35%), Gaps = 61/325 (18%)
Query: 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAI 455
+ F +L RY L +G G V AYD V R VA K + Q++ + A
Sbjct: 11 STFTVLK-RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK-----LSRPFQNQTHAKRAY 64
Query: 456 REYNIHKTLVHHHIVRLWDTFEI-----DQNTFCTVLEYCSGKDLDAVLKATPVLPEREA 510
RE + K + H +I+ L + F + V+E +
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERM 121
Query: 511 RIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGME 570
++ Q+ G+ +L+ IIH DLKP N++ K+ DFGL++
Sbjct: 122 SYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS------F 173
Query: 571 LTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHD---QTQERI 627
+ + T +Y PE VD+WS G + +M+ + F ++
Sbjct: 174 MMTPYVVTRYYRAPEVI---LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
Query: 628 LRE--------------------DTIIKARKVEFPS-------------RPAVSNEAKDL 654
+ + + K + FP +++A+DL
Sbjct: 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290
Query: 655 IRRCLTYNQAERPDVLTLAQDPYLT 679
+ + L + A+R V Q PY+
Sbjct: 291 LSKMLVIDPAKRISVDDALQHPYIN 315
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (333), Expect = 2e-34
Identities = 67/329 (20%), Positives = 114/329 (34%), Gaps = 55/329 (16%)
Query: 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACK---LHGLNAQWSEDKKQSYIRHAIR 456
+ RY L+ LG G FS V+ A D+V + +VA K + + +ED+ + R
Sbjct: 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 69
Query: 457 EYNIHKTLVHHHIVRLWDTFEI---DQNTFCTVLEYCSGKDLDAVLKATPVL-PEREARI 512
+ ++ +HI++L D F + V E L + K P +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 513 IIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELT 572
I Q+ GL Y+++R IIH D+KP NVL + + KI + E
Sbjct: 130 ISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQI--KIADLGNACWYDEHY 186
Query: 573 SQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632
+ T Y PE + D+WS L ++++ G F D+ +D
Sbjct: 187 TNSIQTREYRSPEVLLGAP---WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
Query: 633 IIKARKV------------------------------------------EFPSRPAVSNE 650
I + ++ ++ + E
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
Query: 651 AKDLIRRCLTYNQAERPDVLTLAQDPYLT 679
D + L + +R D L P+L
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.1 bits (194), Expect = 2e-17
Identities = 28/163 (17%), Positives = 50/163 (30%), Gaps = 17/163 (10%)
Query: 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIR---EYNIH 461
A+ L+G+G S V+ Y + K H + + K+ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 462 KTLVHHHIVRLWD---TFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIF 518
+ +L ++E K+ + ++ I
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMIL 113
Query: 519 QGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561
+ + R I+H DL NVL E G+ + DF S V
Sbjct: 114 EEVAKFYHR--GIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 683 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.26 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.97 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.63 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.57 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.68 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.15 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=458.88 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=222.4
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.++|.+++.||+|+||+||+|.+..+|+.||||++....... .+.+.+|+.+++.++|||||+++++|. +.+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~ 90 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-------KELIINEILVMRENKNPNIVNYLDSYL-VGD 90 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-------HHHHHHHHHHHHhCCCCCEeeEeEEEE-ECC
Confidence 458999999999999999999999999999999986543211 246889999999999999999999997 677
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|+|||||+||+|..++... .+++..++.|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 899999999999999988765 5999999999999999999999965 9999999999999999999999999998765
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... ......+||+.|+|||++.... |+.++|||||||++|+|++|..||........+. .+.......+
T Consensus 168 ~~~-----~~~~~~~gt~~Y~aPE~~~~~~---~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~~~~~~~~ 236 (293)
T d1yhwa1 168 PEQ-----SKRSTMVGTPYWMAPEVVTRKA---YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATNGTPEL 236 (293)
T ss_dssp STT-----CCBCCCCSCGGGCCHHHHSSSC---BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHHCSCCC
T ss_pred ccc-----ccccccccCCCccChhhhcCCC---CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH---HHHhCCCCCC
Confidence 432 1233458999999999987543 8999999999999999999999998766655433 2233344455
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
+.++.+|+++++||.+||..||.+|||+.++++||||+.++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 55678999999999999999999999999999999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=457.00 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=218.3
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
-++|.+++.||+|+||+||+|.+..+|+.||||++..... ....+.+.+|+.+++.++|||||+++++|. +.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA------VDCPENIKKEICINKMLNHENVVKFYGHRR-EGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------CHHHHHHHHHTCCCTTBCCEEEEEE-ETT
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc------chHHHHHHHHHHHHHhCCCCCEeeEeeeec-cCc
Confidence 3579999999999999999999999999999999865421 112346889999999999999999999996 678
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|+|||||+||+|.+++...+.+++..++.|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeec
Confidence 89999999999999999988888999999999999999999999965 9999999999999999999999999999875
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
..... ......+||+.|||||++.... .++.++|||||||++|+|++|++||.........+. .........
T Consensus 155 ~~~~~---~~~~~~~GT~~Y~APE~~~~~~--~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---~~~~~~~~~ 226 (271)
T d1nvra_ 155 YNNRE---RLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYL 226 (271)
T ss_dssp ETTEE---CCBCCCCSCGGGSCTHHHHCSS--BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH---HHHTTCTTS
T ss_pred cCCcc---ccccceeeCcCccCHhHhcCCC--CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH---HHhcCCCCC
Confidence 43211 2234558999999999986443 246789999999999999999999976554332221 122233333
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+..+.+|+++.+||.+||.+||.+|||+.++++||||+.
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 445679999999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=451.69 Aligned_cols=255 Identities=31% Similarity=0.469 Sum_probs=218.6
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||+||+|.+..+++.||||++.... .........+.+|+.+++.++|||||+++++|. +.+.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH----ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-ECCE
Confidence 56999999999999999999999999999999875321 112233567889999999999999999999996 7788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+|||||+||+|.+++...+.+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+....
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999999999988888999999999999999999999965 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.. .....||+.|+|||++.... |+.++|||||||++|+|++|+.||......+.+.. +....+.+
T Consensus 159 ~~-------~~~~~Gt~~Y~APE~~~~~~---~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~- 223 (263)
T d2j4za1 159 SR-------RTTLCGTLDYLPPEMIEGRM---HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR----ISRVEFTF- 223 (263)
T ss_dssp CC-------CEETTEEGGGCCHHHHTTCC---CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHTTCCCC-
T ss_pred Cc-------ccccCCCCcccCHHHHcCCC---CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCCCC-
Confidence 31 23347999999999997543 89999999999999999999999987665443321 22233333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
+..+|+++++||.+||.+||.+|||+.++++||||+.
T Consensus 224 -p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 224 -PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 3579999999999999999999999999999999963
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=447.66 Aligned_cols=258 Identities=26% Similarity=0.370 Sum_probs=214.1
Q ss_pred cce-eEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc---
Q 005678 403 HRY-ALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI--- 478 (683)
Q Consensus 403 ~ry-~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~--- 478 (683)
.+| .+.+.||+|+||+||+|.+..++..||+|.+....... ...+.+.+|+.++++++|||||++|++|..
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-----SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-----HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence 345 67788999999999999999999999999886543211 224578899999999999999999999853
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC-CCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD-EFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd-~~g~vKL~DFGls 557 (683)
....+|+|||||++|+|.+++.....+++..++.++.||+.||.|||+.+++||||||||+||||+ .++.+||+|||+|
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred cCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 256789999999999999999888889999999999999999999999766799999999999997 5799999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
+..... .....+||+.|||||++.. .|+.++|||||||++|+|++|+.||........+... +. ..
T Consensus 163 ~~~~~~-------~~~~~~GT~~Y~aPE~~~~----~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~--i~-~~ 228 (270)
T d1t4ha_ 163 TLKRAS-------FAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VT-SG 228 (270)
T ss_dssp GGCCTT-------SBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--HT-TT
T ss_pred eeccCC-------ccCCcccCccccCHHHhCC----CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH--HH-cC
Confidence 865432 2234589999999998852 3899999999999999999999999876655544321 11 11
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 638 KVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 638 ~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
.........+++++.+||.+||.+||++|||+.++++||||+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 111112245789999999999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-54 Score=455.88 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=221.9
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
...|.+++.||+|+||+||+|.+..+++.||||++....... ....+.+.+|+.++++++|||||+++++|. +.+
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS----NEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-REH 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETT
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC----HHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-ECC
Confidence 356999999999999999999999999999999986543322 233567899999999999999999999986 678
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|+|||||++|+|..++...+.+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|....
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccC
Confidence 89999999999999888887788999999999999999999999965 9999999999999999999999999998654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
.. ....||+.|||||++.......|+.++|||||||++|+|++|..||......+.+.. +... ....
T Consensus 167 ~~---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~---i~~~-~~~~ 233 (309)
T d1u5ra_ 167 PA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQN-ESPA 233 (309)
T ss_dssp SB---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHS-CCCC
T ss_pred CC---------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHhC-CCCC
Confidence 32 234799999999999755445689999999999999999999999987766554432 2222 2222
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
+....+|+++.+||.+||.+||.+|||+.++++||||+..
T Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 3345789999999999999999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=459.42 Aligned_cols=264 Identities=27% Similarity=0.421 Sum_probs=216.5
Q ss_pred cccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 399 QILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 399 ~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
++.+++|.+++.||+|+||+||+|.+..+|..||+|++...... .....+.+|+.+++.++|||||+++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~- 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------AIRNQIIRELQVLHECNSPYIVGFYGAFY- 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT------THHHHHHHHGGGGGGCCCTTBCCEEEEEE-
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH------HHHHHHHHHHHHHHhCCCCCCCcEEEEEE-
Confidence 46678999999999999999999999999999999998654321 12356889999999999999999999997
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+.+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+. ++||||||||+||||+.+|.+||+|||+|+
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 6788999999999999999998878899999999999999999999974 239999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH------
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT------ 632 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~------ 632 (683)
.+.... ....+||++|+|||++.+.. |+.++|||||||++|||++|+.||..............
T Consensus 154 ~~~~~~-------~~~~~GT~~Y~APEvl~~~~---y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 223 (322)
T d1s9ja_ 154 QLIDSM-------ANSFVGTRSYMSPERLQGTH---YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223 (322)
T ss_dssp HHHHHT-------C---CCSSCCCCHHHHHCSC---CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------
T ss_pred ccCCCc-------cccccCCccccCchHHcCCC---CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCc
Confidence 765431 23348999999999997544 89999999999999999999999976543322110000
Q ss_pred -----------------------------HHH-hhccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 633 -----------------------------IIK-ARKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 633 -----------------------------i~~-~~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
... ......|. ...+|.++.+||.+||.+||.+|||+.++++||||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000 00000011 1246899999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-54 Score=456.87 Aligned_cols=261 Identities=28% Similarity=0.415 Sum_probs=206.4
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+.+.||+|+||+||+|.+..+++.||||++...... .....+.+|+.+++.++|||||+++++|. +
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~ 78 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE------GKEGSMENEIAVLHKIKHPNIVALDDIYE-S 78 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------------CHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh------hHHHHHHHHHHHHHhCCCCCCCcEEEEEE-E
Confidence 4678899999999999999999999999999999998654321 11246788999999999999999999996 7
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC---CCCcEEEEecCC
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD---EFGVAKVTDFGL 556 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd---~~g~vKL~DFGl 556 (683)
.+.+|+|||||+||+|.+++...+.+++..+..|+.||+.||.|||+.+ ||||||||+|||+. .+|.+||+|||+
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred CCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccce
Confidence 7889999999999999999988888999999999999999999999965 99999999999995 578999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
|+...... .....+||+.|+|||++.... |+.++|||||||++|+|++|++||......+.... .....
T Consensus 157 a~~~~~~~------~~~~~~GT~~y~APE~~~~~~---~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~--i~~~~ 225 (307)
T d1a06a_ 157 SKMEDPGS------VLSTACGTPGYVAPEVLAQKP---YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ--ILKAE 225 (307)
T ss_dssp ----------------------CTTSCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHTTC
T ss_pred eEEccCCC------eeeeeeeCccccCcHHHcCCC---CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH--HhccC
Confidence 98765431 223457999999999987543 89999999999999999999999987665443221 11122
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..+..+..+.+|+++.+||.+||.+||.+|||+.++++||||+.
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 22333445689999999999999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=450.08 Aligned_cols=262 Identities=29% Similarity=0.439 Sum_probs=221.1
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.+.|.+++.||+|+||+||+|.+..++..||||++...... ..+.+.+|+.+++.++|||||+++++|. +.+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~ 82 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-------ELEDYMVEIDILASCDHPNIVKLLDAFY-YEN 82 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG-------GGGGTHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH-------HHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCC
Confidence 35799999999999999999999999999999998654221 1346789999999999999999999996 678
Q ss_pred eEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+|+|||||+||+|..++. ....+++..++.|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+..
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 8999999999999999975 4567999999999999999999999966 999999999999999999999999999765
Q ss_pred ccCcCCCcccccccCCCCCccCCccccccc--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELS--KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~--~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
.... .......||+.|+|||++... ....|+.++|||||||++|+|++|+.||......+.+. .+.....
T Consensus 161 ~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~---~i~~~~~ 232 (288)
T d2jfla1 161 TRTI-----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL---KIAKSEP 232 (288)
T ss_dssp HHHH-----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHHHSCC
T ss_pred CCCc-----ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH---HHHcCCC
Confidence 4321 123345899999999998543 23458999999999999999999999998766655432 2233333
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
..++.++.+|+++.+||.+||.+||.+|||+.++++||||+..
T Consensus 233 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 3444556899999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=445.64 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=204.3
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc-CCc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI-DQN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~-d~~ 481 (683)
+.|.+++.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.++++++|||||+++++|.. ..+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-----AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-----HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-----HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 56999999999999999999999999999999986653322 224678899999999999999999998853 356
Q ss_pred eEEEEEecccCCChhHHHh----cCCCcchHHHHHHHHHHHHHHHHHHhcC---CceEecccCCcceEeCCCCcEEEEec
Q 005678 482 TFCTVLEYCSGKDLDAVLK----ATPVLPEREARIIIVQIFQGLIYLNKRA---QKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~----~~~~Lse~~~~~I~~qIa~aL~yLH~~g---~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
.+|+|||||+||+|.+++. ....+++..++.++.||+.||.|||+.+ ++||||||||+||||+.+|.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 7899999999999999984 3467999999999999999999999864 35999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
|+|+.+.... .......||+.|+|||++.... |+.++|||||||++|+|++|.+||......+... .+.
T Consensus 159 G~a~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~---~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~---~i~ 227 (269)
T d2java1 159 GLARILNHDT-----SFAKAFVGTPYYMSPEQMNRMS---YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---KIR 227 (269)
T ss_dssp HHHHHC----------------CCCSCCCHHHHTTCC---CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHH
T ss_pred cceeecccCC-----CccccCCCCcccCCHHHHcCCC---CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH---HHH
Confidence 9998875432 2234458999999999986443 8999999999999999999999998766544321 122
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYL 678 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l 678 (683)
..... +.+..+|+++.+||.+||..||.+|||+.++++|||+
T Consensus 228 ~~~~~--~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 228 EGKFR--RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCCCC--CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 22111 2235799999999999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=445.24 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=216.9
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+++.||+|+||+||+|.+..+|+.||||++..... ........+.+|+.+++.++|||||+++++|. +.+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-DDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-CSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc----cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-ECCE
Confidence 579999999999999999999999999999999854211 12233567899999999999999999999997 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999999999988888999999999999999999999965 99999999999999999999999999988754
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.... ......+||+.|+|||++.... |+.++|||||||++|+|++|..||......+... . +....+.+|
T Consensus 161 ~~~~---~~~~~~~GT~~Y~APE~~~~~~---~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~---~-i~~~~~~~p 230 (288)
T d1uu3a_ 161 ESKQ---ARANSFVGTAQYVSPELLTEKS---ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---K-IIKLEYDFP 230 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H-HHTTCCCCC
T ss_pred CCcc---cccccccCCccccCceeeccCC---CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH---H-HHcCCCCCC
Confidence 3211 1233457999999999987544 8999999999999999999999998765544321 1 222334444
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLT------LAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~e------Ll~hP~l~~~ 681 (683)
..+++++++||.+||..||.+|||+.+ +++||||+..
T Consensus 231 --~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 231 --EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp --TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred --ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 579999999999999999999999987 5789999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=443.47 Aligned_cols=263 Identities=28% Similarity=0.408 Sum_probs=221.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||+||+|.+..+|+.||||++......... .......+.+|+.+++.++|||||+++++|. +.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~ 85 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR-RGVSREDIEREVSILKEIQHPNVITLHEVYE-NK 85 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS-SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CS
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhh-hhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-EC
Confidence 578999999999999999999999999999999998654332211 1122457889999999999999999999996 77
Q ss_pred ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC----cEEEEecCC
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG----VAKVTDFGL 556 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g----~vKL~DFGl 556 (683)
+.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||+.+ ||||||||+|||++.+| .+||+|||+
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhh
Confidence 899999999999999999988778999999999999999999999965 99999999999998766 599999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
|..+.... ......||+.|+|||++.... ++.++|||||||++|+|++|..||......+.+.. +..
T Consensus 164 a~~~~~~~------~~~~~~~t~~y~APE~~~~~~---~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~----i~~ 230 (293)
T d1jksa_ 164 AHKIDFGN------EFKNIFGTPEFVAPEIVNYEP---LGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSA 230 (293)
T ss_dssp CEECTTSC------BCSCCCCCGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHT
T ss_pred hhhcCCCc------cccccCCCCcccCHHHHcCCC---CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH----HHh
Confidence 98775432 123347999999999987443 89999999999999999999999987766554322 222
Q ss_pred hccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 RKVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ~~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
....++. .+.+|.++.+||.+||.+||.+|||+.++++||||+.
T Consensus 231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 3333332 2578999999999999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-52 Score=434.63 Aligned_cols=268 Identities=27% Similarity=0.399 Sum_probs=225.7
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccc--hhhHHHHHHHHHHHHHHHhhcC-CCceeeecccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWS--EDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEI 478 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~--~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~ 478 (683)
.++|.+.+.||+|+||+||+|.+..+|+.||||++....... ..........+.+|+.++++++ |||||+++++|.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE- 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence 578999999999999999999999999999999987654432 2223445567899999999997 999999999996
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+++.+|||||||+||+|.++|...+.+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 78899999999999999999988888999999999999999999999965 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCccccccc---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELS---KTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~---~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
.+.... ......||+.|+|||++... ..+.++.++||||+||++|+|++|+.||........... ....
T Consensus 159 ~~~~~~------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~--i~~~ 230 (277)
T d1phka_ 159 QLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM--IMSG 230 (277)
T ss_dssp ECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHT
T ss_pred EccCCC------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH--HHhC
Confidence 875432 12335799999999998643 234578999999999999999999999987765443211 1111
Q ss_pred hhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
...+..+..+.+|+++++||.+||.+||.+|||+.++++||||+.
T Consensus 231 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 122333344689999999999999999999999999999999973
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-52 Score=450.53 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=217.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+++.++|||||+++++|. +.+.
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-------~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~ 97 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-------SDKETVRKEIQTMSVLRHPTLVNLHDAFE-DDNE 97 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-------HHHHHHHHHHHHHHHTCCTTBCCEEEEEE-ETTE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-------hhHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCE
Confidence 689999999999999999999999999999999854321 12356889999999999999999999997 6789
Q ss_pred EEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC--CCCcEEEEecCCccc
Q 005678 483 FCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD--EFGVAKVTDFGLSKI 559 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd--~~g~vKL~DFGls~~ 559 (683)
+|+|||||+||+|.+++. ..+.+++..++.|+.||+.||.|||+.+ ||||||||+||||+ .+|.+||+|||+|+.
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999999999999984 4567999999999999999999999965 99999999999996 468999999999987
Q ss_pred cccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 560 VEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 560 ~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
+.... ......||+.|||||++.... |+.++|||||||++|+|++|+.||......+.+.. +.....
T Consensus 176 ~~~~~------~~~~~~gT~~Y~aPEv~~~~~---~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~ 242 (350)
T d1koaa2 176 LDPKQ------SVKVTTGTAEFAAPEVAEGKP---VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDW 242 (350)
T ss_dssp CCTTS------CEEEECSCTTTCCHHHHHTCC---BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCC
T ss_pred ccccc------ccceecCcccccCHHHHcCCC---CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCC
Confidence 75432 123348999999999987544 89999999999999999999999987665543322 222233
Q ss_pred CCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 640 EFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 640 ~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.++. .+.+|+++++||.+||.+||.+|||+.++++||||+..
T Consensus 243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 3332 35789999999999999999999999999999999853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=445.24 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=220.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+++.||+|+||.||+|.+..+|+.||||++..... ........+.+|+.+|+.++|||||+++++|. +.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-CSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc----cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-cccc
Confidence 469999999999999999999999999999999854321 12223567899999999999999999999997 7889
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+|||||+||+|..++...+.+++..++.++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+....
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999999999988888999999999999999999999965 99999999999999999999999999987643
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.. ......+||+.|+|||++.... |+.++|||||||++|+|++|++||......+.+ . .+....+.+|
T Consensus 158 ~~-----~~~~~~~GT~~Y~aPE~~~~~~---y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~---~i~~~~~~~p 225 (337)
T d1o6la_ 158 DG-----ATMKTFCGTPEYLAPEVLEDND---YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-E---LILMEEIRFP 225 (337)
T ss_dssp TT-----CCBCCCEECGGGCCGGGGSSSC---BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-H---HHHHCCCCCC
T ss_pred CC-----cccccceeCHHHhhhhhccCCC---CChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-H---HHhcCCCCCC
Confidence 32 1233458999999999987554 899999999999999999999999877654432 1 2233344554
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~ 680 (683)
..+|+++++||.+||.+||.+||+ +.++++||||+.
T Consensus 226 --~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 226 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred --ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 579999999999999999999994 899999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-52 Score=448.52 Aligned_cols=257 Identities=27% Similarity=0.413 Sum_probs=217.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||+||+|.+..+|+.||||++..... . ....+.+|+.+++.++|||||+++++|. +.
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~ 98 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---L----DKYTVKNEISIMNQLHHPKLINLHDAFE-DK 98 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---H----HHHHHHHHHHHHTTCCSTTBCCEEEEEE-CS
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---h----HHHHHHHHHHHHHhCCCCCCCcEEEEEE-EC
Confidence 34679999999999999999999999999999999865321 1 1246788999999999999999999997 77
Q ss_pred ceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeC--CCCcEEEEecCCc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFD--EFGVAKVTDFGLS 557 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd--~~g~vKL~DFGls 557 (683)
+.+|||||||+||+|.+++... ..+++.+++.|+.||+.||.|||+.+ ||||||||+||||+ .+|.+||+|||+|
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccc
Confidence 8899999999999999887554 46999999999999999999999965 99999999999998 5789999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
+.+.... ......||+.|+|||++.... |+.++|||||||++|+|++|+.||......+.+.. +...
T Consensus 177 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~ 243 (352)
T d1koba_ 177 TKLNPDE------IVKVTTATAEFAAPEIVDREP---VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRC 243 (352)
T ss_dssp EECCTTS------CEEEECSSGGGCCHHHHTTCC---BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHC
T ss_pred eecCCCC------ceeeccCcccccCHHHHcCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhC
Confidence 8875432 233347999999999987544 89999999999999999999999987766543321 2222
Q ss_pred ccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 638 KVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 ~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
...++ ..+.+|+++.+||.+||.+||.+|||+.++++||||+.
T Consensus 244 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 33333 34679999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-52 Score=438.89 Aligned_cols=255 Identities=29% Similarity=0.490 Sum_probs=219.2
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+++.||+|+||+||+|.+..+|+.||||++..... ......+.+.+|+.+++.++|||||+++++|. +.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc----cCHHHHHHHHHHHHHHHhccCcChhheeeeEe-eCCe
Confidence 459999999999999999999999999999999854321 12233567899999999999999999999996 7789
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+|||||+||+|..++.....+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999999999998888999999999999999999999865 99999999999999999999999999987754
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
. ....+||+.|+|||++.... |+.++|||||||++|+|++|+.||......+.+.. +......
T Consensus 157 ~--------~~~~~Gt~~Y~APE~l~~~~---y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----i~~~~~~-- 219 (316)
T d1fota_ 157 V--------TYTLCGTPDYIAPEVVSTKP---YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILNAELR-- 219 (316)
T ss_dssp C--------BCCCCSCTTTCCHHHHTTCC---BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHCCCC--
T ss_pred c--------cccccCcccccCHHHHcCCC---CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH----HHcCCCC--
Confidence 3 22348999999999986444 89999999999999999999999987665543321 1222333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
.++.+|+++.++|.+||.+||.+|| ++.++++||||+..
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 3467999999999999999999996 89999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-51 Score=442.48 Aligned_cols=255 Identities=29% Similarity=0.392 Sum_probs=218.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||+||+|.+..+|+.||||++.... .........+.+|+.+++.++|||||+++++|. +...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK----VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-DNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH----HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH----ccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-cccc
Confidence 68999999999999999999999999999999875321 112233567899999999999999999999996 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++||||+.||+|..++...+.+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999999999988788999999999999999999999965 99999999999999999999999999987753
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
. .....||+.|||||++.... |+.++|||||||++|+|++|++||........+.. +....+.
T Consensus 194 ~--------~~~~~Gt~~Y~APE~~~~~~---~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----i~~~~~~-- 256 (350)
T d1rdqe_ 194 R--------TWTLCGTPEALAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVR-- 256 (350)
T ss_dssp C--------BCCCEECGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCC--
T ss_pred c--------cccccCccccCCHHHHcCCC---CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH----HhcCCCC--
Confidence 2 22347999999999987544 89999999999999999999999987665443221 2222333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
.+..+|+++.+||.+||.+||.+|+ ++.+|++||||+..
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 3457999999999999999999995 89999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-51 Score=444.90 Aligned_cols=262 Identities=22% Similarity=0.346 Sum_probs=213.9
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+++.||+|+||.||+|.+..+|+.||||++........ ...........++.+++.++|||||+++++|. +.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~-~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-~~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH-TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-CSSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh-hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-ECCE
Confidence 469999999999999999999999999999999754221111 11122233445677888889999999999997 6788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+|+|||||+||+|..+|.....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999999988888999999999999999999999965 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
.. .....||+.|+|||++... ..|+.++|||||||+||+|++|+.||.......... ..........+
T Consensus 160 ~~-------~~~~~GT~~y~APE~~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~~~~~~~~~ 227 (364)
T d1omwa3 160 KK-------PHASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLTMAVE 227 (364)
T ss_dssp SC-------CCSCCSCGGGCCHHHHSTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH---HHHHSSSCCCC
T ss_pred Cc-------ccccccccccchhHHhhcC--CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcccCCCC
Confidence 31 2334799999999998533 238999999999999999999999997654332211 11112222333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPD-----VLTLAQDPYLTY 680 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS-----~~eLl~hP~l~~ 680 (683)
.+..+|+++.+||.+||.+||.+||+ +.++++||||+.
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 228 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 34579999999999999999999999 799999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=428.73 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=209.4
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
+|++..++|.+.+.||+|+||+||+|.. +..||||++........ ..+.+.+|+.++++++|||||++++++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~ 73 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQ-----QLQAFKNEVGVLRKTRHVNILLFMGYS 73 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTT-----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHH-----HHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence 5677788999999999999999999953 34699999866543322 256789999999999999999999876
Q ss_pred ccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. .+.+++|||||+||+|.+++.. ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 74 ~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 74 T--APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp C--SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCC
T ss_pred e--ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEcccc
Confidence 4 4568999999999999999964 456999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+|+........ .......||+.|||||++.......|+.++|||||||+||||+||+.||........+... ..
T Consensus 150 la~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~---~~ 223 (276)
T d1uwha_ 150 LATVKSRWSGS---HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VG 223 (276)
T ss_dssp CSCC---------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---HH
T ss_pred ceeeccccCCc---ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH---Hh
Confidence 99876543221 1234458999999999997655556899999999999999999999999876655444321 11
Q ss_pred hhccCCC----CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 636 ARKVEFP----SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 636 ~~~~~~p----~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.....| ....+|+++.+||.+||..||.+|||+.+++++
T Consensus 224 -~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 224 -RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -HTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -cCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111111 235689999999999999999999999999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=428.69 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=210.3
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEE
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTV 486 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV 486 (683)
.+++||+|+||+||+|.+..+|+.||||++....... ........+.+|+.+++.++|||||+++++|. +.+.+|+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-~~~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE--AKDGINRTALREIKLLQELSHPNIIGLLDAFG-HKSNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-CTTCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh--hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCceeeh
Confidence 4689999999999999999999999999986543221 11223456889999999999999999999997 67789999
Q ss_pred EecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCC
Q 005678 487 LEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS 566 (683)
Q Consensus 487 ~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~ 566 (683)
||||.++++..++.....+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 999999888888777788999999999999999999999965 99999999999999999999999999987654321
Q ss_pred CcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh-hccC-----
Q 005678 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA-RKVE----- 640 (683)
Q Consensus 567 ~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~-~~~~----- 640 (683)
.....+||+.|+|||++.... .|+.++|||||||++|+|++|.+||......+.+......... ....
T Consensus 156 ----~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 156 ----AYTHQVVTRWYRAPELLFGAR--MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp ----CCCCSCCCCTTCCHHHHTTCS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ----cccceecChhhccHHHHccCC--CCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 223457999999999986433 3799999999999999999999999887766654332221110 0000
Q ss_pred ----------CCC------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 641 ----------FPS------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 641 ----------~p~------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
++. .+.+++++.+||.+||.+||.+|||+.++++||||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 000 1356889999999999999999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-51 Score=426.27 Aligned_cols=264 Identities=21% Similarity=0.337 Sum_probs=220.8
Q ss_pred ccCCCCCccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCc
Q 005678 389 DEDGSRFNNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHH 468 (683)
Q Consensus 389 ~~~~~~f~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hpn 468 (683)
++..+.|..|++..++|.+.+.||+|+||+||+|.+..+++.||||++..+... .+.+.+|+.+++.++|||
T Consensus 3 ~p~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--------~~~~~~E~~il~~l~Hpn 74 (287)
T d1opja_ 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--------VEEFLKEAAVMKEIKHPN 74 (287)
T ss_dssp CTTSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--------HHHHHHHHHHHHHCCCTT
T ss_pred CCCCCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--------HHHHHHHHHHHHhCCCCC
Confidence 455567788999999999999999999999999999999999999998654221 346889999999999999
Q ss_pred eeeeccccccCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC
Q 005678 469 IVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF 546 (683)
Q Consensus 469 IV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~ 546 (683)
||+++++|. +++.+++|||||++|+|..++.. ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+
T Consensus 75 Iv~~~~~~~-~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~ 151 (287)
T d1opja_ 75 LVQLLGVCT-REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN 151 (287)
T ss_dssp BCCEEEEEC-SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred EecCCccEe-eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC
Confidence 999999986 67789999999999999999954 357899999999999999999999965 9999999999999999
Q ss_pred CcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH
Q 005678 547 GVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER 626 (683)
Q Consensus 547 g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~ 626 (683)
|.+||+|||+|+....... .......||+.|+|||++.... |+.++|||||||++|||++|..||........
T Consensus 152 ~~~Kl~DFG~a~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~---~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~ 224 (287)
T d1opja_ 152 HLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNK---FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224 (287)
T ss_dssp GCEEECCCCCTTTCCSSSS----EEETTEEECGGGCCHHHHHHCC---CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred CcEEEccccceeecCCCCc----eeeccccccccccChHHHcCCC---CCchhhhhhHHHHHHHHHhCCCCCCCcchHHH
Confidence 9999999999987754321 1223346899999999987554 89999999999999999997776654444443
Q ss_pred HHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 627 ILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 627 il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
+.. .+. .....+.+..+|+++.+||.+||..||.+|||+.++++
T Consensus 225 ~~~--~i~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 225 VYE--LLE--KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHH--HHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH--HHh--cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 332 111 22344455679999999999999999999999999976
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=435.30 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=216.4
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+-++|.+++.||+|+||+||+|.+..+++.||||++..... . ...+.+|+.+|+.++|||||+++++|. +.
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~-----~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~ 73 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---D-----QVLVKKEISILNIARHRNILHLHESFE-SM 73 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---H-----HHHHHHHHHHHHHSCCTTBCCEEEEEE-ET
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---c-----HHHHHHHHHHHHhCCCCCCCeEEEEEE-EC
Confidence 45789999999999999999999999999999999865421 1 235778999999999999999999997 67
Q ss_pred ceEEEEEecccCCChhHHHhcCC-CcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC--CCcEEEEecCCc
Q 005678 481 NTFCTVLEYCSGKDLDAVLKATP-VLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE--FGVAKVTDFGLS 557 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L~~~~-~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~--~g~vKL~DFGls 557 (683)
+.+|+|||||+||+|.+++...+ .+++.+++.|+.||+.||.|||+.+ ||||||||+|||++. .+.+||+|||++
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchh
Confidence 88999999999999999997654 6999999999999999999999965 999999999999984 458999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKAR 637 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~ 637 (683)
+...... ......||+.|+|||.+.... |+.++|||||||++|+|++|..||......+.+.. +...
T Consensus 152 ~~~~~~~------~~~~~~~t~~y~ape~~~~~~---~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~----i~~~ 218 (321)
T d1tkia_ 152 RQLKPGD------NFRLLFTAPEYYAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNA 218 (321)
T ss_dssp EECCTTC------EEEEEESCGGGSCHHHHTTCE---ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHT
T ss_pred hccccCC------cccccccccccccchhccCCC---CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhC
Confidence 8764321 223347999999999886444 89999999999999999999999987766543322 2223
Q ss_pred ccCCCC--CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 638 KVEFPS--RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 638 ~~~~p~--~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.+.++. .+.+|+++++||.+||.+||.+|||+.++++||||+.
T Consensus 219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred CCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 333432 2468999999999999999999999999999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=431.40 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=216.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHh-hcCCCceeeeccccccCCc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHK-TLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~-~L~HpnIV~L~~~f~~d~~ 481 (683)
+.|.+++.||+|+||+||+|.+..+++.||||++..... ........+..|..++. .++|||||+++++|. +++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~----~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-TKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-CSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc----cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-cCC
Confidence 469999999999999999999999999999999854321 11223456777777765 689999999999996 778
Q ss_pred eEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
.+|+|||||+||+|..++.....+++..++.++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+++...
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcc
Confidence 89999999999999999988888999999999999999999999965 9999999999999999999999999998654
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEF 641 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~ 641 (683)
... .......||+.|+|||++.... |+.++|||||||++|+|++|+.||......+.+.. +....+.+
T Consensus 155 ~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~~~~ 222 (320)
T d1xjda_ 155 LGD-----AKTNTFCGTPDYIAPEILLGQK---YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFY 222 (320)
T ss_dssp CTT-----CCBCCCCSCGGGCCHHHHTTCC---BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCC
T ss_pred ccc-----ccccccCCCCCcCCHHHHcCCC---CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCC
Confidence 332 2233458999999999997544 89999999999999999999999987665443321 22333333
Q ss_pred CCCcCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCcccCC
Q 005678 642 PSRPAVSNEAKDLIRRCLTYNQAERPDVL-TLAQDPYLTY 680 (683)
Q Consensus 642 p~~~~~s~el~dLI~rCL~~dP~kRPS~~-eLl~hP~l~~ 680 (683)
| ..+|+++.+||.+||..||.+||++. ++++||||+.
T Consensus 223 p--~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 223 P--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp C--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred C--ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 3 46899999999999999999999996 8999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=425.03 Aligned_cols=256 Identities=30% Similarity=0.472 Sum_probs=210.9
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC--CCceeeecccccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV--HHHIVRLWDTFEI 478 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~--HpnIV~L~~~f~~ 478 (683)
+.++|.+.+.||+|+||+||+|.+..+|..||||++.......... ......+.+|+.+++.++ |||||+++++|.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~-~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~- 79 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE- 79 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE-CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh-hhHHHHHHHHHHHHHHhccCCCCccEEEEEEe-
Confidence 4678999999999999999999999999999999986543221110 001123567999999996 899999999996
Q ss_pred CCceEEEEEecccC-CChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-CCcEEEEecCC
Q 005678 479 DQNTFCTVLEYCSG-KDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-FGVAKVTDFGL 556 (683)
Q Consensus 479 d~~~~~LV~Ey~~g-gsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-~g~vKL~DFGl 556 (683)
+.+.+++||||+.+ +++..++.....+++..++.++.||+.||.|||+.+ ||||||||+|||++. ++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence 67889999999976 688888877778999999999999999999999965 999999999999985 57999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
|+..... ......||+.|+|||++.... .++.++|||||||++|+|++|+.||..... + . .
T Consensus 158 a~~~~~~-------~~~~~~GT~~y~aPE~~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~---i------~-~ 218 (273)
T d1xwsa_ 158 GALLKDT-------VYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVCGDIPFEHDEE---I------I-R 218 (273)
T ss_dssp CEECCSS-------CBCCCCSCGGGSCHHHHHHSC--BCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---H------H-H
T ss_pred ceecccc-------cccccccCCCcCCHHHHcCCC--CCCcccccccceeeehhHhhCCCCCCCchH---H------h-h
Confidence 9876432 123458999999999987543 246789999999999999999999965321 1 1 1
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
....+ ++.+|+++.+||.+||.+||.+|||+.++++||||+..
T Consensus 219 ~~~~~--~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 GQVFF--RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred cccCC--CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 22333 35799999999999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=418.44 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=212.8
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
.+|++..++|.+++.||+|+||+||+|.+ .++..||||++...... .+.+.+|+.++++++|||||+++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS--------PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC--------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCC--------HHHHHHHHHHHHhCCCCCEeEEEee
Confidence 46778889999999999999999999986 46789999998653221 2468899999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
+. .+.+++|||||++|+|.+++... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||++++.+||+|
T Consensus 77 ~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 77 VT--QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp EC--SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECC
T ss_pred ec--cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeecc
Confidence 74 45678999999999999987433 35899999999999999999999955 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||+|+.+..... .......||+.|+|||++.... ++.++|||||||++|||+||..||........++. .+
T Consensus 153 FGla~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~---~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~--~i 223 (272)
T d1qpca_ 153 FGLARLIEDNEY----TAREGAKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ--NL 223 (272)
T ss_dssp CTTCEECSSSCE----ECCTTCCCCTTTSCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--HH
T ss_pred ccceEEccCCcc----ccccccCCcccccChHHHhCCC---CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH--HH
Confidence 999998754321 2233457999999999987554 89999999999999999996555433333333322 12
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CcccCC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ--DPYLTY 680 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~--hP~l~~ 680 (683)
.. ....+.+..+++++.+||.+||..||.+|||+.++++ ++||+.
T Consensus 224 ~~--~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 224 ER--GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hh--cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 22 2333444679999999999999999999999999998 788863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-51 Score=433.07 Aligned_cols=256 Identities=28% Similarity=0.417 Sum_probs=207.6
Q ss_pred ccceeEE-EEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeecccccc-
Q 005678 402 NHRYALL-NLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFEI- 478 (683)
Q Consensus 402 ~~ry~l~-~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~~- 478 (683)
-++|.++ +.||+|+||+||+|.+..+++.||||++... ..+.+|+.++.++ +|||||+++++|..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 3568876 4699999999999999999999999997431 2456799887655 89999999999863
Q ss_pred --CCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---CCcEEE
Q 005678 479 --DQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---FGVAKV 551 (683)
Q Consensus 479 --d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~g~vKL 551 (683)
....+|+|||||+||+|.++|... ..+++.+++.|+.||+.||.|||+.+ ||||||||+|||++. .+.+||
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEE
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccc
Confidence 256799999999999999999754 46999999999999999999999965 999999999999985 567999
Q ss_pred EecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Q 005678 552 TDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRED 631 (683)
Q Consensus 552 ~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~ 631 (683)
+|||+|+...... ......||+.|+|||++.... |+.++|||||||++|+|+||++||.............
T Consensus 156 ~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~ 226 (335)
T d2ozaa1 156 TDFGFAKETTSHN------SLTTPCYTPYYVAPEVLGPEK---YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 226 (335)
T ss_dssp CCCTTCEECCCCC------CCCCCSCCCSSCCCCCCCGGG---GSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------
T ss_pred cccceeeeccCCC------ccccccCCcccCCcHHHcCCC---CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 9999998765432 123458999999999987554 8999999999999999999999996554332221111
Q ss_pred HHHHhhccCCCCC--cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 632 TIIKARKVEFPSR--PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 632 ~i~~~~~~~~p~~--~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
..+....+.+|.. +.+|+++.+||.+||.+||.+|||+.++++||||+.
T Consensus 227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 1122233444433 468999999999999999999999999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=420.35 Aligned_cols=264 Identities=27% Similarity=0.450 Sum_probs=211.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++++++|||||+++++|. +++.
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-----EGVPSTAIREISLLKELNHPNIVKLLDVIH-TENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC------------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-----hHHHHHHHHHHHHHHhCCCCcEEEeccccc-cccc
Confidence 5799999999999999999999999999999998654221 122457889999999999999999999996 7789
Q ss_pred EEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+|+|||||.++.+..... ....+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+...
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceecc
Confidence 999999996654444433 3456999999999999999999999965 9999999999999999999999999998765
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh-hcc-
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA-RKV- 639 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~-~~~- 639 (683)
... .......||+.|+|||.+.... .++.++|||||||++|+|++|+.||......+.+......... ...
T Consensus 154 ~~~-----~~~~~~~gt~~y~apE~~~~~~--~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 154 VPV-----RTYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226 (298)
T ss_dssp CCS-----BCTTCCBCCCTTCCHHHHTTCS--SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCc-----ccceeecccceeeehhhhcccc--CCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 432 2233447999999999876443 3688999999999999999999999877665554432211110 000
Q ss_pred ------------CCCC---------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 640 ------------EFPS---------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 640 ------------~~p~---------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.++. .+.++.++++||.+||.+||.+|||+.+|++||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000 13578999999999999999999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-50 Score=421.63 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=198.9
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCe---EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHR---YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~---~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
+..++|.+.+.||+|+||+||+|.+..++. .||||.+..... ....+.+.+|+.++++++|||||+++++|
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT------EKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC------HHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 345689999999999999999999876654 688998754321 12246789999999999999999999998
Q ss_pred ccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. +.+.+++|||||++|+|.+++.. .+.+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 97 ~-~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 97 T-KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp C-SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred e-eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcc
Confidence 6 67789999999999999998865 457999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
+++.+................||+.|||||++.... |+.++|||||||++|||+| |.+||......+.+. .+.
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~---~i~ 247 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK---FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN---AIE 247 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HHH
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCC---CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH---HHH
Confidence 999876543322222223346899999999987544 8999999999999999997 899998776654321 111
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.....+.+..++.++.+||.+||..||.+|||+.+++++
T Consensus 248 --~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 248 --QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 233455566899999999999999999999999887753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.4e-50 Score=416.01 Aligned_cols=267 Identities=27% Similarity=0.382 Sum_probs=210.2
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID 479 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d 479 (683)
.+.++|.+.+.||+|+||+||+|.+..+|+.||||++....... ......+.+|+.+++.++|||||++++++..+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD----PSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC----HHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence 36789999999999999999999999999999999987653322 23456789999999999999999999998653
Q ss_pred C---ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 480 Q---NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 480 ~---~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
. ..+|+|||||+|++|..++...+.+++.+++.|+.||+.||.|||+.+ ||||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred cCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhh
Confidence 3 358999999999999999988888999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+......... .......+||+.|+|||++... .|+.++|||||||++|+|+||++||......+.+.. .+...
T Consensus 158 ~~~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~--~~~~~ 230 (277)
T d1o6ya_ 158 ARAIADSGNS--VTQTAAVIGTAQYLSPEQARGD---SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ--HVRED 230 (277)
T ss_dssp CEECC------------------TTCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHCC
T ss_pred hhhhcccccc--ccccccccCcccccCHHHHcCC---CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH--HHhcC
Confidence 8766443221 1234455899999999998644 389999999999999999999999987766554332 11111
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
........+.+|+++.+||.+||.+||.+||+..+.+.|+|++
T Consensus 231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1111123467999999999999999999999544555577664
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=425.93 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=211.9
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccCC-----eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCcee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVEH-----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g-----~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV 470 (683)
.|++..++|.+.+.||+|+||+||+|.+..++ ..||+|.+..... ......+.+|+.++.++ +|||||
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD------SSEREALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC------HHHHHHHHHHHHHHHHhcCCCcEe
Confidence 45677789999999999999999999876554 3799998754321 12245688999999998 899999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcC-----------------------CCcchHHHHHHHHHHHHHHHHHHhc
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT-----------------------PVLPEREARIIIVQIFQGLIYLNKR 527 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~-----------------------~~Lse~~~~~I~~qIa~aL~yLH~~ 527 (683)
+++++|. +.+.+|+|||||++|+|.++|... ..+++..++.|+.||+.||.|||+.
T Consensus 105 ~l~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~ 183 (325)
T d1rjba_ 105 NLLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183 (325)
T ss_dssp CEEEEEC-SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEEe-eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999996 677899999999999999999643 2489999999999999999999996
Q ss_pred CCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHH
Q 005678 528 AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGIL 607 (683)
Q Consensus 528 g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvI 607 (683)
+ ||||||||+|||++.++.+||+|||+|+........ .......||+.|||||++.... |+.++|||||||+
T Consensus 184 ~--IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 184 S--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGI---YTIKSDVWSYGIL 255 (325)
T ss_dssp T--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCC---CCHHHHHHHHHHH
T ss_pred C--eeeccCchhccccccCCeEEEeeccccccccCCCce---eeeccccCCCccCChHHHcCCC---CCcceeccchhHH
Confidence 5 999999999999999999999999999876543221 2233447899999999987554 8999999999999
Q ss_pred HHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 608 FYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 608 LyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
+|||++ |..||........+.. +. .....++.+..+|+++.+||.+||..||.+|||+.+|++|
T Consensus 256 l~emlt~g~~Pf~~~~~~~~~~~---~~-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 256 LWEIFSLGVNPYPGIPVDANFYK---LI-QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHTTTSCCSSTTCCCSHHHHH---HH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHH---HH-hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999997 8999987655443322 11 2233445556899999999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=417.98 Aligned_cols=265 Identities=26% Similarity=0.463 Sum_probs=209.2
Q ss_pred ccceeEEEEecccCceEEEEEEEccC-CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc---CCCceeeeccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVE-HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL---VHHHIVRLWDTFE 477 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~-g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L---~HpnIV~L~~~f~ 477 (683)
.++|.+++.||+|+||+||+|.+..+ ++.||||++......... ...+.+|+.+++.| +|||||+++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----PLSTIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-----BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-----HHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence 57899999999999999999999765 788999998654322111 12345677776665 7999999999985
Q ss_pred c----CCceEEEEEecccCCChhHHH-hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 478 I----DQNTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 478 ~----d~~~~~LV~Ey~~ggsL~~~L-~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
. ....++++||||+++++.... .....+++..++.++.||+.||.|||+.+ ||||||||+|||++.+|.+||+
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeec
Confidence 3 345789999999887776554 34467999999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDT 632 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~ 632 (683)
|||+++...... ......||+.|+|||++.... |+.++|||||||++|+|++|++||......+.+.....
T Consensus 159 dfg~~~~~~~~~------~~~~~~gT~~Y~APE~~~~~~---y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 159 DFGLARIYSFQM------ALTSVVVTLWYRAPEVLLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp SCCSCCCCCGGG------GGCCCCCCCTTCCHHHHTTCC---CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred chhhhhhhcccc------cCCCcccChhhcCcchhcCCC---CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 999998654332 234458999999999987544 89999999999999999999999987766554433211
Q ss_pred HHHh-hccCCC--------------------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 633 IIKA-RKVEFP--------------------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 633 i~~~-~~~~~p--------------------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.... ....++ ..+.+++.+++||.+||.+||.+|||+.++++||||+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 1100 000010 1245789999999999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=418.57 Aligned_cols=261 Identities=27% Similarity=0.442 Sum_probs=212.5
Q ss_pred ccccceeEEEE-ecccCceEEEEEEEcc--CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccc
Q 005678 400 ILNHRYALLNL-LGKGGFSEVYKAYDLV--EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTF 476 (683)
Q Consensus 400 i~~~ry~l~~~-LGkGgfG~Vyka~d~~--~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f 476 (683)
+..++|.+... ||+|+||+||+|.+.. ++..||||++..... ....+.+.+|+.++++++|||||+++++|
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 78 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE------KADTEEMMREAQIMHQLDNPYIVRLIGVC 78 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC------HHHHHHHHHHHHHHHhCCCCCEeeEeeee
Confidence 44577888885 9999999999997653 466899999864321 12356789999999999999999999988
Q ss_pred ccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 477 EIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 477 ~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
. .+.+|+|||||++|+|.+++.. ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 79 ~--~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 79 Q--AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp E--SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCT
T ss_pred c--cCeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccch
Confidence 5 3468899999999999999854 467999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
+|+.+...... ........||+.|+|||++.... ++.++|||||||++|||+| |..||......+... .+.
T Consensus 155 la~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~---~i~ 226 (285)
T d1u59a_ 155 LSKALGADDSY--YTARSAGKWPLKWYAPECINFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA---FIE 226 (285)
T ss_dssp TCEECTTCSCE--ECCCCSSCCCGGGCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH---HHH
T ss_pred hhhcccccccc--cccccccccCccccChHHHhCCC---CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH---HHH
Confidence 99887543211 12234457999999999987554 8999999999999999998 999998766544321 222
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCcccCC
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTL---AQDPYLTY 680 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eL---l~hP~l~~ 680 (683)
... ..+.++.+|+++.+||.+||..||.+|||+.++ |+|+|+..
T Consensus 227 ~~~--~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 227 QGK--RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCC--CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 222 233446799999999999999999999999888 57888754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=415.43 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=203.8
Q ss_pred EEecccCceEEEEEEEc--cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceEEEE
Q 005678 409 NLLGKGGFSEVYKAYDL--VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTFCTV 486 (683)
Q Consensus 409 ~~LGkGgfG~Vyka~d~--~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~~LV 486 (683)
+.||+|+||+||+|.+. .+++.||||++...... ....+.+.+|+.++++++|||||+++++|. .+.+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~g~~~--~~~~~lv 85 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-----PALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLV 85 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-----HHHHHHHHHHHHHHHhCCCCCCceEEEEec--cCCEEEE
Confidence 46999999999999754 45688999998543221 233467899999999999999999999985 3467899
Q ss_pred EecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCC
Q 005678 487 LEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGS 566 (683)
Q Consensus 487 ~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~ 566 (683)
||||++|+|.+++.....+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+++.+......
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999999999998888999999999999999999999965 999999999999999999999999999876543221
Q ss_pred CcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCc
Q 005678 567 QGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVEFPSRP 645 (683)
Q Consensus 567 ~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~ 645 (683)
........||+.|+|||++.... ++.++|||||||++|||++ |.+||......+... .+.... ..+.+.
T Consensus 164 --~~~~~~~~gt~~y~APE~l~~~~---~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~---~i~~~~--~~~~p~ 233 (277)
T d1xbba_ 164 --YKAQTHGKWPVKWYAPECINYYK---FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---MLEKGE--RMGCPA 233 (277)
T ss_dssp --EEC----CCCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHTTC--CCCCCT
T ss_pred --cccccccCCCceecCchhhcCCC---CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH---HHHcCC--CCCCCc
Confidence 12233457999999999987554 8999999999999999997 899998766544221 222222 334446
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHH---hcCcccC
Q 005678 646 AVSNEAKDLIRRCLTYNQAERPDVLTL---AQDPYLT 679 (683)
Q Consensus 646 ~~s~el~dLI~rCL~~dP~kRPS~~eL---l~hP~l~ 679 (683)
.+|+++.+||.+||..||.+|||+.++ |+|+|+.
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 799999999999999999999999988 5677754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-49 Score=412.79 Aligned_cols=261 Identities=26% Similarity=0.402 Sum_probs=211.4
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|.+++.||+|+||+||+|.+. +|..||||++....... .....+.+|+.+++.++|||||+++++|. +.+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDE-----GIPSTTIREISILKELKHSNIVKLYDVIH-TKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGG-----CCCHHHHHHHHGGGGCCCTTBCCEEEEEE-CSSC
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcCh-----HHHHHHHHHHHHHHhCCCCcEEeeeeecc-cCCc
Confidence 58999999999999999999985 78999999986653321 22457889999999999999999999997 6778
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
++++|+|+.++.+..+....+.+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|.....
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 9999999988888888787888999999999999999999999965 99999999999999999999999999987654
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc-cC-
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK-VE- 640 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~-~~- 640 (683)
... ......|++.|+|||.+.... .++.++|||||||++|+|++|+.||......+.+........... ..
T Consensus 153 ~~~-----~~~~~~~~~~y~~pE~~~~~~--~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 153 PVR-----KYTHEIVTLWYRAPDVLMGSK--KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp --------------CCCTTCCHHHHTTCC--SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred Ccc-----ccceecccchhhhHHHHhCCC--CCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence 321 123336899999999986433 378999999999999999999999987766554433211110000 00
Q ss_pred ------------CC---------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 005678 641 ------------FP---------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLT 679 (683)
Q Consensus 641 ------------~p---------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~ 679 (683)
+. ..+.+++++.+||.+||.+||++|||+.++++||||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 00 1245789999999999999999999999999999997
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=406.30 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=195.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQN 481 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~ 481 (683)
.++|.+++.||+|+||+||+|.+. ++..||||++...... .+.+.+|+.+++.++|||||+++++|. +.+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~ 73 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--------EEDFIEEAEVMMKLSHPKLVQLYGVCL-EQA 73 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc--------HHHHHHHHHHHHhcCCCCcccccceec-cCC
Confidence 367999999999999999999864 6788999998654321 246889999999999999999999986 667
Q ss_pred eEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccc
Q 005678 482 TFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIV 560 (683)
Q Consensus 482 ~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~ 560 (683)
.+++|||||++|+|.+++... ..+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheec
Confidence 889999999999999998544 56899999999999999999999965 999999999999999999999999999877
Q ss_pred ccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCchHHHHHHHHHHHHhhcc
Q 005678 561 EDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFG-RRPFGHDQTQERILREDTIIKARKV 639 (683)
Q Consensus 561 ~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~e~il~~~~i~~~~~~ 639 (683)
...... ......||+.|+|||++.... |+.++|||||||++|||+|+ .+||..... ..++. .+... .
T Consensus 152 ~~~~~~----~~~~~~gt~~y~aPE~l~~~~---~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~--~i~~~--~ 219 (263)
T d1sm2a_ 152 LDDQYT----SSTGTKFPVKWASPEVFSFSR---YSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVE--DISTG--F 219 (263)
T ss_dssp -----------------CTTSCCHHHHTTCC---CCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHH--HHHHT--C
T ss_pred cCCCce----eecceecCcccCChHHhcCCC---CCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHH--HHHhc--C
Confidence 543211 122347999999999987544 89999999999999999995 555554443 33332 12222 2
Q ss_pred CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 640 EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 640 ~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
..+.+..+++++.+||.+||..||.+|||+.++++|
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 333345789999999999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=418.92 Aligned_cols=261 Identities=26% Similarity=0.404 Sum_probs=207.6
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
+.++|.+++.||+|+||+||+|.+..+|+.||||++...... ....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-----ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-----HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC-----hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 578999999999999999999999999999999998654321 233567899999999999999999999986432
Q ss_pred -----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 481 -----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 481 -----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
..+|+||||| +.+|..+++.. .+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred cccccceEEEEEecc-cccHHHHHHhc-cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhccccccccccccc
Confidence 3579999999 67888877654 5999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+|+..... .....||+.|+|||++... ..++.++|||||||++|+|++|++||........+........
T Consensus 167 ~a~~~~~~--------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 167 LARQADSE--------MTGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp TCEECCSS--------CCSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ceeccCCc--------cccccccccccCHHHHcCC--CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 99876533 2334899999999998643 2378999999999999999999999987765544322111100
Q ss_pred -------------------hhccCCC------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 -------------------ARKVEFP------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 -------------------~~~~~~p------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
....... ..+.+++++.+||.+||.+||.+|||+.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 0000111 12457899999999999999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=410.30 Aligned_cols=268 Identities=24% Similarity=0.357 Sum_probs=209.7
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC---
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID--- 479 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d--- 479 (683)
++|.+++.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.+++.++||||++++++|...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-----GFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-----SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----HHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 68999999999999999999999999999999976543221 2245678999999999999999999987532
Q ss_pred ----CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 480 ----QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 480 ----~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
.+.+|+|||||.++++.........+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecc
Confidence 4568999999988877777676778999999999999999999999965 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK 635 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~ 635 (683)
+++.+...... ........+||++|+|||++.... .|+.++|||||||++|+|++|+.||.................
T Consensus 163 ~~~~~~~~~~~-~~~~~~~~~gT~~Y~aPE~~~~~~--~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNS-QPNRYTNRVVTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp TCEECCC------CCCCCSCCSCGGGCCHHHHTTCS--SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eeeeccccccc-ccccccceecCHHHhhHHHHcCCC--CCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99876543211 112233457999999999986443 389999999999999999999999987665554432222211
Q ss_pred hhccCC-CC--------------C-----------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 ARKVEF-PS--------------R-----------PAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 ~~~~~~-p~--------------~-----------~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
...... .. . ...++++.+||.+||.+||.+|||+.++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 100000 00 0 013678899999999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=406.15 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=202.2
Q ss_pred cccccccceeEEEEecccCceEEEEEEEccC---CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDLVE---HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~---g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
+|++..++|.+.+.||+|+||+||+|.+..+ +..||||.+.... .......+.+|+.++++++|||||+++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 74 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT------SDSVREKFLQEALTMRQFDHPHIVKLI 74 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT------SHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 4778889999999999999999999987654 4578888874322 123346789999999999999999999
Q ss_pred cccccCCceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEE
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
++|. .+.+|+|||||++|+|..++. ....+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+
T Consensus 75 ~~~~--~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~ 150 (273)
T d1mp8a_ 75 GVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLG 150 (273)
T ss_dssp EEEC--SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEe--cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEc
Confidence 9985 467899999999999999874 4457999999999999999999999965 9999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILRED 631 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~ 631 (683)
|||+|+.+..... .......||+.|+|||++.... |+.++|||||||++|||++ |.+||......+.+.
T Consensus 151 DfG~a~~~~~~~~----~~~~~~~gt~~y~apE~l~~~~---~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~--- 220 (273)
T d1mp8a_ 151 DFGLSRYMEDSTY----YKASKGKLPIKWMAPESINFRR---FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG--- 220 (273)
T ss_dssp C-----------------------CCGGGCCHHHHHHCC---CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---
T ss_pred cchhheeccCCcc----eeccceecCcccchhhHhccCC---CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH---
Confidence 9999987654321 2234457899999999987554 8999999999999999998 899998776654332
Q ss_pred HHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 632 TIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 632 ~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.+... ...+.++.+|+++.+||.+||..||.+|||+.+++++
T Consensus 221 ~i~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 221 RIENG--ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcC--CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12222 2334556899999999999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=401.22 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=216.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+++.++|||||+++++|. +...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-----EGVPSSALREICLLKELKHKNIVRLHDVLH-SDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-----TTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-----hHHHHHHHHHHHHHHhcCcCCEEeeccccc-cccc
Confidence 5899999999999999999999999999999998655322 123567889999999999999999999996 7788
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
+++|++++.+++|..++...+.+++..++.++.|++.||.|||+.+ ||||||||+|||++.++.+||+|||+|+....
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999999999999999988889999999999999999999999965 99999999999999999999999999987754
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhcc---
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKV--- 639 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~--- 639 (683)
... ......+++.|+|||++.... .++.++|||||||++|+|++|+.||.........+..-........
T Consensus 154 ~~~-----~~~~~~~~~~~~~pe~~~~~~--~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 154 PVR-----CYSAEVVTLWYRPPDVLFGAK--LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CCS-----CCCSCCSCGGGCCHHHHTTCS--CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCc-----cceeeccccchhhhhHhccCC--CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhh
Confidence 321 223346888999999886443 3689999999999999999999997555444433321111111000
Q ss_pred ---------------------CCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 640 ---------------------EFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 640 ---------------------~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.....+.+++.+.+||.+||.+||.+|||+.++++||||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 00112467889999999999999999999999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=404.33 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=199.7
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCC----eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEH----RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g----~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
+....|.+.++||+|+||+||+|.+..++ ..||||++..... ......+.+|+.++++++|||||+++++
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT------EKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC------hHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 34467999999999999999999876554 5799999854322 1224568899999999999999999999
Q ss_pred cccCCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEec
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDF 554 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DF 554 (683)
|. +.+.+++|||||.+++|..++.. .+.+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+||
T Consensus 78 ~~-~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 78 IS-KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp EC-SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC
T ss_pred Ee-cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEccc
Confidence 86 67788999999999999998854 467999999999999999999999955 999999999999999999999999
Q ss_pred CCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 555 GLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 555 Gls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
|+++.+....... .......||+.|+|||++.... ++.++|||||||++|||++|..||........++. .+.
T Consensus 155 Gla~~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~---~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~--~i~ 227 (283)
T d1mqba_ 155 GLSRVLEDDPEAT--YTTSGGKIPIRWTAPEAISYRK---FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK--AIN 227 (283)
T ss_dssp CC-------------------CCCGGGSCHHHHHSCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHH
T ss_pred chhhcccCCCccc--eEeccCCCCccccCHHHHccCC---CCCcccccccHHHHHHHHhCCCCccccCCHHHHHH--HHh
Confidence 9998875432211 1233447899999999987544 89999999999999999996666544444444432 122
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
.....+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 228 --~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 228 --DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 22344555679999999999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=414.86 Aligned_cols=266 Identities=28% Similarity=0.453 Sum_probs=209.8
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
++++|.+++.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+|+.++|||||++++++..+.
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence 4678999999999999999999999999999999985432 1233567899999999999999999999986432
Q ss_pred ----ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 481 ----NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 481 ----~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
..+|++ +|+.+++|.+++... .+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+
T Consensus 80 ~~~~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 80 IEQMKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp TTTCCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCc
Confidence 235555 556699999999765 5999999999999999999999965 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~ 636 (683)
++......... ......+||+.|+|||++.... .++.++||||+||++|+|++|+.||......+...........
T Consensus 156 a~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~ 231 (345)
T d1pmea_ 156 ARVADPDHDHT--GFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231 (345)
T ss_dssp CEECCGGGCBC--CTTCCCCSCGGGCCGGGTTTBC--SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred eeeccCCCccc--eeeccccccceechHHHhhcCC--CCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence 98765432211 2234568999999999975432 3789999999999999999999999876655443221111000
Q ss_pred ----------------hccCCC---------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 637 ----------------RKVEFP---------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 637 ----------------~~~~~p---------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.....+ ..+.+++++++||.+||.+||.+|||+.++++||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 000011 12467889999999999999999999999999999984
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=406.99 Aligned_cols=262 Identities=26% Similarity=0.353 Sum_probs=209.9
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccc
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDT 475 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~ 475 (683)
..|++..++|++.+.||+|+||+||+|.+.. +..||||++...... .+.+.+|+.++++++|||||++|++
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~--------~~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--------PEAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC--------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCC--------HHHHHHHHHHHHhcccCCEeEEEEE
Confidence 4677888999999999999999999998754 467999998654321 2468899999999999999999998
Q ss_pred cccCCceEEEEEecccCCChhHHHhc--CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 476 FEIDQNTFCTVLEYCSGKDLDAVLKA--TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 476 f~~d~~~~~LV~Ey~~ggsL~~~L~~--~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
|. + +.+++|||||++|+|..++.. .+.+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 81 ~~-~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 81 VS-E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp EC-S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred Ee-c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcc
Confidence 85 3 457899999999999988843 356999999999999999999999965 99999999999999999999999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||+++.+..... .......||+.|+|||++.... ++.++|||||||++|||++|..||........++. .+
T Consensus 157 fGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~---~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~--~i 227 (285)
T d1fmka3 157 FGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGR---FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD--QV 227 (285)
T ss_dssp CCTTC------------------CCGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--HH
T ss_pred cchhhhccCCCc----eeeccccccccccChHHHhCCC---CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH--HH
Confidence 999987654321 1223347999999999997554 89999999999999999997666655444444432 12
Q ss_pred HHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CcccCCC
Q 005678 634 IKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ--DPYLTYS 681 (683)
Q Consensus 634 ~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~--hP~l~~~ 681 (683)
.. ....+.++.+++++++||.+||..||++||++.+++. ++||+..
T Consensus 228 ~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 228 ER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HT--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred Hh--cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 22 3344556789999999999999999999999999988 8888754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=405.70 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=204.9
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEcc-----CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCce
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLV-----EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHI 469 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~-----~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnI 469 (683)
..|++..++|.+++.||+|+||.||+|.+.. +++.||||++..... ....+.+.+|..++.++ .||||
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~~e~~~l~~~~~h~~i 79 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------HSEHRALMSELKILIHIGHHLNV 79 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C------HHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC------cHHHHHHHHHHHHHHhhcCCCeE
Confidence 4567788999999999999999999998754 457899999754321 12245677888888877 68899
Q ss_pred eeeccccccCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEe
Q 005678 470 VRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIH 533 (683)
Q Consensus 470 V~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIH 533 (683)
|.+++++..+.+.+++|||||++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |||
T Consensus 80 v~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivH 157 (299)
T d1ywna1 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIH 157 (299)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred EEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcC
Confidence 999998876677899999999999999999543 34899999999999999999999965 999
Q ss_pred cccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc
Q 005678 534 YDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF 613 (683)
Q Consensus 534 rDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt 613 (683)
|||||+||||+.++.+||+|||+|+........ .......||+.|+|||++.... ++.++|||||||++|||++
T Consensus 158 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~---~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp SCCCGGGEEECGGGCEEECC------CCSCTTS---CCTTSCCCGGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHT
T ss_pred CcCCccceeECCCCcEEEccCcchhhccccccc---cccCceeeCccccchhHhhcCC---CCcccceeehHHHHHHHHh
Confidence 999999999999999999999999876543221 2234558999999999997554 8999999999999999998
Q ss_pred C-CCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 614 G-RRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 614 G-~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
| .+||......+.+.. .+.. ...++.+..+++++.+||.+||..||.+|||+.++++|
T Consensus 232 ~~~~p~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 232 LGASPYPGVKIDEEFCR--RLKE--GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TSCCSSTTCCCSHHHHH--HHHH--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHH--HHhc--CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6 567876655444332 1122 22334445799999999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=404.32 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=208.2
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeecccccc-C
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEI-D 479 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~-d 479 (683)
.++|.+++.||+|+||+||+|.+..+|+.||||++.... .+.+.+|+.+|+.+. ||||++++++|.. .
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~ 103 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------KKKIKREIKILENLRGGPNIITLADIVKDPV 103 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----------HHHHHHHHHHHHhccCCCCCcEEEEEEEecC
Confidence 468999999999999999999999999999999985421 245788999999995 9999999999864 3
Q ss_pred CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC-CcEEEEecCCcc
Q 005678 480 QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF-GVAKVTDFGLSK 558 (683)
Q Consensus 480 ~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~-g~vKL~DFGls~ 558 (683)
...+++|||||++++|..+. +.+++..++.++.||+.||.|||+.+ ||||||||+|||++.+ +.+||+|||+|.
T Consensus 104 ~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 104 SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp TCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred CCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccce
Confidence 45799999999999998764 35999999999999999999999966 9999999999999864 469999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-HHHH---
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE-DTII--- 634 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~-~~i~--- 634 (683)
...... ......||+.|+|||.+.... .++.++|||||||++|+|++|+.||............ ..+.
T Consensus 179 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 179 FYHPGQ------EYNVRVASRYFKGPELLVDYQ--MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp ECCTTC------CCCSCCSCGGGCCHHHHTTCC--CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred eccCCC------cccccccCccccCcccccCCC--CCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence 765432 123447999999999876433 3799999999999999999999999765543322111 0000
Q ss_pred ------Hhhc----------------------cCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 005678 635 ------KARK----------------------VEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYSK 682 (683)
Q Consensus 635 ------~~~~----------------------~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~K 682 (683)
.... ...+....+++++.+||.+||.+||.+|||+.++++||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0000 00112245789999999999999999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=396.87 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=209.5
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCce
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~ 482 (683)
+.|.+++.||+|+||+||+|.. .++..||||++...... ...+.+|+.++++++|||||+++++|. +.+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--------~~~~~~Ev~~~~~l~HpnIv~~~g~~~-~~~~ 73 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS--------EDEFIEEAKVMMNLSHEKLVQLYGVCT-KQRP 73 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC--------HHHHHHHHHHHHTCCCTTBCCEEEEEC-CSSS
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC--------HHHHHHHHHHHHhcCCCceeeEEEEEe-eCCc
Confidence 4678899999999999999996 57889999998754321 136889999999999999999999986 6778
Q ss_pred EEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCccccc
Q 005678 483 FCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVE 561 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~ 561 (683)
+++||||+++|+|..++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheecc
Confidence 999999999999999974 4456899999999999999999999965 9999999999999999999999999998765
Q ss_pred cCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHhhccC
Q 005678 562 DDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKARKVE 640 (683)
Q Consensus 562 ~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~~~~~ 640 (683)
..... ......||+.|+|||++.... ++.++|||||||++|||+| |+.||......+... .+.. ...
T Consensus 152 ~~~~~----~~~~~~~t~~y~aPE~~~~~~---~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~---~i~~--~~~ 219 (258)
T d1k2pa_ 152 DDEYT----SSVGSKFPVRWSPPEVLMYSK---FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---HIAQ--GLR 219 (258)
T ss_dssp SSSCC----CCCCSCCCGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH---HHHT--TCC
T ss_pred CCCce----eecccCCCCCcCCcHHhcCCC---CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH---HHHh--CCC
Confidence 43221 122347999999999987554 8999999999999999998 899998877654332 2222 233
Q ss_pred CCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 641 FPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 641 ~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.+.+..+++++.+||.+||..||.+|||+.++++|
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 44456789999999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=409.64 Aligned_cols=257 Identities=28% Similarity=0.396 Sum_probs=205.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc----
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI---- 478 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~---- 478 (683)
..|..+++||+|+||+||+|.+..+|+.||||++..... ...+|+.+++.++|||||+++++|..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----------HHHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 379999999999999999999999999999999865432 12369999999999999999999843
Q ss_pred -CCceEEEEEecccCCChhHHH---hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCC-cEEEEe
Q 005678 479 -DQNTFCTVLEYCSGKDLDAVL---KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFG-VAKVTD 553 (683)
Q Consensus 479 -d~~~~~LV~Ey~~ggsL~~~L---~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g-~vKL~D 553 (683)
+..++|+|||||+++.+..+. .....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++ .+||+|
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECC
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEec
Confidence 344689999999776444433 44567999999999999999999999865 99999999999999765 899999
Q ss_pred cCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Q 005678 554 FGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTI 633 (683)
Q Consensus 554 FGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i 633 (683)
||+++.+.... ......||+.|+|||.+... ..|+.++|||||||++|+|++|+.||......+.+......
T Consensus 167 FG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~ 238 (350)
T d1q5ka_ 167 FGSAKQLVRGE------PNVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238 (350)
T ss_dssp CTTCEECCTTS------CCCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred ccchhhccCCc------ccccccccccccChHHhhcc--cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHH
Confidence 99998765432 12334899999999987543 23899999999999999999999999877765544332111
Q ss_pred H--------Hh-----hccCCC----------CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 634 I--------KA-----RKVEFP----------SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 634 ~--------~~-----~~~~~p----------~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
. .. ....++ ..+.+++++.+||.+||.+||.+|||+.++++||||+.
T Consensus 239 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 0 00 011111 12457899999999999999999999999999999974
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=403.79 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=200.8
Q ss_pred cceeEEEEecccCceEEEEEEEccCCe----EEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDLVEHR----YVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~~~g~----~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
..|.+++.||+|+||+||+|.+..+|+ .||+|.+..... ....+.+.+|+.++++++|||||+++++|.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~- 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS------PKANKEILDEAYVMASVDNPHVCRLLGICL- 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----------CTHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 359999999999999999999887776 588887643221 112467899999999999999999999986
Q ss_pred CCceEEEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
+ +..+++++|+.+++|.+++.. ...+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|
T Consensus 82 ~-~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 82 T-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp S-SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred c-CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccc
Confidence 3 456788999999999988854 467999999999999999999999965 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+.+...... .......||+.|+|||++.... |+.++|||||||++|||+| |.+||......+.. . .+..
T Consensus 159 ~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~---~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~--~i~~- 228 (317)
T d1xkka_ 159 KLLGAEEKE---YHAEGGKVPIKWMALESILHRI---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-S--ILEK- 228 (317)
T ss_dssp HHTTTTCC-----------CCTTTSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-H--HHHH-
T ss_pred eeccccccc---ccccccccCccccChHHHhcCC---CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-H--HHHc-
Confidence 887543221 2233457999999999987554 8999999999999999998 88999776544322 1 1222
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
....+.++.+++++.+||.+||..||.+|||+.+++.|
T Consensus 229 -~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 229 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 23344556899999999999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=407.82 Aligned_cols=262 Identities=25% Similarity=0.389 Sum_probs=206.7
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccC--
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEID-- 479 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d-- 479 (683)
.++|.+++.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.+|+.++|||||+++++|...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-----IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-----HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 679999999999999999999999999999999986543322 2245788999999999999999999998532
Q ss_pred --CceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 480 --QNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 480 --~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
....++|++|+.||+|.+++... .+++..++.|+.||+.||.|||+.+ ||||||||+|||++.+|.+|++|||++
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred cccCceEEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchh
Confidence 22345556777799999999654 5999999999999999999999965 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHh-
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKA- 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~- 636 (683)
...... .....||+.|+|||.+.... .++.++|||||||++|+|++|+.||..................
T Consensus 169 ~~~~~~--------~~~~~g~~~y~apE~~~~~~--~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 169 RHTDDE--------MTGYVATRWYRAPEIMLNWM--HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp -CCTGG--------GSSSCHHHHTSCHHHHTTCS--CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccCcc--------cccccccccccCchhhcCCc--cCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 765432 23347999999999875433 3688999999999999999999999876654433221110000
Q ss_pred ------------------hccCCCC------CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 005678 637 ------------------RKVEFPS------RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTYS 681 (683)
Q Consensus 637 ------------------~~~~~p~------~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~~ 681 (683)
.....+. ...+++++++||.+||.+||.+|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0001111 13578999999999999999999999999999999853
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=409.04 Aligned_cols=266 Identities=26% Similarity=0.372 Sum_probs=214.1
Q ss_pred cceeEEEEecccCceEEEEEEEc---cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC-Cceeeecccccc
Q 005678 403 HRYALLNLLGKGGFSEVYKAYDL---VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH-HHIVRLWDTFEI 478 (683)
Q Consensus 403 ~ry~l~~~LGkGgfG~Vyka~d~---~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H-pnIV~L~~~f~~ 478 (683)
++|.+++.||+|+||+||+|.+. .+|..||||++......... .....+.+|+.++++++| |||++++++|.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~---~~~~~~~~E~~il~~l~h~pnIv~~~~~~~- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA---KTTEHTRTERQVLEHIRQSPFLVTLHYAFQ- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE---SSGGGCCCHHHHHHHHHTCTTBCCEEEEEE-
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch---HHHHHHHHHHHHHHhccCCCeEEEeeeeec-
Confidence 67999999999999999999874 46899999998654322111 112356789999999987 89999999986
Q ss_pred CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
+...+++|||||.+++|..++...+.+++..+..++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+++
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchh
Confidence 67789999999999999999988888999999999999999999999955 9999999999999999999999999998
Q ss_pred ccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhc
Q 005678 559 IVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARK 638 (683)
Q Consensus 559 ~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~ 638 (683)
.+...... ......||+.|+|||.+.... ..++.++|||||||+||+|++|..||.............. ....
T Consensus 178 ~~~~~~~~----~~~~~~g~~~~~~pe~~~~~~-~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~--~~~~ 250 (322)
T d1vzoa_ 178 EFVADETE----RAYDFCGTIEYMAPDIVRGGD-SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILK 250 (322)
T ss_dssp ECCGGGGG----GGCGGGSCCTTCCHHHHTTCC----CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHH
T ss_pred hhcccccc----cccccccccccchhHHhhcCC-cCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hccc
Confidence 76543221 223347999999999986443 2378899999999999999999999966543332221111 1122
Q ss_pred cCCCCCcCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 005678 639 VEFPSRPAVSNEAKDLIRRCLTYNQAERP-----DVLTLAQDPYLTYS 681 (683)
Q Consensus 639 ~~~p~~~~~s~el~dLI~rCL~~dP~kRP-----S~~eLl~hP~l~~~ 681 (683)
...+.+..+|+++.+||.+||.+||.+|| |+.++++||||+..
T Consensus 251 ~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 23334457999999999999999999999 58999999999763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-47 Score=398.64 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=209.9
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCcee
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIV 470 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV 470 (683)
..+++..++|.+++.||+|+||+||+|... .+++.||||++..... ....+.+.+|+.+++.++||||+
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~E~~il~~l~h~niv 79 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------ADMQADFQREAALMAEFDNPNIV 79 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC------HHHHHHHHHHHHHHHTCCCTTBC
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC------hHHHHHHHHHHHHHHhcCCCCcc
Confidence 345666789999999999999999999864 3568999999854321 12356789999999999999999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcC------------------------CCcchHHHHHHHHHHHHHHHHHHh
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT------------------------PVLPEREARIIIVQIFQGLIYLNK 526 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~------------------------~~Lse~~~~~I~~qIa~aL~yLH~ 526 (683)
+++++|. +.+.+++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+
T Consensus 80 ~~~~~~~-~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~ 158 (301)
T d1lufa_ 80 KLLGVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158 (301)
T ss_dssp CEEEEEC-SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cceeeec-cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc
Confidence 9999986 677899999999999999999543 248899999999999999999999
Q ss_pred cCCceEecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHH
Q 005678 527 RAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGI 606 (683)
Q Consensus 527 ~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGv 606 (683)
.+ ||||||||+||||+.++.+||+|||+|+.+...... .......||+.|+|||++.... |+.++|||||||
T Consensus 159 ~~--ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~t~ksDVwS~Gv 230 (301)
T d1lufa_ 159 RK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGV 230 (301)
T ss_dssp TT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---C----CCBCGGGCCHHHHHHCC---CCHHHHHHHHHH
T ss_pred CC--eEeeEEcccceEECCCCcEEEccchhheeccCCccc---cccCCCCcCcCcCCHHHHccCC---CChhhhhccchh
Confidence 55 999999999999999999999999999876543211 2233457999999999997544 899999999999
Q ss_pred HHHHHHcCC-CCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 607 LFYQMLFGR-RPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 607 ILyELLtG~-~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
++|||++|. +||......+.+. .+.... ..+.+..+++++.+||.+||..+|.+|||+.++++
T Consensus 231 vl~ell~~~~~p~~~~~~~e~~~---~v~~~~--~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 231 VLWEIFSYGLQPYYGMAHEEVIY---YVRDGN--ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHH---HHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHccCCCCCCCCCHHHHHH---HHHcCC--CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999985 6787666554332 122221 22334579999999999999999999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=393.91 Aligned_cols=256 Identities=21% Similarity=0.326 Sum_probs=199.3
Q ss_pred ccceeEEEEecccCceEEEEEEEcc-C--CeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLV-E--HRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI 478 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~-~--g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~ 478 (683)
.++|.+++.||+|+||+||+|.... + ...||||++..... ......+.+.+|+.+++.++|||||++|++|.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~----~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~- 81 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL----SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL- 81 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-
Confidence 4569999999999999999997543 3 34789998754432 12234567899999999999999999999985
Q ss_pred CCceEEEEEecccCCChhHHHh-cCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCc
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLK-ATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLS 557 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~-~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls 557 (683)
+ +.+++|||||++++|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred e-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhh
Confidence 3 46789999999999998874 4456999999999999999999999955 999999999999999999999999999
Q ss_pred cccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHHHh
Q 005678 558 KIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTIIKA 636 (683)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~~~ 636 (683)
+.+...... ........|++.|+|||++.... ++.++|||||||++|||++ |.+||......+.+.. +..
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~----i~~ 229 (273)
T d1u46a_ 159 RALPQNDDH--YVMQEHRKVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK----IDK 229 (273)
T ss_dssp EECCC-CCE--EEC-----CCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHT
T ss_pred hhcccCCCc--ceecCccccCcccCCHHHHhCCC---CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHH----HHh
Confidence 987554221 12334457889999999997554 8999999999999999997 8999987666553321 223
Q ss_pred hccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 637 RKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 637 ~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
....++.++.+|+++.+||.+||..||.+|||+.+|++
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33455566789999999999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=391.46 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=200.2
Q ss_pred ccccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccc
Q 005678 398 FQILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFE 477 (683)
Q Consensus 398 ~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~ 477 (683)
|.+.-++|.+++.||+|+||.||+|.+ .|..||||++.... ..+.+.+|+.++++++|||||+++++|.
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~---------~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 70 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---------TAQAFLAEASVMTQLRHSNLVQLLGVIV 70 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH---------HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 566677899999999999999999975 58899999985432 1346789999999999999999999885
Q ss_pred cCCceEEEEEecccCCChhHHHhcC--CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecC
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT--PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFG 555 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~--~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFG 555 (683)
.+.+.+|+||||+++|+|.++|... ..+++..++.|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||
T Consensus 71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg 148 (262)
T d1byga_ 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFG 148 (262)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred ecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccc
Confidence 4566789999999999999999543 35899999999999999999999955 9999999999999999999999999
Q ss_pred CccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHH
Q 005678 556 LSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLF-GRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 556 ls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~e~il~~~~i~ 634 (683)
+++..... .....||+.|+|||++.... ++.++|||||||++|||++ |++||......+.+. .+.
T Consensus 149 ~s~~~~~~--------~~~~~~~~~y~aPE~l~~~~---~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~---~i~ 214 (262)
T d1byga_ 149 LTKEASST--------QDTGKLPVKWTAPEALREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVE 214 (262)
T ss_dssp C--------------------CCTTTSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH---HHT
T ss_pred cceecCCC--------CccccccccCCChHHHhCCC---CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH---HHH
Confidence 99865432 22346899999999987544 8999999999999999998 788887765544322 122
Q ss_pred HhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 635 KARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 635 ~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.. ...+.++.+++++.+||.+||..||.+|||+.+++++
T Consensus 215 ~~--~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 215 KG--YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC--CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22 2333445789999999999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=405.27 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=198.1
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeecccccc---
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEI--- 478 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~--- 478 (683)
-++|.+++.||+|+||+||+|.+..+|..||||++...... ......+.+|+.+++.++|||||+++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-----QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-----HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 36899999999999999999999999999999998654321 2235678899999999999999999999853
Q ss_pred --CCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCC
Q 005678 479 --DQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGL 556 (683)
Q Consensus 479 --d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGl 556 (683)
+...+|+|||||.++.+. .+. ..+++..++.++.||+.||.|||+.| |+||||||.|||++.++.+||+|||+
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~-~~~--~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHH-HHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred cccCceeEEEEeccchHHHH-hhh--cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhh
Confidence 346899999999665444 443 35899999999999999999999966 99999999999999999999999999
Q ss_pred ccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHH-
Q 005678 557 SKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIK- 635 (683)
Q Consensus 557 s~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~- 635 (683)
++...... ......||+.|+|||++.... +++++||||+||++|+|++|+.||.................
T Consensus 166 ~~~~~~~~------~~~~~~~t~~y~aPE~l~~~~---~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 166 ARTAGTSF------MMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_dssp ---------------------CCTTCCHHHHTTCC---CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred hhcccccc------ccccccccccccChhhhcCCC---CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence 88765432 123447999999999987543 89999999999999999999999976655443321110000
Q ss_pred -----------------hhccCC--------------CC----CcCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 005678 636 -----------------ARKVEF--------------PS----RPAVSNEAKDLIRRCLTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 636 -----------------~~~~~~--------------p~----~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~hP~l~~ 680 (683)
.....+ +. ...+++++.+||.+||.+||++|||+.++|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000000 00 0124678999999999999999999999999999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=393.01 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=209.3
Q ss_pred ccccccccceeEEEEecccCceEEEEEEEccCC-------eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCC
Q 005678 396 NNFQILNHRYALLNLLGKGGFSEVYKAYDLVEH-------RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHH 467 (683)
Q Consensus 396 ~~~~i~~~ry~l~~~LGkGgfG~Vyka~d~~~g-------~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~Hp 467 (683)
.+|.+..++|.+.+.||+|+||.||+|.+..++ ..||||++..... ......+.+|+.++.++ +||
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT------EKDLSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC------HHHHHHHHHHHHHHHHHCCCT
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC------hHHHHHHHHHHHHHHHhcCCC
Confidence 457888999999999999999999999875543 5799999865422 12346788899999888 799
Q ss_pred ceeeeccccccCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCce
Q 005678 468 HIVRLWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKI 531 (683)
Q Consensus 468 nIV~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~I 531 (683)
|||+++++|. +.+.+++|||||++|+|.++|... ..+++..+..++.||+.||.|||+.+ |
T Consensus 80 nIv~~~~~~~-~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--i 156 (299)
T d1fgka_ 80 NIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--C 156 (299)
T ss_dssp TBCCEEEEEC-SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred eEEecccccc-cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--E
Confidence 9999999996 677899999999999999999544 35899999999999999999999965 9
Q ss_pred EecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHH
Q 005678 532 IHYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQM 611 (683)
Q Consensus 532 IHrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyEL 611 (683)
|||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.... |+.++|||||||++|||
T Consensus 157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~---y~~k~DiwS~Gvvl~el 230 (299)
T d1fgka_ 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRI---YTHQSDVWSFGVLLWEI 230 (299)
T ss_dssp CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTT---CCCTTSCCGGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHH
T ss_pred EeeeecccceeecCCCCeEeccchhhccccccccc---cccccCCCChhhhhhhHhcCCC---CCchhhhHHhHHHHHHh
Confidence 99999999999999999999999999987654322 1233457999999999987544 99999999999999999
Q ss_pred Hc-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 612 LF-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 612 Lt-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
++ |.+||......... . .+. ....++.+..+++++.+||.+||.+||.+|||+.++++
T Consensus 231 l~~g~~p~~~~~~~~~~-~--~i~--~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 231 FTLGGSPYPGVPVEELF-K--LLK--EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HTTSCCSSTTCCHHHHH-H--HHH--TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCCCCCHHHHH-H--HHH--cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 98 78899766654322 1 222 23344455679999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=393.09 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=203.3
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeE--EEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCceeeeccccc
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRY--VACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIVRLWDTFE 477 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~--VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV~L~~~f~ 477 (683)
..++|.+.+.||+|+||+||+|.+..++.. ||||.+..... ....+.+.+|+.+++.+ +|||||+++++|.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------KDDHRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC------hHHHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 347899999999999999999999888875 66676532211 11245789999999999 7999999999986
Q ss_pred cCCceEEEEEecccCCChhHHHhcC----------------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcce
Q 005678 478 IDQNTFCTVLEYCSGKDLDAVLKAT----------------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNV 541 (683)
Q Consensus 478 ~d~~~~~LV~Ey~~ggsL~~~L~~~----------------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NI 541 (683)
+.+.+++|||||+||+|.++|... ..+++..+..++.||+.||.|||+.+ ||||||||+||
T Consensus 82 -~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NI 158 (309)
T d1fvra_ 82 -HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 158 (309)
T ss_dssp -ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred -cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceE
Confidence 678899999999999999999643 56899999999999999999999965 99999999999
Q ss_pred EeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCC-CCCCC
Q 005678 542 LFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGR-RPFGH 620 (683)
Q Consensus 542 LLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~-~PF~~ 620 (683)
|++.++.+||+|||+++....... .....||+.|+|||++.... |+.++|||||||++|||++|. +||..
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~~------~~~~~gt~~y~aPE~l~~~~---~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYVK------KTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEECC------C----CCTTTCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcCCCceEEcccccccccccccc------ccceecCCcccchHHhccCC---CCccceeehhHHHHHHHHhcCCCCCCC
Confidence 999999999999999986543321 22347999999999997554 899999999999999999975 56765
Q ss_pred CchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 621 ~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
....+ ++. .+.. ...++.+..+++++.+||.+||..||++|||+.+++++
T Consensus 230 ~~~~~-~~~--~i~~--~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 230 MTCAE-LYE--KLPQ--GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCHHH-HHH--HGGG--TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHH-HHH--HHHh--cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 54433 221 1222 23344456799999999999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=391.27 Aligned_cols=259 Identities=22% Similarity=0.352 Sum_probs=212.0
Q ss_pred cccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhc-CCCcee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTL-VHHHIV 470 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L-~HpnIV 470 (683)
+|++..++|.+.+.||+|+||.||+|... .+++.||||++..... ......+.+|+.+++.+ +|||||
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~E~~~~~~l~~HpnIv 90 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH------LTEREALMSELKVLSYLGNHMNIV 90 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC------HHHHHHHHHHHHHHHhccCCCCEE
Confidence 57788899999999999999999999753 5678999999865432 12245788999999999 699999
Q ss_pred eeccccccCCceEEEEEecccCCChhHHHhcCC------------------CcchHHHHHHHHHHHHHHHHHHhcCCceE
Q 005678 471 RLWDTFEIDQNTFCTVLEYCSGKDLDAVLKATP------------------VLPEREARIIIVQIFQGLIYLNKRAQKII 532 (683)
Q Consensus 471 ~L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~------------------~Lse~~~~~I~~qIa~aL~yLH~~g~~II 532 (683)
+++++|. +.+.+++|||||++|+|.+++.... .+++..+..|+.||+.||.|||+.+ ||
T Consensus 91 ~~~g~~~-~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--iv 167 (311)
T d1t46a_ 91 NLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CI 167 (311)
T ss_dssp CEEEEEC-SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred EEEEEEe-eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 9999996 6778999999999999999996432 5899999999999999999999965 99
Q ss_pred ecccCCcceEeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHH
Q 005678 533 HYDLKPGNVLFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQML 612 (683)
Q Consensus 533 HrDLKP~NILLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELL 612 (683)
||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.... ++.++|||||||++|||+
T Consensus 168 HrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~~DIwS~G~~l~ell 241 (311)
T d1t46a_ 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCV---YTFESDVWSYGIFLWELF 241 (311)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHH
T ss_pred ecccccccccccccCcccccccchheeccCCCcc---eEeeecccChHHcCHHHhcCCC---CCCcccccchHHHHHHHH
Confidence 9999999999999999999999999877543221 2234457999999999987544 899999999999999999
Q ss_pred c-CCCCCCCCchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 005678 613 F-GRRPFGHDQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ 674 (683)
Q Consensus 613 t-G~~PF~~~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~ 674 (683)
| |.+||......+.+.. .+. .....+.+..+|.++.+||.+||.+||.+|||+.+|++
T Consensus 242 t~g~p~~~~~~~~~~~~~--~i~--~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 242 SLGSSPYPGMPVDSKFYK--MIK--EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TTTCCSSTTCCSSHHHHH--HHH--HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHH--HHh--cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8 5666655544443322 111 22333444578999999999999999999999999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=390.66 Aligned_cols=263 Identities=21% Similarity=0.338 Sum_probs=214.5
Q ss_pred cccccccceeEEEEecccCceEEEEEEEc-----cCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceee
Q 005678 397 NFQILNHRYALLNLLGKGGFSEVYKAYDL-----VEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVR 471 (683)
Q Consensus 397 ~~~i~~~ry~l~~~LGkGgfG~Vyka~d~-----~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~ 471 (683)
.|++..++|.+.+.||+|+||+||+|.+. .++..||||++..... . .....+.+|+.++++++|||||+
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~----~~~~~~~~E~~il~~l~h~nIv~ 87 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--M----RERIEFLNEASVMKEFNCHHVVR 87 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--H----HHHHHHHHHHHHGGGCCCTTBCC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--h----HHHHHHHHHHHHHHHcCCCCEee
Confidence 57788899999999999999999999864 2467899999854321 1 12356889999999999999999
Q ss_pred eccccccCCceEEEEEecccCCChhHHHhcC----------CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcce
Q 005678 472 LWDTFEIDQNTFCTVLEYCSGKDLDAVLKAT----------PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNV 541 (683)
Q Consensus 472 L~~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~----------~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NI 541 (683)
++++|. ..+.+++|||||++|+|.+++... ..+++..+..|+.+++.||.|||+.+ ||||||||+||
T Consensus 88 ~~~~~~-~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~Ni 164 (308)
T d1p4oa_ 88 LLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNC 164 (308)
T ss_dssp EEEEEC-SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGE
T ss_pred eeeEEe-cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCce
Confidence 999986 667889999999999999998432 24688999999999999999999965 99999999999
Q ss_pred EeCCCCcEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCC-CCCCC
Q 005678 542 LFDEFGVAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGR-RPFGH 620 (683)
Q Consensus 542 LLd~~g~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~-~PF~~ 620 (683)
||+.++.+||+|||+++.+..... ........||+.|+|||++.... ++.++|||||||++|||++|. +||..
T Consensus 165 Lld~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~~t~~y~aPe~l~~~~---~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 165 MVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGC---EEGGGSSEECGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred eecCCceEEEeecccceeccCCcc---eeeccceecccccCCHHHHccCC---CCcccccccHHHHHHHHHhCCCCCCCC
Confidence 999999999999999987754322 12234457999999999987554 899999999999999999984 77766
Q ss_pred CchHHHHHHHHHHHHhhccCCCCCcCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CcccC
Q 005678 621 DQTQERILREDTIIKARKVEFPSRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQ------DPYLT 679 (683)
Q Consensus 621 ~~~~e~il~~~~i~~~~~~~~p~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~------hP~l~ 679 (683)
....+.+ . .+... ...+.++.+++.+.+||.+||..+|.+|||+.++++ +|+|+
T Consensus 239 ~~~~~~~-~--~i~~~--~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 239 LSNEQVL-R--FVMEG--GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp SCHHHHH-H--HHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred CCHHHHH-H--HHHhC--CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 5554432 2 12222 233444679999999999999999999999999987 67764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=390.07 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=201.8
Q ss_pred EEEEecccCceEEEEEEEccCC---eEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCCceE
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEH---RYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQNTF 483 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g---~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~~~~ 483 (683)
+.++||+|+||+||+|.+..++ ..||||.+.... .......+.+|+.++++++|||||++++++....+.+
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc------CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence 3678999999999999876543 469999885322 1223577999999999999999999999886567789
Q ss_pred EEEEecccCCChhHHHhc-CCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEecCCcccccc
Q 005678 484 CTVLEYCSGKDLDAVLKA-TPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTDFGLSKIVED 562 (683)
Q Consensus 484 ~LV~Ey~~ggsL~~~L~~-~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~DFGls~~~~~ 562 (683)
++|||||++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999999999864 456788889999999999999999965 99999999999999999999999999998765
Q ss_pred CcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHHHhhccCCC
Q 005678 563 DVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTIIKARKVEFP 642 (683)
Q Consensus 563 ~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~~~~~~~~p 642 (683)
..... ........||+.|+|||.+.... ++.++||||||+++|||++|..||........+.. .+.... ..+
T Consensus 183 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~--~i~~g~--~~~ 254 (311)
T d1r0pa_ 183 KEFDS-VHNKTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV--YLLQGR--RLL 254 (311)
T ss_dssp TTCCC-TTCTTCSSCCGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSCCSCC------CHH--HHHTTC--CCC
T ss_pred ccccc-ceecccccccccccChHHHhcCC---CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH--HHHcCC--CCC
Confidence 43222 12233457999999999987554 89999999999999999998888866544333322 222222 333
Q ss_pred CCcCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 643 SRPAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 643 ~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
.++.+++++.+||.+||..||.+||++.+++++
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 445789999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-45 Score=381.70 Aligned_cols=262 Identities=20% Similarity=0.268 Sum_probs=202.5
Q ss_pred cccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC
Q 005678 401 LNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ 480 (683)
Q Consensus 401 ~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~ 480 (683)
++++|.+++.||+|+||+||+|.+..+|+.||||++...... ..+.+|+.+++.+.|+|++.++..+..+.
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---------PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---------CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---------HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 467899999999999999999999999999999987654321 23567999999999888777666665678
Q ss_pred ceEEEEEecccCCChhHHH-hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC---CCcEEEEecCC
Q 005678 481 NTFCTVLEYCSGKDLDAVL-KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE---FGVAKVTDFGL 556 (683)
Q Consensus 481 ~~~~LV~Ey~~ggsL~~~L-~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~---~g~vKL~DFGl 556 (683)
+.+++||||| +++|...+ .....+++..+..++.|++.||.|||+.+ ||||||||+|||++. ++.+||+|||+
T Consensus 76 ~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 76 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred CEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCc
Confidence 8999999999 55666655 45567999999999999999999999965 999999999999863 55799999999
Q ss_pred ccccccCcCCCc--ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHH
Q 005678 557 SKIVEDDVGSQG--MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILREDTII 634 (683)
Q Consensus 557 s~~~~~~~~~~~--~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~~~i~ 634 (683)
|+.+........ ........||+.|+|||++.... ++.++|||||||++|||++|..||................
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~ 229 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE---QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC---CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCC---CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence 998765432211 12234558999999999987544 8999999999999999999999997765544332211111
Q ss_pred HhhccCCC---CCcCCCHHHHHHHHHhcccCCCCCCCHHH---HhcCccc
Q 005678 635 KARKVEFP---SRPAVSNEAKDLIRRCLTYNQAERPDVLT---LAQDPYL 678 (683)
Q Consensus 635 ~~~~~~~p---~~~~~s~el~dLI~rCL~~dP~kRPS~~e---Ll~hP~l 678 (683)
......+ ..+.+|+++.+||.+||..+|.+||++.+ +++|+|.
T Consensus 230 -~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 230 -EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 1111111 12468999999999999999999999864 4677764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-45 Score=381.03 Aligned_cols=262 Identities=20% Similarity=0.275 Sum_probs=193.8
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCceeeeccccccCC-
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHIVRLWDTFEIDQ- 480 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnIV~L~~~f~~d~- 480 (683)
...|.+.+.||+|+||.||+|. .+|..||||++.... ... .....|+..+..++|||||++++++..+.
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~--~~g~~vAvK~~~~~~------~~~--~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSRE------ERS--WFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEE--ETTEEEEEEEECGGG------HHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEE--ECCEEEEEEEECccc------hhH--HHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence 4578999999999999999996 478999999884321 111 11224566667889999999999986433
Q ss_pred --ceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhc------CCceEecccCCcceEeCCCCcEEEE
Q 005678 481 --NTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKR------AQKIIHYDLKPGNVLFDEFGVAKVT 552 (683)
Q Consensus 481 --~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~------g~~IIHrDLKP~NILLd~~g~vKL~ 552 (683)
..+|+|||||++|+|..+|... .+++..+..++.+++.||.|||.. .++||||||||+||||+.+|.+||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred cceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 3689999999999999999876 499999999999999999999974 2479999999999999999999999
Q ss_pred ecCCccccccCcCCCcccccccCCCCCccCCcccccccCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHH---
Q 005678 553 DFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKT---PLISSKVDVWSAGILFYQMLFGRRPFGHDQTQER--- 626 (683)
Q Consensus 553 DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~---~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~--- 626 (683)
|||+++.......... .......||+.|+|||++..... ..++.++|||||||+||||+||..||........
T Consensus 151 DFGl~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 151 DLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCTTCEEEETTTTEEC-C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred ecCccccccCCCccee-ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 9999998765432211 12334589999999999864321 1267799999999999999999988743221100
Q ss_pred --------HHHHHHHHHhhcc--CCCCC---cCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 005678 627 --------ILREDTIIKARKV--EFPSR---PAVSNEAKDLIRRCLTYNQAERPDVLTLAQD 675 (683)
Q Consensus 627 --------il~~~~i~~~~~~--~~p~~---~~~s~el~dLI~rCL~~dP~kRPS~~eLl~h 675 (683)
............. .+|.. ...+..+.+||.+||.+||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0000111111111 11211 1233568999999999999999999999763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.3e-44 Score=372.39 Aligned_cols=258 Identities=18% Similarity=0.238 Sum_probs=202.6
Q ss_pred ccccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCC-Cceeeecccccc
Q 005678 400 ILNHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVH-HHIVRLWDTFEI 478 (683)
Q Consensus 400 i~~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~H-pnIV~L~~~f~~ 478 (683)
+++++|.+++.||+|+||+||+|.+..+|+.||||++...... ..+.+|+.+++.+.| +||+.+++++.
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---------~~~~~e~~~~~~l~~~~~i~~~~~~~~- 71 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---------PQLRDEYRTYKLLAGCTGIPNVYYFGQ- 71 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---------CCHHHHHHHHHHTTTCTTCCCEEEEEE-
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---------HHHHHHHHHHHHhcCCCCCCEEEEEee-
Confidence 5788999999999999999999999999999999987543221 235678888888875 89999998886
Q ss_pred CCceEEEEEecccCCChhHHHhcC-CCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCC-----CCcEEEE
Q 005678 479 DQNTFCTVLEYCSGKDLDAVLKAT-PVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDE-----FGVAKVT 552 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL~~~L~~~-~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~-----~g~vKL~ 552 (683)
+....++||||| +++|.+++... ..+++..+..++.|++.||.|||+.+ ||||||||+|||++. ++.+||+
T Consensus 72 ~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 72 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred cCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEc
Confidence 678899999999 78999998654 57999999999999999999999965 999999999999974 5789999
Q ss_pred ecCCccccccCcCCCc--ccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Q 005678 553 DFGLSKIVEDDVGSQG--MELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGHDQTQERILRE 630 (683)
Q Consensus 553 DFGls~~~~~~~~~~~--~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~e~il~~ 630 (683)
|||+|+.+........ ........||+.|||||++.... ++.++|||||||++|+|++|..||............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~---~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~ 225 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE---QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC---CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC---CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH
Confidence 9999998765432221 12233457999999999987543 899999999999999999999999754332211111
Q ss_pred HHHHHhhccCCC--CCcCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 005678 631 DTIIKARKVEFP--SRPAVSNEAKDLIRRCLTYNQAERPDVLTLA 673 (683)
Q Consensus 631 ~~i~~~~~~~~p--~~~~~s~el~dLI~rCL~~dP~kRPS~~eLl 673 (683)
..+........+ ..+.+|+++.+|+..|+..+|.+||++..+.
T Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 226 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 111111111100 1246889999999999999999999977664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-42 Score=366.29 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=192.7
Q ss_pred ccceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-----------CCcee
Q 005678 402 NHRYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-----------HHHIV 470 (683)
Q Consensus 402 ~~ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-----------HpnIV 470 (683)
+.||.+++.||+|+||+||+|.+..+|+.||||++.... .....+.+|+.+++.+. |||||
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 457999999999999999999999999999999986431 12345667888887775 57899
Q ss_pred eecccccc-CCceEEEEEecccCCChhHHH---hcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCC
Q 005678 471 RLWDTFEI-DQNTFCTVLEYCSGKDLDAVL---KATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEF 546 (683)
Q Consensus 471 ~L~~~f~~-d~~~~~LV~Ey~~ggsL~~~L---~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~ 546 (683)
++++++.. .....+++|.++.++...... .....+++..++.++.||+.||.|||+. .+|+||||||+||||+.+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHeeeecc
Confidence 99988854 345666777776655433332 3446789999999999999999999972 359999999999999865
Q ss_pred C------cEEEEecCCccccccCcCCCcccccccCCCCCccCCcccccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005678 547 G------VAKVTDFGLSKIVEDDVGSQGMELTSQGAGTYWYLPPECFELSKTPLISSKVDVWSAGILFYQMLFGRRPFGH 620 (683)
Q Consensus 547 g------~vKL~DFGls~~~~~~~~~~~~~l~~~~~GT~~Y~APE~~~~~~~~~~s~ksDVWSLGvILyELLtG~~PF~~ 620 (683)
+ .++|+|||.+...... ....+||+.|+|||.+.... |+.++||||+||++++|++|+.||..
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAP---WGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCC---CCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CcccccceeeEeecccccccccc--------cccccccccccChhhccccC---CCccccccchHHHHHHHHHCCCCCCC
Confidence 4 4999999999765432 23347999999999987544 89999999999999999999999964
Q ss_pred CchHHH------HHHHHHHH--------Hh----------h------------------ccCCCCCcCCCHHHHHHHHHh
Q 005678 621 DQTQER------ILREDTII--------KA----------R------------------KVEFPSRPAVSNEAKDLIRRC 658 (683)
Q Consensus 621 ~~~~e~------il~~~~i~--------~~----------~------------------~~~~p~~~~~s~el~dLI~rC 658 (683)
...... +.....+. .. . ...+......++++.+||.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m 311 (362)
T d1q8ya_ 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311 (362)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHH
Confidence 432111 11000000 00 0 000111234567899999999
Q ss_pred cccCCCCCCCHHHHhcCcccCC
Q 005678 659 LTYNQAERPDVLTLAQDPYLTY 680 (683)
Q Consensus 659 L~~dP~kRPS~~eLl~hP~l~~ 680 (683)
|.+||.+|||+.++|+||||+.
T Consensus 312 L~~dP~~Rpta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 312 LQLDPRKRADAGGLVNHPWLKD 333 (362)
T ss_dssp GCSSTTTCBCHHHHHTCGGGTT
T ss_pred CCCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999984
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=2.9e-24 Score=208.58 Aligned_cols=141 Identities=22% Similarity=0.234 Sum_probs=109.0
Q ss_pred eeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccch-----------hhHHHHHHHHHHHHHHHhhcCCCceeeec
Q 005678 405 YALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSE-----------DKKQSYIRHAIREYNIHKTLVHHHIVRLW 473 (683)
Q Consensus 405 y~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~-----------~~~~~~i~~~~rEi~il~~L~HpnIV~L~ 473 (683)
+.+.+.||+|+||+||+|.+ .+|+.||||++........ .........+.+|+.++.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46889999999999999987 5789999999765432110 01112234556789999999999999888
Q ss_pred cccccCCceEEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHhcCCceEecccCCcceEeCCCCcEEEEe
Q 005678 474 DTFEIDQNTFCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNKRAQKIIHYDLKPGNVLFDEFGVAKVTD 553 (683)
Q Consensus 474 ~~f~~d~~~~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~~g~~IIHrDLKP~NILLd~~g~vKL~D 553 (683)
++.. .++||||+++..+.. ++...+..++.|++.+|.|||..+ |+||||||+|||++++ .++|+|
T Consensus 81 ~~~~-----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 81 AWEG-----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EEET-----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECC
T ss_pred EecC-----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEE
Confidence 6532 269999998765533 456667789999999999999965 9999999999999974 589999
Q ss_pred cCCccccc
Q 005678 554 FGLSKIVE 561 (683)
Q Consensus 554 FGls~~~~ 561 (683)
||+|....
T Consensus 146 FG~a~~~~ 153 (191)
T d1zara2 146 FPQSVEVG 153 (191)
T ss_dssp CTTCEETT
T ss_pred CCCcccCC
Confidence 99997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.26 E-value=1.9e-06 Score=84.55 Aligned_cols=140 Identities=14% Similarity=0.088 Sum_probs=86.2
Q ss_pred ceeEEEEecccCceEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcC-CCceeeeccccccCCce
Q 005678 404 RYALLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLV-HHHIVRLWDTFEIDQNT 482 (683)
Q Consensus 404 ry~l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~-HpnIV~L~~~f~~d~~~ 482 (683)
.|.+.+..+-|+.+.||+.. .++..+.+|+......... ..+.+|..++..+. +--+.+++.++. +++.
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~-------~~~~~E~~~l~~l~~~vpvP~vl~~~~-~~~~ 84 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTT-------YDVEREKDMMLWLEGKLPVPKVLHFER-HDGW 84 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTST-------TCHHHHHHHHHHHTTTSCCCCEEEEEE-ETTE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccch-------hhHHHHHHHHHHHhccCCCCcEEEEEe-cCCc
Confidence 45656654444457899884 4556677887643322111 13456777766663 322444554443 5677
Q ss_pred EEEEEecccCCChhHHHhcCCCcchHHHHHHHHHHHHHHHHHHh------------------------------------
Q 005678 483 FCTVLEYCSGKDLDAVLKATPVLPEREARIIIVQIFQGLIYLNK------------------------------------ 526 (683)
Q Consensus 483 ~~LV~Ey~~ggsL~~~L~~~~~Lse~~~~~I~~qIa~aL~yLH~------------------------------------ 526 (683)
.++||++++|.++....... .....++.+++..+..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 88999999998876554221 1122234444444555553
Q ss_pred -----------------c----CCceEecccCCcceEeCCCCcEEEEecCCcc
Q 005678 527 -----------------R----AQKIIHYDLKPGNVLFDEFGVAKVTDFGLSK 558 (683)
Q Consensus 527 -----------------~----g~~IIHrDLKP~NILLd~~g~vKL~DFGls~ 558 (683)
. ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 1138999999999999987667799999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.97 E-value=5e-06 Score=87.74 Aligned_cols=81 Identities=23% Similarity=0.236 Sum_probs=47.4
Q ss_pred EEEEecccCceEEEEEEEccCCeEEEEEEeccCc-----ccchhhHHHHHHHHHHHHHHHhhcC-C-C-ceeeecccccc
Q 005678 407 LLNLLGKGGFSEVYKAYDLVEHRYVACKLHGLNA-----QWSEDKKQSYIRHAIREYNIHKTLV-H-H-HIVRLWDTFEI 478 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~~g~~VAVKi~~~~~-----~~~~~~~~~~i~~~~rEi~il~~L~-H-p-nIV~L~~~f~~ 478 (683)
..+.||.|....||++.+..+++.|+||.-.... .|... +.....|+..+..+. + | .++++|. +
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~-----~~R~~~E~~~L~~~~~~~p~~vP~v~~-~-- 101 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLT-----IDRARIESSALIRQGEHVPHLVPRVFY-S-- 101 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCC-----TTHHHHHHHHHHHHHTTCGGGSCCEEE-E--
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCC-----HHHHHHHHHHHHHhhhhCCCCcceEEE-E--
Confidence 3567899999999999877778899999643211 11111 123345777776652 2 3 3444543 3
Q ss_pred CCceEEEEEecccCCCh
Q 005678 479 DQNTFCTVLEYCSGKDL 495 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL 495 (683)
+....++|||++++..+
T Consensus 102 d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp ETTTTEEEECCCTTSEE
T ss_pred cCCCCEEEEeccCCccc
Confidence 34456789999977543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.63 E-value=8.4e-05 Score=71.96 Aligned_cols=75 Identities=15% Similarity=0.007 Sum_probs=46.2
Q ss_pred EecccCc-eEEEEEEEccCCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCC--ceeeeccccccCCceEEEE
Q 005678 410 LLGKGGF-SEVYKAYDLVEHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHH--HIVRLWDTFEIDQNTFCTV 486 (683)
Q Consensus 410 ~LGkGgf-G~Vyka~d~~~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~Hp--nIV~L~~~f~~d~~~~~LV 486 (683)
.+..|.. +.||+.. ..++..+.+|+....... .+.+|+..++.+... .+.+++.+.. +.+..++|
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~----------~l~~E~~~l~~L~~~gvpvP~v~~~~~-~~~~~~~v 84 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALN----------ELQDEAARLSWLATTGVPCAAVLDVVT-EAGRDWLL 84 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTS----------CHHHHHHHHHHHHTTTCCBCCEEEEEE-CSSCEEEE
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCHh----------HHHHHHHHHHHHHhcCCCCCceeeecc-cccceEEE
Confidence 4455543 6799886 356667888976433211 234566666655322 2455565543 56778899
Q ss_pred EecccCCChh
Q 005678 487 LEYCSGKDLD 496 (683)
Q Consensus 487 ~Ey~~ggsL~ 496 (683)
|+|++|.++.
T Consensus 85 ~~~i~G~~~~ 94 (255)
T d1nd4a_ 85 LGEVPGQDLL 94 (255)
T ss_dssp EECCSSEETT
T ss_pred EEeeeccccc
Confidence 9999987653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.57 E-value=0.0054 Score=61.85 Aligned_cols=28 Identities=25% Similarity=0.445 Sum_probs=23.5
Q ss_pred ceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
.+||+|+.|.|||+++ + ..++||+-|..
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 5999999999999974 4 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.68 E-value=0.021 Score=58.81 Aligned_cols=75 Identities=19% Similarity=0.209 Sum_probs=47.4
Q ss_pred EEEEecccCceEEEEEEEcc-------CCeEEEEEEeccCcccchhhHHHHHHHHHHHHHHHhhcCCCce-eeecccccc
Q 005678 407 LLNLLGKGGFSEVYKAYDLV-------EHRYVACKLHGLNAQWSEDKKQSYIRHAIREYNIHKTLVHHHI-VRLWDTFEI 478 (683)
Q Consensus 407 l~~~LGkGgfG~Vyka~d~~-------~g~~VAVKi~~~~~~~~~~~~~~~i~~~~rEi~il~~L~HpnI-V~L~~~f~~ 478 (683)
.++.|+-|-.=.+|++.... ....|.+++.... . .. -...+|..+++.+.-.+| .+++++|.
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~-------idr~~E~~i~~~ls~~gl~Pkll~~~~- 115 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TE-------SHLVAESVIFTLLSERHLGPKLYGIFS- 115 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CH-------HHHHHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hh-------hHHHHHHHHHHHHHhCCCCCeEEEEcC-
Confidence 35678777778899987542 3467888887532 1 11 123467788887753344 45666553
Q ss_pred CCceEEEEEecccCCCh
Q 005678 479 DQNTFCTVLEYCSGKDL 495 (683)
Q Consensus 479 d~~~~~LV~Ey~~ggsL 495 (683)
+ .+|+||++|..|
T Consensus 116 -~---g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 -G---GRLEEYIPSRPL 128 (395)
T ss_dssp -T---EEEECCCCEEEC
T ss_pred -C---ceEEEEeccccC
Confidence 2 478999988554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.15 E-value=0.049 Score=53.71 Aligned_cols=30 Identities=30% Similarity=0.328 Sum_probs=26.9
Q ss_pred ceEecccCCcceEeCCCCcEEEEecCCccc
Q 005678 530 KIIHYDLKPGNVLFDEFGVAKVTDFGLSKI 559 (683)
Q Consensus 530 ~IIHrDLKP~NILLd~~g~vKL~DFGls~~ 559 (683)
++||+|+.++||+++.+...-|+||+.|..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 599999999999999887788999998853
|